PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Giladi, M; Hiller, R; Hirsch, JA; Khananshvili, D				Giladi, Moshe; Hiller, Reuben; Hirsch, Joel A.; Khananshvili, Daniel			Population Shift Underlies Ca2+-induced Regulatory Transitions in the Sodium-Calcium Exchanger (NCX)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2ND CA2+-BINDING DOMAIN; SMALL-ANGLE SCATTERING; CA2+ BINDING DOMAINS; NA+-CA2+ EXCHANGER; NA+/CA2+ EXCHANGER; SENSOR; FEATURES; VIEW	In eukaryotic Na+/Ca2+ exchangers (NCX) the Ca2+ binding CBD1 and CBD2 domains form a two-domain regulatory tandem (CBD12). An allosteric Ca2+ sensor (Ca3-Ca4 sites) is located on CBD1, whereas CBD2 contains a splice-variant segment. Recently, a Ca2+-driven interdomain switch has been described, albeit how it couples Ca2+ binding with signal propagation remains unclear. To resolve the dynamic features of Ca2+-induced conformational transitions we analyze here distinct splice variants and mutants of isolated CBD12 at varying temperatures by using small angle x-ray scattering (SAXS) and equilibrium Ca-45(2+) binding assays. The ensemble optimization method SAXS analysis demonstrates that the apo and Mg2+-bound forms of CBD12 are highly flexible, whereas Ca2+ binding to the Ca3-Ca4 sites results in a population shift of conformational landscape to more rigidified states. Population shift occurs even under conditions in which no effect of Ca2+ is observed on the globally derived D-max (maximal interatomic distance), although under comparable conditions a normal [Ca2+]-dependent allosteric regulation occurs. Low affinity sites (Ca1-Ca2) of CBD1 do not contribute to Ca2+-induced population shift, but the occupancy of these sites by 1 mM Mg2+ shifts the Ca2+ affinity (K-d) at the neighboring Ca3-Ca4 sites from similar to 50 nM to similar to 200 nM and thus, keeps the primary Ca2+ sensor (Ca3-Ca4 sites) within a physiological range. Thus, Ca2+ binding to the Ca3-Ca4 sites results in a population shift, where more constraint conformational states become highly populated at dynamic equilibrium in the absence of global conformational transitions in CBD alignment.	[Giladi, Moshe; Hiller, Reuben; Khananshvili, Daniel] Tel Aviv Univ, Dept Physiol & Pharmacol, Sackler Sch Med, IL-69978 Ramat Aviv, Israel; [Hirsch, Joel A.] Tel Aviv Univ, Dept Biochem & Mol Biol, Fac Life Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Hirsch, JA (corresponding author), Tel Aviv Univ, Dept Biochem & Mol Biol, Fac Life Sci, IL-69978 Tel Aviv, Israel.	jhirsch@post.tau.ac.il; dhanan@post.tau.ac.il	Hirsch, Joel/AAC-8000-2021	Hirsch, Joel/0000-0001-7544-8668; Khananshvili, Daniel/0000-0002-4202-9966; Giladi, Moshe/0000-0002-8589-6920	Israeli Ministry of Health [2010-3-6266]; United States-Israel Binational Foundation [2009-334]; Israel Science Foundation [23/10]; Deutsch-Israelische Projecktkooperation-Deutsche Forschungsgemeinschaft; Bernstein Foundation; Clore Israel Foundation	Israeli Ministry of Health; United States-Israel Binational Foundation; Israel Science Foundation(Israel Science Foundation); Deutsch-Israelische Projecktkooperation-Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bernstein Foundation; Clore Israel Foundation	This work was partially funded by Israeli Ministry of Health Grant 2010-3-6266, United States-Israel Binational Foundation Research Grant 2009-334, Israel Science Foundation Grant 23/10 (to D. K.), a Deutsch-Israelische Projecktkooperation-Deutsche Forschungsgemeinschaft grant (to J. A. H.), and the Bernstein Foundation.; Supported by a Ph.D. fellowship from the Clore Scholars Program of the Clore Israel Foundation.	Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bernado Pau, 2012, Methods Mol Biol, V896, P107, DOI 10.1007/978-1-4614-3704-8_7; Besserer GM, 2007, P NATL ACAD SCI USA, V104, P18467, DOI 10.1073/pnas.0707417104; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Boyman L, 2011, J BIOL CHEM, V286, P28811, DOI 10.1074/jbc.M110.214106; Boyman L, 2009, J BIOL CHEM, V284, P6185, DOI 10.1074/jbc.M809012200; Breukels V, 2011, BIOCHEMISTRY-US, V50, P8804, DOI 10.1021/bi201134u; Chaptal V, 2009, J BIOL CHEM, V284, P14688, DOI 10.1074/jbc.C900037200; Dyck C, 1999, J GEN PHYSIOL, V114, P701, DOI 10.1085/jgp.114.5.701; Giladi M, 2012, BIOCHEMISTRY-US, V51, P7313, DOI 10.1021/bi300739z; Giladi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039985; Giladi M, 2012, CELL CALCIUM, V51, P478, DOI 10.1016/j.ceca.2012.04.007; Giladi M, 2010, J BIOL CHEM, V285, P28117, DOI 10.1074/jbc.M110.127001; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hilge M, 2009, P NATL ACAD SCI USA, V106, P14333, DOI 10.1073/pnas.0902171106; John SA, 2011, P NATL ACAD SCI USA, V108, P1699, DOI 10.1073/pnas.1016114108; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; KOFUJI P, 1994, J BIOL CHEM, V269, P5145; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; Ottolia M, 2010, CHANNELS, V4, P159, DOI 10.4161/chan.4.3.11386; Ottolia M, 2009, J BIOL CHEM, V284, P32735, DOI 10.1074/jbc.M109.055434; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Salinas RK, 2011, J BIOL CHEM, V286, P32123, DOI 10.1074/jbc.M111.249268; Wu MS, 2011, STRUCTURE, V19, P1509, DOI 10.1016/j.str.2011.07.008; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	30	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23141	23149		10.1074/jbc.M113.471698	http://dx.doi.org/10.1074/jbc.M113.471698			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23798674	Green Published, hybrid			2022-12-25	WOS:000330598200021
J	Parsaud, L; Li, LJ; Jung, CH; Park, S; Saw, NMN; Park, S; Kim, MY; Sugita, S				Parsaud, Leon; Li, Lijun; Jung, Chang Hun; Park, Seungmee; Saw, Ner Mu Nar; Park, Sanghyun; Kim, Moo Yup; Sugita, Shuzo			Calcium-dependent Activator Protein for Secretion 1 (CAPS1) Binds to Syntaxin-1 in a Distinct Mode from Munc13-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSE-CORE VESICLE; PLASMA-MEMBRANE; SNARE COMPLEX; CA2+-DEPENDENT EXOCYTOSIS; SYNAPTIC-TRANSMISSION; NEUROTROPHIN RELEASE; PC12 CELLS; FUSION; MUNC18-1; EXPRESSION	Calcium-dependent activator protein for secretion 1 (CAPS1) is a multidomain protein containing a Munc13 homology domain 1 (MHD1). Although CAPS1 and Munc13-1 play crucial roles in the priming stage of secretion, their functions are non-redundant. Similar to Munc13-1, CAPS1 binds to syntaxin-1, a key t-SNARE protein in neurosecretion. However, whether CAPS1 interacts with syntaxin-1 in a similar mode to Munc13-1 remains unclear. Here, using yeast two-hybrid assays followed by biochemical binding experiments, we show that the region in CAPS1 consisting of the C-terminal half of the MHD1 with the corresponding C-terminal region can bind to syntaxin-1. Importantly, the binding mode of CAPS1 to syntaxin-1 is distinct from that of Munc13-1; CAPS1 binds to the full-length of cytoplasmic syntaxin-1 with preference to its "open" conformation, whereas Munc13-1 binds to the first 80 N-terminal residues of syntaxin-1. Unexpectedly, the majority of the MHD1 of CAPS1 is dispensable, whereas the C-terminal 69 residues are crucial for the binding to syntaxin-1. Functionally, a C-terminal truncation of 69 or 134 residues in CAPS1 abolishes its ability to reconstitute secretion in permeabilized PC12 cells. Our results reveal a novel mode of binding between CAPS1 and syntaxin-1, which play a crucial role in neurosecretion. We suggest that the distinct binding modes between CAPS1 and Munc13-1 can account for their non-redundant functions in neurosecretion. We also propose that the preferential binding of CAPS1 to open syntaxin-1 can contribute to the stabilization of the open state of syntaxin-1 during its transition from "closed" state to the SNARE complex formation.	[Parsaud, Leon; Li, Lijun; Jung, Chang Hun; Park, Seungmee; Saw, Ner Mu Nar; Park, Sanghyun; Kim, Moo Yup; Sugita, Shuzo] Univ Hlth Network, Div Fundamental Neurobiol, Toronto, ON M5T 2S8, Canada; [Parsaud, Leon; Li, Lijun; Jung, Chang Hun; Park, Seungmee; Saw, Ner Mu Nar; Sugita, Shuzo] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Sugita, S (corresponding author), Univ Hlth Network, Toronto Western Res Inst, 399 Bathurst St,MP11-304, Toronto, ON M5T 2S8, Canada.	ssugita@uhnres.utoronto.ca		Sugita, Shuzo/0000-0002-9182-873X	Canada Research Chair program; Heart and Stroke Foundation [NA6217, T6700]; Natural Sciences and Engineering Research Council of Canada [456042]; Canadian Institute of Health Research [MOP-93665]	Canada Research Chair program(Canada Research Chairs); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canada Research Chair program, Heart and Stroke Foundation Grants NA6217 and T6700, Natural Sciences and Engineering Research Council of Canada Grant 456042, and Canadian Institute of Health Research Grant MOP-93665.	Arunachalam L, 2008, MOL BIOL CELL, V19, P722, DOI 10.1091/mbc.E07-07-0662; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Betz A, 1997, J BIOL CHEM, V272, P2520; Boswell KL, 2012, J CELL BIOL, V197, P301, DOI 10.1083/jcb.201109132; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Daily NJ, 2010, J BIOL CHEM, V285, P35320, DOI 10.1074/jbc.M110.145169; Dulubova I, 2003, P NATL ACAD SCI USA, V100, P32, DOI 10.1073/pnas.232701299; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fujita Y, 2007, J BIOL CHEM, V282, P21392, DOI 10.1074/jbc.M703699200; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; Grishanin RN, 2002, J BIOL CHEM, V277, P22025, DOI 10.1074/jbc.M201614200; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Han GYA, 2011, MOL BIOL CELL, V22, P4134, DOI 10.1091/mbc.E11-02-0135; Han GA, 2010, J NEUROCHEM, V115, P1, DOI 10.1111/j.1471-4159.2010.06900.x; Han L, 2009, MOL BIOL CELL, V20, P4962, DOI 10.1091/mbc.E09-08-0712; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; James DJ, 2009, P NATL ACAD SCI USA, V106, P17308, DOI 10.1073/pnas.0900755106; Khodthong C, 2011, CELL METAB, V14, P254, DOI 10.1016/j.cmet.2011.07.002; Li G, 2005, J NEUROSCI, V25, P10188, DOI 10.1523/JNEUROSCI.3560-05.2005; Liu YY, 2008, J NEUROSCI, V28, P5594, DOI 10.1523/JNEUROSCI.5672-07.2008; Liu YY, 2010, J CELL BIOL, V190, P1067, DOI 10.1083/jcb.201001164; Ma C, 2011, NAT STRUCT MOL BIOL, V18, P542, DOI 10.1038/nsmb.2047; Madison JM, 2005, CURR BIOL, V15, P2236, DOI 10.1016/j.cub.2005.10.049; Matos MF, 2003, NEUROPHARMACOLOGY, V45, P777, DOI 10.1016/S0028-3908(03)00318-6; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; Renden R, 2001, NEURON, V31, P421, DOI 10.1016/S0896-6273(01)00382-8; Sadakata T, 2006, J COMP NEUROL, V495, P735, DOI 10.1002/cne.20947; Sadakata T, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-25; Sadakata T, 2007, J NEUROSCI, V27, P2472, DOI 10.1523/JNEUROSCI.2279-06.2007; Sassa T, 1999, J NEUROSCI, V19, P4772; Saw NMN, 2011, MOL BIOL CELL, V22, P3394, DOI 10.1091/mbc.E11-02-0155; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Speidel D, 2005, NEURON, V46, P75, DOI 10.1016/j.neuron.2005.02.019; Speidel D, 2003, J BIOL CHEM, V278, P52802, DOI 10.1074/jbc.M304727200; Speidel D, 2008, CELL METAB, V7, P57, DOI 10.1016/j.cmet.2007.11.009; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Wang L, 2005, J BIOL CHEM, V280, P16522, DOI 10.1074/jbc.M413263200; Wang L, 2004, J BIOL CHEM, V279, P19875, DOI 10.1074/jbc.M400522200	46	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23050	23063		10.1074/jbc.M113.494088	http://dx.doi.org/10.1074/jbc.M113.494088			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23801330	Green Published, hybrid			2022-12-25	WOS:000330598200014
J	Srinivasan, S; Meyer, RD; Lugo, R; Rahimi, N				Srinivasan, Srimathi; Meyer, Rosana D.; Lugo, Ricardo; Rahimi, Nader			Identification of PDCL3 as a Novel Chaperone Protein Involved in the Generation of Functional VEGF Receptor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSDUCIN-LIKE PROTEIN; BETA-GAMMA; ENDOPLASMIC-RETICULUM; MOLECULAR-MECHANISMS; CARBOXYL-TERMINUS; QUALITY CONTROL; GROWTH; ACTIVATION; ANGIOGENESIS; REGULATOR	Angiogenesis, a hallmark step in tumor metastasis and ocular neovascularization, is driven primarily by the function of VEGF ligand on one of its receptors, VEGF receptor 2 (VEGFR-2). Central to the proliferation and ensuing angiogenesis of endothelial cells, the abundance of VEGFR-2 on the surface of endothelial cells is essential for VEGF to recognize and activate VEGFR-2. We have identified phosducin-like 3 (PDCL3, also known as PhLP2A), through a yeast two-hybrid system, as a novel protein involved in the stabilization of VEGFR-2 by serving as a chaperone. PDCL3 binds to the juxtamembrane domain of VEGFR-2 and controls the abundance of VEGFR-2 by inhibiting its ubiquitination and degradation. PDCL3 increases VEGF-induced tyrosine phosphorylation and is required for VEGFR-2-dependent endothelial capillary tube formation and proliferation. Taken together, our data provide strong evidence for the role of PDCL3 in angiogenesis and establishes the molecular mechanism by which it regulates VEGFR-2 expression and function.	Boston Univ, Dept Pathol, Sch Med, Boston, MA 02118 USA; Boston Univ, Dept Ophthalmol, Sch Med, Boston, MA 02118 USA	Boston University; Boston University	Rahimi, N (corresponding author), Boston Univ, Dept Pathol, Med Campus,670 Albany St,Rm 510, Boston, MA 02118 USA.	nrahimi@bu.edu		Rahimi, Nader/0000-0002-6745-1725	NEI, National Institutes of Health; Department of Pathology, Boston University; Massachusetts Lions Foundation; NATIONAL EYE INSTITUTE [R01EY017955] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Department of Pathology, Boston University; Massachusetts Lions Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by grants from the NEI, National Institutes of Health (to N. R.). This work was also supported by a grant from the Department of Pathology, Boston University and by a grant from the Massachusetts Lions Foundation (to the Department of Ophthalmology, Boston University).	Annamalai B, 2009, MOL CANCER RES, V7, P1021, DOI 10.1158/1541-7786.MCR-08-0582; Baeriswyl V, 2009, SEMIN CANCER BIOL, V19, P329, DOI 10.1016/j.semcancer.2009.05.003; Bass J, 1998, J CELL BIOL, V141, P637, DOI 10.1083/jcb.141.3.637; Blaauw M, 2003, EMBO J, V22, P5047, DOI 10.1093/emboj/cdg508; Bruns AF, 2009, BIOCHEM SOC T, V37, P1193, DOI 10.1042/BST0371193; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Carvalho AP, 2006, PROG BIOPHYS MOL BIO, V91, P229, DOI 10.1016/j.pbiomolbio.2005.06.012; Dayanir V, 2001, J BIOL CHEM, V276, P17686, DOI 10.1074/jbc.M009128200; Dunn AY, 2001, J STRUCT BIOL, V135, P176, DOI 10.1006/jsbi.2001.4380; Farr GW, 1997, CELL, V89, P927, DOI 10.1016/S0092-8674(00)80278-0; Flanary PL, 2000, J BIOL CHEM, V275, P18462, DOI 10.1074/jbc.M002163200; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Humrich J, 2003, J BIOL CHEM, V278, P4474, DOI 10.1074/jbc.M206347200; Husain D, 2010, INVEST OPHTH VIS SCI, V51, P6803, DOI 10.1167/iovs.10-5255; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Lukov GL, 2005, EMBO J, V24, P1965, DOI 10.1038/sj.emboj.7600673; McLaughlin JN, 2002, P NATL ACAD SCI USA, V99, P7962, DOI 10.1073/pnas.112075699; Meyer RD, 2011, ONCOGENE, V30, P2198, DOI 10.1038/onc.2010.597; Meyer RD, 2004, J BIOL CHEM, V279, P735, DOI 10.1074/jbc.M305575200; Meyer RD, 2011, MOL CELL BIOL, V31, P2010, DOI 10.1128/MCB.01006-10; Rahimi N, 2000, J BIOL CHEM, V275, P16986, DOI 10.1074/jbc.M000528200; Rahimi N, 2006, FRONT BIOSCI-LANDMRK, V11, P818; Rahimi N, 2006, EXP EYE RES, V83, P1005, DOI 10.1016/j.exer.2006.03.019; Rahimi N, 2012, MOL BIOL CELL, V23, P1646, DOI 10.1091/mbc.E11-11-0934; Rahimi N, 2012, MOL CANCER THER, V11, P538, DOI 10.1158/1535-7163.MCT-11-0555; Sato Y, 2000, ANN NY ACAD SCI, V902, P201; Savage JR, 2000, J BIOL CHEM, V275, P30399, DOI 10.1074/jbc.M005120200; Schroder S, 1996, P NATL ACAD SCI USA, V93, P2100, DOI 10.1073/pnas.93.5.2100; Singh AJ, 2005, MOL BIOL CELL, V16, P2106, DOI 10.1091/mbc.E04-08-0749; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Willardson BM, 2007, CELL SIGNAL, V19, P2417, DOI 10.1016/j.cellsig.2007.06.013; YAFFE MB, 1992, J BIOL CHEM, V267, P12233	38	23	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23171	23181		10.1074/jbc.M113.473173	http://dx.doi.org/10.1074/jbc.M113.473173			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23792958	hybrid, Green Published			2022-12-25	WOS:000330598200024
J	Bao, Y; Chen, Y; Ledderose, C; Li, LL; Junger, WG				Bao, Yi; Chen, Yu; Ledderose, Carola; Li, Linglin; Junger, Wolfgang G.			Pannexin 1 Channels Link Chemoattractant Receptor Signaling to Local Excitation and Global Inhibition Responses at the Front and Back of Polarized Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE RECEPTORS; STERILE INFLAMMATION; CELL-MIGRATION; CHEMOTAXIS; ACTIVATION; GTPASES; RHO; RECRUITMENT; INTEGRINS; AGONISTS	Neutrophil chemotaxis requires excitatory signals at the front and inhibitory signals at the back of cells, which regulate cell migration in a chemotactic gradient field. We have previously shown that ATP release via pannexin 1 (PANX1) channels and autocrine stimulation of P2Y(2) receptors contribute to the excitatory signals at the front. Here we show that PANX1 also contributes to the inhibitory signals at the back, namely by providing the ligand for A(2A) adenosine receptors. In resting neutrophils, we found that A(2A) receptors are uniformly distributed across the cell surface. In polarized cells, A(2A) receptors redistributed to the back where their stimulation triggered intracellular cAMP accumulation and protein kinase A (PKA) activation, which blocked chemoattractant receptor signaling. Inhibition of PANX1 blocked A(2A) receptor stimulation and cAMP accumulation in response to formyl peptide receptor stimulation. Treatments that blocked endogenous A(2A) receptor signaling impaired the polarization and migration of neutrophils in a chemotactic gradient field and resulted in enhanced ERK and p38 MAPK signaling in response to formyl peptide receptor stimulation. These findings suggest that chemoattractant receptors require PANX1 to trigger excitatory and inhibitory signals that synergize to fine-tune chemotactic responses at the front and back of neutrophils. PANX1 channels thus link local excitatory signals to the global inhibitory signals that orchestrate chemotaxis of neutrophils in gradient fields.	[Bao, Yi; Chen, Yu; Ledderose, Carola; Li, Linglin; Junger, Wolfgang G.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA; [Junger, Wolfgang G.] Ludwig Boltzmann Inst Traumatol, A-1200 Vienna, Austria	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Ludwig Boltzmann Institute	Junger, WG (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, 330 Brookline Ave, Boston, MA 02215 USA.	wjunger@bidmc.harvard.edu	Junger, Wolfgang G/I-1932-2013; LI, LI/GVS-5344-2022; li, li/GPX-3938-2022; li, li/HII-4157-2022; Li, Li/AEM-3636-2022; Bao, Yi/J-5418-2013	Junger, Wolfgang G/0000-0003-3350-8452; Bao, Yi/0000-0003-0748-1575	National Institutes of Health [GM-51477, GM-60475, AI-072287, AI-080582]; Congressionally Directed Medical Research Program [PR043034]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080582, R01AI072287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060475, R01GM051477, R29GM051477] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Congressionally Directed Medical Research Program(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-51477, GM-60475, AI-072287, and AI-080582 (to W. J.). This work was also supported by the Congressionally Directed Medical Research Program PR043034 (to W. J.).	Bagchi S, 2005, J BIOL CHEM, V280, P39050, DOI 10.1074/jbc.M504819200; Bagorda A, 2008, J CELL SCI, V121, P2621, DOI 10.1242/jcs.018077; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Berzat A, 2010, EMBO J, V29, P2734, DOI 10.1038/emboj.2010.170; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Chen Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000549; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; Corriden R, 2008, J BIOL CHEM, V283, P28480, DOI 10.1074/jbc.M800039200; Erb L, 2006, PFLUG ARCH EUR J PHY, V452, P552, DOI 10.1007/s00424-006-0069-2; Ernens I, 2006, CIRC RES, V99, P590, DOI 10.1161/01.RES.0000241428.82502.d4; Fredholm BB, 2007, PROG NEUROBIOL, V83, P263, DOI 10.1016/j.pneurobio.2007.07.005; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Inoue K, 2008, CELL MOL LIFE SCI, V65, P3074, DOI 10.1007/s00018-008-8210-3; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001121; Kronlage M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000588; Ku CJ, 2012, CELL, V149, P1073, DOI 10.1016/j.cell.2012.03.044; Levchenko A, 2002, BIOPHYS J, V82, P50, DOI 10.1016/S0006-3495(02)75373-3; Liao ZJ, 2007, J CELL SCI, V120, P1654, DOI 10.1242/jcs.03441; Liu LH, 2010, DEV CELL, V19, P845, DOI 10.1016/j.devcel.2010.11.004; Mahadeo DC, 2007, MOL BIOL CELL, V18, P512, DOI 10.1091/mbc.E06-05-0418; McDonald B, 2011, J MOL MED, V89, P1079, DOI 10.1007/s00109-011-0784-9; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Olah ME, 1997, J BIOL CHEM, V272, P337; Orr AG, 2009, NAT NEUROSCI, V12, P872, DOI 10.1038/nn.2341; Peng GE, 2011, MOL BIOL CELL, V22, P3986, DOI 10.1091/mbc.E11-04-0379; Pillinger MH, 1996, J BIOL CHEM, V271, P12049, DOI 10.1074/jbc.271.20.12049; Ralevic V, 1998, PHARMACOL REV, V50, P413; Ridley AJ, 2001, J CELL SCI, V114, P2713; Sauzeau V, 2000, AM J PHYSIOL-HEART C, V278, pH1751, DOI 10.1152/ajpheart.2000.278.6.H1751; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Sullivan GW, 2001, BRIT J PHARMACOL, V132, P1017, DOI 10.1038/sj.bjp.0703893; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Thibault N, 2002, J LEUKOCYTE BIOL, V71, P367; Tkachenko E, 2011, NAT CELL BIOL, V13, P660, DOI 10.1038/ncb2231; Van Keymeulen A, 2006, J CELL BIOL, V174, P437, DOI 10.1083/jcb.200604113; Verghese MW, 1996, J BIOL CHEM, V271, P15597, DOI 10.1074/jbc.271.26.15597; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Wang F, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002980; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5	42	72	75	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22650	22657		10.1074/jbc.M113.476283	http://dx.doi.org/10.1074/jbc.M113.476283			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23798685	Green Published, hybrid			2022-12-25	WOS:000330596300044
J	Cui, Z; Zhang, ST				Cui, Zhi; Zhang, Shetuan			Regulation of the Human Ether-a-go-go-related Gene (hERG) Channel by Rab4 Protein through Neural Precursor Cell-expressed Developmentally Down-regulated Protein 4-2 (Nedd4-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiovascular; Cell Biology; Gene Expression; HERG; Patch Clamp; Potassium Channels; Protein Degradation; Rab; Trafficking; Ubiquitin Ligase	E3 UBIQUITIN LIGASES; LONG QT SYNDROME; POTASSIUM CHANNEL; I-KR; EXTRACELLULAR K+; C2 DOMAIN; RECEPTOR; TRANSPORT; GTPASES; PROLONGATION	The human ether-a-go-go-related gene (hERG) encodes the pore-forming -subunit of the rapidly activating delayed rectifier K+ channel in the heart, which plays a critical role in cardiac action potential repolarization. Dysfunction of I-Kr causes long QT syndrome, a cardiac electrical disorder that predisposes affected individuals to fatal arrhythmias and sudden death. The homeostasis of hERG channels in the plasma membrane depends on a balance between protein synthesis and degradation. Our recent data indicate that hERG channels undergo enhanced endocytic degradation under low potassium (hypokalemia) conditions. The GTPase Rab4 is known to mediate rapid recycling of various internalized proteins to the plasma membrane. In the present study, we investigated the effect of Rab4 on the expression level of hERG channels. Our data revealed that overexpression of Rab4 decreases the expression level of hERG in the plasma membrane. Rab4 does not affect the expression level of the Kv1.5 or EAG K+ channels. Mechanistically, our data demonstrate that overexpression of Rab4 increases the expression level of endogenous Nedd4-2, a ubiquitin ligase that targets hERG but not Kv1.5 or EAG channels for ubiquitination and degradation. Nedd4-2 undergoes self- ubiquitination and degradation. Rab4 interferes with Nedd4-2 degradation, resulting in an increased expression level of Nedd4-2, which targets hERG. In summary, the present study demonstrates a novel pathway for hERG regulation; Rab4 decreases the hERG density at the plasma membrane by increasing the endogenous Nedd4-2 expression.	[Cui, Zhi; Zhang, Shetuan] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Zhang, ST (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Botterell Hall,Rm 429,18 Stuart St, Kingston, ON K7L 3N6, Canada.	shetuan.zhang@queensu.ca		Zhang, Shetuan/0000-0002-2297-0193	Canadian Institutes of Health Research Grant [MOP 72911]; Heart and Stroke Foundation of Ontario Grant [T 6612]; Canadian Institutes of Health Research new investigator award	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario Grant; Canadian Institutes of Health Research new investigator award(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research Grant MOP 72911 and the Heart and Stroke Foundation of Ontario Grant T 6612 (to S. Z.).; Recipient of a Canadian Institutes of Health Research new investigator award.	Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Albesa M, 2011, J MOL CELL CARDIOL, V51, P90, DOI 10.1016/j.yjmcc.2011.03.015; Bruce MC, 2008, BIOCHEM J, V415, P155, DOI 10.1042/BJ20071708; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Caohuy H, 2009, J BIOL CHEM, V284, P25241, DOI 10.1074/jbc.M109.035345; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Daro E, 1996, P NATL ACAD SCI USA, V93, P9559, DOI 10.1073/pnas.93.18.9559; Dupre DJ, 2006, J BIOL CHEM, V281, P34561, DOI 10.1074/jbc.M605012200; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Etzion S, 2010, J MOL CELL CARDIOL, V49, P931, DOI 10.1016/j.yjmcc.2010.08.011; Filipeanu CM, 2006, J BIOL CHEM, V281, P11097, DOI 10.1074/jbc.M511460200; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Fotia AB, 2002, FASEB J, V16, P70, DOI 10.1096/fj.02-0497fje; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Guo J, 2007, J PHARMACOL EXP THER, V321, P911, DOI 10.1124/jpet.107.120931; Guo J, 2012, J BIOL CHEM, V287, P33132, DOI 10.1074/jbc.M112.389643; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Johnson JN, 2011, EUR HEART J, V32, P1114, DOI 10.1093/eurheartj/ehr021; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Kuryshev YA, 2005, J PHARMACOL EXP THER, V312, P316, DOI 10.1124/jpet.104.073692; Madias C, 2011, HEART RHYTHM, V8, P555, DOI 10.1016/j.hrthm.2010.12.012; Malik B, 2005, AM J PHYSIOL-RENAL, V289, pF107, DOI 10.1152/ajprenal.00179.2002; Marban E, 1999, J CARDIOVASC ELECTR, V10, P1425, DOI 10.1111/j.1540-8167.1999.tb00199.x; MARTIN AB, 1994, AM HEART J, V127, P64, DOI 10.1016/0002-8703(94)90510-X; Massaeli H, 2010, CIRC RES, V106, P1072, DOI 10.1161/CIRCRESAHA.109.215970; Mohrmann K, 1999, MOL MEMBR BIOL, V16, P81, DOI 10.1080/096876899294797; Moren A, 2005, J BIOL CHEM, V280, P22115, DOI 10.1074/jbc.M414027200; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Odley A, 2004, P NATL ACAD SCI USA, V101, P7082, DOI 10.1073/pnas.0308335101; Olkkonen VM, 1997, INT REV CYTOL, V176, P1, DOI 10.1016/S0074-7696(08)61608-3; Patel C, 2010, CIRC-ARRHYTHMIA ELEC, V3, P401, DOI 10.1161/CIRCEP.109.921056; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; Pochynyuk O, 2007, EXP BIOL MED, V232, P1258, DOI 10.3181/0703-MR-76; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Saxena SK, 2006, BIOCHEM BIOPH RES CO, V341, P184, DOI 10.1016/j.bbrc.2005.12.170; Saxena SK, 2006, BIOCHEM BIOPH RES CO, V340, P726, DOI 10.1016/j.bbrc.2005.12.036; Shallow H, 2011, BIOPHYS J, V100, P102; Strous GJ, 1999, J CELL SCI, V112, P1417; Sun T, 2011, J BIOL CHEM, V286, P6751, DOI 10.1074/jbc.M110.198408; Tomaselli GF, 1999, CARDIOVASC RES, V42, P270, DOI 10.1016/S0008-6363(99)00017-6; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; Wang J, 2010, J BIOL CHEM, V285, P12279, DOI 10.1074/jbc.M109.086405; Ward ES, 2005, MOL BIOL CELL, V16, P2028, DOI 10.1091/mbc.E04-08-0735; Wu GY, 2001, CIRC RES, V89, P1130, DOI 10.1161/hh2401.100427; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang ST, 2006, AM J PHYSIOL-HEART C, V290, pH1038, DOI 10.1152/ajpheart.00679.2005; Zhang YQ, 2006, AM J PHYSIOL-HEART C, V291, pH1446, DOI 10.1152/ajpheart.01356.2005; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	56	25	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21876	10.1074/jbc.M113.461715	http://dx.doi.org/10.1074/jbc.M113.461715			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23792956	hybrid, Green Published			2022-12-25	WOS:000328841900036
J	Bottner, M; Barrenschee, M; Hellwig, I; Harde, J; Egberts, JH; Becker, T; Zorenkov, D; Schafer, KH; Wedel, T				Boettner, Martina; Barrenschee, Martina; Hellwig, Ines; Harde, Jonas; Egberts, Jan-Hendrik; Becker, Thomas; Zorenkov, Dimitri; Schaefer, Karl-Herbert; Wedel, Thilo			The GDNF System Is Altered in Diverticular Disease - Implications for Pathogenesis	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; MICE LACKING GDNF; NEUROTROPHIC FACTOR; RET PROTOONCOGENE; NEURITE OUTGROWTH; MYENTERIC PLEXUS; CELL-DEATH; C-RET; NEURONS; EXPRESSION	Background & Aims: Absence of glial cell line-derived neurotrophic factor (GDNF) leads to intestinal aganglionosis. We recently demonstrated that patients with diverticular disease (DD) exhibit hypoganglionosis suggesting neurotrophic factor deprivation. Thus, we screened mRNA expression pattern of the GDNF system in DD and examined the effects of GDNF on cultured enteric neurons. Methods: Colonic specimens obtained from patients with DD (n = 21) and controls (n = 20) were assessed for mRNA expression levels of the GDNF system (GDNF, GDNF receptors GFR alpha 1 and RET). To identify the tissue source of GDNF and its receptors, laser-microdissected (LMD) samples of human myenteric ganglia and intestinal muscle layers were analyzed separately by qPCR. Furthermore, the effects of GDNF treatment on cultured enteric neurons (receptor expression, neuronal differentiation and plasticity) were monitored. Results: mRNA expression of GDNF and its receptors was significantly down-regulated in the muscularis propria of patients with DD. LMD samples revealed high expression of GDNF in circular and longitudinal muscle layers, whereas GDNF receptors were also expressed in myenteric ganglia. GDNF treatment of cultured enteric neurons increased mRNA expression of its receptors and promoted neuronal differentiation and plasticity revealed by synaptophysin mRNA and protein expression. Conclusions: Our results suggest that the GDNF system is compromised in DD. In vitro studies demonstrate that GDNF enhances expression of its receptors and promotes enteric neuronal differentiation and plasticity. Since patients with DD exhibit hypoganglionosis, we propose that the observed enteric neuronal loss in DD may be due to lacking neurotrophic support mediated by the GDNF system.	[Boettner, Martina; Barrenschee, Martina; Hellwig, Ines; Harde, Jonas; Wedel, Thilo] Univ Kiel, Inst Anat, Kiel, Germany; [Egberts, Jan-Hendrik; Becker, Thomas] Univ Hosp Schleswig Holstein, Dept Gen & Thorac Surg, Kiel, Germany; [Zorenkov, Dimitri] Univ Hosp Schleswig Holstein, Dept Neurol, Kiel, Germany; [Schaefer, Karl-Herbert] Univ Appl Sci, Dept Informat & Microsyst Tech, Kaiserslautern, Germany	University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kaiserslautern	Bottner, M (corresponding author), Univ Kiel, Inst Anat, Olshausenstr 40, Kiel, Germany.	m.boettner@anat.uni-kiel.de	Egberts, Jan-Hendrik/E-3211-2015; Barrenschee, Martina/AAS-9945-2020; Barrenschee, Martina/E-7688-2015; Wedel, Thilo/B-1247-2010	Barrenschee, Martina/0000-0002-6569-5603; Wedel, Thilo/0000-0002-8146-2711; Barrenschee, Martina/0000-0002-0244-9333	Deutsche Forschungsgemeinschaft (DFG) [WE 2366/4-2]; Faculty of Medicine, Christian-Albrechts-University of Kiel [F347022]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Faculty of Medicine, Christian-Albrechts-University of Kiel	The study was supported by research grants from the Deutsche Forschungsgemeinschaft (DFG, WE 2366/4-2) and the Faculty of Medicine, Christian-Albrechts-University of Kiel (F347022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Attie-Bitach T, 1998, AM J MED GENET, V80, P481, DOI 10.1002/(SICI)1096-8628(19981228)80:5<481::AID-AJMG8>3.0.CO;2-6; Bassotti G, 2001, DIS COLON RECTUM, V44, P1814, DOI 10.1007/BF02234460; Bottner M, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01424.x; Bottner M, 2012, DIGEST DIS, V30, P19, DOI 10.1159/000335699; Bottner M, 2000, J NEUROCHEM, V75, P2227, DOI 10.1046/j.1471-4159.2000.0752227.x; Bottner M., 2010, NEUROGASTROENT MOTIL, V22, pe152; Brose N, 2010, BIOCHEM SOC T, V38, P443, DOI 10.1042/BST0380443; Burgoyne RD, 2011, NAT CELL BIOL, V13, P8, DOI 10.1038/ncb0111-8; Burke RE, 2006, J NEURAL TRANSM-SUPP, P41; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Deduchovas O, 2008, ANN ANAT, V190, P525, DOI 10.1016/j.aanat.2008.09.002; Du F, 2009, NEUROGASTROENT MOTIL, V21, P1229, DOI 10.1111/j.1365-2982.2009.01379.x; Durbec PL, 1996, DEVELOPMENT, V122, P349; Golden JP, 1999, EXP NEUROL, V158, P504, DOI 10.1006/exnr.1999.7127; Golder M, 2003, LANCET, V361, P1945, DOI 10.1016/S0140-6736(03)13583-0; Heuckeroth RO, 1998, DEV BIOL, V200, P116, DOI 10.1006/dbio.1998.8955; Humes DJ, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2011.01863.x; Iwase H, 2005, J CLIN GASTROENTEROL, V39, P674, DOI 10.1097/01.mcg.0000173856.84814.37; Jun S, 2002, BEST PRACT RES CL GA, V16, P529, DOI 10.1053/bega.2002.0328; Keller-Peck CR, 2001, J NEUROSCI, V21, P6136, DOI 10.1523/JNEUROSCI.21-16-06136.2001; Knowles CH, 2010, GUT, V59, P882, DOI 10.1136/gut.2009.200444; KORSCHING S, 1993, J NEUROSCI, V13, P2739; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; PAINTER NS, 1971, BMJ-BRIT MED J, V2, P450, DOI 10.1136/bmj.2.5759.450; Peery AF, 2012, GASTROENTEROLOGY, V142, P266, DOI 10.1053/j.gastro.2011.10.035; PHAM TD, 1991, J COMP NEUROL, V314, P789, DOI 10.1002/cne.903140411; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Rodrigues DM, 2011, NEUROGASTROENT MOTIL, V23, pe44, DOI 10.1111/j.1365-2982.2010.01626.x; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Schafer KH, 1997, BRAIN RES PROTOC, V1, P109, DOI 10.1016/S1385-299X(96)00017-7; Schafer KH, 1999, J INTERF CYTOK RES, V19, P527, DOI 10.1089/107999099313974; Schafer KH, 1999, EXP BRAIN RES, V125, P447, DOI 10.1007/s002210050702; Shen L, 2002, AM J HUM GENET, V70, P435, DOI 10.1086/338712; Simpson J, 2009, NEUROGASTROENT MOTIL, V21, P847, DOI 10.1111/j.1365-2982.2009.01308.x; Simpson John, 2002, Clin Evid, P436; Strate LL, 2009, GASTROENTEROLOGY, V136, P115, DOI 10.1053/j.gastro.2008.09.025; Uesaka T, 2007, DEVELOPMENT, V134, P2171, DOI 10.1242/dev.001388; von Boyen GBT, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-3; Wedel T, 2010, NEUROGASTROENT MOTIL, V22, P407, DOI 10.1111/j.1365-2982.2009.01445.x; Zeng FN, 2010, GASTROENTEROLOGY, V138, P1491, DOI 10.1053/j.gastro.2009.11.048; Zhao ZQ, 2004, EXP NEUROL, V190, P356, DOI 10.1016/j.expneurol.2004.06.015	45	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66290	10.1371/journal.pone.0066290	http://dx.doi.org/10.1371/journal.pone.0066290			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805210	Green Published, gold, Green Submitted			2022-12-25	WOS:000320846500038
J	Li, XR; Zhang, FX; Song, GX; Gu, WJ; Chen, ML; Yang, B; Li, DF; Wang, DW; Cao, KJ				Li, Xiaorong; Zhang, Fengxiang; Song, Guixian; Gu, Weijuan; Chen, Minglong; Yang, Bing; Li, Dianfu; Wang, Daowu; Cao, Kejiang			Intramyocardial Injection of Pig Pluripotent Stem Cells Improves Left Ventricular Function and Perfusion: A Study in a Porcine Model of Acute Myocardial Infarction	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; IPS CELLS; GENERATION; FIBROBLASTS; HEARTS; TRANSPLANTATION; ENGRAFTMENT; DERIVATION; INDUCTION; SURVIVAL	Induced pluripotent stem (iPS) cells have the potential to differentiate to various types of cardiovascular cells to repair an injured heart. The potential therapeutic benefits of iPS cell based treatment have been established in small-animal models of myocardial infarction (MI). We hypothesize that porcine iPS (piPS) cell transplantation may be an effective treatment for MI. After a 90-minute occlusion of the left anterior descending artery in a porcine model, undifferentiated piPS cells or PBS were injected into the ischemic myocardium. Cardiac function, myocardial perfusion and cell differentiation were investigated. One week after piPS cell delivery, global left ventricular ejection fraction (LVEF) significantly decreased in both the iPS group and the PBS group compared to the Sham group (p<0.05, respectively). Six weeks after piPS cell delivery, LVEF of the iPS group significantly improved compared to the PBS group (56.68% vs. 50.93%, p = 0.04) but was still lower than the Sham group. Likewise, the piPS cell transplantation improved the regional perfusion compared to the PBS injection (19.67% vs. 13.67%, p = 0.02). The infarct area was significantly smaller in the iPS group than the PBS group (12.04% vs. 15.98% p = 0.01). PiPS cells engrafted into the myocardium can differentiate into vessel cells, which result in increased formation of new vessels in the infarcted heart. Direct intramyocardial injection of piPS cells can decrease infarct size and improve left ventricular function and perfusion for an immunosuppressed porcine AMI model.	[Li, Xiaorong; Zhang, Fengxiang; Song, Guixian; Gu, Weijuan; Chen, Minglong; Yang, Bing; Li, Dianfu; Wang, Daowu; Cao, Kejiang] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Cao, KJ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	kjcao@njmu.edu.cn	Zhang, Fengxiang/Z-2807-2019		National Natural Science Foundation of China [81170160, 30871077, 30800464]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Six Talents Peak Project of Jiangsu Province [DG216D5044]; Postgraduate research and innovation project in Jiangsu province, China; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU [IRT-004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Six Talents Peak Project of Jiangsu Province; Postgraduate research and innovation project in Jiangsu province, China; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU	This work was supported by grants from the National Natural Science Foundation of China (Grant no. 81170160, 30871077, 30800464) (http://www.nsfc.gov.cn/Portal0/default152.htm), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), the Six Talents Peak Project of Jiangsu Province (Grant no. DG216D5044), the Postgraduate research and innovation project in Jiangsu province, China, and the Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU (IRT-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed RPH, 2011, CIRC RES, V109, P60, DOI 10.1161/CIRCRESAHA.110.240010; Ahmed RPH, 2011, REGEN MED, V6, P171, DOI 10.2217/RME.10.103; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Blin G, 2010, J CLIN INVEST, V120, P1125, DOI 10.1172/JCI40120; Chang HJ, 2009, JACC-CARDIOVASC IMAG, V2, P412, DOI 10.1016/j.jcmg.2008.12.019; Cheng L, 2009, REGEN MED, V4, P787, DOI 10.2217/RME.09.56; Chiang CH, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/219060; Dai B, 2011, J AM COLL CARDIOL, V58, P2118, DOI 10.1016/j.jacc.2011.06.062; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343; Lee AS, 2011, J BIOL CHEM, V286, P32697, DOI 10.1074/jbc.M111.235739; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Mauritz C, 2011, EUR HEART J, V32, P2634, DOI 10.1093/eurheartj/ehr166; Meyer GP, 2009, EUR HEART J, V30, P2978, DOI 10.1093/eurheartj/ehp374; Montserrat N, 2011, J CARDIOVASC TRANSL, V4, P121, DOI 10.1007/s12265-010-9233-3; Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562; Nelson TJ, 2009, CIRCULATION, V120, P408, DOI 10.1161/CIRCULATIONAHA.109.865154; Pasha Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023667; Qu XK, 2012, EUR J RADIOL, V81, pE431, DOI 10.1016/j.ejrad.2011.03.062; Roberts RM, 2009, CELL CYCLE, V8, P3078, DOI 10.4161/cc.8.19.9589; Ruan WM, 2011, SCI CHINA LIFE SCI, V54, P553, DOI 10.1007/s11427-011-4179-5; Singla DK, 2011, MOL PHARMACEUT, V8, P1573, DOI 10.1021/mp2001704; So KH, 2011, INT J CARDIOL, V153, P277, DOI 10.1016/j.ijcard.2010.08.052; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tao ZX, 2011, P NATL ACAD SCI USA, V108, P2064, DOI 10.1073/pnas.1018925108; Telugu BPVL, 2010, STEM CELL REV REP, V6, P31, DOI 10.1007/s12015-009-9101-1; Templin C, 2012, CIRCULATION, V126, P430, DOI 10.1161/CIRCULATIONAHA.111.087684; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Yan BB, 2011, MOL PHARMACEUT, V8, P1602, DOI 10.1021/mp2003576; Yang YJ, 2008, EUR HEART J, V29, P1578, DOI 10.1093/eurheartj/ehn167; Zeng LP, 2007, CIRCULATION, V115, P1866, DOI 10.1161/CIRCULATIONAHA.106.659730; Zhang YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019012; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	35	27	33	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66688	10.1371/journal.pone.0066688	http://dx.doi.org/10.1371/journal.pone.0066688			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805264	gold, Green Published, Green Submitted			2022-12-25	WOS:000320846500092
J	Schuldiner-Harpaz, T; Coll, M				Schuldiner-Harpaz, Tarryn; Coll, Moshe			Effects of Global Warming on Predatory Bugs Supported by Data Across Geographic and Seasonal Climatic Gradients	PLOS ONE			English	Article							THRIPS FRANKLINIELLA-OCCIDENTALIS; BODY-SIZE; ORIUS-LAEVIGATUS; O-ALBIDIPENNIS; ANTHOCORIDAE; TEMPERATURE; INSECTS; REPRODUCTION; HETEROPTERA; LEPIDOPTERA	Global warming may affect species abundance and distribution, as well as temperature-dependent morphometric traits. In this study, we first used historical data to document changes in Orius (Heteroptera: Anthocoridae) species assemblage and individual morphometric traits over the past seven decades in Israel. We then tested whether these changes could have been temperature driven by searching for similar patterns across seasonal and geographic climatic gradients in a present survey. The historical records indicated a shift in the relative abundance of dominant Orius species; the relative abundance of O. albidipennis, a desert-adapted species, increased while that of O. laevigatus decreased in recent decades by 6 and 10-15 folds, respectively. These shifts coincided with an overall increase of up to 2.1 degrees C in mean daily temperatures over the last 25 years in Israel. Similar trends were found in contemporary data across two other climatic gradients, seasonal and geographic; O. albidipennis dominated Orius assemblages under warm conditions. Finally, specimens collected in the present survey were significantly smaller than those from the 1980's, corresponding to significantly smaller individuals collected now during warmer than colder seasons. Taken together, results provide strong support to the hypothesis that temperature is the most likely driver of the observed shifts in species composition and body sizes because (1) historical changes in both species assemblage and body size were associated with rising temperatures in the study region over the last few decades; and (2) similar changes were observed as a result of contemporary drivers that are associated with temperature.	[Schuldiner-Harpaz, Tarryn; Coll, Moshe] Hebrew Univ Jerusalem, Dept Entomol, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem	Schuldiner-Harpaz, T (corresponding author), Hebrew Univ Jerusalem, Dept Entomol, IL-76100 Rehovot, Israel.	tarryn.harpaz@gmail.com			Chief Scientist of the (Israeli) Ministry of Agriculture and Rural Development; Israel Science Foundation; Academy of Science and Humanities (ISF) [574/07]	Chief Scientist of the (Israeli) Ministry of Agriculture and Rural Development; Israel Science Foundation(Israel Science Foundation); Academy of Science and Humanities (ISF)	This study was supported in parts by grants from the Chief Scientist of the (Israeli) Ministry of Agriculture and Rural Development, and from the Israel Science Foundation, founded by the Academy of Science and Humanities (ISF grant 574/07 to MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Azevedo RBR, 1998, EVOLUTION, V52, P1353, DOI [10.1111/j.1558-5646.1998.tb02017.x, 10.2307/2411305]; Bahsi SU, 2008, BIOCONTROL SCI TECHN, V18, P767, DOI 10.1080/09583150802302215; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Baniameri V, 2005, APPL ENTOMOL ZOOL, V40, P545, DOI 10.1303/aez.2005.545; Blanckenhorn WU, 2004, INTEGR COMP BIOL, V44, P413, DOI 10.1093/icb/44.6.413; Bosco L, 2008, B INSECTOL, V61, P209; Calder WA., 1984, SIZE FUNCTION LIFE H; Carayon J., 1959, CAHIERS NATURALISTES, V15, P53; Chen IC, 2011, GLOBAL ECOL BIOGEOGR, V20, P34, DOI 10.1111/j.1466-8238.2010.00594.x; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; CHYZIK R, 1995, PHYTOPARASITICA, V23, P147, DOI 10.1007/BF02980974; Chyzik R, 2002, PHYTOPARASITICA, V30, P335, DOI 10.1007/BF02979681; Cocuzza GE, 1997, ENTOMOL EXP APPL, V85, P189, DOI 10.1023/A:1003127310860; Coll M, 2005, P 2 INT C BIOL CONTR; DAVID JR, 1994, GENET SEL EVOL, V26, P229, DOI 10.1051/gse:19940305; Ferragut F., 1994, Boletin de Sanidad Vegetal Plagas, V20, P89; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; Gaston KJ, 2008, J BIOGEOGR, V35, P483, DOI 10.1111/j.1365-2699.2007.01772.x; Gilchrist GW, 2004, INTEGR COMP BIOL, V44, P461, DOI 10.1093/icb/44.6.461; Goldreich Y., 2012, CLIMATE ISRAEL OBSER; Groenteman R, 2004, THESIS HEBREW U JERU; Hodkinson ID, 2005, BIOL REV, V80, P489, DOI 10.1017/S1464793105006767; HORTON D. R., 2008, ENCY ENTOMOLOGY, P2402, DOI DOI 10.1007/978-1-4020-6359-6_4633; Intergovernmental Panel on Climate Change, 2022, CLIM CHANG 2022 IMP, P1; Johnson C.G., 1969, MIGRATION DISPERSAL; JORDANO D, 1991, J BIOGEOGR, V18, P637, DOI 10.2307/2845545; Krasnov B, 1996, J ARID ENVIRON, V34, P477, DOI 10.1006/jare.1996.0126; Lacasa A., 1996, Folia Entomologica Hungarica, V57, P67; Lattin JD, 2000, HETEROPTERA OF ECONOMIC IMPORTANCE, P607; LINNAVUORI R., 1961, ANN ZOOL SOC ZOOL BOT FENNICAE VANAMO", V22, P1; Menendez Rosa, 2007, Tijdschrift voor Entomologie, V150, P355; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PERICART J, 1989, PHYTOPARASITICA, V17, P91, DOI 10.1007/BF02979516; Pericart J, 1972, HEMIPTERES ANTHOCORI; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Sanchez JA, 2002, B ENTOMOL RES, V92, P77, DOI 10.1079/BER2001136; SAS Institute, 2007, JMP VERS 7; Scharf I, 2009, ZOOLOGY, V112, P139, DOI 10.1016/j.zool.2008.05.004; Schuldiner-Harpaz T, 2012, J ECON ENTOMOL, V105, P1520, DOI 10.1603/EC12068; Shahami D, 2009, ISRAELI METEOROLOGIC, V1, P57; SHOUSTER I, 2003, THESIS HEBREW U JERU; Thomas CD, 2010, DIVERS DISTRIB, V16, P488, DOI 10.1111/j.1472-4642.2010.00642.x; Tommasini Maria Grazia, 2004, Bulletin of Insectology, V57, P65; Wilson RJ, 2011, J INSECT CONSERV, V15, P259, DOI 10.1007/s10841-010-9342-y; Wilson Robert J., 2007, Symposia of the Royal Entomological Society of London, V23, P245, DOI 10.1079/9781845932541.0245; Ziv B, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022796	49	11	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66622	10.1371/journal.pone.0066622	http://dx.doi.org/10.1371/journal.pone.0066622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805249	Green Submitted, gold, Green Published			2022-12-25	WOS:000320846500077
J	Vogt, H; Braback, L; Zetterstrom, O; Zara, K; Falth-Magnusson, K; Nilsson, L				Vogt, Hartmut; Braback, Lennart; Zetterstrom, Olof; Zara, Katalin; Falth-Magnusson, Karin; Nilsson, Lennart			Asthma Heredity, Cord Blood IgE and Asthma-Related Symptoms and Medication in Adulthood: A Long-Term Follow-Up in a Swedish Birth Cohort	PLOS ONE			English	Article							SERUM IMMUNOGLOBULIN-E; ALLERGEN-SPECIFIC IGE; GENDER-DIFFERENCES; CHILDHOOD ASTHMA; NATIONAL COHORT; ATOPIC DISEASE; YOUNG-ADULTS; AGE; SENSITIZATION; CHILDREN	Cord blood IgE has previously been studied as a possible predictor of asthma and allergic diseases. Results from different studies have been contradictory, and most have focused on high-risk infants and early infancy. Few studies have followed their study population into adulthood. This study assessed whether cord blood IgE levels and a family history of asthma were associated with, and could predict, asthma medication and allergy-related respiratory symptoms in adults. A follow-up was carried out in a Swedish birth cohort comprising 1,701 consecutively born children. In all, 1,661 individuals could be linked to the Swedish Prescribed Drug Register and the Medical Birth Register, and 1,227 responded to a postal questionnaire. Cord blood IgE and family history of asthma were correlated with reported respiratory symptoms and dispensed asthma medication at 32-34 years. Elevated cord blood IgE was associated with a two- to threefold increased risk of pollen-induced respiratory symptoms and dispensed anti-inflammatory asthma medication. Similarly, a family history of asthma was associated with an increased risk of pollen-induced respiratory symptoms and anti-inflammatory medication. However, only 8% of the individuals with elevated cord blood IgE or a family history of asthma in infancy could be linked to current dispensation of anti-inflammatory asthma medication at follow-up. In all, 49 out of 60 individuals with dispensed anti-inflammatory asthma medication at 32-34 years of age had not been reported having asthma at previous check-ups of the cohort during childhood. Among those, only 5% with elevated cord blood IgE and 6% with a family history of asthma in infancy could be linked to current dispensation of anti-inflammatory asthma medication as adults. Elevated cord blood IgE and a positive family history of asthma were associated with reported respiratory symptoms and dispensed asthma medication in adulthood, but their predictive power was poor in this long-time follow-up.	[Vogt, Hartmut; Falth-Magnusson, Karin] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Pediat,Pediat & Adolescent Clin,Cty Council O, Linkoping, Sweden; [Braback, Lennart] Vasternorrland Cty Council, Dept Res & Dev, Sundsvall, Sweden; [Braback, Lennart] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Zetterstrom, Olof; Zara, Katalin; Nilsson, Lennart] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Allergy Ctr, Linkoping, Sweden	Linkoping University; Umea University; Linkoping University	Vogt, H (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Pediat,Pediat & Adolescent Clin,Cty Council O, Linkoping, Sweden.	hartmut.vogt@liu.se	Braback, Lennart/A-3793-2015	Braback, Lennart/0000-0001-9930-7755; Nilsson, Lennart/0000-0002-5680-6367	Umea SIMSAM Node (Microdata research on childhood for lifelong health and welfare); Swedish Research Council; Swedish Asthma and Allergy Association (Stockholm, Sweden)	Umea SIMSAM Node (Microdata research on childhood for lifelong health and welfare); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Asthma and Allergy Association (Stockholm, Sweden)	LB was supported by the Umea SIMSAM Node (Microdata research on childhood for lifelong health and welfare) financed by the Swedish Research Council. KFM was supported by the Swedish Research Council. LN and HV were supported by The Swedish Asthma and Allergy Association (Stockholm, Sweden). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almqvist C, 2008, ALLERGY, V63, P47, DOI 10.1111/j.1398-9995.2007.01524.x; Andersson M, 2010, PEDIAT ALLERG IMM-UK, V21, P859, DOI 10.1111/j.1399-3038.2010.01055.x; Arbes Jr SJ, 2012, J ALLERGY CLIN IMMUN; Arbes SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1139, DOI 10.1016/j.jaci.2007.07.056; Arshad SH, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.2.e33; Bjerg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016082; Bonnelykke K, 2010, J ALLERGY CLIN IMMUN, V126, P657, DOI 10.1016/j.jaci.2010.06.027; CRONER S, 1992, ALLERGY, V47, P150, DOI 10.1111/j.1398-9995.1992.tb00956.x; CRONER S, 1982, ARCH DIS CHILD, V57, P364, DOI 10.1136/adc.57.5.364; CRONER S, 1990, PEDIATR ALLERGY IMMU, V1, P14, DOI DOI 10.1111/J.1399-3038.1990.TB00003.X; Crump C, 2011, PEDIATRICS, V127, pE913, DOI 10.1542/peds.2010-2603; Douwes J, 2002, THORAX, V57, P643, DOI 10.1136/thorax.57.7.643; Ferguson A, 2009, PEDIAT ALLERG IMM-UK, V20, P710, DOI 10.1111/j.1399-3038.2009.00869.x; Furu K, 2007, EUR J CLIN PHARMACOL, V63, P693, DOI 10.1007/s00228-007-0301-9; Furu K, 2011, J CLIN EPIDEMIOL, V64, P878, DOI 10.1016/j.jclinepi.2010.10.014; Hansen L G, 1993, Pediatr Allergy Immunol, V4, P34, DOI 10.1111/j.1399-3038.1993.tb00063.x; HANSEN LG, 1992, ALLERGY, V47, P397, DOI 10.1111/j.1398-9995.1992.tb02079.x; Hoffmann F, 2010, EUR J CLIN PHARMACOL, V66, P307, DOI 10.1007/s00228-009-0755-z; Kamemura N, 2012, J ALLERGY CLIN IMMUN, V130, P113, DOI 10.1016/j.jaci.2012.02.023; Kirkwood BR, 2003, ESSENTIAL MED STAT; KJELLMAN NIM, 1984, ANN ALLERGY, V53, P167; Lau S, 2000, LANCET, V356, P1392, DOI 10.1016/S0140-6736(00)02842-7; Leynaert B, 2012, THORAX, V67, P625, DOI 10.1136/thoraxjnl-2011-201249; Lotvall J, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-94; Moth G, 2007, EUR J CLIN PHARMACOL, V63, P605, DOI 10.1007/s00228-007-0286-4; Pesonen M, 2009, PEDIAT ALLERG IMM-UK, V20, P12, DOI 10.1111/j.1399-3038.2008.00736.x; Pfefferle PI, 2008, J ALLERGY CLIN IMMUN, V122, P711, DOI 10.1016/j.jaci.2008.06.035; Postma DS, 2007, GENDER MED, V4, pS133, DOI 10.1016/S1550-8579(07)80054-4; Remes ST, 2002, THORAX, V57, P120, DOI 10.1136/thorax.57.2.120; Sadeghnejad A, 2004, THORAX, V59, P936, DOI 10.1136/thx.2004.024224; Shah PS, 2011, ANN ALLERG ASTHMA IM, V106, P245, DOI 10.1016/j.anai.2010.12.006; Tollefsen E, 2007, RESP MED, V101, P896, DOI 10.1016/j.rmed.2006.09.022; Vogt H, 2011, PEDIATRICS, V127, P1052, DOI 10.1542/peds.2010-3083; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294	34	5	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66777	10.1371/journal.pone.0066777	http://dx.doi.org/10.1371/journal.pone.0066777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805276	Green Published, gold, Green Submitted			2022-12-25	WOS:000320846500104
J	Ren, G; Beech, C; Smas, CM				Ren, Gang; Beech, Cameron; Smas, Cynthia M.			The Immunoglobulin Superfamily Protein Differentiation of Embryonic Stem Cells 1 (Dies1) Has a Regulatory Role in Preadipocyte to Adipocyte Conversion	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ADIPOSE-TISSUE; PPAR-GAMMA; SIGNALING PATHWAY; GENE-EXPRESSION; TNF-ALPHA; FAT; ADIPOGENESIS; METABOLISM; COMMITMENT	Differentiation of Embryonic Stem Cells 1 (Dies1) was recently identified as a novel type I immunoglobulin (IgG) domain-containing plasma membrane protein important for effective differentiation of a murine pluripotent embryonic stem cell line. In this setting, Dies1 enhances bone morphogenetic protein 4 (BMP4) signaling. Here we show Dies1 transcript expression is induced similar to 225-fold during in vitro adipogenesis of 3T3-L1 murine preadipocytes. Immunocytochemical imaging using ectopic expression of Flag-tagged Dies1 in 3T3-L1 adipocytes revealed localization to the adipocyte plasma membrane. Modulation of adipocyte phenotype with with tumor necrosis factor-alpha (TNF alpha) treatment or by siRNA knockdown of the master pro-adipogenic transcription factor peroxisome proliferator activated receptor gamma (PPAR gamma) resulted in a 90% and 60% reduction of Dies1 transcript levels, respectively. Moreover, siRNA-mediated Dies1 knockdown in 3T3-L1 preadipocytes inhibited adipogenic conversion. Such cultures had a 35% decrease in lipid content and a 45%-65% reduction in expression of key adipocyte transcripts, including that for PPARc. The standard protocol for full in vitro adipogenic conversion of committed preadipocytes, such as 3T3-L1, does not include BMP4 treatment. Thus we posit the positive role of Dies1 in adipogenesis, unlike that for Dies1 in differentiation of embryonic stem cells, does not include its pro-BMP4 effects. In support of this idea, 3T3-L1 adipocytes knocked down for Dies1 did not evidence decreased phospho-Smad1 levels upon BMP4 exposure. qPCR analysis of Dies1 transcript in multiple murine and human tissues reveals high enrichment in white adipose tissue (WAT). Interestingly, we observed a 10-fold induction of Dies1 transcript in WAT of fasted vs. fed mice, suggesting a role for Dies1 in nutritional response of mature fat cells in vivo. Together our data identify Dies1 as a new differentiation-dependent adipocyte plasma membrane protein whose expression is required for effective adipogenesis and that may also play a role in regard to nutritional status in WAT.	[Ren, Gang; Beech, Cameron; Smas, Cynthia M.] Univ Toledo, Coll Med, Dept Biochem & Canc Biol, Toledo, OH 43606 USA; [Smas, Cynthia M.] Univ Toledo, Coll Med, Ctr Diabet & Endocrine Res, Toledo, OH 43606 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Smas, CM (corresponding author), Univ Toledo, Coll Med, Dept Biochem & Canc Biol, 2801 W Bancroft St, Toledo, OH 43606 USA.	cynthia.smas@utoledo.edu		Ren, Gang/0000-0002-2555-7804	NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported in part by funding from NIH. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2009, TRENDS ENDOCRIN MET, V20, P424, DOI 10.1016/j.tem.2009.06.002; Aloia L, 2010, J BIOL CHEM, V285, P7776, DOI 10.1074/jbc.M109.077156; Armani A, 2010, J CELL BIOCHEM, V110, P564, DOI 10.1002/jcb.22598; BORTELL R, 1994, J CELL BIOCHEM, V54, P256, DOI 10.1002/jcb.240540214; Bowers RR, 2007, CELL CYCLE, V6, P385, DOI 10.4161/cc.6.4.3804; Cawthorn WP, 2012, J LIPID RES, V53, P227, DOI 10.1194/jlr.R021089; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Demeulemeester D, 2005, BIOCHEM BIOPH RES CO, V329, P105, DOI 10.1016/j.bbrc.2005.01.103; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Gustafson B, 2012, DIABETES, V61, P1217, DOI 10.2337/db11-1419; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Kawaguchi N, 2003, J CELL SCI, V116, P3893, DOI 10.1242/jcs.00699; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V16, P16; Klein J, 2002, BIOESSAYS, V24, P382, DOI 10.1002/bies.10058; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Parisi S, 2012, FASEB J, V26, P3957, DOI 10.1096/fj.12-211607; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Rosen E, 2009, EXPERT OPIN THER TAR, V13, P975, DOI 10.1517/14728220903039706; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ruan H, 2003, J BIOL CHEM, V278, P28181, DOI 10.1074/jbc.M303141200; Ruan H, 2002, DIABETES, V51, P3176, DOI 10.2337/diabetes.51.11.3176; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; Saely CH, 2012, GERONTOLOGY, V58, P15, DOI 10.1159/000321319; Sakr MA, 2010, CANCER SCI, V101, P2368, DOI 10.1111/j.1349-7006.2010.01675.x; Sul HS, 2000, INT J OBESITY, V24, pS15, DOI 10.1038/sj.ijo.0801494; Tan CY, 2008, BIOCHEM SOC T, V36, P935, DOI 10.1042/BST0360935; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Trayhurn Paul, 2011, Archives of Physiology and Biochemistry, V117, P47, DOI 10.3109/13813455.2010.535835; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Van Hul M, 2011, ENDOCR J, V58, P101, DOI 10.1507/endocrj.K10E-267; Wang L, 2011, J EXP MED, V208, P577, DOI 10.1084/jem.20100619; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Wu Y, 2008, AM J PHYSIOL-ENDOC M, V295, pE205, DOI 10.1152/ajpendo.90316.2008; Wu Yu, 2008, BMC Res Notes, V1, P85, DOI 10.1186/1756-0500-1-85; Xing H, 1997, ENDOCRINOLOGY, V138, P2776, DOI 10.1210/en.138.7.2776; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018	43	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65531	10.1371/journal.pone.0065531	http://dx.doi.org/10.1371/journal.pone.0065531			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799023	Green Published, Green Submitted, gold			2022-12-25	WOS:000321397800011
J	Crangle, CE; Perreau-Guimaraes, M; Suppes, P				Crangle, Colleen E.; Perreau-Guimaraes, Marcos; Suppes, Patrick			Structural Similarities between Brain and Linguistic Data Provide Evidence of Semantic Relations in the Brain	PLOS ONE			English	Article							WAVE REPRESENTATIONS; RECOGNITION; INVARIANCE; COMPONENT; MEANINGS	This paper presents a new method of analysis by which structural similarities between brain data and linguistic data can be assessed at the semantic level. It shows how to measure the strength of these structural similarities and so determine the relatively better fit of the brain data with one semantic model over another. The first model is derived from WordNet, a lexical database of English compiled by language experts. The second is given by the corpus-based statistical technique of latent semantic analysis (LSA), which detects relations between words that are latent or hidden in text. The brain data are drawn from experiments in which statements about the geography of Europe were presented auditorily to participants who were asked to determine their truth or falsity while electroencephalographic (EEG) recordings were made. The theoretical framework for the analysis of the brain and semantic data derives from axiomatizations of theories such as the theory of differences in utility preference. Using brain-data samples from individual trials time-locked to the presentation of each word, ordinal relations of similarity differences are computed for the brain data and for the linguistic data. In each case those relations that are invariant with respect to the brain and linguistic data, and are correlated with sufficient statistical strength, amount to structural similarities between the brain and linguistic data. Results show that many more statistically significant structural similarities can be found between the brain data and the WordNet-derived data than the LSA-derived data. The work reported here is placed within the context of other recent studies of semantics and the brain. The main contribution of this paper is the new method it presents for the study of semantics and the brain and the focus it permits on networks of relations detected in brain data and represented by a semantic model.	[Crangle, Colleen E.] Univ Lancaster, Sch Comp & Commun, Lancaster, England; [Crangle, Colleen E.] Converspeech LLC, Palo Alto, CA USA; [Perreau-Guimaraes, Marcos; Suppes, Patrick] Stanford Univ, Ctr Study Language & Informat, Suppes Brain Lab, Stanford, CA 94305 USA	Lancaster University; Stanford University	Crangle, CE (corresponding author), Univ Lancaster, Sch Comp & Commun, Lancaster, England.	crangle@converspeech.com						Ballatore Andrea, 2012, Advances in Conceptual Modeling. Proceedings ER 2012 Workshops: CMS, ECDM-NoCoDA, MoDIC, MORE-BI, RIGiM, SeCoGIS, WISM, P231, DOI 10.1007/978-3-642-33999-8_29; Baroni M, 2010, COGNITIVE SCI, V34, P222, DOI 10.1111/j.1551-6709.2009.01068.x; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Borovsky A, 2012, LANG LEARN DEV, V8, P278, DOI 10.1080/15475441.2011.614893; Brants T., 2006, WEB IT 5 GRAM VERSIO; Brennan J, 2012, NEUROIMAGE, V60, P1139, DOI 10.1016/j.neuroimage.2012.01.030; Budanitsky A, 2001, P NAACL 2001 WORKSH; Chan AM, 2011, NEUROIMAGE, V54, P3028, DOI 10.1016/j.neuroimage.2010.10.073; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Crestani F, 1997, ARTIF INTELL REV, V11, P453, DOI 10.1023/A:1006569829653; DEERWESTER S, 1990, J AM SOC INFORM SCI, V41, P391, DOI 10.1002/(SICI)1097-4571(199009)41:6<391::AID-ASI1>3.0.CO;2-9; Devereux Barry, 2010, P NAACL WORKSH COMP, P70; Fellbaum C., 1998, WORDNET ELECT LEXICA; Guimaraes MP, 2007, IEEE T BIO-MED ENG, V54, P436, DOI 10.1109/TBME.2006.888824; Henkin L., 1974, P TARSK S, VXXV, P465; Hirst G, 1988, LEXICAL AMBIGUITY RE, P73; Huth AG, 2012, NEURON, V76, P1210, DOI 10.1016/j.neuron.2012.10.014; Jelodar Ahmad Babaeian, 2010, P NAACL HLT 2010 1 W, P18; Just MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008622; Karp R.M., 1972, PROC S COMPLEXITY CO, P85, DOI 10.1007/978-1-4684-2001-2_9.; Kelly C., 2010, P NAACL HLT 2010 1 W, P61; Kriegeskorte Nikolaus, 2008, Front Syst Neurosci, V2, P4, DOI 10.3389/neuro.06.004.2008; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Landauer TK, 1998, DISCOURSE PROCESS, V25, P259, DOI 10.1080/01638539809545028; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; LUCE RD, 1956, ECONOMETRICA, V24, P178, DOI 10.2307/1905751; Lund K, 1996, BEHAV RES METH INSTR, V28, P203, DOI 10.3758/BF03204766; Martin P, 2003, LECT NOTES ARTIF INT, V2746, P160; Matsunaga T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-205; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; MILLER GA, 1955, J ACOUST SOC AM, V27, P338, DOI 10.1121/1.1907526; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Murphy B., 2009, P 2009 C EMP METH NA, P619, DOI [10.3115/1699571.1699594, DOI 10.3115/1699571.1699594]; Murphy B., 2010, P NAACL HLT 2010 1 W, P36; Murphy B, 2012, P 1 JOINT C LEX COMP, V2, P114; Murphy B, 2011, BRAIN LANG, V117, P12, DOI 10.1016/j.bandl.2010.09.013; Murphy Brian, 2012, P 1 JOINT C LEX COMP, P114; Patwardhan S, 2004, P 19 NAT C ART INT I; Pereira F.B., 2010, P 2010 IEEE C EV COM, P1, DOI DOI 10.1109/ICCCN.2010.5560019; Princeton University, WORDNET; Scott D., 1958, J SYMBOLIC LOGIC, V23, P113, DOI [DOI 10.2307/2964389, 10.2307/2964389]; Sudre G, 2012, NEUROIMAGE, V62, P451, DOI 10.1016/j.neuroimage.2012.04.048; Suppes P, 1997, P NATL ACAD SCI USA, V94, P14965, DOI 10.1073/pnas.94.26.14965; Suppes P, 1998, P NATL ACAD SCI USA, V95, P15861, DOI 10.1073/pnas.95.26.15861; Suppes P, 1999, P NATL ACAD SCI USA, V96, P14658, DOI 10.1073/pnas.96.25.14658; Suppes P, 1999, P NATL ACAD SCI USA, V96, P12953, DOI 10.1073/pnas.96.22.12953; Suppes P, 2000, P NATL ACAD SCI USA, V97, P8738, DOI 10.1073/pnas.140228397; Suppes P., 1972, AXIOMATIC SET THEORY; Suppes P, 2009, NEURAL COMPUT, V21, P3228, DOI 10.1162/neco.2009.04-08-764; Wong DK, 2008, NEUROIMAGE, V39, P1051, DOI 10.1016/j.neuroimage.2007.07.064; Wong DK, 2006, NEUROCOMPUTING, V70, P373, DOI 10.1016/j.neucom.2006.01.020; Wong DK, 2004, NEUROCOMPUTING, V61, P479, DOI 10.1016/j.neucom.2004.06.004; Woods W.A., 1975, REPRESENTATION UNDER, P35	54	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65366	10.1371/journal.pone.0065366	http://dx.doi.org/10.1371/journal.pone.0065366			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163UV	23799009	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300016
J	Crowe, TP; Cusson, M; Bulleri, F; Davoult, D; Arenas, F; Aspden, R; Benedetti-Cecchi, L; Bevilacqua, S; Davidson, I; Defew, E; Fraschetti, S; Gollety, C; Griffin, JN; Herkul, K; Kotta, J; Migne, A; Molis, M; Nicol, SK; Noel, LMLJ; Pinto, IS; Valdivia, N; Vaselli, S; Jenkins, SR				Crowe, Tasman P.; Cusson, Mathieu; Bulleri, Fabio; Davoult, Dominique; Arenas, Francisco; Aspden, Rebecca; Benedetti-Cecchi, Lisandro; Bevilacqua, Stanislao; Davidson, Irvine; Defew, Emma; Fraschetti, Simonetta; Gollety, Claire; Griffin, John N.; Herkuel, Kristjan; Kotta, Jonne; Migne, Aline; Molis, Markus; Nicol, Sophie K.; Noel, Laure M-L J.; Pinto, Isabel Sousa; Valdivia, Nelson; Vaselli, Stefano; Jenkins, Stuart R.			Large-Scale Variation in Combined Impacts of Canopy Loss and Disturbance on Community Structure and Ecosystem Functioning	PLOS ONE			English	Article							BIODIVERSITY LOSS; MARINE BIODIVERSITY; DIVERSITY; ASSEMBLAGES; PRODUCTIVITY; STABILITY; IDENTITY; ALGAE; REDUNDANCY; PATTERNS	Ecosystems are under pressure from multiple human disturbances whose impact may vary depending on environmental context. We experimentally evaluated variation in the separate and combined effects of the loss of a key functional group (canopy algae) and physical disturbance on rocky shore ecosystems at nine locations across Europe. Multivariate community structure was initially affected (during the first three to six months) at six locations but after 18 months, effects were apparent at only three. Loss of canopy caused increases in cover of non-canopy algae in the three locations in southern Europe and decreases in some northern locations. Measures of ecosystem functioning (community respiration, gross primary productivity, net primary productivity) were affected by loss of canopy at five of the six locations for which data were available. Short-term effects on community respiration were widespread, but effects were rare after 18 months. Functional changes corresponded with changes in community structure and/or species richness at most locations and times sampled, but no single aspect of biodiversity was an effective predictor of longer-term functional changes. Most ecosystems studied were able to compensate in functional terms for impacts caused by indiscriminate physical disturbance. The only consistent effect of disturbance was to increase cover of non-canopy species. Loss of canopy algae temporarily reduced community resistance to disturbance at only two locations and at two locations actually increased resistance. Resistance to disturbance-induced changes in gross primary productivity was reduced by loss of canopy algae at four locations. Location-specific variation in the effects of the same stressors argues for flexible frameworks for the management of marine environments. These results also highlight the need to analyse how species loss and other stressors combine and interact in different environmental contexts.	[Crowe, Tasman P.; Cusson, Mathieu; Nicol, Sophie K.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland; [Cusson, Mathieu; Bulleri, Fabio; Benedetti-Cecchi, Lisandro; Vaselli, Stefano] Univ Pisa, Dept Biol, Consorzio Interuniv Sci Mare, Pisa, Italy; [Cusson, Mathieu] Univ Quebec Chicoutimi, Dept Sci Fondamentales, Chicoutimi, PQ, Canada; [Davoult, Dominique; Gollety, Claire; Migne, Aline; Noel, Laure M-L J.] Univ Paris 06, Stn Biol Roscoff, Roscoff, France; [Davoult, Dominique; Gollety, Claire; Migne, Aline; Noel, Laure M-L J.] CNRS, Stn Biol Roscoff, Roscoff, France; [Arenas, Francisco; Pinto, Isabel Sousa; Vaselli, Stefano] Univ Porto, Lab Coastal Biodivers, Ctr Marine & Environm Res, P-4100 Oporto, Portugal; [Aspden, Rebecca; Davidson, Irvine; Defew, Emma] Univ St Andrews, Scottish Oceans Inst, St Andrews, Fife, Scotland; [Bevilacqua, Stanislao; Fraschetti, Simonetta] Univ Salento, Dept Biol Environm Sci & Technol, Consorzio Nazl Interunv Sci Mare, Lecce, Italy; [Griffin, John N.; Noel, Laure M-L J.; Jenkins, Stuart R.] Marine Biol Assoc UK, Plymouth, Devon, England; [Herkuel, Kristjan; Kotta, Jonne] Univ Tartu, Estonian Marine Inst, Tallinn, Estonia; [Molis, Markus; Valdivia, Nelson] Alfred Wegener Inst Polar & Marine Res, Biol Anstalt Helgoland, Sect Funct Ecol, Helgoland, Germany; [Valdivia, Nelson] Univ Austral Chile, Inst Ciencias Marinas & Limnol, Lab Costero Recursos Acuat Calfuco, Valdivia, Chile; [Jenkins, Stuart R.] Bangor Univ, Sch Ocean Sci, Menai Bridge, Gwynedd, Wales; [Griffin, John N.] Swansea Univ, Dept Biosci, Swansea, W Glam, Wales	University College Dublin; University of Pisa; University of Quebec; University of Quebec Chicoutimi; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universidade do Porto; University of St Andrews; University of Salento; Marine Biological Association United Kingdom; University of Tartu; Estonian Marine Institute; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Universidad Austral de Chile; Bangor University; Swansea University	Crowe, TP (corresponding author), Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland.	tasman.crowe@ucd.ie	Jenkins, Stuart R/D-2032-2010; Davoult, dominique/D-5932-2012; Gollety, Claire/D-6743-2011; Arenas, Francisco/M-6367-2013; Arenas, Francisco/M-7095-2015; Cusson, Mathieu/A-3026-2014; Kotta, Jonne/B-5542-2009; Fraschetti, Simonetta/R-8716-2019; Bevilacqua, Stanislao/I-1393-2019; Pinto, Isabel Sousa/W-1591-2019; Valdivia, Nelson A/C-3613-2009; Benedetti-Cecchi, Lisandro/J-8225-2019; Herkül, Kristjan/G-5791-2016	Jenkins, Stuart R/0000-0002-2299-6318; Davoult, dominique/0000-0001-8678-3998; Arenas, Francisco/0000-0001-6925-3805; Arenas, Francisco/0000-0001-6925-3805; Kotta, Jonne/0000-0002-4970-6755; Fraschetti, Simonetta/0000-0002-1780-1651; Bevilacqua, Stanislao/0000-0002-6417-7134; Pinto, Isabel Sousa/0000-0002-9231-0553; Valdivia, Nelson A/0000-0002-5394-2072; Benedetti-Cecchi, Lisandro/0000-0001-5244-5202; Herkül, Kristjan/0000-0002-4356-8152; Cusson, Mathieu/0000-0002-2111-4803; Griffin, John/0000-0003-3295-6480; Bulleri, Fabio/0000-0002-7335-6791	European Community [GOCE-CT-2003-505446]; Irish Research Council for Science, Engineering and Technology; Natural Environment Research Council [NE/B504649/1] Funding Source: researchfish	European Community(European Commission); Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The project was carried out within the framework of the MarBEF Network of Excellence 'Marine Biodiversity and Ecosystem Functioning' which was funded by the Sustainable Development, Global Change and Ecosystems Programme of the European Community's Sixth Framework Programme (contract no. GOCE-CT-2003-505446). Additional funding was provided by participating institutions and the Irish Research Council for Science, Engineering and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Anderson M. J., 2005, PERMANOVA FORTRAN CO; Araujo R, 2012, MAR BIOL, V159, P697, DOI 10.1007/s00227-011-1847-8; Atalah J, 2010, J EXP MAR BIOL ECOL, V388, P51, DOI 10.1016/j.jembe.2010.03.005; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; BELL EC, 1993, MAR BIOL, V117, P337, DOI 10.1007/BF00345679; Benedetti-Cecchi L, 2001, MAR ECOL PROG SER, V214, P137, DOI 10.3354/meps214137; BENEDETTICECCHI L, 1992, MAR ECOL PROG SER, V90, P183, DOI 10.3354/meps090183; Bertness MD, 1997, ECOLOGY, V78, P1976, DOI 10.1890/0012-9658(1997)078[1976:TROPII]2.0.CO;2; Bertocci I, 2010, MAR ECOL PROG SER, V414, P107, DOI 10.3354/meps08729; BIDWELL RGS, 1985, J EXP MAR BIOL ECOL, V86, P15, DOI 10.1016/0022-0981(85)90040-1; Biles CL, 2003, J EXPT MARINE BIOL E, P285; Boyer KE, 2009, OIKOS, V118, P1062, DOI 10.1111/j.1600-0706.2009.17252.x; Bruno JF, 2005, ECOL LETT, V8, P1165, DOI 10.1111/j.1461-0248.2005.00823.x; Bulleri F, 2002, J EXP MAR BIOL ECOL, V267, P89, DOI 10.1016/S0022-0981(01)00361-6; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Crowe TP, 2012, MARINE BIODIVERSITY AND ECOSYSTEM FUNCTIONING: FRAMEWORKS, METHODOLOGIES, AND INTEGRATION, P185; Crowe TP, 2009, ECOL STUD-ANAL SYNTH, V206, P375, DOI 10.1007/978-3-540-92704-4_27; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Duffy JE, 2001, ECOLOGY, V82, P2417; Dyson KE, 2007, P ROY SOC B-BIOL SCI, V274, P2547, DOI 10.1098/rspb.2007.0922; European Union, 2008, OFF J EUR UNION L, VL164, P19; Folt CL, 1999, LIMNOL OCEANOGR, V44, P864, DOI 10.4319/lo.1999.44.3_part_2.0864; Foster MS, 2003, J EXP MAR BIOL ECOL, V289, P15, DOI 10.1016/S0022-0981(03)00035-2; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; Gollety C, 2008, THESIS UPMC U PARIS, P+4; Gollety C, 2008, J PHYCOL, V44, P1146, DOI 10.1111/j.1529-8817.2008.00569.x; Gorgula SK, 2004, MAR BIOL, V145, P613, DOI 10.1007/s00227-004-1335-5; Griffin John n., 2009, P78; Griffin JN, 2009, OIKOS, V118, P37, DOI 10.1111/j.1600-0706.2008.16960.x; Grimm V, 1997, OECOLOGIA, V109, P323, DOI 10.1007/s004420050090; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Jenkins SR, 2004, J MAR BIOL ASSOC UK, V84, P327, DOI 10.1017/S0025315404009221h; Jenkins SR, 1999, MAR ECOL PROG SER, V188, P81, DOI 10.3354/meps188081; Jenkins SR, 2008, ECOLOGY, V89, pS3, DOI 10.1890/07-1155.1; JOHNSON WS, 1974, ECOLOGY, V55, P450, DOI 10.2307/1935235; JOHNSTON AM, 1986, OECOLOGIA, V69, P288, DOI 10.1007/BF00377636; Kirk JTO, 1994, LIGHT PHOTOSYNTHESIS; Leonard GH, 2000, ECOLOGY, V81, P1015; Maggi E, 2009, MAR ECOL PROG SER, V381, P39, DOI 10.3354/meps07949; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; Migne A, 2002, MAR BIOL, V140, P865, DOI 10.1007/s00227-001-0741-1; Millennium Ecosystem Assessment (MA), 2005, ECOSYSTEMS HUMAN WEL; Moore P, 2007, MAR ECOL PROG SER, V334, P11, DOI 10.3354/meps334011; Mouillot D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017476; Naeem S, 2008, TRENDS ECOL EVOL, V23, P414, DOI 10.1016/j.tree.2008.05.003; Nielsen KJ, 2001, ECOL MONOGR, V71, P187, DOI 10.1890/0012-9615(2001)071[0187:BUATDF]2.0.CO;2; Noel LMLJ, 2010, ESTUAR COAST SHELF S, V88, P153, DOI 10.1016/j.ecss.2010.03.005; O'Connor NE, 2005, ECOLOGY, V86, P1783, DOI 10.1890/04-1172; O'Connor NE, 2008, ECOLOGY, V89, P428, DOI 10.1890/06-2029.1; O'Connor NE, 2007, OIKOS, V116, P2027, DOI 10.1111/j.2007.0030-1299.16085.x; Paine R. T., 1977, ACAD NAT SCI SPEC PU, V12, P245; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Reich PB, 2012, SCIENCE, V336, P589, DOI 10.1126/science.1217909; Reynolds PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036196; Schiel DR, 2007, MAR ECOL PROG SER, V339, P1, DOI 10.3354/meps339001; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stachowicz JJ, 2007, ANNU REV ECOL EVOL S, V38, P739, DOI 10.1146/annurev.ecolsys.38.091206.095659; Stachowicz JJ, 2008, P NATL ACAD SCI USA, V105, P18842, DOI 10.1073/pnas.0806425105; Stachowicz JJ, 2008, ECOLOGY, V89, P3008, DOI 10.1890/07-1873.1; Tait LW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026986; Thompson RC, 2002, ENVIRON CONSERV, V29, P168, DOI 10.1017/S0376892902000115; Underwood A, 1997, EXPT ECOLOGY THEIR L; Valdivia N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036541; WALKER B, 1995, CONSERV BIOL, V9, P747, DOI 10.1046/j.1523-1739.1995.09040747.x; Wernberg T, 2012, GLOBAL CHANGE BIOL, V18, P1491, DOI 10.1111/j.1365-2486.2012.02656.x; Whittaker K, 1975, PRIMARY PRODUCTIVITY, V14, P306; Williams SL, 2005, ECOLOGY, V86, P2373, DOI 10.1890/04-1569; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	77	40	40	2	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66238	10.1371/journal.pone.0066238	http://dx.doi.org/10.1371/journal.pone.0066238			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799082	Green Published, Green Accepted, gold			2022-12-25	WOS:000320363300067
J	Leko, V; Park, GJ; Lao, U; Simon, JA; Bedalov, A				Leko, Vid; Park, Gemma J.; Lao, Uyen; Simon, Julian A.; Bedalov, Antonio			Enterocyte-Specific Inactivation of SIRT1 Reduces Tumor Load in the APC(+/min) Mouse Model	PLOS ONE			English	Article							BETA-CATENIN; C-MYC; INTESTINAL NEOPLASIA; POLYP FORMATION; POOR-PROGNOSIS; CELL-SURVIVAL; STEM-CELLS; EXPRESSION; P53; GROWTH	SIRT1 is a mammalian NAD(+)-dependent histone deacetylase implicated in metabolism, development, aging and tumorigenesis. Prior studies that examined the effect of enterocyte-specific overexpression and global deletion of SIRT1 on polyp formation in the intestines of APC(+/min) mice, a commonly used model for intestinal tumorigenesis, yielded conflicting results, supporting either tumor-suppressive or tumor-promoting roles for SIRT1, respectively. In order to resolve the controversy emerging from these prior in vivo studies, in the present report we examined the effect of SIRT1 deficiency confined to the intestines, avoiding the systemic perturbations such as growth retardation seen with global SIRT1 deletion. We crossed APC(+/min) mice with mice bearing enterocyte-specific inactivation of SIRT1 and examined polyp development in the progeny. We found that SIRT1-inactivation reduced total polyp surface (9.3 mm(2) vs. 23.3 mm(2), p = 0.01), average polyp size (0.24 mm(2) vs. 0.51 mm(2), p = 0.005) and the number of polyps >0.5 mm in diameter (14 vs. 23, p = 0.04), indicating that SIRT1 affects both the number and size of tumors. Additionally, tumors in SIRT1-deficient mice exhibited markedly increased numbers of cells undergoing apoptosis, suggesting that SIRT1 contributes to tumor growth by enabling survival of tumor cells. Our results indicate that SIRT1 acts as a tumor promoter in the APC(+/min) mouse model of intestinal tumorigenesis.	[Leko, Vid; Park, Gemma J.; Lao, Uyen; Simon, Julian A.; Bedalov, Antonio] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Simon, Julian A.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA; [Bedalov, Antonio] Univ Washington, Dept Med, Seattle, WA USA; [Bedalov, Antonio] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bedalov, A (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	abedalov@fhcrc.org			National Institutes of Health (NIH) [CA 129132]; NATIONAL CANCER INSTITUTE [R01CA129132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (NIH), CA 129132, to AB. (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boily G, 2009, ONCOGENE, V28, P2882, DOI 10.1038/onc.2009.147; Bonda DJ, 2011, LANCET NEUROL, V10, P275, DOI 10.1016/S1474-4422(11)70013-8; Bradbury C, 2005, LEUKEMIA, V19, P1751, DOI 10.1038/sj.leu.2403910; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Cha EJ, 2009, CLIN CANCER RES, V15, P4453, DOI 10.1158/1078-0432.CCR-08-3329; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dai JM, 2007, J CELL PHYSIOL, V210, P161, DOI 10.1002/jcp.20831; Eads CA, 2002, CANCER RES, V62, P1296; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Herranz D, 2012, ONCOGENE; Herranz D, 2010, NAT REV CANCER, V10, P819, DOI 10.1038/nrc2962; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Hida Y, 2007, ARCH DERMATOL RES, V299, P103, DOI 10.1007/s00403-006-0725-6; Holloway KR, 2010, P NATL ACAD SCI USA, V107, P9216, DOI 10.1073/pnas.0911325107; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; Jang KY, 2008, AM J SURG PATHOL, V32, P1523, DOI 10.1097/PAS.0b013e31816b6478; Kojima K, 2008, BIOCHEM BIOPH RES CO, V373, P423, DOI 10.1016/j.bbrc.2008.06.045; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; Lara E, 2009, ONCOGENE, V28, P781, DOI 10.1038/onc.2008.436; Lee H, 2011, HUM PATHOL, V42, P204, DOI 10.1016/j.humpath.2010.05.023; Lemieux ME, 2005, MECH AGEING DEV, V126, P1097, DOI 10.1016/j.mad.2005.04.006; Levina E, 2004, ONCOGENE, V23, P4444, DOI 10.1038/sj.onc.1207587; Li L, 2012, CANCER CELL, V21, P266, DOI 10.1016/j.ccr.2011.12.020; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Liu Y, 2006, P NATL ACAD SCI USA, V103, P976, DOI 10.1073/pnas.0510146103; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mahajan Sumit S, 2011, Handb Exp Pharmacol, V206, P241, DOI 10.1007/978-3-642-21631-2_11; Marshall GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002135; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Menssen A, 2012, ONCOTARGET, V3, P112, DOI 10.18632/oncotarget.440; Menssen A, 2012, P NATL ACAD SCI USA, V109, pE187, DOI 10.1073/pnas.1105304109; Mohammad HP, 2011, ONCOGENE, V30, P2659, DOI 10.1038/onc.2010.633; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; Nosho K, 2009, MODERN PATHOL, V22, P922, DOI 10.1038/modpathol.2009.49; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Prelich G, 2012, GENETICS, V190, P841, DOI 10.1534/genetics.111.136911; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Simic P, 2013, EMBO MOL MED, V5, P430, DOI 10.1002/emmm.201201606; Song NY, 2012, ANN NY ACAD SCI, V1271, P10, DOI 10.1111/j.1749-6632.2012.06762.x; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Valenta T, 2006, EMBO J, V25, P2326, DOI 10.1038/sj.emboj.7601147; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wu YP, 2002, CANCER RES, V62, P1030; Yekkala K, 2007, MOL CANCER RES, V5, P1296, DOI 10.1158/1541-7786.MCR-07-0232; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029	63	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66283	10.1371/journal.pone.0066283	http://dx.doi.org/10.1371/journal.pone.0066283			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799088	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300072
J	Ndeledje, N; Bouyer, J; Stachurski, F; Grimaud, P; Belem, AMG; Mbaindingatoloum, FM; Bengaly, Z; Alfaroukh, IO; Cecchi, G; Lancelot, R				Ndeledje, Noel; Bouyer, Jeremy; Stachurski, Frederic; Grimaud, Patrice; Belem, Adrien Marie Gaston; Mbaindingatoloum, Fidele Molele; Bengaly, Zakaria; Alfaroukh, Idriss Oumar; Cecchi, Guiliano; Lancelot, Renaud			Treating Cattle to Protect People? Impact of Footbath Insecticide Treatment on Tsetse Density in Chad	PLOS ONE			English	Article							RESTRICTED APPLICATION; FLIES; POPULATION; TRYPANOSOMOSIS; IDENTIFICATION; PYRETHROIDS; LIVESTOCK; IMPROVE; RISK	Background: In Chad, several species of tsetse flies (Genus: Glossina) transmit African animal trypanosomoses (AAT), which represents a major obstacle to cattle rearing, and sleeping sickness, which impacts public health. After the failure of past interventions to eradicate tsetse, the government of Chad is now looking for other approaches that integrate cost-effective intervention techniques, which can be applied by the stake holders to control tsetse-transmitted trypanosomoses in a sustainable manner. The present study thus attempted to assess the efficacy of restricted application of insecticides to cattle leg extremities using footbaths for controlling Glossina m. submorsitans, G. tachinoides and G. f. fuscipes in southern Chad. Methodology/Principal Findings: Two sites were included, one close to the historical human African trypanosomiasis (HAT) focus of Moundou and the other to the active foci of Bodo and Moissala. At both sites, a treated and an untreated herd were compared. In the treatment sites, cattle were treated on a regular basis using a formulation of deltamethrin 0.005% (67 to 98 cattle were treated in one of the sites and 88 to 102 in the other one). For each herd, tsetse densities were monthly monitored using 7 biconical traps set along the river and beside the cattle pen from February to December 2009. The impact of footbath treatment on tsetse populations was strong (p < 10(-3)) with a reduction of 80% in total tsetse catches by the end of the 6-month footbath treatment. Conclusions/Significance: The impact of footbath treatment as a vector control tool within an integrated strategy to manage AAT and HAT is discussed in the framework of the "One Health" concept. Like other techniques based on the treatment of cattle, this technology should be used under controlled conditions, in order to avoid the development of insecticide and acaricide resistance in tsetse and tick populations, respectively.	[Ndeledje, Noel; Bengaly, Zakaria] Ctr Int Rech Dev Elevage Zone Subhumide CIRDES, Bobo Dioulasso, Burkina Faso; [Bouyer, Jeremy] Inst Senegalais Rech Agr, Lab Natl Elevage & Rech Vet, Dakar, Senegal; [Bouyer, Jeremy; Stachurski, Frederic; Lancelot, Renaud] Ctr Cooperat Int Rech Agron Dev CIRAD, Unite Mixte Rech Controle Malad Anim Exot & Emerg, Montpellier, France; [Bouyer, Jeremy; Stachurski, Frederic; Lancelot, Renaud] INRA, Unite Mixte Rech Controle Malad Anim Exot & Emerg, F-34060 Montpellier, France; [Belem, Adrien Marie Gaston] Univ Polytech Bobo Dioulasso UPB, Bobo Dioulasso, Burkina Faso; [Cecchi, Guiliano] UN, Food & Agr Org, Anim Prod & Hlth Div, Rome, Italy	CIRAD; INRAE; Food & Agriculture Organization of the United Nations (FAO)	Bouyer, J (corresponding author), Inst Senegalais Rech Agr, Lab Natl Elevage & Rech Vet, Dakar, Senegal.	bouyer@cirad.fr	Lancelot, Renaud/HGE-1086-2022; Bouyer, Jérémy/AAK-7370-2020	Lancelot, Renaud/0000-0002-5826-5242; Bouyer, Jérémy/0000-0002-1913-416X	Project "Pole Regional de Recherche Appliquee au developpement des Systemes Agricoles d'Afrique Centrale" (PRASAC); French Embassy in Chad; Government of Italy through the FAO Trust Fund for Food Security and Food Safety; FAO, in the framework of the Programme against African Trypanosomosis (PAAT), through the project "Improving food security in sub-Saharan Africa by supporting the progressive reduction of tsetse-transmitted trypanosomosis in the framework of the NEPAD" [GTFS/RAF/474/ITA]	Project "Pole Regional de Recherche Appliquee au developpement des Systemes Agricoles d'Afrique Centrale" (PRASAC); French Embassy in Chad; Government of Italy through the FAO Trust Fund for Food Security and Food Safety; FAO, in the framework of the Programme against African Trypanosomosis (PAAT), through the project "Improving food security in sub-Saharan Africa by supporting the progressive reduction of tsetse-transmitted trypanosomosis in the framework of the NEPAD"	CEVA Sante Animale provided the insecticide (VectocidND) used in this study, and the field work was funded by the Project "Pole Regional de Recherche Appliquee au developpement des Systemes Agricoles d'Afrique Centrale" (PRASAC) and the French Embassy in Chad. FAO, in the framework of the Programme against African Trypanosomosis (PAAT), provided technical assistance to this research, in particular through the project "Improving food security in sub-Saharan Africa by supporting the progressive reduction of tsetse-transmitted trypanosomosis in the framework of the NEPAD" (GTFS/RAF/474/ITA), funded by the Government of Italy through the FAO Trust Fund for Food Security and Food Safety. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The boundaries and names shown and the designations used on the maps presented in this paper do not imply the expression of any opinion whatsoever on the part of the Food and Agriculture Organization of the United Nations (FAO) concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The views expressed in this paper are those of the authors and do not necessarily reflect the views of FAO.	Adam Y, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002135; [Anonymous], 2005, AFRICA BUSINESS APR; [Anonymous], WORLD FACTB; Bates D, 2011, IME4 LINEAR MIXED EF; Bourn D., 2005, ASPECTS APPL BIOL, V75, P1; Bouyer F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001276; Bouyer J, 2007, PREV VET MED, V78, P223, DOI 10.1016/j.prevetmed.2006.10.008; Bouyer J., 2008, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V61, P161; Bouyer J, 2009, MOL ECOL, V18, P2787, DOI 10.1111/j.1365-294X.2009.04233.x; Bouyer J, 2009, VET PARASITOL, V161, P187, DOI 10.1016/j.vetpar.2009.01.018; Bouyer J., 2010, INFECT PARASITIC DIS, P1936; Bouyer J, 2008, REV ELEV MED VET PAY, V61, P153; Bouyer J, 2006, VET RES, V37, P633, DOI 10.1051/vetres:2006025; Camara M, 2005, Med Trop (Mars), V65, P155; Cecchi Giuliano, 2009, P1; CHALLIER A, 1973, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V11, P251; Core R Team, 2013, R LANG ENV STAT COMP; De Deken R, 1998, ANN NY ACAD SCI, V849, P450, DOI 10.1111/j.1749-6632.1998.tb11095.x; de l'ElevageduMinistere Tchad, 2002, RAPP STAT; Desquesnes M, 2001, ANN TROP MED PARASIT, V95, P141, DOI 10.1080/00034980120050251; Dyer NA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001266; Eisler MC, 2003, TRENDS PARASITOL, V19, P341, DOI 10.1016/S1471-4922(03)00164-8; Funk S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002855; Goldstein H., 1999, MULTILEVEL STAT MODE; Grady SC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000957; Gruvel J, 1966, Rev Elev Med Vet Pays Trop, V19, P169; Habtewold T, 2004, MED VET ENTOMOL, V18, P408, DOI 10.1111/j.0269-283X.2004.00525.x; Hargrove JW., 2003, TSETSE ERADICATION S; Lehner B., 2008, EOS T AM GEOPHYS UN, V89, P93, DOI [10.1029/2008EO100001, DOI 10.1029/2008EO100001, DOI 10.1111/j.1469-8137.2009.03092.x]; Pagabeleguem S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049762; Rayaisse JB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001491; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; ROGERS DJ, 1990, INSECT SCI APPL, V11, P331, DOI 10.1017/S1742758400012753; ROGERS DJ, 1988, PARASITOLOGY, V97, P193, DOI 10.1017/S0031182000066853; Simarro PP, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-57; Simarro PP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001859; Stachurski F, 2000, MED VET ENTOMOL, V14, P391, DOI 10.1046/j.1365-2915.2000.00246.x; Stachurski F, 2006, MED VET ENTOMOL, V20, P402, DOI 10.1111/j.1365-2915.2006.00648.x; Tibayreac R, 1977, Revue Elev Med vet Pays trop, V30, P31; Tibayrenc R, 1977, PROSPECTIONS PULVERI, V20, P19; Torr SJ, 2007, MED VET ENTOMOL, V21, P53, DOI 10.1111/j.1365-2915.2006.00657.x; Torr SJ, 2000, MED VET ENTOMOL, V14, P400, DOI 10.1046/j.1365-2915.2000.00257.x; Vale GA, 2004, B ENTOMOL RES, V94, P273, DOI 10.1079/BER2004300; Van den Bossche P, 2010, TRENDS PARASITOL, V26, P236, DOI 10.1016/j.pt.2010.02.010; Welburn SC, 2006, TRENDS PARASITOL, V22, P123, DOI 10.1016/j.pt.2006.01.011; Welburn SC, 2001, LANCET, V358, P2017, DOI 10.1016/S0140-6736(01)07096-9; Wint W, 2000, PREDICTED DISTRIBUTI; Wint W., 2007, GRIDDED LIVESTOCK WO	48	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e67580	10.1371/journal.pone.0067580	http://dx.doi.org/10.1371/journal.pone.0067580			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799148	Green Published, gold			2022-12-25	WOS:000320363300111
J	Huang, CW; Lai, MC; Cheng, JT; Tsai, JJ; Huang, CC; Wu, SN				Huang, Chin-Wei; Lai, Ming-Chi; Cheng, Juei-Tang; Tsai, Jing-Jane; Huang, Chao-Ching; Wu, Sheng-Nan			Pregabalin Attenuates Excitotoxicity in Diabetes	PLOS ONE			English	Article							SENSITIVE POTASSIUM CHANNELS; ANTIEPILEPTIC DRUGS; PILOCARPINE MODEL; GLUTAMATE RELEASE; DOUBLE-BLIND; K+ CHANNEL; SEIZURES; NEURONS; EPILEPSY; BRAIN	Diabetes can exacerbate seizures and worsen seizure-related brain damage. In the present study, we aimed to determine whether the standard antiepileptic drug pregabalin (PGB) protects against pilocarpine-induced seizures and excitotoxicity in diabetes. Adult male Sprague-Dawley rats were divided into either a streptozotocin (STZ)-induced diabetes group or a normal saline (NS) group. Both groups were further divided into subgroups that were treated intravenously with either PGB (15 mg/kg) or a vehicle; all groups were treated with subcutaneous pilocarpine (60 mg/kg) to induce seizures. To evaluate spontaneous recurrent seizures (SRS), PGB-pretreated rats were fed rat chow containing oral PGB (450 mg) for 28 consecutive days; vehicle-pretreated rats were fed regular chow. SRS frequency was monitored for 2 weeks from post-status epilepticus day 15. We evaluated both acute neuronal loss and chronic mossy fiber sprouting in the CA3 area. In addition, we performed patch clamp recordings to study evoked excitatory postsynaptic currents (eEPSCs) in hippocampal CA1 neurons for both vehicle-treated rats with SRS. Finally, we used an RNA interference knockdown method for Kir6.2 in a hippocampal cell line to evaluate PGB's effects in the presence of high-dose ATP. We found that compared to vehicle-treated rats, PGB-treated rats showed less severe acute seizure activity, reduced acute neuronal loss, and chronic mossy fiber sprouting. In the vehicle-treated STZ rats, eEPSC amplitude was significantly lower after PGB administration, but glibenclamide reversed this effect. The RNA interference study confirmed that PGB could counteract the ATP-sensitive potassium channel (K-ATP)-closing effect of high-dose ATP. By opening K-ATP, PGB protects against neuronal excitotoxicity, and is therefore a potential antiepileptogenic in diabetes. These findings might help develop a clinical algorithm for treating patients with epilepsy and comorbid metabolic disorders.	[Huang, Chin-Wei; Cheng, Juei-Tang] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Neurol, Tainan 70101, Taiwan; [Lai, Ming-Chi] Chi Mei Fdn Med Ctr, Dept Pediat, Tainan, Taiwan; [Cheng, Juei-Tang] Natl Cheng Kung Univ, Dept Pharmacol, Tainan 70101, Taiwan; [Huang, Chao-Ching] Natl Cheng Kung Univ Hosp, Dept Pediat, Tainan 70428, Taiwan; [Wu, Sheng-Nan] Natl Cheng Kung Univ, Dept Physiol, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; Chi Mei Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Huang, CW (corresponding author), Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Neurol, Tainan 70101, Taiwan.	huangcw@mail.ncku.edu.tw; snwu@mail.ncku.edu.tw	Wu, Sheng-Nan/B-9224-2009	Huang, Chao-Ching/0000-0003-2799-7181; Wu, Sheng-Nan/0000-0002-5208-3253	Taiwan National Science Council [NSC-100-2314-B-006-002, NSC-101-2314-B-006-059]; National Cheng Kung University Hospital [NCKUH-10103010]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); National Cheng Kung University Hospital	This project was funded by grants NSC-100-2314-B-006-002 and NSC-101-2314-B-006-059 from the Taiwan National Science Council and grant NCKUH-10103010 from National Cheng Kung University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre V, 2007, EPILEPSIA, V48, P41, DOI 10.1111/j.1528-1167.2007.01288.x; Bancila V, 2004, J NEUROCHEM, V90, P1243, DOI 10.1111/j.1471-4159.2004.02587.x; Betourne A, 2009, NEUROPHARMACOLOGY, V56, P615, DOI 10.1016/j.neuropharm.2008.11.001; Bialer M, 2004, EPILEPSY RES, V61, P1, DOI 10.1016/j.eplepsyres.2004.07.010; Chang YC, 2003, ANN NEUROL, V54, P706, DOI 10.1002/ana.10789; Chuang YC, 2012, EPILEPSIA, V53, P120, DOI 10.1111/j.1528-1167.2011.03316.x; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Dunn-Meynell AA, 1998, BRAIN RES, V814, P41, DOI 10.1016/S0006-8993(98)00956-1; Eckstein-Ludwig U, 1999, BRIT J PHARMACOL, V128, P92, DOI 10.1038/sj.bjp.0702794; FERNER RE, 1992, BAILLIERE CLIN ENDOC, V6, P849, DOI 10.1016/S0950-351X(05)80170-3; Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745; HENNINGSEN L, 1978, HORM METAB RES, V10, P565, DOI 10.1055/s-0028-1095850; Holmes GL, 1998, NEURON, V21, P1231, DOI 10.1016/S0896-6273(00)80642-X; Huang CW, 2008, EPILEPSY RES, V79, P71, DOI 10.1016/j.eplepsyres.2007.12.012; Huang CW, 2007, J NEUROSCI RES, V85, P1468, DOI 10.1002/jnr.21284; Huang CW, 2012, PSYCHOPHARMACOLOGY, V221, P575, DOI 10.1007/s00213-011-2603-y; Huang CW, 2010, NEUROTOX RES, V17, P305, DOI 10.1007/s12640-009-9104-3; Huang CW, 2009, NEUROTOX RES, V15, P71, DOI 10.1007/s12640-009-9008-2; Huang CW, 2006, EPILEPSIA, V47, P720, DOI 10.1111/j.1528-1167.2006.00498.x; Ingram EA, 2009, EPILEPSIA, V50, P56, DOI 10.1111/j.1528-1167.2008.01704.x; Lee EB, 2011, J NEUROSCI, V31, P14361, DOI 10.1523/JNEUROSCI.3171-11.2011; Levin BE, 1998, BRAIN RES BULL, V46, P513, DOI 10.1016/S0361-9230(98)00053-7; Liu D, 2010, J ALZHEIMERS DIS, V22, P443, DOI 10.3233/JAD-2010-101017; Lydiard RB, 2010, INT J NEUROPSYCHOPH, V13, P229, DOI 10.1017/S1461145709990460; MATTIA D, 1994, NEUROPHARMACOLOGY, V33, P1515, DOI 10.1016/0028-3908(94)90124-4; McClelland David, 2004, BMC Pharmacology, V4, P14, DOI 10.1186/1471-2210-4-14; MELLO LEAM, 1993, EPILEPSIA, V34, P985, DOI 10.1111/j.1528-1157.1993.tb02123.x; Morrione A, 2000, CANCER RES, V60, P2263; OBEMBE A, 1991, CENT AFR J MED, V37, P96; Pathak HR, 2007, J NEUROSCI, V27, P14012, DOI 10.1523/JNEUROSCI.4390-07.2007; Pitkanen A, 2006, MODELS OF SEIZURES AND EPILEPSY, P1; Qi H, 1996, CLIN EXP PHARMACOL P, V23, P893, DOI 10.1111/j.1440-1681.1996.tb01140.x; Queiroz CMT, 2007, EUR J NEUROSCI, V25, P3071, DOI 10.1111/j.1460-9568.2007.05573.x; Quintero JE, 2011, J PHARMACOL EXP THER, V338, P240, DOI 10.1124/jpet.110.178384; Rauchenzauner M, 2008, EPILEPSY RES, V80, P142, DOI 10.1016/j.eplepsyres.2008.03.017; Rosenstock J, 2004, PAIN, V110, P628, DOI 10.1016/j.pain.2004.05.001; Rosenstock J, 2007, DIABETES CARE, V30, P1480, DOI 10.2337/dc06-2001; Ryu JH, 2012, BRIT J ANAESTH, V109, P234, DOI 10.1093/bja/aes120; Santos FA, 2005, LIFE SCI, V77, P2953, DOI 10.1016/j.lfs.2005.05.032; Sarantopoulos C, 2003, NEUROSCI LETT, V343, P185, DOI 10.1016/S0304-3940(03)00383-5; Schmitz B, 2010, EPILEPSIA, V51, P2231, DOI 10.1111/j.1528-1167.2010.02759.x; Sharma AK, 2007, TOXICOL PATHOL, V35, P984, DOI 10.1080/01926230701748305; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; SINGH BM, 1980, ANN NEUROL, V8, P155, DOI 10.1002/ana.410080205; Soundarapandian MM, 2007, J NEUROCHEM, V103, P1982, DOI 10.1111/j.1471-4159.2007.04883.x; Szczepanska-Sadowska E, 2010, J PHYSIOL PHARMACOL, V61, P509; Tay AS, 2010, NEUROSCIENCE, V167, P277, DOI 10.1016/j.neuroscience.2010.02.006; Taylor CP, 2007, EPILEPSY RES, V73, P137, DOI 10.1016/j.eplepsyres.2006.09.008; Tomson T, 2011, EPILEPSY RES, V96, P64, DOI 10.1016/j.eplepsyres.2011.05.001; Wulfsen I, 2000, J NEUROENDOCRINOL, V12, P263; Yamada K, 2001, SCIENCE, V292, P1543, DOI 10.1126/science.1059829; Yoon JS, 2011, NEUROBIOL DIS, V41, P624, DOI 10.1016/j.nbd.2010.11.011; Zawar C, 1999, J PHYSIOL-LONDON, V514, P327; Zhang H, 2008, MOL CELL NEUROSCI, V37, P1, DOI 10.1016/j.mcn.2007.08.007; Zhao M, 2008, MOL BIOTECHNOL, V40, P19, DOI 10.1007/s12033-008-9043-x; Zoga V, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-6	57	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65154	10.1371/journal.pone.0065154	http://dx.doi.org/10.1371/journal.pone.0065154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785408	Green Submitted, gold, Green Published			2022-12-25	WOS:000321038800112
J	Kushniarevich, A; Sivitskaya, L; Danilenko, N; Novogrodskii, T; Tsybovsky, I; Kiseleva, A; Kotova, S; Chaubey, G; Metspalu, E; Sahakyan, H; Bahmanimehr, A; Reidla, M; Rootsi, S; Parik, J; Reisberg, T; Achilli, A; Kashani, BH; Gandini, F; Olivieri, A; Behar, DM; Torroni, A; Davydenko, O; Villems, R				Kushniarevich, Alena; Sivitskaya, Larysa; Danilenko, Nina; Novogrodskii, Tadeush; Tsybovsky, Iosif; Kiseleva, Anna; Kotova, Svetlana; Chaubey, Gyaneshwer; Metspalu, Ene; Sahakyan, Hovhannes; Bahmanimehr, Ardeshir; Reidla, Maere; Rootsi, Siiri; Parik, Jueri; Reisberg, Tuuli; Achilli, Alessandro; Kashani, Baharak Hooshiar; Gandini, Francesca; Olivieri, Anna; Behar, Doron M.; Torroni, Antonio; Davydenko, Oleg; Villems, Richard			Uniparental Genetic Heritage of Belarusians: Encounter of Rare Middle Eastern Matrilineages with a Central European Mitochondrial DNA Pool	PLOS ONE			English	Article							Y-CHROMOSOME STR; MTDNA VARIATION; NEAR-EASTERN; HAPLOGROUP-H; WESTERN; DIVERSITY; LANDSCAPE; ORIGIN; TREE; ASIA	Ethnic Belarusians make up more than 80% of the nine and half million people inhabiting the Republic of Belarus. Belarusians together with Ukrainians and Russians represent the East Slavic linguistic group, largest both in numbers and territory, inhabiting East Europe alongside Baltic-, Finno-Permic- and Turkic-speaking people. Till date, only a limited number of low resolution genetic studies have been performed on this population. Therefore, with the phylogeographic analysis of 565 Y-chromosomes and 267 mitochondrial DNAs from six well covered geographic sub-regions of Belarus we strove to complement the existing genetic profile of eastern Europeans. Our results reveal that around 80% of the paternal Belarusian gene pool is composed of R1a, I2a and N1c Y-chromosome haplogroups - a profile which is very similar to the two other eastern European populations - Ukrainians and Russians. The maternal Belarusian gene pool encompasses a full range of West Eurasian haplogroups and agrees well with the genetic structure of central-east European populations. Our data attest that latitudinal gradients characterize the variation of the uniparentally transmitted gene pools of modern Belarusians. In particular, the Y-chromosome reflects movements of people in central-east Europe, starting probably as early as the beginning of the Holocene. Furthermore, the matrilineal legacy of Belarusians retains two rare mitochondrial DNA haplogroups, N1a3 and N3, whose phylogeographies were explored in detail after de novo sequencing of 20 and 13 complete mitogenomes, respectively, from all over Eurasia. Our phylogeographic analyses reveal that two mitochondrial DNA lineages, N3 and N1a3, both of Middle Eastern origin, might mark distinct events of matrilineal gene flow to Europe: during the mid-Holocene period and around the Pleistocene-Holocene transition, respectively.	[Kushniarevich, Alena; Chaubey, Gyaneshwer; Sahakyan, Hovhannes; Rootsi, Siiri; Parik, Jueri; Reisberg, Tuuli] Estonian Biocentre, Tartu, Estonia; [Sivitskaya, Larysa; Danilenko, Nina; Davydenko, Oleg] Natl Acad Sci Belarus, Inst Cytol & Genet, Minsk, BELARUS; [Novogrodskii, Tadeush] Belarusian State Univ, Fac Hist, Dept Ethnol Museol & Hist Arts, Minsk, BELARUS; [Tsybovsky, Iosif; Kiseleva, Anna; Kotova, Svetlana] Ctr Forens Expertise & Criminalist, Minsk, BELARUS; [Metspalu, Ene; Reidla, Maere; Parik, Jueri; Reisberg, Tuuli] Univ Tartu, Dept Evolutionary Biol, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Sahakyan, Hovhannes; Bahmanimehr, Ardeshir] Armenian Acad Sci, Inst Mol Biol, Human Genet Grp, Yerevan, Armenia; [Achilli, Alessandro] Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy; [Kashani, Baharak Hooshiar; Gandini, Francesca; Olivieri, Anna; Torroni, Antonio] Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, I-27100 Pavia, Italy; [Behar, Doron M.] Mol Med Lab, Haifa, Israel; [Villems, Richard] Estonian Acad Sci, EE-200103 Tallinn, Estonia	National Academy of Sciences of Belarus (NASB); Institute of Genetics & Cytology of the National Academy of Sciences of Belarus; Belarusian State University; University of Tartu; National Academy of Sciences of Armenia; Institute of Molecular Biology - NAS RA; Institute of Radiophysics & Electronics - NAS RA; University of Perugia; University of Pavia; Rambam Health Care Campus; Estonian Academy of Sciences	Kushniarevich, A (corresponding author), Estonian Biocentre, Tartu, Estonia.	lkushniarevich@gmail.com	Gandini, Francesca/H-8936-2015; Torroni, Antonio/E-1557-2011; Chaubey, Gyaneshwer/AAC-6409-2019; Achilli, Alessandro/I-9236-2012; Sivitskaya, Larysa/AAD-8068-2020; Bahmanimehr, Ardeshir/K-4367-2019; Chaubey, Gyaneshwer/H-2753-2012; Sivitskaya, Larysa/HHN-4021-2022; OLIVIERI, ANNA/I-9235-2012	Gandini, Francesca/0000-0001-8930-8295; Torroni, Antonio/0000-0002-4163-4478; Chaubey, Gyaneshwer/0000-0003-2899-3852; Achilli, Alessandro/0000-0001-6871-3451; Chaubey, Gyaneshwer/0000-0003-2899-3852; Sivitskaya, Larysa/0000-0001-6359-4967; OLIVIERI, ANNA/0000-0002-3941-8098; Sahakyan, Hovhannes/0000-0003-1596-2838; Svetlana, Kotova/0000-0002-6521-7732; Reisberg, Tuuli/0000-0002-1193-5616	State Committee on Science and Technology of the Republic of Belarus (SCST); Progetti Ricerca Interesse Nazionale (Italian Ministry of the University); FIRB-Futuro in Ricerca (Italian Ministry of the University); Fondazione Alma Mater Ticinensis; Estonian Basic Research [SF0182474]; Estonian Science Foundation [7858]; European Commission [ECOGENE205419]; European Union Regional Development Fund (through the Centre of Excellence in Genomics	State Committee on Science and Technology of the Republic of Belarus (SCST); Progetti Ricerca Interesse Nazionale (Italian Ministry of the University); FIRB-Futuro in Ricerca (Italian Ministry of the University); Fondazione Alma Mater Ticinensis; Estonian Basic Research; Estonian Science Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); European Union Regional Development Fund (through the Centre of Excellence in Genomics	This study was supported by the State Committee on Science and Technology of the Republic of Belarus (SCST), Progetti Ricerca Interesse Nazionale 2009 (Italian Ministry of the University) (to AA and AT), FIRB-Futuro in Ricerca 2008 (Italian Ministry of the University) (to AA and AO), Fondazione Alma Mater Ticinensis (to AT), Estonian Basic Research grant SF0182474 (to RV and EM), Estonian Science Foundation grants (7858) (to EM), European Commission grant (ECOGENE205419) (to RV), the European Union Regional Development Fund (through the Centre of Excellence in Genomics (to RV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-45; Al-Zahery N, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-288; Alekseeva T, 2001, VOSTOCHNYE SLAVIANE; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Balanovsky O, 2008, AM J HUM GENET, V82, P236, DOI 10.1016/j.ajhg.2007.09.019; Balanovsky O, 2011, MOL BIOL EVOL, V28, P2905, DOI 10.1093/molbev/msr126; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Bellusci G, 2010, ANN HUM BIOL, V37, P367, DOI 10.3109/03014461003614358; Belyaeva O, 2003, HUM BIOL, V75, P647, DOI 10.1353/hub.2003.0069; Bermisheva MA, 2002, MOL BIOL+, V36, P802, DOI 10.1023/A:1021677708482; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Derenko M, 2007, AM J HUM GENET, V81, P1025, DOI 10.1086/522933; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fechner A, 2008, AM J PHYS ANTHROPOL, V137, P41, DOI 10.1002/ajpa.20838; Fernandes V, 2012, AM J HUM GENET, V90, P347, DOI 10.1016/j.ajhg.2011.12.010; Forster P, 1996, AM J HUM GENET, V59, P935; Grzybowski T, 2007, FORENSIC SCI INT-GEN, V1, P141, DOI 10.1016/j.fsigen.2007.01.010; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Hudjashov G, 2007, P NATL ACAD SCI USA, V104, P8726, DOI 10.1073/pnas.0702928104; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Karskii EF, 1955, BELORUSY YAZYK BELOR; Kasperaviciute D, 2004, ANN HUM GENET, V68, P438, DOI 10.1046/j.1529-8817.2003.00119.x; Kasperaviciute Dalia, 2002, Journal of Applied Genetics, V43, P255; Kayser M, 2005, HUM GENET, V117, P428, DOI 10.1007/s00439-005-1333-9; Khar'kov V N, 2005, Genetika, V41, P1132; Kharkov V. N., 2004, Genetika, V40, P415; Klimchuk FD, 1983, HAVORKI ZAKHODNIAHA; Lappalainen T, 2009, ANN HUM GENET, V73, P61, DOI 10.1111/j.1469-1809.2008.00487.x; Lappalainen T, 2006, GENE, V376, P207, DOI 10.1016/j.gene.2006.03.004; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Mahnach AS, 2001, GEOLOGIYA BELARUSI; Maliarchuk B A, 2008, Genetika, V44, P401; Malyarchuk B, 2008, MOL BIOL EVOL, V25, P1651, DOI 10.1093/molbev/msn114; Malyarchuk B. A., 2002, Genetika, V38, P1532; Malyarchuk B. A., 2001, Genetika, V37, P1411; Malyarchuk BA, 2002, ANN HUM GENET, V66, P261, DOI 10.1017/S0003480002001161; Malyarchuk B, 2010, MOL BIOL EVOL, V27, P2220, DOI 10.1093/molbev/msq065; Malyarchuk B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010285; Mathew C G, 1985, Methods Mol Biol, V2, P31, DOI 10.1385/0-89603-064-4:31; Mielnik-Sikorska M, 2013, FORENSIC SCI INT-GEN, V7, P200, DOI 10.1016/j.fsigen.2012.05.007; Mirabal S, 2009, EUR J HUM GENET, V17, P1260, DOI 10.1038/ejhg.2009.6; Morozova I, 2012, AM J PHYS ANTHROPOL, V147, P341, DOI 10.1002/ajpa.21649; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; Ottoni C, 2009, ANN HUM BIOL, V36, P785, DOI 10.3109/03014460903198509; Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003; Pericic M, 2005, MOL BIOL EVOL, V22, P1964, DOI 10.1093/molbev/msi185; Pliss L, 2006, ANN HUM GENET, V70, P439, DOI 10.1111/j.1469-1809.2005.00238.x; Rebala K, 2007, J HUM GENET, V52, P406, DOI 10.1007/s10038-007-0125-6; Rebala K, 2011, FORENSIC SCI INT-GEN, V5, pE17, DOI 10.1016/j.fsigen.2009.10.011; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Roewer L, 2008, INT J LEGAL MED, V122, P219, DOI 10.1007/s00414-007-0222-2; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Rootsi S, 2007, EUR J HUM GENET, V15, P204, DOI 10.1038/sj.ejhg.5201748; Rootsi S, 2012, EUR J HUM GENET, V20, P1275, DOI 10.1038/ejhg.2012.86; Rosenberg MS, 2001, PASSAGE PATTERN ANAL; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Schonberg A, 2011, EUR J HUM GENET, V19, P988, DOI 10.1038/ejhg.2011.62; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; SVEZHENTSEV YS, 1993, RADIOCARBON, V35, P495, DOI 10.1017/S0033822200060525; Tambets K, 2004, AM J HUM GENET, V74, P661, DOI 10.1086/383203; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wozniak M, 2010, AM J PHYS ANTHROPOL, V142, P540, DOI 10.1002/ajpa.21253; Yunusbayev B, 2012, MOL BIOL EVOL, V29, P359, DOI 10.1093/molbev/msr221; Zaikouski EM, 1997, ARHEALOGIYA BELARUSI, VI, P21; Zerjal T, 2001, MOL BIOL EVOL, V18, P1077, DOI 10.1093/oxfordjournals.molbev.a003879	77	21	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66499	10.1371/journal.pone.0066499	http://dx.doi.org/10.1371/journal.pone.0066499			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785503	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000321038800018
J	Lamarre, Y; Lalanne-Mistrih, ML; Romana, M; Lemonne, N; Mougenel, D; Waltz, X; Tressieres, B; Etienne-Julan, M; Tarer, V; Hardy-Dessources, MD; Connes, P				Lamarre, Yann; Lalanne-Mistrih, Marie-Laure; Romana, Marc; Lemonne, Nathalie; Mougenel, Daniele; Waltz, Xavier; Tressieres, Benoit; Etienne-Julan, Maryse; Tarer, Vanessa; Hardy-Dessources, Marie-Dominique; Connes, Philippe			Male Gender, Increased Blood Viscosity, Body Mass Index and Triglyceride Levels Are Independently Associated with Systemic Relative Hypertension in Sickle Cell Anemia	PLOS ONE			English	Article							CHOLESTEROL LEVELS; ATHEROGENIC INDEX; HDL-CHOLESTEROL; RISK-FACTORS; LIPID-LEVELS; DISEASE; PRESSURE; CHILDREN; PLASMA; PATHOPHYSIOLOGY	Patients with sickle cell anemia (SCA) have usually lower diastolic, systolic and mean blood pressure (BP) than the general population. However, BP values >= 120/70 mmHg considerably increase the risk for acute and chronic complications in SCA. The aim of this study was to identify biological factors associated with relative hypertension in adults with SCA. We compared the hematological, lipid and hemolytic profiles, as well as blood viscosity, between SCA patients with normal BP (<120/70 mmHg, n = 54) and those with relative hypertension (BP >= 120/70 mmHg, n = 43). Our results demonstrated that male gender (OR: 3.49; 95% CI 1.20 to 10.16, p<0.05), triglycerides (OR: 9.19; 95% CI 2.29 to 36.95, p<0.01), blood viscosity (OR: 1.35; 95% CI 1.01 to 1.81, p<0.05) and body mass index (OR: 1.37; 95% CI 1.14 to 1.64, p<0.01) were independent risks factors for relative hypertension in SCA. No association was found between the BP status and the positive history of painful vaso-occlusive crisis or acute chest syndrome. An association between triglycerides level and the occurrence of these two major acute complications was detected. Our study suggests that male gender, increased triglycerides level, BMI and blood viscosity could increase the risk for developing relative hypertension in SCA. In addition, our results support a role of moderately elevated triglycerides in the pathophysiology of vaso-occlusive events.	[Lamarre, Yann; Lalanne-Mistrih, Marie-Laure; Romana, Marc; Waltz, Xavier; Etienne-Julan, Maryse; Hardy-Dessources, Marie-Dominique; Connes, Philippe] Ctr Hosp Univ Pointe A Pitre, Hop Ricou, Inst Natl Sante & Rech Med UMR 665, Pointe A Pitre, Guadeloupe, France; [Lamarre, Yann; Lalanne-Mistrih, Marie-Laure; Romana, Marc; Waltz, Xavier; Etienne-Julan, Maryse; Hardy-Dessources, Marie-Dominique; Connes, Philippe] Univ Antilles Guyane, Pointe A Pitre, Guadeloupe, France; [Lamarre, Yann; Romana, Marc; Waltz, Xavier; Hardy-Dessources, Marie-Dominique; Connes, Philippe] PRES Sorbonne Paris Cite, Lab Excellence GR Ex Red Cell Genesis Death, Paris, France; [Lalanne-Mistrih, Marie-Laure; Tressieres, Benoit] Ctr Hosp Univ Pointe A Pitre, Ctr Invest Clin Epidemiol Clin Inserm Antilles Gu, Pointe A Pitre, Guadeloupe, France; [Lemonne, Nathalie; Mougenel, Daniele; Etienne-Julan, Maryse; Tarer, Vanessa] Ctr Hosp Univ Pointe A Pitre, Unite Transversale Drepanocytose, Pointe A Pitre, Guadeloupe, France; [Waltz, Xavier] Univ Antilles Guyane, Dept Physiol, Lab EA3596, Pointe A Pitre, Guadeloupe, France	CHU Guadeloupe; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite des Antilles; CHU Guadeloupe; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Guadeloupe; Universite des Antilles	Connes, P (corresponding author), Ctr Hosp Univ Pointe A Pitre, Hop Ricou, Inst Natl Sante & Rech Med UMR 665, Pointe A Pitre, Guadeloupe, France.	pconnes@yahoo.fr	Romana, Marc/K-6442-2017; Connes, Philippe/J-7835-2019; WALTZ, Xavier/M-3606-2016; TRESSIERES, Benoit/ABH-1085-2020; Lamarre, Yann/ABC-2074-2020; , Hardy-dessources/K-9189-2017	Romana, Marc/0000-0002-8715-9836; Connes, Philippe/0000-0002-9232-0268; WALTZ, Xavier/0000-0002-0838-290X; , Hardy-dessources/0000-0003-0861-3648; Lamarre, Yann/0000-0003-0669-793X; Philippe, Connes/0000-0001-8449-7998; ETIENNE-JULAN, Maryse/0000-0003-1339-6545				[Anonymous], BR J HAEMAT IN PRESS; [Anonymous], 2012, HAEMATOLOGICA; [Anonymous], BLOOD IN PRESS; Athanassiou G, 2006, CLIN HEMORHEOL MICRO, V35, P291; Ballas SK, 2012, BLOOD, V120, P3647, DOI 10.1182/blood-2012-04-383430; BALLAS SK, 1989, AM J HEMATOL, V32, P104, DOI 10.1002/ajh.2830320206; Barden EM, 2000, J PEDIATR-US, V136, P73, DOI 10.1016/S0022-3476(00)90053-2; Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Belhassen L, 2001, BLOOD, V97, P1584, DOI 10.1182/blood.V97.6.1584; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Choy E, 2009, ANN RHEUM DIS, V68, P460, DOI 10.1136/ard.2008.101964; da Luz PL, 2008, CLINICS, V63, P427, DOI 10.1590/S1807-59322008000400003; Dart AM, 2001, J AM COLL CARDIOL, V37, P975, DOI 10.1016/S0735-1097(01)01108-1; Dobiasova M, 2006, Vnitr Lek, V52, P64; Dobiasova M, 2004, CLIN CHEM, V50, P1113, DOI 10.1373/clinchem.2004.033175; Dobiasova M, 2001, CLIN BIOCHEM, V34, P583, DOI 10.1016/S0009-9120(01)00263-6; Ernst AA, 2000, SOUTHERN MED J, V93, P590; Frontini MG, 2008, PEDIATRICS, V121, P924, DOI 10.1542/peds.2007-1472; Galie N, 2005, LUPUS, V14, P713, DOI 10.1191/0961203305lu2206oa; Goldberg IJ, 2011, ARTERIOSCL THROM VAS, V31, P1716, DOI 10.1161/ATVBAHA.111.226100; Gordeuk VR, 2008, AM J HEMATOL, V83, P15, DOI 10.1002/ajh.21016; Jankowski P, 2007, BLOOD PRESSURE, V16, P238, DOI 10.1080/08037050701428166; Johnson CS, 2005, HEMATOL ONCOL CLIN N, V19, P827, DOI 10.1016/j.hoc.2005.08.006; Krentz AJ, 2003, DIABETES OBES METAB, V5, pS19, DOI 10.1046/j.1462-8902.2003.0310.x; Lamarre Y, CLIN HEMORH IN PRESS; Lamarre Y, 2012, HAEMATOL-HEMATOL J, V97, P1641, DOI 10.3324/haematol.2012.066670; LANDSBERG L, 1994, J CARDIOVASC PHARM, V23, pS1, DOI 10.1097/00005344-199423001-00002; Lemogoum D, 2004, HYPERTENSION, V44, P924, DOI 10.1161/01.HYP.0000148506.73622.ba; Lemonne N, 2012, AM J HEMATOL, V87, pE129, DOI 10.1002/ajh.23312; Meiselman HJ, 1999, CLIN HEMORHEOL MICRO, V21, P195; Nebor D, 2011, HAEMATOL-HEMATOL J, V96, P1589, DOI 10.3324/haematol.2011.047365; Oguanobi NI, 2010, J CARDIOL, V56, P326, DOI 10.1016/j.jjcc.2010.07.001; Ohene-Frempong K, 1998, BLOOD, V91, P288; Pegelow CH, 1997, AM J MED, V102, P171; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Rahimi Z, 2006, CLIN CHIM ACTA, V365, P217, DOI 10.1016/j.cca.2005.08.022; Redon J, 2001, NUTR METAB CARDIOVAS, V11, P344; RODGERS GP, 1993, AM J MED SCI, V305, P150, DOI 10.1097/00000441-199303000-00004; Rodriguez-Moran M, 2013, DIABETES VASC DIS RE, V10, P17, DOI 10.1177/1479164112440713; SANDHAGEN B, 1990, J INTERN MED, V228, P623, DOI 10.1111/j.1365-2796.1990.tb00289.x; Seixas MO, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-91; Shores J, 2003, J NATL MED ASSOC, V95, P813; Tan ASC, 2001, BLOOD, V98, P250, DOI 10.1182/blood.V98.1.250; Tarer V, 2006, EUR J HAEMATOL, V76, P193, DOI 10.1111/j.1600-0609.2005.00590.x; Tripette J, 2009, HAEMATOL-HEMATOL J, V94, P1060, DOI 10.3324/haematol.2008.005371; Wang LM, 2009, J LIPID RES, V50, P204, DOI 10.1194/jlr.M700505-JLR200; Wang W, 2003, CLIN CHEM, V49, P1679, DOI 10.1373/49.10.1679; Weng S, PLOS ONE IN PRESS; Woods K. F., 2001, Ethnicity and Disease, V11, P30; Yuditskaya S, 2009, BLOOD, V113, P1122, DOI 10.1182/blood-2008-03-142604; Zhang WY, 2006, ARTERIOSCL THROM VAS, V26, P514, DOI 10.1161/01.ATV.0000200226.53994.09; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29; Zorca S, 2010, BRIT J HAEMATOL, V149, P436, DOI 10.1111/j.1365-2141.2010.08109.x	53	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66004	10.1371/journal.pone.0066004	http://dx.doi.org/10.1371/journal.pone.0066004			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785465	Green Submitted, Green Published, gold			2022-12-25	WOS:000321038800057
J	Prole, DL; Taylor, CW				Prole, David L.; Taylor, Colin W.			Identification and Analysis of Putative Homologues of Mechanosensitive Channels in Pathogenic Protozoa	PLOS ONE			English	Article							ESCHERICHIA-COLI; TRP CHANNELS; MECHANICAL STIMULATION; CA2+ CHANNEL; ION CHANNELS; MEMBRANE; PARAMECIUM; TENSION; PROTEIN; YEAST	Mechanosensitive channels play important roles in the physiology of many organisms, and their dysfunction can affect cell survival. This suggests that they might be therapeutic targets in pathogenic organisms. Pathogenic protozoa lead to diseases such as malaria, dysentery, leishmaniasis and trypanosomiasis that are responsible for millions of deaths each year worldwide. We analyzed the genomes of pathogenic protozoa and show the existence within them of genes encoding putative homologues of mechanosensitive channels. Entamoeba histolytica, Leishmania spp., Trypanosoma cruzi and Trichomonas vaginalis have genes encoding homologues of Piezo channels, while most pathogenic protozoa have genes encoding homologues of mechanosensitive small-conductance (MscS) and K+-dependent (MscK) channels. In contrast, all parasites examined lack genes encoding mechanosensitive large-conductance (MscL), mini-conductance (MscM) and degenerin/epithelial Na+ (DEG/ENaC) channels. Multiple sequence alignments of evolutionarily distant protozoan, amoeban, plant, insect and vertebrate Piezo channel subunits define an absolutely conserved motif that may be involved in channel conductance or gating. MscS channels are not present in humans, and the sequences of protozoan and human homologues of Piezo channels differ substantially. This suggests the possibility for specific targeting of mechanosensitive channels of pathogens by therapeutic drugs.	[Prole, David L.; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England	University of Cambridge	Prole, DL (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	dp350@cam.ac.uk	Taylor, Colin/G-2447-2010	Taylor, Colin/0000-0001-7771-1044; Prole, David/0000-0003-2782-6665	Meres from St. John's College, Cambridge; Wellcome Trust [085295]	Meres from St. John's College, Cambridge; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by a Meres senior research associateship from St. John's College, Cambridge (to DLP) and by the Wellcome Trust (grant number 085295, to CWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akitake B, 2005, J GEN PHYSIOL, V125, P143, DOI 10.1085/jgp.200409198; Alam A, 2011, J GEN PHYSIOL, V137, P397, DOI 10.1085/jgp.201010546; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Bae C, 2013, P NATL ACAD SCI USA, V110, pE1162, DOI 10.1073/pnas.1219777110; Bae C, 2011, BIOCHEMISTRY-US, V50, P6295, DOI 10.1021/bi200770q; Balleza D, 2009, EUR BIOPHYS J BIOPHY, V38, P1013, DOI 10.1007/s00249-009-0460-y; Barritt G, 2005, NAT CELL BIOL, V7, P105, DOI 10.1038/ncb0205-105; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Ben-Shahar Y, 2011, ADV GENET, V76, P1, DOI 10.1016/B978-0-12-386481-9.00001-8; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Berrier C, 1996, J MEMBRANE BIOL, V151, P175, DOI 10.1007/s002329900068; Booth IR, 2011, BIOCHEM SOC T, V39, P733, DOI 10.1042/BST0390733; Booth IR, 1999, CURR OPIN MICROBIOL, V2, P166, DOI 10.1016/S1369-5274(99)80029-0; Castillo E, 2010, CURR MED CHEM, V17, P4027, DOI 10.2174/092986710793205345; Chiang CS, 2004, BIOPHYS J, V86, P2846, DOI 10.1016/S0006-3495(04)74337-4; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Cibulsky SM, 2000, J GEN PHYSIOL, V116, P349, DOI 10.1085/jgp.116.3.349; Coste B, 2013, P NATL ACAD SCI USA, V110, P4667, DOI 10.1073/pnas.1221400110; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; DEITMER JW, 1982, J EXP BIOL, V96, P239; Denis V, 2002, J CELL BIOL, V156, P29, DOI 10.1083/jcb.200111004; DEPEYER JE, 1980, J EXP BIOL, V88, P73; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dong XP, 2010, J NEUROCHEM, V113, P313, DOI 10.1111/j.1471-4159.2010.06626.x; ECKERT R, 1972, J EXP BIOL, V56, P683; Edwards MD, 2005, NAT STRUCT MOL BIOL, V12, P113, DOI 10.1038/nsmb895; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Gebauer M, 1999, NATURWISSENSCHAFTEN, V86, P352, DOI 10.1007/s001140050634; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Ghochani M, 2010, BIOPHYS J, V99, P3244, DOI 10.1016/j.bpj.2010.09.038; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Goldstein SAN, 1998, J MOL MED-JMM, V76, P13, DOI 10.1007/s109-1998-8100-0; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Hader DP, 2003, ADV SPACE RES-SERIES, V31, P2181, DOI 10.1016/S0273-1177(03)00242-4; Hader DP, 2001, ADV SPACE RES-SERIES, V27, P861, DOI 10.1016/S0273-1177(01)00149-1; Haswell ES, 2008, CURR BIOL, V18, P730, DOI 10.1016/j.cub.2008.04.039; Haswell ES, 2011, STRUCTURE, V19, P1356, DOI 10.1016/j.str.2011.09.005; Haswell ES, 2006, CURR BIOL, V16, P1, DOI 10.1016/j.cub.2005.11.044; Hemmersbach R, 2005, ADV SPACE RES-SERIES, V35, P296, DOI 10.1016/j.asr.2005.03.024; Kaneko T, 2009, J MEMBRANE BIOL, V228, P33, DOI 10.1007/s00232-009-9156-6; Kang LJ, 2010, NEURON, V67, P381, DOI 10.1016/j.neuron.2010.06.032; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kloda Anna, 2002, Archaea, V1, P35, DOI 10.1155/2002/419261; Krause M, 2006, PROTOPLASMA, V229, P109, DOI 10.1007/s00709-006-0207-x; KRUPPEL T, 1993, J MEMBRANE BIOL, V135, P253; Kung C, 2010, ANNU REV MICROBIOL, V64, P313, DOI 10.1146/annurev.micro.112408.134106; Kurusu T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-11; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Li C, 2007, MOL MICROBIOL, V64, P560, DOI 10.1111/j.1365-2958.2007.05672.x; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Li YZ, 2002, EMBO J, V21, P5323, DOI 10.1093/emboj/cdf537; MACHEMER H, 1979, J PHYSIOL-LONDON, V296, P49, DOI 10.1113/jphysiol.1979.sp012990; Malcolm HR, 2011, BIOPHYS J, V101, P345, DOI 10.1016/j.bpj.2011.05.058; Martinac B, 2003, PROG BIOPHYS MOL BIO, V82, P11, DOI 10.1016/S0079-6107(03)00002-6; Martinac B, 2008, PHYSIOL REV, V88, P1449, DOI 10.1152/physrev.00005.2008; Miller C., 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-4-reviews0004.REVIEWS0004, DOI 10.1186/GB-2000-1-4-REVIEWS0004.REVIEWS0004, 10.1186/gb-2000-1-4-reviews0004, DOI 10.1186/GB-2000-1-4-REVIEWS0004]; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Monzote Lianet, 2011, Open Med Chem J, V5, P1, DOI 10.2174/1874104501105010001; NAITOH Y, 1969, SCIENCE, V164, P963, DOI 10.1126/science.164.3882.963; Nakagawa Y, 2007, P NATL ACAD SCI USA, V104, P3639, DOI 10.1073/pnas.0607703104; Nakayama Y, 2007, P NATL ACAD SCI USA, V104, P5883, DOI 10.1073/pnas.0609996104; Nakayama Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2014; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Palmer CP, 2001, P NATL ACAD SCI USA, V98, P7801, DOI 10.1073/pnas.141036198; Petersen I, 2011, FEBS LETT, V585, P1551, DOI 10.1016/j.febslet.2011.04.042; Peyronnet R, 2008, PLANT SIGNAL BEHAV, V3, P726, DOI 10.4161/psb.3.9.6487; Pivetti CD, 2003, MICROBIOL MOL BIOL R, V67, P66, DOI 10.1128/MMBR.67.1.66-85.2003; Prole DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042404; Prole DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032264; Prole DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026218; Roux A, 2010, P NATL ACAD SCI USA, V107, P4141, DOI 10.1073/pnas.0913734107; Salmi ML, 2011, PLANTA, V233, P911, DOI 10.1007/s00425-010-1343-2; Schumann U, 2010, P NATL ACAD SCI USA, V107, P12664, DOI 10.1073/pnas.1001405107; Shiono H, 1997, J EXP BIOL, V200, P2249; Sibley LD, 2011, IMMUNOL REV, V240, P72, DOI 10.1111/j.1600-065X.2010.00990.x; Su ZW, 2011, J GEN PHYSIOL, V138, P627, DOI 10.1085/jgp.201110693; Sukharev SI, 1999, J GEN PHYSIOL, V113, P525, DOI 10.1085/jgp.113.4.525; Tani T, 2002, CELL BIOL INT, V26, P853, DOI 10.1006/cbir.2002.0937; Taylor CW, 2009, BIOCHEMISTRY-US, V48, P12062, DOI 10.1021/bi901739t; TOMINAGA T, 1994, J EXP BIOL, V189, P117; Toyota M, 2008, PLANT PHYSIOL, V146, P505, DOI 10.1104/pp.107.106450; Upadhyaya A, 2004, BIOPHYS J, V86, P2923, DOI 10.1016/S0006-3495(04)74343-X; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Waller KL, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-19; Wilson ME, 2011, PLANT CELL, V23, P2939, DOI 10.1105/tpc.111.088112; Wiser MF, 2011, PROTOZOA AND HUMAN DISEASE, P1; Wolstenholme AJ, 2011, ADV EXP MED BIOL, V704, P359, DOI 10.1007/978-94-007-0265-3_20; WOOD DC, 1985, J EXP BIOL, V117, P215; Xiao R, 2010, CURR BIOL, V20, pR936, DOI 10.1016/j.cub.2010.09.053; Yamanaka T, 2010, PLANT PHYSIOL, V152, P1284, DOI 10.1104/pp.109.147371; Yoshimura K, 1998, J MEMBRANE BIOL, V166, P149, DOI 10.1007/s002329900456; Yu Frank H, 2004, Sci STKE, V2004, pre15, DOI 10.1126/stke.2532004re15; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057; Zhou XL, 2003, P NATL ACAD SCI USA, V100, P7105, DOI 10.1073/pnas.1230540100	98	38	38	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66068	10.1371/journal.pone.0066068	http://dx.doi.org/10.1371/journal.pone.0066068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785469	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800053
J	Gautreau, A; Hoen, M; Meunier, F				Gautreau, Aurore; Hoen, Michel; Meunier, Fanny			Let's All Speak Together! Exploring the Masking Effects of Various Languages on Spoken Word Identification in Multi-Linguistic Babble	PLOS ONE			English	Article							IN-SPEECH COMPREHENSION; INFORMATIONAL MASKING; INTERFERING-SPEECH; NATIVE-LANGUAGE; PERCEPTION; NOISE; RECOGNITION; MASKER; APPROXIMANTS; ACCESS	This study aimed to characterize the linguistic interference that occurs during speech-in-speech comprehension by combining offline and online measures, which included an intelligibility task (at a -5 dB Signal-to-Noise Ratio) and 2 lexical decision tasks (at a -5 dB and 0 dB SNR) that were performed with French spoken target words. In these 3 experiments we always compared the masking effects of speech backgrounds (i.e., 4-talker babble) that were produced in the same language as the target language (i.e., French) or in unknown foreign languages (i.e., Irish and Italian) to the masking effects of corresponding non-speech backgrounds (i.e., speech-derived fluctuating noise). The fluctuating noise contained similar spectro-temporal information as babble but lacked linguistic information. At -5 dB SNR, both tasks revealed significantly divergent results between the unknown languages (i.e., Irish and Italian) with Italian and French hindering French target word identification to a similar extent, whereas Irish led to significantly better performances on these tasks. By comparing the performances obtained with speech and fluctuating noise backgrounds, we were able to evaluate the effect of each language. The intelligibility task showed a significant difference between babble and fluctuating noise for French, Irish and Italian, suggesting acoustic and linguistic effects for each language. However, the lexical decision task, which reduces the effect of post-lexical interference, appeared to be more accurate, as it only revealed a linguistic effect for French. Thus, although French and Italian had equivalent masking effects on French word identification, the nature of their interference was different. This finding suggests that the differences observed between the masking effects of Italian and Irish can be explained at an acoustic level but not at a linguistic level.	[Gautreau, Aurore; Hoen, Michel; Meunier, Fanny] INSERM, Lyon Neurosci Res Ctr, Brain Dynam & Cognit Team, U1028, F-69000 Lyon, France; [Gautreau, Aurore; Hoen, Michel; Meunier, Fanny] CNRS, Lyon Neurosci Res Ctr, Brain Dynam & Cognit Team, UMR5292, F-69000 Lyon, France; [Gautreau, Aurore; Hoen, Michel; Meunier, Fanny] Univ Lyon, F-69000 Lyon, France; [Meunier, Fanny] CNRS, L2C2, Inst Sci Cognit Lyon, UMR5304, F-69000 Lyon, France	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Gautreau, A (corresponding author), INSERM, Lyon Neurosci Res Ctr, Brain Dynam & Cognit Team, U1028, F-69000 Lyon, France.	aurore.gautreau@isc.cnrs.fr	Michel, Hoen/C-7721-2012	Michel, Hoen/0000-0003-2099-8130	European Research Council [209234]; French "Direction Generale de l'Armement"	European Research Council(European Research Council (ERC)European Commission); French "Direction Generale de l'Armement"(French National Research Agency (ANR))	This research was supported by a European Research Council grant to the SpiN project No209234 (awarded to Fanny Meunier) and by the French "Direction Generale de l'Armement" (awarded to AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEST CT, 1992, J PHONETICS, V20, P305, DOI 10.1016/S0095-4470(19)30637-0; Boersma P., 2013, PRAAT DOING PHONETIC; Boulenger V, 2010, SPEECH COMMUN, V52, P246, DOI 10.1016/j.specom.2009.11.002; Bradlow A, 2010, SPEECH COMMUN, V52, P930, DOI 10.1016/j.specom.2010.06.003; Bronkhorst AW, 2000, ACUSTICA, V86, P117; Brouwer S, 2012, J ACOUST SOC AM, V131, P1449, DOI 10.1121/1.3675943; Brungart DS, 2001, J ACOUST SOC AM, V110, P2527, DOI 10.1121/1.1408946; Calandruccio L, 2010, J SPEECH LANG HEAR R, V53, P1458, DOI 10.1044/1092-4388(2010/09-0210); Calandruccio L, 2010, J ACOUST SOC AM, V128, P860, DOI 10.1121/1.3458857; Cooke M, 2008, J ACOUST SOC AM, V123, P414, DOI 10.1121/1.2804952; Felty RA, 2009, J ACOUST SOC AM, V125, pEL93, DOI 10.1121/1.3073733; FESTEN JM, 1990, J ACOUST SOC AM, V88, P1725, DOI 10.1121/1.400247; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Halle PA, 1999, J PHONETICS, V27, P281, DOI 10.1006/jpho.1999.0097; Hoen M, 2007, SPEECH COMMUN, V49, P905, DOI 10.1016/j.specom.2007.05.008; LANGHANS A, 1992, J ACOUST SOC AM, V91, P3456, DOI 10.1121/1.402834; Lecumberri MLG, 2006, J ACOUST SOC AM, V119, P2445, DOI 10.1121/1.2180210; Luce PA, 1998, EAR HEARING, V19, P1, DOI 10.1097/00003446-199802000-00001; MarslenWilson W, 1996, J EXP PSYCHOL HUMAN, V22, P1376, DOI 10.1037/0096-1523.22.6.1376; McClelland JL, 1986, COGNITIVE PSYCHOL, V8, P1; New B, 2004, BEHAV RES METH INS C, V36, P516, DOI 10.3758/BF03195598; NORRIS D, 1994, COGNITION, V52, P189, DOI 10.1016/0010-0277(94)90043-4; POLLACK I, 1975, J ACOUST SOC AM, V57, pS5, DOI 10.1121/1.1995329; Reel LA, 2012, J SPEECH LANG HEAR R, V55, P89, DOI 10.1044/1092-4388(2011/10-0193); Rhebergen KS, 2005, J ACOUST SOC AM, V118, P1274, DOI 10.1121/1.2000751; Simpson SA, 2005, J ACOUST SOC AM, V118, P2775, DOI 10.1121/1.2062650; Spinelli E, 2010, ATTEN PERCEPT PSYCHO, V72, P775, DOI 10.3758/APP.72.3.775; STUDEBAKER GA, 1985, J SPEECH HEAR RES, V28, P455, DOI 10.1044/jshr.2803.455; Van Engen KJ, 2007, J ACOUST SOC AM, V121, P519, DOI 10.1121/1.2400666	29	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65668	10.1371/journal.pone.0065668	http://dx.doi.org/10.1371/journal.pone.0065668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163FW	23785442	gold, Green Submitted, Green Published			2022-12-25	WOS:000320322400042
J	Lewinsohn, DM; Swarbrick, GM; Cansler, ME; Null, MD; Rajaraman, V; Frieder, MM; Sherman, DR; McWeeney, S; Lewinsohn, DA				Lewinsohn, David M.; Swarbrick, Gwendolyn M.; Cansler, Meghan E.; Null, Megan D.; Rajaraman, Veena; Frieder, Marisa M.; Sherman, David R.; McWeeney, Shannon; Lewinsohn, Deborah A.			Human Mycobacterium tuberculosis CD8 T Cell Antigens/Epitopes Identified by a Proteomic Peptide Library	PLOS ONE			English	Article							PROTECTIVE IMMUNITY; DENDRITIC CELLS; INFECTED-CELLS; HIV-INFECTION; HLA-B; LYMPHOCYTES; VACCINES; ANTIGEN; MICE; VACCINATION	Identification of CD8(+) T cell antigens/epitopes expressed by human pathogens with large genomes is especially challenging, yet necessary for vaccine development. Immunity to tuberculosis, a leading cause of mortality worldwide, requires CD8(+) T cell immunity, yet the repertoire of CD8 antigens/epitopes remains undefined. We used integrated computational and proteomic approaches to screen 10% of the Mycobacterium tuberculosis (Mtb) proteome for CD8 Mtb antigens. We designed a weighting schema based upon a Multiple Attribute Decision Making: framework to select 10% of the Mtb proteome with a high probability of containing CD8(+) T cell epitopes. We created a synthetic peptide library consisting of 15-mers overlapping by 11 aa. Using the interferon-gamma ELISPOT assay and Mtb-infected dendritic cells as antigen presenting cells, we screened Mtb-specific CD8(+) T cell clones restricted by classical MHC class I molecules (MHC class Ia molecules), that were isolated from Mtb-infected humans, against this library. Three novel CD8 antigens were unambiguously identified: the EsxJ family (Rv1038c, Rv1197, Rv3620c, Rv2347c, Rv1792), PE9 (Rv1088), and PE_PGRS42 (Rv2487c). The epitopes are B5701-restricted EsxJ(24-34), B3905-restricted PE9(53-67), and B3514-restricted PE_PGRS42(48-56), respectively. The utility of peptide libraries in identifying unknown epitopes recognized by classically restricted CD8(+) T cells was confirmed, which can be applied to other intracellular pathogens with large size genomes. In addition, we identified three novel Mtb epitopes/antigens that may be evaluated for inclusion in vaccines and/or diagnostics for tuberculosis.	[Lewinsohn, David M.; Frieder, Marisa M.] Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Portland, OR 97201 USA; [Lewinsohn, David M.; Rajaraman, Veena; Frieder, Marisa M.] Portland VA Med Ctr, Portland, OR USA; [Swarbrick, Gwendolyn M.; Cansler, Meghan E.; Null, Megan D.; Lewinsohn, Deborah A.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Rajaraman, Veena; McWeeney, Shannon] Oregon Hlth & Sci Univ, Oregon Canc Inst, Portland, OR 97201 USA; [Sherman, David R.] Seattle Biomed Res Inst, Seattle, WA 98109 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University; Oregon Health & Science University; Center for Infectious Disease Research	Lewinsohn, DM (corresponding author), Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Portland, OR 97201 USA.	lewinsde@ohsu.edu	Nikitchina, Tatiana/P-6814-2015; Lewinsohn, David/I-4936-2013	Nikitchina, Tatiana/0000-0002-1034-3483; McWeeney, Shannon/0000-0001-8333-6607; Lewinsohn, David/0000-0001-9906-9494	VA Merit Review Grant; Portland VA Medical Center, US National Institutes of Health [HHSN266200400081C (NO1-A1-400081), R01AI48090]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048090] Funding Source: NIH RePORTER	VA Merit Review Grant(US Department of Veterans Affairs); Portland VA Medical Center, US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a VA Merit Review Grant and the Portland VA Medical Center, US National Institutes of Health HHSN266200400081C (NO1-A1-400081), and R01AI48090. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2009, IMMUNOL CELL BIOL, V87, P279, DOI 10.1038/icb.2009.14; ANDERSEN P, 1994, INFECT IMMUN, V62, P2536, DOI 10.1128/IAI.62.6.2536-2544.1994; BARNES PF, 1991, NEW ENGL J MED, V324, P1644, DOI 10.1056/NEJM199106063242307; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Brodie SJ, 1999, NAT MED, V5, P34, DOI 10.1038/4716; Chen CY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000392; Cho S, 2000, P NATL ACAD SCI USA, V97, P12210, DOI 10.1073/pnas.210391497; Day CL, 2001, J VIROL, V75, P6279, DOI 10.1128/JVI.75.14.6279-6291.2001; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Gold MC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000957; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Grotzke JE, 2005, MICROBES INFECT, V7, P776, DOI 10.1016/j.micinf.2005.03.001; Heinzel AS, 2002, J EXP MED, V196, P1473, DOI 10.1084/jem.20020609; Hoang TTKT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005928; Horwitz MA, 2000, P NATL ACAD SCI USA, V97, P13853, DOI 10.1073/pnas.250480397; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Lalvani T, 1998, P NATL ACAD SCI USA, V95, P270, DOI 10.1073/pnas.95.1.270; Lambert PH, 2009, CLIN CHEST MED, V30, P811, DOI 10.1016/j.ccm.2009.08.014; Lewinsohn DA, 2003, AM J RESP CRIT CARE, V168, P1346, DOI 10.1164/rccm.200306-837OC; Lewinsohn DA, 2002, AM J RESP CRIT CARE, V166, P843, DOI 10.1164/rccm.2110094; Lewinsohn DA, 2007, PLOS PATHOG, V3, P1240, DOI 10.1371/journal.ppat.0030127; Lewinsohn DA, 2011, IMMUNOL REV, V240, P25, DOI 10.1111/j.1600-065X.2010.00997.x; Lewinsohn DM, 2000, J IMMUNOL, V165, P925, DOI 10.4049/jimmunol.165.2.925; Lewinsohn DM, 1998, J IMMUNOL, V160, P2374; Lewinsohn DM, 2001, J IMMUNOL, V166, P439, DOI 10.4049/jimmunol.166.1.439; McDermott AB, 2012, AIDS, V26, P1281, DOI 10.1097/QAD.0b013e328353bcaf; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Moss P, 2004, HUM IMMUNOL, V65, P456, DOI 10.1016/j.humimm.2004.02.014; Oldstone M B, 1994, Curr Top Microbiol Immunol, V189, P1; Ordway D, 2007, J LEUKOCYTE BIOL, V82, P1221, DOI 10.1189/jlb.0607426; Organization WH, 2008, WHO VACCINE PREVENTA; Reed S, 2005, MICROBES INFECT, V7, P922, DOI 10.1016/j.micinf.2005.03.011; RIDDELL SR, 1992, SCIENCE, V257, P238; ROBERTS AD, 1995, IMMUNOLOGY, V85, P502; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Skjot RLV, 2001, SCAND J INFECT DIS, V33, P643, DOI 10.1080/00365540110026971; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; Woodworth JSM, 2006, CRIT REV IMMUNOL, V26, P317, DOI 10.1615/CritRevImmunol.v26.i4.30; World Health Organization, 2008, GLOBAL TUBERCULOSIS	41	34	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67016	10.1371/journal.pone.0067016	http://dx.doi.org/10.1371/journal.pone.0067016			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805289	Green Submitted, Green Published, gold			2022-12-25	WOS:000320846500117
J	Zhang, CM; Yang, C; Wang, RF; Jiao, Y; Ampah, KK; Wang, XG; Zeng, XL				Zhang, Chunmei; Yang, Chao; Wang, Ruifei; Jiao, Yang; Ampah, Khamal Kwesi; Wang, Xiaoguang; Zeng, Xianlu			c-Abl Kinase Is a Regulator of alpha(v)beta(3) Integrin Mediated Melanoma A375 Cell Migration	PLOS ONE			English	Article							TYROSINE KINASE; F-ACTIN; ACTIVATION; GROWTH; CANCER; PDGF; METASTASIS; EXPRESSION; APOPTOSIS; INVASION	Integrins are heterodimeric transmembrane receptors that physically link the extracellular matrix (ECM) to the intracellular actin cytoskeleton, and are also signaling molecules that transduce signals bi-directionally across the plasma membrane. Integrin regulation is essential for tumor cell migration in response to growth factors. c-Abl kinase is a nonreceptor tyrosine kinase and is critical for signaling transduction from various receptors. Here we show that c-Abl kinase is involved in A375 cell migration mediated by alpha(v)beta(3) integrin in response to PDGF stimulation. c-Abl kinase colocalizes with alpha(v)beta(3) integrin dynamically and affects alpha(v)beta(3) integrin affinity by regulating its cluster. The interaction between c-Abl kinase and alpha(v)beta(3) integrin was dependent on the activity of c-Abl kinase induced by PDGF stimulation, but was not dependent on the binding of alpha(v)beta(3) integrin with its ligands, suggesting that c-Abl kinase is not involved in the outside- in signaling of alpha(v)beta(3) integrin. Talin head domain was required for the interaction between c-Abl kinase and alpha(v)beta(3) integrin, and the SH3 domain of c-Abl kinase was involved in its interaction with talin and alpha(v)beta(3) integrin. Taken together, we have uncovered a novel and critical role of c-Abl kinase in alpha(v)beta(3) integrin mediated melanoma cell migration.	[Yang, Chao; Wang, Ruifei; Jiao, Yang; Ampah, Khamal Kwesi; Zeng, Xianlu] NE Normal Univ, Inst Cytol & Genet, Changchun, Jilin Province, Peoples R China; [Zhang, Chunmei] Jilin Univ, Dept Cell Biol, Norman Bethune Coll Med, Changchun 130023, Jilin Province, Peoples R China; [Wang, Xiaoguang] Changchun Teachers Coll, Dept Biosci, Changchun, Jilin Province, Peoples R China	Northeast Normal University - China; Jilin University	Wang, XG (corresponding author), Changchun Teachers Coll, Dept Biosci, Changchun, Jilin Province, Peoples R China.	wangxiaoguang58@sina.com; zengx779@nenu.edu.cn			National Nature Science Foundation of China [81071726, 81172014]; specialized Research Fund for the Doctoral Program of Higher Education [20100043110007]; Fundamental Research Funds for the Central Universities [10SSXT129]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by grants from the National Nature Science Foundation of China (81071726, 81172014), the specialized Research Fund for the Doctoral Program of Higher Education (20100043110007), and the Fundamental Research Funds for the Central Universities (10SSXT129). The funders had a role in decision to publish.	Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Askari JA, 2009, J CELL SCI, V122, P165, DOI 10.1242/jcs.018556; CICCHETTI P, 1992, SCIENCE, V257, P803, DOI 10.1126/science.1379745; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; Cui LL, 2009, J IMMUNOL, V182, P3233, DOI 10.4049/jimmunol.0802621; Ganguly SS, 2012, ONCOGENE, V31, P1804, DOI 10.1038/onc.2011.361; Geho DH, 2005, PHYSIOLOGY, V20, P194, DOI 10.1152/physiol.00009.2005; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Kerbel RS, 1995, CANCER METAST REV, V14, P259, DOI 10.1007/BF00690597; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lewis JM, 1998, J BIOL CHEM, V273, P14225, DOI 10.1074/jbc.273.23.14225; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; Liden A, 2006, CIRC RES, V98, P635, DOI 10.1161/01.RES.0000207393.67851.d4; Lin J, 2008, ONCOGENE, V27, P4385, DOI 10.1038/onc.2008.86; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; MAYER BJ, 1994, MOL CELL BIOL, V14, P2883, DOI 10.1128/MCB.14.5.2883; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; O'Donovan M, 1999, J CLIN PATHOL-MOL PA, V52, P341, DOI 10.1136/mp.52.6.341; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Plattner R, 2003, NAT CELL BIOL, V5, P309, DOI 10.1038/ncb949; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; Renshaw MW, 2000, ONCOGENE, V19, P3216, DOI 10.1038/sj.onc.1203667; Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Singer CF, 2004, ENDOCR-RELAT CANCER, V11, P861, DOI 10.1677/erc.1.00801; Sirvent A, 2008, BIOL CELL, V100, P617, DOI 10.1042/BC20080020; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Uhm Joon H., 1999, Frontiers in Bioscience, V4, pD188, DOI 10.2741/Uhm; Van Etten RA, 1999, TRENDS CELL BIOL, V9, P179, DOI 10.1016/S0962-8924(99)01549-4; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; Verbisck NV, 2009, CANCER RES, V69, P5546, DOI 10.1158/0008-5472.CAN-08-2976; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Woodard AS, 1998, J CELL SCI, V111, P469; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Xu JY, 2010, BLOOD, V115, P2709, DOI 10.1182/blood-2009-05-223776; Yan W, 2008, MOL BIOL CELL, V19, P2278, DOI 10.1091/mbc.E07-10-1068; Zhao HJ, 2010, NEOPLASIA, V12, P214, DOI 10.1593/neo.91576	41	6	6	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66108	10.1371/journal.pone.0066108	http://dx.doi.org/10.1371/journal.pone.0066108			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805201	gold, Green Published, Green Submitted			2022-12-25	WOS:000320846500029
J	Dobbs, KB; Rodriguez, M; Sudano, MJ; Ortega, MS; Hansen, PJ				Dobbs, Kyle B.; Rodriguez, Marlon; Sudano, Mateus J.; Ortega, M. Sofia; Hansen, Peter J.			Dynamics of DNA Methylation during Early Development of the Preimplantation Bovine Embryo	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; IN-VITRO; MAMMALIAN DEVELOPMENT; NUCLEAR TRANSFER; PATERNAL GENOME; MOUSE; SEX; DEMETHYLATION; EXPRESSION; PATTERNS	There is species divergence in control of DNA methylation during preimplantation development. The exact pattern of methylation in the bovine embryo has not been established nor has its regulation by gender or maternal signals that regulate development such as colony stimulating factor 2 (CSF2). Using immunofluorescent labeling with anti-5-methylcytosine and embryos produced with X-chromosome sorted sperm, it was demonstrated that methylation decreased from the 2-cell stage to the 6-8 cell stage and then increased thereafter up to the blastocyst stage. In a second experiment, embryos of specific genders were produced by fertilization with X-or Y-sorted sperm. The developmental pattern was similar to the first experiment, but there was stage x gender interaction. Methylation was greater for females at the 8-cell stage but greater for males at the blastocyst stage. Treatment with CSF2 had no effect on labeling for DNA methylation in blastocysts. Methylation was lower for inner cell mass cells (i.e., cells that did not label with anti-CDX2) than for trophectoderm (CDX2-positive). The possible role for DNMT3B in developmental changes in methylation was evaluated by determining gene expression and degree of methylation. Steady-state mRNA for DNMT3B decreased from the 2-cell stage to a nadir for D 5 embryos > 16 cells and then increased at the blastocyst stage. High resolution melting analysis was used to assess methylation of a CpG rich region in an intronic region of DNMT3B. Methylation percent decreased between the 6-8 cell and the blastocyst stage but there was no difference in methylation between ICM and TE. Results indicate that DNA methylation undergoes dynamic changes during the preimplantation period in a manner that is dependent upon gender and cell lineage. Developmental changes in expression of DNMT3B are indicative of a possible role in changes in methylation. Moreover, DNMT3B itself appears to be under epigenetic control by methylation.	[Dobbs, Kyle B.; Rodriguez, Marlon; Ortega, M. Sofia; Hansen, Peter J.] Univ Florida, Dept Anim Sci, DH Barron Reprod & Perinatal Biol Res Program, Gainesville, FL 32611 USA; [Dobbs, Kyle B.; Rodriguez, Marlon; Ortega, M. Sofia; Hansen, Peter J.] Univ Florida, Genet Inst, Gainesville, FL 32611 USA; [Sudano, Mateus J.] Univ Estadual Paulista, Fac Med Vet & Zootecnia, Dept Reprod Anim & Radiol Vet, Sao Paulo, Brazil	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Universidade Estadual Paulista	Hansen, PJ (corresponding author), Univ Florida, Dept Anim Sci, DH Barron Reprod & Perinatal Biol Res Program, Gainesville, FL 32611 USA.	pjhansen@ufl.edu	Ortega, Sofia/ABA-3654-2020; , M/AAZ-7804-2020; Hansen, Peter/AAI-4693-2021; Alizadeh/AAK-1398-2021; Sudano, Mateus J/D-7614-2013	Ortega, Sofia/0000-0003-4027-7314; , M/0000-0002-7699-4449; Hansen, Peter/0000-0003-3061-9333; Sudano, Mateus J/0000-0002-7699-4449	Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture [2011-67015-30688]	Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture	This project was supported by Agriculture and Food Research Initiative Competitive Grant no. 2011-67015-30688 from the USDA National Institute of Food and Agriculture (http://www.csrees.usda.gov/fo/agriculturalandfoodresearchinitiativeafri.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVERY B, 1992, MOL REPROD DEV, V32, P265, DOI 10.1002/mrd.1080320312; Beaujean N, 2004, BIOL REPROD, V71, P185, DOI 10.1095/biolreprod.103.026559; Berg DK, 2011, DEV CELL, V20, P244, DOI 10.1016/j.devcel.2011.01.003; Bermejo-Alvarez P, 2008, PHYSIOL GENOMICS, V32, P264, DOI 10.1152/physiolgenomics.00234.2007; Bermejo-Alvarez P, 2010, P NATL ACAD SCI USA, V107, P3394, DOI 10.1073/pnas.0913843107; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Block J, 2009, THERIOGENOLOGY, V71, P1063, DOI 10.1016/j.theriogenology.2008.11.007; Block J, 2003, J ANIM SCI, V81, P1590; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; CAMOUS S, 1986, BIOL CELL, V58, P195, DOI 10.1111/j.1768-322X.1986.tb00506.x; Canovas S, 2012, P NATL ACAD SCI USA, V109, P2400, DOI 10.1073/pnas.1119112109; CARLSON LL, 1992, GENE DEV, V6, P2536, DOI 10.1101/gad.6.12b.2536; Chen T, 2004, FEBS LETT, V578, P69, DOI 10.1016/j.febslet.2004.10.073; de Moraes AAS, 1999, J REPROD IMMUNOL, V42, P135, DOI 10.1016/S0165-0378(98)00075-8; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Dean W, 2003, SEMIN CELL DEV BIOL, V14, P93, DOI 10.1016/S1084-9521(02)00141-6; deMoraes AAS, 1997, BIOL REPROD, V57, P1060, DOI 10.1095/biolreprod57.5.1060; Fields SD, 2011, THERIOGENOLOGY, V75, P1466, DOI 10.1016/j.theriogenology.2010.12.007; Fulka J, 2006, HISTOCHEM CELL BIOL, V126, P213, DOI 10.1007/s00418-006-0153-x; Gebert C, 2006, GENOMICS, V88, P222, DOI 10.1016/j.ygeno.2006.03.011; Giraldo AA, 2008, BIOL REPROD, V78, P832, DOI 10.1095/biolreprod.107.066662; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; GutierrezAdan A, 1997, MOL REPROD DEV, V48, P246, DOI 10.1002/(SICI)1098-2795(199710)48:2&lt;246::AID-MRD12&gt;3.0.CO;2-W; GutierrezAdan A, 1996, THERIOGENOLOGY, V46, P515, DOI 10.1016/0093-691X(96)00173-2; Hou J, 2007, SCI CHINA SER C, V50, P56, DOI 10.1007/s11427-007-0003-7; Kuijk EW, 2008, DEV DYNAM, V237, P918, DOI 10.1002/dvdy.21480; Lonergan P, 1999, J REPROD FERTIL, V117, P159, DOI 10.1530/jrf.0.1170159; Loureiro B, 2009, ENDOCRINOLOGY, V150, P5046, DOI 10.1210/en.2009-0481; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Niemann H, 2010, CELL REPROGRAM, V12, P33, DOI 10.1089/cell.2009.0063; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Ozawa M, 2012, BMC DEV BIOL, V12, P1, DOI 10.1186/1471-213X-12-33; Ozawa M, 2011, FERTIL STERIL, V95, P799, DOI 10.1016/j.fertnstert.2010.10.006; PARRISH JJ, 1986, THERIOGENOLOGY, V25, P591, DOI 10.1016/0093-691X(86)90143-3; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; Sakatani M, 2012, J DAIRY SCI, V95, P3080, DOI 10.3168/jds.2011-4986; Santos F, 2004, REPRODUCTION, V127, P643, DOI 10.1530/rep.1.00221; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Shi W, 2004, BIOL REPROD, V71, P340, DOI 10.1095/biolreprod.103.024554; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Wojdacz TK, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm013; Wojdacz TK, 2008, NAT PROTOC, V3, P1903, DOI 10.1038/nprot.2008.191; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	47	81	82	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66230	10.1371/journal.pone.0066230	http://dx.doi.org/10.1371/journal.pone.0066230			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799080	Green Published, gold, Green Submitted			2022-12-25	WOS:000320363300065
J	Ripoll, E; Merino, A; Goma, M; Aran, JM; Bolanos, N; de Ramon, L; Herrero-Fresneda, I; Bestard, O; Cruzado, JM; Grinyo, JM; Torras, J				Ripoll, Elia; Merino, Ana; Goma, Montse; Aran, Josep M.; Bolanos, Nuria; de Ramon, Laura; Herrero-Fresneda, Immaculada; Bestard, Oriol; Cruzado, Josep M.; Grinyo, Josep M.; Torras, Juan			CD40 Gene Silencing Reduces the Progression of Experimental Lupus Nephritis Modulating Local Milieu and Systemic Mechanisms	PLOS ONE			English	Article							NZB/W F-1 MICE; NF-KAPPA-B; COSTIMULATORY BLOCKADE; CHEMICAL-MODIFICATION; ERYTHEMATOSUS SLE; INFLAMED KIDNEYS; CELL ACTIVATION; ANIMAL-MODELS; MURINE LUPUS; PLASMA-CELLS	Lupus nephritis (LN) is an autoimmune disorder in which co-stimulatory signals have been involved. Here we tested a cholesterol-conjugated-anti-CD40-siRNA in dendritic cells (DC) in vitro and in a model of LPS to check its potency and tissue distribution. Then, we report the effects of Chol-siRNA in an experimental model of mice with established lupus nephritis. Our in vitro studies in DC show a 100% intracellular delivery of Chol-siRNA, with a significant reduction in CD40 after LPS stimuli. In vivo in ICR mice, the CD40-mRNA suppressive effects of our Chol-siRNA on renal tissue were remarkably sustained over a 5 days after a single preliminary dose of Chol-siRNA. The intra-peritoneal administration of Chol-siRNA to NZB/WF1 mice resulted in a reduction of anti-DNA antibody titers, and histopathological renal scores as compared to untreated animals. The higher dose of Chol-siRNA prevented the progression of proteinuria as effectively as cyclophosphamide, whereas the lower dose was as effective as CTLA4. Chol-siRNA markedly reduced insterstitialCD3+ and plasma cell infiltrates as well as glomerular deposits of IgG and C3. Circulating soluble CD40 and activated splenic lymphocyte subsets were also strikingly reduced by Chol-siRNA. Our data show the potency of our compound for the therapeutic use of anti-CD40-siRNA in human LN and other autoimmune disorders.	[Ripoll, Elia; Merino, Ana; Bolanos, Nuria; de Ramon, Laura; Herrero-Fresneda, Immaculada; Bestard, Oriol; Cruzado, Josep M.; Grinyo, Josep M.; Torras, Juan] IDIBELL Hosp Univ Bellvitge, Lab Expt Nephrol, Barcelona, Spain; [Goma, Montse] Hosp Univ Bellvitge, Dept Pathol, Barcelona, Spain; [Aran, Josep M.] IDIBELL, Med & Mol Genet Ctr, Barcelona, Spain	CIBERNED; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Torras, J (corresponding author), IDIBELL Hosp Univ Bellvitge, Lab Expt Nephrol, Barcelona, Spain.	15268jta@comb.cat	Merino, Ana/L-8347-2017; Aran, Josep M./R-9093-2019; Torras, Joan/AAH-8131-2021	Aran, Josep M./0000-0003-2827-9392; Torras, Juan/0000-0002-1135-7588	Instituto de Salud Carlos III/FIS [PS09/00897, PS09/00107, PI10/2991]; European Union Grant SYSKID Framework Programme; IDIBELL; ISCIII; Societat Catalana de Transplantament; Dpt. Salut Generalitat Catalunya; Insitituto de Salud Carlos III, programa Sara Borrell	Instituto de Salud Carlos III/FIS(Instituto de Salud Carlos III); European Union Grant SYSKID Framework Programme; IDIBELL; ISCIII(Instituto de Salud Carlos III); Societat Catalana de Transplantament; Dpt. Salut Generalitat Catalunya; Insitituto de Salud Carlos III, programa Sara Borrell	This study was supported by grants from Instituto de Salud Carlos III/FIS (PS09/00897, PS09/00107, PI10/2991), European Union Grant SYSKID Framework Programme 7 (FP7). Nuria Bolanos is a technician from 'Contratos de tecnico de apoyo en el sistema nacional de la salud' financed by ISCIII. Elia Ripoll was a fellowship from IDIBELL and from Societat Catalana de Transplantament. Josep M. Aran and Immaculada Herrero are a researchers from 'Programa Estabilizacion Investigadores' financed by ISCIII and Dpt. Salut Generalitat Catalunya, and Ana Merino was supported by a contract from Insitituto de Salud Carlos III, programa Sara Borrell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Allerson CR, 2005, J MED CHEM, V48, P901, DOI 10.1021/jm049167j; Bagavant H, 2009, CURR OPIN RHEUMATOL, V21, P489, DOI 10.1097/BOR.0b013e32832efff1; Berden JHM, 2003, NETH J MED, V61, P233; Borchers A, 2000, SEMIN ARTHRITIS RHEU, V29, P385, DOI 10.1053/sarh.2000.7173; Cassese G, 2001, EUR J IMMUNOL, V31, P2726, DOI 10.1002/1521-4141(200109)31:9<2726::AID-IMMU2726>3.0.CO;2-H; Choung S, 2006, BIOCHEM BIOPH RES CO, V342, P919, DOI 10.1016/j.bbrc.2006.02.049; CONNOLLY K, 1992, J IMMUNOL, V149, P3083; Corey DR, 2007, J CLIN INVEST, V117, P3615, DOI 10.1172/JCI33483; Cunnane G, 2004, ARTHRITIS RHEUM-US, V50, P1539, DOI 10.1002/art.20147; Davidson A, 2003, ANN NY ACAD SCI, V987, P188, DOI 10.1111/j.1749-6632.2003.tb06048.x; Davidson A, 2010, NAT REV RHEUMATOL, V6, P13, DOI 10.1038/nrrheum.2009.240; Espeli M, 2011, J AM SOC NEPHROL, V22, P296, DOI 10.1681/ASN.2010050515; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Hahn BH, 2001, LUPUS, V10, P589, DOI 10.1191/096120301682430140; HUSTON DP, 1979, YALE J BIOL MED, V52, P289; Ioannidis JPA, 2000, KIDNEY INT, V57, P258, DOI 10.1046/j.1523-1755.2000.00832.x; Kawai T, 2000, NAT MED, V6, P114, DOI 10.1038/72162; KLINMAN DM, 1990, J CLIN INVEST, V86, P1249, DOI 10.1172/JCI114831; Layzer JM, 2004, RNA, V10, P766, DOI 10.1261/rna.5239604; LLORENTE L, 1995, J EXP MED, V181, P839, DOI 10.1084/jem.181.3.839; Manderson AP, 2004, ANNU REV IMMUNOL, V22, P431, DOI 10.1146/annurev.immunol.22.012703.104549; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; Park YB, 1998, CLIN EXP RHEUMATOL, V16, P283; Peters AL, 2009, SEMIN IMMUNOL, V21, P293, DOI 10.1016/j.smim.2009.05.012; Pluvinet R, 2008, BLOOD, V112, P3624, DOI 10.1182/blood-2008-03-143305; Qin HW, 2005, BLOOD, V106, P3114, DOI 10.1182/blood-2005-02-0759; Reynolds A, 2006, RNA, V12, P988, DOI 10.1261/rna.2340906; Ripoll E, 2011, GENE THER, V18, P945, DOI 10.1038/gt.2011.39; Robles-Carrillo L, 2010, J IMMUNOL, V185, P1577, DOI 10.4049/jimmunol.0903888; Robson MG, 2001, CLIN EXP ALLERGY, V31, P678, DOI 10.1046/j.1365-2222.2001.01147.x; Russell P J, 1966, Lancet, V1, P1280; Sang A, 2012, PROG MOL BIOL TRANSL, V105, P321, DOI 10.1016/B978-0-12-394596-9.00010-X; Schiffer L, 2003, J IMMUNOL, V171, P489, DOI 10.4049/jimmunol.171.1.489; Sekine H, 2011, MOL IMMUNOL, V49, P317, DOI 10.1016/j.molimm.2011.09.015; Shimomura Y, 2008, INT IMMUNOL, V20, P729, DOI 10.1093/intimm/dxn031; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Starke C, 2011, EUR J IMMUNOL, V41, P2107, DOI 10.1002/eji.201041315; Tang S, 1999, J IMMUNOL, V162, P4336; Vowinkel T, 2006, AM J PHYSIOL-HEART C, V290, pH631, DOI 10.1152/ajpheart.00733.2005; Wang XB, 2002, J IMMUNOL, V168, P2046, DOI 10.4049/jimmunol.168.4.2046	43	27	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65068	10.1371/journal.pone.0065068	http://dx.doi.org/10.1371/journal.pone.0065068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799000	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300008
J	Wen, ZZ; Cai, MY; Mai, Z; Jin, DM; Chen, YX; Huang, H; Geng, DF; Wang, JF				Wen, Zhu-zhi; Cai, Mu-yan; Mai, Zun; Jin, Dong-mei; Chen, Yang-xin; Huang, Hui; Geng, Deng-feng; Wang, Jing-feng			Angiotensin II Receptor Blocker Attenuates Intrarenal Renin-Angiotensin-System and Podocyte Injury in Rats with Myocardial Infarction	PLOS ONE			English	Article							GROWTH-FACTOR-I; ACE-INHIBITION; RENAL-FUNCTION; HEART-FAILURE; EXPRESSION; ACTIVATION; DAMAGE; CONTRIBUTES; MECHANISMS; MODEL	The mechanisms and mediators underlying common renal impairment after myocardial infarction (MI) are still poorly understood. The present study aimed to test the hypothesis that angiotensin II type 1 receptor blockers (ARBs) provides renoprotective effects after MI by preventing augmented intrarenal renin-angiotensin-system (RAS)-induced podocyte injury. Sprague-Dawley rats that underwent ligation of their coronary arteries were treated with losartan (20 mg/kg/d) or vehicle for 3 or 9 weeks. Renal function, histology and molecular changes were assessed. The current study revealed that MI-induced glomerular podocyte injury was identified by increased immunostaining for desmin and p16(ink4a), decreased immunostaining for Wilms' tumor-1 and podocin mRNA expression, and an induced increase of blood cystatin C at both 3 and 9 weeks. These changes were associated with increased intrarenal angiotensin II levels and enhanced expressions of angiotensinogen mRNA and angiotensin II receptor mRNA and protein. These changes were also associated with decreased levels of insulin-like growth factor (IGF-1) and decreased expressions of IGF-1 receptor (IGF-1R) protein and mRNA and phosphorylated(p)-Akt protein at 9 weeks, as well as increased expressions of 8-hydroxy-2'-deoxyguanosine at both time points. Treatment with losartan significantly attenuated desmin- and p16(ink4a)-positive podocytes, restored podocin mRNA expression, and decreased blood cystatin C levels. Losartan also prevented RAS activation and oxidative stress and restored the IGF-1/IGF-1R/Akt pathway. In conclusion, ARBs prevent the progression of renal impairment after MI via podocyte protection, partially by inhibiting the activation of the local RAS with subsequent enhanced oxidative stress and an inhibited IGF-1/IGF-1R/Akt pathway.	[Wen, Zhu-zhi; Chen, Yang-xin; Huang, Hui; Geng, Deng-feng; Wang, Jing-feng] Sun Yat Sen Univ, Dept Cardiol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Wen, Zhu-zhi; Chen, Yang-xin; Huang, Hui; Geng, Deng-feng; Wang, Jing-feng] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guandong Prov Key Lab Arrhythmia & Electrophysiol, Guangzhou 510275, Guangdong, Peoples R China; [Cai, Mu-yan] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Mai, Zun] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Jin, Dong-mei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Rehabil Med, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Wang, JF (corresponding author), Sun Yat Sen Univ, Dept Cardiol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China.	syswjf@hotmail.com	wang, jing/GRS-7509-2022		National Natural Science Foundation of China [30971262/81270212]; Academic Scholarship of Ministry of National Education for Doctoral Candidates [81000-3191001]; Doctoral Student Innovation Personnel Training Projects of Sun Yat-sen University; Guangdong Province Natural Science Fund [S2011010002650]; Guangdong Provincial Science and Technology Projects [2012B031800293]; PhD Start-up programme of Guangdong Province Natural Science Fund [S2012040008047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Academic Scholarship of Ministry of National Education for Doctoral Candidates; Doctoral Student Innovation Personnel Training Projects of Sun Yat-sen University; Guangdong Province Natural Science Fund(National Natural Science Foundation of Guangdong Province); Guangdong Provincial Science and Technology Projects; PhD Start-up programme of Guangdong Province Natural Science Fund	This work was supported by the National Natural Science Foundation of China (No: 30971262/81270212), the Academic Scholarship of Ministry of National Education for Doctoral Candidates (No: 81000-3191001) and the Doctoral Student Innovation Personnel Training Projects of Sun Yat-sen University. This work was also supported by the Guangdong Province Natural Science Fund (S2011010002650), Guangdong Provincial Science and Technology Projects (No. 2012B031800293) and the PhD Start-up programme of Guangdong Province Natural Science Fund (S2012040008047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia DM, 2004, J AM SOC NEPHROL, V15, P949, DOI 10.1097/01.ASN.0000118528.00817.8E; Bock JS, 2010, CIRCULATION, V121, P2592, DOI 10.1161/CIRCULATIONAHA.109.886473; Bridgewater DJ, 2008, GROWTH HORM IGF RES, V18, P26, DOI 10.1016/j.ghir.2007.06.003; Bridgewater DJ, 2005, KIDNEY INT, V67, P1308, DOI 10.1111/j.1523-1755.2005.00208.x; Cai MY, 2011, MOL MED, V17, P12, DOI 10.2119/molmed.2010.00103; Carubelli V, 2012, HEART FAIL REV, V17, P271, DOI 10.1007/s10741-011-9265-z; Chertin B, 2004, PEDIATR SURG INT, V20, P283, DOI 10.1007/s00383-003-1127-x; Dean RG, 2003, J HISTOCHEM CYTOCHEM, V51, P831, DOI 10.1177/002215540305100614; Durvasula RV, 2004, KIDNEY INT, V65, P30, DOI 10.1111/j.1523-1755.2004.00362.x; Efrati S, 2012, NEPHROL DIAL TRANSPL, V27, P136, DOI 10.1093/ndt/gfr256; Fujinaka H, 2010, NEPHROLOGY, V15, P700, DOI 10.1111/j.1440-1797.2010.01285.x; Gonzalez A, 2008, CIRC RES, V102, P597, DOI 10.1161/CIRCRESAHA.107.165464; Hillege HL, 2003, EUR HEART J, V24, P412, DOI 10.1016/S0195-668X(02)00526-2; Homma T, 2012, AM J PHYSIOL-RENAL, V302, pF750, DOI 10.1152/ajprenal.00494.2011; Hsu HH, 2011, KIDNEY INT, V80, P959, DOI 10.1038/ki.2011.250; Hsu HH, 2008, J MOL MED, V86, P1379, DOI 10.1007/s00109-008-0399-y; Izuhara Y, 2005, J AM SOC NEPHROL, V16, P3631, DOI 10.1681/ASN.2005050522; Lai KN, 2011, CONTRIB NEPHROL, V170, P135, DOI 10.1159/000325649; Lekawanvijit S, 2012, AM J PHYSIOL-HEART C, V302, pH1884, DOI 10.1152/ajpheart.00967.2011; Liang Kelly V, 2008, Crit Care Med, V36, pS75, DOI 10.1097/01.CCM.0000296270.41256.5C; Liebau MC, 2006, AM J PHYSIOL-RENAL, V290, pF710, DOI 10.1152/ajprenal.00475.2004; Mashima Y, 2013, CLIN NEPHROL, V79, P15, DOI 10.5414/CN107645; Niizuma S, 2011, RENAL FAILURE, V33, P847, DOI 10.3109/0886022X.2011.605531; Rafiq K, 2012, CIRCULATION, V125, P1402, DOI 10.1161/CIRCULATIONAHA.111.064097; Schulze PC, 2003, BASIC RES CARDIOL, V98, P267, DOI 10.1007/s00395-003-0411-1; SCHUNKERT H, 1993, CARDIOVASC RES, V27, P731, DOI 10.1093/cvr/27.5.731; van Dokkum RPE, 2004, J AM SOC NEPHROL, V15, P3103, DOI 10.1097/01.ASN.0000145895.62896.98; Wang CT, 1997, J AM SOC NEPHROL, V8, P535; Wen ZZ, 2013, RENAL FAILURE, V35, P766, DOI 10.3109/0886022X.2013.780561; Windt WAKM, 2006, J AM SOC NEPHROL, V17, P3059, DOI 10.1681/ASN.2006030209; Xu XH, 2008, CARDIOVASC RES, V78, P523, DOI 10.1093/cvr/cvn028	31	14	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e67242	10.1371/journal.pone.0067242	http://dx.doi.org/10.1371/journal.pone.0067242			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799145	gold, Green Submitted, Green Published			2022-12-25	WOS:000320363300108
J	Zhao, W; Huang, Y; Liu, Z; Cao, BB; Peng, YP; Qiu, YH				Zhao, Wei; Huang, Yan; Liu, Zhan; Cao, Bei-Bei; Peng, Yu-Ping; Qiu, Yi-Hua			Dopamine Receptors Modulate Cytotoxicity of Natural Killer Cells via cAMP-PKA-CREB Signaling Pathway	PLOS ONE			English	Article							ACTIVATED T-CELLS; PROTEIN-KINASE-A; FACTOR-KAPPA-B; MEDIATED MECHANISM; NUCLEAR-FACTOR; EXPRESSION; D2; LYMPHOCYTES; SECRETION; PROLIFERATION	Dopamine (DA), a neurotransmitter in the nervous system, has been shown to modulate immune function. We have previously reported that five subtypes of DA receptors, including D1R, D2R, D3R, D4R and D5R, are expressed in T lymphocytes and they are involved in regulation of T cells. However, roles of these DA receptor subtypes and their coupled signal-transduction pathway in modulation of natural killer (NK) cells still remain to be clarified. The spleen of mice was harvested and NK cells were isolated and purified by negative selection using magnetic activated cell sorting. After NK cells were incubated with various drugs for 4 h, flow cytometry measured cytotoxicity of NK cells against YAC-1 lymphoma cells. NK cells expressed the five subtypes of DA receptors at mRNA and protein levels. Activation of D1-like receptors (including D1R and D5R) with agonist SKF38393 enhanced NK cell cytotoxicity, but activation of D2-like receptors (including D2R, D3R and D4R) with agonist quinpirole attenuated NK cells. Simultaneously, SKF38393 elevated D1R and D5R expression, cAMP content, and phosphorylated cAMP-response element-binding (CREB) level in NK cells, while quinpirole reduced D3R and D4R expression, cAMP content, and phosphorylated CREB level in NK cells. These effects of SKF38393 were blocked by SCH23390, an antagonist of D1-like receptors, and quinpirole effects were abolished by haloperidol, an antagonist of D2-like receptors. In support these results, H89, an inhibitor of phosphokinase A (PKA), prevented the SKF38393-dependent enhancement of NK cells and forskolin, an activator of adenylyl cyclase (AC), counteracted the quinpirole-dependent suppression of NK cells. These findings show that DA receptor subtypes are involved in modulation of NK cells and suggest that D1-like receptors facilitate NK cells by stimulating D1R/D5R-cAMP-PKA-CREB signaling pathway and D2-like receptors suppress NK cells by inhibiting D3R/D4R-cAMP-PKA-CREB signaling pathway. The results may provide more targets of therapeutic strategy for neuroimmune diseases.	[Zhao, Wei; Huang, Yan; Liu, Zhan; Cao, Bei-Bei; Peng, Yu-Ping; Qiu, Yi-Hua] Nantong Univ, Sch Med, Dept Physiol, Nantong, Jiangsu, Peoples R China	Nantong University	Peng, YP (corresponding author), Nantong Univ, Sch Med, Dept Physiol, Nantong, Jiangsu, Peoples R China.	yppeng@ntu.edu.cn; yhqiu@ntu.edu.cn	peng, yu/GXW-2071-2022		National Natural Science Foundation of China [30870929, 81271323]; Natural Science Foundation of Jiangsu Province of China [BK2010278, BK2011386]; Nantong Applied Research Program of China [CP12012003, BK2012014, BK2012015]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Nantong Applied Research Program of China; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by grants 30870929 and 81271323 from the National Natural Science Foundation of China, BK2010278 and BK2011386 from the Natural Science Foundation of Jiangsu Province of China, CP12012003, BK2012014 and BK2012015 from the Nantong Applied Research Program of China, and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl EM, 2002, J IMMUNOL, V169, P802, DOI 10.4049/jimmunol.169.2.802; BASU S, 1992, BIOGENIC AMINES, V8, P191; Beck GC, 2004, CRIT CARE, V8, P485, DOI 10.1186/cc2879; Besser MJ, 2005, J NEUROIMMUNOL, V169, P161, DOI 10.1016/j.jneuroim.2005.07.013; Carr L, 2003, J NEUROIMMUNOL, V137, P87, DOI 10.1016/S0165-5728(03)00047-X; Cosentino M, 2007, BLOOD, V109, P632, DOI 10.1182/blood-2006-01-028423; Ghosh MC, 2003, INT IMMUNOPHARMACOL, V3, P1019, DOI 10.1016/S1567-5769(03)00100-0; Harada Y, 1999, BIOCHEM BIOPH RES CO, V266, P129, DOI 10.1006/bbrc.1999.1783; Hasko G, 2002, J NEUROIMMUNOL, V122, P34, DOI 10.1016/S0165-5728(01)00459-3; Hershfield MS, 2005, EUR J IMMUNOL, V35, P25, DOI 10.1002/eji.200425738; Huang Y, 2010, NEUROENDOCRINO LETT, V31, P101; Iizuka Y, 2007, J NEUROSCI, V27, P12390, DOI 10.1523/JNEUROSCI.1689-07.2007; Ilani T, 2004, FASEB J, V18, DOI 10.1096/fj.04-1652fje; JACKSON DM, 1994, PHARMACOL THERAPEUT, V64, P291, DOI 10.1016/0163-7258(94)90041-8; Jimenez JL, 2001, J PHARMACOL EXP THER, V299, P753; Kavelaars A, 2005, J NEUROIMMUNOL, V161, P162, DOI 10.1016/j.jneuroim.2005.01.004; Kipnis J, 2004, J NEUROSCI, V24, P6133, DOI 10.1523/JNEUROSCI.0600-04.2004; Kirillova GP, 2008, J NEUROSCI METH, V174, P272, DOI 10.1016/j.jneumeth.2008.07.018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McKenna F, 2002, J NEUROIMMUNOL, V132, P34, DOI 10.1016/S0165-5728(02)00280-1; Meredith EJ, 2006, P NATL ACAD SCI USA, V103, P13485, DOI 10.1073/pnas.0605993103; Mignini F, 2009, J NEUROIMMUNOL, V206, P5, DOI 10.1016/j.jneuroim.2008.09.018; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; MONSMA FJ, 1990, P NATL ACAD SCI USA, V87, P6723, DOI 10.1073/pnas.87.17.6723; Nakano K, 2008, BIOCHEM BIOPH RES CO, V373, P286, DOI 10.1016/j.bbrc.2008.06.012; NEUMANN M, 1995, EMBO J, V14, P1991, DOI 10.1002/j.1460-2075.1995.tb07191.x; Pacheco R, 2009, J NEUROIMMUNOL, V216, P8, DOI 10.1016/j.jneuroim.2009.07.018; PAPADOPOULOS NG, 1994, J IMMUNOL METHODS, V177, P101, DOI 10.1016/0022-1759(94)90147-3; Ramstad C, 2000, CELL SIGNAL, V12, P557, DOI 10.1016/S0898-6568(00)00097-8; Robinson SW, 1997, MOL PHARMACOL, V52, P508, DOI 10.1124/mol.52.3.508; Saha B, 2001, NEUROIMMUNOMODULAT, V9, P23, DOI 10.1159/000049004; Santanavanich C, 2005, J PINEAL RES, V38, P170, DOI 10.1111/j.1600-079X.2004.00189.x; Teunis MAT, 2004, PSYCHONEUROENDOCRINO, V29, P1058, DOI 10.1016/j.psyneuen.2003.09.007; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; van Weenen JED, 2010, BIOCHEM PHARMACOL, V79, P1827, DOI 10.1016/j.bcp.2010.01.029; Vang T, 2001, J EXP MED, V193, P497, DOI 10.1084/jem.193.4.497; Watanabe Y, 2006, J IMMUNOL, V176, P848, DOI 10.4049/jimmunol.176.2.848; Yang M, 2003, MOL PHARMACOL, V64, P447, DOI 10.1124/mol.64.2.447; Yao WD, 2008, BIOCHEM PHARMACOL, V75, P2055, DOI 10.1016/j.bcp.2008.01.018; Yujnovsky I, 2006, P NATL ACAD SCI USA, V103, P6386, DOI 10.1073/pnas.0510691103; Zawilska Jolanta B, 2003, Postepy Hig Med Dosw, V57, P293	41	47	54	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65860	10.1371/journal.pone.0065860	http://dx.doi.org/10.1371/journal.pone.0065860			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799052	Green Submitted, Green Published, gold			2022-12-25	WOS:000320363300046
J	Bertsche, U; Yang, SJ; Kuehner, D; Wanner, S; Mishra, NN; Roth, T; Nega, M; Schneider, A; Mayer, C; Grau, T; Bayer, AS; Weidenmaier, C				Bertsche, Ute; Yang, Soo-Jin; Kuehner, Daniel; Wanner, Stefanie; Mishra, Nagendra N.; Roth, Tobias; Nega, Mulugeta; Schneider, Alexander; Mayer, Christoph; Grau, Timo; Bayer, Arnold S.; Weidenmaier, Christopher			Increased Cell Wall Teichoic Acid Production and D-alanylation Are Common Phenotypes among Daptomycin-Resistant Methicillin-Resistant Staphylococcus aureus (MRSA) Clinical Isolates	PLOS ONE			English	Article							REDUCED VANCOMYCIN SUSCEPTIBILITY; ANTIMICROBIAL PEPTIDE RESISTANCE; INTERMEDIATE; STRAINS; MPRF; NONSUSCEPTIBILITY; PEPTIDOGLYCAN; BIOSYNTHESIS; MECHANISMS; EXPRESSION	Multiple mechanisms have been correlated with daptomycin-resistance (DAP-R) in Staphylococcus aureus. However, one common phenotype observed in many DAP-R S. Aureus strains is a thickened cell wall (CW). The first evidence for an impact of CW-linked glycopolymers on this phenotype was recently demonstrated in a single, well-characterized DAP-R methicillin-susceptible S. aureus (MSSA) strain. In this isolate the thickened CW phenotype was linked to an increased production and D-alanylation of wall teichoic acids (WTA). In the current report, we extended these observations to methicillin-resistant daptomycin-sensitive/daptomyin-resistant (DAP-S/DAP-R) strain-pairs. These pairs included methicillin-resistant S. aureus (MRSA) isolates with and without single nucleotide polymorphisms (SNPs) in mprF (a genetic locus linked to DAP-R phenotype). We found increased CW dry mass in all DAP-R vs DAP-S isolates. This correlated with an increased expression of the WTA biosynthesis gene tagA, as well as an increased amount of WTA in the DAP-R vs DAP-S isolates. In addition, all DAP-R isolates showed a higher proportion of WTA D-alanylation vs their corresponding DAP-S isolate. We also detected an increased positive surface charge amongst the DAP-R strains (presumably related to the enhanced D-alanylation). In comparing the detailed CW composition of all isolate pairs, substantive differences were only detected in one DAP-S/DAP-R pair. The thickened CW phenotype, together with an increased surface charge most likely contributes to either: i) a charge-dependent repulsion of calcium complexed-DAP; and/or ii) steric-limited access of DAP to the bacterial cell envelope target. Taken together well-defined perturbations of CW structural and functional metrics contribute to the DAP-R phenotype and are common phenotypes in DAP-R S. Aureus isolates, both MSSA and MRSA. Note: Although "daptomycin-nonsusceptibility" is the generally accepted terminology, we have utilized the term "daptomycin resistance" for ease of presentation in this manuscript	[Bertsche, Ute; Kuehner, Daniel; Wanner, Stefanie; Roth, Tobias; Nega, Mulugeta; Schneider, Alexander; Mayer, Christoph; Grau, Timo; Weidenmaier, Christopher] Univ Tubingen, Interfak Inst Mikrobiol & Infektionsmed, Tubingen, Germany; [Yang, Soo-Jin; Mishra, Nagendra N.; Bayer, Arnold S.] Harbor UCLA Med Ctr, Div Infect Dis, LA Biomed Res Inst, Torrance, CA 90509 USA; [Yang, Soo-Jin; Bayer, Arnold S.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Kuehner, Daniel] Cecolabs UG, Tubingen, Germany	Eberhard Karls University of Tubingen; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Weidenmaier, C (corresponding author), Univ Tubingen, Interfak Inst Mikrobiol & Infektionsmed, Tubingen, Germany.	christopher.weidenmaier@med.uni-tuebingen.de	Mayer, Christoph/S-8666-2017	Mayer, Christoph/0000-0003-4731-4851; Weidenmaier, Christopher/0000-0003-4107-739X	German Research Foundation [SFB766, TR-SFB34]; National Institutes of Health (NIAID) [RO1-AI-039108-15]; American Heart Association (Western States Affiliate) [12BGIA11780035]; Los Angeles Biomedical Research Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039108] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association (Western States Affiliate)(American Heart Association); Los Angeles Biomedical Research Institute(University of California System); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	UB was supported by German Research Foundation Grant SFB766. CW was supported by German Research Foundation Grants TR-SFB34 and SFB766. This study was supported in part by a grant from the National Institutes of Health (NIAID) RO1-AI-039108-15 (to ASB), a Beginning Grant-in-Aid from the American Heart Association (Western States Affiliate) 12BGIA11780035 (to S-JY) and a Research Seed Grant from the Los Angeles Biomedical Research Institute (to S-JY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer AS, 2013, ANN NY ACAD SCI, V1277, P139, DOI 10.1111/j.1749-6632.2012.06819.x; Bertsche U, 2011, ANTIMICROB AGENTS CH; Boneca IG, 1997, J BIOL CHEM, V272, P29053, DOI 10.1074/jbc.272.46.29053; Boucher HW, 2007, CLIN INFECT DIS, V45, P601, DOI 10.1086/520655; Boyle-Vavra S, 2011, ANTIMICROB AGENTS CH, V55, P2018, DOI 10.1128/AAC.01593-10; Camargo ILBD, 2008, ANTIMICROB AGENTS CH, V52, P4289, DOI 10.1128/AAC.00417-08; Cui LZ, 2006, ANTIMICROB AGENTS CH, V50, P1079, DOI 10.1128/AAC.50.3.1079-1082.2006; DEJONGE BLM, 1993, J BACTERIOL, V175, P2779, DOI 10.1128/JB.175.9.2779-2782.1993; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Dubrac S, 2008, MOL MICROBIOL, V70, P1307, DOI 10.1111/j.1365-2958.2008.06483.x; Ernst CM, 2011, MOL MICROBIOL, V80, P290, DOI 10.1111/j.1365-2958.2011.07576.x; Fischer A, 2011, J ANTIMICROB CHEMOTH, V66, P1696, DOI 10.1093/jac/dkr195; Ginsberg C, 2006, ACS CHEM BIOL, V1, P25, DOI 10.1021/cb0500041; Gohring N, 2011, ANTIMICROB AGENTS CH, V55, P5452, DOI 10.1128/AAC.00286-11; Hayden MK, 2005, J CLIN MICROBIOL, V43, P5285, DOI 10.1128/JCM.43.10.5285-5287.2005; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Jones T, 2008, ANTIMICROB AGENTS CH, V52, P269, DOI 10.1128/AAC.00719-07; Julian K, 2007, ANTIMICROB AGENTS CH, V51, P3445, DOI 10.1128/AAC.00559-07; Kristian SA, 2005, J BACTERIOL, V187, P6719, DOI 10.1128/JB.187.19.6719-6725.2005; Liu C, 2011, CLIN INFECT DIS, V52, P285, DOI 10.1093/cid/cir034; McAleese F, 2006, J BACTERIOL, V188, P1120, DOI 10.1128/JB.188.3.1120-1133.2006; Mishra NN, 2011, ANTIMICROB AGENTS CH, V55, P4012, DOI 10.1128/AAC.00223-11; Mishra NN, 2009, ANTIMICROB AGENTS CH, V53, P2312, DOI 10.1128/AAC.01682-08; Mohedano ML, 2005, J BACTERIOL, V187, P2357, DOI 10.1128/JB.187.7.2357-2367.2005; Muthaiyan A, 2008, ANTIMICROB AGENTS CH, V52, P980, DOI 10.1128/AAC.01121-07; Peschel A, 2000, ANTIMICROB AGENTS CH, V44, P2845, DOI 10.1128/AAC.44.10.2845-2847.2000; Peschel A, 1996, FEMS MICROBIOL LETT, V137, P279; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Pillai SK, 2007, ANTIMICROB AGENTS CH, V51, P2223, DOI 10.1128/AAC.00202-07; Sakoulas G, 2003, J INFECT DIS, V187, P929, DOI 10.1086/368128; Skiest DJ, 2006, J CLIN MICROBIOL, V44, P655, DOI 10.1128/JCM.44.2.655-656.2006; Stranden AM, 1997, J BACTERIOL, V179, P9, DOI 10.1128/jb.179.1.9-16.1997; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Wootton M, 2006, ANTIMICROB AGENTS CH, V50, P4195, DOI 10.1128/AAC.00678-06; Xia G, 2008, CHEM BIOL, V15, P95, DOI 10.1016/j.chembiol.2008.02.005; Yang SJ, 2010, ANTIMICROB AGENTS CH, V54, P3079, DOI 10.1128/AAC.00122-10; Yang SJ, 2009, J INFECT DIS, V200, P1916, DOI 10.1086/648473; Yang SJ, 2009, ANTIMICROB AGENTS CH, V53, P2636, DOI 10.1128/AAC.01415-08; Zhou XX, 2012, BIOCHEMISTRY-US, V51, P8143, DOI 10.1021/bi3012115	40	65	65	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e67398	10.1371/journal.pone.0067398	http://dx.doi.org/10.1371/journal.pone.0067398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785522	Green Submitted, gold, Green Published			2022-12-25	WOS:000321038800002
J	Kim, JH; Kim, HK; Ko, JH; Bang, H; Lee, DC				Kim, Jung-Ha; Kim, Hye Kyung; Ko, Jae-Hong; Bang, Hyoweon; Lee, Duk-Chul			The Relationship between Leukocyte Mitochondrial DNA Copy Number and Telomere Length in Community-Dwelling Elderly Women	PLOS ONE			English	Article							PERIPHERAL-BLOOD; CALORIC RESTRICTION; RHESUS-MONKEYS; DIETARY RESTRICTION; QUANTITATIVE PCR; HEALTHY WOMEN; LIFE-SPAN; DYSFUNCTION; HYPERTENSION; STRESS	Purpose: Both telomere length and mitochondrial function are accepted as reflective indices of aging. Recent studies have shown that telomere dysfunction may influence impaired mitochondrial biogenesis and function. However, there has been no study regarding the possible association between telomere and mitochondrial function in humans. Therefore, the purpose of the study was to identify any relationships between mitochondrial and telomere function. Methods: The present study included 129 community-dwelling, elderly women. The leukocyte mitochondrial DNA copy number and telomere length were measured using a quantitative real-time polymerase chain reaction method. Anthropometric measurement, biochemical blood testing, a depression screening questionnaire using a 15-question geriatric depression scale (GDS-15), and a cognitive function test using the Korean version of the mini mental state examination (K-MMSE) were performed. Results: Leukocyte mtDNA copy number was positively associated with telomere length (r=0.39, p=<0.0001) and K-MMSE score (r=0.06, p=0.02). Additionally, leukocyte mtDNA copy number was negatively correlated with GDS-15 score (r=-0.17, p=0.04). Age (r=-0.15, p=0.09), waist circumference (r=-0.16, p=0.07), and serum ferritin level (r=-0.13, p=0.07) tended to be inversely correlated with leukocyte mtDNA copy number. With a stepwise multiple regression analysis, telomere length was found to be an independent factor associated with leukocyte mtDNA copy number after adjustment for confounding variables including age, body mass index, waist circumference, total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides, hs-CRP, serum ferritin, HOMA-IR, K-MMSE, GDS-15, hypertension, diabetes, dyslipidemia, currently smoking, alcohol drinking, and regular exercise. Conclusions: This study showed that leukocyte mtDNA copy number was positively correlated with leukocyte telomere length in community-dwelling elderly women. Our findings suggest that telomere function may influence mitochondrial function in humans.	[Kim, Jung-Ha] Chung Ang Univ Healthcare Syst, Dept Family Med, Seoul, South Korea; [Kim, Hye Kyung] Yonsei Univ, Coll Med, Hlth Promot Ctr, Gangnam Severance Hosp, Seoul, South Korea; [Ko, Jae-Hong; Bang, Hyoweon] Chung Ang Univ, Coll Med, Dept Physiol, Seoul 156756, South Korea; [Lee, Duk-Chul] Yonsei Univ, Coll Med, Dept Family Med, Severance Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System; Chung Ang University; Chung Ang University Hospital; Yonsei University; Yonsei University Health System	Bang, H (corresponding author), Chung Ang Univ, Coll Med, Dept Physiol, Seoul 156756, South Korea.	haena@cau.ac.kr; faith@yuhs.ac		Lee, Duk Chul/0000-0001-9166-1813; , Jung-Ha/0000-0002-7630-9501				Alder JK, 2011, AM J RESP CRIT CARE, V184, P904, DOI 10.1164/rccm.201103-0520OC; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cho MJ., 1999, J KOREAN NEUROPSYCHI, V38, P48; Colman RJ, 2008, J GERONTOL A-BIOL, V63, P556, DOI 10.1093/gerona/63.6.556; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Conley KE, 2007, CURR OPIN CLIN NUTR, V10, P688, DOI 10.1097/MCO.0b013e3282f0dbfb; Das M, 2004, Obes Rev, V5, P13, DOI 10.1111/j.1467-789X.2004.00115.x; Dedkova EN, 2008, CELL CALCIUM, V44, P77, DOI 10.1016/j.ceca.2007.11.002; Eisenberg DTA, 2011, AM J HUM BIOL, V23, P149, DOI 10.1002/ajhb.21127; Entringer S, 2011, P NATL ACAD SCI USA, V108, pE513, DOI 10.1073/pnas.1107759108; Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Jin HS, 2011, AM J HYPERTENS, V24, P1127, DOI 10.1038/ajh.2011.131; Kang HT, 2012, CLIN CHIM ACTA, V413, P636, DOI 10.1016/j.cca.2011.12.011; Kiefel BR, 2006, INT REV CYTOL, V254, P151, DOI 10.1016/S0074-7696(06)54004-5; Kim CH, 2011, METABOLISM, V60, P414, DOI 10.1016/j.metabol.2010.03.007; Kim MY, 2011, ARCH GERONTOL GERIAT, V53, pE218, DOI 10.1016/j.archger.2010.11.019; Lee HK, 1998, DIABETES RES CLIN PR, V42, P161, DOI 10.1016/S0168-8227(98)00110-7; Lee JW, 2010, CLIN CHIM ACTA, V411, P592, DOI 10.1016/j.cca.2010.01.024; Lim Chae Young, 2010, Korean J Gastroenterol, V55, P384, DOI 201006256; Lim S, 2001, ATHEROSCLEROSIS, V158, P399, DOI 10.1016/S0021-9150(01)00436-1; Lim S, 2000, EUR J APPL PHYSIOL, V82, P407, DOI 10.1007/s004210000238; Liu CS, 2005, ANN NY ACAD SCI, V1042, P70, DOI 10.1196/annals.1338.008; Lombard David B, 2011, Handb Exp Pharmacol, V206, P163, DOI 10.1007/978-3-642-21631-2_8; Mainous AG, 2010, ATHEROSCLEROSIS, V210, P262, DOI 10.1016/j.atherosclerosis.2009.10.047; Masoro EJ, 2006, J GERONTOL A-BIOL, V61, P14, DOI 10.1093/gerona/61.1.14; Mur C, 2004, LIFE SCI, V75, P611, DOI 10.1016/j.lfs.2003.12.026; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Puddu P, 2007, CLIN EXP HYPERTENS, V29, P427, DOI 10.1080/10641960701613852; Ramachandran A, 2002, FREE RADICAL BIO MED, V33, P1465, DOI 10.1016/S0891-5849(02)01142-5; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Smith DL, 2011, J GERONTOL A-BIOL, V66, P1163, DOI 10.1093/gerona/glr136; Song J, 2001, DIABETES CARE, V24, P865, DOI 10.2337/diacare.24.5.865; Syrovatka P, 2009, ANN NUTR METAB, V54, P268, DOI 10.1159/000229507; Tentolouris N, 2007, DIABETES CARE, V30, P2909, DOI 10.2337/dc07-0633; von Zglinicki T, 2000, LAB INVEST, V80, P1739, DOI 10.1038/labinvest.3780184; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang CF, 2010, AGING-US, V2, P555, DOI 10.18632/aging.100196; Wei YH, 1998, ANN NY ACAD SCI, V854, P155, DOI 10.1111/j.1749-6632.1998.tb09899.x; Weindruch R., 1988, RETARDATION AGING DI; Weng SW, 2009, DIABETES RES CLIN PR, V83, P94, DOI 10.1016/j.diabres.2008.10.002; Wong Alice, 2002, Methods Mol Biol, V197, P129, DOI 10.1385/1-59259-284-8:129; Yamaguchi Y, 2005, EUR J CLIN INVEST, V35, P186, DOI 10.1111/j.1365-2362.2005.01472.x; Zimmerman MC, 2009, HYPERTENSION, V53, P112, DOI 10.1161/HYPERTENSIONAHA.108.125567	48	56	58	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e67227	10.1371/journal.pone.0067227	http://dx.doi.org/10.1371/journal.pone.0067227			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	172XB	23785520	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800004
J	Ming, FP; Yang, J; Chu, PP; Ma, MP; Shi, JQ; Cai, HM; Huang, CY; Li, HZ; Jiang, ZG; Wang, HG; Wang, WF; Zhang, SQ; Zhang, LH				Ming, Feiping; Yang, Jun; Chu, Pinpin; Ma, Miaopeng; Shi, Juqing; Cai, Haiming; Huang, Chaoyuan; Li, Huazhou; Jiang, Zhenggu; Wang, Houguang; Wang, Weifang; Zhang, Shuiqing; Zhang, Linghua			Immunization of Aged Pigs with Attenuated Pseudorabies Virus Vaccine Combined with CpG Oligodeoxynucleotide Restores Defective Th1 Immune Responses	PLOS ONE			English	Article							SYNTHETIC IMMUNOSTIMULATORY MOTIFS; RAPID COLORIMETRIC ASSAY; IN-VIVO; T-CELLS; CYTOKINES; CD4(+); INNATE; SUBPOPULATIONS; ACTIVATION; ADJUVANT	Background and Aims: Attempts to immunize aged subjects often result in the failure to elicit a protective immune response. Murine model studies have shown that oligonucleotides containing CpG motifs (CpG ODN) can stimulate immune system in aged mice as effectively as in young mice. Since many physiological and pathophysiological data of pigs can be transferred to humans, research in pigs is important to confirm murine data. Here we investigated whether immunization of aged pig model with attenuated pseudorabies virus vaccine (PRV vaccine) formulated with CpG ODN could promote a successful development of immune responses that were comparable to those induced in young pigs in a similar manner. Methodology: Young and aged pigs were immunized IM with PRV vaccine alone, or in combination with CpG ODN respectively. At days 3, 7, 14 post immunization sera were assayed by ELISA for IgG titres, at day 7 for IgG1 and IgG2 subtypes titres. All blood samples collected in evacuated test tubes with K-EDTA at day 7 were analyzed for flow cytometer assay. Blood samples at day 7 collected in evacuated test tubes with heparin were analysed for antigen-specific cytokines production and peripheral blood mononuclear cells (PBMCs) proliferative responses. Results: CpG ODN could enhance Th1 responses (PRV-specific IgG2/IgG1 ratio, proliferative responses, Th1 cytokines production) when used as an adjuvant for the vaccination of aged pigs, which were correlated with enhanced CD4+ T cells percentage, decreased CD4+CD8+CD45RO+ T cells percentage and improved PRV-specific CD4+ T cells activation. Conclusions: Our results demonstrate a utility for CpG ODN, as a safe vaccine adjuvant for promoting effective systemic immune responses in aged pig model. This agent could have important clinical uses in overcoming some of age-associated depressions in immune function that occur in response to vaccination.	[Ming, Feiping; Yang, Jun; Chu, Pinpin; Ma, Miaopeng; Shi, Juqing; Cai, Haiming; Huang, Chaoyuan; Zhang, Shuiqing; Zhang, Linghua] South China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Li, Huazhou; Jiang, Zhenggu; Wang, Houguang; Wang, Weifang] Swine Seed Breeding Ctr Guangzhou, Guangzhou, Guangdong, Peoples R China; [Zhang, Linghua] South China Agr Univ, Guangdong Prov Key Lab Prot Funct & Regulat Agr O, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University	Zhang, LH (corresponding author), South China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	lhzhang73212000@yahoo.com.cn			National Natural Science Foundation of China [31072114]; Guangdong Provincial Key Laboratory of Protein Function and Regulation in Agricultural Organisms; Guangdong Province Agricultural Technological Project [2009B020307010]; Guangzhou Sciences and Technologies Project [2013Z1]; Project and Key Laboratory of Animal Disease Control and Prevention of the Ministry of Agriculture	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Key Laboratory of Protein Function and Regulation in Agricultural Organisms; Guangdong Province Agricultural Technological Project; Guangzhou Sciences and Technologies Project; Project and Key Laboratory of Animal Disease Control and Prevention of the Ministry of Agriculture	This study was supported by National Natural Science Foundation of China (No. 31072114), Guangdong Provincial Key Laboratory of Protein Function and Regulation in Agricultural Organisms, Guangdong Province Agricultural Technological Project (No. 2009B020307010), Guangzhou Sciences and Technologies Project (No. 2013Z1), Project and Key Laboratory of Animal Disease Control and Prevention of the Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2006, MECH AGEING DEV, V127, P560, DOI 10.1016/j.mad.2006.01.014; Bailey M, 1998, SCAND J IMMUNOL, V48, P177; Boeker M, 1999, IMMUNOBIOLOGY, V201, P74, DOI 10.1016/S0171-2985(99)80048-5; Cao D, 2010, VACCINE, V28, P6006, DOI 10.1016/j.vaccine.2010.06.103; Chan KG, 2007, INFECT IMMUN, V75, P3033, DOI 10.1128/IAI.01549-06; COUTELIER JP, 1991, J IMMUNOL, V147, P1383; COUTELIER JP, 1988, J EXP MED, V168, P2373, DOI 10.1084/jem.168.6.2373; Deng YP, 2004, J IMMUNOL, V172, P3437, DOI 10.4049/jimmunol.172.6.3437; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Estes DM, 1996, VET IMMUNOL IMMUNOP, V54, P61, DOI 10.1016/S0165-2427(96)05684-X; Fulop T, 2006, MECH AGEING DEV, V127, P526, DOI 10.1016/j.mad.2006.01.025; Gomez CR, 2008, EXP GERONTOL, V43, P718, DOI 10.1016/j.exger.2008.05.016; Grubeck-Loebenstein B, 2002, ADV IMMUNOL, V80, P243, DOI 10.1016/S0065-2776(02)80017-7; Haynes L, 2005, IMMUNOL REV, V205, P220, DOI 10.1111/j.0105-2896.2005.00255.x; Holtmeier W, 2002, J IMMUNOL, V169, P1993, DOI 10.4049/jimmunol.169.4.1993; KAWANO Y, 1994, J IMMUNOL, V153, P4948; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Lipford GB, 1997, EUR J IMMUNOL, V27, P3420, DOI 10.1002/eji.1830271242; Ma MP, 2012, MOL IMMUNOL, V52, P217, DOI 10.1016/j.molimm.2012.05.016; Maletto BA, 2005, CLIN IMMUNOL, V117, P251, DOI 10.1016/j.clim.2005.08.016; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Masuda K, 2000, J VET MED SCI, V62, P995, DOI 10.1292/jvms.62.995; McCluskie MJ, 2006, CURR TOP MICROBIOL, V311, P155; Morgan EL, 2010, VACCINE, V28, P8275, DOI 10.1016/j.vaccine.2010.10.008; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pawelec G, 2002, FRONT BIOSCI-LANDMRK, V7, pD1056; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Schellack C, 2006, VACCINE, V24, P5461, DOI 10.1016/j.vaccine.2006.03.071; Schwab R, 1997, J IMMUNOL, P158; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Snapper CM, 1998, FUNDAMENTAL IMMUNOLO, P831; Tsiagbe VK, 1996, CRIT REV IMMUNOL, V16, P381; Vollmer J, 2009, ADV DRUG DELIVER REV, V61, P195, DOI 10.1016/j.addr.2008.12.008; Zhang LH, 2006, DEV COMP IMMUNOL, V30, P589, DOI 10.1016/j.dci.2005.07.005; Zhang LH, 2006, RES VET SCI, V80, P281, DOI 10.1016/j.rvsc.2005.07.009; Zhang LH, 2006, VACCINE, V24, P1874, DOI 10.1016/j.vaccine.2005.10.033; Zhang LH, 2008, VACCINE, V26, P224, DOI 10.1016/j.vaccine.2007.10.058; Zhang LH, 2007, MOL IMMUNOL, V44, P1141, DOI 10.1016/j.molimm.2006.07.001; Zhang LH, 2007, VACCINE, V25, P1735, DOI 10.1016/j.vaccine.2006.11.033; Zheng B, 1997, IMMUNOL REV, V160, P63, DOI 10.1111/j.1600-065X.1997.tb01028.x; Zuckermann FA, 2000, VET RES, V31, P121, DOI 10.1051/vetres:2000060	42	9	10	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65536	10.1371/journal.pone.0065536	http://dx.doi.org/10.1371/journal.pone.0065536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785433	Green Submitted, Green Published, gold			2022-12-25	WOS:000321038800088
J	Luo, J; Lee, SO; Liang, L; Huang, CK; Li, L; Wen, S; Chang, C				Luo, J.; Lee, S. Ok; Liang, L.; Huang, C-K; Li, L.; Wen, S.; Chang, C.			Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling	ONCOGENE			English	Article						bone marrow mesenchymal stem cells; CCL5; androgen receptor; prostate cancer stem cells	STROMAL CELLS; GROWTH-FACTOR; DIFFERENTIATION; TUMORIGENESIS; MAINTENANCE; EXPRESSION; TUMORS; ROLES; CD133; MSCS	Although the contribution of the bone marrow mesenchymal stem cells (BM-MSCs) in cancer progression is emerging, their potential roles in prostate cancer (PCa) remain unclear. Here, we showed that PCa cells could recruit BM-MSCs and consequently the metastatic ability of PCa cells was increased. We also found that the increased metastatic ability of PCa cells could be due to the increased PCa stem cell population. Mechanism dissection studies found that the upregulation of Chemokine ligand 5 (CCL5) expression in BM-MSCs and PCa cells, after MSCs infiltrated into the PCa cells, subsequently downregulated androgen receptor (AR) signaling, which was due to inhibition of AR nuclear translocation. Interruption of such signaling led to suppression of the BM-MSCs-induced PCa stem cell population increase and thereby inhibited the metastatic ability of PCa cells. The PCa stem cell increase then led to the upregulation of matrix metalloproteinase 9, ZEB-1, CD133 and CXCR4 molecules, and enhanced the metastatic ability of PCa cells. Therefore, we conclude that the BM-MSCs-mediated increased metastatic ability of PCa cells can be due to the PCa stem cell increase via alteration of the CCL5-AR signaling pathway. Together, these results uncover the important roles of BM-MSCs as key components in the prostate tumor microenvironment to promote PCa metastasis and may provide a new potential target to suppress PCa metastasis by blocking BM-MSCs infiltration into PCa.	[Luo, J.; Lee, S. Ok; Liang, L.; Huang, C-K; Li, L.; Wen, S.; Chang, C.] Univ Rochester, Med Ctr, Dept Pathol, Dept Urol,Dept Radio Oncol,George Whipple Lab Can, Rochester, NY 14642 USA; [Luo, J.; Lee, S. Ok; Liang, L.; Huang, C-K; Li, L.; Wen, S.; Chang, C.] Univ Rochester, Med Ctr, Wilmot Canc Ctr, Rochester, NY 14642 USA; [Chang, C.] China Med Univ & Hosp, Sex Hormone Res Ctr, Taichung, Taiwan	University of Rochester; University of Rochester; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chang, C (corresponding author), Univ Rochester, Med Ctr, Dept Pathol, Dept Urol,Dept Radio Oncol,George Whipple Lab Can, 601 Elmwood Ave, Rochester, NY 14642 USA.	chang@urmc.rochester.edu	Luo, Jie/AAG-3091-2019	Wen, Simeng/0000-0001-7989-7700	NIH [CA122840, CA256700]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH102-TD-B-111-004]; NATIONAL CANCER INSTITUTE [R01CA122840] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taiwan Department of Health Clinical Trial and Research Center of Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Karen Wolf for help with the manuscript preparation. This work was supported by NIH Grants (CA122840 and CA256700), and Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004) to China Medical University, Taiwan.	Altuwaijri S, 2007, ASIAN J ANDROL, V9, P181, DOI 10.1111/j.1745-7262.2007.00258.x; Augsten M, 2009, P NATL ACAD SCI USA, V106, P3414, DOI 10.1073/pnas.0813144106; Auletta JJ, 2012, BLOOD, V119, P1801, DOI 10.1182/blood-2011-10-384354; Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001; Charoenfuprasert S, 2011, ONCOGENE, V30, P3570, DOI 10.1038/onc.2011.77; Chong JJH, 2011, CELL STEM CELL, V9, P527, DOI 10.1016/j.stem.2011.10.002; Dayyani F, 2011, JNCI-J NATL CANCER I, V103, P1665, DOI 10.1093/jnci/djr362; Delude C, 2011, NATURE, V480, pS43, DOI 10.1038/480S43a; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Gao Y, 2010, ONCOGENE, V29, P2784, DOI 10.1038/onc.2010.38; Goldstein RH, 2010, CANCER RES, V70, P10044, DOI 10.1158/0008-5472.CAN-10-1254; Huang XP, 2010, CIRCULATION, V122, P2419, DOI 10.1161/CIRCULATIONAHA.110.955971; Jodele S, 2005, CANCER RES, V65, P3200, DOI 10.1158/0008-5472.CAN-04-3770; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kleeberger W, 2007, CANCER RES, V67, P9199, DOI 10.1158/0008-5472.CAN-07-0806; Kobayashi A, 2011, J EXP MED, V208, P2641, DOI 10.1084/jem.20110840; Kumar SM, 2012, ONCOGENE, V31, P4898, DOI 10.1038/onc.2011.656; Lee CH, 2010, J CLIN INVEST, V120, P3340, DOI 10.1172/JCI43230; Lee SO, 2013, J MOL CELL BIOL, V5, P14, DOI 10.1093/jmcb/mjs042; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Liu SL, 2011, CANCER RES, V71, P614, DOI 10.1158/0008-5472.CAN-10-0538; Loebinger MR, 2009, CANCER RES, V69, P4134, DOI 10.1158/0008-5472.CAN-08-4698; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12188, DOI 10.1073/pnas.0804701105; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rybak AP, 2011, BBA-MOL CELL RES, V1813, P683, DOI 10.1016/j.bbamcr.2011.01.018; Shi XD, 2007, DEV BIOL, V312, P396, DOI 10.1016/j.ydbio.2007.09.042; Sun YT, 2012, CANCER RES, V72, P527, DOI 10.1158/0008-5472.CAN-11-3004; Trerotola M, 2010, AM J TRANSL RES, V2, P135; Wegiel B, 2008, JNCI-J NATL CANCER I, V100, P1022, DOI 10.1093/jnci/djn214; Xu S, 2012, STEM CELLS, V30, P266, DOI 10.1002/stem.787; Ye HM, 2012, CANCER INVEST, V30, P513, DOI 10.3109/07357907.2012.692171; Yong RL, 2009, CANCER RES, V69, P8932, DOI 10.1158/0008-5472.CAN-08-3873; Yu XZ, 2011, CURR COLORECT CANC R, V7, P253, DOI 10.1007/s11888-011-0106-1; Zeng YP, 2006, CANCER RES, V66, P9566, DOI 10.1158/0008-5472.CAN-06-1488; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032	43	109	112	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 22	2014	33	21					2768	2778		10.1038/onc.2013.233	http://dx.doi.org/10.1038/onc.2013.233			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EH	23792449				2022-12-25	WOS:000337231700010
J	Elhebir, ES; Hughes, JD; Hilmi, SC				Elhebir, Elsamaul S.; Hughes, Jeffery D.; Hilmi, Samantha C.			Calcium Antagonists Use and Its Association with Lower Urinary Tract Symptoms: A Cross-Sectional Study	PLOS ONE			English	Article							BLADDER SMOOTH-MUSCLE; DETRUSOR HYPERACTIVITY; ENTRY BLOCKADE; PREVALENCE; INCONTINENCE; WOMEN; MEN; COMMUNITY; OLDER; CONTRACTION	Background: Lower urinary tract symptoms (LUTS) have been reported amongst the side effects of calcium antagonists (CA). CAs act on the bladder by affecting the ability of the detrusor muscle to create enough contractile force to overcome obstruction to normal voiding. We aimed to determine the relationship between CA use and LUTS in general medical inpatients. Methods and Findings: In this cross-sectional study we recruited 278 medical inpatients (including 85 CA users) aged >= 40 (72.1 +/- 13.7) years. LUTS was assessed using the International Prostate Symptoms Score (IPSS) questionnaire. A Logistic regression model using a 'backwards-elimination' strategy was used to identify variables associated with LUTS and for calculating the adjusted odds ratios and the 95% confidence intervals (CI). After adjusting for other risk factors and drugs, patients on amlodipine/nifedipine and diltiazem/verapamil (compared to non-users) were more likely to suffer from severe LUTS [Males: 12.45(CI: 1.57-98.63) and Females: 7.75(CI: 0.94-63.94)] and moderate-to-severe LUTS [Males: 17.43(CI: 2.26-134.39) and Females: 47.8(CI: 6.22-367.37)]. Patients on felodipine/lercanidipine were less likely to suffer from either severe or moderate-to-severe LUTS. Further, 19 (22.4%) CA-users were on treatment for LUTS compared to 18 (9.3%) of the non-users group, p = 0.003. Both male and female CA-users were three times more likely to be on alpha-blockers than non-users, p<0.001. CA-users were more likely to have undergone urinary tract-related surgery (Males: two times, p = 0.07 and females: nine times, p = 0.029). The study was limited by the fact that a causal relationship could not be established between CA use and LUTS. Conclusions: Our results demonstrate an association between CA use and an increasing severity of LUTS. They also demonstrate that CA-users are more likely to have medical or surgical treatment for LUTS. However, these CA's effects on LUTS vary, and the use of highly vascular selective agents does not appear to pose significant risk.	[Elhebir, Elsamaul S.; Hughes, Jeffery D.] Curtin Univ, Curtin Hlth Innovat Res Inst, Sch Pharm, Perth, WA 6845, Australia; [Hilmi, Samantha C.] Royal Perth Hosp, Dept Pharm, Perth, WA, Australia	Curtin University; Royal Perth Hospital; University of Western Australia	Elhebir, ES (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Sch Pharm, Perth, WA 6845, Australia.	E.Elhebir@curtin.edu.au; J.D.Hughes@curtin.edu.au		Hughes, Jeffery David/0000-0003-0040-4753				American Urological Associaation, 2006, AUA GUID MAN BEN PRO; Andersson KE, 2004, PHYSIOL REV, V84, P935, DOI 10.1152/physrev.00038.2003; Andersson KE, 1999, BJU INT, V84, P923; Antonelli D, 1984, BR MED J, V288; Araki I, 2003, J UROLOGY, V170, P1901, DOI 10.1097/01.ju.0000092942.87643.27; Australian Government: Department of Health and Ageing, 2009, AUSTR STAT MED 2008, P74; Boyle P, 2003, BJU INT, V92, P409, DOI 10.1046/j.1464-410X.2003.04369.x; CHANCELLOR MB, 1993, J UROLOGY, V150, P1706, DOI 10.1016/S0022-5347(17)35872-X; Chapple CR, 2008, EUR UROL, V54, P563, DOI 10.1016/j.eururo.2008.03.109; FAUSTINI S, 1989, ARZNEIMITTEL-FORSCH, V39-2, P899; Frazier EP, 2008, N-S ARCH PHARMACOL, V377, P449, DOI 10.1007/s00210-007-0208-0; Frohlich G, 1998, ARZNEIMITTEL-FORSCH, V48, P486; GEYSKES GG, 1992, TOHOKU J EXP MED, V166, P135, DOI 10.1620/tjem.166.135; Guarneri L, 1996, ARZNEIMITTELFORSCH, V46, P15; Hall SA, 2012, BJU INT, V109, P1676, DOI 10.1111/j.1464-410X.2011.10593.x; HARARI D, 1993, J AM GERIATR SOC, V41, P1130, DOI 10.1111/j.1532-5415.1993.tb06463.x; Homma Y, 1997, Int J Urol, V4, P40, DOI 10.1111/j.1442-2042.1997.tb00138.x; Hughes Jeffery D, 2011, Qual Prim Care, V19, P223; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Ito H, 2012, NEUROUROL URODYNAM, V12, P22267; Kakizaki H, 2002, UROLOGY, V59, P58, DOI 10.1016/S0090-4295(01)01487-X; KRUSELL LR, 1987, HYPERTENSION, V10, P577, DOI 10.1161/01.HYP.10.6.577; Masters JG, 1999, BRIT J PHARMACOL, V127, P996, DOI 10.1038/sj.bjp.0702640; MATTIASSON A, 1989, J UROLOGY, V141, P174, DOI 10.1016/S0022-5347(17)40635-5; Muscatello DJ, 2001, INTERN MED J, V31, P151, DOI 10.1046/j.1445-5994.2001.00035.x; Naglie G, 2002, J UROLOGY, V167, P586, DOI 10.1016/S0022-5347(01)69090-6; Naslund MJ, 2007, INT J CLIN PRACT, V61, P1437, DOI 10.1111/j.1742-1241.2007.01508.x; NORMAN RW, 1994, BRIT J UROL, V74, P542, DOI 10.1111/j.1464-410X.1994.tb09181.x; Pinnock CB, 1997, MED J AUSTRALIA, V167, P72, DOI 10.5694/j.1326-5377.1997.tb138783.x; SLUITER HE, 1985, DRUGS, V29, P26, DOI 10.2165/00003495-198500292-00006; Terai A, 2004, UROLOGY, V63, P487, DOI 10.1016/j.urology.2003.09.070; Walsh K, 2004, BJU INT, V94, P272, DOI 10.1111/j.1464-410X.2003.04961.x; Wegener JW, 2004, FASEB J, V18, P1159, DOI 10.1096/fj.04-1516fje; WILLIAMS G, 1986, LANCET, V1, P738; Young MA, 1985, BR J CLIN PHARM, V20	35	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66708	10.1371/journal.pone.0066708	http://dx.doi.org/10.1371/journal.pone.0066708			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805268	Green Submitted, gold, Green Published			2022-12-25	WOS:000320846500096
J	Hsu, WY				Hsu, Wei-Yen			A Practical Approach Based on Analytic Deformable Algorithm for Scenic Image Registration	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE	Background: Image registration is to produce an entire scene by aligning all the acquired image sequences. A registration algorithm is necessary to tolerance as much as possible for intensity and geometric variation among images. However, captured image views of real scene usually produce unexpected distortions. They are generally derived from the optic characteristics of image sensors or caused by the specific scenes and objects. Methods and Findings: An analytic registration algorithm considering the deformation is proposed for scenic image applications in this study. After extracting important features by the wavelet-based edge correlation method, an analytic registration approach is then proposed to achieve deformable and accurate matching of point sets. Finally, the registration accuracy is further refined to obtain subpixel precision by a feature-based Levenberg-Marquardt (FLM) method. It converges evidently faster than most other methods because of its feature-based characteristic. Conclusions: We validate the performance of proposed method by testing with synthetic and real image sequences acquired by a hand-held digital still camera (DSC) and in comparison with an optical flow-based motion technique in terms of the squared sum of intensity differences (SSD) and correlation coefficient (CC). The results indicate that the proposed method is satisfactory in the registration accuracy and quality of DSC images.	Natl Chung Cheng Univ, Dept Informat Management, Chiayi Cty, Taiwan	National Chung Cheng University	Hsu, WY (corresponding author), Natl Chung Cheng Univ, Dept Informat Management, Chiayi Cty, Taiwan.	shenswy@gmail.com			National Science Council, Taiwan [NSC101-2221-E-194-066]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The author would like to express his sincere appreciation for a grant from NSC101-2221-E-194-066, National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alic L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022835; Caskey CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027372; Chui HL, 2003, COMPUT VIS IMAGE UND, V89, P114, DOI 10.1016/S1077-3142(03)00009-2; Daubechies I, 1992, CBMS NSF LECT NOTES, V61; Heeger DJ, 1996, PSYCH 267 CS 348D EE; Hsu WY, 2008, J MICROSC-OXFORD, V231, P408, DOI 10.1111/j.1365-2818.2008.02052.x; Hsu WY, 2013, INT J NEURAL SYST, V23, DOI 10.1142/S012906571350007X; Hsu WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040558; Hsu WY, 2012, CLIN EEG NEUROSCI, V43, P87, DOI 10.1177/1550059412445051; Hsu WY, 2012, CLIN EEG NEUROSCI, V43, P32, DOI 10.1177/1550059411429528; Hsu WY, 2012, INT J NEURAL SYST, V22, P51, DOI 10.1142/S0129065712002979; Hsu WY, 2011, MICROSC RES TECHNIQ, V74, P523, DOI 10.1002/jemt.20942; Khalifa F, 2011, MULTI MODALITY STATE-OF-THE-ART MEDICAL IMAGE SEGMENTATION AND REGISTRATION METHODOLOGIES, VOL 1, P235, DOI 10.1007/978-1-4419-8195-0_9; Magara F, 2010, PLOS ONE, V5, DOI DOI 10.1371/JOURNAL.PONE.0014094; Mann S, 1997, IEEE T IMAGE PROCESS, V6, P1281, DOI 10.1109/83.623191; Shi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018746; Sighoko D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018415; Viergever RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014701; Zuo XN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026703	19	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66656	10.1371/journal.pone.0066656	http://dx.doi.org/10.1371/journal.pone.0066656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805257	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500085
J	Luo, N; Kumar, A; Conwell, M; Weinreb, RN; Anderson, R; Sun, Y				Luo, Na; Kumar, Akhilesh; Conwell, Michael; Weinreb, Robert N.; Anderson, Ryan; Sun, Yang			Compensatory Role of Inositol 5-Phosphatase INPP5B to OCRL in Primary Cilia Formation in Oculocerebrorenal Syndrome of Lowe	PLOS ONE			English	Article							SYNDROME PROTEIN OCRL1; POLYPHOSPHATE 5-PHOSPHATASE; BINDING DOMAIN; CILIOPATHIES; MEMBRANE; POLYPHOSPHATE-5-PHOSPHATASE; DEFICIENT; MUTATIONS; CELLS; MICE	Inositol phosphatases are important regulators of cell signaling, polarity, and vesicular trafficking. Mutations in OCRL, an inositol polyphosphate 5-phosphatase, result in Oculocerebrorenal syndrome of Lowe, an X-linked recessive disorder that presents with congenital cataracts, glaucoma, renal dysfunction and mental retardation. INPP5B is a paralog of OCRL and shares similar structural domains. The roles of OCRL and INPP5B in the development of cataracts and glaucoma are not understood. Using ocular tissues, this study finds low levels of INPP5B present in human trabecular meshwork but high levels in murine trabecular meshwork. In contrast, OCRL is localized in the trabecular meshwork and Schlemm's canal endothelial cells in both human and murine eyes. In cultured human retinal pigmented epithelial cells, INPP5B was observed in the primary cilia. A functional role for INPP5B is revealed by defects in cilia formation in cells with silenced expression of INPP5B. This is further supported by the defective cilia formation in zebrafish Kupffer's vesicles and in cilia-dependent melanosome transport assays in inpp5b morphants. Taken together, this study indicates that OCRL and INPP5B are differentially expressed in the human and murine eyes, and play compensatory roles in cilia development.	[Luo, Na; Kumar, Akhilesh; Conwell, Michael; Sun, Yang] Indiana Univ Indianapolis, Dept Dermatol, Dept Biochem & Cell Biol, Glick Eye Inst,Dept Ophthalmol, Indiana, PA USA; [Weinreb, Robert N.] Univ Calif San Diego, Dept Ophthalmol, San Diego, CA 92103 USA; [Anderson, Ryan] Indiana Univ Indianapolis, Dept Pediat, Indiana, PA USA	University of California System; University of California San Diego	Luo, N (corresponding author), Indiana Univ Indianapolis, Dept Dermatol, Dept Biochem & Cell Biol, Glick Eye Inst,Dept Ophthalmol, Indiana, PA USA.	sunyo@iupui.edu	Luo, Na/L-4228-2014	Luo, Na/0000-0002-8046-9372; Conwell, Michael/0000-0003-1562-2729	National Institutes of Health [NEI K08 22058-01]; NATIONAL EYE INSTITUTE [K08EY022058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was supported by the National Institutes of Health NEI K08 22058-01. http://projectreporter.nih.gov/project_info_details.cfm?aid = 8223419&icde = 15619386 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allingham RRD, 2005, SHIELDS TXB GLAUCOMA, P11; ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; Bernard DJ, 2010, MAMM GENOME, V21, P186, DOI 10.1007/s00335-010-9255-9; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Bothwell SP, 2011, J AM SOC NEPHROL, V22, P443, DOI 10.1681/ASN.2010050565; Bothwell SP, 2010, MAMM GENOME, V21, P458, DOI 10.1007/s00335-010-9281-7; Colwill K, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-13; Conduit SE, 2012, FEBS LETT, V586, P2846, DOI 10.1016/j.febslet.2012.07.037; Coon BG, 2012, HUM MOL GENET, V21, P1835, DOI 10.1093/hmg/ddr615; Coon BG, 2009, HUM MOL GENET, V18, P4478, DOI 10.1093/hmg/ddp407; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; Faucherre A, 2005, HUM MOL GENET, V14, P1441, DOI 10.1093/hmg/ddi153; GAARY EA, 1993, J ULTRAS MED, V12, P234; Ghosh AK, 2010, HUM MOL GENET, V19, P90, DOI 10.1093/hmg/ddp469; Heller B, 2010, J BIOL CHEM, V285, P12308, DOI 10.1074/jbc.M109.096230; Hellsten E, 2002, BIOL REPROD, V66, P1522, DOI 10.1095/biolreprod66.5.1522; Hichri H, 2011, HUM MUTAT, V32, P379, DOI 10.1002/humu.21391; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hou XM, 2011, EMBO J, V30, P1659, DOI 10.1038/emboj.2011.60; Humbert MC, 2012, P NATL ACAD SCI USA, V109, P19691, DOI 10.1073/pnas.1210916109; Hyvola N, 2006, EMBO J, V25, P3750, DOI 10.1038/sj.emboj.7601274; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Jacoby M, 2009, NAT GENET, V41, P1027, DOI 10.1038/ng.427; Janne PA, 1998, J CLIN INVEST, V101, P2042, DOI 10.1172/JCI2414; JEFFERSON AB, 1995, J BIOL CHEM, V270, P9370, DOI 10.1074/jbc.270.16.9370; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Lowe M, 2005, TRAFFIC, V6, P711, DOI 10.1111/j.1600-0854.2005.00311.x; Luo N., 2012, HUMAN MOL GENETICS; Luo N, 2012, VISION RES IN PRESS; Luo N, 2012, HUM MOL GENET, V21, P3333, DOI 10.1093/hmg/dds163; Matzaris M, 1998, J BIOL CHEM, V273, P8256, DOI 10.1074/jbc.273.14.8256; MITCHELL CA, 1989, J BIOL CHEM, V264, P8873; Murga-Zamalloa CA, 2010, HUM MOL GENET, V19, P3591, DOI 10.1093/hmg/ddq275; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Novarino G, 2011, CELL, V147, P70, DOI 10.1016/j.cell.2011.09.014; Praetorius HA, 2005, ANNU REV PHYSIOL, V67, P515, DOI 10.1146/annurev.physiol.67.040403.101353; Rbaibi Y, 2012, TRAFFIC, V9999; Richardson MR, 2010, MOL VIS, V16, P2376; Russell-Randall KR, 2011, INVEST OPHTH VIS SCI, V52, P5233, DOI 10.1167/iovs.10-6613; Sarmah B, 2007, P NATL ACAD SCI USA, V104, P19843, DOI 10.1073/pnas.0706934104; Schmid AC, 2004, FEBS LETT, V576, P9, DOI 10.1016/j.febslet.2004.08.052; Schneider I, 2008, DEVELOPMENT, V135, P75, DOI 10.1242/dev.004713; Schurman SJ, 2009, NAT REV NEPHROL, V5, P529, DOI 10.1038/nrneph.2009.124; Ungewickell A, 2004, P NATL ACAD SCI USA, V101, P13501, DOI 10.1073/pnas.0405664101; Walton DS, 2005, J GLAUCOMA, V14, P181, DOI 10.1097/01.ijg.0000158850.07732.05; Yen HJ, 2006, HUM MOL GENET, V15, P667, DOI 10.1093/hmg/ddi468; ZHANG XL, 1995, P NATL ACAD SCI USA, V92, P4853, DOI 10.1073/pnas.92.11.4853	47	32	33	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66727	10.1371/journal.pone.0066727	http://dx.doi.org/10.1371/journal.pone.0066727			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805271	Green Submitted, Green Published, gold			2022-12-25	WOS:000320846500099
J	Sipiczki, M; Pfliegler, WP; Holb, IJ				Sipiczki, Matthias; Pfliegler, Walter P.; Holb, Imre J.			Metschnikowia Species Share a Pool of Diverse rRNA Genes Differing in Regions That Determine Hairpin-Loop Structures and Evolve by Reticulation	PLOS ONE			English	Article							LARGE-SUBUNIT RDNA; SP-NOV.; SACCHAROMYCES-CEREVISIAE; INTERSPECIES HYBRIDIZATION; CONCERTED EVOLUTION; SECONDARY STRUCTURE; DNA REPEATS; ACTIN GENE; YEAST; SEQUENCE	Modern taxonomy of yeasts is mainly based on phylogenetic analysis of conserved DNA and protein sequences. By far the most frequently used sequences are those of the repeats of the chromosomal rDNA array. It is generally accepted that the rDNA repeats of a genome have identical sequences due to the phenomenon of sequence homogenisation and can thus be used for identification and barcoding of species. Here we show that the rDNA arrays of the type strains of Metschnikowia andauensis and M. fructicola are not homogenised. Both have arrays consisting of diverse repeats that differ from each other in the D1/D2 domains by up to 18 and 25 substitutions. The variable sites are concentrated in two regions that correspond to back-folding stretches of hairpin loops in the predicted secondary structure of the RNA molecules. The substitutions do not alter significantly the overall hairpin-loop structure due to wobble base pairing at sites of C-T transitions and compensatory mutations in the complementary strand of the hairpin stem. The phylogenetic and network analyses of the cloned sequences revealed that the repeats had not evolved in a vertical tree-like way but reticulation might have shaped the rDNA arrays of both strains. The neighbour-net analysis of all cloned sequences of the type strains and the database sequences of different strains further showed that these species share a continuous pool of diverse repeats that appear to evolve by reticulate evolution.	[Sipiczki, Matthias; Pfliegler, Walter P.] Univ Debrecen, Dept Genet & Appl Microbiol, Debrecen, Hungary; [Holb, Imre J.] Hungarian Acad Sci, Inst Plant Protect, Debrecen, Hungary; [Holb, Imre J.] Univ Debrecen, Debrecen, Hungary	University of Debrecen; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; University of Debrecen	Sipiczki, M (corresponding author), Univ Debrecen, Dept Genet & Appl Microbiol, Debrecen, Hungary.	gecela@post.sk	Sipiczki, Matthias/R-1496-2019; Pfliegler, Walter P./D-1114-2018; , lipovy/AAT-5960-2021	Pfliegler, Walter P./0000-0001-6723-4416; Sipiczki, Matthias/0000-0002-1059-1305	Hungarian Scientific Research Fund [OTKA-81792]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the grant OTKA-81792 provided by the Hungarian Scientific Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper I, 2011, FUNGAL BIOL-UK, V115, P1259, DOI 10.1016/j.funbio.2011.09.002; [Anonymous], 2011, PHYLOGENETIC NETWORK; [Anonymous], 2013, MOL PHYL EV IN PRESS; Balazs A, 2012, FUNGAL GENET BIOL, V49, P235, DOI 10.1016/j.fgb.2012.01.003; BROSIUS J, 1980, P NATL ACAD SCI-BIOL, V77, P201, DOI 10.1073/pnas.77.1.201; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DAMMANN R, 1993, NUCLEIC ACIDS RES, V21, P2331, DOI 10.1093/nar/21.10.2331; Daniel HM, 2001, INT J SYST EVOL MICR, V51, P1593, DOI 10.1099/00207713-51-4-1593; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Dress AWM, 2004, IEEE ACM T COMPUT BI, V1, P109, DOI 10.1109/TCBB.2004.27; Dunn B, 2008, GENOME RES, V18, P1610, DOI 10.1101/gr.076075.108; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; FELSENSTEIN J, 2007, PHYLIP PHYLOGENY INF; French SL, 2003, MOL CELL BIOL, V23, P1558, DOI 10.1128/MCB.23.5.1558-1568.2003; Ganley ARD, 2007, GENOME RES, V17, P184, DOI 10.1101/gr.5457707; Ganley ARD, 2011, MOL BIOL EVOL, V28, P2883, DOI 10.1093/molbev/msr117; Gordon JL, 2008, YEAST, V25, P449, DOI 10.1002/yea.1598; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; James SA, 2009, GENOME RES, V19, P626, DOI 10.1101/gr.084517.108; KIMURA M, 1981, P NATL ACAD SCI-BIOL, V78, P454, DOI 10.1073/pnas.78.1.454; Kobayashi T, 2008, BIOESSAYS, V30, P267, DOI 10.1002/bies.20723; Kurtzman Cletus P., 2006, Mycoscience, V47, P65, DOI 10.1007/s10267-006-0280-1; Kurtzman CP, 2013, FEMS YEAST RES, V13, P23, DOI 10.1111/1567-1364.12006; Kurtzman CP, 2001, SYST APPL MICROBIOL, V24, P395, DOI 10.1078/0723-2020-00045; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Lachance MA, 2003, FEMS YEAST RES, V4, P253, DOI 10.1016/S1567-1356(03)00113-2; Lachance MA, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P575, DOI 10.1016/B978-0-444-52149-1.00046-X; Lachance MA, 2010, ANTON LEEUW INT J G, V97, P155, DOI 10.1007/s10482-009-9399-3; Lott M, 2009, BIOINFORMATICS, V25, P1199, DOI 10.1093/bioinformatics/btp133; Louis VL, 2012, G3-GENES GENOM GENET, V2, P299, DOI 10.1534/g3.111.000745; Makarenkov V, 2006, APPL MYCOL BIOTECH, V6, P61; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Molnar O, 2005, SYST APPL MICROBIOL, V28, P717, DOI 10.1016/j.syapm.2005.05.009; Morales L, 2012, MICROBIOL MOL BIOL R, V76, P721, DOI 10.1128/MMBR.00022-12; Moret BME, 2004, IEEE ACM T COMPUT BI, V1, P13, DOI 10.1109/TCBB.2004.10; Naumov GI, 2011, MICROBIOLOGY+, V80, P135, DOI 10.1134/S0026261711020111; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pfliegler WP, 2012, FEMS YEAST RES, V12, P703, DOI 10.1111/j.1567-1364.2012.00820.x; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SACCONE C, 1990, METHOD ENZYMOL, V183, P570; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schnare MN, 1996, J MOL BIOL, V256, P701, DOI 10.1006/jmbi.1996.0119; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Sipiczki M, 2003, INT J SYST EVOL MICR, V53, P2079, DOI 10.1099/ijs.0.02649-0; Sipiczki M, 2008, FEMS YEAST RES, V8, P996, DOI 10.1111/j.1567-1364.2008.00369.x; Sipiczki M, 2006, APPL ENVIRON MICROB, V72, P6716, DOI 10.1128/AEM.01275-06; Sipiczki M, 2012, INT J SYST EVOL MICR, V62, P3099, DOI 10.1099/ijs.0.044974-0; Solieri L, 2005, INT J BIOTECHNOL BIO, V1, P11; Suh SO, 2004, INT J SYST EVOL MICR, V54, P1883, DOI 10.1099/ijs.0.63152-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; VELDMAN GM, 1981, NUCLEIC ACIDS RES, V9, P6935, DOI 10.1093/nar/9.24.6935; Xue ML, 2006, INT J SYST EVOL MICR, V56, P2245, DOI 10.1099/ijs.0.64391-0	60	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67384	10.1371/journal.pone.0067384	http://dx.doi.org/10.1371/journal.pone.0067384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805311	Green Published, gold, Green Submitted			2022-12-25	WOS:000320846500139
J	Jacob, RE; Carson, JP; Thomas, M; Einstein, DR				Jacob, Richard E.; Carson, James P.; Thomas, Mathew; Einstein, Daniel R.			Dynamic Multiscale Boundary Conditions for 4D CT of Healthy and Emphysematous Rats	PLOS ONE			English	Article							COMPUTATIONAL FLUID-DYNAMICS; IMAGING TELL US; COMPUTED-TOMOGRAPHY; REGIONAL VENTILATION; PARTICLE DEPOSITION; SURFACE-TENSION; VOLUME CHANGE; LUNG INJURY; B-SPLINE; REGISTRATION	Changes in the shape of the lung during breathing determine the movement of airways and alveoli, and thus impact airflow dynamics. Modeling airflow dynamics in health and disease is a key goal for predictive multiscale models of respiration. Past efforts to model changes in lung shape during breathing have measured shape at multiple breath-holds. However, breath-holds do not capture hysteretic differences between inspiration and expiration resulting from the additional energy required for inspiration. Alternatively, imaging dynamically - without breath-holds - allows measurement of hysteretic differences. In this study, we acquire multiple micro-CT images per breath (4DCT) in live rats, and from these images we develop, for the first time, dynamic volume maps. These maps show changes in local volume across the entire lung throughout the breathing cycle and accurately predict the global pressure-volume (PV) hysteresis. Male Sprague-Dawley rats were given either a full- or partial-lung dose of elastase or saline as a control. After three weeks, 4DCT images of the mechanically ventilated rats under anesthesia were acquired dynamically over the breathing cycle (11 time points, <= 100 ms temporal resolution, 8 cmH(2)O peak pressure). Non-rigid image registration was applied to determine the deformation gradient - a numerical description of changes to lung shape - at each time point. The registration accuracy was evaluated by landmark identification. Of 67 landmarks, one was determined misregistered by all three observers, and 11 were determined misregistered by two observers. Volume change maps were calculated on a voxel-by-voxel basis at all time points using both the Jacobian of the deformation gradient and the inhaled air fraction. The calculated lung PV hysteresis agrees with pressure-volume curves measured by the ventilator. Volume maps in diseased rats show increased compliance and ventilation heterogeneity. Future predictive multiscale models of rodent respiration may leverage such volume maps as boundary conditions.	[Jacob, Richard E.; Carson, James P.; Thomas, Mathew; Einstein, Daniel R.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Jacob, RE (corresponding author), Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA.	richard.jacob@pnnl.gov		Carson, James/0000-0001-9009-5645	National Heart, Lung, and Blood Institute [R01HL073598]; PNNL through internal Laboratory Directed Research and Development LDRD [DE-AC05-76RL01830]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073598] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PNNL through internal Laboratory Directed Research and Development LDRD; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported by Award Number R01HL073598 from the National Heart, Lung, and Blood Institute and by PNNL through internal Laboratory Directed Research and Development LDRD DE-AC05-76RL01830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonet J., 1997, NONLINEAR CONTINUUM; Cai J, 2009, INT J RADIAT ONCOL, V75, P276, DOI 10.1016/j.ijrobp.2009.03.051; Carney DE, 1999, AM J RESP CRIT CARE, V160, P1697, DOI 10.1164/ajrccm.160.5.9812031; Carson JP, 2010, COMPUT MED IMAG GRAP, V34, P572, DOI 10.1016/j.compmedimag.2010.03.001; Carson JP, 2010, BIOMECH MODEL MECHAN, V9, P187, DOI 10.1007/s10237-009-0170-5; Castillo R, 2010, PHYS MED BIOL, V55, P4661, DOI 10.1088/0031-9155/55/16/004; Chen Q, 2001, MAGNET RESON MED, V45, P24, DOI 10.1002/1522-2594(200101)45:1<24::AID-MRM1004>3.0.CO;2-6; CILLEY RE, 1993, J PEDIATR SURG, V28, P488, DOI 10.1016/0022-3468(93)90253-H; Corley RA, 2012, TOXICOL SCI, V128, P500, DOI 10.1093/toxsci/kfs168; Ding K, 2009, LECT NOTES COMPUT SC, V5761, P739, DOI 10.1007/978-3-642-04268-3_91; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Einstein DR, 2008, ANAT REC, V291, P1628, DOI 10.1002/ar.20771; Emami K, 2010, MAGN RESON MED, V63, P137, DOI 10.1002/mrm.22186; Fouras A, 2012, ANN BIOMED ENG, V40, P1160, DOI 10.1007/s10439-011-0493-0; Fuld MK, 2008, J APPL PHYSIOL, V104, P1177, DOI 10.1152/japplphysiol.00212.2007; Guerrero T, 2006, PHYS MED BIOL, V51, P1101, DOI 10.1088/0031-9155/51/5/003; Guerrero T, 2007, INT J RADIAT ONCOL, V67, P879, DOI 10.1016/j.ijrobp.2006.10.037; HILDEBRANDT J, 1972, B PHYSIO-PATHOL RESP, V8, P337; Hsia CCW, 2012, J APPL PHYSIOL, V113, P937, DOI 10.1152/japplphysiol.00289.2012; Hsieh Jiang, 2009, COMPUTED TOMOGRAPHY; Jacob RE, 2008, J APPL PHYSIOL, V105, P1291, DOI 10.1152/japplphysiol.90375.2008; Jacob RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027577; Jiao XM, 2009, MED BIOL ENG COMPUT, V47, P989, DOI 10.1007/s11517-009-0501-9; Kreck TC, 2001, J APPL PHYSIOL, V91, P1741, DOI 10.1152/jappl.2001.91.4.1741; Kuprat AP, 2009, J COMPUT PHYS, V228, P619, DOI 10.1016/j.jcp.2008.09.030; Kuprat AP, 2012, J COMPUT PH IN PRESS; Lee EY, 2009, J THORAC IMAG, V24, P110, DOI 10.1097/RTI.0b013e3181909f4a; Luo HY, 2007, J BIOMECH, V40, P3096, DOI 10.1016/j.jbiomech.2007.03.027; Ma B, 2009, ANN BIOMED ENG, V37, P271, DOI 10.1007/s10439-008-9620-y; Mathew L, 2011, EUR J RADIOL, V79, P140, DOI 10.1016/j.ejrad.2009.10.028; Minard KR, 2012, J MAGN RESON, V221, P129, DOI 10.1016/j.jmr.2012.05.007; Mistry NN, 2010, MAGN RESON MED, V63, P658, DOI 10.1002/mrm.22311; Namati E, 2008, AM J RESP CELL MOL, V38, P572, DOI 10.1165/rcmb.2007-0120OC; Nazridoust K, 2008, INHAL TOXICOL, V20, P595, DOI 10.1080/08958370801939374 ; Nyeng TB, 2011, ACTA ONCOL, V50, P897, DOI 10.3109/0284186X.2011.577096; OTIS DR, 1994, J APPL PHYSIOL, V77, P2681, DOI 10.1152/jappl.1994.77.6.2681; PALECEK F, 1969, J APPL PHYSIOL, V27, P149, DOI 10.1152/jappl.1969.27.1.149; Plathow C, 2009, KOREAN J RADIOL, V10, P559, DOI 10.3348/kjr.2009.10.6.559; Porra L, 2004, J APPL PHYSIOL, V96, P1899, DOI 10.1152/japplphysiol.00866.2003; Rasband W., 2006, IMAGEJ; Reinhardt JM, 2008, MED IMAGE ANAL, V12, P752, DOI 10.1016/j.media.2008.03.007; Robertson HT, 2010, J APPL PHYSIOL, V108, P1395, DOI 10.1152/japplphysiol.01161.2009; Schmidt-Richberg A, 2012, MED IMAGE ANAL, V16, P150, DOI 10.1016/j.media.2011.06.007; Schroeter JD, 2008, INHAL TOXICOL, V20, P227, DOI 10.1080/08958370701864235 ; Shackleford JA, 2010, PHYS MED BIOL, V55, P6329, DOI 10.1088/0031-9155/55/21/001; Simon BA, 2000, J CLIN MONITOR COMP, V16, P433, DOI 10.1023/A:1011444826908; Simon BA, 2012, J APPL PHYSIOL, V113, P647, DOI 10.1152/japplphysiol.00353.2012; SOBIN SS, 1988, J APPL PHYSIOL, V64, P1659, DOI 10.1152/jappl.1988.64.4.1659; STAMENOVIC D, 1986, J APPL PHYSIOL, V60, P1358, DOI 10.1152/jappl.1986.60.4.1358; van Ertbruggen C, 2005, J APPL PHYSIOL, V98, P970, DOI 10.1152/japplphysiol.00795.2004; Walker MG, 2011, RESPIRATION, V81, P333, DOI 10.1159/000323609; Wu ZJ, 2008, MED PHYS, V35, P775, DOI 10.1118/1.2828378; Yamamoto T, 2011, PHYS MED BIOL, V56, P2279, DOI 10.1088/0031-9155/56/7/023; Yin Y, 2011, MDCT BASED DYNAMIC S; Yin YB, 2009, MED PHYS, V36, P4213, DOI 10.1118/1.3193526	55	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65874	10.1371/journal.pone.0065874	http://dx.doi.org/10.1371/journal.pone.0065874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799057	gold, Green Submitted, Green Published			2022-12-25	WOS:000320363300049
J	Lohberger, B; Rinner, B; Stuendl, N; Kaltenegger, H; Steinecker-Frohnwieser, B; Bernhart, E; Rad, EB; Weinberg, AM; Leithner, A; Bauer, R; Kretschmer, N				Lohberger, Birgit; Rinner, Beate; Stuendl, Nicole; Kaltenegger, Heike; Steinecker-Frohnwieser, Bibiane; Bernhart, Eva; Rad, Ehsan Bonyadi; Weinberg, Annelie Martina; Leithner, Andreas; Bauer, Rudolf; Kretschmer, Nadine			Sesquiterpene Lactones Downregulate G2/M Cell Cycle Regulator Proteins and Affect the Invasive Potential of Human Soft Tissue Sarcoma Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; DEHYDROCOSTUS LACTONE; APOPTOSIS; COSTUNOLIDE; INHIBITION; ARREST; LINE; OSTEOSARCOMA; ACTIVATION; EXPRESSION	Soft tissue sarcomas (STS) represent a rare group of malignant tumors that frequently exhibit chemotherapeutic resistance and increased metastatic potential. Many studies have demonstrated the great potential of plant-derived agents in the treatment of various malignant entities. The present study investigates the effects of the sesquiterpene lactones costunolide and dehydrocostus lactone on cell cycle, MMP expression, and invasive potential of three human STS cell lines of various origins. Both compounds reduced cell proliferation in a time-and dose-dependent manner. Dehydrocostus lactone significantly inhibited cell proliferation, arrested the cells at the G2/M interface and caused a decrease in the expression of the cyclin-dependent kinase CDK2 and the cyclin-dependent kinase inhibitor p27(Kip1). In addition, accumulation of cells at the G2/M phase transition interface resulted in a significant decrease in cdc2 (CDK1) together with cyclin B1. Costunolide had no effect on the cell cycle. Based on the fact that STS tend to form daughter cell nests and metastasize, the expression levels of matrix metalloproteinases (MMPs), which play a crucial role in extracellular matrix degradation and metastasis, were investigated by Luminex (R) technology and real-time RT-PCR. In the presence of costunolide, MMP-2 and -9 levels were significantly increased in SW-982 and TE-671 cells. Dehydrocostus lactone treatment significantly reduced MMP-2 and -9 expression in TE-671 cells, but increased MMP-9 level in SW-982 cells. In addition, the invasion potential was significantly reduced after treatment with both sesquiterpene lactones as investigated by the HTS FluoroBlock (TM) insert system.	[Lohberger, Birgit; Stuendl, Nicole; Kaltenegger, Heike; Weinberg, Annelie Martina; Leithner, Andreas] Med Univ Graz, Dept Orthoped Surg, Graz, Austria; [Rinner, Beate] Med Univ Graz, Med Res Ctr, Graz, Austria; [Steinecker-Frohnwieser, Bibiane] Ludwig Boltzmann Inst Rehabil Internal Dis, Saalfelden, Austria; [Bernhart, Eva] Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria; [Rad, Ehsan Bonyadi] Med Univ Graz, Dept Dermatol, Canc Biol Unit, Graz, Austria; [Rad, Ehsan Bonyadi; Weinberg, Annelie Martina] Med Univ Graz, Dept Pediat & Adolescence Surg, Graz, Austria; [Bauer, Rudolf; Kretschmer, Nadine] Karl Franzens Univ Graz, Inst Pharmaceut Sci, Dept Pharmacognosy, Graz, Austria	Medical University of Graz; Medical University of Graz; Ludwig Boltzmann Institute; Medical University of Graz; Medical University of Graz; Medical University of Graz; University of Graz	Lohberger, B (corresponding author), Med Univ Graz, Dept Orthoped Surg, Graz, Austria.	birgit.lohberger@medunigraz.at	Bauer, Rudolf/F-8468-2010	Bauer, Rudolf/0000-0002-0057-5547; Steinecker-Frohnwieser, Bibiane/0000-0001-6852-4466; Rinner, Beate/0000-0002-6340-4905; Kretschmer, Nadine/0000-0001-9823-6166	Austrian Science Fond (FWF) [P21114]; Medical University of Graz	Austrian Science Fond (FWF)(Austrian Science Fund (FWF)); Medical University of Graz	Financial support by the Austrian Science Fond (FWF, P21114) and the Medical University of Graz is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2004, J GENE MED, V6, P1216, DOI 10.1002/jgm.616; Amalinei C, 2010, ROM J MORPHOL EMBRYO, V51, P215; Bargonetti J, 2002, CURR OPIN ONCOL, V14, P86, DOI 10.1097/00001622-200201000-00015; Bjornland K, 2005, J SURG RES, V127, P151, DOI 10.1016/j.jss.2004.12.016; Bongiorno MR, 2010, DERMATOL THER, V23, pS33, DOI 10.1111/j.1529-8019.2010.01297.x; BORDEN EC, 1990, CANCER, V66, P862, DOI 10.1002/1097-0142(19900901)66:5<862::AID-CNCR2820660509>3.0.CO;2-R; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Choi EJ, 2009, INT J MOL MED, V23, P211, DOI 10.3892/ijmm_00000119; Choi JH, 2002, JPN J CANCER RES, V93, P1327, DOI 10.1111/j.1349-7006.2002.tb01241.x; Choi SH, 2005, CANCER LETT, V227, P153, DOI 10.1016/j.canlet.2005.01.011; Chugh R, 2005, J CLIN ONCOL, V23, P3597, DOI 10.1200/JCO.2005.02.170; Dobashi Y, 2001, INT J CANCER, V94, P353, DOI 10.1002/ijc.1479; Duan JA, 2010, NAT PROD COMMUN, V5, P1531; Duke JA, 1985, MED PLANTS CHINA, V1; Ferrari C, 2004, ACTA ORTHOP SCAND, V75, P487, DOI 10.1080/00016470410001295-1; Hsu YL, 2009, J PHARMACOL EXP THER, V329, P808, DOI 10.1124/jpet.108.148395; Hung JY, 2010, LUNG CANCER, V68, P355, DOI 10.1016/j.lungcan.2009.07.017; Innocente SA, 1999, P NATL ACAD SCI USA, V96, P2147, DOI 10.1073/pnas.96.5.2147; JESSUS C, 1992, CELL, V68, P323, DOI 10.1016/0092-8674(92)90473-P; Jiang XL, 2005, J CELL PHYSIOL, V202, P723, DOI 10.1002/jcp.20162; Jiang XL, 2003, J ORTHOP RES, V21, P1063, DOI 10.1016/S0736-0266(03)00079-2; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim EJ, 2008, FOOD CHEM TOXICOL, V46, P3651, DOI 10.1016/j.fct.2008.08.038; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; Ko SG, 2005, CANCER LETT, V220, P11, DOI 10.1016/j.canlet.2004.06.026; Kretschmer N, 2012, PLANTA MED, V78, P1749, DOI 10.1055/s-0032-1315385; Mannello F, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-95; MORLA AO, 1989, CELL, V58, P193, DOI 10.1016/0092-8674(89)90415-7; Obaya AJ, 2002, CELL MOL LIFE SCI, V59, P126, DOI 10.1007/s00018-002-8410-1; Pandey MM, 2007, J ETHNOPHARMACOL, V110, P379, DOI 10.1016/j.jep.2006.12.033; Pazzaglia L, 2004, ANTICANCER RES, V24, P967; Roomi MW, 2007, MED ONCOL, V24, P394, DOI 10.1007/s12032-007-0022-z; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Sun CM, 2003, J NAT PROD, V66, P1175, DOI 10.1021/np030147e; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xing JZ, 2005, CHEM RES TOXICOL, V18, P154, DOI 10.1021/tx049721s; Yamazaki T, 2003, IN VITRO CELL DEV-AN, V39, P337; Yuan J, 2005, J ORTHOP RES, V23, P1467, DOI 10.1016/j.orthres.2005.04.004; Zhang Siyuan, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P239, DOI 10.2174/1568011053765976	41	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66300	10.1371/journal.pone.0066300	http://dx.doi.org/10.1371/journal.pone.0066300			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799090	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300074
J	Cieplak, M; Robbins, MO				Cieplak, Marek; Robbins, Mark O.			Nanoindentation of 35 Virus Capsids in a Molecular Model: Relating Mechanical Properties to Structure	PLOS ONE			English	Article							CHLOROTIC MOTTLE VIRUS; VIRAL CAPSIDS; PROTEIN; DYNAMICS; SHELL; PART	A coarse-grained model is used to study the mechanical response of 35 virus capsids of symmetries T = 1, T = 2, T = 3, pseudo T = 3, T = 4, and T = 7. The model is based on the native structure of the proteins that constitute the capsids and is described in terms of the C-alpha atoms associated with each amino acid. The number of these atoms ranges between 8 460 (for SPMV - satellite panicum mosaic virus) and 135 780 (for NBV - nudaureli virus). Nanoindentation by a broad AFM tip is modeled as compression between two planes: either both flat or one flat and one curved. Plots of the compressive force versus plate separation show a variety of behaviors, but in each case there is an elastic region which extends to a characteristic force F-c. Crossing F-c results in a drop in the force and irreversible damage. Across the 35 capsids studied, both F-c and the elastic stiffness are observed to vary by a factor of 20. The changes in mechanical properties do not correlate simply with virus size or symmetry. There is a strong connection to the mean coordination number < z >, defined as the mean number of interactions to neighboring amino acids. The Young's modulus for thin shell capsids rises roughly quadratically with < z >-6, where 6 is the minimum coordination for elastic stability in three dimensions.	[Cieplak, Marek] Polish Acad Sci, Inst Phys, Warsaw, Poland; [Robbins, Mark O.] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA	Polish Academy of Sciences; Institute of Physics - Polish Academy of Sciences; Johns Hopkins University	Cieplak, M (corresponding author), Polish Acad Sci, Inst Phys, Warsaw, Poland.	mc@ifpan.edu.pl		Robbins, Mark Owen/0000-0001-7160-3608	European Regional Development Fund under the Operational Programme Innovative Economy NanoFun [POIG.02.02.00-00-025/09]; Polish National Science Centre Grant [011/01/B/ST3/02190]; National Science Foundation [DMR 1006805]; Simons Foundation; Direct For Mathematical & Physical Scien [1006805] Funding Source: National Science Foundation	European Regional Development Fund under the Operational Programme Innovative Economy NanoFun; Polish National Science Centre Grant; National Science Foundation(National Science Foundation (NSF)); Simons Foundation; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The computer resources were financed by the European Regional Development Fund under the Operational Programme Innovative Economy NanoFun POIG.02.02.00-00-025/09. This research has been supported by the Polish National Science Centre Grant No. 011/01/B/ST3/02190 (MC), the National Science Foundation under Grant No. DMR 1006805 (MR), and the Simons Foundation (MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M. P., 1987, COMPUTER SIMULATIONS; Arkhipov A, 2006, STRUCTURE, V14, P1767, DOI 10.1016/j.str.2006.10.003; Arkhipov A, 2009, BIOPHYS J, V97, P2061, DOI 10.1016/j.bpj.2009.07.039; Baclayon M, 2011, NANO LETT, V11, P4865, DOI 10.1021/nl202699r; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Buenemann M, 2007, P NATL ACAD SCI USA, V104, P9925, DOI 10.1073/pnas.0611472104; Buenemann M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051924; Carrasco C, 2006, P NATL ACAD SCI USA, V103, P13706, DOI 10.1073/pnas.0601881103; Carrasco C, 2008, P NATL ACAD SCI USA, V105, P4150, DOI 10.1073/pnas.0708017105; Carrillo-Tripp M, 2009, NUCLEIC ACIDS RES, V37, pD436, DOI 10.1093/nar/gkn840; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Castellanos M, 2012, BIOPHYS J, V102, P2615, DOI 10.1016/j.bpj.2012.04.026; Cieplak M, 2004, PROTEINS, V56, P285, DOI 10.1002/prot.20081; Cieplak M, 2003, BIOPHYS J, V84, P475, DOI 10.1016/S0006-3495(03)74867-X; Cieplak M, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3276287; Ding JP, 2002, STRUCTURE, V10, P999, DOI 10.1016/S0969-2126(02)00793-1; FENG S, 1984, PHYS REV LETT, V52, P216, DOI 10.1103/PhysRevLett.52.216; Gibbons MM, 2008, BIOPHYS J, V95, P3640, DOI 10.1529/biophysj.108.136176; Gibbons MM, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031901; GREST GS, 1986, PHYS REV A, V33, P3628, DOI 10.1103/PhysRevA.33.3628; JACOBS DJ, 1995, PHYS REV LETT, V75, P4051, DOI 10.1103/PhysRevLett.75.4051; Klug WS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.228101; Liu AJ, 2010, ANNU REV CONDEN MA P, V1, P347, DOI 10.1146/annurev-conmatphys-070909-104045; Mao XM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.085504; Michel JP, 2006, P NATL ACAD SCI USA, V103, P6184, DOI 10.1073/pnas.0601744103; Reddy VS, 2001, J VIROL, V75, P11943, DOI 10.1128/JVI.75.24.11943-11947.2001; Roos WH, 2010, NAT PHYS, V6, P733, DOI 10.1038/NPHYS1797; Roos WH, 2010, BIOPHYS J, V99, P1175, DOI 10.1016/j.bpj.2010.05.033; Roos WH, 2012, P NATL ACAD SCI USA, V109, P2342, DOI 10.1073/pnas.1109590109; Sikora M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000547; SPEIR JA, 1995, STRUCTURE, V3, P63, DOI 10.1016/S0969-2126(01)00135-6; STEELE WA, 1973, SURF SCI, V36, P317, DOI 10.1016/0039-6028(73)90264-1; Sulkowska JI, 2008, BIOPHYS J, V95, P3174, DOI 10.1529/biophysj.107.127233; Sulkowska JI, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/28/283201; Szymczak P, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2358346; Tama F, 2005, J MOL BIOL, V345, P299, DOI 10.1016/j.jmb.2004.10.054; Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829; Veitshans T, 1997, FOLD DES, V2, P1, DOI 10.1016/S1359-0278(97)00002-3; VRIEND G, 1986, J MOL BIOL, V191, P453, DOI 10.1016/0022-2836(86)90140-3; Zink M, 2009, BIOPHYS J, V96, P1350, DOI 10.1016/j.bpj.2008.11.028	40	42	42	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e63640	10.1371/journal.pone.0063640	http://dx.doi.org/10.1371/journal.pone.0063640			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785395	gold, Green Submitted, Green Published			2022-12-25	WOS:000321038800122
J	Gradstedt, H; Iovino, F; Bijlsma, JJE				Gradstedt, Henrik; Iovino, Federico; Bijlsma, Jetta J. E.			Streptococcus pneumoniae Invades Endothelial Host Cells via Multiple Pathways and Is Killed in a Lysosome Dependent Manner	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; BLOOD-BRAIN-BARRIER; EPITHELIAL-CELLS; INVASION; INTERNALIZATION; VIRUS; PNEUMOCOCCI; INFECTION; DISEASE; KINASE	Streptococcus pneumoniae is one of the major causative agents of pneumonia, sepsis, meningitis and other morbidities. In spite of its heavy disease burden, surprisingly little is known about the mechanisms involved in the switch of life style, from commensal colonizer of the nasopharynx to invasive pathogen. In vitro experiments, and mouse models have shown that S. pneumoniae can be internalized by host cells, which coupled with intracellular vesicle transport through the cells, i.e. transcytosis, is suggested to be the first step of invasive disease. To further dissect the process of S. pneumoniae internalization, we chemically inhibited discrete parts of the cellular uptake system. We show that this invasion of the host cells was facilitated via both clathrin- and caveolae-mediated endocytosis. After internalization we demonstrated that the bulk of the internalized S. pneumoniae was killed in the lysosome. Interestingly, inhibition of the lysosome altered transcytosis dynamics as it resulted in an increase in the transport of the internalized bacteria out of the cells via the basal side. These results show that uptake of S. pneumoniae into host cells occurs via multiple pathways, as opposed to the often proposed view of invasion being dependent on specific, and singular receptor-mediated endocytosis. This indicates that the endothelium not only has a critical role as a physical barrier against S. pneumoniae in the blood stream, but also in degrading S. pneumonia cells that have adhered to, and invaded the endothelial cells.	[Gradstedt, Henrik; Iovino, Federico; Bijlsma, Jetta J. E.] Univ Groningen, Univ Med Ctr Groningen, Lab Mol Bacteriol, Dept Med Microbiol, Groningen, Netherlands	University of Groningen	Bijlsma, JJE (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Lab Mol Bacteriol, Dept Med Microbiol, Groningen, Netherlands.	j.j.e.bijlsma@umcg.nl	Iovino, Federico/AGW-9968-2022; Iovino, Federico/R-2721-2017	Iovino, Federico/0000-0001-5249-9120; Iovino, Federico/0000-0001-5249-9120	NWO [40-00506-98-9021, 175-010-2009-023]; Rosalind Franklin Fellowship of the UMCG	NWO(Netherlands Organization for Scientific Research (NWO)); Rosalind Franklin Fellowship of the UMCG	Part of this work has been performed at the UMCG Microscopy and Imaging Center (UMIC), which is sponsored by NWO-grants 40-00506-98-9021 and 175-010-2009-023. J.J.E. Bijlsma is a Rosalind Franklin Fellow of the UMCG; H. Gradstedt is funded by the Rosalind Franklin Fellowship of the UMCG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2010, J BIOL CHEM, V285, P23484, DOI 10.1074/jbc.M110.142703; Agarwal V, 2009, J BIOL CHEM, V284, P19427, DOI 10.1074/jbc.M109.003442; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Bhattacharyya S, 2010, VIROLOGY, V401, P18, DOI 10.1016/j.virol.2010.02.015; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Burghout P, 2010, J BACTERIOL, V192, P4054, DOI 10.1128/JB.00151-10; Cantin C, 2007, J GEN VIROL, V88, P559, DOI 10.1099/vir.0.82150-0; Chiaraviglio L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002012; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Elm C, 2004, J BIOL CHEM, V279, P6296, DOI 10.1074/jbc.M310528200; Futter CE, 1998, J CELL BIOL, V141, P611, DOI 10.1083/jcb.141.3.611; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hofmann I, 2006, J CELL SCI, V119, P1494, DOI 10.1242/jcs.02958; Jia LJ, 2009, INT J BIOCHEM CELL B, V41, P2594, DOI 10.1016/j.biocel.2009.08.019; Misinzo G, 2008, J VIROL, V82, P1128, DOI 10.1128/JVI.01229-07; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; Orihuela CJ, 2009, J CLIN INVEST, V119, P1638, DOI 10.1172/JCI36759; Pizarro-Cerda J, 2010, BIOESSAYS, V32, P496, DOI 10.1002/bies.200900172; Radin JN, 2005, INFECT IMMUN, V73, P7827, DOI 10.1128/IAI.73.12.7827-7835.2005; Rahner C, 2000, GASTROENTEROLOGY, V119, P1692, DOI 10.1053/gast.2000.20233; Ring A, 1998, J CLIN INVEST, V102, P347, DOI 10.1172/JCI2406; Schroder A, 2006, MED MICROBIOL IMMUN, V195, P185, DOI 10.1007/s00430-006-0015-0; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; Sukumaran SK, 2002, J BIOL CHEM, V277, P50716, DOI 10.1074/jbc.M208830200; Uchiyama S, 2009, J EXP MED, V206, P1845, DOI 10.1084/jem.20090386; Uriarte SM, 2009, AM J PHYSIOL-CELL PH, V296, pC857, DOI 10.1152/ajpcell.00454.2008; Van Hamme E, 2008, J GEN VIROL, V89, P2147, DOI 10.1099/vir.0.2008/001602-0; Wang YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030632; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	31	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65626	10.1371/journal.pone.0065626	http://dx.doi.org/10.1371/journal.pone.0065626			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785439	Green Published, gold, Green Submitted			2022-12-25	WOS:000321038800081
J	Hao, J; Wang, C; Yuan, J; Chen, M; Zhao, MH				Hao, Jian; Wang, Chen; Yuan, Jun; Chen, Min; Zhao, Ming-Hui			A Pro-Inflammatory Role of C5L2 in C5a-Primed Neutrophils for ANCA-Induced Activation	PLOS ONE			English	Article							ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; 2ND C5A RECEPTOR; COMPLEMENT ACTIVATION; SIGNAL-TRANSDUCTION; VASCULITIS; PROTEIN; GLOMERULONEPHRITIS; AUTOANTIBODIES; RESPONSIVENESS; ANAPHYLATOXIN	Background: The complement system is crucial for the development of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). In particular, C5a and its receptor on neutrophils, CD88, play a central role. The functional role of the second receptor of C5a, C5L2, remains unclear. In the current study, we investigated the role of C5L2 in C5a-primed neutrophils for ANCA-induced activation. Methods: The effect of blocking C5L2 by anti-human C5L2 blocking antibody were tested on respiratory burst and degranulation of C5a-primed neutrophils activated with ANCA, as well as on membrane-bound proteinase 3 (mPR3) and concentration of myeloperoxidase (MPO) in supernatant of C5a-primed neutrophils. An antagonist for CD88 was also employed. Results: Blocking C5L2 resulted in a significantly decreased MPO concentration in the supernatant of C5a-primed neutrophils. mPR3 expression increased from 209.0 +/- 43.0 in untreated cells to 444.3 +/- 60.8 after C5a treatment (P<0.001), and decreased to 375.8 +/- 65.44, 342.2 +/- 54.3 and 313.7 +/- 43.6 by pre-incubating blocking C5L2 antibody at 2.5 mg/ml, 5 mg/ml or 10 mg/ml (compared with C5a-priming group, P<0.001, P<0.001, and P<0.001), respectively. In C5a-primed neutrophils, subsequently activating with MPO-ANCA-positive IgG, the MFI value was 425.8 +/- 160.6, which decreased to 292.8 +/- 141.2, 289.7 +/- 130.0 and 280.3 +/- 136.4 upon pre-incubation with mouse anti-human C5L2 blocking antibody at 2.5 mg/ml, 5 mg/ml or 10 mg/ml (compared with C5a-primed neutrophils, for MPO-ANCA-positive IgG-induced activation, P<0.05, P<0.05, and P<0.05), respectively. Blocking C5L2 also resulted in significantly decreased C5a-primed neutrophils for PR3-ANCA-positive IgG-induced activation. Moreover, the lactoferrin concentration in the supernant significantly decreased in pre-incubation with anti-human C5L2 blocking antibody, compared with C5a-primed neutrophils induced by PR3- or MPO-ANCA-positive IgG. Conclusions: C5L2 may be implicated in the pro-inflammatory role in C5a-primed neutrophils for ANCA-induced activation.	[Hao, Jian; Wang, Chen; Yuan, Jun; Chen, Min; Zhao, Ming-Hui] Peking Univ, Hosp 1,Peking Tsinghua Ctr Life Sci,Dept Med,Rena, Inst Nephrol,Key Lab Chron Kidney Dis Prevent & T, Key Lab Renal Dis,Minist Hlth China,Minist Educ, Beijing 100871, Peoples R China	Peking University	Chen, M (corresponding author), Peking Univ, Hosp 1,Peking Tsinghua Ctr Life Sci,Dept Med,Rena, Inst Nephrol,Key Lab Chron Kidney Dis Prevent & T, Key Lab Renal Dis,Minist Hlth China,Minist Educ, Beijing 100871, Peoples R China.	leimeng@public3.bta.net.cn			Chinese 973 project [2012CB517702]; Research Fund for the Doctoral Program of Higher Education of China [20120001110018]; "National Key Technology Research and Development (R&D) Program" of the Ministry of Science and Technology of China [2011BAI10B04]; National Natural Science Fund [81021004]	Chinese 973 project(National Basic Research Program of China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); "National Key Technology Research and Development (R&D) Program" of the Ministry of Science and Technology of China; National Natural Science Fund(National Natural Science Foundation of China (NSFC))	This study is supported by a grant of Chinese 973 project (No. 2012CB517702), the Research Fund for the Doctoral Program of Higher Education of China (No. 20120001110018), "National Key Technology Research and Development (R&D) Program" of the Ministry of Science and Technology of China (No. 2011BAI10B04) and a grant of the National Natural Science Fund (No. 81021004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker EN, 2005, CELL MOL LIFE SCI, V62, P2531, DOI 10.1007/s00018-005-5368-9; Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Cain SA, 2002, J BIOL CHEM, V277, P7165, DOI 10.1074/jbc.C100714200; CHARLES LA, 1991, J LEUKOCYTE BIOL, V50, P539, DOI 10.1002/jlb.50.6.539; Chen M, 2009, NEPHROL DIAL TRANSPL, V24, P1247, DOI 10.1093/ndt/gfn586; Chen NJ, 2007, NATURE, V446, P203, DOI 10.1038/nature05559; Choi M, 2003, KIDNEY INT, V63, P96, DOI 10.1046/j.1523-1755.2003.00718.x; FALK RJ, 1990, P NATL ACAD SCI USA, V87, P4115, DOI 10.1073/pnas.87.11.4115; Gao HW, 2005, FASEB J, V19, P1003, DOI 10.1096/fj.04-3424fje; Gavrilyuk V, 2005, J NEUROCHEM, V92, P1140, DOI 10.1111/j.1471-4159.2004.02942.x; GERARD NP, 1989, J BIOL CHEM, V264, P1760; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; Gou SJ, 2013, KIDNEY INT, V83, P129, DOI 10.1038/ki.2012.313; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038317; Hess C, 2000, BLOOD, V96, P2822; Hewins P, 2006, KIDNEY INT, V69, P605, DOI 10.1038/sj.ki.5000167; Huugen D, 2007, KIDNEY INT, V71, P646, DOI 10.1038/sj.ki.5002103; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Kalant D, 2005, J BIOL CHEM, V280, P23936, DOI 10.1074/jbc.M406921200; KEOGAN MT, 1992, CLIN EXP IMMUNOL, V90, P228; Kettritz R, 2001, J AM SOC NEPHROL, V12, P37, DOI 10.1681/ASN.V12137; Lee H, 2008, IMMUNOL CELL BIOL, V86, P153, DOI 10.1038/sj.icb.7100166; Manthey HD, 2009, INT J BIOCHEM CELL B, V41, P2114, DOI 10.1016/j.biocel.2009.04.005; MULDER AHL, 1994, CLIN EXP IMMUNOL, V98, P270; Okinaga S, 2003, BIOCHEMISTRY-US, V42, P9406, DOI 10.1021/bi034489v; PORGES AJ, 1994, J IMMUNOL, V153, P1271; Raby AC, 2011, EUR J IMMUNOL, V41, P2741, DOI 10.1002/eji.201041350; REUMAUX D, 1995, BLOOD, V86, P3189; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Schreiber A, 2010, KIDNEY INT, V77, P118, DOI 10.1038/ki.2009.420; Schreiber A, 2009, J AM SOC NEPHROL, V20, P289, DOI 10.1681/ASN.2008050497; Scola AM, 2009, MOL IMMUNOL, V46, P1149, DOI 10.1016/j.molimm.2008.11.001; Talor MV, 2007, CLIN EXP IMMUNOL, V150, P42, DOI 10.1111/j.1365-2249.2007.03453.x; Ward PA, 2009, J MOL MED, V87, P375, DOI 10.1007/s00109-009-0442-7; Witko-Sarsat V, 1999, BLOOD, V94, P2487, DOI 10.1182/blood.V94.7.2487.419k07_2487_2496; Xiao H, 2007, AM J PATHOL, V170, P52, DOI 10.2353/ajpath.2007.060573; Xing GQ, 2009, J CLIN IMMUNOL, V29, P282, DOI 10.1007/s10875-008-9268-2; Yuan J, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3873; Zhang X, 2010, J IMMUNOL, V185, P6741, DOI 10.4049/jimmunol.1000892	40	22	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66305	10.1371/journal.pone.0066305	http://dx.doi.org/10.1371/journal.pone.0066305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785491	gold, Green Published, Green Submitted			2022-12-25	WOS:000321038800031
J	Jensen, BAH; Pedersen, SR; Christensen, JP; Thomsen, AR				Jensen, Benjamin A. H.; Pedersen, Sara R.; Christensen, Jan P.; Thomsen, Allan R.			The Availability of a Functional Tumor Targeting T-Cell Repertoire Determines the Anti-Tumor Efficiency of Combination Therapy with Anti-CTLA-4 and Anti-4-1BB Antibodies	PLOS ONE			English	Article							ANTIGEN; BLOCKADE; CTLA-4; VACCINATION; REGRESSION; IMMUNITY; SIGNALS; TIM-3; LEAD; VIVO	It has previously been found that combination therapy with anti-CTLA-4 and anti-4-1BB antibodies may enhance tumor immunity. However, this treatment is not efficient against all tumors, and it has been suggested that variations in tumor control may reflect differences in the immunogenicity of different tumors. In the present report, we have formally tested this hypothesis. Comparing the efficiency of combination antibody therapy against two antigenically distinct variants of the B16.F10 melanoma cell line, we observed that antibody therapy delayed the growth of a variant expressing an exogenous antigen (P<0.0001), while this treatment failed to protect against the non-transfected parental line (P = 0.1850) consistent with published observations. As both cell lines are poorly immunogenic in wild type mice, these observations suggested that the magnitude of the tumor targeting T-cell repertoire plays a major role in deciding the efficiency of this antibody treatment. To directly test this assumption, we made use of mice expressing the exogenous antigen as a self-antigen and therefore carrying a severely purged T-cell repertoire directed against the major tumor antigen. Notably, combination therapy completely failed to inhibit tumor growth in the latter mice (P = 0.8584). These results underscore the importance of a functionally intact T-cell population as a precondition for the efficiency of treatment with immunomodulatory antibodies. Clinically, the implication is that this type of antibody therapy should be attempted as an early form of tumor-specific immunotherapy before extensive exhaustion of the tumor-specific T-cell repertoire has occurred.	[Jensen, Benjamin A. H.; Pedersen, Sara R.; Christensen, Jan P.; Thomsen, Allan R.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark	University of Copenhagen	Thomsen, AR (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Int Hlth Immunol & Microbiol, Blegdamsvej 3C, Copenhagen, Denmark.	athomsen@sund.ku.dk	Jensen, Benjamin A. H./M-4661-2014; Christensen, Jan Pravsgaard/I-4782-2017	Jensen, Benjamin A. H./0000-0001-6991-0828; Christensen, Jan Pravsgaard/0000-0002-4299-9479; Thomsen, Allan Randrup/0000-0002-2392-9803	Novo Nordisk Foundation	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The project was funded by the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Curran MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019499; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Gray JC, 2008, EUR J IMMUNOL, V38, P2499, DOI 10.1002/eji.200838208; Holst PJ, 2008, J IMMUNOL, V180, P3339, DOI 10.4049/jimmunol.180.5.3339; Kocak E, 2006, CANCER RES, V66, P7276, DOI 10.1158/0008-5472.CAN-05-2128; Lynch DH, 2008, IMMUNOL REV, V222, P277, DOI 10.1111/j.1600-065X.2008.00621.x; Melero I, 2007, NAT REV CANCER, V7, P95, DOI 10.1038/nrc2051; Ochsenbein AF, 2001, NATURE, V411, P1058, DOI 10.1038/35082583; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pedersen AE, 2006, CANCER LETT, V235, P229, DOI 10.1016/j.canlet.2005.04.012; Phan GQ, 2003, P NATL ACAD SCI USA, V100, P8372, DOI 10.1073/pnas.1533209100; Prevost-Blondel A, 1998, J IMMUNOL, V161, P2187; Robertson SJ, 2008, J IMMUNOL, V180, P5267, DOI 10.4049/jimmunol.180.8.5267; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Scalapino KJ, 2008, IMMUNOL REV, V223, P143, DOI 10.1111/j.1600-065X.2008.00639.x; Seliger B, 2001, CANCER RES, V61, P1095; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Sorensen MR, 2010, VACCINE, V28, P6757, DOI 10.1016/j.vaccine.2010.07.066; Sorensen MR, 2009, EUR J IMMUNOL, V39, P2725, DOI 10.1002/eji.200939543; Sun YL, 2002, NAT MED, V8, P1405, DOI 10.1038/nm796; Voehringer D, 2000, J IMMUNOL, V165, P2415, DOI 10.4049/jimmunol.165.5.2415; Weinberg AD, 2011, IMMUNOL REV, V244, P218, DOI 10.1111/j.1600-065X.2011.01069.x; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062	24	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66081	10.1371/journal.pone.0066081	http://dx.doi.org/10.1371/journal.pone.0066081			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785471	Green Published, gold			2022-12-25	WOS:000321038800051
J	Jiang, SY; Jiao, J; Zhang, TT; Xu, YP				Jiang, Su-yun; Jiao, Jian; Zhang, Ting-ting; Xu, Yong-ping			Pharmacokinetics Study of Recombinant Hirudin in the Plasma of Rats Using Chromogenic Substrate, ELISA, and Radioisotope Assays	PLOS ONE			English	Article								Aim: To compare the analytical methods used to study the pharmacokinetics of recombinant hirudin in the plasma of rats that had been injected with I-125-recombinant hirudin. Methods: 2.0 mg/kg I-125-recombinant hirudin were injected intravenously into rats. The recombinant hirudins in the plasma was analyzed by chromogenic substrate assay, enzyme-linked immunosorbent assay (ELISA), total radioisotope assay (RA) and trichloroacetic acid pre-treated total radioisotope assay (TCA-RA). Results: The chromogenic substrate assay standard curve was linear over the concentration range from 3.12 to 40.00 ng/ml for the recombinant hirudin in plasma. The relative standard deviations (RSD) for the intra- and inter-day variation were 5.0 to 6.3% and 11.9 to 12.6%, respectively. The recoveries of recombinant hirudin was 89.8% to 100.7%. The limit of quantification (LOQ) was 3.12 ng/ml. The concentration-time curve of the recombinant hirudin in the plasma could be explained as a two-compartment model. Pharmacokinetic parameters, including the half-life of distribution phase (t(1/2) alpha), the half-life of elimination phase (t(1/2) beta), volume of apparent distribution (Vd), and area under the concentration-time curve from zero to infinite time (AUC(0-t)) were 7.59 min, 46.99 min, 0.17 L/kg, and 204.5 mg/L/min, respectively, as determined by chromogenic substrate assay; 6.41 min, 47.28 min, 1.24 L/kg, and 575.18 mg/L/min, respectively, as determined by ELISA; 3.69 min, 701.90 min, 0.04 L/kg, and 4189 mg/L/min, respectively as determined by RA; and 4.57 min, 724.9 min, 0.09 L/kg, and 2329 mg/L/min, respectively, as determined by TCA-RA. Conclusions: The chromogenic substrate assay on the concentration dynamics of the recombinant hirudin in the plasma is a specific, sensitive, and accurate analytical method for pharmacokinetic studies. Moreover, the pharmacokinetic parameters determined by the chromogenic substrate assay and ELISA are congruent except for AUC.	[Jiang, Su-yun; Xu, Yong-ping] Dalian Univ Technol, Dalian, Peoples R China; [Jiang, Su-yun; Jiao, Jian; Zhang, Ting-ting] Dalian Inst Food & Drug Control, Dalian, Peoples R China	Dalian University of Technology	Jiang, SY (corresponding author), Dalian Univ Technol, Dalian, Peoples R China.	syjiangsy@263.net			Technology Research and Development Funding of Dalian Finance Bureau [2007E11SF059]	Technology Research and Development Funding of Dalian Finance Bureau	This work was supported by the Technology Research and Development Funding of Dalian Finance Bureau (No. 2007E11SF059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	GRIESSBACH U, 1985, THROMB RES, V37, P347, DOI 10.1016/0049-3848(85)90023-4; Han G, 2003, CHINESE TRADITIONAL, V8, P6; Han G, 2000, HER MED, V19, P1; HARVEY RP, 1986, P NATL ACAD SCI USA, V83, P1084, DOI 10.1073/pnas.83.4.1084; [黄玉荣 Huang Yurong], 2005, [中草药, Chinese Traditional and Herbal Drugs], V36, P1352; Jiang S, 2002, CHIN J PHARM SCI, V7, P556; MARKWARDT F, 1985, BIOMED BIOCHIM ACTA, V44, P1007; MARKWARDT F, 1994, THROMB RES, V74, P1, DOI 10.1016/0049-3848(94)90032-9; Markwardt F., 1970, METHOD ENZYMOL, V19, P924, DOI [10.1016/0076-6879(70)19082-3, DOI 10.1016/0076-6879(70)19082-3]; Meiring SM, 1999, J PHARM SCI, V88, P523, DOI 10.1021/js980407q; Richter M, 1988, Folia Haematol Int Mag Klin Morphol Blutforsch, V115, P64; SCHARF M, 1989, FEBS LETT, V255, P105, DOI 10.1016/0014-5793(89)81070-1; Yan H, 2005, MED STAT, P133; [张婷婷 Zhang Tingting], 2011, [中国新药杂志, Chinese Journal New Drugs], V20, P372	14	5	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e64336	10.1371/journal.pone.0064336	http://dx.doi.org/10.1371/journal.pone.0064336			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785400	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800117
J	Lee, SM; Park, JS; Norwitz, ER; Koo, JN; Oh, IH; Park, JW; Kim, SM; Kim, YH; Park, CW; Song, YS				Lee, Seung Mi; Park, Joong Shin; Norwitz, Errol R.; Koo, Ja Nam; Oh, Ig Hwan; Park, Jeong Woo; Kim, Sun Min; Kim, Yun Hwan; Park, Chan-Wook; Song, Yong Sang			Risk of Vertical Transmission of Human Papillomavirus throughout Pregnancy: A Prospective Study	PLOS ONE			English	Article							RECURRENT RESPIRATORY PAPILLOMATOSIS; PERINATAL TRANSMISSION; TRANSPLACENTAL TRANSMISSION; INFECTION-RATE; CANCER; INFANTS; HEAD; DNA; ASSOCIATION; CONCORDANCE	Objective: Much controversy still exists about maternal-to-infant transmission of human papillomavirus (HPV) infection, specifically about the magnitude of the risk and the route and timing of such vertical transmission. This prospective cohort study examines the risk of vertical transmission of maternal HPV in each trimester of pregnancy. Study design: One hundred fifty three healthy pregnant women were followed longitudinally throughout pregnancy and cervical swabs obtained in each trimester and postpartum for HPV detection. Cord blood, neonatal nasopharyngeal aspirates, and placental biopsies were collected at delivery. DNA isolation, polymerase chain reaction, and hybridization were performed using the GG HPV Genotyping Chip Kit (Goodgene Inc., Seoul, Korea). Detection of HPV in neonates was defined as the presence of HPV DNA in either cord blood or neonatal nasopharyngeal aspirate. Results: HPV DNA was detected in 14%(22/153) of healthy women in the first trimester, 18%(22/124) in the second trimester, and 10%(15/153) in the third trimester; 24%(37/153) were positive for HPV DNA on at least one occasion in pregnancy. At birth, 5.2%(8/153) of neonates were HPV DNA positive. Seven of these eight infants were born to HPV-positive mothers. Placental HPV DNA was positive in 3.3%(5/152) of cases, and all five cases were from mothers with at least one HPV-positive test. Detection of HPV DNA in neonates was associated with detection of HPV in mothers during any of the three trimesters of pregnancy. Conclusion: HPV DNA was detected at birth in 5.2%(8/153) of neonates born to healthy women, and was associated with the detection of HPV in mothers during any of the three trimesters of pregnancy.	[Lee, Seung Mi; Park, Joong Shin; Kim, Sun Min; Park, Chan-Wook; Song, Yong Sang] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Lee, Seung Mi] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Obstet & Gynecol, Seoul, South Korea; [Norwitz, Errol R.] Tufts Univ, Sch Med, Dept Obstet & Gynecol, Boston, MA 02111 USA; [Koo, Ja Nam; Oh, Ig Hwan] Seoul Womens Hosp, Inchon, South Korea; [Park, Jeong Woo] Inje Univ, Coll Med, Dept Obstet & Gynecol, Ilsan Paik Hosp, Gyeonggi, South Korea; [Kim, Yun Hwan] Ewha Womans Univ, Dept Obstet & Gynecol, Sch Med, Seoul, South Korea; [Song, Yong Sang] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Song, Yong Sang] Seoul Natl Univ, World Class Univ, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Tufts University; Inje University; Ewha Womans University; Seoul National University (SNU); Seoul National University (SNU)	Park, JS (corresponding author), Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.	jsparkmd@snu.ac.kr	Park, Joong Shin/D-5741-2012; PARK, Chan-Wook/G-3663-2013	Park, Joong Shin/0000-0002-5246-0477; PARK, Chan-Wook/0000-0002-1290-6438; Park, Jeong Woo/0000-0001-6499-0814; Kim, Yun Hwan/0000-0001-9498-2938; SONG, YONGSANG/0000-0001-7115-4021	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology, Republic of Korea [2009-0074892]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by a grant of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0074892), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaya-Saavedra G, 2008, ARCH MED RES, V39, P189, DOI 10.1016/j.arcmed.2007.08.003; Applebaum KM, 2007, JNCI-J NATL CANCER I, V99, P1801, DOI 10.1093/jnci/djm233; ARMBRUSTERMORAES E, 1994, GYNECOL ONCOL, V54, P152, DOI 10.1006/gyno.1994.1185; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; CASON J, 1995, J MED VIROL, V47, P209, DOI 10.1002/jmv.1890470305; Czegledy Judit, 2001, Acta Microbiologica et Immunologica Hungarica, V48, P511, DOI 10.1556/AMicr.48.2001.3-4.17; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Derkay CS, 2008, LARYNGOSCOPE, V118, P1236, DOI 10.1097/MLG.0b013e31816a7135; FREDERICKS BD, 1993, AUST NZ J OBSTET GYN, V33, P30, DOI 10.1111/j.1479-828X.1993.tb02047.x; Gallagher TQ, 2008, CURR OPIN OTOLARYNGO, V16, P536, DOI 10.1097/MOO.0b013e328316930e; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Huh WK, 2009, OBSTET GYNECOL, V114, P139, DOI 10.1097/AOG.0b013e3181ab6878; Koskimaa HM, 2012, J PEDIATR-US, V160, P837, DOI 10.1016/j.jpeds.2011.10.027; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; LEVI JE, 1989, AM J PATHOL, V135, P1179; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Medeiros Lidia Rosi, 2005, Cad. Saúde Pública, V21, P1006, DOI 10.1590/S0102-311X2005000400003; PAKARIAN F, 1994, BRIT J OBSTET GYNAEC, V101, P514, DOI 10.1111/j.1471-0528.1994.tb13153.x; Park H, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-80; Rintala MAM, 2005, CLIN INFECT DIS, V41, P1728, DOI 10.1086/498114; Rombaldi Renato L, 2009, Virol J, V6, P83, DOI 10.1186/1743-422X-6-83; Rombaldi RL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-106; Sarkola M, 2008, ACTA OBSTET GYN SCAN, V87, P1181, DOI 10.1080/00016340802468308; Smith EM, 2004, INT J CANCER, V108, P766, DOI 10.1002/ijc.11633; Smith EM, 2004, SEX TRANSM DIS, V31, P57, DOI 10.1097/01.OLQ.0000105327.40288.DB; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Syrjanen S, 2000, CRIT REV ORAL BIOL M, V11, P259, DOI 10.1177/10454411000110020801; Tenti P, 1999, OBSTET GYNECOL, V93, P475, DOI 10.1016/S0029-7844(98)00459-1; TSENG CJ, 1992, AM J OBSTET GYNECOL, V166, P35, DOI 10.1016/0002-9378(92)91825-U; Tseng CJ, 1998, OBSTET GYNECOL, V91, P92, DOI 10.1016/S0029-7844(97)00593-0; Xu Shushen, 1998, Chinese Medical Sciences Journal, V13, P29	31	37	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66368	10.1371/journal.pone.0066368	http://dx.doi.org/10.1371/journal.pone.0066368			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785495	gold, Green Published, Green Submitted			2022-12-25	WOS:000321038800027
J	Lovero, KL; Blankenship, SM; Shi, Y; Nicoll, RA				Lovero, Kathryn L.; Blankenship, Sabine M.; Shi, Yun; Nicoll, Roger A.			SynDIG1 Promotes Excitatory Synaptogenesis Independent of AMPA Receptor Trafficking and Biophysical Regulation	PLOS ONE			English	Article							LONG-TERM POTENTIATION; AUXILIARY SUBUNITS; SYNAPTIC PLASTICITY; GLUTAMATE RECEPTORS; CORNICHON PROTEINS; ION CHANNELS; HIPPOCAMPUS; MODULATION; TARPS	AMPA receptors-mediators of fast, excitatory transmission and synaptic plasticity in the brain-achieve great functional diversity through interaction with different auxiliary subunits, which alter both the trafficking and biophysical properties of these receptors. In the past several years an abundance of new AMPA receptor auxiliary subunits have been identified, adding astounding variety to the proteins known to directly bind and modulate AMPA receptors. SynDIG1 was recently identified as a novel AMPA receptor interacting protein that directly binds to the AMPA receptor subunit GluA2 in heterologous cells. Functionally, SynDIG1 was found to regulate the strength and density of AMPA receptor containing synapses in hippocampal neurons, though the way in which SynDIG1 exerts these effects remains unknown. Here, we aimed to determine if SynDIG1 acts as a traditional auxiliary subunit, directly regulating the function and localization of AMPA receptors in the rat hippocampus. We find that, unlike any of the previously characterized AMPA receptor auxiliary subunits, SynDIG1 expression does not impact AMPA receptor gating, pharmacology, or surface trafficking. Rather, we show that SynDIG1 regulates the number of functional excitatory synapses, altering both AMPA and NMDA receptor mediated transmission. Our findings suggest that SynDIG1 is not a typical auxiliary subunit to AMPA receptors, but instead is a protein critical to excitatory synaptogenesis.	[Lovero, Kathryn L.; Blankenship, Sabine M.; Shi, Yun; Nicoll, Roger A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Lovero, Kathryn L.; Blankenship, Sabine M.; Shi, Yun; Nicoll, Roger A.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA; [Lovero, Kathryn L.] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	nicoll@cmp.ucsf.edu	Shi, Yun S/T-8845-2018; Shi, Yun/B-5623-2009	Shi, Yun/0000-0002-8842-9818	National Science Foundation; German Academic Exchange Service; National Institute of Mental Health [R37 MH038256-29, R01 MH080379-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070957, R01MH080379] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	K.L.L. is funded by a National Science Foundation Graduate Research Fellowship. S. M. B. was supported by a fellowship from the German Academic Exchange Service. R.A.N. is funded by grants from the National Institute of Mental Health (R37 MH038256-29, R01 MH080379-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Herring BE, 2013, NEURON, V77, P1083, DOI 10.1016/j.neuron.2013.01.017; Jackson AC, 2011, J NEUROSCI, V31, P7511, DOI 10.1523/JNEUROSCI.6688-10.2011; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Jackson AC, 2011, J NEUROSCI, V31, P3939, DOI 10.1523/JNEUROSCI.5134-10.2011; Jonas P, 2000, NEWS PHYSIOL SCI, V15, P83; Kalashnikova E, 2010, NEURON, V65, P80, DOI 10.1016/j.neuron.2009.12.021; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Mayer ML, 2005, CURR OPIN NEUROBIOL, V15, P282, DOI 10.1016/j.conb.2005.05.004; Milstein AD, 2008, TRENDS PHARMACOL SCI, V29, P333, DOI 10.1016/j.tips.2008.04.004; Milstein AD, 2007, NEURON, V55, P905, DOI 10.1016/j.neuron.2007.08.022; Pongs O, 2010, PHYSIOL REV, V90, P755, DOI 10.1152/physrev.00020.2009; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Schwenk J, 2012, NEURON, V74, P621, DOI 10.1016/j.neuron.2012.03.034; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Shanks NF, 2012, CELL REP, V1, P590, DOI 10.1016/j.celrep.2012.05.004; Shi Y, 2010, P NATL ACAD SCI USA, V107, P16315, DOI 10.1073/pnas.1011706107; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; von Engelhardt J, 2010, SCIENCE, V327, P1518, DOI 10.1126/science.1184178	27	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66171	10.1371/journal.pone.0066171	http://dx.doi.org/10.1371/journal.pone.0066171			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785483	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800039
J	Park, MJ; Green, J; Ishikawa, H; Yamazaki, Y; Kitagawa, A; Ono, M; Yasukata, F; Kiuchi, T				Park, M. J.; Green, Joseph; Ishikawa, Hirono; Yamazaki, Yoshihiko; Kitagawa, Akira; Ono, Miho; Yasukata, Fumiko; Kiuchi, Takahiro			Decay of Impact after Self-Management Education for People with Chronic Illnesses: Changes in Anxiety and Depression over One Year	PLOS ONE			English	Article							QUALITY-OF-LIFE; LONG-TERM OUTCOMES; CHRONIC DISEASE; HEALTH-STATUS; CLINICAL-SIGNIFICANCE; FOLLOW-UP; PROGRAM; ARTHRITIS; CHINESE; IMPLEMENTATION	Background: In people with chronic illnesses, self-management education can reduce anxiety and depression. Those benefits, however, decay over time. Efforts have been made to prevent or minimize that "decay of impact", but they have not been based on information about the decay's characteristics, and they have failed. Here we show how the decay's basic characteristics (prevalence, timing, and magnitude) can be quantified. Regarding anxiety and depression, we also report the prevalence, timing, and magnitude of the decay. Methods: Adults with various chronic conditions participated in a self-management educational program (n = 369). Data were collected with the Hospital Anxiety and Depression Scale four times over one year. Using within-person effect sizes, we defined decay of impact as a decline of >= 0.5 standard deviations after improvement by at least the same amount. We also interpret the results using previously-set criteria for non-cases, possible cases, and probable cases. Results: Prevalence: On anxiety, decay occurred in 19% of the participants (70/369), and on depression it occurred in 24% (90/369). Timing: In about one third of those with decay, it began 3 months after the baseline measurement (6 weeks after the educational program ended). Magnitude: The median magnitudes of decay on anxiety and on depression were both 4 points, which was about 1 standard deviation. Early in the follow-up year, many participants with decay moved into less severe clinical categories (e.g., becoming non-cases). Later, many of them moved into more severe categories (e.g., becoming probable cases). Conclusions: Decay of impact can be identified and quantified from within-person effect sizes. This decay occurs in about one fifth or more of this program's participants. It can start soon after the program ends, and it is large enough to be clinically important. These findings can be used to plan interventions aimed at preventing or minimizing the decay of impact.	[Park, M. J.; Ishikawa, Hirono; Kiuchi, Takahiro] Univ Tokyo, Grad Sch Med, Dept Hlth Commun, Tokyo, Japan; [Green, Joseph] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Yamazaki, Yoshihiko] Nihon Fukushi Univ, Fac Social Welf, Nagoya, Aichi, Japan; [Kitagawa, Akira; Yasukata, Fumiko] Fukuoka Prefectural Univ, Dept Fundamental Nursing, Tagawa, Fukuoka, Japan; [Ono, Miho] Kawasaki Univ Med Welf, Dept Hlth Sci & Nursing, Kurashiki, Okayama, Japan	University of Tokyo; University of Tokyo	Park, MJ (corresponding author), Univ Tokyo, Grad Sch Med, Dept Hlth Commun, Tokyo, Japan.	mjpark417@gmail.com			Japanese Ministry of Health, Labor and Welfare Aids for Scientific Research (health disease prevention, treatment and research projects for allergy and immunology)	Japanese Ministry of Health, Labor and Welfare Aids for Scientific Research (health disease prevention, treatment and research projects for allergy and immunology)	This work was supported by the Japanese Ministry of Health, Labor and Welfare Aids for Scientific Research (health disease prevention, treatment and research projects for allergy and immunology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, J CLIN EPIDEMIOL, V62, P1165, DOI 10.1016/j.jclinepi.2009.03.015; [Anonymous], 2008, IMPL MAN STANF SELF; Barlow J, 2009, RHEUMATOLOGY, V48, P128, DOI 10.1093/rheumatology/ken429; Barlow JH, 2005, BRIT J HEALTH PSYCH, V10, P589, DOI 10.1348/135910705X26317; Barlow JH, 1998, BRIT J RHEUMATOL, V37, P1315; Barlow J, 2009, PATIENT EDUC COUNS, V77, P81, DOI 10.1016/j.pec.2009.02.009; Barth J., 2005, HEALTH QUAL LIFE OUT, V3, P15, DOI DOI 10.1186/1477-7525-3-15; Bennette C, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-21; BJELLAND I, 2002, J PSYCHOSOM RES, V0052; Campbell D.T., 1999, PRIMER REGRESSION AR; Caplin DL, 2001, J ASTHMA, V38, P343, DOI 10.1081/JAS-100000263; Cappellery JC, 2013, STAT METHODS MED RES; Chan SCC, 2005, INT J REHABIL RES, V28, P351, DOI 10.1097/00004356-200512000-00008; Clark NM, 2003, ANNU REV PUBL HEALTH, V24, P289, DOI 10.1146/annurev.publhealth.24.100901.141021; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Damush TM, 2003, ARCH INTERN MED, V163, P2632, DOI 10.1001/archinte.163.21.2632; Edwards PJ, 2009, COCHRANE DB SYST REV, V3, P1; Elzen H, 2007, SOC SCI MED, V64, P1832, DOI 10.1016/j.socscimed.2007.02.008; Foster G, 2007, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD005108.PUB2; Franks P, 2009, BRIT J HEALTH PSYCH, V14, P473, DOI 10.1348/135910708X360700; Fu DB, 2003, B WORLD HEALTH ORGAN, V81, P174; Gitlin LN, 2008, GERONTOLOGIST, V48, P698, DOI 10.1093/geront/48.5.698; Glasgow RE, 2002, PATIENT EDUC COUNS, V48, P115, DOI 10.1016/S0738-3991(02)00025-3; Goeppinger J, 2007, ARTHRIT RHEUM-ARTHR, V57, P1081, DOI 10.1002/art.22896; GREEN LW, 1977, AM J PUBLIC HEALTH, V67, P155, DOI 10.2105/AJPH.67.2.155; Guyatt GH, 2002, MAYO CLIN PROC, V77, P371, DOI 10.4065/77.4.371; GUYATT GH, 1987, THORAX, V42, P773, DOI 10.1136/thx.42.10.773; Gwaltney CJ, 2005, J ABNORM PSYCHOL, V114, P661, DOI 10.1037/0021-843X.114.4.661; Haas M, 2005, J MANIP PHYSIOL THER, V28, P228, DOI 10.1016/j.jmpt.2005.03.010; Hennessy M, 1999, STRUCT EQU MODELING, V6, P322, DOI 10.1080/10705519909540139; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Jerant A, 2008, MED CARE, V46, P523, DOI 10.1097/MLR.0b013e31815f53a4; Jerant A, 2009, ANN FAM MED, V7, P319, DOI 10.1370/afm.996; Jordan JE, 2009, J CLIN EPIDEMIOL, V62, P642, DOI 10.1016/j.jclinepi.2008.07.019; KENNY DA, 1995, J CONSULT CLIN PSYCH, V63, P52, DOI 10.1037/0022-006X.63.1.52; Krebs P, 2010, PREV MED, V51, P214, DOI 10.1016/j.ypmed.2010.06.004; Linden M, 2013, CLIN PSYCHOL PSYCHOT, V20, P286, DOI 10.1002/cpp.1765; LORIG K, 1989, SOC SCI MED, V29, P221, DOI 10.1016/0277-9536(89)90170-6; Lorig K., 2020, LIVING HLTHY LIFE CH; Lorig K, 2001, LIVING HLTH LIFE CHR; Lorig K, 2000, LIVING HLTH LIFE CHR; Lorig K R, 2001, Eff Clin Pract, V4, P256; Lorig K, 2008, DIABETES CARE, V31, P408, DOI 10.2337/dc07-1313; Lorig K, 2010, DIABETES CARE, V33, P1275, DOI 10.2337/dc09-2153; Lorig KR, 2006, MED CARE, V44, P964, DOI 10.1097/01.mlr.0000233678.80203.c1; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Lorig KR, 2005, DIABETES EDUCATOR, V31, P401, DOI 10.1177/0145721705276574; Lorig KR, 2004, MED CARE, V42, P346, DOI 10.1097/01.mlr.0000118709.74348.65; Matsudaira T, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-42; McArdle JJ, 2002, DEV PSYCHOL, V38, P115, DOI 10.1037//0012-1649.38.1.115; McDowell I, 2006, MEASURING HLTH GUIDE, P294; McLeod LD, 2011, EXPERT REV PHARM OUT, V11, P163, DOI [10.1586/erp.11.12, 10.1586/ERP.11.12]; Mulligan K, 2007, CAMBRIDGE HANDBOOK OF PSYCHOLOGY, HEALTH AND MEDICINE, 2ND EDITION, P393; Muschalla B, 2011, REHABILITATION, V50, P103, DOI 10.1055/s-0030-1265182; Newman S, 2009, CHRONIC PHYS ILLNESS, P72; Nguyen HQ, 2005, HEART LUNG, V34, P51, DOI 10.1016/j.hrtlng.2004.06.005; Nolte S, 2007, PATIENT EDUC COUNS, V65, P351, DOI 10.1016/j.pec.2006.08.016; Norman Geoffrey R, 2004, Expert Rev Pharmacoecon Outcomes Res, V4, P581, DOI 10.1586/14737167.4.5.581; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Osborne RH, 2007, PATIENT EDUC COUNS, V66, P192, DOI 10.1016/j.pec.2006.12.002; Osborne RH, 2006, ARTHRIT RHEUM-ARTHR, V55, P458, DOI 10.1002/art.21982; Park MJ, 2013, CHRONIC ILLN, V9, P73, DOI 10.1177/1742395312453351; Park MJ, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-145; Puhan MA, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-46; Riemsma RP, 2003, ARTHRIT RHEUM-ARTHR, V49, P556, DOI 10.1002/art.11207; Schwartz C, 2006, QUAL LIFE RES, V15, P1503, DOI 10.1007/s11136-006-0008-x; Siu AMH, 2007, PATIENT EDUC COUNS, V65, P42, DOI 10.1016/j.pec.2006.04.013; Smith L, 2007, SOC SCI MED, V64, P1501, DOI 10.1016/j.socscimed.2006.11.006; Swerissen H, 2006, PATIENT EDUC COUNS, V64, P360, DOI 10.1016/j.pec.2006.04.003; Tousman S, 2010, CLIN NURS RES, V19, P71, DOI 10.1177/1054773809354290; Wyrwich KW, 2013, QUAL LIFE RES, V22, P475, DOI 10.1007/s11136-012-0175-x; Wyrwich KW, 2005, QUAL LIFE RES, V14, P285, DOI 10.1007/s11136-004-0705-2; Yip Yin-Bing, 2008, Psychol Health Med, V13, P402, DOI 10.1080/13548500701584030	73	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65316	10.1371/journal.pone.0065316	http://dx.doi.org/10.1371/journal.pone.0065316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	172XB	23785418	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800102
J	Wang, H; Gondre-Lewis, MC				Wang, Hong; Gondre-Lewis, Marjorie C.			Prenatal Nicotine and Maternal Deprivation Stress De-Regulate the Development of CA1, CA3, and Dentate Gyrus Neurons in Hippocampus of Infant Rats	PLOS ONE			English	Article							NEUROTROPHIC FACTOR EXPRESSION; HYPORESPONSIVE PERIOD; SYNAPTIC PLASTICITY; CELL-PROLIFERATION; PREFRONTAL CORTEX; RECEPTOR FUNCTION; MAJOR DEPRESSION; CHILDHOOD TRAUMA; NMDA RECEPTORS; MESSENGER-RNA	Adverse experiences by the developing fetus and in early childhood are associated with profound effects on learning, emotional behavior, and cognition as a whole. In this study we investigated the effects of prenatal nicotine exposure (NIC), postnatal maternal deprivation (MD) or the combination of the two (NIC+MD) to determine if hippocampal neuron development is modulated by exposure to drugs of abuse and/or stress. Growth of rat offspring exposed to MD alone or NIC+MD was repressed until after weaning. In CA1 but not CA3 of postnatal day 14 (P14) pups, MD increased pyramidal neurons, however, in dentate gyrus (DG), decreased granule neurons. NIC had no effect on neuron number in CA1, CA3 or DG. Unexpectedly, NIC plus MD combined caused a synergistic increase in the number of CA1 or CA3 neurons. Neuron density in CA regions was unaffected by treatment, but in the DG, granule neurons had a looser packing density after NIC, MD or NIC+MD exposure. When septotemporal axes were analyzed, the synergism of stress and drug exposure in CA1 and CA3 was associated with rostral, whereas MD effects were predominantly associated with caudal neurons. TUNEL labeling suggests no active apoptosis at P14, and doublecortin positive neurons and mossy fibers were diminished in NIC+MD relative to controls. The laterality of the effect of nicotine and/or maternal deprivation in right versus left hippocampus was also analyzed and found to be insiginificant. We report for the first time that early life stressors such as postnatal MD and prenatal NIC exposure, when combined, may exhibit synergistic consequences for CA1 and CA3 pyramidal neuron development, and a potential antagonistic influence on developing DG neurons. These results suggest that early stressors may modulate neurogenesis, apoptosis, or maturation of glutamatergic neurons in the hippocampus in a region-specific manner during critical periods of neurodevelopment.	[Wang, Hong; Gondre-Lewis, Marjorie C.] Howard Univ, Coll Med, Dept Anat, Lab Neurodevelopment, Washington, DC 20059 USA	Howard University	Gondre-Lewis, MC (corresponding author), Howard Univ, Coll Med, Dept Anat, Lab Neurodevelopment, Washington, DC 20059 USA.	mgondre-lewis@howard.edu	Gondre-Lewis, Marjorie/M-8055-2017		Howard University;  [NS065385]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [SC2NS065385] Funding Source: NIH RePORTER	Howard University; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grant # NS065385 (www.nih.gov) and a Howard University intramural SEED grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agid O, 1999, MOL PSYCHIATR, V4, P163, DOI 10.1038/sj.mp.4000473; Aisa B, 2009, HIPPOCAMPUS, V19, P1222, DOI 10.1002/hipo.20586; Aisa B, 2009, PSYCHONEUROENDOCRINO, V34, P1495, DOI 10.1016/j.psyneuen.2009.05.003; Neto JBB, 2012, NEUROPHARMACOLOGY, V62, P518, DOI 10.1016/j.neuropharm.2011.09.011; Bendel O, 2005, MOL BRAIN RES, V137, P119, DOI 10.1016/j.molbrainres.2005.02.023; Biagini G, 1998, INT J DEV NEUROSCI, V16, P187, DOI 10.1016/S0736-5748(98)00019-7; Blood-Siegfried J, 2010, J MIDWIFERY WOM HEAL, V55, P143, DOI 10.1016/j.jmwh.2009.05.006; Chen WJA, 2006, LIFE SCI, V79, P2221, DOI 10.1016/j.lfs.2006.07.019; Davila-Garcia MI, 2003, J NEUROCHEM, V85, P1237, DOI 10.1046/j.1471-4159.2003.01774.x; De Bellis MD, 2002, PSYCHONEUROENDOCRINO, V27, P155, DOI 10.1016/S0306-4530(01)00042-7; De Bellis MD, 2002, BIOL PSYCHIAT, V51, P544, DOI 10.1016/S0006-3223(01)01374-9; De Bellis MD, 2002, BIOL PSYCHIAT, V51, P553, DOI 10.1016/S0006-3223(01)01375-0; Dent G, 2007, BRAIN RES, V1138, P1, DOI 10.1016/j.brainres.2006.04.082; Dong HX, 2003, J NEUROSCI, V23, P1742; Enoch MA, 2011, PSYCHOPHARMACOLOGY, V214, P17, DOI 10.1007/s00213-010-1916-6; Enoch MA, 2010, BIOL PSYCHIAT, V67, P20, DOI 10.1016/j.biopsych.2009.08.019; Eppolito AK, 2010, NEUROTOXICOL TERATOL, V32, P336, DOI 10.1016/j.ntt.2009.12.009; Eyler FD, 1999, CLIN PERINATOL, V26, P107, DOI 10.1016/S0095-5108(18)30075-7; Fabricius K, 2008, BRAIN STRUCT FUNCT, V212, P403, DOI 10.1007/s00429-007-0169-6; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Gondre-Lewis MC, 2012, INT REV CEL MOL BIO, V299, P27, DOI 10.1016/B978-0-12-394310-1.00002-3; Gondre-Lewis MC, 2003, CURR BIOL, V13, P1324, DOI 10.1016/S0960-9822(03)00531-1; Goto K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015468; Greisen MH, 2005, J NEUROSCI RES, V79, P772, DOI 10.1002/jnr.20418; Gruss M, 2008, NEUROSCIENCE, V152, P1, DOI 10.1016/j.neuroscience.2007.12.033; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Heim C, 2008, BIOL PSYCHIAT, V63, P398, DOI 10.1016/j.biopsych.2007.07.002; Hosseini-Sharifabad M, 2007, J NEUROSCI METH, V162, P206, DOI 10.1016/j.jneumeth.2007.01.009; Huang LT, 2002, EPILEPSIA, V43, P1141, DOI 10.1046/j.1528-1157.2002.14602.x; Hulshof HJ, 2011, BEHAV BRAIN RES, V216, P552, DOI 10.1016/j.bbr.2010.08.038; Huot RL, 2002, BRAIN RES, V950, P52, DOI 10.1016/S0006-8993(02)02985-2; Jabes A, 2011, J COMP NEUROL, V519, P1051, DOI 10.1002/cne.22549; Kaffman A, 2009, BIOL PSYCHIAT, V66, DOI 10.1016/j.biopsych.2009.08.002; Ku HY, 2008, NEUROPSYCHOPHARMACOL, V33, P2847, DOI 10.1038/npp.2008.36; Kuma H, 2004, NEUROSCI LETT, V372, P68, DOI 10.1016/j.neulet.2004.09.012; Lajud N, 2012, PSYCHONEUROENDOCRINO, V37, P410, DOI 10.1016/j.psyneuen.2011.07.011; Law AJ, 2009, NEUROPSYCHOPHARMACOL, V34, P1381, DOI 10.1038/npp.2008.106; Lee HJ, 2001, MOL PSYCHIATR, V6, P725, DOI 10.1038/sj.mp.4000947; Litvin Y, 2010, HORM BEHAV, V58, P241, DOI 10.1016/j.yhbeh.2010.03.010; Manaye KF, 2011, AGE DORDR; Marco EM, 2012, NEUROPHARMACOLOGY; Marco EM, 2007, PHARMACOL BIOCHEM BE, V86, P334, DOI 10.1016/j.pbb.2006.10.006; Monroy E, 2010, J CHEM NEUROANAT, V40, P93, DOI 10.1016/j.jchemneu.2010.05.005; MURRIN LC, 1987, LIFE SCI, V40, P1699, DOI 10.1016/0024-3205(87)90020-8; O'Neil JN, 2007, J CHEM NEUROANAT, V34, P102, DOI 10.1016/j.jchemneu.2007.05.008; Parameshwaran K, 2012, CELL MOL LIFE SCI, V69, P829, DOI 10.1007/s00018-011-0805-4; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Pickering C, 2006, BRAIN RES, V1099, P101, DOI 10.1016/j.brainres.2006.04.136; Ramachandra R, 2011, ATLAS NEONATAL RAT B, Vxxiii; Reus GZ, 2011, NEUROCHEM RES, V36, P460, DOI 10.1007/s11064-010-0364-3; Roceri M, 2004, BIOL PSYCHIAT, V55, P708, DOI 10.1016/j.biopsych.2003.12.011; Roceri M, 2002, MOL PSYCHIATR, V7, P609, DOI 10.1038/sj.mp.4001036; Rodenas-Ruano A, 2012, NAT NEUROSCI, V15, P1382, DOI 10.1038/nn.3214; Roy TS, 1998, NEUROTOXICOL TERATOL, V20, P465, DOI 10.1016/S0892-0362(97)00137-2; Shinohara Y, 2008, P NATL ACAD SCI USA, V105, P19498, DOI 10.1073/pnas.0807461105; SORIANO E, 1994, J COMP NEUROL, V342, P571, DOI 10.1002/cne.903420406; Strange BA, 1999, P NATL ACAD SCI USA, V96, P4034, DOI 10.1073/pnas.96.7.4034; Talge NM, 2007, J CHILD PSYCHOL PSYC, V48, P245, DOI 10.1111/j.1469-7610.2006.01714.x; Tottenham N, 2010, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.068.2009; Uysal N, 2005, NEUROSCI LETT, V384, P98, DOI 10.1016/j.neulet.2005.04.052; Vaglenova J, 2008, NEUROBIOL LEARN MEM, V90, P527, DOI 10.1016/j.nlm.2008.06.009; Wang H, 2011, NEUROSCIENCE, V188, P168, DOI 10.1016/j.neuroscience.2011.04.069; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; White LD, 2001, CELL DEATH DIFFER, V8, P345, DOI 10.1038/sj.cdd.4400816	65	29	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65517	10.1371/journal.pone.0065517	http://dx.doi.org/10.1371/journal.pone.0065517			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785432	Green Submitted, Green Published, gold			2022-12-25	WOS:000321038800089
J	Yuan, RH; Chang, KT; Chen, YL; Hsu, HC; Lee, PH; Lai, PL; Jeng, YM				Yuan, Ray-Hwang; Chang, Ko-Tung; Chen, Yu-Ling; Hsu, Hey-Chi; Lee, Po-Huang; Lai, Po-Lin; Jeng, Yung-Ming			S100P Expression Is a Novel Prognostic Factor in Hepatocellular Carcinoma and Predicts Survival in Patients with High Tumor Stage or Early Recurrent Tumors	PLOS ONE			English	Article							BETA-CATENIN MUTATIONS; BINDING PROTEIN S100P; POOR-PROGNOSIS; P53 GENE; FAVORABLE PROGNOSIS; PANCREATIC-CANCER; PERIPHERAL-TYPE; CELL-MIGRATION; OVEREXPRESSION; GROWTH	The calcium-binding protein S100P is expressed in a variety of human cancer cells and is important in cancer cell growth and invasion. Using differential display, we found S100P is overexpressed in human hepatocellular carcinoma (HCC). We examined the expression of 305 unifocal, primary HCC tumors using immunohistochemistry. The S100P protein was expressed in 173 of the 305 (56.7%) HCC tumors. The expression of S100P correlated with female sex (P=0.0162), high serum a-fetoprotein level (P=0.0001), high tumor grade (P=0.0029), high tumor stage (P=0.0319), the presence of the p53 mutation (P=0.0032), and the absence of the beta-catenin mutation (P=0.0489). Patients with HCC tumors that expressed S100P were more likely to have early tumor recurrence (ETR) (P=0.0189) and lower 5-year survival (P=0.0023). The multivariate analysis confirmed that S100P expression was an independent prognostic factor in HCC. The combinatorial analysis showed an additive unfavorable prognostic interaction between S100P expression and the p53 mutation. In contrast, the beta-catenin mutation was associated with better prognosis in both S100P-positive and -negative HCCs. Furthermore, S100P expression was a predictor of survival in HCC patients with high tumor stage or ETR (P=0.0026 and P=0.0002, respectively). Our study indicates the expression of the S100P protein is a novel independent predictor for poor prognosis in HCC, and it is also an unfavorable prognostic predictor in HCC patients with high tumor stage or ETR.	[Yuan, Ray-Hwang; Lee, Po-Huang] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Yuan, Ray-Hwang; Lee, Po-Huang] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Yuan, Ray-Hwang] Natl Taiwan Univ Hosp, Dept Surg, Yun Lin Branch, Yunlin, Taiwan; [Chang, Ko-Tung] Natl Pingtung Univ Sci & Technol, Dept Life Sci, Pingtung, Taiwan; [Chen, Yu-Ling; Hsu, Hey-Chi; Jeng, Yung-Ming] Natl Taiwan Univ, Grad Inst Pathol, Taipei 10764, Taiwan; [Hsu, Hey-Chi; Lai, Po-Lin] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Pingtung University Science & Technology; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Jeng, YM (corresponding author), Natl Taiwan Univ, Grad Inst Pathol, Taipei 10764, Taiwan.	d83409009@ntu.edu.tw		LEE, PO-HUANG/0000-0001-5831-035X; Yuan, Ray-Hwang/0000-0002-2767-633X; JENG, YUNG-MING/0000-0002-3878-4491	National Taiwan University Hospital, Yun-Lin Branch [NTUHYL101.N004]	National Taiwan University Hospital, Yun-Lin Branch	This research was supported by a grant from National Taiwan University Hospital, Yun-Lin Branch (NTUHYL101.N004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El All Howayda, 2007, Diagn Pathol, V2, P9, DOI 10.1186/1746-1596-2-9; Aishima S, 2011, AM J SURG PATHOL, V35, P590, DOI 10.1097/PAS.0b013e31820ffdf1; Arumugam T, 2004, J BIOL CHEM, V279, P5059, DOI 10.1074/jbc.M310124200; Arumugam T, 2005, CLIN CANCER RES, V11, P5356, DOI 10.1158/1078-0432.CCR-05-0092; Austermann J, 2008, J BIOL CHEM, V283, P29331, DOI 10.1074/jbc.M806145200; Bartling B, 2007, EUR J CANCER, V43, P1935, DOI 10.1016/j.ejca.2007.06.010; Basu GD, 2008, INT J CANCER, V123, P330, DOI 10.1002/ijc.23447; BECKER T, 1992, EUR J BIOCHEM, V207, P541, DOI 10.1111/j.1432-1033.1992.tb17080.x; Befeler AS, 2002, GASTROENTEROLOGY, V122, P1609, DOI 10.1053/gast.2002.33411; Chandramouli A, 2010, CANCER BIOL THER, V10, P1057, DOI 10.4161/cbt.10.10.13373; Chang XF, 2010, CANCER RES, V70, P2870, DOI 10.1158/0008-5472.CAN-09-3427; Crnogorac-Jurcevic T, 2003, J PATHOL, V201, P63, DOI 10.1002/path.1418; Da Silva IDCG, 2000, INT J ONCOL, V16, P231; Dowen SE, 2005, AM J PATHOL, V166, P81, DOI 10.1016/S0002-9440(10)62234-1; Du M, 2012, J BIOL CHEM, V287, P15330, DOI 10.1074/jbc.M112.349787; Edge SB, 2010, AJCC CANC STAGING MA; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Filipek A, 2002, J BIOL CHEM, V277, P28848, DOI 10.1074/jbc.M203602200; Fuentes MK, 2007, DIS COLON RECTUM, V50, P1230, DOI 10.1007/s10350-006-0850-5; Hamada S, 2011, CANCER SCI, V102, P150, DOI 10.1111/j.1349-7006.2010.01757.x; Heizmann CW, 2007, SUBCELL BIOCH, P45; Hsieh HL, 2004, BIOCHEM BIOPH RES CO, V316, P949, DOI 10.1016/j.bbrc.2004.02.135; Hsu HC, 1997, CANCER RES, V57, P5179; HSU HC, 1993, CANCER RES, V53, P4691; Hsu HC, 2000, AM J PATHOL, V157, P763, DOI 10.1016/S0002-9440(10)64590-7; HSU HC, 1994, HEPATOLOGY, V19, P122, DOI 10.1016/0270-9139(94)90062-0; HSU HC, 1994, INT J ONCOL, V4, P1341; HUANG LR, 1995, CANCER RES, V55, P4717; Jiang HF, 2012, J CANCER RES CLIN, V138, P1, DOI 10.1007/s00432-011-1062-5; Kim JK, 2009, INT J ONCOL, V35, P1257, DOI 10.3892/ijo_00000442; Koltzscher M, 2003, MOL BIOL CELL, V14, P2372, DOI 10.1091/mbc.E02-09-0553; Laurent-Puig P, 2001, GASTROENTEROLOGY, V120, P1763, DOI 10.1053/gast.2001.24798; Lee YC, 2007, EUR J CANCER, V43, P736, DOI 10.1016/j.ejca.2006.11.020; Ohuchida K, 2006, CLIN CANCER RES, V12, P5411, DOI 10.1158/1078-0432.CCR-06-0298; Pan HW, 2006, CELL CYCLE, V5, P2676, DOI 10.4161/cc.5.22.3500; Pan HW, 2003, CANCER-AM CANCER SOC, V98, P119, DOI 10.1002/cncr.11487; Parkkila S, 2008, BMC CLIN PATHOL, V8, DOI 10.1186/1472-6890-8-2; Peng SY, 2008, ONCOL REP, V19, P1045; Peng SY, 2004, INT J CANCER, V112, P44, DOI 10.1002/ijc.20279; Sato N, 2002, ANAT REC, V267, P60, DOI 10.1002/ar.10085; Schafer DF, 1999, LANCET, V353, P1253, DOI 10.1016/S0140-6736(98)09148-X; Schor APT, 2006, ONCOL REP, V15, P3; Surowiak P, 2007, HISTOPATHOLOGY, V51, P125, DOI 10.1111/j.1365-2559.2007.02714.x; Tsai JH, 2012, HISTOPATHOLOGY, V61, P1106, DOI 10.1111/j.1365-2559.2012.04316.x; Wang GZ, 2006, CANCER RES, V66, P1199, DOI 10.1158/0008-5472.CAN-05-2605; Wang Q, 2012, ONCOL REP, V28, P303, DOI 10.3892/or.2012.1794; Yuan RH, 2006, J PATHOL, V209, P549, DOI 10.1002/path.2011; Yuan RH, 2007, CLIN CANCER RES, V13, P5368, DOI 10.1158/1078-0432.CCR-07-1113; Yuan RH, 2011, J GASTROINTEST SURG, V15, P321, DOI 10.1007/s11605-010-1373-x; Yuan RH, 2005, CLIN CANCER RES, V11, P2568, DOI 10.1158/1078-0432.CCR-04-2039; Zhou CH, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3144	51	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65501	10.1371/journal.pone.0065501	http://dx.doi.org/10.1371/journal.pone.0065501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785431	gold, Green Published, Green Submitted			2022-12-25	WOS:000321038800090
J	Zunini, RAL; Thivierge, JP; Kousaie, S; Sheppard, C; Taler, V				Zunini, Rocio A. Lopez; Thivierge, Jean-Philippe; Kousaie, Shanna; Sheppard, Christine; Taler, Vanessa			Alterations in Resting-State Activity Relate to Performance in a Verbal Recognition Task	PLOS ONE			English	Article							ALPHA OSCILLATIONS; WORKING-MEMORY; EEG; FREQUENCY; SYNCHRONIZATION; RETRIEVAL; ATTENTION	In the brain, resting-state activity refers to non-random patterns of intrinsic activity occurring when participants are not actively engaged in a task. We monitored resting-state activity using electroencephalogram (EEG) both before and after a verbal recognition task. We show a strong positive correlation between accuracy in verbal recognition and pre-task resting-state alpha power at posterior sites. We further characterized this effect by examining resting-state post-task activity. We found marked alterations in resting-state alpha power when comparing pre- and post-task periods, with more pronounced alterations in participants that attained higher task accuracy. These findings support a dynamical view of cognitive processes where patterns of ongoing brain activity can facilitate -or interfere- with optimal task performance.	[Zunini, Rocio A. Lopez; Thivierge, Jean-Philippe; Sheppard, Christine; Taler, Vanessa] Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada; [Zunini, Rocio A. Lopez; Kousaie, Shanna; Sheppard, Christine; Taler, Vanessa] Bruyere Res Inst, Ottawa, ON, Canada	University of Ottawa; University of Ottawa	Zunini, RAL (corresponding author), Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada.	rlope056@ottawa.ca	López Zunini, Rocío/T-5432-2017	López Zunini, Rocío/0000-0001-9579-7718; Kousaie, Shanna/0000-0002-8218-2746	Alzheimer Society of Canada [1122]; Canadian Institutes of Health Research [112241]	Alzheimer Society of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by a Young Investigator Award from the Alzheimer Society of Canada and (grant number: 1122, http://www.alzheimer.ca/en)a Canadian Institutes of Health Research Catalyst Grant (grant number: 112241, http://www.cihr-irsc.gc.ca/) to VT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Angelakis E, 2004, CLIN NEUROPHYSIOL, V115, P887, DOI 10.1016/j.clinph.2003.11.034; Baayen R. H., 1993, CELEX LEXICAL DATABA; Babiloni C, 2007, EUR J NEUROSCI, V25, P3742, DOI 10.1111/j.1460-9568.2007.05601.x; Barry RJ, 2007, CLIN NEUROPHYSIOL, V118, P2765, DOI 10.1016/j.clinph.2007.07.028; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Caravaglios G, 2010, J NEURAL TRANSM, V117, P1195, DOI 10.1007/s00702-010-0488-2; Dockree PM, 2007, EUR J NEUROSCI, V25, P900, DOI 10.1111/j.1460-9568.2007.05324.x; Finnigan S, 2011, PSYCHOPHYSIOLOGY, V48, P1083, DOI 10.1111/j.1469-8986.2010.01173.x; Foxe JJ, 1998, NEUROREPORT, V9, P3929, DOI 10.1097/00001756-199812010-00030; Freyer F, 2011, J NEUROSCI, V31, P6353, DOI 10.1523/JNEUROSCI.6693-10.2011; Gevins A, 2000, CEREB CORTEX, V10, P829, DOI 10.1093/cercor/10.9.829; Haig AR, 1998, PSYCHOPHYSIOLOGY, V35, P591, DOI 10.1017/S0048577298970512; Hsieh LT, 2011, J NEUROSCI, V31, P10803, DOI 10.1523/JNEUROSCI.0828-11.2011; Jacobs J, 2006, NEUROIMAGE, V32, P978, DOI 10.1016/j.neuroimage.2006.02.018; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Klimesch W, 2001, COGNITIVE BRAIN RES, V12, P33, DOI 10.1016/S0926-6410(01)00024-6; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Klimesch W, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00118; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Maltseva IV, 1997, INT J PSYCHOPHYSIOL, V26, P369, DOI 10.1016/S0167-8760(97)00776-9; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mathewson KE, 2012, PSYCHOPHYSIOLOGY, V49, P1558, DOI 10.1111/j.1469-8986.2012.01474.x; Montez T, 2009, P NATL ACAD SCI USA, V106, P1614, DOI 10.1073/pnas.0811699106; Northoff G, 2010, TRENDS NEUROSCI, V33, P277, DOI 10.1016/j.tins.2010.02.006; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Sauseng P, 2005, HUM BRAIN MAPP, V26, P148, DOI 10.1002/hbm.20150; Smit DJA, 2011, J NEUROSCI, V31, P13128, DOI 10.1523/JNEUROSCI.1678-11.2011; Sporns O., 2016, NETWORKS BRAIN; Taubert M, 2010, J NEUROSCI, V30, P11670, DOI 10.1523/JNEUROSCI.2567-10.2010; Thatcher RW, 2008, HUM BRAIN MAPP, V29, P1400, DOI 10.1002/hbm.20474; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; van der Hiele K, 2007, CLIN NEUROPHYSIOL, V118, P1931, DOI 10.1016/j.clinph.2007.05.070; Vogt F, 1998, J CLIN NEUROPHYSIOL, V15, P167, DOI 10.1097/00004691-199803000-00011; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x	34	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65608	10.1371/journal.pone.0065608	http://dx.doi.org/10.1371/journal.pone.0065608			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785436	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800085
J	Viarengo, G; Sciara, MI; Salazar, MO; Kieffer, PM; Furlan, RLE; Vescovi, EG				Viarengo, Gaston; Sciara, Mariela I.; Salazar, Mario O.; Kieffer, Pablo M.; Furlan, Ricardo L. E.; Garcia Vescovi, Eleonora			Unsaturated Long Chain Free Fatty Acids Are Input Signals of the Salmonella enterica PhoP/PhoQ Regulatory System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRULENCE GENE-EXPRESSION; ESCHERICHIA-COLI; SEROVAR TYPHIMURIUM; ENVIRONMENTAL-REGULATION; HISTIDINE KINASE; TRANSCRIPTION; PROTEINS; TARGET; PHOQ; ENVZ	The Salmonella enterica serovar Typhimurium PhoP/PhoQ system has largely been studied as a paradigmatic two-component regulatory system not only to dissect structural and functional aspects of signal transduction in bacteria but also to gain knowledge about the versatile devices that have evolved allowing a pathogenic bacterium to adjust to or counteract environmental stressful conditions along its life cycle. Mg2+ limitation, acidic pH, and the presence of cationic antimicrobial peptides have been identified as cues that the sensor protein PhoQ can monitor to reprogram Salmonella gene expression to cope with extra-or intracellular challenging conditions. In this work, we show for the first time that long chain unsaturated free fatty acids (LCUFAs) present in Salmonella growth medium are signals specifically detected by PhoQ. We demonstrate that LCUFAs inhibit PhoQ autokinase activity, turning off the expression of the PhoP-dependent regulon. We also show that LCUFAs exert their action independently of their cellular uptake and metabolic utilization by means of the beta-oxidative pathway. Our findings put forth the complexity of input signals that can converge to finely tune the activity of the PhoP/PhoQ system. In addition, they provide a new potential biochemical platform for the development of antibacterial strategies to fight against Salmonella infections.	[Viarengo, Gaston; Sciara, Mariela I.; Kieffer, Pablo M.; Garcia Vescovi, Eleonora] Univ Nacl Rosario, Predio CCT CONICET Rosario Ocampo & Esmeralda, Inst Biol Mol & Celular Rosario IBR CONICET, Fac Ciencias Bioquim & Farmaceut,Dept Microbiol, RA-2000 Rosario, Santa Fe, Argentina; [Salazar, Mario O.; Furlan, Ricardo L. E.] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, RA-2000 Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; National University of Rosario	Vescovi, EG (corresponding author), Univ Nacl Rosario, Predio CCT CONICET Rosario Ocampo & Esmeralda, Inst Biol Mol & Celular Rosario IBR CONICET, Fac Ciencias Bioquim & Farmaceut,Dept Microbiol, RA-2000 Rosario, Santa Fe, Argentina.	garciavescovi@ibr-conicet.gov.ar	Salazar, Mario/AAR-6723-2021; Furlan, Ricardo/AGU-7634-2022; SCIARA, MARIELA/ABE-3753-2021	Garcia Vescovi, Eleonora/0000-0002-4431-8606; Furlan, Ricardo/0000-0001-6136-0980; Salazar, Mario O./0000-0002-0006-7614	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET); Secretaria de Estado de Ciencia, Tecnologia e Innovacion (SECTEI), Provincia de Santa Fe, Argentina; CONICET, Argentina	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Secretaria de Estado de Ciencia, Tecnologia e Innovacion (SECTEI), Provincia de Santa Fe, Argentina; CONICET, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work is supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET), and Secretaria de Estado de Ciencia, Tecnologia e Innovacion (SECTEI), Provincia de Santa Fe, Argentina (to E. G. V. and R. L. F.).; Recipient of a fellowship from CONICET, Argentina.	Aguirre A, 2006, J BACTERIOL, V188, P6889, DOI 10.1128/JB.00804-06; Antunes LCM, 2012, J BACTERIOL, V194, P2286, DOI 10.1128/JB.00104-12; ARANDA CMA, 1992, P NATL ACAD SCI USA, V89, P10079, DOI 10.1073/pnas.89.21.10079; Bader MW, 2003, MOL MICROBIOL, V50, P219, DOI 10.1046/j.1365-2958.2003.03675.x; Bearson BL, 1998, J BACTERIOL, V180, P2409, DOI 10.1128/JB.180.9.2409-2417.1998; Bilwes AM, 1999, CELL, V96, P131, DOI 10.1016/S0092-8674(00)80966-6; Black PN, 2003, MICROBIOL MOL BIOL R, V67, P454, DOI 10.1128/MMBR.67.3.454-472.2003; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BULLAS LR, 1983, J BACTERIOL, V156, P471, DOI 10.1128/JB.156.1.471-474.1983; Bury-Mone S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000651; Castelli ME, 2000, J BIOL CHEM, V275, P22948, DOI 10.1074/jbc.M909335199; Chatterjee A, 2007, INFECT IMMUN, V75, P1946, DOI 10.1128/IAI.01435-06; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Crawford RW, 2010, P NATL ACAD SCI USA, V107, P4353, DOI 10.1073/pnas.1000862107; Cronan JE, 1998, MOL MICROBIOL, V29, P937, DOI 10.1046/j.1365-2958.1998.00917.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; DiGiuseppe PA, 2003, J BACTERIOL, V185, P2432, DOI 10.1128/JB.185.8.2432-2440.2003; DiRusso CC, 2004, J BIOL CHEM, V279, P49563, DOI 10.1074/jbc.R400026200; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; ELY B, 1974, GENETICS, V76, P625; Fujita Y, 2007, MOL MICROBIOL, V66, P829, DOI 10.1111/j.1365-2958.2007.05947.x; GIBSON MM, 1987, MOL GEN GENET, V207, P120, DOI 10.1007/BF00331499; Goh EB, 2004, J BACTERIOL, V186, P4019, DOI 10.1128/JB.186.12.4019-4024.2004; Goldberg SD, 2010, P NATL ACAD SCI USA, V107, P8141, DOI 10.1073/pnas.1003166107; Groisman EA, 1998, BIOESSAYS, V20, P96, DOI 10.1002/(SICI)1521-1878(199801)20:1<96::AID-BIES13>3.0.CO;2-3; Gunn JS, 2000, MICROBES INFECT, V2, P907, DOI 10.1016/S1286-4579(00)00392-0; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Iram SH, 2006, J BACTERIOL, V188, P599, DOI 10.1128/JB.188.2.599-608.2006; JACKOWSKI S, 1986, J BIOL CHEM, V261, P1328; JACKOWSKI S, 1994, J BIOL CHEM, V269, P2921; Kishii R, 2007, J BIOL CHEM, V282, P26401, DOI 10.1074/jbc.M701342200; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lam KS, 2007, TRENDS MICROBIOL, V15, P279, DOI 10.1016/j.tim.2007.04.001; Lejona S, 2003, J BACTERIOL, V185, P6287, DOI 10.1128/JB.185.21.6287-6294.2003; LEPAGE G, 1988, J LIPID RES, V29, P227; Lepore BW, 2011, P NATL ACAD SCI USA, V108, P10121, DOI 10.1073/pnas.1018532108; Lesley JA, 2003, J BACTERIOL, V185, P2563, DOI 10.1128/JB.185.8.2563-2570.2003; Lippa AM, 2012, J BACTERIOL, V194, P1457, DOI 10.1128/JB.06055-11; Lopez SN, 2007, P NATL ACAD SCI USA, V104, P441, DOI 10.1073/pnas.0608438104; Lowden MJ, 2010, P NATL ACAD SCI USA, V107, P2860, DOI 10.1073/pnas.0915021107; Maniatis T., 1982, MOL CLONING LAB MANU; Martin-Orozco N, 2006, MOL BIOL CELL, V17, P498, DOI 10.1091/mbc.E04-12-1096; MURAKAMI K, 1986, J BIOL CHEM, V261, P5424; Olveira G, 2006, BRIT J NUTR, V96, P343, DOI 10.1079/BJN20051655; Osborne SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021648; Pech-Canul A, 2011, J BACTERIOL, V193, P6295, DOI 10.1128/JB.05450-11; Audero MEP, 2010, MOL MICROBIOL, V78, P853, DOI 10.1111/j.1365-2958.2010.07370.x; Portillo FGD, 2008, CURR OPIN MICROBIOL, V11, P46, DOI 10.1016/j.mib.2008.01.001; Prouty AM, 2002, INFECT IMMUN, V70, P2640, DOI 10.1128/IAI.70.5.2640-2649.2002; Prouty AM, 2000, INFECT IMMUN, V68, P6763, DOI 10.1128/IAI.68.12.6763-6769.2000; RALEIGH JA, 1977, INT J RADIAT BIOL, V31, P203, DOI 10.1080/09553007714550251; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Soncini FC, 1996, J BACTERIOL, V178, P5092, DOI 10.1128/jb.178.17.5092-5099.1996; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; STOLL LL, 1984, IN VITRO CELL DEV B, V20, P732; Thompson JA, 2011, MICROBIOL-SGM, V157, P2084, DOI 10.1099/mic.0.048926-0; Tsuchiya Y, 2006, CLIN BIOCHEM, V39, P410, DOI 10.1016/j.clinbiochem.2005.11.006; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Visioli Francesco, 2006, Nutrition and Health (Bicester), V18, P127; WANNER BL, 1992, J BACTERIOL, V174, P2053, DOI 10.1128/JB.174.7.2053-2058.1992; Watson KG, 2010, CELL MICROBIOL, V12, P1389, DOI 10.1111/j.1462-5822.2010.01511.x; Yoshida T, 2007, METHOD ENZYMOL, V423, P184, DOI 10.1016/S0076-6879(07)23008-3; Yu JL, 2011, J PROTEOME RES, V10, P2992, DOI 10.1021/pr101177g; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zwir I, 2012, MOL MICROBIOL, V84, P463, DOI 10.1111/j.1365-2958.2012.08036.x	67	29	30	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22346	22358		10.1074/jbc.M113.472829	http://dx.doi.org/10.1074/jbc.M113.472829			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23782700	hybrid, Green Published			2022-12-25	WOS:000330596300016
J	Takeuchi, A; Kobayashi, A; Ironside, JW; Mohri, S; Kitamoto, T				Takeuchi, Atsuko; Kobayashi, Atsushi; Ironside, James W.; Mohri, Shirou; Kitamoto, Tetsuyuki			Characterization of Variant Creutzfeldt-Jakob Disease Prions in Prion Protein-humanized Mice Carrying Distinct Codon 129 Genotypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Microbiology; Neurobiology; Prions; Protein Misfolding; Knock-in Mouse; Codon 129 Genotype; Folicular Dendritic Cell; vCJD	GERSTMANN-STRAUSSLER SYNDROME; BLOOD-TRANSFUSION; MOLECULAR PHENOTYPE; TRANSGENIC MICE; TISSUE SAMPLES; TRANSMISSION; VCJD; CJD; INFECTION; SUSCEPTIBILITY	To date, all clinical variant Creutzfeldt-Jakob disease (vCJD) patients are homozygous for methionine at polymorphic codon 129 (129M/M) of the prion protein (PrP) gene. However, the appearance of asymptomatic secondary vCJD infection in individuals with a PRNP codon 129 genotype other than M/M and transmission studies using animal models have raised the concern that all humans might be susceptible to vCJD prions, especially via secondary infection. To reevaluate this possibility and to analyze in detail the transmission properties of vCJD prions to transgenic animals carrying distinct codon 129 genotype, we performed intracerebral inoculation of vCJD prions to humanized knock-in mice carrying all possible codon 129 genotypes (129M/M, 129M/V, or 129V/V). All humanized knock-in mouse lines were susceptible to vCJD infection, although the attack rate gradually decreased from 129M/M to 129M/V and to 129V/V. The amount of PrP deposition including florid/amyloid plaques in the brain also gradually decreased from 129M/M to 129M/V and to 129V/V. The biochemical properties of protease-resistant abnormal PrP in the brain and transmissibility of these humanized mouse-passaged vCJD prions upon subpassage into knock-in mice expressing bovine PrP were not affected by the codon 129 genotype. These results indicate that individuals with the 129V/V genotype may be more susceptible to secondary vCJD infection than expected and may lack the neuropathological characteristics observed in vCJD patients with the 129M/M genotype. Besides the molecular typing of protease-resistant PrP in the brain, transmission studies using knock-in mice carrying bovine PrP may aid the differential diagnosis of secondary vCJD infection, especially in individuals with the 129V/V genotype.	[Takeuchi, Atsuko; Kobayashi, Atsushi; Kitamoto, Tetsuyuki] Tohoku Univ, Grad Sch Med, Dept Neurol Sci, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Ironside, James W.] Univ Edinburgh, Western Gen Hosp, Natl Creutzfeldt Jakob Dis Res & Surveillance Uni, Div Pathol,Sch Mol & Clin Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Mohri, Shirou] Natl Inst Anim Hlth, Prion Dis Res Ctr, Tsukuba, Ibaraki 3050856, Japan	Tohoku University; University of Edinburgh; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan	Kitamoto, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Neurol Sci, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	kitamoto@med.tohoku.ac.jp	Mohri, Shirou/AAK-1281-2020	Ironside, James/0000-0001-5869-2108	National Institute of Biomedical Innovation; Research Committee of Prion Disease and Slow Virus Infection, the Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare, Japan [H23-Shokuhin-lppan-005]; Medical Research Council [G0600953, G0900580] Funding Source: researchfish; Grants-in-Aid for Scientific Research [24650185] Funding Source: KAKEN; MRC [G0600953, G0900580] Funding Source: UKRI	National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Research Committee of Prion Disease and Slow Virus Infection, the Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Program for Promotion of Fundamental Studies in Health Sciences of National Institute of Biomedical Innovation (to S. M. and T. K.), grants-in-aid from the Research Committee of Prion Disease and Slow Virus Infection, the Ministry of Health, Labor and Welfare of Japan (to A. T., S. M., and T. K.), a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology (to A. T., A. K., and T. K.), and a grant for TSE research from the Ministry of Health, Labour and Welfare, Japan (H23-Shokuhin-lppan-005) (to T. K.).	Asano M, 2006, BIOCHEM BIOPH RES CO, V342, P293, DOI 10.1016/j.bbrc.2006.01.149; Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; Asante EA, 2006, P NATL ACAD SCI USA, V103, P10759, DOI 10.1073/pnas.0604292103; Beck JA, 2010, HUM MUTAT, V31, pE1551, DOI 10.1002/humu.21281; Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; Grathwohl KUD, 1996, ARCH VIROL, V141, P1863, DOI 10.1007/BF01718200; Head MW, 2001, ANN NEUROL, V50, P258, DOI 10.1002/ana.1100; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Hizume M, 2009, J BIOL CHEM, V284, P3603, DOI 10.1074/jbc.M809254200; Ironside JW, 2006, BRIT MED J, V332, P1186, DOI 10.1136/bmj.38804.511644.55; Kaski D, 2009, LANCET, V374, P2128, DOI 10.1016/S0140-6736(09)61568-3; KITAMOTO T, 1993, BIOCHEM BIOPH RES CO, V191, P709, DOI 10.1006/bbrc.1993.1275; Kitamoto T, 2002, BIOCHEM BIOPH RES CO, V294, P280, DOI 10.1016/S0006-291X(02)00476-X; KITAMOTO T, 1991, BRAIN RES, V545, P319, DOI 10.1016/0006-8993(91)91306-L; KITAMOTO T, 1991, J VIROL, V65, P6292, DOI 10.1128/JVI.65.11.6292-6295.1991; Kobayashi A, 2007, J BIOL CHEM, V282, P30022, DOI 10.1074/jbc.M704597200; Kobayashi A, 2010, J VIROL, V84, P3230, DOI 10.1128/JVI.02387-09; Lasmezas CI, 2001, P NATL ACAD SCI USA, V98, P4142, DOI 10.1073/pnas.041490898; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Lukic A, 2010, ARCH NEUROL-CHICAGO, V67, P1021, DOI 10.1001/archneurol.2010.184; Mead S, 2007, ARCH NEUROL-CHICAGO, V64, P1780, DOI 10.1001/archneur.64.12.1780; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Peden A, 2010, HAEMOPHILIA, V16, P296, DOI 10.1111/j.1365-2516.2009.02181.x; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Scott MR, 2005, J VIROL, V79, P5259, DOI 10.1128/JVI.79.9.5259-5271.2005; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; Soldevila Marta, 2003, Hum Mutat, V22, P104, DOI 10.1002/humu.9157; Taguchi Y, 2003, AM J PATHOL, V163, P2585, DOI 10.1016/S0002-9440(10)63613-9; Wadsworth JDF, 2004, SCIENCE, V306, P1793, DOI 10.1126/science.1103932; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Will RG, 2000, ANN NEUROL, V47, P575; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8	34	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21659	21666		10.1074/jbc.M113.470328	http://dx.doi.org/10.1074/jbc.M113.470328			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23792955	Green Published, hybrid			2022-12-25	WOS:000328841900018
J	Beyeler, A; Retailleau, A; Molter, C; Mehidi, A; Szabadics, J; Leinekugel, X				Beyeler, Anna; Retailleau, Aude; Molter, Colin; Mehidi, Amine; Szabadics, Janos; Leinekugel, Xavier			Recruitment of Perisomatic Inhibition during Spontaneous Hippocampal Activity In Vitro	PLOS ONE			English	Article							GUINEA-PIG HIPPOCAMPUS; INTERNEURON DIVERSITY SERIES; PYRAMIDAL CELLS; RAT HIPPOCAMPUS; NETWORK OSCILLATIONS; SYNAPTIC PLASTICITY; NEURONS; MEMORY; POTENTIALS; CIRCUITS	It was recently shown that perisomatic GABAergic inhibitory postsynaptic potentials (IPSPs) originating from basket and chandelier cells can be recorded as population IPSPs from the hippocampal pyramidal layer using extracellular electrodes (eIPSPs). Taking advantage of this approach, we have investigated the recruitment of perisomatic inhibition during spontaneous hippocampal activity in vitro. Combining intracellular and extracellular recordings from pyramidal cells and interneurons, we confirm that inhibitory signals generated by basket cells can be recorded extracellularly, but our results suggest that, during spontaneous activity, eIPSPs are mostly confined to the CA3 rather than CA1 region. CA3 eIPSPs produced the powerful time-locked inhibition of multi-unit activity expected from perisomatic inhibition. Analysis of the temporal dynamics of spike discharges relative to eIPSPs suggests significant but moderate recruitment of excitatory and inhibitory neurons within the CA3 network on a 10 ms time scale, within which neurons recruit each other through recurrent collaterals and trigger powerful feedback inhibition. Such quantified parameters of neuronal interactions in the hippocampal network may serve as a basis for future characterisation of pathological conditions potentially affecting the interactions between excitation and inhibition in this circuit.	[Beyeler, Anna; Retailleau, Aude; Molter, Colin; Mehidi, Amine; Leinekugel, Xavier] Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France; [Beyeler, Anna; Retailleau, Aude; Molter, Colin; Mehidi, Amine; Leinekugel, Xavier] Inst Malad Neurodegenerat, CNRS, UMR 5293, Bordeaux, France; [Beyeler, Anna; Retailleau, Aude; Molter, Colin; Mehidi, Amine; Leinekugel, Xavier] European Network Inst, Bordeaux, France; [Szabadics, Janos] Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Leinekugel, X (corresponding author), Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France.	xavier@arcadi.eu	Leinekugel, Xavier/F-4034-2014; Leinekugel, Xavier/ABD-8347-2021; Beyeler, Anna/V-9934-2019	Leinekugel, Xavier/0000-0003-2878-3791; /0000-0003-2371-5706; Szabadics, Janos/0000-0002-4968-2562; Retailleau, Aude/0000-0001-6367-1889	INSERM; FRM; CNRS; Region Aquitaine; ENI-Net; French Ministry of Research and Education; ANR; Wellcome Trust [087497]; Lendulet initiative of the Hungarian Academy of Sciences	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); FRM(Fondation pour la Recherche Medicale); CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Aquitaine(Region Nouvelle-Aquitaine); ENI-Net; French Ministry of Research and Education; ANR(French National Research Agency (ANR)); Wellcome Trust(Wellcome Trust); Lendulet initiative of the Hungarian Academy of Sciences	This worked was performed thanks to the following funding sources: INSERM (XL), FRM (XL), CNRS (XL), Region Aquitaine (XL), ENI-Net (XL), French Ministry of Research and Education (AR), ANR (XL, AB, CM), Wellcome Trust #087497 (JS), and Lendulet initiative of the Hungarian Academy of Sciences (JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANKRI N, 1994, J NEUROSCI METH, V52, P87, DOI 10.1016/0165-0270(94)90060-4; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Bazelot M, 2010, J PHYSIOL-LONDON, V588, P2077, DOI 10.1113/jphysiol.2009.185918; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Buzsaki G., 2006, RHYTHMS BRAIN; Cohen I, 2000, J PHYSIOL-LONDON, V524, P485, DOI 10.1111/j.1469-7793.2000.00485.x; Cossart R, 2005, TRENDS NEUROSCI, V28, P108, DOI 10.1016/j.tins.2004.11.011; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; de la Prida LM, 2006, NEURON, V49, P131, DOI 10.1016/j.neuron.2005.10.034; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fricker D, 1999, J PHYSIOL-LONDON, V517, P791, DOI 10.1111/j.1469-7793.1999.0791s.x; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Glickfeld LL, 2009, NAT NEUROSCI, V12, P21, DOI 10.1038/nn.2230; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hasselmo ME, 1999, CURR OPIN NEUROBIOL, V9, P184, DOI 10.1016/S0959-4388(99)80025-7; Hebb Donald O., 1949, ORG BEHAV; Kanerva P., 1988, SPARSE DISTRIBUTED M; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Maccaferri G, 2003, TRENDS NEUROSCI, V26, P564, DOI 10.1016/j.tins.2003.08.002; MACVICAR BA, 1980, BRAIN RES, V184, P220, DOI 10.1016/0006-8993(80)90602-2; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; MILES R, 1984, J PHYSIOL-LONDON, V356, P97, DOI 10.1113/jphysiol.1984.sp015455; MILES R, 1983, NATURE, V306, P371, DOI 10.1038/306371a0; MILES R, 1987, J PHYSIOL-LONDON, V388, P611, DOI 10.1113/jphysiol.1987.sp016634; MILES R, 1987, NATURE, V329, P724, DOI 10.1038/329724a0; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Palm G, 2009, NEURAL ASSEMBLIES; Paulsen O, 1998, TRENDS NEUROSCI, V21, P273, DOI 10.1016/S0166-2236(97)01205-8; Pawelzik H, 1999, EUR J NEUROSCI, V11, P3552, DOI 10.1046/j.1460-9568.1999.00772.x; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Racz A, 2009, J NEUROSCI, V29, P2563, DOI 10.1523/JNEUROSCI.5036-08.2009; Singer W, 1997, TRENDS COGN SCI, V1, P252, DOI 10.1016/S1364-6613(97)01079-6; Tyzio R, 2003, J NEUROPHYSIOL, V90, P2964, DOI 10.1152/jn.00172.2003; Whittington MA, 2003, TRENDS NEUROSCI, V26, P676, DOI 10.1016/j.tins.2003.09.016; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905	49	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66509	10.1371/journal.pone.0066509	http://dx.doi.org/10.1371/journal.pone.0066509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805227	Green Published, gold, Green Submitted			2022-12-25	WOS:000320846500055
J	Li, D; Lei, Y; Deng, J; Zhou, CJ; Zhang, Y; Li, WJ; Huang, HG; Cheng, SG; Zhang, HZ; Zhang, L; Huang, RZ; Liu, X; Ma, LH; Wang, X; Li, J; Xie, P				Li, Dan; Lei, Yang; Deng, Jing; Zhou, Chanjuan; Zhang, Yong; Li, Wenjuan; Huang, Hua; Cheng, Shigang; Zhang, Hongzhi; Zhang, Liang; Huang, Rongzhong; Liu, Xia; Ma, Lihua; Wang, Xiao; Li, Juan; Xie, Peng			Human but Not Laboratory Borna Disease Virus Inhibits Proliferation and Induces Apoptosis in Human Oligodendrocytes In Vitro	PLOS ONE			English	Article							INFECTION; CELLS	Borna disease virus (BDV) is a neurotropic virus that produces neuropsychiatric dysfunction in a wide range of warm-blooded species. Several studies have associated BDV with human psychiatric illness, but the findings remain controversial. Although oligodendrocytes are a major glial component of brain white matter and play a pivotal role in neuronal cell function, BDV's effects on human oligodendrocytes have not been clarified. Here, the effects of two BDV strains, Hu-H1 (isolated from a bipolar patient) and Strain V (a laboratory strain), on the proliferation and apoptosis of human oligodendrocytes were investigated. Three experimental cell lines were constructed: Hu-H1-infected oligodendroglioma (Hu-H1) cells, Strain V-infected oligodendroglioma (Strain V) cells, and non-infected oligodendroglioma (control) cells. BDV infection was assayed by BDV nucleoprotein (p40) immunofluorescence, cell proliferation was assayed by Cell Counting Kit-8 (CCK8), and cell cycle phases and apoptosis were assayed by flow cytometry. Expressions of the apoptosis-related proteins Bax and Bcl-2 were measured by Western blotting. p40 expression was confirmed in Hu-H1 and Strain V on and after day three post-infection. Strain V cells showed significantly greater cellular proliferation than Hu-H1 cells on and after day three post-infection. In Hu-H1 cells, Bax and Bcl-2 expression were significantly increased and decreased, respectively, on and after day three post-infection. In contrast, in Strain V cells, Bax and Bcl-2 expression were significantly decreased and increased, respectively, on and after day three post-infection. In conclusion, Hu-H1 inhibits cellular proliferation and promotes apoptosis in human oligodendrocytes via Bax upregulation and Bcl-2 downregulation. In contrast, Strain V promotes cellular proliferation and inhibits apoptosis in human oligodendrocytes via Bax downregulation and Bcl-2 upregulation. The effects of the Hu-H1 strain (isolated from a bipolar patient) are opposite from those of Strain V (a laboratory strain), thereby providing a proof of authenticity for both.	[Li, Dan] Chongqing Med Univ, Fac Basic Med, Dept Pathol, Chongqing, Peoples R China; [Li, Dan; Lei, Yang; Deng, Jing; Zhou, Chanjuan; Zhang, Yong; Li, Wenjuan; Huang, Hua; Cheng, Shigang; Zhang, Hongzhi; Zhang, Liang; Huang, Rongzhong; Liu, Xia; Ma, Lihua; Wang, Xiao; Li, Juan; Xie, Peng] Ctr Neurosci, Key Lab Neurobiol Chongqing, Chongqing, Peoples R China; [Lei, Yang; Zhou, Chanjuan; Huang, Hua; Zhang, Hongzhi; Zhang, Liang; Huang, Rongzhong; Liu, Xia; Ma, Lihua; Li, Juan; Xie, Peng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Deng, Jing] Chongqing Zhongshan Hosp, Dept Neurol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Xie, P (corresponding author), Ctr Neurosci, Key Lab Neurobiol Chongqing, Chongqing, Peoples R China.	xiepeng@cqmu.edu.cn			National Basic Research Program of China (973 Program) [2009CB918300]; National Natural Science Foundation of China [31271189]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program) (Grant No. 2009CB918300), National Natural Science Foundation of China (Grant No. 31271189). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bode L, 2003, CLIN MICROBIOL REV, V16, P534, DOI 10.1128/CMR.16.3.534-545.2003; Bode L, 1996, MOL PSYCHIATR, V1, P200; Brnic D, 2012, J VIROL, V86, P2512, DOI 10.1128/JVI.05663-11; Carbone KM, 2001, CLIN MICROBIOL REV, V14, P513, DOI 10.1128/CMR.14.3.513-527.2001; Clemente R, 2007, J VIROL, V81, P5968, DOI 10.1128/JVI.02426-06; Das S, 2011, NEUROCHEM INT, V59, P357, DOI 10.1016/j.neuint.2011.02.020; de la Torre JC, 2001, VIRUS TAXONOMY, P531; delaTorre JC, 1996, VIRUS RES, V44, P33, DOI 10.1016/0168-1702(96)01338-X; Elder RT, 2002, FRONT BIOSCI-LANDMRK, V7, pD349, DOI 10.2741/elder; Fluur C, 2007, J IMMUNOL, V178, P5340, DOI 10.4049/jimmunol.178.8.5340; Gibbs JD, 2009, J VIROL, V83, P12424, DOI 10.1128/JVI.00806-09; Hans A, 2001, J BIOL CHEM, V276, P7258, DOI 10.1074/jbc.M005107200; Huang RZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044665; Ikuta K, 2002, FRONT BIOSCI-LANDMRK, V7, pD470, DOI 10.2741/ikuta; Kamitani W, 2001, J VIROL, V75, P8742, DOI 10.1128/JVI.75.18.8742-8751.2001; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Li Q, 2009, EUR J NEUROL, V16, P399, DOI 10.1111/j.1468-1331.2008.02516.x; Lipkin WI, 2007, FIELDS VIROLOGY, VII, P1829; Ludwig H, 1993, Arch Virol Suppl, V7, P111; Ludwig H, 2000, REV SCI TECH OIE, V19, P259, DOI 10.20506/rst.19.1.1217; Ovanesov MV, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-50; Ovanesov MV, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-16; Planz O, 2003, J VIROL, V77, P11186, DOI 10.1128/JVI.77.20.11186-11192.2003; Poenisch M, 2009, J VIROL, V83, P4297, DOI 10.1128/JVI.02321-08; Thakur R, 2009, INDIAN J MED MICROBI, V27, P191, DOI 10.4103/0255-0857.53200; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; Nunes SOV, 2008, J CLIN LAB ANAL, V22, P314, DOI 10.1002/jcla.20261; Watanabe Y, 2007, MICROBES INFECT, V9, P417, DOI 10.1016/j.micinf.2006.12.015; Williams BL, 2008, J VIROL, V82, P1748, DOI 10.1128/JVI.02014-07; Wu YJ, 2013, P NATL ACAD SCI USA, V110, P1899, DOI 10.1073/pnas.1214939110; Zhao JF, 2011, J CLIN NEUROSCI, V19, P60	31	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66623	10.1371/journal.pone.0066623	http://dx.doi.org/10.1371/journal.pone.0066623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805250	Green Published, gold, Green Submitted			2022-12-25	WOS:000320846500078
J	Pileggi, C; Lotito, F; Bianco, A; Nobile, CGA; Pavia, M				Pileggi, Claudia; Lotito, Francesca; Bianco, Aida; Nobile, Carmelo G. A.; Pavia, Maria			Relationship between Chronic Short Sleep Duration and Childhood Body Mass Index: A School-Based Cross-Sectional Study	PLOS ONE			English	Article							RISK-FACTORS; OBESITY; CHILDREN; OVERWEIGHT; ADOLESCENTS; WEIGHT; ASSOCIATION; PREVALENCE; ACTIGRAPHY; TRENDS	Objective: To assess relationship between obesity and chronic shorter sleep duration in children and to determine if lack of sleep represents an independent determinant of childhood Body Mass Index. Methods: This cross-sectional study was conducted in all children enrolled in the fifth class (approximately 10 years of age) of all public primary schools in Catanzaro (Southern Italy). The overall response rate was 62% resulting in 542 participating children. Parents completed a questionnaire with information on their demographics and socio-economic characteristics, their health status, characteristics of their child birth and health status. The sleeping habits were investigated in the 3 months preceding the consultation and parents were asked to indicate hours of bedtime and wake-up of their children. Multivariate linear regression analysis was performed to examine the association between child BMI and chronic lack of sleep. Results: 36.7% of the children surveyed were overweight or obese. A quarter of children did not routinely play sports and many of them spent more than an hour a day watching TV (60.7%) and using videogames or computer (51.1%). Widespread dietary habits were inadequate, especially concerning vegetables and fruit intake with more than 95% of children who consumed insufficient amounts. The average duration of sleep was equal to 9.4 (SD = +/- 60.6) hours, and the short-sleepers accounted for 38.9% of the total sample. The results of multivariate analysis showed a significant 0.77 Kg/m(2) increase of BMI for children classified as short compared to normal sleepers (95% CI = 0.16-1.38, p = 0.01). Conclusions: Chronic lack of sleep appears to be associated to higher BMI even in middle childhood and strongly suggests that public health strategies, focused on promoting healthy lifestyles should include an innovative approach to ensure an adequate duration of sleep at night especially in children, alongside more traditional approaches.	[Pileggi, Claudia; Lotito, Francesca; Bianco, Aida; Nobile, Carmelo G. A.; Pavia, Maria] Univ Catanzaro Magna Graecia, Dept Hlth Sci, Catanzaro, Italy	Magna Graecia University of Catanzaro	Pavia, M (corresponding author), Univ Catanzaro Magna Graecia, Dept Hlth Sci, Catanzaro, Italy.	pavia@unicz.it	Bianco, Aida/R-6612-2016; PILEGGI, Claudia/AGU-6397-2022	PILEGGI, Claudia/0000-0002-6288-5540; BIANCO, Aida/0000-0003-4674-0306; PAVIA, Maria/0000-0003-3879-1322; NOBILE, Carmelo Giuseppe Angelo/0000-0002-0762-513X				Agras WS, 2004, J PEDIATR-US, V145, P20, DOI 10.1016/j.jpeds.2004.03.023; Bayer O, 2009, SLEEP, V32, P1183, DOI 10.1093/sleep/32.9.1183; Ben Slama Fethi, 2002, Tunis Med, V80, P542; Benedict C, 2012, J CLIN ENDOCR METAB, V97, pE443, DOI 10.1210/jc.2011-2759; Cacciari E, 2002, EUR J CLIN NUTR, V56, P171, DOI 10.1038/sj.ejcn.1601314; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Carter PJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2712; Chaput JP, 2006, INT J OBESITY, V30, P1080, DOI 10.1038/sj.ijo.0803291; CREA, 2018, LINEE GUIDA SANA ALI; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Giannotti F, 2005, SLEEP BIOL RHYTHMS, V3, P15, DOI [10.1111/j.1479-8425.2005.00155.x, DOI 10.1111/J.1479-8425.2005.00155.X]; Hense S, 2011, SLEEP, V34, P633, DOI 10.1093/sleep/34.5.633; Holley S, 2010, BEHAV SLEEP MED, V8, P16, DOI 10.1080/15402000903425462; Iglowstein I, 2003, PEDIATRICS, V111, P302, DOI 10.1542/peds.111.2.302; Istituto Superiore di Sanita. Cnesps, CNESPS PROM SAL CRES; Kleiser C, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-46; LOCARD E, 1992, INT J OBESITY, V16, P721; Martin LE, 2010, OBESITY, V18, P254, DOI 10.1038/oby.2009.220; National Sleep Foundation, 2005, AD SLEEP HAB STYL; Nixon GM, 2008, SLEEP, V31, P71, DOI 10.1093/sleep/31.1.71; Padez C, 2005, ACTA PAEDIATR, V94, P1550, DOI 10.1080/08035250510042924; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; Pileggi C, 2005, J PAEDIATR CHILD H, V41, P347, DOI 10.1111/j.1440-1754.2005.00629.x; Regione Calabria, STIL VIT SAL DCI GIO; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Sadeh A, 1996, SLEEP, V19, P757, DOI 10.1093/sleep/19.10.757; Seegers V, 2011, AM J EPIDEMIOL, V173, P621, DOI 10.1093/aje/kwq389; Seicean A, 2007, SLEEP BREATH, V11, P285, DOI 10.1007/s11325-007-0108-z; Sekine M, 2002, CHILD CARE HLTH DEV, V28, P163, DOI 10.1046/j.1365-2214.2002.00260.x; Snell EK, 2007, CHILD DEV, V78, P309, DOI 10.1111/j.1467-8624.2007.00999.x; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Touchette E, 2008, SLEEP, V31, P1507, DOI 10.1093/sleep/31.11.1507; von Kries R, 2002, INT J OBESITY, V26, P710, DOI 10.1038/sj.ijo.0801980; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; WHO Europe, IN YOUNG PEOPL HLTH; Yu YX, 2007, SLEEP, V30, P1688, DOI 10.1093/sleep/30.12.1688	37	14	16	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66680	10.1371/journal.pone.0066680	http://dx.doi.org/10.1371/journal.pone.0066680			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805261	gold, Green Published			2022-12-25	WOS:000320846500089
J	Su, CW; Chiou, YW; Tsai, YH; Teng, RD; Chau, GY; Lei, HJ; Hung, HH; Huo, TI; Wu, JC				Su, Chien-Wei; Chiou, Yu-Wei; Tsai, Yi-Hsuan; Teng, Ruei-Dun; Chau, Gar-Yang; Lei, Hao-Jan; Hung, Hung-Hsu; Huo, Teh-Ia; Wu, Jaw-Ching			The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy	PLOS ONE			English	Article							CORE PROMOTER MUTATIONS; PORTAL-HYPERTENSION; LIVER; RISK; ASSOCIATION; RESECTION; SURVIVAL; PROGNOSIS	Background: Whether or not hepatitis B virus (HBV) genotypes, mutations, and viral loads determine outcomes for patients with HBV-induced hepatocellular carcinoma (HCC) remains controversial. Aims: To study the influence of HBV viral factors on prognoses for patients with HBV-induced HCC after resection surgery and investigate if antiviral therapy could counteract the adverse effects of viral factors. Methods: A total of 333 HBV-related HCC patients who underwent tumor resection were enrolled retrospectively. Serum HBV DNA levels, mutations, anti-viral therapy, and other clinical variables were analyzed for their association with post-operative recurrence. Results: After a median follow-up of 45.9 months, 208 patients had HCC recurrence after resection. The 5-year overall survival and recurrence-free survival rates were 55.4% and 35.3%, respectively. Multivariate analysis showed indocyanine green retention rate at 15 minutes > 10%, gamma-glutamyltransferase (GGT) level >60 U/L, macroscopic and microscopic venous invasion, and the absence of anti-viral therapy were significant risk factors for recurrence. Anti-viral therapy could decrease recurrence in patients with early stage HCC, but the effect was less apparent in those with the Barcelona-Clinic Liver Cancer stage C HCC. For patients without antiviral therapy after resection, serum HBV DNA levels > 10(6) copies/mL, GGT >60 U/L, and macroscopic and microscopic venous invasion were significant risk factors predicting recurrence. Among the 216 patients without anti-viral therapy but with complete HBV surface gene mapping data, 73 were with pre-S deletion mutants. Among patients with higher serum HBV DNA levels, those with pre-S deletion had significantly higher rates of recurrence. Moreover, multivariate analysis showed multi-nodularity, macroscopic venous invasion, cirrhosis, advanced tumor cell differentiation, and pre-S deletion were significant risk factors predictive of recurrence. Conclusions: Ongoing HBV viral replication and pre-S deletion are crucial for determining post-operative tumor recurrence. Anti-viral therapy can help reduce recurrence and improve prognosis, especially for those with early stage HCC.	[Su, Chien-Wei; Huo, Teh-Ia] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Su, Chien-Wei; Chau, Gar-Yang; Lei, Hao-Jan; Hung, Hung-Hsu] Natl Yang Ming Univ, Canc Res Ctr, Fac Med, Taipei 112, Taiwan; [Su, Chien-Wei; Tsai, Yi-Hsuan; Teng, Ruei-Dun; Hung, Hung-Hsu; Wu, Jaw-Ching] Natl Yang Ming Univ, Canc Res Ctr, Inst Clin Med, Taipei 112, Taiwan; [Chiou, Yu-Wei; Wu, Jaw-Ching] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Chau, Gar-Yang; Lei, Hao-Jan] Taipei Vet Gen Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan; [Hung, Hung-Hsu] Cheng Hsin Gen Hosp, Div Gastroenterol, Dept Med, Taipei, Taiwan; [Huo, Teh-Ia] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Cheng Hsin General Hospital; National Yang Ming Chiao Tung University	Wu, JC (corresponding author), Natl Yang Ming Univ, Canc Res Ctr, Inst Clin Med, Taipei 112, Taiwan.	jcwu@vghtpe.gov.tw	Su, Chien-Wei/AHC-8307-2022; Su, Chien-Wei/C-1521-2012	Su, Chien-Wei/0000-0003-3889-7004; Su, Chien-Wei/0000-0003-3889-7004	National Science Council of Taiwan, Taipei, Taiwan [NSC 101-2314-B-075-013-MY2]; Taipei Veterans General Hospital, Taipei, Taiwan [V95C1-014, VGHUST100-G7-2-1]; Yang-Ming University (Ministry of Education, Aim for the Top University Plan), Taipei, Taiwan [101AC-T501]; Center of Excellence for Cancer Research at TVGH, Taipei, Taiwan [DOH101-TD-C-111-007]	National Science Council of Taiwan, Taipei, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital, Taipei, Taiwan(Taipei Veterans General Hospital); Yang-Ming University (Ministry of Education, Aim for the Top University Plan), Taipei, Taiwan; Center of Excellence for Cancer Research at TVGH, Taipei, Taiwan	This work was supported by grants from the National Science Council of Taiwan (NSC 101-2314-B-075-013-MY2), Taipei Veterans General Hospital (V95C1-014, VGHUST100-G7-2-1), Yang-Ming University (101AC-T501, Ministry of Education, Aim for the Top University Plan), and the Center of Excellence for Cancer Research at TVGH (DOH101-TD-C-111-007), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan ACY, 2011, ARCH SURG-CHICAGO, V146, P675, DOI 10.1001/archsurg.2011.125; Chan HLY, 2008, J CLIN ONCOL, V26, P177, DOI 10.1200/JCO.2007.13.2043; Chen CH, 2007, GASTROENTEROLOGY, V133, P1466, DOI 10.1053/j.gastro.2007.09.002; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; CHISARI FV, 1995, SPRINGER SEMIN IMMUN, V17, P261, DOI 10.1007/BF00196169; Choi GH, 2011, LIVER INT, V31, P485, DOI 10.1111/j.1478-3231.2010.02436.x; Colombo M, 2010, DIGEST LIVER DIS, V42, pS298, DOI 10.1016/S1590-8658(10)60520-8; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Fan ST, 2011, ANN SURG, V253, P745, DOI 10.1097/SLA.0b013e3182111195; Fuks D, 2012, HEPATOLOGY, V55, P132, DOI 10.1002/hep.24680; Huang YH, 2011, GASTROENTEROLOGY, V141, P1412, DOI 10.1053/j.gastro.2011.06.048; Hung HH, 2011, CLIN GASTROENTEROL H, V9, P79, DOI 10.1016/j.cgh.2010.08.018; Hung IFN, 2008, AM J GASTROENTEROL, V103, P1663, DOI 10.1111/j.1572-0241.2008.01872.x; Ishizawa T, 2008, GASTROENTEROLOGY, V134, P1908, DOI 10.1053/j.gastro.2008.02.091; Kao JH, 2003, GASTROENTEROLOGY, V124, P327, DOI 10.1053/gast.2003.50053; Kao JH, 2012, LIVER INT, V32, P1373, DOI 10.1111/j.1478-3231.2012.02826.x; Liaw YF, 2010, DIGEST LIVER DIS, V42, pS293, DOI 10.1016/S1590-8658(10)60519-1; Locarnini S, 2010, ANTIVIR THER, V15, P3, DOI 10.3851/IMP1619; Neuveut C, 2010, J HEPATOL, V52, P594, DOI 10.1016/j.jhep.2009.10.033; de Lope CR, 2012, J HEPATOL, V56, pS75, DOI 10.1016/S0168-8278(12)60009-9; Ryu HJ, 2011, J MED VIROL, V83, P2088, DOI 10.1002/jmv.22238; Su CW, 2012, ARCH SURG-CHICAGO, V147, P137, DOI 10.1001/archsurg.2011.288; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Tseng TC, 2012, GASTROENTEROLOGY, V142, P1140, DOI 10.1053/j.gastro.2012.02.007; Wang LHC, 2012, CARCINOGENESIS, V33, P466, DOI 10.1093/carcin/bgr296; Wong JSW, 2011, ALIMENT PHARM THER, V33, P1104, DOI 10.1111/j.1365-2036.2011.04634.x; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Wu JC, 2009, J HEPATOL, V51, P890, DOI 10.1016/j.jhep.2009.07.009; Yeh CT, 2010, HEPATOLOGY, V52, P1922, DOI 10.1002/hep.23898; Yeung P, 2011, J INFECT DIS, V203, P646, DOI 10.1093/infdis/jiq096	31	66	65	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66457	10.1371/journal.pone.0066457	http://dx.doi.org/10.1371/journal.pone.0066457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805222	Green Submitted, Green Published, gold			2022-12-25	WOS:000320846500050
J	Ceccato, L; Masiero, S; Roy, DS; Bencivenga, S; Roig-Villanova, I; Ditengou, FA; Palme, K; Simon, R; Colombo, L				Ceccato, Luca; Masiero, Simona; Roy, Dola Sinha; Bencivenga, Stefano; Roig-Villanova, Irma; Ditengou, Franck Anicet; Palme, Klaus; Simon, Ruediger; Colombo, Lucia			Maternal Control of PIN1 Is Required for Female Gametophyte Development in Arabidopsis	PLOS ONE			English	Article							DEPENDENT AUXIN GRADIENTS; OVULE DEVELOPMENT; WILD-TYPE; TRANSPORT; THALIANA; EFFLUX; GENE; PLANTS; TRANSFORMATION; BIOSYNTHESIS	Land plants are characterised by haplo-diploid life cycles, and developing ovules are the organs in which the haploid and diploid generations coexist. Recently it has been shown that hormones such as auxin and cytokinins play important roles in ovule development and patterning. The establishment and regulation of auxin levels in cells is predominantly determined by the activity of the auxin efflux carrier proteins PIN-FORMED (PIN). To study the roles of PIN1 and PIN3 during ovule development we have used mutant alleles of both genes and also perturbed PIN1 and PIN3 expression using micro-RNAs controlled by the ovule specific DEFH9 (DEFIFICENS Homologue 9) promoter. PIN1 down-regulation and pin1-5 mutation severely affect female gametophyte development since embryo sacs arrest at the mono- and/or bi-nuclear stages (FG1 and FG3 stage). PIN3 function is not required for ovule development in wild-type or PIN1-silenced plants. We show that sporophytically expressed PIN1 is required for megagametogenesis, suggesting that sporophytic auxin flux might control the early stages of female gametophyte development, although auxin response is not visible in developing embryo sacs.	[Ceccato, Luca; Masiero, Simona; Roy, Dola Sinha; Bencivenga, Stefano; Roig-Villanova, Irma; Colombo, Lucia] Univ Milan, Dipartimento BioSci, Milan, Italy; [Ditengou, Franck Anicet; Palme, Klaus; Colombo, Lucia] Univ Freiburg, Inst Biol 2, Fac Biol, Freiburg, Germany; [Simon, Ruediger; Colombo, Lucia] Univ Dusseldorf, Inst Entwicklungsgenet, D-40225 Dusseldorf, Germany; [Colombo, Lucia] CNR, Ist Biofis, I-20133 Milan, Italy	University of Milan; University of Freiburg; Heinrich Heine University Dusseldorf; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Colombo, L (corresponding author), Univ Milan, Dipartimento BioSci, Milan, Italy.	lucia.colombo@unimi.it	Ditengou, Franck Anicet/E-6626-2016; Palme, Klaus/A-9524-2013; Masiero, Simona/J-2898-2013; Roig Villanova, Irma/K-3865-2014; Simon, Rudiger/T-6755-2018	Ditengou, Franck Anicet/0000-0001-5355-0282; Palme, Klaus/0000-0002-2728-3835; masiero, simona/0000-0002-7563-7634; Roig Villanova, Irma/0000-0001-9124-0429; Simon, Rudiger/0000-0002-1317-7716; Colombo, Lucia/0000-0001-8415-1399; Bencivenga, Stefano/0000-0002-3862-5159	short term EMBO fellowship [ASTF 388.00-2008]; Universita degli Studi di Milano	short term EMBO fellowship; Universita degli Studi di Milano	The authors thank R. Gatta for their help and J. Friml, E. Benkova, M. Heisler and Y. Zhao for providing material. Luca Ceccato was supported by a short term EMBO fellowship (ASTF 388.00-2008). The authors thank A. Spena for DEH9 promoter sequence. L.C., D.S.-R., and B.C. were funded by a PhD fellowship from the Universita degli Studi di Milano. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2000, DEVELOPMENT, V127, P4227; Bencivenga S, 2012, PLANT CELL, V24, P2886, DOI 10.1105/tpc.112.100164; Bencivenga S, 2011, SEX PLANT REPROD, V24, P113, DOI 10.1007/s00497-011-0162-3; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Bennett MJ, 1996, SCIENCE, V273, P948, DOI 10.1126/science.273.5277.948; Brambilla V, 2007, PLANT CELL, V19, P2544, DOI 10.1105/tpc.107.051797; Braselton JP, 1996, BIOTECH HISTOCHEM, V71, P84, DOI 10.3109/10520299609117139; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; Christensen CA, 1997, SEX PLANT REPROD, V10, P49, DOI 10.1007/s004970050067; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dal Bosco C, 2012, PLANT J, V71, P860, DOI 10.1111/j.1365-313X.2012.05037.x; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kieffer M, 2010, CURR OPIN PLANT BIOL, V13, P12, DOI 10.1016/j.pbi.2009.10.006; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; Mirabella R, 2004, PLANT PHYSIOL, V135, P1879, DOI 10.1104/pp.103.038539; Note-Wilson S, 2010, DEV BIOL, V346, P181, DOI 10.1016/j.ydbio.2010.07.016; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Okada K, 1994, ARABIDOPSIS ATLAS MO, P180; Pagnussat GC, 2009, SCIENCE, V324, P1684, DOI 10.1126/science.1167324; Paponov IA, 2005, TRENDS PLANT SCI, V10, P170, DOI 10.1016/j.tplants.2005.02.009; Rotino GL, 1997, NAT BIOTECHNOL, V15, P1398, DOI 10.1038/nbt1297-1398; SCHNEITZ K, 1995, PLANT J, V7, P731, DOI 10.1046/j.1365-313X.1995.07050731.x; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Sohlberg JJ, 2006, PLANT J, V47, P112, DOI 10.1111/j.1365-313X.2006.02775.x; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vielle-Calzada JP, 2000, NATURE, V404, P91, DOI 10.1038/35003595; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; YADEGARI R, 1994, PLANT CELL, V6, P1713, DOI 10.1105/tpc.6.12.1713; Yadegari R, 2004, PLANT CELL, V16, pS133, DOI 10.1105/tpc.018192; Zadnikova P, 2010, DEVELOPMENT, V137, P607, DOI 10.1242/dev.041277; Zazimalova E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001552	35	85	88	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66148	10.1371/journal.pone.0066148	http://dx.doi.org/10.1371/journal.pone.0066148			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799075	gold, Green Published, Green Submitted			2022-12-25	WOS:000321397800024
J	Gomes, FM; Subramanian, SV; Escobar, AMDU; Valente, MH; Grisi, SJFE; Brentani, A; Fink, G				Gomes, Filumena Maria; Subramanian, S. V.; de Ulhoa Escobar, Ana Maria; Valente, Maria Helena; Ferraz Ellero Grisi, Sandra Josefina; Brentani, Alexandra; Fink, Guenther			No Association between Low Birth Weight and Cardiovascular Risk Factors in Early Adulthood: Evidence from Sao Paulo, Brazil	PLOS ONE			English	Article							FETAL ORIGINS; GROWTH; OBESITY; CHILDHOOD; INFANCY; COHORT; SIZE	Background: A growing literature suggests that low birth weight increases the risk of poor health outcomes in adulthood. We tested this hypothesis among young adults living in Sao Paulo State, Brazil. Methods and Findings: To identify the effects of low birth weight on young adulthood outcomes, a medical assessment of 297 individuals born between 1977 and 1989 was conducted at a primary care unit in Sao Paulo State, Brazil. We analyzed body mass index (BMI), waist-hip ratio, blood pressure, fasting glucose and total cholesterol levels using linear and logistic regressions. Low birth was negatively associated with BMI (beta = 22.0, 95% CI: 23.69, 20.27, p = 0.02), fasting glucose levels (beta = 21.9, 95% CI: 23.9, 20.07, p = 0.05), waist-hip ratio (beta = 20.03, 95% CI: 20.07, 20.01, p = 0.10), systolic blood pressure (beta = 23.32, 95% CI: 27.60, 0.96, p = 0.12), and total cholesterol levels (beta = 23.19, 95% CI: 216.43, 10.05, p = 0.636). Low birth weight was also associated with lower odds of young adults being overweight and obese, but neither association was statistically significant. Weight gain in the first 12 months of life was associated with higher adult BMI (beta = 0.79, 95% CI: 20.0455, 1.623, p = 0.064) and blood pressure (beta = 2.79, 95% CI: 0.22, 5.35, p = 0.034). No associations were found between low birth weight and early life (catch-up) growth. Conclusions: Low birth weight was not associated with poor health outcomes among young adults in Brazil. These results appear inconsistent with the original Barker hypothesis, but will need to be corroborated in larger samples with longer follow-ups to allow a more general evaluation of the validity of the hypothesis in low and middle income countries.	[Gomes, Filumena Maria; Valente, Maria Helena] Univ Sao Paulo, Fac Med, Ctr Saude Samuel Barnsley Pessoa, Sao Paulo, Brazil; [Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [de Ulhoa Escobar, Ana Maria; Ferraz Ellero Grisi, Sandra Josefina; Brentani, Alexandra] Univ Sao Paulo, Fac Med, Dept Pediat, Sao Paulo, Brazil; [Fink, Guenther] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Universidade de Sao Paulo; Harvard University; Harvard T.H. Chan School of Public Health; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Harvard University; Harvard T.H. Chan School of Public Health	Brentani, A (corresponding author), Univ Sao Paulo, Fac Med, Dept Pediat, Sao Paulo, Brazil.	abrentani@hu.usp.br	Grisi, Sandra/ABB-9976-2020; Gomes, Filumena/W-5178-2019; Brentani, Alexandra/G-4535-2013	Gomes, Filumena/0000-0002-0889-231X; Brentani, Alexandra/0000-0001-6650-9705; Grisi, Sandra Josefina Ferraz Ellero/0000-0003-1846-3591	Robert Wood Johnson Investigator Award in Health Policy Research	Robert Wood Johnson Investigator Award in Health Policy Research	The present study had no other funding besides the Medicine School's support. SVS is also supported by the Robert Wood Johnson Investigator Award in Health Policy Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Barker DJP, 1992, FETAL INFANT ORIGINS; Barker DJP, 1997, NUTR ABSTR REV, P13; Binelliy C, 2009, ED WAGES BRAZIL; Gigante DP, 2008, REV SAUDE PUBL, V42, P60, DOI 10.1590/S0034-89102008000900009; Johnson RC, 2011, BE J ECON ANAL POLI, P11; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Monteiro POA, 2003, INT J OBESITY, V27, P1274, DOI 10.1038/sj.ijo.0802409; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Stevens LM, 2002, JAMA-J AM MED ASSOC, P287; Unicef, 2012, UNIC COUNTR STAT; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora CG, 2006, INT J EPIDEMIOL, V35, P237, DOI 10.1093/ije/dyi290; Wells JCK, 2011, AM J EPIDEMIOL, V174, P1028, DOI 10.1093/aje/kwr232; Wells JCK, 2011, AM J HUM BIOL, V23, P65, DOI 10.1002/ajhb.21100; Xita N, 2010, ANN NY ACAD SCI, V1205, P148, DOI 10.1111/j.1749-6632.2010.05658.x; Yajnik CS, 2008, REV ENDOCR METAB DIS, V9, P203, DOI 10.1007/s11154-008-9087-z; Yu ZB, 2011, OBES REV, V12, P525, DOI 10.1111/j.1467-789X.2011.00867.x; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	21	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66554	10.1371/journal.pone.0066554	http://dx.doi.org/10.1371/journal.pone.0066554			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799115	gold, Green Published, Green Submitted			2022-12-25	WOS:000321397800036
J	Seto, SW; Au, ALS; Poon, CCW; Zhang, Q; Li, RWS; Yeung, JHK; Kong, SK; Ngai, SM; Wan, S; Ho, HP; Lee, SMY; Hoi, MPM; Chan, SW; Leung, GPH; Kwan, YW				Seto, Sai Wang; Au, Alice Lai Shan; Poon, Christina Chui Wa; Zhang, Qian; Li, Rachel Wai Sum; Yeung, John Hok Keung; Kong, Siu Kai; Ngai, Sai Ming; Wan, Song; Ho, Ho Pui; Lee, Simon Ming Yuen; Hoi, Maggie Pui Man; Chan, Shun Wan; Leung, George Pak Heng; Kwan, Yiu Wa			Acute Simvastatin Inhibits K-ATP Channels of Porcine Coronary Artery Myocytes	PLOS ONE			English	Article							ACTIVATED-PROTEIN-KINASE; SENSITIVE POTASSIUM CHANNELS; VASCULAR SMOOTH-MUSCLE; HMG-COA REDUCTASE; ENDOTHELIAL-CELLS; NITRIC-OXIDE; GLUCOSE-UPTAKE; INSULIN-SECRETION; PHOSPHATASE 2A; AMPK ACTIVITY	Background: Statins (3-hydroxy-3-methyl-glutaryl coenzyme A (HMG-CoA) reductase inhibitors) consumption provides beneficial effects on cardiovascular systems. However, effects of statins on vascular KATP channel gatings are unknown. Methods: Pig left anterior descending coronary artery and human left internal mammary artery were isolated and endothelium-denuded for tension measurements and Western immunoblots. Enzymatically-dissociated/cultured arterial myocytes were used for patch-clamp electrophysiological studies and for [Ca2+](i), [ATP](i) and [glucose](o) uptake measurements. Results: The cromakalim (10 nM to 10 mu M)- and pinacidil (10 nM to 10 mu M)-induced concentration-dependent relaxation of porcine coronary artery was inhibited by simvastatin (3 and 10 mu M). Simvastatin (1, 3 and 10 mu M) suppressed (in okadaic acid (10 nM)-sensitive manner) cromakalim (10 mM)-and pinacidil (10 mu M)-mediated opening of whole-cell K-ATP channels of arterial myocytes. Simvastatin (10 mu M) and AICAR (1 mM) elicited a time-dependent, compound C (1 mu M)-sensitive [H-3]-2-deoxy- glucose uptake and an increase in [ATP](i) levels. A time (2-30 min)- and concentration (0.1-10 mu M)-dependent increase by simvastatin of p-AMPK alpha-Thr(172) and p-PP2A-Tyr(307) expression was observed. The enhanced p-AMPK alpha-Thr(172) expression was inhibited by compound C, ryanodine (100 mu M) and KN93 (10 mu M). Simvastatin-induced p-PP2A-Tyr(307) expression was suppressed by okadaic acid, compound C, ryanodine, KN93, phloridzin (1 mM), ouabain (10 mu M), and in [glucose](o)-free or [Na+](o)-free conditions. Conclusions: Simvastatin causes ryanodine-sensitive Ca2+ release which is important for AMPK alpha-Thr(172) phosphorylation via Ca2+/CaMK II. AMPK alpha-Thr(172) phosphorylation causes [glucose](o) uptake (and an [ATP](i) increase), closure of K-ATP channels, and phosphorylation of AMPK alpha-Thr(172) and PP2A-Tyr(307) resulted. Phosphorylation of PP2A-Tyr(307) occurs at a site downstream of AMPK alpha-Thr(172) phosphorylation.	[Seto, Sai Wang] James Cook Univ, Vasc Biol Unit, Queensland Res Ctr Peripheral Vasc Dis, Sch Med & Dent, Townsville, Qld 4811, Australia; [Seto, Sai Wang; Au, Alice Lai Shan; Poon, Christina Chui Wa; Zhang, Qian; Yeung, John Hok Keung; Kwan, Yiu Wa] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Li, Rachel Wai Sum; Leung, George Pak Heng] Univ Hong Kong, Dept Pharmacol & Pharm, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Chan, Shun Wan] Hong Kong Polytech Univ, State Key Lab Chinese Med & Mol Pharmacol, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China; [Kong, Siu Kai; Ngai, Sai Ming] Chinese Univ Hong Kong, Sch Life Sci, Fac Sci, Shatin, Hong Kong, Peoples R China; [Wan, Song] Chinese Univ Hong Kong, Dept Surg, Fac Med, Shatin, Hong Kong, Peoples R China; [Ho, Ho Pui] Chinese Univ Hong Kong, Fac Engn, Dept Elect Engn, Shatin, Hong Kong, Peoples R China; [Lee, Simon Ming Yuen; Hoi, Maggie Pui Man] Univ Macau, Inst Chinese Med Sci, Macau, Peoples R China	James Cook University; Chinese University of Hong Kong; University of Hong Kong; Hong Kong Polytechnic University; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; University of Macau	Chan, SW (corresponding author), Hong Kong Polytech Univ, State Key Lab Chinese Med & Mol Pharmacol, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China.	sw.chan@polyu.edu.hk; gphleung@hkucc.hku.hk; yiuwakwan@cuhk.edu.hk	Hoi, Maggie Pui Man/AAY-5962-2021; Wan, Song/N-7352-2016; Chan, Shun-Wan/K-9363-2013; HO, Ho-Pui/AAT-9650-2021; Ngai, Sai Ming/S-4898-2018; Kwan, Yiu Wa/R-6468-2018; Wan, Song/AAV-6696-2020; Leung, George Pak Heng/B-4529-2009	Chan, Shun-Wan/0000-0001-8238-798X; Ngai, Sai Ming/0000-0002-4484-2483; Kwan, Yiu Wa/0000-0002-9024-1275; Wan, Song/0000-0002-9394-1672; Seto, Sai Wang/0000-0003-0236-4935; Leung, George Pak Heng/0000-0003-3529-9367; Poon, Chui Wa Christina/0000-0002-4569-876X; Hoi, Maggie Pui Man/0000-0003-2630-3707	University Grant Council (UGC) Earmarked Grants of Hong Kong [4107/01M, 4166/02M, 2140565]; Direct Grants for Research (The Chinese University of Hong Kong) [2401149, 2041231, 2401296]; Australia Government National Health and Medical Research Council (NHMRC) Fellowship [1016349]; National Heart Foundation (NHF) of Australia Fellowship [PF12B6825]	University Grant Council (UGC) Earmarked Grants of Hong Kong; Direct Grants for Research (The Chinese University of Hong Kong)(Chinese University of Hong Kong); Australia Government National Health and Medical Research Council (NHMRC) Fellowship; National Heart Foundation (NHF) of Australia Fellowship(National Heart Foundation of Australia)	This project is financially supported by University Grant Council (UGC) Earmarked Grants of Hong Kong (Ref. #: 4107/01M; 4166/02M, project code: 2140565) and Direct Grants for Research (The Chinese University of Hong Kong) (Reference no.: 2401149; Project code/ID: 2041231; 2401296). Dr SW Seto, Ms CCW Poon, Ms ALS Au and Ms Q Zhang are recipients of postgraduate studentship of the Department of Pharmacology/School of Biomedical Sciences (The Chinese University of Hong Kong, Hong Kong). Dr SW Seto is supported by the Australia Government National Health and Medical Research Council (NHMRC) Fellowship (1016349) and the National Heart Foundation (NHF) of Australia Fellowship (PF12B6825). Provision of the Student Campus Work Scheme by the Chou's Foundation Fund and the Student Campus Work Scheme (Shaw College, The Chinese University of Hong Kong) is appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au ALS, 2004, EUR J PHARMACOL, V502, P123, DOI 10.1016/j.ejphar.2004.08.045; Aziz Q, 2010, EUR J PHARMACOL, V634, P26, DOI 10.1016/j.ejphar.2010.02.023; Bao N, 2007, CIRC J, V71, P1622, DOI 10.1253/circj.71.1622; Bergdahl A, 2003, PHARMACOL TOXICOL, V93, P128, DOI 10.1034/j.1600-0773.2003.930304.x; Calderon-Sanchez E, 2009, CARDIOVASC RES, V82, P115, DOI 10.1093/cvr/cvp006; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Choi HC, 2008, J BIOL CHEM, V283, P20186, DOI 10.1074/jbc.M803020200; CLARKE PR, 1990, EMBO J, V9, P2439, DOI 10.1002/j.1460-2075.1990.tb07420.x; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; de Sotomayor MA, 2001, EUR J PHARMACOL, V415, P217, DOI 10.1016/S0014-2999(01)00819-6; Finder JD, 1997, J BIOL CHEM, V272, P13484, DOI 10.1074/jbc.272.21.13484; Fisslthaler B, 2007, CIRC RES, V100, pE12, DOI 10.1161/01.RES.0000257747.74358.1c; Ford RJ, 2011, AM J PHYSIOL-HEART C, V300, pH64, DOI 10.1152/ajpheart.00597.2010; Gimeno-Alcaniz JV, 2003, J MOL BIOL, V333, P201, DOI 10.1016/j.jmb.2003.08.022; Goirand F, 2007, J PHYSIOL-LONDON, V581, P1163, DOI 10.1113/jphysiol.2007.132589; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Grosser N, 2004, FREE RADICAL BIO MED, V37, P2064, DOI 10.1016/j.freeradbiomed.2004.09.009; Hamelin BA, 1998, TRENDS PHARMACOL SCI, V19, P26, DOI 10.1016/S0165-6147(97)01147-4; Han J, 2001, J BIOL CHEM, V276, P22140, DOI 10.1074/jbc.M010103200; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hayabuchi Y, 2001, J PHYSIOL-LONDON, V530, P193, DOI 10.1111/j.1469-7793.2001.0193l.x; HOPFER U, 1987, ANNU REV PHYSIOL, V49, P51, DOI 10.1146/annurev.ph.49.030187.000411; Isomoto S, 1996, J BIOL CHEM, V271, P24321, DOI 10.1074/jbc.271.40.24321; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V292, pE1308, DOI 10.1152/ajpendo.00456.2006; Jorgensen SB, 2008, FRONT BIOSCI-LANDMRK, V13, P5589; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Koh HJ, 2008, CURR OPIN CLIN NUTR, V11, P227, DOI 10.1097/MCO.0b013e3282fb7b76; Kou R, 2009, J BIOL CHEM, V284, P14734, DOI 10.1074/jbc.M808664200; Lange Y, 2002, BIOCHEM BIOPH RES CO, V290, P488, DOI 10.1006/bbrc.2001.6156; Lee TM, 2007, BASIC RES CARDIOL, V102, P171, DOI 10.1007/s00395-006-0628-x; Li HB, 2008, EUR J PHARMACOL, V588, P165, DOI 10.1016/j.ejphar.2008.04.036; Lin SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049605; Lorkowska B, 2005, PROSTAG LEUKOTR ESS, V72, P133, DOI 10.1016/j.plefa.2004.10.012; Majithiya JB, 2006, LIFE SCI, V78, P2615, DOI 10.1016/j.lfs.2005.10.020; McNeish AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046735; Nishizaki T, 1998, STROKE, V29, P844, DOI 10.1161/01.STR.29.4.844; Nissen SE, 2005, AM J CARDIOL, V96, p61F, DOI 10.1016/j.amjcard.2005.07.013; Pallottini V, 2007, MECH AGEING DEV, V128, P688, DOI 10.1016/j.mad.2007.10.001; Park JE, 2008, XENOBIOTICA, V38, P1240, DOI [10.1080/00498250802334391, 10.1080/00498250802334391 ]; Park S, 2013, CELL CALCIUM, V53, P217, DOI 10.1016/j.ceca.2012.12.001; Perez-Guerrero C, 2000, Z NATURFORSCH C, V55, P121; Robertson TP, 2008, EUR J PHARMACOL, V595, P39, DOI 10.1016/j.ejphar.2008.07.035; Rohra DK, 2005, EUR J PHARMACOL, V514, P175, DOI 10.1016/j.ejphar.2005.02.041; Rossoni LV, 2011, CLIN SCI, V121, P449, DOI 10.1042/CS20110259; Rubin LJ, 2005, J APPL PHYSIOL, V98, P296, DOI 10.1152/japplphysiol.00075.2004; Sadaba JR, 2000, EUR J CARDIO-THORAC, V17, P319, DOI 10.1016/S1010-7940(00)00325-0; Seto SW, 2007, BRIT J PHARMACOL, V151, P987, DOI 10.1038/sj.bjp.0707327; Seto SW, 2007, EUR J PHARMACOL, V572, P40, DOI 10.1016/j.ejphar.2007.05.070; Shi Y, 2007, AM J PHYSIOL-REG I, V293, pR1205, DOI 10.1152/ajpregu.00337.2007; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Sun W, 2006, CIRCULATION, V114, P2655, DOI 10.1161/CIRCULATIONAHA.106.630194; Terata Y, 2003, PHARMACOLOGY, V68, P169, DOI 10.1159/000070455; Tesfamariam B, 1999, J CARDIOVASC PHARM, V34, P95, DOI 10.1097/00005344-199907000-00016; Uhiara CO, 2012, EUR J PHARMACOL, V690, P158, DOI 10.1016/j.ejphar.2012.07.006; Urena J, 2007, CELL CALCIUM, V42, P513, DOI 10.1016/j.ceca.2007.04.010; Uydes-Dogan BS, 2005, LIFE SCI, V76, P1771, DOI 10.1016/j.lfs.2004.11.002; Wang CZ, 2005, BIOCHEM BIOPH RES CO, V330, P1073, DOI 10.1016/j.bbrc.2005.03.093; Witters LA, 2006, TRENDS BIOCHEM SCI, V31, P13, DOI 10.1016/j.tibs.2005.11.009; Wu HM, 2011, MOL PHARMACOL, V80, P859, DOI 10.1124/mol.111.072769; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Yang YJ, 2007, EUR J HEART FAIL, V9, P30, DOI 10.1016/j.ejheart.2006.04.013	61	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66404	10.1371/journal.pone.0066404	http://dx.doi.org/10.1371/journal.pone.0066404			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799098	Green Published, gold, Green Accepted			2022-12-25	WOS:000321397800030
J	Stojanovic, A; Chen, SH; Chen, XJ; Stojanovic, F; Zhang, J; Zhang, T; Utheim, TP				Stojanovic, Aleksandar; Chen, Shihao; Chen, Xiangjun; Stojanovic, Filip; Zhang, Jia; Zhang, Ting; Utheim, Tor Paaske			One-Step Transepithelial Topography-Guided Ablation in the Treatment of Myopic Astigmatism	PLOS ONE			English	Article							ASSISTED SUBEPITHELIAL KERATECTOMY; LASER EPITHELIAL KERATOMILEUSIS; OPTIMIZED SURFACE ABLATION; IN-SITU KERATOMILEUSIS; PHOTOREFRACTIVE KERATECTOMY; EXCIMER-LASER; KERATOCYTE APOPTOSIS; EPI-LASIK; REFRACTIVE SURGERY; CLINICAL-OUTCOMES	Purpose: To evaluate one-step topography-guided transepithelial ablation in the treatment of low to moderate myopic astigmatism using a 1KHz excimer laser. Methods: Retrospective study of 117 consecutive eyes available for evaluation 12 months after surgery. Pre- and postoperative visual and refractive data as well as post-operative pain and haze were analyzed. A novel technique integrating custom refractive-and epithelial-ablation in a single uninterrupted procedure was used. Results: The mean pre-operative spherical equivalent (SE) and the mean cylinder were: -3.22 diopters (D) +/- 1.54 (SD) (range -0.63 to -7.25 D) and -0.77 D +/- 0.65 (range 0 to -4.50 D), respectively. At 12 months after surgery: no eyes lost >= 2 lines of corrected distant visual acuity (CDVA). Safety and efficacy indexes were 1.27 and 1.09, respectively. Uncorrected distant visual acuity (UDVA) was >= 20/20 in 96.6% of the eyes. Manifest refraction spherical equivalent was within +/- 0.5 D of the desired refraction in 93.2% of the eyes. Average root mean square (RMS) wavefront error measured at central 6 mm, increased from 0.38 pre-operatively to 0.47 mu m post-operatively. Refractive stability was achieved and sustained 1 month after surgery. No visually significant haze was registered during the observation period. Post-operative pain was reported in 4.5% of patients. Conclusions: One-step transepithelial topography-guided treatment for low to moderate myopia and astigmatism performed with a 1 KHz laser, provided safe, effective, predictable and stable results with low pain and no visually significant haze.	[Stojanovic, Aleksandar; Chen, Xiangjun; Utheim, Tor Paaske] SynsLaser Kirurgi, Oslo, Norway; [Stojanovic, Aleksandar; Chen, Xiangjun; Utheim, Tor Paaske] SynsLaser Kirurgi, Tromso, Norway; [Stojanovic, Aleksandar] Univ Hosp North Norway, Eye Dept, Tromso, Norway; [Chen, Shihao; Zhang, Jia; Zhang, Ting] Wenzhou Med Coll, Sch Optometry & Ophthalmol, Wenzhou, Zhejiang, Peoples R China; [Chen, Shihao; Zhang, Jia; Zhang, Ting] Wenzhou Med Coll, Hosp Eye, Wenzhou, Zhejiang, Peoples R China; [Chen, Shihao; Zhang, Jia] Minist Hlth PR China, Key Lab Vis Sci, Wenzhou, Zhejiang, Peoples R China; [Stojanovic, Filip] Univ Tromso, Fac Med, Tromso, Norway; [Utheim, Tor Paaske] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; Wenzhou Medical University; Wenzhou Medical University; UiT The Arctic University of Tromso; University of Oslo	Stojanovic, A (corresponding author), SynsLaser Kirurgi, Oslo, Norway.	aleks@online.no	Stojanovic, Aleksandar/AAG-9933-2019	Chen, Xiangjun/0000-0003-0331-9028	SynsLaser Kirurgi AS, Tromso, Norway; Norges forskningsrad, Oslo, Norway	SynsLaser Kirurgi AS, Tromso, Norway; Norges forskningsrad, Oslo, Norway	This work was supported by SynsLaser Kirurgi AS, Tromso, Norway and Norges forskningsrad, Oslo, Norway. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessio G, 2001, OPHTHALMOLOGY, V108, P1695, DOI 10.1016/S0161-6420(01)00706-0; Ambrosio Renato Jr, 2003, Semin Ophthalmol, V18, P2, DOI 10.1080/08820530390897738; Argento C, 2006, J REFRACT SURG, V22, P782, DOI 10.3928/1081-597X-20061001-08; Autrata R, 2003, J CATARACT REFR SURG, V29, P661, DOI 10.1016/S0886-3350(02)01897-7; Bilgihan K, 2002, EYE, V16, P63, DOI 10.1038/sj.eye.6700065; Buzzonetti L, 2009, J REFRACT SURG, V25, P709, DOI [10.3928/1081597X-20090115-08, 10.3928/1081597X-20090707-05]; Caffi M, 1966, Ann Ottalmol Clin Ocul, V92, P429; Carr J D, 1995, J Refract Surg, V11, pS309; Chen X, 2010, 28 C EUR SOC CAT REF; Chen XJ, 2012, J REFRACT SURG, V28, P120, DOI 10.3928/1081597X-20110926-01; Chen XJ, 2010, J REFRACT SURG, V26, P529, DOI 10.3928/1081597X-20100226-01; Clinch TE, 1999, OPHTHALMOLOGY, V106, P483, DOI 10.1016/S0161-6420(99)90135-5; Cummings AB, 2010, J REFRACT SURG, V26, P478, DOI 10.3928/1081597X-20090814-05; Cusumano A, 1998, OPHTHALMOLOGY, V105, P300, DOI 10.1016/S0161-6420(98)93211-0; de Benito-Llopis L, 2007, J REFRACT SURG, V23, P139; El Awady HE, 2011, OPHTHAL SURG LAS IM, V42, P314, DOI 10.3928/15428877-20110421-01; Fadlallah A, 2011, J CATARACT REFR SURG, V37, P1852, DOI 10.1016/j.jcrs.2011.04.029; Faktorovich EG, 2010, J REFRACT SURG, V26, P934, DOI 10.3928/1081597X-20100212-06; Falavarjani KG, 2011, J REFRACT SURG, V27, P13, DOI 10.3928/1081597X-20100310-02; Gambato C, 2011, J REFRACT SURG, V27, P792, DOI 10.3928/1081597X-20110407-01; Ghadhfan F, 2007, J CATARACT REFR SURG, V33, P2041, DOI 10.1016/j.jcrs.2007.07.026; GIMBEL HV, 1995, J REFRACT SURG, V11, P36; Helena MC, 1998, INVEST OPHTH VIS SCI, V39, P276; Kanitkar KD, 2000, J REFRACT SURG, V16, P519; Kapadia MS, 1999, OPHTHALMOLOGY, V106, P29, DOI 10.1016/S0161-6420(99)90002-7; Kapadia MS, 1998, AM J OPHTHALMOL, V126, P827, DOI 10.1016/S0002-9394(98)00222-0; Kermani O, 2006, J REFRACT SURG, V22, P754, DOI 10.3928/1081-597X-20061001-05; Khoramnia R, 2011, ACTA OPHTHALMOL; Kim WJ, 1998, J REFRACT SURG, V14, P526; Koller T, 2009, J CATARACT REFR SURG, V35, P1358, DOI 10.1016/j.jcrs.2009.03.035; Kolozsvari L, 2002, INVEST OPHTH VIS SCI, V43, P2165; Krueger RR, 2008, J REFRACT SURG, V24, pS713, DOI 10.3928/1081597X-20080901-13; La Tegola MG, 2007, J REFRACT SURG, V23, P681; Leccisotti A, 2003, EUR J OPHTHALMOL, V13, P676, DOI 10.1177/112067210301300802; Lee HK, 2005, AM J OPHTHALMOL, V139, P56, DOI 10.1016/j.ajo.2004.08.049; Lee JB, 2001, J CATARACT REFR SURG, V27, P565, DOI 10.1016/S0886-3350(00)00880-4; Manche Edward E, 2011, Trans Am Ophthalmol Soc, V109, P201; Mifflin MD, 2012, J REFRACT SURG, V28, P127, DOI 10.3928/1081597X-20120103-01; O'Doherty M, 2007, J REFRACT SURG, V23, P133; Pedrotti E, 2006, J CATARACT REFR SURG, V32, P1288, DOI 10.1016/j.jcrs.2006.03.032; Phillips AF, 1997, AM J OPHTHALMOL, V123, P42, DOI 10.1016/S0002-9394(14)70990-0; Pop M, 2005, J REFRACT SURG, V21, pS636; Porter J, 2006, J CATARACT REFR SURG, V32, P21, DOI 10.1016/j.jcrs.2005.10.027; Reinstein DZ, 2008, J REFRACT SURG, V24, P571, DOI 10.3928/1081597X-20080601-05; Seiler T, 2000, GRAEF ARCH CLIN EXP, V238, P822, DOI 10.1007/s004179900111; Seiler T, 1990, Refract Corneal Surg, V6, P99; Shortt AJ, 2006, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD005135.PUB2; Sia RK, 2012, J REFRACT SURG, V28, P65, DOI 10.3928/1081597X-20111004-01; Stojanovic A, 2003, J REFRACT SURG, V19, P338; Stojanovic A, 2001, J CATARACT REFR SURG, V27, P404, DOI 10.1016/S0886-3350(00)00742-2; Stulting RD, 2011, CORNEA, V30, P945, DOI 10.1097/ICO.0b013e31820a0e53; Torres LF, 2007, J REFRACT SURG, V23, P126; Vinciguerra P, 1998, J REFRACT SURG, V14, pS204; Vinciguerra P, 2007, J REFRACT SURG, V23, pS1029, DOI 10.3928/1081-597X-20071102-09; von Mohrenfels CW, 2010, J CATARACT REFR SURG, V36, P449, DOI 10.1016/j.jcrs.2009.10.041; Waring George, 2007, Trans Am Ophthalmol Soc, V105, P240	56	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66618	10.1371/journal.pone.0066618	http://dx.doi.org/10.1371/journal.pone.0066618			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799124	Green Published, gold			2022-12-25	WOS:000321397800044
J	Catchpole, I; Germaschewski, V; Kam, JH; von Leithner, PL; Ford, S; Gough, G; Adamson, P; Overend, P; Hilpert, J; Lopez, FJ; Ng, YSE; Coffey, P; Jeffery, G				Catchpole, Ian; Germaschewski, Volker; Kam, Jaimie Hoh; von Leithner, Peter Lundh; Ford, Susannah; Gough, Gerald; Adamson, Peter; Overend, Philip; Hilpert, Jan; Lopez, Francisco J.; Ng, Yin Shan Eric; Coffey, Pete; Jeffery, Glen			Systemic Administration of Abeta mAb Reduces Retinal Deposition of Abeta and Activated Complement C3 in Age-Related Macular Degeneration Mouse Model	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; FACTOR-H; BETA; DRUSEN; POLYMORPHISM; PATHOGENESIS; ASSOCIATION; PATHOLOGY; BRAIN	Age-related macular degeneration (AMD) is a leading cause of legal blindness in the Western world. There are effective treatments for the vascular complications of neo-vascular AMD, but no effective therapies are available for the dry/atrophic form of the disease. A previously described transgenic CFH-gene deficient mouse model, (cfh-/-), shows hallmarks of early AMD. The ocular phenotype has been further analysed to demonstrate amyloid beta (A beta) rich basement membrane deposits associated with activated complement C3. Cfh-/- mice were treated systemically in both prophylactic and therapeutic regimes with an anti-A beta monoclonal antibody (mAb), 6F6, to determine the effect on the cfh-/- retinal phenotype. Prophylactic treatment with 6F6 demonstrated a dose dependent reduction in the accumulation of both A beta and activated C3 deposition. A similar reduction in the retinal endpoints could be seen after therapeutic treatment. Serum A beta levels after systemic administration of 6F6 show accumulation of Ab in the periphery suggestive of a peripheral sink mechanism. In summary, anti-A beta mAb treatment can partially prevent or reverse ocular phenotypes of the cfh-/- mouse. The data support this therapeutic approach in humans potentially modulating two key elements in the pathogenesis of AMD - A beta and activated, complement C3.	[Catchpole, Ian; Germaschewski, Volker; Ford, Susannah; Gough, Gerald] Top BioPharm Discovery Res & Dev Unit, King Of Prussia, PA USA; [Kam, Jaimie Hoh; von Leithner, Peter Lundh; Ng, Yin Shan Eric; Coffey, Pete; Jeffery, Glen] UCL, Inst Ophthalmol, London, England; [Catchpole, Ian; Adamson, Peter; Lopez, Francisco J.] GSK Ophthalmol, King Of Prussia, PA USA; [Overend, Philip; Hilpert, Jan] GlaxoSmithKline, BioPharm Discovery Med, Stevenage, Herts, England	University of London; University College London; GlaxoSmithKline; GlaxoSmithKline	Catchpole, I (corresponding author), Top BioPharm Discovery Res & Dev Unit, King Of Prussia, PA USA.	ian.r.catchpole@gsk.com	Ng, Wing Yin/HHN-1743-2022	Ng, Yin Shan/0000-0002-4982-1999; Coffey, Peter/0000-0002-5427-2939	GSK	GSK(GlaxoSmithKline)	JHK, PLvL, PC & GJ received funding from GSK for this work which was performed collaboratively by Institute of Ophthalmology and GSK researchers. The funders were actively involved in study design, some aspects of experimental end point analysis and in rigorous statistical analysis of the data and jointly decided to publish and prepare the manuscript with their academic colleagues.; IC, VG, SF, GG, PA, PO, JH are or were during some stage of this work employed by GSK who funded this study. GSK owns intellectual property on anti-amyloid beta monoclonal antibodies. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Anderson DH, 2004, EXP EYE RES, V78, P243, DOI 10.1016/j.exer.2003.10.011; Baker ML, 2009, ARCH OPHTHALMOL-CHIC, V127, P667, DOI 10.1001/archophthalmol.2009.30; Baumritter A, 2007, ARVO M AG EYE MAY 6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bowes Rickman C, 2007, 11 ANN VIS RES C RET; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Dentchev T, 2003, MOL VIS, V9, P184; Ding JD, 2008, VISION RES, V48, P339, DOI 10.1016/j.visres.2007.07.025; Ding JD, 2011, P NATL ACAD SCI USA, V108, pE279, DOI 10.1073/pnas.1100901108; Dutescu RM, 2009, GRAEF ARCH CLIN EXP, V247, P1213, DOI 10.1007/s00417-009-1060-3; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hamilton G, 2007, NEUROMOL MED, V9, P331, DOI 10.1007/s12017-007-8013-y; He XY, 2007, J NEUROSCI, V27, P4052, DOI 10.1523/JNEUROSCI.3993-06.2007; Hoh Kam J, 2012, PATHOGENS TRIG UNPUB; Howlett DR, 2011, EXP BRAIN RES, V214, P185, DOI 10.1007/s00221-011-2819-4; Isas JM, 2010, INVEST OPHTH VIS SCI, V51, P1304, DOI 10.1167/iovs.09-4207; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Johnson LV, 2002, P NATL ACAD SCI USA, V99, P11830, DOI 10.1073/pnas.192203399; Kam JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013127; KEARNEY JF, 1979, J IMMUNOL, V123, P1548; Klaver CCW, 1999, AM J EPIDEMIOL, V150, P963; Kliffen M, 2000, BRIT J OPHTHALMOL, V84, P1415, DOI 10.1136/bjo.84.12.1415; Koronyo-Hamaoui M, 2011, NEUROIMAGE, V54, pS204, DOI 10.1016/j.neuroimage.2010.06.020; Le Fur I, 2010, NEUROBIOL AGING, V31, P165, DOI 10.1016/j.neurobiolaging.2008.03.003; Ling CY, 2008, International Patent Application, Patent No. [WO 2008/110885, 2008110885]; Liu BQ, 2009, AM J PATHOL, V175, P2099, DOI 10.2353/ajpath.2009.090159; Liu TR, 2013, INVEST OPHTHMOL VIS, V54, P2225; LOFFLER KU, 1995, INVEST OPHTH VIS SCI, V36, P24; Luibl V, 2006, J CLIN INVEST, V116, P378, DOI 10.1172/JCI25843; Malek G, 2005, P NATL ACAD SCI USA, V102, P11900, DOI 10.1073/pnas.0503015102; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Ning A, 2008, INVEST OPHTH VIS SCI, V49, P5136, DOI 10.1167/iovs.08-1849; Ohno-Matsui K, 2011, PROG RETIN EYE RES, V30, P217, DOI 10.1016/j.preteyeres.2011.02.004; Perez SE, 2009, INVEST OPHTH VIS SCI, V50, P793, DOI 10.1167/iovs.08-2384; Petrukhin K, 2007, EXPERT OPIN THER TAR, V11, P625, DOI 10.1517/14728222.11.5.625; Puzzo D, 2013, J ALZHEIMERS DIS, V33, pS111, DOI 10.3233/JAD-2012-129033; Puzzo D, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.020; Rodrigues EB, 2007, OPHTHALMOLOGICA, V221, P143, DOI 10.1159/000099293; Rosenthal A, 2004, International Patent Application, Patent No. [WO 2004/032868, 2004032868]; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Terai K, 2001, NEUROSCIENCE, V104, P299, DOI 10.1016/S0306-4522(01)00095-1; von Leithner PL, 2009, AM J PATHOL, V175, P412, DOI 10.2353/ajpath.2009.080927; Wang J, 2008, J IMMUNOL, V181, P16651; Wang JY, 2009, J CELL PHYSIOL, V220, P119, DOI 10.1002/jcp.21742; Yang SP, 2004, NEUROBIOL AGING, V25, P283, DOI 10.1016/S0197-4580(03)00111-8; Yoshida T, 2005, J CLIN INVEST, V115, P2793, DOI 10.1172/JCI24635; Zetterberg M, 2008, AM J MED GENET B, V147B, P720, DOI 10.1002/ajmg.b.30668; Zlokovic BV, 2004, J NEUROCHEM, V89, P807, DOI 10.1111/j.1471-4159.2004.02385.x	49	27	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65518	10.1371/journal.pone.0065518	http://dx.doi.org/10.1371/journal.pone.0065518			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799019	gold, Green Published, Green Submitted			2022-12-25	WOS:000320363300020
J	Hernaus, D; Collip, D; Lataster, J; Ceccarini, J; Kenis, G; Booij, L; Pruessner, J; Van Laere, K; van Winkel, R; van Os, J; Myin-Germeys, I				Hernaus, Dennis; Collip, Dina; Lataster, Johan; Ceccarini, Jenny; Kenis, Gunther; Booij, Linda; Pruessner, Jens; Van Laere, Koen; van Winkel, Ruud; van Os, Jim; Myin-Germeys, Inez			COMT Val(158)Met Genotype Selectively Alters Prefrontal [F-18]Fallypride Displacement and Subjective Feelings of Stress in Response to a Psychosocial Stress Challenge	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; POSITRON-EMISSION-TOMOGRAPHY; DOPAMINE RELEASE; F-18 FALLYPRIDE; WORKING-MEMORY; PET; SCHIZOPHRENIA; BINDING; RECEPTOR; SENSITIVITY	Catechol-O-methyltransferase (COMT) plays an essential role in degradation of extracellular dopamine in prefrontal regions of the brain. Although a polymorphism in this gene, COMT Val(158)Met, affects human behavior in response to stress little is known about its effect on dopaminergic activity associated with the human stress response, which may be of interest for stress-related psychiatric disorders such as psychosis. We aimed to investigate the effect of variations in COMT genotype on in vivo measures of stress-induced prefrontal cortex (PFC) dopaminergic processing and subjective stress responses. A combined sample of healthy controls and healthy first-degree relatives of psychosis patients (n = 26) were subjected to an [F-18] fallypride Positron Emission Tomography scan. Psychosocial stress during the scan was induced using the Montreal Imaging Stress Task and subjective stress was assessed every 12 minutes. Parametric t-maps, generated using the linear extension of the simplified reference region model, revealed an effect of COMT genotype on the spatial extent of [F-18] fallypride displacement. Detected effects of exposure to psychosocial stress were unilateral and remained restricted to the left superior and right inferior frontal gyrus, with Met-hetero- and homozygotes showing less [F-18] fallypride displacement than Val-homozygotes. Additionally, Met-hetero- and homozygotes experienced larger subjective stress responses than Val-homozygotes. The direction of the effects remained the same when the data was analyzed separately for controls and first-degree relatives. The human stress response may be mediated in part by COMT-dependent dopaminergic PFC activity, providing speculation for the neurobiology underlying COMT-dependent differences in human behaviour following stress. Implications of these results for stress-related psychopathology and models of dopaminergic functioning are discussed.	[Hernaus, Dennis; Collip, Dina; Lataster, Johan; Kenis, Gunther; van Winkel, Ruud; van Os, Jim; Myin-Germeys, Inez] MHeNS Maastricht Univ, Dept Psychiat & Neuropsychol, South Limburg Mental Hlth Res & Teaching Network, EURON,Sch Mental Hlth & NeuroSci, Maastricht, Netherlands; [Lataster, Johan] Open Univ Netherlands, Fac Psychol, Heerlen, Netherlands; [Ceccarini, Jenny; Van Laere, Koen] Univ Hosp, Div Nucl Med, Louvain, Belgium; [Ceccarini, Jenny; Van Laere, Koen] Catholic Univ Louvain, B-3000 Louvain, Belgium; [Booij, Linda] Hop St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Booij, Linda] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada; [Booij, Linda] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Pruessner, Jens] McGill Univ, Dept Psychiat, Douglas Mental Hlth Inst, Montreal, PQ, Canada; [van Winkel, Ruud] Catholic Univ Louvain, Univ Psychiat Ctr, Kortenberg, Belgium; [van Os, Jim] Kings Coll London, Kings Hlth Partners, Dept Psychosis Studies, Inst Psychiat, London WC2R 2LS, England	Maastricht University; Open University Netherlands; Universite Catholique Louvain; Universite de Montreal; Universite de Montreal; McGill University; McGill University; Universite Catholique Louvain; University of London; King's College London	Myin-Germeys, I (corresponding author), MHeNS Maastricht Univ, Dept Psychiat & Neuropsychol, South Limburg Mental Hlth Res & Teaching Network, EURON,Sch Mental Hlth & NeuroSci, Maastricht, Netherlands.	i.germeys@maastrichtuniversity.nl	Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/C-2113-2014; Myin-Germeys, Inez/L-5106-2014; Ceccarini, Jenny/AAY-9271-2020; van Os, Jim/V-8884-2019; Lataster, Johan/S-9462-2017; Ceccarini, Jenny/AAE-5084-2019	Ceccarini, Jenny/0000-0003-2774-9516; van Os, Jim/0000-0002-7245-1586; Lataster, Johan/0000-0003-3889-8154; Pruessner, Jens/0000-0002-8582-2980; Hernaus, Dennis/0000-0002-8370-5756; Myin-Germeys, Inez/0000-0002-3731-4930	Dutch Medical Research Council; Fonds de recherche du Quebec-Sante; King Baudouin Foundation; Maastricht University	Dutch Medical Research Council(Danish Medical Research Council); Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); King Baudouin Foundation; Maastricht University	Inez Myin-Germeys was supported by a 2006 NARSAD Young Investigator Award and by a VIDI grant from the Dutch Medical Research Council, which were used to cover all costs (materials, personnel) related to the experiment. Koen Van Laere is Senior Clinical Investigator for the Flemish Fund for Scientific Research (FWO). Linda Booij is supported by a career award from the Fonds de recherche du Quebec-Sante. Ruud van Winkel is supported by the King Baudouin Foundation (Fund Dr. Gustave Delport). Dina Collip is supported by a Maastricht University post-doc Kootstra fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 1998, AM J PSYCHIAT, V155, P761; Alpert NM, 2003, NEUROIMAGE, V19, P1049, DOI 10.1016/S1053-8119(03)00186-1; Arnsten AFT, 1998, ARCH GEN PSYCHIAT, V55, P362, DOI 10.1001/archpsyc.55.4.362; Backman L, 2000, AM J PSYCHIAT, V157, P635; Backman L, 2011, SCIENCE, V333, P718, DOI 10.1126/science.1204978; Badgaiyan RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028075; Buckert M, 2012, PSYCHONEUROENDOCRINO; Castner SA, 2004, J NEUROSCI, V24, P1446, DOI 10.1523/JNEUROSCI.3987-03.2004; Ceccarini J, 2012, J NUCL MED, V53, P1565, DOI 10.2967/jnumed.111.099416; Christian BT, 2006, NEUROIMAGE, V31, P139, DOI 10.1016/j.neuroimage.2005.11.052; Collip D, 2011, CNS NEUROSCI THER, V17, P612, DOI 10.1111/j.1755-5949.2010.00213.x; Cropley VL, 2008, SYNAPSE, V62, P399, DOI 10.1002/syn.20506; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; DEUTCH AY, 1990, BRAIN RES, V521, P311, DOI 10.1016/0006-8993(90)91557-W; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Hirvonen MM, 2010, MOL IMAGING BIOL, V12, P192, DOI 10.1007/s11307-009-0257-5; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Jabbi M, 2007, MOL PSYCHIATR, V12, P483, DOI 10.1038/sj.mp.4001975; Karlsson S, 2009, NEUROIMAGE, V48, P398, DOI 10.1016/j.neuroimage.2009.06.030; Lammertsma AA, 1996, J CEREBR BLOOD F MET, V16, P42, DOI 10.1097/00004647-199601000-00005; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Lataster J, 2013, SCHIZOPHRENIA B; Lataster J, 2011, NEUROIMAGE, V58, P1081, DOI 10.1016/j.neuroimage.2011.07.030; Lataster T, 2009, ACTA PSYCHIAT SCAND, V119, P45, DOI 10.1111/j.1600-0447.2008.01263.x; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; Meyer-Lindenberg A, 2006, MOL PSYCHIATR, V11, P867, DOI 10.1038/sj.mp.4001860; Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36; Mizrahi R, 2012, BIOL PSYCHIAT, V71, P561, DOI 10.1016/j.biopsych.2011.10.009; Mukherjee J, 2002, SYNAPSE, V46, P170, DOI 10.1002/syn.10128; Myin-Germeys I, 2005, PSYCHOL MED, V35, P733, DOI 10.1017/S0033291704004179; Papaleo F, 2008, J NEUROSCI, V28, P8709, DOI 10.1523/JNEUROSCI.2077-08.2008; Peerbooms O, 2012, ACTA PSYCHIAT SCAND, V125, P247, DOI 10.1111/j.1600-0447.2011.01806.x; Pruessner JC, 2004, J NEUROSCI, V24, P2825, DOI 10.1523/JNEUROSCI.3422-03.2004; Riccardi P, 2006, NEUROPSYCHOPHARMACOL, V31, P1016, DOI 10.1038/sj.npp.1300916; Scornaiencki R, 2009, INT J NEUROPSYCHOPH, V12, P1195, DOI 10.1017/S1461145709000121; SERVANSCHREIBER D, 1990, SCIENCE, V249, P892, DOI 10.1126/science.2392679; Slifstein M, 2008, MOL PSYCHIATR, V13, P821, DOI 10.1038/mp.2008.19; Slifstein M, 2010, SYNAPSE, V64, P350, DOI 10.1002/syn.20734; Smolka MN, 2005, J NEUROSCI, V25, P836, DOI 10.1523/JNEUROSCI.1792-04.2005; StataCorp, 2009, STATA SE STAT SOFTW; Stein DJ, 2006, CNS SPECTRUMS, V11, P745, DOI 10.1017/S1092852900014863; Stokes PRA, 2010, NEUROIMAGE, V52, P1521, DOI 10.1016/j.neuroimage.2010.04.274; Tunbridge E, 2004, SYNAPSE, V51, P112, DOI 10.1002/syn.10286; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; Ursini G, 2011, J NEUROSCI, V31, P6692, DOI 10.1523/JNEUROSCI.6631-10.2011; van Winkel R, 2008, SCHIZOPHRENIA BULL, V34, P1095, DOI 10.1093/schbul/sbn101; van Winkel R, 2008, AM J MED GENET B, V147B, P10, DOI 10.1002/ajmg.b.30559; Vernaleken I, 2011, J CEREBR BLOOD F MET, V31, P1958, DOI 10.1038/jcbfm.2011.73; Volkow ND, 1998, AM J PSYCHIAT, V155, P344; Vrieze E, 2011, HUMAN BRAIN MAPPING; Walder DJ, 2010, PSYCHIAT GENET, V20, P166, DOI 10.1097/YPG.0b013e32833a1ff3; Woodward ND, 2011, AM J PSYCHIAT, V168, P418, DOI 10.1176/appi.ajp.2010.10020165; Yacubian J, 2007, P NATL ACAD SCI USA, V104, P8125, DOI 10.1073/pnas.0702029104; Yoder KK, 2004, J NUCL MED, V45, P903	57	31	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65662	10.1371/journal.pone.0065662	http://dx.doi.org/10.1371/journal.pone.0065662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799032	Green Published, gold, Green Submitted			2022-12-25	WOS:000320363300032
J	Mizuki, T; Sawai, M; Nagaoka, Y; Morimoto, H; Maekawa, T				Mizuki, Toru; Sawai, Miyuki; Nagaoka, Yutaka; Morimoto, Hisao; Maekawa, Toru			Activity of Lipase and Chitinase Immobilized on Superparamagnetic Particles in a Rotational Magnetic Field	PLOS ONE			English	Article							ENZYME-ACTIVITY; NANOPARTICLES; STABILITY	We immobilize hydrolases such as lipase and chitinase on superparamagnetic particles, which are subjected to a rotational magnetic field, and measure the activities of the enzymes. We find that the activities of lipase and chitinase increase in the rotational magnetic field compared to those in the absence of a magnetic field and reach maximum at certain frequencies. The present methodology may well be utilized for the design and development of efficient micro reactors and micro total analysis systems (mu-TASs).	[Mizuki, Toru; Sawai, Miyuki; Nagaoka, Yutaka; Morimoto, Hisao; Maekawa, Toru] Toyo Univ, Bio Nano Elect Res Ctr, Saitama, Japan	Toyo University	Maekawa, T (corresponding author), Toyo Univ, Bio Nano Elect Res Ctr, Saitama, Japan.	maekawa@toyo.jp		Mizuki, Toru/0000-0003-2744-881X	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [S1101017]	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grant for the Program for the Strategic Research Foundation at Private Universities S1101017 organized by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy S, 1998, J BIOTECHNOL, V60, P37, DOI 10.1016/S0168-1656(97)00179-X; Arica MY, 2000, J MOL CATAL B-ENZYM, V11, P127, DOI 10.1016/S1381-1177(00)00223-X; Chen DH, 2002, J MOL CATAL B-ENZYM, V16, P283, DOI 10.1016/S1381-1177(01)00074-1; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Duo-Chuan L, 2006, MYCOPATHOLOGIA, V161, P345, DOI 10.1007/s11046-006-0024-y; Dyal A, 2003, J AM CHEM SOC, V125, P1684, DOI 10.1021/ja021223n; Gao C, 2006, J PHYS CHEM B, V110, P7213, DOI 10.1021/jp0602474; Gijs MAM, 2010, CHEM REV, V110, P1518, DOI 10.1021/cr9001929; Grobert N, 1999, APPL PHYS LETT, V75, P3363, DOI 10.1063/1.125352; Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012; HABERDIT.W, 1967, NATURE, V213, P72, DOI 10.1038/213072a0; Hasumura T, 2011, J NANOPART RES, V13, P53, DOI 10.1007/s11051-010-0142-9; Hayasaki Yasuhiro, 2012, Advances in Natural Sciences: Nanoscience & Nanotechnology, V3, DOI 10.1088/2043-6262/3/3/035010; Ho KM, 2008, LANGMUIR, V24, P11036, DOI 10.1021/la8016529; Kim J, 2006, BIOTECHNOL ADV, V24, P296, DOI 10.1016/j.biotechadv.2005.11.006; Koutsopoulos S, 2004, LANGMUIR, V20, P6401, DOI 10.1021/la049821y; Liao MH, 2001, BIOTECHNOL LETT, V23, P1723, DOI 10.1023/A:1012485221802; Liu XQ, 2005, J CHROMATOGR B, V822, P91, DOI 10.1016/j.jchromb.2005.06.001; Mandal S, 2005, CURR APPL PHYS, V5, P118, DOI 10.1016/j.cap.2004.06.006; Mateo C, 2007, ENZYME MICROB TECH, V40, P1451, DOI 10.1016/j.enzmictec.2007.01.018; Mizuki T, 2010, BIOCHEM BIOPH RES CO, V393, P779, DOI 10.1016/j.bbrc.2010.02.081; Morimoto H, 2000, J PHYS A-MATH GEN, V33, P247, DOI 10.1088/0305-4470/33/2/302; Morimoto H, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.021403; Nagaoka Y, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.032502; Nagaoka Y, 2011, LANGMUIR, V27, P9160, DOI 10.1021/la201156q; Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201; Schmidt-Dannert C, 1999, BIOORGAN MED CHEM, V7, P2123, DOI 10.1016/S0968-0896(99)00141-8; Ukai T, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.061406; Yang ZP, 2008, BIOCHEM BIOPH RES CO, V367, P169, DOI 10.1016/j.bbrc.2007.12.113	29	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66528	10.1371/journal.pone.0066528	http://dx.doi.org/10.1371/journal.pone.0066528			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799111	gold, Green Published, Green Submitted			2022-12-25	WOS:000320363300088
J	Sanz-Sanchez, L; Risco, C				Sanz-Sanchez, Laura; Risco, Cristina			Multilamellar Structures and Filament Bundles Are Found on the Cell Surface during Bunyavirus Egress	PLOS ONE			English	Article							ACTIN-BASED MOTILITY; BUNYAMWERA-VIRUS; FEVER VIRUS; ADHESION; GOLGI; FACTORIES; RELEASE; ARCHITECTURE; REPLICATION; ATTACHMENT	Inside cells, viruses build specialized compartments for replication and morphogenesis. We observed that virus release associates with specific structures found on the surface of mammalian cells. Cultured adherent cells were infected with a bunyavirus and processed for oriented sectioning and transmission electron microscopy. Imaging of cell basal regions showed sophisticated multilamellar structures (MLS) and extracellular filament bundles with attached viruses. Correlative light and electron microscopy confirmed that both MLS and filaments proliferated during the maximum egress of new viruses. MLS dimensions and structure were reminiscent of those reported for the nanostructures on gecko fingertips, which are responsible for the extraordinary attachment capacity of these lizards. As infected cells with MLS were more resistant to detachment than control cells, we propose an adhesive function for these structures, which would compensate for the loss of adherence during release of new virus progeny.	[Sanz-Sanchez, Laura; Risco, Cristina] CSIC, CNB, Cell Struct Lab, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Risco, C (corresponding author), CSIC, CNB, Cell Struct Lab, Madrid, Spain.	crisco@cnb.csic.es	Risco, Cristina/K-4308-2014	Risco, Cristina/0000-0001-7501-5934	Spanish Ministry of Education and Science (FPU Program); Spanish Ministry of Economy and Competitiveness [BIO2009-07255]	Spanish Ministry of Education and Science (FPU Program)(German Research Foundation (DFG)); Spanish Ministry of Economy and Competitiveness(Spanish Government)	Our gratitude to Dr. Sylvia Gutierrez Erlandsson for expert support with confocal and live cell video microscopy, to Drs. Ines M. Anton, Isidoro Martinez and Richard M. Elliott for providing reagents, and to Catherine Mark for editorial assistance. LSS received a fellowship from the Spanish Ministry of Education and Science (FPU Program). This research was funded by a grant from the Spanish Ministry of Economy and Competitiveness (BIO2009-07255 to C.R.).	Autumn K, 2006, J EXP BIOL, V209, P3569, DOI 10.1242/jeb.02486; Boesel LF, 2010, ADV MATER, V22, P2125, DOI 10.1002/adma.200903200; Burckhardt CJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000621; Connolly-Andersen AM, 2007, J VIROL, V81, P2158, DOI 10.1128/JVI.02070-06; CUDMORE S, 1995, NATURE, V378, P636, DOI 10.1038/378636a0; de Castro IF, 2013, CELL MICROBIOL, V15, P24, DOI 10.1111/cmi.12029; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Fontana J, 2008, CELL MICROBIOL, V10, P2012, DOI 10.1111/j.1462-5822.2008.01184.x; Fontana J, 2007, CELL MICROBIOL, V9, P875, DOI 10.1111/j.1462-5822.2006.00837.x; FULLER S, 1984, CELL, V38, P65, DOI 10.1016/0092-8674(84)90527-0; Gauthier NC, 2012, TRENDS CELL BIOL, V22, P527, DOI 10.1016/j.tcb.2012.07.005; Gladnikoff M, 2009, BIOPHYS J, V97, P2419, DOI 10.1016/j.bpj.2009.08.016; Grove J, 2011, J CELL BIOL, V195, P1071, DOI 10.1083/jcb.201108131; Hemmings DG, 2002, J VIROL, V76, P6710, DOI 10.1128/JVI.76.13.6710-6717.2002; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hill GC, 2011, J R SOC INTERFACE, V8, P926, DOI 10.1098/rsif.2010.0720; Hu SH, 2012, SMALL, V8, P2464, DOI 10.1002/smll.201200413; Huber G, 2005, BIOL LETTERS, V1, P2, DOI 10.1098/rsbl.2004.0254; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Jouvenet N, 2006, CELL MICROBIOL, V8, P1803, DOI 10.1111/j.1462-5822.2006.00750.x; Kim TW, 2007, ULTRAMICROSCOPY, V107, P902, DOI 10.1016/j.ultramic.2006.11.008; LAPPIN DF, 1994, J GEN VIROL, V75, P3441, DOI 10.1099/0022-1317-75-12-3441; Lee H, 2007, NATURE, V448, P338, DOI 10.1038/nature05968; Lopez-Montero N, 2011, CELL MICROBIOL, V13, P300, DOI 10.1111/j.1462-5822.2010.01536.x; Lopez-Souza N, 2004, AM J PHYSIOL-LUNG C, V286, pL373, DOI 10.1152/ajplung.00300.2003; Mahdavi A, 2008, P NATL ACAD SCI USA, V105, P2307, DOI 10.1073/pnas.0712117105; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Mothes W, 2010, J VIROL, V84, P8360, DOI 10.1128/JVI.00443-10; Novoa RR, 2005, J VIROL, V79, P10852, DOI 10.1128/JVI.79.17.10852-10863.2005; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; Raucher D, 1999, BIOPHYS J, V77, P1992, DOI 10.1016/S0006-3495(99)77040-2; Reichelt M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002740; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; Risco C, 2013, STRUCTURE P IN PRESS; Risco C, 2012, STRUCTURE, V20, P759, DOI 10.1016/j.str.2012.04.001; RODRIGUEZBOULAN E, 1978, P NATL ACAD SCI USA, V75, P5071, DOI 10.1073/pnas.75.10.5071; Salanueva IJ, 2003, J VIROL, V77, P1368, DOI 10.1128/JVI.77.2.1368-1381.2003; Shannon-Lowe C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001338; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Shi XH, 2006, J VIROL, V80, P8089, DOI 10.1128/JVI.00579-06; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574; Tian Y, 2006, P NATL ACAD SCI USA, V103, P19320, DOI 10.1073/pnas.0608841103; Titushkin I, 2006, BIOPHYS J, V90, P2582, DOI 10.1529/biophysj.105.073775; van Weering JRT, 2010, METHOD CELL BIOL, V96, P619, DOI 10.1016/S0091-679X(10)96026-3; Weber F, 2001, VIROLOGY, V281, P67, DOI 10.1006/viro.2000.0774; Wileman T, 2007, ANNU REV MICROBIOL, V61, P149, DOI 10.1146/annurev.micro.57.030502.090836; Zimmer G, 2002, J VIROL, V76, P4103, DOI 10.1128/JVI.76.8.4103-4107.2002	48	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65526	10.1371/journal.pone.0065526	http://dx.doi.org/10.1371/journal.pone.0065526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799021	gold, Green Submitted, Green Published			2022-12-25	WOS:000320363300021
J	Dwidar, M; Leung, BM; Yaguchi, T; Takayama, S; Mitchell, RJ				Dwidar, Mohammed; Leung, Brendan M.; Yaguchi, Toshiyuki; Takayama, Shuichi; Mitchell, Robert J.			Patterning Bacterial Communities on Epithelial Cells	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; BDELLOVIBRIO-BACTERIOVORUS; ESCHERICHIA-COLI; BIOFILM FORMATION; LARGE PLASMID; GENE-TRANSFER; SALMONELLA; VIRULENCE; COLONIZATION; RECOMBINANT	Micropatterning of bacteria using aqueous two phase system (ATPS) enables the localized culture and formation of physically separated bacterial communities on human epithelial cell sheets. This method was used to compare the effects of Escherichia coli strain MG1655 and an isogenic invasive counterpart that expresses the invasin (inv) gene from Yersinia pseudotuberculosis on the underlying epithelial cell layer. Large portions of the cell layer beneath the invasive strain were killed or detached while the non-invasive E. coli had no apparent effect on the epithelial cell layer over a 24 h observation period. In addition, simultaneous testing of the localized effects of three different bacterial species; E. coli MG1655, Shigella boydii KACC 10792 and Pseudomonas sp DSM 50906 on an epithelial cell layer is also demonstrated. The paper further shows the ability to use a bacterial predator, Bdellovibrio bacteriovorus HD 100, to selectively remove the E. coli, S. boydii and P. sp communities from this bacteria-patterned epithelial cell layer. Importantly, predation and removal of the P. Sp was critical for maintaining viability of the underlying epithelial cells. Although this paper focuses on a few specific cell types, the technique should be broadly applicable to understand a variety of bacteria-epithelial cell interactions.	[Dwidar, Mohammed; Leung, Brendan M.; Yaguchi, Toshiyuki; Takayama, Shuichi; Mitchell, Robert J.] Ulsan Natl Inst Sci & Technol, Sch Nanobiosci & Chem Engn, Ulsan, South Korea; [Yaguchi, Toshiyuki] Nagoya Inst Technol, Biomechan Lab, Showa Ku, Nagoya, Aichi, Japan; [Takayama, Shuichi] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Takayama, Shuichi] Univ Michigan, Macromol Sci & Engn Program, Ann Arbor, MI 48109 USA	Ulsan National Institute of Science & Technology (UNIST); Nagoya Institute of Technology; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Takayama, S (corresponding author), Ulsan Natl Inst Sci & Technol, Sch Nanobiosci & Chem Engn, Ulsan, South Korea.	takayama@umich.edu; esgott@unist.ac.kr	Dwidar, Mohammed/AAD-3451-2019; Mitchell, Robert J./E-9062-2010	Dwidar, Mohammed/0000-0003-1366-0393; Mitchell, Robert J./0000-0002-9608-5381; Dague, Etienne/0000-0003-3290-9166	Creativity and Innovation Project [1.120051.01]; UNIST (Ulsan National Institute of Science and Technology); WCU (World Class University) through the National Research Foundation of Korea (NRF) [R322008000200540]; Ministry of Education, Science and Technology (MEST)	Creativity and Innovation Project; UNIST (Ulsan National Institute of Science and Technology); WCU (World Class University) through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Grant # 1.120051.01 from the Creativity and Innovation Project funded by UNIST (Ulsan National Institute of Science and Technology) and by the WCU (World Class University) program (No. R322008000200540) through the National Research Foundation of Korea (NRF) as funded by the Ministry of Education, Science and Technology (MEST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atterbury RJ, 2011, APPL ENVIRON MICROB, V77, P5794, DOI 10.1128/AEM.00426-11; Bansal T, 2007, INFECT IMMUN, V75, P4597, DOI 10.1128/IAI.00630-07; Boddicker JD, 2002, MOL MICROBIOL, V45, P1255, DOI 10.1046/j.1365-2958.2002.03121.x; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Byun CK, 2013, J AM CHEM SOC, V135, P2242, DOI 10.1021/ja3094923; Canny GO, 2008, INFECT IMMUN, V76, P3360, DOI 10.1128/IAI.00187-08; Courvalin P, 1995, CR ACAD SCI III-VIE, V318, P1207; Critchley R, 2004, GENE THER, V11, P1224, DOI 10.1038/sj.gt.3302281; Dashiff A, 2011, J APPL MICROBIOL, V110, P431, DOI 10.1111/j.1365-2672.2010.04900.x; Dwidar M, 2012, BMB REP, V45, P71, DOI 10.5483/BMBRep.2012.45.2.71; Elliott N, 2011, INTEGR BIOL-UK, V3, P696, DOI 10.1039/c0ib00137f; Esteves CLC, 2005, INFECT IMMUN, V73, P5198, DOI 10.1128/IAI.73.8.5198-5203.2005; Fang Y, 2012, TISSUE ENG PART C-ME, V18, P647, DOI [10.1089/ten.tec.2011.0709, 10.1089/ten.TEC.2011.0709]; Feng WJ, 2003, ANAL CHEM, V75, P4148, DOI 10.1021/ac0343127; Frampton JP, 2013, JOVE-J VIS EXP, DOI 10.3791/50304; Frampton JP., 2013, ADV HEALTHC MAT MEDL, DOI [10.1002/adhm. 201300049, DOI 10.1002/ADHM.201300049.PUBMED:23592706.PUBMED:23592706]; Grillot-Courvalin C, 1998, NAT BIOTECHNOL, V16, P862, DOI 10.1038/nbt0998-862; Kadouri D, 2005, APPL ENVIRON MICROB, V71, P4044, DOI 10.1128/AEM.71.7.4044-4051.2005; Kadouri D, 2007, APPL ENVIRON MICROB, V73, P605, DOI 10.1128/AEM.01893-06; Kim J, 2010, LAB CHIP, V10, P43, DOI 10.1039/b911367c; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; LENZ RW, 1978, ARCH MICROBIOL, V119, P245, DOI 10.1007/BF00405402; Monnappa AK, 2013, SOIL BIOL BIOCHEM, V57, P427, DOI 10.1016/j.soilbio.2012.09.010; PAL T, 1989, INFECT IMMUN, V57, P2580; Pawelek JM, 1997, CANCER RES, V57, P4537; SASAKAWA C, 1992, CURR TOP MICROBIOL, V180, P21; SASAKAWA C, 1986, INFECT IMMUN, V51, P470, DOI 10.1128/IAI.51.2.470-475.1986; Schmid-Hempel P, 2007, PLOS PATHOG, V3, P1372, DOI 10.1371/journal.ppat.0030147; Schwudke D, 2003, J BIOL CHEM, V278, P27502, DOI 10.1074/jbc.M303012200; Sockett RE, 2004, NAT REV MICROBIOL, V2, P669, DOI 10.1038/nrmicro959; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100; STOLP H, 1963, ANTON VAN LEE J M S, V29, P217, DOI 10.1007/BF02046064; TAKAHASHI K, 1988, MICROBIOL IMMUNOL, V32, P221, DOI 10.1111/j.1348-0421.1988.tb01380.x; Tavana H, 2009, NAT MATER, V8, P736, DOI [10.1038/NMAT2515, 10.1038/nmat2515]; Tavana H, 2010, ADV MATER, V22, P2628, DOI 10.1002/adma.200904271; TOBE T, 1992, J BACTERIOL, V174, P6359, DOI 10.1128/JB.174.20.6359-6367.1992; Tomlin KL, 2004, J MICROBIOL METH, V57, P95, DOI 10.1016/j.mimet.2003.12.007; Uliczka F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002117; Wang X, 2006, CELL MOL LIFE SCI, V63, P2352, DOI 10.1007/s00018-006-6222-4; WESTERGAARD JM, 1977, APPL ENVIRON MICROB, V34, P506, DOI 10.1128/AEM.34.5.506-511.1977; Xavier KB, 2003, CURR OPIN MICROBIOL, V6, P191, DOI 10.1016/S1369-5274(03)00028-6; Yaguchi T, 2012, BIOMACROMOLECULES, V13, P2655, DOI 10.1021/bm300500y; Yaguchi T, 2010, ANALYST, V135, P2848, DOI 10.1039/c0an00464b	43	25	25	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e67165	10.1371/journal.pone.0067165	http://dx.doi.org/10.1371/journal.pone.0067165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785519	Green Published, gold, Green Submitted			2022-12-25	WOS:000321038800005
J	He, LN; Yang, ZH; Zhao, ZH; Lin, HF; Li, YP				He, Linna; Yang, Zhihao; Zhao, Zhehuan; Lin, Hongfei; Li, Yanpeng			Extracting Drug-Drug Interaction from the Biomedical Literature Using a Stacked Generalization-Based Approach	PLOS ONE			English	Article							KERNELS; ISSUES	Drug-drug interaction (DDI) detection is particularly important for patient safety. However, the amount of biomedical literature regarding drug interactions is increasing rapidly. Therefore, there is a need to develop an effective approach for the automatic extraction of DDI information from the biomedical literature. In this paper, we present a Stacked Generalization-based approach for automatic DDI extraction. The approach combines the feature-based, graph and tree kernels and, therefore, reduces the risk of missing important features. In addition, it introduces some domain knowledge based features (the keyword, semantic type, and DrugBank features) into the feature-based kernel, which contribute to the performance improvement. More specifically, the approach applies Stacked generalization to automatically learn the weights from the training data and assign them to three individual kernels to achieve a much better performance than each individual kernel. The experimental results show that our approach can achieve a better performance of 69.24% in F-score compared with other systems in the DDI Extraction 2011 challenge task.	[He, Linna; Yang, Zhihao; Zhao, Zhehuan; Lin, Hongfei; Li, Yanpeng] Dalian Univ Technol, Sch Comp Sci & Technol, Dalian, Peoples R China	Dalian University of Technology	Yang, ZH (corresponding author), Dalian Univ Technol, Sch Comp Sci & Technol, Dalian, Peoples R China.	yangzh@dlut.edu.cn			Natural Science Foundation of China [61070098, 61272373]; Fundamental Research Funds for the Central Universities [DUT13JB09]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by grants from the Natural Science Foundation of China (No. 61070098 and 61272373, http://www.nsfc.gov.cn/Portal0/default152.htm) and the Fundamental Research Funds for the Central Universities (No. DUT13JB09, http://www.moe.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAMODT A, 1994, AI COMMUN, V7, P39; Aiken LS., 2003, HDB PSYCHOL, P481; Airola A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S11-S2; Bartlett P. J., 2000, ADV LARGE MARGIN CLA; Bjorne J., 2011, P DDIEXTRACTION 2011, P35; Blasco SG, 2011, CEUR WORKSHOP P, V761, P51; Breiman L, 1996, MACH LEARN, V24, P49; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Breiman L., 1996, BIAS VARIANCE ARCING; Bunescu RC, 2005, P C HUM LANG TECHN E, P724, DOI DOI 10.3115/1220575.1220666; Chowdhury M., 2011, P 1 CHALL TASK DRUG, P27; Chowdhury M.F.M., 2011, P BIONLP 2011 WORKSH, P124; Collins M, 2002, ADV NEUR IN, V14, P625; Culotta A, 2004, P 42 ANN M ASS COMP, P423, DOI [10.3115/1218955.1219009, DOI 10.3115/1218955.1219009]; Fayruzov T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-374; Giuliano C., 2006, P 11 C EUR CHAPT ASS, P401; Kim S, 2008, BIOINFORMATICS, V24, P118, DOI 10.1093/bioinformatics/btm544; Minard A L, 2011, CHALLENGE TASK DRUG; Miwa M, 2009, INT J MED INFORM, V78, pE39, DOI 10.1016/j.ijmedinf.2009.04.010; Mooney RJ, 2006, ADV NEURAL INFORM PR, P171; Moschitti A, 2006, P 11 C EUR CHAPT ASS, P113; Moschitti A., 2004, P 42 ANN M ASS COMP; Neves ML, 2009, P BIONLP 2009 WORKSH, P68; Rodriguez-Terol A, 2009, Farm Hosp, V33, P134; SAETRE R, 2008, P 2 INT S LANG BIOL; Segura-Bedmar I., 2011, CHALLENGE TASK DRUG, P1; Segura-Bedmar I, 2011, J BIOMED INFORM, V44, P789, DOI 10.1016/j.jbi.2011.04.005; Segura-Bedmar I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S2-S1; Thomas P., 2011, P 1 CHALL TASK DRUG, P11; Tikk D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000837; Ting KM, 1999, J ARTIF INTELL RES, V10, P271, DOI 10.1613/jair.594; Vapnik V., 1998, STAT LEARNING THEORY; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; WOLPERT DH, 1992, NEURAL NETWORKS, V5, P241, DOI 10.1016/S0893-6080(05)80023-1; Xiao J, 2005, P S SEM MIN BIOM, P51; Yang ZH, 2011, PROTEOMICS, V11, P3811, DOI 10.1002/pmic.201100188; Yang ZH, 2011, ARTIF INTELL MED, V51, P163, DOI 10.1016/j.artmed.2010.12.002; Zweigenbaum P, 2007, BRIEF BIOINFORM, V8, P358, DOI 10.1093/bib/bbm045	38	34	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65814	10.1371/journal.pone.0065814	http://dx.doi.org/10.1371/journal.pone.0065814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785452	Green Published, gold			2022-12-25	WOS:000321038800070
J	Manocheewa, S; Swain, JV; Lanxon-Cookson, E; Rolland, M; Mullins, JI				Manocheewa, Siriphan; Swain, J. Victor; Lanxon-Cookson, Erinn; Rolland, Morgane; Mullins, James I.			Fitness Costs of Mutations at the HIV-1 Capsid Hexamerization Interface	PLOS ONE			English	Article							T-CELL RESPONSES; REPLICATION; PROTEIN; CORE; DIVERSITY	The recently available x-ray crystal structure of HIV-1 capsid hexamers has provided insight into the molecular interactions crucial for the virus's mature capsid formation. Amino acid changes at these interaction points are likely to have a strong impact on capsid functionality and, hence, viral infectivity and replication fitness. To test this hypothesis, we introduced the most frequently observed single amino acid substitution at 30 sites: 12 at the capsid hexamerization interface and 18 at non-interface sites. Mutations at the interface sites were more likely to be lethal (Fisher's exact test p = 0.027) and had greater negative impact on viral replication fitness (Wilcoxon rank sum test p = 0.040). Among the interface mutations studied, those located in the cluster of hydrophobic contacts at NTD-NTD interface and those that disrupted NTD-CTD inter-domain helix capping hydrogen bonds were the most detrimental, indicating that these interactions are particularly important for maintaining capsid structure and/or function. These functionally constrained sites provide potential targets for novel HIV drug development and vaccine immunogen design.	[Manocheewa, Siriphan; Swain, J. Victor; Lanxon-Cookson, Erinn; Rolland, Morgane; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Mullins, JI (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	jmullins@uw.edu			U.S. Public Health Service [AI47734, AI57005]; University of Washington Center for AIDS Research Computational Biology Core [AI27757]; Bill and Melinda Gates Foundation [43437]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047734, P30AI027757, P01AI057005, R37AI047734] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); University of Washington Center for AIDS Research Computational Biology Core; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the U.S. Public Health Service to JIM (AI47734 and AI57005), the University of Washington Center for AIDS Research Computational Biology Core (AI27757), and the Bill and Melinda Gates Foundation (43437). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Bailey GD, 2012, J MOL BIOL, V417, P212, DOI 10.1016/j.jmb.2012.01.014; Bartonova V, 2008, J BIOL CHEM, V283, P32024, DOI 10.1074/jbc.M804230200; Berthet-Colominas C, 1999, EMBO J, V18, P1124, DOI 10.1093/emboj/18.5.1124; Bocanegra R, 2012, VIRUS RES; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; Deng WJ, 2010, BIOTECHNIQUES, V48, P405, DOI 10.2144/000113370; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; LIU Y, 2012, J VIROL MET IN PRESS; Liu Y, 2006, J VIROL, V80, P9519, DOI 10.1128/JVI.00575-06; Ma JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-261; Maddison WP, 2011, MESQUITE MODULAR SYS; McClure J, 2007, JAIDS-J ACQ IMM DEF, V44, P254, DOI 10.1097/QAI.0b013e318030f5c5; Mothe B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029717; Mothe B, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-208; Nickle DC, 2003, SCIENCE, V299, P1515; Niu LG, 2011, VACCINE, V29, P2110, DOI 10.1016/j.vaccine.2010.12.131; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; REED L. J., 1938, AMER JOUR HYG, V27, P493; ROLLAND M, 2013, J VIROL; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Rolland M, 2007, J VIROL, V81, P8507, DOI 10.1128/JVI.02683-06; Tang SX, 2001, J VIROL, V75, P9357, DOI 10.1128/JVI.75.19.9357-9366.2001; Troyer RM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000365; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; Wu HL, 2006, J VIROL, V80, P2380, DOI 10.1128/JVI.80.5.2380-2389.2006	33	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66065	10.1371/journal.pone.0066065	http://dx.doi.org/10.1371/journal.pone.0066065			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785468	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800054
J	van de Pasch, LAL; Miles, AJ; Nijenhuis, W; Brabers, NACH; van Leenen, D; Lijnzaad, P; Brown, MK; Ouellet, J; Barral, Y; Kops, GJPL; Holstege, FCP				van de Pasch, Loes A. L.; Miles, Antony J.; Nijenhuis, Wilco; Brabers, Nathalie A. C. H.; van Leenen, Dik; Lijnzaad, Philip; Brown, Markus K.; Ouellet, Jimmy; Barral, Yves; Kops, Geert J. P. L.; Holstege, Frank C. P.			Centromere Binding and a Conserved Role in Chromosome Stability for SUMO-Dependent Ubiquitin Ligases	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; KINETOCHORE PROTEIN; SUMOYLATION; RNF4; LOCALIZATION; ANAPHASE; SLX5; DEGRADATION; DISSECTION; REGULATOR	The Saccharomyces cerevisiae Slx5/8 complex is the founding member of a recently defined class of SUMO-targeted ubiquitin ligases (STUbLs). Slx5/8 has been implicated in genome stability and transcription, but the precise contribution is unclear. To characterise Slx5/8 function, we determined genome-wide changes in gene expression upon loss of either subunit. The majority of mRNA changes are part of a general stress response, also exhibited by mutants of other genome integrity pathways and therefore indicative of an indirect effect on transcription. Genome-wide binding analysis reveals a uniquely centromeric location for Slx5. Detailed phenotype analyses of slx5 Delta and slx8 Delta mutants show severe mitotic defects that include aneuploidy, spindle mispositioning, fish hooks and aberrant spindle kinetics. This is associated with accumulation of the PP2A regulatory subunit Rts1 at centromeres prior to entry into anaphase. Knockdown of the human STUbL orthologue RNF4 also results in chromosome segregation errors due to chromosome bridges. The study shows that STUbLs have a conserved role in maintenance of chromosome stability and links SUMO-dependent ubiquitination to a centromere-specific function during mitosis.	[van de Pasch, Loes A. L.; Miles, Antony J.; Nijenhuis, Wilco; Brabers, Nathalie A. C. H.; van Leenen, Dik; Lijnzaad, Philip; Brown, Markus K.; Kops, Geert J. P. L.; Holstege, Frank C. P.] Univ Med Ctr Utrecht, Mol Canc Res, Utrecht, Netherlands; [Ouellet, Jimmy; Barral, Yves] ETH Honggerberg, Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland	Utrecht University; Utrecht University Medical Center; Swiss Federal Institutes of Technology Domain; ETH Zurich	Holstege, FCP (corresponding author), Univ Med Ctr Utrecht, Mol Canc Res, Univ Weg 100, Utrecht, Netherlands.	f.c.p.holstege@umcutrecht.nl	Holstege, Frank/AAM-9944-2021; Lijnzaad, Philip/ABE-4205-2021	Lijnzaad, Philip/0000-0002-7535-583X; Barral, Yves/0000-0002-0989-3373; Ouellet, Jimmy/0000-0002-0215-7023; Kops, Geert/0000-0003-3555-5295	Netherlands Bioinformatics Centre (NBIC); Netherlands Organization of Scientific Research (NWO) [016.108.607, 817.02.015, 050.71.057, 911.06.009]	Netherlands Bioinformatics Centre (NBIC); Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was funded by the Netherlands Bioinformatics Centre (NBIC) and the Netherlands Organization of Scientific Research (NWO), grants 016.108.607, 817.02.015, 050.71.057, 911.06.009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Burgess RC, 2007, MOL CELL BIOL, V27, P6153, DOI 10.1128/MCB.00787-07; Caydasi AK, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-28; Chan LY, 2009, GENE DEV, V23, P1639, DOI 10.1101/gad.1804609; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Cook CE, 2009, CELL CYCLE, V8, P1080, DOI 10.4161/cc.8.7.8123; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Darst RP, 2008, MOL CELL BIOL, V28, P1361, DOI 10.1128/MCB.01291-07; Dobbelaere J, 2003, DEV CELL, V4, P345, DOI 10.1016/S1534-5807(03)00061-3; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gentry MS, 2002, MOL BIOL CELL, V13, P3477, DOI 10.1091/mbc.02-05-0065; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; Grava S, 2006, DEV CELL, V10, P425, DOI 10.1016/j.devcel.2006.02.018; Guo BQ, 2009, MOL CELL BIOL, V29, P3204, DOI 10.1128/MCB.01128-08; HIETER P, 1985, CELL, V40, P381, DOI 10.1016/0092-8674(85)90152-7; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hyland KM, 1999, J CELL BIOL, V145, P15, DOI 10.1083/jcb.145.1.15; Ii T, 2007, CELL CYCLE, V6, P2800, DOI 10.4161/cc.6.22.4882; Indjeian VB, 2005, SCIENCE, V307, P130, DOI 10.1126/science.1101366; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kosoy A, 2007, J BIOL CHEM, V282, P20388, DOI 10.1074/jbc.M702652200; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Margaritis T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.21; Martin N, 2009, EMBO J, V28, P3534, DOI 10.1038/emboj.2009.279; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; Montpetit B, 2006, J CELL BIOL, V174, P653, DOI 10.1083/jcb.200605019; Mukhopadhyay D, 2010, J CELL BIOL, V188, P681, DOI 10.1083/jcb.200909008; Mullen JR, 2001, GENETICS, V157, P103; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; Neurohr G, 2011, SCIENCE, V332, P465, DOI 10.1126/science.1201578; Nixon CE, 2010, GENETICS, V185, P497, DOI 10.1534/genetics.110.115907; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SPENCER F, 1990, GENETICS, V124, P237; Straight AF, 1997, SCIENCE, V277, P574, DOI 10.1126/science.277.5325.574; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Tsalik EL, 1998, YEAST, V14, P847, DOI 10.1002/(SICI)1097-0061(19980630)14:9<847::AID-YEA285>3.0.CO;2-9; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; van Bakel H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1144; van Hagen M, 2010, NUCLEIC ACIDS RES, V38, P1922, DOI 10.1093/nar/gkp1157; van Wageningen S, 2010, CELL, V143, P991, DOI 10.1016/j.cell.2010.11.021; van Werven FJ, 2008, GENE DEV, V22, P2359, DOI 10.1101/gad.1682308; Vizeacoumar FJ, 2010, J CELL BIOL, V188, P69, DOI 10.1083/jcb.200909013; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang Z, 2009, MOL CELL BIOL, V29, P1694, DOI 10.1128/MCB.01470-08; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Zhang CY, 2006, DNA REPAIR, V5, P336, DOI 10.1016/j.dnarep.2005.10.010; Zhao Y, 1997, J BIOL CHEM, V272, P8256, DOI 10.1074/jbc.272.13.8256	59	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65628	10.1371/journal.pone.0065628	http://dx.doi.org/10.1371/journal.pone.0065628			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785440	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800084
J	Rollenhagen, M; Buettner, FFR; Reismann, M; Jirmo, AC; Grove, M; Behrens, GMN; Gerardy-Schahn, R; Hanisch, FG; Muhlenhoff, M				Rollenhagen, Manuela; Buettner, Falk F. R.; Reismann, Marc; Jirmo, Adan Chari; Grove, Melanie; Behrens, Georg M. N.; Gerardy-Schahn, Rita; Hanisch, Franz-Georg; Muehlenhoff, Martina			Polysialic Acid on Neuropilin-2 Is Exclusively Synthesized by the Polysialyltransferase ST8SiaIV and Attached to Mucin-type O-Glycans Located between the b2 and c Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION-MOLECULE; POSTNATAL MOUSE-BRAIN; HUMAN DENDRITIC CELLS; IN-VIVO; SEMAPHORIN-III; SYNCAM 1; POLYSIALYLATION; NCAM; RECEPTOR; EXPRESSION	Neuropilin-2 (NRP2) is well known as a co-receptor for class 3 semaphorins and vascular endothelial growth factors, involved in axon guidance and angiogenesis. Moreover, NRP2 was shown to promote chemotactic migration of human monocyte-derived dendritic cells (DCs) toward the chemokine CCL21, a function that relies on the presence of polysialic acid (polySia). In vertebrates, this posttranslational modification is predominantly found on the neural cell adhesion molecule (NCAM), where it is synthesized on N-glycans by either of the two polysialyltransferases, ST8SiaII or ST8SiaIV. In contrast to NCAM, little is known on the biosynthesis of polySia on NRP2. Here we identified the polySia attachment sites and demonstrate that NRP2 is recognized only by ST8SiaIV. Although polySia-NRP2 was found on bone marrow-derived DCs from wild-type and St8sia2(-/-) mice, polySia was completely lost in DCs from St8sia4(-/-) mice despite normal NRP2 expression. In COS-7 cells, co-expression of NRP2 with ST8SiaIV but not ST8SiaII resulted in the formation of polySia-NRP2, highlighting distinct acceptor specificities of the two polysialyltransferases. Notably, ST8SiaIV synthesized polySia selectively on a NRP2 glycoform that was characterized by the presence of sialylated core 1 and core 2 O-glycans. Based on a comprehensive site-directed mutagenesis study, we localized the polySia attachment sites to an O-glycan cluster located in the linker region between b2 and c domain. Combined alanine exchange of Thr-607,-613,-614, -615,-619, and -624 efficiently blocked polysialylation. Restoration of single sites only partially rescued polysialylation, suggesting that within this cluster, polySia is attached to more than one site.	[Rollenhagen, Manuela; Buettner, Falk F. R.; Grove, Melanie; Gerardy-Schahn, Rita; Muehlenhoff, Martina] Hannover Med Sch, Inst Cellular Chem, D-30623 Hannover, Germany; [Reismann, Marc] Hannover Med Sch, Dept Pediat Surg, D-30623 Hannover, Germany; [Jirmo, Adan Chari; Behrens, Georg M. N.] Hannover Med Sch, Clin Immunol & Rheumatol, D-30623 Hannover, Germany; [Hanisch, Franz-Georg] Univ Cologne, Inst Biochem 2, Fac Med, D-50931 Cologne, Germany; [Hanisch, Franz-Georg] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; University of Cologne; University of Cologne	Muhlenhoff, M (corresponding author), Hannover Med Sch, Abt Zellulare Chem, Carl Neuberg Str 1, D-30623 Hannover, Germany.	muehlenhoff.martina@mh-hannover.de	Behrens, Georg MN/Q-4486-2016	Jirmo, Adan Chari/0000-0002-4693-0081; Reismann, Marc/0000-0001-7426-1578	Deutsche Forschungsgemeinschaft [MU 1774/3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant MU 1774/3 (to M. M.).	Angata K, 1998, J BIOL CHEM, V273, P28524, DOI 10.1074/jbc.273.43.28524; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; Bax M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006987; BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; Breloy I, 2012, J BIOL CHEM, V287, P18275, DOI 10.1074/jbc.M111.280297; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; DENNIS JW, 1993, GLYCOBIOLOGY, V3, P91, DOI 10.1093/glycob/3.2.91; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; Esko JD, 1996, CURR OPIN STRUC BIOL, V6, P663, DOI 10.1016/S0959-440X(96)80034-0; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Frankel P, 2008, EMBO REP, V9, P983, DOI 10.1038/embor.2008.151; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Galuska SP, 2008, J BIOL CHEM, V283, P17, DOI 10.1074/jbc.M707024200; Galuska SP, 2006, J BIOL CHEM, V281, P31605, DOI 10.1074/jbc.M606516200; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; GILLESPIE W, 1993, J BIOL CHEM, V268, P3801; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hirose J, 2002, BBA-GEN SUBJECTS, V1571, P219, DOI 10.1016/S0304-4165(02)00232-5; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; HUANG J, 1992, ONCOL RES, V4, P507; HUET G, 1995, J CELL SCI, V108, P1275; Jensen PH, 2010, FEBS J, V277, P81, DOI 10.1111/j.1742-4658.2009.07429.x; Johnson CP, 2005, BIOCHEMISTRY-US, V44, P546, DOI 10.1021/bi048263j; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kanato Y, 2008, GLYCOBIOLOGY, V18, P1044, DOI 10.1093/glycob/cwn084; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Liedtke S, 2001, GLYCOBIOLOGY, V11, P373, DOI 10.1093/glycob/11.5.373; Muhlenhoff M, 2009, BIOL CHEM, V390, P567, DOI 10.1515/BC.2009.078; Muhlenhoff M, 1996, EMBO J, V15, P6943, DOI 10.1002/j.1460-2075.1996.tb01086.x; Muhlenhoff M, 1996, CURR BIOL, V6, P1188, DOI 10.1016/S0960-9822(02)70687-8; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Oltmann-Norden I, 2008, J BIOL CHEM, V283, P1463, DOI 10.1074/jbc.M708463200; Ono S, 2012, J BIOL CHEM, V287, P3710, DOI 10.1074/jbc.M111.276618; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Pellet-Many C, 2011, BIOCHEM J, V435, P609, DOI 10.1042/BJ20100580; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Rey-Gallardo A, 2011, GLYCOBIOLOGY, V21, P655, DOI 10.1093/glycob/cwq216; Rey-Gallardo A, 2010, GLYCOBIOLOGY, V20, P1139, DOI 10.1093/glycob/cwq078; Rollenhagen M, 2012, J BIOL CHEM, V287, P35170, DOI 10.1074/jbc.M112.375642; Rossignol M, 2000, GENOMICS, V70, P211, DOI 10.1006/geno.2000.6381; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sanchez-Sanchez N, 2006, J IMMUNOL, V176, P5153, DOI 10.4049/jimmunol.176.9.5153; Sarris M, 2008, IMMUNITY, V28, P402, DOI 10.1016/j.immuni.2008.01.012; Schwarz Q, 2010, CELL ADHES MIGR, V4, P61, DOI 10.4161/cam.4.1.10207; Shintani Y, 2006, EMBO J, V25, P3045, DOI 10.1038/sj.emboj.7601188; Sozzani S, 2000, J CLIN IMMUNOL, V20, P151, DOI 10.1023/A:1006659211340; Stummeyer K, 2005, NAT STRUCT MOL BIOL, V12, P90, DOI 10.1038/nsmb874; Takamatsu H, 2010, NAT IMMUNOL, V11, P594, DOI 10.1038/ni.1885; Takashima S, 2002, J BIOL CHEM, V277, P24030, DOI 10.1074/jbc.M112367200; Teintenier-Lelievre M, 2005, BIOCHEM J, V392, P665, DOI 10.1042/BJ20051120; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; von der Ohe M, 2002, GLYCOBIOLOGY, V12, P47, DOI 10.1093/glycob/12.1.47; Vutskits L, 2001, EUR J NEUROSCI, V13, P1391, DOI 10.1046/j.0953-816x.2001.01516.x; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; YOSHIDA Y, 1995, J BIOL CHEM, V270, P14628, DOI 10.1074/jbc.270.24.14628; Yuan L, 2002, DEVELOPMENT, V129, P4797; Zhang H, 2004, J CELL SCI, V117, P93, DOI 10.1242/jcs.00827; ZUBER C, 1992, J BIOL CHEM, V267, P9965	72	31	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					22880	22892		10.1074/jbc.M113.463927	http://dx.doi.org/10.1074/jbc.M113.463927			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23801331	Green Published, hybrid			2022-12-25	WOS:000330598200001
J	Probert, F; Whittaker, SBM; Crispin, M; Mitchell, DA; Dixon, AM				Probert, Fay; Whittaker, Sara B. -M.; Crispin, Max; Mitchell, Daniel A.; Dixon, Ann M.			Solution NMR Analyses of the C-type Carbohydrate Recognition Domain of DC-SIGNR Protein Reveal Different Binding Modes for HIV-derived Oligosaccharides and Smaller Glycan Fragments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACKBONE DYNAMICS; STRUCTURAL BASIS; LIGAND-BINDING; SARS CORONAVIRUS; PULSE SEQUENCES; LECTIN; SPECTROSCOPY; N-15; MECHANISM; RECEPTOR	The C-type lectin DC-SIGNR (dendritic cell-specific ICAM-3-grabbing non-integrin-related; also known as L-SIGN or CD299) is a promising drug target due to its ability to promote infection and/or within-host survival of several dangerous pathogens (e.g. HIV and severe acute respiratory syndrome coronavirus (SARS)) via interactions with their surface glycans. Crystallography has provided excellent insight into the mechanism by which DC-SIGNR interacts with small glycans, such as (GlcNAc)(2)Man(3); however, direct observation of complexes with larger, physiological oligosaccharides, such as Man(9)GlcNAc(2), remains elusive. We have utilized solution-state nuclear magnetic resonance spectroscopy to investigate DC-SIGNR binding and herein report the first backbone assignment of its active, calcium-bound carbohydrate recognition domain. Direct interactions with the small sugar fragments Man(3), Man(5), and (GlcNAc)(2)Man(3) were investigated alongside Man(9)GlcNAc derived from recombinant gp120 (present on the HIV viral envelope), providing the first structural data for DC-SIGNR in complex with a virus-associated ligand, and unique binding modes were observed for each glycan. In particular, our data show that DC-SIGNR has a different binding mode for glycans on the HIV viral envelope compared with the smaller glycans previously observed in the crystalline state. This suggests that using the binding mode of Man(9)GlcNAc, instead of those of small glycans, may provide a platform for the design of DC-SIGNR inhibitors selective for high mannose glycans (like those on HIV). N-15 relaxation measurements provided the first information on the dynamics of the carbohydrate recognition domain, demonstrating that it is a highly flexible domain that undergoes ligand-induced conformational and dynamic changes that may explain the ability of DC-SIGNR to accommodate a range of glycans on viral surfaces.	[Probert, Fay] Univ Warwick, Mol Org & Assembly Cells Doctoral Training Ctr, Coventry CV4 7AL, W Midlands, England; [Mitchell, Daniel A.] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Dixon, Ann M.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Whittaker, Sara B. -M.] Univ Birmingham, Sch Canc Sci, Birmingham Canc Res UK Ctr, Henry Wellcome Bldg Biomol NMR Spect, Birmingham B15 2TT, W Midlands, England; [Crispin, Max] Univ Oxford, Oxford Glycobiol Inst, Dept Biochem, Oxford OX1 3QU, England	University of Warwick; University of Warwick; University of Warwick; University of Birmingham; University of Oxford	Dixon, AM (corresponding author), Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England.	ann.dixon@warwick.ac.uk	Mitchell, Daniel A/A-6580-2009; Crispin, Max/AAG-4098-2020; Dixon, Ann M/I-3696-2012	Mitchell, Daniel A/0000-0003-0936-6212; Crispin, Max/0000-0002-1072-2694; Dixon, Ann M/0000-0002-5261-304X; Probert, Fay/0000-0002-8580-2023	Engineering and Physical Sciences Research Council through the Molecular Organisation and Assembly in Cells Doctoral Training Centre; International AIDS Vaccine Initiative; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery	Engineering and Physical Sciences Research Council through the Molecular Organisation and Assembly in Cells Doctoral Training Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); International AIDS Vaccine Initiative; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery	Recipient of a studentship from the Engineering and Physical Sciences Research Council through the Molecular Organisation and Assembly in Cells Doctoral Training Centre.; Supported by the International AIDS Vaccine Initiative and the Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery.	Angulo J, 2008, CHEMBIOCHEM, V9, P2225, DOI 10.1002/cbic.200800361; BAX A, 1991, Journal of Biomolecular NMR, V1, P99, DOI 10.1007/BF01874573; Boily-Larouche G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007211; Bonomelli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023521; Chan VSF, 2006, NAT GENET, V38, P38, DOI 10.1038/ng1698; Chen YX, 2007, J EXP MED, V204, P2529, DOI 10.1084/jem.20070462; Chirife J, 1997, J FOOD ENG, V33, P221, DOI 10.1016/S0260-8774(97)00060-5; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P7387, DOI 10.1021/bi00484a006; CLUBB RT, 1992, J MAGN RESON, V97, P213, DOI 10.1016/0022-2364(92)90252-3; Copie V, 1996, J BIOMOL NMR, V7, P335; Csizmok V, 2008, J AM CHEM SOC, V130, P16873, DOI 10.1021/ja805510b; DAVIS AL, 1992, J MAGN RESON, V98, P207, DOI 10.1016/0022-2364(92)90126-R; Dejnirattisai W, 2011, J INFECT DIS, V203, P1775, DOI 10.1093/infdis/jir173; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demers JP, 2009, J AM CHEM SOC, V131, P4355, DOI 10.1021/ja808255d; Diehl C, 2010, J AM CHEM SOC, V132, P14577, DOI 10.1021/ja105852y; Drickamer K, 1997, STRUCTURE, V5, P465, DOI 10.1016/S0969-2126(97)00202-5; Drickamer K, 2005, NAT STRUCT MOL BIOL, V12, P830, DOI 10.1038/nsmb1005-830; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Dunlop DC, 2010, GLYCOBIOLOGY, V20, P812, DOI 10.1093/glycob/cwq020; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Feinberg H, 2007, J BIOL CHEM, V282, P4202, DOI 10.1074/jbc.M609689200; Fielding L, 2007, PROG NUCL MAG RES SP, V51, P219, DOI 10.1016/j.pnmrs.2007.04.001; Fogh Rasmus, 2002, Nature Structural Biology, V9, P416, DOI 10.1038/nsb0602-416; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Guzzi C, 2011, ORG BIOMOL CHEM, V9, P7705, DOI 10.1039/c1ob05938f; Hibbert RG, 2005, J EXP MED, V202, P751, DOI 10.1084/jem.20050811; Ho MR, 2010, J MOL BIOL, V402, P682, DOI 10.1016/j.jmb.2010.07.061; Johnson TR, 2012, J VIROL, V86, P1339, DOI 10.1128/JVI.06096-11; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Keeler J., 2010, UNDERSTANDING NMR SP, V2; Kneller D. G., 1993, UCSF SPARKY NMR DISP; Lameignere E, 2008, BIOCHEM J, V411, P307, DOI [10.1042/BJ20071276, 10.1042/bj20071276]; Leckband DE, 2011, BIOCHEMISTRY-US, V50, P6125, DOI 10.1021/bi2003444; Lian LY, 2011, PROTEIN NMR SPECTROSCOPY: PRACTICAL TECHNIQUES AND APPLICATIONS, P1, DOI 10.1002/9781119972006; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; Londrigan SL, 2011, J VIROL, V85, P2990, DOI 10.1128/JVI.01705-10; Mari S, 2005, ANGEW CHEM INT EDIT, V44, P296, DOI 10.1002/anie.200461574; Miller MC, 2009, BIOCHEM J, V421, P211, DOI 10.1042/BJ20090265; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Nesmelova IV, 2010, J MOL BIOL, V397, P1209, DOI 10.1016/j.jmb.2010.02.033; Ng KKS, 1998, BIOCHEMISTRY-US, V37, P17965, DOI 10.1021/bi981972a; Nielbo S, 2004, BIOCHEMISTRY-US, V43, P8636, DOI 10.1021/bi049570s; Onizuka T, 2012, FEBS J, V279, P2645, DOI 10.1111/j.1742-4658.2012.08643.x; Pavlicek J, 2003, BIOCHEMISTRY-US, V42, P9295, DOI 10.1021/bi0272981; Poget SF, 2001, BIOCHEMISTRY-US, V40, P10966, DOI 10.1021/bi002698z; Prost LR, 2012, ACS CHEM BIOL, V7, P1603, DOI 10.1021/cb300260p; Reina JJ, 2008, ORG BIOMOL CHEM, V6, P2743, DOI 10.1039/b802144a; Reina JJ, 2007, CHEMMEDCHEM, V2, P1030, DOI 10.1002/cmdc.200700047; Sambrook J, 2001, MOL CLONING LAB MANU; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Snyder GA, 2005, J MOL BIOL, V347, P979, DOI 10.1016/j.jmb.2005.01.063; Soilleux EJ, 2000, J IMMUNOL, V165, P2937, DOI 10.4049/jimmunol.165.6.2937; SUDMEIER JL, 1980, J MAGN RESON, V40, P377, DOI 10.1016/0022-2364(80)90261-9; Timpano G, 2008, CHEMBIOCHEM, V9, P1921, DOI 10.1002/cbic.200800139; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Watson AA, 2011, J BIOL CHEM, V286, P24208, DOI 10.1074/jbc.M111.226142; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Yu QD, 2009, J MOL BIOL, V387, P1075, DOI 10.1016/j.jmb.2009.02.046	68	12	12	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22745	22757		10.1074/jbc.M113.458299	http://dx.doi.org/10.1074/jbc.M113.458299			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23788638	Green Published, hybrid			2022-12-25	WOS:000330596300052
J	Tang, YQ; Wilmann, PG; Reeve, SB; Coetzer, TH; Smith, AI; Whisstock, JC; Pike, RN; Wijeyewickrema, LC				Tang Yongqing; Wilmann, Pascal G.; Reeve, Shane B.; Coetzer, Theresa H.; Smith, A. Ian; Whisstock, James C.; Pike, Robert N.; Wijeyewickrema, Lakshmi C.			The X-ray Crystal Structure of Mannose-binding Lectin-associated Serine Proteinase-3 Reveals the Structural Basis for Enzyme Inactivity Associated with the Carnevale, Mingarelli, Malpuech, and Michels (3MC) Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UMBILICAL ANOMALIES; PATHWAY ACTIVATION; ANTERIOR-CHAMBER; DIFFRACTION DATA; SERUM LECTIN; COMPLEMENT; PROTEASE; MUTATIONS; SKELETAL; PTOSIS	The mannose-binding lectin associated-protease-3 (MASP-3) is a member of the lectin pathway of the complement system, a key component of human innate and active immunity. Mutations in MASP-3 have recently been found to be associated with Carnevale, Mingarelli, Malpuech, and Michels (3MC) syndrome, a severe developmental disorder manifested by cleft palate, intellectual disability, and skeletal abnormalities. However, the molecular basis for MASP-3 function remains to be understood. Here we characterize the substrate specificity of MASP-3 by screening against a combinatorial peptide substrate library. Through this approach, we successfully identified a peptide substrate that was 20-fold more efficiently cleaved than any other identified to date. Furthermore, we demonstrated that mutant forms of the enzyme associated with 3MC syndrome were completely inactive against this substrate. To address the structural basis for this defect, we determined the 2.6-angstrom structure of the zymogen form of the G666E mutant of MASP-3. These data reveal that the mutation disrupts the active site and perturbs the position of the catalytic serine residue. Together, these insights into the function of MASP-3 reveal how a mutation in this enzyme causes it to be inactive and thus contribute to the 3MC syndrome.	[Tang Yongqing; Wilmann, Pascal G.; Reeve, Shane B.; Smith, A. Ian; Whisstock, James C.; Pike, Robert N.; Wijeyewickrema, Lakshmi C.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Whisstock, James C.] Monash Univ, Australian Ctr Excellence Struct & Funct Microbia, Clayton, Vic 3800, Australia; [Coetzer, Theresa H.] Univ KwaZulu Natal, Sch Life Sci, Dept Biochem, ZA-3209 Scottsville, South Africa	Monash University; Monash University; University of Kwazulu Natal	Pike, RN (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	rob.pike@monash.edu; lakshmi.wijeyewickrema@monash.edu	Wijeyewickrema, Lakshmi/A-9676-2015; Coetzer, Theresa/AAM-9193-2021; Coetzer, Theresa/AAE-6207-2019	Wijeyewickrema, Lakshmi/0000-0001-6084-4887; Coetzer, Theresa/0000-0003-0706-3808; Pike, Robert/0000-0002-2083-0269; Smith, Ian/0000-0002-4143-2892; Whisstock, James/0000-0003-4200-5611; Wilmann, Pascal/0000-0002-8376-5150	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a program grant from the National Health and Medical Research Council of Australia.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al Kaissi A, 2007, AM J MED GENET A, V143A, P349, DOI 10.1002/ajmg.a.31610; Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; CARNEVALE F, 1989, AM J MED GENET, V33, P186, DOI 10.1002/ajmg.1320330210; Cortesio CL, 2006, ARCH BIOCHEM BIOPHYS, V449, P164, DOI 10.1016/j.abb.2006.02.006; Degn SE, 2012, J IMMUNOL, V189, P3957, DOI 10.4049/jimmunol.1201736; Degn SE, 2010, J IMMUNOL METHODS, V361, P37, DOI 10.1016/j.jim.2010.07.006; Duncan RC, 2012, J IMMUNOL, V189, P2365, DOI 10.4049/jimmunol.1201085; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Endo Y, 1998, J IMMUNOL, V161, P4924; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Goldring JPD, 2005, IMMUNOL INVEST, V34, P101, DOI 10.1081/IMM-200049537; Hansen S, 2010, J IMMUNOL, V185, P6096, DOI 10.4049/jimmunol.1002185; Heja D, 2012, P NATL ACAD SCI USA, V109, P10498, DOI 10.1073/pnas.1202588109; IKEDA K, 1987, J BIOL CHEM, V262, P7451; Iwaki D, 2011, J IMMUNOL, V187, P3751, DOI 10.4049/jimmunol.1100280; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Leal GF, 2008, AM J MED GENET A, V146A, P1059, DOI 10.1002/ajmg.a.32252; MALPUECH G, 1983, AM J MED GENET, V16, P475, DOI 10.1002/ajmg.1320160405; Matsushita M, 1996, J BIOL CHEM, V271, P2448, DOI 10.1074/jbc.271.5.2448; MICHELS VV, 1978, J PEDIATR-US, V93, P444, DOI 10.1016/S0022-3476(78)81154-8; Mingarelli R, 1996, J MED GENET, V33, P884, DOI 10.1136/jmg.33.10.884; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Rooryck C, 2011, NAT GENET, V43, P197, DOI 10.1038/ng.757; Rossi V, 2001, J BIOL CHEM, V276, P40880, DOI 10.1074/jbc.M105934200; Sim RB, 2004, BIOCHEM SOC T, V32, P21, DOI 10.1042/BST0320021; Sirmaci A, 2010, AM J HUM GENET, V87, P679, DOI 10.1016/j.ajhg.2010.09.018; Thielens NM, 2001, J IMMUNOL, V166, P5068, DOI 10.4049/jimmunol.166.8.5068; Wallis R, 2000, J BIOL CHEM, V275, P30962, DOI 10.1074/jbc.M004030200; Wijeyewickrema LC, 2013, J BIOL CHEM, V288, P15571, DOI 10.1074/jbc.M113.451757; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701	35	20	19	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22399	22407		10.1074/jbc.M113.483875	http://dx.doi.org/10.1074/jbc.M113.483875			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23792966	Green Published, hybrid			2022-12-25	WOS:000330596300021
J	Alfonso-Morales, A; Martinez-Perez, O; Dolz, R; Valle, R; Perera, CL; Bertran, K; Frias, MT; Majo, N; Ganges, L; Perez, LJ				Alfonso-Morales, Abdulahi; Martinez-Perez, Orlando; Dolz, Roser; Valle, Rosa; Perera, Carmen L.; Bertran, Kateri; Frias, Maria T.; Majo, Natalia; Ganges, Llilianne; Perez, Lester J.			Spatiotemporal Phylogenetic Analysis and Molecular Characterisation of Infectious Bursal Disease Viruses Based on the VP2 Hyper-Variable Region	PLOS ONE			English	Article							WILD BIRDS; RECOMBINATION; INFERENCE; OUTBREAK; IBDV; EPIDEMIOLOGY; ALGORITHM; SEQUENCES; SELECTION; REVEALS	Background: Infectious bursal disease is a highly contagious and acute viral disease caused by the infectious bursal disease virus (IBDV); it affects all major poultry producing areas of the world. The current study was designed to rigorously measure the global phylogeographic dynamics of IBDV strains to gain insight into viral population expansion as well as the emergence, spread and pattern of the geographical structure of very virulent IBDV (vvIBDV) strains. Methodology/Principal Findings: Sequences of the hyper-variable region of the VP2 (HVR-VP2) gene from IBDV strains isolated from diverse geographic locations were obtained from the GenBank database; Cuban sequences were obtained in the current work. All sequences were analysed by Bayesian phylogeographic analysis, implemented in the Bayesian Evolutionary Analysis Sampling Trees (BEAST), Bayesian Tip-association Significance testing (BaTS) and Spatial Phylogenetic Reconstruction of Evolutionary Dynamics (SPREAD) software packages. Selection pressure on the HVR-VP2 was also assessed. The phylogeographic association-trait analysis showed that viruses sampled from individual countries tend to cluster together, suggesting a geographic pattern for IBDV strains. Spatial analysis from this study revealed that strains carrying sequences that were linked to increased virulence of IBDV appeared in Iran in 1981 and spread to Western Europe (Belgium) in 1987, Africa (Egypt) around 1990, East Asia (China and Japan) in 1993, the Caribbean Region (Cuba) by 1995 and South America (Brazil) around 2000. Selection pressure analysis showed that several codons in the HVR-VP2 region were under purifying selection. Conclusions/Significance: To our knowledge, this work is the first study applying the Bayesian phylogeographic reconstruction approach to analyse the emergence and spread of vvIBDV strains worldwide.	[Alfonso-Morales, Abdulahi; Perera, Carmen L.; Frias, Maria T.; Perez, Lester J.] Ctr Nacl Sanidad Agropecuaria CENSA, Havana, Cuba; [Martinez-Perez, Orlando] UCI, Havana, Cuba; [Dolz, Roser; Valle, Rosa; Bertran, Kateri; Majo, Natalia; Ganges, Llilianne] Ctr Recerca Sanitat Anim CReSA, Barcelona, Spain; [Majo, Natalia] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, E-08193 Barcelona, Spain	IRTA; Autonomous University of Barcelona	Perez, LJ (corresponding author), Ctr Nacl Sanidad Agropecuaria CENSA, Havana, Cuba.	lesterjosue@censa.edu.cu	Masferrer, Natàlia Majó/AAV-3696-2021; Perez, Lester J./A-1339-2016; Ganges, Llilianne/O-7342-2017; Bertran, Kateri/H-3458-2019	Perez, Lester J./0000-0002-5717-5181; Ganges, Llilianne/0000-0002-8644-3560; Bertran, Kateri/0000-0002-6920-4154; Perera, Carmen Laura/0000-0002-8032-0412; Alfonso, Abdulahi/0000-0002-8710-6099; Majo, Natalia/0000-0003-0189-9751	MAEC-AECID program of the Spanish government	MAEC-AECID program of the Spanish government	The work was partially supported by a 2011/12 scholarship from the MAEC-AECID program of the Spanish government. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghakhan S. M., 1994, Archives de l'Institut Razi, P1; Anisimova M, 2007, MOL BIOL EVOL, V24, P1219, DOI 10.1093/molbev/msm042; Babaahmady E, 2005, REDVET, V4; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Banda A, 2004, AVIAN DIS, V48, P540, DOI 10.1637/7157-12304R; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; CHETTLE N, 1989, VET REC, V125, P271, DOI 10.1136/vr.125.10.271; Cortey M, 2012, AVIAN PATHOL, V41, P277, DOI 10.1080/03079457.2012.682562; COSGROVE AS, 1962, AVIAN DIS, V6, P385, DOI 10.2307/1587909; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; DOBOS P, 1979, J VIROL, V32, P593, DOI 10.1128/JVI.32.2.593-605.1979; Dolz R, 2005, AVIAN DIS, V49, P332, DOI 10.1637/7299-110204R1.1; Domingo E, 1996, FASEB J, V10, P859, DOI 10.1096/fasebj.10.8.8666162; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duret L, 2008, NATURE ED, V1, P1; Elena SF, 1997, EVOLUTION, V51, P984, DOI 10.1111/j.1558-5646.1997.tb03679.x; Esbjornsson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017025; de Carvalho LMF, 2013, INFECT GENET EVOL, V13, P76, DOI 10.1016/j.meegid.2012.08.016; Faria NR, 2011, CURR OPIN VIROL, V1, P423, DOI 10.1016/j.coviro.2011.10.003; Fernandez A, 1998, TALL INT GUMB 98 CUB, P17; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gonzalez Insua R, 2005, REDVET, V4; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Heath L, 2006, J VIROL, V80, P11827, DOI 10.1128/JVI.01100-06; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; Hon CC, 2006, J VIROL, V80, P8503, DOI 10.1128/JVI.00585-06; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; ISMAIL NM, 1991, AVIAN DIS, V35, P460, DOI 10.2307/1591208; ISMAIL NM, 1988, AVIAN DIS, V32, P757, DOI 10.2307/1590995; Jackwood DJ, 2007, VIROLOGY, V365, P369, DOI 10.1016/j.virol.2007.03.046; Jeon WJ, 2008, VIRUS RES, V137, P153, DOI 10.1016/j.virusres.2008.06.013; Kasanga CJ, 2008, VIRUS GENES, V36, P521, DOI 10.1007/s11262-008-0219-z; KIBENGE FSB, 1988, J GEN VIROL, V69, P1757, DOI 10.1099/0022-1317-69-8-1757; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; KISHINO H, 1990, J MOL EVOL, V31, P151, DOI 10.1007/BF02109483; Lasher HN, 1997, AVIAN DIS, V41, P11, DOI 10.2307/1592439; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Liu HJ, 2001, RES VET SCI, V70, P139, DOI 10.1053/rvsc.2001.0450; Lukert PD, 1997, DIS POULTRY, P721; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; MCFERRAN JB, 1980, AVIAN PATHOL, V9, P395, DOI 10.1080/03079458008418423; Moscoso H, 2006, AVIAN DIS, V50, P391, DOI 10.1637/7505-011306R.1; NEI M, 1986, MOL BIOL EVOL, V3, P418; Noda J., 2003, Revista Cubana de Ciencia Avicola, V27, P139; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Perera CL, 2002, REV CUBANA CIENCIA A, V26, P137; Perera CL, 2005, REDVET, V6; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pybus OG, 2012, PARASITOLOGY, V139, P1914, DOI 10.1017/S0031182012000261; Rambaut A., 2008, FIGTREE V112; Rodriguez-Lecompte JC, 2005, COMP IMMUNOL MICROB, V28, P321, DOI 10.1016/j.cimid.2005.08.004; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Silva FMF, 2013, INFECT GENET EVOL, V13, P18, DOI 10.1016/j.meegid.2012.09.005; SMITH JM, 1992, J MOL EVOL, V34, P126; VAKHARIA VN, 1994, VIRUS RES, V31, P265, DOI 10.1016/0168-1702(94)90009-4; Van den Berg TP, 2004, AVIAN PATHOL, V1, P1; VANDENBERG TP, 1991, AVIAN PATHOL, V20, P409, DOI 10.1080/03079459108418779; Venereo M., 1982, Revista Cubana de Ciencias Veterinarias, V13, P29; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	70	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e65999	10.1371/journal.pone.0065999	http://dx.doi.org/10.1371/journal.pone.0065999			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805195	Green Published, gold, Green Submitted			2022-12-25	WOS:000320846500023
J	Bengani, H; Mendiratta, S; Maini, J; Vasanthi, D; Sultana, H; Ghasemi, M; Ahluwalia, J; Ramachandran, S; Mishra, RK; Brahmachari, V				Bengani, Hemant; Mendiratta, Shweta; Maini, Jayant; Vasanthi, Dasari; Sultana, Hina; Ghasemi, Mohsen; Ahluwalia, Jasmine; Ramachandran, Sowmya; Mishra, Rakesh K.; Brahmachari, Vani			Identification and Validation of a Putative Polycomb Responsive Element in the Human Genome	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; DROSOPHILA-ENGRAILED GENE; TRITHORAX-GROUP GENE; GROUP PROTEINS; BITHORAX COMPLEX; DNA-BINDING; EPIGENETIC INHERITANCE; REPRESSOR COMPLEX; STEM-CELLS; IN-VIVO	Epigenetic cellular memory mechanisms that involve polycomb and trithorax group of proteins are well conserved across metazoans. The cis-acting elements interacting with these proteins, however, are poorly understood in mammals. In a directed search we identified a potential polycomb responsive element with 25 repeats of YY1 binding motifthatwe designate PRE-PIK3C2B as it occurs in the first intron of human PIK3C2B gene. It down regulates reporter gene expression in HEK cells and the repression is dependent on polycomb group of proteins (PcG). We demonstrate that PRE-PIK3C2B interacts directly with YY1 in vitro and recruits PRC2 complex in vivo. The localization of PcG proteins including YY1 to PRE-PIK3C2B in HEK cells is decreased on knock-down of either YY1 or SUZ12. Endogenous PRE-PIK3C2B shows bivalent marking having H3K27me3 and H3K4me3 for repressed and active state respectively. In transgenic Drosophila, PRE-PIK3C2B down regulates mini-white expression, exhibits variegation and pairing sensitive silencing (PSS), which has not been previously demonstrated for mammalian PRE. Taken together, our results strongly suggest that PRE-PIK3C2B functions as a site of interaction for polycomb proteins.	[Bengani, Hemant; Mendiratta, Shweta; Maini, Jayant; Ghasemi, Mohsen; Ahluwalia, Jasmine; Ramachandran, Sowmya; Brahmachari, Vani] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India; [Vasanthi, Dasari; Sultana, Hina; Mishra, Rakesh K.] Ctr Cellular & Mol Biol CSIR, Hyderabad, Andhra Pradesh, India	University of Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Brahmachari, V (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India.	vbrahmachari@acbr.du.ac.in	Ramachandran, Sowmya/AAF-9554-2019; Maini, Jayant/ABH-3245-2021; Mishra, Rakesh K/F-3496-2010	Mishra, Rakesh K/0000-0001-6636-7380	Department of Science and Technology; Council for Scientific and Industrial Research, Government of India	Department of Science and Technology(Department of Science & Technology (India)); Council for Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	VB and RKM acknowledge the grant from Department of Science and Technology and Council for Scientific and Industrial Research, Government of India. HB, HS, JA, SM, SR and JM acknowledge the financial assistance through research fellowship from Council for Scientific and Industrial Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcaro A, 2000, MOL CELL BIOL, V20, P3817, DOI 10.1128/MCB.20.11.3817-3830.2000; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blastyak A, 2006, MOL CELL BIOL, V26, P1434, DOI 10.1128/MCB.26.4.1434-1444.2006; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; Brown JL, 2005, NUCLEIC ACIDS RES, V33, P5181, DOI 10.1093/nar/gki827; Brown JL, 1998, MOL CELL, V1, P1057, DOI 10.1016/S1097-2765(00)80106-9; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; CAMPBELL RB, 1995, MOL GEN GENET, V246, P291, DOI 10.1007/BF00288601; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; Cuddapah S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036365; Dejardin J, 2005, NATURE, V434, P533, DOI 10.1038/nature03386; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; Fritsch C, 1999, DEVELOPMENT, V126, P3905; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; Gupta R, 2011, NUCLEIC ACIDS RES, V39, pD92, DOI 10.1093/nar/gkq1171; Hagstrom K, 1997, GENETICS, V14, P61365; Hodgson JW, 2001, MOL CELL BIOL, V21, P4528, DOI 10.1128/MCB.21.14.4528-4543.2001; Kahn TG, 2006, J BIOL CHEM, V281, P29064, DOI 10.1074/jbc.M605430200; Kal AJ, 2000, GENE DEV, V14, P1058; Kassis JA, 2002, ADV GENET, V46, P421; KASSIS JA, 1994, GENETICS, V136, P1025; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Klymenko T, 2004, EMBO REP, V5, P373, DOI 10.1038/sj.embor.7400111; Kobrossy L, 2006, J BIOL CHEM, V281, P25926, DOI 10.1074/jbc.M602555200; Kok K, 2009, TRENDS BIOCHEM SCI, V34, P115, DOI 10.1016/j.tibs.2009.01.003; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Mihaly J, 1998, MOL CELL, V1, P1065, DOI 10.1016/S1097-2765(00)80107-0; Mishra RK, 2007, GENESIS, V45, P570, DOI 10.1002/dvg.20326; Mishra RK, 2001, MOL CELL BIOL, V21, P1311, DOI 10.1128/MCB.21.4.1311-1318.2001; Mousavi K, 2012, MOL CELL, V45, P255, DOI 10.1016/j.molcel.2011.11.019; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Muller M, 1999, GENETICS, V153, P1333; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Ono R, 2005, INT J HEMATOL, V81, P288, DOI 10.1532/IJH97.04196; Orlando V, 1998, EMBO J, V17, P5141, DOI 10.1093/emboj/17.17.5141; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Ratajewski L, 2009, GENE, V94, P407; Ringrose L, 2003, DEV CELL, V5, P759, DOI 10.1016/S1534-5807(03)00337-X; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Sipos L, 2007, P NATL ACAD SCI USA, V104, P12416, DOI 10.1073/pnas.0703144104; Soshnikova N, 2009, EPIGENETICS-US, V4, P537, DOI 10.4161/epi.4.8.10132; Srinivasan L, 2004, GENE DEV, V18, P2596, DOI 10.1101/gad.1228204; Srivastava S, 2009, MOL BIOL CELL, V20, P3783, DOI 10.1091/mbc.E09-05-0390; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Voie A, 1997, CELL BIOL LAB HDB, V3, P510; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632; Yu M, 2012, MOL CELL, V45, P330, DOI 10.1016/j.molcel.2011.11.032; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	67	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67217	10.1371/journal.pone.0067217	http://dx.doi.org/10.1371/journal.pone.0067217			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805300	gold, Green Published, Green Submitted			2022-12-25	WOS:000320846500128
J	Brante, A; Fernandez, M; Viard, F				Brante, Antonio; Fernandez, Miriam; Viard, Frederique			Non-Random Sibling Cannibalism in the Marine Gastropod Crepidula coquimbensis	PLOS ONE			English	Article							EGG MASSES; OXYGEN AVAILABILITY; KIN RECOGNITION; SIZE; INVERTEBRATES; CONSTRAINTS; PERFORMANCE; EMBRYOS; AGE; IDENTIFICATION	Sibling cannibalism is commonly observed in marine species. For instance, intrabrood cannibalism has been documented in marine gastropods with direct development, suggesting a relationship between embryo behavior and the evolution of life history strategies. However, there has been little effort to document the factors driving sibling cannibalism in marine species. The kin selection theory suggests that the level of relatedness plays an important role in cannibalism patterns. We examined Crepidula coquimbensis, a marine gastropod that broods and encloses its brooded offspring in capsules. Encapsulated embryos show sibling cannibalism and high levels of intracapsular multiple paternity. Given these features, cannibalistic behavior may be driven by kin-relatedness. To test this hypothesis, we constructed artificial aggregations of embryos to mimic three levels of relatedness: high, medium and low. For each category of aggregation, the cannibalism rate and benefits (i.e. size at hatching of surviving offspring) were estimated. In addition, at the end of embryo development, we performed parentage analyses to determine if cannibalism was associated with the relatedness between cannibal and victim embryos. Our results show that the intensity of sibling cannibalism increased in aggregations characterized by the lowest level of relatedness. There were important benefits of cannibalism in terms of hatching cannibal size. In addition, cannibalism between embryos was not random: the variation in reproductive success between males increased over the course of the experiment and the effective number of fathers decreased. Altogether, these results suggest that polyandry may play an important role in the evolution of sibling cannibalism in C. coquimbensis and that kin selection may operate during early embryonic stages in this species.	[Brante, Antonio] Univ Catolica Santisima Concepcion, Fac Ciencias, Dept Ecol, Concepcion, Chile; [Fernandez, Miriam] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Estn Costera Invest Marinas Las Cruces, Ctr Marine Conservat,Dept Ecol, Santiago, Chile; [Brante, Antonio; Fernandez, Miriam; Viard, Frederique] Int Associated Lab Dispersal & Adaptat Marine Spe, Stn Biol Roscoff, Roscoff, France; [Brante, Antonio; Fernandez, Miriam; Viard, Frederique] Int Associated Lab Dispersal & Adaptat Marine Spe, Ctr Adv Studies Ecol & Biodivers CASEB, Roscoff, France; [Viard, Frederique] UPMC Univ Paris 06, Adaptat & Div Marine Environm UMR 7144, Stn Biolog Roscoff, F-29682 Roscoff, France; [Viard, Frederique] CNRS, Stn Biol Roscoff, Team Divers & Connect Coastal Marine Landscapes, UMR 7144, F-29682 Roscoff, France	Universidad Catolica de la Santisima Concepcion; Pontificia Universidad Catolica de Chile; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Brante, A (corresponding author), Univ Catolica Santisima Concepcion, Fac Ciencias, Dept Ecol, Concepcion, Chile.	abrante@ucsc.cl	Viard, Frédérique/O-4360-2018	Viard, Frédérique/0000-0001-5603-9527; Brante, Antonio/0000-0002-2699-9700	CONICYT [AT 24050187]; French Ministry for Higher Education and Research; International Relations Department of the National Centre for Scientific (CNRS); ECOS funds; Fondecyt [11090221, 1060489]; FONDAP-FONDECYT grant [1501-0001]; French National Research Agency [ANR-05-BLAN-0001]; CNRS	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); French Ministry for Higher Education and Research; International Relations Department of the National Centre for Scientific (CNRS); ECOS funds; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDAP-FONDECYT grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYTCONICYT FONDAP); French National Research Agency(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	AB received financial support from a CONICYT PhD scholarship (AT 24050187), French Ministry for Higher Education and Research, and the International Relations Department of the National Centre for Scientific (CNRS). Travel grants were provided by ECOS funds. AB thanks the IDEA Wild foundation and Fondecyt project # 11090221. MF thanks Fondecyt project # 1060489 and FONDAP-FONDECYT grant 1501-0001 to the Center for Advanced Studies in Ecology and Biodiversity. FV and AB were supported by the French National Research Agency (Project MIRAGE, No. ANR-05-BLAN-0001). FV, MF and AB acknowledge the CNRS for its financial support of the International Associated Laboratory DIAMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist Goran, 2005, pUnpaginated; BAUR B, 1990, FUNCT ECOL, V4, P679, DOI 10.2307/2389736; Baur Bruno, 1992, P102; Brante A, 2008, MAR ECOL PROG SER, V368, P197, DOI 10.3354/meps07605; Brante A, 2011, J EXP MAR BIOL ECOL, V396, P83, DOI 10.1016/j.jembe.2010.10.001; Brante A, 2009, J EXP BIOL, V212, P2287, DOI 10.1242/jeb.016329; Brown DI, 1996, J NAT HIST, V30, P1443, DOI 10.1080/00222939600770821; CHAFFEE C, 1984, J EXP MAR BIOL ECOL, V84, P73, DOI 10.1016/0022-0981(84)90231-4; Collin R, 2003, MAR ECOL PROG SER, V247, P103, DOI 10.3354/meps247103; COLLINS JP, 1983, AM ZOOL, V23, P77; Crump Martha L., 1992, P256; Dugin C, 2007, MOL ECOL NOTES, DOI [10.1111/j.1471-8286.2007.01788.x, DOI 10.1111/J.1471-8286.2007.01788.X]; EICKWORT KR, 1973, AM NAT, V107, P452, DOI 10.1086/282847; Elgar M., 1992, CANNIBALISM ECOLOGY, V1st; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Emlet RB, 1997, EVOLUTION, V51, P141, DOI 10.1111/j.1558-5646.1997.tb02395.x; Fioroni P, 1967, VIE MILLEU, V18, P143; GALLARDO CS, 1979, BIOL BULL, V157, P453, DOI 10.2307/1541030; Gibson G, 1999, MAR BIOL, V134, P743, DOI 10.1007/s002270050591; GODFRAY HCJ, 1992, NATURE, V360, P213, DOI 10.1038/360213a0; GRBIC M, 1992, NATURE, V360, P254, DOI 10.1038/360254a0; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HEDGECOCK D, 1994, GENETICS AND EVOLUTION OF AQUATIC ORGANISMS, P122; Higuchi R, 1989, PCR TECHNOLOGY PRINC, P31; Ito K, 1997, MAR ECOL PROG SER, V152, P187, DOI 10.3354/meps152187; Kamel SJ, 2010, INTEGR COMP BIOL, V50, P619, DOI 10.1093/icb/icq104; Kamel SJ, 2010, TRENDS ECOL EVOL, V25, P442, DOI 10.1016/j.tree.2010.05.008; KAWAI A, 1978, Kontyu, V46, P14; KLAHN JE, 1983, SCIENCE, V221, P482, DOI 10.1126/science.221.4609.482; Kudo S, 2004, OIKOS, V107, P28, DOI 10.1111/j.0030-1299.2004.13169.x; Lardies MA, 2002, MAR ECOL PROG SER, V239, P139, DOI 10.3354/meps239139; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; MEAGHER TR, 1986, AM NAT, V128, P199, DOI 10.1086/284554; Miloslavich P, 2001, NAUTILUS, V115, P39; Mock D. W., 1997, EVOLUTION SIBLING RI; Mock Douglas W., 1998, P146; Moran AL, 2001, ECOLOGY, V82, P1597, DOI 10.2307/2679803; Moran AL, 2007, J EXP BIOL, V210, P722, DOI 10.1242/jeb.02702; Ng SM, 1986, ECOLOGY APHIDOPHAGA, P69; OSAWA N, 1992, RES POPUL ECOL, V34, P45, DOI 10.1007/BF02513521; PECHENIK JA, 1979, AM NAT, V114, P859, DOI 10.1086/283533; PERRON FE, 1982, OECOLOGIA, V55, P319, DOI 10.1007/BF00376919; PFENNIG DW, 1993, NATURE, V362, P836, DOI 10.1038/362836a0; PFENNIG DW, 1993, ANIM BEHAV, V46, P87, DOI 10.1006/anbe.1993.1164; Pfennig DW, 1997, BIOSCIENCE, V47, P667, DOI 10.2307/1313207; PFENNIG DW, 1994, BEHAV ECOL, V5, P225, DOI 10.1093/beheco/5.2.225; PIENKOWSKI ROBERT L., 1965, ANN ENTOMOL SOC AMER, V58, P150, DOI 10.1093/aesa/58.2.150; POLIS GA, 1981, ANNU REV ECOL SYST, V12, P225, DOI 10.1146/annurev.es.12.110181.001301; RATNIEKS FLW, 1989, NATURE, V342, P796, DOI 10.1038/342796a0; RUMRILL SS, 1990, OPHELIA, V32, P163, DOI 10.1080/00785236.1990.10422030; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; SPIGHT TM, 1976, BIOL BULL, V150, P491, DOI 10.2307/1540687; STRATHMANN RR, 1982, AM NAT, V119, P91, DOI 10.1086/283892; STRATHMANN RR, 1984, J EXP MAR BIOL ECOL, V84, P85, DOI 10.1016/0022-0981(84)90232-6; TRIVERS RL, 1974, AM ZOOL, V14, P249; Veliz D, 2003, MAR BIOL, V143, P131, DOI 10.1007/s00227-003-1042-7; WADE MJ, 1980, EVOLUTION, V34, P844, DOI 10.1111/j.1558-5646.1980.tb04023.x; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; WOURMS JP, 1977, AM ZOOL, V17, P379; YUND PO, 1994, ECOLOGY, V75, P2151, DOI 10.2307/1940874	60	17	17	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67050	10.1371/journal.pone.0067050	http://dx.doi.org/10.1371/journal.pone.0067050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805291	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500119
J	Csolle, C; Baranyi, M; Zsilla, G; Kittel, A; Goloncser, F; Illes, P; Papp, E; Vizi, ES; Sperlagh, B				Csoelle, Cecilia; Baranyi, Maria; Zsilla, Gabriella; Kittel, Agnes; Goeloencser, Flora; Illes, Peter; Papp, Edit; Vizi, E. Sylvester; Sperlagh, Beata			Neurochemical Changes in the Mouse Hippocampus Underlying the Antidepressant Effect of Genetic Deletion of P2X7 Receptors	PLOS ONE			English	Article							NEUROTROPHIC FACTOR BDNF; C-FOS EXPRESSION; P2X(7) RECEPTORS; NMDA RECEPTORS; ANIMAL-MODELS; P2RX7 GENE; NEUROTRANSMITTER RELEASE; DIFFERENTIAL REGULATION; GLN460ARG POLYMORPHISM; GLUTAMATE RELEASE	Recent investigations have revealed that the genetic deletion of P2X7 receptors (P2rx7) results in an antidepressant phenotype in mice. However, the link between the deficiency of P2rx7 and changes in behavior has not yet been explored. In the present study, we studied the effect of genetic deletion of P2rx7 on neurochemical changes in the hippocampus that might underlie the antidepressant phenotype. P2X7 receptor deficient mice (P2rx7-/-) displayed decreased immobility in the tail suspension test (TST) and an attenuated anhedonia response in the sucrose preference test (SPT) following bacterial endotoxin (LPS) challenge. The attenuated anhedonia was reproduced through systemic treatments with P2rx7 antagonists. The activation of P2rx7 resulted in the concentration-dependent release of [H-3]glutamate in P2rx7+/+ but not P2rx7-/- mice, and the NR2B subunit mRNA and protein was upregulated in the hippocampus of P2rx7-/- mice. The brain-derived neurotrophic factor (BDNF) expression was higher in saline but not LPS-treated P2rx7-/- mice; the P2rx7 antagonist Brilliant blue G elevated and the P2rx7 agonist benzoylbenzoyl ATP (BzATP) reduced BDNF level. This effect was dependent on the activation of NMDA and non-NMDA receptors but not on Group I metabotropic glutamate receptors (mGluR(1,5)). An increased 5-bromo-2-deoxyuridine (BrdU) incorporation was also observed in the dentate gyrus derived from P2rx7-/- mice. Basal level of 5-HT was increased, whereas the 5HIAA/5-HT ratio was lower in the hippocampus of P2rx7-/- mice, which accompanied the increased uptake of [H-3]5-HT and an elevated number of [H-3]citalopram binding sites. The LPS-induced elevation of 5-HT level was absent in P2rx7-/- mice. In conclusion there are several potential mechanisms for the antidepressant phenotype of P2rx7-/- mice, such as the absence of P2rx7-mediated glutamate release, elevated basal BDNF production, enhanced neurogenesis and increased 5-HT bioavailability in the hippocampus.	[Csoelle, Cecilia; Baranyi, Maria; Zsilla, Gabriella; Kittel, Agnes; Goeloencser, Flora; Vizi, E. Sylvester; Sperlagh, Beata] Hungarian Acad Sci, Inst Expt Med, Dept Pharmacol, Budapest, Hungary; [Papp, Edit] Hungarian Acad Sci, Inst Expt Med, Dept Cellular & Network Neurobiol, Budapest, Hungary; [Vizi, E. Sylvester] Semmelweis Univ, Dept Pharmacol & Pharmacotherapy, H-1085 Budapest, Hungary; [Illes, Peter] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, D-04109 Leipzig, Germany	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Semmelweis University; Leipzig University	Sperlagh, B (corresponding author), Hungarian Acad Sci, Inst Expt Med, Dept Pharmacol, Budapest, Hungary.	sperlagh@koki.hu			Hungarian Research and Development Fund [NN79957]; Hungarian Medical Research Council [ETT 05-102]; Gedeon Richter plc [4700127848]; NIH grant [U24NS050606]; NATIONAL CANCER INSTITUTE [P01CA095616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS050606] Funding Source: NIH RePORTER	Hungarian Research and Development Fund; Hungarian Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Gedeon Richter plc; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants from the Hungarian Research and Development Fund (Grant NN79957 to B.S.) and the Hungarian Medical Research Council (ETT 05-102 to B.S.) and the Gedeon Richter plc (4700127848). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study received funding from the Gedeon Richter plc (4700127848). This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.; The authors are grateful to Zsuzsanna Korossy for the participation in [<SUP>3</SUP>H]glutamate, [<SUP>3</SUP>H]5-HT and [<SUP>3</SUP>H]NA release experiments. They wish to thank Mr. Laszlo Barna, the Nikon Microscopy Center at IEM, Nikon Austria GmbH and Auro-Science Consulting Ltd for kindly providing microscopy support and for Kata Kenesei and Katalin Kerti (IEM HAS) for their valuable help at microscopic work. The monoclonal antibody GluN2B/NR2B was developed by and obtained from the UC Davis/NIH NeuroMab Facility, supported by NIH grant U24NS050606 and maintained by the Department of Neurobiology, Physiology and Behaviour, College of Biological Sciences, University of California, Davis, CA 95616.	Alloisio S, 2008, FEBS LETT, V582, P3948, DOI 10.1016/j.febslet.2008.10.041; Anderson CM, 2006, TRENDS NEUROSCI, V29, P257, DOI 10.1016/j.tins.2006.03.003; Backlund L, 2011, BIPOLAR DISORD, V13, P500, DOI 10.1111/j.1399-5618.2011.00952.x; Balazsa T, 2008, NEUROCHEM INT, V52, P95, DOI 10.1016/j.neuint.2007.07.008; Balu DT, 2008, BRAIN RES, V1211, P37, DOI 10.1016/j.brainres.2008.03.023; BANERJEE SP, 1977, NATURE, V268, P455, DOI 10.1038/268455a0; Baranyi M, 2006, J CHROMATOGR A, V1120, P13, DOI 10.1016/j.chroma.2006.03.018; BARBACCIA ML, 1983, P NATL ACAD SCI-BIOL, V80, P5134, DOI 10.1073/pnas.80.16.5134; Barbera-Cremades M, 2012, FASEB J, V26, P2951, DOI 10.1096/fj.12-205765; Barden N, 2006, AM J MED GENET B, V141B, P374, DOI 10.1002/ajmg.b.30303; Barnholtz JS, 1999, GENET EPIDEMIOL, V17, pS49; Basso AM, 2009, BEHAV BRAIN RES, V198, P83, DOI 10.1016/j.bbr.2008.10.018; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bocchio-Chiavetto L, 2006, EUR NEUROPSYCHOPHARM, V16, P620, DOI 10.1016/j.euroneuro.2006.04.010; Boucher AA, 2011, NEUROSCIENCE, V189, P170, DOI 10.1016/j.neuroscience.2011.05.049; Boyce-Rustay JM, 2006, NEUROPSYCHOPHARMACOL, V31, P2405, DOI 10.1038/sj.npp.1301039; Brautigam VM, 2005, J NEUROIMMUNOL, V166, P113, DOI 10.1016/j.jneuroim.2005.05.012; Castren E, 2005, NAT REV NEUROSCI, V6, P241, DOI 10.1038/nrn1629; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Csolle C, 2013, INT J NEUROPSYCHOPH, V16, P213, DOI 10.1017/S1461145711001933; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Delarasse C, 2009, J NEUROCHEM, V109, P846, DOI 10.1111/j.1471-4159.2009.06008.x; Deltheil T, 2008, NEUROPHARMACOLOGY, V55, P1006, DOI 10.1016/j.neuropharm.2008.08.001; Deltheil T, 2008, PHARMACOL BIOCHEM BE, V90, P174, DOI 10.1016/j.pbb.2007.09.018; Diaz-Hernandez M, 2008, J CELL SCI, V121, P3717, DOI 10.1242/jcs.034082; Drigues N, 2003, J NEURAL TRANSM, V110, P1413, DOI 10.1007/s00702-003-0077-8; Duan SM, 2003, J NEUROSCI, V23, P1320, DOI 10.1523/JNEUROSCI.23-04-01320.2003; Duman RS, 1998, J ECT, V14, P181; Dwivedi Y, 2003, ARCH GEN PSYCHIAT, V60, P804, DOI 10.1001/archpsyc.60.8.804; Fossati P, 2004, EUR NEUROPSYCHOPHARM, V14, pS503, DOI 10.1016/j.euroneuro.2004.09.001; Frenois F, 2007, PSYCHONEUROENDOCRINO, V32, P516, DOI 10.1016/j.psyneuen.2007.03.005; Fuchs E, 2004, EUR NEUROPSYCHOPHARM, V14, pS481, DOI 10.1016/j.euroneuro.2004.09.002; Gourine AV, 2005, BRIT J PHARMACOL, V146, P139, DOI 10.1038/sj.bjp.0706287; Green EK, 2009, AM J MED GENET B, V150B, P1063, DOI 10.1002/ajmg.b.30931; GRIFFITHS RJ, 1995, J IMMUNOL, V154, P2821; Grigoroiu-Serbanescu M, 2009, AM J MED GENET B, V150B, P1017, DOI 10.1002/ajmg.b.30952; Groves JO, 2007, MOL PSYCHIATR, V12, P1079, DOI 10.1038/sj.mp.4002075; Guerra AN, 2003, J ENDOTOXIN RES, V9, P256, DOI 10.1179/096805103225001468; Guiard BP, 2008, INT J NEUROPSYCHOPH, V11, P79, DOI 10.1017/S1461145707007857; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hashimoto K, 2007, BIOL PSYCHIAT, V62, P1310, DOI 10.1016/j.biopsych.2007.03.017; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; Hejjas K, 2009, AM J MED GENET B, V150B, P295, DOI 10.1002/ajmg.b.30799; Hogg RC, 2004, EUR J NEUROSCI, V19, P2410, DOI 10.1111/j.0953-816X.2004.03346.x; Hracsko Z, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-28; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; Kitabatake Y, 2007, NEUROSURG CLIN N AM, V18, P105, DOI 10.1016/j.nec.2006.10.008; Koehl M, 2011, EUR J NEUROSCI, V33, P1101, DOI 10.1111/j.1460-9568.2011.07609.x; Kozisek ME, 2008, PHARMACOL THERAPEUT, V117, P30, DOI 10.1016/j.pharmthera.2007.07.001; Kozisek ME, 2008, NEUROPHARMACOLOGY, V54, P251, DOI 10.1016/j.neuropharm.2007.08.001; Krueger JM, 2010, J APPL PHYSIOL, V109, P1318, DOI 10.1152/japplphysiol.00586.2010; Labrousse VF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006006; LAPCHAK PA, 1993, NEUROBIOL AGING, V14, P121, DOI 10.1016/0197-4580(93)90087-R; Lavebratt C, 2010, J AFFECT DISORDERS, V125, P249, DOI 10.1016/j.jad.2010.02.113; Law AJ, 2003, EUR J NEUROSCI, V18, P1197, DOI 10.1046/j.1460-9568.2003.02850.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lucae S, 2006, HUM MOL GENET, V15, P2438, DOI 10.1093/hmg/ddl166; Malberg JE, 2004, J PSYCHIATR NEUROSCI, V29, P196; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Masin M, 2012, BRIT J PHARMACOL, V165, P978, DOI 10.1111/j.1476-5381.2011.01624.x; McQuillin A, 2009, MOL PSYCHIATR, V14, P614, DOI 10.1038/mp.2008.6; Meador-Woodruff JH, 2001, NEUROPSYCHOPHARMACOL, V24, P545, DOI 10.1016/S0893-133X(00)00189-5; Michel AD, 2008, BRIT J PHARMACOL, V153, P737, DOI 10.1038/sj.bjp.0707625; Miras-Portugal MT, 2003, NEUROCHEM RES, V28, P1597, DOI 10.1023/A:1025690913206; MONLEON S, 1995, PSYCHOPHARMACOLOGY, V117, P453, DOI 10.1007/BF02246218; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Mundo E, 2003, MOL PSYCHIATR, V8, P241, DOI 10.1038/sj.mp.4001218; Nagy G, 2008, PROG NEURO-PSYCHOPH, V32, P1884, DOI 10.1016/j.pnpbp.2008.08.021; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Nowak G, 1998, EUR J PHARMACOL, V342, P367, DOI 10.1016/S0014-2999(97)01589-6; Papp L, 2004, NEUROREPORT, V15, P2387, DOI 10.1097/00001756-200410250-00017; Papp L, 2004, J PHARMACOL EXP THER, V310, P973, DOI 10.1124/jpet.104.066712; Patti L, 2006, NEUROPHARMACOLOGY, V50, P705, DOI 10.1016/j.neuropharm.2005.11.016; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rodrigues RJ, 2005, J NEUROSCI, V25, P6286, DOI 10.1523/JNEUROSCI.0628-05.2005; Sanacora G, 2008, J CLIN PSYCHIAT, V69, P22; Sanacora G, 2008, NAT REV DRUG DISCOV, V7, P426, DOI 10.1038/nrd2462; Sanacora G, 2010, BIOL PSYCHIAT, V67, P397, DOI 10.1016/j.biopsych.2010.01.003; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schnydrig S, 2007, NEUROSCI LETT, V429, P69, DOI 10.1016/j.neulet.2007.09.067; Scimemi A, 2004, J NEUROSCI, V24, P4767, DOI 10.1523/JNEUROSCI.0364-04.2004; Shimizu E, 2003, BIOL PSYCHIAT, V54, P70, DOI 10.1016/S0006-3223(03)00181-1; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Shukla V, 2005, J NEUROSCI RES, V80, P600, DOI 10.1002/jnr.20508; Skolnick P, 1996, PHARMACOPSYCHIATRY, V29, P23, DOI 10.1055/s-2007-979537; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Soronen P, 2011, AM J MED GENET B, V156B, P435, DOI 10.1002/ajmg.b.31179; Sperlagh B, 2002, J NEUROCHEM, V81, P1196, DOI 10.1046/j.1471-4159.2002.00920.x; Sperlagh B, 2007, PURINERG SIGNAL, V3, P269, DOI 10.1007/s11302-007-9080-0; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Stokes L, 2010, FASEB J, V24, P2916, DOI 10.1096/fj.09-150862; Szapacs ME, 2004, J NEUROSCI METH, V140, P81, DOI 10.1016/j.jneumeth.2004.03.026; Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005; Toro C, 2005, SCHIZOPHR RES, V80, P323, DOI 10.1016/j.schres.2005.07.003; Tovar KR, 1999, J NEUROSCI, V19, P4180; Vanhoutte P, 2003, CURR OPIN NEUROBIOL, V13, P366, DOI 10.1016/S0959-4388(03)00073-4; Verderio C, 2006, BRAIN CELL BIOL, V35, P187, DOI 10.1007/s11068-007-9011-6; Viwatpinyo K, 2009, NEUROSCI LETT, V467, P127, DOI 10.1016/j.neulet.2009.10.020; Wager-Smith K, 2011, NEUROSCI BIOBEHAV R, V35, P742, DOI 10.1016/j.neubiorev.2010.09.010; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156; Williams SN, 2010, J PHARMACOL EXP THER, V332, P463, DOI 10.1124/jpet.109.158535; Wood GE, 2003, HORM BEHAV, V43, P205, DOI 10.1016/S0018-506X(02)00026-0; Zhang L, 2011, J PSYCHIATR RES, V45, P435, DOI 10.1016/j.jpsychires.2010.08.012; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684	106	80	83	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66547	10.1371/journal.pone.0066547	http://dx.doi.org/10.1371/journal.pone.0066547			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805233	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000320846500061
J	Dacheux, E; Vincent, A; Nazaret, N; Combet, C; Wierinckx, A; Mazoyer, S; Diaz, JJ; Lachuer, J; Venezia, ND				Dacheux, Estelle; Vincent, Anne; Nazaret, Nicolas; Combet, Christophe; Wierinckx, Anne; Mazoyer, Sylvie; Diaz, Jean-Jacques; Lachuer, Joel; Venezia, Nicole Dalla			BRCA1-Dependent Translational Regulation in Breast Cancer Cells	PLOS ONE			English	Article							IRES-MEDIATED TRANSLATION; ACETYL-COA CARBOXYLASE; TRANS-ACTING FACTORS; MESSENGER-RNAS; POLY(A)-BINDING PROTEIN; BRCA1 INTERACTS; TOPOISOMERASE-I; HIPK2; EXPRESSION; CLEAVAGE	BRCA1 (Breast Cancer 1) has been implicated in a number of cellular processes, including transcription regulation, DNA damage repair and protein ubiquitination. We previously demonstrated that BRCA1 interacts with PABP1 (Poly(A)-Binding Protein 1) and that BRCA1 modulates protein synthesis through this interaction. To identify the mRNAs that are translationally regulated by BRCA1, we used a microarray analysis of polysome-bound mRNAs in BRCA1-depleted and non-depleted MCF7 cells. Our findings show that BRCA1 modifies the translational efficiency of approximately 7% of the mRNAs expressed in these cells. Further analysis revealed that several processes contributing to cell surveillance such as cell cycle arrest, cell death, cellular growth and proliferation, DNA repair and gene expression, are largely enriched for the mRNAs whose translation is impacted by BRCA1. The BRCA1-dependent translation of these species of mRNAs therefore uncovers a novel mechanism through which BRCA1 exerts its onco-suppressive role. In addition, the BRCA1-dependent translation of mRNAs participating in unexpected functions such as cellular movement, nucleic acid metabolism or protein trafficking is indicative of novel functions for BRCA1. Finally, this study contributes to the identification of several markers associated with BRCA1 deficiency and to the discovery of new potential anti-neoplastic therapeutic targets.	[Dacheux, Estelle; Vincent, Anne; Combet, Christophe; Wierinckx, Anne; Mazoyer, Sylvie; Diaz, Jean-Jacques; Lachuer, Joel; Venezia, Nicole Dalla] Univ Lyon, Lyon, France; [Dacheux, Estelle; Vincent, Anne; Wierinckx, Anne; Mazoyer, Sylvie; Diaz, Jean-Jacques; Lachuer, Joel; Venezia, Nicole Dalla] Univ Lyon 1, ISPB, F-69365 Lyon, France; [Dacheux, Estelle; Vincent, Anne; Wierinckx, Anne; Mazoyer, Sylvie; Diaz, Jean-Jacques; Lachuer, Joel; Venezia, Nicole Dalla] Ctr Rech Cancerol Lyon, INSERM, U1052, Lyon, France; [Dacheux, Estelle; Vincent, Anne; Wierinckx, Anne; Mazoyer, Sylvie; Diaz, Jean-Jacques; Lachuer, Joel; Venezia, Nicole Dalla] Ctr Rech Cancerol Lyon, CNRS, UMR5286, Lyon, France; [Dacheux, Estelle; Vincent, Anne; Mazoyer, Sylvie; Venezia, Nicole Dalla] Equipe Labellisee LIGUE 2008, Lyon, France; [Nazaret, Nicolas; Wierinckx, Anne; Lachuer, Joel] ProfileXpert, Lyon, France; [Combet, Christophe] CNRS, Unite Bases Mol & Struct Systemes Infect, UMR5086, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Venezia, ND (corresponding author), Univ Lyon, Lyon, France.	nicole.dalla-venezia@lyon.unicancer.fr	DIAZ, Jean-Jacques/H-3018-2014; DIAZ, Jean-Jacques/AAT-3846-2021; VENEZIA, Nicole DALLA/C-6542-2017; VINCENT, Anne/X-6761-2019; Mazoyer, Sylvie/N-7559-2017; Wierinckx, Anne/AAF-5233-2021	DIAZ, Jean-Jacques/0000-0002-7914-4319; DIAZ, Jean-Jacques/0000-0002-7914-4319; VENEZIA, Nicole DALLA/0000-0002-4553-3535; VINCENT, Anne/0000-0003-4616-7685; Wierinckx, Anne/0000-0002-0186-6645; Mazoyer, Sylvie/0000-0002-2135-0160; COMBET, Christophe/0000-0002-7348-3520; lachuer, joel/0000-0002-5209-5094; Dacheux, Estelle/0000-0001-8713-2185	'Institut National contre le Cancer' (INCa) (RIBOCAN); 'Ligue Nationale Contre le Cancer'(LNCC) (Equipe labellisee); 'Association pour la Recherche sur le Cancer' (ARC); 'Electricite de France' (EDF) (Commission de Radioprotection); French Ministry of Research; Universite Lyon 1 (Attache Temporaire d'Enseignement et de Recherche)	'Institut National contre le Cancer' (INCa) (RIBOCAN); 'Ligue Nationale Contre le Cancer'(LNCC) (Equipe labellisee); 'Association pour la Recherche sur le Cancer' (ARC)(Fondation ARC pour la Recherche sur le Cancer); 'Electricite de France' (EDF) (Commission de Radioprotection); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Universite Lyon 1 (Attache Temporaire d'Enseignement et de Recherche)	This work was supported by the 'Institut National contre le Cancer' (INCa) (RIBOCAN), the 'Ligue Nationale Contre le Cancer'(LNCC) (Equipe labellisee 2008), the 'Association pour la Recherche sur le Cancer' (ARC) and the 'Electricite de France' (EDF) (Commission de Radioprotection). ED is supported by a fellowship from the French Ministry of Research and from the Universite Lyon 1 (Attache Temporaire d'Enseignement et de Recherche). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Al-Beiti MAM, 2008, AUST NZ J OBSTET GYN, V48, P329, DOI 10.1111/j.1479-828X.2008.00874.x; Anh TNL, 2011, J PROTEOMICS, V74, P167, DOI 10.1016/j.jprot.2010.10.007; Belin S., 2010, CURR PROTOC CELL BIO; Bendell JC, 2012, J CLIN ONCOL, V30, P282, DOI 10.1200/JCO.2011.36.1360; Bilanges B, 2007, ONCOGENE, V26, P5973, DOI 10.1038/sj.onc.1210431; Brunet J, 2008, MOL CARCINOGEN, V47, P157, DOI 10.1002/mc.20364; Bushell M, 2006, MOL CELL, V23, P401, DOI 10.1016/j.molcel.2006.06.012; D'Orazi G, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-63; De Piccoli G, 2009, CHROMOSOME RES, V17, P251, DOI 10.1007/s10577-008-9016-8; Deshmukh H, 2008, ONCOGENE, V27, P4745, DOI 10.1038/onc.2008.110; Dizin E, 2008, APOPTOSIS, V13, P237, DOI 10.1007/s10495-007-0167-4; Dizin E, 2006, J BIOL CHEM, V281, P24236, DOI 10.1074/jbc.M602176200; Fabbro M, 2004, EXP CELL RES, V298, P661, DOI 10.1016/j.yexcr.2004.05.004; Fabbro M, 2003, EXP CELL RES, V282, P59, DOI 10.1016/S0014-4827(02)00019-8; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Gorski JJ, 2011, NUCLEIC ACIDS RES, V39, P9536, DOI 10.1093/nar/gkr679; Gorski JJ, 2010, BREAST CANCER RES TR, V122, P721, DOI 10.1007/s10549-009-0565-0; Hakem R, 1998, J MAMMARY GLAND BIOL, V3, P431, DOI 10.1023/A:1018792200700; Hauge H, 2007, GENOMICS, V90, P14, DOI 10.1016/j.ygeno.2007.03.002; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hofmann TG, 2013, BIOESSAYS, V35, P55, DOI 10.1002/bies.201200060; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Kawai T, 2004, MOL CELL BIOL, V24, P6773, DOI 10.1128/MCB.24.15.6773-6787.2004; King HA, 2010, BIOCHEM SOC T, V38, P1581, DOI 10.1042/BST0381581; Komar AA, 2011, CELL CYCLE, V10, P229, DOI 10.4161/cc.10.2.14472; Lamber EP, 2010, CANCER RES, V70, P996, DOI 10.1158/0008-5472.CAN-09-2842; Lamy PJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2824; Lange CA, 2011, ENDOCR-RELAT CANCER, V18, pC19, DOI 10.1530/ERC-11-0112; Laulier C, 2011, CANCER RES, V71, P3590, DOI 10.1158/0008-5472.CAN-10-3119; Lewis SM, 2008, ONCOGENE, V27, P1033, DOI 10.1038/sj.onc.1210777; Lewis SM, 2007, MOL BIOL CELL, V18, P1302, DOI 10.1091/mbc.E06-06-0515; Lin JC, 2007, P NATL ACAD SCI USA, V104, P2235, DOI 10.1073/pnas.0611015104; Lin NU, 2011, J NEURO-ONCOL, V105, P613, DOI 10.1007/s11060-011-0629-y; Magnard C, 2002, ONCOGENE, V21, P6729, DOI 10.1038/sj.onc.1205915; Moreau K, 2006, J BIOL CHEM, V281, P3172, DOI 10.1074/jbc.M504652200; NAGAI MA, 1994, GENE CHROMOSOME CANC, V11, P58, DOI 10.1002/gcc.2870110109; Nousch M, 2007, RNA, V13, P374, DOI 10.1261/rna.372307; Okada S, 2003, J BIOL CHEM, V278, P2015, DOI 10.1074/jbc.M208685200; Ortega FJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033233; Pesole G, 2000, NUCLEIC ACIDS RES, V28, P193, DOI 10.1093/nar/28.1.193; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Powley IR, 2009, GENE DEV, V23, P1207, DOI 10.1101/gad.516509; Qin XL, 2004, J BIOL CHEM, V279, P13721, DOI 10.1074/jbc.M312854200; Rakha EA, 2008, HUM PATHOL, V39, P857, DOI 10.1016/j.humpath.2007.10.011; Ramaswamy B, 2012, BREAST CANCER RES TR, V132, P1063, DOI 10.1007/s10549-011-1928-x; Ray H, 2006, J MOL BIOL, V359, P973, DOI 10.1016/j.jmb.2006.04.010; Rio PG, 1999, INT J CANCER, V80, P823, DOI 10.1002/(SICI)1097-0215(19990315)80:6<823::AID-IJC5>3.0.CO;2-3; Rivera CI, 2008, VIROLOGY, V375, P59, DOI 10.1016/j.virol.2008.02.002; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Sombroek D, 2009, CELL DEATH DIFFER, V16, P187, DOI 10.1038/cdd.2008.154; Sordet O, 2008, J MOL BIOL, V381, P540, DOI 10.1016/j.jmb.2008.06.028; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Thomas JD, 2007, RNA, V13, P1116, DOI 10.1261/rna.534807; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang H, 2010, CANCER RES, V70, P6258, DOI 10.1158/0008-5472.CAN-09-4713; Warmoes M, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013334; Wei GW, 2007, P NATL ACAD SCI USA, V104, P13040, DOI 10.1073/pnas.0703213104; Wilson CA, 1999, NAT GENET, V21, P236, DOI 10.1038/6029; Yang ES, 2010, FEBS J, V277, P3079, DOI 10.1111/j.1742-4658.2010.07734.x; Zhu XG, 2010, CURR OPIN ENDOCRINOL, V17, P408, DOI 10.1097/MED.0b013e32833d6d46	63	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67313	10.1371/journal.pone.0067313	http://dx.doi.org/10.1371/journal.pone.0067313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805307	Green Published, gold, Green Submitted			2022-12-25	WOS:000320846500135
J	Day, TE; Ravi, N; Xian, H; Brugh, A				Day, Theodore Eugene; Ravi, Nathan; Xian, Hong; Brugh, Ann			An Agent-Based Modeling Template for a Cohort of Veterans with Diabetic Retinopathy	PLOS ONE			English	Article							MACULAR DEGENERATION; HEALTH; PREVALENCE	Background: Agent-based models are valuable for examining systems where large numbers of discrete individuals interact with each other, or with some environment. Diabetic Veterans seeking eye care at a Veterans Administration hospital represent one such cohort. Objective: The objective of this study was to develop an agent-based template to be used as a model for a patient with diabetic retinopathy (DR). This template may be replicated arbitrarily many times in order to generate a large cohort which is representative of a real-world population, upon which in-silico experimentation may be conducted. Methods: Agent-based template development was performed in java-based computer simulation suite AnyLogic Professional 6.6. The model was informed by medical data abstracted from 535 patient records representing a retrospective cohort of current patients of the VA St. Louis Healthcare System Eye clinic. Logistic regression was performed to determine the predictors associated with advancing stages of DR. Predicted probabilities obtained from logistic regression were used to generate the stage of DR in the simulated cohort. Results: The simulated cohort of DR patients exhibited no significant deviation from the test population of real-world patients in proportion of stage of DR, duration of diabetes mellitus (DM), or the other abstracted predictors. Simulated patients after 10 years were significantly more likely to exhibit proliferative DR (P<0.001). Conclusions: Agent-based modeling is an emerging platform, capable of simulating large cohorts of individuals based on manageable data abstraction efforts. The modeling method described may be useful in simulating many different conditions where course of disease is described in categorical stages.	[Day, Theodore Eugene; Ravi, Nathan; Xian, Hong; Brugh, Ann] VA St Louis Healthcare Syst, St Louis, MO USA; [Ravi, Nathan] Washington Univ, Dept Ophthalmol & Visual Sci, St Louis, MO 63130 USA; [Ravi, Nathan] Washington Univ, Dept Energy Environm & Chem Engn, St Louis, MO USA; [Xian, Hong] St Louis Univ, Dept Biostat, St Louis, MO 63103 USA	Washington University (WUSTL); Washington University (WUSTL); Saint Louis University	Day, TE (corresponding author), Childrens Hosp Philadelphia, Off Patient Safety & Qual, Philadelphia, PA 19104 USA.	dayt@chop.edu			Veterans Affairs Office of Research and Development's Health Services Research and Development Merit Review Pilot Program [PPO 11-167]; Veterans Affairs [I01HX000622] Funding Source: NIH RePORTER	Veterans Affairs Office of Research and Development's Health Services Research and Development Merit Review Pilot Program; Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Veterans Affairs Office of Research and Development's Health Services Research and Development Merit Review Pilot Program, PPO 11-167. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An G, 2004, CRIT CARE MED, V32, P2050, DOI 10.1097/01.CCM.0000139707.13729.7D; Auchincloss AH, 2008, AM J EPIDEMIOL, V168, P1, DOI 10.1093/aje/kwn118; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Elliott E, 2002, P NATL ACAD SCI USA, V99, P7193, DOI 10.1073/pnas.102079099; Forrest S., 1994, COMPLEX SYSTEMS MECH; Gorman DM, 2006, AM J PUBLIC HEALTH, V96, P2055, DOI 10.2105/AJPH.2005.063289; Harper C Alex, 1999, Clin Exp Optom, V82, P98; Jones Spencer S, 2008, AMIA Annu Symp Proc, P338; KLEIN R, 1995, DIABETES AM, P293; Kupersmith J, 2007, HEALTH AFFAIR, V26, pW156, DOI 10.1377/hlthaff.26.2.w156; Landers J, 2012, CLIN EXP OPHTHALMOL, V40, P83, DOI 10.1111/j.1442-9071.2011.02725.x; Miller DR, 2004, DIABETES CARE, V27, pB10, DOI 10.2337/diacare.27.suppl_2.B10; MOSS SE, 1988, OPHTHALMOLOGY, V95, P1340; Rein DB, 2007, OPHTHALMOLOGY, V114, P1319, DOI 10.1016/j.ophtha.2006.10.041; Rein DB, 2009, ARCH OPHTHALMOL-CHIC, V127, P533, DOI 10.1001/archophthalmol.2009.58; Segovia-Juarez JL, 2004, J THEOR BIOL, V231, P357, DOI 10.1016/j.jtbi.2004.06.031; Sloan FA, 2003, ARCH OPHTHALMOL-CHIC, V121, P1462, DOI 10.1001/archopht.121.10.1462; Tapp RJ, 2008, DIABETES CARE, V31, P1349, DOI 10.2337/dc07-1707; Vodovotz Yoram, 2004, Curr Opin Crit Care, V10, P383, DOI 10.1097/01.ccx.0000139360.30327.69; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111	20	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66812	10.1371/journal.pone.0066812	http://dx.doi.org/10.1371/journal.pone.0066812			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805280	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500108
J	Gordon, J; Sariyer, IK; De La Fuente-Granada, M; Augelli, BJ; Otte, J; Azizi, SA; Amini, S; Khalili, K; Krynska, B				Gordon, Jennifer; Sariyer, Ilker K.; De La Fuente-Granada, Marisol; Augelli, Brian J.; Otte, Jessica; Azizi, S. Ausim; Amini, Shohreh; Khalili, Kamel; Krynska, Barbara			Neural Crest Cells Isolated from the Bone Marrow of Transgenic Mice Express JCV T-Antigen	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; HUMAN NEUROTROPIC POLYOMAVIRUS; STEM-CELLS; STROMAL CELLS; PROGENITOR CELLS; BRAIN-TUMORS; VIRUS; DIFFERENTIATION; PATHOGENESIS	JC virus (JCV), a common human polyomavirus, is the etiological agent of the demyelinating disease, progressive multifocal leukoencephalopathy (PML). In addition to its role in PML, studies have demonstrated the transforming ability of the JCV early protein, T-antigen, and its association with some human cancers. JCV infection occurs in childhood and latent virus is thought to be maintained within the bone marrow, which harbors cells of hematopoietic and non-hematopoietic lineages. Here we show that non-hematopoietic mesenchymal stem cells (MSCs) isolated from the bone marrow of JCV T-antigen transgenic mice give rise to JCV T-antigen positive cells when cultured under neural conditions. JCV T-antigen positive cells exhibited neural crest characteristics and demonstrated p75, SOX-10 and nestin positivity. When cultured in conditions typical for mesenchymal cells, a population of T-antigen negative cells, which did not express neural crest markers arose from the MSCs. JCV T-antigen positive cells could be cultured long-term while maintaining their neural crest characteristics. When these cells were induced to differentiate into neural crest derivatives, JCV T-antigen was downregulated in cells differentiating into bone and maintained in glial cells expressing GFAP and S100. We conclude that JCV T-antigen can be stably expressed within a fraction of bone marrow cells differentiating along the neural crest/glial lineage when cultured in vitro. These findings identify a cell population within the bone marrow permissible for JCV early gene expression suggesting the possibility that these cells could support persistent viral infection and thus provide clues toward understanding the role of the bone marrow in JCV latency and reactivation. Further, our data provides an excellent experimental model system for studying the cell-type specificity of JCV T-antigen expression, the role of bone marrow-derived stem cells in the pathogenesis of JCV-related diseases and the opportunities for the use of this model in development of therapeutic strategies.	[Gordon, Jennifer; Sariyer, Ilker K.; Otte, Jessica; Amini, Shohreh; Khalili, Kamel] Temple Univ, Sch Med, Ctr Neurovirol, Dept Neurosci, Philadelphia, PA USA; [De La Fuente-Granada, Marisol; Augelli, Brian J.; Azizi, S. Ausim; Krynska, Barbara] Temple Univ, Sch Med, Dept Neurol, Philadelphia, PA 19122 USA; [De La Fuente-Granada, Marisol; Krynska, Barbara] Temple Univ, Sch Med, Ctr Neural Repair & Rehabil, Shriners Hosp,Pediat Res Ctr, Philadelphia, PA USA; [Amini, Shohreh] Temple Univ, Dept Biol, Coll Sci & Technol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Shriners Hospitals Children Philadelphia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Krynska, B (corresponding author), Temple Univ, Sch Med, Dept Neurol, Philadelphia, PA 19122 USA.	krynskb@tuhs.temple.edu	De La Fuente-Granada, Marisol/F-3745-2019; Sariyer, Ilker/AAE-7677-2020	De La Fuente-Granada, Marisol/0000-0002-6878-4265; Azizi, Sayed/0000-0002-0888-5013	National Institutes of Health; SHPRC; Comprehensive NeuroAIDS Center (CNAC NIMH) at Temple University School of Medicine [P30MH092177]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH092177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SHPRC; Comprehensive NeuroAIDS Center (CNAC NIMH) at Temple University School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was made possible by grants awarded by National Institutes of Health to JG and by SHPRC to BK. This study utilized services offered by core facilities of the Comprehensive NeuroAIDS Center (CNAC NIMH P30MH092177) at Temple University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTROM KE, 1958, BRAIN, V81, P93, DOI 10.1093/brain/81.1.93; Azizi SA, 2002, CONT NEUROS, P395; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; BEGGS AH, 1990, J GEN VIROL, V71, P151, DOI 10.1099/0022-1317-71-1-151; Beltrami S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053447; Berger JR, 2003, J NEUROVIROL, V9, P38, DOI 10.1080/13550280390195261; Del Valle L, 2010, CANC BIOL THER, V9; Franks RR, 1996, ONCOGENE, V12, P2573; Glejzer A, 2011, CELL MOL LIFE SCI, V68, P2101, DOI 10.1007/s00018-010-0558-5; HOUFF SA, 1988, NEW ENGL J MED, V318, P301, DOI 10.1056/NEJM198802043180507; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Keene CD, 2003, CELL TRANSPLANT, V12, P201, DOI 10.3727/000000003108746768; Khalili K, 2003, ONCOGENE, V22, P5181, DOI 10.1038/sj.onc.1206559; Krynska B, 1999, ONCOGENE, V18, P39, DOI 10.1038/sj.onc.1202278; Kucia M, 2006, LEUKEMIA, V20, P857, DOI 10.1038/sj.leu.2404171; Kucia M, 2004, BLOOD CELL MOL DIS, V32, P52, DOI 10.1016/j.bcmd.2003.09.025; Marshall LJ, 2010, J NEUROIMMUNE PHARM, V5, P404, DOI 10.1007/s11481-010-9203-1; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Paratore C, 2001, DEVELOPMENT, V128, P3949; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Sariyer IK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014630; Shollar D, 2004, ONCOGENE, V23, P5459, DOI 10.1038/sj.onc.1207728; SMALL JA, 1986, P NATL ACAD SCI USA, V83, P8288, DOI 10.1073/pnas.83.21.8288; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Tan CS, 2009, J INFECT DIS, V199, P881, DOI 10.1086/597117; Warnke C, 2011, MULT SCLER J, V17, P151, DOI 10.1177/1352458510385834; Weber T, 1997, INTERVIROLOGY, V40, P98, DOI 10.1159/000150537; White MK, 2005, BRAIN RES REV, V50, P69, DOI 10.1016/j.brainresrev.2005.04.007	31	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e65947	10.1371/journal.pone.0065947	http://dx.doi.org/10.1371/journal.pone.0065947			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805194	Green Published, gold, Green Submitted			2022-12-25	WOS:000320846500022
J	Jha, A; Shankar, R				Jha, Ashwani; Shankar, Ravi			miReader: Discovering Novel miRNAs in Species without Sequenced Genome	PLOS ONE			English	Article							MICRORNA BIOGENESIS; PREDICTION; IDENTIFICATION; TRANSCRIPTION; PRECURSORS; MACHINE; GENES; REAL; TOOL	Along with computational approaches, NGS led technologies have caused a major impact upon the discoveries made in the area of miRNA biology, including novel miRNAs identification. However, to this date all microRNA discovery tools compulsorily depend upon the availability of reference or genomic sequences. Here, for the first time a novel approach, miReader, has been introduced which could discover novel miRNAs without any dependence upon genomic/reference sequences. The approach used NGS read data to build highly accurate miRNA models, molded through a Multi-boosting algorithm with Best-First Tree as its base classifier. It was comprehensively tested over large amount of experimental data from wide range of species including human, plants, nematode, zebrafish and fruit fly, performing consistently with >90% accuracy. Using the same tool over Illumina read data for Miscanthus, a plant whose genome is not sequenced; the study reported 21 novel mature miRNA duplex candidates. Considering the fact that miRNA discovery requires handling of high throughput data, the entire approach has been implemented in a standalone parallel architecture. This work is expected to cause a positive impact over the area of miRNA discovery in majority of species, where genomic sequence availability would not be a compulsion any more.	[Jha, Ashwani; Shankar, Ravi] CSIR Inst Himalayan Bioresource Technol, Div Biotechnol, Studio Computat Biol & Bioinformat, Palampur, Himachal Prades, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT)	Shankar, R (corresponding author), CSIR Inst Himalayan Bioresource Technol, Div Biotechnol, Studio Computat Biol & Bioinformat, Palampur, Himachal Prades, India.	ravish@ihbt.res.in		jha, Ashwani/0000-0001-8752-3477	ICAR [NFBSFARA/RNA-3022/2012-13]; CSIR 12th FYP project [GENESIS BSC0121]; CSIR, Govt of India	ICAR(Indian Council of Agricultural Research (ICAR)); CSIR 12th FYP project; CSIR, Govt of India(Council of Scientific & Industrial Research (CSIR) - India)	The present work was supported by ICAR grant NFBSFARA/RNA-3022/2012-13 and CSIR 12th FYP project GENESIS BSC0121. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful to CSIR, Govt of India, for support to Ashwani Jha. We are grateful to Dr RD Singh, CSIR-IHBT, for proofreading and editing this MS for language. We are also thankful to the Director, CSIR-IHBT, for his support. Also, we would like to show our gratitude to open source and open access communities and portals.	Auyeung VC, 2013, CELL, V152, P844, DOI 10.1016/j.cell.2013.01.031; Baigude H, 2012, ANGEW CHEM INT EDIT, V51, P5880, DOI 10.1002/anie.201201512; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gardner PP, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-140; Gkirtzou K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011843; He CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051673; Jha A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045782; Jha A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-636; Jha A, 2011, J BIOSCIENCES, V36, P621, DOI 10.1007/s12038-011-9109-y; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lai EC, 2003, CURR BIOL, V13, pR925, DOI 10.1016/j.cub.2003.11.017; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Piriyapongsa J, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-61; Ritchie W, 2008, BIOINFORMATICS, V24, P1394, DOI 10.1093/bioinformatics/btn137; Ronen R, 2010, BIOINFORMATICS, V26, p[261, 5]; Shi H., 2007, BEST 1 DECISION TREE; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Suzuki HI, 2011, J BIOCHEM, V149, P15, DOI 10.1093/jb/mvq113; Terai G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044314; Wang WC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-328; Webb Geoffrey I., 2000, MACHINE LEARNING, V40; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Wu YG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-107; Xuan P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027422; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491	36	18	18	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66857	10.1371/journal.pone.0066857	http://dx.doi.org/10.1371/journal.pone.0066857			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805282	Green Published, gold			2022-12-25	WOS:000320846500110
J	Meli, R; Raso, GM; Irace, C; Simeoli, R; Di Pascale, A; Paciello, O; Pagano, TB; Calignano, A; Colonna, A; Santamaria, R				Meli, Rosaria; Raso, Giuseppina Mattace; Irace, Carlo; Simeoli, Raffaele; Di Pascale, Antonio; Paciello, Orlando; Pagano, Teresa Bruna; Calignano, Antonio; Colonna, Alfredo; Santamaria, Rita			High Fat Diet Induces Liver Steatosis and Early Dysregulation of Iron Metabolism in Rats	PLOS ONE			English	Article							REGULATORY PROTEINS; INSULIN-RESISTANCE; MESSENGER-RNA; HEPCIDIN; DISEASE; INFLAMMATION; HOMEOSTASIS; FERRITIN; RECEPTOR; STEATOHEPATITIS	This paper is dedicated to the memory of our wonderful colleague Professor Alfredo Colonna, who passed away the same day of its acceptance. Fatty liver accumulation, inflammatory process and insulin resistance appear to be crucial in non-alcoholic fatty liver disease (NAFLD), nevertheless emerging findings pointed an important role also for iron overload. Here, we investigate the molecular mechanisms of hepatic iron metabolism in the onset of steatosis to understand whether its impairment could be an early event of liver inflammatory injury. Rats were fed with control diet or high fat diet (HFD) for 5 or 8 weeks, after which liver morphology, serum lipid profile, transaminases levels and hepatic iron content (HIC), were evaluated. In liver of HFD fed animals an increased time-dependent activity of iron regulatory protein 1 (IRP1) was evidenced, associated with the increase in transferrin receptor-1 (TfR1) expression and ferritin down-regulation. Moreover, ferroportin (FPN-1), the main protein involved in iron export, was down-regulated accordingly with hepcidin increase. These findings were indicative of an increased iron content into hepatocytes, which leads to an increase of harmful free-iron also related to the reduction of hepatic ferritin content. The progressive inflammatory damage was evidenced by the increase of hepatic TNF-alpha, IL-6 and leptin, in parallel to increased iron content and oxidative stress. The major finding that emerged of this study is the impairment of iron homeostasis in the ongoing and sustaining of liver steatosis, suggesting a strong link between iron metabolism unbalance, inflammatory damage and progression of disease.	[Meli, Rosaria; Raso, Giuseppina Mattace; Irace, Carlo; Simeoli, Raffaele; Di Pascale, Antonio; Calignano, Antonio; Colonna, Alfredo; Santamaria, Rita] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Paciello, Orlando; Pagano, Teresa Bruna] Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Italy	University of Naples Federico II; University of Naples Federico II	Meli, R (corresponding author), Univ Naples Federico II, Dept Pharm, Naples, Italy.	meli@unina.it; alfcolon@unina.it	Calignano, Antonio/K-2542-2018; Simeoli, Raffaele/J-1101-2018	Simeoli, Raffaele/0000-0002-3989-7703; CALIGNANO, Antonio/0000-0002-1742-3179; Mattace Raso, Giuseppina/0000-0002-5254-139X; Meli, Rosaria/0000-0002-6246-6813	Ministero dell'Istruzione, dell'Universita e della Rierca, Progetti di ricerca di interesse nazionale, Italy [prot. 2003060394-002]	Ministero dell'Istruzione, dell'Universita e della Rierca, Progetti di ricerca di interesse nazionale, Italy	This study was partially supported by a grant from the Ministero dell'Istruzione, dell'Universita e della Rierca, Progetti di ricerca di interesse nazionale (prot. 2003060394-002), Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; AZIZ N, 1987, P NATL ACAD SCI USA, V84, P8478, DOI 10.1073/pnas.84.23.8478; Baynes RD, 1996, CLIN BIOCHEM, V29, P209, DOI 10.1016/0009-9120(96)00010-K; Chitturi Shivakumar, 2003, Curr Gastroenterol Rep, V5, P18, DOI 10.1007/s11894-003-0005-y; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; DRAPIER JC, 1993, EMBO J, V12, P3643, DOI 10.1002/j.1460-2075.1993.tb06038.x; Evstatiev R, 2012, GUT, V61, P933, DOI 10.1136/gut.2010.214312; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Imeryuz N, 2007, J HEPATOL, V47, P851, DOI 10.1016/j.jhep.2007.06.018; Irace C, 2005, J NEUROCHEM, V95, P1321, DOI 10.1111/j.1471-4159.2005.03449.x; ITAYA K, 1965, J LIPID RES, V6, P16; Kirsch R, 2006, LIVER INT, V26, P1258, DOI 10.1111/j.1478-3231.2006.01329.x; Maffettone C, 2008, J CELL BIOCHEM, V104, P213, DOI 10.1002/jcb.21618; Maffettone C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010163; McCord JM, 1998, SEMIN HEMATOL, V35, P5; Meli R, 2004, ENDOCRINOLOGY, V145, P3115, DOI 10.1210/en.2004-0129; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; MULLNER EW, 1989, CELL, V58, P373, DOI 10.1016/0092-8674(89)90851-9; Nelson JE, 2011, HEPATOLOGY, V53, P448, DOI 10.1002/hep.24038; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2009, ACTA HAEMATOL-BASEL, V122, P78, DOI 10.1159/000243791; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pantopoulos K, 1997, J BIOL CHEM, V272, P9802; Pietrangelo A, 2009, CURR OPIN GASTROEN, V25, P209, DOI 10.1097/MOG.0b013e328329e13d; Raso GM, 2009, BIOCHEM PHARMACOL, V78, P1001, DOI 10.1016/j.bcp.2009.05.034; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Scheuer PJ, 2006, LIVER BIOPSY INTERPR, P304; Sebastiani G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025138; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Svegliati-Baroni G, 2006, AM J PATHOL, V169, P846, DOI 10.2353/ajpath.2006.050953; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Trombini P, 2007, J HEPATOL, V46, P549, DOI 10.1016/j.jhep.2007.01.004; Turlin B, 2001, AM J CLIN PATHOL, V116, P263; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825	39	67	73	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66570	10.1371/journal.pone.0066570	http://dx.doi.org/10.1371/journal.pone.0066570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805238	Green Submitted, Green Published, gold			2022-12-25	WOS:000320846500066
J	Rossi, F; Gribsholt, B; Gazeau, F; Di Santo, V; Middelburg, JJ				Rossi, Francesca; Gribsholt, Britta; Gazeau, Frederic; Di Santo, Valentina; Middelburg, Jack J.			Complex Effects of Ecosystem Engineer Loss on Benthic Ecosystem Response to Detrital Macroalgae	PLOS ONE			English	Article							COMMUNITY STRUCTURE; MARINE-SEDIMENTS; SPECIES RICHNESS; DIVERSITY; BIODIVERSITY; STABILITY; IMPACT; ENRICHMENT; ARENICOLA; BURROW	Ecosystem engineers change abiotic conditions, community assembly and ecosystem functioning. Consequently, their loss may modify thresholds of ecosystem response to disturbance and undermine ecosystem stability. This study investigates how loss of the bioturbating lugworm Arenicola marina modifies the response to macroalgal detrital enrichment of sediment biogeochemical properties, microphytobenthos and macrofauna assemblages. A field manipulative experiment was done on an intertidal sandflat (Oosterschelde estuary, The Netherlands). Lugworms were deliberately excluded from 1x m sediment plots and different amounts of detrital Ulva (0, 200 or 600 g Wet Weight) were added twice. Sediment biogeochemistry changes were evaluated through benthic respiration, sediment organic carbon content and porewater inorganic carbon as well as detrital macroalgae remaining in the sediment one month after enrichment. Microalgal biomass and macrofauna composition were measured at the same time. Macroalgal carbon mineralization and transfer to the benthic consumers were also investigated during decomposition at low enrichment level (200 g WW). The interaction between lugworm exclusion and detrital enrichment did not modify sediment organic carbon or benthic respiration. Weak but significant changes were instead found for porewater inorganic carbon and microalgal biomass. Lugworm exclusion caused an increase of porewater carbon and a decrease of microalgal biomass, while detrital enrichment drove these values back to values typical of lugworm-dominated sediments. Lugworm exclusion also decreased the amount of macroalgae remaining into the sediment and accelerated detrital carbon mineralization and CO2 release to the water column. Eventually, the interaction between lugworm exclusion and detrital enrichment affected macrofauna abundance and diversity, which collapsed at high level of enrichment only when the lugworms were present. This study reveals that in nature the role of this ecosystem engineer may be variable and sometimes have no or even negative effects on stability, conversely to what it should be expected based on current research knowledge.	[Rossi, Francesca] Univ Montpellier 2, Lab Ecol Syst Marins Cotiers, Montpellier, France; [Gribsholt, Britta; Middelburg, Jack J.] Royal Netherlands Inst Sea Res, Dept Ecosyst, Yerseke, Netherlands; [Gazeau, Frederic] Ctr Natl Rech Sci, Inst Natl Sci Univers, Lab Oceanograph Villefranche, Villefranche Sur Mer, France; [Gazeau, Frederic] Univ Paris 06, Observ Oceanol Villefranche, Villefranche Sur Mer, France; [Di Santo, Valentina] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Middelburg, Jack J.] Univ Utrecht, Dept Earth Sci Geochem, Fac Geosci, Utrecht, Netherlands	Universite de Montpellier; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Boston University; Utrecht University	Rossi, F (corresponding author), Univ Montpellier 2, Lab Ecol Syst Marins Cotiers, Montpellier, France.		Rossi, Francesca/G-2807-2013; Middelburg, Jack/B-4951-2011; Gazeau, Frédéric/G-3050-2011	Rossi, Francesca/0000-0003-1928-9193; Middelburg, Jack/0000-0003-3601-9072; Gazeau, Frédéric/0000-0001-8807-4597; Di Santo, Valentina/0000-0002-5419-3747	PIONIER grant of the Netherlands Organization for Scientific Research	PIONIER grant of the Netherlands Organization for Scientific Research	This work was funded by a PIONIER grant of the Netherlands Organization for Scientific Research to JJM. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Allison G, 2004, ECOL MONOGR, V74, P117, DOI 10.1890/02-0681; Berke SK, 2010, INTEGR COMP BIOL, V50, P147, DOI 10.1093/icb/icq077; Bolam SG, 2002, ECOL MONOGR, V72, P599, DOI 10.1890/0012-9615(2002)072[0599:DBAEPI]2.0.CO;2; Bolam SG, 2000, J EXP MAR BIOL ECOL, V249, P123, DOI 10.1016/S0022-0981(00)00185-4; Braeckman U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018078; BUCHSBAUM R, 1991, MAR ECOL PROG SER, V72, P131, DOI 10.3354/meps072131; Cebrian J, 2004, ECOL LETT, V7, P232, DOI 10.1111/j.1461-0248.2004.00574.x; D'Andrea AF, 2009, LIMNOL OCEANOGR, V54, P1911, DOI 10.4319/lo.2009.54.6.1911; Downing AL, 2010, FRESHWATER BIOL, V55, P2123, DOI 10.1111/j.1365-2427.2010.02472.x; Eisenhauer N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003489; Eklof JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023229; Emmerson MC, 2001, NATURE, V411, P73, DOI 10.1038/35075055; Fontaine S, 2004, ECOL LETT, V7, P314, DOI 10.1111/j.1461-0248.2004.00579.x; Ford RB, 1999, MAR ECOL PROG SER, V191, P163, DOI 10.3354/meps191163; Godbold JA, 2009, OIKOS, V118, P77, DOI 10.1111/j.1600-0706.2008.17072.x; Goodsell PJ, 2008, OECOLOGIA, V157, P509, DOI 10.1007/s00442-008-1087-x; Grime JP, 1997, SCIENCE, V277, P1260, DOI 10.1126/science.277.5330.1260; Hansen K, 1998, J EXP MAR BIOL ECOL, V231, P201, DOI 10.1016/S0022-0981(98)00070-7; Herman PMJ, 2000, MAR ECOL PROG SER, V204, P79, DOI 10.3354/meps204079; Hillebrand H, 2000, MAR ECOL PROG SER, V204, P27, DOI 10.3354/meps204027; Huettel M, 2003, HYDROBIOLOGIA, V494, P231, DOI 10.1023/A:1025426601773; HULL SC, 1987, ESTUAR COAST SHELF S, V25, P519, DOI 10.1016/0272-7714(87)90112-0; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kelaher BP, 2003, MAR ECOL PROG SER, V261, P85, DOI 10.3354/meps261085; Kristensen E, 2001, ABSTR PAP AM CHEM S, V221, pU538; Kristensen E, 2012, MAR ECOL PROG SER, V446, P285, DOI 10.3354/meps09506; Lennon JT, 2004, OECOLOGIA, V138, P584, DOI 10.1007/s00442-003-1459-1; Lohrer AM, 2004, NATURE, V431, P1092, DOI 10.1038/nature03042; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Mckie BG, 2009, OECOLOGIA, V160, P757, DOI 10.1007/s00442-009-1336-7; Meysman FJR, 2006, LIMNOL OCEANOGR, V51, P142, DOI 10.4319/lo.2006.51.1.0142; Nedergaard RI, 2002, J EXP MAR BIOL ECOL, V275, P15, DOI 10.1016/S0022-0981(02)00211-3; Needham HR, 2011, ECOSYSTEMS, V14, P1096, DOI 10.1007/s10021-011-9468-0; Norkko A, 1996, MAR ECOL PROG SER, V140, P141, DOI 10.3354/meps140141; Norkko J, 2012, GLOBAL CHANGE BIOL, V18, P422, DOI 10.1111/j.1365-2486.2011.02513.x; O'Brien AL, 2009, J EXP MAR BIOL ECOL, V371, P51, DOI 10.1016/j.jembe.2009.01.004; Papaspyrou S, 2007, ESTUAR COAST SHELF S, V72, P213, DOI 10.1016/j.ecss.2006.10.020; Pfisterer AB, 2002, NATURE, V416, P84, DOI 10.1038/416084a; Raffaelli DG, 1998, OCEANOGR MAR BIOL<D>, V36, P97; Retraubun ASW, 1996, J EXP MAR BIOL ECOL, V202, P107, DOI 10.1016/0022-0981(96)00017-2; Riera P, 2010, J SEA RES, V63, P78, DOI 10.1016/j.seares.2009.10.001; Romanuk TN, 2009, OIKOS, V118, P819, DOI 10.1111/j.1600-0706.2008.17273.x; Rossi F, 2006, J EXP MAR BIOL ECOL, V332, P84, DOI 10.1016/j.jembe.2005.11.003; Rossi F, 2002, MAR ECOL PROG SER, V241, P29, DOI 10.3354/meps241029; Rossi F, 2007, MAR BIOL, V150, P1073, DOI 10.1007/s00227-006-0438-6; Rossi F, 2009, OIKOS, V118, P503, DOI 10.1111/j.1600-0706.2009.17112.x; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; THRUSH SF, 1986, J EXP MAR BIOL ECOL, V96, P199, DOI 10.1016/0022-0981(86)90203-0; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Volkenborn N, 2006, J EXP MAR BIOL ECOL, V330, P169, DOI 10.1016/j.jembe.2005.12.025; Vonk JA, 2008, ESTUAR COAST SHELF S, V79, P79, DOI 10.1016/j.ecss.2008.03.003; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	54	17	17	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66650	10.1371/journal.pone.0066650	http://dx.doi.org/10.1371/journal.pone.0066650			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805256	Green Published, gold, Green Submitted			2022-12-25	WOS:000320846500084
J	Staggs, SE; Beckman, EM; Keely, SP; Mackwan, R; Ware, MW; Moyer, AP; Ferretti, JA; Abu Sayed; Xiao, LH; Villegas, EN				Staggs, Sarah E.; Beckman, Erin M.; Keely, Scott P.; Mackwan, Reena; Ware, Michael W.; Moyer, Alan P.; Ferretti, James A.; Abu Sayed; Xiao, Lihua; Villegas, Eric N.			The Applicability of TaqMan-Based Quantitative Real-Time PCR Assays for Detecting and Enumerating Cryptosporidium spp. Oocysts in the Environment	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; N. SP APICOMPLEXA; SOURCE TRACKING; WATER; PARVUM; GENOTYPES; QUANTIFICATION; CUNICULUS; HOMINIS	Quantitative real-time polymerase chain reaction (qPCR) assays to detect Cryptosporidium oocysts in clinical samples are increasingly being used to diagnose human cryptosporidiosis, but a parallel approach for detecting and identifying Cryptosporidium oocyst contamination in surface water sources has yet to be established for current drinking water quality monitoring practices. It has been proposed that Cryptosporidium qPCR-based assays could be used as viable alternatives to current microscopic-based detection methods to quantify levels of oocysts in drinking water sources; however, data on specificity, analytical sensitivity, and the ability to accurately quantify low levels of oocysts are limited. The purpose of this study was to provide a comprehensive evaluation of TaqMan-based qPCR assays, which were developed for either clinical or environmental investigations, for detecting Cryptosporidium oocyst contamination in water. Ten different qPCR assays, six previously published and four developed in this study were analyzed for specificity and analytical sensitivity. Specificity varied between all ten assays, and in one particular assay, which targeted the Cryptosporidium 18S rRNA gene, successfully detected all Cryptosporidium spp. tested, but also cross-amplified T. gondii, fungi, algae, and dinoflagellates. When evaluating the analytical sensitivity of these qPCR assays, results showed that eight of the assays could reliably detect ten flow-sorted oocysts in reagent water or environmental matrix. This study revealed that while a qPCR-based detection assay can be useful for detecting and differentiating different Cryptosporidium species in environmental samples, it cannot accurately measure low levels of oocysts that are typically found in drinking water sources.	[Staggs, Sarah E.; Keely, Scott P.; Ware, Michael W.; Villegas, Eric N.] US EPA, Natl Exposure Res Lab, Cincinnati, OH 45268 USA; [Beckman, Erin M.; Mackwan, Reena; Abu Sayed] Dynamac Corp, Cincinnati, OH USA; [Moyer, Alan P.; Villegas, Eric N.] Univ Cincinnati, McMicken Sch Arts & Sci, Dept Biol Sci, Cincinnati, OH USA; [Ferretti, James A.] US EPA, Edison, NJ USA; [Xiao, Lihua] Ctr Dis Control & Prevent, Atlanta, GA USA	United States Environmental Protection Agency; University System of Ohio; University of Cincinnati; United States Environmental Protection Agency; Centers for Disease Control & Prevention - USA	Villegas, EN (corresponding author), US EPA, Natl Exposure Res Lab, Cincinnati, OH 45268 USA.	villegas.eric@epa.gov	Keely, Scott/W-5761-2019; Xiao, Lihua/B-1704-2013; Villegas, Eric N/A-7373-2015	Keely, Scott/0000-0002-5343-3649; Xiao, Lihua/0000-0001-8532-2727; Villegas, Eric N/0000-0002-8059-8588	United States Environmental Protection Agency through its Office of Research and Development [EP-D-06-096]	United States Environmental Protection Agency through its Office of Research and Development(United States Environmental Protection Agency)	The United States Environmental Protection Agency through its Office of Research and Development partially funded and collaborated in the research described here under contract number EP-D-06-096. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi DE, 2003, INFECT IMMUN, V71, P1828, DOI 10.1128/IAI.71.4.1828-1832.2003; Akiyoshi DE, 2002, INFECT IMMUN, V70, P5670, DOI 10.1128/IAI.70.10.5670-5675.2002; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arrowood MJ, 1996, J EUKARYOT MICROBIOL, V43, pS89, DOI 10.1111/j.1550-7408.1996.tb05015.x; Brescia CC, 2009, APPL ENVIRON MICROB, V75, P6856, DOI 10.1128/AEM.00540-09; Caraguel CGB, 2011, J VET DIAGN INVEST, V23, P2, DOI 10.1177/104063871102300102; Chalmers RM, 2011, EMERG INFECT DIS, V17, P536, DOI 10.3201/eid1703.100410; Di Giovanni GD, 2005, APPL ENVIRON MICROB, V71, P1495, DOI 10.1128/AEM.71.3.1495-1500.2005; Fayer R, 2004, VET PARASITOL, V126, P37, DOI 10.1016/j.vetpar.2004.09.004; Fayer R, 2010, VET PARASITOL, V172, P23, DOI 10.1016/j.vetpar.2010.04.028; Fayer R, 2009, VET PARASITOL, V164, P192, DOI 10.1016/j.vetpar.2009.05.011; Fayer R, 2010, EXP PARASITOL, V124, P90, DOI 10.1016/j.exppara.2009.03.005; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fontaine M, 2003, J MICROBIOL METH, V54, P29, DOI 10.1016/S0167-7012(03)00005-8; Fontaine M, 2002, FEMS MICROBIOL LETT, V214, P13, DOI 10.1111/j.1574-6968.2002.tb11318.x; Hadfield SJ, 2011, J CLIN MICROBIOL, V49, P918, DOI 10.1128/JCM.01733-10; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Haque R, 2007, AM J TROP MED HYG, V76, P713, DOI 10.4269/ajtmh.2007.76.713; Haugland RA, 2005, WATER RES, V39, P559, DOI 10.1016/j.watres.2004.11.011; Hayes SL, 2003, J APPL MICROBIOL, V94, P54, DOI 10.1046/j.1365-2672.2003.01805.x; Hester JD, 2002, MOL CELL PROBE, V16, P435, DOI 10.1006/mcpr.2002.0442; Hill VR, 2007, APPL ENVIRON MICROB, V73, P4218, DOI 10.1128/AEM.02713-06; Jiang JL, 2005, APPL ENVIRON MICROB, V71, P1135, DOI 10.1128/AEM.71.3.1135-1141.2005; Jiang JL, 2005, APPL ENVIRON MICROB, V71, P4446, DOI 10.1128/AEM.71.8.4446-4454.2005; Johnson AM, 2011, APPL ENV MICROBIOL; Jothikumar N, 2008, J MED MICROBIOL, V57, P1099, DOI 10.1099/jmm.0.2008/001461-0; JUKES T H, 1969, P21; MacKenzie WR, 1995, EPIDEMIOL INFECT, V115, P545, DOI 10.1017/S0950268800058714; Masago Y, 2006, WATER SCI TECHNOL, V54, P119, DOI 10.2166/wst.2006.457; Messner MJ, 2001, WATER RES, V35, P3934, DOI 10.1016/S0043-1354(01)00119-1; Morgan-Ryan UM, 2002, J EUKARYOT MICROBIOL, V49, P433, DOI 10.1111/j.1550-7408.2002.tb00224.x; Nichols Gordon, 2007, P79, DOI 10.1201/9781420052275.ch4; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quintero-Betancourt W, 2003, APPL ENVIRON MICROB, V69, P5380, DOI 10.1128/AEM.69.9.5380-5388.2003; Ren XP, 2012, EXP PARASITOL, V130, P274, DOI 10.1016/j.exppara.2011.07.012; Robinson G, 2008, EMERG INFECT DIS, V14, P1800, DOI 10.3201/eid1411.080239; Robinson G, 2010, INT J PARASITOL, V40, P1539, DOI 10.1016/j.ijpara.2010.05.010; Rossignol JF, 2010, EXP PARASITOL, V124, P45, DOI 10.1016/j.exppara.2009.07.005; Ryu H, 2011, J MICROBIOL METH, V86, P337, DOI 10.1016/j.mimet.2011.06.001; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHAEFER FW, 1991, APPL ENVIRON MICROB, V57, P2408, DOI 10.1128/AEM.57.8.2408-2409.1991; Smith HV, 2010, EXP PARASITOL, V124, P61, DOI 10.1016/j.exppara.2009.05.014; Smith HV, 1998, PARASITOL TODAY, V14, P14, DOI 10.1016/S0169-4758(97)01150-2; Stadhouders R, 2010, J MOL DIAGN, V12, P109, DOI 10.2353/jmoldx.2010.090035; Stroup SE, 2006, J MED MICROBIOL, V55, P1217, DOI 10.1099/jmm.0.46678-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; USEPA, 2005, 1622 USEPA; Ware MW, 2010, VET PARASITOL, V168, P329, DOI 10.1016/j.vetpar.2009.11.019; Ware MW, 2003, J MICROBIOL METH, V55, P575, DOI 10.1016/j.mimet.2003.06.001; Whale AS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks203; Xiao L, 2009, EXP PARASITOL; Xiao Lihua, 2008, P119; Yang RC, 2011, VET PARASITOL, V179, P22, DOI 10.1016/j.vetpar.2011.02.011; Yang WL, 2008, APPL ENVIRON MICROB, V74, P6495, DOI 10.1128/AEM.01345-08; Yoder JS, 2010, EXP PARASITOL, V124, P31, DOI 10.1016/j.exppara.2009.09.020	55	19	19	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66562	10.1371/journal.pone.0066562	http://dx.doi.org/10.1371/journal.pone.0066562			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805235	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500063
J	Wedellova, Z; Kovacova, Z; Tencerova, M; Vedral, T; Rossmeislova, L; Siklova-Vitkova, M; Stich, V; Polak, J				Wedellova, Zuzana; Kovacova, Zuzana; Tencerova, Michaela; Vedral, Tomas; Rossmeislova, Lenka; Siklova-Vitkova, Michaela; Stich, Vladimir; Polak, Jan			The Impact of Full-Length, Trimeric and Globular Adiponectin on Lipolysis in Subcutaneous and Visceral Adipocytes of Obese and Non-Obese Women	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ADIPOSE-TISSUE LIPOLYSIS; FATTY-ACID OXIDATION; INSULIN-RESISTANCE; ENDOTHELIAL-CELLS; MULTIMERIC COMPLEXES; MOUSE ADIPOCYTES; WEIGHT-LOSS; TNF-ALPHA; KAPPA-B	Contribution of individual adiponectin isoforms to lipolysis regulation remains unknown. We investigated the impact of full-length, trimeric and globular adiponectin isoforms on spontaneous lipolysis in subcutaneous abdominal (SCAAT) and visceral adipose tissues (VAT) of obese and non-obese subjects. Furthermore, we explored the role of AMPK (5'-AMP-activated protein kinase) in adiponectin-dependent lipolysis regulation and expression of adiponectin receptors type 1 and 2 (AdipoR1 and AdipoR2) in SCAAT and VAT. Primary adipocytes isolated from SCAAT and VAT of obese and non-obese women were incubated with 20 mu g/ml of: A) full-length adiponectin (physiological mixture of all adiponectin isoforms), B) trimeric adiponectin isoform or C) globular adiponectin isoform. Glycerol released into media was used as a marker of lipolysis. While full-length adiponectin inhibited lipolysis by 22% in non-obese SCAAT, globular isoform inhibited lipolysis by 27% in obese SCAAT. No effect of either isoform was detected in non-obese VAT, however trimeric isoform inhibited lipolysis by 21% in obese VAT (all p<0.05). Trimeric isoform induced Thr172 p-AMPK in differentiated preadipocytes from a non-obese donor, while globular isoform induced Ser79 p-ACC by 32% (p<0.05) and Ser565 p-HSL by 52% (p = 0.08) in differentiated preadipocytes from an obese donor. AdipoR2 expression was 17% and 37% higher than AdipoR1 in SCAAT of obese and non-obese groups and by 23% higher in VAT of obese subjects (all p<0.05). In conclusion, the anti-lipolytic effect of adiponectin isoforms is modified with obesity: while full-length adiponectin exerts anti-lipolytic action in non-obese SCAAT, globular and trimeric isoforms show anti-lipolytic activity in obese SCAAT and VAT, respectively.	[Wedellova, Zuzana; Kovacova, Zuzana; Tencerova, Michaela; Siklova-Vitkova, Michaela; Stich, Vladimir; Polak, Jan] Charles Univ Prague, Fac Med 3, Dept Sport Med, Prague, Czech Republic; [Wedellova, Zuzana; Polak, Jan] Univ Hosp Kralovske Vinohrady, Dept Internal Med 2, Prague, Czech Republic; [Vedral, Tomas] Univ Hosp Kralovske Vinohrady, Dept Gen Surg, Prague, Czech Republic; [Rossmeislova, Lenka; Stich, Vladimir] Charles Univ Prague, Fac Med 3, Francoczech Lab Clin Res Obes, Prague, Czech Republic; [Rossmeislova, Lenka; Stich, Vladimir] Charles Univ Prague, INSERM Unite 586, Prague, Czech Republic; [Polak, Jan] Johns Hopkins Univ, Div Pulm & Crit Care Med, Baltimore, MD USA	Charles University Prague; University Hospital Vinohrady; University Hospital Vinohrady; Charles University Prague; Charles University Prague; Johns Hopkins University	Polak, J (corresponding author), Charles Univ Prague, Fac Med 3, Dept Sport Med, Prague, Czech Republic.	jan.polak@lf3.cuni.cz	Siklova, Michaela/G-6939-2015; Rossmeislová, Lenka/D-1931-2013; Tencerova, Michaela/G-8089-2017; Polak, Jan/J-3404-2014	Siklova, Michaela/0000-0003-0489-1069; Rossmeislová, Lenka/0000-0002-7611-7585; Tencerova, Michaela/0000-0001-8670-425X; Polak, Jan/0000-0001-9964-652X	Grant Agency of Charles University in Prague [1269/08/C/2008]; Research Project of the Czech Ministry of Education [MSM 0021620814]	Grant Agency of Charles University in Prague; Research Project of the Czech Ministry of Education	The study was supported by the grant of The Grant Agency of Charles University in Prague 1269/08/C/2008 and by the Research Project of the Czech Ministry of Education MSM 0021620814. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addabbo F, 2011, AM J PHYSIOL-ENDOC M, V301, pE1143, DOI 10.1152/ajpendo.00208.2011; Arner P, 2005, BEST PRACT RES CL EN, V19, P471, DOI 10.1016/j.beem.2005.07.004; Arner P, 2002, DIABETES-METAB RES, V18, pS5, DOI 10.1002/dmrr.254; Bluher M, 2007, DIABETES CARE, V30, P3110, DOI 10.2337/dc07-1257; Chedid P, 2012, AM J PATHOL, V180, P682, DOI 10.1016/j.ajpath.2011.10.013; DOLE VP, 1956, J CLIN INVEST, V35, P150, DOI 10.1172/JCI103259; Dostalova I, 2009, REGUL PEPTIDES, V155, P156, DOI 10.1016/j.regpep.2009.03.008; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; GARTON AJ, 1990, EUR J BIOCHEM, V191, P245, DOI 10.1111/j.1432-1033.1990.tb19116.x; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Kim JE, 2010, J ENDOCRINOL, V207, P35, DOI 10.1677/JOE-10-0093; Klein S, 2004, CIRCULATION, V110, P2952, DOI 10.1161/01.CIR.0000145546.97738.1E; Kolditz CI, 2010, CURR OPIN CLIN NUTR, V13, P377, DOI 10.1097/MCO.0b013e32833bed6a; Kovacova Z, 2011, INT J OBES LOND, V36, P1360; Kovacova Z, 2009, EUR J ENDOCRINOL, V160, P585, DOI 10.1530/EJE-08-0727; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Langin D, 2006, TRENDS ENDOCRIN MET, V17, P314, DOI 10.1016/j.tem.2006.08.003; Laurencikiene J, 2007, J LIPID RES, V48, P1069, DOI 10.1194/jlr.M600471-JLR200; Liu QQ, 2010, FASEB J, V24, P4229, DOI 10.1096/fj.10-159723; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Nannipieri M, 2007, INT J OBESITY, V31, P1843, DOI 10.1038/sj.ijo.0803676; OPIE LH, 1963, NEW ENGL J MED, V268, P757, DOI 10.1056/NEJM196304042681404; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Polak J, 2007, CLIN SCI, V112, P557, DOI 10.1042/CS20060296; Qiao LP, 2011, DIABETES, V60, P1519, DOI 10.2337/db10-1017; Tan BK, 2006, DIABETOLOGIA, V49, P2723, DOI 10.1007/s00125-006-0419-9; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Trujillo ME, 2004, J CLIN ENDOCR METAB, V89, P5577, DOI 10.1210/jc.2004-0603; Tsao TS, 2002, EUR J PHARMACOL, V440, P213, DOI 10.1016/S0014-2999(02)01430-9; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; van Hall G, 2003, J CLIN ENDOCR METAB, V88, P3005, DOI 10.1210/jc.2002-021687; Waki H, 2005, ENDOCRINOLOGY, V146, P790, DOI 10.1210/en.2004-1096; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wedellova Z, 2011, PHYSIOL RES, V60, P139, DOI 10.33549/physiolres.931863; Wu XD, 2003, DIABETES, V52, P1355, DOI 10.2337/diabetes.52.6.1355; Wu X, 2007, AM J PHYSIOL-ENDOC M, V293, pE1836, DOI 10.1152/ajpendo.00115.2007; Xiao XH, 2011, ENDOCRINE, V40, P386, DOI 10.1007/s12020-011-9531-9; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yin W, 2003, J BIOL CHEM, V278, P43074, DOI 10.1074/jbc.M308484200; Zhang HR, 2010, WORLD J CARDIOL, V2, P370, DOI 10.4330/wjc.v2.i11.370	46	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66783	10.1371/journal.pone.0066783	http://dx.doi.org/10.1371/journal.pone.0066783			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805277	Green Submitted, Green Published, gold			2022-12-25	WOS:000320846500105
J	Yin, J; Wang, C; Mody, A; Bao, L; Hung, SH; Svoronos, SA; Tseng, Y				Yin, Jun; Wang, Chengyuan; Mody, Aaron; Bao, Lin; Hung, Shen-Hsiu; Svoronos, Spyros A.; Tseng, Yiider			The Effect of Z-Ligustilide on the Mobility of Human Glioblastoma T98G Cells	PLOS ONE			English	Article							PC12 CELLS; IN-VITRO; RHO	Z-ligustilide (LIG), an essential oil extract from Radix Angelica sinensis, has broad pharmaceutical applications in treating cardio-vascular diseases and ischemic brain injury. Recently, LIG has been connected to Glioblastoma multiforme (GBM) because of its structural similarity to 3-n-alkyphthalide (NBP), which is specifically cytotoxic to GBM cells. Hence, we investigated LIG's effect on GBM T98G cells. The study shows that LIG can significantly reduce T98G cells' migration in a dose-dependent manner. Furthermore, the attenuation of cellular mobility can be linked to the activity of the Rho GTPases (RhoA, Rac1 and Cdc42), the three critical molecular switches governing cytoskeleton remodeling; thus, regulating cell migration. LIG significantly reduces the expression of RhoA and affects in a milder manner the expression of Cdc42 and Rac1.	[Yin, Jun; Mody, Aaron; Bao, Lin; Hung, Shen-Hsiu; Svoronos, Spyros A.; Tseng, Yiider] Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA; [Wang, Chengyuan] Chongqing Technol & Business Univ, Res Ctr Med Chem & Chem Biol, Chongqing, Peoples R China; [Yin, Jun; Hung, Shen-Hsiu; Tseng, Yiider] NCI, Phys Sci Oncol Ctr, Gainesville, FL USA; [Tseng, Yiider] Inst Cell Engn & Regenerat Med, Gainesville, FL USA	State University System of Florida; University of Florida; Chongqing Technology & Business University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Tseng, Y (corresponding author), Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA.	ytseng@che.ufl.edu		Mody, Aaron/0000-0002-9883-389X	NIH/NCI [U54CA143868]; NATIONAL CANCER INSTITUTE [U54CA143868] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by grants from NIH/NCI U54CA143868. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Chao WW, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-29; Kuang X, 2006, BRAIN RES, V1102, P145, DOI 10.1016/j.brainres.2006.04.110; Liang MJ, 2005, LIFE SCI, V78, P128, DOI 10.1016/j.lfs.2005.04.038; Lin Q, 2011, CHIN J EXP MED FORMU, V17, P165; Lu Q, 2006, EUR J PHARMACOL, V542, P136, DOI 10.1016/j.ejphar.2006.04.023; Mong PY, 2008, J IMMUNOL, V180, P550, DOI 10.4049/jimmunol.180.1.550; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Qi HY, 2012, NEUROTOX RES, V22, P345, DOI 10.1007/s12640-012-9319-6; Qi HY, 2012, NEUROPHARMACOLOGY, V62, P1659, DOI 10.1016/j.neuropharm.2011.11.012; Tsai NM, 2006, J NEUROCHEM, V99, P1251, DOI 10.1111/j.1471-4159.2006.04151.x; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; [王雁南 Wang Yannan], 2010, [华西药学杂志, West China Journal of Pharmaceutical Sciences], V25, P685; WINKLBAUER R, 1992, DEV DYNAM, V195, P290, DOI 10.1002/dvdy.1001950407; Wu Guangtong, 1998, Yaoxue Xuebao, V33, P457; Yang JY, 2012, CHIN HERB MED, V4, P26, DOI 10.3969/j.issn.1674-6384.2012.01.005; Zhu ZG, 2004, MOD PRAC MED, V16, P51	17	22	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66598	10.1371/journal.pone.0066598	http://dx.doi.org/10.1371/journal.pone.0066598			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805245	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500073
J	Zhang, WL; Bielaszewska, M; Kunsmann, L; Mellmann, A; Bauwens, A; Kock, R; Kossow, A; Anders, A; Gatermann, S; Karch, H				Zhang, Wenlan; Bielaszewska, Martina; Kunsmann, Lisa; Mellmann, Alexander; Bauwens, Andreas; Koeck, Robin; Kossow, Annelene; Anders, Agnes; Gatermann, Soeren; Karch, Helge			Lability of the pAA Virulence Plasmid in Escherichia coli O104:H4: Implications for Virulence in Humans	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; O104/H4 STRAINS; IN-VIVO; OUTBREAK; INFECTION; GERMANY; TIME; IDENTIFICATION; FRANCE; PCR	Background: Escherichia coli O104:H4 that caused the large German outbreak in 2011 is a highly virulent hybrid of enterohemorrhagic (EHEC) and enteroaggregative (EAEC) E. coli. The strain displays "stacked-brick'' aggregative adherence to human intestinal epithelial cells mediated by aggregative adherence fimbriae I (AAF/I) encoded on the pAA plasmid. The AAF/I-mediated augmented intestinal adherence might facilitate systemic absorption of Shiga toxin, the major virulence factor of EHEC, presumably enhancing virulence of the outbreak strain. However, the stability of pAA in the outbreak strain is unknown. We therefore tested outbreak isolates for pAA, monitored pAA loss during infection, and determined the impact of pAA loss on adherence and clinical outcome of infection. Methodology/Principal Findings: E. coli O104:H4 outbreak isolates from 170 patients (128 with hemolytic uremic syndrome [HUS] and 42 with diarrhea without HUS) were tested for pAA using polymerase chain reaction and plasmid profiling. pAA-harboring bacteria in stool samples were quantified using colony blot hybridization, and adherence to HCT-8 cells was determined. Isolates from 12 (7.1%) patients lacked pAA. Analyses of sequential stool samples demonstrated that the percentages of pAA-positive populations in the initial stools were significantly higher than those in the follow-up stools collected two to eight days later in disease (P <= 0.01). This indicates a rapid loss of pAA during infections of humans. The pAA loss was associated with loss of the aggregative adherence phenotype and significantly reduced correlation with HUS (P = 0.001). Conclusions/Significance: The pAA plasmid can be lost by E. coli O104:H4 outbreak strain in the human gut in the course of disease. pAA loss might attenuate virulence and diminish the ability to cause HUS. The pAA instability has clinical, diagnostic, epidemiologic, and evolutionary implications.	[Zhang, Wenlan; Bielaszewska, Martina; Kunsmann, Lisa; Mellmann, Alexander; Bauwens, Andreas; Koeck, Robin; Kossow, Annelene; Karch, Helge] Univ Munster, Inst Hyg, D-48149 Munster, Germany; [Zhang, Wenlan; Bielaszewska, Martina; Kunsmann, Lisa; Mellmann, Alexander; Bauwens, Andreas; Koeck, Robin; Kossow, Annelene; Karch, Helge] Univ Munster, Natl Consulting Lab Hemolyt Urem Syndrome, D-48149 Munster, Germany; [Mellmann, Alexander; Karch, Helge] Univ Munster, Interdisciplinary Ctr Clin Res IZKF, D-48149 Munster, Germany; [Anders, Agnes; Gatermann, Soeren] Ruhr Univ Bochum, Inst Hyg & Microbiol, Bochum, Germany	University of Munster; University of Munster; University of Munster; Ruhr University Bochum	Karch, H (corresponding author), Univ Munster, Inst Hyg, D-48149 Munster, Germany.	hkarch@uni-muenster.de	Köck, Robin/AAC-1552-2019; Bielaszewska, Martina/AAC-9812-2022	Mellmann, Alexander/0000-0002-0649-5185	Interdisciplinary Center of Clinical Research (IZKF) Munster [Me2/021/12]; EU [278976]; Medical Faculty of the University of Munster [BD9817044]	Interdisciplinary Center of Clinical Research (IZKF) Munster; EU(European Commission); Medical Faculty of the University of Munster	This work was supported by grants from the Interdisciplinary Center of Clinical Research (IZKF) Munster (no. Me2/021/12), the EU FP7 ANTIGONE (278976), and the Medical Faculty of the University of Munster (no. BD9817044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048228; Al Safadi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041628; Aurass P, 2011, ENVIRON MICROBIOL, V13, P3139, DOI 10.1111/j.1462-2920.2011.02604.x; Beutin L, 2012, J VIROL, V86, P10444, DOI 10.1128/JVI.00986-12; Beutin L, 2012, J FOOD PROTECT, V75, P408, DOI 10.4315/0362-028X.JFP-11-452; Bielaszewska M, 2005, THROMB HAEMOSTASIS, V94, P312, DOI 10.1160/TH05-04-0265; Bielaszewska M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001024; Bielaszewska M, 2007, APPL ENVIRON MICROB, V73, P3144, DOI 10.1128/AEM.02937-06; Bielaszewska M, 2006, CLIN INFECT DIS, V43, P1160, DOI 10.1086/508195; Bielaszewska M, 2012, ANTIMICROB AGENTS CH, V56, P3277, DOI 10.1128/AAC.06315-11; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Boisen N, 2008, INFECT IMMUN, V76, P3281, DOI 10.1128/IAI.01646-07; Brzuszkiewicz E, 2011, ARCH MICROBIOL, V193, P883, DOI 10.1007/s00203-011-0725-6; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Delannoy S, 2012, J CLIN MICROBIOL, V50, P3485, DOI 10.1128/JCM.01656-12; EUCAST, 2012, ANT SUSC TEST EUCAT; EUCAST, 2012, EUCAST MIC ZONE DIAM; European Food Safety Association, 2011, TRACING SEEDS PARTIC; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Gault G, 2011, EUROSURVEILLANCE, V16, P5; Grad YH, 2013, MBIO, V4, DOI 10.1128/mBio.00452-12; Grad YH, 2012, P NATL ACAD SCI USA, V109, P3065, DOI 10.1073/pnas.1121491109; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Karch H, 2012, EMBO MOL MED, V4, P841, DOI 10.1002/emmm.201201662; King LA, 2012, CLIN INFECT DIS, V54, P1588, DOI 10.1093/cid/cis255; Mellmann A, 2005, CLIN INFECT DIS, V41, P785, DOI 10.1086/432722; Mellmann A, 2008, APPL ENVIRON MICROB, V74, P67, DOI 10.1128/AEM.01906-07; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Mellmann A, 2009, GASTROENTEROLOGY, V136, P1925, DOI 10.1053/j.gastro.2008.12.072; Mendez-Arancibia E, 2008, AM J TROP MED HYG, V78, P985, DOI 10.4269/ajtmh.2008.78.985; Monecke S, 2011, APPL ENVIRON MICROB, V77, P8784, DOI 10.1128/AEM.06524-11; Muller D, 2007, APPL ENVIRON MICROB, V73, P3380, DOI 10.1128/AEM.02855-06; Nataro JP, 2005, CURR OPIN GASTROEN, V21, P4; Prager R, 2003, INT J MED MICROBIOL, V292, P477, DOI 10.1078/1438-4221-00226; Pritchard L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034498; Qin JJ, 2011, J CLIN MICROBIOL, V49, P3439, DOI 10.1128/JCM.01312-11; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Restieri C, 2007, APPL ENVIRON MICROB, V73, P1553, DOI 10.1128/AEM.01542-06; RICHARDSON SE, 1988, HUM PATHOL, V19, P1102, DOI 10.1016/S0046-8177(88)80093-5; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Scavia G, 2011, EMERG INFECT DIS, V17, P1957, DOI 10.3201/eid1710.111072; SCHMIDT H, 1995, J CLIN MICROBIOL, V33, P701, DOI 10.1128/JCM.33.3.701-705.1995; Smet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011202; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601; Zangari Tonia, 2013, Infect Immun, V81, P1562, DOI 10.1128/IAI.01310-12; Zhang WL, 2012, J CLIN MICROBIOL, V50, P1752, DOI 10.1128/JCM.06817-11; Zoja C, 2010, PEDIATR NEPHROL, V25, P2231, DOI 10.1007/s00467-010-1522-1	49	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66717	10.1371/journal.pone.0066717	http://dx.doi.org/10.1371/journal.pone.0066717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805269	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500097
J	Torchia, MLG; Conze, DB; Ashwell, JD				Giardino Torchia, Maria Letizia; Conze, Dietrich B.; Ashwell, Jonathan D.			c-IAP1 and c-IAP2 Redundancy Differs between T and B Cells	PLOS ONE			English	Article							NF-KAPPA-B; ALPHA-DEPENDENT APOPTOSIS; MULTIPLE-MYELOMA; ACTIVATION; CIAP2; TRAF2; UBIQUITINATION; RECEPTOR; IAPS; INHIBITOR	Cellular Inhibitors of Apoptosis 1 and 2 (c-IAP1 and c-IAP2) are ubiquitin protein ligases (E3s) that constitutively ubiquitinate and induce proteasomal-mediated degradation of NF-kappa B Inducing Kinase (NIK) and repress non-canonical NF-kappa B activation. Mice expressing an E3-inactive c-IAP2 mutant (c-IAP2(H570A)) have constitutive activation of non-canonical NF-kappa B, resulting in B cell hyperplasia and T cell costimulation-independence. If, and if so to what extent, c-IAP1 and c-IAP2 are redundant in NF-kappa B regulation in these mice is not known. Here we have generated mice expressing a mutant c-IAP1 that lacks E3 activity (c-IAP1(H582A)). These mice were phenotypically normal and did not have constitutive NF-kappa B activation in B cells or MEFs. siRNA-mediated knockdown of c-IAP2 showed that accumulated c-IAP2, resulting from lack of c-IAP1-dependent degradation, compensated for absent c-IAP1 E3 activity. Surprisingly, c-IAP1(H582A) T cells had a lower p100/p52 ratio than wild type T cells, and in the absence of costimulation proliferated to a degree intermediate between wild type and c-IAP2(H570A) T cells. Therefore, although c-IAP1 and c-IAP2 both can repress constitutive NF-kappa B activation, the relative importance of each varies according to cell type.	[Giardino Torchia, Maria Letizia; Conze, Dietrich B.; Ashwell, Jonathan D.] NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ashwell, JD (corresponding author), NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA.	jda@pop.nci.nih.gov			National Institutes of Health, Center for Cancer Research, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010779] Funding Source: NIH RePORTER	National Institutes of Health, Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health, Center for Cancer Research, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBONDANZO SJ, 1993, METHOD ENZYMOL, V225, P803; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Conte D, 2006, MOL CELL BIOL, V26, P699, DOI 10.1128/MCB.26.2.699-708.2006; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Conze DB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000518; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Corn RA, 2003, J IMMUNOL, V171, P1816, DOI 10.4049/jimmunol.171.4.1816; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Gardam S, 2008, IMMUNITY, V28, P391, DOI 10.1016/j.immuni.2008.01.009; Gardam S, 2011, BLOOD, V117, P4041, DOI 10.1182/blood-2010-10-312793; Geserick P, 2009, J CELL BIOL, V187, P1037, DOI 10.1083/jcb.200904158; Graber TE, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.20; Grech AP, 2004, IMMUNITY, V21, P629, DOI 10.1016/j.immuni.2004.09.011; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Holcik M, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-5; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Li YQ, 2005, J BIOL CHEM, V280, P1217, DOI 10.1074/jbc.M409492200; Mace PD, 2010, J MOL BIOL, V400, P8, DOI 10.1016/j.jmb.2010.04.055; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Moulin M, 2012, EMBO J; Muller JR, 2003, J BIOL CHEM, V278, P12006, DOI 10.1074/jbc.M210768200; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Prakash H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006519; Sanjo H, 2010, J BIOL CHEM, V285, P17148, DOI 10.1074/jbc.M110.105874; Silke J, 2010, CELL DEATH DIFFER, V17, P35, DOI 10.1038/cdd.2009.114; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Torchia MLG, 2013, J IMMUNOL, V190, P549, DOI 10.4049/jimmunol.1201697; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vandenabeele P, 2012, NAT REV IMMUNOL, V12, P833, DOI 10.1038/nri3325; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; Xie P, 2007, IMMUNITY, V27, P253, DOI 10.1016/j.immuni.2007.07.012; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhao YG, 2007, J BIOL CHEM, V282, P7777, DOI 10.1074/jbc.M609146200; Zheng C, 2010, MOL CELL, V38, P101, DOI 10.1016/j.molcel.2010.03.009; Zhou HL, 2005, CANCER CELL, V7, P425, DOI 10.1016/j.ccr.2005.04.012	46	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66161	10.1371/journal.pone.0066161	http://dx.doi.org/10.1371/journal.pone.0066161			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799077	Green Published, gold, Green Submitted			2022-12-25	WOS:000321397800026
J	Hoffmann, C; Dollive, S; Grunberg, S; Chen, J; Li, HZ; Wu, GD; Lewis, JD; Bushman, FD				Hoffmann, Christian; Dollive, Serena; Grunberg, Stephanie; Chen, Jun; Li, Hongzhe; Wu, Gary D.; Lewis, James D.; Bushman, Frederic D.			Archaea and Fungi of the Human Gut Microbiome: Correlations with Diet and Bacterial Residents	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; METHANOBREVIBACTER-SMITHII; DIVERSITY; FERMENTATION; COMMUNITIES; INFECTION; HEALTH	Diet influences health as a source of nutrients and toxins, and by shaping the composition of resident microbial populations. Previous studies have begun to map out associations between diet and the bacteria and viruses of the human gut microbiome. Here we investigate associations of diet with fungal and archaeal populations, taking advantage of samples from 98 well-characterized individuals. Diet was quantified using inventories scoring both long-term and recent diet, and archaea and fungi were characterized by deep sequencing of marker genes in DNA purified from stool. For fungi, we found 66 genera, with generally mutually exclusive presence of either the phyla Ascomycota or Basiodiomycota. For archaea, Methanobrevibacter was the most prevalent genus, present in 30% of samples. Several other archaeal genera were detected in lower abundance and frequency. Myriad associations were detected for fungi and archaea with diet, with each other, and with bacterial lineages. Methanobrevibacter and Candida were positively associated with diets high in carbohydrates, but negatively with diets high in amino acids, protein, and fatty acids. A previous study emphasized that bacterial population structure was associated primarily with long-term diet, but high Candida abundance was most strongly associated with the recent consumption of carbohydrates. Methobrevibacter abundance was associated with both long term and recent consumption of carbohydrates. These results confirm earlier targeted studies and provide a host of new associations to consider in modeling the effects of diet on the gut microbiome and human health.	[Hoffmann, Christian; Dollive, Serena; Grunberg, Stephanie; Bushman, Frederic D.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Wu, Gary D.] Univ Penn, Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Li, Hongzhe; Lewis, James D.] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Li, Hongzhe; Lewis, James D.] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Hoffmann, Christian] Univ Fed Goias, Inst Ciencias Biol, Goiania, Go, Brazil; [Chen, Jun] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Universidade Federal de Goias; Harvard University; Harvard T.H. Chan School of Public Health	Wu, GD (corresponding author), Univ Penn, Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA.	gdwu@mail.med.upenn.edu; lewisjd@mail.med.upenn.edu; bushman@mail.med.upenn.edu	Hoffmann, Christian/C-1298-2015	Hoffmann, Christian/0000-0003-1736-8007; Bushman, Frederic/0000-0003-4740-4056	Penn Genome Frontiers Institute; National Institutes of Health (NIH) [DK 089472]; Joint Penn-CHOP Center for Digestive, Liver, and Pancreatic Medicine [S10RR024525, UL1RR024134, K24DK078228]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134, S10RR024525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089472, K24DK078228, UH2DK083981, P30DK050306] Funding Source: NIH RePORTER	Penn Genome Frontiers Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joint Penn-CHOP Center for Digestive, Liver, and Pancreatic Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Project UH2/3 DK083981, the Penn Genome Frontiers Institute; National Institutes of Health (NIH) DK 089472 (GDW); Penn Digestive Disease Center (P30 DK050306); The Joint Penn-CHOP Center for Digestive, Liver, and Pancreatic Medicine; S10RR024525; UL1RR024134, and K24DK078228. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources, National Institutes of Health, or Pennsylvania Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson HW, 1917, J INFECT DIS, V21, P341, DOI 10.1093/infdis/21.4.341; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CDC/NCHS, 2011, NAT HLTH NUTR EX SUR; Chen J, 2012, BIOINFORMATICS, V28, P2106, DOI 10.1093/bioinformatics/bts342; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dollive S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r60; Downes J, 2010, INT J SYST EVOL MICR, V60, P2458, DOI 10.1099/ijs.0.014720-0; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Dridi B, 2011, ANAEROBE, V17, P56, DOI 10.1016/j.anaerobe.2011.03.001; Dridi B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007063; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Gumbo T, 1999, MEDICINE, V78, P220, DOI 10.1097/00005792-199907000-00002; Hamad I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040888; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; IANNOTTI EL, 1973, J BACTERIOL, V114, P1231, DOI 10.1128/JB.114.3.1231-1240.1973; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kovatcheva-Datchary P, 2009, ENVIRON MICROBIOL, V11, P914, DOI 10.1111/j.1462-2920.2008.01815.x; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Lepp PW, 2004, P NATL ACAD SCI USA, V101, P6176, DOI 10.1073/pnas.0308766101; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Matarazzo F, 2012, CLIN MICROBIOL INFEC, V18, P834, DOI 10.1111/j.1469-0691.2012.03958.x; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; MILLER TL, 1982, APPL ENVIRON MICROB, V43, P227, DOI 10.1128/AEM.43.1.227-232.1982; Minot S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042342; Minot S, 2012, P NATL ACAD SCI USA, V109, P3962, DOI 10.1073/pnas.1119061109; Minot Samuel, 2011, GENOME RES; Murdoch TB, 2012, INFLAMM BOWEL DIS, V18, P1743, DOI 10.1002/ibd.22884; Ott SJ, 2008, SCAND J GASTROENTERO, V43, P831, DOI 10.1080/00365520801935434; Purushe J, 2010, MICROB ECOL, V60, P721, DOI 10.1007/s00248-010-9692-8; Reyes A, 2012, NAT REV MICROBIOL, V10, P607, DOI 10.1038/nrmicro2853; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Samuel BS, 2007, P NATL ACAD SCI USA, V104, P10643, DOI 10.1073/pnas.0704189104; Scupham AJ, 2006, APPL ENVIRON MICROB, V72, P793, DOI 10.1128/AEM.72.1.793-801.2006; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Seibold F, 2001, SCAND J GASTROENTERO, V36, P196, DOI 10.1080/003655201750065960; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Stams AJM, 2009, NAT REV MICROBIOL, V7, P568, DOI 10.1038/nrmicro2166; Stewart JA, 2006, LETT APPL MICROBIOL, V43, P58, DOI 10.1111/j.1472-765X.2006.01906.x; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Ursell LK, 2012, J ALLERGY CLIN IMMUN, V129, P1204, DOI 10.1016/j.jaci.2012.03.010; VANGYLSWYK NO, 1995, INT J SYST BACTERIOL, V45, P297, DOI 10.1099/00207713-45-2-297; WILLETT WC, 1983, AM J CLIN NUTR, V38, P631, DOI 10.1093/ajcn/38.4.631; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	60	454	485	7	171	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66019	10.1371/journal.pone.0066019	http://dx.doi.org/10.1371/journal.pone.0066019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799070	Green Published, Green Submitted, gold			2022-12-25	WOS:000321397800022
J	Pradel, A; Didier, D; Casane, D; Tafforeau, P; Maisey, JG				Pradel, Alan; Didier, Dominique; Casane, Didier; Tafforeau, Paul; Maisey, John Graham			Holocephalan Embryo Provides New Information on the Evolution of the Glossopharyngeal Nerve, Metotic Fissure and Parachordal Plate in Gnathostomes	PLOS ONE			English	Article							CHIMAEROID FISH; BRAINCASE; CHONDRICHTHYAN; PHYLOGENY; SKULL	The phylogenetic relationships between the different groups of Paleozoic gnathostomes are still debated, mainly because of incomplete datasets on Paleozoic jawed vertebrate fossils and ontogeny of some modern taxa. This issue is illustrated by the condition of the glossopharyngeal nerve relative to the parachordal plate, the otic capsules and the metotic fissure in gnathostomes. Two main conditions are observed in elasmobranchs (shark and rays) and osteichthyans (bony fishes and tetrapods). The condition in the other chondrichthyan taxon, the holocephalans, is still poorly known, and without any information on this taxon, it remains difficult to polarize the condition in gnathostomes. Based on the anatomical study of an embryo of the holocephalan Callorhinchus milii by means of propagation X-Ray Synchrotron phase contrast microtomography using both holotomography and single distance phase retrieval process, we show that, contrary to what was previously inferred for holocephalans (i.e. an osteichthyan-like condition), the arrangement of the glossopharyngeal nerve relative to the surrounding structure in holocephalans is more similar to that of elasmobranchs. Furthermore, the holocephalan condition represents a combination of plesiomorphic characters for gnathostomes (e. g., the glossopharyngeal nerve leaves the braincase via the metotic fissure) and homoplastic characters. By contrast, the crown osteichthyans are probably derived in having the glossopharyngeal nerve that enters the saccular chamber and in having the glossopharyngeal foramen separated from the metotic fissure.	[Pradel, Alan; Maisey, John Graham] Amer Museum Nat Hist, Dept Vertebrate Paleontol, New York, NY 10024 USA; [Didier, Dominique] Millersville Univ Pennsylvania, Dept Biol, Millersville, PA 17551 USA; [Casane, Didier] UPR 9034 CNRS, Lab Evolut Genome & Speciat, Gif Sur Yvette, France; [Casane, Didier] Univ Paris Diderot, Paris, France; [Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France	American Museum of Natural History (AMNH); Pennsylvania State System of Higher Education (PASSHE); Millersville University of Pennsylvania; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; European Synchrotron Radiation Facility (ESRF)	Pradel, A (corresponding author), Amer Museum Nat Hist, Dept Vertebrate Paleontol, New York, NY 10024 USA.	apradel@amnh.org		Tafforeau, Paul/0000-0002-5962-1683	H.R. & E. Axelrod Research Chair in paleoichthyology at the AMNH; ESRF; National Science Foundation Assembling the Tree Of Life (ATOL) [1132229]; National Science Foundation ("Collaborative Research: Jaws and Backbone: Chondrichthyan Phylogeny and a Spine for the Vertebrate Tree of Life'') [1036488]; Herbert and Evelyn Research Chair in Vertebrate Paleontology at the AMNH; NSF DEB Assembling the Tree Of Life (ATOL) [1036505]; Direct For Biological Sciences [1036488, 1036505] Funding Source: National Science Foundation	H.R. & E. Axelrod Research Chair in paleoichthyology at the AMNH; ESRF; National Science Foundation Assembling the Tree Of Life (ATOL)(National Science Foundation (NSF)); National Science Foundation ("Collaborative Research: Jaws and Backbone: Chondrichthyan Phylogeny and a Spine for the Vertebrate Tree of Life'')(National Science Foundation (NSF)); Herbert and Evelyn Research Chair in Vertebrate Paleontology at the AMNH; NSF DEB Assembling the Tree Of Life (ATOL); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The main work was supported by the H.R. & E. Axelrod Research Chair in paleoichthyology at the AMNH, the ESRF (beamline ID19, proposal ec361) and part by the National Science Foundation Assembling the Tree Of Life (ATOL) 1132229, the National Science Foundation Award No. 1036488 ("Collaborative Research: Jaws and Backbone: Chondrichthyan Phylogeny and a Spine for the Vertebrate Tree of Life''). Research for this project was also supported by the Herbert and Evelyn Research Chair in Vertebrate Paleontology at the AMNH. Dominique Didier research is supported by NSF DEB Assembling the Tree Of Life (ATOL) 1036505. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basden AM, 2001, J VERTEBR PALEONTOL, V21, P754, DOI 10.1671/0272-4634(2001)021[0754:APANFT]2.0.CO;2; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; Coates MI, 2001, J VERTEBR PALEONTOL, V21, P438, DOI 10.1671/0272-4634(2001)021[0438:ANSCFT]2.0.CO;2; Coates MI, 1998, T ROY SOC EDIN-EARTH, V89, P63, DOI 10.1017/S026359330000701X; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; de Beer G., 1937, DEV VERTEBRATE SKULL; Didier DA, 1998, J MORPHOL, V236, P25; Didier DA, 1995, AM MUS NOVIT, V3119, P1; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; Gillis JA, 2011, P NATL ACAD SCI USA, V108, P1507, DOI 10.1073/pnas.1012968108; Heimberg AM, 2010, P NATL ACAD SCI USA, V107, P19379, DOI 10.1073/pnas.1010350107; Holmgren Nils, 1943, ADA ZOOL [STOCKHOLM], V24, P1; Holmgren Nils, 1940, ACTA ZOOL [STOCKHOLM], V21, P51; Inoue JG, 2010, MOL BIOL EVOL, V27, P2576, DOI 10.1093/molbev/msq147; Janvier P., 1996, EARLY VERTEBRATES; JARVIK ERIK, 1954, K SVENSKA VETENSKAPSAKAD HANDL, V5, P1; JOLLIE M, 1971, J MORPHOL, V133, P17, DOI 10.1002/jmor.1051330103; Khonsari RH, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-27; MAISEY J G, 1983, American Museum Novitates, P1; Maisey J.G., 1984, Journal of Vertebrate Paleontology, V4, P359; Maisey JG, 2005, B AM MUS NAT HIST, P1; Maisey JG, 2001, J VERTEBR PALEONTOL, V21, P702, DOI 10.1671/0272-4634(2001)021[0702:APCBFT]2.0.CO;2; Maisey JG, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)429<0001:MOTBIT>2.0.CO;2; Maisey J, 2009, ACTA ZOOL-STOCKHOLM, V90, P109, DOI 10.1111/j.1463-6395.2008.00330.x; Maisey JG, 2007, B AM MUS NAT HIST, P4; Maisey JG, 2010, CR PALEVOL, V9, P289, DOI 10.1016/j.crpv.2010.07.021; MILES RS, 1977, ZOOL J LINN SOC-LOND, V61, P1, DOI 10.1111/j.1096-3642.1977.tb01031.x; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; PATTERSO.C, 1965, PHILOS T ROY SOC B, V249, P101, DOI 10.1098/rstb.1965.0010; Poplin C, 1974, ETUDE QUELQUES PALEO; Pradel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024938; Pradel A, 2010, GEODIVERSITAS, V32, P595, DOI 10.5252/g2010n4a2; Pradel A, 2009, P NATL ACAD SCI USA, V106, P5224, DOI 10.1073/pnas.0807047106; Sanchez S, 2012, MICROSC MICROANAL, V18, P1095, DOI 10.1017/S1431927612001079; Schaeffer B., 1981, B AM MUS NAT HIST, V169, P3; Stensio E., 1963, Kungliga Svenska Vetenskapsakademiens Handlingar (4), V9, P1; YOUNG G C, 1980, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V167, P10; YOUNG GC, 1979, ZOOL J LINN SOC-LOND, V66, P309, DOI 10.1111/j.1096-3642.1979.tb01912.x	38	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66988	10.1371/journal.pone.0066988	http://dx.doi.org/10.1371/journal.pone.0066988			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799138	Green Published, Green Submitted, gold			2022-12-25	WOS:000321397800047
J	Wu, MY; Dai, DQ; Zhang, XF; Zhu, Y				Wu, Meng-Yun; Dai, Dao-Qing; Zhang, Xiao-Fei; Zhu, Yuan			Cancer Subtype Discovery and Biomarker Identification via a New Robust Network Clustering Algorithm	PLOS ONE			English	Article							GENE-EXPRESSION; MAXIMUM-LIKELIHOOD; FACTOR ANALYZERS; ADAPTIVE LASSO; LEUKEMIA; MIXTURES; CLASSIFICATION; UNIVARIATE; SELECTION; ONTOLOGY	In cancer biology, it is very important to understand the phenotypic changes of the patients and discover new cancer subtypes. Recently, microarray-based technologies have shed light on this problem based on gene expression profiles which may contain outliers due to either chemical or electrical reasons. These undiscovered subtypes may be heterogeneous with respect to underlying networks or pathways, and are related with only a few of interdependent biomarkers. This motivates a need for the robust gene expression-based methods capable of discovering such subtypes, elucidating the corresponding network structures and identifying cancer related biomarkers. This study proposes a penalized model-based Student's t clustering with unconstrained covariance (PMT-UC) to discover cancer subtypes with cluster-specific networks, taking gene dependencies into account and having robustness against outliers. Meanwhile, biomarker identification and network reconstruction are achieved by imposing an adaptive L-1 penalty on the means and the inverse scale matrices. The model is fitted via the expectation maximization algorithm utilizing the graphical lasso. Here, a network-based gene selection criterion that identifies biomarkers not as individual genes but as subnetworks is applied. This allows us to implicate low discriminative biomarkers which play a central role in the subnetwork by interconnecting many differentially expressed genes, or have cluster-specific underlying network structures. Experiment results on simulated datasets and one available cancer dataset attest to the effectiveness, robustness of PMT-UC in cancer subtype discovering. Moveover, PMT-UC has the ability to select cancer related biomarkers which have been verified in biochemical or biomedical research and learn the biological significant correlation among genes.	[Wu, Meng-Yun; Dai, Dao-Qing; Zhang, Xiao-Fei; Zhu, Yuan] Sun Yat Sen Univ, Ctr Comp Vis, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Meng-Yun; Dai, Dao-Qing; Zhang, Xiao-Fei; Zhu, Yuan] Sun Yat Sen Univ, Dept Math, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Yuan] Guangdong Univ Business Studies, Dept Math, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangdong University of Finance & Economics	Dai, DQ (corresponding author), Sun Yat Sen Univ, Ctr Comp Vis, Guangzhou 510275, Guangdong, Peoples R China.	stsddq@mail.sysu.edu.cn			National Science Foundation of China [90920007, 11171354]; Ministry of Education of China [20120171110016]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	Funding provided by National Science Foundation of China (90920007, 11171354), and the Ministry of Education of China (20120171110016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal M, 2009, MODERN PATHOL, V22, P206, DOI 10.1038/modpathol.2008.148; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baek J, 2011, BIOINFORMATICS, V27, P1269, DOI 10.1093/bioinformatics/btr112; Banerjee O, 2008, J MACH LEARN RES, V9, P485; BANFIELD JD, 1993, BIOMETRICS, V49, P803, DOI 10.2307/2532201; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bentink S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030269; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Candes EJ, 2008, J FOURIER ANAL APPL, V14, P877, DOI 10.1007/s00041-008-9045-x; Chen LS, 2010, AM J HUM GENET, V86, P860, DOI 10.1016/j.ajhg.2010.04.014; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Cozzini A, 2013, J BIOINFORM IN PRESS; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Di Camillo B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032200; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Fan JQ, 2009, ANN APPL STAT, V3, P521, DOI 10.1214/08-AOAS215; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Fruhwirth-Schnatter S, 2010, BIOSTATISTICS, V11, P317, DOI 10.1093/biostatistics/kxp062; Glazko GV, 2009, BIOINFORMATICS, V25, P2348, DOI 10.1093/bioinformatics/btp406; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; KANSAS GS, 1993, J EXP MED, V177, P833, DOI 10.1084/jem.177.3.833; Kim J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052973; Klener P, 2006, J VIROL, V80, P1922, DOI 10.1128/JVI.80.4.1922-1938.2006; Krajinovic M, 2001, INT J CANCER S, V97, P230; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Lee H, 2011, IEEE T MED IMAGING, V30, P1154, DOI 10.1109/TMI.2011.2140380; Li J., 2012, NAT COMMUN, V3, P655, DOI [10.1038/ncomms1400, DOI 10.1038/NCOMMS1400]; MCLACHLAN G, 2000, WILEY SER PROB STAT, P1; Mukherjee S, 2011, BIOINFORMATICS, V27, P994, DOI 10.1093/bioinformatics/btr070; Nahar R, 2009, CELL CYCLE, V8, P3874, DOI 10.4161/cc.8.23.10035; Ng EKO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053141; Ni IBP, 2010, PATHOL RES PRACT, V206, P223, DOI 10.1016/j.prp.2009.11.006; OSSERMAN EF, 1966, J EXP MED, V124, P921, DOI 10.1084/jem.124.5.921; Pan W, 2007, J MACH LEARN RES, V8, P1145; Payne Kimberly J., 2011, Critical Reviews in Oncogenesis, V16, P3; Peel D, 2000, STAT COMPUT, V10, P339, DOI 10.1023/A:1008981510081; Ramezani-Rad P, 2013, BLOOD, V121, P148, DOI 10.1182/blood-2012-05-428938; Roy J, 2012, BRIEF BIOIN IN PRESS; Sakhinia E, 2005, BRIT J HAEMATOL, V130, P233, DOI 10.1111/j.1365-2141.2005.05594.x; Shachar I, 2011, LEUKEMIA LYMPHOMA, V52, P1446, DOI 10.3109/10428194.2011.565437; Shand JC, 2010, CANCER IMMUNOL IMMUN, V59, P1633, DOI 10.1007/s00262-010-0889-y; Shen K, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040900, 10.1371/journal.pone.0049529]; Shen SM, 2010, CARCINOGENESIS, V31, P419, DOI 10.1093/carcin/bgp320; Simoes RD, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-38; Song WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031929; Steidl U, 2006, NAT GENET, V38, P1269, DOI 10.1038/ng1898; Tadesse MG, 2005, J AM STAT ASSOC, V100, P602, DOI 10.1198/016214504000001565; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Winter C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002511; Wu MY, 2012, IEEE ACM T COMPUT BI, V9, P1649, DOI 10.1109/TCBB.2012.105; Xie BH, 2010, BIOINFORMATICS, V26, P501, DOI 10.1093/bioinformatics/btp707; Xie BH, 2008, ELECTRON J STAT, V2, P168, DOI 10.1214/08-EJS194; Yang WH, 2011, IEEE T KNOWL DATA EN, V23, P568, DOI 10.1109/TKDE.2010.150; Yu Y, 2012, BIOCHEM BIOPH RES CO, V423, P721, DOI 10.1016/j.bbrc.2012.06.025; Zhang J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002656; Zhang XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043092; Zhang XF, 2012, IEEE ACM T COMPUT BI, V9, P857, DOI 10.1109/TCBB.2012.20; Zhou H, 2009, ELECTRON J STAT, V3, P1473, DOI 10.1214/09-EJS487; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	61	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66256	10.1371/journal.pone.0066256	http://dx.doi.org/10.1371/journal.pone.0066256			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799085	Green Published, Green Submitted, gold			2022-12-25	WOS:000321397800027
J	Farahani, HS; Lagergren, J				Farahani, Hossein Shahrabi; Lagergren, Jens			Learning Oncogenetic Networks by Reducing to Mixed Integer Linear Programming	PLOS ONE			English	Article							CONJUNCTIVE BAYESIAN NETWORKS; HYBRIDIZATION DATA; TREE MODELS; PATHWAYS; CARCINOMA	Cancer can be a result of accumulation of different types of genetic mutations such as copy number aberrations. The data from tumors are cross-sectional and do not contain the temporal order of the genetic events. Finding the order in which the genetic events have occurred and progression pathways are of vital importance in understanding the disease. In order to model cancer progression, we propose Progression Networks, a special case of Bayesian networks, that are tailored to model disease progression. Progression networks have similarities with Conjunctive Bayesian Networks (CBNs) [1], a variation of Bayesian networks also proposed for modeling disease progression. We also describe a learning algorithm for learning Bayesian networks in general and progression networks in particular. We reduce the hard problem of learning the Bayesian and progression networks to Mixed Integer Linear Programming (MILP). MILP is a Non-deterministic Polynomial-time complete (NP-complete) problem for which very good heuristics exists. We tested our algorithm on synthetic and real cytogenetic data from renal cell carcinoma. We also compared our learned progression networks with the networks proposed in earlier publications. The software is available on the website https://bitbucket.org/farahani/diprog.	[Farahani, Hossein Shahrabi; Lagergren, Jens] KTH Royal Inst Technol, Sci Life Lab SciLifeLab, Ctr Ind & Appl Math, Sch Comp Sci & Commun, Stockholm, Sweden	Royal Institute of Technology; SciLifeLab	Lagergren, J (corresponding author), KTH Royal Inst Technol, Sci Life Lab SciLifeLab, Ctr Ind & Appl Math, Sch Comp Sci & Commun, Stockholm, Sweden.	jensl@csc.kth.se		Lagergren, Jens/0000-0002-4552-0240; Farahani, Hossein/0000-0002-9503-1875	Center for Industrial and Applied Mathematics	Center for Industrial and Applied Mathematics	Funding provided by the Center for Industrial and Applied Mathematics, website: http://www.ciam.kth.se/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudis M, 2001, PROGENETIX NET ONLIN; Beerenwinkel N, 2005, J COMPUT BIOL, V12, P584, DOI 10.1089/cmb.2005.12.584; Beerenwinkel N, 2005, BIOINFORMATICS, V21, P2106, DOI 10.1093/bioinformatics/bti274; Beerenwinkel N, 2007, BERNOULLI, V13, P893, DOI 10.3150/07-BEJ6133; Beerenwinkel N, 2006, J THEOR BIOL, V242, P409, DOI 10.1016/j.jtbi.2006.03.013; Cheng YK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002337; Cussens J., 2010, P WORKSH CONSTR BAS; Desper R, 1999, J COMPUT BIOL, V6, P37, DOI 10.1089/cmb.1999.6.37; Gerstung M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027136; Gerstung M, 2009, BIOINFORMATICS, V25, P2809, DOI 10.1093/bioinformatics/btp505; Greenman CD, 2012, GENOME RES, V22, P346, DOI 10.1101/gr.118414.110; Hjelm M, 2006, J COMPUT BIOL, V13, P853, DOI 10.1089/cmb.2006.13.853; Hoglund M, 2002, CANCER RES, V62, P5939; Hoglund M, 2002, CANCER RES, V62, P2675; Hoglund M, 2004, CANC GENETICS CYTOGE; Jiang F, 2000, CANCER RES, V60, P6503; Koller D., 2009, PROBABILISTIC GRAPHI; Mitelman F, 2012, MITELMAN DATABASE CH; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Pearl J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Tofigh A., 2011, ADV NEURAL INFORM PR, V24, P163; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901	23	22	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65773	10.1371/journal.pone.0065773	http://dx.doi.org/10.1371/journal.pone.0065773			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799047	Green Published, gold, Green Submitted			2022-12-25	WOS:000320363300042
J	Kwon, KC; Verma, D; Jin, SX; Singh, ND; Daniell, H				Kwon, Kwang-Chul; Verma, Dheeraj; Jin, Shuangxia; Singh, Nameirakpam D.; Daniell, Henry			Release of Proteins from Intact Chloroplasts Induced by Reactive Oxygen Species during Biotic and Abiotic Stress	PLOS ONE			English	Article							BOUND TRANSCRIPTION FACTORS; MG-PROTOPORPHYRIN IX; ARABIDOPSIS-THALIANA; TOBACCO CHLOROPLASTS; GENE-EXPRESSION; SALICYLIC-ACID; CELL-DEATH; HIGH LIGHT; NUCLEUS; CAROTOVORA	Plastids sustain life on this planet by providing food, feed, essential biomolecules and oxygen. Such diverse metabolic and biosynthetic functions require efficient communication between plastids and the nucleus. However, specific factors, especially large molecules, released from plastids that regulate nuclear genes have not yet been fully elucidated. When tobacco and lettuce transplastomic plants expressing GFP within chloroplasts, were challenged with Erwinia carotovora (biotic stress) or paraquat (abiotic stress), GFP was released into the cytoplasm. During this process GFP moves gradually towards the envelope, creating a central red zone of chlorophyll fluorescence. GFP was then gradually released from intact chloroplasts into the cytoplasm with an intact vacuole and no other visible cellular damage. Different stages of GFP release were observed inside the same cell with a few chloroplasts completely releasing GFP with detection of only red chlorophyll fluorescence or with no reduction in GFP fluorescence or transitional steps between these two phases. Time lapse imaging by confocal microscopy clearly identified sequence of these events. Intactness of chloroplasts during this process was evident from chlorophyll fluorescence emanated from thylakoid membranes and in vivo Chla fluorescence measurements (maximum quantum yield of photosystem II) made before or after infection with pathogens to evaluate their photosynthetic competence. Hydrogen peroxide and superoxide anion serve as signal molecules for generation of reactive oxygen species and Tiron, scavenger of superoxide anion, blocked release of GFP from chloroplasts. Significant increase in ion leakage in the presence of paraquat and light suggests changes in the chloroplast envelope to facilitate protein release. Release of GFP-RC101 (an antimicrobial peptide), which was triggered by Erwinia infection, ceased after conferring protection, further confirming this export phenomenon. These results suggest a novel signaling mechanism, especially for participation of chloroplast proteins (e.g. transcription factors) in retrograde signaling, thereby offering new opportunities to regulate pathways outside chloroplasts.	[Kwon, Kwang-Chul; Verma, Dheeraj; Jin, Shuangxia; Singh, Nameirakpam D.; Daniell, Henry] Univ Cent Florida, Coll Med, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA; [Kwon, Kwang-Chul; Daniell, Henry] Univ Penn, Sch Dent Med, Dept Biochem, Philadelphia, PA 19104 USA; [Kwon, Kwang-Chul; Daniell, Henry] Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA	State University System of Florida; University of Central Florida; University of Pennsylvania; University of Pennsylvania	Daniell, H (corresponding author), Univ Cent Florida, Coll Med, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA.	hdaniell@upenn.edu	Daniell, Henry/L-3655-2019; Kwon, Kwang-Chul/T-8694-2019; Kwon, Kwang-Chul/P-6558-2017	Daniell, Henry/0000-0003-4485-1176; Kwon, Kwang-Chul/0000-0002-4037-1776; Jin, Shuangxia/0000-0002-1495-9154	United States Department of Agriculture (USDA) CSREES [2009-39200-19972]; USDA-National Institute of Food and Agriculture [2010-39200-21704]; National Institutes of Health (NIH) [R01 GM 63879, NIH R01 HL 109442, NIH R01 HL 107904]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109442, R01HL107904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063879] Funding Source: NIH RePORTER	United States Department of Agriculture (USDA) CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); USDA-National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	All investigators were supported by funding from the following grants to Henry Daniell: United States Department of Agriculture (USDA) CSREES 2009-39200-19972, USDA-National Institute of Food and Agriculture 2010-39200-21704, National Institutes of Health (NIH) R01 GM 63879, NIH R01 HL 109442 and NIH R01 HL 107904. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi AR, 2007, PLANT PHYSIOL, V143, P1720, DOI 10.1104/pp.106.094771; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; BABBS CF, 1989, PLANT PHYSIOL, V90, P1267, DOI 10.1104/pp.90.4.1267; BAKER NR, 1991, PHYSIOL PLANTARUM, V81, P563, DOI 10.1111/j.1399-3054.1991.tb05101.x; BUCHANAN BB, 1980, ANNU REV PLANT PHYS, V31, P341, DOI 10.1146/annurev.pp.31.060180.002013; Caplan J, 2008, CELL HOST MICROBE, V3, P126, DOI 10.1016/j.chom.2008.02.010; Caplan JL, 2008, CELL, V132, P449, DOI 10.1016/j.cell.2007.12.031; Chen YN, 2008, CURR OPIN PLANT BIOL, V11, P695, DOI 10.1016/j.pbi.2008.10.005; Daniell H, 2001, J MOL BIOL, V311, P1001, DOI 10.1006/jmbi.2001.4921; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; Desikan R, 2001, PLANT PHYSIOL, V126, P1579, DOI 10.1104/pp.126.4.1579; Dutta S, 2009, PLANT PHYSIOL, V150, P1050, DOI 10.1104/pp.109.137265; Enami K, 2011, PLANT PHYSIOL, V157, P518, DOI 10.1104/pp.111.178897; ENSMINGER MP, 1985, PLANT PHYSIOL, V78, P46, DOI 10.1104/pp.78.1.46; Estavillo GM, 2011, PLANT CELL, V23, P3992, DOI 10.1105/tpc.111.091033; Fernandez AP, 2008, CURR OPIN PLANT BIOL, V11, P509, DOI 10.1016/j.pbi.2008.06.002; Fey V, 2005, J BIOL CHEM, V280, P5318, DOI 10.1074/jbc.M406358200; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Govindjee, 2004, PHOTOSYNTH RES, V80, P447; Hess FD, 2000, WEED SCI, V48, P160, DOI 10.1614/0043-1745(2000)048[0160:LDHAO]2.0.CO;2; Hortensteiner S, 2006, ANNU REV PLANT BIOL, V57, P55, DOI 10.1146/annurev.arplant.57.032905.105212; Hoppe T, 2001, CURR OPIN CELL BIOL, V13, P344, DOI 10.1016/S0955-0674(00)00218-0; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Inaba T, 2010, BIOSCI BIOTECH BIOCH, V74, P471, DOI 10.1271/bbb.90842; Ishida H, 2008, PLANT PHYSIOL, V148, P142, DOI 10.1104/pp.108.122770; Jin SX, 2012, PLANT BIOTECHNOL J, V10, P313, DOI 10.1111/j.1467-7652.2011.00663.x; Jung HS, 2010, PLANT PHYSIOL, V152, P453, DOI 10.1104/pp.109.149070; Kariola T, 2003, MOL PLANT MICROBE IN, V16, P179, DOI 10.1094/MPMI.2003.16.3.179; Kiba A, 2006, MOL PLANT MICROBE IN, V19, P112, DOI 10.1094/MPMI-19-0112; Lazar D, 2006, FUNCT PLANT BIOL, V33, P9, DOI 10.1071/FP05095; Lee KP, 2007, P NATL ACAD SCI USA, V104, P10270, DOI 10.1073/pnas.0702061104; Lee SB, 2011, PLANT BIOTECHNOL J, V9, P100, DOI 10.1111/j.1467-7652.2010.00538.x; Li HM, 2010, ANNU REV PLANT BIOL, V61, P157, DOI 10.1146/annurev-arplant-042809-112222; Lo SM, 2012, PLANT J, V71, P656, DOI 10.1111/j.1365-313X.2012.05020.x; Lo SM, 2011, METHODS MOL BIOL, V684, P139, DOI [10.1007/978.1.60761.925.3_13, 10.1007/978-1-60761-925-3_13]; Maruta T, 2012, J BIOL CHEM, V287, P11717, DOI 10.1074/jbc.M111.292847; Mochizuki N, 2008, P NATL ACAD SCI USA, V105, P15184, DOI 10.1073/pnas.0803245105; Montesano M, 2004, MOL PLANT PATHOL, V5, P115, DOI 10.1111/J.1364-3703.2004.00213.X; Moulin M, 2008, P NATL ACAD SCI USA, V105, P15178, DOI 10.1073/pnas.0803054105; Noguchi H, 2003, DIABETES, V52, P1732, DOI 10.2337/diabetes.52.7.1732; Orozco-Cardenas M, 1999, P NATL ACAD SCI USA, V96, P6553, DOI 10.1073/pnas.96.11.6553; PALVA TK, 1993, MOL PLANT MICROBE IN, V6, P190, DOI 10.1094/MPMI-6-190; Pfannschmidt T, 2010, TRENDS PLANT SCI, V15, P427, DOI 10.1016/j.tplants.2010.05.009; Ramel F, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-28; Ruhlman T, 2007, PLANT BIOTECHNOL J, V5, P495, DOI 10.1111/j.1467-7652.2007.00259.x; Ruhlman T, 2010, PLANT PHYSIOL, V152, P2088, DOI 10.1104/pp.109.152017; Sambrook J, 2001, MOL CLONING LAB MANU; Scarpeci TE, 2008, PLANT MOL BIOL, V66, P361, DOI 10.1007/s11103-007-9274-4; Seo PJ, 2008, TRENDS PLANT SCI, V13, P550, DOI 10.1016/j.tplants.2008.06.008; Singh N. Dolendro, 2009, V483, P163, DOI 10.1007/978-1-59745-407-0_10; Singh ND, 2008, PLANT CELL, V20, P3405, DOI 10.1105/tpc.108.063172; Strand A, 2003, NATURE, V421, P79, DOI 10.1038/nature01204; Sun XW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1486; Sunil B, 2008, INDIAN J BIOCHEM BIO, V45, P37; Suzuki N, 2012, PLANT CELL ENVIRON, V35, P259, DOI 10.1111/j.1365-3040.2011.02336.x; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Vandenabeele S, 2004, PLANT J, V39, P45, DOI 10.1111/j.1365-313X.2004.02105.x; Verma D, 2008, NAT PROTOC, V3, P739, DOI 10.1038/nprot.2007.522; Verma D, 2010, PLANT BIOTECHNOL J, V8, P332, DOI 10.1111/j.1467-7652.2009.00486.x; Vidal S, 1997, PLANT J, V11, P115, DOI 10.1046/j.1365-313X.1997.11010115.x; Vidal S, 1998, MOL PLANT MICROBE IN, V11, P23, DOI 10.1094/MPMI.1998.11.1.23; Vranova E, 2002, P NATL ACAD SCI USA, V99, P10870, DOI 10.1073/pnas.152337999; Yoshimoto K, 2004, PLANT CELL, V16, P2967, DOI 10.1105/tpc.104.025395	63	26	26	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e67106	10.1371/journal.pone.0067106	http://dx.doi.org/10.1371/journal.pone.0067106			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799142	gold, Green Published			2022-12-25	WOS:000320363300104
J	Lansade, L; Coutureau, E; Marchand, A; Baranger, G; Valenchon, M; Calandreau, L				Lansade, Lea; Coutureau, Etienne; Marchand, Alain; Baranger, Gersende; Valenchon, Mathilde; Calandreau, Ludovic			Dimensions of Temperament Modulate Cue-Controlled Behavior: A Study on Pavlovian to Instrumental Transfer in Horses (Equus Caballus)	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; COGNITIVE PERFORMANCE; LEARNING PERFORMANCES; STRESS; TRAIT; TIME; HIPPOCAMPAL; PERSONALITY; REACTIVITY; ANXIETY	Pavlovian to instrumental transfer (PIT) is a central factor in how cues influence animal behavior. PIT refers to the capacity of a Pavlovian cue that predicts a reward to elicit or increase a response intended to obtain the same reward. In the present study, using an equine model, we assessed whether PIT occurs in hoofed domestic animals and whether its efficacy can be modulated by temperamental dimensions. To study PIT, horses were submitted to Pavlovian conditioning whereby an auditory-visual stimulus was repeatedly followed by food delivery. Then, horses were submitted to instrumental conditioning during which they learned to touch with their noses an object signaled by the experimenter in order to obtain the same reward. During the PIT test, the Pavlovian conditioned stimulus was presented to the animal in the absence of reward. At the end of the experiment, a battery of behavioral tests was performed on all animals to assess five temperamental dimensions and investigate their relationships with instrumental performance. The results indicate that PIT can be observed in horses and that its efficacy is greatly modulated by individual temperament. Indeed, individuals with a specific pattern of temperamental dimensions (i.e., higher levels of gregariousness, fearfulness, and sensory sensitivity) exhibited the strongest PIT. The demonstration of the existence of PIT in domesticated animals (i.e., horses) is important for the optimization of its use by humans and the improvement of training methods. Moreover, because PIT may be implicated in psychological phenomena, including addictive behaviors, the observation of relationships between specific temperamental dimensions and PIT efficacy may aid in identifying predisposing temperamental attributes.	[Lansade, Lea; Baranger, Gersende; Valenchon, Mathilde; Calandreau, Ludovic] INRA, UMR Physiol Reprod & Comportements 85, F-37380 Nouzilly, France; [Lansade, Lea; Baranger, Gersende; Valenchon, Mathilde; Calandreau, Ludovic] CNRS, UMR 7247, Nouzilly, France; [Lansade, Lea; Baranger, Gersende; Valenchon, Mathilde; Calandreau, Ludovic] Univ Tours, Tours, France; [Lansade, Lea; Baranger, Gersende; Valenchon, Mathilde; Calandreau, Ludovic] IFCE, Nouzilly, France; [Coutureau, Etienne; Marchand, Alain] Univ Bordeaux, INCIA, Talence, France; [Coutureau, Etienne; Marchand, Alain] CNRS, UMR 5287, INCIA, Talence, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Tours; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Lansade, L (corresponding author), INRA, UMR Physiol Reprod & Comportements 85, F-37380 Nouzilly, France.	lansade@tours.inra.fr	INCIA, NeurexTeam/D-6197-2014	Coutureau, Etienne/0000-0001-6695-020X; Valenchon, Mathilde/0000-0003-0226-8433; Marchand, Alain/0000-0002-0231-5562	National French Stud (les Haras nationaux)	National French Stud (les Haras nationaux)	The National French Stud (les Haras nationaux) funded this experiment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates J.E., 1989, TEMPERAMENT CHILDHOO, P3; Brinks V, 2007, FRONT BEHAV NEUROSCI, V1, DOI [10.3389/neuro.08.008.2007, 10.3389/neuro.08/008.2007]; Budaev SV, 1998, J COMP PSYCHOL, V112, P92, DOI 10.1037/0735-7036.112.1.92; De Martino B, 2006, SCIENCE, V313, P684, DOI 10.1126/science.1128356; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; Dunn W, 2001, AM J OCCUP THER, V55, P608, DOI 10.5014/ajot.55.6.608; Flagel SB, 2010, NEUROPSYCHOPHARMACOL, V35, P388, DOI 10.1038/npp.2009.142; GOLDSMITH HH, 1987, CHILD DEV, V58, P505, DOI 10.1111/j.1467-8624.1987.tb01398.x; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Herrero AI, 2006, NEUROBIOL LEARN MEM, V86, P150, DOI 10.1016/j.nlm.2006.02.001; Holland PC, 2004, J EXP PSYCHOL-ANIM B, V30, P104, DOI 10.1037/0097-7403.30.2.104; Holmes NM, 2010, NEUROSCI BIOBEHAV R, V34, P1277, DOI 10.1016/j.neubiorev.2010.03.007; Joels M, 2006, TRENDS COGN SCI, V10, P152, DOI 10.1016/j.tics.2006.02.002; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; Kurland A., 2003, CLICK TEACHES STEP B; Lansade L, 2008, APPL ANIM BEHAV SCI, V114, P534, DOI 10.1016/j.applanim.2008.02.012; Lansade L, 2008, APPL ANIM BEHAV SCI, V114, P492, DOI 10.1016/j.applanim.2008.04.012; Lansade L, 2008, APPL ANIM BEHAV SCI, V109, P355, DOI 10.1016/j.applanim.2007.03.003; Lansade L, 2010, APPL ANIM BEHAV SCI, V125, P30, DOI 10.1016/j.applanim.2010.02.010; Lansade L, 2008, APPL ANIM BEHAV SCI, V115, P182, DOI 10.1016/j.applanim.2008.06.011; Lindberg AC, 1999, APPL ANIM BEHAV SCI, V61, P187, DOI 10.1016/S0168-1591(98)00184-1; MADER DR, 1980, J ANIM SCI, V50, P962, DOI 10.2527/jas1980.505962x; Mendl M, 1999, APPL ANIM BEHAV SCI, V65, P221, DOI 10.1016/S0168-1591(99)00088-X; O'Brien CP, 1998, J PSYCHOPHARMACOL, V12, P15, DOI 10.1177/026988119801200103; Ohl F, 2003, EUR J NEUROSCI, V17, P128, DOI 10.1046/j.1460-9568.2003.02436.x; Ohl F, 2002, BEHAV NEUROSCI, V116, P464, DOI 10.1037//0735-7044.116.3.464; Robinson TE, 2009, BIOL PSYCHIAT, V65, P869, DOI 10.1016/j.biopsych.2008.09.006; Rosenkranz JA, 2010, BIOL PSYCHIAT, V67, P1128, DOI 10.1016/j.biopsych.2010.02.008; Sandi Carmen, 2007, Neural Plasticity, V2007, DOI 10.1055/2007/78970; Saunders BT, 2010, BIOL PSYCHIAT, V67, P730, DOI 10.1016/j.biopsych.2009.11.015; Schwabe L, 2011, BEHAV BRAIN RES, V219, P321, DOI 10.1016/j.bbr.2010.12.038; Schwabe L, 2010, NEUROBIOL LEARN MEM, V93, P183, DOI 10.1016/j.nlm.2009.09.009; Schwabe L, 2009, J NEUROSCI, V29, P7191, DOI 10.1523/JNEUROSCI.0979-09.2009; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P157, DOI 10.1016/S0168-1591(02)00120-X; Talmi D, 2008, J NEUROSCI, V28, P360, DOI 10.1523/JNEUROSCI.4028-07.2008; Teskey GC, 1998, PHYSIOL BEHAV, V65, P555, DOI 10.1016/S0031-9384(98)00196-6; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Visser EK, 2003, APPL ANIM BEHAV SCI, V80, P311, DOI 10.1016/S0168-1591(02)00235-6; Vyas A, 2002, J NEUROSCI, V22, P6810; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	40	17	18	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e64853	10.1371/journal.pone.0064853	http://dx.doi.org/10.1371/journal.pone.0064853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23798994	Green Submitted, Green Published, gold			2022-12-25	WOS:000320363300003
J	Matser, A; Luu, N; Geskus, R; Heijman, T; Heiligenberg, M; van Veen, M; van der Loeff, MS				Matser, Amy; Luu, Nancy; Geskus, Ronald; Heijman, Titia; Heiligenberg, Marlies; van Veen, Maaike; van der Loeff, Maarten Schim			Higher Chlamydia trachomatis Prevalence in Ethnic Minorities Does Not Always Reflect Higher Sexual Risk Behaviour	PLOS ONE			English	Article							TRANSMITTED INFECTIONS; MIGRANT POPULATIONS; MIXING PATTERNS; NETHERLANDS; GONORRHEA; AFRICAN; HEALTH; SERVICES; BARRIERS; BRITAIN	Background: In affluent countries, the prevalence of Chlamydia trachomatis (CT) is often higher in certain ethnic minorities than in the majority population. In the Netherlands, we examined why CT prevalence is higher in Surinamese/Antilleans, the largest minority in the country. Methods: Heterosexuals were recruited for a cross-sectional survey from May through August 2010 at the sexually transmitted infections (STI) clinic in Amsterdam. Participants completed a questionnaire and were tested for STI. A causal directed acyclic graph was assumed to investigate whether the association between ethnicity and CT could be explained by differences in sexual risk behaviour and socio-economic status. Results: Subjects included 1044 with Dutch background and 335 with Surinamese/Antillean background. Median age for the combined population was 25 (IQR 22-30) years, and 55.4% was female. Sexual risk behaviour did not differ significantly between the two groups. CT was diagnosed in 17.9% of Surinamese/Antilleans and in 11.4% of Dutch. Surinamese/Antilleans were significantly more likely to have CT (OR 1.70; 95% CI 1.21-2.38). The association between ethnicity and CT remained statistically significant after adjusting for sexual risk behaviour, age, sex, and ethnic mixing (aOR 1.48; 95% CI 1.00-2.18), but not after adjusting for education and neighbourhood, markers of socioeconomic status (aOR 1.08; 95% CI 0.71-1.64). Conclusion: The difference in CT prevalence between the minority and majority groups was not explained by differences in sexual risk behaviour. The higher CT prevalence found among Surinamese/Antilleans appeared to reflect their lower educational level and neighbourhood, two markers of lower socio-economic status. We hypothesise that the effect results from lower health-seeking behaviour.	[Matser, Amy; Luu, Nancy; Geskus, Ronald; Heijman, Titia; Heiligenberg, Marlies; van Veen, Maaike; van der Loeff, Maarten Schim] Publ Hlth Serv Amsterdam, Cluster Infect Dis, Amsterdam, Netherlands; [Matser, Amy] UMCU, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Geskus, Ronald] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Heiligenberg, Marlies; van der Loeff, Maarten Schim] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immunol Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands	Public Health Service Amsterdam; Unilever; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Matser, A (corresponding author), Publ Hlth Serv Amsterdam, Cluster Infect Dis, Amsterdam, Netherlands.	amatser@ggd.amsterdam.nl	Geskus, Ronald B/H-3684-2019	Geskus, Ronald B/0000-0002-2740-3155; Heijman, Titia/0000-0002-1944-2007; Matser, Amy/0000-0003-4291-1905	Netherlands Organisation for Health and Research (ZonMw) [71150001]	Netherlands Organisation for Health and Research (ZonMw)	This work was supported by the Netherlands Organisation for Health and Research (ZonMw) (grant number 71150001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aral SO, 2000, SEX TRANSM INFECT, V76, P415, DOI 10.1136/sti.76.6.415; Burns FM, 2007, AIDS CARE, V19, P102, DOI 10.1080/09540120600908440; Fakoya I, 2008, HIV MED, V9, P23, DOI 10.1111/j.1468-1293.2008.00587.x; Fenton KA, 2005, LANCET, V365, P1246, DOI 10.1016/S0140-6736(05)74813-3; Fenton KA, 2001, CURR OPIN INFECT DIS, V14, P63, DOI 10.1097/00001432-200102000-00011; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; Ford K, 2002, SEX TRANSM DIS, V29, P13, DOI 10.1097/00007435-200201000-00003; Geronimus AT, 1998, AM J EPIDEMIOL, V148, P475; Gotz HM, 2005, SEX TRANSM INFECT, V81, P24, DOI 10.1136/sti.2004.010181; Gras MJ, 1999, AIDS, V13, P1953, DOI 10.1097/00002030-199910010-00019; Heijman RLJ, 2009, SEX TRANSM INFECT, V85, P249, DOI 10.1136/sti.2008.033258; Heijne JCM, 2011, J INFECT DIS, V203, P372, DOI 10.1093/infdis/jiq050; James AB, 2012, J NATL MED ASSOC, V104, P20, DOI 10.1016/S0027-9684(15)30129-2; Knol F, 2012, DEV STATUS NEIGHBOUR; Kramer MA, 2008, SEX TRANSM INFECT, V84, P554, DOI 10.1136/sti.2008.032094; Kretzschmar M, 2009, SEX TRANSM INFECT, V85, P359, DOI 10.1136/sti.2009.036251; Laumann EO, 1999, SEX TRANSM DIS, V26, P250, DOI 10.1097/00007435-199905000-00003; Low N, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11080; Low N, 2001, SEX TRANSM INFECT, V77, P15, DOI 10.1136/sti.77.1.15; Navarro Christine, 2002, Can J Infect Dis, V13, P195; Op de Coul ELM, 2012, SEX TRANSM DIS, V39, P97, DOI 10.1097/OLQ.0b013e3182383097; Prost A, 2007, SEX TRANSM INFECT, V83, P547, DOI 10.1136/sti.2007.027110; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Scheppers E, 2006, FAM PRACT, V23, P325, DOI 10.1093/fampra/cmi113; Stuart B, 2010, J BIOSOC SCI, V42, P27, DOI 10.1017/S0021932009990289; van Bergen JEAM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-293; van Bergen JEAM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-42; van Buuren S, 2011, J STAT SOFTW, V45, P1; van den Broek IVF, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4316; van der Helm JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032122; van Veen MG, 2011, INT J STD AIDS, V22, P245, DOI 10.1258/ijsa.2009.008511; van Veen MG, 2009, AIDS CARE, V21, P683, DOI 10.1080/09540120802511984; Vriend HJ, 2011, SEXUALLY TRANSMITTED, P1	33	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e67287	10.1371/journal.pone.0067287	http://dx.doi.org/10.1371/journal.pone.0067287			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163UV	23799146	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300109
J	Van der Hauwaert, C; Savary, G; Gnemmi, V; Glowacki, F; Pottier, N; Bouillez, A; Maboudou, P; Zini, L; Leroy, X; Cauffiez, C; Perrais, M; Aubert, S				Van der Hauwaert, Cynthia; Savary, Gregoire; Gnemmi, Viviane; Glowacki, Francois; Pottier, Nicolas; Bouillez, Audrey; Maboudou, Patrice; Zini, Laurent; Leroy, Xavier; Cauffiez, Christelle; Perrais, Michael; Aubert, Sebastien			Isolation and Characterization of a Primary Proximal Tubular Epithelial Cell Model from Human Kidney by CD10/CD13 Double Labeling	PLOS ONE			English	Article							PRIMARY CULTURES; DISTAL TUBULE; IN-VITRO; EXPRESSION; IMMUNODISSECTION; LOCALIZATION; PROTEINURIA; TRANSPORT; SEGMENTS	uRenal proximal tubular epithelial cells play a central role in renal physiology and are among the cell types most sensitive to ischemia and xenobiotic nephrotoxicity. In order to investigate the molecular and cellular mechanisms underlying the pathophysiology of kidney injuries, a stable and well-characterized primary culture model of proximal tubular cells is required. An existing model of proximal tubular cells is hampered by the cellular heterogeneity of kidney; a method based on cell sorting for specific markers must therefore be developed. In this study, we present a primary culture model based on the mechanical and enzymatic dissociation of healthy tissue obtained from nephrectomy specimens. Renal epithelial cells were sorted using co-labeling for CD10 and CD13, two renal proximal tubular epithelial markers, by flow cytometry. Their purity, phenotypic stability and functional properties were evaluated over several passages. Our results demonstrate that CD10/CD13 double-positive cells constitute a pure, functional and stable proximal tubular epithelial cell population that displays proximal tubule markers and epithelial characteristics over the long term, whereas cells positive for either CD10 or CD13 alone appear to be heterogeneous. In conclusion, this study describes a method for establishing a robust renal proximal tubular epithelial cell model suitable for further experimentation.	[Van der Hauwaert, Cynthia; Savary, Gregoire; Glowacki, Francois; Pottier, Nicolas; Cauffiez, Christelle] Fac Med Lille, Dept Biochim & Biol Mol, EA4483, F-59045 Lille, France; [Gnemmi, Viviane; Bouillez, Audrey; Zini, Laurent; Leroy, Xavier; Perrais, Michael; Aubert, Sebastien] INSERM, U837, Ctr Rech Jean Pierre Aubert, Equipe Mucines Differentiat & Cancerogenese Epith, F-59045 Lille, France; [Gnemmi, Viviane; Leroy, Xavier; Aubert, Sebastien] CHRU Lille, Serv Anat Pathol, Ctr Biol & Pathol, F-59037 Lille, France; [Gnemmi, Viviane; Glowacki, Francois; Pottier, Nicolas; Zini, Laurent; Leroy, Xavier; Cauffiez, Christelle; Perrais, Michael; Aubert, Sebastien] Univ Lille 2, Fac Med Lille, Lille, France; [Glowacki, Francois] CHRU Lille, Hop Huriez, Serv Nephrol, F-59037 Lille, France; [Maboudou, Patrice] CHRU Lille, Ctr Biol & Pathol, Serv Biochim, F-59037 Lille, France; [Zini, Laurent] CHRU Lille, Hop Huriez, Serv Urol, F-59037 Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille	Aubert, S (corresponding author), INSERM, U837, Ctr Rech Jean Pierre Aubert, Equipe Mucines Differentiat & Cancerogenese Epith, F-59045 Lille, France.	sebastien.aubert@inserm.fr	Cauffiez, Christelle/H-5816-2019	Cauffiez, Christelle/0000-0003-0951-7973; Glowacki, Francois/0000-0001-5443-9172; Van der Hauwaert, Cynthia/0000-0001-9549-3722; pottier, nicolas/0000-0001-8913-6286; Savary, Gregoire/0000-0001-8021-2676	University of Lille 2 graduate scholarship; Agence Nationale de la Recherche [ANR-09-JCJC-0002]; Conseil Regional du Nord Pas de Calais	University of Lille 2 graduate scholarship; Agence Nationale de la Recherche(French National Research Agency (ANR)); Conseil Regional du Nord Pas de Calais(Region Hauts-de-FranceRegion Ile-de-France)	CVDH is supported by University of Lille 2 graduate scholarship. This study was supported by grants from Agence Nationale de la Recherche (ANR-09-JCJC-0002 (MP)) and the Conseil Regional du Nord Pas de Calais (CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2009, CLIN J AM SOC NEPHRO, V4, P1523, DOI 10.2215/CJN.02010309; Baer PC, 2006, CELLS TISSUES ORGANS, V184, P16, DOI 10.1159/000096947; Baer PC, 1999, EXP NEPHROL, V7, P306; Baer PC, 1997, KIDNEY INT, V52, P1321, DOI 10.1038/ki.1997.457; Bai SJ, 2012, INT J BIOL SCI, V8, P859, DOI 10.7150/ijbs.3490; Bakris GL, 2009, KIDNEY INT, V75, P1272, DOI 10.1038/ki.2009.87; Bens M, 2008, PFLUG ARCH EUR J PHY, V457, P1, DOI 10.1007/s00424-008-0507-4; Brown CDA, 2008, TOXICOL APPL PHARM, V233, P428, DOI 10.1016/j.taap.2008.09.018; BROWN D, 1990, P NATL ACAD SCI USA, V87, P7457, DOI 10.1073/pnas.87.19.7457; COURJAULTGAUTIER F, 1995, J AM SOC NEPHROL, V5, P1949; Cummings BS, 2000, J PHARMACOL EXP THER, V293, P677; DeFronzo RA, 2012, DIABETES OBES METAB, V14, P5, DOI 10.1111/j.1463-1326.2011.01511.x; Delabarre S, 1997, TISSUE CELL, V29, P99, DOI 10.1016/S0040-8166(97)80076-6; Denker BM, 2011, J AM SOC NEPHROL, V22, P622, DOI 10.1681/ASN.2010090922; Elberg G, 2008, CELL TISSUE RES, V331, P495, DOI 10.1007/s00441-007-0521-4; Gonzalez-Mariscal L, 2000, KIDNEY INT, V57, P2386, DOI 10.1046/j.1523-1755.2000.00098.x; Helbert MJF, 2001, KIDNEY INT, V59, P554, DOI 10.1046/j.1523-1755.2001.059002554.x; Helbert MJF, 1997, KIDNEY INT, V52, P414, DOI 10.1038/ki.1997.348; Kamiyama M, 2012, J HYPERTENS, V30, P2365, DOI 10.1097/HJH.0b013e3283598eed; Kamiyama M, 2012, INT J MOL SCI, V13, P5098, DOI 10.3390/ijms13045098; Konigs M, 2009, TOXICOLOGY, V258, P106, DOI 10.1016/j.tox.2009.01.012; Lash LH, 1995, TOXICOLOGY, V103, P85, DOI 10.1016/0300-483X(95)03110-2; Li W, 2003, TOXICOL IN VITRO, V17, P107, DOI 10.1016/S0887-2333(02)00128-5; Li W, 2006, TOXICOL IN VITRO, V20, P669, DOI 10.1016/j.tiv.2005.09.016; Maria OM, 2011, INT J BIOCHEM CELL B, V43, P622, DOI 10.1016/j.biocel.2011.01.001; Molitoris BA, 1996, KIDNEY INT, V49, P1592, DOI 10.1038/ki.1996.231; Prozialeck WC, 2006, TOXICOL IN VITRO, V20, P942, DOI 10.1016/j.tiv.2005.11.006; Qi W, 2007, NEPHROLOGY, V12, P155, DOI 10.1111/j.1440-1797.2007.00779.x; Rahmoune H, 2005, DIABETES, V54, P3427, DOI 10.2337/diabetes.54.12.3427; Schaaf GJ, 2001, CHEM-BIOL INTERACT, V134, P167, DOI 10.1016/S0009-2797(01)00151-X; Schlatter P, 2006, EUR J PHARM SCI, V28, P141, DOI 10.1016/j.ejps.2006.01.009; Sens DA, 1999, EXP NEPHROL, V7, P344; Terryn S, 2007, AM J PHYSIOL-RENAL, V293, pF476, DOI 10.1152/ajprenal.00363.2006; Valente MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019337; VANDERBIEST I, 1994, KIDNEY INT, V45, P85, DOI 10.1038/ki.1994.10; Wang Q, 2013, AM J PHYSIOL-RENAL, V304, pF168, DOI 10.1152/ajprenal.00129.2012; Weiland C, 2007, TOXICOL IN VITRO, V21, P466, DOI 10.1016/j.tiv.2006.10.008; Xia Y, 2010, J AM SOC NEPHROL, V21, P666, DOI 10.1681/ASN.2009050511	38	58	58	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66750	10.1371/journal.pone.0066750	http://dx.doi.org/10.1371/journal.pone.0066750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799132	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300097
J	Wang, T; Wang, ZQ; Wang, L; Yan, L; Wan, J; Zhang, S; Jiang, HQ; Li, WF; Lin, ZF				Wang, Tao; Wang, Zhi-qin; Wang, Lv; Yan, Li; Wan, Jian; Zhang, Sheng; Jiang, Hong-quan; Li, Wen-fang; Lin, Zhao-fen			CRISPLD2 Is Expressed at Low Levels during Septic Shock and Is Associated with Procalcitonin	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING PROTEIN; SEVERE SEPSIS; BRANCHING MORPHOGENESIS; PREDICTS MORTALITY; DR EXPRESSION; ORGAN FAILURE; LGL1; ENDOTOXIN; EPIDEMIOLOGY; DEFINITIONS	Introduction: Previous studies have shown that cysteine-rich secretory protein containing LCCL domain 2 (CRISPLD2) is a novel lipopolysaccharide (LPS)-binding protein, and the upregulation of CRISPLD2 expression protects mice against LPS-induced lethality. The aim of this study was to examine the expression of CRISPLD2 in patients with sepsis and characterize the association of this protein with procalcitonin. Methods: The expression of CRISPLD2 was determined in 100 healthy volunteers and 119 septic patients. According to the definition of sepsis, patients were divided into three groups sepsis, severe sepsis, and septic shock. The relationship between CRISPLD2 levels and procalcitonin was also examined and statistically analyzed. Results: The CRISPLD2 levels in healthy individuals were 219.3 +/- 69.1 mu g/ml. Patients with sepsis exhibited higher CRISPLD2 levels than observed in healthy individuals (p = 0.001), but CRISPLD2 expression was not upregulated in patients with septic shock. No significant differences were observed between the levels of CRISPLD2 in surviving and non-surviving spesis patients. CRISPLD2 levels were negatively correlated with procalcitonin levels(r = -0.334, p<0.001). Conclusions: The present study is the first to demonstrate the decreased expression of CRISPLD2 in septic shock and its association with PCT in sepsis. Further studies are needed to clarify the potential association between CRISPLD2 expression and clinical outcomes to determine if it could be used as a novel sepsis biomarker.	[Wang, Tao] Chinese Peoples Liberat Army Gen Hosp, Dept Emergency, Sanya, Hainan Province, Peoples R China; [Wang, Tao] Chinese Peoples Liberat Army Gen Hosp, Intens Care Unit, Hainan Branch, Sanya, Hainan Province, Peoples R China; [Wang, Tao; Wang, Lv; Yan, Li; Wan, Jian; Zhang, Sheng; Li, Wen-fang; Lin, Zhao-fen] Second Mil Med Univ, Changzheng Hosp, Dept Emergency & Crit Care Med, Shanghai, Peoples R China; [Wang, Zhi-qin; Jiang, Hong-quan] Shanghai South Gene Technol Co Ltd, Shanghai, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Naval Medical University	Li, WF (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Emergency & Crit Care Med, Shanghai, Peoples R China.	jijiuke415@163.com; Linzhaofen@sina.com	tao, wang/N-4875-2016	tao, wang/0000-0001-6427-8800	National Natural Science Foundation of China [81171844/H1511]; Innovation Fund for Small Technology-based Firms [1002H124800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Fund for Small Technology-based Firms	This work was supported by National Natural Science Foundation of China (81171844/H1511), and the Innovation Fund for Small Technology-based Firms (1002H124800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2003, SHOCK, V20, P197, DOI 10.1097/01.shk.0000079423.72656.2f; Appelmelk BJ, 1992, IMMUNO PATHO, V2, P375; ARDITI M, 1993, INFECT IMMUN, V61, P3149, DOI 10.1128/IAI.61.8.3149-3156.1993; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Caille V, 2004, SHOCK, V22, P521, DOI 10.1097/01.shk.0000143410.63698.57; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheng BL, 2007, CRIT CARE MED, V35, P2538, DOI 10.1097/01.CCM.0000284492.30800.00; Chiquet BT, 2007, HUM MOL GENET, V16, P2241, DOI 10.1093/hmg/ddm176; DUNN DL, 1988, ARCH SURG-CHICAGO, V123, P1389; GALLAY P, 1994, J INFECT DIS, V170, P1319, DOI 10.1093/infdis/170.5.1319; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Gomis S, 2003, INFECT IMMUN, V71, P857, DOI 10.1128/IAI.71.2.857-863.2003; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lan J, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-83; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Monneret G, 2006, INTENS CARE MED, V32, P1175, DOI 10.1007/s00134-006-0204-8; Nadeau K, 2010, PEDIATR RES, V67, P375, DOI 10.1203/PDR.0b013e3181d23656; Opal SM, 1999, J INFECT DIS, V180, P1584, DOI 10.1086/315093; Oyewumi L, 2003, BIOCHEM J, V376, P61, DOI 10.1042/BJ20030591; Oyewumi L, 2003, AM J RESP CELL MOL, V28, P232, DOI 10.1165/rcmb.4877; Prucha M, 2003, CRIT CARE, V7, pR154, DOI 10.1186/cc2386; Quinlan J, 2007, AM J PHYSIOL-RENAL, V293, pF987, DOI 10.1152/ajprenal.00098.2007; Rice L, 2005, J INFECT DIS, V191, P1368, DOI 10.1086/428452; Ruiz-Alvarez M J, 2009, J Intensive Care Med, V24, P63, DOI 10.1177/0885066608327095; Sakr Y, 2008, CRIT CARE MED, V36, P2014, DOI 10.1097/CCM.0b013e31817b86e3; Schefold JC, 2010, INTENS CARE MED, V36, P1810, DOI 10.1007/s00134-010-1965-7; Schuetz P, 2010, CLIN BIOCHEM, V43, P341, DOI 10.1016/j.clinbiochem.2009.08.029; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Steinbach G, 2004, CLIN CHEM LAB MED, V42, P440, DOI 10.1515/CCLM.2004.077; Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8, DOI 10.1002/jlb.60.1.8; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Uzzan B, 2006, CRIT CARE MED, V34, P1996, DOI 10.1097/01.CCM.0000226413.54364.36; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Vreugdenhil ACE, 1999, J IMMUNOL, V163, P2792; Waag DM, 2006, INFECT IMMUN, V74, P1944, DOI 10.1128/IAI.74.3.1944-1948.2006; Wang ZQ, 2009, J IMMUNOL, V183, P6646, DOI 10.4049/jimmunol.0802348; Zeni F, 1997, CRIT CARE MED, V25, P1095, DOI 10.1097/00003246-199707000-00001	44	10	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65743	10.1371/journal.pone.0065743	http://dx.doi.org/10.1371/journal.pone.0065743			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799041	Green Published, gold, Green Submitted			2022-12-25	WOS:000320363300037
J	Zimmer, JY; Smeets, F; Simonon, G; Fagot, J; Haubruge, E; Francis, F; Losson, B				Zimmer, Jean-Yves; Smeets, Francois; Simonon, Gregory; Fagot, Jean; Haubruge, Eric; Francis, Frederic; Losson, Bertrand			Are Bogs Reservoirs for Emerging Disease Vectors? Evaluation of Culicoides Populations in the Hautes Fagnes Nature Reserve (Belgium)	PLOS ONE			English	Article							SCOTTISH BITING MIDGE; BLUETONGUE VIRUS; IMPUNCTATUS DIPTERA; NORTHERN EUROPE; CERATOPOGONIDAE; IDENTIFICATION; BLOODMEALS; EPIDEMIC; CATTLE; HOST	Several species of Culicoides (Diptera: Ceratopogonidae) biting midges serve as biological vectors for the bluetongue virus (BTV) and the recently described Schmallenberg virus (SBV) in northern Europe. Since their recent emergence in this part of the continent, these diseases have caused considerable economic losses to the sheep and cattle industries. Much data is now available that describe the distribution, population dynamics, and feeding habits of these insects. However, little is known regarding the presence of Culicoides in unusual habitats such as peaty marshes, nor their potential vector capacity. This study evaluated Culicoides biting midges present in the bogs of a Belgian nature reserve compared to those residing at a nearby cattle farm. Culicoides were trapped in 2011 at four different sites (broadleaved and coniferous forested areas, open environments, and at a scientific station) located in the Hautes Fagnes Nature Reserve (Belgium). An additional light trap was operated on a nearby cattle farm. Very high numbers of biting midges were captured in the marshy area and most of them (70 to 95%) were Culicoides impunctatus, a potential vector of BTV and other pathogens. In addition, fewer numbers of C. obsoletus/C. scoticus species, C. chiopterus, and C. dewulfi were observed in the bogs compared to the farm. The wet environment and oligotrophic nature of the soil were probably responsible for these changes in the respective populations. A total of 297,808 Culicoides midges belonging to 27 species were identified during this study and 3 of these species (C. sphagnumensis, C. clintoni and C. comosioculatus) were described in Belgium for the first time.	[Zimmer, Jean-Yves; Simonon, Gregory; Fagot, Jean; Haubruge, Eric; Francis, Frederic] Univ Liege, Gembloux Agrobio Tech, Dept Agron Sci, Unit Funct & Evolutionary Entomol, Gembloux, Belgium; [Smeets, Francois; Losson, Bertrand] Univ Liege, Fac Vet Med, Dept Infect & Parasit Dis, Lab Parasitol & Parasit Dis, Liege, Belgium	University of Liege; University of Liege	Zimmer, JY (corresponding author), Univ Liege, Gembloux Agrobio Tech, Dept Agron Sci, Unit Funct & Evolutionary Entomol, Gembloux, Belgium.	entomologie.gembloux@ulg.ac.be		Haubruge, Eric/0000-0002-8138-0476	Gembloux Agro-Bio Tech (University of Liege, Belgium)	Gembloux Agro-Bio Tech (University of Liege, Belgium)	Funding for this research was provided by Gembloux Agro-Bio Tech (University of Liege, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldet T, 2008, PREV VET MED, V87, P84, DOI 10.1016/j.prevetmed.2008.06.014; Balenghien T., 2008, CULICOIDES CHIOPTERU; BLACKWELL A, 1992, B ENTOMOL RES, V82, P299, DOI 10.1017/S0007485300041055; BLACKWELL A, 1995, MED VET ENTOMOL, V9, P214, DOI 10.1111/j.1365-2915.1995.tb00183.x; BLACKWELL A, 1994, MED VET ENTOMOL, V8, P20, DOI 10.1111/j.1365-2915.1994.tb00378.x; BOORMAN J, 1970, B ENTOMOL RES, V60, P189, DOI 10.1017/S0007485300058624; Carpenter S, 2008, VET REC, V163, P589, DOI 10.1136/vr.163.20.589; Carpenter S, 2008, J APPL ECOL, V45, P1237, DOI 10.1111/j.1365-2664.2008.01511.x; Collard R., 1993, GUIDE PLATEAU HAUTES; De Regge N, 2012, TRANSBOUND EMERG DIS, V59, P471, DOI 10.1111/tbed.12000; Del?colle J.C., 1985, THESIS U LOUIS PASTE; Delecolle Jean-Claude, 2002, Bulletin de la Societe Entomologique de France, V107, P371; Dijkstra E, 2008, VET REC, V162, P422, DOI 10.1136/vr.162.13.422-a; Du Toit R. M., 1944, ONDERSTEPOORT JOUR VET SCI AND ANIMAL INDUST, V19, P7; DYCE A L, 1969, Journal of the Australian Entomological Society, V8, P11; Dzhafarov SH, 1976, BITING MIDGES DIPTER; Fassotte C, 2008, PREV VET MED, V87, P74, DOI 10.1016/j.prevetmed.2008.06.007; Glushchenko N. P., 2008, Russian Entomological Journal, V17, P63; Goetghebuer M., 1952, Biologisch Jaarboek Antwerpen, V19, P185; Harrup LE, 2013, MED VET ENTOMOL, V27, P441, DOI 10.1111/mve.12006; HENDRY G, 1988, Scottish Forestry, V42, P113; HILL MA, 1947, ANN TROP MED PARASIT, V41, P55, DOI 10.1080/00034983.1947.11685315; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Hoffmann B, 2009, EMERG INFECT DIS, V15, P1481, DOI 10.3201/eid1509.090562; HOLMES PR, 1987, MED VET ENTOMOL, V1, P349, DOI 10.1111/j.1365-2915.1987.tb00366.x; JENNINGS DM, 1988, VET MICROBIOL, V17, P1, DOI 10.1016/0378-1135(88)90074-0; KETTLE D. S., 1961, BULL ENTOMOL RES, V52, P381, DOI 10.1017/S0007485300055474; KETTLE DS, 1952, B ENTOMOL RES, V43, P421, DOI 10.1017/S000748530002945X; Logan JG, 2009, J MED ENTOMOL, V46, P208, DOI 10.1603/033.046.0205; Mehlhorn H, 2007, PARASITOL RES, V101, P219, DOI 10.1007/s00436-007-0519-6; Meiswinkel R, 2008, PREV VET MED, V87, P182, DOI 10.1016/j.prevetmed.2008.06.008; Meiswinkel R, 2008, PREV VET MED, V87, P55, DOI 10.1016/j.prevetmed.2008.06.005; Meiswinkel R, 2007, VET REC, V161, P564, DOI 10.1136/vr.161.16.564; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; MURRAY WILLIAM S., 1957, MOSQUITO NEWS, V17, P77; Purse BV, 2012, MED VET ENTOMOL, V26, P168, DOI 10.1111/j.1365-2915.2011.00991.x; Saegerman C, 2008, POINT VET, V39, P41; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; Saegerman C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009405; Takken W, 2008, PREV VET MED, V87, P41, DOI 10.1016/j.prevetmed.2008.06.015; Thiry E, 2006, VET REC, V159, P327, DOI 10.1136/vr.159.10.327; Uslu U, 2006, MED VET ENTOMOL, V20, P350, DOI 10.1111/j.1365-2915.2006.00626.x; Valkiunas G, 2004, J PARASITOL, V90, P196, DOI 10.1645/GE-3223RN; Weinburgh H. B., 1962, CULICOIDES PUBLIC HL; Zimmer JY, 2008, VET REC, V162, P131, DOI 10.1136/vr.162.4.131; Zimmer JY, 2013, VET PARASITOL, V191, P197, DOI 10.1016/j.vetpar.2012.08.014; Zimmer JY, 2009, ANN SOC ENTOMOL FR, V45, P393, DOI 10.1080/00379271.2009.10697623; Zimmer JY, 2010, EMERG INFECT DIS, V16, P575, DOI 10.3201/eid1603.091311	48	12	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66893	10.1371/journal.pone.0066893	http://dx.doi.org/10.1371/journal.pone.0066893			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799137	Green Submitted, Green Published, gold			2022-12-25	WOS:000320363300102
J	Averna, M; Pedrazzi, M; Minicucci, L; De Tullio, R; Cresta, F; Salamino, F; Pontremoli, S; Melloni, E				Averna, Monica; Pedrazzi, Marco; Minicucci, Laura; De Tullio, Roberta; Cresta, Federico; Salamino, Franca; Pontremoli, Sandro; Melloni, Edon			Calpain Inhibition Promotes the Rescue of F(508)del-CFTR in PBMC from Cystic Fibrosis Patients	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PROTEIN-QUALITY CONTROL; CFTR; DEGRADATION; TRAFFICKING; CALPASTATIN; PROTEASOME; SECRETION; SYSTEM; LEVEL	A basal calpain activity promotes the limited proteolysis of wild type (WT) cystic fibrosis conductance regulator (CFTR), inducing the internalization of the split channel. This process contributes to the regulation in the level of the active CFTR at the plasma membranes. In peripheral blood mononuclear cells (PBMC) from 16 healthy donors, the inhibition of calpain activity induces a 3-fold increase in the amount of active WT CFTR at the plasma membranes. Instead, in PBMC from cystic fibrosis (CF) patients, calpain activity is expressed at aberrant levels causing the massive removal of F(508)del-CFTR from the cell surface. In these patients, the inhibition of such abnormal proteolysis rescues physiological amounts of active mutated CFTR in 90% of the patients (25 over 28). The recovery of functional F(508)del-CFTR at the physiological location, in cells treated with a synthetic calpain inhibitor, indicates that F(508)del-CFTR folding, maturation, and trafficking operate in CF-PBMC at significant rate. Thus, an increase in the basal calpain activity seems primarily involved in the CFTR defect observed in various CF cells. Furthermore, in CF-PBMC the recovery of the scaffolding protein Na+/H+ exchanger regulatory factor 1 (NHERF-1), occurring following inhibition of the aberrant calpain activity, can contribute to rescue CFTR-functional clusters.	[Averna, Monica; Pedrazzi, Marco; De Tullio, Roberta; Salamino, Franca; Pontremoli, Sandro; Melloni, Edon] Univ Genoa, Biochem Sect, Dept Expt Med DIMES, Genoa, Italy; [Averna, Monica; Pedrazzi, Marco; De Tullio, Roberta; Salamino, Franca; Pontremoli, Sandro; Melloni, Edon] Univ Genoa, CEBR, Genoa, Italy; [Minicucci, Laura; Cresta, Federico] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Sci Moth, G Gaslini Hosp, Cyst Fibrosis Pediat Ctr, Genoa, Italy	University of Genoa; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini	Melloni, E (corresponding author), Univ Genoa, Biochem Sect, Dept Expt Med DIMES, Genoa, Italy.	melloni@unige.it	AVERNA, MONICA/R-5719-2019; Cresta, Federico/AAA-7564-2020	AVERNA, MONICA/0000-0002-9463-7533; Cresta, Federico/0000-0002-2483-5374	Ministero dell'Istruzione dell'Universita e della Ricerca; University of Genoa	Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); University of Genoa	The work was supported by grants from Ministero dell'Istruzione dell'Universita e della Ricerca (PRIN 2008), and from the University of Genoa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antigny F, 2008, CELL CALCIUM, V43, P175, DOI 10.1016/j.ceca.2007.05.002; Antigny F, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-70; Aronson N N Jr, 1974, Methods Enzymol, V31, P90; Averna M, 2011, BBA-MOL BASIS DIS, V1812, P1649, DOI 10.1016/j.bbadis.2011.09.013; Averna M, 2011, BBA-MOL CELL RES, V1813, P50, DOI 10.1016/j.bbamcr.2010.11.008; Averna M, 2010, BIOCHEM J, V430, P255, DOI 10.1042/BJ20100344; Brodsky JL, 2001, AM J PHYSIOL-LUNG C, V281, pL39, DOI 10.1152/ajplung.2001.281.1.L39; Caci E, 2008, BIOCHEM J, V413, P135, DOI 10.1042/BJ20080029; Coligan JE, 1991, CURRENT PROTOCOL IMM; DAUBNER SC, 1987, P NATL ACAD SCI USA, V84, P8912, DOI 10.1073/pnas.84.24.8912; De Tullio R, 2003, BIOCHEM J, V375, P689, DOI 10.1042/BJ20030706; De Tullio R, 1999, BIOCHEM J, V343, P467; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Favia M, 2010, MOL BIOL CELL, V21, P73, DOI 10.1091/mbc.E09-03-0185; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Grove DE, 2009, MOL BIOL CELL, V20, P4059, DOI 10.1091/mbc.E08-09-0929; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hwang TC, 1997, AM J PHYSIOL-CELL PH, V273, pC988, DOI 10.1152/ajpcell.1997.273.3.C988; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; KOPITO RR, 1999, PHYSIOL REV, V79, P167; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Gars M, 2012, AM J RESP C IN PRESS; Loo TW, 2009, BIOCHEMISTRY-US, V48, P9882, DOI 10.1021/bi9004842; Molinski S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00160; Moran O, 2005, FEBS LETT, V579, P3979, DOI 10.1016/j.febslet.2005.06.026; Mueller C, 2011, AM J RESP CELL MOL, V44, P922, DOI 10.1165/rcmb.2010-0224OC; Norez C, 2006, TRAFFIC, V7, P562, DOI 10.1111/j.1600-0854.2006.00409.x; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Ono Y, 2012, BBA-PROTEINS PROTEOM, V1824, P224, DOI 10.1016/j.bbapap.2011.08.005; PALEJWALA S, 1992, P NATL ACAD SCI USA, V89, P4202, DOI 10.1073/pnas.89.9.4202; Regamey N, 2012, THORAX, V67, P170, DOI 10.1136/thoraxjnl-2011-200585; Ribeiro CMP, 2005, J BIOL CHEM, V280, P10202, DOI 10.1074/jbc.M410317200; Sasaki T, 1990, J Enzyme Inhib, V3, P195, DOI 10.3109/14756369009035837; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Sorio C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022212; Stifanese R, 2008, ARCH BIOCHEM BIOPHYS, V479, P145, DOI 10.1016/j.abb.2008.09.002; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Tang XX, 2012, J CELL PHYSIOL, V227, P3887, DOI 10.1002/jcp.24101; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wolins N, 1997, J CELL BIOL, V139, P1735, DOI 10.1083/jcb.139.7.1735	42	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66089	10.1371/journal.pone.0066089	http://dx.doi.org/10.1371/journal.pone.0066089			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785472	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800050
J	Craigo, JK; Ezzelarab, C; Cook, SJ; Chong, L; Horohov, D; Issel, CJ; Montelaro, RC				Craigo, Jodi K.; Ezzelarab, Corin; Cook, Sheila J.; Chong, Liu; Horohov, David; Issel, Charles J.; Montelaro, Ronald C.			Envelope Determinants of Equine Lentiviral Vaccine Protection	PLOS ONE			English	Article							INFECTIOUS-ANEMIA VIRUS; SIMIAN IMMUNODEFICIENCY VIRUS; ATTENUATED HIV VACCINES; PRINCIPAL NEUTRALIZING DOMAIN; TRANSIENT IMMUNE SUPPRESSION; TERM INAPPARENT CARRIER; CYTOTOXIC T-LYMPHOCYTE; REPLICATION IN-VITRO; PERSISTENT INFECTION; VIRAL REPLICATION	Lentiviral envelope (Env) antigenic variation and associated immune evasion present major obstacles to vaccine development. The concept that Env is a critical determinant for vaccine efficacy is well accepted, however defined correlates of protection associated with Env variation have yet to be determined. We reported an attenuated equine infectious anemia virus (EIAV) vaccine study that directly examined the effect of lentiviral Env sequence variation on vaccine efficacy. The study identified a significant, inverse, linear correlation between vaccine efficacy and increasing divergence of the challenge virus Env gp90 protein compared to the vaccine virus gp90. The report demonstrated approximately 100% protection of immunized ponies from disease after challenge by virus with a homologous gp90 (EV0), and roughly 40% protection against challenge by virus (EV13) with a gp90 13% divergent from the vaccine strain. In the current study we examine whether the protection observed when challenging with the EV0 strain could be conferred to animals via chimeric challenge viruses between the EV0 and EV13 strains, allowing for mapping of protection to specific Env sequences. Viruses containing the EV13 proviral backbone and selected domains of the EV0 gp90 were constructed and in vitro and in vivo infectivity examined. Vaccine efficacy studies indicated that homology between the vaccine strain gp90 and the N-terminus of the challenge strain gp90 was capable of inducing immunity that resulted in significantly lower levels of post-challenge virus and significantly delayed the onset of disease. However, a homologous N-terminal region alone inserted in the EV13 backbone could not impart the 100% protection observed with the EV0 strain. Data presented here denote the complicated and potentially contradictory relationship between in vitro virulence and in vivo pathogenicity. The study highlights the importance of structural conformation for immunogens and emphasizes the need for antibody binding, not neutralizing, assays that correlate with vaccine protection.	[Craigo, Jodi K.; Ezzelarab, Corin; Montelaro, Ronald C.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15213 USA; [Craigo, Jodi K.; Montelaro, Ronald C.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Cook, Sheila J.; Chong, Liu; Horohov, David; Issel, Charles J.] Univ Kentucky, Gluck Equine Res Ctr, Dept Vet Sci, Lexington, KY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Kentucky	Craigo, JK (corresponding author), Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15213 USA.	craigoj@pitt.edu	Liu, Chong/G-1734-2014		NIH/NIAID [RO1 AI25850]; Lucille P. Markey Charitable Trust; University of Kentucky Agricultural Experiment Station; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025850] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Lucille P. Markey Charitable Trust; University of Kentucky Agricultural Experiment Station; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH/NIAID Grant RO1 AI25850 and by funds from the Lucille P. Markey Charitable Trust, the University of Kentucky Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel K, 2003, J VIROL, V77, P3099, DOI 10.1128/JVI.77.5.3099-3118.2003; Almond N, 1999, IMMUNOL LETT, V66, P167, DOI 10.1016/S0165-2478(98)00153-9; Amara RR, 2005, J VIROL, V79, P15356, DOI 10.1128/JVI.79.24.15356-15367.2005; Baba TW, 1999, NAT MED, V5, P194, DOI 10.1038/5557; BABA TW, 1995, SCIENCE, V267, P1820, DOI 10.1126/science.7892606; BALL JM, 1992, J VIROL, V66, P732, DOI 10.1128/JVI.66.2.732-742.1992; Berkhout B, 1999, J VIROL, V73, P1138, DOI 10.1128/JVI.73.2.1138-1145.1999; Blower SM, 2001, P NATL ACAD SCI USA, V98, P3618, DOI 10.1073/pnas.061029998; Bogers WMJM, 2000, AIDS, V14, pS141; Busch M, 2005, VACCINE, V23, P4036, DOI 10.1016/j.vaccine.2005.03.013; COGGINS L, 1970, CORNELL VET, V60, P330; Cook RF, 2002, J VIROL METHODS, V105, P171, DOI 10.1016/S0166-0934(02)00101-5; Craigo J.K., 2008, ENCY VIROL, V3, P167; Craigo JK, 2006, VIROLOGY, V344, P340, DOI 10.1016/j.virol.2005.09.006; Craigo JK, 2005, J VIROL, V79, P2666, DOI 10.1128/JVI.79.5.2666-2677.2005; Craigo JK, 2002, J GEN VIROL, V83, P1353, DOI 10.1099/0022-1317-83-6-1353; Craigo JK, 2007, P NATL ACAD SCI USA, V104, P15105, DOI 10.1073/pnas.0706449104; Craigo JK, 2007, VACCINE, V25, P834, DOI 10.1016/j.vaccine.2006.09.040; Craigo JK, 2012, J VIROL METHODS, V185, P221, DOI 10.1016/j.jviromet.2012.07.007; Craigo JK, 2010, VACCINE, V28, P8095, DOI 10.1016/j.vaccine.2010.10.003; Craigo JK, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-95; Das AT, 2005, J VIROL, V79, P3855, DOI 10.1128/JVI.79.6.3855-3858.2005; GRUND CH, 1994, J GEN VIROL, V75, P657, DOI 10.1099/0022-1317-75-3-657; Hambleton S, 2008, FRONT BIOSCI-LANDMRK, V13, P2696, DOI 10.2741/2876; Hammond SA, 1999, VIROLOGY, V254, P37, DOI 10.1006/viro.1998.9550; Hammond SA, 2000, J VIROL, V74, P5968, DOI 10.1128/JVI.74.13.5968-5981.2000; Hammond SA, 1997, J VIROL, V71, P3840, DOI 10.1128/JVI.71.5.3840-3852.1997; Harrold SM, 2000, J VIROL, V74, P3112, DOI 10.1128/JVI.74.7.3112-3121.2000; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hofmann-Lehmann R, 2003, AIDS, V17, P157, DOI 10.1097/00002030-200301240-00004; Howe L, 2005, J GEN VIROL, V86, P139, DOI 10.1099/vir.0.80374-0; Howe L, 2002, J VIROL, V76, P10588, DOI 10.1128/JVI.76.21.10588-10597.2002; HUSSAIN KA, 1988, ARCH VIROL, V98, P213, DOI 10.1007/BF01322170; ISSEL CJ, 1992, J VIROL, V66, P3398, DOI 10.1128/JVI.66.6.3398-3408.1992; Johnson RP, 1999, J VIROL, V73, P4952, DOI 10.1128/JVI.73.6.4952-4961.1999; Johnson RP, 1999, NAT MED, V5, P154, DOI 10.1038/5515; Johnson RP, 1998, CURR OPIN IMMUNOL, V10, P436, DOI 10.1016/S0952-7915(98)80118-0; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; KONO Y, 1976, NATL I ANIM HEALTH Q, V16, P8; Kumar A, 2002, VIROLOGY, V301, P189, DOI 10.1006/viro.2002.1544; Kumar A, 2008, VIROLOGY, V371, P238, DOI 10.1016/j.virol.2007.10.008; Leroux C, 1997, J VIROL, V71, P9627, DOI 10.1128/JVI.71.12.9627-9639.1997; Leroux C, 2004, VET RES, V35, P485, DOI 10.1051/vetres:2004020; Leroux C, 2001, J VIROL, V75, P4570, DOI 10.1128/JVI.75.10.4570-4583.2001; Li F, 1998, J VIROL, V72, P8344, DOI 10.1128/JVI.72.10.8344-8348.1998; Li F, 2000, J VIROL, V74, P573, DOI 10.1128/JVI.74.1.573-579.2000; Li F, 2003, J VIROL, V77, P7244, DOI 10.1128/JVI.77.13.7244-7253.2003; LICHTENSTEIN DL, 1995, J VIROL, V69, P2881, DOI 10.1128/JVI.69.5.2881-2888.1995; Lichtenstein DL, 1996, J VIROL, V70, P3346, DOI 10.1128/JVI.70.6.3346-3354.1996; McMichael AJ, 2012, NAT IMMUNOL, V13, P423, DOI 10.1038/ni.2264; Melink JA, 1994, VACCINES, P155; Mills J, 2000, AIDS RES HUM RETROV, V16, P1453, DOI 10.1089/088922200750005976; Mims CA, 1987, PATHOGENESIS INFECT, P303; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Montelaro R C, 1995, AIDS, V9 Suppl A, pS111; Montelaro R. C., 1993, The Retroviridae, volume 2., P257; Montelaro RC, 1998, AIDS RES HUM RETROV, V14, pS255; Papandreou MJ, 1996, FEBS LETT, V379, P171, DOI 10.1016/0014-5793(95)01505-1; PAYNE SL, 1987, VIROLOGY, V161, P321, DOI 10.1016/0042-6822(87)90124-3; Raabe ML, 1998, VIROLOGY, V245, P151, DOI 10.1006/viro.1998.9142; Raabe MR, 1998, J VIROL METHODS, V71, P87, DOI 10.1016/S0166-0934(97)00204-8; Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524; Ruprecht RM, 1999, IMMUNOL REV, V170, P135, DOI 10.1111/j.1600-065X.1999.tb01335.x; RWAMBO PM, 1990, ARCH VIROL, V111, P199, DOI 10.1007/BF01311054; RWAMBO PM, 1990, ARCH VIROL, V111, P275, DOI 10.1007/BF01311062; SHEN RX, 1985, EIAV NATL REV POLICI; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Sponseller BA, 2007, VIROLOGY, V363, P156, DOI 10.1016/j.virol.2007.01.037; Tagmyer TL, 2008, J VIROL, V82, P4052, DOI 10.1128/JVI.02028-07; Tagmyer TL, 2007, J GEN VIROL, V88, P1324, DOI 10.1099/vir.0.82391-0; Uhl EW, 2002, VET IMMUNOL IMMUNOP, V90, P113, DOI 10.1016/S0165-2427(02)00227-1; WANG SZS, 1994, VIROLOGY, V199, P247, DOI 10.1006/viro.1994.1120; Whitney JB, 2004, CURR OPIN INFECT DIS, V17, P17, DOI 10.1097/00001432-200402000-00004; Zheng YH, 1997, J GEN VIROL, V78, P807, DOI 10.1099/0022-1317-78-4-807; Zheng YH, 1997, J VIROL, V71, P5031, DOI 10.1128/JVI.71.7.5031-5039.1997	75	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66093	10.1371/journal.pone.0066093	http://dx.doi.org/10.1371/journal.pone.0066093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785473	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000321038800049
J	Gierthmuehlen, M; Freiman, TM; Haastert-Talini, K; Mueller, A; Kaminsky, J; Stieglitz, T; Plachta, DTT				Gierthmuehlen, Mortimer; Freiman, Thomas M.; Haastert-Talini, Kirsten; Mueller, Alexandra; Kaminsky, Jan; Stieglitz, Thomas; Plachta, Dennis T. T.			Computational Tissue Volume Reconstruction of a Peripheral Nerve Using High-Resolution Light-Microscopy and Reconstruct	PLOS ONE			English	Article							SELECTIVE STIMULATION; NEURAL PROCESSES; SEGMENTATION; CUFF; FIBERS; IMAGES; INTERFACE; TIME	The development of neural cuff-electrodes requires several in vivo studies and revisions of the electrode design before the electrode is completely adapted to its target nerve. It is therefore favorable to simulate many of the steps involved in this process to reduce costs and animal testing. As the restoration of motor function is one of the most interesting applications of cuff-electrodes, the position and trajectories of myelinated fibers in the simulated nerve are important. In this paper, we investigate a method for building a precise neuroanatomical model of myelinated fibers in a peripheral nerve based on images obtained using high-resolution light microscopy. This anatomical model describes the first aim of our "Virtual workbench" project to establish a method for creating realistic neural simulation models based on image datasets. The imaging, processing, segmentation and technical limitations are described, and the steps involved in the transition into a simulation model are presented. The results showed that the position and trajectories of the myelinated axons were traced and virtualized using our technique, and small nerves could be reliably modeled based on of light microscopy images using low-cost OpenSource software and standard hardware. The anatomical model will be released to the scientific community.	[Gierthmuehlen, Mortimer; Freiman, Thomas M.; Kaminsky, Jan] Univ Med Ctr Freiburg, Dept Neurosurg, Freiburg, Germany; [Haastert-Talini, Kirsten] Hannover Med Sch, Inst Neuroanat, Hannover, Germany; [Mueller, Alexandra] Univ Med Ctr Freiburg, Dept Neuropathol, Freiburg, Germany; [Kaminsky, Jan] St Gertrauden Hosp, Dept Neurosurg, Berlin, Germany; [Stieglitz, Thomas; Plachta, Dennis T. T.] Univ Freiburg, Dept Microsyst Engn, Lab Biomed Microtechnol, D-79106 Freiburg, Germany	University of Freiburg; Hannover Medical School; University of Freiburg; University of Freiburg	Gierthmuehlen, M (corresponding author), Univ Med Ctr Freiburg, Dept Neurosurg, Freiburg, Germany.	mortimer.gierthmuehlen@uniklinik-freiburg.de	Haastert-Talini, Kirsten/D-2348-2010; Freiman, Thomas/AAV-8494-2021; Stieglitz, Thomas/C-7916-2013	Haastert-Talini, Kirsten/0000-0003-2502-8969; Freiman, Thomas/0000-0002-2591-2829; Stieglitz, Thomas/0000-0002-7349-4254; Gierthmuehlen, Mortimer/0000-0001-8575-6445	German Society of Neurosurgery	German Society of Neurosurgery	This study was supported by a scholarship from the "German Society of Neurosurgery" (http://www.dgnc.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres B, 2012, MED IMAGE ANAL, V16, P796, DOI 10.1016/j.media.2011.11.004; [Anonymous], 2010, COMMUNICATION; Boretius T, 2010, BIOSENS BIOELECTRON, V26, P62, DOI 10.1016/j.bios.2010.05.010; Chomiak T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007754; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Dercksen VJ, 2008, MATH VIS, P3, DOI 10.1007/978-3-540-72630-2_1; Dhillon GS., 2004, NEUROPROSTHETICS THE; Fazan VPS, 2001, AM J PHYSIOL-HEART C, V280, pH1560, DOI 10.1152/ajpheart.2001.280.4.H1560; Forkert ND, 2009, METHOD INFORM MED, V48, P399, DOI 10.3414/ME9237; Freeman TL, 2004, BASIC ANATOMY PHYSL; Gijtenbeek J. M. M., 2005, Angiogenesis, V8, P297; Grill W M, 1998, IEEE Trans Rehabil Eng, V6, P364, DOI 10.1109/86.736150; Grill WM, 2000, J BIOMED MATER RES, V50, P215; Haastert-Talini K, 2010, TISSUE ENG PT A, V16, P3085, DOI [10.1089/ten.tea.2010.0180, 10.1089/ten.TEA.2010.0180]; Haugland M. K., 1994, IEEE Transactions on Rehabilitation Engineering, V2, P18, DOI 10.1109/86.296346; Jabaley M E, 1980, J Hand Surg Am, V5, P1; Jeong WK, 2009, IEEE T VIS COMPUT GR, V15, P1505, DOI 10.1109/TVCG.2009.178; Joswig H, 2011, END ZU END VS END ZU; Jurrus E, 2009, MED IMAGE ANAL, V13, P180, DOI 10.1016/j.media.2008.05.002; Karen P, 2003, MICROSC RES TECHNIQ, V62, P415, DOI 10.1002/jemt.10405; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; Lang S, 2011, J COMPUT NEUROSCI, V31, P533, DOI 10.1007/s10827-011-0316-1; Lell MM, 2006, RADIOGRAPHICS, V26, pS45, DOI 10.1148/rg.26si065508; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005655; Morales J, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00018; More HL, 2011, J NEUROSCI METH, V201, P149, DOI 10.1016/j.jneumeth.2011.07.026; Narayanaswamy A, 2010, IEEE T MED IMAGING, V29, P583, DOI 10.1109/TMI.2009.2022086; Plachta DTT, 2012, IEEE ENG MED BIO, P3416, DOI 10.1109/EMBC.2012.6346699; Plachta DTT, 2012, BIOMEDIZINISCHE TECH; Plachta DTT, 2012, VDI AUTOMED, V17, P61; Richerson S, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-53; Rodriguez FJ, 2000, J NEUROSCI METH, V98, P105, DOI 10.1016/S0165-0270(00)00192-8; Romero E, 2000, J NEUROSCI METH, V97, P111, DOI 10.1016/S0165-0270(00)00167-9; ROZMAN J, 1992, J MED ENG TECHNOL, V16, P194, DOI 10.3109/03091909209021983; Schultze O., 1910, Z WISS MIKROSK, V27, P465; Stieglitz T, 2012, P SPIE, V8251, p82510 A; Tyler DJ, 2002, IEEE T NEUR SYS REH, V10, P294, DOI 10.1109/TNSRE.2002.806840; Vollmer J, 1999, EUROGRAPHICS, P18; YOSHIDA K, 1993, IEEE T BIO-MED ENG, V40, P492, DOI 10.1109/10.243412; Yoshida K., 2004, THEORY PERIPHERAL NE, P342; Zariffa J, 2009, IFMBE P 25 9 WORLD C; Zariffa J, 2009, IEEE T NEUR SYS REH, V17, P53, DOI 10.1109/TNSRE.2008.2010475; Zariffa J, 2008, IEEE ENG MED BIO, P4216, DOI 10.1109/IEMBS.2008.4650139	44	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66191	10.1371/journal.pone.0066191	http://dx.doi.org/10.1371/journal.pone.0066191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785485	Green Published, gold, Green Submitted			2022-12-25	WOS:000321038800037
J	Hussain, G; Schmitt, F; Henriques, A; Lequeu, T; Rene, F; Bindler, F; Dirrig-Grosch, S; Oudart, H; Palamiuc, L; Metz-Boutigue, MH; Dupuis, L; Marchioni, E; De Aguilar, JLG; Loeffler, JP				Hussain, Ghulam; Schmitt, Florent; Henriques, Alexandre; Lequeu, Thiebault; Rene, Frederique; Bindler, Francoise; Dirrig-Grosch, Sylvie; Oudart, Hugues; Palamiuc, Lavinia; Metz-Boutigue, Marie-Helene; Dupuis, Luc; Marchioni, Eric; De Aguilar, Jose-Luis Gonzalez; Loeffler, Jean-Philippe			Systemic Down-Regulation of Delta-9 Desaturase Promotes Muscle Oxidative Metabolism and Accelerates Muscle Function Recovery following Nerve Injury	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; STEAROYL-COA DESATURASE; SKELETAL-MUSCLE; PLASMA TRIGLYCERIDES; GENE-EXPRESSION; TRANSGENIC MICE; ANIMAL-MODEL; MOUSE MODEL; PGC-1-ALPHA; TRANSCRIPTION	The progressive deterioration of the neuromuscular axis is typically observed in degenerative conditions of the lower motor neurons, such as amyotrophic lateral sclerosis (ALS). Neurodegeneration in this disease is associated with systemic metabolic perturbations, including hypermetabolism and dyslipidemia. Our previous gene profiling studies on ALS muscle revealed down-regulation of delta-9 desaturase, or SCD1, which is the rate-limiting enzyme in the synthesis of monounsaturated fatty acids. Interestingly, knocking out SCD1 gene is known to induce hypermetabolism and stimulate fatty acid beta-oxidation. Here we investigated whether SCD1 deficiency can affect muscle function and its restoration in response to injury. The genetic ablation of SCD1 was not detrimental per se to muscle function. On the contrary, muscles in SCD1 knockout mice shifted toward a more oxidative metabolism, and enhanced the expression of synaptic genes. Repressing SCD1 expression or reducing SCD-dependent enzymatic activity accelerated the recovery of muscle function after inducing sciatic nerve crush. Overall, these findings provide evidence for a new role of SCD1 in modulating the restorative potential of skeletal muscles.	[Hussain, Ghulam; Schmitt, Florent; Henriques, Alexandre; Lequeu, Thiebault; Rene, Frederique; Dirrig-Grosch, Sylvie; Palamiuc, Lavinia; Dupuis, Luc; De Aguilar, Jose-Luis Gonzalez; Loeffler, Jean-Philippe] INSERM, U1118, Strasbourg, France; [Hussain, Ghulam; Schmitt, Florent; Henriques, Alexandre; Lequeu, Thiebault; Rene, Frederique; Dirrig-Grosch, Sylvie; Palamiuc, Lavinia; Dupuis, Luc; De Aguilar, Jose-Luis Gonzalez; Loeffler, Jean-Philippe] Univ Strasbourg, UMRS1118, Strasbourg, France; [Bindler, Francoise; Marchioni, Eric] Inst Pluridisciplinaire Hubert Curien, CNRS, UMR7178, Equipe Chim Analyt Mol Bioact, Illkirch Graffenstaden, France; [Oudart, Hugues] Inst Pluridisciplinaire Hubert Curien, UPR9010, CNRS, Dept Ecol Physiol & Ethol, Strasbourg, France; [Metz-Boutigue, Marie-Helene] INSERM, U977, Lab Biomat & Ingn Tissulaire, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	De Aguilar, JLG (corresponding author), INSERM, U1118, Strasbourg, France.	gonzalez@unistra.fr; loeffler@unistra.fr	Dupuis, Luc/A-6981-2012; LOEFFLER, Jean-Philippe/AAS-4401-2020; Hussain, Ghulam/Y-9776-2019; HUSSAIN, Ghulam/S-7609-2016	Hussain, Ghulam/0000-0001-9090-7789; HUSSAIN, Ghulam/0000-0001-9090-7789	European Community's Health Seventh Framework Programme [259867]; Thierry Latran Foundation; "Appel a Projets 2009 du Conseil Scientifique" (University of Strasbourg); Association pour la Recherche sur la Sclerose Laterale Amyotrophique et autres Maladies du Motoneurone; Higher Education Commission of the Pakistani government; "Association pour la Recherche et le Developpement de Moyens de Lutte contre les Maladies Neurodegeneratives" (AREMANE); Association Francaise contre les Myopathies; AREMANE; FP7; Chaire d'Exellence INSERM/Universite de Strasbourg	European Community's Health Seventh Framework Programme; Thierry Latran Foundation; "Appel a Projets 2009 du Conseil Scientifique" (University of Strasbourg); Association pour la Recherche sur la Sclerose Laterale Amyotrophique et autres Maladies du Motoneurone; Higher Education Commission of the Pakistani government; "Association pour la Recherche et le Developpement de Moyens de Lutte contre les Maladies Neurodegeneratives" (AREMANE); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); AREMANE; FP7; Chaire d'Exellence INSERM/Universite de Strasbourg	This work was supported by funds from European Community's Health Seventh Framework Programme under grant agreement no. 259867 (FP7/2007-2013) and Thierry Latran Foundation to JPL; "Appel a Projets 2009 du Conseil Scientifique" (University of Strasbourg) to JLGDA; and "Association pour la Recherche sur la Sclerose Laterale Amyotrophique et autres Maladies du Motoneurone" to JLGDA and FR. GH is supported by the Higher Education Commission of the Pakistani government and "Association pour la Recherche et le Developpement de Moyens de Lutte contre les Maladies Neurodegeneratives" (AREMANE). FS is granted by "Association Francaise contre les Myopathies" and AREMANE. AH is a research fellow receiving funds from FP7/2007-2013. JLGDA is recipient of a "Chaire d'Exellence INSERM/Universite de Strasbourg". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attie AD, 2002, J LIPID RES, V43, P1899, DOI 10.1194/jlr.M200189-JLR200; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bouteloup C, 2009, J NEUROL, V256, P1236, DOI 10.1007/s00415-009-5100-z; de Aguilar JLG, 2008, PHYSIOL GENOMICS, V32, P207, DOI 10.1152/physiolgenomics.00017.2007; Diaz-Amarilla P, 2011, P NATL ACAD SCI USA, V108, P18126, DOI 10.1073/pnas.1110689108; Dobrzyn A, 2005, AM J PHYSIOL-ENDOC M, V288, pE599, DOI 10.1152/ajpendo.00439.2004; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6; Dupuis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005390; ENOCH HG, 1976, J BIOL CHEM, V251, P5095; Fergani A, 2007, J LIPID RES, V48, P1571, DOI 10.1194/jlr.M700017-JLR200; Halter B, 2010, FREE RADICAL BIO MED, V48, P915, DOI 10.1016/j.freeradbiomed.2010.01.014; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Leger S, 2010, BIOORG MED CHEM LETT, V20, P499, DOI 10.1016/j.bmcl.2009.11.111; LOWRIE MB, 1982, J PHYSIOL-LONDON, V331, P51, DOI 10.1113/jphysiol.1982.sp014364; MARTINOU JC, 1991, J NEUROSCI, V11, P1291; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Perez-Garcia MJ, 2012, CELL REPORTS, V2, P497, DOI 10.1016/j.celrep.2012.08.004; Pradat PF, 2012, NEURODEGENER DIS, V9, P38, DOI 10.1159/000329723; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; Rouaux C, 2007, J NEUROSCI, V27, P5535, DOI 10.1523/JNEUROSCI.1139-07.2007; Sampath H, 2011, ANN NY ACAD SCI, V1243, P47, DOI 10.1111/j.1749-6632.2011.06303.x; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Selsby JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030063; Sharp PS, 2005, NEUROSCIENCE, V130, P897, DOI 10.1016/j.neuroscience.2004.09.069; Wang J, 2005, BIOCHEM BIOPH RES CO, V332, P735, DOI 10.1016/j.bbrc.2005.05.013; Wong M, 2010, HUM MOL GENET, V19, P2284, DOI 10.1093/hmg/ddq106	33	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e64525	10.1371/journal.pone.0064525	http://dx.doi.org/10.1371/journal.pone.0064525			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785402	Green Published, gold, Green Submitted			2022-12-25	WOS:000321038800115
J	Mwitari, PG; Ayeka, PA; Ondicho, J; Matu, EN; Bii, CC				Mwitari, Peter G.; Ayeka, Peter A.; Ondicho, Joyce; Matu, Esther N.; Bii, Christine C.			Antimicrobial Activity and Probable Mechanisms of Action of Medicinal Plants of Kenya: Withania somnifera, Warbugia ugandensis, Prunus africana and Plectrunthus barbatus	PLOS ONE			English	Article							T-CELLS; EXPRESSION; IL-7; PROLIFERATION; ANTIBACTERIAL; SECRETION	Withania somnifera, Warbugia ugandensis, Prunus africana and Plectrunthus barbatus are used traditionally in Kenya for treatment of microbial infections and cancer. Information on their use is available, but scientific data on their bioactivity, safety and mechanisms of action is still scanty. A study was conducted on the effect of organic extracts of these plants on both bacterial and fungal strains, and their mechanisms of action. Extracts were evaluated through the disc diffusion assay. Bacteria and yeast test strains were cultured on Mueller-Hinton agar and on Sabouraud dextrose agar for the filamentous fungi. A 0.5 McFarland standard suspension was prepared. Sterile paper discs 6 mm in diameter impregnated with 10 ml of the test extract (100 mg/ml) were aseptically placed onto the surface of the inoculated media. Chloramphenicol (30 mu g) and fluconazole (25 mu g) were used as standards. Discs impregnated with dissolution medium were used as controls. Activity of the extracts was expressed according to zone of inhibition diameter. MIC was determined at 0.78-100 mg/ml. Safety studies were carried using Cell Counting Kit 8 cell proliferation assay protocol. To evaluate extracts mechanisms of action, IEC-6 cells and RT-PCR technique was employed in vitro to evaluate Interleukin 7 cytokine. Investigated plants extracts have both bactericidal and fungicidal activity. W. ugandensis is cytotoxic at IC50<50 mu g/ml with MIC values of less than 0.78 mg/ml. Prunus africana shuts down expression of IL 7 mRNA at 50 mu g/ml. W. somnifera has the best antimicrobial (1.5625 mg/ml), immunopotentiation (2 times IL 7 mRNA expression) and safety level (IC50>200 mu g/ml). Fractions from W. ugandensis and W. somnifera too demonstrated antimicrobial activity. Mechanisms of action can largely be attributed to cytotoxicity, Gene silencing and immunopotentiation. Use of medicinal plants in traditional medicine has been justified and possible mechanisms of action demonstrated. Studies to isolate and characterize the bioactive constituents continue.	[Mwitari, Peter G.; Ondicho, Joyce; Matu, Esther N.] Kenya Govt Med Res Ctr, Ctr Tradit Med & Drug Res, Nairobi, Kenya; [Mwitari, Peter G.; Ayeka, Peter A.] Tianjin Univ Tradit Chinese Med, Tianjin, Peoples R China; [Ayeka, Peter A.] Egerton Univ, Egerton, Kenya; [Bii, Christine C.] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya	Kenya Medical Research Institute; Tianjin University of Traditional Chinese Medicine; Egerton University; Kenya Medical Research Institute	Mwitari, PG (corresponding author), Kenya Govt Med Res Ctr, Ctr Tradit Med & Drug Res, Nairobi, Kenya.	pmwitari67@yahoo.com	Ayeka, Peter/AAE-7421-2020					Abu-Shanab Bassam, 2004, Turkish Journal of Biology, V28, P99; Akwatulira F, 2011, J MED PLANTS RES, V5, P6615, DOI 10.5897/JMPR11.160; Beentje H., 1994, KENYA TREES SHRUBS L; Bii C, 2010, J MED PLANTS RES, V4, P995; Comber JD, 2012, VACCINE, V30, P2140, DOI 10.1016/j.vaccine.2012.01.037; Davis L, 2002, J EXP CLIN CANC RES, V21, P115; Dorman HJD, 2000, J APPL MICROBIOL, V88, P308, DOI 10.1046/j.1365-2672.2000.00969.x; Foster S., 2006, DESK REFERENCE NATUR, Vfirst; Gagnon J, 2010, IMMUNOL CELL BIOL, V88, P451, DOI 10.1038/icb.2009.109; Ichikawa H, 2006, MOL CANCER THER, V14, P34; ICRAF, 2009, AGR TREE DAT TREE SP; Ivana BS, 2006, BRAZILIAN J INFECT D, V10; Kariba RM, 2001, J ETHNOPHARMACOL, V74, P41, DOI 10.1016/S0378-8741(00)00337-8; Kobayashi H, 2005, BLOOD, V105, P721, DOI 10.1182/blood-2003-12-4187; Kokwaro J.O., 1993, MED PLANTS E AFRICA; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; Lukhoba CW, 2006, J ETHNOPHARMACOL, V103, P1, DOI 10.1016/j.jep.2005.09.011; Matu EN, 2003, J ETHNOPHARMACOL, V87, P35, DOI 10.1016/S0378-8741(03)00107-7; McGee DW, 1996, CLIN EXP IMMUNOL, V105, P274, DOI 10.1046/j.1365-2249.1996.d01-750.x; Mishra L C, 2000, Altern Med Rev, V5, P334; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mwangi JW, 2005, J ESSENTIAL OIL RES; Noor A, 2013, CURRENT SCI, V104; Olila D, 2002, J AFR HLTH SCI, V210, P2; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Phillipson J D, 1994, Trans R Soc Trop Med Hyg, V88 Suppl 1, pS17; Rasoanaivo P, 1993, IFS NAPLECA WORKSH B; Ray AB, 2004, MED PROPERTIES PLANT; Rios JL, 2005, J ETHNOPHARMACOL, V100, P80, DOI 10.1016/j.jep.2005.04.025; Rozen S, 2000, Methods Mol Biol, V132, P365; Runyoro D. K., 2006, BMC COMPLEM ALTERN M, V30, P6, DOI DOI 10.1186/1472-6882-6-11; Schmelzer GH, 2008, PLANTS RESOURCES TRO; Singh G., 2010, Annals of Biological Research, V1, P56; Suzuki S, 2007, INT ARCH ALLERGY IMM, V143, P89, DOI 10.1159/000101413; Vlientink J, 1995, J ETHNOPHARMACOL, V46, P31; Wamalwa NL., 2006, GENETIC VARIATION WA; Yoshioka A, 2008, CYTOKINE, V44, P57, DOI 10.1016/j.cyto.2008.06.004	37	45	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65619	10.1371/journal.pone.0065619	http://dx.doi.org/10.1371/journal.pone.0065619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785437	Green Published, gold, Green Submitted			2022-12-25	WOS:000321038800083
J	Toscano, MJ; Wilkins, LJ; Millburn, G; Thorpe, K; Tarlton, JF				Toscano, Michael J.; Wilkins, Lindsay J.; Millburn, Georgina; Thorpe, Katherine; Tarlton, John F.			Development of an Ex Vivo Protocol to Model Bone Fracture in Laying Hens Resulting from Collisions	PLOS ONE			English	Article							BROKEN BONES; OSTEOPOROSIS; STRENGTH; KEEL; PREVALENCE; SYSTEM	Fractures of the keel bone, a bone extending ventrally from the sternum, are a serious health and welfare problem in free range laying hens. Recent findings suggest that a major cause of keel damage within extensive systems is collisions with internal housing structures, though investigative efforts have been hindered by difficulties in examining mechanisms and likely influencing factors at the moment of fracture. The objectives of this study were to develop an ex vivo impact protocol to model bone fracture in hens caused by collision, to assess impact and bird-related factors influencing fracture occurrence and severity, and to identify correlations of mechanical and structural properties between different skeletal sites. We induced keel bone fractures in euthanized hens using a drop-weight impact tester able to generate a range of impact energies, producing fractures that replicate those commonly found in commercial settings. The results demonstrated that impact energies of a similar order to those expected in normal housing were able to produce fractures, and that greater collision energies resulted in an increased likelihood of fractures and of greater severity. Relationships were also seen with keel's lateral surface bone mineral density, and the peak reactive force (strength) at the base of the manubrial spine. Correlations were also identified between the keel and long bones with respect to both strength and bone mineral density. This is the first study able to relate impact and bone characteristics with keel bone fracture at the moment of collision. Greater understanding of these relationships will provide means to reduce levels of breakage and severity in commercial systems.	[Toscano, Michael J.; Wilkins, Lindsay J.; Millburn, Georgina; Thorpe, Katherine; Tarlton, John F.] Univ Bristol, Sch Vet Sci, Lower Langford, North Somerset, England	University of Bristol	Toscano, MJ (corresponding author), Univ Bristol, Sch Vet Sci, Lower Langford, North Somerset, England.	Michael.toscano@vetsuisse.unibe.ch		Tarlton, John/0000-0002-4886-6634	UK's Biological and Biotechnology Scientific Research Council [BB/G012709/1]; Welcome Trust; Nuffield Foundation; Biotechnology and Biological Sciences Research Council [BB/K001906/1, BB/G012709/1] Funding Source: researchfish; BBSRC [BB/G012709/1, BB/K001906/1] Funding Source: UKRI	UK's Biological and Biotechnology Scientific Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Welcome Trust(Wellcome Trust); Nuffield Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Work on this grant was supported by the UK's Biological and Biotechnology Scientific Research Council (BB/G012709/1) as well as grants from the Welcome Trust and Nuffield Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEIC, 2012, EGG FACTS FIG; Bishop SC, 2000, BRIT POULTRY SCI, V41, P33, DOI 10.1080/00071660086376; Clark WD, 2008, POULTRY SCI, V87, P1964, DOI 10.3382/ps.2008-00115; Donaldson CJ, 2012, POULTRY SCI, V91, P304, DOI 10.3382/ps.2011-01774; Dunn IC, 2007, ANIM GENET, V38, P45, DOI 10.1111/j.1365-2052.2006.01547.x; FAWC, 2010, OP OST BON FRACT LAY; Gregory NG, 1996, NEW ZEAL VET J, V44, P31, DOI 10.1080/00480169.1996.35928; GREGORY NG, 1990, BRIT POULTRY SCI, V31, P59, DOI 10.1080/00071669008417231; HEWSON P, 1986, BRIT POULTRY SCI, V27, P525, DOI 10.1080/00071668608416912; King AS, 1975, SISSON GROSSMANS ANA, P1787; Nelson HD, 2002, ANN INTERN MED, V137, P529, DOI 10.7326/0003-4819-137-6-200209170-00015; Rasbash J, 2009, USERS GUIDE MLWIN V2, V2, P10; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Sandilands V., 2010, P 44 C INT SOC APPL, P249; Tarlton JF, 2013, BONE, V52, P578, DOI 10.1016/j.bone.2012.11.003; Whitehead CC, 2004, POULT SCI S, V27, P259, DOI 10.1079/9780851998138.0259; Wilkins LJ, 2011, VET REC, V169, P414, DOI 10.1136/vr.d4831; Wilkins LJ, 2004, VET REC, V155, P547, DOI 10.1136/vr.155.18.547	18	27	27	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66215	10.1371/journal.pone.0066215	http://dx.doi.org/10.1371/journal.pone.0066215			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785487	Green Submitted, Green Published, gold			2022-12-25	WOS:000321038800036
J	Yoshimura, T; Benny, O; Bazinet, L; D'Amato, RJ				Yoshimura, Takeru; Benny, Ofra; Bazinet, Lauren; D'Amato, Robert J.			Suppression of Autoimmune Retinal Inflammation by an Antiangiogenic Drug	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; CELL-CYCLE INHIBITION; ANGIOGENESIS INHIBITOR; UVEORETINITIS; TNP-470; UVEITIS; DISEASE; MODEL; P53	Chronic and recurrent uveitis account for approximately 10% of legal blindness in the western world. Autoimmune uveitis is driven by activated CD4(+) T cells that differentiate into effector T helper cells (Th1, Th2, and Th17) which release proinflammatory cytokines that damage the retina. In this study we investigated the effect of the methionine aminopeptidase 2 (MetAP2) inhibitor, Lodamin, on T cell activation and differentiation. MetAp2 is an enzyme which regulates cellular protein synthesis and is highly expressed in T cells. Lodamin was found to suppress T cell receptor (TCR) mediated T cell proliferation and reduced the production of Th1 and Th17 cells. Further, Lodamin suppressed overall inflammation in the mouse model of experimental autoimmune uveitis (EAU) by a six fold. This effect was attributed in part to a reduction in retinal proinflammatory cytokines, down regulation of MetAP2 expression in purified lymph node CD4+ T cells, and a general normalization of the systemic immune reaction.	[Yoshimura, Takeru; Benny, Ofra; Bazinet, Lauren; D'Amato, Robert J.] Harvard Univ, Sch Med, Dept Surg, Boston Childrens Hosp,Vasc Biol Program, Boston, MA 02115 USA; [D'Amato, Robert J.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston Childrens Hosp, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Benny, O (corresponding author), Harvard Univ, Sch Med, Dept Surg, Boston Childrens Hosp,Vasc Biol Program, Boston, MA 02115 USA.	ofra.bennyratsaby@childrens.harvard.edu	Benny, Ofra/AAB-3294-2021	Yoshimura, Takeru/0000-0002-5983-7193				Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Avichezer D, 2000, INVEST OPHTH VIS SCI, V41, P127; Benita Y, 2010, BLOOD, V115, P5376, DOI 10.1182/blood-2010-01-263855; Benny O, 2008, NAT BIOTECHNOL, V26, P799, DOI 10.1038/nbt1415; Benny O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012515; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brahn E, 2009, J PHARMACOL EXP THER, V329, P615, DOI 10.1124/jpet.108.148478; Caspi RR, 2008, OPHTHAL RES, V40, P169, DOI 10.1159/000119871; Caspi RR, 2003, CURR PROTOC IMMUNOL, V15, P16; Chao CC, 1997, J IMMUNOL, V159, P1686; Chi W, 2008, INVEST OPHTH VIS SCI, V49, P3058, DOI 10.1167/iovs.07-1390; Clavel G, 2003, JOINT BONE SPINE, V70, P321, DOI 10.1016/S1297-319X(03)00088-5; Damsker JM, 2010, ANN NY ACAD SCI, V1183, P211, DOI 10.1111/j.1749-6632.2009.05133.x; de Smet MD, 2011, PROG RETIN EYE RES, V30, P452, DOI 10.1016/j.preteyeres.2011.06.005; Griffith EC, 1998, P NATL ACAD SCI USA, V95, P15183, DOI 10.1073/pnas.95.26.15183; Hansel TT, 2010, NAT REV DRUG DISCOV, V9, P325, DOI 10.1038/nrd3003; Horai R, 2011, J INTERF CYTOK RES, V31, P733, DOI 10.1089/jir.2011.0042; Mauriz JL, 2007, TRANSL RES, V149, P46, DOI 10.1016/j.trsl.2006.07.004; McEwen BS, 1997, BRAIN RES REV, V23, P79, DOI 10.1016/S0165-0173(96)00012-4; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; Ogata A, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/946048; OLIVER SJ, 1994, CELL IMMUNOL, V157, P291, DOI 10.1006/cimm.1994.1223; PEACOCK DJ, 1992, J EXP MED, V175, P1135, DOI 10.1084/jem.175.4.1135; Smolen JS, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/ar3094, 10.1186/1478-6354-13-S1-S2]; Thurau SR, 1997, CLIN EXP IMMUNOL, V109, P370, DOI 10.1046/j.1365-2249.1997.4571356.x; Venturi GM, 2003, IMMUNITY, V19, P713, DOI 10.1016/S1074-7613(03)00295-4; Weninger W, 2003, J IMMUNOL, V170, P4638, DOI 10.4049/jimmunol.170.9.4638; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P6427, DOI 10.1073/pnas.97.12.6427	28	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66219	10.1371/journal.pone.0066219	http://dx.doi.org/10.1371/journal.pone.0066219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785488	gold, Green Submitted, Green Published			2022-12-25	WOS:000321038800034
J	Xu, Z; Pei, L; Wang, L; Zhang, F; Hu, X; Gui, Y				Xu, Z.; Pei, L.; Wang, L.; Zhang, F.; Hu, X.; Gui, Y.			Snail1-dependent transcriptional repression of Cezanne2 in hepatocellular carcinoma	ONCOGENE			English	Article						Snail1; Cezanne2; HCC; metastasis	NF-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITIONS; GENE-EXPRESSION; SNAIL; MICROENVIRONMENT; HEPATOCYTES; COOPERATION; MECHANISMS; ICAM-1; CELLS	High malignancy and early metastasis are the hallmarks of hepatocellular carcinoma (HCC). Here, we report that Cezanne2 expression is downregulated in HCC cells and in HCC patients' tumorous tissues and that Cezanne2 is inversely associated with Snail1 expression in HCC patients' tumorous tissues. Chromatin immunoprecipitation assays and the reporter gene assay showed that Snail1 binds to the promoter of the Cezanne2 gene and mediates the direct consequence of Cezanne2 repression. Enhanced expression of Cezanne2 could suppress proliferation, migration and invasion in HCC cells. Further, Cezanne2 could regulate MMP (matrix metalloproteinase) 2, MMP9 and ICAM1 (intercellular adhesion molecule) levels through modulation of the NF-kappa B (nuclear factor kappa-light-chain-enhancer of activated B cell) signaling cascade. Co-immunoprecipitation and in vivo deubiquitination assay indicated that Cezanne2 interacts with TNF receptor-associated factor (TRAF) 6 and cleaves the polyubiquitin from TRAF6 substrates. Our data reveal that Snail1-mediated suppression of Cezanne2 may have a key role in HCC malignancy.	[Xu, Z.; Pei, L.; Zhang, F.] ZhongCheng Translat Med Inc, Dept Mol Diag, Shanghai 2, Peoples R China; [Wang, L.] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Hu, X.; Gui, Y.] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Hangzhou 310027, Zhejiang, Peoples R China	Shanghai Jiao Tong University; Zhejiang University	Xu, Z (corresponding author), Univ Chicago, Dept Med, JFK R322, BSLC, 57th St, Chicago, IL 60637 USA.	Xuzhonping@gmail.com		GUI, YAXING/0000-0002-0466-3608	Institute of Health Science, Shanghai Institutes for Biological Sciences; Chinese Academy of Sciences; Department of Medicine, University of Chicago; Startup Package of Zhongcheng Translational- Medicine Incorporation, Shanghai, China; SLRC laboratory animal company, Shanghai, China	Institute of Health Science, Shanghai Institutes for Biological Sciences; Chinese Academy of Sciences(Chinese Academy of Sciences); Department of Medicine, University of Chicago(University of Chicago); Startup Package of Zhongcheng Translational- Medicine Incorporation, Shanghai, China; SLRC laboratory animal company, Shanghai, China	Dr Zhongping Xu obtained his PhD in January 2011 from the Institute of Health Science, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, and at present he works as a postdoctoral fellow at the Department of Medicine, University of Chicago. Dr Zhongping Xu started to found Zhongcheng Translational-medicine Incorporation in June 2011. This study was sponsored by the Startup Package of Zhongcheng Translational-Medicine Incorporation, Shanghai, China. The nude mice were supplied by SLRC laboratory animal company, Shanghai, China.	Astarci E, 2012, FEBS J, V279, P2966, DOI 10.1111/j.1742-4658.2012.08677.x; Bu W, 1997, Zhonghua Yi Xue Za Zhi, V77, P661; Budhu A, 2006, CANCER CELL, V10, P99, DOI 10.1016/j.ccr.2006.06.016; Chaffer CL, SCIENCE, V331, P1559; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Enesa K, 2008, J BIOL CHEM, V283, P7036, DOI 10.1074/jbc.M708690200; Evans PC, 2001, BIOCHEM J, V357, P617, DOI 10.1042/0264-6021:3570617; Evans PC, 2003, J BIOL CHEM, V278, P23180, DOI 10.1074/jbc.M301863200; Gao JM, 2008, J BIOL CHEM, V283, P8802, DOI 10.1074/jbc.M708470200; de Herreros AG, 2010, J MAMMARY GLAND BIOL, V15, P135, DOI 10.1007/s10911-010-9179-8; Gotzmann J, 2002, J CELL SCI, V115, P1189; Katzenellenbogen M, 2006, CANCER RES, V66, P4001, DOI 10.1158/0008-5472.CAN-05-2937; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Khetchoumian K, 2007, NAT GENET, V39, P1500, DOI 10.1038/ng.2007.15; La Starza R, 2007, CANCER GENET CYTOGEN, V175, P73, DOI 10.1016/j.cancergencyto.2007.01.011; Massoumi R, 2009, J EXP MED, V206, P221, DOI 10.1084/jem.20082044; Nguyen H, 2006, VIROLOGY, V354, P58, DOI 10.1016/j.virol.2006.04.028; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Shalom-Barak T, 1998, J BIOL CHEM, V273, P27467, DOI 10.1074/jbc.273.42.27467; Sun HC, 2004, J CANCER RES CLIN, V130, P307, DOI 10.1007/s00432-003-0530-y; Tan C, 2001, ONCOGENE, V20, P133, DOI 10.1038/sj.onc.1204052; Xu ZP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014514; Xue JP, 2009, PHYSIOL GENOMICS, V38, P42, DOI 10.1152/physiolgenomics.00012.2009; Yang P, 2009, HEPATOL RES, V39, P1169, DOI 10.1111/j.1872-034X.2009.00563.x	24	20	22	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 29	2014	33	22					2836	2845		10.1038/onc.2013.243	http://dx.doi.org/10.1038/onc.2013.243			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EI	23792447				2022-12-25	WOS:000337231800003
J	Tang, YQ; Wilmann, PG; Reeve, SB; Coetzer, TH; Smith, AI; Whisstock, JC; Pike, RN; Wijeyewickrema, LC				Tang Yongqing; Wilmann, Pascal G.; Reeve, Shane B.; Coetzer, Theresa H.; Smith, A. Ian; Whisstock, James C.; Pike, Robert N.; Wijeyewickrema, Lakshmi C.			The x-ray crystal structure of mannose-binding lectin-associated serine proteinase-3 reveals the structural basis for enzyme inactivity associated with the Carnevale, Mingarelli, Malpuech, and Michels (3MC) syndrome (vol 288, pg 22399, 2013)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Wijeyewickrema, Lakshmi/A-9676-2015; Coetzer, Theresa/AAM-9193-2021; Coetzer, Theresa/AAE-6207-2019	Wijeyewickrema, Lakshmi/0000-0001-6084-4887; Coetzer, Theresa/0000-0003-0706-3808; Pike, Robert/0000-0002-2083-0269; Smith, Ian/0000-0002-4143-2892; Whisstock, James/0000-0003-4200-5611; Wilmann, Pascal/0000-0002-8376-5150				Tang YQ, 2013, J BIOL CHEM, V288, P28307, DOI 10.1074/jbc.A113.483875	1	20	19	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28307	28307		10.1074/jbc.A113.483875	http://dx.doi.org/10.1074/jbc.A113.483875			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23792966	Green Published, hybrid			2022-12-25	WOS:000330612800055
J	Chavan, H; Khan, MMT; Tegos, G; Krishnamurthy, P				Chavan, Hemantkumar; Khan, Mohiuddin Md Taimur; Tegos, George; Krishnamurthy, Partha			Efficient Purification and Reconstitution of ATP Binding Cassette Transporter B6 (ABCB6) for Functional and Structural Studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN MULTIDRUG TRANSPORTER; P-GLYCOPROTEIN; HEPATOCELLULAR-CARCINOMA; LIPID FLIPPASE; MECHANISM; EXPRESSION; PROTEOLIPOSOMES; RESISTANCE; LOCALIZES; MUTATIONS	The mitochondrial ATP binding cassette transporter ABCB6 has been associated with a broad range of physiological functions, including growth and development, therapy-related drug resistance, and the new blood group system Langereis. ABCB6 has been proposed to regulate heme synthesis by shuttling coproporphyrinogen III from the cytoplasm into the mitochondria. However, direct functional information of the transport complex is not known. To understand the role of ABCB6 in mitochondrial transport, we developed an in vitro system with pure and active protein. ABCB6 overexpressed in HEK293 cells was solubilized from mitochondrial membranes and purified to homogeneity. Purified ABCB6 showed a high binding affinity for MgATP (K-d = 0.18 mu M) and an ATPase activity with a K-m of 0.99 mM. Reconstitution of ABCB6 into liposomes allowed biochemical characterization of the ATPase including (i) substrate-stimulated ATPase activity, (ii) transport kinetics of its proposed endogenous substrate coproporphyrinogen III, and (iii) transport kinetics of substrates identified using a high throughput screening assay. Mutagenesis of the conserved lysine to alanine (K629A) in the Walker A motif abolished ATP hydrolysis and substrate transport. These results suggest a direct interaction between mitochondrial ABCB6 and its transport substrates that is critical for the activity of the transporter. Furthermore, the simple immunoaffinity purification of ABCB6 to near homogeneity and efficient reconstitution of ABCB6 into liposomes might provide the basis for future studies on the structure/function of ABCB6.	[Chavan, Hemantkumar; Krishnamurthy, Partha] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Khan, Mohiuddin Md Taimur] Washington State Univ, Dept Chem Engn & Bioengn, Pullman, WA 99146 USA; [Khan, Mohiuddin Md Taimur] Pacific NW Natl Lab, Div Bioenergy & Biotechnol, Richland, WA 99352 USA; [Tegos, George] Univ New Mexico, Ctr Mol Discovery, Albuquerque, NM 87131 USA; [Tegos, George] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA; [Chavan, Hemantkumar; Krishnamurthy, Partha] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Tegos, George] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02114 USA	University of Kansas; University of Kansas Medical Center; Washington State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of New Mexico; University of New Mexico; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Krishnamurthy, P (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	pkasturi@kumc.edu	Chavan, Hemant/ABA-4925-2021; Chavan, Hemantkumar/AAN-6756-2020	Chavan, Hemantkumar/0000-0002-9963-6230	National Institutes of Health [P20RR021940, R03MH093193]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH093193] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants P20RR021940 and R03MH093193.	Abele R, 2009, CURR OPIN CELL BIOL, V21, P508, DOI 10.1016/j.ceb.2009.04.008; Andolfo I, 2013, AM J HEMATOL, V88, P66, DOI 10.1002/ajh.23357; Beharry S, 2004, J BIOL CHEM, V279, P53972, DOI 10.1074/jbc.M405216200; Biemans-Oldehinkel E, 2006, FEBS LETT, V580, P1023, DOI 10.1016/j.febslet.2005.11.079; Borel F, 2012, HEPATOLOGY, V55, P821, DOI 10.1002/hep.24682; Chang XB, 1997, J BIOL CHEM, V272, P30962, DOI 10.1074/jbc.272.49.30962; Chavan H, 2012, J BIOL CHEM, V287, P32054, DOI 10.1074/jbc.M112.371476; Chavan H, 2011, TOXICOL SCI, V120, P519, DOI 10.1093/toxsci/kfr008; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chloupkova M, 2007, BIOCHEMISTRY-US, V46, P7992, DOI 10.1021/bi700020m; Coleman JA, 2013, BBA-MOL CELL BIOL L, V1831, P555, DOI 10.1016/j.bbalip.2012.10.006; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Emadi-Konjin HP, 2002, BBA-GENE STRUCT EXPR, V1574, P117, DOI 10.1016/S0167-4781(01)00340-2; Fukuda Y, 2011, J BIOL CHEM, V286, P8481, DOI 10.1074/jbc.M110.174516; George AM, 2012, PROG BIOPHYS MOL BIO, V109, P95, DOI 10.1016/j.pbiomolbio.2012.06.003; Helias V, 2012, NAT GENET, V44, P170, DOI 10.1038/ng.1069; Helmerl S, 2007, MELANOMA RES, V17, P265, DOI 10.1097/CMR.0b013e3282a7e0b9; Hlavata I, 2012, MUTAGENESIS, V27, P187, DOI 10.1093/mutage/ger075; Hofacker M, 2007, J BIOL CHEM, V282, P3951, DOI 10.1074/jbc.M609899200; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Jalil YA, 2008, AM J PHYSIOL-CELL PH, V294, pC579, DOI 10.1152/ajpcell.00612.2006; Jones PM, 2013, CRIT REV BIOCHEM MOL, V48, P39, DOI 10.3109/10409238.2012.735644; Kiss K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037378; Klappe K, 2009, CHEM PHYS LIPIDS, V161, P57, DOI 10.1016/j.chemphyslip.2009.07.004; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Krishnamurthy P, 2007, PHARMACOL THERAPEUT, V114, P345, DOI 10.1016/j.pharmthera.2007.02.001; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Kuhnke G, 2006, MOL MEMBR BIOL, V23, P173, DOI 10.1080/09687860500473630; Mitta B, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf112; Palmeira A, 2012, CURR MED CHEM, V19, P1946, DOI 10.2174/092986712800167392; Park S, 2006, BREAST CANCER RES TR, V99, P9, DOI 10.1007/s10549-006-9175-2; Paterson JK, 2007, BIOCHEMISTRY-US, V46, P9443, DOI 10.1021/bi700015m; Polireddy K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040005; Polireddy K, 2011, MOL ONCOL, V5, P410, DOI 10.1016/j.molonc.2011.07.005; Rebeiz N, 1996, ARCH BIOCHEM BIOPHYS, V333, P475, DOI 10.1006/abbi.1996.0417; Saison C, 2013, VOX SANG, V104, P159, DOI 10.1111/j.1423-0410.2012.01650.x; Sharom FJ, 2005, J BIOENERG BIOMEMBR, V37, P481, DOI 10.1007/s10863-005-9496-6; SHAROM FJ, 1993, J BIOL CHEM, V268, P24197; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; Tarling EJ, 2013, TRENDS ENDOCRIN MET, V24, P342, DOI 10.1016/j.tem.2013.01.006; Tsuchida M, 2008, BIOCHEM BIOPH RES CO, V369, P369, DOI 10.1016/j.bbrc.2008.02.027; Ulrich DL, 2012, J BIOL CHEM, V287, P12679, DOI 10.1074/jbc.M111.336180; Wang LJ, 2012, AM J HUM GENET, V90, P40, DOI 10.1016/j.ajhg.2011.11.026; Warren MS, 2009, PHARMACOL RES, V59, P404, DOI 10.1016/j.phrs.2009.02.007; Wink M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00130; Yasui K, 2004, CANCER RES, V64, P1403, DOI 10.1158/0008-5472.CAN-3263-2; Zehnpfennig B, 2009, BIOCHEMISTRY-US, V48, P4423, DOI 10.1021/bi9001908; Zhang C., 2013, J INVEST DE IN PRESS; Zhao SG, 2012, ANN SURG ON IN PRESS	50	22	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22658	22669		10.1074/jbc.M113.485284	http://dx.doi.org/10.1074/jbc.M113.485284			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23792964	hybrid, Green Published			2022-12-25	WOS:000330596300045
J	Weihmann, T				Weihmann, Tom			Crawling at High Speeds: Steady Level Locomotion in the Spider Cupiennius salei-Global Kinematics and Implications for Centre of Mass Dynamics	PLOS ONE			English	Article							SLIT SENSE-ORGANS; INSECT LOCOMOTION; MECHANICAL MODELS; STEPPING PATTERNS; HORIZONTAL PLANE; LEG BEHAVIOR; WALKING; ARANEAE; ENERGY; STABILITY	Spiders are an old yet very successful predatory group of arthropods. Their locomotor system differs from those of most other arthropods by the lack of extensor muscles in two major leg joints. Though specific functional characteristics can be expected regarding the locomotion dynamics of spiders, this aspect of movement physiology has been only scarcely examined so far. This study presents extensive analyses of a large dataset concerning global kinematics and the implications for dynamics of adult female specimens of the large Central American spider Cupiennius salei (Keyserling). The experiments covered the entire speed-range of straight runs at constant speeds. The analyses revealed specific characteristics of velocity dependent changes in the movements of the individual legs, as well as in the translational and rotational degrees of freedom of both the centre of mass and the body. In contrast to many other fast moving arthropods, C. salei avoid vertical fluctuations of their centre of mass during fast locomotion. Accordingly, aerial phases were not observed here. This behaviour is most likely a consequence of optimising energy expenditure with regard to the specific requirements of spiders' leg anatomy. A strong synchronisation of two alternating sets of legs appears to play only a minor role in the locomotion of large spiders. Reduced frequency and low centre of mass amplitudes as well as low angular changes of the body axes, in turn, seems to be the result of relatively low leg coordination.	Univ Jena, Inst Sports Sci, Jena, Germany	Friedrich Schiller University of Jena	Weihmann, T (corresponding author), Univ Jena, Inst Sports Sci, Jena, Germany.	tom@uni-jena.de	Weihmann, Tom/GYJ-8011-2022	Weihmann, Tom/0000-0002-6628-1816	German Science Foundation [BI 236/14-1]	German Science Foundation(German Research Foundation (DFG))	This work was partly supported by the German Science Foundation (www.dfg.de), grant no. BI 236/14-1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study	ALEXANDER RM, 1989, PHYSIOL REV, V69, P1199, DOI 10.1152/physrev.1989.69.4.1199; ANDERSON JF, 1975, Z MORPHOL TIERE, V81, P257, DOI 10.1007/BF00298488; [Anonymous], 2002, ANGEW STAT ANWENDUNG; Barth FG, 1986, NATURWISSENSCHAFTEN, V73; Bethe A, 1930, PFLUG ARCH GES PHYS, V224, P793, DOI 10.1007/BF01771422; Biancardi CM, 2011, J EXP BIOL, V214, P3433, DOI 10.1242/jeb.057471; BLICKHAN R, 1986, J BIOMECH, V19, P375, DOI 10.1016/0021-9290(86)90014-X; BLICKHAN R, 1987, J EXP BIOL, V130, P155; BLICKHAN R, 1993, J COMP PHYSIOL A, V173, P509; BLICKHAN R, 1989, J BIOMECH, V22, P1217, DOI 10.1016/0021-9290(89)90224-8; Blickhan R, 1983, THESIS WOLFGANG GOET; BLICKHAN R, 2005, AUTONOMES LAUFEN, P19; Blickhan R, 2007, PHILOS T R SOC A, V365, P199, DOI 10.1098/rsta.2006.1911; Bohmann L, 1998, Z ANGEW MATH MECH, V78, P87, DOI 10.1002/(SICI)1521-4001(199802)78:2<87::AID-ZAMM87>3.0.CO;2-H; Brussel A, 1987, THESIS JW GOETHE U F; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; Cruse H, 2007, PHILOS T R SOC A, V365, P221, DOI 10.1098/rsta.2006.1913; Damen WGM, 1998, DEV GENES EVOL, V208, P586, DOI 10.1007/s004270050218; Dudek DM, 2006, J EXP BIOL, V209, P1502, DOI 10.1242/jeb.02146; ECKWEILER W, 1988, J COMP PHYSIOL A, V162, P611, DOI 10.1007/BF01342636; Ehlers M., 1939, Zoologische Jahrbuecher Jena Systematik, V72, P373; Fenk LM, 2010, J EXP BIOL, V213, P3111, DOI 10.1242/jeb.041939; FERDINAND W, 1981, ZOOL JAHRB ALLG ZOOL, V85, P46; Fisher NI, 1995, STAT ANAL CIRCULAR D; Frischholz RW, 1993, CLASS ALGORITHMS REA; Full Robert J., 1993, P3; Gaiser I, 2010, ENHANCED FLEXIBLE FL, P1423; Geyer H, 2006, P R SOC B, V273, P2861, DOI 10.1098/rspb.2006.3637; Goldman DI, 2006, J EXP BIOL, V209, P2990, DOI 10.1242/jeb.02322; GRAHAM D, 1978, J EXP BIOL, V73, P147; GRAHAM D, 1985, ADV INSECT PHYSIOL, V18, P31; GRAHAM D, 1981, J EXP BIOL, V92, P229; Grimmer S, 2008, J EXP BIOL, V211, P2989, DOI 10.1242/jeb.014357; Gunther M, 2004, J MATH BIOL, V48, P623, DOI 10.1007/s00285-004-0269-3; Herreid C.F. II, 1981, P491; HILDEBRAND M, 1977, J MAMMAL, V58, P131, DOI 10.2307/1379571; HUGHES GM, 1952, J EXP BIOL, V29, P267; Ijspeert AJ, 2008, NEURAL NETWORKS, V21, P642, DOI 10.1016/j.neunet.2008.03.014; Jacobi-Kleemann M, 1953, J COMP PHYSL, V34, P606; Jindrich DL, 2002, J EXP BIOL, V205, P2803; Koditschek DE, 2004, ARTHROPOD STRUCT DEV, V33, P251, DOI 10.1016/j.asd.2004.06.003; Kram R, 1997, J EXP BIOL, V200, P1919; Kukillaya RP, 2007, BIOL CYBERN, V97, P379, DOI 10.1007/s00422-007-0180-2; Lewis J. G. E., 1981, BIOL CENTIPEDES; LINZEN B, 1975, J COMP PHYSIOL, V96, P101, DOI 10.1007/BF00706589; Manton, 1977, ARTHROPODA HABITS FU; MCMAHON TA, 1987, J APPL PHYSIOL, V62, P2326, DOI 10.1152/jappl.1987.62.6.2326; McMeeking RM, 2012, J THEOR BIOL, V297, P17, DOI 10.1016/j.jtbi.2011.12.003; Menon C, 2006, BIOINSPIR BIOMIM, V1, P52, DOI 10.1088/1748-3182/1/2/003; MOFFETT S, 1980, J EXP ZOOL, V213, P219, DOI 10.1002/jez.1402130209; Moya-Larano J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001841; PARRY DA, 1959, J EXP BIOL, V36, P654; Pelletier Y, 2001, BIOL CYBERN, V84, P269, DOI 10.1007/s004220000214; PRESTWICH KN, 1988, J COMP PHYSIOL B, V158, P449, DOI 10.1007/BF00691142; Ringrose RP, 1997, SELF STABILIZING RUN; RUHLAND M, 1978, ZOOMORPHOLOGIE, V89, P33, DOI 10.1007/BF00993780; Ruina A, 2005, J THEOR BIOL, V237, P170, DOI 10.1016/j.jtbi.2005.04.004; Schmid A, 1998, J EXP BIOL, V201, P221; Schmitt J, 2000, BIOL CYBERN, V83, P501, DOI 10.1007/s004220000181; Schmitt J, 2000, BIOL CYBERN, V83, P517, DOI 10.1007/s004220000180; Schmitz A, 2005, J EXP BIOL, V208, P1401, DOI 10.1242/jeb.01497; Seidl T, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-8; Sens J, 1996, THESIS U SAARLANDES; Sensenig AT, 2006, J ARACHNOL, V34, P627, DOI 10.1636/0161-8202(2006)034[0627:MEODLI]2.0.CO;2; Sensenig AT, 2003, J EXP BIOL, V206, P771, DOI 10.1242/jeb.00182; Seyfarth A, 2001, BIOL CYBERN, V84, P365, DOI 10.1007/PL00007982; SEYFARTH EA, 1972, J COMP PHYSIOL, V78, P176, DOI 10.1007/BF00693611; SEYFARTH EA, 1978, J COMP PHYSIOL, V125, P45, DOI 10.1007/BF00656830; SEYFARTH EA, 1984, J NEUROBIOL, V15, P365, DOI 10.1002/neu.480150506; SHULTZ JW, 1987, J EXP BIOL, V128, P427; Siebert T, 2010, J COMP PHYSIOL B, V180, P199, DOI 10.1007/s00360-009-0401-1; Spagna JC, 2011, J ARACHNOL, V39, P84, DOI 10.1636/B10-45.1; Sponberg S, 2008, J EXP BIOL, V211, P433, DOI 10.1242/jeb.012385; Srinivasan M, 2008, J THEOR BIOL, V255, P1, DOI 10.1016/j.jtbi.2008.06.034; STEWART DM, 1974, J COMP PHYSIOL, V88, P141, DOI 10.1007/BF00695405; TING LH, 1994, J EXP BIOL, V197, P251; WARD TM, 1981, J EXP BIOL, V92, P323; WARD TM, 1981, J EXP BIOL, V92, P305; Weihmann T, 2007, THESIS F SCHILLER U; Weihmann T, 2009, J COMP PHYSL A; Weihmann T, 2006, J BIOMECHANICS S1, V39, P361; Weihmann T, 2012, J EXP BIOL, V215, P578, DOI 10.1242/jeb.054585; Weihmann T, 2010, J COMP PHYSIOL A, V196, P421, DOI 10.1007/s00359-010-0527-3; WILSON DM, 1966, ANNU REV ENTOMOL, V11, P103, DOI 10.1146/annurev.en.11.010166.000535; WILSON DM, 1967, J EXP BIOL, V47, P133; ZOLLIKOFER CPE, 1994, J EXP BIOL, V192, P107	87	23	23	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e65788	10.1371/journal.pone.0065788	http://dx.doi.org/10.1371/journal.pone.0065788			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805189	Green Published, gold, Green Submitted			2022-12-25	WOS:000320846500017
J	Lambert, O; Piroux, M; Puyo, S; Thorin, C; L'Hostis, M; Wiest, L; Bulete, A; Delbac, F; Pouliquen, H				Lambert, Olivier; Piroux, Melanie; Puyo, Sophie; Thorin, Chantal; L'Hostis, Monique; Wiest, Laure; Bulete, Audrey; Delbac, Frederic; Pouliquen, Herve			Widespread Occurrence of Chemical Residues in Beehive Matrices from Apiaries Located in Different Landscapes of Western France	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; BEES APIS-MELLIFERA; LAND-USE CHANGE; SPECIES RICHNESS; HONEY; PESTICIDE; POLLEN; IMPACT; PROCHLORAZ; SENTINELS	Background: The honey bee, Apis mellifera, is frequently used as a sentinel to monitor environmental pollution. In parallel, general weakening and unprecedented colony losses have been reported in Europe and the USA, and many factors are suspected to play a central role in these problems, including infection by pathogens, nutritional stress and pesticide poisoning. Honey bee, honey and pollen samples collected from eighteen apiaries of western France from four different landscape contexts during four different periods in 2008 and in 2009 were analyzed to evaluate the presence of pesticides and veterinary drug residues. Methodology/Findings: A multi-residue analysis of 80 compounds was performed using a modified QuEChERS method, followed by GC-ToF and LC-MS/MS. The analysis revealed that 95.7%, 72.3% and 58.6% of the honey, honey bee and pollen samples, respectively, were contaminated by at least one compound. The frequency of detection was higher in the honey samples (n = 28) than in the pollen (n = 23) or honey bee (n = 20) samples, but the highest concentrations were found in pollen. Although most compounds were rarely found, some of the contaminants reached high concentrations that might lead to adverse effects on bee health. The three most frequent residues were the widely used fungicide carbendazim and two acaricides, amitraz and coumaphos, that are used by beekeepers to control Varroa destructor. Apiaries in rural-cultivated landscapes were more contaminated than those in other landscape contexts, but the differences were not significant. The contamination of the different matrices was shown to be higher in early spring than in all other periods. Conclusions/Significance: Honey bees, honeys and pollens are appropriate sentinels for monitoring pesticide and veterinary drug environmental pollution. This study revealed the widespread occurrence of multiple residues in beehive matrices and suggests a potential issue with the effects of these residues alone or in combination on honey bee health.	[Lambert, Olivier; Piroux, Melanie; Puyo, Sophie; L'Hostis, Monique; Pouliquen, Herve] LUNAM Univ, Oniris, Ecole Natl Vet Agroalimentaire & Alimentat Nantes, Ctr Vet Faune Sauvage & Ecosyst Pays Loire CVFSE, Nantes, France; [Thorin, Chantal] LUNAM Univ, Oniris, Ecole Natl Vet Agroalimentaire & Alimentat Nantes, Unite Physiopathol Anim & Pharmacol Fonct, Nantes, France; [Wiest, Laure; Bulete, Audrey] Univ Lyon 1, Inst Sci Analyt, Dept Serv Cent Anal, ENS Lyon,UMR CNRS 5280, F-69622 Villeurbanne, France; [Lambert, Olivier; Piroux, Melanie; Delbac, Frederic] Univ Blaise Pascal, Clermont Univ, Lab Microorganismes Genome & Environm, Clermont Ferrand, France; [Lambert, Olivier; Piroux, Melanie; Delbac, Frederic] LMGE, CNRS, UMR 6023, Aubiere, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA)	Lambert, O (corresponding author), LUNAM Univ, Oniris, Ecole Natl Vet Agroalimentaire & Alimentat Nantes, Ctr Vet Faune Sauvage & Ecosyst Pays Loire CVFSE, Nantes, France.	olivier.lambert@oniris-nantes.fr		Wiest, Laure/0000-0001-7271-9143	European Union through European Agricultural Guidance Guarantee fund projects; Nantes Metropole; le Conseil General de Loire Atlantique; le Conseil Regional des Pays de la Loire; Pullman hotels by Bee My Friend	European Union through European Agricultural Guidance Guarantee fund projects; Nantes Metropole(Region Pays de la Loire); le Conseil General de Loire Atlantique(Region Pays de la Loire); le Conseil Regional des Pays de la Loire(Region Pays de la Loire); Pullman hotels by Bee My Friend	This project was supported by the European Union through European Agricultural Guidance Guarantee fund projects, Nantes Metropole, le Conseil General de Loire Atlantique, le Conseil Regional des Pays de la Loire and Pullman hotels by Bee My Friend. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Andresen JA, 2004, SCI TOTAL ENVIRON, V332, P155, DOI 10.1016/j.scitotenv.2004.04.021; Aufauvre J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00326; Balayiannis G, 2008, ARCH ENVIRON CON TOX, V55, P462, DOI 10.1007/s00244-007-9126-x; Barmaz S, 2010, ECOTOXICOLOGY, V19, P1347, DOI 10.1007/s10646-010-0521-0; Belzunces LP, 2012, APIDOLOGIE, V43, P348, DOI 10.1007/s13592-012-0134-0; Bilandzic N, 2011, FOOD CHEM, V128, P1160, DOI 10.1016/j.foodchem.2011.04.023; Brittain CA, 2010, BASIC APPL ECOL, V11, P106, DOI 10.1016/j.baae.2009.11.007; Butler SJ, 2010, AGR ECOSYST ENVIRON, V137, P348, DOI 10.1016/j.agee.2010.03.005; Celli Giorgio, 2003, Bulletin of Insectology, V56, P137; Chauzat MP, 2011, ENVIRON TOXICOL CHEM, V30, P103, DOI 10.1002/etc.361; Chaves A, 2008, CHEMOSPHERE, V71, P629, DOI 10.1016/j.chemosphere.2007.11.015; COLIN ME, 1992, PESTIC SCI, V36, P115, DOI 10.1002/ps.2780360206; Core A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029639; Crowl TA, 2008, FRONT ECOL ENVIRON, V6, P238, DOI 10.1890/070151; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; El Hassani AK, 2008, ARCH ENVIRON CON TOX, V54, P653, DOI 10.1007/s00244-007-9071-8; Ghini S, 2004, ARCH ENVIRON CON TOX, V47, P479, DOI 10.1007/s00244-003-3219-y; Guzman-Novoa E, 2010, APIDOLOGIE, V41, P443, DOI 10.1051/apido/2009076; Han P, 2010, ECOTOXICOLOGY, V19, P1612, DOI 10.1007/s10646-010-0546-4; Hejda M, 2009, J ECOL, V97, P393, DOI 10.1111/j.1365-2745.2009.01480.x; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Higes M, 2010, APIDOLOGIE, V41, P375, DOI 10.1051/apido/2010019; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Johnson RM, 2011, AM BEE J, V151, P975; Orantes-Bermejo FJ, 2010, J APICULT RES, V49, P243, DOI 10.3896/IBRA.1.49.3.03; Kalbande DM, 2008, ENVIRON MONIT ASSESS, V138, P233, DOI 10.1007/s10661-007-9793-0; Kenis M, 2009, BIOL INVASIONS, V11, P21, DOI 10.1007/s10530-008-9318-y; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Lambert O, 2012, ENVIRON POLLUT, V170, P254, DOI 10.1016/j.envpol.2012.07.012; Lambert O, 2012, CHEMOSPHERE, V86, P98, DOI 10.1016/j.chemosphere.2011.09.025; Lodesani M., 2003, APIACTA, V38, P31; MACKENZIE KE, 1989, APIDOLOGIE, V20, P29, DOI 10.1051/apido:19890104; Martel AC, 2007, APIDOLOGIE, V38, P534, DOI 10.1051/apido:2007038; Maver L., 2003, APIACTA, V38, P54; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; McLaughlin A, 1995, AGR ECOSYST ENVIRON, V55, P201, DOI 10.1016/0167-8809(95)00609-V; Morgano MA, 2010, J AGR FOOD CHEM, V58, P6876, DOI 10.1021/jf100433p; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Office of Pesticide Programs USEPA, 2000, ASS VAL NOND NONQ PE; Perugini M, 2011, BIOL TRACE ELEM RES, V140, P170, DOI 10.1007/s12011-010-8688-z; Perugini M, 2009, J AGR FOOD CHEM, V57, P7440, DOI 10.1021/jf9011054; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; PILLING ED, 1995, PESTIC BIOCHEM PHYS, V51, P1, DOI 10.1006/pest.1995.1001; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P3, DOI DOI 10.1007/0-387-22747-4_1; Porrini C., 2003, APIACTA, V38, P63, DOI DOI 10.1080/10942912.2015.1107578; R Core Team, 2012, R LANG ENV STAT COMP; Reidsma P, 2006, AGR ECOSYST ENVIRON, V114, P86, DOI 10.1016/j.agee.2005.11.026; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Sabatini AG, 2003, APIACTA, V38, P46; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Tsigouri A., 2003, APIACTA, V38, P50; Tuzen M, 2007, FOOD CHEM, V103, P325, DOI 10.1016/j.foodchem.2006.07.053; VANBUREN NWM, 1992, ENVIRON ENTOMOL, V21, P860, DOI 10.1093/ee/21.4.860; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Wallner K, 1999, APIDOLOGIE, V30, P235, DOI 10.1051/apido:19990212; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Wiest L, 2011, J CHROMATOGR A, V1218, P5743, DOI 10.1016/j.chroma.2011.06.079; Wu JY, 2012, J INVERTEBR PATHOL, V109, P326, DOI 10.1016/j.jip.2012.01.005; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743	65	116	116	2	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e67007	10.1371/journal.pone.0067007	http://dx.doi.org/10.1371/journal.pone.0067007			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799139	gold, Green Submitted, Green Published			2022-12-25	WOS:000321397800048
J	Gowher, A; Smirnov, A; Tarassov, I; Entelis, N				Gowher, Ali; Smirnov, Alexandre; Tarassov, Ivan; Entelis, Nina			Induced tRNA Import into Human Mitochondria: Implication of a Host Aminoacyl-tRNA-Synthetase	PLOS ONE			English	Article							5S RIBOSOMAL-RNA; YEAST MITOCHONDRIA; BINDING DOMAIN; PROTEIN IMPORT; ENCODED RNAS; TRANSLATION; ENOLASE; DNA; REQUIREMENTS; CONSEQUENCES	In human cell, a subset of small non-coding RNAs is imported into mitochondria from the cytosol. Analysis of the tRNA import pathway allowing targeting of the yeast tRNA(CUU)(Lys) into human mitochondria demonstrates a similarity between the RNA import mechanisms in yeast and human cells. We show that the cytosolic precursor of human mitochondrial lysyl-tRNA synthetase (preKARS2) interacts with the yeast tRNA(CUU)(Lys) and small artificial RNAs which contain the structural elements determining the tRNA mitochondrial import, and facilitates their internalization by isolated human mitochondria. The tRNA import efficiency increased upon addition of the glycolytic enzyme enolase, previously found to be an actor of the yeast RNA import machinery. Finally, the role of preKARS2 in the RNA mitochondrial import has been directly demonstrated in vivo, in cultured human cells transfected with the yeast tRNA and artificial importable RNA molecules, in combination with preKARS2 overexpression or downregulation by RNA interference. These findings suggest that the requirement of protein factors for the RNA mitochondrial targeting might be a conserved feature of the RNA import pathway in different organisms.	[Gowher, Ali; Smirnov, Alexandre; Tarassov, Ivan; Entelis, Nina] Univ Strasbourg, CNRS, UMR Genet Mol 7156, Dept Mol & Cellular Genet,Microbiol GMGM, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Entelis, N (corresponding author), Univ Strasbourg, CNRS, UMR Genet Mol 7156, Dept Mol & Cellular Genet,Microbiol GMGM, Strasbourg, France.	n.entelis@unistra.fr	Smirnov, Alexandre/H-4253-2019	Smirnov, Alexandre/0000-0002-9142-7979; Entelis, Nina/0000-0002-7915-5528; Tarassov, Ivan/0000-0001-8763-6703	CNRS (Centre National de Recherche Scientifique); University of Strasbourg; AFM (Association Francaise contre les Myopathies); ANR (Agence Nationale de la Recherche); FRM (Fondation pour la Recherche Medicale); National Program "Investissment d'Avenir" (Labex MitoCross); Pakistan Government's HEC-SFERE PhD fellowship	CNRS (Centre National de Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); University of Strasbourg; AFM (Association Francaise contre les Myopathies)(Association Francaise contre les Myopathies); ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); FRM (Fondation pour la Recherche Medicale)(Fondation pour la Recherche Medicale); National Program "Investissment d'Avenir" (Labex MitoCross); Pakistan Government's HEC-SFERE PhD fellowship	This work was supported by CNRS (Centre National de Recherche Scientifique), University of Strasbourg, AFM (Association Francaise contre les Myopathies), ANR (Agence Nationale de la Recherche), FRM (Fondation pour la Recherche Medicale) and National Program "Investissment d'Avenir" (Labex MitoCross). A. G. was supported by Pakistan Government's HEC-SFERE PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; Bandiera S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020746; Barrey E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020220; Belostotsky R, 2012, RNA BIOL, V9, P33, DOI 10.4161/rna.9.1.18009; Bouzaidi-Tiali N, 2007, EMBO J, V26, P4302, DOI 10.1038/sj.emboj.7601857; Brandina I, 2006, BBA-BIOENERGETICS, V1757, P1217, DOI 10.1016/j.bbabio.2006.07.001; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Comte C, 2012, NUCL ACIDS RES; Das S, 2012, CIRC RES, V110, P1596, DOI 10.1161/CIRCRESAHA.112.267732; Dias J, 2012, BIOCHEMISTRY-US, V51, P909, DOI 10.1021/bi201337b; Diaz-Lazcoz Y, 1998, MOL BIOL EVOL, V15, P1548, DOI 10.1093/oxfordjournals.molbev.a025882; Duchene AM, 2008, CURR GENET; Entelis N, 2002, GENET ENG P, V24, P191; Entelis N, 2006, GENE DEV, V20, P1609, DOI 10.1101/gad.385706; Entelis NS, 1996, FEBS LETT, V384, P38, DOI 10.1016/0014-5793(96)00259-1; Entelis NS, 1998, P NATL ACAD SCI USA, V95, P2838, DOI 10.1073/pnas.95.6.2838; Entelis NS, 2001, J BIOL CHEM, V276, P45642, DOI 10.1074/jbc.M103906200; Francin M, 2002, J BIOL CHEM, V277, P1762, DOI 10.1074/jbc.M109759200; Kamenski P, 2007, MOL CELL, V26, P625, DOI 10.1016/j.molcel.2007.04.019; Kamenski P, 2010, MITOCHONDRION, V10, P284, DOI 10.1016/j.mito.2010.01.002; Kaminska M, 2000, EMBO J, V19, P6908, DOI 10.1093/emboj/19.24.6908; Kaminska M, 2007, J VIROL, V81, P68, DOI 10.1128/JVI.01267-06; Karicheva OZ, 2011, NUCLEIC ACIDS RES, V39, P8173, DOI 10.1093/nar/gkr546; Kolesnikova OA, 2000, SCIENCE, V289, P1931, DOI 10.1126/science.289.5486.1931; Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267; Kolesnikova O, 2010, RNA, V16, P926, DOI 10.1261/rna.1914110; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; MARTIN RP, 1979, BIOCHEMISTRY-US, V18, P4600, DOI 10.1021/bi00588a021; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; NEGRUTSKII BS, 1991, P NATL ACAD SCI USA, V88, P4991, DOI 10.1073/pnas.88.11.4991; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Puranam RS, 2001, MOL CELL BIOL, V21, P548, DOI 10.1128/MCB.21.2.548-561.2001; Rubio MAT, 2008, P NATL ACAD SCI USA, V105, P9186, DOI 10.1073/pnas.0804283105; Salinas T, 2008, TRENDS BIOCHEM SCI, V33, P320, DOI 10.1016/j.tibs.2008.04.010; Salinas T, 2006, P NATL ACAD SCI USA, V103, P18362, DOI 10.1073/pnas.0606449103; Schneider A, 2011, ANNU REV BIOCHEM, V80, P1033, DOI 10.1146/annurev-biochem-060109-092838; Sepuri NBV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035321; Smirnov A, 2008, RNA, V14, P749, DOI 10.1261/rna.952208; Smirnov A, 2011, GENE DEV, V25, P1289, DOI 10.1101/gad.624711; Smirnov A, 2010, J BIOL CHEM, V285, P30792, DOI 10.1074/jbc.M110.151183; Sripada L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044873; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; TARASSOV I, 1995, EMBO J, V14, P3461, DOI 10.1002/j.1460-2075.1995.tb07352.x; TARASSOV I, 1995, J MOL BIOL, V245, P315, DOI 10.1006/jmbi.1994.0026; Tarassov I, 2007, CELL CYCLE, V6, P2473, DOI 10.4161/cc.6.20.4783; Tolkunova E, 2000, J BIOL CHEM, V275, P35063, DOI 10.1074/jbc.M006265200; Wang G, 2012, P NATL ACAD SCI USA, V109, P4840, DOI 10.1073/pnas.1116792109; Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035	50	24	26	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66228	10.1371/journal.pone.0066228	http://dx.doi.org/10.1371/journal.pone.0066228			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799079	gold, Green Published, Green Submitted			2022-12-25	WOS:000320363300064
J	Johnsen, AB; Hoydal, M; Rosbjorgen, R; Stolen, T; Wisloff, U				Johnsen, Anne Berit; Hoydal, Morten; Rosbjorgen, Ragnhild; Stolen, Tomas; Wisloff, Ulrik			Aerobic Interval Training Partly Reverse Contractile Dysfunction and Impaired Ca2+ Handling in Atrial Myocytes from Rats with Post Infarction Heart Failure	PLOS ONE			English	Article							SARCOPLASMIC-RETICULUM CA2+; MOLECULAR DETERMINANTS; MYOCARDIAL-INFARCTION; CALCIUM-RELEASE; LEAK; FIBRILLATION; PHOSPHORYLATION; HYPERTROPHY; EXPRESSION; EXCHANGER	Background: There is limited knowledge about atrial myocyte Ca2+ handling in the failing hearts. The aim of this study was to examine atrial myocyte contractile function and Ca2+ handling in rats with post-infarction heart failure (HF) and to examine whether aerobic interval training could reverse a potential dysfunction. Methods and results: Post-infarction HF was induced in Sprague Dawley rats by ligation of the left descending coronary artery. Atrial myocyte shortening was depressed (p<0.01) and time to relaxation was prolonged (p<0.01) in sedentary HF-rats compared to healthy controls. This was associated with decreased Ca2+ amplitude, decreased SR Ca2+ content, and slower Ca2+ transient decay. Atrial myocytes from HF-rats had reduced sarcoplasmic reticulum Ca2+ ATPase activity, increased Na+/Ca2+-exchanger activity and increased diastolic Ca2+ leak through ryanodine receptors. High intensity aerobic interval training in HF-rats restored atrial myocyte contractile function and reversed changes in atrial Ca2+ handling in HF. Conclusion: Post infarction HF in rats causes profound impairment in atrial myocyte contractile function and Ca2+ handling. The observed dysfunction in atrial myocytes was partly reversed after aerobic interval training.	[Johnsen, Anne Berit; Hoydal, Morten; Rosbjorgen, Ragnhild; Stolen, Tomas; Wisloff, Ulrik] Norwegian Univ Sci & Technol, Fac Med, KG Jebsen Ctr Exercise Med, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Wisloff, U (corresponding author), Norwegian Univ Sci & Technol, Fac Med, KG Jebsen Ctr Exercise Med, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway.	ulrik.wisloff@ntnu.no	Høydal, Morten A/K-2806-2012; Wisloff, Ulrik/K-2899-2012	Høydal, Morten A/0000-0003-1804-2578; Wisloff, Ulrik/0000-0002-7211-3587	K.G. Jebsen Foundation; Norwegian Research Council Funding for Outstanding Young investigators	K.G. Jebsen Foundation; Norwegian Research Council Funding for Outstanding Young investigators	This work was supported by grants from K.G. Jebsen Foundation and the Norwegian Research Council Funding for Outstanding Young investigators (to Ulrik Wisloff). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Armoundas AA, 2007, AM J PHYSIOL-HEART C, V292, pH1607, DOI 10.1152/ajpheart.00525.2006; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Bers D.M., 2001, EXCITATION CONTRACTI, V2nd ed.; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2003, CIRC RES, V93, P487, DOI 10.1161/01.RES.0000091871.54907.6B; Bers DM, 2006, PHYSIOLOGY, V21, P380, DOI 10.1152/physiol.00019.2006; Bers Donald M., 2002, Basic Research in Cardiology, V97; BEUCKELMANN DJ, 1992, CIRCULATION, V85, P1046, DOI 10.1161/01.CIR.85.3.1046; Chelu MG, 2007, BIOCHEM SOC T, V35, P952, DOI 10.1042/BST0350952; Curran J, 2007, CIRC RES, V100, P391, DOI 10.1161/01.RES.0000258172.74570.e6; El-Armouche A, 2006, CIRCULATION, V114, P670, DOI 10.1161/CIRCULATIONAHA.106.636845; Greiser M, 2009, J MOL CELL CARDIOL, V46, P385, DOI 10.1016/j.yjmcc.2008.11.012; Hasenfuss G, 1999, CIRCULATION, V99, P641, DOI 10.1161/01.CIR.99.5.641; Hasenfuss G, 2002, J MOL CELL CARDIOL, V34, P951, DOI 10.1006/jmcc.2002.2037; Hasenfuss G, 1998, CIRC RES, V83, P966; Hobai IA, 2001, CIRCULATION, V103, P1577; Hove-Madsen L, 2004, CIRCULATION, V110, P1358, DOI 10.1161/01.CIR.0000141296.59876.87; Kemi OJ, 2002, J APPL PHYSIOL, V93, P1301, DOI 10.1152/japplphysiol.00231.2002; Kemi OJ, 2012, J CELL PHYSIOL, V227, P20, DOI 10.1002/jcp.22771; Kemi OJ, 2007, CARDIOVASC RES, V76, P91, DOI 10.1016/j.cardiores.2007.06.008; Loennechen JP, 2001, AM J PHYSIOL-HEART C, V280, pH2902, DOI 10.1152/ajpheart.2001.280.6.H2902; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Nattel S, 2007, PHYSIOL REV, V87, P425, DOI 10.1152/physrev.00014.2006; Neef S, 2009, CIRC RES; Pogwizd SM, 2000, CIRC RES, V87, P641, DOI 10.1161/01.RES.87.8.641; Pogwizd SM, 1999, CIRC RES, V85, P1009; Schotten U, 2002, CARDIOVASC RES, V53, P192, DOI 10.1016/S0008-6363(01)00453-9; Shannon TR, 2002, CIRC RES, V91, P594, DOI 10.1161/01.RES.0000036914.12686.28; Shioya T, 2007, J PHYSIOL SCI, V57, P327, DOI 10.2170/physiolsci.RP010107; Stolen TO, 2009, CIRC RES, V105, P527, DOI 10.1161/CIRCRESAHA.109.199810; Sun H, 1998, CIRCULATION, V98, P719, DOI 10.1161/01.CIR.98.7.719; Wehrens XHT, 2004, SCIENCE, V304, P292, DOI 10.1126/science.1094301; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; Wisloff U, 2002, CARDIOVASC RES, V54, P162, DOI 10.1016/S0008-6363(01)00565-X; Wisloff U, 2001, AM J PHYSIOL-HEART C, V280, pH1301, DOI 10.1152/ajpheart.2001.280.3.H1301; Wisloff U, 2007, CIRCULATION, V115, P3086, DOI 10.1161/CIRCULATIONAHA.106.675041; Workman AJ, 2010, N-S ARCH PHARMACOL, V381, P235, DOI 10.1007/s00210-009-0474-0; Yeh YH, 2008, CIRC-ARRHYTHMIA ELEC, V1, P93, DOI 10.1161/CIRCEP.107.754788	42	18	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66288	10.1371/journal.pone.0066288	http://dx.doi.org/10.1371/journal.pone.0066288			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799089	gold, Green Published, Green Submitted			2022-12-25	WOS:000320363300073
J	von Jonquieres, G; Mersmann, N; Klugmann, CB; Harasta, AE; Lutz, B; Teahan, O; Housley, GD; Frohlich, D; Kramer-Albers, EM; Klugmann, M				von Jonquieres, Georg; Mersmann, Nadine; Klugmann, Claudia Bettina; Harasta, Anne Editha; Lutz, Beat; Teahan, Orla; Housley, Gary David; Frohlich, Dominik; Kramer-Albers, Eva-Maria; Klugmann, Matthias			Glial Promoter Selectivity following AAV-Delivery to the Immature Brain	PLOS ONE			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; CENTRAL-NERVOUS-SYSTEM; MOUSE-BRAIN; GENE DELIVERY; NONHUMAN-PRIMATES; EXPRESSION; OLIGODENDROCYTES; NEURONS; TRANSDUCTION; ASTROCYTES	Recombinant adeno-associated virus (AAV) vectors are versatile tools for gene transfer to the central nervous system (CNS) and proof-of-concept studies in adult rodents have shown that the use of cell type-specific promoters is sufficient to target AAV-mediated transgene expression to glia. However, neurological disorders caused by glial pathology usually have an early onset. Therefore, modelling and treatment of these conditions require expanding the concept of targeted glial transgene expression by promoter selectivity for gene delivery to the immature CNS. Here, we have investigated the AAV-mediated green fluorescent protein (GFP) expression driven by the myelin basic protein (MBP) or glial fibrillary acidic protein (GFAP) promoters in the developing mouse brain. Generally, the extent of transgene expression after infusion at immature stages was widespread and higher than in adults. The GFAP promoter-driven GFP expression was found to be highly specific for astrocytes following vector infusion to the brain of neonates and adults. In contrast, the selectivity of the MBP promoter for oligodendrocytes was poor following neonatal AAV delivery, but excellent after vector injection at postnatal day 10. To extend these findings obtained in naive mice to a disease model, we performed P10 infusions of AAV-MBP-GFP in aspartoacylase (ASPA)-deficient mouse mutants presenting with early onset oligodendrocyte pathology. Spread of GFP expression and selectivity for oligodendrocytes in ASPA-mutants was comparable with our observations in normal animals. Our data suggest that direct AAV infusion to the developing postnatal brain, utilising cellular promoters, results in targeted and long-term transgene expression in glia. This approach will be relevant for disease modelling and gene therapy for the treatment of glial pathology.	[von Jonquieres, Georg; Klugmann, Claudia Bettina; Harasta, Anne Editha; Teahan, Orla; Housley, Gary David; Klugmann, Matthias] Univ New S Wales, Sch Med Sci, Dept Physiol, Translat Neurosci Facil, Sydney, NSW, Australia; [Mersmann, Nadine; Lutz, Beat; Klugmann, Matthias] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, D-55122 Mainz, Germany; [Frohlich, Dominik; Kramer-Albers, Eva-Maria] Johannes Gutenberg Univ Mainz, Dept Mol Cell Biol, D-55122 Mainz, Germany	University of New South Wales Sydney; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Klugmann, M (corresponding author), Univ New S Wales, Sch Med Sci, Dept Physiol, Translat Neurosci Facil, Sydney, NSW, Australia.	m.klugmann@unsw.edu.au	Eva-Maria, Kraemer-Albers/AAP-8805-2020; Lutz, Beat/AFK-6229-2022; Lutz, Beat/AAG-4538-2022; von Jonquieres, Georg/W-1781-2019	Eva-Maria, Kraemer-Albers/0000-0001-7994-1185; von Jonquieres, Georg/0000-0002-7423-3355; Frohlich, Dominik/0000-0002-9551-3620; Housley, Gary/0000-0002-8413-588X	EU; European Leukodystrophy Association (ELA)	EU(European Commission); European Leukodystrophy Association (ELA)	This work was supported by a project grant of the EU FP7 LeukoTreat to MK, a project grant of the European Leukodystrophy Association (ELA) to MK and EMKA. MK is an Australian Research Council (ARC) Future Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buning H, 2008, J GENE MED, V10, P717, DOI 10.1002/jgm.1205; Buntinx M, 2003, J NEUROCYTOL, V32, P25, DOI 10.1023/A:1027324230923; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chen H, 1999, J NEUROSCI RES, V55, P504, DOI 10.1002/(SICI)1097-4547(19990215)55:4<504::AID-JNR10>3.0.CO;2-0; Chen H, 1998, GENE THER, V5, P50, DOI 10.1038/sj.gt.3300547; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Dayton RD, 2012, EXPERT OPIN BIOL TH, V12, P757, DOI 10.1517/14712598.2012.681463; de Leeuw B, 2006, J NEUROSCI RES, V83, P744, DOI 10.1002/jnr.20776; Dong JY, 1996, HUM GENE THER, V7, P2101, DOI 10.1089/hum.1996.7.17-2101; During Matthew J, 2003, Methods Mol Med, V76, P221; Feldmann A, 2009, J NEUROSCI RES, V87, P1760, DOI 10.1002/jnr.22020; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Franich NR, 2008, MOL THER, V16, P947, DOI 10.1038/mt.2008.50; Gray SJ, 2011, MOL THER, V19, P1058, DOI 10.1038/mt.2011.72; Klein RL, 1998, EXP NEUROL, V150, P183, DOI 10.1006/exnr.1997.6736; Klein RL, 2008, MOL THER, V16, P89, DOI 10.1038/sj.mt.6300331; Klugmann M, 2005, MOL THER, V11, P745, DOI 10.1016/j.ymthe.2005.01.006; Klugmann M, 2005, MOL CELL NEUROSCI, V28, P347, DOI 10.1016/j.mcn.2004.10.002; Koerber JT, 2009, MOL THER, V17, P2088, DOI 10.1038/mt.2009.184; Lawlor PA, 2009, MOL THER, V17, P1692, DOI 10.1038/mt.2009.170; Markakis EA, 2010, MOL THER, V18, P588, DOI 10.1038/mt.2009.286; Mattar CN, 2013, GENE THER, V20, P69, DOI 10.1038/gt.2011.216; Mays LE, 2011, MOL THER, V19, P16, DOI 10.1038/mt.2010.250; McClure C, 2011, JOVE-J VIS EXP, DOI 10.3791/3348; Mersmann N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020336; Oluich LJ, 2012, J NEUROSCI, V32, P8317, DOI 10.1523/JNEUROSCI.1053-12.2012; Piguet F, 2012, HUM GENE THER, V23, P903, DOI 10.1089/hum.2012.015; Pilpel N, 2009, J NEUROSCI METH, V182, P55, DOI 10.1016/j.jneumeth.2009.05.020; Taymans JM, 2007, HUM GENE THER, V18, P195, DOI 10.1089/hum.2006.178; TROTTER J, 1989, J NEUROSCI RES, V22, P369, DOI 10.1002/jnr.490220402; Zhang HW, 2011, MOL THER, V19, P1440, DOI 10.1038/mt.2011.98; Zhang JY, 2005, NEUROIMAGE, V26, P1042, DOI 10.1016/j.neuroimage.2005.03.009	32	89	90	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65646	10.1371/journal.pone.0065646	http://dx.doi.org/10.1371/journal.pone.0065646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799030	Green Published, gold, Green Submitted			2022-12-25	WOS:000320363300030
J	Zhou, B; Pearce, MB; Li, Y; Wang, JR; Mason, RJ; Tumpey, TM; Wentworth, DE				Zhou, Bin; Pearce, Melissa B.; Li, Yan; Wang, Jieru; Mason, Robert J.; Tumpey, Terrence M.; Wentworth, David E.			Asparagine Substitution at PB2 Residue 701 Enhances the Replication, Pathogenicity, and Transmission of the 2009 Pandemic H1N1 Influenza A Virus	PLOS ONE			English	Article							ALVEOLAR TYPE-II; MOLECULAR-BASIS; EPITHELIAL-CELLS; HOST-RANGE; POLYMERASE; H5N1; DETERMINANT; VIRULENCE; SUBUNIT; FERRETS	The 2009/2010 pandemic influenza virus (H1N1pdm) contains an avian-lineage PB2 gene that lacks E627K and D701N substitutions important in the pathogenesis and transmission of avian-origin viruses in humans or other mammals. Previous studies have shown that PB2-627K is not necessary because of a compensatory Q591R substitution. The role that PB2-701N plays in the H1N1pdm phenotype is not well understood. Therefore, PB2-D701N was introduced into an H1N1pdm virus (A/New York/1682/2009 (NY1682)) and analyzed in vitro and in vivo. Mini-genome replication assay, in vitro replication characteristics in cell lines, and analysis in the mouse and ferret models demonstrated that PB2-D701N increased virus replication rates and resulted in more severe pathogenicity in mice and more efficient transmission in ferrets. In addition, compared to the NY1682-WT virus, the NY1682-D701N mutant virus induced less IFN-lambda and replicated to a higher titer in primary human alveolar epithelial cells. These findings suggest that the acquisition of the PB2-701N substitution by H1N1pdm viruses may result in more severe disease or increase transmission in humans.	[Zhou, Bin; Wentworth, David E.] J Craig Venter Inst, Rockville, MD USA; [Zhou, Bin; Li, Yan; Wentworth, David E.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Zhou, Bin; Wentworth, David E.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA; [Pearce, Melissa B.; Tumpey, Terrence M.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA USA; [Wang, Jieru; Mason, Robert J.] Natl Jewish Hlth, Dept Med, Denver, CO USA	J. Craig Venter Institute; State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Centers for Disease Control & Prevention - USA; National Jewish Health	Wentworth, DE (corresponding author), J Craig Venter Inst, Rockville, MD USA.	dwentworth@JCVI.org	Zhou, Bin/H-8688-2014	Zhou, Bin/0000-0002-1535-6283; Wentworth, David/0000-0002-5190-980X	NIH/NIAID [U54-AI057158, P01AI059576-05]; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200900007C]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, P01AI059576, R03AI101953] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by NIH/NIAID U54-AI057158 (Northeast Biodefense Center-Lipkin). DEW was also supported by NIH/NIAID P01AI059576-05. DEW and BZ are also supported in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under contract number HHSN272200900007C. The findings and conclusions in this report are those of the authors and do not necessarily reflect the views of the funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Belser JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025091; Bogner P, 2006, NATURE, V442, P981, DOI 10.1038/442981a; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Gabriel G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1158; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Graef KM, 2010, J VIROL, V84, P8433, DOI 10.1128/JVI.00879-10; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Herfst S, 2010, J VIROL, V84, P3752, DOI 10.1128/JVI.02634-09; Jagger BW, 2010, MBIO, V1, DOI 10.1128/mBio.00067-10; Jayaraman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017616; Le QM, 2010, J GEN VIROL, V91, P2485, DOI 10.1099/vir.0.021659-0; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mason RJ, 2006, RESPIROLOGY, V11, pS12, DOI 10.1111/j.1440-1843.2006.00800.x; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; Munster VJ, 2007, J INFECT DIS, V196, P258, DOI 10.1086/518792; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ozawa M, 2011, J VIROL, V85, P4596, DOI 10.1128/JVI.00029-11; Pearce MB, 2012, P NATL ACAD SCI USA, V109, P3944, DOI 10.1073/pnas.1119945109; Quinlivan M, 2005, J VIROL, V79, P8431, DOI 10.1128/JVI.79.13.8431-8439.2005; Quynh ML, 2009, J VIROL, V83, P5278, DOI 10.1128/JVI.00063-09; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Squires RB, 2012, INFLUENZA OTHER RESP, V6, P404, DOI 10.1111/j.1750-2659.2011.00331.x; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Wang JR, 2007, AM J RESP CELL MOL, V36, P661, DOI 10.1165/rcmb.2006-0410OC; Wang JR, 2006, FREE RADICAL BIO MED, V40, P1914, DOI 10.1016/j.freeradbiomed.2006.01.017; Wang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029879; Wang JR, 2011, AM J RESP CELL MOL, V45, P582, DOI 10.1165/rcmb.2010-0108OC; Wang JR, 2009, J IMMUNOL, V182, P1296, DOI 10.4049/jimmunol.182.3.1296; Wang TT, 2009, CELL, V137, P983, DOI 10.1016/j.cell.2009.05.032; Yamada S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001034; Yu WCL, 2011, J VIROL, V85, P6844, DOI 10.1128/JVI.02200-10; Zhou B, 2012, VACCINE, V30, P3691, DOI 10.1016/j.vaccine.2012.03.025; Zhou B, 2011, J VIROL METHODS, V173, P378, DOI 10.1016/j.jviromet.2011.01.021; Zhou B, 2011, J VIROL, V85, P357, DOI 10.1128/JVI.01694-10; Zhou B, 2010, VACCINE, V28, P8015, DOI 10.1016/j.vaccine.2010.08.106; Zhou B, 2009, J VIROL, V83, P10309, DOI 10.1128/JVI.01109-09; Zhu HC, 2010, VIROLOGY, V401, P1, DOI 10.1016/j.virol.2010.02.024	45	43	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e67616	10.1371/journal.pone.0067616	http://dx.doi.org/10.1371/journal.pone.0067616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799150	gold, Green Submitted, Green Published			2022-12-25	WOS:000320363300113
J	Bourgine, A; Pilet, P; Diouani, S; Sourice, S; Lesoeur, J; Beck-Cormier, S; Khoshniat, S; Weiss, P; Friedlander, G; Guicheux, J; Beck, L				Bourgine, Annabelle; Pilet, Paul; Diouani, Sara; Sourice, Sophie; Lesoeur, Julie; Beck-Cormier, Sarah; Khoshniat, Solmaz; Weiss, Pierre; Friedlander, Gerard; Guicheux, Jerome; Beck, Laurent			Mice with Hypomorphic Expression of the Sodium-Phosphate Cotransporter PiT1/Slc20a1 Have an Unexpected Normal Bone Mineralization	PLOS ONE			English	Article							OSTEOBLAST-LIKE CELLS; TRANSPORTER RETROVIRUS RECEPTOR; INORGANIC-PHOSPHATE; CALCIUM-PHOSPHATE; GROWTH; MATRIX; PIT1; GLVR-1; PHASE; CHONDROCYTES	The formation of hydroxyapatite crystals and their insertion into collagen fibrils of the matrix are essential steps for bone mineralization. As phosphate is a main structural component of apatite crystals, its uptake by skeletal cells is critical and must be controlled by specialized membrane proteins. In mammals, in vitro studies have suggested that the high-affinity sodium-phosphate cotransporter PiT1 could play this role. In vivo, PiT1 expression was detected in hypertrophic chondrocytes of murine metatarsals, but its implication in bone physiology is not yet deciphered. As the complete deletion of PiT1 results in embryonic lethality at E12.5, we took advantage of a mouse model bearing two copies of PiT1 hypomorphic alleles to study the effect of a low expression of PiT1 on bone mineralization in vivo. In this report, we show that a 85% down-regulation of PiT1 in long bones resulted in a slight (6%) but significant reduction of femur length in young mice (15- and 30-day-old). However, despite a defect in alcian blue / alizarin red S and Von Kossa staining of hypomorphic 1-day-old mice, using X-rays micro-computed tomography, energy dispersive X-ray spectroscopy and histological staining techniques we could not detect differences between hypomorphic and wild-type mice of 15- to 300-days old. Interestingly, the expression of PiT2, the paralog of PiT1, was increased 2-fold in bone of PiT1 hypomorphic mice accounting for a normal phosphate uptake in mutant cells. Whether this may contribute to the absence of bone mineralization defects remains to be further deciphered.	[Bourgine, Annabelle; Pilet, Paul; Sourice, Sophie; Lesoeur, Julie; Beck-Cormier, Sarah; Khoshniat, Solmaz; Weiss, Pierre; Guicheux, Jerome; Beck, Laurent] STEP Grp Skeletal Tissue Engn & Physiopathol, LIOAD, INSERM, U791, Nantes, France; [Bourgine, Annabelle; Pilet, Paul; Sourice, Sophie; Lesoeur, Julie; Beck-Cormier, Sarah; Khoshniat, Solmaz; Weiss, Pierre; Guicheux, Jerome; Beck, Laurent] Univ Nantes, UFR Odontol, Nantes, France; [Diouani, Sara; Friedlander, Gerard] Ctr Rech Croissance & Signalisat, INSERM, U845, Paris, France; [Diouani, Sara; Friedlander, Gerard] Univ Paris 05, Paris, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Beck, L (corresponding author), STEP Grp Skeletal Tissue Engn & Physiopathol, LIOAD, INSERM, U791, Nantes, France.	laurent.beck@inserm.fr	Paul, Pilet/A-3755-2015; WEISS, Pierre/AAE-9260-2020; Beck-Cormier, Sarah/P-3091-2014; Weiss, Pierre/P-1372-2014; BECK, Laurent/P-2952-2014; guicheux, Jerome/F-7767-2013	WEISS, Pierre/0000-0002-6159-8590; Beck-Cormier, Sarah/0000-0001-5258-1933; Weiss, Pierre/0000-0002-6159-8590; BECK, Laurent/0000-0002-6730-2762; guicheux, Jerome/0000-0003-2754-3024; Friedlander, Gerard/0000-0002-6854-4261	INSERM; Fondation pour la Recherche Medicale (FRM); Region des Pays de la Loire [R10125NN, 2010-2817, 2010-2818]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Region des Pays de la Loire(Region Pays de la Loire)	This work was supported by grants from INSERM, the Fondation pour la Recherche Medicale (FRM), the Region des Pays de la Loire ("Bioregos II" project, "CIMATH 2" project #R10125NN and "Nouvelles thematiques Nouvelles equipes" project #2010-2817 and 2010-2818). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson HC, 2005, FRONT BIOSCI-LANDMRK, V10, P822, DOI 10.2741/1576; Beck GR, 2003, J BIOL CHEM, V278, P41921, DOI 10.1074/jbc.M304470200; Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Beck L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009148; Beck L, 2009, J BIOL CHEM, V284, P31363, DOI 10.1074/jbc.M109.053132; Bottger P, 2006, AM J PHYSIOL-CELL PH, V291, pC1377, DOI 10.1152/ajpcell.00015.2006; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Byskov K, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-7; ESCOUBET B, 1992, J ENDOCRINOL, V133, P301, DOI 10.1677/joe.0.1330301; Fernandez-Vojvodich P, 2012, HORM RES PAEDIAT, V77, P180, DOI 10.1159/000337569; GLIMCHER MJ, 1984, PHILOS T R SOC B, V304, P479, DOI 10.1098/rstb.1984.0041; Guicheux J, 2000, BONE, V27, P69, DOI 10.1016/S8756-3282(00)00302-1; HALE JE, 1987, J BIOL CHEM, V262, P1916; HANSEN NM, 1976, BIOCHIM BIOPHYS ACTA, V451, P549, DOI 10.1016/0304-4165(76)90150-1; Jahnen-Dechent W, 2000, PROGR BIOL MOL BIOL, P21; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahamid J, 2008, P NATL ACAD SCI USA, V105, P12748, DOI 10.1073/pnas.0803354105; Mahamid J, 2011, J STRUCT BIOL, V174, P527, DOI 10.1016/j.jsb.2011.03.014; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Nielsen LB, 2001, BONE, V28, P160, DOI 10.1016/S8756-3282(00)00418-X; Olszta MJ, 2003, CONNECT TISSUE RES, V44, P326, DOI 10.1080/03008200390181852; Palmer G, 2000, ENDOCRINOLOGY, V141, P2236, DOI 10.1210/en.141.6.2236; Palmer G, 1997, ENDOCRINOLOGY, V138, P5202, DOI 10.1210/en.138.12.5202; Palmer G, 1999, BONE, V24, P1, DOI 10.1016/S8756-3282(98)00151-3; POSNER AS, 1978, METAB BONE DIS RELAT, V1, P179, DOI 10.1016/0221-8747(78)90057-7; Ravera S, 2007, AM J PHYSIOL-CELL PH, V293, pC606, DOI 10.1152/ajpcell.00064.2007; Sabbagh Y, 2009, J AM SOC NEPHROL, V20, P2348, DOI 10.1681/ASN.2009050559; Salaun C, 2010, J BIOL CHEM, V285, P34408, DOI 10.1074/jbc.M110.130989; Segawa H, 2002, J BIOL CHEM, V277, P19665, DOI 10.1074/jbc.M200943200; Segawa H, 2009, AM J PHYSIOL-RENAL, V297, pF671, DOI 10.1152/ajprenal.00156.2009; Silverstein D, 1996, KIDNEY INT, V49, P1023, DOI 10.1038/ki.1996.148; Suzuki A, 2006, J BONE MINER RES, V21, P674, DOI 10.1359/JBMR.020603; Suzuki A, 2001, BONE, V28, P589, DOI 10.1016/S8756-3282(01)00459-8; Suzuki A, 2010, J BONE MINER METAB, V28, P139, DOI 10.1007/s00774-009-0121-3; Wang DS, 2001, J BIOL CHEM, V276, P33995, DOI 10.1074/jbc.M007757200; Wittrant Y, 2009, BIOCHEM BIOPH RES CO, V381, P259, DOI 10.1016/j.bbrc.2009.02.034; Yoshiko Y, 2007, MOL CELL BIOL, V27, P4465, DOI 10.1128/MCB.00104-07; Zoidis E, 2004, J ENDOCRINOL, V181, P531, DOI 10.1677/joe.0.1810531	38	26	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65979	10.1371/journal.pone.0065979	http://dx.doi.org/10.1371/journal.pone.0065979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785462	Green Published, gold, Green Submitted			2022-12-25	WOS:000321038800060
J	Thuringer, D; Jego, G; Wettstein, G; Terrier, O; Cronier, L; Yousfi, N; Hebrard, S; Bouchot, A; Hazoume, A; Joly, AL; Gleave, M; Rosa-Calatrava, M; Solary, E; Garrido, C				Thuringer, Dominique; Jego, Gaetan; Wettstein, Guillaume; Terrier, Olivier; Cronier, Laurent; Yousfi, Nadhir; Hebrard, Sophie; Bouchot, Andre; Hazoume, Adonis; Joly, Anne-Laure; Gleave, Martin; Rosa-Calatrava, Manuel; Solary, Eric; Garrido, Carmen			Extracellular HSP27 mediates angiogenesis through Toll-like receptor 3	FASEB JOURNAL			English	Article						tubulogenesis; chorioallantoic membrane; autocrine VEGFR2 activation; microvascular endothelial cell; endocytosis; NF-B pathway; VEGF release	ENDOTHELIAL GROWTH-FACTOR; KAPPA-B; PROTEIN; VEGF; ACTIVATION; TLR3; RNA; PHOSPHORYLATION; INTERLEUKIN-8; EXPRESSION	The heat-shock protein 27 (HSP27) is up-regulated in tumor cells and released in their microenvironment. Here, we show that extracellular HSP27 has a proangiogenic effect evidenced on chick chorioallantoic membrane. To explore this effect, we test the recombinant human protein (rhHSP27) at physiopathological doses (0.1-10 g/ml) onto human microvascular endothelial cells (HMECs) grown as monolayers or spheroids. When added onto HMECs, rhHSP27 dose-dependently accelerates cell migration (with a peak at 5 g/ml) and favors spheroid sprouting within 12-24 h. rhHSP27 increases VEGF gene transcription and promotes secretion of VEGF-activating VEGF receptor type 2. Increased VEGF transcription is related to NF-B activation in 30 min. All of these effects are initiated by rhHSP27 interaction with Toll-like receptor 3 (TLR3). Such an interaction can be detected by immunoprecipitation but does not seem to be direct, as we failed to detect an interaction between rhHSP27 and monomeric TLR3 by SPR analysis. rhHSP27 is rapidly internalized with a pool of TLR3 to the endosomal compartment (within 15-30 min), which is required for NF-B activation in a cytosolic Ca2+-dependent manner. The HSP27/TLR3 interaction induces NF-B activation, leading to VEGF-mediated cell migration and angiogenesis. Such a pathway provides alternative targets for antiangiogenic cancer therapy.Thuringer, D., Jego, G., Wettstein, G., Terrier, O., Cronier, L., Yousfi, N., Hebrard, S., Bouchot, A., Hazoume, A., Joly, A.-L., Gleave, M., Rosa-Calatrava, M., Solary, E., and Garrido, C. Extracellular HSP27 mediates angiogenesis through Toll-like receptor 3.	[Thuringer, Dominique; Jego, Gaetan; Wettstein, Guillaume; Yousfi, Nadhir; Hebrard, Sophie; Hazoume, Adonis; Joly, Anne-Laure; Solary, Eric; Garrido, Carmen] Univ Burgundy, INSERM, U866, F-21000 Dijon, France; [Jego, Gaetan; Garrido, Carmen] Univ Burgundy, Fac Med Pharm, F-21000 Dijon, France; [Terrier, Olivier; Rosa-Calatrava, Manuel] Univ Lyon 1, Fac Med, Lab Virol & Pathol Humaine VirPath EA4610, F-69365 Lyon, France; [Cronier, Laurent] Univ Poitiers, CNRS, FRE3511, IPBC, Poitiers, France; [Bouchot, Andre] IFR100, Fac Med, Dijon, France; [Gleave, Martin] Univ British Columbia, Dept Urol, Vancouver, BC V5Z 1M9, Canada; [Solary, Eric] Univ Paris 11, INSERM, U1009, Inst Gustave Roussy, Villejuif, France; [Garrido, Carmen] CHU Dijon, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Universite de Bourgogne; University of British Columbia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; CHU Dijon Bourgogne	Thuringer, D (corresponding author), INSERM, U866, Fac Med, 7 Blvd Jeanne dArc, F-21000 Dijon, France.	dominique.thuringer@u-bourgogne.fr	Thuringer, Dominique/AAA-7448-2020; Rosa-calatrava, Manuel/M-7263-2014; Terrier, Olivier/B-6301-2009; Garrido, Carolina/GWM-5557-2022; jego, gaetan/N-7226-2018; Garrido, carmen/G-1633-2018	Terrier, Olivier/0000-0001-9393-7684; jego, gaetan/0000-0003-0376-9299; Garrido, carmen/0000-0003-1368-1493; CRONIER, Laurent/0000-0002-5088-9325; Gleave, Martin/0000-0003-4235-0167; Rosa-calatrava, Manuel/0000-0002-7559-9527; Solary, Eric/0000-0002-8629-1341	Centre National de la Recherche Scientifique (CNRS); INSERM; Conseil Regional de Bourgogne (Faber Program); European Commission Seventh Framework Programme [SPEDOC 248835]; Ligue Nationale contre le Cancer (Label); Agence Nationale de la Recherche; Institut National du Cancer (INCa)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Conseil Regional de Bourgogne (Faber Program)(Region Bourgogne-Franche-Comte); European Commission Seventh Framework Programme(European Commission); Ligue Nationale contre le Cancer (Label)(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France)	The authors are grateful to Christine Arnould [Centre Microbiologie du Sol et de l'Environnement (CMSE), Institut National de Recherche Agronomique, Dijon, France] for confocal microscopy and to Amandine Bataille and Eric Fourmaux for technical assistance. The authors thank Dr. Mike Maillasson [Platform Molecular Interactions Proteins Microarrays Activities(IMPACT) Biogenouest, Centre de Recherche en Cancerologie Nantes/Angers (CRCNA), Institut National de la Sante et de la Recherche Medicale (INSERM) U892, Nantes, France] for analysis of agonist/receptor interaction using the surface plasmon resonance technique. The authors thank Dr. Dominique Chevrier (InvivoGen, Toulouse, France) for cell assays using HEK 293T cells overexpressing or not overexpressing TLR3. Stably transfected human cell lines MCA205/OVA<SUP>+/-</SUP> shTRIF or sh lamin were kindly provided by Dr. Dalil Hannani (Institut Gustave Roussy, INSERM U1015, Villejuif, France). This work was supported by Centre National de la Recherche Scientifique (CNRS), by INSERM, by Conseil Regional de Bourgogne (Faber Program), and the European Commission Seventh Framework Programme (SPEDOC 248835 to C.G.). C.G. and E.S. are supported by grants from Ligue Nationale contre le Cancer (Label), Agence Nationale de la Recherche, and Institut National du Cancer (INCa).	Banerjee S, 2011, CANCER RES, V71, P318, DOI 10.1158/0008-5472.CAN-10-1778; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Cho WG, 2009, P NATL ACAD SCI USA, V106, P7137, DOI 10.1073/pnas.0812317106; Crawford Y, 2009, CELL TISSUE RES, V335, P261, DOI 10.1007/s00441-008-0675-8; De AK, 2000, J IMMUNOL, V165, P3951, DOI 10.4049/jimmunol.165.7.3951; Didelot C, 2006, HANDB EXP PHARM, V172, P171; DOUKAS J, 1994, AM J PATHOL, V145, P137; Durupt F, 2012, CANCER GENE THER, V19, P58, DOI 10.1038/cgt.2011.68; Evans IM, 2008, CELL SIGNAL, V20, P1375, DOI 10.1016/j.cellsig.2008.03.002; Fanelli MA, 1998, CANCER EPIDEM BIOMAR, V7, P791; Feng JT, 2005, PROTEOMICS, V5, P4581, DOI 10.1002/pmic.200401309; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663; Fischer S, 2007, BLOOD, V110, P2457, DOI 10.1182/blood-2006-08-040691; Fischer S, 2009, FASEB J, V23, P2100, DOI 10.1096/fj.08-121608; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Ghayour-Mobarhan M, 2012, CLIN CHIM ACTA, V413, P15, DOI 10.1016/j.cca.2011.04.005; Goutagny N, 2012, TARGET ONCOL, V7, P29, DOI 10.1007/s11523-012-0213-1; Grote K, 2011, THESCIENTIFICWORLDJO, V11, P981, DOI 10.1100/tsw.2011.92; Heidemann J, 2003, J BIOL CHEM, V278, P8508, DOI 10.1074/jbc.M208231200; Jego G, 2013, CANCER LETT, V332, P275, DOI 10.1016/j.canlet.2010.10.014; Kampinga HH, 2012, INT J BIOCHEM CELL B, V44, P1706, DOI 10.1016/j.biocel.2012.06.005; Kawamura H, 2008, BLOOD, V112, P3638, DOI 10.1182/blood-2007-12-125856; Kawamura H, 2008, CANCER RES, V68, P4683, DOI 10.1158/0008-5472.CAN-07-6577; Kelly RJ, 2009, TARGET ONCOL, V4, P297, DOI 10.1007/s11523-009-0126-9; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Koff JL, 2008, AM J PHYSIOL-LUNG C, V294, pL1068, DOI 10.1152/ajplung.00025.2008; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; Moon Su-Jin, 2010, Korean Journal of Internal Medicine, V25, P429, DOI 10.3904/kjim.2010.25.4.429; Paone A, 2010, NEOPLASIA, V12, P539, DOI 10.1593/neo.92106; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Piotrowicz RS, 1998, FASEB J, V12, P1481, DOI 10.1096/fasebj.12.14.1481; Pohar J, 2013, J BIOL CHEM, V288, P442, DOI 10.1074/jbc.M112.413922; Rousseau S, 2000, TRENDS CARDIOVAS MED, V10, P321, DOI 10.1016/S1050-1738(01)00072-X; Salaun B, 2011, CANCER RES, V71, P1607, DOI 10.1158/0008-5472.CAN-10-3490; Schraufstatter IU, 2001, AM J PHYSIOL-LUNG C, V280, pL1094, DOI 10.1152/ajplung.2001.280.6.L1094; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Vercammen E, 2008, CLIN MICROBIOL REV, V21, P13, DOI 10.1128/CMR.00022-07; Wang Y, 2010, J BIOL CHEM, V285, P36836, DOI 10.1074/jbc.M110.167973; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Winston WM, 2007, P NATL ACAD SCI USA, V104, P10565, DOI 10.1073/pnas.0611282104; Yamashita M, 2012, J IMMUNOL, V188, P2825, DOI 10.4049/jimmunol.1103220	43	74	76	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					4169	4183		10.1096/fj.12-226977	http://dx.doi.org/10.1096/fj.12-226977			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23804239				2022-12-25	WOS:000329747100028
J	Wang, XT; Wang, L; Guo, SC; Bao, Y; Ma, YY; Yan, FY; Xu, K; Xu, ZY; Jin, L; Lu, DR; Xu, JB; Wang, JC				Wang, Xiaotian; Wang, Lei; Guo, Shicheng; Bao, Yang; Ma, Yanyun; Yan, Fengyang; Xu, Kuan; Xu, Zhiyun; Jin, Li; Lu, Daru; Xu, Jibin; Wang, Jiu-Cun			Hypermethylation reduces expression of tumor-suppressor PLZF and regulates proliferation and apoptosis in non-small-cell lund cancers	FASEB JOURNAL			English	Article						BSP; MSP	LEUKEMIA ZINC-FINGER; ACID RECEPTOR-ALPHA; PROMYELOCYTIC LEUKEMIA; DNA-BINDING; PROTEIN PLZF; GROWTH; GENE; TRANSCRIPTION; METHYLATION; DIFFERENTIATION	Deregulation of promyelocytic leukemia zinc finger protein (PLZF), a tumor suppressor gene, was reported in different types of solid tumors. This study for the first time explored the reduced expression of PLZF and its effects in non-small-cell lung cancer (NSCLC) carcinogenesis. PLZF was found to be down-regulated by 62.8% in 87.1% of 154 paired NSCLC samples by quantitative real-time PCR, and its expression was found to be associated with the sex of the patient (P=0.02). Further analysis showed that down-regulation of PLZF in 35.6% NSCLC samples (31 out of 87) was triggered by hypermethylation in the promoter region. This was validated by demethylation analysis using the A549 cell line. Dual-luciferase reporter assay indicated that CTCF binding to the promoter region could activate PLZF transcription. Overexpression of PLZF in both A549 and LTEP lung cancer cell lines was found to inhibit proliferation and increase apoptosis. Therefore, reduced expression of PLZF was found to be common in NSCLC. PLZF down-regulation was partially correlated with hypermethylation in the promoter region. Decreased levels of PLZF expression may contribute to the pathogenesis of NSCLC by promoting cell survival. Therefore, the restoration of PLZF expression may serve as a new strategy for NSCLC therapy.Wang, X., Wang, L., Guo, S., Bao, Y., Ma, Y., Yan, F., Xu, K., Xu, Z., Jin, L., Lu, D., Xu, J., Wang, J.-C. Hypermethylation reduces expression of tumor-suppressor PLZF and regulates proliferation and apoptosis in non-small-cell lung cancers.	[Wang, Xiaotian; Wang, Lei; Guo, Shicheng; Ma, Yanyun; Yan, Fengyang; Jin, Li; Lu, Daru; Wang, Jiu-Cun] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Wang, Xiaotian; Guo, Shicheng; Ma, Yanyun; Yan, Fengyang; Jin, Li; Lu, Daru; Wang, Jiu-Cun] Fudan Univ, Sch Life Sci, Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Wang, Lei] Peoples Liberat Army, Hosp 455, Dept Cardiothorac Surg, Shanghai, Peoples R China; [Bao, Yang] Yangzhou 1 Peoples Hosp, Yangzhou, Peoples R China; [Xu, Kuan] Fudan Univ, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Xu, Zhiyun; Xu, Jibin] Second Mil Med Univ, Dept Cardiothorac Surg, Changhai Hosp Shanghai, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Naval Medical University	Wang, JC (corresponding author), Fudan Univ, Natl Minist Educ, Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China.	jibinx@yahoo.com; jcwang@fudan.edu.cn	Jin, Li/C-1468-2009; Guo, Shicheng/A-1204-2016; Wang, Jiucun/J-8744-2012; Jin, Li/M-5063-2019; MA, YAN/HHN-2912-2022	Jin, Li/0000-0002-4546-2415; Guo, Shicheng/0000-0002-7047-9972; Wang, Jiucun/0000-0003-2765-0620; 	National Science Foundation of China (NSFC) [81172228]; National S&T Major Special Project [2011ZX09102-010-01]; National Science Foundation of China [81270120, 31271338]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National S&T Major Special Project; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Prof. Jian Yu (State Key Laboratory of Oncogenes and Related Genes, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai Cancer Institute, Shanghai, China) for providing MBD-Seq data of NSCLC and normal lung tissues. This study was partially supported by the grants from the National Science Foundation of China (NSFC; 81172228), and National S&T Major Special Project (2011ZX09102-010-01). J.-C.W. and L.J. were supported by the grants from the National Science Foundation of China (81270120, 31271338).	Atienza JM, 2005, J BIOMOL SCREEN, V10, P795, DOI 10.1177/1087057105279635; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Brunner G, 2008, CANCER BIOTHER RADIO, V23, P451, DOI 10.1089/cbr.2008.0473; CHEN SJ, 1993, J CLIN INVEST, V91, P2260, DOI 10.1172/JCI116453; Chen Wanqing, 2010, Zhongguo Fei Ai Za Zhi, V13, P488, DOI 10.3779/j.issn.1009-3419.2010.05.20; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Cheung M, 2010, ONCOGENE, V29, P1633, DOI 10.1038/onc.2009.455; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; De la Rosa-Velazquez IA, 2007, CANCER RES, V67, P2577, DOI 10.1158/0008-5472.CAN-06-2024; Doulatov S, 2009, GENE DEV, V23, P2076, DOI 10.1101/gad.1788109; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Felicetti F, 2004, ONCOGENE, V23, P4567, DOI 10.1038/sj.onc.1207597; Goldman M, 2013, NUCLEIC ACIDS RES, V41, pD949, DOI 10.1093/nar/gks1008; Hong SH, 1997, P NATL ACAD SCI USA, V94, P9028, DOI 10.1073/pnas.94.17.9028; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kikugawa T, 2006, PROSTATE, V66, P1092, DOI 10.1002/pros.20443; Li JY, 1997, J BIOL CHEM, V272, P22447, DOI 10.1074/jbc.272.36.22447; McConnell MJ, 2003, MOL CELL BIOL, V23, P9375, DOI 10.1128/MCB.23.24.9375-9388.2003; Melnick A, 2000, MOL CELL BIOL, V20, P6550, DOI 10.1128/MCB.20.17.6550-6567.2000; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; REID A, 1995, BLOOD, V86, P4544, DOI 10.1182/blood.V86.12.4544.bloodjournal86124544; Renda M, 2007, J BIOL CHEM, V282, P33336, DOI 10.1074/jbc.M706213200; Rho SB, 2006, FEBS LETT, V580, P4073, DOI 10.1016/j.febslet.2006.06.047; Rottmann S, 2006, CURR TOP MICROBIOL, V302, P63; Rottmann S, 2005, J BIOL CHEM, V280, P15489, DOI 10.1074/jbc.C400611200; Shaknovich R, 1998, MOL CELL BIOL, V18, P5533, DOI 10.1128/MCB.18.9.5533; Shiraishi K, 2007, ONCOGENE, V26, P339, DOI 10.1038/sj.onc.1209800; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Vincent A, 2011, CLIN CANCER RES, V17, P4341, DOI 10.1158/1078-0432.CCR-10-3431; Ward JO, 2001, BLOOD, V98, P3290, DOI 10.1182/blood.V98.12.3290; Xu JB, 2007, LUNG CANCER, V58, P36, DOI 10.1016/j.lungcan.2007.04.019; Yeyati PL, 1999, ONCOGENE, V18, P925, DOI 10.1038/sj.onc.1202375; Yu J, 2007, CLIN CANCER RES, V13, P7296, DOI 10.1158/1078-0432.CCR-07-0861; Yu NC, 2006, ANAL CHEM, V78, P35, DOI 10.1021/ac051695v	35	21	22	2	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					4194	4203		10.1096/fj.13-229070	http://dx.doi.org/10.1096/fj.13-229070			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23804241				2022-12-25	WOS:000329747100030
J	Choudhary, G; Ranjitkumar, N; Surapaneni, M; Deborah, DA; Vipparla, A; Anuradha, G; Siddiq, EA; Vemireddy, LR				Choudhary, Gangaprasad; Ranjitkumar, Nagireddy; Surapaneni, Malathi; Deborah, Dondapati Annekitty; Vipparla, Abhilash; Anuradha, Ghanta; Siddiq, Ebrahimali Abubacker; Vemireddy, Lakshminarayana Reddy			Molecular Genetic Diversity of Major Indian Rice Cultivars over Decadal Periods	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; TEMPORAL TRENDS; WHEAT GERMPLASM; MARKER SYSTEM; PCR; ACCESSIONS; VARIETIES; LENGTH; CHINA; AFLP	Genetic diversity in representative sets of high yielding varieties of rice released in India between 1970 and 2010 was studied at molecular level employing hypervariable microsatellite markers. Of 64 rice SSR primer pairs studied, 52 showed polymorphism, when screened in 100 rice genotypes. A total of 184 alleles was identified averaging 3.63 alleles per locus. Cluster analysis clearly grouped the 100 genotypes into their respective decadal periods i.e., 1970s, 1980s, 1990s and 2000s. The trend of diversity over the decadal periods estimated based on the number of alleles (Na), allelic richness (Rs), Nei's genetic diversity index (He), observed heterozygosity (Ho) and polymorphism information content (PIC) revealed increase of diversity over the periods in year of releasewise and longevitywise classification of rice varieties. Analysis of molecular variance (AMOVA) suggested more variation in within the decadal periods than among the decades. Pairwise comparison of population differentiation (Fst) among decadal periods showed significant difference between all the pairs except a few. Analysis of trends of appearing and disappearing alleles over decadal periods showed an increase in the appearance of alleles and decrease in disappearance in both the categories of varieties. It was obvious from the present findings, that genetic diversity was progressively on the rise in the varieties released during the decadal periods, between 1970s and 2000s.	[Choudhary, Gangaprasad; Ranjitkumar, Nagireddy; Surapaneni, Malathi; Deborah, Dondapati Annekitty; Vipparla, Abhilash; Anuradha, Ghanta; Siddiq, Ebrahimali Abubacker; Vemireddy, Lakshminarayana Reddy] Acharya NG Ranga Agr Univ, Inst Biotechnol, Hyderabad, Andhra Pradesh, India	Acharya N. G. Ranga Agricultural University	Vemireddy, LR (corresponding author), Acharya NG Ranga Agr Univ, Inst Biotechnol, Hyderabad, Andhra Pradesh, India.	vlnreddi@gmail.com	ANNEKITTY DEBORAH, DONDAPATI/GOE-6684-2022; Vemireddy, Lakshmi Narayana Reddy/GSD-9210-2022; Vemireddy, Lakshminarayana R/S-7926-2019	Vemireddy, Lakshmi Narayana Reddy/0000-0002-9452-8492; Vemireddy, Lakshminarayana R/0000-0002-9452-8492	ANGRAU (Acharya NG Ranga Agricultural University) under Rashtriya Krishi Vikas Yojana (RKVY)	ANGRAU (Acharya NG Ranga Agricultural University) under Rashtriya Krishi Vikas Yojana (RKVY)	The authors acknowledge ANGRAU (Acharya NG Ranga Agricultural University) for providing the financial and lab facilities under Rashtriya Krishi Vikas Yojana (RKVY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Christiansen MJ, 2002, MOL BREEDING, V9, P1, DOI 10.1023/A:1019234323372; Chuan-Guang Gui-Quan Z, 2010, ACTA AGRON SIN, V36, P1843; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fu YB, 2006, THEOR APPL GENET, V112, P1239, DOI 10.1007/s00122-006-0225-2; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Giarrocco LE, 2007, CROP SCI, V47, P853, DOI 10.2135/cropsci2005.07.0198; GLASZMANN JC, 1987, THEOR APPL GENET, V74, P21, DOI 10.1007/BF00290078; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hazen SP, 2002, GENET RESOUR CROP EV, V49, P437, DOI 10.1023/A:1020670013249; Heal G, 2004, RESOUR ENERGY ECON, V26, P175, DOI 10.1016/j.reseneeco.2003.11.006; Huang XQ, 2007, CROP SCI, V47, P343, DOI 10.2135/cropsci2006.04.0261; Hysing S-C, 2008, PLANT GENETIC RESOUR, P6; Jain S, 2004, THEOR APPL GENET, V109, P965, DOI 10.1007/s00122-004-1700-2; Jayamani P, 2007, CROP SCI, V47, P879, DOI 10.2135/cropsci2006.04.0236; Luce C, 2001, ACTA HORTIC, P221, DOI 10.17660/ActaHortic.2001.546.26; Mantegazza R, 2008, CROP SCI, V48, P1832, DOI 10.2135/cropsci2007.09.0532; Mir RR, 2012, GENET RESOUR CROP EV, V59, P717, DOI 10.1007/s10722-011-9713-6; Morin S. R., 2002, Agriculture and Human Values, V19, P133, DOI 10.1023/A:1016018711315; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nagaraju J, 2002, P NATL ACAD SCI USA, V99, P5836, DOI 10.1073/pnas.042099099; Narshimulu G, 2011, PLANT BREEDING, V130, P314, DOI 10.1111/j.1439-0523.2010.01834.x; Neeraja CN, 2009, ELECTRON J BIOTECHN, P12; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Priti Upadhyay, 2011, International Journal of Plant Breeding and Genetics, V5, P130, DOI 10.3923/ijpbg.2011.130.140; Qi YW, 2006, CHINESE SCI BULL, V51, P681, DOI 10.1007/s11434-006-0681-8; Ramkumar G, 2010, MOL BREEDING, V26, P735, DOI 10.1007/s11032-010-9492-3; Roussel V, 2004, THEOR APPL GENET, V108, P920, DOI 10.1007/s00122-003-1502-y; Sambrook J, 2001, MOL CLONING LAB MANU; Singh A, 2010, MOL BREEDING, V26, P325, DOI 10.1007/s11032-010-9425-1; Spada A, 2004, PLANT BREEDING, V123, P105, DOI 10.1046/j.1439-0523.2003.00950.x; Steele KA, 2009, FIELD CROP RES, V113, P24, DOI 10.1016/j.fcr.2009.04.002; Sundaram RM, 2010, MOL BREEDING, V26, P719, DOI 10.1007/s11032-010-9482-5; Tian QZ, 2005, GENET RESOUR CROP EV, V52, P325, DOI 10.1007/s10722-005-5716-5; van de Wouw M, 2010, THEOR APPL GENET, V120, P1241, DOI 10.1007/s00122-009-1252-6; Wei XH, 2009, J GENET GENOMICS, V36, P363, DOI 10.1016/S1673-8527(08)60125-3; White J, 2008, THEOR APPL GENET, V116, P439, DOI 10.1007/s00122-007-0681-3; Yonemaru J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032982; Yu SB, 2003, THEOR APPL GENET, V108, P131, DOI 10.1007/s00122-003-1400-3; Yuan XP, 2007, RICE SCI, V14, P78, DOI 10.1016/S1672-6308(07)60012-2; [朱明雨 Zhu Mingyu], 2004, [华中农业大学学报, Journal of Huazhong Agricultural University], V23, P187	42	39	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66197	10.1371/journal.pone.0066197	http://dx.doi.org/10.1371/journal.pone.0066197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805204	Green Published, gold, Green Submitted			2022-12-25	WOS:000320846500032
J	Daru, BH; Yessoufou, K; Mankga, LT; Davies, TJ				Daru, Barnabas H.; Yessoufou, Kowiyou; Mankga, Ledile T.; Davies, T. Jonathan			A Global Trend towards the Loss of Evolutionarily Unique Species in Mangrove Ecosystems	PLOS ONE			English	Article							EXTINCTION RISK; PHYLOGENETIC DIVERSITY; NONRANDOM EXTINCTION; BIODIVERSITY; CONSERVATION; IMPACTS; FORESTS; FUTURE; RATES	The mangrove biome stands out as a distinct forest type at the interface between terrestrial, estuarine, and near-shore marine ecosystems. However, mangrove species are increasingly threatened and experiencing range contraction across the globe that requires urgent conservation action. Here, we assess the spatial distribution of mangrove species richness and evolutionary diversity, and evaluate potential predictors of global declines and risk of extinction. We found that human pressure, measured as the number of different uses associated with mangroves, correlated strongly, but negatively, with extinction probability, whereas species ages were the best predictor of global decline, explaining 15% of variation in extinction risk. Although the majority of mangrove species are categorised by the IUCN as Least Concern, our finding that the more threatened species also tend to be those that are more evolutionarily unique is of concern because their extinction would result in a greater loss of phylogenetic diversity. Finally, we identified biogeographic regions that are relatively species-poor but rich in evolutionary history, and suggest these regions deserve greater conservation priority. Our study provides phylogenetic information that is important for developing a unified management plan for mangrove ecosystems worldwide.	[Daru, Barnabas H.; Yessoufou, Kowiyou; Mankga, Ledile T.] Univ Johannesburg, African Ctr DNA Barcoding, Johannesburg, South Africa; [Davies, T. Jonathan] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	University of Johannesburg; McGill University	Daru, BH (corresponding author), Univ Johannesburg, African Ctr DNA Barcoding, Johannesburg, South Africa.	darunabas@gmail.com	Mankga, Ledile/GPF-8316-2022; Daru, Barnabas/B-4051-2011; Elansary, Hosam O./E-3684-2019	Mankga, Ledile/0000-0002-5326-1197; Daru, Barnabas/0000-0002-2115-0257; Elansary, Hosam O./0000-0002-4476-2408; Yessoufou, Prof. Kowiyou/0000-0002-4789-1723	University of Johannesburg through the African Centre for DNA Barcoding	University of Johannesburg through the African Centre for DNA Barcoding	The University of Johannesburg through the African Centre for DNA Barcoding provide logistics and financial support to the first two authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Butchart SHM, 2010, BIOL CONSERV, V143, P239, DOI 10.1016/j.biocon.2009.10.008; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Chapman VJ, 1977, WET COASTAL ECOSYSTE, V1, P1; Chapman VJ, 1975, P INT S BIOL MANAGEM, P3; Clough BF, 1993, EC ENV VALUES MANGRO, V1, P1; Cooper N, 2008, GLOBAL ECOL BIOGEOGR, V17, P211, DOI 10.1111/j.1466-8238.2007.00355.x; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Dahdouh-Guebas F, 2000, ECON BOT, V54, P513, DOI 10.1007/BF02866549; Das S, 2009, P NATL ACAD SCI USA, V106, P7357, DOI 10.1073/pnas.0810440106; Davies RG, 2006, P ROY SOC B-BIOL SCI, V273, P2127, DOI 10.1098/rspb.2006.3551; Davies TJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000620; Dorenbosch M, 2004, ESTUAR COAST SHELF S, V60, P37, DOI 10.1016/j.ecss.2003.11.018; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Duke N.C., 1992, TROPICAL MANGROVE EC, V41, P63, DOI [10.1029/ce041p0063, DOI 10.1029/CE041P0063]; Duke NC, 1998, GLOBAL ECOL BIOGEOGR, V7, P27, DOI 10.2307/2997695; Duke NC, 2006, AUSTR MANGROVES AUTH; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellison AM, 2008, J SEA RES, V59, P2, DOI 10.1016/j.seares.2007.05.003; Ellison J, 2005, PALAEOGEOGR PALAEOCL, V220, P291, DOI 10.1016/j.palaeo.2005.01.008; EONG OJ, 1993, CHEMOSPHERE, V27, P1097, DOI 10.1016/0045-6535(93)90070-L; Ewel KC, 1998, GLOBAL ECOL BIOGEOGR, V7, P83, DOI 10.2307/2997700; Faith DP, 2010, CURR OPIN ENV SUST, V2, P66, DOI 10.1016/j.cosust.2010.04.002; FAO, 2007, 153 FAO FOR RES DIV; Field CB, 1998, GLOBAL ECOL BIOGEOGR, V7, P3, DOI 10.2307/2997693; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Fordham DA, 2012, GLOBAL CHANGE BIOL, V18, P1357, DOI 10.1111/j.1365-2486.2011.02614.x; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Garcia N, 2010, STATUS DISTRIBUTION, pxiii; Goulder L. H., 1997, Nature's services: societal dependence on natural ecosystems., P23; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Hauff Robert D., 2006, Wetlands Ecology and Management, V14, P95, DOI 10.1007/s11273-005-2567-y; Helmus MR, 2007, ECOL LETT, V10, P917, DOI 10.1111/j.1461-0248.2007.01083.x; Huang S, 2012, BIOL LETTERS, V8, P222, DOI 10.1098/rsbl.2011.0752; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; IUCN, 2012, IUCN RED LIST THREAT; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kissling WD, 2012, P NATL ACAD SCI USA, V109, P7379, DOI 10.1073/pnas.1120467109; Lee TM, 2011, P ROY SOC B-BIOL SCI, V278, P1329, DOI 10.1098/rspb.2010.1877; Liu X, 2005, ORYX, V39, P335, DOI 10.1017/S0030605305000712; Luther DA, 2009, BIOSCIENCE, V59, P602, DOI 10.1525/bio.2009.59.7.11; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; May Robert M., 1995, P1; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; Michie M, 1993, 5 CHANN ISL FIELD ST; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Miththapala S, 2008, COASTAL ECOSYSTEMS S, V2, P28; Mooers AO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003700; Ndenecho EN, 2007, INT J SUST DEV WORLD, V14, P618, DOI 10.1080/13504500709469759; Nee S, 1997, SCIENCE, V278, P692, DOI 10.1126/science.278.5338.692; NYLANDER JAA, 2004, MODELTEST V2; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Paphavasit N, 1993, EC ENV VALUE MANGROV; Parhar RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023528; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; Queen WH, 1974, ECOLOGY HALOPHYTES, P31; Rasolofo M.V., 1997, MANGROVE SALT MARSHE, V1, P243, DOI DOI 10.1023/A:1009923022474; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; Schwartz MW, 2001, ECOL LETT, V4, P464, DOI 10.1046/j.1461-0248.2001.00241.x; Short FT, 2011, BIOL CONSERV, V144, P1961, DOI 10.1016/j.biocon.2011.04.010; Siddiqi NA, 1994, P 7 PAC SCI INT C MA; Sodhi NS, 2008, DIVERS DISTRIB, V14, P1, DOI 10.1111/j.1472-4642.2007.00398.x; Sullivan C, 2005, IMPORTANCE MANGROVES; Tomlinson PB, 2016, BOTANY OF MANGROVES, 2ND EDITION, P315; Valiente-Banuet A, 2007, ECOL LETT, V10, P1029, DOI 10.1111/j.1461-0248.2007.01100.x; Vamosi JC, 2008, ECOL LETT, V11, P1047, DOI 10.1111/j.1461-0248.2008.01215.x; Vamosi JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003886; Walters BB, 2003, ENVIRON CONSERV, V30, P293, DOI 10.1017/S0376892903000298; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wilkie ML, 2003, 63 FAO FOR RES DIV F; WILSON EO, 1961, AM NAT, V95, P169, DOI 10.1086/282174; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yessoufou K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047082	85	38	38	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66686	10.1371/journal.pone.0066686	http://dx.doi.org/10.1371/journal.pone.0066686			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805263	Green Published, gold			2022-12-25	WOS:000320846500091
J	Fernandez, V; Abdala, F; Carlson, KJ; Cook, DC; Rubidge, BS; Yates, A; Tafforeau, P				Fernandez, Vincent; Abdala, Fernando; Carlson, Kristian J.; Cook, Della Collins; Rubidge, Bruce S.; Yates, Adam; Tafforeau, Paul			Synchrotron Reveals Early Triassic Odd Couple: Injured Amphibian and Aestivating Therapsid Share Burrow	PLOS ONE			English	Article							KAROO BASIN; POSTCRANIAL SKELETON; VERTEBRATE TAPHONOMY; EARLIEST EVIDENCE; BEAUFORT GROUP; HIBERNATION; SURVIVAL	Fossorialism is a beneficial adaptation for brooding, predator avoidance and protection from extreme climate. The abundance of fossilised burrow casts from the Early Triassic of southern Africa is viewed as a behavioural response by many tetrapods to the harsh conditions following the Permo-Triassic mass-extinction event. However, scarcity of vertebrate remains associated with these burrows leaves many ecological questions unanswered. Synchrotron scanning of a lithified burrow cast from the Early Triassic of the Karoo unveiled a unique mixed-species association: an injured temnospondyl amphibian (Broomistega) that sheltered in a burrow occupied by an aestivating therapsid (Thrinaxodon). The discovery of this rare rhinesuchid represents the first occurrence in the fossil record of a temnospondyl in a burrow. The amphibian skeleton shows signs of a crushing trauma with partially healed fractures on several consecutive ribs. The presence of a relatively large intruder in what is interpreted to be a Thrinaxodon burrow implies that the therapsid tolerated the amphibian's presence. Among possible explanations for such unlikely cohabitation, Thrinaxodon aestivation is most plausible, an interpretation supported by the numerous Thrinaxodon specimens fossilised in curled-up postures. Recent advances in synchrotron imaging have enabled visualization of the contents of burrow casts, thus providing a novel tool to elucidate not only anatomy but also ecology and biology of ancient tetrapods.	[Fernandez, Vincent; Abdala, Fernando; Carlson, Kristian J.; Rubidge, Bruce S.; Yates, Adam] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, Gauteng, South Africa; [Carlson, Kristian J.; Cook, Della Collins] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA; [Yates, Adam] Museum Cent Australia, Alice Springs, NT, Australia; [Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France	University of Witwatersrand; Indiana University System; Indiana University Bloomington; European Synchrotron Radiation Facility (ESRF)	Fernandez, V (corresponding author), Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, Gauteng, South Africa.	vinfernand@gmail.com	Rubidge, Bruce/AAE-7021-2019; Abdala, Fernando/I-8054-2019	Rubidge, Bruce/0000-0003-2477-1873; Tafforeau, Paul/0000-0002-5962-1683; Fernandez, Vincent/0000-0002-8315-1458	ESRF [EC-847]; University Research Committee (URC) of Wits; Palaeontological Scientific Trust (PAST); National Research Foundation (NRF); Department of Science and Technology (DST); Intel South Africa; Running Computers	ESRF; University Research Committee (URC) of Wits; Palaeontological Scientific Trust (PAST); National Research Foundation (NRF); Department of Science and Technology (DST)(Department of Science & Technology (India)); Intel South Africa; Running Computers	This work was supported by the ESRF (proposal EC-847), the University Research Committee (URC) of Wits, and the Palaeontological Scientific Trust (PAST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the National Research Foundation (NRF), Department of Science and Technology (DST), Intel South Africa and Running Computers for supporting the Virtual Image Processing Laboratory (VIP Lab) at the University of the Witwatersrand (Wits: Johannesburg, South Africa). We acknowledge the assistance of Michael Day for proofreading various drafts of the manuscript. This article benefited greatly from thoughtful comments and important scientific insights from reviewers Ann Warren and Roger Smith and the editor.	Abdala F, 2006, PALAIOS, V21, P507, DOI 10.2110/palo.2005.P06-001R; Bordy EM, 2011, LETHAIA, V44, P33, DOI 10.1111/j.1502-3931.2010.00223.x; BRINK A. S., 1958, PALAEONTOL AFRICANA, V6, P15; Carlson KJ, 2011, SCIENCE, V333, P1402, DOI 10.1126/science.1203922; Chinsamy-Turan A., 2011, FORERUNNERS MAMMALS; Damiani R, 2003, P ROY SOC B-BIOL SCI, V270, P1747, DOI 10.1098/rspb.2003.2427; deBraga M, 2003, CAN J EARTH SCI, V40, P527, DOI 10.1139/E02-082; Faux CM, 2007, PALEOBIOLOGY, V33, P201, DOI 10.1666/06015.1; Fiorillo AR, 2000, PALAIOS, V15, P373, DOI 10.2307/3515510; Gastaldo RA, 2008, PALAEONTOLOGY, V51, P215, DOI 10.1111/j.1475-4983.2007.00743.x; Geiser F, 1998, CLIN EXP PHARMACOL P, V25, P736, DOI 10.1111/j.1440-1681.1998.tb02287.x; Geiser F, 2009, NATURWISSENSCHAFTEN, V96, P1235, DOI 10.1007/s00114-009-0583-0; Groenewald G, 1991, BURROW CASTS LYSTROS, P34; Groenewald GH, 2001, PALAIOS, V16, P148, DOI 10.2307/3515526; KEMP TS, 2005, ORIGIN EVOLUTION MAM; Kinlaw A, 1999, J ARID ENVIRON, V41, P127, DOI 10.1006/jare.1998.0476; Klevezal G.A., 1967, AGE DETERMINATION MA; Kowalczyk R, 2008, CAN J ZOOL, V86, P1389, DOI 10.1139/Z08-127; Modesto SP, 2010, PALAIOS, V25, P274, DOI 10.2110/palo.2009.p09-077r; Morrison C, 2004, HERPETOLOGICA, V60, P34, DOI 10.1655/02-68; MYERS TP, 1980, AM ANTIQUITY, V45, P483, DOI 10.2307/279863; Navas CA., 2010, AESTIVATION MOL PHYS, DOI [10.1007/978-3-642-02421-4, DOI 10.1007/978-3-642-02421-4]; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; Pawley Kat, 2004, Palaeontologia Africana, V40, P1; Reichman O.J., 1990, Current Mammalogy, V2, P197; Roznik EA, 2009, J HERPETOL, V43, P431, DOI 10.1670/08-159R.1; Shipman P., 1981, LIFE HIST FOSSIL INT; Shishkin MA, 2000, PALAEONTOLOGY, V43, P653, DOI 10.1111/1475-4983.00144; Smith R, 2005, CR PALEVOL, V4, P623, DOI 10.1016/j.crpv.2005.07.005; Smith RMH, 2002, PALAIOS, V17, P249, DOI 10.1669/0883-1351(2002)017<0249:CFEAVT>2.0.CO;2; SMITH RMH, 1987, PALAEOGEOGR PALAEOCL, V60, P155, DOI 10.1016/0031-0182(87)90030-7; SMITH RMH, 1993, PALAIOS, V8, P45, DOI 10.2307/3515221; Smith R, 2009, J VERTEBR PALEONTOL, V29, p183A; Steyer JS, 2004, PALAEOGEOGR PALAEOCL, V206, P193, DOI 10.1016/j.palaeo.2004.01.003; Vander Wall SB., 1990, FOOD HOARDING ANIMAL; VAUGHAN TERRY A., 1961, JOUR MAMMAL, V42, P171, DOI 10.2307/1376826; Voorhies M.R., 1975, STUDY TRACE FOSSILS, P325; WARREN A, 1991, ALCHERINGA, V15, P43, DOI 10.1080/03115519108619009; Waterman JM, 2007, BEHAV ECOL SOCIOBIOL, V61, P1675, DOI 10.1007/s00265-007-0398-y; Yates AM, 1999, J VERTEBR PALEONTOL, V19, P302, DOI 10.1080/02724634.1999.10011143; Zeigler Kate E., 2005, New Mexico Geological Society Field Conference Guidebook, V56, P297; Zervanos SM, 2009, J COMP PHYSIOL B, V179, P411, DOI 10.1007/s00360-008-0327-z	42	57	58	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e64978	10.1371/journal.pone.0064978	http://dx.doi.org/10.1371/journal.pone.0064978			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805181	Green Submitted, Green Published, gold			2022-12-25	WOS:000320846500009
J	Gui, J; Moore, JH; Williams, SM; Andrews, P; Hillege, HL; van der Harst, P; Navis, G; Van Gilst, WH; Asselbergs, FW; Gilbert-Diamond, D				Gui, Jiang; Moore, Jason H.; Williams, Scott M.; Andrews, Peter; Hillege, Hans L.; van der Harst, Pim; Navis, Gerjan; Van Gilst, Wiek H.; Asselbergs, Folkert W.; Gilbert-Diamond, Diane			A Simple and Computationally Efficient Approach to Multifactor Dimensionality Reduction Analysis of Gene-Gene Interactions for Quantitative Traits	PLOS ONE			English	Article							PENALIZED LOGISTIC-REGRESSION; PLASMA T-PA; RENIN-ANGIOTENSIN; EPISTASIS; SUSCEPTIBILITY; POLYMORPHISMS; POPULATION; BRADYKININ; DISEASE; SYSTEMS	We present an extension of the two-class multifactor dimensionality reduction (MDR) algorithm that enables detection and characterization of epistatic SNP-SNP interactions in the context of a quantitative trait. The proposed Quantitative MDR (QMDR) method handles continuous data by modifying MDR's constructive induction algorithm to use a T-test. QMDR replaces the balanced accuracy metric with a T-test statistic as the score to determine the best interaction model. We used a simulation to identify the empirical distribution of QMDR's testing score. We then applied QMDR to genetic data from the ongoing prospective Prevention of Renal and Vascular End-Stage Disease (PREVEND) study.	[Gui, Jiang; Moore, Jason H.; Williams, Scott M.; Andrews, Peter; Gilbert-Diamond, Diane] Geisel Sch Med, Inst Quantitat Biomed Sci, Lebanon, NH USA; [Gui, Jiang; Moore, Jason H.; Gilbert-Diamond, Diane] Geisel Sch Med, Dept Community Med, Sect Biostat & Epidemiol, Lebanon, NH USA; [Gui, Jiang; Moore, Jason H.; Gilbert-Diamond, Diane] Geisel Sch Med, Dept Family Med, Lebanon, NH USA; [Moore, Jason H.; Williams, Scott M.] Geisel Sch Med, Dept Genet, Lebanon, NH USA; [Hillege, Hans L.; van der Harst, Pim; Van Gilst, Wiek H.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9713 AV Groningen, Netherlands; [Navis, Gerjan] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, NL-9713 AV Groningen, Netherlands; [Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Dept Cardiol, Div Heart & Lungs, Utrecht, Netherlands	Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College; University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center	Moore, JH (corresponding author), Geisel Sch Med, Inst Quantitat Biomed Sci, Lebanon, NH USA.	jason.h.moore@dartmouth.edu	van Gilst, Wiek/R-1806-2019; Williams, Scott/Q-4812-2019; Asselbergs, Folkert W./ABD-6752-2021; Moore, Jason H./AAV-9645-2021	van Gilst, Wiek/0000-0003-2968-8585; Williams, Scott/0000-0002-4835-9544; Asselbergs, Folkert W./0000-0002-1692-8669; Moore, Jason H./0000-0002-5015-1099	National Center for Research Resources of the National Institutes of Health [P20 RR024475]; National Institute of General Medical Sciences of the National Institutes of Health [P20 GM103534, LM010098, AI59694]; National Library of Medicine of the National Institutes of Health [LM010098, R01 LM009012]; National Institute for Allergy and Infectious Diseases of the National Institutes of Health [R01 AI59693]; Netherlands Organization for Health Research and Development [ZonMw 90700342]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103534] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009012, R01LM010098] Funding Source: NIH RePORTER	National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Library of Medicine of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institute for Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This project was supported by grants from the National Center for Research Resources (P20 RR024475), the National Institute of General Medical Sciences (P20 GM103534, LM010098 and AI59694), The National Library of Medicine (R01 LM009012 and LM010098) and the National Institute for Allergy and Infectious Diseases (R01 AI59693) of the National Institutes of Health. Folkert W. Asselbergs is supported by a clinical fellowship from the Netherlands Organization for Health Research and Development (ZonMw 90700342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselbergs FW, 2007, GENOMICS, V89, P362, DOI 10.1016/j.ygeno.2006.11.004; Asselbergs FW, 2006, THROMB HAEMOSTASIS, V96, P471, DOI 10.1160/TH06-06-0335; Calle M.L., 2008, MB MDR MODEL BASED M; Chung YJ, 2007, BIOINFORMATICS, V23, P71, DOI 10.1093/bioinformatics/btl557; Culverhouse R, 2004, GENET EPIDEMIOL, V27, P141, DOI 10.1002/gepi.20006; Freund Y., 1995, DESICION THEORETIC G, P23, DOI DOI 10.1007/3-540-59119-2_166; Gui JA, 2011, HUM GENET, V129, P101, DOI 10.1007/s00439-010-0905-5; Gui J, 2011, ANN HUM GENET, V75, P20, DOI 10.1111/j.1469-1809.2010.00624.x; Gui JA, 2010, HUM HERED, V70, P219, DOI 10.1159/000319175; Hahn Lance W, 2004, In Silico Biol, V4, P183; He H, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-127; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Huang J, 2004, P NATL ACAD SCI USA, V101, P10529, DOI 10.1073/pnas.0403794101; Li M, 2011, GENET EPIDEMIOL, V35, P457, DOI 10.1002/gepi.20594; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Manolio TA, 2009, NAT GENET, V41, P5, DOI 10.1038/ng0109-5; Margaglione M, 1998, ARTERIOSCL THROM VAS, V18, P562, DOI 10.1161/01.ATV.18.4.562; MICHALSKI RS, 1983, ARTIF INTELL, V20, P111, DOI 10.1016/0004-3702(83)90016-4; Moore J. H., 2007, KNOWLEDGE DISCOVERY, P17; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Moore JH, 2009, AM J HUM GENET, V85, P309, DOI 10.1016/j.ajhg.2009.08.006; Moore JH, 2004, EXPERT REV MOL DIAGN, V4, P795, DOI 10.1586/14737159.4.6.795; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; Park MY, 2008, BIOSTATISTICS, V9, P30, DOI 10.1093/biostatistics/kxm010; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Velez DR, 2007, GENET EPIDEMIOL, V31, P306, DOI 10.1002/gepi.20211	28	68	74	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66545	10.1371/journal.pone.0066545	http://dx.doi.org/10.1371/journal.pone.0066545			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805232	Green Submitted, Green Published, gold			2022-12-25	WOS:000320846500060
J	O'Mahony, AM; Ogier, J; Darcy, R; Cryan, JF; O'Driscoll, CM				O'Mahony, Aoife M.; Ogier, Julien; Darcy, Raphael; Cryan, John F.; O'Driscoll, Caitriona M.			Cationic and PEGylated Amphiphilic Cyclodextrins: Co-Formulation Opportunities for Neuronal Sirna Delivery	PLOS ONE			English	Article							SMALL INTERFERING RNA; GENE DELIVERY; INTRACELLULAR TRAFFICKING; TRANSFECTION; COMPLEXES; NANOPARTICLES; DNA; CONJUGATE; BARRIERS; VECTORS	Optimising non-viral vectors for neuronal siRNA delivery presents a significant challenge. Here, we investigate a co-formulation, consisting of two amphiphilic cyclodextrins (CDs), one cationic and the other PEGylated, which were blended together for siRNA delivery to a neuronal cell culture model. Co-formulated CD-siRNA complexes were characterised in terms of size, charge and morphology. Stability in salt and serum was also examined. Uptake was determined by flow cytometry and toxicity was measured by MTT assay. Knockdown of a luciferase reporter gene was used as a measure of gene silencing efficiency. Incorporation of a PEGylated CD in the formulation had significant effects on the physical and biological properties of CD. siRNA complexes. Co-formulated complexes exhibited a lower surface charge and greater stability in a high salt environment. However, the inclusion of the PEGylated CD also dramatically reduced gene silencing efficiency due to its effects on neuronal uptake. The co-formulation strategy for cationic and PEGylated CDs improved the stability of the CD. siRNA delivery systems, although knockdown efficiency was impaired. Future work will focus on the addition of targeting ligands to the co-formulated complexes to restore transfection capabilities.	[O'Mahony, Aoife M.; O'Driscoll, Caitriona M.] Univ Coll Cork, Sch Pharm, Pharmacodelivery Grp, Cork, Ireland; [Ogier, Julien; Darcy, Raphael] Univ Coll Dublin, Sch Chem & Chem Biol, Dublin 2, Ireland; [Cryan, John F.] Univ Coll Cork, Dept Anat & Neurosci, Cork, Ireland	University College Cork; University College Dublin; University College Cork	O'Driscoll, CM (corresponding author), Univ Coll Cork, Sch Pharm, Pharmacodelivery Grp, Cork, Ireland.	caitriona.odriscoll@ucc.ie	Cryan, John F./A-6950-2013	Cryan, John F./0000-0001-5887-2723; OGIER, Julien/0000-0002-2093-1617; O'Driscoll, Caitriona/0000-0002-6915-6201	Science Foundation Ireland [07/SRC/B1154]; Irish Drug Delivery Network; Irish Research Council of Science, Engineering and Technology	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Drug Delivery Network(Science Foundation Ireland); Irish Research Council of Science, Engineering and Technology(Irish Research Council for Science, Engineering and Technology)	This work was supported by Science Foundation Ireland (Grant no. 07/SRC/B1154), the Irish Drug Delivery Network and by a scholarship to AO'M from the Irish Research Council of Science, Engineering and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett DW, 2007, BIOCONJUGATE CHEM, V18, P456, DOI 10.1021/bc0603539; Belsham DD, 2004, ENDOCRINOLOGY, V145, P393, DOI 10.1210/en.2003-0946; Bergen JM, 2008, PHARM RES-DORDR, V25, P983, DOI 10.1007/s11095-007-9439-5; Bergen JM, 2008, J GENE MED, V10, P187, DOI 10.1002/jgm.1137; Beyerle A, 2010, TOXICOL APPL PHARM, V242, P146, DOI 10.1016/j.taap.2009.10.001; Bumcrot D, 2006, NAT CHEM BIOL, V2, P711, DOI 10.1038/nchembio839; Cardoso ALC, 2010, J CONTROL RELEASE, V142, P392, DOI 10.1016/j.jconrel.2009.11.004; Cheng TL, 1999, BIOCONJUGATE CHEM, V10, P520, DOI 10.1021/bc980143z; Cryan SA, 2004, J DRUG DELIV SCI TEC, V14, P57, DOI 10.1016/S1773-2247(04)50006-0; Cryan SA, 2004, EUR J PHARM SCI, V21, P625, DOI 10.1016/j.ejps.2004.01.001; Davidson TJ, 2004, J NEUROSCI, V24, P10040, DOI 10.1523/JNEUROSCI.3643-04.2004; Davis ME, 2009, MOL PHARMACEUT, V6, P659, DOI 10.1021/mp900015y; Desigaux L, 2007, P NATL ACAD SCI USA, V104, P16534, DOI 10.1073/pnas.0707431104; Diaz-Moscoso A, 2011, BIOMATERIALS, V32, P7263, DOI 10.1016/j.biomaterials.2011.06.025; Donohue R, 2002, CHEM COMMUN, P2864, DOI 10.1039/b207238f; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Godinho BMDC, 2013, MOL PHARMACEUT, V10, P640, DOI 10.1021/mp3003946; Guo JF, 2012, BIOMATERIALS, V33, P7775, DOI 10.1016/j.biomaterials.2012.07.012; Guo JF, 2012, EUR J PHARM SCI, V45, P521, DOI 10.1016/j.ejps.2011.11.024; Guo JF, 2010, MOL BIOSYST, V6, P1143, DOI 10.1039/c001050m; Hong KL, 1997, FEBS LETT, V400, P233, DOI 10.1016/S0014-5793(96)01397-X; Jung S, 2010, J CONTROL RELEASE, V144, P306, DOI 10.1016/j.jconrel.2010.03.002; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kong WH, 2009, J CONTROL RELEASE, V138, P141, DOI 10.1016/j.jconrel.2009.04.034; Kostarelos K, 2005, CHEM SOC REV, V34, P970, DOI 10.1039/b307062j; Krichevsky AM, 2002, P NATL ACAD SCI USA, V99, P11926, DOI 10.1073/pnas.182272699; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Lee SH, 2007, BIOCHEM BIOPH RES CO, V357, P511, DOI 10.1016/j.bbrc.2007.03.185; Lingor P, 2004, BIOCHEM BIOPH RES CO, V315, P1126, DOI 10.1016/j.bbrc.2004.01.170; McMahon A, 2008, J DRUG DELIV SCI TEC, V18, P303, DOI 10.1016/S1773-2247(08)50060-8; McMahon A, 2012, J PHARM PHARMACOL, V64, P1063, DOI 10.1111/j.2042-7158.2012.01497.x; Mendez-Ardoy A, 2011, NANOMEDICINE-UK, V6, P1697, DOI [10.2217/nnm.11.59, 10.2217/NNM.11.59]; Mendonca LS, 2010, BIOCONJUGATE CHEM, V21, P157, DOI 10.1021/bc9004365; Mishra S, 2004, EUR J CELL BIOL, V83, P97, DOI 10.1078/0171-9335-00363; Morille M, 2011, BIOMATERIALS, V32, P2327, DOI 10.1016/j.biomaterials.2010.11.063; O'Mahony AM, 2012, EUR J PHARM SCI, V47, P896, DOI 10.1016/j.ejps.2012.08.020; O'Mahony AM, 2012, ACS CHEM NEUROSCI, V3, P744, DOI 10.1021/cn3000372; O'Mahony AM, 2013, PHARM NANOTECHNOL, V1, P6, DOI DOI 10.2174/2211738511301010006; O'Mahony AM, 2013, PHARM RES-DORDR, V30, P1086, DOI 10.1007/s11095-012-0945-8; O'Mahony AM, 2012, ORG BIOMOL CHEM, V10, P4954, DOI 10.1039/c2ob25490e; O' Neill MJ, 2011, INT J PHARMACEUT, V413, P174, DOI 10.1016/j.ijpharm.2011.04.021; Ohki EC, 2001, J NEUROSCI METH, V112, P95, DOI 10.1016/S0165-0270(01)00441-1; Mellet CO, 2011, CHEM SOC REV, V40, P1586, DOI 10.1039/c0cs00019a; Perez-Martinez FC, 2011, PHARM RES-DORDR, V28, P1843, DOI 10.1007/s11095-010-0364-7; Ping Y, 2011, BIOMATERIALS, V32, P8328, DOI 10.1016/j.biomaterials.2011.07.038; Pun SH, 2002, BIOCONJUGATE CHEM, V13, P630, DOI 10.1021/bc0155768; Rettig GR, 2012, MOL THER, V20, P483, DOI 10.1038/mt.2011.263; Schafer J, 2010, BIOMATERIALS, V31, P6892, DOI 10.1016/j.biomaterials.2010.05.043; Tsutsumi T, 2008, J PHARM SCI-US, V97, P3022, DOI 10.1002/jps.21206; Vader P, 2012, PHARM RES-DORDR, V29, P352, DOI 10.1007/s11095-011-0545-z	50	30	32	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66413	10.1371/journal.pone.0066413	http://dx.doi.org/10.1371/journal.pone.0066413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805220	Green Published, gold, Green Submitted			2022-12-25	WOS:000320846500048
J	Shinya, R; Morisaka, H; Kikuchi, T; Takeuchi, Y; Ueda, M; Futai, K				Shinya, Ryoji; Morisaka, Hironobu; Kikuchi, Taisei; Takeuchi, Yuko; Ueda, Mitsuyoshi; Futai, Kazuyoshi			Secretome Analysis of the Pine Wood Nematode Bursaphelenchus xylophilus Reveals the Tangled Roots of Parasitism and Its Potential for Molecular Mimicry	PLOS ONE			English	Article							THAUMATIN-LIKE; ESOPHAGEAL-GLAND; ANCYLOSTOMA-CANINUM; CYSTEINE PROTEASES; WILT DISEASE; 1ST REPORT; PROTEINS; IDENTIFICATION; EXPRESSION; EVOLUTION	Since it was first introduced into Asia from North America in the early 20th century, the pine wood nematode Bursaphelenchus xylophilus has caused the devastating forest disease called pine wilt. The emerging pathogen spread to parts of Europe and has since been found as the causal agent of pine wilt disease in Portugal and Spain. In 2011, the entire genome sequence of B. xylophilus was determined, and it allowed us to perform a more detailed analysis of B. xylophilus parasitism. Here, we identified 1,515 proteins secreted by B. xylophilus using a highly sensitive proteomics method combined with the available genomic sequence. The catalogue of secreted proteins contained proteins involved in nutrient uptake, migration, and evasion from host defenses. A comparative functional analysis of the secretome profiles among parasitic nematodes revealed a marked expansion of secreted peptidases and peptidase inhibitors in B. xylophilus via gene duplication and horizontal gene transfer from fungi and bacteria. Furthermore, we showed that B. xylophilus secreted the potential host mimicry proteins that closely resemble the host pine's proteins. These proteins could have been acquired by host-parasite co-evolution and might mimic the host defense systems in susceptible pine trees during infection. This study contributes to an understanding of their unique parasitism and its tangled roots, and provides new perspectives on the evolution of plant parasitism among nematodes.	[Shinya, Ryoji; Morisaka, Hironobu; Takeuchi, Yuko; Ueda, Mitsuyoshi; Futai, Kazuyoshi] Kyoto Univ, Grad Sch Agr, Kyoto, Japan; [Shinya, Ryoji] Chubu Univ, Coll Biosci & Biotechnol, Kasugai, Aichi 487, Japan; [Kikuchi, Taisei] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 305, Japan	Kyoto University; Chubu University; Forestry & Forest Products Research Institute - Japan	Shinya, R (corresponding author), Kyoto Univ, Grad Sch Agr, Kyoto, Japan.	shinya@caltech.edu		Shinya, Ryoji/0000-0002-2450-3054; Kikuchi, Taisei/0000-0003-2759-9167	JSPS Research Fellowship for Young Scientists;  [KAKENHI 23248024];  [21780147]; Grants-in-Aid for Scientific Research [25660121] Funding Source: KAKEN	JSPS Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI 23248024 and 21780147) (http://www.jsps.go.jp/). Ryoji Shinya was supported by JSPS Research Fellowship for Young Scientists (http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelleira A, 2011, PLANT DIS, V95, P776, DOI 10.1094/PDIS-12-10-0902; Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; [Anonymous], 2004, CURR OPIN PLANT BIOL, V7, P1; [Anonymous], PINE WILT DIS; [Anonymous], 2008, PINE WILT DISEASE; Arai S, 2002, J AGR FOOD CHEM, V50, P6612, DOI 10.1021/jf0201935; Aro N, 2005, FEMS MICROBIOL REV, V29, P719, DOI 10.1016/j.femsre.2004.11.006; Baermann G., 1917, Geneeskundig Tijdschrift voor Nederlandsch-Indie Batavia, V57; Batalia MA, 1996, NAT STRUCT BIOL, V3, P19, DOI 10.1038/nsb0196-19; Belenghi B, 2003, EUR J BIOCHEM, V270, P2593, DOI 10.1046/j.1432-1033.2003.03630.x; Bellafiore S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000192; Bennuru S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000410; BIRD AF, 1968, J PARASITOL, V54, P879, DOI 10.2307/3277114; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Brandazza A, 2004, FEBS LETT, V572, P3, DOI 10.1016/j.febslet.2004.07.003; Brinkworth RI, 2001, J BIOL CHEM, V276, P38844, DOI 10.1074/jbc.M101934200; Curtis Rosane H. C., 2007, Briefings in Functional Genomics & Proteomics, V6, P50, DOI 10.1093/bfgp/elm006; Davis EL, 2000, ANNU REV PHYTOPATHOL, V38, P365, DOI 10.1146/annurev.phyto.38.1.365; Davis EL, 2008, CURR OPIN PLANT BIOL, V11, P360, DOI 10.1016/j.pbi.2008.04.003; Dwinell LD, 1997, ANNU REV PHYTOPATHOL, V35, P153, DOI 10.1146/annurev.phyto.35.1.153; El-Kereamy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017973; Falcone FH, 2001, J IMMUNOL, V167, P5348, DOI 10.4049/jimmunol.167.9.5348; Fierens E, 2007, BIOCHEM J, V403, P583, DOI 10.1042/BJ20061291; Gao B, 2001, INT J PARASITOL, V31, P1617, DOI 10.1016/S0020-7519(01)00300-9; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grenier J, 2000, MYCOLOGIA, V92, P841, DOI 10.2307/3761579; Grenier J, 1999, PLANT J, V19, P473, DOI 10.1046/j.1365-313X.1999.00551.x; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Guo YF, 2011, PLANT PHYSIOL, V157, P476, DOI 10.1104/pp.111.180554; Han H, 2008, PLANT DIS, V92, P1251, DOI 10.1094/PDIS-92-8-1251A; HAWDON JM, 1995, EXP PARASITOL, V80, P205, DOI 10.1006/expr.1995.1025; Hirao T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-13; Huang GZ, 2006, MOL PLANT MICROBE IN, V19, P463, DOI 10.1094/MPMI-19-0463; Huang GZ, 2003, MOL PLANT MICROBE IN, V16, P376, DOI 10.1094/MPMI.2003.16.5.376; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Hussey Richard S., 2002, Braz. J. Plant Physiol., V14, P183, DOI 10.1590/S1677-04202002000300002; HUSSEY RS, 1989, J NEMATOL, V21, P392; Iwahori H., 1993, JPN J NEMATOL, V23, P79, DOI [10.3725/jjn1993.23.2_79, DOI 10.3725/JJN1993.23.2_79]; Jasmer DP, 2004, MOL BIOCHEM PARASIT, V137, P297, DOI 10.1016/j.molbiopara.2004.06.010; Jaubert S, 2002, MOL BIOCHEM PARASIT, V121, P205, DOI 10.1016/S0166-6851(02)00034-8; Kikuchi T, 2006, MOL PLANT MICROBE IN, V19, P280, DOI 10.1094/MPMI-19-0280; Kikuchi T, 2005, BIOCHEM J, V389, P117, DOI 10.1042/BJ20042042; Kikuchi T, 2004, FEBS LETT, V572, P201, DOI 10.1016/j.febslet.2004.07.039; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kikuchi T, 2009, NEMATOLOGY, V11, P355, DOI 10.1163/156854109X446953; Kitajima S, 1999, J BIOCHEM, V125, P1, DOI 10.1093/oxfordjournals.jbchem.a022244; Kiyohara T., 1971, Journal of the Japanese Forestry Society, V53, P210; KOBAYASHI F, 1984, ANNU REV ENTOMOL, V29, P115, DOI 10.1146/annurev.en.29.010184.000555; Komatsu M, 2006, TREE FOR HLTH, V10, P25; Kuroda M, 2001, BIOSCI BIOTECH BIOCH, V65, P22, DOI 10.1271/bbb.65.22; Lambert KN, 1999, MOL PLANT MICROBE IN, V12, P328, DOI 10.1094/MPMI.1999.12.4.328; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lin SF, 2011, EXP PARASITOL, V127, P440, DOI 10.1016/j.exppara.2010.10.013; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Marokhazi J, 2004, APPL ENVIRON MICROB, V70, P7311, DOI 10.1128/AEM.70.12.7311-7320.2004; Martinez M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-198; Mitchum MG, 2012, ANNU REV PHYTOPATHOL, V50, P175, DOI 10.1146/annurev-phyto-081211-173008; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Motokawa M, 2002, J CHROMATOGR A, V961, P53, DOI 10.1016/S0021-9673(02)00133-4; MYERS RF, 1988, J NEMATOL, V20, P236; ODANI K, 1985, Journal of the Japanese Forestry Society, V67, P366; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Pernas M, 1999, MOL PLANT MICROBE IN, V12, P624, DOI 10.1094/MPMI.1999.12.7.624; PIATIGORSKY J, 1991, SCIENCE, V252, P1078, DOI 10.1126/science.252.5009.1078; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Rawlings ND, 2008, BIOCHIMIE, V90, P243, DOI 10.1016/j.biochi.2007.09.014; Robertson L, 1999, PARASITOLOGY, V119, P167, DOI 10.1017/S0031182099004448; Rojo E, 2004, CURR BIOL, V14, P1897, DOI 10.1016/j.cub.2004.09.056; Rosso M.N., 2012, EFFECTORS PLANT MICR, V13, P327; Sakamoto Y, 2006, PLANT PHYSIOL, V141, P793, DOI 10.1104/pp.106.076679; Santamaria ME, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-307; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Shinya R, 2010, PHYTOPATHOLOGY, V100, P1289, DOI 10.1094/PHYTO-04-10-0109; Steiner G, 1934, J AGRIC RES, V48, P0949; Toubarro D, 2010, J BIOL CHEM, V285, P30666, DOI 10.1074/jbc.M110.129346; Toubarro D, 2009, INT J PARASITOL, V39, P1319, DOI 10.1016/j.ijpara.2009.04.013; van Megen H, 2009, NEMATOLOGY, V11, P927, DOI 10.1163/156854109X456862; Vieira P, 2011, J EXP BOT, V62, P1241, DOI 10.1093/jxb/erq352; Wang JY, 2011, MOL PLANT PATHOL, V12, P177, DOI 10.1111/j.1364-3703.2010.00660.x; Williamson AL, 2006, INFECT IMMUN, V74, P961, DOI 10.1128/IAI.74.2.961-967.2006; Yatsuda AP, 2006, INFECT IMMUN, V74, P1989, DOI 10.1128/IAI.74.3.1989-1993.2006; Yi C. K., 1989, Research Reports of the Forestry Research Institute (Seoul), P141; Zhao Y, 1996, PLANT PHYSIOL, V111, P1299, DOI 10.1104/pp.111.4.1299	83	82	86	5	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67377	10.1371/journal.pone.0067377	http://dx.doi.org/10.1371/journal.pone.0067377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805310	Green Published, gold, Green Submitted			2022-12-25	WOS:000320846500138
J	Motozono, C; Miles, JJ; Hasan, Z; Gatanaga, H; Meribe, SC; Price, DA; Oka, S; Sewell, AK; Ueno, T				Motozono, Chihiro; Miles, John J.; Hasan, Zafrul; Gatanaga, Hiroyuki; Meribe, Stanley C.; Price, David A.; Oka, Shinichi; Sewell, Andrew K.; Ueno, Takamasa			CD8(+) T Cell Cross-Reactivity Profiles and HIV-1 Immune Escape towards an HLA-B35-Restricted Immunodominant Nef Epitope	PLOS ONE			English	Article							HUMAN-LEUKOCYTE ANTIGEN; CLASS-I MOLECULES; RECEPTOR; RECOGNITION; CLONOTYPES; REPERTOIRE; RESPONSES; ENGAGEMENT; INFECTION; PEPTIDES	Antigen cross-reactivity is an inbuilt feature of the T cell compartment. However, little is known about the flexibility of T cell recognition in the context of genetically variable pathogens such as HIV-1. In this study, we used a combinatorial library containing 24 billion octamer peptides to characterize the cross-reactivity profiles of CD8(+) T cells specific for the immunodominant HIV-1 subtype B Nef epitope VY8 (VPLRPMTY) presented by HLA-B*35:01. In conjunction, we examined naturally occurring antigenic variations within the VY8 epitope. Sequence analysis of plasma viral RNA isolated from 336 HIV-1-infected individuals revealed variability at position (P) 3 and P8 of VY8; Phe at P8, but not Val at P3, was identified as an HLA-B*35:01-associated polymorphism. VY8-specific T cells generated from several different HIV-1-infected patients showed unique and clonotype-dependent cross-reactivity footprints. Nonetheless, all T cells recognized both the index Leuandmutant Val atP3 equally well. In contrast, competitive titration assays revealed that the Tyr to Phe substitution at P8 reduced T cell recognition by 50-130 fold despite intact peptide binding to HLA-B*35:01. These findings explain the preferential selection of Phe at the C-terminus of VY8 in HLA-B*35:01(+) individuals and demonstrate that HIV-1 can exploit the limitations of T cell recognition in vivo.	[Motozono, Chihiro; Miles, John J.; Price, David A.; Sewell, Andrew K.] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF10 3AX, S Glam, Wales; [Motozono, Chihiro; Hasan, Zafrul; Gatanaga, Hiroyuki; Meribe, Stanley C.; Oka, Shinichi; Ueno, Takamasa] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan; [Miles, John J.] Queensland Inst Med Res, Australian Ctr Vaccine Dev, Human Immun Lab, Brisbane, Qld 4006, Australia; [Miles, John J.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Gatanaga, Hiroyuki; Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan	Cardiff University; Kumamoto University; QIMR Berghofer Medical Research Institute; University of Queensland; National Center for Global Health & Medicine - Japan	Sewell, AK (corresponding author), Cardiff Univ, Sch Med, Inst Infect & Immun, Heath Pk, Cardiff CF10 3AX, S Glam, Wales.	sewellak@cardiff.ac.uk; uenotaka@kumamoto-u.ac.jp	Ueno, Takamasa/AAW-9491-2020; Hasan, Zafrul/G-2984-2015; Ueno, Takamasa/F-5788-2013; Miles, John J/ABC-1105-2020; Sewell, Andrew/GPT-4220-2022; Price, David A/C-7876-2013	Ueno, Takamasa/0000-0003-4852-4236; Ueno, Takamasa/0000-0003-4852-4236; Miles, John J/0000-0001-5506-6304; Sewell, Andrew/0000-0003-3194-3135; Price, David A/0000-0001-9416-2737; Oka, Shinichi/0000-0002-9283-2167	Ministry of Education, Science, Sports, and Culture (MEXT); Ministry of Health, Labor, and Welfare of Japan; Biotechnology and Biological Sciences Research Council [BB/H001085/1]; BBSRC [BB/H001085/1] Funding Source: UKRI; Wellcome Trust [100326/Z/12/Z] Funding Source: researchfish	Ministry of Education, Science, Sports, and Culture (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This research was supported by a grant-in-aid for scientific research and a Global COE Program (Global Education and Research Center Aiming at the Control of AIDS) from the Ministry of Education, Science, Sports, and Culture (MEXT), and by a grant-in-aid for AIDS research from the Ministry of Health, Labor, and Welfare of Japan (to TU). ZH and SCM are supported by scholarships from The International Priority Graduate Programs, MEXT. JJM is a National Health and Medical Research Council (NHMRC) Career Development Fellow. The authors' studies of TCR binding degeneracy were made possible by generous support from the Biotechnology and Biological Sciences Research Council (grant BB/H001085/1 to AKS and DAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Brumme ZL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006687; Bulek AM, 2012, NAT IMMUNOL, V13, P283, DOI 10.1038/ni.2206; Chen HB, 2012, NAT IMMUNOL, V13, P691, DOI 10.1038/ni.2342; Cole DK, 2010, J IMMUNOL, V185, P2600, DOI 10.4049/jimmunol.1000629; De Rosa SC, 2004, J IMMUNOL, V173, P5372, DOI 10.4049/jimmunol.173.9.5372; Dong T, 2004, J EXP MED, V200, P1547, DOI 10.1084/jem.20032044; Douek DC, 2002, J IMMUNOL, V168, P3099, DOI 10.4049/jimmunol.168.6.3099; Ekeruche-Makinde J, 2013, BLOOD, V121, P1112, DOI 10.1182/blood-2012-06-437202; Ekeruche-Makinde J, 2012, J BIOL CHEM, V287, P37269, DOI 10.1074/jbc.M112.386409; Hoof I, 2010, J IMMUNOL, V184, P5383, DOI 10.4049/jimmunol.0903516; Iglesias MC, 2011, BLOOD, V118, P2138, DOI 10.1182/blood-2011-01-328781; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997; Ladell K, 2013, IMMUNITY, V38, P425, DOI 10.1016/j.immuni.2012.11.021; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Meyer-Olson D, 2006, BLOOD, V107, P2373, DOI 10.1182/blood-2005-04-1636; Motozono C, 2009, J IMMUNOL, V182, P5528, DOI 10.4049/jimmunol.0803471; Mwimanzi P, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-50; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Smith KJ, 1996, IMMUNITY, V4, P203, DOI 10.1016/S1074-7613(00)80429-X; Ueno T, 2002, J IMMUNOL, V169, P4961, DOI 10.4049/jimmunol.169.9.4961; Ueno T, 2008, J IMMUNOL, V180, P1107, DOI 10.4049/jimmunol.180.2.1107; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Wooldridge L, 2010, J IMMUNOL, V185, P4625, DOI 10.4049/jimmunol.1001480; Yamada T, 2003, J VIROL, V77, P1589, DOI 10.1128/JVI.77.2.1589-1594.2003	28	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66152	10.1371/journal.pone.0066152	http://dx.doi.org/10.1371/journal.pone.0066152			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799076	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000321397800025
J	de Carvalho, MDC; De Mesquita, JF				Castela de Carvalho, Mariana Dias; De Mesquita, Joelma Freire			Structural Modeling and In Silico Analysis of Human Superoxide Dismutase 2	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; N-ACETYL CYSTEINE; PROTEIN-STRUCTURE; BIPOLAR DISORDER; DOUBLE-BLIND; DISEASE; MUTATIONS; POLYMORPHISMS; ASSOCIATION; SEQUENCE	Aging in the world population has increased every year. Superoxide dismutase 2 (Mn-SOD or SOD2) protects against oxidative stress, a main factor influencing cellular longevity. Polymorphisms in SOD2 have been associated with the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease, as well as psychiatric disorders, such as schizophrenia, depression and bipolar disorder. In this study, all of the described natural variants (S10I, A16V, E66V, G76R, I82T and R156W) of SOD2 were subjected to in silico analysis using eight different algorithms: SNPeffect, PolyPhen-2, PhD-SNP, PMUT, SIFT, SNAP, SNPs&GO and nsSNPAnalyzer. This analysis revealed disparate results for a few of the algorithms. The results showed that, from at least one algorithm, each amino acid substitution appears to harmfully affect the protein. Structural theoretical models were created for variants through comparative modelling performed using the MHOLline server (which includes MODELLER and PROCHECK) and ab initio modelling, using the I-Tasser server. The predicted models were evaluated using TM-align, and the results show that the models were constructed with high accuracy. The RMSD values of the modelled mutants indicated likely pathogenicity for all missense mutations. Structural phylogenetic analysis using ConSurf revealed that human SOD2 is highly conserved. As a result, a human-curated database was generated that enables biologists and clinicians to explore SOD2 nsSNPs, including predictions of their effects and visualisation of the alignment of both the wild-type and mutant structures. The database is freely available at http://bioinfogroup.com/database/ and will be regularly updated.	[Castela de Carvalho, Mariana Dias; De Mesquita, Joelma Freire] Univ Fed Estado Rio de Janeiro, Bioinformat & Computat Biol Grp, Dept Genet & Mol Biol, Rio De Janeiro, Brazil	Universidade Federal do Estado do Rio de Janeiro	De Mesquita, JF (corresponding author), Univ Fed Estado Rio de Janeiro, Bioinformat & Computat Biol Grp, Dept Genet & Mol Biol, Rio De Janeiro, Brazil.	jomesquita@gmail.com	De Mesquita, Joelma/J-4837-2012; De Mesquita, Joelma/W-5553-2019	De Mesquita, Joelma/0000-0003-1684-3830	Federal University of Rio de Janeiro State	Federal University of Rio de Janeiro State	MDCC received a fellowship from the Federal University of Rio de Janeiro State. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akyol O, 2005, PROG NEURO-PSYCHOPH, V29, P123, DOI 10.1016/j.pnpbp.2004.10.014; [Anonymous], CLIN BIOCH; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bao L, 2005, NUCLEIC ACIDS RES, V33, pW480, DOI 10.1093/nar/gki372; Berk M, 2008, BIOL PSYCHIAT, V64, P468, DOI 10.1016/j.biopsych.2008.04.022; Berk M, 2008, BIOL PSYCHIAT, V64, P361, DOI 10.1016/j.biopsych.2008.03.004; Borgstahl GEO, 1996, BIOCHEMISTRY-US, V35, P4287, DOI 10.1021/bi951892w; Bromberg Y, 2008, BIOINFORMATICS, V24, P2397, DOI 10.1093/bioinformatics/btn435; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Capriles PVSZ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-610; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; De Baets G, 2012, NUCLEIC ACIDS RES, V40, pD935, DOI 10.1093/nar/gkr996; Ferrer-Costa C, 2002, J MOL BIOL, V315, P771, DOI 10.1006/jmbi.2001.5255; Fullerton JM, 2010, BIPOLAR DISORD, V12, P550, DOI 10.1111/j.1399-5618.2010.00834.x; Galecki P, 2010, PSYCHIAT RES, V179, P43, DOI 10.1016/j.psychres.2009.06.016; Jimenez-Lopez JC, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-43; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mistri M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039122; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sanchez R, 1997, PROTEINS, P50; ShimodaMatsubayashi S, 1996, BIOCHEM BIOPH RES CO, V226, P561, DOI 10.1006/bbrc.1996.1394; Singh M, 2008, MOL CELL BIOCHEM, V312, P131, DOI 10.1007/s11010-008-9728-2; Wang V, 2010, CLIN BIOCH; Wiener HW, 2007, GENES BRAIN BEHAV, V6, P770, DOI 10.1111/j.1601-183X.2007.00308.x; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	29	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65558	10.1371/journal.pone.0065558	http://dx.doi.org/10.1371/journal.pone.0065558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785434	Green Published, gold			2022-12-25	WOS:000321038800087
J	Christoforou, N; Liau, B; Chakraborty, S; Chellapan, M; Bursac, N; Leong, KW				Christoforou, Nicolas; Liau, Brian; Chakraborty, Syandan; Chellapan, Malathi; Bursac, Nenad; Leong, Kam W.			Induced Pluripotent Stem Cell-Derived Cardiac Progenitors Differentiate to Cardiomyocytes and Form Biosynthetic Tissues	PLOS ONE			English	Article							IN-VITRO; MYOCARDIAL-INFARCTION; SMOOTH-MUSCLE; CARDIOVASCULAR PROGENITORS; ISCHEMIC CARDIOMYOPATHY; MAMMALIAN HEART; PRECURSOR CELLS; DEFINED FACTORS; DRUG DISCOVERY; ES CELLS	The mammalian heart has little capacity to regenerate, and following injury the myocardium is replaced by non-contractile scar tissue. Consequently, increased wall stress and workload on the remaining myocardium leads to chamber dilation, dysfunction, and heart failure. Cell-based therapy with an autologous, epigenetically reprogrammed, and cardiac-committed progenitor cell source could potentially reverse this process by replacing the damaged myocardium with functional tissue. However, it is unclear whether cardiac progenitor cell-derived cardiomyocytes are capable of attaining levels of structural and functional maturity comparable to that of terminally-fated cardiomyocytes. Here, we first describe the derivation of mouse induced pluripotent stem (iPS) cells, which once differentiated allow for the enrichment of Nkx2-5(+) cardiac progenitors, and the cardiomyocyte-specific expression of the red fluorescent protein. We show that the cardiac progenitors are multipotent and capable of differentiating into endothelial cells, smooth muscle cells and cardiomyocytes. Moreover, cardiac progenitor selection corresponds to cKit(+) cell enrichment, while cardiomyocyte cell-lineage commitment is concomitant with dual expression of either cKit/Flk1 or cKit/Sca-1. We proceed to show that the cardiac progenitor-derived cardiomyocytes are capable of forming electrically and mechanically coupled large-scale 2D cell cultures with mature electrophysiological properties. Finally, we examine the cell progenitors' ability to form electromechanically coherent macroscopic tissues, using a physiologically relevant 3D culture model and demonstrate that following long-term culture the cardiomyocytes align, and form robust electromechanical connections throughout the volume of the biosynthetic tissue construct. We conclude that the iPS cell-derived cardiac progenitors are a robust cell source for tissue engineering applications and a 3D culture platform for pharmacological screening and drug development studies.	[Christoforou, Nicolas; Liau, Brian; Chakraborty, Syandan; Chellapan, Malathi; Bursac, Nenad; Leong, Kam W.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA	Duke University	Leong, KW (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	kam.leong@duke.edu	Bursac, Nenad/AAU-5548-2021; Leong, Kam W/A-7270-2009; Leong, Kam/O-9302-2019	Bursac, Nenad/0000-0002-5688-6061; Leong, Kam W/0000-0002-8133-4955; Leong, Kam/0000-0002-8133-4955; Liau, Brian/0000-0002-8233-771X	Flight Attendant Medical Research Institute; NIH [HL104326, HL095069, EB015300]; NIH Common Fund for the Microphysiological Systems Initiative;  [UH2TR000505]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000505] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL095069, R01HL104326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB015300] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Common Fund for the Microphysiological Systems Initiative; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Flight Attendant Medical Research Institute (Young Clinical Scientist Award to N.C.) and NIH (HL104326 and HL095069 to N.B., and EB015300 to K.W.L.). The work was also supported by UH2TR000505 and the NIH Common Fund for the Microphysiological Systems Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai A, 1997, DEV DYNAM, V210, P344, DOI 10.1002/(SICI)1097-0177(199711)210:3<344::AID-AJA13>3.0.CO;2-A; Bian WN, 2009, NAT PROTOC, V4, P1522, DOI 10.1038/nprot.2009.155; Blin G, 2010, J CLIN INVEST, V120, P1125, DOI 10.1172/JCI40120; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Bursac N, 2002, CIRC RES, V91, pE45, DOI 10.1161/01.RES.0000047530.88338.EB; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Christoforou N, 2008, J CLIN INVEST, V118, P894, DOI 10.1172/JCI33942; Christoforou N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011536; Chugh AR, 2012, CIRCULATION, V126, pS54, DOI 10.1161/CIRCULATIONAHA.112.092627; David R, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0312-2; Davis RP, 2011, TRENDS MOL MED, V17, P475, DOI 10.1016/j.molmed.2011.05.001; Domian IJ, 2009, SCIENCE, V326, P426, DOI 10.1126/science.1177350; Fijnvandraat AC, 2003, J MOL CELL CARDIOL, V35, P1461, DOI 10.1016/j.yjmcc.2003.09.011; Gepstein L, 2010, STEM CELLS, V28, P2151, DOI 10.1002/stem.545; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; GULICK J, 1991, J BIOL CHEM, V266, P9180; Hidaka K, 2003, FASEB J, V17, P740, DOI 10.1096/fj.02-0104fje; Hong YK, 2004, FASEB J, V18, P1111, DOI 10.1096/fj.03-1179fje; Hu XY, 2007, EUR J CARDIO-THORAC, V31, P438, DOI 10.1016/j.ejcts.2006.11.057; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kamkin A, 2003, PFLUG ARCH EUR J PHY, V446, P220, DOI 10.1007/s00424-003-1018-y; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343; Kensah G, 2013, EUR HEART J, V34, P1134, DOI 10.1093/eurheartj/ehs349; Kim C, 2010, STEM CELLS DEV, V19, P783, DOI 10.1089/scd.2009.0349; Klinger R, 2008, IEEE ENG MED BIOL, V27, P72, DOI 10.1109/MEMB.2007.913849; Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769; KUBALAK SW, 1994, J BIOL CHEM, V269, P16961; Kuzmenkin A, 2009, FASEB J, V23, P4168, DOI 10.1096/fj.08-128546; Liau B, 2012, REGEN MED, V7, P187, DOI [10.2217/RME.11.122, 10.2217/rme.11.122]; Liau B, 2011, BIOMATERIALS, V32, P9180, DOI 10.1016/j.biomaterials.2011.08.050; Lien CL, 1999, DEVELOPMENT, V126, P75; MAHDAVI V, 1987, CIRC RES, V60, P804, DOI 10.1161/01.RES.60.6.804; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; MALTSEV VA, 1994, CIRC RES, V75, P233, DOI 10.1161/01.RES.75.2.233; MALTSEV VA, 1993, MECH DEVELOP, V44, P41, DOI 10.1016/0925-4773(93)90015-P; Matsuura K, 2009, J CLIN INVEST, V119, P2204, DOI 10.1172/JCI37456; Miake J, 2003, J CLIN INVEST, V111, P1529, DOI 10.1172/JCI200317959; Miller RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002176; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Moretti A, 2010, FASEB J, V24, P700, DOI 10.1096/fj.09-139477; Muller M, 2000, FASEB J, V14, P2540, DOI 10.1096/fj.00-0002com; Pillekamp F, 2005, CELL PHYSIOL BIOCHEM, V16, P127, DOI 10.1159/000087739; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Saga Y, 2000, TRENDS CARDIOVAS MED, V10, P345, DOI 10.1016/S1050-1738(01)00069-X; Schaaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026397; SHEKHONIN BV, 1990, J MOL CELL CARDIOL, V22, P533, DOI 10.1016/0022-2828(90)90955-2; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takamiya M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025265; Terami H, 2007, BIOCHEM BIOPH RES CO, V355, P47, DOI 10.1016/j.bbrc.2007.01.109; Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Xu HS, 2012, CELL RES, V22, P142, DOI 10.1038/cr.2011.171; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zwi-Dantsis L, 2012, CELL MOL LIFE SCI, V69, P3285, DOI 10.1007/s00018-012-1078-2	62	49	51	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65963	10.1371/journal.pone.0065963	http://dx.doi.org/10.1371/journal.pone.0065963			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785459	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800063
J	Liao, Y; He, F; Gong, T; Bi, EF; Gao, XD				Liao, Yuan; He, Fei; Gong, Ting; Bi, Erfei; Gao, Xiang-Dong			Msb1 Interacts with Cdc42, Boi1, and Boi2 and May Coordinate Cdc42 and Rho1 Functions during Early Stage of Bud Development in Budding Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; POLARIZED GROWTH; CELL POLARITY; 1,3-BETA-GLUCAN SYNTHASE; SMALL GTPASES; PROTEIN; IDENTIFICATION; GENES; ROLES; MORPHOGENESIS	Msb1 is not essential for growth in the budding yeast Saccharomyces cerevisiae since msb1 Delta cells do not display obvious phenotypes. Genetic studies suggest that Msb1 positively regulates Cdc42 function during bud development, since high-copy MSB1 suppressed the growth defect of temperature-sensitive cdc24 and cdc42 mutants at restrictive temperature, while deletion of MSB1 showed synthetic lethality with cdc24, bem1, and bem2 mutations. However, the mechanism of how Msb1 regulates Cdc42 function remains poorly understood. Here, we show that Msb1 localizes to sites of polarized growth during bud development and interacts with Cdc42 in the cells. In addition, Msb1 interacts with Boi1 and Boi2, two scaffold proteins that also interact with Cdc42 and Bem1. These findings suggest that Msb1 may positively regulate Cdc42 function by interacting with Cdc42, Boi1, and Boi2, which may promote the efficient assembly of Cdc42, Cdc24, and other proteins into a functional complex. We also show that Msb1 interacts with Rho1 in the cells and Msb1 overproduction inhibits the growth of rho1-104 and rho1-3 but not rho1-2 cells. The growth inhibition appears to result from the down-regulation of Rho1 function in glucan synthesis, specifically during early stage of bud development. These results suggest that Msb1 may coordinate Cdc42 and Rho1 functions during early stage of bud development by promoting Cdc42 function and inhibiting Rho1 function. Msb1 overproduction also affects cell morphology, septin organization, and causes increased, aberrant deposition of 1,3-beta-glucan and chitin at the mother-bud neck. However, the stimulation of glucan synthesis mainly occurs during late, but not early, stage of bud development.	[Liao, Yuan; He, Fei; Gong, Ting; Gao, Xiang-Dong] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China; [Bi, Erfei] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA	Wuhan University; University of Pennsylvania; Pennsylvania Medicine	Gao, XD (corresponding author), Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China.	xdgao@whu.edu.cn		Gao, Xiang-Dong/0000-0002-1008-2324	National Natural Science Foundation of China [30770017, 30871347]; Chinese 111 Project [B06018]; National Institutes of Health [GM59216]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 111 Project(Ministry of Education, China - 111 Project); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Natural Science Foundation of China (grant numbers 30770017 and 30871347) and the Chinese 111 Project (number B06018) to XDG, and by the National Institutes of Health grant (GM59216) to EB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; Bender L, 1996, J CELL BIOL, V133, P879, DOI 10.1083/jcb.133.4.879; Bi EF, 2000, MOL BIOL CELL, V11, P773, DOI 10.1091/mbc.11.2.773; Bi EF, 1996, MOL CELL BIOL, V16, P5264; Bouquin N, 2000, J CELL SCI, V113, P1435; Caviston JP, 2003, MOL BIOL CELL, V14, P4051, DOI 10.1091/mbc.E03-04-0247; Caviston JP, 2002, P NATL ACAD SCI USA, V99, P12185, DOI 10.1073/pnas.182370299; Drgonova J, 1996, SCIENCE, V272, P277, DOI 10.1126/science.272.5259.277; Gandhi M, 2006, GENETICS, V174, P665, DOI 10.1534/genetics.106.058180; Gao XD, 2004, MOL BIOL CELL, V15, P3977, DOI 10.1091/mbc.E04-01-0079; Gao XD, 2003, J CELL BIOL, V162, P635, DOI 10.1083/jcb.200302038; Gao XD, 2007, MOL BIOL CELL, V18, P2542, DOI 10.1091/mbc.e06-09-0822; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gong T, 2013, EUKARYOT CELL, V12, P368, DOI 10.1128/EC.00277-12; Guo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016744; Guo W, 2001, NAT CELL BIOL, V3, P353, DOI 10.1038/35070029; Guthrie C, 1991, METHODS ENZYMOL, V194; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mack D, 1996, MOL CELL BIOL, V16, P4387; Matsui Y, 1996, J CELL BIOL, V133, P865, DOI 10.1083/jcb.133.4.865; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Qadota H, 1996, SCIENCE, V272, P279, DOI 10.1126/science.272.5259.279; Richman TJ, 2002, EUKARYOT CELL, V1, P458, DOI 10.1128/EC.1.3.458-468.2002; Saka A, 2001, J BIOL CHEM, V276, P46165, DOI 10.1074/jbc.M103805200; Sekiya-Kawasaki M, 2002, GENETICS, V162, P663; TYERS M, 1993, EMBO J, V12, P1955, DOI 10.1002/j.1460-2075.1993.tb05845.x; YAMOCHI W, 1994, J CELL BIOL, V125, P1077, DOI 10.1083/jcb.125.5.1077; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200	34	7	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66321	10.1371/journal.pone.0066321	http://dx.doi.org/10.1371/journal.pone.0066321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785492	Green Submitted, Green Published, gold			2022-12-25	WOS:000321038800030
J	Marion, V; Sankaranarayanan, S; de Theije, C; van Dijk, P; Hakvoort, TBM; Lamers, WH; Kohler, ES				Marion, Vincent; Sankaranarayanan, Selvakumari; de Theije, Chiel; van Dijk, Paul; Hakvoort, Theo B. M.; Lamers, Wouter H.; Koehler, Eleonore S.			Hepatic Adaptation Compensates Inactivation of Intestinal Arginine Biosynthesis in Suckling Mice	PLOS ONE			English	Article							LYSINURIC PROTEIN INTOLERANCE; AMINO-ACID-CONCENTRATIONS; NECROTIZING ENTEROCOLITIS; NEONATAL PIGLETS; TRANSGENIC MICE; METABOLISM; MOUSE; PIGS; DEFICIENCY; PROLINE	Suckling mammals, including mice, differ from adults in the abundant expression of enzymes that synthesize arginine from citrulline in their enterocytes. To investigate the importance of the small-intestinal arginine synthesis for whole-body arginine production in suckling mice, we floxed exon 13 of the argininosuccinate synthetase (Ass) gene, which codes for a key enzyme in arginine biosynthesis, and specifically and completely ablated Ass in enterocytes by crossing Ass(fl) and Villin-Cre mice. Unexpectedly, Ass(fl/fl)/VilCre(tg/-) mice showed no developmental impairments. Amino-acid fluxes across the intestine, liver, and kidneys were calculated after determining the blood flow in the portal vein, and hepatic and renal arteries (86%, 14%, and 33%, respectively, of the transhepatic blood flow in 14-day-old mice). Relative to control mice, citrulline production in the splanchnic region of Ass(fl/fl)/VilCre(tg/-) mice doubled, while arginine production was abolished. Furthermore, the net production of arginine and most other amino acids in the liver of suckling control mice declined to naught or even changed to consumption in Ass(fl/fl)/VilCre(tg/-) mice, and had, thus, become remarkably similar to that of post-weaning wild-type mice, which no longer express arginine-biosynthesizing enzymes in their small intestine. The adaptive changes in liver function were accompanied by an increased expression of genes involved in arginine metabolism (Asl, Got1, Gpt2, Glud1, Arg1, and Arg2) and transport (Slc25a13, Slc25a15, and Slc3a2), whereas no such changes were found in the intestine. Our findings suggest that the genetic premature deletion of arginine synthesis in enterocytes causes a premature induction of the post-weaning pattern of amino-acid metabolism in the liver.	[Marion, Vincent; Sankaranarayanan, Selvakumari; de Theije, Chiel; van Dijk, Paul; Hakvoort, Theo B. M.; Lamers, Wouter H.; Koehler, Eleonore S.] Maastricht Univ, Dept Anat & Embryol, Maastricht, Netherlands; [Marion, Vincent] INSERM, Med Genet Lab, U1112, Strasbourg, France; [Hakvoort, Theo B. M.; Lamers, Wouter H.] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Gastrointestinal Res, NL-1105 AZ Amsterdam, Netherlands	Maastricht University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Amsterdam; Academic Medical Center Amsterdam	Kohler, ES (corresponding author), Maastricht Univ, Dept Anat & Embryol, Maastricht, Netherlands.	Leo.Koehler@maastrichtuniversity.nl	Marion, Vincent/H-9730-2016; Lamers, Wouter H./D-2965-2012; Köhler, Eleonore/D-2915-2012	Köhler, Eleonore/0000-0003-1977-9977; Marion, Vincent/0000-0002-8271-7376	graduate school NUTRIM, Maastricht University	graduate school NUTRIM, Maastricht University	This study was supported by a grant from the graduate school NUTRIM, Maastricht University, to WHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D.G., 1991, PRACTICAL STATISTIC; BATSHAW ML, 1984, J PEDIATR-US, V105, P86, DOI 10.1016/S0022-3476(84)80369-8; Becker RM, 2000, J PEDIATR-US, V137, P785, DOI 10.1067/mpd.2000.109145; Bertolo RFP, 2000, J NUTR, V130, P1261, DOI 10.1093/jn/130.5.1261; Bertolo RFP, 2003, AM J PHYSIOL-ENDOC M, V284, pE915, DOI 10.1152/ajpendo.00269.2002; BLACHIER F, 1993, EUR J BIOCHEM, V216, P109, DOI 10.1111/j.1432-1033.1993.tb18122.x; Borsani G, 1999, NAT GENET, V21, P297, DOI 10.1038/6815; Brunton JA, 1999, AM J PHYSIOL-ENDOC M, V277, pE223, DOI 10.1152/ajpendo.1999.277.2.E223; DAVIS TA, 1994, J NUTR, V124, P1126, DOI 10.1093/jn/124.7.1126; DAVIS TA, 1993, J NUTR, V123, P947, DOI 10.1093/jn/123.5.947; de Jonge WJ, 2002, AM J CLIN NUTR, V76, P128, DOI 10.1093/ajcn/76.1.128; de Jonge WJ, 2002, J CLIN INVEST, V110, P1539, DOI [10.1172/JCI200216143, 10.1172/JCI0216143]; De Jonge WJ, 1998, PEDIATR RES, V43, P442, DOI 10.1203/00006450-199804000-00002; de Jonge WJ, 2001, J NUTR, V131, P2732, DOI 10.1093/jn/131.10.2732; Deutz NEP, 1998, J NUTR, V128, P2435, DOI 10.1093/jn/128.12.2435; Flynn NE, 2002, BIOMED PHARMACOTHER, V56, P427, DOI 10.1016/S0753-3322(02)00273-1; Geng MM, 2011, AMINO ACIDS, V40, P1513, DOI 10.1007/s00726-010-0761-6; GOLDBLUM OM, 1986, J AM ACAD DERMATOL, V14, P321, DOI 10.1016/S0190-9622(86)70035-2; Hallemeesch MM, 2001, LAB ANIM-UK, V35, P101, DOI 10.1258/0023677011911426; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; HURWITZ R, 1986, AM J PHYSIOL, V251, pG103, DOI 10.1152/ajpgi.1986.251.1.G103; Illnerova H, 1965, Biol Neonat, V9, P197; Kohler ES, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-107; LEVILLAIN O, 1993, AM J PHYSIOL, V264, pF1038, DOI 10.1152/ajprenal.1993.264.6.F1038; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; MALO C, 1994, COMP BIOCHEM PHYS A, V109, P1049, DOI 10.1016/0300-9629(94)90254-2; MAUNOURY R, 1992, DEVELOPMENT, V115, P717; MEIJER AJ, 1990, PHYSIOL REV, V70, P701, DOI 10.1152/physrev.1990.70.3.701; Moonen RMJ, 2007, PEDIATR RES, V62, P188, DOI 10.1203/PDR.0b013e3180a0324e; NAGY LE, 1988, J NUTR, V118, P189, DOI 10.1093/jn/118.2.189; Palacin M, 2001, CURR OPIN GENET DEV, V11, P328, DOI 10.1016/S0959-437X(00)00198-2; PATEJUNAS G, 1994, SOMAT CELL MOLEC GEN, V20, P55, DOI 10.1007/BF02257486; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ruijter JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-2; Sangild PT, 2006, GASTROENTEROLOGY, V130, P1776, DOI 10.1053/j.gastro.2006.02.026; SARIN SK, 1990, AM J PHYSIOL, V258, pG365, DOI 10.1152/ajpgi.1990.258.3.G365; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SOUTHERN LL, 1983, J ANIM SCI, V57, P402, DOI 10.2527/jas1983.572402x; Torrents D, 1999, NAT GENET, V21, P293, DOI 10.1038/6809; Toyoshima K, 1998, J HISTOCHEM CYTOCHEM, V46, P1329, DOI 10.1177/002215549804601113; Urschel KL, 2007, AM J PHYSIOL-ENDOC M, V293, pE811, DOI 10.1152/ajpendo.00290.2007; Urschel KL, 2007, J NUTR, V137, P601, DOI 10.1093/jn/137.3.601; VANEIJK HMH, 1993, J CHROMATOGR-BIOMED, V620, P143, DOI 10.1016/0378-4347(93)80062-9; VISEK WJ, 1986, J NUTR, V116, P36, DOI 10.1093/jn/116.1.36; WANG T, 1995, NAT GENET, V11, P185, DOI 10.1038/ng1095-185; WU GY, 1994, J NUTR, V124, P415, DOI 10.1093/jn/124.3.415; Wu GY, 1997, AM J PHYSIOL-GASTR L, V272, pG1382, DOI 10.1152/ajpgi.1997.272.6.G1382; WU GY, 1994, J NUTR, V124, P2437, DOI 10.1093/jn/124.12.2437; WU GY, 1995, AM J PHYSIOL-REG I, V269, pR621, DOI 10.1152/ajpregu.1995.269.3.R621; Wu GY, 2004, J NUTR BIOCHEM, V15, P442, DOI 10.1016/j.jnutbio.2003.11.010; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Zamora SA, 1997, J PEDIATR-US, V131, P226, DOI 10.1016/S0022-3476(97)70158-6	52	5	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e67021	10.1371/journal.pone.0067021	http://dx.doi.org/10.1371/journal.pone.0067021			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785515	gold, Green Published, Green Submitted			2022-12-25	WOS:000321038800008
J	Martinez-Giner, M; Noguera, JL; Balcells, I; Fernandez-Rodriguez, A; Pena, RN				Martinez-Giner, Maria; Luis Noguera, Jose; Balcells, Ingrid; Fernandez-Rodriguez, Amanda; Pena, Ramona N.			Selection of Internal Control Genes for Real-Time Quantitative PCR in Ovary and Uterus of Sows across Pregnancy	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; POLYMERASE-CHAIN-REACTION; RT-PCR; EXPRESSION; QUANTIFICATION; NORMALIZATION	Background: Reproductive traits play a key role in pig production in order to reduce costs and increase economic returns. Among others, gene expression analyses represent a useful approach to study genetic mechanisms underlying reproductive traits in pigs. The application of reverse-transcription quantitative PCR requires the selection of appropriate reference genes, whose expression levels should not be affected by the experimental conditions, especially when comparing gene expression across different physiological stages. Results: The gene expression stability of ten potential reference genes was studied by three different methods (geNorm, NormFinder and BestKeeper) in ovary and uterus collected at five different physiological time points (heat, and 15, 30, 45 and 60 days of pregnancy). Although final ranking differed, the three algorithms gave very similar results. Thus, the most stable genes across time were TBP and UBC in uterus and TBP and HPRT1 in ovary, while HMBS and ACTB showed the less stable expression in uterus and ovary, respectively. When studied as a systematic effect, the reproductive stage did not significantly affect the expression of the candidate reference genes except at 30d and 60d of pregnancy, when a general drop in expression was observed in ovary. Conclusions: Based in our results, we propose the use of TBP, UBC and SDHA in uterus and TBP, GNB2L1 and HPRT1 in ovary for normalization of longitudinal expression studies using quantitative PCR in sows.	[Martinez-Giner, Maria; Luis Noguera, Jose; Pena, Ramona N.] IRTA, Lleida, Spain; [Balcells, Ingrid] Univ Autonoma Barcelona, Dept Genet Anim, CRAG, E-08193 Barcelona, Spain; [Fernandez-Rodriguez, Amanda] INIA, Madrid, Spain; [Pena, Ramona N.] Univ Lleida, Dept Anim Prod, Lleida, Spain	IRTA; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); University of Barcelona; Universitat de Lleida	Pena, RN (corresponding author), IRTA, Lleida, Spain.	romi.pena@prodan.udl.cat	Rodríguez, Amanda Fernández/Q-4062-2016; Pena, Romi/C-7756-2011	Rodríguez, Amanda Fernández/0000-0002-5110-2213; Pena, Romi/0000-0002-3558-7302	Spanish Ministerio de Ciencia e Innovacion [AGL2004-08368-C03/GAN]; INIA; MICINN	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); INIA(Instituto de Investigacion Agropecuaria (INIA)); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	This study was funded by the Spanish Ministerio de Ciencia e Innovacion (grant AGL2004-08368-C03/GAN). RN Pena received a contractual grant from INIA. M Martinez-Giner received a predoctoral fellowship from MICINN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Hafez B.H.E.S.E., 2000, REPROD FARM ANIMALS, V7th ed.; Haller F, 2004, ANAL BIOCHEM, V335, P1, DOI 10.1016/j.ab.2004.08.024; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Kuijk EW, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-58; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Noguera JL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-636; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Raftery AE., 1992, BAYESIAN STAT, V4, P763; Robert C, 2002, BIOL REPROD, V67, P1465, DOI 10.1095/biolreprod.102.006320; Rodriguez C, 2005, ANIM GENET, V36, P490, DOI 10.1111/j.1365-2052.2005.01358.x; Sambrook J, 2001, MOL CLONING LAB MANU; Svobodova K, 2008, J APPL GENET, V49, P263, DOI 10.1007/BF03195623; Tramontana S, 2008, J DAIRY SCI, V91, P3057, DOI 10.3168/jds.2008-1164; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wang SQ, 2011, BIOCHEM BIOPH RES CO, V408, P265, DOI 10.1016/j.bbrc.2011.04.010; Wessels JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028940; Zhang XZ, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-4	22	23	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66023	10.1371/journal.pone.0066023	http://dx.doi.org/10.1371/journal.pone.0066023			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785467	Green Submitted, Green Published, gold			2022-12-25	WOS:000321038800055
J	Gupta, D; Leahy, AA; Monga, N; Peshavaria, M; Jetton, TL; Leahy, JL				Gupta, Dhananjay; Leahy, Averi A.; Monga, Navjot; Peshavaria, Mina; Jetton, Thomas L.; Leahy, Jack L.			Peroxisome Proliferator-activated Receptor gamma(PPAR gamma) and Its Target Genes Are Downstream Effectors of FoxO1 Protein in Islet beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXO1; GLYCEROL PHOSPHATE DEHYDROGENASE; MALATE-PYRUVATE SHUTTLE; PANCREATIC-ISLETS; PPAR-GAMMA; INSULIN-RESISTANCE; GLUCOSE-HOMEOSTASIS; RESPONSE ELEMENT; DOWN-REGULATION; FATTY RATS	The molecular mechanisms and signaling pathways that drive islet beta-cell compensation and failure are not fully resolved. We have used in vitro and in vivo systems to show that FoxO1, an integrator of metabolic stimuli, inhibits PPAR gamma expression in beta-cells, thus transcription of its target genes (Pdx1, glucose-dependent insulinotropic polypeptide (GIP) receptor, and pyruvate carboxylase) that are important regulators of beta-cell function, survival, and compensation. FoxO1 inhibition of target gene transcription is normally relieved when upstream activation induces its translocation from the nucleus to the cytoplasm. Attesting to the central importance of this pathway, islet expression of PPAR gamma and its target genes was enhanced in nondiabetic insulin-resistant rats and markedly reduced with diabetes induction. Insight into the impaired PPAR gamma signaling with hyperglycemia was obtained with confocal microscopy of pancreas sections that showed an intense nuclear FoxO1 immunostaining pattern in the beta-cells of diabetic rats in contrast to the nuclear and cytoplasmic FoxO1 in nondiabetic rats. These findings suggest a FoxO1/PPAR gamma-mediated network acting as a core component of beta-cell adaptation to metabolic stress, with failure of this response from impaired FoxO1 activation causing or exacerbating diabetes.	Univ Vermont, Div Endocrinol Diabet & Metab, Burlington, VT 05405 USA; Univ Vermont, Dept Med, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Leahy, JL (corresponding author), Univ Vermont, Colchester Res Facil, 208 S Pk Dr, Colchester, VT 05446 USA.	jleahy@uvm.edu		Gibson MD, PhD, Averi/0000-0003-2118-5430	National Institutes of Health [DK56818]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056818, R56DK056818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK56818 (to J. L. L.). This work was also supported by the American Diabetes Association (to M. P.).	Al-Masri M, 2010, DIABETOLOGIA, V53, P699, DOI 10.1007/s00125-009-1632-0; Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Brissova M, 2005, AM J PHYSIOL-ENDOC M, V288, pE707, DOI 10.1152/ajpendo.00252.2004; Buteau J, 2006, DIABETES, V55, P1190, DOI 10.2337/db05-0825; Cline GW, 2011, DIABETES METAB J, V35, P458, DOI 10.4093/dmj.2011.35.5.458; Delghingaro-Augusto V, 2009, DIABETOLOGIA, V52, P1122, DOI 10.1007/s00125-009-1317-8; Dubois M, 2000, DIABETOLOGIA, V43, P1165, DOI 10.1007/s001250051508; Evans-Molina C, 2009, MOL CELL BIOL, V29, P2053, DOI 10.1128/MCB.01179-08; Fan WQ, 2009, J BIOL CHEM, V284, P12188, DOI 10.1074/jbc.M808915200; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Folli F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028050; Gupta D, 2008, J BIOL CHEM, V283, P32462, DOI 10.1074/jbc.M801813200; Gupta D, 2010, DIABETES, V59, P1445, DOI 10.2337/db09-1655; Ivashchenko CY, 2007, AM J PHYSIOL-GASTR L, V293, pG319, DOI 10.1152/ajpgi.00056.2007; Jetton TL, 2008, AM J PHYSIOL-ENDOC M, V294, pE679, DOI 10.1152/ajpendo.00569.2007; Jetton TL, 2005, DIABETES, V54, P2294, DOI 10.2337/diabetes.54.8.2294; Jitrapakdee S, 2005, J BIOL CHEM, V280, P27466, DOI 10.1074/jbc.M503836200; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; Khoo C, 2012, MOL ENDOCRINOL, V26, P521, DOI 10.1210/me.2011-1231; Kim H, 2000, DIABETES, V49, P1517, DOI 10.2337/diabetes.49.9.1517; Kim HI, 2002, DIABETES, V51, P676, DOI 10.2337/diabetes.51.3.676; Kim HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050128; Kim SJ, 2005, J BIOL CHEM, V280, P22297, DOI 10.1074/jbc.M500540200; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura T, 2007, ENDOCR J, V54, P507, DOI 10.1507/endocrj.KR-109; Kitamura T, 2009, MOL CELL BIOL, V29, P4417, DOI 10.1128/MCB.01622-08; Kluth O, 2011, DIABETOLOGIA, V54, P605, DOI 10.1007/s00125-010-1973-8; Kono T, 2012, MOL ENDOCRINOL, V26, P257, DOI 10.1210/me.2011-1181; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Leahy JL, 2009, CURR DIABETES REP, V9, P215, DOI 10.1007/s11892-009-0035-4; Liu YQ, 2005, AM J PHYSIOL-ENDOC M, V288, pE471, DOI 10.1152/ajpendo.00427.2004; Liu YQ, 2004, J BIOL CHEM, V279, P7470, DOI 10.1074/jbc.M307921200; Liu YQ, 2002, J BIOL CHEM, V277, P39163, DOI 10.1074/jbc.M207157200; MacDonald MJ, 2009, DIABETOLOGIA, V52, P1087, DOI 10.1007/s00125-009-1319-6; MACDONALD MJ, 1993, METABOLISM, V42, P1229, DOI 10.1016/0026-0495(93)90118-8; MacDonald MJ, 1996, DIABETES, V45, P1626, DOI 10.2337/diabetes.45.11.1626; MacDonald MJ, 1996, DIABETES, V45, P886, DOI 10.2337/diabetes.45.7.886; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; Moibi JA, 2007, DIABETES, V56, P88, DOI 10.2337/db06-0948; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Okamoto H, 2006, J CLIN INVEST, V116, P775, DOI 10.1172/JCI24967; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Qiang L, 2010, J BIOL CHEM, V285, P27396, DOI 10.1074/jbc.M110.140228; Rosen ED, 2003, MOL CELL BIOL, V23, P7222, DOI 10.1128/MCB.23.20.7222-7229.2003; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Shu LA, 2009, HUM MOL GENET, V18, P2388, DOI 10.1093/hmg/ddp178; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Welters HJ, 2012, ENDOCRINOLOGY, V153, P4593, DOI 10.1210/en.2012-1243; Xu J, 2008, DIABETOLOGIA, V51, P2022, DOI 10.1007/s00125-008-1130-9; Yan L, 2012, BIOCHEM J, V444, P239, DOI 10.1042/BJ20111606; Yang BT, 2012, MOL ENDOCRINOL, V26, P1203, DOI 10.1210/me.2012-1004; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Zangen DH, 1997, DIABETES, V46, P258, DOI 10.2337/diabetes.46.2.258; Zhao Y, 2011, J MOL CELL BIOL, V3, P276, DOI 10.1093/jmcb/mjr013	57	18	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 30	2013	288	35					25440	25449		10.1074/jbc.M113.486852	http://dx.doi.org/10.1074/jbc.M113.486852			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302QC	23788637	Green Published, hybrid			2022-12-25	WOS:000330619000040
J	Bar-Rogovsky, H; Hugenmatter, A; Tawfik, DS				Bar-Rogovsky, Hagit; Hugenmatter, Adrian; Tawfik, Dan S.			The Evolutionary Origins of Detoxifying Enzymes THE MAMMALIAN SERUM PARAOXONASES (PONs) RELATE TO BACTERIAL HOMOSERINE LACTONASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANCESTRAL PROTEIN RECONSTRUCTION; DIRECTED EVOLUTION; GLUTATHIONE TRANSFERASES; SEQUENCE ALIGNMENT; FAMILY; PHARMACOGENETICS; PROMISCUITY; DUPLICATION; ALGORITHM; HYDROLASE	Serum paraoxonases (PONs) are detoxifying lactonases that were first identified in mammals. Three mammalian families are known, PON1, 2, and 3 that reside primarily in the liver. They catalyze essentially the same reaction, lactone hydrolysis, but differ in their substrate specificity. Although some members are highly specific, others have a broad specificity profile. The evolutionary origins and substrate specificities of PONs therefore remain poorly understood. Here, we report a newly identified family of bacterial PONs, and the reconstruction of the ancestor of the three families of mammalian PONs. Both the mammalian ancestor and the characterized bacterial PONX_OCCAL were found to efficiently hydrolyze N-acyl homoserine lactones that mediate quorum sensing in many bacteria, including pathogenic ones. The mammalian PONs may therefore relate to a newly identified family of bacterial, PON-like "quorum-quenching" lactonases. The appearance of PONs in metazoa is likely to relate to innate immunity rather than detoxification. Unlike the bacterial PON, the mammalian ancestor also hydrolyzes, with low efficiency, lactones other than homoserine lactones, thus preceding the detoxifying functions that diverged later in two of the three mammalian families. The bifunctionality of the mammalian ancestor and the trade-off between the quorum-quenching and detoxifying lactonase activities explain the broad and overlapping specificities of some mammalian PONs versus the singular specificity of others.	[Bar-Rogovsky, Hagit; Hugenmatter, Adrian; Tawfik, Dan S.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Tawfik, DS (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tawfik@weizmann.ac.il			Defense Threat Reduction Agency; Sasson and Marjorie Peress Philanthropic Fund	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Sasson and Marjorie Peress Philanthropic Fund	This work was supported by the Defense Threat Reduction Agency and the Sasson and Marjorie Peress Philanthropic Fund.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Afriat L, 2006, BIOCHEMISTRY-US, V45, P13677, DOI 10.1021/bi061268r; Aharoni A, 2004, P NATL ACAD SCI USA, V101, P482, DOI 10.1073/pnas.2536901100; Alcolombri U, 2011, J MOL BIOL, V411, P837, DOI 10.1016/j.jmb.2011.06.037; Allali-Hassani A, 2007, PLOS BIOL, V5, P1063, DOI 10.1371/journal.pbio.0050097; Altenhofer S, 2010, J BIOL CHEM, V285, P24398, DOI 10.1074/jbc.M110.118604; Aviram Michael, 2008, V477, P259, DOI 10.1007/978-1-60327-517-0_20; Barkman T, 2009, NATURE, V462, pE1, DOI 10.1038/nature08663; Bates PA, 2001, PROTEINS, P39; BURCHELL B, 1991, DNA CELL BIOL, V10, P487, DOI 10.1089/dna.1991.10.487; Chandrasekharan UM, 1996, SCIENCE, V271, P502, DOI 10.1126/science.271.5248.502; Chang BSW, 2005, METHOD ENZYMOL, V395, P652, DOI 10.1016/S0076-6879(05)95034-9; Chen ZW, 2012, J BIOL CHEM, V287, P25335, DOI 10.1074/jbc.M112.362640; Connelly PW, 2011, BBA-MOL CELL BIOL L, V1811, P39, DOI 10.1016/j.bbalip.2010.10.002; Des Marais DL, 2008, NATURE, V454, P762, DOI 10.1038/nature07092; Dixon DP, 2010, PHYTOCHEMISTRY, V71, P338, DOI 10.1016/j.phytochem.2009.12.012; DOBZHANSKY T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; Dong YH, 2002, APPL ENVIRON MICROB, V68, P1754, DOI 10.1128/AEM.68.4.1754-1759.2002; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; Draganov DI, 2004, N-S ARCH PHARMACOL, V369, P78, DOI 10.1007/s00210-003-0833-1; Duan K, 2007, J BACTERIOL, V189, P4827, DOI 10.1128/JB.00043-07; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elias M, 2012, J BIOL CHEM, V287, P11, DOI 10.1074/jbc.R111.257329; Frova C, 2006, BIOMOL ENG, V23, P149, DOI 10.1016/j.bioeng.2006.05.020; Gaidukov L, 2005, BIOCHEMISTRY-US, V44, P11843, DOI 10.1021/bi050862i; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hanson-Smith V, 2010, MOL BIOL EVOL, V27, P1988, DOI 10.1093/molbev/msq081; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; HEARSE DJ, 1973, BIOCHEM J, V132, P519, DOI 10.1042/bj1320519; Herman A, 2007, PROTEIN ENG DES SEL, V20, P219, DOI 10.1093/protein/gzm014; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; Honaker MT, 2011, J BIOL CHEM, V286, P42770, DOI 10.1074/jbc.M111.304386; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Huang RQ, 2012, P NATL ACAD SCI USA, V109, P2966, DOI 10.1073/pnas.1019605109; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Khersonsky O, 2006, CHEMBIOCHEM, V7, P49, DOI 10.1002/cbic.200500334; Khersonsky O, 2005, BIOCHEMISTRY-US, V44, P6371, DOI 10.1021/bi047440d; Khersonsky O, 2009, BIOCHEMISTRY-US, V48, P6644, DOI 10.1021/bi900583y; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; La Du BN, 1999, CHEM-BIOL INTERACT, V119, P379, DOI 10.1016/S0009-2797(99)00049-6; Lane CE, 2008, TRENDS ECOL EVOL, V23, P268, DOI 10.1016/j.tree.2008.02.004; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu DL, 2005, P NATL ACAD SCI USA, V102, P11882, DOI 10.1073/pnas.0505255102; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Ma F, 2009, APPL MICROBIOL BIOT, V83, P135, DOI 10.1007/s00253-009-1890-2; MACKNESS MI, 1989, BIOCHEM PHARMACOL, V38, P385, DOI 10.1016/0006-2952(89)90376-6; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; Marques AC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r54; Nam H, 2012, SCIENCE, V337, P1101, DOI 10.1126/science.1216861; Ng CJ, 2005, FREE RADICAL BIO MED, V38, P153, DOI 10.1016/j.freeradbiomed.2004.09.035; Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200; O'Maille PE, 2008, NAT CHEM BIOL, V4, P617, DOI 10.1038/nchembio.113; Ohno S., 1970, P1; PIATIGORSKY J, 1991, SCIENCE, V252, P1078, DOI 10.1126/science.252.5009.1078; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Pupko T, 2000, MOL BIOL EVOL, V17, P890, DOI 10.1093/oxfordjournals.molbev.a026369; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Shield AJ, 2004, MOL PSYCHIATR, V9, P151, DOI 10.1038/sj.mp.4001386; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Smith RS, 2003, CURR OPIN MICROBIOL, V6, P56, DOI 10.1016/S1369-5274(03)00008-0; Soskine M, 2010, NAT REV GENET, V11, P572, DOI 10.1038/nrg2808; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoltz DA, 2007, AM J PHYSIOL-LUNG C, V292, pL852, DOI 10.1152/ajplung.00370.2006; Teiber JF, 2008, INFECT IMMUN, V76, P2512, DOI 10.1128/IAI.01606-07; Thomas JH, 2007, PLOS GENET, V3, P720, DOI 10.1371/journal.pgen.0030067; Thomson JM, 2005, NAT GENET, V37, P630, DOI 10.1038/ng1553; Thornton JW, 2003, SCIENCE, V301, P1714, DOI 10.1126/science.1086185; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Tokuriki N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2246; Ugalde JA, 2004, SCIENCE, V305, P1433, DOI 10.1126/science.1099597; Weinshilboum R, 2001, DRUG METAB DISPOS, V29, P601; Weng JK, 2012, SCIENCE, V336, P1667, DOI 10.1126/science.1217411; Williams PD, 2006, PLOS COMPUT BIOL, V2, P598, DOI 10.1371/journal.pcbi.0020069; Witte I, 2012, J LIPIDS, V2012, DOI 10.1155/2012/342806; Wouters MA, 2003, MOL CELL, V12, P343, DOI 10.1016/S1097-2765(03)00308-3; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4	81	85	93	0	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23914	23927		10.1074/jbc.M112.427922	http://dx.doi.org/10.1074/jbc.M112.427922			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23788644	Green Published, hybrid			2022-12-25	WOS:000330611400031
J	Barboza, R; Camara, NOS; Gomes, E; Sa-Nunes, A; Florsheim, E; Mirotti, L; Labrada, A; Alcantara-Neves, NM; Russo, M				Barboza, Renato; Saraiva Camara, Niels Olsen; Gomes, Eliane; Sa-Nunes, Anderson; Florsheim, Esther; Mirotti, Luciana; Labrada, Alexis; Alcantara-Neves, Neuza Maria; Russo, Momtchilo			Endotoxin Exposure during Sensitization to Blomia tropicalis Allergens Shifts TH2 Immunity Towards a TH17-Mediated Airway Neutrophilic Inflammation: Role of TLR4 and TLR2	PLOS ONE			English	Article							INDUCED EOSINOPHIL RECRUITMENT; ENDOTHELIAL GROWTH-FACTOR; RESPIRATORY ALLERGY; EXPERIMENTAL-MODEL; MOUSE; LIPOPOLYSACCHARIDE; ASTHMA; RECEPTOR; INNATE; CELLS	Experimental evidence and epidemiological studies indicate that exposure to endotoxin lipopolysaccharide (eLPS) or other TLR agonists prevent asthma. We have previously shown in the OVA-model of asthma that eLPS administration during alum-based allergen sensitization blocked the development of lung TH2 immune responses via MyD88 pathway and IL-12/IFN-gamma axis. In the present work we determined the effect of eLPS exposure during sensitization to a natural airborne allergen extract derived from the house dust mite Blomia tropicalis (Bt). Mice were subcutaneously sensitized with Bt allergens co-adsorbed onto alum with or without eLPS and challenged twice intranasally with Bt. Cellular and molecular parameters of allergic lung inflammation were evaluated 24 h after the last Bt challenge. Exposure to eLPS but not to ultrapure LPS (upLPS) preparation during sensitization to Bt allergens decreased the influx of eosinophils and increased the influx of neutrophils to the airways. Inhibition of airway eosinophilia was not observed in IFN-gamma deficient mice while airway neutrophilia was not observed in IL-17RA-deficient mice as well in mice lacking MyD88, CD14, TLR4 and, surprisingly, TLR2 molecules. Notably, exposure to a synthetic TLR2 agonist (PamCSK4) also induced airway neutrophilia that was dependent on TLR2 and TLR4 molecules. In the OVA model, exposure to eLPS or PamCSK4 suppressed OVA-induced airway inflammation. Our results suggest that B. tropicalis allergens engage TLR4 that potentiates TLR2 signaling. This dual TLR activation during sensitization results in airway neutrophilic inflammation associated with increased frequency of lung TH17 cells. Our work highlight the complex interplay between bacterial products, house dust mite allergens and TLR signaling in the induction of different phenotypes of airway inflammation.	[Barboza, Renato; Saraiva Camara, Niels Olsen; Gomes, Eliane; Sa-Nunes, Anderson; Florsheim, Esther; Mirotti, Luciana; Russo, Momtchilo] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508 Sao Paulo, Brazil; [Labrada, Alexis] Ctr Nacl Biopreparados, Dept Alergenos, Havana, Cuba; [Alcantara-Neves, Neuza Maria] Univ Fed Bahia, Inst Ciencias Saude, BR-41170290 Salvador, BA, Brazil	Universidade de Sao Paulo; Universidade Federal da Bahia	Russo, M (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508 Sao Paulo, Brazil.	momtchilo@usp.br	Barboza, Renato/G-5833-2012; Sa-Nunes, Anderson/D-8667-2012; Florsheim, Esther Borges/G-5260-2015; camara, niels olsen saraiva/AAX-3269-2020; Labrada, Alexis/AAD-9750-2019; Camara, Niels OS/G-8336-2011; Sa-Nunes, Anderson/M-5654-2019	Barboza, Renato/0000-0002-6441-7513; Sa-Nunes, Anderson/0000-0002-1859-4973; Florsheim, Esther Borges/0000-0002-5889-7442; camara, niels olsen saraiva/0000-0001-5436-1248; Labrada, Alexis/0000-0003-0956-7946; Camara, Niels OS/0000-0001-5436-1248; Sa-Nunes, Anderson/0000-0002-1859-4973; Alcantara-Neves, Neuza Maria/0000-0002-2102-260X	State of Sao Paulo Foundation for Research Support (FAPESP) [07/03031-3, 11/17880-8]; CAPES, Brazilian Council of Scientific and Technologic Development	State of Sao Paulo Foundation for Research Support (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES, Brazilian Council of Scientific and Technologic Development	This study was supported by grants 07/03031-3 and 11/17880-8 from the State of Sao Paulo Foundation for Research Support (FAPESP), CAPES, Brazilian Council of Scientific and Technologic Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda LK, 1997, AM J RESP CRIT CARE, V155, P343, DOI 10.1164/ajrccm.155.1.9001334; Baqueiro T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-51; Besnard AG, 2012, J MOL CELL BIOL, V4, P3, DOI 10.1093/jmcb/mjr042; Bortolatto J, 2008, CLIN EXP ALLERGY; Carvalho AF, 2004, J CLIN IMMUNOL, V24, P533, DOI 10.1023/B:JOCI.0000040924.37824.29; Cerqueira-Lima AT, 2010, CURR DRUG TARGETS, V11, P1458; Chew FT, 1999, CLIN EXP ALLERGY, V29, P982, DOI 10.1046/j.1365-2222.1999.00543.x; Dziarski R, 2001, J IMMUNOL, V166, P1938, DOI 10.4049/jimmunol.166.3.1938; Eisenbarth SC, 2008, CLIN EXP ALLERGY, V38, P1572, DOI 10.1111/j.1365-2222.2008.03069.x; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Epstein MM, 2004, INT ARCH ALLERGY IMM, V133, P84, DOI 10.1159/000076131; Fahy John V, 2009, Proc Am Thorac Soc, V6, P256, DOI 10.1513/pats.200808-087RM; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; IWAMOTO I, 1993, J EXP MED, V177, P573, DOI 10.1084/jem.177.2.573; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kheradmand F, 2002, J IMMUNOL, V169, P5904, DOI 10.4049/jimmunol.169.10.5904; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kim YK, 2007, J IMMUNOL, V178, P5375, DOI 10.4049/jimmunol.178.8.5375; Kim YS, 2009, J IMMUNOL, V183, P5113, DOI 10.4049/jimmunol.0901566; Kuo IC, 2003, J ALLERGY CLIN IMMUN, V111, P603, DOI 10.1067/mai.2003.167; Lee CG, 2004, NAT MED, V10, P1095, DOI 10.1038/nm1105; Lo Re S, 2010, J IMMUNOL, V184, P6367, DOI 10.4049/jimmunol.0900459; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Michel O, 1996, AM J RESP CRIT CARE, V154, P1641, DOI 10.1164/ajrccm.154.6.8970348; Mirotti L, 2013, ALLERGY, V68, P74, DOI 10.1111/all.12057; Murphy SC, 2001, AM J TROP MED HYG, V64, P57, DOI 10.4269/ajtmh.2001.64.57; NAKAJIMA H, 1993, AM REV RESPIR DIS, V148, P1102, DOI 10.1164/ajrccm/148.4_Pt_1.1102; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Pichavant M, 2008, J EXP MED, V205, P385, DOI 10.1084/jem.20071507; Rizzo MC, 1997, PEDIAT ALLERG IMM-UK, V8, P121; Rogerio AP, 2010, PHARMACOL RES, V62, P298, DOI 10.1016/j.phrs.2010.04.005; Sa-Nunes A, 2007, MICROBES INFECT, V9, P1393, DOI 10.1016/j.micinf.2006.10.007; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Schroder NWJ, 2007, ALLERGY, V62, P579, DOI 10.1111/j.1398-9995.2007.01386.x; Schulz O, 1997, EUR J IMMUNOL, V27, P584, DOI 10.1002/eji.1830270303; Schulz O, 1998, J EXP MED, V187, P271, DOI 10.1084/jem.187.2.271; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tsai JJ, 1998, INT ARCH ALLERGY IMM, V115, P144, DOI 10.1159/000023894; von Mutius E, 2000, CLIN EXP ALLERGY, V30, P1230; Wakelin SJ, 2006, IMMUNOL LETT, V106, P1, DOI 10.1016/j.imlet.2006.04.007; Williams LK, 2005, ANN ALLERG ASTHMA IM, V94, P323, DOI 10.1016/S1081-1206(10)60983-0; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005	47	30	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67115	10.1371/journal.pone.0067115	http://dx.doi.org/10.1371/journal.pone.0067115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805294	gold, Green Published, Green Submitted			2022-12-25	WOS:000320846500122
J	Fillafer, C; Schneider, MF				Fillafer, Christian; Schneider, Matthias F.			On the Temperature Behavior of Pulse Propagation and Relaxation in Worms, Nerves and Gels	PLOS ONE			English	Article							SPREADING DEPRESSION; CONDUCTION-VELOCITY; ACTION-POTENTIALS; CHEMICAL WAVES; DEPENDENCE; AXON; MEMBRANE; NITELLA; RETINA	The effect of temperature on pulse propagation in biological systems has been an important field of research. Environmental temperature not only affects a host of physiological processes e.g. in poikilotherms but also provides an experimental means to investigate the thermodynamic phenomenology of nerves and muscle. In the present work, the temperature dependence of blood vessel pulsation velocity and frequency was studied in the annelid Lumbriculus variegatus. The pulse velocity was found to vary linearily between 0 degrees C and 30 degrees C. In contrast, the pulse frequency increased non-linearly in the same temperature range. A heat block ultimately resulted in complete cessation of vessel pulsations at 37.2 +/- 2.7 degrees C (lowest: 33 degrees C, highest: 43 degrees C). However, quick cooling of the animal led to restoration of regularly propagating pulses. This experimentally observed phenomenology of pulse propagation and frequency is interpreted without any assumptions about molecules in the excitable membrane (e.g. ion channels) or their temperature-dependent behaviour. By following Einstein's approach to thermodynamics and diffusion, a relation between relaxation time tau and compressibility kappa of the excitable medium is derived that can be tested experimentally (for k(T) similar to k(S)). Without fitting parameters this theory predicts the temperature dependence of the limiting (i.e. highest) pulse frequency in good agreement with experimental data. The thermodynamic approach presented herein is neither limited to temperature nor to worms nor to living systems. It describes the coupling between pulse propagation and relaxation equally well in nerves and gels. The inherent consistency and universality of the concept underline its potential to explain the dependence of pulse propagation and relaxation on any thermodynamic observable.	[Fillafer, Christian; Schneider, Matthias F.] Boston Univ, Dept Mech Engn, Biol Phys Grp, Boston, MA 02215 USA	Boston University	Schneider, MF (corresponding author), Boston Univ, Dept Mech Engn, Biol Phys Grp, Boston, MA 02215 USA.	mfs@bu.edu		/0000-0002-6124-4899	Max Kade Foundation; Austrian Academy of Sciences; BU-ENG-ME; German Science Foundation (DFG); research unit SHENC	Max Kade Foundation; Austrian Academy of Sciences; BU-ENG-ME; German Science Foundation (DFG)(German Research Foundation (DFG)); research unit SHENC	CF is grateful for funding by the Max Kade Foundation (http://maxkadefoundation.org/) and the Austrian Academy of Sciences (www.oeaw.ac.at/). Furthermore, financial support by BU-ENG-ME (www.bu.edu/me/) is acknowledged. MFS would also like to recognize funding through the German Science Foundation (DFG) and the research unit SHENC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SSL, 2009, PROG NEUROBIOL, V88, P104, DOI 10.1016/j.pneurobio.2009.03.002; BEILBY M J, 1976, Australian Journal of Plant Physiology, V3, P275; BLATT FJ, 1974, BIOCHIM BIOPHYS ACTA, V339, P382, DOI 10.1016/0005-2736(74)90165-5; Castro G de O, 1970, J Neurophysiol, V33, P891; CHAPMAN RA, 1967, NATURE, V213, P1143, DOI 10.1038/2131143a0; COHEN LB, 1972, J PHYSIOL-LONDON, V224, P727, DOI 10.1113/jphysiol.1972.sp009920; Engelhardt A, 1951, J COMP PHYSL NEUROET, V128, P125; Fernandes De Lima VM, 1997, PROGR RETINAL EYE RE, V16, P657; FRANZ DN, 1968, J PHYSIOL-LONDON, V199, P319, DOI 10.1113/jphysiol.1968.sp008656; Grabitz P, 2002, BIOPHYS J, V82, P299, DOI 10.1016/S0006-3495(02)75395-2; Griesbauer J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.198103; Griesbauer J, 2009, BIOPHYS J, V97, P2710, DOI 10.1016/j.bpj.2009.07.049; Hamilton M.F, 1998, NONLINEAR ACOUSTICS; Heimburg T, 2005, P NATL ACAD SCI USA, V102, P9790, DOI 10.1073/pnas.0503823102; HODGKIN AL, 1949, J PHYSIOL-LONDON, V109, P240, DOI 10.1113/jphysiol.1949.sp004388; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HUTCHINSON NA, 1970, J PHYSIOL-LONDON, V208, P279, DOI 10.1113/jphysiol.1970.sp009119; INOUE I, 1973, BIOCHIM BIOPHYS ACTA, V307, P471, DOI 10.1016/0005-2736(73)90294-0; IWASA K, 1980, SCIENCE, V210, P338, DOI 10.1126/science.7423196; Jaffe LF, 2002, CELL CALCIUM, V32, P217, DOI 10.1016/S0143416002001574; Kaufmann K., 1989, ACTION POTENTIALS; Lesiuk NM, 1999, AM BIOL TEACH, V61, P48, DOI 10.2307/4450609; LOWITZSCH K, 1977, J NEUROL, V216, P181, DOI 10.1007/BF00313619; LUDIN HP, 1977, J NEUROL, V216, P173, DOI 10.1007/BF00313618; MARTINSFERREIRA H, 1974, J NEUROPHYSIOL, V37, P773, DOI 10.1152/jn.1974.37.4.773; Miyakawa K, 2000, PHYS REV E, V62, P793, DOI 10.1103/PhysRevE.62.793; RITCHIE JM, 1985, Q REV BIOPHYS, V18, P451, DOI 10.1017/S0033583500005382; ROOTS BI, 1962, J EXP BIOL, V39, P617; SANDLIN R, 1968, NATURE, V217, P575, DOI 10.1038/217575b0; TASAKI I, 1969, SCIENCE, V163, P683, DOI 10.1126/science.163.3868.683; TASAKI I, 1949, BIOCHIM BIOPHYS ACTA, V3, P494, DOI 10.1016/0006-3002(49)90121-3; TASAKI I, 1989, BIOPHYS J, V55, P1033, DOI 10.1016/S0006-3495(89)82902-9; TASAKI I, 1991, BIOCHEM BIOPH RES CO, V174, P293, DOI 10.1016/0006-291X(91)90519-D; TASAKI I, 1948, J NEUROPHYSIOL, V11, P311, DOI 10.1152/jn.1948.11.4.311; UEDA T, 1974, J MEMBRANE BIOL, V18, P177, DOI 10.1007/BF01870110; Weimer M, 2005, EXP BRAIN RES, V161, P201, DOI 10.1007/s00221-004-2060-5; Wilke E, 1912, PFLUGERS ARCH EUROPE, P35; WOOD PM, 1985, J CHEM PHYS, V82, P1924, DOI 10.1063/1.448376	38	12	12	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66773	10.1371/journal.pone.0066773	http://dx.doi.org/10.1371/journal.pone.0066773			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805275	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500103
J	Huyet, J; Naylor, CE; Savva, CG; Gibert, M; Popoff, MR; Basak, AK				Huyet, Jessica; Naylor, Claire E.; Savva, Christos G.; Gibert, Maryse; Popoff, Michel R.; Basak, Ajit K.			Structural Insights into Clostridium perfringens Delta Toxin Pore Formation	PLOS ONE			English	Article							STAPHYLOCOCCAL ALPHA-HEMOLYSIN; CRYSTAL-STRUCTURE; GAMMA-HEMOLYSIN; FORMING TOXINS; BETA-TOXIN; REVEALS; BINDING; LUKF; COMPONENT; MEMBRANE	Clostridium perfringens Delta toxin is one of the three hemolysin-like proteins produced by C. perfringens type C and possibly type B strains. One of the others, NetB, has been shown to be the major cause of Avian Nectrotic Enteritis, which following the reduction in use of antibiotics as growth promoters, has become an emerging disease of industrial poultry. Delta toxin itself is cytotoxic to the wide range of human and animal macrophages and platelets that present G(M2) ganglioside on their membranes. It has sequence similarity with Staphylococcus aureus beta-pore forming toxins and is expected to heptamerize and form pores in the lipid bilayer of host cell membranes. Nevertheless, its exact mode of action remains undetermined. Here we report the 2.4 angstrom crystal structure of monomeric Delta toxin. The superposition of this structure with the structure of the phospholipid-bound F component of S. aureus leucocidin (LukF) revealed that the glycerol molecules bound to Delta toxin and the phospholipids in LukF are accommodated in the same hydrophobic clefts, corresponding to where the toxin is expected to latch onto the membrane, though the binding sites show significant differences. From structure-based sequence alignment with the known structure of staphylococcal alpha-hemolysin, a model of the Delta toxin pore form has been built. Using electron microscopy, we have validated our model and characterized the Delta toxin pore on liposomes. These results highlight both similarities and differences in the mechanism of Delta toxin (and by extension NetB) cytotoxicity from that of the staphylococcal pore-forming toxins.	[Huyet, Jessica; Naylor, Claire E.; Savva, Christos G.; Basak, Ajit K.] Birkbeck Coll, Dept Biol Sci, London, England; [Gibert, Maryse; Popoff, Michel R.] Inst Pasteur, Dept Microbiol, Paris, France	University of London; Birkbeck University London; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Basak, AK (corresponding author), Birkbeck Coll, Dept Biol Sci, London, England.	a.basak@mail.cryst.bbk.ac.uk	Popoff, Michel/O-7719-2016	Popoff, Michel/0000-0001-9305-8989	Medical Research Council [G0700051]; Wellcome Trust [WT089618MA]; MRC [G0700051] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to thank the Medical Research Council for the salaries of CEN and JH (award number G0700051), the Wellcome Trust for the salary of CS (award number WT089618MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ALOUF JE, 1981, INFECT IMMUN, V31, P536, DOI 10.1128/IAI.31.2.536-546.1981; [Anonymous], 2001, WHO GLOBAL STRATEGY; Briggs DC, 2011, J MOL BIOL, V413, P138, DOI 10.1016/j.jmb.2011.07.066; CAVAILLON JM, 1986, J LEUKOCYTE BIOL, V40, P65, DOI 10.1002/jlb.40.1.65; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cole AR, 2004, NAT STRUCT MOL BIOL, V11, P797, DOI 10.1038/nsmb804; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fivaz M, 2001, CURR TOP MICROBIOL, V257, P35; Geny B, 2006, BIOL CELL, V98, P667, DOI 10.1042/BC20050082; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guillet V, 2004, J BIOL CHEM, V279, P41028, DOI 10.1074/jbc.M406904200; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; Heuck AP, 2010, SUBCELL BIOCHEM, V51, P551, DOI 10.1007/978-90-481-8622-8_20; Huyet J, 2011, ACTA CRYSTALLOGR F, V67, P369, DOI 10.1107/S1744309110054187; Jayasinghe L, 2006, J BIOL CHEM, V281, P2195, DOI 10.1074/jbc.M510841200; JOLIVETREYNAUD C, 1982, INFECT IMMUN, V38, P860, DOI 10.1128/IAI.38.3.860-864.1982; JOLIVETREYNAUD C, 1988, ARCH BIOCHEM BIOPHYS, V262, P59, DOI 10.1016/0003-9861(88)90168-3; JOLIVETREYNAUD C, 1983, J BIOL CHEM, V258, P1871; JOLIVETREYNAUD C, 1989, TOXICON, V27, P1113, DOI 10.1016/0041-0101(89)90005-6; Keyburn AL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040026; Knapp O, 2010, TOXICON, V55, P61, DOI 10.1016/j.toxicon.2009.06.037; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Manich M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003764; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menestrina G, 2001, TOXICON, V39, P1661, DOI 10.1016/S0041-0101(01)00153-2; Meyer F, 2009, INFECT IMMUN, V77, P266, DOI 10.1128/IAI.00402-08; Monma N, 2004, J BIOCHEM, V136, P427, DOI 10.1093/jb/mvh140; Moran Y, 2012, MOL BIOL EVOL, V29, P2223, DOI 10.1093/molbev/mss089; Nguyen AH, 2006, BIOCHEMISTRY-US, V45, P2570, DOI 10.1021/bi0514156; Nguyen VT, 2002, MOL MICROBIOL, V45, P1485, DOI 10.1046/j.1365-2958.2002.03125.x; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Pedelacq JD, 1999, STRUCTURE, V7, P277, DOI 10.1016/S0969-2126(99)80038-0; Potrich C, 2009, J MEMBRANE BIOL, V227, P13, DOI 10.1007/s00232-008-9140-6; Rossjohn J, 2007, J MOL BIOL, V367, P1227, DOI 10.1016/j.jmb.2007.01.042; Savva CG, 2013, J BIOL CHEM, V288, P3512, DOI 10.1074/jbc.M112.430223; Schwarz S, 2001, INT J ANTIMICROB AG, V17, P431, DOI 10.1016/S0924-8579(01)00297-7; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Sonnino S, 2010, ADV EXP MED BIOL, V688, P165; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Steinthorsdottir V, 1998, FEMS MICROBIOL LETT, V158, P17, DOI 10.1016/S0378-1097(97)00470-9; Tanaka Y, 2011, PROTEIN SCI, V20, P448, DOI 10.1002/pro.579; Theobald DL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040043; Theobald DL, 2012, BIOINFORMATICS, V28, P1972, DOI 10.1093/bioinformatics/bts243; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; WALKER B, 1995, J BIOL CHEM, V270, P23065, DOI 10.1074/jbc.270.39.23065; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamashita K, 2011, P NATL ACAD SCI USA, V108, P17314, DOI 10.1073/pnas.1110402108; Yan XX, 2013, MBIO, V4, DOI 10.1128/mBio.00019-13	53	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66673	10.1371/journal.pone.0066673	http://dx.doi.org/10.1371/journal.pone.0066673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805259	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000320846500087
J	Jeoung, M; Abdelmoti, L; Jang, ER; Kooi, CWV; Galperin, E				Jeoung, Myoungkun; Abdelmoti, Lina; Jang, Eun Ryoung; Kooi, Craig W. Vander; Galperin, Emilia			Functional Integration of the Conserved Domains of Shoc2 Scaffold	PLOS ONE			English	Article							LEUCINE-RICH-REPEAT; MAP KINASE ACTIVATION; GROWTH-FACTOR; STRUCTURAL DIVERSITY; SIGNAL-TRANSDUCTION; RAS KSR; PROTEIN; BINDING; MEK; SUPPRESSOR	Shoc2 is a positive regulator of signaling to extracellular signal-regulated protein kinases 1 and 2 (ERK1/2). Shoc2 is also proposed to interact with RAS and Raf-1 in order to accelerate ERK1/2 activity. To understand the mechanisms by which Shoc2 regulates ERK1/2 activation by the epidermal growth factor receptor (EGFR), we dissected the role of Shoc2 structural domains in binding to its signaling partners and its role in regulating ERK1/2 activity. Shoc2 is comprised of two main domains: the 21 leucine rich repeats (LRRs) core and the N-terminal non-LRR domain. We demonstrated that the N-terminal domain mediates Shoc2 binding to both M-Ras and Raf-1, while the C-terminal part of Shoc2 contains a late endosomal targeting motif. We found that M-Ras binding to Shoc2 is independent of its GTPase activity. While overexpression of Shoc2 did not change kinetics of ERK1/2 activity, both the N-terminal and the LRR-core domain were able to rescue ERK1/2 activity in cells depleted of Shoc2, suggesting that these Shoc2 domains are involved in modulating ERK1/2 activity.	[Jeoung, Myoungkun; Abdelmoti, Lina; Jang, Eun Ryoung; Kooi, Craig W. Vander; Galperin, Emilia] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA; [Kooi, Craig W. Vander] Univ Kentucky, Struct Biol Ctr, Lexington, KY USA	University of Kentucky; University of Kentucky	Galperin, E (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA.	emilia.galperin@uky.edu		Galperin, Emilia/0000-0002-8743-026X	National Cancer Institute [R00CA126161]; National Institutes of Health (NIH) Grant from the National Center for Research Resources [P20GM103486]; NATIONAL CANCER INSTITUTE [R00CA126161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103486] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH) Grant from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by grants from the National Cancer Institute (R00CA126161 to EG) and National Institutes of Health (NIH) Grant P20GM103486 from the National Center for Research Resources. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH or the NIGMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Berridge MJ, 2012, CELL SIGNALING BIOL; Brown M. D., 2008, V186, P205, DOI 10.1007/978-3-540-72843-6_9; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Cacace AM, 1999, MOL CELL BIOL, V19, P229; Ceulemans H, 1999, FEBS LETT, V456, P349, DOI 10.1016/S0014-5793(99)00965-5; Claperon A, 2007, ONCOGENE, V26, P3143, DOI 10.1038/sj.onc.1210408; Cordeddu V, 2009, NAT GENET, V41, P1022, DOI 10.1038/ng.425; Denouel-Galy A, 1998, CURR BIOL, V8, P46, DOI 10.1016/S0960-9822(98)70019-3; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Ehrhardt GRA, 1999, BLOOD, V94, P2433, DOI 10.1182/blood.V94.7.2433.419k31_2433_2444; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Galperin E, 2005, METHOD ENZYMOL, V403, P119, DOI 10.1016/S0076-6879(05)03011-9; Galperin E, 2008, TRAFFIC, V9, P1776, DOI 10.1111/j.1600-0854.2008.00788.x; Galperin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036469; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Herreros L, 2000, J BIOL CHEM, V275, P26436, DOI 10.1074/jbc.M003970200; Istomin AY, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-48; Jiang XJ, 2003, TRAFFIC, V4, P529, DOI 10.1034/j.1600-0854.2003.t01-1-00109.x; Joneson T, 1998, J BIOL CHEM, V273, P7743, DOI 10.1074/jbc.273.13.7743; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kajava AV, 2001, J STRUCT BIOL, V134, P132, DOI 10.1006/jsbi.2000.4328; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kim HM, 2007, J BIOL CHEM, V282, P6726, DOI 10.1074/jbc.M608471200; Ko J, 2007, J NEUROSCI RES, V85, P2824, DOI 10.1002/jnr.21306; Kobe B, 2000, TRENDS BIOCHEM SCI, V25, P509, DOI 10.1016/S0968-0004(00)01667-4; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KOBE B, 1993, NATURE, V366, P751, DOI 10.1038/366751a0; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Li WQ, 2000, GENE DEV, V14, P895; Matallanas David, 2011, Genes Cancer, V2, P232, DOI 10.1177/1947601911407323; Matsunaga-Udagawa R, 2010, J BIOL CHEM, V285, P7818, DOI 10.1074/jbc.M109.053975; Matsushima N, 2005, CELL MOL LIFE SCI, V62, P2771, DOI 10.1007/s00018-005-5187-z; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Park H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-599; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Rodriguez-Viciana P, 2006, MOL CELL, V22, P217, DOI 10.1016/j.molcel.2006.03.027; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Selfors LM, 1998, P NATL ACAD SCI USA, V95, P6903, DOI 10.1073/pnas.95.12.6903; Sharma C, 2005, J CELL BIOCHEM, V94, P708, DOI 10.1002/jcb.20344; She J, 2011, NATURE, V474, P472, DOI 10.1038/nature10178; Sieburth DS, 1998, CELL, V94, P119, DOI 10.1016/S0092-8674(00)81227-1; Sorkin A, 2010, QUANTITATIVE ANAL EN; Sugimoto T, 1998, EMBO J, V17, P1717, DOI 10.1093/emboj/17.6.1717; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; Wezner-Ptasinska M, 2011, BBA-PROTEINS PROTEOM, V1814, P1140, DOI 10.1016/j.bbapap.2011.05.009; Wunderlich W, 2001, J CELL BIOL, V152, P765, DOI 10.1083/jcb.152.4.765; Yi J, 2010, DEV DYNAM, V239, P2005, DOI 10.1002/dvdy.22343; Yoshiki S, 2010, MOL BIOL CELL, V21, P1088, DOI 10.1091/mbc.E09-06-0455; Zeke A, 2009, TRENDS CELL BIOL, V19, P364, DOI 10.1016/j.tcb.2009.05.007	58	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66067	10.1371/journal.pone.0066067	http://dx.doi.org/10.1371/journal.pone.0066067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805200	Green Submitted, Green Published, gold			2022-12-25	WOS:000320846500028
J	Chen, J; Tang, HM; Wu, ZH; Zhou, CZ; Jiang, T; Xue, YM; Huang, GY; Yan, DW; Peng, ZH				Chen, Jian; Tang, Huamei; Wu, Zehua; Zhou, Chongzhi; Jiang, Tao; Xue, Yingming; Huang, Guoyu; Yan, Dongwang; Peng, Zhihai			Overexpression of RBBP6, Alone or Combined with Mutant TP53, Is Predictive of Poor Prognosis in Colon Cancer	PLOS ONE			English	Article							COLORECTAL-CANCER; P53; MUTATIONS; UBIQUITIN; PROTEIN; GAIN; PROLIFERATION; METASTASIS; RECURRENCE; INTERACTS	Retinoblastoma binding protein 6 (RBBP6) plays an important role in chaperone-mediated ubiquitination and interacts with TP53 in carcinogenesis. However, the clinicopathologic significance of RBBP6 expression in colon cancer is unknown; in particular, the prognostic value of RBBP6 combined with TP53 expression has not been explored. Therefore, quantitative real-time PCR and western blot analyses were performed to detect RBBP6 expression in colon cancer tissues. RBBP6 and TP53 expression were assessed by immunohistochemistry in a tissue microarray format, in which the primary colon cancer tissue was paired with noncancerous tissue. Tissue specimens were obtained from 203 patients. We found that RBBP6 was overexpressed in colon tumorous tissues and was significantly associated with clinical stage, depth of tumor invasion, lymph node metastasis (LNM), distant metastasis, and histologic grade. Further studies revealed that a corresponding correlation between RBBP6 overexpression and mutant TP53 was evident in colon cancer (r = 0.450; P<0.001). RBBP6 expression was an independent prognostic factor for overall survival (OS) and disease free survival (DFS). Interestingly, patients with tumors that had both RBBP6 overexpression and mutant TP53 protein accumulation relapsed and died within a significantly short period after surgery (P<0.001). Multivariate analysis showed that patients with LNM and patients with both RBBP6- and TP53-positive tumors had extremely poor OS (HR 6.75; 95% CI 2.63-17.35; P<0.001) and DFS (HR 8.08; 95% CI 2.80-23.30; P<0.001). These clinical findings indicate that the assessment of both RBBP6 and mutant TP53 expression will be helpful in predicting colon cancer prognosis.	[Chen, Jian; Wu, Zehua; Zhou, Chongzhi; Jiang, Tao; Xue, Yingming; Huang, Guoyu; Yan, Dongwang; Peng, Zhihai] Shanghai Jiao Tong Univ, Dept Gen Surg, Affiliated Peoples Hosp 1, Shanghai 200030, Peoples R China; [Tang, Huamei] Shanghai Jiao Tong Univ, Dept Pathol, Affiliated Peoples Hosp 1, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yan, DW (corresponding author), Shanghai Jiao Tong Univ, Dept Gen Surg, Affiliated Peoples Hosp 1, Shanghai 200030, Peoples R China.	yandw70@163.com	Wong, Gregory/AAA-1063-2020		National Natural Science Foundation of China [81072008, 81172328]; Medical Guidance Project of Shanghai Science and Technology Commission [114119a4600, 124119a1700]; Natural Science Foundation of Shanghai Municipality [11ZR1429200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Guidance Project of Shanghai Science and Technology Commission; Natural Science Foundation of Shanghai Municipality(Natural Science Foundation of Shanghai)	This project was supported by the funds: National Natural Science Foundation of China (81072008, 81172328), Medical Guidance Project of Shanghai Science and Technology Commission (114119a4600, 124119a1700), Natural Science Foundation of Shanghai Municipality (11ZR1429200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Cao Z, 2009, NEOPLASMA, V56, P114, DOI 10.4149/neo_2009_02_114; Chibi M, 2008, J MOL BIOL, V384, P908, DOI 10.1016/j.jmb.2008.09.060; Compagnin C, 2010, CELL PROLIFERAT, V43, P262, DOI 10.1111/j.1365-2184.2010.00673.x; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; GALANDIUK S, 1992, SURG GYNECOL OBSTET, V174, P27; Goldstein I, 2011, CANCER GENE THER, V18, P2, DOI 10.1038/cgt.2010.63; Hashimoto Y, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-488; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Ji F, 2009, WORLD J GASTROENTERO, V15, P2228, DOI 10.3748/wjg.15.2228; Kirkin V, 2011, CURR OPIN GENET DEV, V21, P21, DOI 10.1016/j.gde.2010.10.004; LEVY A, 1994, CLIN ENDOCRINOL, V41, P809, DOI 10.1111/j.1365-2265.1994.tb02797.x; Li DW, 2009, ANN SURG ONCOL, V16, P3499, DOI 10.1245/s10434-009-0648-5; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Mbita Z, 2012, MOL CELL BIOCHEM, V362, P249, DOI 10.1007/s11010-011-1150-5; Midgley CA, 1997, ONCOGENE, V15, P1179, DOI 10.1038/sj.onc.1201459; Miladi-Abdennadher I, 2011, APPL IMMUNOHISTO M M, V19, P1562, DOI 10.1097/PAI.0b013e3182143380; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Phimsen S, 2012, APOPTOSIS, V17, P679, DOI 10.1007/s10495-012-0711-8; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pugh DJR, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-1; Selivanova G, 2009, CELL, V139, P1220, DOI 10.1016/j.cell.2009.12.016; Simons A, 1997, ONCOGENE, V14, P145, DOI 10.1038/sj.onc.1200825; Smith G, 2002, P NATL ACAD SCI USA, V99, P9433, DOI 10.1073/pnas.122612899; Solomon H, 2011, J PATHOL, V225, P475, DOI 10.1002/path.2988; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Wild PJ, 2012, EMBO MOL MED, V4, P808, DOI 10.1002/emmm.201101063; Won KY, 2012, HUM PATHOL, V43, P221, DOI 10.1016/j.humpath.2011.04.021; Yan DW, 2010, BRIT J CANCER, V103, P961, DOI 10.1038/sj.bjc.6605870; Yan DW, 2012, BBA-MOL BASIS DIS, V1822, P918, DOI 10.1016/j.bbadis.2012.02.021; Yoshitake Y, 2004, CLIN CANCER RES, V10, P6437, DOI 10.1158/1078-0432.CCR-04-0841	33	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66524	10.1371/journal.pone.0066524	http://dx.doi.org/10.1371/journal.pone.0066524			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799110	Green Published, Green Submitted, gold			2022-12-25	WOS:000321397800034
J	Hoepfner, AR; Goller, F				Hoepfner, Amanda R.; Goller, Franz			Atypical Song Reveals Spontaneously Developing Coordination between Multi-Modal Signals in Brown-Headed Cowbirds (Molothrus ater)	PLOS ONE			English	Article							RESPONSES	The courtship and dominance behavior of brown-headed cowbirds (Molothrus ater) consists of a multi-modal display, including song as well as postural and wing movements. The temporal sequences of the acoustic and the visual display are coordinated. In adult male cowbirds the largest wing movements of the display are synchronized with silent periods of song, but it is unknown how this coordination emerges during song development. Here we investigate how visual display features are coordinated with song by using atypical song sequence structure of isolation-reared male cowbirds. In birds with atypical song, all components of the visual display were highly similar to those of "normal" song displays, but their timing was slightly different. The number of maximal wing movement cycles of isolation-reared males was linked to the number of sound units in the song, and was therefore reduced during the abbreviated song types of isolates. These data indicate that young cowbirds do not need to be exposed to a model of the visual display during ontogeny and that there is synchronization with the temporal structure of song. A physiological link between respiratory and syringeal control of silent periods between sound units and wing movement cycles may be driving this synchronization.	[Hoepfner, Amanda R.; Goller, Franz] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Hoepfner, AR (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	amanda.hoepfner@utah.edu			National Institutes of Health (NIH) [DC 04390]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004390, R01DC006876] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by National Institutes of Health (NIH) DC 04390. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN SE, 1994, J NEUROBIOL, V25, P1154, DOI 10.1002/neu.480250910; Cooper BG, 2004, SCIENCE, V303, P544, DOI 10.1126/science.1091099; DUFTY AM, 1985, Z TIERPSYCHOL, V69, P177; KING AP, 1977, SCIENCE, V195, P1002, DOI 10.1126/science.841321; KING AP, 1980, J COMP PHYSIOL PSYCH, V94, P1028, DOI 10.1037/h0077737; NERO ROBERT W., 1963, WILSON BULL, V75, P376; O'Loghlen AL, 2010, CONDOR, V112, P615, DOI 10.1525/cond.2010.090216; O'Loghlen AL, 2010, ANIM BEHAV, V79, P1285, DOI 10.1016/j.anbehav.2010.03.001; Riede T, 2006, P NATL ACAD SCI USA, V103, P5543, DOI 10.1073/pnas.0601262103; ROTHSTEIN SI, 1988, ANIM BEHAV, V36, P73, DOI 10.1016/S0003-3472(88)80251-3; Suthers RA, 1999, PHILOS T ROY SOC B, V354, P927, DOI 10.1098/rstb.1999.0444; SUTHERS RA, 2008, NEUROSCIENCE BIRDSON, P78; West MJ, 1998, ETHOLOGY, V104, P250; WEST MJ, 1980, J COMP PHYSIOL PSYCH, V94, P263, DOI 10.1037/h0077657; Wild JM, 1998, J NEUROBIOL, V36, P441, DOI 10.1002/(SICI)1097-4695(19980905)36:3<441::AID-NEU11>3.0.CO;2-E	15	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65525	10.1371/journal.pone.0065525	http://dx.doi.org/10.1371/journal.pone.0065525			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799020	Green Submitted, gold, Green Published			2022-12-25	WOS:000321397800010
J	Lim, S; Becker, A; Zimmer, A; Lu, JR; Buettner, R; Kirfel, J				Lim, Soyoung; Becker, Astrid; Zimmer, Andreas; Lu, Jianrong; Buettner, Reinhard; Kirfel, Jutta			SNAI1-Mediated Epithelial-Mesenchymal Transition Confers Chemoresistance and Cellular Plasticity by Regulating Genes Involved in Cell Death and Stem Cell Maintenance	PLOS ONE			English	Article							NF-KAPPA-B; HUMAN BREAST-CANCER; TGF-BETA; SELF-RENEWAL; IN-VITRO; ACTIVATION; SNAIL; INFLAMMATION; METASTASIS; MECHANISMS	Tumor cells at the tumor margin lose epithelial properties and acquire features of mesenchymal cells, a process called epithelial-to-mesenchymal transition (EMT). Recently, features of EMT were shown to be linked to cells with tumor-founding capability, so-called cancer stem cells (CSCs). Inducers of the EMT include several transcription factors, such as Snail (SNAI1) and Slug (SNAI2), as well as the secreted transforming growth factor (TGF beta). In the present study, we found that EMT induction in MCF10A cells by stably expressing SNAI1 contributed to drug resistance and acquisition of stem/progenitor-like character as shown by increased cell population for surface marker CD44(+)/CD24(-) and mammosphere forming capacity. Using a microarray approach, we demonstrate that SNAI1 overexpression results in a dramatic change in signaling pathways involved in the regulation of cell death and stem cell maintenance. We showed that NF-kappa B/MAPK signaling pathways are highly activated in MCF10A-SNAI1 cells by IL1 beta stimulation, leading to the robust induction in IL6 and IL8. Furthermore, MCF10A-SNAI1 cells showed enhanced TCF/beta-catenin activity responding to the exogenous Wnt3a treatment. However, EMT-induced stem/progenitor cell activation process is tightly regulated in non-transformed MCF10A cells, as WNT5A and TGFB2 are strongly upregulated in MCF10A-SNAI1 cells antagonizing canonical Wnt pathway. In summary, our data provide new molecular findings how EMT contributes to the enhanced chemoresistance and the acquisition of stem/progenitor-like character by regulating signaling pathways.	[Lim, Soyoung; Buettner, Reinhard] Univ Cologne, Inst Pathol, D-50931 Cologne, Germany; [Becker, Astrid; Zimmer, Andreas] Univ Bonn, Inst Mol Psychiat, Bonn, Germany; [Lu, Jianrong] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Kirfel, Jutta] Univ Bonn, Inst Pathol, Bonn, Germany	University of Cologne; University of Bonn; State University System of Florida; University of Florida; University of Bonn	Kirfel, J (corresponding author), Univ Bonn, Inst Pathol, Bonn, Germany.	Jutta.Kirfel@ukb.uni-bonn.de	Zimmer, Andreas/B-8357-2009; Lu, Jianrong/F-5240-2013	Lu, Jianrong/0000-0002-4969-6040	Deutsche Forschungsgemeinschaft [FOR 926, GRK 804]; German Cancer Aid (KoSAR Research Grant) [109742]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Cancer Aid (KoSAR Research Grant)	A.B. was funded by a grant from the Deutsche Forschungsgemeinschaft (FOR 926). R.B. and J.K. were funded by grants from the Deutsche Forschungsgemeinschaft (GRK 804) and the German Cancer Aid (KoSAR Research Grant 109742). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Benoy IH, 2004, CLIN CANCER RES, V10, P7157, DOI 10.1158/1078-0432.CCR-04-0812; Bierie B, 2009, CELL CYCLE, V8, P3319, DOI 10.4161/cc.8.20.9727; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Fuxe J, 2010, CELL CYCLE, V9, P2363, DOI 10.4161/cc.9.12.12050; Gavert N, 2008, TRENDS MOL MED, V14, P199, DOI 10.1016/j.molmed.2008.03.004; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190; Kooreman NG, 2010, J R SOC INTERFACE, V7, pS753, DOI 10.1098/rsif.2010.0353.focus; Korkaya H, 2011, CLIN CANCER RES, V17, P6125, DOI 10.1158/1078-0432.CCR-10-2743; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Li L, 2011, CLIN CANCER RES, V17, P4936, DOI 10.1158/1078-0432.CCR-10-1499; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Lin T, 2010, ONCOGENE, V29, P4896, DOI 10.1038/onc.2010.234; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Maugeri-Sacca M, 2011, CLIN CANCER RES, V17, P4942, DOI 10.1158/1078-0432.CCR-10-2538; Pantschenko AG, 2003, INT J ONCOL, V23, P269; Park SA, 2009, CANCER RES, V69, P2416, DOI 10.1158/0008-5472.CAN-08-2177; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Sansone P, 2007, STEM CELLS, V25, P807, DOI 10.1634/stemcells.2006-0442; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Serra R, 2011, J MAMMARY GLAND BIOL, V16, P157, DOI 10.1007/s10911-011-9205-5; Sethi N, 2011, CANCER CELL, V19, P192, DOI 10.1016/j.ccr.2010.12.022; Shostak K, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2886; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Tse JC, 2007, J CELL BIOCHEM, V101, P816, DOI 10.1002/jcb.21215; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	41	62	65	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66558	10.1371/journal.pone.0066558	http://dx.doi.org/10.1371/journal.pone.0066558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799116	Green Published, Green Submitted, gold			2022-12-25	WOS:000321397800037
J	Liu, W; Chen, Z; Ma, YS; Wu, XC; Jin, YP; Hou, S				Liu, Wei; Chen, Zhi; Ma, Yansen; Wu, Xiaochun; Jin, Yaping; Hou, Steven			Genetic Characterization of the Drosophila Birt-Hogg-Dube Syndrome Gene	PLOS ONE			English	Article							MTOR ACTIVATION; AMINO-ACIDS; GROWTH; TUMORIGENESIS; REQUIREMENTS; MELANOGASTER; MECHANISMS; FOLLICULIN; INTERACTS; RAPAMYCIN	Folliculin (FLCN) is a conserved tumor suppressor gene whose loss is associated with the human Birt-Hogg-Dube (BHD) syndrome. However, its molecular functions remain largely unknown. In this work, we generated a Drosophila BHD model through genomic deletion of the FLCN gene (DBHD-). The DBHD mutant larvae grew slowly and stopped development before pupation, displaying various characteristics of malnutrition. We found the growth delay was sensitive to the nutrient supplies. It became more severe upon restrictions of the dietary yeast; while high levels of yeast significantly restored the normal growth, but not viability. We further demonstrated that leucine was able to substitute for yeast to provide similar rescues. Moreover, the human FLCN could partially rescue the DBHD- phenotypes, indicating the two genes are involved in certain common mechanisms. Our work provides a new animal model of the BHD syndrome and suggests that modulation of the local nutrient condition might be a potential treatment of the BHD lesions.	[Liu, Wei; Chen, Zhi; Ma, Yansen; Wu, Xiaochun; Jin, Yaping] Northwest A&F Univ, Coll Vet Med, Minist Agr, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China; [Liu, Wei; Hou, Steven] NCI, Mouse Canc Genet Program, NIH, Frederick, MD 21701 USA	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Jin, YP (corresponding author), Northwest A&F Univ, Coll Vet Med, Minist Agr, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China.	yapingjin@163.com; hous@mail.nih.gov			NSAF Foundation; Doctoral Programs Foundation of Ministry of Education of China; Intramural Research Program of the National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010738] Funding Source: NIH RePORTER	NSAF Foundation; Doctoral Programs Foundation of Ministry of Education of China(Ministry of Education, China); Intramural Research Program of the National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NSAF Foundation (W.L.), Doctoral Programs Foundation of Ministry of Education of China (Y.J.) and the Intramural Research Program of the National Institutes of Health, National Cancer Institute (S.H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba M, 2008, JNCI-J NATL CANCER I, V100, P140, DOI 10.1093/jnci/djm288; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; Britton JS, 1998, DEVELOPMENT, V125, P2149; BURNET B, 1968, GENETICS, V59, P211; Cash TP, 2011, ONCOGENE, V30, P2534, DOI 10.1038/onc.2010.628; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Hartman TR, 2009, ONCOGENE, V28, P1594, DOI 10.1038/onc.2009.14; Hasumi Y, 2009, P NATL ACAD SCI USA, V106, P18722, DOI 10.1073/pnas.0908853106; Hong SB, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-160; Hudon V, 2010, J MED GENET, V47, P182, DOI 10.1136/jmg.2009.072009; Knoblich JA, 1997, CURR OPIN CELL BIOL, V9, P833, DOI 10.1016/S0955-0674(97)80085-3; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Layman DK, 2006, J NUTR, V136, p319S, DOI 10.1093/jn/136.1.319S; Le Rohellec M, 2009, EXP GERONTOL, V44, P695, DOI 10.1016/j.exger.2009.08.001; Li FN, 2011, AMINO ACIDS, V41, P1185, DOI 10.1007/s00726-011-0983-2; Menko FH, 2009, LANCET ONCOL, V10, P1199, DOI 10.1016/S1470-2045(09)70188-3; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Perrimon N, 1998, INT J DEV BIOL, V42, P243; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; SANG JH, 1961, J EXP BIOL, V38, P793; Singh SR, 2006, ONCOGENE, V25, P5933, DOI 10.1038/sj.onc.1209593; Tatum EL, 1941, P NATL ACAD SCI USA, V27, P193, DOI 10.1073/pnas.27.4.193; Toro JR, 2008, J MED GENET, V45, P321, DOI 10.1136/jmg.2007.054304; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Zbar B, 2002, CANCER EPIDEM BIOMAR, V11, P393; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zinke I, 1999, DEVELOPMENT, V126, P5275	27	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65869	10.1371/journal.pone.0065869	http://dx.doi.org/10.1371/journal.pone.0065869			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799055	Green Published, gold, Green Submitted			2022-12-25	WOS:000321397800018
J	Campolo, J; De Maria, R; Mariotti, C; Tomasello, C; Parolini, M; Frontali, M; Inzitari, D; Valenti, R; Federico, A; Taroni, F; Parodi, O				Campolo, Jonica; De Maria, Renata; Mariotti, Caterina; Tomasello, Chiara; Parolini, Marina; Frontali, Marina; Inzitari, Domenico; Valenti, Raffaella; Federico, Antonio; Taroni, Franco; Parodi, Oberdan			Is the Oxidant/Antioxidant Status Altered in CADASIL Patients?	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT ARTERIOPATHY; OXIDATIVE STRESS; NITRIC-OXIDE; SUBCORTICAL INFARCTS; LIPID-PEROXIDATION; ALZHEIMERS-DISEASE; GLUTATHIONE SYSTEM; BLOOD GLUTATHIONE; PLASMA; VASOREACTIVITY	The altered aggregation of proteins in non-native conformation is associated with endoplasmic reticulum derangements, mitochondrial dysfunction and excessive production of reactive oxygen species. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a rare hereditary systemic vasculopathy, caused by NOTCH3 mutations within the receptor extracellular domain, that lead to abnormal accumulation of the mutated protein in the vascular wall. NOTCH3 misfolding could cause free radicals increase also in CADASIL. Aim of the study was to verify whether CADASIL patients have increased oxidative stress compared to unrelated healthy controls. We enrolled 15 CADASIL patients and 16 gender- and age-matched healthy controls with comparable cardiovascular risk factor. Blood and plasma reduced and total aminothiols (homocysteine, cysteine, glutathione, cysteinylglycine) were measured by HPLC and plasma 3-nitrotyrosine by ELISA. Only plasma reduced cysteine (Pr-Cys) and blood reduced glutathione (Br-GSH) concentrations differed between groups: in CADASIL patients Br-GSH levels were higher (p = 0.019) and Pr-Cys lower (p = 0.010) than in controls. No correlation was found between Br-GSH and Pr-Cys either in CADASIL patients (rho 0.25, P=0.36) or in controls (rho -0.15, P=0.44). Conversely, 3-nitrotyrosine values were similar in CADASIL and healthy subjects (p = 0.82). The high levels of antioxidant molecules and low levels of oxidant mediators found in our CADASIL population might either be expression of an effective protective action against free radical formation at an early stage of clinical symptoms or they could suggest that oxidative stress is not directly involved in the pathogenesis of CADASIL.	[Campolo, Jonica; De Maria, Renata; Parolini, Marina; Parodi, Oberdan] Osped Niguarda Ca Granda, Cardiothorac & Vasc Dept, Community Networking Resources Inst Clin Physiol, Milan, Italy; [Mariotti, Caterina; Tomasello, Chiara; Taroni, Franco] Fdn IRCCS Ist Neurol Carlo Besta, Unit Genet Neurodegenerat & Metab Dis, Milan, Italy; [Frontali, Marina] Community Networking Resources Inst Translat Phar, Rome, Italy; [Inzitari, Domenico; Valenti, Raffaella] Univ Florence, Dept Neurol & Psychiat Sci, Florence, Italy; [Federico, Antonio] Univ Siena, Dept Neurol Neurosurg & Behav Sci, I-53100 Siena, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; IRCCS Istituto Neurologico Besta; University of Florence; University of Siena	Campolo, J (corresponding author), Osped Niguarda Ca Granda, Cardiothorac & Vasc Dept, Community Networking Resources Inst Clin Physiol, Milan, Italy.	jonica.campolo@ospedaleniguarda.it	De Maria, Renata/I-9065-2012; Mariotti, Caterina/AAP-9425-2021; Campolo, Jonica/ABC-5841-2020; Inzitari, Domenico/AAH-8722-2020; Valenti, Raffaella/AAB-7974-2019; Taroni, Franco/N-3879-2013	De Maria, Renata/0000-0002-8474-7923; Mariotti, Caterina/0000-0003-2405-3564; Valenti, Raffaella/0000-0002-4975-3754; Taroni, Franco/0000-0002-2420-5233; federico, antonio/0000-0002-5246-1621	Italian Medicine Agency (AIFA) [FARM659PTX]	Italian Medicine Agency (AIFA)	This study was supported by grant FARM659PTX from the Italian Medicine Agency (AIFA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accinni R, 1998, J CHROMATOGR A, V828, P397, DOI 10.1016/S0021-9673(98)00661-X; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Campolo J, 2007, INT J CARDIOL, V117, P45, DOI 10.1016/j.ijcard.2006.04.065; Campolo J, 2012, J NEUROL NEUROSUR PS, V83, P268, DOI 10.1136/jnnp-2011-300080; Cesar Tobon-Velasco Julio, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P278; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Chen H, 2011, ANTIOXID REDOX SIGN, V14, P1505, DOI 10.1089/ars.2010.3576; Chen Yung-Hsiang, 2006, Cardiovascular & Hematological Disorders - Drug Targets, V6, P279; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; El-Khairy L, 2001, CIRCULATION, V103, P2544; Ferrer I, 2002, NEUROSCI LETT, V321, P21, DOI 10.1016/S0304-3940(01)02465-X; Formichi P, 2009, J CELL PHYSIOL, V219, P494, DOI 10.1002/jcp.21695; Franco R., 2007, Archives of Physiology and Biochemistry, V113, P234, DOI 10.1080/13813450701661198; Fujiwara Y, 2012, CEREBROVASC DIS, V33, P128, DOI 10.1159/000334185; Gavin JR, 1999, DIABETES CARE, V22, pS5; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guglielmotto M, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.003.2010; Heales SJR, 1999, BBA-BIOENERGETICS, V1410, P215, DOI 10.1016/S0005-2728(98)00168-6; Hogg N, 1999, FREE RADICAL BIO MED, V27, P28, DOI 10.1016/S0891-5849(99)00029-5; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Kleinman WA, 2000, BIOCHEM PHARMACOL, V60, P19, DOI 10.1016/S0006-2952(00)00293-8; Kolesnichenko LS, 2008, ZH NEVROL PSIKHIATR, V108, P36; Kolesnichenko L. S., 2007, Biomeditsinskaya Khimiya, V53, P454; LI J, 1993, J PHARMACOL EXP THER, V267, P371; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; MEYER M, 1993, EMBO J, V12, P2005, DOI 10.1002/j.1460-2075.1993.tb05850.x; Montezano AC, 2012, CAN J CARDIOL, V28, P288, DOI 10.1016/j.cjca.2012.01.017; Nakamura T, 2011, CELL DEATH DIFFER, V18, P1478, DOI 10.1038/cdd.2011.65; Ozkul A, 2007, J CLIN NEUROSCI, V14, P1062, DOI 10.1016/j.jocn.2006.11.008; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; Ragno M, 2011, NEUROGENETICS, V12, P337, DOI 10.1007/s10048-011-0298-1; Rufa A, 2005, STROKE, V36, P2554, DOI 10.1161/01.STR.0000190832.17620.25; Stenborg A, 2007, STROKE, V38, P2692, DOI 10.1161/STROKEAHA.107.490029; Tinkel J, 2012, CARDIOL REV, V20, P77, DOI 10.1097/CRD.0b013e31823dbbad; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Zimmerman MC, 2004, PROG BIOPHYS MOL BIO, V84, P125, DOI 10.1016/j.pbiomolbio.2003.11.009	37	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e67077	10.1371/journal.pone.0067077	http://dx.doi.org/10.1371/journal.pone.0067077			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799141	Green Published, gold, Green Submitted			2022-12-25	WOS:000320363300103
J	D'Amico, LA; Boujard, D; Coumailleau, P				D'Amico, Laure Anne; Boujard, Daniel; Coumailleau, Pascal			The Neurogenic Factor NeuroD1 Is Expressed in Post-Mitotic Cells during Juvenile and Adult Xenopus Neurogenesis and Not in Progenitor or Radial Glial Cells	PLOS ONE			English	Article							ZEBRAFISH BRAIN; NERVOUS-SYSTEM; HIPPOCAMPAL NEUROGENESIS; DIFFERENTIAL EXPRESSION; PROJECTION PATTERN; DENTATE GYRUS; LAEVIS; PROLIFERATION; PROTEINS; BETA2/NEUROD1	In contrast to mammals that have limited proliferation and neurogenesis capacities, the Xenopus frog exhibit a great potential regarding proliferation and production of new cells in the adult brain. This ability makes Xenopus a useful model for understanding the molecular programs required for adult neurogenesis. Transcriptional factors that control adult neurogenesis in vertebrate species undergoing widespread neurogenesis are unknown. NeuroD1 is a member of the family of proneural genes, which function during embryonic neurogenesis as a potent neuronal differentiation factor. Here, we study in detail the expression of NeuroD1 gene in the juvenile and adult Xenopus brains by in situ hybridization combined with immunodetections for proliferation markers (PCNA, BrdU) or in situ hybridizations for cell type markers (Vimentin, Sox2). We found NeuroD1 gene activity in many brain regions, including olfactory bulbs, pallial regions of cerebral hemispheres, preoptic area, habenula, hypothalamus, cerebellum and medulla oblongata. We also demonstrated by double staining NeuroD1/BrdU experiments, after long post-BrdU administration survival times, that NeuroD1 gene activity was turned on in new born neurons during post-metamorphic neurogenesis. Importantly, we provided evidence that NeuroD1-expressing cells at this brain developmental stage were post-mitotic (PCNA-) cells and not radial glial (Vimentin+) or progenitors (Sox2+) cells.	[D'Amico, Laure Anne; Boujard, Daniel; Coumailleau, Pascal] CNRS, Ctr Ressources Biol Xenope UMS U3387, Rennes, France; [D'Amico, Laure Anne; Boujard, Daniel; Coumailleau, Pascal] Univ Rennes 1, Rennes, France; [Coumailleau, Pascal] INSERM, IRSET U1085, Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm)	Coumailleau, P (corresponding author), CNRS, Ctr Ressources Biol Xenope UMS U3387, Rennes, France.	Pascal.coumailleau@univ-rennes1.fr	coumailleau, pascal/K-1697-2015		Bretagne region; Ministry of Nationale Education	Bretagne region(Region Bretagne); Ministry of Nationale Education	This research was supported by funds from the Bretagne region, the Ministry of Nationale Education and by an undergraduate fellowship from Bretagne region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; BARNEA A, 1994, P NATL ACAD SCI USA, V91, P11217, DOI 10.1073/pnas.91.23.11217; Chae JH, 2004, MOL CELLS, V18, P271; Chapouton P, 2007, BIOESSAYS, V29, P745, DOI 10.1002/bies.20615; Cho JH, 2006, DEV BIOL, V290, P125, DOI 10.1016/j.ydbio.2005.11.024; Cho JH, 2004, MOL NEUROBIOL, V30, P35, DOI 10.1385/MN:30:1:035; Coumailleau P, 2009, INT J DEV BIOL, V53, P149, DOI 10.1387/ijdb.082659pc; D'Amico LA, 2011, BRAIN RES, V1405, P31, DOI 10.1016/j.brainres.2011.06.032; Ganz J, 2012, J COMP NEUROL, V520, P633, DOI 10.1002/cne.22757; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Guillemot F, 2007, DEVELOPMENT, V134, P3771, DOI 10.1242/dev.006379; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; KAPLAN MS, 1984, J NEUROSCI, V4, P1429; Kaslin J, 2008, PHILOS T R SOC B, V363, P101, DOI 10.1098/rstb.2006.2015; Kiyota T, 2008, DEV BIOL, V315, P579, DOI 10.1016/j.ydbio.2007.12.013; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Lee JK, 2000, DEV DYNAM, V217, P361, DOI 10.1002/(SICI)1097-0177(200004)217:4<361::AID-DVDY3>3.0.CO;2-8; Lindsey BW, 2006, PROG NEUROBIOL, V80, P281, DOI 10.1016/j.pneurobio.2006.11.007; Liu M, 2000, GENE DEV, V14, P2839, DOI 10.1101/gad.840500; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; LOPEZGARCIA C, 1988, DEV BRAIN RES, V43, P167, DOI 10.1016/0165-3806(88)90096-X; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Marin O, 1998, J COMP NEUROL, V392, P285; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Mueller T, 2003, DEV BRAIN RES, V140, P137, DOI 10.1016/S0165-3806(02)00583-7; Mueller T, 2002, BRAIN RES BULL, V57, P377, DOI 10.1016/S0361-9230(01)00694-3; Nieber F, 2009, DEV DYNAM, V238, P451, DOI 10.1002/dvdy.21845; Nottebohm F, 2004, ANN NY ACAD SCI, V1016, P628, DOI 10.1196/annals.1298.027; Pellegrini E, 2007, J COMP NEUROL, V501, P150, DOI 10.1002/cne.21222; Perron M, 1999, P NATL ACAD SCI USA, V96, P14996, DOI 10.1073/pnas.96.26.14996; Pleasure SJ, 2000, J NEUROSCI, V20, P6095, DOI 10.1523/JNEUROSCI.20-16-06095.2000; Rogers CD, 2008, DEV BIOL, V313, P307, DOI 10.1016/j.ydbio.2007.10.023; Roth G, 2007, J COMP NEUROL, V501, P443, DOI 10.1002/cne.21255; Roybon L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004779; Roybon L, 2009, EUR J NEUROSCI, V29, P232, DOI 10.1111/j.1460-9568.2008.06595.x; Schlosser G, 2000, J COMP NEUROL, V418, P121; Schlosser G, 2003, CELL TISSUE RES, V312, P21, DOI 10.1007/s00441-003-0710-8; Schlosser G, 2002, DEV DYNAM, V225, P485, DOI 10.1002/dvdy.10179; Schwab MH, 2000, J NEUROSCI, V20, P3714, DOI 10.1523/JNEUROSCI.20-10-03714.2000; Seki T, 2002, J NEUROSCI RES, V70, P327, DOI 10.1002/jnr.10387; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Tuinhof R, 1998, CELL TISSUE RES, V292, P251, DOI 10.1007/s004410051056; Uittenbogaard M, 2000, NEUROSCI LETT, V280, P95, DOI 10.1016/S0304-3940(00)00761-8; Westhoff G, 2002, J COMP NEUROL, V445, P97, DOI 10.1002/cne.10136; Wullimann MF, 2005, J COMP NEUROL, V489, P387, DOI 10.1002/cne.20634; Yokoyama M, 1996, MOL BRAIN RES, V42, P135, DOI 10.1016/S0169-328X(96)00154-4; Yoshida M, 2001, J NEUROSCI RES, V63, P284, DOI 10.1002/1097-4547(20010201)63:3<284::AID-JNR1022>3.0.CO;2-6; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zupanc GKH, 2006, J COMP PHYSIOL A, V192, P649, DOI 10.1007/s00359-006-0104-y; Zupanc GKH, 2005, J COMP NEUROL, V488, P290, DOI 10.1002/cne.20571; Zupanc GKH, 2011, EUR J NEUROSCI, V34, P917, DOI 10.1111/j.1460-9568.2011.07854.x	56	32	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66487	10.1371/journal.pone.0066487	http://dx.doi.org/10.1371/journal.pone.0066487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799108	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300086
J	Ryu, YH; Kim, YH; Lee, JY; Shim, GB; Uhm, HS; Park, G; Choi, EH				Ryu, Young-Hyo; Kim, Yong-Hee; Lee, Jin-Young; Shim, Gun-Bo; Uhm, Han-Sup; Park, Gyungsoon; Choi, Eun Ha			Effects of Background Fluid on the Efficiency of Inactivating Yeast with Non-Thermal Atmospheric Pressure Plasma	PLOS ONE			English	Article							ESCHERICHIA-COLI; STERILIZATION; DISCHARGE; STRESS; WATER; DEGRADATION; BACTERIA	Non-thermal plasma at atmospheric pressure has been actively applied to sterilization. However, its efficiency for inactivating microorganisms often varies depending on microbial species and environments surrounding the microorganisms. We investigated the influence of environmental factors (surrounding media) on the efficiency of microbial inactivation by plasma using an eukaryotic model microbe, Saccharomyces cerevisiae, to elucidate the mechanisms for differential efficiency of sterilization by plasma. Yeast cells treated with plasma in water showed the most severe damage in viability and cell morphology as well as damage to membrane lipids, and genomic DNA. Cells in saline were less damaged compared to those in water, and those in YPD (Yeast extract, Peptone, Dextrose) were least impaired. HOG1 mitogen activated protein kinase was activated in cells exposed to plasma in water and saline. Inactivation of yeast cells in water and saline was due to the acidification of the solutions by plasma, but higher survival of yeast cells treated in saline may have resulted from the additional effect related to salt strength. Levels of hydroxyl radical (OH.) produced by plasma were the highest in water and the lowest in YPD. This may have resulted in differential inactivation of yeast cells in water, saline, and YPD by plasma. Taken together, our data suggest that the surrounding media (environment) can crucially affect the outcomes of yeast cell plasma treatment because-plasma modulates vital properties of media, and the toxic nature of plasma can also be altered by the surrounding media.	[Ryu, Young-Hyo; Kim, Yong-Hee; Lee, Jin-Young; Shim, Gun-Bo; Uhm, Han-Sup; Park, Gyungsoon; Choi, Eun Ha] Kwangwoon Univ, Plasma Biosci Res Ctr, Seoul, South Korea	Kwangwoon University	Park, G (corresponding author), Kwangwoon Univ, Plasma Biosci Res Ctr, Seoul, South Korea.	gyungp@kw.ac.kr; ehchoi@kw.ac.kr	Choi, Eun Ha/AFN-9488-2022	Choi, Eun Ha/0000-0001-5385-1878; Park, Gyungsoon/0000-0003-1592-3847	National Foundation of Korea (NRF); Korean Government (MEST) [2010-20100029418, 20110014825]	National Foundation of Korea (NRF)(National Research Foundation of Korea); Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Foundation of Korea (NRF) Grant funded by the Korean Government (MEST), No. 2010-20100029418 and No. 20110014825 (G. Park). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Monge R, 2009, CLIN MICROBIOL INFEC, V15, P17, DOI 10.1111/j.1469-0691.2008.02690.x; Avramidis G, 2010, SURF COAT TECH, V205, pS405, DOI 10.1016/j.surfcoat.2010.08.141; Bai MD, 2010, PLASMA CHEM PLASMA P, V30, P831, DOI 10.1007/s11090-010-9252-5; Baik KY, 2013, PLASMA PROCESS POLYM, V10, P235, DOI 10.1002/ppap.201200076; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Brown AJP, 2009, CURR OPIN MICROBIOL, V12, P384, DOI 10.1016/j.mib.2009.06.007; David A, 2010, PHYSIOL PLANTARUM, V140, P342, DOI 10.1111/j.1399-3054.2010.01408.x; De Geyter N, 2012, ANNU REV BIOMED ENG, V14, P255, DOI 10.1146/annurev-bioeng-071811-150110; Dobrynin D, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/10/103033; Gweon B, 2009, CURR APPL PHYS, V9, P625, DOI 10.1016/j.cap.2008.06.001; JAHN B, 1995, J CLIN MICROBIOL, V33, P661, DOI 10.1128/JCM.33.3.661-667.1995; Jones CA, 2007, MOL BIOL CELL, V18, P2123, DOI 10.1091/mbc.E06-03-0226; Kamgang-Youbi G, 2009, LETT APPL MICROBIOL, V48, P13, DOI 10.1111/j.1472-765X.2008.02476.x; Kanazawa S, 2011, PLASMA SOURCES SCI T, V20, DOI 10.1088/0963-0252/20/3/034010; Kang SK, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3574639; Kim KW, 2007, MICRON, V38, P626, DOI 10.1016/j.micron.2006.09.006; Korachi M, 2011, PLASMA SCI TECHNOL, V13, P99, DOI 10.1088/1009-0630/13/1/20; Korachi M, 2010, J ELECTROSTAT, V68, P508, DOI 10.1016/j.elstat.2010.06.014; Lee K, 2006, J MICROBIOL, V44, P269; Lerouge S., 2001, PLASMAS POLYM, V6, P175, DOI DOI 10.1023/A:1013196629791; McClung JM, 2010, AM J PHYSIOL-CELL PH, V298, pC542, DOI 10.1152/ajpcell.00192.2009; Muranyi P, 2007, J APPL MICROBIOL, V103, P1535, DOI 10.1111/j.1365-2672.2007.03385.x; Pang H, 2011, IEEE T PLASMA SCI, V39, P1689, DOI 10.1109/TPS.2011.2155104; Park G, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3684632; Park JC, 2004, J MICROBIOL BIOTECHN, V14, P188; Pavlovich MJ, 2013, PLASMA PROCESS POLYM, V10, P69, DOI 10.1002/ppap.201200073; Sambrook J, 2001, MOL CLONING LAB MANU; Shintani H, 2010, EXP THER MED, V1, P731, DOI 10.3892/etm.2010.136; Song HP, 2009, FOOD MICROBIOL, V26, P432, DOI 10.1016/j.fm.2009.02.010; Tang YZ, 2008, PLASMA PROCESS POLYM, V5, P552, DOI 10.1002/ppap.200800014; Tukmechi A, 2013, AQUA RES, P1; Wolf RA, 2013, ATMOSPHERIC PRESSURE, P181; Xiong Z, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3526678; Yang Y, 2013, ENVIRON SCI-PROC IMP, V15, P39, DOI 10.1039/c2em30655g	34	61	63	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66231	10.1371/journal.pone.0066231	http://dx.doi.org/10.1371/journal.pone.0066231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799081	gold, Green Published, Green Submitted			2022-12-25	WOS:000320363300066
J	Adamski, J; Price, A; Dive, C; Makin, G				Adamski, Jennifer; Price, Andrew; Dive, Caroline; Makin, Guy			Hypoxia-Induced Cytotoxic Drug Resistance in Osteosarcoma Is Independent of HIF-1Alpha	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; ETOPOSIDE-INDUCED APOPTOSIS; GROWTH-FACTOR EXPRESSION; BREAST-CANCER CELLS; P53-DEPENDENT APOPTOSIS; INDUCED CHEMORESISTANCE; NEUROBLASTOMA-CELLS; GLIOBLASTOMA CELLS; CONFERS PROTECTION; GENE-EXPRESSION	Survival rates from childhood cancer have improved dramatically in the last 40 years, such that over 80% of children are now cured. However in certain subgroups, including metastatic osteosarcoma, survival has remained stubbornly poor, despite dose intensive multi-agent chemotherapy regimens, and new therapeutic approaches are needed. Hypoxia is common in adult solid tumours and is associated with treatment resistance and poorer outcome. Hypoxia induces chemotherapy resistance in paediatric tumours including neuroblastoma, rhabdomyosarcoma and Ewing's sarcoma, in vitro, and this drug resistance is dependent on the oxygen-regulated transcription factor hypoxia inducible factor-1 (HIF-1). In this study the effects of hypoxia on the response of the osteosarcoma cell lines 791T, HOS and U2OS to the clinically relevant cytotoxics cisplatin, doxorubicin and etoposide were evaluated. Significant hypoxia-induced resistance to all three agents was seen in all three cell lines and hypoxia significantly reduced drug-induced apoptosis. Hypoxia also attenuated drug-induced activation of p53 in the p53 wild-type U2OS osteosarcoma cells. Drug resistance was not induced by HIF-1 alpha stabilisation in normoxia by cobalt chloride nor reversed by the suppression of HIF-1 alpha in hypoxia by shRNAi, siRNA, dominant negative HIF or inhibition with the small molecule NSC-134754, strongly suggesting that hypoxia-induced drug resistance in osteosarcoma cells is independent of HIF-1 alpha. Inhibition of the phosphoinositide 3-kinase (PI3K) pathway using the inhibitor PI-103 did not reverse hypoxia-induced drug resistance, suggesting the hypoxic activation of Akt in osteosarcoma cells does not play a significant role in hypoxia-induced drug resistance. Targeting hypoxia is an exciting prospect to improve current anti-cancer therapy and combat drug resistance. Significant hypoxia-induced drug resistance in osteosarcoma cells highlights the potential importance of hypoxia as a target to reverse drug resistance in paediatric osteosarcoma. The novel finding of HIF-1 alpha independent drug resistance suggests however other hypoxia related targets may be more relevant in paediatric osteosarcoma.	[Adamski, Jennifer; Price, Andrew; Dive, Caroline; Makin, Guy] Paterson Inst Canc Res, Manchester M20 9BX, Lancs, England; [Adamski, Jennifer; Dive, Caroline; Makin, Guy] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester Canc Res Ctr, Inst Canc Sci, Manchester, Lancs, England; [Adamski, Jennifer; Makin, Guy] Royal Manchester Childrens Hosp, Dept Paediat Oncol, Manchester M27 1HA, Lancs, England	Paterson Institute for Cancer Research; University of Manchester; Royal Manchester Children's Hospital	Makin, G (corresponding author), Paterson Inst Canc Res, Manchester M20 9BX, Lancs, England.	Guy.makin@manchester.ac.uk		Makin, Guy/0000-0003-3513-3957; Dive, Caroline/0000-0002-1726-8850	Friends of Rosie Children's Cancer Charity; Cancer Research United Kingdom; Christie Hospital endowment fund	Friends of Rosie Children's Cancer Charity; Cancer Research United Kingdom(Cancer Research UK); Christie Hospital endowment fund	This work was supported by the Friends of Rosie Children's Cancer Charity, Cancer Research United Kingdom and the Christie Hospital endowment fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achison M, 2003, ONCOGENE, V22, P3431, DOI 10.1038/sj.onc.1206434; Alvarez-Tejado M, 2001, J BIOL CHEM, V276, P22368, DOI 10.1074/jbc.M011688200; Blancher C, 2001, CANCER RES, V61, P7349; Boller YC, 2001, ONCOL RES, V12, P383, DOI 10.3727/096504001108747846; Brown LM, 2006, MOL PHARMACOL, V69, P411, DOI 10.1124/mol.105.015743; Carroll VA, 2006, CANCER RES, V66, P6264, DOI 10.1158/0008-5472.CAN-05-2519; Chau NM, 2005, CANCER RES, V65, P4918, DOI 10.1158/0008-5472.CAN-04-4453; Chen EY, 2001, CANCER RES, V61, P2429; Chen J, 2009, ONCOGENE, V28, P2581, DOI 10.1038/onc.2009.124; Chen WL, 2008, ORAL SURG ORAL MED O, V106, P254, DOI 10.1016/j.tripleo.2008.01.029; Clark AS, 2002, MOL CANCER THER, V1, P707; Comerford KM, 2002, CANCER RES, V62, P3387; Cosse JPJ, 2009, NEOPLASIA, V11, P976, DOI 10.1593/neo.09632; Dai S, 2003, INT J RADIAT ONCOL, V55, P1027, DOI 10.1016/S0360-3016(02)04507-8; Dai T, 2008, ACTA PHARMACOL SIN, V29, P1425, DOI 10.1111/j.1745-7254.2008.00904.x; Damia G, 2001, NEOPLASIA, V3, P10, DOI 10.1038/sj.neo.7900122; Dong Z, 2001, J BIOL CHEM, V276, P18702, DOI 10.1074/jbc.M011774200; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Erler JT, 2004, MOL CELL BIOL, V24, P2875, DOI 10.1128/MCB.24.7.2875-2889.2004; FLORENES VA, 1994, J NATL CANCER I, V86, P1297, DOI 10.1093/jnci/86.17.1297; Gatta G, 2003, ANN ONCOL, V14, pV119, DOI 10.1093/annonc/mdg755; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Graziani I, 2008, CANCER RES, V68, P9678, DOI 10.1158/0008-5472.CAN-08-0969; Hammond EM, 2005, BIOCHEM BIOPH RES CO, V331, P718, DOI 10.1016/j.bbrc.2005.03.154; Hao J, 2008, CANCER GENE THER, V15, P449, DOI 10.1038/cgt.2008.4; Harting MT, 2006, J PEDIATR SURG, V41, P194, DOI 10.1016/j.jpedsurg.2005.10.089; Hovelmann S, 2004, BRIT J CANCER, V90, P2370, DOI 10.1038/sj.bjc.6601876; Huang L, 2010, J CANCER RES CLIN, V136, P447, DOI 10.1007/s00432-009-0675-4; Hussein D, 2006, MOL CANCER THER, V5, P2241, DOI 10.1158/1535-7163.MCT-06-0145; Jackson MW, 2004, ONCOGENE, V23, P4477, DOI 10.1038/sj.onc.1207575; KALRA R, 1993, INT J CANCER, V54, P650, DOI 10.1002/ijc.2910540421; Kaya M, 2000, CLIN CANCER RES, V6, P572; Kilic M, 2007, ONCOGENE, V26, P2027, DOI 10.1038/sj.onc.1210008; Klymenko T, 2011, MOL CANCER THER, V10, P2373, DOI 10.1158/1535-7163.MCT-11-0326; Koch S, 2003, BRIT J CANCER, V89, P2133, DOI 10.1038/sj.bjc.6601375; Lee SM, 2006, CANCER LETT, V242, P231, DOI 10.1016/j.canlet.2005.11.001; LINK MP, 1986, NEW ENGL J MED, V314, P1600, DOI 10.1056/NEJM198606193142502; Liu LL, 2008, CANCER SCI, V99, P121, DOI 10.1111/j.1349-7006.2007.00643.x; Liu XW, 2010, PHARMACOL RES, V62, P416, DOI 10.1016/j.phrs.2010.07.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MEYERS PA, 1993, J CLIN ONCOL, V11, P449, DOI 10.1200/JCO.1993.11.3.449; Mizobuchi H, 2008, CLIN ORTHOP RELAT R, V466, P2052, DOI 10.1007/s11999-008-0328-y; Opel D, 2008, CANCER RES, V68, P6271, DOI 10.1158/0008-5472.CAN-07-6769; Park SY, 2002, BIOCHEM BIOPH RES CO, V291, P150, DOI 10.1006/bbrc.2002.6421; Piret JP, 2006, EXP CELL RES, V312, P2908, DOI 10.1016/j.yexcr.2006.05.018; Ravizza R, 2009, EUR J CANCER, V45, P890, DOI 10.1016/j.ejca.2008.12.021; Risbud MV, 2005, SPINE, V30, P2503, DOI 10.1097/01.brs.0000186326.82747.13; Roberts AM, 2009, CANCER RES, V69, P9056, DOI 10.1158/0008-5472.CAN-09-1770; Roberts DL, 2009, BRIT J CANCER, V101, P1290, DOI 10.1038/sj.bjc.6605311; Rohwer N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012038; Sabbatini P, 1999, J BIOL CHEM, V274, P24263, DOI 10.1074/jbc.274.34.24263; Schnitzer SE, 2006, CELL DEATH DIFFER, V13, P1611, DOI 10.1038/sj.cdd.4401864; Selvendiran K, 2009, INT J CANCER, V125, P2198, DOI 10.1002/ijc.24601; Sermeus A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-27; Song JR, 2009, AUTOPHAGY, V5, P1131, DOI 10.4161/auto.5.8.9996; Song XR, 2006, CANCER CHEMOTH PHARM, V58, P776, DOI 10.1007/s00280-006-0224-7; Stiller CA, 2007, CANCER TREAT REV, V33, P631, DOI 10.1016/j.ctrv.2007.01.001; Sullivan R, 2008, MOL CANCER THER, V7, P1961, DOI 10.1158/1535-7163.MCT-08-0198; Sullivan R, 2009, MOL CANCER THER, V8, P1702, DOI 10.1158/1535-7163.MCT-08-1090; TEICHER BA, 1981, CANCER RES, V41, P73; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang DD, 2010, PHARMAZIE, V65, P51, DOI 10.1691/ph.2010.9618; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang JZ, 2006, J AM SOC NEPHROL, V17, P1875, DOI 10.1681/ASN.2005121371; Yang QC, 2007, JPN J CLIN ONCOL, V37, P127, DOI 10.1093/jjco/hyl137; Yokoi K, 2004, CLIN CANCER RES, V10, P2299, DOI 10.1158/1078-0432.CCR-03-0488; Yuan XW, 2007, ACTA PHARMACOL SIN, V28, P1835, DOI 10.1111/j.1745-7254.2007.00662.x; Zhang L, 2004, CANCER RES, V64, P4180, DOI 10.1158/0008-5472.CAN-03-3038	71	56	59	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65304	10.1371/journal.pone.0065304	http://dx.doi.org/10.1371/journal.pone.0065304			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785417	Green Published, gold, Green Submitted			2022-12-25	WOS:000321038800103
J	Hoesein, FAAM; de Jong, PA; Lammers, JWJ; Mali, WP; Schmidt, M; de Koning, HJ; van der Aalst, C; Oudkerk, M; Vliegenthart, R; van Ginneken, B; van Rikxoort, EM; Zanen, P				Hoesein, Firdaus A. A. Mohamed; de Jong, Pim A.; Lammers, Jan-Willem J.; Mali, Willem PThM; Schmidt, Michael; de Koning, Harry J.; van der Aalst, Carlijn; Oudkerk, Matthijs; Vliegenthart, Rozemarijn; van Ginneken, Bram; van Rikxoort, Eva M.; Zanen, Pieter			Computed Tomography Structural Lung Changes in Discordant Airflow Limitation	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; FEV1/FVC LESS-THAN-0.70; DIAGNOSING COPD; EMPHYSEMA; POPULATION; PREVALENCE; RISK; ASSOCIATION; THRESHOLDS; BURDEN	Background: There is increasing evidence that structural lung changes may be present before the occurrence of airflow limitation as assessed by spirometry. This study investigated the prevalence of computed tomography (CT) quantified emphysema, airway wall thickening and gas trapping according to classification of airflow limitation (FEV1/FVC <70% and/or < the lower limit of normal (LLN)) in (heavy) smokers. Methods: A total number of 1,140 male former and current smokers participating in a lung cancer screenings trial (NELSON) were included and underwent chest CT scanning and spirometry. Emphysema was quantified by the 15th percentile, air way wall thickening by the square root of wall area for a theoretical airway with 10mm lumen perimeter (Pi10) and gas trapping by the mean lung density expiratory/inspiratory (E/I)-ratio. Participants were classified by entry FEV1/FVC: group 1>70%; group 2<70% but >LLN; and group 3<LLN. 32 restricted subjects, i.e. FEV1/FVC >70% but FEV1 <80% predicted, were excluded. Multivariate regression analysis correcting for covariates was used to asses the extent of emphysema, airway wall thickening and gas trapping according to three groups of airflow limitation. Results: Mean (standard deviation) age was 62.5 (5.2) years and packyears smoked was 41.0 (18.0). Group 2 subjects when compared to group 1 had a significantly lower 15th percentile, -920.6 HU versus -912.2 HU; a higher Pi10, 2.87 mm versus 2.57 mm; and a higher E/I-ratio, 88.6% versus 85.6% (all p<0.001). Conclusion: Subjects with an FEV1/FVC <70%, but above the LLN, have a significant greater degree of structural lung changes on CT compared to subjects without airflow limitation.	[Hoesein, Firdaus A. A. Mohamed; Lammers, Jan-Willem J.; Zanen, Pieter] Univ Med Ctr Utrecht, Dept Resp Med, Div Heart & Lungs, Utrecht, Netherlands; [Hoesein, Firdaus A. A. Mohamed; de Jong, Pim A.; Mali, Willem PThM] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Schmidt, Michael] Inst Med Image Comp, Fraunhofer MEVIS, Bremen, Germany; [de Koning, Harry J.; van der Aalst, Carlijn] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Oudkerk, Matthijs] Univ Groningen, Univ Med Ctr Groningen, Ctr Med Imaging North East Netherlands, Groningen, Netherlands; [Vliegenthart, Rozemarijn] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands; [van Ginneken, Bram; van Rikxoort, Eva M.] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6525 ED Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; University of Groningen; University of Groningen; Radboud University Nijmegen	Hoesein, FAAM (corresponding author), Univ Med Ctr Utrecht, Dept Resp Med, Div Heart & Lungs, Utrecht, Netherlands.	fmohamedhoesein@gmail.com	de+Koning, Harry/AAF-9062-2019; van Rikxoort, Eva/P-2640-2014; Mali, Willem PThM/I-1123-2014; van Ginneken, Bram/A-3728-2012; van der Aalst, Carlijn/AAG-7522-2019; de Jong, Pim A/G-7220-2014	de+Koning, Harry/0000-0003-4682-3646; van Rikxoort, Eva/0000-0001-6418-9760; Mali, Willem PThM/0000-0003-4391-0904; van Ginneken, Bram/0000-0003-2028-8972; de Jong, Pim A/0000-0003-4840-6854; zanen, pieter/0000-0002-5318-8276; Oudkerk, Matthijs/0000-0003-2800-4110	European Union (EU) Framework Package Seven (FP7) [201379]; Netherlands Organisation for Health Research and Development (ZonMw); Dutch Cancer Society Koningin Wilhelmina Fonds (KWF); Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen (RvvZ); Siemens Germany; Roche Diagnostics; Rotterdam Oncologic Thoracic Steering committee (ROTS); G.Ph.Verhagen Trust; Flemish League Against Cancer; Foundation Against Cancer; Erasmus Trust Fund	European Union (EU) Framework Package Seven (FP7); Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Dutch Cancer Society Koningin Wilhelmina Fonds (KWF); Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen (RvvZ); Siemens Germany(Siemens AG); Roche Diagnostics; Rotterdam Oncologic Thoracic Steering committee (ROTS); G.Ph.Verhagen Trust; Flemish League Against Cancer; Foundation Against Cancer; Erasmus Trust Fund	Funding was provided by European Union (EU) Framework Package Seven (FP7), grant number 201379, COPACETIC. The NELSON-trial was sponsored by: Netherlands Organisation for Health Research and Development (ZonMw); Dutch Cancer Society Koningin Wilhelmina Fonds (KWF); Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen (RvvZ); Siemens Germany; Roche Diagnostics; Rotterdam Oncologic Thoracic Steering committee (ROTS); and G.Ph.Verhagen Trust, Flemish League Against Cancer, Foundation Against Cancer and Erasmus Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; HK is member of the medical advisory board of Roche Diagnostics. Siemens Germany and Roche Diagnostics provided funding towards this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Baggerman W., 2009, P 2 INT WORKSH PULM, P341; BARBERA JA, 1994, AM J RESP CRIT CARE, V149, P423, DOI 10.1164/ajrccm.149.2.8306040; Bednarek M, 2008, THORAX, V63, P402, DOI 10.1136/thx.2007.085456; Celli BR, 2010, CHEST, V138, P1037, DOI 10.1378/chest.10-2049; Danielsson P, 2012, CLIN RESPIR J, V6, P120, DOI 10.1111/j.1752-699X.2011.00257.x; Garcia-Rio F, 2011, CHEST, V139, P1072, DOI 10.1378/chest.10-1721; Grydeland TB, 2009, EUR RESPIR J, V34, P858, DOI 10.1183/09031936.00167908; Hackx M, 2012, RADIOLOGY, V265, P34, DOI 10.1148/radiol.12111270; Hoesein FAAM, 2011, EUR RESPIR J, V38, P1012, DOI 10.1183/09031936.00050711; Hoesein FAAM, 2012, COPD, V9, P338, DOI 10.3109/15412555.2012.667851; Hoesein FAAM, 2011, THORAX, V66, P782, DOI 10.1136/thx.2010.145995; Hoesein FAAM, 2011, RESP MED, V105, P907, DOI 10.1016/j.rmed.2011.01.008; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Alonso JLI, 2012, ARCH BRONCONEUMOL, V48, P223, DOI 10.1016/j.arbres.2012.02.007; Jordan RE, 2010, THORAX, V65, P492, DOI 10.1136/thx.2009.129395; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mannino DM, 2012, CHEST, V141, P73, DOI 10.1378/chest.11-0797; Mets OM, 2011, JAMA-J AM MED ASSOC, V306, P1775, DOI 10.1001/jama.2011.1531; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Ofir D, 2008, AM J RESP CRIT CARE, V177, P622, DOI 10.1164/rccm.200707-1064OC; Patel BD, 2008, AM J RESP CRIT CARE, V178, P500, DOI 10.1164/rccm.200801-059OC; Prentice HA, 2010, COPD, V7, P323, DOI 10.3109/15412555.2010.510161; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rodriguez-Roisin R, 2009, J APPL PHYSIOL, V106, P1902, DOI 10.1152/japplphysiol.00085.2009; Schilham AMR, 2006, IEEE T MED IMAGING, V25, P451, DOI 10.1109/TMI.2006.871545; Schmidt M, 2010, P SPIE SPIE, V7624; van Iersel CA, 2007, INT J CANCER, V120, P868, DOI 10.1002/ijc.22134; van Rikxoort EM, 2009, MED PHYS, V36, P2934, DOI 10.1118/1.3147146; Vestbo J, 2012, AM J RESP CRIT CARE, DOI [10.1164/rccm.201204-0596, DOI 10.1164/RCCM.201204-0596]	29	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65177	10.1371/journal.pone.0065177	http://dx.doi.org/10.1371/journal.pone.0065177			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785411	Green Published, gold, Green Submitted			2022-12-25	WOS:000321038800109
J	Meseda, CA; Campbell, J; Kumar, A; Garcia, AD; Merchlinsky, M; Weir, JP				Meseda, Clement A.; Campbell, Joseph; Kumar, Arunima; Garcia, Alonzo D.; Merchlinsky, Michael; Weir, Jerry P.			Effect of the Deletion of Genes Encoding Proteins of the Extracellular Virion Form of Vaccinia Virus on Vaccine Immunogenicity and Protective Effectiveness in the Mouse Model	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSE; OUTER-MEMBRANE PROTEINS; 2 INFECTIOUS FORMS; SMALLPOX VACCINE; DNA VACCINE; NEUTRALIZING ANTIBODY; ENVELOPE PROTEIN; MONKEYPOX; MICE; ANTIGENS	Antibodies to both infectious forms of vaccinia virus, the mature virion (MV) and the enveloped virion (EV), as well as cell-mediated immune response appear to be important for protection against smallpox. EV virus particles, although more labile and less numerous than MV, are important for dissemination and spread of virus in infected hosts and thus important in virus pathogenesis. The importance of the EV A33 and B5 proteins for vaccine induced immunity and protection in a murine intranasal challenge model was evaluated by deletion of both the A33R and B5R genes in a vaccine-derived strain of vaccinia virus. Deletion of either A33R or B5R resulted in viruses with a small plaque phenotype and reduced virus yields, as reported previously, whereas deletion of both EV proteinen-coding genes resulted in a virus that formed small infection foci that were detectable and quantifiable only by immunostaining and an even more dramatic decrease in total virus yield in cell culture. Deletion of B5R, either as a single gene knockout or in the double EV gene knockout virus, resulted in a loss of EV neutralizing activity, but all EV gene knockout viruses still induced a robust neutralizing activity against the vaccinia MV form of the virus. The effect of elimination of A33 and/or B5 on the protection afforded by vaccination was evaluated by intranasal challenge with a lethal dose of either vaccinia virus WR or IHD-J, a strain of vaccinia virus that produces relatively higher amounts of EV virus. The results from multiple experiments, using a range of vaccination doses and virus challenge doses, and using mortality, morbidity, and virus dissemination as endpoints, indicate that the absence of A33 and B5 have little effect on the ability of a vaccinia vaccine virus to provide protection against a lethal intranasal challenge in a mouse model.	[Meseda, Clement A.; Campbell, Joseph; Kumar, Arunima; Garcia, Alonzo D.; Merchlinsky, Michael; Weir, Jerry P.] US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Meseda, CA (corresponding author), US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA.	Clement.Meseda@fda.hhs.gov	Meseda, Clement/I-6336-2019		US Food and Drug Administration [Y1-AI-6153-01]; National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIAID) [Y1-AI-6153-01]	US Food and Drug Administration; National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIAID)	Funding for this work was partly provided by an Inter- Agency Agreement between the US Food and Drug Administration and the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIAID Agreement number Y1-AI-6153-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo JE, 2009, J GEN VIROL, V90, P2604, DOI 10.1099/vir.0.008474-0; Arness MK, 2004, AM J EPIDEMIOL, V160, P642, DOI 10.1093/aje/kwh269; Bell E, 2004, VIROLOGY, V325, P425, DOI 10.1016/j.virol.2004.05.004; Benhnia MREI, 2008, J VIROL, V82, P3751, DOI 10.1128/JVI.02244-07; BOULTER EA, 1971, AM J EPIDEMIOL, V94, P612, DOI 10.1093/oxfordjournals.aje.a121360; Breman JG, 2002, NEW ENGL J MED, V346, P1300, DOI 10.1056/NEJMra020025; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102; DUNCAN SA, 1992, J VIROL, V66, P1610, DOI 10.1128/JVI.66.3.1610-1621.1992; Earl PL, 1998, CURRENT PROTOCOLS MO; Empig C, 2006, VACCINE, V24, P3686, DOI 10.1016/j.vaccine.2005.03.029; ENGELSTAD M, 1993, VIROLOGY, V194, P627, DOI 10.1006/viro.1993.1302; Fang M, 2006, VIROLOGY, V345, P231, DOI 10.1016/j.virol.2005.09.056; Fogg C, 2004, J VIROL, V78, P10230, DOI 10.1128/JVI.78.19.10230-10237.2004; Fulginiti VA, 2003, CLIN INFECT DIS, V37, P241, DOI 10.1086/375824; Galmiche MC, 1999, VIROLOGY, V254, P71, DOI 10.1006/viro.1998.9516; Garcia AD, 2007, CLIN VACCINE IMMUNOL, V14, P1032, DOI 10.1128/CVI.00050-07; GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2; Golden JW, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-441; Halsell JS, 2003, JAMA-J AM MED ASSOC, V289, P3283, DOI 10.1001/jama.289.24.3283; Heymann DL, 1998, BRIT MED BULL, V54, P693, DOI 10.1093/oxfordjournals.bmb.a011720; Hooper JW, 2004, J VIROL, V78, P4433, DOI 10.1128/JVI.78.9.4433-4443.2004; Jezek Z, 1988, HUMAN MONKEYPOX; Jing LC, 2005, J IMMUNOL, V175, P7550, DOI 10.4049/jimmunol.175.11.7550; Jones-Trower A, 2005, VIROLOGY, V343, P128, DOI 10.1016/j.virol.2005.08.008; Kidokoro M, 2005, P NATL ACAD SCI USA, V102, P4152, DOI 10.1073/pnas.0406671102; KOTWAL GJ, 1988, VIROLOGY, V167, P524, DOI 10.1016/S0042-6822(88)90115-8; LENNETTE EH, 1964, DIAGNOSTIC PROCEDURE, P45; Lustig S, 2004, VIROLOGY, V328, P30, DOI 10.1016/j.virol.2004.07.024; Meseda CA, 2005, VIROLOGY, V339, P164, DOI 10.1016/j.virol.2005.06.002; Meseda CA, 2002, J INFECT DIS, V186, P1065, DOI 10.1086/344234; Meseda CA, 2010, FUTURE MICROBIOL, V5, P1367, DOI 10.2217/FMB.10.98; Meseda CA, 2009, CLIN VACCINE IMMUNOL, V16, P1261, DOI 10.1128/CVI.00040-09; Meyer H, 2002, J CLIN MICROBIOL, V40, P2919, DOI 10.1128/JCM.40.8.2919-2921.2002; Moss B, 2011, IMMUNOL REV, V239, P8, DOI 10.1111/j.1600-065X.2010.00975.x; Orr N, 2004, J INFECT DIS, V190, P1295, DOI 10.1086/423851; Pelkonen PM, 2003, EMERG INFECT DIS, V9, P1458, DOI 10.3201/eid0911.020814; Putz MM, 2006, NAT MED, V12, P1310, DOI 10.1038/nm1457; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Roberts KL, 2008, TRENDS MICROBIOL, V16, P472, DOI 10.1016/j.tim.2008.07.009; Roper RL, 1998, J VIROL, V72, P4192, DOI 10.1128/JVI.72.5.4192-4204.1998; Saijo M, 2006, J VIROL, V80, P5179, DOI 10.1128/JVI.02642-05; Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/0022-1317-83-12-2915; TURNER GS, 1971, J GEN VIROL, V13, P19, DOI 10.1099/0022-1317-13-1-19; Viner KM, 2005, MICROBES INFECT, V7, P579, DOI 10.1016/j.micinf.2005.02.004; Vorou RM, 2008, CURR OPIN INFECT DIS, V21, P153, DOI 10.1097/QCO.0b013e3282f44c74; Weltzin R, 2003, NAT MED, V9, P1125, DOI 10.1038/nm916; WOLFFE EJ, 1993, J VIROL, V67, P4732, DOI 10.1128/JVI.67.8.4732-4741.1993; Wyatt LS, 2004, P NATL ACAD SCI USA, V101, P4590, DOI 10.1073/pnas.0401165101; Wyatt LS, 1996, VACCINE, V14, P1451, DOI 10.1016/S0264-410X(96)00072-2; Xu R, 2004, J IMMUNOL, V172, P6265, DOI 10.4049/jimmunol.172.10.6265; Yadav S, 2010, ARCH VIROL, V155, P255, DOI 10.1007/s00705-009-0562-y; Zaitseva M, 2011, J VIROL, V85, P9147, DOI 10.1128/JVI.00121-11; Zaitseva M, 2009, J VIROL, V83, P10437, DOI 10.1128/JVI.01296-09	54	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e67984	10.1371/journal.pone.0067984	http://dx.doi.org/10.1371/journal.pone.0067984			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785523	Green Published, gold, Green Submitted			2022-12-25	WOS:000321038800001
J	Surova, Y; Szczepankiewicz, F; Latt, J; Nilsson, M; Eriksson, B; Leemans, A; Hansson, O; van Westen, D; Nilsson, C				Surova, Yulia; Szczepankiewicz, Filip; Latt, Jimmy; Nilsson, Markus; Eriksson, Bengt; Leemans, Alexander; Hansson, Oskar; van Westen, Danielle; Nilsson, Christer			Assessment of Global and Regional Diffusion Changes along White Matter Tracts in Parkinsonian Disorders by MR Tractography	PLOS ONE			English	Article							MULTIPLE-SYSTEM ATROPHY; PROGRESSIVE SUPRANUCLEAR PALSY; VOXEL BASED MORPHOMETRY; MEAN DIFFUSIVITY; CORPUS-CALLOSUM; HUMAN BRAIN; DISEASE; DIAGNOSIS; VARIANT; CINGULUM	Purpose: The aim of the study was to determine the usefulness of diffusion tensor tractography (DTT) in parkinsonian disorders using a recently developed method for normalization of diffusion data and tract size along white matter tracts. Furthermore, the use of DTT in selected white matter tracts for differential diagnosis was assessed. Methods: We quantified global and regional diffusion parameters in major white matter tracts in patients with multiple system atrophy (MSA), progressive nuclear palsy (PSP), idiopathic Parkinson's disease (IPD) and healthy controls). Diffusion tensor imaging data sets with whole brain coverage were acquired at 3 T using 48 diffusion encoding directions and a voxel size of 26262 mm(3). DTT of the corpus callosum (CC), cingulum (CG), corticospinal tract (CST) and middle cerebellar peduncles (MCP) was performed using multiple regions of interest. Regional evaluation comprised projection of fractional anisotropy (FA), mean diffusivity (MD), radial diffusivity (RD) and the apparent area coefficient (AAC) onto a calculated mean tract and extraction of their values along each structure. Results: There were significant changes of global DTT parameters in the CST (MSA and PSP), CC (PSP) and CG (PSP). Consistent tract-specific variations in DTT parameters could be seen along each tract in the different patient groups and controls. Regional analysis demonstrated significant changes in the anterior CC (MD, RD and FA), CST (MD) and CG (AAC) of patients with PSP compared to controls. Increased MD in CC and CST, as well as decreased AAC in CG, was correlated with a diagnosis of PSP compared to IPD. Conclusions: DTT can be used for demonstrating disease-specific regional white matter changes in parkinsonian disorders. The anterior portion of the CC was identified as a promising region for detection of neurodegenerative changes in patients with PSP, as well as for differential diagnosis between PSP and IPD.	[Surova, Yulia; Eriksson, Bengt; Hansson, Oskar; van Westen, Danielle] Lund Univ, Dept Clin Sci, Lund, Sweden; [Surova, Yulia] Skane Univ Hosp, Dept Neurol Lund, Lund, Sweden; [Szczepankiewicz, Filip] Lund Univ, Dept Med Radiat Phys, Lund, Sweden; [Latt, Jimmy; van Westen, Danielle] Skane Univ Hosp, Ctr Med Imaging & Physiol, Lund, Sweden; [Nilsson, Markus] Lund Univ, Bioimaging Ctr, Lund, Sweden; [Eriksson, Bengt; Hansson, Oskar; Nilsson, Christer] Lund Univ, Dept Clin Sci Malmo, Clin Memory Res Unit, Lund, Sweden; [Leemans, Alexander] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands	Lund University; Lund University; Skane University Hospital; Lund University; Lund University; Skane University Hospital; Lund University; Lund University; Utrecht University; Utrecht University Medical Center	Surova, Y (corresponding author), Lund Univ, Dept Clin Sci, Lund, Sweden.	yulia.surova@med.lu.se	Leemans, Alexander/A-1784-2011; Szczepankiewicz, Filip/AAV-9958-2021; Hansson, Oskar/A-7134-2013; Nilsson, Markus/C-6920-2012	Leemans, Alexander/0000-0002-9306-6126; Szczepankiewicz, Filip/0000-0002-5251-587X; Hansson, Oskar/0000-0001-8467-7286; Nilsson, Markus/0000-0002-3140-8223; van Westen, Danielle/0000-0001-8649-9874	Swedish Parkinson foundation; Swedish Science Council through the Linnaeus project BAGADILICO; Swedish Parkinson Academy; province of Skane University Hospital; ALF; Swedish Cancer Society [CAN 2009/1076, CAN 2012/597]	Swedish Parkinson foundation; Swedish Science Council through the Linnaeus project BAGADILICO; Swedish Parkinson Academy; province of Skane University Hospital; ALF; Swedish Cancer Society(Swedish Cancer Society)	This research was supported by the Swedish Parkinson foundation, the Swedish Science Council grants through the Linnaeus project BAGADILICO, the Swedish Parkinson Academy and research funds from province of Skane University Hospital and state grants (inclusively ALF) and in part by the Swedish Cancer Society (GrantNo CAN 2009/1076 and CAN 2012/597). The funders had no role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	[Anonymous], 2013, MAGMA IN PRESS; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Brenneis C, 2004, J NEUROL NEUROSUR PS, V75, P246; CALNE DB, 1992, ANN NEUROL, V32, pS125, DOI 10.1002/ana.410320721; Canu E, 2011, MOVEMENT DISORD, V26, P1752, DOI 10.1002/mds.23739; Colby JB, 2012, NEUROIMAGE, V59, P3227, DOI 10.1016/j.neuroimage.2011.11.004; Cordato NJ, 2005, BRAIN, V128, P1259, DOI 10.1093/brain/awh508; Deprez S, 2013, BRAIN IMAGI IN PRESS, V18; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Erbetta A, 2009, AM J NEURORADIOL, V30, P1482, DOI 10.3174/ajnr.A1615; Fillard P, 2003, LECT NOTES COMPUT SC, V2879, P16; Gilman S, 1999, J NEUROL SCI, V163, P94, DOI 10.1016/S0022-510X(98)00304-9; Gong GL, 2005, HUM BRAIN MAPP, V24, P92, DOI 10.1002/hbm.20072; Hattori T, 2012, HUM BRAIN MAPP, V33, P727, DOI 10.1002/hbm.21245; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Hrabetova S, 2007, FRONT NEUROENG, V1, P167; Hsu JL, 2008, NEUROIMAGE, V39, P566, DOI 10.1016/j.neuroimage.2007.09.017; Hsu JL, 2010, NEUROIMAGE, V49, P32, DOI 10.1016/j.neuroimage.2009.08.031; Hughes AJ, 2002, BRAIN, V125, P861, DOI 10.1093/brain/awf080; Ito S, 2008, NEURORADIOLOGY, V50, P981, DOI 10.1007/s00234-008-0447-x; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Jeurissen B, 2011, HUM BRAIN MAPP, V32, P461, DOI 10.1002/hbm.21032; Jones DK, 2011, METHODS MOL BIOL, V711, P127, DOI 10.1007/978-1-61737-992-5_6; Kamagata K, 2012, AM J NEURORADIOL, V33, P890, DOI 10.3174/ajnr.A2860; Kamagata K, 2013, EUR RADIOL IN PRESS, P13; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Knake S, 2010, MOVEMENT DISORD, V25, P1232, DOI 10.1002/mds.23054; Kollensperger M, 2007, MOVEMENT DISORD, V22, P1771, DOI 10.1002/mds.21614; Kollensperger M, 2010, MOVEMENT DISORD, V25, P2604, DOI 10.1002/mds.23192; KUME A, 1993, J NEUROL SCI, V117, P33, DOI 10.1016/0022-510X(93)90151-N; Kvickstrom P, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-13; Lee CEC, 2009, NEURORADIOLOGY, V51, P3, DOI 10.1007/s00234-008-0441-3; Leemans, 2009, P INT SOC MAG RESON, V245, P3537, DOI DOI 10.1093/occmed/kqr069; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Lim KO, 1999, ARCH GEN PSYCHIAT, V56, P367, DOI 10.1001/archpsyc.56.4.367; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Makino T, 2011, J NEUROL SCI, V303, P61, DOI 10.1016/j.jns.2011.01.014; Martensson J, 2011, P INT SOC MAG RESON, P4876; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Muller MJ, 2007, NEUROBIOL AGING, V28, P398, DOI 10.1016/j.neurobiolaging.2006.01.009; Nicoletti G, 2008, MOVEMENT DISORD, V23, P2370, DOI 10.1002/mds.22279; Nilsson C, 2007, NEURORADIOLOGY, V49, P111, DOI 10.1007/s00234-006-0165-1; Nucifora PGP, 2007, RADIOLOGY, V245, P367, DOI 10.1148/radiol.2452060445; Padovani A, 2006, J NEUROL NEUROSUR PS, V77, P457, DOI 10.1136/jnnp.2005.075713; Paviour DC, 2007, MOVEMENT DISORD, V22, P68, DOI 10.1002/mds.21204; Peran P, 2010, BRAIN, V133, P3423, DOI 10.1093/brain/awq212; Piccini P, 2006, MOVEMENT DISORD, V21, P2035, DOI 10.1002/mds.20845; Reich DS, 2006, AM J NEURORADIOL, V27, P2168; Salat DH, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P205, DOI 10.1016/B978-0-12-374709-9.00010-9; Schocke MFH, 2004, NEUROIMAGE, V21, P1443, DOI 10.1016/j.neuroimage.2003.12.005; Schocke MFH, 2002, NEUROLOGY, V58, P575, DOI 10.1212/WNL.58.4.575; Seppi K, 2003, NEUROLOGY, V60, P922, DOI 10.1212/01.WNL.0000049911.91657.9D; Seppi K, 2006, NEUROIMAGE, V31, P240, DOI 10.1016/j.neuroimage.2005.12.006; Shiga K, 2005, J NEUROL, V252, P589, DOI 10.1007/s00415-005-0708-0; Stieltjes B, 2001, NEUROIMAGE, V14, P723, DOI 10.1006/nimg.2001.0861; Szczepankiewicz F, 2012, P INT SOC MAG RESON, P3628; Tha KK, 2010, RADIOLOGY, V255, P563, DOI 10.1148/radiol.10090988; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Tsukamoto K, 2012, NEURORADIOLOGY, V54, P947, DOI 10.1007/s00234-012-1009-9; Vaillancourt DE, 2009, NEUROLOGY, V72, P1378, DOI 10.1212/01.wnl.0000340982.01727.6e; Van Camp N, 2009, NMR BIOMED, V22, P697, DOI 10.1002/nbm.1381; Vos SB, 2012, NEUROIMAGE, V59, P2208, DOI 10.1016/j.neuroimage.2011.09.086; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wang HC, 2012, ARCH NEUROL-CHICAGO, V23, P1, DOI DOI 10.1001/ARCHNEUR0L.2012.633; Wang JJ, 2010, J MAGN RESON IMAGING, V32, P69, DOI 10.1002/jmri.22229; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Wenning GK, 1997, MOVEMENT DISORD, V12, P133, DOI 10.1002/mds.870120203; Whitwell JL, 2011, ARCH NEUROL-CHICAGO, V68, P753, DOI 10.1001/archneurol.2011.107; Xu DR, 2002, NEUROIMAGE, V17, P1131, DOI 10.1006/nimg.2002.1285; Yoshikawa K, 2004, J NEUROL NEUROSUR PS, V75, P481, DOI 10.1136/jnnp.2003.021873; Zhan W, 2012, MOVEMENT DISORD, V27, P90, DOI 10.1002/mds.23917; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01	74	24	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66022	10.1371/journal.pone.0066022	http://dx.doi.org/10.1371/journal.pone.0066022			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785466	Green Published, gold, Green Submitted			2022-12-25	WOS:000321038800056
J	Tan, K; Yang, S; Wang, ZW; Menzel, R				Tan, Ken; Yang, Shuang; Wang, Zhengwei; Menzel, Randolf			Effect of Flumethrin on Survival and Olfactory Learning in Honeybees	PLOS ONE			English	Article							PROBOSCIS EXTENSION; BEES HYMENOPTERA; TOXICITY; PESTICIDES; EXPOSURE; SPERMATOGENESIS; FLUVALINATE; COUMAPHOS; VARROA; APIDAE	Flumethrin has been widely used as an acaricide for the control of Varroa mites in commercial honeybee keeping throughout the world for many years. Here we test the mortality of the Asian honeybee Apis cerana cerana after treatment with flumethrin. We also ask (1) how bees react to the odor of flumethrin, (2) whether its odor induces an innate avoidance response, (3) whether its taste transmits an aversive reinforcing component in olfactory learning, and (4) whether its odor or taste can be associated with reward in classical conditioning. Our results show that flumethrin has a negative effect on Apis cerana's lifespan, induces an innate avoidance response, acts as a punishing reinforcer in olfactory learning, and interferes with the association of an appetitive conditioned stimulus. Furthermore flumethrin uptake within the colony reduces olfactory learning over an extended period of time.	[Tan, Ken] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Peoples R China; [Tan, Ken; Yang, Shuang; Wang, Zhengwei] Yunnan Agr Univ, Eastern Bee Res Inst, Kunming, Peoples R China; [Menzel, Randolf] Free Univ Berlin, Inst Biol & Neurobiol, Berlin, Germany	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Yunnan Agricultural University; Free University of Berlin	Tan, K (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Peoples R China.	kentan@xtbg.ac.cn			Key Laboratory of Tropical Forest Ecology, Xishuangbanna Tropical Botanical Garden, Chinese Academy of Science; China National Research Fund [31260585]; China National Agricultural Production Systematic Fund [CARS-45-kxj14]	Key Laboratory of Tropical Forest Ecology, Xishuangbanna Tropical Botanical Garden, Chinese Academy of Science(Chinese Academy of Sciences); China National Research Fund; China National Agricultural Production Systematic Fund	This work was supported by the Key Laboratory of Tropical Forest Ecology, Xishuangbanna Tropical Botanical Garden, Chinese Academy of Science, China National Research Fund (31260585) and China National Agricultural Production Systematic Fund (CARS-45-kxj14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; Andreatta M, 2010, P ROY SOC B-BIOL SCI, V277, P2411, DOI 10.1098/rspb.2010.0103; Bernadou A, 2009, J INSECT PHYSIOL, V55, P1099, DOI 10.1016/j.jinsphys.2009.08.019; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Bogdanov S, 1998, J APICULT RES, V37, P57, DOI 10.1080/00218839.1998.11100956; [陈亚 CHEN Ya], 2007, [云南农业大学学报, Journal of Yunnan Agricultural University], V22, P309; Collins AM, 2004, J APICULT RES, V43, P128, DOI 10.1080/00218839.2004.11101123; Costa L, 1997, BASIC TOXICOLOGY PES, P251; Davies TGE, 2007, IUBMB LIFE, V59, P151, DOI 10.1080/15216540701352042; Decourtye A, 2005, ARCH ENVIRON CON TOX, V48, P242, DOI 10.1007/s00244-003-0262-7; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Ecocichon D., 1999, CASARETT DOULLS TOXI, V5th; El Hassani AK, 2009, INVERTEBR NEUROSCI, V9, P91, DOI 10.1007/s10158-009-0092-z; ELLIS M, 1988, AM BEE J, V128, P262; EMEA, 1998, SUMM REP COMM VET ME; Farina WM, 2007, NATURWISSENSCHAFTEN, V94, P55, DOI 10.1007/s00114-006-0157-3; Grunewald B, 2004, ACTA BIOL HUNG, V55, P53, DOI 10.1556/ABiol.55.2004.1-4.7; Haarmann T, 2002, J ECON ENTOMOL, V95, P28, DOI 10.1603/0022-0493-95.1.28; Johnson RM, 2006, J ECON ENTOMOL, V99, P1046, DOI 10.1603/0022-0493-99.4.1046; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Joshi SC, 2011, TOXICOL ENVIRON CHEM, V93, P593, DOI 10.1080/02772248.2010.537441; Leahey J.P, 1985, PYRETHROID INSECTICI; Mamood AN, 2008, PHYSIOL ENTOMOL, V15, P55; Matsumoto Y, 2012, J NEUROSCI METH, V211, P159, DOI 10.1016/j.jneumeth.2012.08.018; Menzel Randolf, 2006, Behav Cogn Neurosci Rev, V5, P24, DOI 10.1177/1534582306289522; Mota T, 2011, LEARN MEMORY, V18, P144, DOI 10.1101/lm.2073511; Oruc HH, 2012, J ECON ENTOMOL, V105, P1890, DOI 10.1603/EC12055; Pettis JS, 2004, APIDOLOGIE, V35, P605, DOI 10.1051/apido:2004056; Rinderer TE, 1999, AM BEE J, V139, P134; SATTELLE DB, 1988, ADV INSECT PHYSIOL, V20, P147, DOI 10.1016/S0065-2806(08)60025-9; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; SODERLUND DM, 1989, ANNU REV ENTOMOL, V34, P77, DOI 10.1146/annurev.en.34.010189.000453; TAYLOR KS, 1987, APIDOLOGIE, V18, P243, DOI 10.1051/apido:19870304; VitaEuropeLtd, 2009, APIGUARD; Yarali A, 2009, J NEUROGENET, V23, P235, DOI 10.1080/01677060802441372; Yousef MI, 2010, FOOD CHEM TOXICOL, V48, P1152, DOI 10.1016/j.fct.2010.02.002; Zhang H, 2010, J APPL TOXICOL, V30, P369, DOI 10.1002/jat.1507; Zhang H, 2010, FOOD CHEM TOXICOL, V48, P1160, DOI 10.1016/j.fct.2010.02.003; Zhao XF, 2011, ARCH TOXICOL, V85, P1101, DOI 10.1007/s00204-011-0654-9; Zlotkin E, 1999, ANNU REV ENTOMOL, V44, P429, DOI 10.1146/annurev.ento.44.1.429	40	16	19	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66295	10.1371/journal.pone.0066295	http://dx.doi.org/10.1371/journal.pone.0066295			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785490	Green Published, gold			2022-12-25	WOS:000321038800032
J	Su, H; Liu, BC; Frohlich, O; Ma, HP; Sands, JM; Chen, GP				Su, Hua; Liu, Bingchen; Froehlich, Otto; Ma, Heping; Sands, Jeff M.; Chen, Guangping			Small GTPase Rahl4 down-regulates UT-A1 urea transport activity through enhanced clathrin-dependent endocytosis	FASEB JOURNAL			English	Article						protein interaction; membrane protein; inner medulla	EPITHELIAL SODIUM-CHANNEL; RENAL COLLECTING DUCT; RAB GTPASES; AQUAPORIN-2 TRAFFICKING; MEMBRANE TRAFFICKING; BINDING-PROTEINS; APICAL MEMBRANE; PLASMA-MEMBRANE; WATER CHANNELS; CELLS	The UT-A1 urea transporter plays an important role in the urinary concentration mechanism. However, the molecular mechanisms regarding UT-A1 trafficking, endocytosis, and degradation are still unclear. In this study, we identified the small GTPase Rab14 as a binding partner to the C terminus of UT-A1 in a yeast 2-hybrid assay. Interestingly, UT-A1 binding is preferential for the GDP-bound inactive form of Rab14. Coinjection of Rab14 in Xenopus oocytes results in a decrease of UT-A1 urea transport activity, suggesting that Rab14 acts as a negative regulator of UT-A1. We subsequently found that Rab14 reduces the cell membrane expression of UT-A1, as evidenced by cell surface biotinylation. This effect is blocked by chlorpromazine, an inhibitor of the clathrin-mediated endocytic pathway, but not by filipin, an inhibitor of the caveolin-mediated endocytic pathway. In kidney, Rab14 is mainly expressed in IMCD epithelial cells with a pattern identical to UT-A1 expression. Consistent with its role in participating in clathrin-mediated endocytosis, Rab14 localizes in nonlipid raft microdomains and codistributes with Rab5, a marker of the clathrin-mediated endocytic pathway. Taken together, our study suggests that Rab14, as a novel UT-A1 partner, may have an important regulatory function for UT-A1 urea transport activity in the kidney inner medulla.Su, H., Liu, B., Frohlich, O., Ma, H., Sands, J. M., Chen, G. Small GTPase Rab14 down-regulates UT-A1 urea transport activity through enhanced clathrin-dependent endocytosis.	[Su, Hua; Liu, Bingchen; Froehlich, Otto; Ma, Heping; Sands, Jeff M.; Chen, Guangping] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA; [Sands, Jeff M.; Chen, Guangping] Emory Univ, Sch Med, Div Renal, Dept Med, Atlanta, GA 30322 USA	Emory University; Emory University	Chen, GP (corresponding author), Emory Univ, Sch Med, Dept Physiol, 615 Michael St, Atlanta, GA 30322 USA.	gchen3@emory.edu	LIU, BING-CHEN/AAG-9141-2020		U.S. National Institutes of Health [R01-DK087838, R01-DK041707]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087838, R01DK041707] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors greatly acknowledge Richard Scheller (Genentech, South San Francisco, CA, USA) for the Rabl 4 antibody and pGEX-KG-Rabl 4 construct. This work was supported by U.S. National Institutes of Health grants R01-DK087838 (to G.C.) and R01-DK041707 (to J M.S.).	Bradford AD, 2001, AM J PHYSIOL-RENAL, V281, pF133, DOI 10.1152/ajprenal.2001.281.1.F133; Butterworth MB, 2007, J BIOL CHEM, V282, P37885, DOI 10.1074/jbc.M707989200; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CHAVRIER P, 1991, NATURE, V353, P769, DOI 10.1038/353769a0; Chen G, 2008, AM J PHYSIOL-RENAL, V295, pF1528, DOI 10.1152/ajprenal.90482.2008; Chen GP, 2006, J BIOL CHEM, V281, P27436, DOI 10.1074/jbc.M605525200; Chen GP, 2011, FASEB J, V25, P4531, DOI 10.1096/fj.11-185991; Feng XY, 2009, AM J PHYSIOL-RENAL, V296, pF1514, DOI 10.1152/ajprenal.00068.2009; Fenton RA, 2004, P NATL ACAD SCI USA, V101, P7469, DOI 10.1073/pnas.0401704101; Huang HD, 2010, AM J PHYSIOL-RENAL, V299, pF1389, DOI 10.1152/ajprenal.00718.2009; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Junutula JR, 2004, MOL BIOL CELL, V15, P2218, DOI 10.1091/mbc.E03-10-0777; Kitt KN, 2008, TRAFFIC, V9, P1218, DOI 10.1111/j.1600-0854.2008.00752.x; KNEPPER MA, 1993, AM J PHYSIOL, V265, pF214, DOI 10.1152/ajprenal.1993.265.2.F214; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Linford A, 2012, DEV CELL, V22, P952, DOI 10.1016/j.devcel.2012.04.010; Liu GY, 2008, MOL BIOL REP, V35, P201, DOI 10.1007/s11033-007-9071-9; Marples D, 1998, AM J PHYSIOL-RENAL, V274, pF384, DOI 10.1152/ajprenal.1998.274.2.F384; MARTINEZ O, 1994, J CELL BIOL, V127, P1575, DOI 10.1083/jcb.127.6.1575; Mistry AC, 2007, J BIOL CHEM, V282, P30097, DOI 10.1074/jbc.M705866200; Mistry AC, 2009, AM J PHYSIOL-RENAL, V297, pF292, DOI 10.1152/ajprenal.00196.2009; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; NIELSEN S, 1993, AM J PHYSIOL, V265, pF204, DOI 10.1152/ajprenal.1993.265.2.F204; Noda Y, 2004, BIOCHEM BIOPH RES CO, V322, P740, DOI 10.1016/j.bbrc.2004.07.195; Noda Y, 2004, FEBS LETT, V568, P139, DOI 10.1016/j.febslet.2004.05.021; Noda Y, 2008, J CELL BIOL, V182, P587, DOI 10.1083/jcb.200709177; Pfeffer S, 2003, CELL, V112, P507, DOI 10.1016/S0092-8674(03)00118-1; Pfeffer SR, 2005, J BIOL CHEM, V280, P15485, DOI 10.1074/jbc.R500003200; Procino G, 2008, J CELL SCI, V121, P2097, DOI 10.1242/jcs.022210; Proikas-Cezanne T, 2006, FEBS LETT, V580, P5241, DOI 10.1016/j.febslet.2006.08.053; Rodman JS, 2000, J CELL SCI, V113, P183; Sands JM, 2004, CURR OPIN NEPHROL HY, V13, P525, DOI 10.1097/00041552-200409000-00008; Sands JM, 2003, J MEMBRANE BIOL, V191, P149, DOI 10.1007/s00232-002-1053-1; Saxena S, 2005, BIOCHEM BIOPH RES CO, V337, P1219, DOI 10.1016/j.bbrc.2005.09.186; Saxena SK, 2006, BIOCHEM BIOPH RES CO, V341, P184, DOI 10.1016/j.bbrc.2005.12.170; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; Shakor ABA, 2012, CELL SIGNAL, V24, P677, DOI 10.1016/j.cellsig.2011.10.016; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Su H, 2012, AM J PHYSIOL-RENAL, V303, pF1325, DOI 10.1152/ajprenal.00248.2012; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tamma G, 2001, AM J PHYSIOL-RENAL, V281, pF1092, DOI 10.1152/ajprenal.0091.2001; Valenti G, 2005, ENDOCRINOLOGY, V146, P5063, DOI 10.1210/en.2005-0868; van de Graaf SFJ, 2006, MOL CELL BIOL, V26, P303, DOI 10.1128/MCB.26.1.303-312.2006; Xu G, 2012, AM J PHYSIOL-CELL PH, V302, pC1012, DOI 10.1152/ajpcell.00440.2011; Zuk PA, 2000, J BIOL CHEM, V275, P26754	45	11	11	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					4100	4107		10.1096/fj.13-229294	http://dx.doi.org/10.1096/fj.13-229294			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23796783	Green Published			2022-12-25	WOS:000329747100022
J	Dou, L; Zhao, T; Wang, LL; Huang, XQ; Jiao, J; Gao, D; Zhang, HX; Shen, T; Man, Y; Wang, S; Li, J				Dou, Lin; Zhao, Ting; Wang, Lilin; Huang, Xiuqing; Jiao, Juan; Gao, Dan; Zhang, Hangxiang; Shen, Tao; Man, Yong; Wang, Shu; Li, Jian			miR-200s Contribute to Interleukin-6 (IL-6)-induced Insulin Resistance in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-METABOLISM; MICRORNAS; OBESITY; EXPRESSION; CELLS; MICE	By influencing the activity of the PI3K/AKT pathway, IL-6 acts as an important regulator of hepatic insulin resistance. miR-200s have been shown to control growth by regulating PI3K, but the role of miR-200s in the development of hepatic insulin resistance remains unclear. The present study showed that elevated serum concentration of IL-6 is associated with decreased levels of miR-200s, impaired activation of the AKT/glycogen synthase kinase (GSK) pathway, and reduced glycogenesis that occurred in the livers of db/db mice. As shown in the murine NCTC 1469 hepatocytes and the primary hepatocytes treated with 10 ng/ml IL-6 for 24 h and in 12-week-old male C57BL/6J mice injected with 16 mu g/ml IL-6 by pumps for 7 days, IL-6 administration induced insulin resistance through downregulation of miR-200s. Moreover, IL-6 treatment inhibited the phosphorylation of AKT and GSK and decreased the glycogenesis. The effects of IL-6 could be diminished by suppression of FOG2 expression. We concluded that IL-6 treatment may impair the activities of the PI3K/AKT/GSK pathway and inhibit the synthesis of glycogen, perhaps via down-regulating miR-200s while augmenting FOG2 expression.	[Dou, Lin; Zhao, Ting; Jiao, Juan; Gao, Dan; Zhang, Hangxiang; Li, Jian] Peking Union Med Coll, Grad Sch, Beijing 100730, Peoples R China; [Dou, Lin; Zhao, Ting; Jiao, Juan; Gao, Dan; Zhang, Hangxiang; Li, Jian] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Dou, Lin; Zhao, Ting; Wang, Lilin; Huang, Xiuqing; Jiao, Juan; Gao, Dan; Zhang, Hangxiang; Shen, Tao; Man, Yong; Wang, Shu; Li, Jian] Beijing Inst Geriatr, Key Lab Geriatr, Beijing 100730, Peoples R China; [Dou, Lin; Zhao, Ting; Wang, Lilin; Huang, Xiuqing; Jiao, Juan; Gao, Dan; Zhang, Hangxiang; Shen, Tao; Man, Yong; Wang, Shu; Li, Jian] Beijing Hosp, Minist Hlth, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Beijing Hospital	Li, J (corresponding author), Beijing Inst Geriatr, Key Lab Geriatr, Beijing 100730, Peoples R China.	lijian@bjhmoh.cn	Lin, Xin/L-9950-2013	Lin, Xin/0000-0002-7491-8928	National Basic Research Program of China [2012CB517502]; National Natural Science Foundation of China [81270887, 81070634, 81270495]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grant 2012CB517502 and National Natural Science Foundation of China Grants 81270887, 81070634, and 81270495.	Allen TL, 2010, DIABETOLOGIA, V53, P399, DOI 10.1007/s00125-009-1627-x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; David M, 2010, J INTERF CYTOK RES, V30, P825, DOI 10.1089/jir.2010.0080; Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109; Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694; Hirabara SM, 2007, J CELL PHYSIOL, V210, P7, DOI 10.1002/jcp.20811; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Jack BHA, 2010, J BIOL CHEM, V285, P32405, DOI 10.1074/jbc.M110.141317; Joglekar MV, 2011, INDIAN J EXP BIOL, V49, P401; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Kim JH, 2009, VITAM HORM, V80, P613, DOI 10.1016/S0083-6729(08)00621-3; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Klover PJ, 2005, ENDOCRINOLOGY, V146, P3417, DOI 10.1210/en.2004-1468; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Leclercq IA, 2007, J HEPATOL, V47, P142, DOI 10.1016/j.jhep.2007.04.002; Moore KJ, 2011, ANNU REV NUTR, V31, P49, DOI 10.1146/annurev-nutr-081810-160756; Oh YS, 2011, DIABETES-METAB RES, V27, P813, DOI 10.1002/dmrr.1233; Ono K, 2011, CELL RES, V21, P864, DOI 10.1038/cr.2011.78; Petersen KF, 2006, OBESITY, V14, p34S, DOI 10.1038/oby.2006.280; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Ramachandran D, 2011, FEBS J, V278, P1167, DOI 10.1111/j.1742-4658.2011.08042.x; Reddy MA, 2012, ARTERIOSCL THROM VAS, V32, P721, DOI 10.1161/ATVBAHA.111.241109; Ryu HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017343; Shantikumar S, 2012, CARDIOVASC RES, V93, P583, DOI 10.1093/cvr/cvr300; Snowdon J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022828; Ulvila J, 2004, BIOCHEM J, V381, P887, DOI 10.1042/BJ20040387; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	28	53	58	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22596	22606		10.1074/jbc.M112.423145	http://dx.doi.org/10.1074/jbc.M112.423145			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23798681	hybrid, Green Published			2022-12-25	WOS:000330596300040
J	Liu, SP; Misquitta, YR; Olland, A; Johnson, MA; Kelleher, KS; Kriz, R; Lin, LL; Stahl, M; Mosyak, L				Liu, Shenping; Misquitta, Yohann R.; Olland, Andrea; Johnson, Mark A.; Kelleher, Kerry S.; Kriz, Ron; Lin, Laura L.; Stahl, Mark; Mosyak, Lidia			Crystal Structure of a Human I kappa B Kinase beta Asymmetric Dimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; IKK-BETA; ACTIVATION; BINDING; INHIBITOR; PATHWAY; COMPLEX; ALPHA; PHOSPHORYLATION; ENZYME	Phosphorylation of inhibitor of nuclear transcription factor kappa B (I kappa B) by I kappa B kinase (IKK) triggers the degradation of I kappa B and migration of cytoplasmic kappa B to the nucleus where it promotes the transcription of its target genes. Activation of IKK is achieved by phosphorylation of its main subunit, IKK beta, at the activation loop sites. Here, we report the 2.8 angstrom resolution crystal structure of human IKK beta (hIKK beta), which is partially phosphorylated and bound to the staurosporine analog K252a. The hIKK beta protomer adopts a trimodular structure that closely resembles that from Xenopus laevis (xIKK beta): an N-terminal kinase domain (KD), a central ubiquitin-like domain (ULD), and a C-terminal scaffold/dimerization domain (SDD). Although hIKK beta and xIKK beta utilize a similar dimerization mode, their overall geometries are distinct. In contrast to the structure resembling closed shears reported previously for xIKK beta, hIKK beta exists as an open asymmetric dimer in which the two KDs are further apart, with one in an active and the other in an inactive conformation. Dimer interactions are limited to the C-terminal six-helix bundle that acts as a hinge between the two subunits. The observed domain movements in the structures of IKK beta may represent trans-phosphorylation steps that accompany IKK beta activation.	[Liu, Shenping; Misquitta, Yohann R.] Pfizer Worldwide Res, Struct Biol & Biophys Grp, Groton, CT 06340 USA; [Misquitta, Yohann R.; Olland, Andrea; Johnson, Mark A.; Kelleher, Kerry S.; Kriz, Ron; Lin, Laura L.; Stahl, Mark; Mosyak, Lidia] Pfizer Worldwide Res, Global Biotherapeut Technol, Cambridge, MA 02140 USA	Pfizer; Pfizer	Liu, SP (corresponding author), Pfizer Worldwide Res, Struct Biol & Biophys, Eastern Point Rd, Groton, CT 06340 USA.	shenping.liu@pfizer.com; lidia.mosyak@pfizer.com						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Davies TG, 2007, J MOL BIOL, V367, P882, DOI 10.1016/j.jmb.2007.01.004; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Goncalves A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023971; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hatada EN, 2000, CURR OPIN IMMUNOL, V12, P52, DOI 10.1016/S0952-7915(99)00050-3; Huynh QK, 2000, J BIOL CHEM, V275, P25883, DOI 10.1074/jbc.M000296200; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kishore N, 2002, J BIOL CHEM, V277, P13840, DOI 10.1074/jbc.M110474200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larabi A, 2013, CELL REP, V3, P734, DOI 10.1016/j.celrep.2013.01.034; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Ma XL, 2012, P NATL ACAD SCI USA, V109, P9378, DOI 10.1073/pnas.1121552109; May MJ, 2004, J BIOL CHEM, V279, P45528, DOI 10.1074/jbc.M408579200; Mbalaviele G, 2009, J PHARMACOL EXP THER, V329, P14, DOI 10.1124/jpet.108.143800; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; Niederberger E, 2008, FASEB J, V22, P3432, DOI 10.1096/fj.08-109355; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Rushe M, 2008, STRUCTURE, V16, P798, DOI 10.1016/j.str.2008.02.012; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Schrofelbauer B, 2012, MOL CELL, V47, P111, DOI 10.1016/j.molcel.2012.04.020; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Tu DQ, 2013, CELL REP, V3, P747, DOI 10.1016/j.celrep.2013.01.033; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Young ERR, 2012, RSC DRUG DISCOV, V26, P255, DOI 10.1039/9781849735346-00255; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423	46	80	88	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22758	22767		10.1074/jbc.M113.482596	http://dx.doi.org/10.1074/jbc.M113.482596			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23792959	hybrid, Green Published			2022-12-25	WOS:000330596300053
J	Diaz, MH; Waller, JL; Napoliello, RA; Islam, MS; Wolff, BJ; Burken, DJ; Holden, RL; Srinivasan, V; Arvay, M; McGee, L; Oberste, MS; Whitney, CG; Schrag, SJ; Winchell, JM; Saha, SK				Diaz, Maureen H.; Waller, Jessica L.; Napoliello, Rebecca A.; Islam, Md. Shahidul; Wolff, Bernard J.; Burken, Daniel J.; Holden, Rhiannon L.; Srinivasan, Velusamy; Arvay, Melissa; McGee, Lesley; Oberste, M. Steven; Whitney, Cynthia G.; Schrag, Stephanie J.; Winchell, Jonas M.; Saha, Samir K.			Optimization of Multiple Pathogen Detection Using the TaqMan Array Card: Application for a Population-Based Study of Neonatal Infection	PLOS ONE			English	Article							REAL-TIME PCR; COMMUNITY-ACQUIRED PNEUMONIA; POLYMERASE-CHAIN-REACTION; CHILD-MORTALITY; BLOOD; DIAGNOSIS; ETIOLOGY; ASSAYS; DNA	Identification of etiology remains a significant challenge in the diagnosis of infectious diseases, particularly in resource-poor settings. Viral, bacterial, and fungal pathogens, as well as parasites, play a role for many syndromes, and optimizing a single diagnostic system to detect a range of pathogens is challenging. The TaqMan Array Card (TAC) is a multiple-pathogen detection method that has previously been identified as a valuable technique for determining etiology of infections and holds promise for expanded use in clinical microbiology laboratories and surveillance studies. We selected TAC for use in the Aetiology of Neonatal Infection in South Asia (ANISA) study for identifying etiologies of severe disease in neonates in Bangladesh, India, and Pakistan. Here we report optimization of TAC to improve pathogen detection and overcome technical challenges associated with use of this technology in a large-scale surveillance study. Specifically, we increased the number of assay replicates, implemented a more robust RT-qPCR enzyme formulation, and adopted a more efficient method for extraction of total nucleic acid from blood specimens. We also report the development and analytical validation of ten new assays for use in the ANISA study. Based on these data, we revised the study-specific TACs for detection of 22 pathogens in NP/OP swabs and 12 pathogens in blood specimens as well as two control reactions (internal positive control and human nucleic acid control) for each specimen type. The cumulative improvements realized through these optimization studies will benefit ANISA and perhaps other studies utilizing multiple-pathogen detection approaches. These lessons may also contribute to the expansion of TAC technology to the clinical setting.	[Diaz, Maureen H.; Waller, Jessica L.; Napoliello, Rebecca A.; Wolff, Bernard J.; Burken, Daniel J.; Holden, Rhiannon L.; Srinivasan, Velusamy; McGee, Lesley; Whitney, Cynthia G.; Schrag, Stephanie J.; Winchell, Jonas M.] Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial Dis, Atlanta, GA 30333 USA; [Islam, Md. Shahidul; Saha, Samir K.] Dhaka Shishu Hosp, Child Hlth Res Fdn, Bangladesh Inst Child Hlth, Dept Microbiol, Dhaka, Bangladesh; [Arvay, Melissa] Ctr Dis Control & Prevent, Div Preparedness & Emerging Infect, Atlanta, GA USA; [Oberste, M. Steven] Ctr Dis Control & Prevent, Polio & Picornavirus Lab Branch, Div Viral Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Winchell, JM (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial Dis, Atlanta, GA 30333 USA.	jwinchell@cdc.gov	Islam, Shahidul/N-5897-2013; Diaz, Maureen/AAM-4587-2020	Islam, Md Shahidul/0000-0003-4712-4046	Bill and Melinda Gates Foundation [OPPGH5307]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill and Melinda Gates Foundation (http://www.gatesfoundation.org/) grant number OPPGH5307 to Child Health Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat N, 2012, CLIN INFECT DIS, V54, pS153, DOI 10.1093/cid/cir1060; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Cieslak Paul R., 2012, Morbidity and Mortality Weekly Report, V61, P480; DALKEY N, 1963, MANAGE SCI, V9, P458, DOI 10.1287/mnsc.9.3.458; Jain S, 2012, ETIOLOGY COMMUNITY A; Jordan JA, 2005, J MOL DIAGN, V7, P575, DOI 10.1016/S1525-1578(10)60590-9; Kodani M, 2012, J CLIN MICROBIOL, V50, P1057, DOI 10.1128/JCM.05987-11; Kodani M, 2011, J CLIN MICROBIOL, V49, P2175, DOI 10.1128/JCM.02270-10; Lee WM, 2007, J CLIN MICROBIOL, V45, P2626, DOI 10.1128/JCM.02501-06; Liu J, 2013, J CLIN MICROBIOL, V51, P472, DOI 10.1128/JCM.02658-12; Malorny B, 2004, APPL ENVIRON MICROB, V70, P7046, DOI 10.1128/AEM.70.12.7046-7052.2004; Marrie TJ, 2012, SEMIN RESP CRIT CARE, V33, P244, DOI 10.1055/s-0032-1315636; Rachwal PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035971; Regan JF, 2012, J MOL DIAGN, V14, P120, DOI 10.1016/j.jmoldx.2011.10.001; Templeton KE, 2005, CLIN INFECT DIS, V41, P345, DOI 10.1086/431588; Vernet G, 2011, CLIN MICROBIOL INFEC, V17, P1, DOI 10.1111/j.1469-0691.2011.03496.x; Weller SA, 2012, J MED MICROBIOL, V61, P1546, DOI 10.1099/jmm.0.049007-0; You DZ, 2010, LANCET, V376, P931, DOI 10.1016/S0140-6736(10)61429-8; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865; Zhao JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033127	21	46	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66183	10.1371/journal.pone.0066183	http://dx.doi.org/10.1371/journal.pone.0066183			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805203	gold, Green Published			2022-12-25	WOS:000320846500031
J	Parra, GI; Azure, J; Fischer, R; Bok, K; Sandoval-Jaime, C; Sosnovtsev, SV; Sander, P; Green, KY				Parra, Gabriel I.; Azure, JoLynn; Fischer, Renate; Bok, Karin; Sandoval-Jaime, Carlos; Sosnovtsev, Stanislav V.; Sander, Peter; Green, Kim Y.			Identification of a Broadly Cross-Reactive Epitope in the Inner Shell of the Norovirus Capsid	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; BLOOD GROUP ANTIGENS; MONOCLONAL-ANTIBODIES; GENOGROUP-II; PROTEIN; GASTROENTERITIS; EXPRESSION; INFECTION; VACCINE; DETERMINANTS	Noroviruses are major pathogens associated with acute gastroenteritis. They are diverse viruses, with at least six genogroups (GI-GVI) and multiple genotypes defined by differences in the major capsid protein, VP1. This diversity has challenged the development of broadly cross-reactive vaccines as well as efficient detection methods. Here, we report the characterization of a broadly cross-reactive monoclonal antibody (MAb) raised against the capsid protein of a GII. 3 norovirus strain. The MAb reacted with VLPs and denatured VP1 protein from GI, GII, GIV and GV noroviruses, and mapped to a linear epitope located in the inner shell domain. An alignment of all available VP1 sequences showed that the putative epitope (residues 52-56) is highly conserved across the genus Norovirus. This broadly cross-reactive MAb thus constitutes a valuable reagent for the diagnosis and study of these diverse viruses.	[Parra, Gabriel I.; Azure, JoLynn; Bok, Karin; Sandoval-Jaime, Carlos; Sosnovtsev, Stanislav V.; Green, Kim Y.] NIAID, Caliciviruses Sect, Infect Dis Lab, DHHS,NIH, Bethesda, MD 20892 USA; [Fischer, Renate; Sander, Peter] R Biopharm AG, Clin Diagnost, Darmstadt, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Parra, GI (corresponding author), NIAID, Caliciviruses Sect, Infect Dis Lab, DHHS,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	parrag@niaid.nih.gov; kgreen@niaid.nih.gov	Parra, Gabriel I./H-4339-2019; Sandoval-Jaime, Carlos/AAR-7196-2020	Parra, Gabriel I./0000-0002-1102-4740; Sandoval-Jaime, Carlos/0000-0001-6649-9180	NIH, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000897] Funding Source: NIH RePORTER	NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was partially supported by the Intramural Research Program of the NIH, NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Almanza H, 2008, J CLIN MICROBIOL, V46, P3971, DOI 10.1128/JCM.01204-08; Atmar RL, 2006, GASTROENTEROL CLIN N, V35, P275, DOI 10.1016/j.gtc.2006.03.001; Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Batten CA, 2006, VIROLOGY, V356, P179, DOI 10.1016/j.virol.2006.07.034; Bertolotti-Ciarlet A, 2003, J VIROL, V77, P11603, DOI 10.1128/JVI.77.21.11603-11615.2003; Bok K, 2011, P NATL ACAD SCI USA, V108, P325, DOI 10.1073/pnas.1014577107; de Bruin E, 2006, J VIROL METHODS, V137, P259, DOI 10.1016/j.jviromet.2006.06.024; Debbink K, 2012, J VIROL, V86, P1214, DOI 10.1128/JVI.06189-11; Donaldson EF, 2010, NAT REV MICROBIOL, V8, P231, DOI 10.1038/nrmicro2296; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Geginat G, 2012, EUR J CLIN MICROBIOL, V31, P733, DOI 10.1007/s10096-011-1366-z; Green K. Y., 2007, FIELDS VIROLOGY, V1, P949; GREEN KY, 1993, J CLIN MICROBIOL, V31, P2185, DOI 10.1128/JCM.31.8.2185-2191.1993; Harrington PR, 2002, J VIROL, V76, P12335, DOI 10.1128/JVI.76.23.12335-12343.2002; Herbst-Kralovetz M, 2010, EXPERT REV VACCINES, V9, P299, DOI [10.1586/erv.09.163, 10.1586/ERV.09.163]; Holzinger A, 1996, BIOTECHNIQUES, V20, P804; Kirby A, 2010, J CLIN VIROL, V49, P254, DOI 10.1016/j.jcv.2010.08.004; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Leite JPG, 1996, ARCH VIROL, V141, P865, DOI 10.1007/BF01718161; LEW JF, 1994, VIROLOGY, V200, P319, DOI 10.1006/viro.1994.1194; Li XA, 2010, VIRUS RES, V151, P142, DOI 10.1016/j.virusres.2010.04.005; Li X, 2009, VIRUS RES, V140, P188, DOI 10.1016/j.virusres.2008.12.004; Lindesmith LC, 2012, J VIROL, V86, P873, DOI 10.1128/JVI.06200-11; LoBue AD, 2006, VACCINE, V24, P5220, DOI 10.1016/j.vaccine.2006.03.080; Lochridge VP, 2005, J GEN VIROL, V86, P2799, DOI 10.1099/vir.0.81134-0; Mesquita JR, 2010, EMERG INFECT DIS, V16, P980, DOI 10.3201/eid1606.091861; Oliver SL, 2006, J CLIN MICROBIOL, V44, P992, DOI 10.1128/JCM.44.3.992-998.2006; Parker TD, 2005, J VIROL, V79, P7402, DOI 10.1128/JVI.79.12.7402-7409.2005; Parra GI, 2012, J VIROL, V86, P7414, DOI 10.1128/JVI.06729-11; Parra GI, 2012, VACCINE, V30, P3580, DOI 10.1016/j.vaccine.2012.03.050; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Reeck A, 2010, J INFECT DIS, V202, P1212, DOI 10.1086/656364; Shiota T, 2007, J VIROL, V81, P12298, DOI 10.1128/JVI.00891-07; Tacket CO, 2003, CLIN IMMUNOL, V108, P241, DOI 10.1016/S1521-6616(03)00120-7; Tan M, 2008, VIROLOGY, V382, P115, DOI 10.1016/j.virol.2008.08.047; Tan M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000983; WYATT LS, 1995, VIROLOGY, V210, P202, DOI 10.1006/viro.1995.1332; XI JA, 1992, J VIROL, V66, P6527, DOI 10.1128/JVI.66.11.6527-6532.1992; Yoda T, 2000, MICROBIOL IMMUNOL, V44, P905, DOI 10.1111/j.1348-0421.2000.tb02582.x	43	39	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67592	10.1371/journal.pone.0067592	http://dx.doi.org/10.1371/journal.pone.0067592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805319	gold, Green Published, Green Submitted			2022-12-25	WOS:000320846500147
J	Schneider, E; Zimmermann, H; Oberwahrenbrock, T; Kaufhold, F; Kadas, EM; Petzold, A; Bilger, F; Borisow, N; Jarius, S; Wildemann, B; Ruprecht, K; Brandt, AU; Paul, F				Schneider, Elisa; Zimmermann, Hanna; Oberwahrenbrock, Timm; Kaufhold, Falko; Kadas, Ella Maria; Petzold, Axel; Bilger, Frieder; Borisow, Nadja; Jarius, Sven; Wildemann, Brigitte; Ruprecht, Klemens; Brandt, Alexander U.; Paul, Friedemann			Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis	PLOS ONE			English	Article							NERVE-FIBER LAYER; MICROCYSTIC MACULAR EDEMA; CLINICAL-COURSE; SPINAL MS; DISEASE; AQUAPORIN-4; SPECTRUM; DEGENERATION; NATALIZUMAB; ANTIBODIES	Background: Neuromyelitis optica (NMO) and relapsing-remitting multiple sclerosis (RRMS) are difficult to differentiate solely on clinical grounds. Optical coherence tomography (OCT) studies investigating retinal changes in both diseases focused primarily on the retinal nerve fiber layer (RNFL) while rare data are available on deeper intra-retinal layers. Objective: To detect different patterns of intra-retinal layer alterations in patients with NMO spectrum disorders (NMOSD) and RRMS with focus on the influence of a previous optic neuritis (ON). Methods: We applied spectral-domain OCT in eyes of NMOSD patients and compared them to matched RRMS patients and healthy controls (HC). Semi-automatic intra-retinal layer segmentation was used to quantify intra-retinal layer thicknesses. In a subgroup low contrast visual acuity (LCVA) was assessed. Results: NMOSD-, MS- and HC-groups, each comprising 17 subjects, were included in analysis. RNFL thickness was more severely reduced in NMOSD compared to MS following ON. In MS-ON eyes, RNFL thinning showed a clear temporal preponderance, whereas in NMOSD-ON eyes RNFL was more evenly reduced, resulting in a significantly lower ratio of the nasal versus temporal RNFL thickness. In comparison to HC, ganglion cell layer thickness was stronger reduced in NMOSD-ON than in MS-ON, accompanied by a more severe impairment of LCVA. The inner nuclear layer and the outer retinal layers were thicker in NMOSD-ON patients compared to NMOSD without ON and HC eyes while these differences were primarily driven by microcystic macular edema. Conclusion: Our study supports previous findings that ON in NMOSD leads to more pronounced retinal thinning and visual function impairment than in RRMS. The different retinal damage patterns in NMOSD versus RRMS support the current notion of distinct pathomechanisms of both conditions. However, OCT is still insufficient to help with the clinically relevant differentiation of both conditions in an individual patient.	[Schneider, Elisa; Zimmermann, Hanna; Oberwahrenbrock, Timm; Kaufhold, Falko; Kadas, Ella Maria; Bilger, Frieder; Borisow, Nadja; Brandt, Alexander U.; Paul, Friedemann] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Petzold, Axel] Vrije Univ Amsterdam, Med Ctr, MS Ctr Amsterdam, Amsterdam, Netherlands; [Jarius, Sven; Wildemann, Brigitte] Heidelberg Univ, Dept Neurol, Div Mol Neuroimmunol, Heidelberg, Germany; [Ruprecht, Klemens; Paul, Friedemann] Charite, Clin & Expt Multiple Sclerosis Res Ctr, D-13353 Berlin, Germany; [Ruprecht, Klemens; Paul, Friedemann] Charite, Dept Neurol, D-13353 Berlin, Germany; [Paul, Friedemann] Max Delbruck Ctr Mol Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Vrije Universiteit Amsterdam; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Paul, F (corresponding author), Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany.	friedemann.paul@charite.de	Paul, Friedemann/ABF-9415-2020; Petzold, Axel/C-1090-2009	Petzold, Axel/0000-0002-0344-9749; Zimmermann, Hanna/0000-0002-0276-8051; paul, friedemann/0000-0002-6378-0070	German Research Council [DFG Exc 257]	German Research Council(German Research Foundation (DFG))	This work was supported by the German Research Council (DFG Exc 257 to FP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegg M, 2012, BRAIN, V135, DOI 10.1093/brain/aws215; Albrecht P, 2012, MULT SCLER J, V18, P1422, DOI 10.1177/1352458512439237; Balk LJ, 2012, BRAIN, V135, DOI 10.1093/brain/aws216; Barnett MH, 2012, MULT SCLER J, V18, P108, DOI 10.1177/1352458511421185; Bock M, 2012, BRIT J OPHTHALMOL, V96, P62, DOI 10.1136/bjo.2010.193581; Bock M, 2010, CLIN NEUROL NEUROSUR, V112, P647, DOI 10.1016/j.clineuro.2010.04.014; Bock M, 2010, MULT SCLER J, V16, P893, DOI 10.1177/1352458510365156; Bomprezzi R, 2011, NEUROLOGY, V77, P195, DOI 10.1212/WNL.0b013e318219dde5; Bouyon M, 2013, MULT SCLER J, V19, P1320, DOI 10.1177/1352458513476562; Brandt AU, 2011, BRAIN, V134, DOI 10.1093/brain/awr095; Burkholder BM, 2009, ARCH NEUROL-CHICAGO, V66, P1366, DOI 10.1001/archneurol.2009.230; Costello F, 2008, MULT SCLER J, V14, P893, DOI 10.1177/1352458508091367; Costello F, 2011, MULT SCLER INT, V2011, DOI 10.1155/2011/148394; de Seze J, 2008, ARCH NEUROL-CHICAGO, V65, P920, DOI 10.1001/archneur.65.7.920; Dorr J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018132; Evangelou N, 2001, BRAIN, V124, P1813, DOI 10.1093/brain/124.9.1813; Fernandes DB, 2012, OPHTHALMOLOGY; FRISEN L, 1974, ARCH OPHTHALMOL-CHIC, V92, P91, DOI 10.1001/archopht.1974.01010010097001; Gelfand JM, 2013, JAMA NEUROL, V70, P629, DOI 10.1001/jamaneurol.2013.1832; Gelfand JM, 2012, BRAIN, V135, P1786, DOI 10.1093/brain/aws098; Gordon-Lipkin E, 2007, NEUROLOGY, V69, P1603, DOI 10.1212/01.wnl.0000295995.46586.ae; Green AJ, 2009, J NEUROL NEUROSUR PS, V80, P1002, DOI 10.1136/jnnp.2008.166207; Jacob A, 2012, NEUROLOGY, V79, P1065, DOI 10.1212/WNL.0b013e31826845fe; Jarernsook B, 2012, MULT SCLER; Jarius S, 2010, J NEUROL SCI, V291, P52, DOI 10.1016/j.jns.2010.01.002; Jarius S, 2008, NAT CLIN PRACT NEURO, V4, P202, DOI 10.1038/ncpneuro0764; Jarius S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-14; Jarius S, 2010, NAT REV NEUROL, V6, P383, DOI 10.1038/nrneurol.2010.72; Kalluri SR, 2010, ARCH NEUROL-CHICAGO, V67, P1201, DOI 10.1001/archneurol.2010.269; KERRISON JB, 1994, RETINA-J RET VIT DIS, V14, P445, DOI 10.1097/00006982-199414050-00010; Kim SH, 2012, MULT SCLER J, V18, P1480, DOI 10.1177/1352458512439439; Kleiter I, 2012, ARCH NEUROL-CHICAGO, V69, P239, DOI 10.1001/archneurol.2011.216; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Li J, 2002, INVEST OPHTH VIS SCI, V43, P573; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Mealy MA, 2012, ARCH NEUROL-CHICAGO, V69, P1176, DOI 10.1001/archneurol.2012.314; Merle H, 2008, INVEST OPHTH VIS SCI, V49, P4412, DOI 10.1167/iovs.08-1815; Min JH, 2012, MULT SCLER J, V18, P113, DOI 10.1177/1352458511431973; Monteiro MLR, 2012, INVEST OPHTH VIS SCI, V53, P3959, DOI 10.1167/iovs.11-9324; Mowry EM, 2009, J NEUROL NEUROSUR PS, V80, P767, DOI 10.1136/jnnp.2008.165449; Naismith RT, 2009, NEUROLOGY, V72, P1077, DOI 10.1212/01.wnl.0000345042.53843.d5; Nakamura M, 2010, GRAEF ARCH CLIN EXP, V248, P1777, DOI 10.1007/s00417-010-1344-7; Noval S, 2011, MULT SCLER INT, V2011, DOI 10.1155/2011/472790; Oberwahrenbrock T, 2013, MULT SCLER J, V19, P1887, DOI 10.1177/1352458513489757; Oberwahrenbrock T, 2012, MULT SCLER INT, V2012, DOI 10.1155/2012/530305; Papeix C, 2007, MULT SCLER, V13, P256, DOI 10.1177/1352458506070732; Paul F, 2007, PLOS MED, V4, P669, DOI 10.1371/journal.pmed.0040133; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Pulicken M, 2007, NEUROLOGY, V69, P2085, DOI 10.1212/01.wnl.0000294876.49861.dc; Ratchford JN, 2009, NEUROLOGY, V73, P302, DOI 10.1212/WNL.0b013e3181af78b8; Saidha S, 2012, ARCH NEUROL-CHICAGO, P1; Saidha S, 2011, BRAIN, V134, P518, DOI 10.1093/brain/awq346; Sellner J, 2010, EUR J NEUROL, V17, P1019, DOI 10.1111/j.1468-1331.2010.03066.x; Sepulcre J, 2007, NEUROLOGY, V68, P1488, DOI 10.1212/01.wnl.0000260612.51849.ed; Shimizu J, 2010, NEUROLOGY, V75, P1423, DOI 10.1212/WNL.0b013e3181f8832e; Siger M, 2008, J NEUROL, V255, P1555, DOI 10.1007/s00415-008-0985-5; Sotirchos ES, 2013, NEUROLOGY, V80, P1406, DOI 10.1212/WNL.0b013e31828c2f7a; Stricker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023024; Suhs KW, 2012, ANN NEUROL, V72, P199, DOI 10.1002/ana.23573; Syc SB, 2012, BRAIN, V135, P521, DOI 10.1093/brain/awr264; Tewarie P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034823; Toledo J, 2008, MULT SCLER J, V14, P906, DOI 10.1177/1352458508090221; Trip SA, 2005, ANN NEUROL, V58, P383, DOI 10.1002/ana.20575; van Horssen J, 2012, MULT SCLER J, V18, P1058, DOI 10.1177/1352458512452924; Walter SD, 2012, OPHTHALMOLOGY, V119, P1250, DOI 10.1016/j.ophtha.2011.11.032; Wingerchuk DM, 2007, NEUROLOGY, V68, P603, DOI 10.1212/01.wnl.0000254502.87233.9a; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wingerchuk DM, 2003, NEUROLOGY, V60, P848, DOI 10.1212/01.WNL.0000049912.02954.2C; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107; Zimmermann H, 2013, MULT SCLER J, V19, P443, DOI 10.1177/1352458512457844	73	114	118	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66151	10.1371/journal.pone.0066151	http://dx.doi.org/10.1371/journal.pone.0066151			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805202	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000320846500030
J	Zhang, YH; Yan, WS; Jung, YS; Chen, XB				Zhang, Yanhong; Yan, Wensheng; Jung, Yong Sam; Chen, Xinbin			PUMA Cooperates with p21 to Regulate Mammary Epithelial Morphogenesis and Epithelial-To-Mesenchymal Transition	PLOS ONE			English	Article							CELL POLARITY; DNA-DAMAGE; TRANSCRIPTION FACTORS; P53; EXPRESSION; APOPTOSIS; P73; GENE; DELTA-NP73; SURVIVAL	Lumen formation is essential for mammary morphogenesis and requires proliferative suppression and apoptotic clearance of the inner cells within developing acini. Previously, we showed that knockdown of p53 or p73 leads to aberrant mammary acinus formation accompanied with decreased expression of p53 family targets PUMA and p21, suggesting that PUMA, an inducer of apoptosis, and p21, an inducer of cell cycle arrest, directly regulate mammary morphogenesis. To address this, we generated multiple MCF10A cell lines in which PUMA, p21, or both were stably knocked down. We found that morphogenesis of MCF10A cells was altered modestly by knockdown of either PUMA or p21 alone but markedly by knockdown of both PUMA and p21. Moreover, we found that knockdown of PUMA and p21 leads to loss of E-cadherin expression along with increased expression of epithelial-to-mesenchymal transition (EMT) markers. Interestingly, we found that knockdown of Delta Np73, which antagonizes the ability of wide-type p53 and TA isoform of p73 to regulate PUMA and p21, mitigates the abnormal morphogenesis and EMT induced by knockdown of PUMA or p21. Together, our data suggest that PUMA cooperates with p21 to regulate normal acinus formation and EMT.	[Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Sch Med, Davis, CA 95616 USA; Univ Calif Davis, Comparat Oncol Lab, Sch Vet Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Sch Med, Davis, CA 95616 USA.	xbchen@ucdavis.edu			National Cancer Institute [CA081237]; NATIONAL CANCER INSTITUTE [R01CA081237] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Cancer Institute Grant CA081237. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bachman KE, 2004, CANCER BIOL THER, V3, P221, DOI 10.4161/cbt.3.2.666; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Chen XB, 2001, ONCOGENE, V20, P769, DOI 10.1038/sj.onc.1204149; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; DENOOIJ JC, 1995, SCIENCE, V270, P983, DOI 10.1126/science.270.5238.983; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Foroni C, 2012, CANCER TREAT REV, V38, P689, DOI 10.1016/j.ctrv.2011.11.001; Gartel AL, 1996, EXP CELL RES, V227, P171, DOI 10.1006/excr.1996.0264; Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798; HUPPI K, 1994, ONCOGENE, V9, P3017; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Karakas B, 2006, ONCOGENE, V25, P5561, DOI 10.1038/sj.onc.1209540; Leibowitz BJ, 2011, MOL CANCER RES, V9, P616, DOI 10.1158/1541-7786.MCR-11-0052; Liu G, 2004, MOL CELL BIOL, V24, P487, DOI 10.1128/MCB.24.2.487-501.2004; Liu MR, 2009, P NATL ACAD SCI USA, V106, P19035, DOI 10.1073/pnas.0910009106; Ming LH, 2008, CARCINOGENESIS, V29, P1878, DOI 10.1093/carcin/bgn150; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Parichy DM, 2003, DEV BIOL, V256, P221, DOI 10.1016/S0012-1606(03)00016-2; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Ravni A, 2010, CELL CYCLE, V9, P1523, DOI 10.4161/cc.9.8.11291; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Royer C, 2011, CELL DEATH DIFFER, V18, P1470, DOI 10.1038/cdd.2011.60; Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; Schuster A, 2010, CELL CYCLE, V9, P2629, DOI 10.4161/cc.9.13.12110; Shaltouki A, 2007, APOPTOSIS, V12, P2143, DOI 10.1007/s10495-007-0135-z; Simoes-Wust AP, 2005, J NEURO-ONCOL, V72, P29, DOI 10.1007/s11060-004-3118-8; Stadanlick JE, 2011, J IMMUNOL, V187, P664, DOI 10.4049/jimmunol.1100029; Strange R, 2001, MICROSC RES TECHNIQ, V52, P171, DOI 10.1002/1097-0029(20010115)52:2<171::AID-JEMT1003>3.3.CO;2-K; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179; Zhang KJ, 2011, MED ONCOL, V28, pS301, DOI 10.1007/s12032-010-9759-x; Zhang KJ, 2011, INT J MOL SCI, V12, P385, DOI 10.3390/ijms12010385; Zhang YH, 2008, J BIOL CHEM, V283, P30689, DOI 10.1074/jbc.M801711200; Zhang YH, 2012, J BIOL CHEM, V287, P17746, DOI 10.1074/jbc.M112.358143; Zhang YH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.214585	42	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66464	10.1371/journal.pone.0066464	http://dx.doi.org/10.1371/journal.pone.0066464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805223	gold, Green Submitted, Green Published			2022-12-25	WOS:000320846500051
J	Fitzsimmons, KE; Hambach, U; Veres, D; Iovita, R				Fitzsimmons, Kathryn E.; Hambach, Ulrich; Veres, Daniel; Iovita, Radu			The Campanian Ignimbrite Eruption: New Data on Volcanic Ash Dispersal and Its Potential Impact on Human Evolution	PLOS ONE			English	Article							GRANDE-DI-MONTICCHIO; UPPER PALEOLITHIC TRANSITION; LATE PLEISTOCENE; DEPOSITIONAL PROCESSES; VOJVODINA REGION; CLIMATE-CHANGE; LOESS; TEPHRA; NORTHERN; HISTORY	The Campanian Ignimbrite (CI) volcanic eruption was the most explosive in Europe in the last 200,000 years. The event coincided with the onset of an extremely cold climatic phase known as Heinrich Event 4 (HE4) approximately 40,000 years ago. Their combined effect may have exacerbated the severity of the climate through positive feedbacks across Europe and possibly globally. The CI event is of particular interest not only to investigate the role of volcanism on climate forcing and palaeoenvironments, but also because its timing coincides with the arrival into Europe of anatomically modern humans, the demise of Neanderthals, and an associated major shift in lithic technology. At this stage, however, the degree of interaction between these factors is poorly known, based on fragmentary and widely dispersed data points. In this study we provide important new data from Eastern Europe which indicate that the magnitude of the CI eruption and impact of associated distal ash (tephra) deposits may have been substantially greater than existing models suggest. The scale of the eruption is modelled by tephra distribution and thickness, supported by local data points. CI ashfall extends as far as the Russian Plain, Eastern Mediterranean and northern Africa. However, modelling input is limited by very few data points in Eastern Europe. Here we investigate an unexpectedly thick CI tephra deposit in the southeast Romanian loess steppe, positively identified using geochemical and geochronological analyses. We establish the tephra as a widespread primary deposit, which blanketed the topography both thickly and rapidly, with potentially catastrophic impacts on local ecosystems. Our discovery not only highlights the need to reassess models for the magnitude of the eruption and its role in climatic transition, but also suggests that it may have substantially influenced hominin population and subsistence dynamics in a region strategic for human migration into Europe.	[Fitzsimmons, Kathryn E.; Iovita, Radu] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Hambach, Ulrich] Univ Bayreuth, Chair Geomorphol, Lab Palaeo & Enviromagnetism, Bayreuth, Germany; [Veres, Daniel] Romanian Acad, Inst Speleol, Cluj Napoca, Romania; [Veres, Daniel] Univ Babes Bolyai, Fac Environm Sci, R-3400 Cluj Napoca, Romania; [Iovita, Radu] RGZM, MONREPOS Archaeol Res Ctr, Neuwied, Germany; [Iovita, Radu] RGZM, Museum Human Behav Evolut, Neuwied, Germany	Max Planck Society; University of Bayreuth; Emil Racovita Institute of Speleology; Romanian Academy of Sciences; Babes Bolyai University from Cluj; Leibniz-Forschungsinstitut fur Archaologie (RGZM); Leibniz-Forschungsinstitut fur Archaologie (RGZM)	Fitzsimmons, KE (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany.	kathryn_fitzsimmons@eva.mpg.de	Fitzsimmons, Kathryn/U-3565-2018; Veres, Daniel/AAX-3319-2020; Iovita, Radu/B-9580-2015; Veres, Daniel S/GNH-2578-2022; Fitzsimmons, Kathryn/P-3471-2014; Veres, Daniel/GNH-2718-2022	Fitzsimmons, Kathryn/0000-0002-9337-0793; Veres, Daniel/0000-0003-3932-577X; Iovita, Radu/0000-0001-9531-1159; Fitzsimmons, Kathryn/0000-0002-9337-0793; 	Max Planck Society through the project "Lower Danube Survey for Palaeolithic Sites''; CNCS-UEFISCDI [PN-II-RU-TE-2011-3-0062, 73/05.10.2011]	Max Planck Society through the project "Lower Danube Survey for Palaeolithic Sites''; CNCS-UEFISCDI	This work was funded by the Max Planck Society through the project "Lower Danube Survey for Palaeolithic Sites''. D. Veres acknowledges the support of CNCS-UEFISCDI through grant PN-II-RU-TE-2011-3-0062, contract no. 73/05.10.2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott PM, 2012, EARTH-SCI REV, V115, P173, DOI 10.1016/j.earscirev.2012.09.001; Accorsi C.A., 1979, ATTI SOC TOSCANA S A, V86, P435; Adamiec G., 1998, ANCIENT TL, V16, P37, DOI DOI 10.1016/S0277-3791(03)00021-0; Andersen KK, 2006, QUATERNARY SCI REV, V25, P3246, DOI 10.1016/j.quascirev.2006.08.002; Anghelinu M, 2013, QUAT INT IN PRESS, DOI [10.1016/j.quaint.2012.03.013, DOI 10.1016/J.QUAINT.2012.03.013.(IN]; Baales M, 2002, QUATERNARY RES, V58, P273, DOI 10.1006/qres.2002.2379; Bar-Yosef O, 2002, ANNU REV ANTHROPOL, V31, P363, DOI 10.1146/annurev.anthro.31.040402.085416; Barberi F., 1978, B VOLCANOL, V41, P10, DOI DOI 10.1007/BF02597680; Barton L, 2007, DEV QUATER SCI, V9, P105, DOI 10.1016/S1571-0866(07)09009-4; Baumgart P, 2013, QUATERN INT, V296, P82, DOI 10.1016/j.quaint.2012.12.021; Botter-Jensen L, 1999, QUATERNARY SCI REV, V18, P303, DOI 10.1016/S0277-3791(98)00063-8; Botter-Jensen L, 2000, RADIAT MEAS, V32, P523, DOI 10.1016/S1350-4487(00)00039-1; Buggle B, 2013, GEOLOGY IN PRESS, DOI [10.1130/G34198.1, DOI 10.1130/G34198.1.(IN]; Buggle B, 2008, QUATERNARY SCI REV, V27, P1058, DOI 10.1016/j.quascirev.2008.01.018; Buggle B, 2009, QUATERN INT, V196, P86, DOI 10.1016/j.quaint.2008.07.013; Buylaert JP, 2012, BOREAS, V41, P435, DOI 10.1111/j.1502-3885.2012.00248.x; Byerly RM, 2007, J ARCHAEOL SCI, V34, P1847, DOI 10.1016/j.jas.2007.01.001; Civetta L, 1997, J VOLCANOL GEOTH RES, V75, P183, DOI 10.1016/S0377-0273(96)00027-3; Clarkson C, 2012, QUATERN INT, V258, P165, DOI 10.1016/j.quaint.2011.11.007; Constantin D, 2012, QUAT GEOCHRONOL, V10, P81, DOI 10.1016/j.quageo.2012.01.012; Costa A, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051605; Cronin SJ, 2003, J VOLCANOL GEOTH RES, V121, P271, DOI 10.1016/S0377-0273(02)00465-1; D'Alessandro W, 2006, WIT TR BIOMED HEALTH, V10, P21, DOI 10.2495/ETOX060031; Davies SM, 2010, EARTH PLANET SC LETT, V294, P69, DOI 10.1016/j.epsl.2010.03.004; De Vivo B, 2001, MINER PETROL, V73, P47, DOI 10.1007/s007100170010; Dumond DE, 2004, ARCTIC ANTHROPOL, V41, P112, DOI 10.1353/arc.2011.0023; Evans ME, 2001, EARTH-SCI REV, V54, P129, DOI 10.1016/S0012-8252(01)00044-7; Fedele F., 2007, LIVING SHADOW CULTUR, P19; Fedele F. G., 2003, GEOPHYS MONOGR SER, V139, P301, DOI DOI 10.1029/139GM20; Fedele FG, 2008, J HUM EVOL, V55, P834, DOI 10.1016/j.jhevol.2008.08.012; Ferrier C, 2000, TEMNATA CAVE EXCAVAT, P13; Fitzsimmons KE, 2012, QUATERNARY SCI REV, V41, P104, DOI 10.1016/j.quascirev.2012.03.002; Frechen M, 1996, ANCIENT TL, V14, P15; Galbraith RF, 1999, ARCHAEOMETRY, V41, P339, DOI 10.1111/j.1475-4754.1999.tb00987.x; Gambassini P., 1997, PALEOLITICO CASTELCI; Gamble C, 2004, PHILOS T R SOC B, V359, P243, DOI 10.1098/rstb.2003.1396; Giaccio B., 2006, NEANDERTHALS MODERN, P343; Giaccio B, 2008, J VOLCANOL GEOTH RES, V177, P208, DOI 10.1016/j.jvolgeores.2007.10.007; Grattan J, 2006, QUATERN INT, V151, P10, DOI 10.1016/j.quaint.2006.01.019; GRATTAN JP, 1994, J ARCHAEOL SCI, V21, P851, DOI 10.1006/jasc.1994.1082; Haase D, 2007, QUATERNARY SCI REV, V26, P1301, DOI 10.1016/j.quascirev.2007.02.003; Hambach U., 2010, NEW ASPECTS CENTRAL, V72, P295; Hambach U, 2008, EISZEITALTER GEGENWA, V57, P25, DOI DOI 10.3285/EG.57.1-2.2; Haslam M, 2010, J ARCHAEOL SCI, V37, P3370, DOI 10.1016/j.jas.2010.07.034; HEINRICH H, 1988, QUATERNARY RES, V29, P142, DOI 10.1016/0033-5894(88)90057-9; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; Hoffecker JF, 2009, P NATL ACAD SCI USA, V106, P16040, DOI 10.1073/pnas.0903446106; Hoffecker JF, 2008, J HUM EVOL, V55, P858, DOI 10.1016/j.jhevol.2008.08.018; Horwell CJ, 2006, B VOLCANOL, V69, P1, DOI 10.1007/s00445-006-0052-y; Hublin JJ, 2012, P NATL ACAD SCI USA, V109, P13471, DOI 10.1073/pnas.1211082109; Iovita R, 2012, ANTIQUITY, V86, P973, DOI 10.1017/S0003598X00048195; Iovita RP, 2013, QUAT INT IN PRESS; Jones SC, 2012, QUATERN INT, V258, P100, DOI 10.1016/j.quaint.2011.09.017; Kadereit A, 2013, QUATERNARY SCI REV, V59, P67, DOI 10.1016/j.quascirev.2012.10.026; Klein R, 1999, HUMAN BIOL CULTURAL; Kockum PCF, 2006, CHEM GEOL, V231, P57, DOI 10.1016/j.chemgeo.2005.12.008; KUKLA GJ, 1975, AUSTRALOPITHECINES, P99; Lane CS, 2012, QUATERNARY SCI REV, V36, P50, DOI 10.1016/j.quascirev.2010.10.015; Lowe J, 2012, P NATL ACAD SCI USA, V109, P13532, DOI 10.1073/pnas.1204579109; Markovic SB, 2012, NETH J GEOSCI, V91, P173; Markovic SB, 2008, J QUATERNARY SCI, V23, P73, DOI 10.1002/jqs.1124; Melekeszev I. V., 1984, VULCANOLOGIA SEISMOL, V3, P35; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; Mihailovic D, 2008, PALAEOLITHIC BALKANS, V1819, P93; Morley MW, 2011, QUATERNARY RES, V75, P683, DOI 10.1016/j.yqres.2011.02.005; Munteanu Mihai Tudor, 2008, Acta Palaeontologica Romaniae, V6, P229; Murray AS, 2000, RADIAT MEAS, V32, P57, DOI 10.1016/S1350-4487(99)00253-X; Nowaczyk NR, 2012, EARTH PLANET SC LETT, V351, P54, DOI 10.1016/j.epsl.2012.06.050; Ort MH, 2003, B VOLCANOL, V65, P55, DOI 10.1007/s00445-002-0241-2; Panaiotu CG, 2001, PHYS CHEM EARTH PT A, V26, P893, DOI 10.1016/S1464-1895(01)00138-7; Pappalardo L, 2002, J VOLCANOL GEOTH RES, V114, P479, DOI 10.1016/S0377-0273(01)00302-X; Paterne M., 1992, TEMNATA CAVE EXCAVAT, V1, P99; Pawlikowskj M, 1992, TEMNATA CAVE EXCAVAT, P89; PRESCOTT JR, 1994, RADIAT MEAS, V23, P497, DOI 10.1016/1350-4487(94)90086-8; Pyle DM, 2006, QUATERNARY SCI REV, V25, P2713, DOI 10.1016/j.quascirev.2006.06.008; PYLE DM, 1989, B VOLCANOL, V51, P1, DOI 10.1007/BF01086757; Rees-Jones J, 1995, ANCIENT TL, V13, P9; ReesJones J, 1997, ARCHAEOMETRY, V39, P177, DOI 10.1111/j.1475-4754.1997.tb00797.x; Riede F, 2008, J ARCHAEOL SCI, V35, P591, DOI 10.1016/j.jas.2007.05.007; Riede F, 2009, LITHIC TECHNOL, V34, P27, DOI 10.1080/01977261.2009.11721072; Riede F, 2009, J ARCHAEOL SCI, V36, P675, DOI 10.1016/j.jas.2008.10.013; Romanowska I., 2012, UNRAVELLING PALAEOLI, P1; Rosi M, 1999, J VOLCANOL GEOTH RES, V91, P179, DOI 10.1016/S0377-0273(99)00035-9; Rousseau DD, 2006, QUATERNARY SCI REV, V25, P2025, DOI 10.1016/j.quascirev.2006.03.009; Signorelli S, 1999, J VOLCANOL GEOTH RES, V91, P199, DOI 10.1016/S0377-0273(99)00036-0; Sinitsyn AA, 2006, QUATERN INT, V152, P164, DOI 10.1016/j.quaint.2005.12.007; Sinitsyn AA, 2003, ANTIQUITY, V77, P9, DOI 10.1017/S0003598X00061299; Sitlivy V, 2014, QUATERN INT, V351, P193, DOI 10.1016/j.quaint.2012.07.024; SMALLEY IJ, 1978, SEDIMENT GEOL, V21, P1, DOI 10.1016/0037-0738(78)90031-3; SPARKS S, 2005, SUPERERUPTIONS GLOBA; Stevens T, 2011, QUATERNARY SCI REV, V30, P662, DOI 10.1016/j.quascirev.2010.12.011; Storey M, 2012, P NATL ACAD SCI USA, V109, P18684, DOI 10.1073/pnas.1208178109; Stringer CB, 2007, VERTEBR PALEOBIOL PA, P315; Stuut JB, 2009, QUATERN INT, V198, P234, DOI 10.1016/j.quaint.2008.10.007; Timar A, 2010, QUAT GEOCHRONOL, V5, P143, DOI 10.1016/j.quageo.2009.03.003; Timmreck C, 2012, QUATERN INT, V258, P30, DOI 10.1016/j.quaint.2011.10.008; Ton-That T, 2001, EARTH PLANET SC LETT, V184, P645, DOI 10.1016/S0012-821X(00)00358-7; Trinkaus E, 2003, P NATL ACAD SCI USA, V100, P11231, DOI 10.1073/pnas.2035108100; Tzedakis PC, 2002, SCIENCE, V297, P2044, DOI 10.1126/science.1073083; Ujvari G, 2008, QUATERNARY RES, V69, P421, DOI 10.1016/j.yqres.2008.02.001; Upton J, 2002, QUAT RES ASS 1 POSTG; van der Kaars S, 2012, QUATERN INT, V258, P45, DOI 10.1016/j.quaint.2011.09.006; Veres D, 2013, QUATERN INT, V293, P22, DOI 10.1016/j.quaint.2012.02.042; Watts WA, 2000, PALAEOGEOGR PALAEOCL, V155, P83, DOI 10.1016/S0031-0182(99)00096-6; Watts WA, 1996, QUATERNARY SCI REV, V15, P133, DOI 10.1016/0277-3791(95)00093-3; Williams M, 2012, QUATERN INT, V258, P19, DOI 10.1016/j.quaint.2011.08.025; Wolff EW, 2010, QUATERNARY SCI REV, V29, P2828, DOI 10.1016/j.quascirev.2009.10.013; Wood RE, 2013, P NATL ACAD SCI USA, V110, P2781, DOI 10.1073/pnas.1207656110; Zielinski GA, 1996, QUATERNARY RES, V45, P109, DOI 10.1006/qres.1996.0013; Zilhao Joao, 2007, RETHINKING HUMAN REV, P249; Zolitschka B, 1996, QUATERNARY SCI REV, V15, P101, DOI 10.1016/0277-3791(95)00022-4	111	71	72	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65839	10.1371/journal.pone.0065839	http://dx.doi.org/10.1371/journal.pone.0065839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799050	Green Published, gold, Green Submitted			2022-12-25	WOS:000321397800017
J	Hunter, LJR; Westwood, JH; Heath, G; Macaulay, K; Smith, AG; MacFarlane, SA; Palukaitis, P; Carr, JP				Hunter, Lydia J. R.; Westwood, Jack H.; Heath, Geraldine; Macaulay, Keith; Smith, Alison G.; MacFarlane, Stuart A.; Palukaitis, Peter; Carr, John P.			Regulation of RNA-Dependent RNA Polymerase 1 and Isochorismate Synthase Gene Expression in Arabidopsis	PLOS ONE			English	Article							DICER-LIKE PROTEINS; SALICYLIC-ACID; ABSCISIC-ACID; VIRUS; PLANT; RESISTANCE; BIOGENESIS; DEFENSE; INFECTION; THALIANA	Background: RNA-dependent RNA polymerases (RDRs) function in anti-viral silencing in Arabidopsis thaliana and other plants. Salicylic acid (SA), an important defensive signal, increases RDR1 gene expression, suggesting that RDR1 contributes to SA-induced virus resistance. In Nicotiana attenuata RDR1 also regulates plant-insect interactions and is induced by another important signal, jasmonic acid (JA). Despite its importance in defense RDR1 regulation has not been investigated in detail. Methodology/Principal Findings: In Arabidopsis, SA-induced RDR1 expression was dependent on 'NON-EXPRESSER OF PATHOGENESIS-RELATED GENES 1', indicating regulation involves the same mechanism controlling many other SA-defenserelated genes, including pathogenesis-related 1 (PR1). Isochorismate synthase 1 (ICS1) is required for SA biosynthesis. In defensive signal transduction RDR1 lies downstream of ICS1. However, supplying exogenous SA to ics1-mutant plants did not induce RDR1 or PR1 expression to the same extent as seen in wild type plants. Analysing ICS1 gene expression using transgenic plants expressing ICS1 promoter: reporter gene (beta-glucuronidase) constructs and by measuring steady-state ICS1 transcript levels showed that SA positively regulates ICS1. In contrast, ICS2, which is expressed at lower levels than ICS1, is unaffected by SA. The wound-response hormone JA affects expression of Arabidopsis RDR1 but jasmonate-induced expression is independent of CORONATINE-INSENSITIVE 1, which conditions expression of many other JA-responsive genes. Transiently increased RDR1 expression following tobacco mosaic virus inoculation was due to wounding and was not a direct effect of infection. RDR1 gene expression was induced by ethylene and by abscisic acid (an important regulator of drought resistance). However, rdr1-mutant plants showed normal responses to drought. Conclusions/Significance: RDR1 is regulated by a much broader range of phytohormones than previously thought, indicating that it plays roles beyond those already suggested in virus resistance and plant-insect interactions. SA positively regulates ICS1.	[Hunter, Lydia J. R.; Westwood, Jack H.; Heath, Geraldine; Macaulay, Keith; Smith, Alison G.; Carr, John P.] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Hunter, Lydia J. R.; MacFarlane, Stuart A.; Palukaitis, Peter] James Hutton Inst, Dundee, Scotland; [Palukaitis, Peter] Seoul Womens Univ, Div Environm & Life Sci, Seoul, South Korea	University of Cambridge; James Hutton Institute; Seoul Women's University	Carr, JP (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge, England.	jpc1005@hermes.cam.ac.uk	Carr, John/H-5646-2016; Carr, John Peter/N-7707-2019	Carr, John/0000-0002-5028-2160; Carr, John Peter/0000-0002-5028-2160; Smith, Alison Gail/0000-0001-6511-5704	James Hutton Institute; UK Biotechnological and Biological Sciences Research Council (BBSRC); Leverhulme Trust [RPG-2012-667]; BBSRC [BB/D014376/1, BB/J011762/1]; Cambridge University Newton Trust; Biotechnology and Biological Sciences Research Council [BB/J011762/1] Funding Source: researchfish	James Hutton Institute; UK Biotechnological and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cambridge University Newton Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	First author (LJRH) supported by a studentship co-funded by the James Hutton (formerly Scottish Crop Research) Institute and the UK Biotechnological and Biological Sciences Research Council (BBSRC). Work in the JPC lab is funded by The Leverhulme Trust (RPG-2012-667), BBSRC (BB/D014376/1, BB/J011762/1) and the Cambridge University Newton Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo J, 2010, GENE DEV, V24, P904, DOI 10.1101/gad.1908710; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Carr JP, 2010, ADV VIRUS RES, V76, P57, DOI 10.1016/S0065-3527(10)76003-6; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Csorba T, 2009, ADV VIRUS RES, V75, P35, DOI 10.1016/S0065-3527(09)07502-2; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Devoto A, 2005, PLANT MOL BIOL, V58, P497, DOI 10.1007/s11103-005-7306-5; Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449; Donaire L, 2008, J VIROL, V82, P5167, DOI 10.1128/JVI.00272-08; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Earley K, 2010, SILENCE, V1, P15, DOI [10.1186/1758-907X-1-15, DOI 10.1186/1758-907X-1-15]; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Garcia-Ruiz H, 2010, PLANT CELL, V22, P481, DOI 10.1105/tpc.109.073056; Garcion C, 2008, PLANT PHYSIOL, V147, P1279, DOI 10.1104/pp.108.119420; Harvey JJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014639; Hase S, 2003, PHYSIOL MOL PLANT P, V62, P219, DOI 10.1016/S0885-5765(03)00059-6; He JG, 2010, MOL BIOL REP, V37, P865, DOI 10.1007/s11033-009-9692-2; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Kachroo P, 2000, PLANT CELL, V12, P677, DOI 10.1105/tpc.12.5.677; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Lee WS, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-41; Lewsey MG, 2010, MOL PLANT MICROBE IN, V23, P835, DOI 10.1094/MPMI-23-7-0835; Li W, 2012, PLANT PHYSIOL, V158, P1279, DOI 10.1104/pp.111.188789; MacDiarmid R, 2005, ANNU REV PHYTOPATHOL, V43, P523, DOI 10.1146/annurev.phyto.43.040204.140204; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; Molnar A, 2005, J VIROL, V79, P7812, DOI 10.1128/JVI.79.12.7812-7818.2005; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Muangsan N, 2004, PLANT J, V38, P1004, DOI 10.1111/j.1365-313X.2004.02103.x; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Palukaitis P, 2011, PLANT PATHOLOGY J, V27, P197, DOI 10.5423/PPJ.2011.27.3.197; Pandey SP, 2008, P NATL ACAD SCI USA, V105, P4559, DOI 10.1073/pnas.0711363105; Pandey SP, 2007, PLANT J, V50, P40, DOI 10.1111/j.1365-313X.2007.03030.x; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; Qu F, 2008, P NATL ACAD SCI USA, V105, P14732, DOI 10.1073/pnas.0805760105; Rakhshandehroo F, 2009, MOL PLANT MICROBE IN, V22, P1312, DOI 10.1094/MPMI-22-10-1312; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Robertson F, 2009, PLANT MOL BIOL, V69, P419, DOI 10.1007/s11103-008-9407-4; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Shah J, 1997, MOL PLANT MICROBE IN, V10, P69, DOI 10.1094/MPMI.1997.10.1.69; Stotz HU, 2011, PLANT CELL PHYSIOL, V52, P1941, DOI 10.1093/pcp/pcr127; Strawn MA, 2007, J BIOL CHEM, V282, P5919, DOI 10.1074/jbc.M605193200; Thaler JS, 2004, PLANT PHYSIOL, V135, P530, DOI 10.1104/pp.104.041566; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; Westwood JH, 2013, MOL PLANT PATHOL, V14, P158, DOI 10.1111/j.1364-3703.2012.00840.x; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Wong CE, 2002, MOL PLANT MICROBE IN, V15, P75, DOI 10.1094/MPMI.2002.15.1.75; Xie ZX, 2001, P NATL ACAD SCI USA, V98, P6516, DOI 10.1073/pnas.111440998; Xu P, 2008, NEW PHYTOL, V180, P911, DOI 10.1111/j.1469-8137.2008.02627.x; Yang HF, 2011, MOL BIOL REP, V38, P929, DOI 10.1007/s11033-010-0186-z; Yang SJ, 2004, P NATL ACAD SCI USA, V101, P6297, DOI 10.1073/pnas.0304346101; Ying XB, 2010, PLANT CELL, V22, P1358, DOI 10.1105/tpc.109.072058; Yu DQ, 2003, MOL PLANT MICROBE IN, V16, P206, DOI 10.1094/MPMI.2003.16.3.206; ZAITLIN M, 1987, ANNU REV PLANT PHYS, V38, P291, DOI 10.1146/annurev.pp.38.060187.001451; Zhang YX, 2010, P NATL ACAD SCI USA, V107, P18220, DOI 10.1073/pnas.1005225107	64	60	61	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66530	10.1371/journal.pone.0066530	http://dx.doi.org/10.1371/journal.pone.0066530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799112	Green Submitted, Green Published, gold			2022-12-25	WOS:000321397800035
J	Sealy-Jefferson, S; Gillespie, BW; Aiello, AE; Haan, MN; Morgenstern, LB; Lisabeth, LD				Sealy-Jefferson, Shawnita; Gillespie, Brenda W.; Aiello, Allison E.; Haan, Mary N.; Morgenstern, Lewis B.; Lisabeth, Lynda D.			Antibody Levels to Persistent Pathogens and Incident Stroke in Mexican Americans	PLOS ONE			English	Article							HELICOBACTER-PYLORI-INFECTION; C-REACTIVE PROTEIN; BRAIN ATTACK SURVEILLANCE; TYPE-2 DIABETES-MELLITUS; POPULATION-BASED COHORT; CORONARY-HEART-DISEASE; MIDDLE-AGED MEN; ISCHEMIC-STROKE; UNITED-STATES; RISK-FACTORS	Background: Persistent pathogens have been proposed as risk factors for stroke; however, the evidence remains inconclusive. Mexican Americans have an increased risk of stroke especially at younger ages, as well as a higher prevalence of infections caused by several persistent pathogens. Methodology/Principal: Findings Using data from the Sacramento Area Latino Study on Aging (n = 1621), the authors used discrete-time regression to examine associations between stroke risk and (1) immunoglobulin G antibody levels to Helicobacter pylori (H. pylori), Cytomegalovirus, Varicella Zoster Virus, Toxoplasma gondii and Herpes simplex virus 1, and (2) concurrent exposure to several pathogens (pathogen burden), defined as: (a) summed sero-positivity, (b) number of pathogens eliciting high antibody levels, and (c) average antibody level. Models were adjusted for socio-demographics and stroke risk factors. Antibody levels to H. pylori predicted incident stroke in fully adjusted models (Odds Ratio: 1.58; 95% Confidence Interval: 1.09, 2.28). No significant associations were found between stroke risk and antibody levels to the other four pathogens. No associations were found for pathogen burden and incident stroke in fully adjusted models. Conclusions/Significance: Our results suggest that exposure to H. pylori may be a stroke risk factor in Mexican Americans and may contribute to ethnic differences in stroke risk given the increased prevalence of exposure to H. pylori in this population. Future studies are needed to confirm this association.	[Sealy-Jefferson, Shawnita] Wayne State Univ, Sch Med, Dept Family Med & Publ Hlth Sci, Detroit, MI 48202 USA; [Gillespie, Brenda W.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Gillespie, Brenda W.] Univ Michigan, Ctr Stat Consultat & Res, Ann Arbor, MI 48109 USA; [Aiello, Allison E.; Lisabeth, Lynda D.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ctr Social Epidemiol & Populat Hlth, Ann Arbor, MI 48109 USA; [Haan, Mary N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Morgenstern, Lewis B.; Lisabeth, Lynda D.] Univ Michigan, Sch Med, Stroke Program, Ann Arbor, MI USA; [Morgenstern, Lewis B.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	Wayne State University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sealy-Jefferson, S (corresponding author), Wayne State Univ, Sch Med, Dept Family Med & Publ Hlth Sci, Detroit, MI 48202 USA.	ssealyj@med.wayne.edu	Sealy-Jefferson, Shawnita/AAS-8992-2020; Haan, Mary N/Y-9354-2018	Haan, Mary N/0000-0001-9312-4501	National Research Service Award [NRSA: 1F31NS070430-01A1]; National Institutes of Health [AG12975, DK60753]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS070430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012975] Funding Source: NIH RePORTER	National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Research Service Award (NRSA: 1F31NS070430-01A1) and the National Institutes of Health Grants AG12975 and DK60753. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello AE, 2008, J INFECT DIS, V197, P34, DOI 10.1086/524144; Allison PD, 2010, SURV AN US SAS PRACT; American Stroke Association, ATH STROK; BARNES RJ, 1991, BRIT J GEN PRACT, V41, P286; Baudron CR, 2013, J AM GERIATR SOC, V61, P74, DOI 10.1111/jgs.12065; Beck JD, 2005, J PERIODONTOL, V76, P2089, DOI 10.1902/jop.2005.76.11-S.2089; Corder EH, 1998, NAT MED, V4, P1182, DOI 10.1038/2677; Dierkes J, 2003, DIGEST DIS, V21, P237, DOI 10.1159/000073341; Elkind MSV, 2010, ARCH NEUROL-CHICAGO, V67, P33, DOI 10.1001/archneurol.2009.271; Elkind MSV, 2006, STROKE, V37, P790, DOI 10.1161/01.STR.0000202624.89869.e9; Engstad T, 2000, STROKE, V31, P1602, DOI 10.1161/01.STR.31.7.1602; Epstein SE, 1999, CIRCULATION, V100, pE20, DOI 10.1161/01.CIR.100.4.e20; Everhart JE, 2000, J INFECT DIS, V181, P1359, DOI 10.1086/315384; Evrengul H, 2007, HELICOBACTER, V12, P298, DOI 10.1111/j.1523-5378.2007.00505.x; Fernandez-Real JM, 2001, J CLIN ENDOCR METAB, V86, P1154, DOI 10.1210/jc.86.3.1154; Genco R, 2002, J AM DENT ASSOC, V133, p14S, DOI 10.14219/jada.archive.2002.0375; Gerard HC, 2005, MICROB PATHOGENESIS, V39, P19, DOI 10.1016/j.micpath.2005.05.002; Glymour MM, 2009, STROKE, V40, P873, DOI 10.1161/STROKEAHA.108.529479; Haan MN, 2003, J AM GERIATR SOC, V51, P169, DOI 10.1046/j.1532-5415.2003.51054.x; Haider AW, 2002, J AM COLL CARDIOL, V40, P1408, DOI 10.1016/S0735-1097(02)02272-6; Heckbert SR, 2004, AM J EPIDEMIOL, V160, P1152, DOI 10.1093/aje/kwh314; Itou Simon, 2007, Int J Med Sci, V4, P98; Itzhaki RF, 1997, LANCET, V349, P241, DOI 10.1016/S0140-6736(96)10149-5; Jeon CY, 2012, DIABETES CARE, V35, P520, DOI 10.2337/dc11-1043; Jones JL, 2007, AM J TROP MED HYG, V77, P405, DOI 10.4269/ajtmh.2007.77.405; Kis Z, 2007, NEW MICROBIOL, V30, P213; Liao W, 1996, J LAB CLIN MED, V128, P452, DOI 10.1016/S0022-2143(96)90042-6; Lindsberg PJ, 2003, STROKE, V34, P2518, DOI 10.1161/01.STR.0000089015.51603.CC; Lip GYH, 1996, BRIT MED J, V312, P250; Liu LJ, 2007, CIRC J, V71, P1761, DOI 10.1253/circj.71.1761; McColl BW, 2009, NEUROSCIENCE, V158, P1049, DOI 10.1016/j.neuroscience.2008.08.019; Miggins M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018890; Moon SK, 2004, J CELL PHYSIOL, V198, P417, DOI 10.1002/jcp.10435; Morgenstern LB, 2004, AM J EPIDEMIOL, V160, P376, DOI 10.1093/aje/kwh225; Nazmi A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-706; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; OMURA Y, 1988, ACUPUNCTURE ELECTRO, V13, P131, DOI 10.3727/036012988816358633; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Price DA, 2006, GUT, V55, P715, DOI 10.1136/gut.2005.079905; Pussinen PJ, 2007, ATHEROSCLEROSIS, V193, P222, DOI 10.1016/j.atherosclerosis.2006.06.027; Pussinen PJ, 2004, STROKE, V35, P2020, DOI 10.1161/01.STR.0000136148.29490.fe; Redeen S, 2010, DIGEST DIS SCI, V55, P351, DOI 10.1007/s10620-009-0761-0; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rubicz Rohina, 2011, BMC Res Notes, V4, P433, DOI 10.1186/1756-0500-4-433; Sacco RL, 1997, STROKE, V28, P1507, DOI 10.1161/01.STR.28.7.1507; Schottker B, 2012, ATHEROSCLEROSIS, V220, P569, DOI 10.1016/j.atherosclerosis.2011.11.029; Simpson CF, 2004, J AM GERIATR SOC, V52, P123, DOI 10.1111/j.1532-5415.2004.52021.x; Smith MA, 2003, STROKE, V34, P2671, DOI 10.1161/01.STR.0000096459.62826.1F; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Stettin D, 2008, ADV MED SCI-POLAND, V53, P205, DOI 10.2478/v10039-008-0050-8; Thorand B, 2003, ARCH INTERN MED, V163, P93, DOI 10.1001/archinte.163.1.93; Triantafillidis John K, 2003, Hepatogastroenterology, V50 Suppl 2, pcccxviii; Turchan-Cholewo J, 2006, NEUROBIOL DIS, V23, P109, DOI 10.1016/j.nbd.2006.02.005; Vecchione C, 2009, HYPERTENSION, V54, P150, DOI 10.1161/HYPERTENSIONAHA.108.128124; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455; Whincup PH, 1996, HEART, V75, P568, DOI 10.1136/hrt.75.6.568; Wozniak MA, 2002, HEPATOLOGY, V36, P456, DOI 10.1053/jhep.2002.34745; Wu JH, 2003, DIABETES CARE, V26, P314, DOI 10.2337/diacare.26.2.314; Xu F., 2010, Morbidity and Mortality Weekly Report, V59, P456	59	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65959	10.1371/journal.pone.0065959	http://dx.doi.org/10.1371/journal.pone.0065959			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799066	Green Published, gold, Green Submitted			2022-12-25	WOS:000320363300056
J	Thome, R; Moraes, AS; Bombeiro, AL; Farias, AD; Francelin, C; da Costa, TA; Di Gangi, R; dos Santos, LMB; de Oliveira, ALR; Verinaud, L				Thome, Rodolfo; Moraes, Adriel S.; Bombeiro, Andre Luis; Farias, Alessandro dos Santos; Francelin, Carolina; da Costa, Thiago Alves; Di Gangi, Rosaria; Barbosa dos Santos, Leonilda Maria; Rodrigues de Oliveira, Alexandre Leite; Verinaud, Liana			Chloroquine Treatment Enhances Regulatory T Cells and Reduces the Severity of Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; IMMUNOLOGICAL SELF-TOLERANCE; VERSUS-HOST-DISEASE; MULTIPLE-SCLEROSIS; RHEUMATOID-ARTHRITIS; TGF-BETA; ORAL TOLERANCE; FACTOR-ALPHA; TH17 CELLS; HYDROXYCHLOROQUINE	Background: The modulation of inflammatory processes is a necessary step, mostly orchestrated by regulatory T (Treg) cells and suppressive Dendritic Cells (DCs), to prevent the development of deleterious responses and autoimmune diseases. Therapies that focused on adoptive transfer of Treg cells or their expansion in vivo achieved great success in controlling inflammation in several experimental models. Chloroquine (CQ), an anti-malarial drug, was shown to reduce inflammation, although the mechanisms are still obscure. In this context, we aimed to access whether chloroquine treatment alters the frequency of Treg cells and DCs in normal mice. In addition, the effects of the prophylactic and therapeutic treatment with CQ on Experimental Autoimmune Encephalomyelitis (EAE), an experimental model for human Multiple Sclerosis, was investigated as well. Methodology/Principal Findings: EAE was induced in C57BL/6 mice by immunization with myelin oligodendrocyte glycoprotein (MOG(35-55)) peptide. C57BL/6 mice were intraperitoneally treated with chloroquine. Results show that the CQ treatment provoked an increase in Treg cells frequency as well as a decrease in DCs. We next evaluated whether prophylactic CQ administration is capable of reducing the clinical and histopathological signs of EAE. Our results demonstrated that CQ-treated mice developed mild EAE compared to controls that was associated with lower infiltration of inflammatory cells in the central nervous system CNS) and increased frequency of Treg cells. Also, proliferation of MOG(35-55)-reactive T cells was significantly inhibited by chloroquine treatment. Similar results were observed when chloroquine was administrated after disease onset. Conclusion: We show for the first time that CQ treatment promotes the expansion of Treg cells, corroborating previous reports indicating that chloroquine has immunomodulatory properties. Our results also show that CQ treatment suppress the inflammation in the CNS of EAE-inflicted mice, both in prophylactic and therapeutic approaches. We hypothesized that the increased number of regulatory T cells induced by the CQ treatment is involved in the reduction of the clinical signs of EAE.	[Thome, Rodolfo; Bombeiro, Andre Luis; Francelin, Carolina; da Costa, Thiago Alves; Di Gangi, Rosaria; Rodrigues de Oliveira, Alexandre Leite; Verinaud, Liana] Univ Estadual Campinas, Dept Struct & Funct Biol, Sao Paulo, Brazil; [Moraes, Adriel S.; Farias, Alessandro dos Santos; Barbosa dos Santos, Leonilda Maria] Univ Estadual Campinas, Dept Genet Evolut & Bioagents, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Verinaud, L (corresponding author), Univ Estadual Campinas, Dept Struct & Funct Biol, Sao Paulo, Brazil.	verinaud@unicamp.br	da Costa, Thiago Alves/F-8187-2016; Oliveira, Alexandre L. R./C-4436-2012; Francelin, Carolina/AAZ-9572-2020; Moraes, Adriel S/F-1259-2013; Thome, Rodolfo/C-1564-2012; Oliveira, Alexandre/AAI-6815-2020; Farias, Alessandro/AAH-2228-2020	Oliveira, Alexandre L. R./0000-0003-4224-4575; Francelin, Carolina/0000-0001-7439-3124; Moraes, Adriel S/0000-0002-9365-573X; Thome, Rodolfo/0000-0001-7627-4137; Oliveira, Alexandre/0000-0003-4224-4575; Farias, Alessandro/0000-0001-6759-1819; Alves da Costa, Thiago/0000-0001-9591-331X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/17965-3]; FAPESP [2011-13191-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) under grant number 2011/17965-3. R. T. was recipient of a FAPESP scholarship (#2011-13191-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backstrom NF, 2004, ARTHRITIS RES THER, V6, pR151, DOI 10.1186/ar1049; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; BERNARD CCA, 1976, J IMMUNOGENET, V3, P263; Bernstein H N, 1967, Surv Ophthalmol, V12, P415; BERNSTEIN HN, 1983, AM J MED, V75, P25, DOI 10.1016/0002-9343(83)91267-6; Bondeson J, 1998, GEN PHARMACOL, V30, P357, DOI 10.1016/S0306-3623(97)00269-3; Buttmann M, 2010, EXPERT REV NEUROTHER, V10, P791, DOI [10.1586/ern.10.38, 10.1586/ERN.10.38]; Capalbo D, 2012, INT REV IMMUNOL, V31, P344, DOI 10.3109/08830185.2012.697230; Corthay A, 2009, SCAND J IMMUNOL, V70, P326, DOI 10.1111/j.1365-3083.2009.02308.x; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Dejaco C, 2006, IMMUNOLOGY, V117, P289, DOI 10.1111/j.1365-2567.2005.02317.x; DIIANNI M, 2011, BLOOD, V117, P3921, DOI [DOI 10.1182/blood-2010-10-311894, DOI 10.1182/BLOOD-2010-10-311894]; Domingues HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015531; Farias AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017849; Fissolo N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-139; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; FOX RI, 1993, SEMIN ARTHRITIS RHEU, V23, P82, DOI 10.1016/S0049-0172(10)80012-5; Grierson DJ, 1997, ANN RHEUM DIS, V56, P188, DOI 10.1136/ard.56.3.188; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Jee Y, 2007, CLIN IMMUNOL, V125, P34, DOI 10.1016/j.clim.2007.05.020; Jeong JY, 1997, J IMMUNOL, V158, P4901; Kang YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049994; Karres I, 1998, AM J PHYSIOL-REG I, V274, pR1058, DOI 10.1152/ajpregu.1998.274.4.R1058; KOJIMA A, 1976, LAB INVEST, V34, P601; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lapierre P, 2013, HEPATOLOGY, V57, P217, DOI 10.1002/hep.26023; Loehberg CR, 2012, BIOCHEM PHARMACOL, V83, P480, DOI 10.1016/j.bcp.2011.11.022; Mavrikakis I, 2003, OPHTHALMOLOGY, V110, P1321, DOI 10.1016/S0161-6420(03)00409-3; Mellergard J, 2010, MULT SCLER J, V16, P208, DOI 10.1177/1352458509355068; Mix E, 2010, PROG NEUROBIOL, V92, P386, DOI 10.1016/j.pneurobio.2010.06.005; MORAND EF, 1992, ANN RHEUM DIS, V51, P1318, DOI 10.1136/ard.51.12.1318; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Peron JPS, 2010, J NEUROIMMUNOL, V227, P10, DOI 10.1016/j.jneuroim.2010.06.002; Petermann F, 2011, FEBS LETT; PICOT S, 1993, IMMUNOLOGY, V80, P127; RAINES MF, 1989, INVEST OPHTH VIS SCI, V30, P1726; Rintelen B, 2006, CLIN RHEUMATOL, V25, P557, DOI 10.1007/s10067-005-0149-2; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; SANTOS LMB, 1994, CELL IMMUNOL, V157, P439, DOI 10.1006/cimm.1994.1240; Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5; Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X; SCHULTZ KR, 1995, BLOOD, V86, P4344, DOI 10.1182/blood.V86.11.4344.bloodjournal86114344; Schultz KR, 2002, BIOL BLOOD MARROW TR, V8, P648, DOI 10.1053/bbmt.2002.v8.abbmt080648; Segal BM, 1998, J EXP MED, V187, P537, DOI 10.1084/jem.187.4.537; Sprent J, 1995, Int Rev Immunol, V13, P95, DOI 10.3109/08830189509061740; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Sundelin SP, 2002, APMIS, V110, P481, DOI 10.1034/j.1600-0463.2002.100606.x; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; Takahashi T, 2003, CURR MOL MED, V3, P693, DOI 10.2174/1566524033479429; Takata K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027644; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Thome R, 2012, CELL IMMUNOL, V280, P113, DOI 10.1016/j.cellimm.2012.11.017; van Herwijnen MJC, 2012, P NATL ACAD SCI USA, V109, P14134, DOI 10.1073/pnas.1206803109; vandenBorne BEEM, 1997, J RHEUMATOL, V24, P55; Weber SM, 2000, J IMMUNOL, V165, P1534, DOI 10.4049/jimmunol.165.3.1534; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Yurchenko E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035572; Zhao YG, 2012, J IMMUNOL, V189, P4417, DOI 10.4049/jimmunol.1200919; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	65	53	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65913	10.1371/journal.pone.0065913	http://dx.doi.org/10.1371/journal.pone.0065913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799062	gold, Green Submitted, Green Published			2022-12-25	WOS:000320363300053
J	Leone, MA; Barizzone, N; Esposito, F; Lucenti, A; Harbo, HF; Goris, A; Kockum, I; Oturai, AB; Celius, EG; Mero, IL; Dubois, B; Olsson, T; Sondergaard, HB; Cusi, D; Lupoli, S; Andreassen, BK; Myhr, KM; Guerini, FR; Comi, G; Martinelli-Boneschi, F; D'Alfonso, S				Leone, Maurizio A.; Barizzone, Nadia; Esposito, Federica; Lucenti, Ausiliatrice; Harbo, Hanne F.; Goris, An; Kockum, Ingrid; Oturai, Annette Bang; Celius, Elisabeth Gulowsen; Mero, Inger L.; Dubois, Benedicte; Olsson, Tomas; Sondergaard, Helle Bach; Cusi, Daniele; Lupoli, Sara; Andreassen, Bettina Kulle; Myhr, Kjell-Morten; Guerini, Franca R.; Comi, Giancarlo; Martinelli-Boneschi, Filippo; D'Alfonso, Sandra		International Multiple Sclerosis G	Association of Genetic Markers with CSF Oligoclonal Bands in Multiple Sclerosis Patients	PLOS ONE			English	Article							DISABILITY	Objective: to explore the association between genetic markers and Oligoclonal Bands (OCB) in the Cerebro Spinal Fluid (CSF) of Italian Multiple Sclerosis patients. Methods: We genotyped 1115 Italian patients for HLA-DRB1*15 and HLA-A*02. In a subset of 925 patients we tested association with 52 non-HLA SNPs associated with MS susceptibility and we calculated a weighted Genetic Risk Score. Finally, we performed a Genome Wide Association Study (GWAS) with OCB status on a subset of 562 patients. The best associated SNPs of the Italian GWAS were replicated in silico in Scandinavian and Belgian populations, and meta-analyzed. Results: HLA-DRB1*15 is associated with OCB+: p = 0.03, Odds Ratio (OR) = 1.6, 95% Confidence Limits (CL) = 1.1-2.4. None of the 52 non-HLA MS susceptibility loci was associated with OCB, except one SNP (rs2546890) near IL12B gene (OR: 1.45; 1.09-1.92). The weighted Genetic Risk Score mean was significantly (p = 0.0008) higher in OCB+ (7.668) than in OCB- (7.412) patients. After meta-analysis on the three datasets (Italian, Scandinavian and Belgian) for the best associated signals resulted from the Italian GWAS, the strongest signal was a SNP (rs9320598) on chromosome 6q (p = 9.4 x 10(-7)) outside the HLA region (65 Mb). Discussion: genetic factors predispose to the development of OCB.	[Leone, Maurizio A.; Lucenti, Ausiliatrice] MS Ctr, SCDU Neurol, Novara, Italy; [Leone, Maurizio A.; Barizzone, Nadia; D'Alfonso, Sandra] Univ Piemonte Orientale, IRCAD, Novara, Italy; [Barizzone, Nadia; D'Alfonso, Sandra] Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy; [Esposito, Federica; Comi, Giancarlo; Martinelli-Boneschi, Filippo] Ist Sci San Raffaele, Inst Expt Neurol, CNS Inflammatory Unit, Dept Neurol & Lab Neurogenet Complex Dis, I-20132 Milan, Italy; [Harbo, Hanne F.; Celius, Elisabeth Gulowsen; Mero, Inger L.] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Harbo, Hanne F.; Mero, Inger L.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Goris, An; Dubois, Benedicte] Katholieke Univ Leuven, Sect Expt Neurol, Lab Neuroimmunol, Louvain, Belgium; [Olsson, Tomas] Karolinska Hosp, Karolinska Inst, Ctr Mol Med CMM, Dept Clin Neurosci, S-10401 Stockholm, Sweden; [Oturai, Annette Bang; Sondergaard, Helle Bach] Copenhagen Univ Hosp, Rigshosp, Danish Multiple Sclerosis Ctr, Copenhagen, Denmark; [Cusi, Daniele; Lupoli, Sara] Univ Milan, Dept Hlth Sci, Milan, Italy; [Andreassen, Bettina Kulle] Univ Oslo, Dept Clin Mol Biol & Lab Sci EpiGen, Oslo, Norway; Haukeland Hosp, Dept Neurol, Norwegian Multiple Sclerosis Registry & Biobank, N-5021 Bergen, Norway; Univ Bergen, Dept Clin Med, KG Jebsen Ctr MS Res, Bergen, Norway; [Guerini, Franca R.] Fdn Don C Gnocchi, IRCCS S Maria Nascente, Milan, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Oslo; University of Oslo; KU Leuven; Karolinska Institutet; Karolinska University Hospital; Rigshospitalet; University of Copenhagen; University of Milan; University of Oslo; University of Bergen; Haukeland University Hospital; University of Bergen; IRCCS Fondazione Don Carlo Gnocchi Onlus	Leone, MA (corresponding author), MS Ctr, SCDU Neurol, Novara, Italy.	maurizio.leone@maggioreosp.novara.it	Goris, An/F-2943-2010; Goris, An/L-5852-2019; Leone, Maurizio A./J-4130-2016; Esposito, Federica/K-6537-2016; Kockum, Ingrid/O-8781-2018; Boneschi, Filippo Martinelli/H-8592-2012; Galimberti, Daniela/N-7209-2019; Myhr, Kjell-Morten/H-1528-2018; Celius, Elisabeth Gulowsen/S-1387-2019; D'Alfonso, Sandra/K-7295-2014; Scarpini, Elio/K-6547-2016; Liberatore, Giuseppe/ABH-3685-2020; Dubois, Benedicte/A-4338-2019	Goris, An/0000-0002-1276-6682; Goris, An/0000-0002-1276-6682; Leone, Maurizio A./0000-0002-6339-5738; Esposito, Federica/0000-0003-2550-0805; Kockum, Ingrid/0000-0002-0867-4726; Galimberti, Daniela/0000-0002-9284-5953; Myhr, Kjell-Morten/0000-0002-0980-510X; Celius, Elisabeth Gulowsen/0000-0002-9127-6488; D'Alfonso, Sandra/0000-0002-3983-9925; Scarpini, Elio/0000-0002-6395-2119; Liberatore, Giuseppe/0000-0003-2666-1678; Di Sapio, Alessia/0000-0002-5575-7567; Cavalla, Paola/0000-0003-4589-4864; Comabella Lopez, Manuel/0000-0002-2373-6657; Sondergaard, Helle Bach/0000-0001-9435-0658; Rapa, Anna/0000-0002-5523-5224; Olsson, Tomas/0000-0002-2938-1877; martinelli boneschi, filippo/0000-0002-9955-1368; Benedetti, Maria Donata/0000-0002-8340-2915; moiola, lucia/0000-0001-6313-4952; Dubois, Benedicte/0000-0003-0604-8702; McCauley, Jacob/0000-0002-1805-1733	Italian Foundation for Multiple Sclerosis (FISM grant "Progetto Speciale Immunochip," Fondazione Cariplo) [2010-0728]; Italian Ministry of University and Research (MIUR); CRT Foundation, Turin; Belgian Charcot Foundation; Onderzoeksfonds KU Leuven/ Research Fund KU Leuven [OT/11/087]; Wetenschappelijk Onderzoek Multiple Sclerose - Vlaanderen; Belgian Neurological Society; Bibbi and Niels Jensens Foundation; Hjarnfonden; Swedish Medical Research Council [8691]; Stockholm County Council [562183]; Swedish Council for Working life and Social Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049477] Funding Source: NIH RePORTER	Italian Foundation for Multiple Sclerosis (FISM grant "Progetto Speciale Immunochip," Fondazione Cariplo); Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); CRT Foundation, Turin(Fondazione CRT); Belgian Charcot Foundation; Onderzoeksfonds KU Leuven/ Research Fund KU Leuven(KU Leuven); Wetenschappelijk Onderzoek Multiple Sclerose - Vlaanderen; Belgian Neurological Society; Bibbi and Niels Jensens Foundation; Hjarnfonden; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Stockholm County Council(Stockholm County Council); Swedish Council for Working life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was funded by the Italian Foundation for Multiple Sclerosis (FISM grant "Progetto Speciale Immunochip," Fondazione Cariplo (no 2010-0728); the Italian Ministry of University and Research (MIUR, PRIN08), and the CRT Foundation, Turin. The Belgian part of this project was supported by a Research Grant from the Belgian Charcot Foundation (AG); and Onderzoeksfonds KU Leuven/ Research Fund KU Leuven (OT/11/087, AG and BD). AG and BD are supported by Wetenschappelijk Onderzoek Multiple Sclerose - Vlaanderen; and the Belgian Neurological Society. BD is a Clinical Investigator of the Research Foundation Flanders (FWO - Vlaanderen) and holds the Biogen Idec Chair Translational Research in Multiple Sclerosis, and the Bayer Chair on Fundamental Genetic Research regarding the Neuroimmunological aspects of Multiple Sclerosis. The Swedish part of this project was supported by Bibbi and Niels Jensens Foundation, Hjarnfonden and Swedish Medical Research Council (8691), Stockholm County Council (562183) and Swedish Council for Working life and Social Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balnyte R, 2011, MEDICINA-LITHUANIA, V47, P368, DOI 10.3390/medicina47070052; Bergamaschi L, 2010, GENES IMMUN, V11, P173, DOI 10.1038/gene.2009.101; De Jager PL, 2009, LANCET NEUROL, V8, P1111, DOI 10.1016/S1474-4422(09)70275-3; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Dobson R, 2013, J NEUROL NEUROSUR PS, V84, P909, DOI 10.1136/jnnp-2012-304695; Imrell K, 2006, NEUROLOGY, V67, P1062, DOI 10.1212/01.wnl.0000237343.93389.35; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lechner-Scott J, 2012, MULT SCLER J, V18, P974, DOI 10.1177/1352458511431729; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; OLSSON T, 1984, CLIN CHEM, V30, P1246; Piwko W, 2010, EMBO J, V29, P4210, DOI 10.1038/emboj.2010.304; Romero-Pinel L, 2011, EUR J NEUROL, V18, P1258, DOI 10.1111/j.1468-1331.2011.03379.x; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251	14	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e64408	10.1371/journal.pone.0064408	http://dx.doi.org/10.1371/journal.pone.0064408			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785401	Green Submitted, Green Published, gold			2022-12-25	WOS:000321038800116
J	Micholt, L; Gartner, A; Prodanov, D; Braeken, D; Dotti, CG; Bartic, C				Micholt, Liesbeth; Gartner, Annette; Prodanov, Dimiter; Braeken, Dries; Dotti, Carlos G.; Bartic, Carmen			Substrate Determines Neuronal Polarization and Growth In Vitro	PLOS ONE			English	Article							FOCAL ADHESION KINASE; HIPPOCAMPAL-NEURONS; MYOSIN-II; POLARITY; CENTROSOME; TOPOGRAPHY; GUIDANCE; MICROTOPOGRAPHY; DIFFERENTIATION; MECHANOSENSORS	The establishment of neuronal connectivity depends on the correct initial polarization of the young neurons. In vivo, developing neurons sense a multitude of inputs and a great number of molecules are described that affect their outgrowth. In vitro, many studies have shown the possibility to influence neuronal morphology and growth by biophysical, i.e. topographic, signaling. In this work we have taken this approach one step further and investigated the impact of substrate topography in the very early differentiation stages of developing neurons, i.e. when the cell is still at the round stage and when the first neurite is forming. For this purpose we fabricated micron sized pillar structures with highly reproducible feature sizes, and analyzed neurons on the interface of flat and topographic surfaces. We found that topographic signaling was able to attract the polarization markers of mouse embryonic neurons -N-cadherin, Golgi-centrosome complex and the first bud were oriented towards topographic stimuli. Consecutively, the axon was also preferentially extending along the pillars. These events seemed to occur regardless of pillar dimensions in the range we examined. However, we found differences in neurite length that depended on pillar dimensions. This study is one of the first to describe in detail the very early response of hippocampal neurons to topographic stimuli.	[Micholt, Liesbeth; Prodanov, Dimiter; Braeken, Dries; Bartic, Carmen] IMEC, Louvain, Belgium; [Micholt, Liesbeth; Bartic, Carmen] Katholieke Univ Leuven, Solid State Phys & Magnetism Sect, Louvain, Belgium; [Gartner, Annette; Dotti, Carlos G.] VIB Ctr Biol Dis, Louvain, Belgium; [Dotti, Carlos G.] CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid, Spain	IMEC; KU Leuven; Flanders Institute for Biotechnology (VIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Gartner, A (corresponding author), VIB Ctr Biol Dis, Louvain, Belgium.	annette.gaertner@med.kuleuven.be; dries.braeken@imec.be; cdotti@cbm.uam.es	Gaertner, Annette/B-5393-2013; Bartic, Carmen/I-1310-2013; Bartic, Carmen/AAA-6514-2022; Prodanov, Dimiter/AAE-8938-2019; Dotti, Carlos G/I-5533-2015	Prodanov, Dimiter/0000-0001-8694-0535; Dotti, Carlos G/0000-0003-4052-1719; Bartic, Carmen/0000-0001-9577-2844; Braeken, Dries/0000-0002-5752-3203	Flanders Fund for Scientific Research [FWO G 0.666.10N]; Federal Office for Scientific Affairs [IUAP p6/43]; Flemish Government Methusalem Grant; Spanish Ministry of Science and Innovation Ingenio-Consolider [CSD2010-00064, SAF2010-14906]	Flanders Fund for Scientific Research(FWO); Federal Office for Scientific Affairs; Flemish Government Methusalem Grant; Spanish Ministry of Science and Innovation Ingenio-Consolider(Ministry of Science and Innovation, Spain (MICINN))	Part of this work was supported by the Flanders Fund for Scientific Research (FWO G 0.666.10N, www.fwo.be), the Federal Office for Scientific Affairs (IUAP p6/43), Flemish Government Methusalem Grant and Spanish Ministry of Science and Innovation Ingenio-Consolider CSD2010-00064 and SAF2010-14906 (CGD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Barnes AP, 2008, CURR OPIN NEUROBIOL, V18, P44, DOI 10.1016/j.conb.2008.05.003; Braeken D, 2010, BIOSENS BIOELECTRON; Bruder JM, 2007, J BIOMAT SCI-POLYM E, V18, P967, DOI 10.1163/156856207781494412; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Chacon MR, 2012, DEVELOPMENT, V139, P3200, DOI 10.1242/dev.080564; Cheng PL, 2012, ANNU REV NEUROSCI, V35, P181, DOI 10.1146/annurev-neuro-061010-113618; CLARK P, 1993, J CELL SCI, V105, P203; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; de Anda FC, 2008, J CELL SCI, V121, P178, DOI 10.1242/jcs.023143; de Anda Froylan Calderon, 2011, Commun Integr Biol, V4, P304, DOI 10.4161/cib.4.3.14781; Diggle PJ, 1983, STAT ANAL SPATIAL PO; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Dowell-Mesfin NM, 2004, J NEURAL ENG, V1, P78, DOI 10.1088/1741-2560/1/2/003; Esch T, 1999, J NEUROSCI, V19, P6417; Ferrari A, 2010, BIOMATERIALS, V31, P4682, DOI 10.1016/j.biomaterials.2010.02.032; Fozdar DY, 2011, INT J NANOMED, V6, P45, DOI 10.2147/IJN.S12376; Fozdar DY, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/035005; Frey MT, 2006, BIOPHYS J, V90, P3774, DOI 10.1529/biophysj.105.074526; Gartner A, 2012, EMBO J, V31, P1893, DOI 10.1038/emboj.2012.41; Ganz A, 2006, BIOL CELL, V98, P721, DOI 10.1042/BC20060039; Gartner A, 2011, ADV NEUROBIOL, V5, P161, DOI 10.1007/978-1-4419-7368-9_9; Gomez N, 2007, BIOMATERIALS, V28, P271, DOI 10.1016/j.biomaterials.2006.07.043; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; HALFTER W, 1985, J COMP NEUROL, V232, P466, DOI 10.1002/cne.902320405; Hanson JN, 2009, LAB CHIP, V9, P122, DOI 10.1039/b803595d; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351; Huys R, 2012, LAB CHIP, V12, P1274, DOI 10.1039/c2lc21037a; HYNES RO, 1986, J NEUROSCI, V6, P867; Jang KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015966; Kim DH, 2009, BIOMATERIALS, V30, P5433, DOI 10.1016/j.biomaterials.2009.06.042; Lamoureux P, 2002, J CELL BIOL, V159, P499, DOI 10.1083/jcb.200207174; Makino A, 2006, AM J PHYSIOL-CELL PH, V290, pC1633, DOI 10.1152/ajpcell.00576.2005; Matschegewski C, 2010, BIOMATERIALS, V31, P5729, DOI 10.1016/j.biomaterials.2010.03.073; Migliorini E, 2011, BIOTECHNOL BIOENG, V108, P2736, DOI 10.1002/bit.23232; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moore SW, 2011, DEV NEUROBIOL, V71, P1090, DOI 10.1002/dneu.20947; O'Connor TP, 1999, CELL MOL LIFE SCI, V55, P1358, DOI 10.1007/s000180050376; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Pollarolo G, 2011, NAT NEUROSCI, V14, P1525, DOI 10.1038/nn.2976; Prodanov D, 2007, J NEUROSCI METH, V160, P93, DOI 10.1016/j.jneumeth.2006.08.017; Rajnicek AM, 1997, J CELL SCI, V110, P2905; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Robles E, 2006, NAT NEUROSCI, V9, P1274, DOI 10.1038/nn1762; Roth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033623; Seo CH, 2011, BIOMATERIALS, V32, P9568, DOI 10.1016/j.biomaterials.2011.08.077; Sero JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028303; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Whitington PM, 2004, INT J DEV NEUROSCI, V22, P157, DOI 10.1016/j.ijdevneu.2004.01.001; Zmuda JF, 1998, CELL MOTIL CYTOSKEL, V41, P18, DOI 10.1002/(SICI)1097-0169(1998)41:1<18::AID-CM2>3.0.CO;2-B	53	53	53	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66170	10.1371/journal.pone.0066170	http://dx.doi.org/10.1371/journal.pone.0066170			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785482	gold, Green Published, Green Submitted			2022-12-25	WOS:000321038800040
J	Novitskaya, V; Romanska, H; Kordek, R; Potemski, P; Kusinska, R; Parsons, M; Odintsova, E; Berditchevski, F				Novitskaya, V.; Romanska, H.; Kordek, R.; Potemski, P.; Kusinska, R.; Parsons, M.; Odintsova, E.; Berditchevski, F.			Integrin alpha 3 beta 1-CD151 complex regulates dimerization of ErbB2 via RhoA	ONCOGENE			English	Article						tetraspanin; integrin; CD151; breast cancer; ErbB2	BREAST-CANCER CELLS; SELF-ASSOCIATION; LIPID RAFTS; ADHESION; GROWTH; ACTIVATION; PROTEINS; BETA-1-INTEGRIN; PROLIFERATION; TRASTUZUMAB	Integrin alpha 3 beta 1 regulates adhesive interactions of cells with laminins and have a critical role in adhesion-dependent cellular responses. Here, we examined the role of alpha 3 beta 1-integrin in ErbB2-dependent proliferation of breast cancer cells in three-dimensional laminin-rich extracellular matrix (3D lr-ECM). Depletion of alpha 3 beta 1 in ErbB2-overexpressing breast cancer cells suppressed growth and restore cell polarity in 3D lr-ECM. The phenotype of alpha 3 beta 1-depleted cells was reproduced upon depletion of tetraspanin CD151 and mirrored that of the cells treated with Herceptin, an established ErbB2 antagonist. Breast cancer cells expressing the alpha 3 beta 1-CD151 complex have higher steady-state phosphorylation of ErbB2 and show enhanced dimerization of the protein when compared with alpha 3 beta 1-/CD151-depleted cells. Furthermore, Herceptin-dependent dephosphorylation of ErbB2 was only observed in alpha 3 beta 1-CD151-expressing cells. Importantly, the inhibitory activity of Herceptin was more pronounced when cells expressed both alpha 3 beta 1 and CD151. We also found that the level of active RhoA was increased in alpha 3 beta 1- and CD151-depleted cells and that Rho controls dimerization of ErbB2. Expression of alpha 3 beta 1 alone did not have significant prognostic value in patients with invasive ductal carcinoma of the breast. However, expression of alpha 3 beta 1 in combination with CD151 represented a more stringent indicator of poor survival than CD151 alone. Taken together, these results demonstrate that the alpha 3 beta 1-CD151 complex has a critical regulatory role in ErbB2-dependent signalling and thereby may be involved in breast cancer progression.	[Novitskaya, V.; Odintsova, E.; Berditchevski, F.] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England; [Romanska, H.; Kordek, R.; Potemski, P.; Kusinska, R.] Med Univ Lodz, Dept Pathol & Chemotherapy, Lodz, Poland; [Parsons, M.] Kings Coll London, Randall Div Cell & Mol Biophys, London, England	University of Birmingham; Medical University Lodz; University of London; King's College London	Odintsova, E (corresponding author), Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England.	e.odintsova@bham.ac.uk; f.berditchevski@bham.ac.uk	Kordek, Radzislaw/S-9616-2016; Parsons, Maddy/B-2203-2013; Mieszkowska, Magdalena/O-6753-2017	Parsons, Maddy/0000-0002-2021-8379; Romanska-Knight, Hanna/0000-0002-2328-710X	WE Dunn Trust, CR UK [C1322/A5705]; Royal Society University Research Fellowship; NCN [2011/01/B/NZ4/04910]	WE Dunn Trust, CR UK; Royal Society University Research Fellowship(Royal Society of London); NCN	We are very grateful to all our colleagues for their generous gifts of the reagents that were used in this study. This work was supported by the WE Dunn Trust, CR UK Grant C1322/A5705 (to FB), Royal Society University Research Fellowship (to MP) and NCN Grant No. 2011/01/B/NZ4/04910 (to RK).	Alexi X, 2011, BIOCHEM SOC T, V39, P568, DOI 10.1042/BST0390568; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Bailey Tameka A, 2011, J Carcinog, V10, P28, DOI 10.4103/1477-3163.90442; Baldwin G, 2008, J BIOL CHEM, V283, P35445, DOI 10.1074/jbc.M806394200; Banyard J, 2000, ONCOGENE, V19, P580, DOI 10.1038/sj.onc.1203338; Berditchevski F, 1997, J BIOL CHEM, V272, P29174, DOI 10.1074/jbc.272.46.29174; Berry MG, 2004, EJSO, V30, P484, DOI 10.1016/j.ejso.2004.01.016; Chen LL, 2008, CELL COMMUN ADHES, V15, P317, DOI 10.1080/15419060802428356; Dave B, 2011, J CLIN ONCOL, V29, P166, DOI 10.1200/JCO.2009.27.7814; Deng XY, 2012, NEOPLASIA, V14, P678, DOI 10.1593/neo.12922; Duan L, 2010, J BIOL CHEM, V285, P1555, DOI 10.1074/jbc.M109.057976; Falcioni R, 1997, EXP CELL RES, V236, P76, DOI 10.1006/excr.1997.3695; Ghosh R, 2011, CANCER RES, V71, P1871, DOI 10.1158/0008-5472.CAN-10-1872; Giancotti FG, 2007, TRENDS PHARMACOL SCI, V28, P506, DOI 10.1016/j.tips.2007.08.004; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Haenssen KK, 2010, J CELL SCI, V123, P1373, DOI 10.1242/jcs.050906; HEMLER ME, 1983, J IMMUNOL, V131, P334; Hong IK, 2012, J BIOL CHEM, V287, P32027, DOI 10.1074/jbc.M111.314443; Hopkins AM, 2003, J CELL SCI, V116, P725, DOI 10.1242/jcs.00300; Huang C, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2936; Huck L, 2010, P NATL ACAD SCI USA, V107, P15559, DOI 10.1073/pnas.1003034107; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Kazarov AR, 2002, J CELL BIOL, V158, P1299, DOI 10.1083/jcb.200204056; Kwon MJ, 2012, BRIT J CANCER, V106, P923, DOI 10.1038/bjc.2012.11; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; Lesniak D, 2009, CANCER RES, V69, P8620, DOI 10.1158/0008-5472.CAN-09-1591; Malaval C, 2009, CELL SIGNAL, V21, P120, DOI 10.1016/j.cellsig.2008.09.016; Morini M, 2000, INT J CANCER, V87, P336, DOI 10.1002/1097-0215(20000801)87:3<336::AID-IJC5>3.0.CO;2-3; Morton PE, 2011, METHODS MOL BIOL, V769, P403, DOI 10.1007/978-1-61779-207-6_27; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nagy P, 2002, J CELL SCI, V115, P4251, DOI 10.1242/jcs.00118; Novitskaya V, 2010, CANCER RES, V70, P4698, DOI 10.1158/0008-5472.CAN-09-4330; Orr G, 2005, BIOPHYS J, V89, P1362, DOI 10.1529/biophysj.104.056192; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Penuel E, 2002, J BIOL CHEM, V277, P28468, DOI 10.1074/jbc.M202510200; Prakash A, 2011, BIOPHYS J, V101, P1949, DOI 10.1016/j.bpj.2011.09.017; Ramirez NE, 2011, J CLIN INVEST, V121, P226, DOI 10.1172/JCI42328; Reim F, 2009, CANCER RES, V69, P8058, DOI 10.1158/0008-5472.CAN-09-0834; Sadej R, 2009, MOL CANCER RES, V7, P787, DOI 10.1158/1541-7786.MCR-08-0574; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Scales TME, 2013, ONCOGENE, V32, P3965, DOI 10.1038/onc.2012.415; Scaltriti M, 2011, P NATL ACAD SCI USA, V108, P3761, DOI 10.1073/pnas.1014835108; Sharpe S, 2002, BIOCHEMISTRY-US, V41, P2341, DOI 10.1021/bi011340f; Sottocornola E, 2006, FEBS J, V273, P1821, DOI 10.1111/j.1742-4658.2006.05203.x; Stipp CS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001355; Tachibana I, 1997, J BIOL CHEM, V272, P29181, DOI 10.1074/jbc.272.46.29181; Wang SE, 2009, CANCER RES, V69, P475, DOI 10.1158/0008-5472.CAN-08-2649; Weigelt B, 2010, BREAST CANCER RES TR, V122, P35, DOI 10.1007/s10549-009-0502-2; WEITZMAN JB, 1993, J BIOL CHEM, V268, P8651; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yang XWH, 2010, CANCER RES, V70, P2256, DOI 10.1158/0008-5472.CAN-09-4032; Zhang F, 2011, BLOOD, V118, P4274, DOI 10.1182/blood-2011-03-339531	54	32	32	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 22	2014	33	21					2779	2789		10.1038/onc.2013.231	http://dx.doi.org/10.1038/onc.2013.231			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EH	23792450				2022-12-25	WOS:000337231700011
J	Jensen, MV; Haldeman, JM; Zhang, HT; Lu, DH; Huising, MO; Vale, WW; Hohmeier, HE; Rosenberg, P; Newgard, CB				Jensen, Mette V.; Haldeman, Jonathan M.; Zhang, Hengtao; Lu, Danhong; Huising, Mark O.; Vale, Wylie W.; Hohmeier, Hans E.; Rosenberg, Paul; Newgard, Christopher B.			Control of Voltage-gated Potassium Channel Kv2.2 Expression by Pyruvate-Isocitrate Cycling Regulates Glucose-stimulated Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; NMR ISOTOPOMER ANALYSIS; SENSITIVE K+ CHANNELS; ATP-CITRATE LYASE; MALIC ENZYME; ELECTRICAL-ACTIVITY; STATE DEPENDENCE; ISLETS; ANAPLEROSIS; ADENOVIRUS	Recent studies have shown that the pyruvate-isocitrate cycling pathway, involving the mitochondrial citrate/isocitrate carrier and the cytosolic NADP-dependent isocitrate dehydrogenase (ICDc), is involved in control of glucose-stimulated insulin secretion (GSIS). Here we demonstrate that pyruvate-isocitrate cycling regulates expression of the voltage-gated potassium channel family member Kv2.2 in islet b-cells. siRNA-mediated suppression of ICDc, citrate/isocitrate carrier, or Kv2.2 expression impaired GSIS, and the effect of ICDc knockdown was rescued by re-expression of Kv2.2. Moreover, chronic exposure of b-cells to elevated fatty acids, which impairs GSIS, resulted in decreased expression of Kv2.2. Surprisingly, knockdown of ICDc or Kv2.2 increased rather than decreased outward K+ current in the 832/13 b-cell line. Immunoprecipitation studies demonstrated interaction of Kv2.1 and Kv2.2, and co-overexpression of the two channels reduced outward K+ current compared with overexpression of Kv2.1 alone. Also, siRNA-mediated knockdown of ICDc enhanced the suppressive effect of the Kv2.1-selective inhibitor stromatoxin1 on K+ currents. Our data support a model in which a key function of the pyruvate-isocitrate cycle is to maintain levels of Kv2.2 expression sufficient to allow it to serve as a negative regulator of Kv channel activity.	[Jensen, Mette V.; Haldeman, Jonathan M.; Zhang, Hengtao; Lu, Danhong; Hohmeier, Hans E.; Rosenberg, Paul; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27704 USA; [Jensen, Mette V.; Haldeman, Jonathan M.; Zhang, Hengtao; Lu, Danhong; Hohmeier, Hans E.; Rosenberg, Paul; Newgard, Christopher B.] Duke Univ, Med Ctr, Duke Inst Mol Physiol, Durham, NC 27704 USA; [Jensen, Mette V.; Haldeman, Jonathan M.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27704 USA; [Zhang, Hengtao; Hohmeier, Hans E.; Rosenberg, Paul; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27704 USA; [Huising, Mark O.; Vale, Wylie W.] Salk Inst Biol Studies, Clayton Fdn, Labs Peptide Biol, La Jolla, CA 92037 USA; [Huising, Mark O.] Salk Inst Biol Studies, Salk Ctr Nutr Genom, La Jolla, CA 92037 USA	Duke University; Duke University; Duke University; Duke University; Salk Institute; Salk Institute	Newgard, CB (corresponding author), Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Independence Pk Facil, 4321 Med Pk Dr, Durham, NC 27704 USA.	chris.newgard@duke.edu	Huising, Mark O./H-3885-2019	Huising, Mark O./0000-0002-6594-2205; Rosenberg, Paul/0000-0002-5659-160X; Haldeman, Jonathan/0000-0002-8270-7039	National Institutes of Health [DK42583, DK026741]; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK026741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK42583 (to C. B. N.) and DK026741 (to W. W. V. and M. O. H.). This work was also supported by the Juvenile Diabetes Research Foundation (to M. O. H.).	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Bain JR, 2004, DIABETES, V53, P2190, DOI 10.2337/diabetes.53.9.2190; BECKER TC, 1994, J BIOL CHEM, V269, P21234; Blaine JT, 1998, J NEUROSCI, V18, P9585; Boehmer C, 2008, CELL PHYSIOL BIOCHEM, V22, P591, DOI 10.1159/000185543; Boucher A, 2004, J BIOL CHEM, V279, P27263, DOI 10.1074/jbc.M401167200; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Brun T, 1996, DIABETES, V45, P190, DOI 10.2337/diabetes.45.2.190; Chouinard SW, 2000, RECEPTOR CHANNEL, V7, P237; Cline GW, 2004, J BIOL CHEM, V279, P44370, DOI 10.1074/jbc.M311842200; Dai XQ, 2012, DIABETOLOGIA, V55, P1709, DOI 10.1007/s00125-012-2512-6; Dai XQ, 2011, DIABETES, V60, P838, DOI 10.2337/db10-0440; Dai XQ, 2009, J CELL SCI, V122, P775, DOI 10.1242/jcs.036632; Drews G, 2010, ADV EXP MED BIOL, V654, P115, DOI 10.1007/978-90-481-3271-3_7; Escoubas P, 2002, MOL PHARMACOL, V62, P48, DOI 10.1124/mol.62.1.48; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Fink M, 1996, J BIOL CHEM, V271, P26341, DOI 10.1074/jbc.271.42.26341; Fransson U, 2006, DIABETOLOGIA, V49, P1578, DOI 10.1007/s00125-006-0263-y; GEMBAL M, 1992, J CLIN INVEST, V89, P1288, DOI 10.1172/JCI115714; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Hermanstyne TO, 2010, J COMP NEUROL, V518, P4298, DOI 10.1002/cne.22457; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Herrington J, 2006, DIABETES, V55, P1034, DOI 10.2337/diabetes.55.04.06.db05-0788; Herrington J, 2005, J PHYSIOL-LONDON, V567, P159, DOI 10.1113/jphysiol.2005.089375; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Huising MO, 2010, P NATL ACAD SCI USA, V107, P912, DOI 10.1073/pnas.0913610107; Huypens P, 2011, DIABETOLOGIA, V54, P135, DOI 10.1007/s00125-010-1923-5; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jacobson DA, 2007, DIABETES OBES METAB, V9, P89, DOI 10.1111/j.1463-1326.2007.00784.x; Jacobson DA, 2007, CELL METAB, V6, P229, DOI 10.1016/j.cmet.2007.07.010; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Jindal HK, 2008, AM J PHYSIOL-HEART C, V294, pH2012, DOI 10.1152/ajpheart.01374.2007; Joseph JW, 2007, J BIOL CHEM, V282, P31592, DOI 10.1074/jbc.M706080200; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Kerschensteiner D, 1999, BIOPHYS J, V77, P248, DOI 10.1016/S0006-3495(99)76886-4; Kihira Y, 2010, J BIOL CHEM, V285, P15048, DOI 10.1074/jbc.M109.074260; Komatsu M, 2001, ENDOCR J, V48, P275, DOI 10.1507/endocrj.48.275; Li XY, 2013, IEEE T VIS COMPUT GR, V19, P344, DOI 10.1109/TVCG.2012.109; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MacDonald PE, 2003, J PHYSIOL-LONDON, V546, P647, DOI 10.1113/jphysiol.2002.035709; MacDonald PE, 2002, J BIOL CHEM, V277, P44938, DOI 10.1074/jbc.M205532200; MILBURN JL, 1995, J BIOL CHEM, V270, P1295, DOI 10.1074/jbc.270.3.1295; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nitabach MN, 2002, J NEUROSCI, V22, P7913; Odegaard ML, 2010, J BIOL CHEM, V285, P16530, DOI 10.1074/jbc.M109.092593; Pedersen MG, 2010, BIOPHYS J, V99, P3200, DOI 10.1016/j.bpj.2010.09.004; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Pongs O, 1999, ANN NY ACAD SCI, V868, P344, DOI 10.1111/j.1749-6632.1999.tb11296.x; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Rieck S, 2009, MOL ENDOCRINOL, V23, P1702, DOI 10.1210/me.2009-0144; Roe MW, 1996, J BIOL CHEM, V271, P32241, DOI 10.1074/jbc.271.50.32241; Ronnebaum SM, 2008, J BIOL CHEM, V283, P28909, DOI 10.1074/jbc.M804665200; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Sano Y, 2002, FEBS LETT, V512, P230, DOI 10.1016/S0014-5793(02)02267-6; Sato Y, 1999, ENDOCRINOLOGY, V140, P2252, DOI 10.1210/en.140.5.2252; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; Sigalla J, 1997, HUM GENE THER, V8, P1625, DOI 10.1089/hum.1997.8.13-1625; Tamarina NA, 2005, AM J PHYSIOL-ENDOC M, V289, pE578, DOI 10.1152/ajpendo.00054.2005; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Wolf-Goldberg T, 2006, MOL PHARMACOL, V70, P818, DOI 10.1124/mol.105.021717; Yan LZ, 2004, DIABETES, V53, P597, DOI 10.2337/diabetes.53.3.597; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	68	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23128	23140		10.1074/jbc.M113.491654	http://dx.doi.org/10.1074/jbc.M113.491654			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23788641	Green Published, hybrid			2022-12-25	WOS:000330598200020
J	Wang, XL; Yu, YYL; Myers, N; Hansen, TH				Wang, Xiaoli; Yu, Y. Y. Lawrence; Myers, Nancy; Hansen, Ted H.			Decoupling the Role of Ubiquitination for the Dislocation Versus Degradation of Major Histocompatibility Complex (MHC) Class I Proteins during Endoplasmic Reticulum-associated Degradation (ERAD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; MEMBRANE-PROTEIN; HEAVY-CHAINS; MISFOLDED PROTEINS; ANTIGEN PRESENTATION; CYTOPLASMIC TAIL; QUALITY CONTROL; PEPTIDE; ATPASE; RETROTRANSLOCATION	Aberrantly or excessively expressed proteins in the endoplasmic reticulum are identified by quality control mechanisms and dislocated to the cytosol for proteasome-mediated, ubiquitin-dependent degradation by a process termed endoplasmic reticulum-associated degradation (ERAD). In addition to its role in degradation, ubiquitination has also been implicated in substrate dislocation, although whether direct ubiquitin conjugation of ERAD substrates is required for dislocation has been difficult to ascertain. An obstacle in probing the mechanism of quality control-induced ERAD is the paucity of ERAD substrates being dislocated and detected at any given time. To obviate this problem, we report here the use of a sensitive biotinylation system to probe the dislocation of major histocompatibility complex I (MHCI) heavy chain substrates in the absence of immune evasion proteins. Using this assay system the dislocation of MHCI heavy chains was found not to require potential ubiquitin conjugation sites in the cytoplasmic tail or Lys residues in the ectodomain. By contrast, dislocation of MHCI heavy chains did require deubiquitinating enzyme activity and rapid proteasome-mediated degradation required Lys residues in MHCI heavy chain ectodomain. These combined findings support the model that the endoplasmic reticulum quality control-induced dislocation of MHCI heavy chains may not require direct ubiquitination/deubiquitination as is required for proteasome-mediated degradation post dislocation.	[Wang, Xiaoli; Yu, Y. Y. Lawrence; Myers, Nancy; Hansen, Ted H.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Wang, XL (corresponding author), 660 S Euclid Ave, St Louis, MO 63110 USA.	xiwang@pathology.wustl.edu; hansen@pathology.wustl.edu			National Institutes of Health [AI019687]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI019687.	Albring J, 2004, MOL IMMUNOL, V40, P733, DOI 10.1016/j.molimm.2003.08.008; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Aviel S, 2000, J BIOL CHEM, V275, P23491, DOI 10.1074/jbc.M002052200; Barel MT, 2003, EUR J IMMUNOL, V33, P1707, DOI 10.1002/eji.200323912; BARKER DF, 1981, J MOL BIOL, V146, P451, DOI 10.1016/0022-2836(81)90042-5; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Burr Marian L, 2013, Methods Mol Biol, V960, P109, DOI 10.1007/978-1-62703-218-6_9; Burr ML, 2011, P NATL ACAD SCI USA, V108, P2034, DOI 10.1073/pnas.1016229108; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Dong M, 2008, MOL BIOL CELL, V19, P2620, DOI 10.1091/mbc.E07-07-0674; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Elkabetz Y, 2004, J BIOL CHEM, V279, P3980, DOI 10.1074/jbc.M309938200; Ernst R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000605; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Fiebiger E, 2004, MOL BIOL CELL, V15, P1635, DOI 10.1091/mbc.E03-07-0506; Furman MH, 2003, J BIOL CHEM, V278, P34804, DOI 10.1074/jbc.M300913200; Greenblatt EJ, 2011, NAT STRUCT MOL BIOL, V18, P1147, DOI 10.1038/nsmb.2111; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; Hassink GC, 2006, J BIOL CHEM, V281, P30063, DOI 10.1074/jbc.M602248200; Hassink GC, 2009, EMBO REP, V10, P755, DOI 10.1038/embor.2009.69; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hughes EA, 1997, P NATL ACAD SCI USA, V94, P1896, DOI 10.1073/pnas.94.5.1896; Ishikura S, 2010, J BIOL CHEM, V285, P23916, DOI 10.1074/jbc.M110.127936; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2005, IMMUNOL REV, V207, P126, DOI 10.1111/j.0105-2896.2005.00318.x; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Liu YF, 2012, CURR PROTEIN PEPT SC, V13, P436, DOI 10.2174/138920312802430608; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Lybarger L, 2003, IMMUNITY, V18, P121, DOI 10.1016/S1074-7613(02)00509-5; Mehnert M, 2010, BIOESSAYS, V32, P905, DOI 10.1002/bies.201000046; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Olzmann JA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013185; Petris G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023712; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Riemer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017037; Sanyal S, 2012, J BIOL CHEM, V287, P23594, DOI 10.1074/jbc.M112.365312; Scaglione KM, 2011, MOL CELL, V43, P599, DOI 10.1016/j.molcel.2011.05.036; Seiberlich V, 2012, BBA-MOL CELL RES, V1823, P2057, DOI 10.1016/j.bbamcr.2012.04.011; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; Shimizu Y, 2010, MOL CELL, V40, P917, DOI 10.1016/j.molcel.2010.11.033; SMITH JD, 1995, MOL IMMUNOL, V32, P531, DOI 10.1016/0161-5890(95)00013-5; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stagg HR, 2009, J CELL BIOL, V186, P685, DOI 10.1083/jcb.200906110; Tsai YC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001038; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XL, 2012, TRAFFIC, V13, P19, DOI 10.1111/j.1600-0854.2011.01269.x; Wang XL, 2004, J VIROL, V78, P8673, DOI 10.1128/JVI.78.16.8673-8686.2004; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yu H, 1999, J BIOL CHEM, V274, P36852, DOI 10.1074/jbc.274.52.36852	66	10	10	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23295	23306		10.1074/jbc.M113.482018	http://dx.doi.org/10.1074/jbc.M113.482018			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23801327	hybrid, Green Published			2022-12-25	WOS:000330598200035
J	Kumfor, F; Irish, M; Hodges, JR; Piguet, O				Kumfor, Fiona; Irish, Muireann; Hodges, John R.; Piguet, Olivier			Discrete Neural Correlates for the Recognition of Negative Emotions: Insights from Frontotemporal Dementia	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; FACIAL EXPRESSIONS; BEHAVIORAL-VARIANT; BASIC EMOTIONS; HUMAN AMYGDALA; IMPAIRED RECOGNITION; SEMANTIC DEMENTIA; HUNTINGTONS-DISEASE; FUNCTIONAL NEUROANATOMY; PROCESSING IMPAIRMENTS	Patients with frontotemporal dementia have pervasive changes in emotion recognition and social cognition, yet the neural changes underlying these emotion processing deficits remain unclear. The multimodal system model of emotion proposes that basic emotions are dependent on distinct brain regions, which undergo significant pathological changes in frontotemporal dementia. As such, this syndrome may provide important insight into the impact of neural network degeneration upon the innate ability to recognise emotions. This study used voxel-based morphometry to identify discrete neural correlates involved in the recognition of basic emotions (anger, disgust, fear, sadness, surprise and happiness) in frontotemporal dementia. Forty frontotemporal dementia patients (18 behavioural-variant, 11 semantic dementia, 11 progressive nonfluent aphasia) and 27 healthy controls were tested on two facial emotion recognition tasks: The Ekman 60 and Ekman Caricatures. Although each frontotemporal dementia group showed impaired recognition of negative emotions, distinct associations between emotion-specific task performance and changes in grey matter intensity emerged. Fear recognition was associated with the right amygdala; disgust recognition with the left insula; anger recognition with the left middle and superior temporal gyrus; and sadness recognition with the left subcallosal cingulate, indicating that discrete neural substrates are necessary for emotion recognition in frontotemporal dementia. The erosion of emotion-specific neural networks in neurodegenerative disorders may produce distinct profiles of performance that are relevant to understanding the neurobiological basis of emotion processing.	[Kumfor, Fiona; Irish, Muireann; Hodges, John R.; Piguet, Olivier] Neurosci Res Australia, Sydney, NSW, Australia; [Kumfor, Fiona; Hodges, John R.; Piguet, Olivier] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Kumfor, Fiona; Irish, Muireann; Hodges, John R.; Piguet, Olivier] Univ New S Wales, ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia; [Irish, Muireann] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Piguet, O (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.	o.piguet@neura.edu.au	Kumfor, Fiona/D-8839-2016; Piguet, Olivier/C-9658-2011; Kumfor, Fiona/AAK-9997-2020	Kumfor, Fiona/0000-0002-3208-075X; Piguet, Olivier/0000-0002-6696-1440; Irish, Muireann/0000-0002-4950-8169	National Health and Medical Research Council (NHMRC), of Australia [510106, APP1022684]; Australian Research Council (ARC) Centre of Excellence in Cognition and its Disorders [CE110001021]; Australian Postgraduate Award; ARC Federation Fellowship [FF0776229]	National Health and Medical Research Council (NHMRC), of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC) Centre of Excellence in Cognition and its Disorders(Australian Research Council); Australian Postgraduate Award(Australian Government); ARC Federation Fellowship(Australian Research Council)	This work was supported by a National Health and Medical Research Council (NHMRC), of Australia project grant [510106]; the Australian Research Council (ARC) Centre of Excellence in Cognition and its Disorders [CE110001021]; an Australian Postgraduate Award (to FK); an ARC Federation Fellowship [FF0776229 to JRH]; and an NHMRC of Australia Career Development Fellowship [APP1022684 to OP]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; ADOLPHS R, 1995, J NEUROSCI, V15, P5879; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Andersson J.L., 2007, TR07JA1 FMRIB U OXF; Andersson J.L.R., 2007, TR07JA2 FMRIB AN GR; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Aviezer H, 2012, SCIENCE, V338, P1225, DOI 10.1126/science.1224313; Bertoux M, 2012, J INT NEUROPSYCH SOC, V18, P972, DOI 10.1017/S1355617712001300; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; Brambati SM, 2009, NEUROBIOL AGING, V30, P103, DOI 10.1016/j.neurobiolaging.2007.05.014; Broks P, 1998, NEUROPSYCHOLOGIA, V36, P59, DOI 10.1016/S0028-3932(97)00105-X; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Calder AJ, 1996, COGNITIVE NEUROPSYCH, V13, P699, DOI 10.1080/026432996381890; Calder AJ, 2000, NAT NEUROSCI, V3, P1077, DOI 10.1038/80586; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Calder AJ, 1997, P ROY SOC B-BIOL SCI, V264, P919, DOI 10.1098/rspb.1997.0127; Calder AJ, 2000, COGNITION, V76, P105, DOI 10.1016/S0010-0277(00)00074-3; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Darwin C., 1872, EXPRESS EMOT MAN, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Ekman P., 1976, PICTURES FACIAL AFFE; Fernandez-Duque D, 2005, NEUROPSYCHOLOGIA, V43, P1673, DOI 10.1016/j.neuropsychologia.2005.01.005; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Goodkind MS, 2012, HUM BRAIN MAPP, V33, P753, DOI 10.1002/hbm.21251; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Grandjean D, 2005, NAT NEUROSCI, V8, P145, DOI 10.1038/nn1392; Hamani C, 2011, BIOL PSYCHIAT, V69, P301, DOI 10.1016/j.biopsych.2010.09.034; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Harmer CJ, 2001, NAT NEUROSCI, V4, P17, DOI 10.1038/82854; Heberlein AS, 2008, J COGNITIVE NEUROSCI, V20, P721, DOI 10.1162/jocn.2008.20049; Hennenlotter A, 2006, PROG BRAIN RES, V156, P443, DOI 10.1016/S0079-6123(06)56024-8; HITCHCOCK J, 1986, BEHAV NEUROSCI, V100, P11, DOI 10.1037/0735-7044.100.1.11; Hornak J, 2003, BRAIN, V126, P1691, DOI 10.1093/brain/awg168; Hsieh S, 2012, NEUROPSYCHOLOGY, V26, P624, DOI 10.1037/a0029326; Irish M, 2012, BRAIN, V135, P2178, DOI 10.1093/brain/aws119; Irish M, 2012, NAT REV NEUROL, V8, P152, DOI 10.1038/nrneurol.2012.11; IZARD CE, 1992, PSYCHOL REV, V99, P561, DOI 10.1037/0033-295X.99.3.561; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kipps CM, 2007, J COGNITIVE NEUROSCI, V19, P1206, DOI 10.1162/jocn.2007.19.7.1206; Kipps CM, 2009, BRAIN, V132, P592, DOI 10.1093/brain/awn314; Kril JJ, 2005, J NEUROL SCI, V232, P83, DOI 10.1016/j.jns.2005.02.003; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kubota M, 2011, NEUROSCI RES, V70, P206, DOI 10.1016/j.neures.2011.01.019; Kumfor F, NEURODEGENE IN PRESS; Kumfor F, 2012, NEUROPSYCHOL REV, V22, P280, DOI 10.1007/s11065-012-9201-6; Kumfor F, 2011, SOC NEUROSCI-UK, V6, P502, DOI 10.1080/17470919.2011.620779; Lavenu I, 1999, ALZ DIS ASSOC DIS, V13, P96, DOI 10.1097/00002093-199904000-00007; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Mechelli A, 2005, CURR MED IMAGING, V1, P105, DOI 10.2174/1573405054038726; Meyers J., 1995, MEYERS SCORING SYSTE; Miller LA, 2012, BEHAV NEUROL, V25, P53, DOI [10.1155/2012/683052, 10.3233/BEN-2012-0349]; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Murphy FC, 2003, COGN AFFECT BEHAV NE, V3, P207, DOI 10.3758/CABN.3.3.207; Mutschler I, 2009, NEUROSCI LETT, V457, P66, DOI 10.1016/j.neulet.2009.03.101; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Perry RJ, 2006, DEMENT GERIATR COGN, V22, P278, DOI 10.1159/000095128; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phan KL, 2004, CNS SPECTRUMS, V9, P258, DOI 10.1017/S1092852900009196; Phillips ML, 1998, P ROY SOC B-BIOL SCI, V265, P1809, DOI 10.1098/rspb.1998.0506; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Piguet O, DEMENTIA GE IN PRESS; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Rohrer JD, 2012, CORTEX, V48, P308, DOI 10.1016/j.cortex.2010.09.004; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Rosen HJ, 2006, NEUROPSYCHOLOGIA, V44, P365, DOI 10.1016/j.neuropsychologia.2005.06.012; Rosen HJ, 2004, DEMENT GERIATR COGN, V17, P277, DOI 10.1159/000077154; Rosen HJ, 2002, NEUROLOGY, V58, P198, DOI 10.1212/WNL.58.2.198; Rosen HJ, 2002, BRAIN, V125, P2286, DOI 10.1093/brain/awf225; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Seeley WW, 2008, ARCH NEUROL-CHICAGO, V65, P249, DOI 10.1001/archneurol.2007.38; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Snowden JS, 2008, NEUROPSYCHOLOGIA, V46, P2638, DOI 10.1016/j.neuropsychologia.2008.04.018; Sollberger M, 2009, NEUROPSYCHOLOGIA, V47, P2812, DOI 10.1016/j.neuropsychologia.2009.06.006; Sprengelmeyer R, 1999, P ROY SOC B-BIOL SCI, V266, P2451, DOI 10.1098/rspb.1999.0945; Sprengelmeyer R, 1996, BRAIN, V119, P1647, DOI 10.1093/brain/119.5.1647; Sprengelmeyer R, 1998, P ROY SOC B-BIOL SCI, V265, P1927, DOI 10.1098/rspb.1998.0522; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Vytal K, 2010, J COGNITIVE NEUROSCI, V22, P2864, DOI 10.1162/jocn.2009.21366; Wechsler D, 1997, WAIS 3 ADM SCORING M; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Wright P, 2004, NEUROREPORT, V15, P2347, DOI 10.1097/00001756-200410250-00009; Wu XL, 2011, EUR NEUROL, V66, P98, DOI 10.1159/000329371; Young AW, 2002, FACIAL EXPRESSIONS E; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	91	119	123	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67457	10.1371/journal.pone.0067457	http://dx.doi.org/10.1371/journal.pone.0067457			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	170JP	23805313	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500141
J	Lenchi, N; Inceoglu, O; Kebbouche-Gana, S; Gana, ML; Lliros, M; Servais, P; Garcia-Armisen, T				Lenchi, Nesrine; Inceoglu, Ozgul; Kebbouche-Gana, Salima; Gana, Mohamed Lamine; Lliros, Marc; Servais, Pierre; Garcia-Armisen, Tamara			Diversity of Microbial Communities in Production and Injection Waters of Algerian Oilfields Revealed by 16S rRNA Gene Amplicon 454 Pyrosequencing	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; CONTINENTAL HIGH-TEMPERATURE; IN-SITU HYBRIDIZATION; OIL-FIELD; ARCHAEAL COMMUNITY; NORTH-SEA; SP-NOV; SHEWANELLA-PUTREFACIENS; PHYLOGENETIC DIVERSITY; PETROLEUM RESERVOIRS	The microorganisms inhabiting many petroleum reservoirs are multi-extremophiles capable of surviving in environments with high temperature, pressure and salinity. Their activity influences oil quality and they are an important reservoir of enzymes of industrial interest. To study these microbial assemblages and to assess any modifications that may be caused by industrial practices, the bacterial and archaeal communities in waters from four Algerian oilfields were described and compared. Three different types of samples were analyzed: production waters from flooded wells, production waters from non-flooded wells and injection waters used for flooding (water-bearing formations). Microbial communities of production and injection waters appeared to be significantly different. From a quantitative point of view, injection waters harbored roughly ten times more microbial cells than production waters. Bacteria dominated in injection waters, while Archaea dominated in production waters. Statistical analysis based on the relative abundance and bacterial community composition (BCC) revealed significant differences between production and injection waters at both OTUs(0.03) and phylum level. However, no significant difference was found between production waters from flooded and non-flooded wells, suggesting that most of the microorganisms introduced by the injection waters were unable to survive in the production waters. Furthermore, a Venn diagram generated to compare the BCC of production and injection waters of one flooded well revealed only 4% of shared bacterial OTUs. Phylogenetic analysis of bacterial sequences indicated that Alpha-, Beta-and Gammaproteobacteria were the main classes in most of the water samples. Archaeal sequences were only obtained from production wells and each well had a unique archaeal community composition, mainly belonging to Methanobacteria, Methanomicrobia, Thermoprotei and Halobacteria classes. Many of the bacterial genera retrieved had already been reported as degraders of complex organic molecules and pollutants. Nevertheless, a large number of unclassified bacterial and archaeal sequences were found in the analyzed samples, indicating that subsurface waters in oilfields could harbor new and still-non-described microbial species.	[Lenchi, Nesrine; Kebbouche-Gana, Salima] Univ MHamed Bougara Boumerdes, Dept Biol, Lab Conservat & Valorisat Biol Ressources, Boumerdes, Algeria; [Lenchi, Nesrine; Inceoglu, Ozgul; Servais, Pierre; Garcia-Armisen, Tamara] Univ Libre Bruxelles, Brussels, Belgium; [Gana, Mohamed Lamine] Biocorros Lab Sonatrach, Ctr Res & Dev, Boumerdes, Algeria; [Lliros, Marc] Univ Autonoma Barcelona, Biosci Fac, Dept Genet & Microbiol, Bellaterra, Spain	Universite de M'hammed Bougara Boumerdes; Universite Libre de Bruxelles; Universite de M'hammed Bougara Boumerdes; Autonomous University of Barcelona	Lenchi, N (corresponding author), Univ MHamed Bougara Boumerdes, Dept Biol, Lab Conservat & Valorisat Biol Ressources, Boumerdes, Algeria.	nesrine.lenchi@hotmail.fr; pservais@ulb.ac.be	Llirós, Marc/R-5241-2016; SALIMA, KEBBOUCHE GANA/R-7906-2019; Nesrine, LENCHI/AAO-9442-2021	Llirós, Marc/0000-0001-8456-4230; SALIMA, KEBBOUCHE GANA/0000-0002-6021-7522; KEBBOUCHE-GANA, SALIMA/0000-0001-5263-2999	Wallonie-Bruxelles International	Wallonie-Bruxelles International	Funding provided by Wallonie-Bruxelles International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken CM, 2004, NATURE, V431, P291, DOI 10.1038/nature02922; Akit RJ, 1989, GEOMICROBIOL J, V7, P115; Al-Awadhi H, 2007, APPL MICROBIOL BIOT, V77, P183, DOI 10.1007/s00253-007-1127-1; Albuquerque L, 2009, SYST APPL MICROBIOL, V32, P306, DOI 10.1016/j.syapm.2009.05.002; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Amann R, 2008, NAT REV MICROBIOL, V6, P339, DOI 10.1038/nrmicro1888; [Anonymous], 2005, STANDARD METHODS EXA; Antipov VA, 2002, PETRO CHEM, V6, P475; Bagge D, 2001, APPL ENVIRON MICROB, V67, P2319, DOI 10.1128/AEM.67.5.2319-2325.2001; Bastin ES, 1926, AAPG BULL, V10, P1270; Bauer M, 2004, J MOL EVOL, V59, P571, DOI 10.1007/s00239-004-2643-6; Billi D, 2000, APPL ENVIRON MICROB, V66, P1489, DOI 10.1128/AEM.66.4.1489-1492.2000; Burns DG, 2010, INT J SYST EVOL MICR, V60, P1196, DOI 10.1099/ijs.0.010017-0; Callaway TR, 2009, POULTRY SCI, V88, P298, DOI 10.3382/ps.2008-00222; Casamayor EO, 2012, AQUAT SCI, V74, P61, DOI 10.1007/s00027-011-0196-5; Chen JF, 2008, MAR POLLUT BULL, V57, P695, DOI 10.1016/j.marpolbul.2008.03.013; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Das Nilanjana, 2011, Biotechnol Res Int, V2011, P941810, DOI 10.4061/2011/941810; DAVYDOVACHARAKH.IA, 1993, MICROBIOLOGY, V61, P306; Eckford RE, 2002, J IND MICROBIOL BIOT, V29, P83, DOI 10.1038/sj.jim.7000274; Folarin Y, 2012, INT BIODETERIOR, Vxxx, P1; Fratesi S.E., 2002, THESIS MISSISSIPPI S; FRONTIER S, 1985, OCEANOGR MAR BIOL, V23, P253; Gana ML, 2011, J IND MICROBIOL BIOT, V38, P391, DOI 10.1007/s10295-010-0887-2; Garcia-Armisen T, 2010, APPL MICROBIOL BIOT, V87, P2281, DOI 10.1007/s00253-010-2698-9; Grabowski A, 2005, FEMS MICROBIOL ECOL, V54, P427, DOI 10.1016/j.femsec.2005.05.007; Grassia GS, 1996, FEMS MICROBIOL ECOL, V21, P47; Greene AC, 1997, INT J SYST BACTERIOL, V47, P505, DOI 10.1099/00207713-47-2-505; Hou Y. F., 2009, ENG OUR FUTURE ARE W, P27; Hubert C, 2007, APPL ENVIRON MICROB, V73, P2644, DOI 10.1128/AEM.02332-06; Jeon CO, 2004, INT J SYST EVOL MICR, V54, P93, DOI 10.1099/ijs.0.02636-0; KISHIMOTO N, 1993, CURR MICROBIOL, V27, P131, DOI 10.1007/BF01576009; Korenblum E, 2012, BMC MICROBIOL, V12, DOI [10.1155/2012/156537, 10.1186/1471-2180-12-252]; Kotelnikova S, 1998, FEMS MICROBIOL ECOL, V26, P121, DOI 10.1016/S0168-6496(98)00028-2; Kryachko Y, 2012, ANTON LEEUW INT J G, V101, P493, DOI 10.1007/s10482-011-9658-y; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; LHARIDON S, 1995, NATURE, V377, P223, DOI 10.1038/377223a0; Li H, 2006, FEMS MICROBIOL LETT, V257, P92, DOI 10.1111/j.1574-6968.2006.00149.x; Li H, 2007, CURR MICROBIOL, V55, P382, DOI 10.1007/s00284-007-9002-y; Li H, 2007, FEMS MICROBIOL ECOL, V60, P74, DOI 10.1111/j.1574-6941.2006.00266.x; Liu YJ, 2009, ANAEROBE, V15, P214, DOI 10.1016/j.anaerobe.2009.03.007; Lliros M, 2008, FEMS MICROBIOL ECOL, V66, P331, DOI 10.1111/j.1574-6941.2008.00583.x; MAGOT M, 1992, INT J SYST BACTERIOL, V42, P398, DOI 10.1099/00207713-42-3-398; Magot M, 2000, ANTON LEEUW INT J G, V77, P103, DOI 10.1023/A:1002434330514; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martin-Gil J, 2004, ANTON LEEUW INT J G, V86, P283, DOI 10.1023/B:ANTO.0000047939.49597.eb; Miranda E, 2006, CORROS SCI, V48, P2417, DOI 10.1016/j.corsci.2005.09.005; Mitterer RM, 2010, EARTH PLANET SC LETT, V295, P358, DOI 10.1016/j.epsl.2010.04.009; Mueller RF, 1996, APPL ENVIRON MICROB, V62, P3083, DOI 10.1128/AEM.62.9.3083-3087.1996; Musat F, 2008, ENVIRON MICROBIOL, V10, P10, DOI 10.1111/j.1462-2920.2007.01425.x; Nazina T N, 2006, Mikrobiologiia, V75, P70; Nazina Tamara N., 2000, Resource and Environmental Biotechnology, V3, P161; Nazina TN, 1995, GEOMICROBIOL J, V13, P181, DOI 10.1080/01490459509378016; Nilsen RK, 1996, APPL ENVIRON MICROB, V62, P1793, DOI 10.1128/AEM.62.5.1793-1798.1996; Nilsen RK, 1996, APPL ENVIRON MICROB, V62, P728, DOI 10.1128/AEM.62.2.728-731.1996; Orphan VJ, 2003, GEOMICROBIOL J, V20, P295, DOI 10.1080/01490450303898; Orphan VJ, 2000, APPL ENVIRON MICROB, V66, P700, DOI 10.1128/AEM.66.2.700-711.2000; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Pernthaler A., 2004, Molecular microbial ecology manual. Volumes 1 and 2, P711; Pham VD, 2009, ENVIRON MICROBIOL, V11, P176, DOI 10.1111/j.1462-2920.2008.01751.x; Plotnikova EG, 2011, RUSS J ECOL+, V42, P502, DOI 10.1134/S1067413611060130; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Qian PY, 2011, ISME J, V5, P507, DOI 10.1038/ismej.2010.112; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RASKIN L, 1994, APPL ENVIRON MICROB, V60, P1232, DOI 10.1128/AEM.60.4.1232-1240.1994; Ren HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023258; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rosario-Passapera, 2012, INT J SYST EVOL MICR; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Rozanova EP, 2001, MICROBIOLOGY+, V70, P102, DOI 10.1023/A:1004809308305; RUETER P, 1994, NATURE, V372, P455, DOI 10.1038/372455a0; Salinas MB, 2004, INT J SYST EVOL MICR, V54, P645, DOI 10.1099/ijs.0.02732-0; Schafer G, 1996, BBA-BIOENERGETICS, V1275, P16, DOI 10.1016/0005-2728(96)00043-6; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sen R, 2008, PROG ENERG COMBUST, V34, P714, DOI 10.1016/j.pecs.2008.05.001; [佘跃惠 She Yuehui], 2005, [生态学报, Acta Ecologica Sinica], V25, P237; Silva T. R., 2012, INT BIODETERIOR, P1; Slobodkin AI, 1999, CURR MICROBIOL, V39, P99, DOI 10.1007/s002849900426; Smith DM, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-41; STETTER KO, 1993, NATURE, V365, P743, DOI 10.1038/365743a0; Takai K, 2000, APPL ENVIRON MICROB, V66, P5066, DOI 10.1128/AEM.66.11.5066-5072.2000; Tang YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033535; Tapilatu YH, 2010, EXTREMOPHILES, V14, P225, DOI 10.1007/s00792-010-0301-z; Teira E, 2004, APPL ENVIRON MICROB, V70, P4411, DOI 10.1128/AEM.70.7.4411-4414.2004; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; van der Kraan GM, 2010, FEMS MICROBIOL ECOL, V71, P428, DOI 10.1111/j.1574-6941.2009.00813.x; Wang L-Y., 2012, BIOGEOSCIENCES DISCU, V9, P5177; Wang XX, 2011, J ENVIRON SCI-CHINA, V23, P1858, DOI 10.1016/S1001-0742(10)60640-7; Warren Ean, 2003, Bioremediation Journal, V7, P139, DOI 10.1080/713607984; Wei L, 2010, BIORESOURCE TECHNOL, V101, P2643, DOI 10.1016/j.biortech.2009.10.068; Widdel F, 2007, SULPHATE-REDUCING BACTERIA: ENVIRONMENTAL AND ENGINEERED SYSTEMS, P265, DOI 10.1017/CBO9780511541490.010; Wierzchos J, 2006, ASTROBIOLOGY, V6, P415, DOI 10.1089/ast.2006.6.415; Worden RH, 2006, APPL GEOCHEM, V21, P455, DOI 10.1016/j.apgeochem.2005.12.007; Youssef N, 2007, APPL ENVIRON MICROB, V73, P1239, DOI 10.1128/AEM.02264-06; Yuan San-qing, 2007, Weishengwu Xuebao, V47, P290; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865; Zvyagintseva I. S., 1995, Mikrobiologiya, V64, P83; ZWEIFEL UL, 1995, APPL ENVIRON MICROB, V61, P2180, DOI 10.1128/AEM.61.6.2180-2185.1995	99	69	73	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66588	10.1371/journal.pone.0066588	http://dx.doi.org/10.1371/journal.pone.0066588			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805243	Green Published, gold, Green Submitted			2022-12-25	WOS:000320846500071
J	Otte, DM; de Arellano, MLB; Bilkei-Gorzo, A; Albayram, O; Imbeault, S; Jeung, H; Alferink, J; Zimmer, A				Otte, David-Marian; de Arellano, Maria Luisa Barcena; Bilkei-Gorzo, Andras; Albayram, Oender; Imbeault, Sophie; Jeung, Haang; Alferink, Judith; Zimmer, Andreas			Effects of Chronic D-Serine Elevation on Animal Models of Depression and Anxiety-Related Behavior	PLOS ONE			English	Article							D-ASPARTATE RECEPTOR; LONG-TERM POTENTIATION; NMDA-RECEPTOR; GLUTAMINE-SYNTHETASE; D-CYCLOSERINE; RAT-BRAIN; GLYCINE SITE; GLUTAMATERGIC NEUROTRANSMISSION; FUNCTIONAL ANTAGONISTS; MEDIATED RESPONSES	NMDA receptors are activated after binding of the agonist glutamate to the NR2 subunit along with a co-agonist, either L-glycine or D-serine, to the NR1 subunit. There is substantial evidence to suggest that D-serine is the most relevant co-agonist in forebrain regions and that alterations in D-serine levels contribute to psychiatric disorders. D-serine is produced through isomerization of L-serine by serine racemase (Srr), either in neurons or in astrocytes. It is released by astrocytes by an activity-dependent mechanism involving secretory vesicles. In the present study we generated transgenic mice (SrrTg) expressing serine racemase under a human GFAP promoter. These mice were biochemically and behaviorally analyzed using paradigms of anxiety, depression and cognition. Furthermore, we investigated the behavioral effects of long-term administration of D-serine added to the drinking water. Elevated brain D-serine levels in SrrTg mice resulted in specific behavioral phenotypes in the forced swim, novelty suppression of feeding and olfactory bulbectomy paradigms that are indicative of a reduced proneness towards depression-related behavior. Chronic dietary D-serine supplement mimics the depression-related behavioral phenotype observed in SrrTg mice. Our results suggest that D-serine supplementation may improve mood disorders.	[Otte, David-Marian; de Arellano, Maria Luisa Barcena; Bilkei-Gorzo, Andras; Albayram, Oender; Imbeault, Sophie; Alferink, Judith; Zimmer, Andreas] Univ Bonn, Inst Mol Psychiat, Bonn, Germany; [Jeung, Haang; Alferink, Judith] Univ Bonn, Dept Psychiat, Bonn, Germany	University of Bonn; University of Bonn	Zimmer, A (corresponding author), Univ Bonn, Inst Mol Psychiat, Bonn, Germany.	a.zimmer@uni-bonn.de	Bilkei-Gorzo, Andras/F-8114-2010; Zimmer, Andreas/B-8357-2009; Barcena, Maria Luisa Luisa/AAX-6732-2021; Otte, David-Marian/J-7402-2012	Barcena, Maria Luisa Luisa/0000-0003-1391-9262; Imbeault, Sophie/0000-0003-1454-9267; Albayram, Onder/0000-0002-2028-1458; alferink, judith/0000-0002-3251-6584	Federal Ministry of Education and Research [NGFN2 01G10474, NGFN-MOODS FKZ 01GS08144, 01GW0511]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the Federal Ministry of Education and Research (NGFN2 01G10474, NGFN-MOODS FKZ 01GS08144 and 01GW0511). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamec RE, 1999, PHYSIOL BEHAV, V65, P739; Bado P, 2011, PSYCHOPHARMACOLOGY, V218, P461, DOI 10.1007/s00213-011-2330-4; Baptista V, 2005, J NEUROPHYSIOL, V94, P147, DOI 10.1152/jn.00927.2004; Baranano DE, 2001, TRENDS NEUROSCI, V24, P99, DOI 10.1016/S0166-2236(00)01716-1; Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; Bendikov I, 2007, SCHIZOPHR RES, V90, P41, DOI 10.1016/j.schres.2006.10.010; Benneyworth MA, 2012, CELL MOL NEUROBIOL, V32, P613, DOI 10.1007/s10571-012-9808-4; Berger AJ, 1998, J NEUROPHYSIOL, V80, P3336, DOI 10.1152/jn.1998.80.6.3336; Bergeron R, 1998, P NATL ACAD SCI USA, V95, P15730, DOI 10.1073/pnas.95.26.15730; Bilkei-Gorzo A, 2002, J NEUROSCI, V22, P10046; Bilkei-Gorzo A, 2007, NEUROPSYCHOPHARMACOL, V32, P2330, DOI 10.1038/sj.npp.1301370; Breier A, 1997, AM J PSYCHIAT, V154, P805; BRUNELLI SA, 1994, J COMP PSYCHOL, V108, P298, DOI 10.1037/0735-7036.108.3.298; Chen L, 2003, J NEUROPHYSIOL, V89, P691, DOI 10.1152/jn.00680.2002; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; Coyle JT, 2003, ANN NY ACAD SCI, V1003, P318, DOI 10.1196/annals.1300.020; De Miranda J, 2000, GENE, V256, P183, DOI 10.1016/S0378-1119(00)00356-5; de Miranda J, 2002, P NATL ACAD SCI USA, V99, P14542, DOI 10.1073/pnas.222421299; Duncan EJ, 2004, SCHIZOPHR RES, V71, P239, DOI 10.1016/j.schres.2004.03.013; GARDNER CR, 1985, J PHARMACOL METHOD, V14, P181, DOI 10.1016/0160-5402(85)90031-2; Grant SL, 2006, J CHROMATOGR B, V844, P278, DOI 10.1016/j.jchromb.2006.07.022; HALLERMAYER K, 1981, J NEUROCHEM, V37, P43, DOI 10.1111/j.1471-4159.1981.tb05289.x; Hashimoto A, 2004, EUR J PHARMACOL, V495, P153, DOI 10.1016/j.ejphar.2004.05.036; HASHIMOTO A, 1993, J NEUROCHEM, V60, P783, DOI 10.1111/j.1471-4159.1993.tb03219.x; HASHIMOTO A, 1992, FEBS LETT, V296, P33, DOI 10.1016/0014-5793(92)80397-Y; Hashimoto K, 2007, BIOL PSYCHIAT, V62, P1310, DOI 10.1016/j.biopsych.2007.03.017; Hashimoto K, 2011, EXPERT REV NEUROTHER, V11, P33, DOI 10.1586/ERN.10.176; HEIMER L, 1968, J ANAT, V103, P413; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Heresco-Levy U, 2002, INT J NEUROPSYCHOPH, V5, P301, DOI 10.1017/S1461145702003061; Heresco-Levy U, 2006, J AFFECT DISORDERS, V93, P239, DOI 10.1016/j.jad.2006.03.004; Horio M, 2011, NEUROCHEM INT, V59, P853, DOI 10.1016/j.neuint.2011.08.017; Kantrowitz JT, 2010, SCHIZOPHR RES, V121, P125, DOI 10.1016/j.schres.2010.05.012; Kelly JP, 1997, PHARMACOL THERAPEUT, V74, P299, DOI 10.1016/S0163-7258(97)00004-1; KEMP JA, 1993, TRENDS PHARMACOL SCI, V14, P20, DOI 10.1016/0165-6147(93)90108-V; Kim PM, 2005, P NATL ACAD SCI USA, V102, P2105, DOI 10.1073/pnas.0409723102; Kinney GG, 2003, J NEUROSCI, V23, P7586; LAAKE K, 2002, COCHRANE DB SYST REV; Li F, 2009, NEW ENGL J MED, V361, P302, DOI 10.1056/NEJMcibr0902052; Lim R, 2004, J NEUROPHYSIOL, V92, P2530, DOI 10.1152/jn.01123.2003; Lopes T, 1997, PHARMACOL BIOCHEM BE, V58, P1059, DOI 10.1016/S0091-3057(97)00302-X; Malkesman O, 2011, INT J NEUROPSYCHOPH, V12, P1; Martina M, 2003, J PHYSIOL-LONDON, V548, P411, DOI 10.1113/jphysiol.2002.037127; MARTINEZHERNANDEZ A, 1977, SCIENCE, V195, P1356, DOI 10.1126/science.14400; MATSUI T, 1995, J NEUROCHEM, V65, P454; Merali Z, 2003, BIOL PSYCHIAT, V54, P552, DOI 10.1016/S0006-3223(02)01827-9; MICZEK KA, 1995, PSYCHOPHARMACOLOGY, V121, P38, DOI 10.1007/BF02245590; Miczek KA, 2008, PHARMACOL THERAPEUT, V120, P102, DOI 10.1016/j.pharmthera.2008.07.006; Minkeviciene R, 2008, NEUROPHARMACOLOGY, V54, P1079, DOI 10.1016/j.neuropharm.2008.02.014; Moghaddam B, 1997, J NEUROSCI, V17, P2921; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORSE WH, 1958, J EXP ANAL BEHAV, V1, P103, DOI 10.1901/jeab.1958.1-103; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; NOIROT E, 1972, DEV PSYCHOBIOL, V5, P371, DOI 10.1002/dev.420050410; Nolte C, 2001, GLIA, V33, P72; Onur OA, 2010, BIOL PSYCHIAT, V67, P1205, DOI 10.1016/j.biopsych.2010.01.022; Panizzutti R, 2005, NEUROSCI LETT, V380, P111, DOI 10.1016/j.neulet.2005.01.062; Papageorgiou IE, 2011, GLIA, V59, P1706, DOI 10.1002/glia.21217; Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029; Platel JC, 2009, GLIA, V57, P66, DOI 10.1002/glia.20735; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; PRIESTLEY T, 1995, MOL PHARMACOL, V48, P841; Rex A, 1998, PHARMACOL BIOCHEM BE, V59, P677, DOI 10.1016/S0091-3057(97)00461-9; Rochford J, 1997, PSYCHOPHARMACOLOGY, V132, P145, DOI 10.1007/s002130050330; Rodgers RJ, 2002, PHYSIOL BEHAV, V77, P301, DOI 10.1016/S0031-9384(02)00856-9; Rowland LM, 2005, AM J PSYCHIAT, V162, P394, DOI 10.1176/appi.ajp.162.2.394; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Schell MJ, 1997, J NEUROSCI, V17, P1604; Shimazaki T, 2010, PSYCHOPHARMACOLOGY, V209, P263, DOI 10.1007/s00213-010-1794-y; Skolnick P, 2009, TRENDS PHARMACOL SCI, V30, P563, DOI 10.1016/j.tips.2009.09.002; Stevens ER, 2003, P NATL ACAD SCI USA, V100, P6789, DOI 10.1073/pnas.1237052100; Suarez I, 2002, NEUROCHEM INT, V41, P123, DOI 10.1016/S0197-0186(02)00033-5; THOMSON AM, 1989, NATURE, V338, P422, DOI 10.1038/338422a0; TRULLAS R, 1990, EUR J PHARMACOL, V185, P1, DOI 10.1016/0014-2999(90)90204-J; Wang LZ, 2003, ACTA PHARMACOL SIN, V24, P965; Welberg Leonie, 2010, Nat Rev Neurosci, V11, P666; WINSLOW JT, 1990, EUR J PHARMACOL, V190, P11, DOI 10.1016/0014-2999(90)94107-9; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Zhang Z, 2008, CEREB CORTEX, V18, P2391, DOI 10.1093/cercor/bhn008	84	40	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67131	10.1371/journal.pone.0067131	http://dx.doi.org/10.1371/journal.pone.0067131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805296	Green Published, gold, Green Submitted			2022-12-25	WOS:000320846500124
J	Wang, X; Mu, ZD; Shangguan, FQ; Liu, R; Pu, YP; Yin, LH				Wang, Xuan; Mu, Zhongde; Shangguan, Fengqi; Liu, Ran; Pu, Yuepu; Yin, Lihong			Simultaneous Detection of Fenitrothion and Chlorpyrifos-Methyl with a Photonic Suspension Array	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; SOLID-PHASE MICROEXTRACTION; LINKED-IMMUNOSORBENT-ASSAY; MASS-SPECTROMETRY; ORGANOPHOSPHORUS INSECTICIDES; GAS-CHROMATOGRAPHY; WATER SAMPLES; MULTIPLEXED IMMUNOASSAYS; SORPTIVE EXTRACTION; PESTICIDE-RESIDUES	A technique was developed for simultaneous detection of fenitrothion (FNT) and chlorpyrifos-methyl (CLT) using a photonic suspension array based on silica colloidal crystal beads (SCCBs). The SCCBs were encoded with the characteristic reflection peak originating from the stop-band of colloidal crystal. This approach avoids the bleaching, fading or potential interference seen when encoding by fluorescence. SCCBs with a nanopatterned surface had increased biomolecule binding capacity and improved stability. Under optimal conditions, the proposed suspension array allowed simultaneous detection of the selected pesticides in the ranges of 0.25 to 1024 ng/mL and 0.40 to 735.37 ng/mL, with the limits of detection (LODs) of 0.25 and 0.40 ng/mL, respectively. The suspension array was specific and had no significant cross-reactivity with other chemicals. The mean recoveries in tests in which samples were spiked with target standards were 82.35% to 109.90% with a standard deviation within 9.93% for CLT and 81.64% to 108.10% with a standard deviation within 8.82% for FNT. The proposed method shows a potentially powerful capability for fast quantitative analysis of pesticide residues.	[Wang, Xuan; Liu, Ran; Pu, Yuepu; Yin, Lihong] Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing, Jiangsu, Peoples R China; [Mu, Zhongde; Shangguan, Fengqi] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Yin, LH (corresponding author), Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing, Jiangsu, Peoples R China.	lhyin@seu.edu.cn			Science and Technology Project of Suzhou [SYN201207]	Science and Technology Project of Suzhou	The authors gratefully acknowledge the financial support by Science and Technology Project of Suzhou (No. SYN201207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GP, 2006, ANAL CHEM, V78, P2279, DOI 10.1021/ac051995c; Gonzalez-Curbelo MA, 2011, FOOD CHEM, V125, P1083, DOI 10.1016/j.foodchem.2010.09.083; Blasco C, 2004, J CHROMATOGR A, V1030, P77, DOI 10.1016/j.chroma.2003.11.037; Cajka T, 2008, J CHROMATOGR A, V1186, P281, DOI 10.1016/j.chroma.2007.12.009; Cakir S, 2005, FOOD CHEM TOXICOL, V43, P443, DOI 10.1016/j.fct.2004.11.010; Chen F, 2009, FOOD CHEM, V112, P956, DOI 10.1016/j.foodchem.2008.07.016; Daglish GJ, 2008, J STORED PROD RES, V44, P71, DOI 10.1016/j.jspr.2007.06.003; Dai RH, 2011, B ENVIRON CONTAM TOX, V86, P559, DOI 10.1007/s00128-011-0264-5; de Barros LA, 2010, ANAL BIOANAL CHEM, V397, P1355, DOI 10.1007/s00216-010-3629-4; Eskandari H, 2012, ANAL CHIM ACTA, V743, P137, DOI 10.1016/j.aca.2012.07.012; Gao YL, 2011, SMALL, V7, P137, DOI 10.1002/smll.201000909; Giordano A, 2011, TALANTA, V85, P2425, DOI 10.1016/j.talanta.2011.07.087; Giordano G, 2007, TOXICOL APPL PHARM, V219, P181, DOI 10.1016/j.taap.2006.09.016; GOSLING JP, 1990, CLIN CHEM, V36, P1408; Han MY, 2001, NAT BIOTECHNOL, V19, P631, DOI 10.1038/90228; He B, 2007, ANAL CHEM, V79, P5257, DOI 10.1021/ac0704964; Hua XD, 2010, BIOSENS BIOELECTRON, V26, P189, DOI 10.1016/j.bios.2010.06.005; Jani IV, 2002, LANCET INFECT DIS, V2, P243, DOI 10.1016/S1473-3099(02)00242-6; Kang HG, 2004, TOXICOLOGY, V199, P219, DOI 10.1016/j.tox.2004.02.025; Kavvalakis MP, 2012, FORENSIC SCI INT, V218, P111, DOI 10.1016/j.forsciint.2011.10.019; Kim BK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2247; Kim HJ, 2004, ANAL CHIM ACTA, V509, P111, DOI 10.1016/j.aca.2003.12.006; Kim YJ, 2007, ANAL CHIM ACTA, V591, P183, DOI 10.1016/j.aca.2007.03.072; Klostranec JM, 2007, NANO LETT, V7, P2812, DOI 10.1021/nl071415m; Kong Y, 2010, J AGR FOOD CHEM, V58, P8189, DOI 10.1021/jf101483w; Leandro CC, 2006, J CHROMATOGR A, V1103, P94, DOI 10.1016/j.chroma.2005.10.077; LeDoux M, 2011, J CHROMATOGR A, V1218, P1021, DOI 10.1016/j.chroma.2010.12.097; Ling MM, 2007, EXPERT REV MOL DIAGN, V7, P87, DOI 10.1586/14737159.7.1.87; Liu N, 2009, ANAL CHIM ACTA, V632, P128, DOI 10.1016/j.aca.2008.10.061; Nolan JP, 2002, TRENDS BIOTECHNOL, V20, P9, DOI 10.1016/S0167-7799(01)01844-3; Pedersen JA, 2006, ENVIRON SCI TECHNOL, V40, P2120, DOI 10.1021/es051677v; Pope C, 2005, ENVIRON TOXICOL PHAR, V19, P433, DOI 10.1016/j.etap.2004.12.048; Qian GL, 2009, FOOD CHEM, V117, P364, DOI 10.1016/j.foodchem.2009.03.097; Rahman MF, 2002, MUTAT RES-GEN TOX EN, V516, P139, DOI 10.1016/S1383-5718(02)00033-5; Ravelo-Perez LM, 2008, J CHROMATOGR A, V1211, P33, DOI 10.1016/j.chroma.2008.09.084; Sanchez-Ortega A, 2005, J CHROMATOGR A, V1094, P70, DOI 10.1016/j.chroma.2005.07.089; Sanghi R, 2001, B ENVIRON CONTAM TOX, V67, P587, DOI 10.1007/s001280164; Sarikaya R, 2004, CHEMOSPHERE, V56, P697, DOI 10.1016/j.chemosphere.2004.04.008; STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5; Su P, 2011, TALANTA, V85, P1160, DOI 10.1016/j.talanta.2011.05.040; Sun JW, 2009, ANAL BIOANAL CHEM, V394, P2223, DOI 10.1007/s00216-009-2911-9; Tankiewicz M, 2010, TRAC-TREND ANAL CHEM, V29, P1050, DOI 10.1016/j.trac.2010.05.008; Tao CJ, 2009, B ENVIRON CONTAM TOX, V82, P111, DOI 10.1007/s00128-008-9528-0; Uygun U, 2005, FOOD CHEM, V92, P643, DOI 10.1016/j.foodchem.2004.08.045; Wang HQ, 2007, J FLUORESC, V17, P133, DOI 10.1007/s10895-007-0157-5; Wilson R, 2006, ANGEW CHEM INT EDIT, V45, P6104, DOI 10.1002/anie.200600288; Yan XM, 2004, INT CONGR SER, V1263, P342, DOI 10.1016/j.ics.2004.02.075; Yang L, 2001, GENOME RES, V11, P1888, DOI 10.1101/gr.190901; Yang ZJ, 2008, ADV FUNCT MATER, V18, P3991, DOI 10.1002/adfm.200801022; Yeh SP, 2005, AQUACULTURE, V243, P383, DOI 10.1016/j.aquaculture.2004.10.017; Zhang BH, 2008, TALANTA, V75, P1055, DOI 10.1016/j.talanta.2008.01.032; Zhao WJ, 2011, FOOD CHEM, V127, P683, DOI 10.1016/j.foodchem.2010.12.122; Zhao YJ, 2008, ANAL CHEM, V80, P1598, DOI 10.1021/ac702249a; Zhao YJ, 2011, J AM CHEM SOC, V133, P8790, DOI 10.1021/ja200729w; Zhao YJ, 2010, ADV FUNCT MATER, V20, P2970, DOI 10.1002/adfm.201000098	55	11	12	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66703	10.1371/journal.pone.0066703	http://dx.doi.org/10.1371/journal.pone.0066703			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805266	gold, Green Submitted, Green Published			2022-12-25	WOS:000320846500094
J	Guerreiro, LTA; Robottom-Ferreira, AB; Ribeiro-Alves, M; Toledo-Pinto, TG; Brito, TR; Rosa, PS; Sandoval, FG; Jardim, MR; Antunes, SG; Shannon, EJ; Sarno, EN; Pessolani, MCV; Williams, DL; Moraes, MO				Albuquerque Guerreiro, Luana Tatiana; Robottom-Ferreira, Anna Beatriz; Ribeiro-Alves, Marcelo; Toledo-Pinto, Thiago Gomes; Brito, Tiana Rosa; Rosa, Patricia Sammarco; Sandoval, Felipe Galvan; Jardim, Marcia Rodrigues; Antunes, Sergio Gomes; Shannon, Edward J.; Sarno, Euzenir Nunes; Vidal Pessolani, Maria Cristina; Williams, Diana Lynn; Moraes, Milton Ozorio			Gene Expression Profiling Specifies Chemokine, Mitochondrial and Lipid Metabolism Signatures in Leprosy	PLOS ONE			English	Article							MYCOBACTERIUM-LEPRAE; REAL-TIME; GENOMEWIDE ASSOCIATION; SUSCEPTIBILITY GENES; LEPROMATOUS LEPROSY; LYMPHOTOXIN-ALPHA; TUBERCULOSIS; MODEL; DIAGNOSIS; CELLS	Herein, we performed microarray experiments in Schwann cells infected with live M. leprae and identified novel differentially expressed genes (DEG) in M. leprae infected cells. Also, we selected candidate genes associated or implicated with leprosy in genetic studies and biological experiments. Forty-seven genes were selected for validation in two independent types of samples by multiplex qPCR. First, an in vitro model using THP-1 cells was infected with live Mycobacterium leprae and M. bovis bacillus Calmette-Guerin (BCG). In a second situation, mRNA obtained from nerve biopsies from patients with leprosy or other peripheral neuropathies was tested. We detected DEGs that discriminate M. bovis BCG from M. leprae infection. Specific signatures of susceptible responses after M. leprae infection when compared to BCG lead to repression of genes, including CCL2, CCL3, IL8 and SOD2. The same 47-gene set was screened in nerve biopsies, which corroborated the down-regulation of CCL2 and CCL3 in leprosy, but also evidenced the down-regulation of genes involved in mitochondrial metabolism, and the up-regulation of genes involved in lipid metabolism and ubiquitination. Finally, a gene expression signature from DEG was identified in patients confirmed of having leprosy. A classification tree was able to ascertain 80% of the cases as leprosy or non-leprous peripheral neuropathy based on the expression of only LDLR and CCL4. A general immune and mitochondrial hypo-responsive state occurs in response to M. leprae infection. Also, the most important genes and pathways have been highlighted providing new tools for early diagnosis and treatment of leprosy.	[Albuquerque Guerreiro, Luana Tatiana; Robottom-Ferreira, Anna Beatriz; Ribeiro-Alves, Marcelo; Toledo-Pinto, Thiago Gomes; Brito, Tiana Rosa; Jardim, Marcia Rodrigues; Antunes, Sergio Gomes; Sarno, Euzenir Nunes; Moraes, Milton Ozorio] FIOCRUZ RJ, Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Hanseniase, Rio De Janeiro, Brazil; [Ribeiro-Alves, Marcelo] FIOCRUZ RJ, Inst Pesquisa Clin Evandro Chagas IPEC, Lab Pesquisa Farmacogenet, Rio De Janeiro, Brazil; [Vidal Pessolani, Maria Cristina] FIOCRUZ RJ, Lab Microbiol Celular, Rio De Janeiro, Brazil; [Rosa, Patricia Sammarco] Inst Lauro Souza Lima, Sao Paulo, Brazil; [Sandoval, Felipe Galvan; Shannon, Edward J.; Williams, Diana Lynn] Louisiana State Univ, Sch Vet Med, Hlth Resources & Serv Adm HRSA,Lab Res Branch, Bur Primary Hlth Care BPHC,Div Natl Hansens Dis P, Baton Rouge, LA 70803 USA	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; United States Health Resources & Service Administration (HRSA)	Moraes, MO (corresponding author), FIOCRUZ RJ, Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Hanseniase, Rio De Janeiro, Brazil.	mmoraes@fiocruz.br	Moraes, Milton Ozório/G-9753-2011; Moraes, Milton/AFF-1842-2022; Rosa, Patrïcia/G-5880-2012	Moraes, Milton Ozório/0000-0003-2653-0037; Robottom Ferreira, Anna Beatriz/0000-0003-3553-1744; Nunes Sarno, Euzenir/0000-0003-0129-2159; Ribeiro-Alves, Marcelo/0000-0002-8663-3364	PAPES (Programa Estrategico de Apoio a Pesquisa em Saude, FIOCRUZ); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)	PAPES (Programa Estrategico de Apoio a Pesquisa em Saude, FIOCRUZ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work has been funded by PAPES (Programa Estrategico de Apoio a Pesquisa em Saude, FIOCRUZ); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). LTAG and ABRF were PhD students sponsored by CNPq and CAPES. There are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mubarak R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001303; Alcais A, 2007, NAT GENET, V39, P517, DOI 10.1038/ng2000; Alter A, 2010, HUM GENET, V127, P337, DOI 10.1007/s00439-009-0775-x; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Basso D., 2009, PERMUTATION TESTS ST, V3, DOI DOI 10.1007/978-0-387-85956-9_5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger AK, 2009, HUM MOL GENET, V18, P4317, DOI 10.1093/hmg/ddp384; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bloom CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046191; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cardoso CC, 2010, HUM GENET, V128, P481, DOI 10.1007/s00439-010-0872-x; Cardoso CC, 2011, J INFECT DIS, V204, P1256, DOI 10.1093/infdis/jir521; Cardoso CC, 2011, FUTURE MICROBIOL, V6, P533, DOI [10.2217/FMB.11.39, 10.2217/fmb.11.39]; Fine PEM, 1996, LANCET, V348, P17, DOI 10.1016/S0140-6736(96)02166-6; Garg N, 2003, BBA-MOL BASIS DIS, V1638, P106, DOI 10.1016/S0925-4439(03)00060-7; Geluk A, 2012, J IMMUNOL, V188, P4782, DOI 10.4049/jimmunol.1103452; Antunes SLG, 2012, MEM I OSWALDO CRUZ, V107, P246, DOI 10.1590/S0074-02762012000200015; Grant AV, 2012, J INFECT DIS, V206, P1763, DOI 10.1093/infdis/jis588; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Hagge DA, 2002, J INFECT DIS, V186, P1283, DOI 10.1086/344313; Hagge DA, 2009, AM J PATHOL, V174, P1379, DOI 10.2353/ajpath.2009.080550; Hasan Z, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-78; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jamieson SE, 2004, GENES IMMUN, V5, P46, DOI 10.1038/sj.gene.6364029; Jardim MR, 2005, LEPROSY REV, V76, P232; JOB CK, 1970, ARCH PATHOL, V89, P195; Lahiri R, 2005, J MED MICROBIOL, V54, P235, DOI 10.1099/jmm.0.45700-0; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Maertzdorf Jeroen, 2011, PLoS One, V6, pe26938, DOI 10.1371/journal.pone.0026938; Martinez AN, 2006, J CLIN MICROBIOL, V44, P3154, DOI 10.1128/JCM.02250-05; Martinez AN, 2009, J CLIN MICROBIOL, V47, P2124, DOI 10.1128/JCM.00512-09; Martinez AN, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001354; Mattos KA, 2011, J IMMUNOL, V187, P2548, DOI 10.4049/jimmunol.1101344; Mattos KA, 2010, J LEUKOCYTE BIOL, V87, P371, DOI 10.1189/jlb.0609433; Menicucci LA, 2005, J AM ACAD DERMATOL, V52, P648, DOI 10.1016/j.jaad.2004.11.068; Merle CSC, 2010, EXPERT REV VACCINES, V9, P209, DOI 10.1586/ERV.09.161; Miller EN, 2004, GENES IMMUN, V5, P63, DOI 10.1038/sj.gene.6364031; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; Montoya D, 2009, CELL HOST MICROBE, V6, P343, DOI 10.1016/j.chom.2009.09.002; Murray RA, 2007, J IMMUNOL, V178, P338, DOI 10.4049/jimmunol.178.1.338; Oliveira MM, 2001, MEM I OSWALDO CRUZ, V96, P973, DOI 10.1590/S0074-02762001000700015; Ottenhoff THM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045839; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Paul S, 1996, J INFECT DIS, V174, P105, DOI 10.1093/infdis/174.1.105; Pereira AC, 2009, GENES IMMUN, V10, P174, DOI 10.1038/gene.2008.97; Peyron P, 2000, J IMMUNOL, V165, P5186, DOI 10.4049/jimmunol.165.9.5186; R Development Core Team, 2009, R FDN STAT COMP; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Sapkota BR, 2010, HUM IMMUNOL, V71, P992, DOI 10.1016/j.humimm.2010.07.001; Savage RS, 2010, BIOINFORMATICS, V26, pi158, DOI 10.1093/bioinformatics/btq210; Schuring RP, 2009, J INFECT DIS, V199, P1816, DOI 10.1086/599121; Scollard DM, 2006, CLIN MICROBIOL REV, V19, P338, DOI 10.1128/CMR.19.2.338-381.2006; Sinsimer D, 2010, INFECT IMMUN, V78, P293, DOI 10.1128/IAI.00816-09; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sun YH, 2011, EXP DERMATOL, V20, P520, DOI 10.1111/j.1600-0625.2011.01270.x; SUZUKI K, 1993, INT J LEPROSY, V61, P609; Teles RMB, 2013, SCIENCE, V339, P1448, DOI 10.1126/science.1233665; Theus SA, 2004, INFECT IMMUN, V72, P1169, DOI 10.1128/IAI.72.2.1169-1173.2004; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Truman RW, 2001, INT J LEPROSY, V69, P1; Vandesompele J, 2003, GENOME BIOL, DOI [10.1186/gb-2002-3-7-re-search0034, DOI 10.1186/GB-2002-3-7-RE-SEARCH0034]; Virchow R, 1863, KRANKHAFTEN GESCHWU; Wong SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000979; Wong SH, 2010, NEW ENGL J MED, V362, P1446, DOI 10.1056/NEJMc1001451; Wu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038367; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753	68	36	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e64748	10.1371/journal.pone.0064748	http://dx.doi.org/10.1371/journal.pone.0064748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23798993	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300002
J	Caron, MA; Morissette, MC; Theriault, ME; Nikota, JK; Stampfli, MR; Debigare, R				Caron, Marc-Andre; Morissette, Mathieu C.; Theriault, Marie-Eve; Nikota, Jake K.; Staempfli, Martin R.; Debigare, Richard			Alterations in Skeletal Muscle Cell Homeostasis in a Mouse Model of Cigarette Smoke Exposure	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; UBIQUITIN-PROTEASOME PATHWAY; INDUCED OXIDATIVE STRESS; NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; IN-VIVO/; ATROPHY; COPD; HYPERTROPHY; DYSFUNCTION	Background: Skeletal muscle dysfunction is common in chronic obstructive pulmonary disease (COPD), a disease mainly caused by chronic cigarette use. An important proportion of patients with COPD have decreased muscle mass, suggesting that chronic cigarette smoke exposure may interfere with skeletal muscle cellular equilibrium. Therefore, the main objective of this study was to investigate the kinetic of the effects that cigarette smoke exposure has on skeletal muscle cell signaling involved in protein homeostasis and to assess the reversibility of these effects. Methods: A mouse model of cigarette smoke exposure was used to assess skeletal muscle changes. BALB/c mice were exposed to cigarette smoke or room air for 8 weeks, 24 weeks or 24 weeks followed by 60 days of cessation. The gastrocnemius and soleus muscles were collected and the activation state of key mediators involved in protein synthesis and degradation was assessed. Results: Gastrocnemius and soleus were smaller in mice exposed to cigarette smoke for 8 and 24 weeks compared to room air exposed animals. Pro-degradation proteins were induced at the mRNA level after 8 and 24 weeks. Twenty-four weeks of cigarette smoke exposure induced pro-degradation proteins and reduced Akt phosphorylation and glycogen synthase kinase-3 beta quantity. A 60-day smoking cessation period reversed the cell signaling alterations induced by cigarette smoke exposure. Conclusions: Repeated cigarette smoke exposure induces reversible muscle signaling alterations that are dependent on the duration of the cigarette smoke exposure. These results highlights a beneficial aspect associated with smoking cessation.	[Caron, Marc-Andre; Theriault, Marie-Eve; Debigare, Richard] Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada; [Caron, Marc-Andre; Theriault, Marie-Eve; Debigare, Richard] Univ Laval, Quebec City, PQ, Canada; [Morissette, Mathieu C.; Nikota, Jake K.; Staempfli, Martin R.] McMaster Univ, Dept Pathol & Mol Med, McMaster Immunol Res Ctr, Hamilton, ON, Canada; [Staempfli, Martin R.] McMaster Univ, St Josephs Healthcare, Firestone Inst Resp Hlth, Hamilton, ON, Canada	Laval University; Laval University; McMaster University; McMaster University	Debigare, R (corresponding author), Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada.	Richard.Debigare@rea.ulaval.ca		Stampfli, Martin/0000-0003-4918-5889	 [CIHR 93776]		This research was supported by grant CIHR 93776, which funded the cost of reagents and the technician salary of RD research team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AR, 2012, AM J PHYSIOL-LUNG C, V303, pL889, DOI 10.1152/ajplung.00219.2012; Altun M, 2010, J BIOL CHEM, V285, P39597, DOI 10.1074/jbc.M110.129718; Barreiro E, 2012, RESP PHYSIOL NEUROBI, V182, P9, DOI 10.1016/j.resp.2012.02.001; Barreiro E, 2010, AM J RESP CRIT CARE, V182, P477, DOI 10.1164/rccm.200908-1220OC; Basic VT, 2012, AM J PHYSIOL-LUNG C, V303, pL519, DOI 10.1152/ajplung.00007.2012; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Botelho FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028457; Botelho FM, 2010, AM J RESP CELL MOL, V42, P394, DOI 10.1165/rcmb.2008-0301OC; Caron MA, 2011, AM J RESP CRIT CARE, V183; Caron MA, 2009, J APPL PHYSIOL, V107, P952, DOI 10.1152/japplphysiol.00194.2009; de Oca MM, 2008, CHEST, V133, P13, DOI 10.1378/chest.07-1592; De Paepe B, 2008, ACTA NEUROPATHOL, V115, P675, DOI 10.1007/s00401-008-0348-4; Debigarte R, 2001, AM J RESP CRIT CARE, V164, P1712, DOI 10.1164/ajrccm.164.9.2104035; Doucet M, 2007, AM J RESP CRIT CARE, V176, P261, DOI 10.1164/rccm.200605-704OC; Eisner MD, 2010, AM J RESP CRIT CARE, V182, P693, DOI 10.1164/rccm.200811-1757ST; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gosker HR, 2009, AM J RESP CELL MOL, V40, P710, DOI 10.1165/rcmb.2008-0312OC; Gosselink R, 1996, AM J RESP CRIT CARE, V153, P976, DOI 10.1164/ajrccm.153.3.8630582; Jobse BN, 2013, J NUCL MED, V54, P616, DOI 10.2967/jnumed.112.111419; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Li W, 2009, AM J PHYSIOL-CELL PH, V297, pC706, DOI 10.1152/ajpcell.00626.2008; Li YP, 1998, FASEB J, V12, P871, DOI 10.1096/fasebj.12.10.871; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marquis K, 2002, AM J RESP CRIT CARE, V166, P809, DOI 10.1164/rccm.2107031; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mostert R, 2000, RESP MED, V94, P859, DOI 10.1053/rmed.2000.0829; Plant PJ, 2010, AM J RESP CELL MOL, V42, P461, DOI 10.1165/rcmb.2008-0382OC; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Rinaldi M, 2012, DIS MODEL MECH, V5, P333, DOI 10.1242/dmm.008508; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Tang K, 2010, J CELL PHYSIOL, V222, P320, DOI 10.1002/jcp.21955; Tanni SE, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-29; Wang XM, 2001, EMBO J, V20, P4349, DOI 10.1093/emboj/20.16.4349; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008	37	40	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66433	10.1371/journal.pone.0066433	http://dx.doi.org/10.1371/journal.pone.0066433			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799102	Green Submitted, gold, Green Published			2022-12-25	WOS:000320363300081
J	Bauer, CA; Wisner, KW; Baizer, JS; Brozoski, TJ				Bauer, Carol A.; Wisner, Kurt W.; Baizer, Joan S.; Brozoski, Thomas J.			Tinnitus, Unipolar Brush Cells, and Cerebellar Glutamatergic Function in an Animal Model	PLOS ONE			English	Article							DORSAL COCHLEAR NUCLEUS; DOUBLECORTIN EXPRESSION; ADULT NEUROGENESIS; NEURAL ACTIVITY; RAT; PLASTICITY; CORTEX; PARAFLOCCULUS; INTERNEURONS; HYPERACUSIS	Unipolar brush cells (UBCs) are excitatory interneurons found in the dorsal cochlear nucleus (DCN) and the granule cell layer of cerebellar cortex, being particularly evident in the paraflocculus (PFL) and flocculus (FL). UBCs receive glutamatergic inputs and make glutamatergic synapses with granule cells and other UBCs. It has been hypothesized that UBCs comprise local networks of tunable feed-forward amplifiers. In the DCN they might also participate in feed-back amplification of signals from higher auditory centers. Recently it has been shown that UBCs, in the vestibulocerebellum and DCN of adult rats, express doublecortin (DCX), previously considered a marker of newborn and migrating neurons. In an animal model, both the DCN, and more recently the PFL, have been implicated in contributing to the sensation of acoustic-exposure-induced tinnitus. These studies support the working hypothesis that tinnitus emerges after loss of peripheral sensitivity because inhibitory processes homeostatically down regulate, and excitatory processes up regulate. Here we report the results of two sequential experiments that examine the potential role of DCN and cerebellar UBCs in tinnitus, and the contribution of glutamatergic transmission in the PFL. In Experiment 1 it was shown that adult rats with psychophysical evidence of tinnitus induced by a single unilateral high-level noise exposure, had elevated DCX in the DCN and ventral PFL. In Experiment 2 it was shown that micro-quantities of glutamatergic antagonists, delivered directly to the PFL, reversibly reduced chronically established tinnitus, while similarly applied glutamatergic agonists induced tinnitus-like behavior in non-tinnitus controls. These results are consistent with the hypothesis that UBC up regulation and enhanced glutamatergic transmission in the cerebellum contribute to the pathophysiology of tinnitus.	[Bauer, Carol A.; Wisner, Kurt W.; Brozoski, Thomas J.] So Illinois Univ, Sch Med, Dept Otolaryngol, Springfield, IL 62702 USA; [Baizer, Joan S.] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA	Southern Illinois University System; Southern Illinois University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Brozoski, TJ (corresponding author), So Illinois Univ, Sch Med, Dept Otolaryngol, Springfield, IL 62702 USA.	tbrozoski@siumed.edu			National Institute on Deafness and Other Communication Disorders [1R01DC009669-01]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009669] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project was supported by the National Institute on Deafness and Other Communication Disorders, 1R01DC009669-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibardi L., 2004, Journal of Submicroscopic Cytology and Pathology, V36, P193; Andersson G, 2001, ARCH OTOLARYNGOL, V127, P175, DOI 10.1001/archotol.127.2.175; AXELSSON A, 1985, British Journal of Audiology, V19, P271, DOI 10.3109/03005368509078983; Azevedo Andreia A, 2005, Braz J Otorhinolaryngol, V71, P618; AZIZI SA, 1985, EXP BRAIN RES, V59, P36; AZIZI SA, 1990, BRAIN RES, V533, P255, DOI 10.1016/0006-8993(90)91347-J; Bartnik G, 2001, SCAND AUDIOL, V30, P187, DOI 10.1080/010503901300007489; Bauer CA, 2001, JARO-J ASSOC RES OTO, V2, P54, DOI 10.1007/s101620010030; Bauer CA, 2013, HEARING RES, V295, P130, DOI 10.1016/j.heares.2012.03.009; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Brozoski TJ, 2007, HEARING RES, V228, P168, DOI 10.1016/j.heares.2007.02.003; Brozoski TJ, 2007, JARO-J ASSOC RES OTO, V8, P105, DOI 10.1007/s10162-006-0067-2; Brozoski TJ, 2010, HEARING RES, V270, P71, DOI 10.1016/j.heares.2010.09.006; Brozoski TJ, 2012, JARO-J ASSOC RES OTO, V13, P55, DOI 10.1007/s10162-011-0290-3; Brozoski TJ, 2005, HEARING RES, V206, P227, DOI 10.1016/j.heares.2004.12.013; Brozoski TJ, 2002, J NEUROSCI, V22, P2383, DOI 10.1523/JNEUROSCI.22-06-02383.2002; Coles RR, 1984, J LARYNGOL OTOL S, V9, P7; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; D'Angelo E, 2009, TRENDS NEUROSCI, V32, P30, DOI 10.1016/j.tins.2008.09.007; Dauman R, 2005, ACTA OTO-LARYNGOL, V125, P503, DOI 10.1080/00016480510027565; Dorrn AL, 2010, NATURE, V465, P932, DOI 10.1038/nature09119; EISENMAN LM, 1980, BRAIN RES, V188, P550, DOI 10.1016/0006-8993(80)90053-0; FLORIS A, 1994, ANAT EMBRYOL, V189, P495; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Glitsch M, 1999, J NEUROSCI, V19, P511; HINCHCLIFF R, 1961, BRIT J PREV SOC MED, V15, P128; Ito M, 1984, CEREBELLUM NEURAL CO; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Kaltenbach JA, 2000, HEARING RES, V147, P282, DOI 10.1016/S0378-5955(00)00138-6; Kaltenbach JA, 2008, AM J AUDIOL, V17, pS148, DOI 10.1044/1059-0889(2008/08-0004); Kenyon GT, 1997, P NATL ACAD SCI USA, V94, P14200, DOI 10.1073/pnas.94.25.14200; Lakowicz J. R., 2009, PRINCIPLES FLUORESCE; Li FW, 2011, BEHAV BRAIN RES, V224, P376, DOI 10.1016/j.bbr.2011.06.021; Liberman M C, 1978, Acta Otolaryngol Suppl, V358, P1; Manohar S, 2012, NEUROSCIENCE, V202, P169, DOI 10.1016/j.neuroscience.2011.12.013; Meikle M. B., 2004, TINNITUS ARCH; Morest DK, 1997, HEARING RES, V103, P151, DOI 10.1016/S0378-5955(96)00172-4; MORTIMER JA, 1975, BRAIN RES, V83, P369, DOI 10.1016/0006-8993(75)90831-8; MUGNAINI E, 1994, J COMP NEUROL, V339, P174, DOI 10.1002/cne.903390203; Mugnaini E, 2011, BRAIN RES REV, V66, P220, DOI 10.1016/j.brainresrev.2010.10.001; Muhr P, 2010, INT J AUDIOL, V49, P317, DOI 10.3109/14992020903431280; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Nondahl David M, 2002, J Am Acad Audiol, V13, P323; Norena AJ, 2011, NEUROSCI BIOBEHAV R, V35, P1089, DOI 10.1016/j.neubiorev.2010.11.003; Oertel D, 2004, TRENDS NEUROSCI, V27, P104, DOI 10.1016/j.tins.2003.12.001; Osaki Y, 2005, NEUROREPORT, V16, P1625, DOI 10.1097/01.wnr.0000183899.85277.08; Rasmussen G., 1990, RES NOTEBOOKS HIST M, P1; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Rousseau CV, 2012, J NEUROSCI, V32, P4632, DOI 10.1523/JNEUROSCI.5122-11.2012; Ruigrok TJH, 2011, J NEUROSCI, V31, P712, DOI 10.1523/JNEUROSCI.1959-10.2011; Sekerkova G, 2004, NEUROSCIENCE, V127, P845, DOI 10.1016/j.neuroscience.2004.05.050; Shore SE, 2008, EUR J NEUROSCI, V27, P155, DOI 10.1111/j.1460-9568.2007.05983.x; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; TRUSSELL LO, 1988, P NATL ACAD SCI USA, V85, P4562, DOI 10.1073/pnas.85.12.4562-a; TURNER J, 2012, J NEUROSCI RES; Turner JG, 2008, AM J AUDIOL, V17, pS185, DOI 10.1044/1059-0889(2008/08-0006); Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Van der Gucht E, 2006, ANAT REC PART A, V288A, P753, DOI 10.1002/ar.a.20350; Wang HN, 2011, HEARING RES, V279, P111, DOI 10.1016/j.heares.2011.04.004; Yang SC, 2011, P NATL ACAD SCI USA, V108, P14974, DOI 10.1073/pnas.1107998108; Zeng CH, 2009, J NEUROSCI, V29, P4210, DOI 10.1523/JNEUROSCI.0208-09.2009; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	63	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e64726	10.1371/journal.pone.0064726	http://dx.doi.org/10.1371/journal.pone.0064726			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785405	Green Submitted, Green Published, gold			2022-12-25	WOS:000321038800114
J	Davis, BJ; Risinger, JI; Chandramouli, GVR; Bushel, PR; Baird, DD; Peddada, SD				Davis, Barbara J.; Risinger, John I.; Chandramouli, Gadisetti V. R.; Bushel, Pierre R.; Baird, Donna Day; Peddada, Shyamal D.			Gene Expression in Uterine Leiomyoma from Tumors Likely to Be Growing (from Black Women over 35) and Tumors Likely to Be Non-Growing (from White Women over 35)	PLOS ONE			English	Article							SUPPRESSOR PROTEIN; GROWTH; PREGNANCY; DIFFERENTIATION; FIBROIDS; INSIGHTS; ARRAYS; PVHL	The study of uterine leiomyomata (fibroids) provides a unique opportunity to investigate the physiological and molecular determinants of hormone dependent tumor growth and spontaneous tumor regression. We conducted a longitudinal clinical study of premenopausal women with leiomyoma that showed significantly different growth rates between white and black women depending on their age. Growth rates for leiomyoma were on average much higher from older black women than for older white women, and we now report gene expression pattern differences in tumors from these two groups of study participants. Total RNA from 52 leiomyoma and 8 myometrial samples were analyzed using Affymetrix Gene Chip expression arrays. Gene expression data was first compared between all leiomyoma and normal myometrium and then between leiomyoma from older black women (age 35 or older) and from older white women. Genes that were found significant in pairwise comparisons were further analyzed for canonical pathways, networks and biological functions using the Ingenuity Pathway Analysis (IPA) software. Whereas our comparison of leiomyoma to myometrium produced a very large list of genes highly similar to numerous previous studies, distinct sets of genes and signaling pathways were identified in comparisons of older black and white women whose tumors were likely to be growing and non-growing, respectively. Key among these were genes associated with regulation of apoptosis. To our knowledge, this is the first study to compare two groups of tumors that are likely to have different growth rates in order to reveal molecular signals likely to be influential in tumor growth.	[Davis, Barbara J.] Tufts Univ, Cummings Sch Vet Med, North Grafton, MA USA; [Risinger, John I.; Chandramouli, Gadisetti V. R.] Michigan State Univ, Coll Human Med, Grand Rapids, MI USA; [Bushel, Pierre R.; Peddada, Shyamal D.] NIEHS, Biostat Branch, NIH, Res Triangle Pk, NC 27709 USA; [Baird, Donna Day] NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA	Tufts University; Michigan State University; Michigan State University College of Human Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Peddada, SD (corresponding author), NIEHS, Biostat Branch, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	Peddada@niehs.nih.gov	Baird, Donna D/D-5214-2017	Baird, Donna D/0000-0002-5544-2653; Peddada, Shyamal/0000-0002-5014-6513	Intramural Research Program of the NIEHS, National Institutes of Health [Z01ES 101663-05, Z01 ES102345-04]; National Center on Minority Health and Health Disparities Grant [MO1RR00046]; NIEHS [N01-ES-95446, 273-01-C-0157]; Integrated Laboratory Systems in RT-PCR assays; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES102345, ZIAES049013, ZIAES101663, ZIAES102345, N01ES095446, Z01ES101663] Funding Source: NIH RePORTER	Intramural Research Program of the NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Center on Minority Health and Health Disparities Grant; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Integrated Laboratory Systems in RT-PCR assays; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project was supported by Intramural Research Program of the NIEHS, National Institutes of Health (Grant Z01ES 101663-05 and Z01 ES102345-04), with partial funding from the National Center on Minority Health and Health Disparities Grant MO1RR00046 and NIEHS Contracts N01-ES-95446 and 273-01-C-0157. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the study participants; the contributions of Dr. Pamela Blackshear and support of Integrated Laboratory Systems in RT-PCR assays; and Dr. Kissling (NIEHS), Dr. Leppert (Duke University) for careful reading of an earlier version of the manuscript.	Arslan AA, 2005, HUM REPROD, V20, P852, DOI 10.1093/humrep/deh698; Baird DD, 2003, EPIDEMIOLOGY, V14, P247; Baird DD, 2011, FERTIL STERIL, V95, P242, DOI 10.1016/j.fertnstert.2010.05.011; Breton S, 2001, JOP, V2, P159; Burroughs KD, 2002, J ENDOCRINOL, V172, P83, DOI 10.1677/joe.0.1720083; Catherino WH, 2004, GENE CHROMOSOME CANC, V40, P204, DOI 10.1002/gcc.20035; Catherino WH, 2003, FERTIL STERIL, V80, P293, DOI 10.1016/S0015-0282(03)00958-0; Catherino WH, 2007, FERTIL STERIL, V87, P1388, DOI 10.1016/j.fertnstert.2006.11.093; Cesen-Cummings K, 2003, J SOC GYNECOL INVEST, V10, P11, DOI 10.1016/S1071-5576(02)00191-0; Cesen-Cummings K, 2000, MED HYPOTHESES, V55, P485, DOI 10.1054/mehy.2000.1098; Chiquet M, 2009, BIOCHIM BIOPHYS ACTA, V1793, p[1793, 1795]; Chou Jeff W., 2005, Journal of Bioinformatics and Computational Biology, V3, P225, DOI 10.1142/S0219720005001028; Davis BJ, 2009, J WOMENS HEALTH, V18, P725, DOI 10.1089/jwh.2008.0903; Ding N, 2009, J BIOL CHEM, V284, P2648, DOI 10.1074/jbc.M806514200; Efron B., 1994, INTRO BOOTSTRAP; Esteban-Barragan MA, 2002, CANCER RES, V62, P2929; Fuller SJ, 2008, J MOL CELL CARDIOL, V44, P831, DOI 10.1016/j.yjmcc.2008.02.278; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Hoffman PJ, 2004, FERTIL STERIL, V82, P639, DOI 10.1016/j.fertnstert.2004.01.047; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Mayer A, 2008, CANCER RES, V68, P4719, DOI 10.1158/0008-5472.CAN-07-6339; Negro A, 2006, P NATL ACAD SCI USA, V103, P15889, DOI 10.1073/pnas.0607499103; Norian JM, 2012, MATRIX BIOL, V31, P57, DOI 10.1016/j.matbio.2011.09.001; Ono M, 2007, P NATL ACAD SCI USA, V104, P18700, DOI 10.1073/pnas.0704472104; Peddada S, 2005, BIOINFORMATICS, V21, P3933, DOI 10.1093/bioinformatics/bti637; Peddada SD, 2003, BIOINFORMATICS, V19, P834, DOI 10.1093/bioinformatics/btg093; Peddada SD, 2008, P NATL ACAD SCI USA, V105, P19887, DOI 10.1073/pnas.0808188105; Rajagopalan V, 2008, AM J PHYSIOL-HEART C, V295, pH543, DOI 10.1152/ajpheart.91436.2007; Sleeman JP, 2011, CELL, V145, DOI 10.1016/j.cell.2011.03.029; Sutton TA, 2008, AM J PHYSIOL-RENAL, V295, pF1666, DOI 10.1152/ajprenal.90304.2008; Thoma CR, 2010, J CELL BIOL, V190, P991, DOI 10.1083/jcb.201006059; Tsibris JCM, 2003, BIOCHEM BIOPH RES CO, V312, P249, DOI 10.1016/j.bbrc.2003.09.189; Tsibris JCM, 2002, FERTIL STERIL, V78, P114, DOI 10.1016/S0015-0282(02)03191-6; Turcotte S, 2004, AM J PHYSIOL-RENAL, V286, pF338, DOI 10.1152/ajprenal.00254.2003; Walker CL, 2001, CARCINOGENESIS, V22, P2049, DOI 10.1093/carcin/22.12.2049; Wang TS, 2007, GENE CHROMOSOME CANC, V46, P336, DOI 10.1002/gcc.20415; Wei JJ, 2006, HUM REPROD, V21, P57, DOI 10.1093/humrep/dei309; Wray S, 2007, EXP PHYSIOL, V92, P621, DOI 10.1113/expphysiol.2007.038125; Zhao SL, 1997, INT REV CYTOL, V171, P225; Zhou QY, 2011, FASEB J, V25, P3032, DOI 10.1096/fj.10-177824	43	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e63909	10.1371/journal.pone.0063909	http://dx.doi.org/10.1371/journal.pone.0063909			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785396	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800121
J	Gunka, K; Stannek, L; Care, RA; Commichau, FM				Gunka, Katrin; Stannek, Lorena; Care, Rachel A.; Commichau, Fabian M.			Selection-Driven Accumulation of Suppressor Mutants in Bacillus subtilis: The Apparent High Mutation Frequency of the Cryptic gudB Gene and the Rapid Clonal Expansion of gudB(+) Suppressors Are Due to Growth under Selection	PLOS ONE			English	Article							STRESS-INDUCED MUTAGENESIS; GLUTAMATE-DEHYDROGENASE ROCG; ESCHERICHIA-COLI; TRANSCRIPTION FACTOR; MOLECULAR-MECHANISM; NITROGEN-METABOLISM; REPEAT INSTABILITY; DNA BREAKS; BIOSYNTHESIS; BACTERIA	Soil bacteria like Bacillus subtilis can cope with many growth conditions by adjusting gene expression and metabolic pathways. Alternatively, bacteria can spontaneously accumulate beneficial mutations or shape their genomes in response to stress. Recently, it has been observed that a B. subtilis mutant lacking the catabolically active glutamate dehydrogenase (GDH), RocG, mutates the cryptic gudB(CR) gene at a high frequency. The suppressor mutants express the active GDH GudB, which can fully replace the function of RocG. Interestingly, the cryptic gudB(CR) allele is stably inherited as long as the bacteria synthesize the functional GDH RocG. Competition experiments revealed that the presence of the cryptic gudB(CR) allele provides the bacteria with a selective growth advantage when glutamate is scarce. Moreover, the lack of exogenous glutamate is the driving force for the selection of mutants that have inactivated the active gudB gene. In contrast, two functional GDHs are beneficial for the cells when glutamate was available. Thus, the amount of GDH activity strongly affects fitness of the bacteria depending on the availability of exogenous glutamate. At a first glance the high mutation frequency of the cryptic gudB(CR) allele might be attributed to stress-induced adaptive mutagenesis. However, other loci on the chromosome that could be potentially mutated during growth under the selective pressure that is exerted on a GDH-deficient mutant remained unaffected. Moreover, we show that a GDH-proficient B. subtilis strain has a strong selective growth advantage in a glutamate-dependent manner. Thus, the emergence and rapid clonal expansion of the active gudB allele can be in fact explained by spontaneous mutation and growth under selection without an increase of the mutation rate. Moreover, this study shows that the selective pressure that is exerted on a maladapted bacterium strongly affects the apparent mutation frequency of mutational hot spots.	[Gunka, Katrin; Stannek, Lorena; Care, Rachel A.; Commichau, Fabian M.] Univ Gottingen, Dept Gen Microbiol, D-37073 Gottingen, Germany	University of Gottingen	Commichau, FM (corresponding author), Univ Gottingen, Dept Gen Microbiol, D-37073 Gottingen, Germany.	fcommic1@gwdg.de	Commichau, Fabian/A-9664-2018	Commichau, Fabian/0000-0003-0323-7479	Deutsche Forschungsgemeinschaft [CO 1139/1-1]; Fonds der Chemischen Industrie; Gottingen Centre for Molecular Biology (GZMB); Fulbright Scholar Grant;  [SFB860]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Gottingen Centre for Molecular Biology (GZMB); Fulbright Scholar Grant; 	Work in the author's lab was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de; CO 1139/1-1), the Fonds der Chemischen Industrie and the Gottingen Centre for Molecular Biology (GZMB). Rachel A. Care was supported by a Fulbright Scholar Grant. Work of KG in the authors lab was supported by the grant SFB860. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Mamun AM, 2012, SCIENCE, V338, P1344, DOI 10.1126/science.1226683; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Belitsky BR, 1998, J BACTERIOL, V180, P6298; Belitsky BR, 2004, J BACTERIOL, V186, P3399, DOI 10.1128/JB.186.11.3399-3407.2004; Belitsky BR, 2004, J BACTERIOL, V186, P5939; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bichara M, 2006, MUTAT RES-FUND MOL M, V598, P144, DOI 10.1016/j.mrfmmm.2006.01.020; Bisicchia P, 2010, PLASMID, V64, P143, DOI 10.1016/j.plasmid.2010.06.002; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Blom EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027160; Blount ZD, 2012, NATURE, V489, P513, DOI 10.1038/nature11514; BOHANNON DE, 1989, J BACTERIOL, V171, P4718, DOI 10.1128/jb.171.9.4718-4727.1989; Brill J, 2011, J BACTERIOL, V193, P5335, DOI 10.1128/JB.05490-11; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; Burch LH, 2011, CELL CYCLE, V10, P1073, DOI 10.4161/cc.10.7.15319; BURKHOLDER PR, 1947, AM J BOT, V34, P345, DOI 10.2307/2437147; CAIRNS J, 1988, NATURE, V335, P142, DOI 10.1038/335142a0; Commichau FM, 2008, MOL MICROBIOL, V67, P692, DOI 10.1111/j.1365-2958.2007.06071.x; Commichau FM, 2008, J BACTERIOL, V190, P3557, DOI 10.1128/JB.00099-08; Commichau FM, 2007, MOL MICROBIOL, V65, P642, DOI 10.1111/j.1365-2958.2007.05816.x; Commichau FM, 2007, J MOL MICROB BIOTECH, V12, P106, DOI 10.1159/000096465; Commichau FM, 2006, CURR OPIN MICROBIOL, V9, P167, DOI 10.1016/j.mib.2006.01.001; de Jong IG, 2011, JOVE-J VIS EXP, DOI 10.3791/3145; FISHER SH, 1984, J BACTERIOL, V158, P379, DOI 10.1128/JB.158.1.379-382.1984; Florez LA, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-5; Foster PL, 2007, CRIT REV BIOCHEM MOL, V42, P373, DOI 10.1080/10409230701648494; Frimmersdorf E, 2010, ENVIRON MICROBIOL, V12, P1734, DOI 10.1111/j.1462-2920.2010.02253.x; Gerth U, 2008, J BACTERIOL, V190, P321, DOI 10.1128/JB.01233-07; Gunka K, 2012, MOL MICROBIOL, V85, P213, DOI 10.1111/j.1365-2958.2012.08105.x; Gunka K, 2012, J BACTERIOL, V194, P1036, DOI 10.1128/JB.06470-11; Gunka K, 2010, J MOL BIOL, V400, P815, DOI 10.1016/j.jmb.2010.05.055; Hu P, 1999, J BACTERIOL, V181, P5042, DOI 10.1128/JB.181.16.5042-5050.1999; Koonin EV, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-33; Kovtun IV, 2008, CELL RES, V18, P198, DOI 10.1038/cr.2008.5; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; Lee YH, 2012, J BACTERIOL, V194, P993, DOI 10.1128/JB.06547-11; Leigh JA, 2007, ANNU REV MICROBIOL, V61, P349, DOI 10.1146/annurev.micro.61.080706.093409; Magasanik B, 2003, EUKARYOT CELL, V2, P827, DOI 10.1128/EC.2.5.827-829.2003; Manabe K, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-18; Martin DD, 1999, APPL ENVIRON MICROB, V65, P1815; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Picossi S, 2007, J MOL BIOL, V365, P1298, DOI 10.1016/j.jmb.2006.10.100; Rosenberg SM, 2012, BIOESSAYS, V34, P885, DOI 10.1002/bies.201200050; Rosenberg SM, 2011, MBIO, V2, DOI 10.1128/mBio.00200-11; Roth JR, 2006, ANNU REV MICROBIOL, V60, P477, DOI 10.1146/annurev.micro.60.080805.142045; Rothe FM, 2013, J BACTERIOL, V195, P2146, DOI 10.1128/JB.00117-13; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Saum SH, 2006, J BACTERIOL, V188, P6808, DOI 10.1128/JB.00781-06; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Stulke J, 1997, MOL MICROBIOL, V25, P65, DOI 10.1046/j.1365-2958.1997.4351797.x; Taddei F, 1997, MOL GEN GENET, V256, P277, DOI 10.1007/s004380050570; Wacker I, 2003, MICROBIOL-SGM, V149, P3001, DOI 10.1099/mic.0.26479-0; Wang Q, 2012, SCIENCE, V327, P1004; Wohlhueter R, 1973, ENZYMES GLUTAMINE ME, P45; Wrande M, 2008, P NATL ACAD SCI USA, V105, P11863, DOI 10.1073/pnas.0804739105; Zeigler DR, 2008, J BACTERIOL, V190, P6983, DOI 10.1128/JB.00722-08	58	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66120	10.1371/journal.pone.0066120	http://dx.doi.org/10.1371/journal.pone.0066120			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785476	Green Published, gold, Green Submitted			2022-12-25	WOS:000321038800048
J	Arendt, W; Groenewold, MK; Hebecker, S; Dickschat, JS; Moser, J				Arendt, Wiebke; Groenewold, Maike K.; Hebecker, Stefanie; Dickschat, Jeroen S.; Moser, Juergen			Identification and Characterization of a Periplasmic Aminoacyl-phosphatidylglycerol Hydrolase Responsible for Pseudomonas aeruginosa Lipid Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHIZOBIUM-TROPICI CIAT899; ALANYL-PHOSPHATIDYLGLYCEROL; LYSYL-PHOSPHATIDYLGLYCEROL; ANAEROBIC SURVIVAL; BACTERIAL-MEMBRANE; PEPTIDE RESISTANCE; MPRF; PH; ADAPTATION; PROTEIN	Specific aminoacylation of the phospholipid phosphatidylglycerol (PG) with alanine (or with lysine) was shown to render various organisms less susceptible to antimicrobial agents and environmental stresses. In this study, we make use of the opportunistic pathogen Pseudomonas aeruginosa to decode ORF PA0919-dependent lipid homeostasis. Analysis of the polar lipid content of the deletion mutant Delta PA0919 indicated significantly enlarged levels of alanyl-PG. The resulting phenotype manifested an increased susceptibility to several antimicrobial compounds when compared with the wild type. A pH-dependent PA0919 promoter located within the upstream gene PA0920 was identified. Localization experiments demonstrated that the PA0919 protein is anchored to the periplasmic surface of the inner bacterial membrane. The recombinant overproduction of wild type and several site-directed mutant proteins in the periplasm of Escherichia coli facilitated a detailed in vitro analysis of the enzymatic PA0919 function. A series of artificial substrates (p-nitrophenyl esters of various amino acids/aliphatic acids) indicated enzymatic hydrolysis of the alanine, glycine, or lysine moiety of the respective ester substrates. Our final in vitro activity assay in the presence of radioactively labeled alanyl-PG then revealed hydrolysis of the aminoacyl linkage, resulting in the formation of alanine and PG. Consequently, PA0919 was termed alanyl-PG hydrolase. The elucidated enzymatic activity implies a new regulatory circuit for the appropriate tuning of cellular alanyl-PG concentrations.	[Arendt, Wiebke; Groenewold, Maike K.; Hebecker, Stefanie; Moser, Juergen] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; [Dickschat, Jeroen S.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Organ Chem, D-38106 Braunschweig, Germany	Braunschweig University of Technology; Braunschweig University of Technology	Moser, J (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany.	j.moser@tu-bs.de	Tauchert, Maike/AAZ-3990-2021	Tauchert, Maike/0000-0001-6777-0948	Deutsche Forschungsgemeinschaft Grant [MO 1749/1-1]	Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant MO 1749/1-1.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Arendt W, 2012, J BACTERIOL, V194, P1401, DOI 10.1128/JB.06576-11; Becher A, 2000, BIOTECHNIQUES, V29, P948, DOI 10.2144/00295bm04; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Coakley RD, 2003, P NATL ACAD SCI USA, V100, P16083, DOI 10.1073/pnas.2634339100; Dowhan W., 2002, NEW COMPR BIOCH, P1, DOI DOI 10.1016/50167-7306(02)36003-4; Eitel J, 2002, INFECT IMMUN, V70, P4880, DOI 10.1128/IAI.70.9.4880-4891.2002; Ernst CM, 2011, MOL MICROBIOL, V80, P290, DOI 10.1111/j.1365-2958.2011.07576.x; Ernst CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000660; Eschbach M, 2004, J BACTERIOL, V186, P4596, DOI 10.1128/JB.186.14.4596-4604.2004; Fischer W, 1999, INT J SYST BACTERIOL, V49, P653, DOI 10.1099/00207713-49-2-653; Fujiwara Atushi, 1998, Annals of the Phytopathological Society of Japan, V64, P191, DOI 10.3186/jjphytopath.64.191; Hebecker S, 2011, MOL MICROBIOL, V80, P935, DOI 10.1111/j.1365-2958.2011.07621.x; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HOUTSMULLER UMT, 1963, BIOCHIM BIOPHYS ACTA, V70, P211; Jensch T, 1997, J BASIC MICROB, V37, P115, DOI 10.1002/jobm.3620370206; Ke D, 2009, TETRAHEDRON, V65, P8269, DOI 10.1016/j.tet.2009.07.048; Klein S, 2009, MOL MICROBIOL, V71, P551, DOI 10.1111/j.1365-2958.2008.06562.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewenza S, 2005, GENOME RES, V15, P321, DOI 10.1101/gr.3257305; Lopez D, 2010, GENE DEV, V24, P1893, DOI 10.1101/gad.1945010; MACFARLANE MG, 1962, NATURE, V196, P136, DOI 10.1038/196136a0; Majumder Parimal, 1999, Annals of the Phytopathological Society of Japan, V65, P254, DOI 10.3186/jjphytopath.65.254; Maloney E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000534; MILLER JH, 1992, SHORT COURSE BACTERI, P71; Moser J, 1999, J BIOL CHEM, V274, P30679, DOI 10.1074/jbc.274.43.30679; Muraih JK, 2011, BBA-BIOMEMBRANES, V1808, P1154, DOI 10.1016/j.bbamem.2011.01.001; PAN SQ, 1995, MOL MICROBIOL, V17, P259, DOI 10.1111/j.1365-2958.1995.mmi_17020259.x; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Pogliano J, 2012, J BACTERIOL, V194, P4494, DOI 10.1128/JB.00011-12; Qiu T, 2010, AFR J BIOTECHNOL, V9, P8679; Rompf A, 1998, MOL MICROBIOL, V29, P985, DOI 10.1046/j.1365-2958.1998.00980.x; Roy H, 2008, P NATL ACAD SCI USA, V105, P4667, DOI 10.1073/pnas.0800006105; Roy H, 2009, J BIOL CHEM, V284, P29677, DOI 10.1074/jbc.M109.046367; Roy H, 2009, IUBMB LIFE, V61, P940, DOI 10.1002/iub.240; Roy H, 2009, MOL MICROBIOL, V71, P547, DOI 10.1111/j.1365-2958.2008.06563.x; SACRE MM, 1977, CHEM PHYS LIPIDS, V20, P305, DOI 10.1016/0009-3084(77)90071-8; Sambrook J, 2001, MOL CLONING LAB MANU; SCHNABEL E, 1964, LIEBIGS ANN CHEM, V674, P218; Schreiber K, 2006, J BACTERIOL, V188, P659, DOI 10.1128/JB.188.2.659-668.2006; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; SIMMEN HP, 1994, INFECTION, V22, P386, DOI 10.1007/BF01715494; Slavetinsky CJ, 2012, ANTIMICROB AGENTS CH, V56, P3492, DOI 10.1128/AAC.00370-12; Sohlenkamp C, 2007, MOL PLANT MICROBE IN, V20, P1421, DOI 10.1094/MPMI-20-11-1421; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Thedieck K, 2006, MOL MICROBIOL, V62, P1325, DOI 10.1111/j.1365-2958.2006.05452.x; Thoma S, 2009, FEMS MICROBIOL LETT, V294, P127, DOI 10.1111/j.1574-6968.2009.01556.x; Uchiyama I, 2010, NUCLEIC ACIDS RES, V38, pD361, DOI 10.1093/nar/gkp948; Vinuesa P, 2003, MOL PLANT MICROBE IN, V16, P159, DOI 10.1094/MPMI.2003.16.2.159; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; Weber MHW, 2001, MOL MICROBIOL, V39, P1321, DOI 10.1046/j.1365-2958.2001.02322.x; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; WIRAWAN IGP, 1993, J BACTERIOL, V175, P3208, DOI 10.1128/JB.175.10.3208-3212.1993; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	57	23	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 23	2013	288	34					24717	24730		10.1074/jbc.M113.482935	http://dx.doi.org/10.1074/jbc.M113.482935			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NW	23792962	hybrid, Green Published			2022-12-25	WOS:000330612300038
J	Sorino, C; Bruno, T; Desantis, A; Di Certo, MG; Iezzi, S; De Nicola, F; Catena, V; Floridi, A; Chessa, L; Passananti, C; Cundari, E; Fanciulli, M				Sorino, Cristina; Bruno, Tiziana; Desantis, Agata; Di Certo, Maria Grazia; Iezzi, Simona; De Nicola, Francesca; Catena, Valeria; Floridi, Aristide; Chessa, Luciana; Passananti, Claudio; Cundari, Enrico; Fanciulli, Maurizio			Centrosomal Che-1 Protein Is Involved in the Regulation of Mitosis and DNA Damage Response by Mediating Pericentrin (PCNT)-dependent Chk1 Protein Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REGULATION; P53 TRANSCRIPTION; CHECKPOINT; ATM; PHOSPHORYLATION; SUPPRESSION; PARTNER; BIOLOGY; GROWTH	To combat threats posed by DNA damage, cells have evolved mechanisms, collectively termed DNA damage response (DDR). These mechanisms detect DNA lesions, signal their presence, and promote their repair. Centrosomes integrate G(2)/M checkpoint control and repair signals in response to genotoxic stress, acting as an efficient control mechanism when G(2)/M checkpoint function fails and mitosis begins in the presence of damaged DNA. Che-1 is an RNA polymerase II-binding protein involved in the regulation of gene transcription, induction of cell proliferation, and DDR. Here we provide evidence that in addition to its nuclear localization, Che-1 localizes at interphase centrosomes, where it accumulates following DNA damage or spindle poisons. We show that Che-1 depletion generates supernumerary centrosomes, multinucleated cells, and multipolar spindle formation. Notably, Che-1 depletion abolishes the ability of Chk1 to bind pericentrin and to localize at centrosomes, which, in its turn, deregulates the activation of centrosomal cyclin B-Cdk1 and advances entry into mitosis. Our results reinforce the notion that Che-1 plays an important role in DDR and that its contribution seems to be relevant for the spindle assembly checkpoint.	[Sorino, Cristina; Bruno, Tiziana; Desantis, Agata; Iezzi, Simona; De Nicola, Francesca; Floridi, Aristide; Fanciulli, Maurizio] Regina Elena Inst Canc Res, Mol Med Area, Lab Epigenet, I-00144 Rome, Italy; [Di Certo, Maria Grazia] IRCCS Santa Lucia Fdn, CNR IBCN, I-00143 Rome, Italy; [Catena, Valeria] Univ Aquila, Dept Expt Med, I-67100 Laquila, Italy; [Chessa, Luciana] Univ Roma La Sapienza, Dept Clin & Mol Med, I-00161 Rome, Italy; [Passananti, Claudio] Univ Roma La Sapienza, Dept Mol Med, CNR IBPM, I-00161 Rome, Italy; [Cundari, Enrico] Univ Roma La Sapienza, Dept Genet, CNR IBPM, I-00185 Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); IRCCS Santa Lucia; University of L'Aquila; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	Fanciulli, M (corresponding author), Regina Elena Inst Canc Res, Mol Med Area, Lab Epigenet, Via E Chianesi 53, I-00144 Rome, Italy.	fanciulli@ifo.it	fanciulli, maurizio/ABH-6745-2020; bruno, tiziana/AAC-4913-2022; Passananti, Claudio/K-9593-2016; Maria Grazia, Di Certo/AAW-8769-2020; Sorino, Cristina/AAB-9941-2022; Catena, Valeria/AAA-3267-2021; Iezzi, Simona/AAA-3275-2021; De Nicola, Francesca/AAC-6887-2022	bruno, tiziana/0000-0003-0352-4523; Sorino, Cristina/0000-0002-6100-289X; Catena, Valeria/0000-0002-9639-1944; Iezzi, Simona/0000-0002-7484-5861; De Nicola, FRANCESCA/0000-0002-2187-7544; PASSANANTI, CLAUDIO/0000-0002-9288-5736	Italian Association for Cancer Research (AIRC); AIRC	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); AIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Italian Association for Cancer Research (AIRC) (to M. F.).; Recipient of an AIRC fellowship.	Blomberg-Wirschell M, 1998, METHOD ENZYMOL, V298, P228, DOI 10.1016/S0076-6879(98)98022-3; Bruno T, 2008, CELL DEATH DIFFER, V15, P515, DOI 10.1038/sj.cdd.4402284; Bruno T, 2002, CANCER CELL, V2, P387, DOI 10.1016/S1535-6108(02)00182-4; Bruno T, 2006, CANCER CELL, V10, P473, DOI 10.1016/j.ccr.2006.10.012; Bruno T, 2010, CANCER CELL, V18, P122, DOI 10.1016/j.ccr.2010.05.027; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Castedo Maria, 2004, Journal de la Societe de Biologie, V198, P97; Chen D, 2004, J BIOL CHEM, V279, P4829, DOI 10.1074/jbc.M311196200; Chila R, 2013, CELL CYCLE, V12, P1083, DOI 10.4161/cc.24090; Ciciarello M, 2001, J BIOL CHEM, V276, P19205, DOI 10.1074/jbc.M009528200; Collura A, 2005, MOL CELL BIOL, V25, P7889, DOI 10.1128/MCB.25.17.7889-7899.2005; Diviani D, 2000, CURR BIOL, V10, P417, DOI 10.1016/S0960-9822(00)00422-X; Dotiwala F, 2010, CURR BIOL, V20, P328, DOI 10.1016/j.cub.2009.12.033; Fanciulli M, 2000, FASEB J, V14, P904, DOI 10.1096/fasebj.14.7.904; Felten A, 2007, BIOL CHEM, V388, P569, DOI 10.1515/BC.2007.073; Floridi A, 2007, CELL CYCLE, V6, P804, DOI 10.4161/cc.6.7.4043; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hopker K, 2012, EMBO J, V31, P3961, DOI 10.1038/emboj.2012.236; Ishigaki S, 2010, CELL DEATH DIFFER, V17, P774, DOI 10.1038/cdd.2009.175; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kim EM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000015; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Krause DR, 2003, ONCOGENE, V22, P5927, DOI 10.1038/sj.onc.1206691; Loffler H, 2007, CELL CYCLE, V6, P2541; Marx J, 2001, SCIENCE, V292, P426, DOI 10.1126/science.292.5516.426; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Oricchio E, 2006, CELL CYCLE, V5, P88, DOI 10.4161/cc.5.1.2269; Passananti C, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-21; Robert A, 2007, J CELL SCI, V120, P628, DOI 10.1242/jcs.03366; Salisbury JL, 1999, BIOL CELL, V91, P451, DOI 10.1016/S0248-4900(99)80086-0; Tibelius A, 2009, J CELL BIOL, V185, P1149, DOI 10.1083/jcb.200810159; Tritarelli A, 2004, MOL BIOL CELL, V15, P3751, DOI 10.1091/mbc.E03-12-0900; Wang YM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-8; Wilsker D, 2008, P NATL ACAD SCI USA, V105, P20752, DOI 10.1073/pnas.0806917106; Yang CY, 2012, DNA REPAIR, V11, P185, DOI 10.1016/j.dnarep.2011.10.018; Zhang SS, 2007, J CELL BIOCHEM, V101, P451, DOI 10.1002/jcb.21195	37	15	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23348	23357		10.1074/jbc.M113.465302	http://dx.doi.org/10.1074/jbc.M113.465302			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23798705	hybrid, Green Published			2022-12-25	WOS:000330598200039
J	Park, JT; Kato, M; Yuan, H; Castro, N; Lanting, L; Wang, M; Natarajan, R				Park, Jung Tak; Kato, Mitsuo; Yuan, Hang; Castro, Nancy; Lanting, Linda; Wang, Mei; Natarajan, Rama			FOG2 Protein Down-regulation by Transforming Growth Factor-beta 1-induced MicroRNA-200b/c Leads to Akt Kinase Activation and Glomerular Mesangial Hypertrophy Related to Diabetic Nephropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-INDUCED HYPERTROPHY; INDUCED COLLAGEN EXPRESSION; TGF-BETA; KIDNEY-DISEASE; PHOSPHOINOSITIDE 3-KINASE; FIBRONECTIN EXPRESSION; TRANSCRIPTOME ANALYSIS; SIGNAL-TRANSDUCTION; RENAL HYPERTROPHY; CELL HYPERTROPHY	Glomerular hypertrophy is a hallmark of diabetic nephropathy. Akt kinase activated by transforming growth factor-beta 1 (TGF-beta) plays an important role in glomerular mesangial hypertrophy. However, the mechanisms of Akt activation by TGF-beta are not fully understood. Recently, miR-200 and its target FOG2 were reported to regulate the activity of phosphatidylinositol 3-kinase (the upstream activator of Akt) in insulin signaling. Here, we show that TGF-beta activates Akt in glomerular mesangial cells by inducing miR-200b and miR-200c, both of which target FOG2, an inhibitor of phosphatidylinositol 3-kinase activation. FOG2 expression was reduced in the glomeruli of diabetic mice as well as TGF-beta-treated mouse mesangial cells (MMC). FOG2 knockdown by siRNAs in MMC activated Akt and increased the protein content/cell ratio suggesting hypertrophy. A significant increase of miR-200b/c levels was detected in diabetic mouse glomeruli and TGF-beta-treated MMC. Transfection of MMC with miR-200b/c mimics significantly decreased the expression of FOG2. Conversely, miR-200b/c inhibitors attenuated TGF-beta-induced decrease in FOG2 expression. Furthermore, miR-200b/c mimics increased the protein content/cell ratio, whereas miR-200b/c inhibitors abrogated the TGF-beta-induced increase in protein content/cell. In addition, down-regulation of FOG2 by miR-200b/c could activate not only Akt but also ERK, which was also through PI3K activation. These data suggest a new mechanism for TGF-beta induced Akt activation through FOG2 down-regulation by miR-200b/c, which can lead to glomerular mesangial hypertrophy in the progression of diabetic nephropathy.	[Park, Jung Tak; Kato, Mitsuo; Yuan, Hang; Castro, Nancy; Lanting, Linda; Wang, Mei; Natarajan, Rama] Beckman Res Inst City Hope, Dept Diabet, Div Mol Diabet Res, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Natarajan, R (corresponding author), Beckman Res Inst City Hope, Dept Diabet, 1500 E Duarte Rd, Duarte, CA 91010 USA.	RNatarajan@coh.org	Kato, Mitsuo/D-5411-2009	Park, Jung Tak/0000-0002-2325-8982	National Institutes of Health [DK081705, DK058191]; NIDDK; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081705, R01DK058191] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK081705 and DK058191 (to R. N.) and an NIDDK supplement (for N. C.). This work was also supported by a mentor-based post-doctoral fellowship from the American Diabetes Association (to N. C.).	Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Brosius Frank C, 2010, Expert Rev Endocrinol Metab, V5, P51; Caja L, 2007, CELL SIGNAL, V19, P683, DOI 10.1016/j.cellsig.2006.09.002; Choudhury GG, 2004, CELL SIGNAL, V16, P31, DOI 10.1016/S0898-6568(03)00094-9; Chuang TD, 2007, KIDNEY INT, V71, P867, DOI 10.1038/sj.ki.5002155; Chung ACK, 2010, J AM SOC NEPHROL, V21, P1317, DOI 10.1681/ASN.2010020134; Dai Y, 2009, RHEUMATOL INT, V29, P749, DOI 10.1007/s00296-008-0758-6; Dey N, 2011, J BIOL CHEM, V286, P25586, DOI 10.1074/jbc.M110.208066; Fossett N, 2001, TRENDS CARDIOVAS MED, V11, P185, DOI 10.1016/S1050-1738(01)00092-5; Fossett N, 2001, P NATL ACAD SCI USA, V98, P7342, DOI 10.1073/pnas.131215798; Fujita H, 2004, AM J PHYSIOL-RENAL, V286, pF120, DOI 10.1152/ajprenal.00351.2002; Garcia Z, 2006, EMBO J, V25, P655, DOI 10.1038/sj.emboj.7600967; Gewin L, 2012, SEMIN NEPHROL, V32, P228, DOI 10.1016/j.semnephrol.2012.04.001; Goruppi S, 2002, EMBO J, V21, P5427, DOI 10.1093/emboj/cdf535; Haneda M, 1997, DIABETES, V46, P847, DOI 10.2337/diabetes.46.5.847; Hayashida T, 1999, KIDNEY INT, V56, P1710, DOI 10.1046/j.1523-1755.1999.00733.x; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hoffman BB, 1998, KIDNEY INT, V54, P1107, DOI 10.1046/j.1523-1755.1998.00119.x; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Kantharidis P, 2011, DIABETES, V60, P1832, DOI 10.2337/db11-0082; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kato M, 2006, J AM SOC NEPHROL, V17, P3325, DOI 10.1681/ASN.2006070754; Kato M, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003389; Kato M, 2012, EXP CELL RES, V318, P993, DOI 10.1016/j.yexcr.2012.02.034; Kato M, 2011, KIDNEY INT, V80, P358, DOI 10.1038/ki.2011.43; Kato M, 2010, J BIOL CHEM, V285, P34004, DOI 10.1074/jbc.M110.165027; Kato M, 2009, CLIN J AM SOC NEPHRO, V4, P1255, DOI 10.2215/CJN.00520109; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kim YK, 2012, MOL CELL, V46, P893, DOI 10.1016/j.molcel.2012.05.036; Lee HT, 2008, AM J PHYSIOL-RENAL, V294, pF371, DOI 10.1152/ajprenal.00277.2007; Lin CL, 2006, KIDNEY INT, V69, P1593, DOI 10.1038/sj.ki.5000329; Long JY, 2011, J BIOL CHEM, V286, P11837, DOI 10.1074/jbc.M110.194969; Lorenzen JM, 2011, NAT REV NEPHROL, V7, P286, DOI 10.1038/nrneph.2011.26; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Nanni S, 2006, MOL CANCER RES, V4, P79, DOI 10.1158/1541-7786.MCR-05-0098; Natarajan R, 2012, J CARDIOVASC TRANSL, V5, P413, DOI 10.1007/s12265-012-9368-5; OBryan GT, 1997, SEMIN NEPHROL, V17, P93; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Schiffer M, 2004, J BIOL CHEM, V279, P37004, DOI 10.1074/jbc.M403534200; Schnaper HW, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341126; SHARMA K, 1994, AM J PHYSIOL-RENAL, V267, pF1094, DOI 10.1152/ajprenal.1994.267.6.F1094; SHARMA K, 1995, DIABETES, V44, P1139, DOI 10.2337/diabetes.44.10.1139; Sun YQ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh186; Tian ZM, 2008, GENOME RES, V18, P404, DOI 10.1101/gr.6587008; Valderrama-Carvajal H, 2002, NAT CELL BIOL, V4, P963, DOI 10.1038/ncb885; Wachi S, 2005, BIOINFORMATICS, V21, P4205, DOI 10.1093/bioinformatics/bti688; Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055; Wang B, 2011, DIABETES, V60, P280, DOI 10.2337/db10-0892; Wang G, 2010, LAB INVEST, V90, P98, DOI 10.1038/labinvest.2009.118; Wang G, 2010, AM J HYPERTENS, V23, P78, DOI 10.1038/ajh.2009.208; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Wolf G, 2003, DIABETOLOGIA, V46, P1090, DOI 10.1007/s00125-003-1163-z; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181; YAMAMOTO T, 1993, P NATL ACAD SCI USA, V90, P1814, DOI 10.1073/pnas.90.5.1814; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200; Zhu YQ, 2005, DIABETES, V54, P1976, DOI 10.2337/diabetes.54.7.1976; ZIYADEH FN, 1993, AM J KIDNEY DIS, V22, P736, DOI 10.1016/S0272-6386(12)80440-9; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097	64	64	68	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22469	22480		10.1074/jbc.M113.453043	http://dx.doi.org/10.1074/jbc.M113.453043			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23788640	Green Published, hybrid			2022-12-25	WOS:000330596300028
J	Clendenning, M; Young, JP; Walsh, MD; Woodall, S; Arnold, J; Jenkins, M; Win, AK; Hopper, JL; Sweet, K; Gallinger, S; Rosty, C; Parry, S; Buchanan, DD				Clendenning, Mark; Young, Joanne P.; Walsh, Michael D.; Woodall, Sonja; Arnold, Julie; Jenkins, Mark; Win, Aung Ko; Hopper, John L.; Sweet, Kevin; Gallinger, Steven; Rosty, Christophe; Parry, Susan; Buchanan, Daniel D.			Germline Mutations in the Polyposis-Associated Genes BMPR1A, SMAD4, PTEN, MUTYH and GREM1 Are Not Common in Individuals with Serrated Polyposis Syndrome	PLOS ONE			English	Article							COLORECTAL-CANCER PATIENTS; HYPERPLASTIC POLYPOSIS; MOLECULAR CLASSIFICATION; RISK; PHENOTYPE; VARIANTS; IDENTIFICATION; EXPRESSION; RELATIVES; SERIES	Background: Recent reports have observed that individuals with serrated polyps, some of whom meet the clinical diagnostic criteria for Serrated Polyposis Syndrome (SPS), are among those who carry germline mutations in genes associated with polyposis syndromes including; (1) genes known to underlie hamartomatous polyposes (SMAD4, BMPR1A, and PTEN), (2) MUTYH-associated polyposis and (3) GREM1 in Hereditary Mixed Polyposis Syndrome (HMPS). The aim of this study was to characterise individuals fulfilling the current WHO criteria for SPS for germline mutations in these polyposis-associated genes. Methods: A total of 65 individuals with SPS (fulfilling WHO criteria 1 or 3), were recruited to the Genetics of Serrated Neoplasia study between 2000 and 2012, through multiple Genetics or Family Cancer Clinics within Australia, or from the New Zealand Familial Gastrointestinal Cancer Service. Individuals with SPS were tested for coding mutations and large deletions in the PTEN, SMAD4, and BMPR1A genes, for the MUTYH variants in exons 7 (Y179C) and 13 (G396D), and for the duplication upstream of GREM1. Results: We found no variants that were likely to be deleterious germline mutations in the SPS cases in the PTEN, SMAD4, and BMPR1A genes. A novel variant in intron 2 (c.164+223T.C) of PTEN was identified in one individual and was predicted by in silico analysis to have no functional consequences. One further individual with SPS was found to be mono-allelic for the MUTYH G396D mutation. No individuals carried the recently reported duplication within GREM1. Conclusions: Genes involved in the gastrointestinal hamartomatous polyposis, Hereditary Mixed Polyposis Syndrome and MUTYH-associated polyposis syndromes are not commonly altered in individuals with SPS.	[Clendenning, Mark; Young, Joanne P.; Walsh, Michael D.; Rosty, Christophe; Buchanan, Daniel D.] Queensland Inst Med Res, Canc & Populat Studies Grp, Brisbane, Qld 4006, Australia; [Walsh, Michael D.] Sullivan Nicolaides Pathol, Dept Histopathol, Brisbane, Qld, Australia; [Woodall, Sonja; Arnold, Julie; Parry, Susan] Auckland Hosp, New Zealand Familial Gastrointestinal Canc Serv, Auckland, New Zealand; [Jenkins, Mark; Win, Aung Ko; Hopper, John L.] Univ Melbourne, Ctr MEGA Epidemiol, Melbourne, Vic, Australia; [Sweet, Kevin] Ohio State Univ, Med Ctr, Div Human Genet, Columbus, OH 43210 USA; [Gallinger, Steven] Canc Care Ontario, Toronto, ON, Canada; [Gallinger, Steven] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Gallinger, Steven] Mt Sinai Hosp, Zane Cohen Ctr Digest Dis, Toronto, ON M5G 1X5, Canada; [Rosty, Christophe] Univ Queensland, Dept Mol & Cellular Pathol, Brisbane, Qld, Australia; [Rosty, Christophe] Envoi Specialist Pathologists, Brisbane, Qld, Australia; [Parry, Susan] Middlemore Hosp, Dept Gastroenterol & Hepatol, Auckland 6, New Zealand	QIMR Berghofer Medical Research Institute; Auckland City Hospital; University of Melbourne; University System of Ohio; Ohio State University; Cancer Care Ontario; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Queensland	Buchanan, DD (corresponding author), Queensland Inst Med Res, Canc & Populat Studies Grp, Brisbane, Qld 4006, Australia.	Daniel.Buchanan@qimr.edu.au	Young, Joanne P/H-7774-2014; Jenkins, Mark/P-7803-2015; Win, Aung K./J-6204-2015; Rosty, Christophe/F-1796-2010; Gallinger, Steven/E-4575-2013	Jenkins, Mark/0000-0002-8964-6160; Win, Aung K./0000-0002-2794-5261; Young, Joanne/0000-0002-1514-1522; Buchanan, Daniel/0000-0003-2225-6675; Rosty, Christophe/0000-0001-7671-2651; Woodall, Sonja/0000-0002-9910-5560	Cancer Council Queensland [1006290]; National Cancer Institute [RO1 CA123010]; NATIONAL CANCER INSTITUTE [U24CA097735, U01CA097735] Funding Source: NIH RePORTER	Cancer Council Queensland(Cancer Council Queensland); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from Cancer Council Queensland (1006290) and National Cancer Institute (RO1 CA123010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boparai KS, 2010, GUT, V59, P1222, DOI 10.1136/gut.2009.200741; Boparai KS, 2010, GUT, V59, P1094, DOI 10.1136/gut.2009.185884; Boparai KS, 2008, GASTROENTEROLOGY, V135, P2014, DOI 10.1053/j.gastro.2008.09.020; Buchanan D, 2009, GASTROENTEROLOGY, V136, P2407, DOI 10.1053/j.gastro.2008.12.076; Buchanan DD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011636; Buchanan DD, 2010, INT J COLORECTAL DIS, V25, P703, DOI 10.1007/s00384-010-0907-8; Carvajal-Carmona LG, 2007, J PATHOL, V212, P378, DOI 10.1002/path.2187; Cheah PY, 2009, AM J GASTROENTEROL, V104, P3027, DOI 10.1038/ajg.2009.542; Clendenning M, 2011, FAM CANCER, V10, P297, DOI 10.1007/s10689-011-9427-0; English DR, 2008, CANCER EPIDEM BIOMAR, V17, P1774, DOI 10.1158/1055-9965.EPI-08-0091; Heald B, 2010, GASTROENTEROLOGY, V139, P1927, DOI 10.1053/j.gastro.2010.06.061; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Jaeger E, 2012, NAT GENET, V44, P699, DOI 10.1038/ng.2263; Kalady MF, 2011, DIS COLON RECTUM, V54, P164, DOI 10.1007/DCR.0b013e3181fd4c15; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Mongin C, 2012, CLIN GENET, V81, P38, DOI 10.1111/j.1399-0004.2011.01676.x; Morak M, 2010, CLIN GENET, V78, P353, DOI 10.1111/j.1399-0004.2010.01478.x; Nieminen TT, 2011, GASTROENTEROLOGY, V141, pE23, DOI 10.1053/j.gastro.2011.03.063; Rosty C, 2012, AM J SURG PATHOL; Rosty C, 2011, PATHOLOG RES INT, V2011, DOI DOI 10.4061/2011/157073; Rosty C, 2012, AM J SURG PATHOL, V36, P876, DOI 10.1097/PAS.0b013e31824e133f; Snover D, 2010, WHO CLASSIFICATION T; Spjut H, 1977, Pathol Annu, V12 Pt 1, P147; Stanich PP, 2011, MAYO CLIN PROC, V86, P489, DOI 10.4065/mcp.2010.0816; Sweet K, 2005, JAMA-J AM MED ASSOC, V294, P2465, DOI 10.1001/jama.294.19.2465; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Venkatachalam R, 2011, INT J CANCER, V129, P1635, DOI 10.1002/ijc.25821; Walsh MD, 2009, FAM CANCER, V8, P313, DOI 10.1007/s10689-009-9238-8; Ward RL, 2013, GENET MED, V15, P25, DOI 10.1038/gim.2012.91; Whitelaw SC, 1997, GASTROENTEROLOGY, V112, P327, DOI 10.1053/gast.1997.v112.pm9024286; Win AK, 2012, AM J GASTROENTEROL, V107, P770, DOI 10.1038/ajg.2012.52; Yeoman Andrew, 2007, N Z Med J, V120, pU2827; Zbuk KM, 2007, NAT CLIN PRACT GASTR, V4, P492, DOI 10.1038/ncpgasthep0902	33	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66705	10.1371/journal.pone.0066705	http://dx.doi.org/10.1371/journal.pone.0066705			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805267	Green Published, gold			2022-12-25	WOS:000320846500095
J	Meitern, R; Sild, E; Lind, MA; Manniste, M; Sepp, T; Karu, U; Horak, P				Meitern, Richard; Sild, Elin; Lind, Mari-Ann; Maenniste, Marju; Sepp, Tuul; Karu, Ulvi; Hoerak, Peeter			Effects of Endotoxin and Psychological Stress on Redox Physiology, Immunity and Feather Corticosterone in Greenfinches	PLOS ONE			English	Article							TOTAL ANTIOXIDANT CAPACITY; OXIDATIVE STRESS; TRADE-OFFS; ECOLOGICAL IMMUNOLOGY; LIFE-HISTORY; IN-VIVO; LIPOPOLYSACCHARIDE; RESPONSES; CONSEQUENCES; COLORATION	Assessment of costs accompanying activation of immune system and related neuroendocrine pathways is essential for understanding the selective forces operating on these systems. Here we attempted to detect such costs in terms of disruption to redox balance and interference between different immune system components in captive wild-caught greenfinches (Carduelis chloris). Study birds were subjected to an endotoxin-induced inflammatory challenge and temporary exposure to a psychological stressor (an image of a predator) in a 2*2 factorial experiment. Injection of bacterial endotoxin resulted in up-regulation of two markers of antioxidant protection - erythrocyte glutathione, and plasma oxygen radical absorbance (OXY). These findings suggest that inflammatory responses alter redox homeostasis. However, no effect on markers of oxidative damage to proteins or DNA in erythrocytes could be detected. We found no evidence that the endotoxin injection interfered with antibody production against Brucella abortus antigen or the intensity of chronic coccidiosis. The hypothesis of within-immune system trade-offs as a cost of immunity was thus not supported in our model system. We showed for the first time that administration of endotoxin can reduce the level of corticosterone deposited into feathers. This finding suggests a down-regulation of the corticosterone secretion cascade due to an endotoxin-induced immune response, a phenomenon that has not been reported previously. Exposure to the predator image did not affect any of the measured physiological parameters.	[Meitern, Richard; Sild, Elin; Lind, Mari-Ann; Maenniste, Marju; Sepp, Tuul; Karu, Ulvi; Hoerak, Peeter] Univ Tartu, Dept Zool, Inst Ecol & Earth Sci, EE-50090 Tartu, Estonia; [Sild, Elin] Lund Univ, Dept Biol, Mol Ecol & Evolut Lab, Lund, Sweden	University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Lund University	Horak, P (corresponding author), Univ Tartu, Dept Zool, Inst Ecol & Earth Sci, Ulikooli 18, EE-50090 Tartu, Estonia.	horak@ut.ee	Horak, Peeter/A-2351-2009	Horak, Peeter/0000-0002-1442-9903; Meitern, Richard/0000-0002-2600-3002; Sepp, Tuul/0000-0002-8677-7069	Estonian Science Foundation [7737]; Estonian Ministry of Education and Science [0180004s09]; European Union through the European Regional Development Fund (Centre of Excellence FIBIR)	Estonian Science Foundation; Estonian Ministry of Education and Science(Ministry of Education and Research, Estonia); European Union through the European Regional Development Fund (Centre of Excellence FIBIR)(European Commission)	The study was financed by Estonian Science Foundation grants #7737, the Estonian Ministry of Education and Science (target-financing project #0180004s09) and by the European Union through the European Regional Development Fund (Centre of Excellence FIBIR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-El-Saad AASA, 2007, IMMUNOBIOLOGY, V212, P179, DOI 10.1016/j.imbio.2007.01.006; Ardia DR, 2011, FUNCT ECOL, V25, P61, DOI 10.1111/j.1365-2435.2010.01759.x; Baze MM, 2011, J EXP BIOL, V214, P3255, DOI 10.1242/jeb.054544; Bortolotti GR, 2008, FUNCT ECOL, V22, P494, DOI 10.1111/j.1365-2435.2008.01387.x; Bradley JE, 2008, PARASITOLOGY, V135, P807, DOI 10.1017/S0031182008000322; Casagrande S, 2012, COMP BIOCHEM PHYS A, V163, P296, DOI 10.1016/j.cbpa.2012.07.018; Cohen A, 2007, COMP BIOCHEM PHYS B, V147, P110, DOI 10.1016/j.cbpb.2006.12.015; Collins AR, 2009, MUTAT RES-REV MUTAT, V681, P24, DOI 10.1016/j.mrrev.2007.10.002; Costantini D, 2008, ECOL LETT, V11, P1238, DOI 10.1111/j.1461-0248.2008.01246.x; Costantini D, 2006, COMP BIOCHEM PHYS A, V145, P137, DOI 10.1016/j.cbpa.2006.06.002; Costantini D, 2011, J COMP PHYSIOL B, V181, P447, DOI 10.1007/s00360-011-0566-2; Costantini D, 2011, METHODS ECOL EVOL, V2, P321, DOI 10.1111/j.2041-210X.2010.00080.x; Costantini D, 2010, ECOL LETT, V13, P1435, DOI 10.1111/j.1461-0248.2010.01531.x; Cote J, 2010, J EXP BIOL, V213, P271, DOI 10.1242/jeb.035188; Cyr NE, 2007, GEN COMP ENDOCR, V154, P59, DOI 10.1016/j.ygcen.2007.06.016; Cyr NE, 2009, GEN COMP ENDOCR, V161, P295, DOI 10.1016/j.ygcen.2009.02.001; Degen WGJ, 2005, VET MICROBIOL, V105, P163, DOI 10.1016/j.vetmic.2004.12.001; DEMAS GE, 2011, ECOIMMUNOLOGY; Dhabhar FS, 1997, BRAIN BEHAV IMMUN, V11, P286, DOI 10.1006/brbi.1997.0508; Dickens MJ, 2009, P R SOC B, V276, P2051, DOI 10.1098/rspb.2008.1778; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Fair JM, 1999, P ROY SOC B-BIOL SCI, V266, P1735, DOI 10.1098/rspb.1999.0840; Freeman-Gallant CR, 2011, BIOL LETTERS, V7, P429, DOI 10.1098/rsbl.2010.1186; French SS, 2009, INTEGR COMP BIOL, V49, P246, DOI 10.1093/icb/icp032; Galvan I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003335; Gasparini J, 2009, J EVOLUTION BIOL, V22, P2348, DOI 10.1111/j.1420-9101.2009.01831.x; Goutte A, 2010, GEN COMP ENDOCR, V167, P246, DOI 10.1016/j.ygcen.2010.03.018; Graham AL, 2005, ANNU REV ECOL EVOL S, V36, P373, DOI 10.1146/annurev.ecolsys.36.102003.152622; Graham AL, 2002, Q REV BIOL, V77, P409, DOI 10.1086/344414; Graham AL, 2011, FUNCT ECOL, V25, P5, DOI 10.1111/j.1365-2435.2010.01777.x; Halliwell B., 2007, FREE RADICALS BIOL M; HAMPTON RR, 1994, BEHAVIOUR, V130, P41, DOI 10.1163/156853994X00136; Horak P, 2006, J EVOLUTION BIOL, V19, P277, DOI 10.1111/j.1420-9101.2005.00988.x; Horak P, 2004, J ANIM ECOL, V73, P935, DOI 10.1111/j.0021-8790.2004.00870.x; Horak P, 2006, J EXP BIOL, V209, P4329, DOI 10.1242/jeb.02502; Horak P, 2010, J EXP BIOL, V213, P2225, DOI 10.1242/jeb.042085; Isaksson C, 2011, BIOSCIENCE, V61, P194, DOI 10.1525/bio.2011.61.3.5; JAESCHKE H, 1992, AM J PHYSIOL, V263, pG60, DOI 10.1152/ajpgi.1992.263.1.G60; Khatun MM, 2009, J INFECT DEV COUNTR, V3, P392; Klasing K.C., 2004, ACTA ZOOL SINICA, V50, P961; Krams I, 2012, COMP BIOCHEM PHYS A, V161, P422, DOI 10.1016/j.cbpa.2011.12.018; Larcombe SD, 2008, J EXP BIOL, V211, P2859, DOI 10.1242/jeb.017970; Lattin CR, 2011, J AVIAN BIOL, V42, P247, DOI 10.1111/j.1600-048X.2010.05310.x; Laugero KD, 2000, AM J PHYSIOL-ENDOC M, V279, pE44, DOI 10.1152/ajpendo.2000.279.1.E44; Lee KA, 2006, INTEGR COMP BIOL, V46, P1000, DOI 10.1093/icb/icl049; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lohmus M, 2011, COMP BIOCHEM PHYS A, V158, P560, DOI 10.1016/j.cbpa.2011.01.002; Lynn SE, 2010, GEN COMP ENDOCR, V165, P337, DOI 10.1016/j.ygcen.2009.07.018; Manniste M, 2013, ETHOLOGY, V119, P581, DOI 10.1111/eth.12099; Martin LB, 2006, FUNCT ECOL, V20, P630, DOI 10.1111/j.1365-2435.2006.01138.x; Martin LB, 2011, J EXP BIOL, V214, P2579, DOI 10.1242/jeb.057216; Martin LB, 2009, GEN COMP ENDOCR, V163, P70, DOI 10.1016/j.ygcen.2009.03.008; Meitern R, 2013, J EXP BIOL, V216, P2713, DOI 10.1242/jeb.087528; Miller GE, 2002, HEALTH PSYCHOL, V21, P531, DOI 10.1037//0278-6133.21.6.531; Mireles AJ, 2005, POULTRY SCI, V84, P553, DOI 10.1093/ps/84.4.553; Muller C, 2009, GEN COMP ENDOCR, V160, P59, DOI 10.1016/j.ygcen.2008.10.018; Owen-Ashley NT, 2007, J ORNITHOL, V148, pS583, DOI 10.1007/s10336-007-0197-2; Owen-Ashley NT, 2006, HORM BEHAV, V49, P15, DOI 10.1016/j.yhbeh.2005.04.009; Parmentier HK, 2004, POULTRY SCI, V83, P1133, DOI 10.1093/ps/83.7.1133; Patterson SH, 2011, ANIM BEHAV, V81, P1239, DOI 10.1016/j.anbehav.2011.03.012; Portoles MT, 1996, MOL CELL BIOCHEM, V159, P115, DOI 10.1007/BF00420913; Prior RL, 1999, FREE RADICAL BIO MED, V27, P1173, DOI 10.1016/S0891-5849(99)00203-8; Pursall E. R., 2012, ECOIMMUNOLOGY, P530; Qujeq D, 2005, INT J DIABETES METAB, V13, P96; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Saks L, 2006, FUNCT ECOL, V20, P75, DOI 10.1111/j.1365-2435.2006.01068.x; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sarv T, 2009, J AVIAN BIOL, V40, P569, DOI 10.1111/j.1600-048X.2009.04713.x; Segerstrom SC, 2007, CURR DIR PSYCHOL SCI, V16, P326, DOI 10.1111/j.1467-8721.2007.00522.x; Sepp T, 2012, PHYSIOL BIOCHEM ZOOL, V85, P299, DOI 10.1086/664827; Sepp T, 2011, EXP PARASITOL, V127, P651, DOI 10.1016/j.exppara.2010.12.004; Sepp T, 2010, PHYSIOL BIOCHEM ZOOL, V83, P276, DOI 10.1086/648580; Serra L, 2012, BEHAV ECOL SOCIOBIOL, V66, P697, DOI 10.1007/s00265-012-1318-3; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Sies H., 2007, ENCY STRESS, V2nd ed., P45, DOI DOI 10.1016/B978-012373947-6.00285-3; Sild E, 2011, BRAIN BEHAV IMMUN, V25, P1349, DOI 10.1016/j.bbi.2011.03.020; Sohn SH, 2012, POULTRY SCI, V91, P829, DOI 10.3382/ps.2011-01904; Sompamit K, 2009, EUR J PHARMACOL, V616, P192, DOI 10.1016/j.ejphar.2009.06.014; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Star L, 2008, POULTRY SCI, V87, P1031, DOI 10.3382/ps.2007-00143; Travers M, 2010, ECOL LETT, V13, P980, DOI 10.1111/j.1461-0248.2010.01488.x; van de Crommenacker J, 2010, J EXP BIOL, V213, P3527, DOI 10.1242/jeb.045591; van Oers K, 2007, J ORNITHOL, V148, pS185, DOI 10.1007/s10336-007-0200-y; WINGFIELD JC, 1992, J EXP ZOOL, V264, P419, DOI 10.1002/jez.1402640407; Xie H, 2000, POULTRY SCI, V79, P33, DOI 10.1093/ps/79.1.33; Zhang HJ, 2008, BRIT POULTRY SCI, V49, P213, DOI 10.1080/00071660801989836; Zhang WH, 2011, POULTRY SCI, V90, P2592, DOI 10.3382/ps.2011-01446	87	17	17	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67545	10.1371/journal.pone.0067545	http://dx.doi.org/10.1371/journal.pone.0067545			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805316	Green Submitted, Green Published, gold			2022-12-25	WOS:000320846500144
J	Monnerat, S; Costa, CIA; Forkert, AC; Benz, C; Hamilton, A; Tetley, L; Burchmore, R; Novo, C; Mottram, JC; Hammarton, TC				Monnerat, Severine; Costa, Cristina I. Almeida; Forkert, Andrea C.; Benz, Corinna; Hamilton, Alana; Tetley, Laurence; Burchmore, Richard; Novo, Carlos; Mottram, Jeremy C.; Hammarton, Tansy C.			Identification and Functional Characterisation of CRK12:CYC9, a Novel Cyclin-Dependent Kinase (CDK)-Cyclin Complex in Trypanosoma brucei	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; BLOOD-STREAM FORMS; POLO-LIKE KINASE; CELL-CYCLE; PROTEIN-KINASES; INDUCIBLE EXPRESSION; TRANSCRIPTION FACTOR; RNA INTERFERENCE; PROCYCLIC FORM; TARGETS	The protozoan parasite, Trypanosoma brucei, is spread by the tsetse fly and causes trypanosomiasis in humans and animals. Both the life cycle and cell cycle of the parasite are complex. Trypanosomes have eleven cdc2-related kinases (CRKs) and ten cyclins, an unusually large number for a single celled organism. To date, relatively little is known about the function of many of the CRKs and cyclins, and only CRK3 has previously been shown to be cyclin-dependent in vivo. Here we report the identification of a previously uncharacterised CRK:cyclin complex between CRK12 and the putative transcriptional cyclin, CYC9. CRK12:CYC9 interact to form an active protein kinase complex in procyclic and bloodstream T. brucei. Both CRK12 and CYC9 are essential for the proliferation of bloodstream trypanosomes in vitro, and we show that CRK12 is also essential for survival of T. brucei in a mouse model, providing genetic validation of CRK12:CYC9 as a novel drug target for trypanosomiasis. Further, functional characterisation of CRK12 and CYC9 using RNA interference reveals roles for these proteins in endocytosis and cytokinesis, respectively.	[Monnerat, Severine; Forkert, Andrea C.; Hamilton, Alana; Mottram, Jeremy C.] Univ Glasgow, Inst Infect Immun & Inflammat, Wellcome Trust Ctr Mol Parasitol, Glasgow, Lanark, Scotland; [Costa, Cristina I. Almeida; Novo, Carlos] Univ Nova Lisboa, Inst Higiene & Med Trop, P-1200 Lisbon, Portugal; [Tetley, Laurence] Univ Glasgow, Sch Life Sci, Glasgow, Lanark, Scotland; [Costa, Cristina I. Almeida; Benz, Corinna; Burchmore, Richard; Hammarton, Tansy C.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	University of Glasgow; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; University of Glasgow; University of Glasgow	Mottram, JC (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Wellcome Trust Ctr Mol Parasitol, Glasgow, Lanark, Scotland.	Jeremy.Mottram@glasgow.ac.uk; Tansy.Hammarton@glasgow.ac.uk	Hammarton, Tansy/A-5632-2011; Benz, Corinna/AAD-8702-2021; Novo, Carlos/I-5537-2012	Hammarton, Tansy/0000-0002-0799-6600; Benz, Corinna/0000-0003-4367-2758; Novo, Carlos/0000-0003-3572-5426; Correia de Almeida Costa, Cristina Isabel/0000-0003-1733-2530; Hamilton, Alana/0000-0001-5704-2293; Burchmore, Richard/0000-0003-1663-9004; Mottram, Jeremy/0000-0001-5574-3766	Wellcome Trust [070231, 085349/Z/08/Z]; Swiss National Foundation [PBLA33-103364]; MRC [G120/1001, GO900239]; RCUK (Academic fellowship) [GR/T28003/01]; Fundacao para a Cieancia e Tecnologia, Portugal [SFRH/BD/40223/2007, PTDC/CVT/098183/2008]; MRC [G0900239] Funding Source: UKRI; Medical Research Council [G0900239, G120/1001] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Swiss National Foundation(Swiss National Science Foundation (SNSF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); RCUK (Academic fellowship); Fundacao para a Cieancia e Tecnologia, Portugal; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by grants from the Wellcome Trust (to JCM and TCH; reference number 070231), the Swiss National Foundation (to SM and JCM; reference number PBLA33-103364), the MRC (Career Development fellowship reference number G120/1001 and New Investigator Research Grant, reference number GO900239, both to TCH), RCUK (Academic fellowship reference number GR/T28003/01 to TCH) and Fundacao para a Cieancia e Tecnologia, Portugal (to CC: PhD Grant reference number SFRH/BD/40223/2007; and CN:Project Development Grant reference number PTDC/CVT/098183/2008). The Wellcome Trust Centre for Molecular Parasitology is supported by core funding from the Wellcome Trust [085349/Z/08/Z]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; Alsford S, 2008, MOL BIOCHEM PARASIT, V161, P76, DOI 10.1016/j.molbiopara.2008.05.006; Badjatia N, 2013, MOL CELL BIOL, V33, P1965, DOI 10.1128/MCB.00156-13; Barette C, 2001, ONCOGENE, V20, P551, DOI 10.1038/sj.onc.1204129; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Biebinger S, 1997, MOL BIOCHEM PARASIT, V85, P99, DOI 10.1016/S0166-6851(96)02815-0; Bingham J, 2000, BIOINFORMATICS, V16, P660, DOI 10.1093/bioinformatics/16.7.660; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; Cho S, 2010, CELL CYCLE, V9, P1697, DOI 10.4161/cc.9.9.11346; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Enserink JM, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-11; Field MC, 2004, MICROSC MICROANAL, V10, P621, DOI 10.1017/S1431927604040942; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Gopinathan L, 2011, RESULTS PROBL CELL D, V53, P365, DOI 10.1007/978-3-642-19065-0_16; Gourguechon S, 2007, J MOL BIOL, V368, P939, DOI 10.1016/j.jmb.2007.02.050; Gourguechon S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-68; Gregory SL, 2007, FLY, V1, P13, DOI 10.4161/fly.3806; Hammarton TC, 2007, MOL BIOCHEM PARASIT, V153, P1, DOI 10.1016/j.molbiopara.2007.01.017; Hammarton TC, 2007, MOL MICROBIOL, V65, P1229, DOI 10.1111/j.1365-2958.2007.05866.x; Hammarton TC, 2000, MOL BIOCHEM PARASIT, V111, P229, DOI 10.1016/S0166-6851(00)00308-X; Hammarton TC, 2004, J BIOL CHEM, V279, P24757, DOI 10.1074/jbc.M401276200; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; Helms MJ, 2006, J CELL SCI, V119, P1105, DOI 10.1242/jcs.02809; Hisanaga S, 2010, J NEUROCHEM, V115, P1309, DOI 10.1111/j.1471-4159.2010.07050.x; Hu DL, 2003, J BIOL CHEM, V278, P8623, DOI 10.1074/jbc.M210057200; Hu DL, 2007, J CELL SCI, V120, P2424, DOI 10.1242/jcs.007963; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; Kiernan RE, 2001, MOL CELL BIOL, V21, P7956, DOI 10.1128/MCB.21.23.7956-7970.2001; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; LaCount DJ, 2000, MOL BIOCHEM PARASIT, V111, P67, DOI 10.1016/S0166-6851(00)00300-5; Lahti J M, 1995, Prog Cell Cycle Res, V1, P329; LANGRETH SG, 1975, J PROTOZOOL, V22, P40, DOI 10.1111/j.1550-7408.1975.tb00943.x; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Li ZY, 2003, J BIOL CHEM, V278, P20652, DOI 10.1074/jbc.M301635200; Ma JT, 2010, J BIOL CHEM, V285, P15356, DOI 10.1074/jbc.M109.074591; Mackey ZB, 2011, CHEM BIOL DRUG DES, V78, P454, DOI 10.1111/j.1747-0285.2011.01156.x; May SF, 2012, MOL MICROBIOL, V84, P77, DOI 10.1111/j.1365-2958.2012.08008.x; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morgan GW, 2001, J CELL SCI, V114, P2605; Mottram JC, 1996, BIOCHEM J, V316, P833, DOI 10.1042/bj3160833; Munday JC, 2011, MOL BIOCHEM PARASIT, V175, P49, DOI 10.1016/j.molbiopara.2010.09.003; Naula C, 2005, BBA-PROTEINS PROTEOM, V1754, P151, DOI 10.1016/j.bbapap.2005.08.018; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; Nishizawa M, 2010, EUKARYOT CELL, V9, P943, DOI 10.1128/EC.00247-09; Nolan DP, 2000, J BIOL CHEM, V275, P4072, DOI 10.1074/jbc.275.6.4072; Petretti C, 2006, EMBO REP, V7, P418, DOI 10.1038/sj.embor.7400639; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; SHIEKHATTAR R, 1995, NATURE, V374, P283, DOI 10.1038/374283a0; Silverman JS, 2011, MOL MICROBIOL, V82, P664, DOI 10.1111/j.1365-2958.2011.07842.x; STEVERDING D, 1995, J CELL BIOL, V131, P1173, DOI 10.1083/jcb.131.5.1173; TANG DM, 1995, J BIOL CHEM, V270, P26897, DOI 10.1074/jbc.270.45.26897; Tang DM, 1997, J BIOL CHEM, V272, P12318, DOI 10.1074/jbc.272.19.12318; TASSAN JP, 1994, J CELL BIOL, V127, P467, DOI 10.1083/jcb.127.2.467; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trembley JH, 2002, J BIOL CHEM, V277, P2589, DOI 10.1074/jbc.M109755200; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Tu XM, 2005, MOL BIOL CELL, V16, P97, DOI 10.1091/mbc.E04-05-0368; Tu XM, 2004, J BIOL CHEM, V279, P20519, DOI 10.1074/jbc.M312862200; Umeyama T, 2008, EUKARYOT CELL, V7, P1582, DOI 10.1128/EC.00150-08; Van Hellemond JJ, 2000, J BIOL CHEM, V275, P8315, DOI 10.1074/jbc.275.12.8315; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; XIANG JL, 1994, BIOCHEM BIOPH RES CO, V199, P1167, DOI 10.1006/bbrc.1994.1353; Yang ZF, 2010, MOL CELL, V38, P250, DOI 10.1016/j.molcel.2010.02.033; Zong HL, 2005, FEBS LETT, V579, P3579, DOI 10.1016/j.febslet.2005.05.039; Zong HL, 2007, MOL CELL BIOL, V27, P7125, DOI 10.1128/MCB.01753-06	71	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67327	10.1371/journal.pone.0067327	http://dx.doi.org/10.1371/journal.pone.0067327			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805309	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000320846500137
J	Rajaram, M; Zhang, JP; Wang, T; Li, JY; Kuscu, C; Qi, H; Kato, M; Grubor, V; Weil, RJ; Helland, A; Borrenson-Dale, AL; Cho, KR; Levine, DA; Houghton, AN; Wolchok, JD; Myeroff, L; Markowitz, SD; Lowe, SW; Zhang, M; Krasnitz, A; Lucito, R; Mu, D; Powers, RS				Rajaram, Megha; Zhang, Jianping; Wang, Tim; Li, Jinyu; Kuscu, Cem; Qi, Huan; Kato, Mamoru; Grubor, Vladimir; Weil, Robert J.; Helland, Aslaug; Borrenson-Dale, Anne-Lise; Cho, Kathleen R.; Levine, Douglas A.; Houghton, Alan N.; Wolchok, Jedd D.; Myeroff, Lois; Markowitz, Sanford D.; Lowe, Scott W.; Zhang, Michael; Krasnitz, Alex; Lucito, Robert; Mu, David; Powers, R. Scott			Two Distinct Categories of Focal Deletions in Cancer Genomes	PLOS ONE			English	Article							COMMON FRAGILE SITES; SOMATIC MUTATIONS; ONCOGENIC PROPERTIES; LIVER-CANCER; AMPLIFICATION; GENE; IDENTIFICATION; INACTIVATION; FRA3B	One of the key questions about genomic alterations in cancer is whether they are functional in the sense of contributing to the selective advantage of tumor cells. The frequency with which an alteration occurs might reflect its ability to increase cancer cell growth, or alternatively, enhanced instability of a locus may increase the frequency with which it is found to be aberrant in tumors, regardless of oncogenic impact. Here we've addressed this on a genome-wide scale for cancer-associated focal deletions, which are known to pinpoint both tumor suppressor genes (tumor suppressors) and unstable loci. Based on DNA copy number analysis of over one-thousand human cancers representing ten different tumor types, we observed five loci with focal deletion frequencies above 5%, including the A2BP1 gene at 16p13.3 and the MACROD2 gene at 20p12.1. However, neither RNA expression nor functional studies support a tumor suppressor role for either gene. Further analyses suggest instead that these are sites of increased genomic instability and that they resemble common fragile sites (CFS). Genome-wide analysis revealed properties of CFS-like recurrent deletions that distinguish them from deletions affecting tumor suppressor genes, including their isolation at specific loci away from other genomic deletion sites, a considerably smaller deletion size, and dispersal throughout the affected locus rather than assembly at a common site of overlap. Additionally, CFS-like deletions have less impact on gene expression and are enriched in cell lines compared to primary tumors. We show that loci affected by CFS-like deletions are often distinct from known common fragile sites. Indeed, we find that each tumor tissue type has its own spectrum of CFS-like deletions, and that colon cancers have many more CFS-like deletions than other tumor types. We present simple rules that can pinpoint focal deletions that are not CFS-like and more likely to affect functional tumor suppressors.	[Rajaram, Megha; Zhang, Jianping; Wang, Tim; Li, Jinyu; Kuscu, Cem; Qi, Huan; Kato, Mamoru; Grubor, Vladimir; Lowe, Scott W.; Zhang, Michael; Krasnitz, Alex; Lucito, Robert; Mu, David; Powers, R. Scott] Cold Spring Harbor Lab, Canc Genome Ctr, Woodbury, NY USA; [Weil, Robert J.] Cleveland Clin, Dept Neurosurg, Cleveland, OH 44106 USA; [Helland, Aslaug; Borrenson-Dale, Anne-Lise] Norwegian Radium Hosp, Dept Genet, Oslo, Norway; [Cho, Kathleen R.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Cho, Kathleen R.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Levine, Douglas A.; Houghton, Alan N.; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Levine, Douglas A.; Houghton, Alan N.; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Myeroff, Lois; Markowitz, Sanford D.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Myeroff, Lois; Markowitz, Sanford D.] Case Western Reserve Univ, Ireland Canc Ctr, Cleveland, OH 44106 USA; [Myeroff, Lois; Markowitz, Sanford D.] Univ Hosp Cleveland, Cleveland, OH 44106 USA	Cold Spring Harbor Laboratory; Cleveland Clinic Foundation; University of Oslo; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Powers, RS (corresponding author), Cold Spring Harbor Lab, Canc Genome Ctr, Woodbury, NY USA.	powers@cshl.edu	Helland, Åslaug/H-3910-2015; Mu, David/E-8933-2011; Lucito, Robert/AID-7159-2022	Helland, Åslaug/0000-0002-5520-0275; Mu, David/0000-0002-7762-0182; Levine, Douglas/0000-0003-1038-8232; Wang, Timothy/0000-0001-5730-3019; Powers, Scott/0000-0003-2769-1932; Cho, Kathleen/0000-0003-0500-9998	NIH [CA124648, RC2CA148532]; NATIONAL CANCER INSTITUTE [RC2CA148532, U01CA168409, P30CA008748] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants CA124648 and RC2CA148532. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeen SK, 2011, ONCOGENE, V30, P3900, DOI 10.1038/onc.2011.115; Agarwal SK, 1997, HUM MOL GENET, V6, P1169, DOI 10.1093/hmg/6.7.1169; Andersen CL, 2011, INT J CANCER, V129, P1848, DOI 10.1002/ijc.25841; Arlt MF, 2009, AM J HUM GENET, V84, P339, DOI 10.1016/j.ajhg.2009.01.024; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; CHEN S, 2008, CANC BIOL THER, V7; Chi YH, 2009, INT J CANCER, V124, P1483, DOI 10.1002/ijc.24094; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Farrell CL, 2008, CANCER BIOL THER, V7, P609, DOI 10.4161/cbt.7.4.5623; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Fungtammasan A, 2012, GENOME RES, V22, P993, DOI 10.1101/gr.134395.111; Hasan MK, 2009, J BIOL CHEM, V284, P1664, DOI 10.1074/jbc.M805778200; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Huebner K, 2001, NAT REV CANCER, V1, P214, DOI 10.1038/35106058; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Komuro Hiroaki, 1999, Neoplasia (New York), V1, P253, DOI 10.1038/sj.neo.7900033; Kuroyanagi H, 2009, CELL MOL LIFE SCI, V66, P3895, DOI 10.1007/s00018-009-0120-5; Lee SH, 2012, PATHOL ONCOL RES; Letessier A, 2011, NATURE, V470, P120, DOI 10.1038/nature09745; Li J, 2002, NAT GENET, V31, P133, DOI 10.1038/ng888; McAvoy S, 2007, CYTOGENET GENOME RES, V118, P260, DOI 10.1159/000108309; Mu D, 2003, CANCER CELL, V3, P297, DOI 10.1016/S1535-6108(03)00054-0; MURANO I, 1989, HUM GENET, V83, P45, DOI 10.1007/BF00274145; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nancarrow DJ, 2008, CANCER RES, V68, P4163, DOI 10.1158/0008-5472.CAN-07-6710; Poulogiannis G, 2010, P NATL ACAD SCI USA, V107, P15145, DOI 10.1073/pnas.1009941107; Raschke S, 2005, GENE CHROMOSOME CANC, V42, P58, DOI 10.1002/gcc.20119; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; Suzuki M, 2005, ONCOGENE, V24, P1302, DOI 10.1038/sj.onc.1208263; Teng DHF, 1997, CANCER RES, V57, P4177; Thiagalingam S, 1996, CANCER RES, V56, P2936; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Watanabe A, 2003, CANCER RES, V63, P8629; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108	38	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66264	10.1371/journal.pone.0066264	http://dx.doi.org/10.1371/journal.pone.0066264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805207	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000320846500035
J	Weinhold, M; Eisenblatter, M; Jasny, E; Fehlings, M; Finke, A; Gayum, H; Ruschendorf, U; Viveros, PR; Moos, V; Allers, K; Schneider, T; Schaible, UE; Schumann, RR; Mielke, ME; Ignatius, R				Weinhold, Mario; Eisenblaetter, Martin; Jasny, Edith; Fehlings, Michael; Finke, Antje; Gayum, Hermine; Rueschendorf, Ursula; Viveros, Pablo Renner; Moos, Verena; Allers, Kristina; Schneider, Thomas; Schaible, Ulrich E.; Schumann, Ralf R.; Mielke, Martin E.; Ignatius, Ralf			The Attenuated Brucella abortus Strain 19 Invades, Persists in, and Activates Human Dendritic Cells, and Induces the Secretion of IL-12p70 but Not IL-23	PLOS ONE			English	Article							DELAYED-TYPE HYPERSENSITIVITY; TOLL-LIKE RECEPTOR-4; PROINFLAMMATORY RESPONSE; MUCOSAL IMMUNITY; HIV-1 PEPTIDE; B-ABORTUS; T-CELLS; IN-VIVO; V3 LOOP; INDUCTION	Background: Bacterial vectors have been proposed as novel vaccine strategies to induce strong cellular immunity. Attenuated strains of Brucella abortus comprise promising vector candidates since they have the potential to induce strong CD4(+) and CD8(+) T-cell mediated immune responses in the absence of excessive inflammation as observed with other Gram-negative bacteria. However, some Brucella strains interfere with the maturation of dendritic cells (DCs), which is essential for antigen-specific T-cell priming. In the present study, we investigated the interaction of human monocyte-derived DCs with the smooth attenuated B. abortus strain (S) 19, which has previously been employed successfully to vaccinate cattle. Methodology/Principal findings: We first looked into the potential of S19 to hamper the cytokine-induced maturation of DCs; however, infected cells expressed CD25, CD40, CD80, and CD86 to a comparable extent as uninfected, cytokine-matured DCs. Furthermore, S19 activated DCs in the absence of exogeneous stimuli, enhanced the expression of HLA-ABC and HLA-DR, and was able to persist intracellularly without causing cytotoxicity. Thus, DCs provide a cellular niche for persisting brucellae in vivo as a permanent source of antigen. S19-infected DCs produced IL-12/23p40, IL-12p70, and IL-10, but not IL-23. While heat-killed bacteria also activated DCs, soluble mediators were not involved in S19-induced activation of human DCs. HEK 293 transfectants revealed cellular activation by S19 primarily through engagement of Toll-like receptor (TLR)2. Conclusions/Significance: Thus, as an immunological prerequisite for vaccine efficacy, B. abortus S19 potently infects and potently activates (most likely via TLR2) human DCs to produce Th1-promoting cytokines.	[Weinhold, Mario; Eisenblaetter, Martin; Jasny, Edith; Fehlings, Michael; Gayum, Hermine; Rueschendorf, Ursula; Viveros, Pablo Renner; Schumann, Ralf R.; Ignatius, Ralf] Charite, Dept Infect Immunol, Inst Microbiol & Hyg, D-13353 Berlin, Germany; [Finke, Antje] Robert Koch Inst, Berlin, Germany; [Viveros, Pablo Renner; Ignatius, Ralf] Charite, Inst Trop Med & Int Hlth, D-13353 Berlin, Germany; [Moos, Verena; Allers, Kristina; Schneider, Thomas] Charite, Med Clin 1, D-13353 Berlin, Germany; [Schaible, Ulrich E.] Res Ctr Borstel, Dept Mol Infect Res, Borstel, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Forschungszentrum Borstel	Ignatius, R (corresponding author), Charite, Dept Infect Immunol, Inst Microbiol & Hyg, D-13353 Berlin, Germany.	ralf.ignatius@charite.de		Fehlings, Michael/0000-0002-5722-6364; Schneider, Thomas/0000-0003-1125-0518; Moos, Verena/0000-0002-9558-7291	H.W.&J. Hector Foundation; Charite-Universitatsmedizin Berlin; MRC [G0700163] Funding Source: UKRI; Medical Research Council [G0700163] Funding Source: researchfish	H.W.&J. Hector Foundation; Charite-Universitatsmedizin Berlin; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the H.W.&J. Hector Foundation and by the Charite-Universitatsmedizin Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrionuevo P, 2008, INFECT IMMUN, V76, P250, DOI 10.1128/IAI.00949-07; Bergner PM, 2006, J IMMUNOL, V176, P2366, DOI 10.4049/jimmunol.176.4.2366; Billard E, 2005, INFECT IMMUN, V73, P8418, DOI 10.1128/IAI.73.12.8418-8424.2005; Billard E, 2007, INFECT IMMUN, V75, P5916, DOI 10.1128/IAI.00931-07; Billard E, 2007, INFECT IMMUN, V75, P4980, DOI 10.1128/IAI.00637-07; Campos MA, 2004, INFECT IMMUN, V72, P176, DOI 10.1128/IAI.72.1.176-186.2004; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Chandran SS, 2009, J IMMUNOL, V183, P7832, DOI 10.4049/jimmunol.0901683; Corbel MJ, 1997, J MED MICROBIOL, V46, P267, DOI 10.1099/00222615-46-4-267; Crasta OR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002193; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; Eller N, 2004, J MED PRIMATOL, V33, P167, DOI 10.1111/j.1600-0684.2004.00068.x; Fernandes DM, 1996, FEMS IMMUNOL MED MIC, V16, P193, DOI 10.1016/S0928-8244(96)00083-1; Ferrero MC, 2011, MICROBES INFECT, V13, P852, DOI 10.1016/j.micinf.2011.04.010; Galen JE, 2009, IMMUNOL CELL BIOL, V87, P400, DOI 10.1038/icb.2009.31; Gandotra S, 2007, INFECT IMMUN, V75, P5127, DOI 10.1128/IAI.00458-07; Giambartolomei GH, 2004, J IMMUNOL, V173, P4635, DOI 10.4049/jimmunol.173.7.4635; Golding B, 2002, VACCINE, V20, P1445, DOI 10.1016/S0264-410X(01)00477-7; GOLDING B, 1995, J VIROL, V69, P3299, DOI 10.1128/JVI.69.6.3299-3307.1995; GOLDSTEIN J, 1992, INFECT IMMUN, V60, P1385, DOI 10.1128/IAI.60.4.1385-1389.1992; He YQ, 2001, INFECT IMMUN, V69, P5502, DOI 10.1128/IAI.69.9.5502-5508.2001; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Hort GM, 2003, MICROBES INFECT, V5, P95, DOI 10.1016/S1286-4579(02)00076-X; Huang LY, 1999, INFECT IMMUN, V67, P6257; Huang LY, 2005, J IMMUNOL, V175, P3964, DOI 10.4049/jimmunol.175.6.3964; Huang LY, 2003, J IMMUNOL, V171, P1441, DOI 10.4049/jimmunol.171.3.1441; Huang LY, 2001, J IMMUNOL, V167, P1423, DOI 10.4049/jimmunol.167.3.1423; Ignatius R, 2000, J VIROL, V74, P11329, DOI 10.1128/JVI.74.23.11329-11338.2000; Jasny E, 2008, J IMMUNOL, V180, P6629, DOI 10.4049/jimmunol.180.10.6629; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Lapham C, 1996, J VIROL, V70, P3084, DOI 10.1128/JVI.70.5.3084-3092.1996; Macedo GC, 2013, INFECT IMMUN; Macedo GC, 2008, J IMMUNOL, V180, P1080, DOI 10.4049/jimmunol.180.2.1080; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Oliveira F. S., 2012, CLIN DEV IMMUNOL, V2012, DOI DOI 10.1155/2012/861426; Oliveira SC, 1996, CELL IMMUNOL, V172, P262, DOI 10.1006/cimm.1996.0241; OLIVEIRA SC, 1995, EUR J IMMUNOL, V25, P2551, DOI 10.1002/eji.1830250922; Oliveira SC, 2012, VET IMMUNOL IMMUNOP, V148, P129, DOI 10.1016/j.vetimm.2011.05.036; Pasquevich KA, 2010, J IMMUNOL, V184, P5200, DOI 10.4049/jimmunol.0902209; Porte F, 2003, INFECT IMMUN, V71, P1481, DOI 10.1128/IAI.71.3.1481-1490.2003; Ramamoorthy S, 2007, INT J PARASITOL, V37, P1521, DOI 10.1016/j.ijpara.2007.04.020; Rittig MG, 2003, J LEUKOCYTE BIOL, V74, P1045, DOI 10.1189/jlb.0103015; Rouot B, 2003, INFECT IMMUN, V71, P1075, DOI 10.1128/IAI.71.3.1075-1082.2003; Garcia JVSY, 2008, MICROBES INFECT, V10, P635, DOI 10.1016/j.micinf.2008.02.010; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Schnurr M, 2005, BLOOD, V105, P1582, DOI 10.1182/blood-2004-05-1718; Schroder NWJ, 2005, J IMMUNOL, V175, P2534, DOI 10.4049/jimmunol.175.4.2534; Schurig GG, 2002, VET MICROBIOL, V90, P479, DOI 10.1016/S0378-1135(02)00255-9; Steinman RM, 2002, J CLIN INVEST, V109, P1519, DOI 10.1172/JCI200215962; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Vemullpalli R, 2000, INFECT IMMUN, V68, P3290, DOI 10.1128/IAI.68.6.3290-3296.2000; Wallach JC, 2008, CLIN MICROBIOL INFEC, V14, P805, DOI 10.1111/j.1469-0691.2008.02029.x; Weiss DS, 2005, INFECT IMMUN, V73, P5137, DOI 10.1128/IAI.73.8.5137-5143.2005; Zaitseva M, 2001, INFECT IMMUN, V69, P3817, DOI 10.1128/IAI.69.6.3817-3826.2001; Zaitseva M, 1996, INFECT IMMUN, V64, P3109, DOI 10.1128/IAI.64.8.3109-3117.1996; Zwerdling A, 2009, MICROBES INFECT, V11, P689, DOI 10.1016/j.micinf.2009.04.010; Zwerdling A, 2008, MICROBES INFECT, V10, P1346, DOI 10.1016/j.micinf.2008.07.035	59	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e65934	10.1371/journal.pone.0065934	http://dx.doi.org/10.1371/journal.pone.0065934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805193	Green Published, gold, Green Submitted			2022-12-25	WOS:000320846500021
J	Furuhashi, K; Saga, K; Okada, S; Imou, K				Furuhashi, Kenichi; Saga, Kiyotaka; Okada, Shigeru; Imou, Kenji			Seawater-Cultured Botryococcus braunii for Efficient Hydrocarbon Extraction	PLOS ONE			English	Article							MICROALGAE; GROWTH; CULTIVATION; RECOVERY; WATER	As a potential source of biofuel, the green colonial microalga Botryococcus braunii produces large amounts of hydrocarbons that are accumulated in the extracellular matrix. Generally, pretreatment such as drying or heating of wet algae is needed for sufficient recoveries of hydrocarbons from B. braunii using organic solvents. In this study, the Showa strain of B. braunii was cultured in media derived from the modified Chu13 medium by supplying artificial seawater, natural seawater, or NaCl. After a certain period of culture in the media with an osmotic pressure corresponding to 1/4-seawater, hydrocarbon recovery rates exceeding 90% were obtained by simply mixing intact wet algae with n-hexane without any pretreatments and the results using the present culture conditions indicate the potential for hydrocarbon milking. Highlights: Seawater was used for efficient hydrocarbon extraction from Botryococcus braunii. The alga was cultured in media prepared with seawater or NaCl. Hydrocarbon recovery rate exceeding 90% was obtained without any pretreatment.	[Furuhashi, Kenichi; Saga, Kiyotaka; Imou, Kenji] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Biol & Mech Engn, Bunkyo Ku, Yayoi, Japan; [Okada, Shigeru] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Aquat & Nat Prod Chem, Bunkyo Ku, Yayoi, Japan	University of Tokyo; University of Tokyo	Imou, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Biol & Mech Engn, Bunkyo Ku, Yayoi, Japan.	aimou@mail.ecc.u-tokyo.ac.jp	Okada, Shigeru/U-8305-2017	Okada, Shigeru/0000-0003-3663-7778	Tokyo Gas Co. Ltd.; Grants-in-Aid for Scientific Research [13J07091] Funding Source: KAKEN	Tokyo Gas Co. Ltd.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Tokyo Gas Co. Ltd. for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN AC, 1969, PHYTOCHEMISTRY, V8, P543, DOI 10.1016/S0031-9422(00)85397-2; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Dayananda C, 2007, BIOMASS BIOENERG, V31, P87, DOI 10.1016/j.biombioe.2006.05.001; DOTE Y, 1994, FUEL, V73, P1855, DOI 10.1016/0016-2361(94)90211-9; Eroglu E, 2011, J APPL PHYCOL, V23, P763, DOI 10.1007/s10811-010-9577-8; Eroglu E, 2010, BIORESOURCE TECHNOL, V101, P2359, DOI 10.1016/j.biortech.2009.11.043; FRENZ J, 1989, BIOTECHNOL BIOENG, V34, P755, DOI 10.1002/bit.260340605; Hejazi MA, 2004, TRENDS BIOTECHNOL, V22, P189, DOI 10.1016/j.tibtech.2004.02.009; Kita K, 2010, APPL ENERG, V87, P2420, DOI 10.1016/j.apenergy.2009.11.036; LARGEAU C, 1980, PHYTOCHEMISTRY, V19, P1043, DOI 10.1016/0031-9422(80)83054-8; Li Y, 2005, J APPL PHYCOL, V17, P551, DOI 10.1007/s10811-005-9005-7; Metzger P, 2005, APPL MICROBIOL BIOT, V66, P486, DOI 10.1007/s00253-004-1779-z; Niehaus TD, 2011, P NATL ACAD SCI USA, V108, P12260, DOI 10.1073/pnas.1106222108; Okada S, 1995, J APPL PHYCOL, V7, P555, DOI 10.1007/BF00003942; Rao AR, 2007, BIORESOURCE TECHNOL, V98, P560, DOI 10.1016/j.biortech.2006.02.007; SHIFRIN NS, 1981, J PHYCOL, V17, P374, DOI 10.1111/j.0022-3646.1981.00374.x; VAZQUEZDUHALT R, 1991, PHYTOCHEMISTRY, V30, P2919, DOI 10.1016/S0031-9422(00)98225-6; Weiss TL, 2012, EUKARYOT CELL, V11, P1424, DOI 10.1128/EC.00184-12; Weiss TL, 2010, J BIOL CHEM, V285, P32458, DOI 10.1074/jbc.M110.157230; Yeesang C, 2011, BIORESOURCE TECHNOL, V102, P3034, DOI 10.1016/j.biortech.2010.10.013; Yonezawa N, 2012, BIORESOURCE TECHNOL, V109, P304, DOI 10.1016/j.biortech.2011.07.090; Yoo G, 2012, BIORESOURCE TECHNOL, V123, P717, DOI 10.1016/j.biortech.2012.07.102; Zhang HF, 2011, BIOMASS BIOENERG, V35, P1710, DOI 10.1016/j.biombioe.2011.01.002	23	22	22	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66483	10.1371/journal.pone.0066483	http://dx.doi.org/10.1371/journal.pone.0066483			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799107	Green Submitted, Green Published, gold			2022-12-25	WOS:000320363300085
J	Gao, SJ; Damaj, MB; Park, JW; Beyene, G; Buenrostro-Nava, MT; Molina, J; Wang, XF; Ciomperlik, JJ; Manabayeva, SA; Alvarado, VY; Rathore, KS; Scholthof, HB; Mirkov, TE				Gao, San-Ji; Damaj, Mona B.; Park, Jong-Won; Beyene, Getu; Buenrostro-Nava, Marco T.; Molina, Joe; Wang, Xiaofeng; Ciomperlik, Jessica J.; Manabayeva, Shuga A.; Alvarado, Veria Y.; Rathore, Keerti S.; Scholthof, Herman B.; Mirkov, T. Erik			Enhanced Transgene Expression in Sugarcane by Co-Expression of Virus-Encoded RNA Silencing Suppressors	PLOS ONE			English	Article							TRANSIENT GENE-EXPRESSION; DOUBLE-STRANDED-RNA; VIRAL SUPPRESSORS; MICROPROJECTILE BOMBARDMENT; GFP EXPRESSION; NICOTIANA-BENTHAMIANA; PARTICLE BOMBARDMENT; SUSPENSION-CULTURES; BETA-GLUCURONIDASE; PROTOPLAST SYSTEM	Post-transcriptional gene silencing is commonly observed in polyploid species and often poses a major limitation to plant improvement via biotechnology. Five plant viral suppressors of RNA silencing were evaluated for their ability to counteract gene silencing and enhance the expression of the Enhanced Yellow Fluorescent Protein (EYFP) or the beta-glucuronidase (GUS) reporter gene in sugarcane, a major sugar and biomass producing polyploid. Functionality of these suppressors was first verified in Nicotiana benthamiana and onion epidermal cells, and later tested by transient expression in sugarcane young leaf segments and protoplasts. In young leaf segments co-expressing a suppressor, EYFP reached its maximum expression at 48-96 h post-DNA introduction and maintained its peak expression for a longer time compared with that in the absence of a suppressor. Among the five suppressors, Tomato bushy stunt virus-encoded P19 and Barley stripe mosaic virus-encoded gamma b were the most efficient. Co-expression with P19 and gamma b enhanced EYFP expression 4.6-fold and 3.6-fold in young leaf segments, and GUS activity 2.3-fold and 2.4-fold in protoplasts compared with those in the absence of a suppressor, respectively. In transgenic sugarcane, co-expression of GUS and P19 suppressor showed the highest accumulation of GUS levels with an average of 2.7-fold more than when GUS was expressed alone, with no detrimental phenotypic effects. The two established transient expression assays, based on young leaf segments and protoplasts, and confirmed by stable transgene expression, offer a rapid versatile system to verify the efficiency of RNA silencing suppressors that proved to be valuable in enhancing and stabilizing transgene expression in sugarcane.	[Gao, San-Ji] Fujian Agr & Forestry Univ, Minist Agr, Key Lab Sugarcane Biol & Genet Breeding, Fuzhou, Fujian, Peoples R China; [Damaj, Mona B.; Park, Jong-Won; Molina, Joe; Mirkov, T. Erik] Texas A&M AgriLife Res, Dept Plant Pathol & Microbiol, Weslaco, TX USA; [Beyene, Getu] Donald Danforth Plant Sci Ctr, Inst Int Crop Improvement, St Louis, MO USA; [Buenrostro-Nava, Marco T.] Univ Colima, FCBA Lab Biotecnol, Tecoman, Colima, Mexico; [Wang, Xiaofeng] VirginiaTech Univ, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA USA; [Ciomperlik, Jessica J.; Scholthof, Herman B.] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Manabayeva, Shuga A.] Natl Ctr Biotechnol Republ Kazakhstan, Astana, Kazakhstan; [Alvarado, Veria Y.] Texas A&M Univ, Stoller Enterprises Inc, Norman E Borlaug Ctr Southern Crop Improvement, College Stn, TX USA; [Rathore, Keerti S.] Texas A&M Univ, Inst Plant Genom & Biotechnol, Norman E Borlaug Ctr Southern Crop Improvement, Lab Crop Transformat, College Stn, TX USA	Fujian Agriculture & Forestry University; Ministry of Agriculture & Rural Affairs; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; Donald Danforth Plant Science Center; Universidad de Colima; Texas A&M University System; Texas A&M University College Station; National Center for Biotechnology (NCB); Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Mirkov, TE (corresponding author), Texas A&M AgriLife Res, Dept Plant Pathol & Microbiol, Weslaco, TX USA.	e-mirkov@tamu.edu	Manabayeva, Shuga A./A-2529-2015; Wang, Xiaofeng/E-9940-2016; Park, Jong-Won/O-5097-2014; Gao, San-Ji/AAZ-3967-2021	Manabayeva, Shuga A./0000-0001-7884-1713; Wang, Xiaofeng/0000-0002-3850-3274; Park, Jong-Won/0000-0002-1936-8230; Duguma, Getu/0000-0002-4194-1267	Texas AgriLife Bioenergy grant [0809]	Texas AgriLife Bioenergy grant	This work was supported by a Texas AgriLife Bioenergy grant 0809. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftab F, 1999, PLANT CELL TISS ORG, V56, P155, DOI 10.1023/A:1006296320725; Alvarez ML, 2008, PLANT MOL BIOL, V68, P61, DOI 10.1007/s11103-008-9352-2; Anandalakshmi R, 1998, P NATL ACAD SCI USA, V95, P13079, DOI 10.1073/pnas.95.22.13079; ARAGAO FJL, 1993, PLANT CELL REP, V12, P483, DOI 10.1007/BF00236092; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Beyene G, 2011, PLANT CELL REP, V30, P13, DOI 10.1007/s00299-010-0936-3; Birch R. G., 2010, Tropical Plant Biology, V3, P88, DOI 10.1007/s12042-010-9047-0; BOWER R, 1992, PLANT J, V2, P409, DOI 10.1111/j.1365-313X.1992.00409.x; Bragg JN, 2004, MOL PLANT PATHOL, V5, P465, DOI [10.1111/j.1364-3703.2004.00246.x, 10.1111/J.1364-3703.2004.00246.X]; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Burgyan J, 2011, TRENDS PLANT SCI, V16, P265, DOI 10.1016/j.tplants.2011.02.010; Carrington JC, 2000, NATURE, V408, P150, DOI 10.1038/35041662; CHAREST PJ, 1993, PLANT CELL REP, V12, P189, DOI 10.1007/BF00237051; Chen SB, 2006, MOL PLANT PATHOL, V7, P417, DOI 10.1111/j.1364-3703.2006.00346.x; CHEN WH, 1987, PLANT CELL REP, V6, P297, DOI 10.1007/BF00272003; Chiba M, 2006, VIROLOGY, V346, P7, DOI 10.1016/j.virol.2005.09.068; Chiera JM, 2008, TRANSGENIC RES, V17, P1143, DOI 10.1007/s11248-008-9192-5; Chiera JM, 2007, PLANT CELL REP, V26, P1501, DOI 10.1007/s00299-007-0359-y; CHOWDHURY MKU, 1992, PLANT CELL REP, V11, P494, DOI 10.1007/BF00236264; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Circelli Patrizia, 2010, Bioeng Bugs, V1, P221, DOI 10.4161/bbug.1.3.11722; Damavandi MY, 2009, EL C EL POW EN CONV, P1; Dhillon T, 2009, PLANT CELL REP, V28, P639, DOI 10.1007/s00299-009-0675-5; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Fagard M, 2000, ANNU REV PLANT PHYS, V51, P167, DOI 10.1146/annurev.arplant.51.1.167; FINER JJ, 1992, PLANT CELL REP, V11, P323, DOI 10.1007/BF00233358; GALLOMEAGHER M, 1993, PLANT CELL REP, V12, P666, DOI 10.1007/BF00233416; Goodin MM, 2002, PLANT J, V31, P375, DOI 10.1046/j.1365-313X.2002.01360.x; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; He XJ, 2011, CELL RES, V21, P442, DOI 10.1038/cr.2011.23; HOOD EE, 1986, J BACTERIOL, V168, P1291, DOI 10.1128/jb.168.3.1291-1301.1986; Hsieh YC, 2009, J VIROL, V83, P2188, DOI 10.1128/JVI.02186-08; HUNOLD R, 1994, PLANT J, V5, P593, DOI 10.1046/j.1365-313X.1994.5040593.x; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Ingelbrecht IL, 1999, PLANT PHYSIOL, V119, P1187, DOI 10.1104/pp.119.4.1187; JEFFERSON RA, 1987, EMBO J, V6, P3901; Joyce P, 2010, PLANT CELL REP, V29, P173, DOI 10.1007/s00299-009-0810-3; KRISHNAMURTHI M, 1976, EUPHYTICA, V25, P145, DOI 10.1007/BF00041539; Lakatos L, 2004, EMBO J, V23, P876, DOI 10.1038/sj.emboj.7600096; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Lozsa R, 2008, NUCLEIC ACIDS RES, V36, P4099, DOI 10.1093/nar/gkn365; Mallory AC, 2001, PLANT CELL, V13, P571, DOI 10.1105/tpc.13.3.571; Mangwende T, 2009, VIROLOGY, V384, P38, DOI 10.1016/j.virol.2008.10.034; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Matzke MA, 2001, CURR OPIN GENET DEV, V11, P221, DOI 10.1016/S0959-437X(00)00183-0; Menossi M, 2008, Int J Plant Genomics, V2008, P458732, DOI 10.1155/2008/458732; Merai Z, 2006, J VIROL, V80, P5747, DOI 10.1128/JVI.01963-05; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Mudge SR, 2009, PLANTA, V229, P549, DOI 10.1007/s00425-008-0852-8; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Omarov R, 2006, J VIROL, V80, P3000, DOI 10.1128/JVI.80.6.3000-3008.2006; Omarov Rustem T, 2012, Methods Mol Biol, V894, P39, DOI 10.1007/978-1-61779-882-5_3; Pantaleo V, 2011, ADV EXP MED BIOL, V722, P39, DOI 10.1007/978-1-4614-0332-6_3; Papp I, 2003, PLANT PHYSIOL, V132, P1382, DOI 10.1104/pp.103.021980; PROLS F, 1992, PLANT J, V2, P465; Qi YJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh180; Qiu WP, 2002, MOL PLANT MICROBE IN, V15, P269, DOI 10.1094/MPMI.2002.15.3.269; Qu F, 2005, FEBS LETT, V579, P5958, DOI 10.1016/j.febslet.2005.08.041; RATHUS C, 1992, PLANT SCI, V82, P81, DOI 10.1016/0168-9452(92)90010-J; Reddy MSS, 2003, PLANT CELL REP, V21, P676, DOI 10.1007/s00299-002-0567-4; Roth BM, 2004, VIRUS RES, V102, P97, DOI 10.1016/j.virusres.2004.01.020; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Sambrook J, 2001, MOL CLONING LAB MANU; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Saxena P, 2011, PLANT BIOTECHNOL J, V9, P703, DOI 10.1111/j.1467-7652.2010.00574.x; Senshu H, 2011, J VIROL, V85, P10269, DOI 10.1128/JVI.05273-11; Shimura H, 2008, J GEN PLANT PATHOL, V74, P326, DOI 10.1007/s10327-008-0099-z; Siddiqui SA, 2008, MOL PLANT MICROBE IN, V21, P178, DOI 10.1094/MPMI-21-2-0178; Silhavy D, 2002, EMBO J, V21, P3070, DOI 10.1093/emboj/cdf312; Snyman SJ, 2006, PLANT CELL REP, V25, P1016, DOI 10.1007/s00299-006-0148-z; Tai T., 1990, PLANT MOL BIOL REP, V8, P297, DOI [10.1007/BF02668766, DOI 10.1007/BF02668766]; TAYLOR PWJ, 1992, PLANT CELL TISS ORG, V28, P69, DOI 10.1007/BF00039917; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334; Vanithatani R, 2003, P NATL ACAD SCI USA, V100, P9632, DOI 10.1073/pnas.1733874100; Varallyay E, 2010, EMBO J, V29, P3507, DOI 10.1038/emboj.2010.215; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Villani ME, 2009, PLANT BIOTECHNOL J, V7, P59, DOI 10.1111/j.1467-7652.2008.00371.x; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Voinnet O, 2008, TRENDS PLANT SCI, V13, P317, DOI 10.1016/j.tplants.2008.05.004; Wang MB, 2005, CURR OPIN PLANT BIOL, V8, P216, DOI 10.1016/j.pbi.2005.01.006; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Weld R, 2001, PLANT MOL BIOL, V45, P377, DOI 10.1023/A:1010798625203; Yelina NE, 2002, J VIROL, V76, P12981, DOI 10.1128/JVI.76.24.12981-12991.2002; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yu B, 2006, FEBS LETT, V580, P3117, DOI 10.1016/j.febslet.2006.04.063; Zhai ZY, 2009, PLANT PHYSIOL, V149, P642, DOI 10.1104/pp.108.130260; Zheng ZM, 2010, PLANT J, V62, P92, DOI 10.1111/j.1365-313X.2010.04130.x	90	22	24	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66046	10.1371/journal.pone.0066046	http://dx.doi.org/10.1371/journal.pone.0066046			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799071	Green Submitted, Green Published, gold			2022-12-25	WOS:000320363300060
J	Liu, J; Luo, Y; Ge, HT; Han, CQ; Zhang, H; Wang, YS; Su, JM; Quan, FS; Gao, MQ; Zhang, Y				Liu, Jun; Luo, Yan; Ge, Hengtao; Han, Chengquan; Zhang, Hui; Wang, Yongsheng; Su, Jianmin; Quan, Fusheng; Gao, Mingqing; Zhang, Yong			Anti-Bacterial Activity of Recombinant Human beta-Defensin-3 Secreted in the Milk of Transgenic Goats Produced by Somatic Cell Nuclear Transfer	PLOS ONE			English	Article							LARGE-SCALE PRODUCTION; MAMMARY-GLAND; HUMAN LACTOFERRIN; ANTIMICROBIAL PEPTIDE; FETAL FIBROBLASTS; EPITHELIAL-CELLS; BETA-DEFENSINS; DONOR CELLS; MASTITIS; EXPRESSION	The present study was conducted to determine whether recombinant human beta-defensin-3 (rHBD3) in the milk of transgenic goats has an anti-bacterial activity against Escherichia coli (E. coli), Staphylococcus aureus (S. aureus) and Streptococcus agalactiae (S. agalactiae) that could cause mastitis. A HBD3 mammary-specific expression vector was transfected by electroporation into goat fetal fibroblasts which were used to produce fourteen healthy transgenic goats by somatic cell nuclear transfer. The expression level of rHBD3 in the milk of the six transgenic goats ranged from 98 to 121 mu g/ml at 15 days of lactation, and was maintained at 90-111 mu g/ml during the following 2 months. Milk samples from transgenic goats showed an obvious inhibitory activity against E. coli, S. aureus and S. agalactiae in vitro. The minimal inhibitory concentrations of rHBD3 in milk against E. coli, S. aureus and S. agalactiae were 9.5-10.5, 21.8-23.0 and 17.3-18.5 mu g/mL, respectively, which was similar to those of the HBD3 standard (P>0.05). The in vivo anti-bacterial activities of rHBD3 in milk were examined by intramammary infusion of viable bacterial inoculums. We observed that 9/10 and 8/10 glands of non-transgenic goats infused with S. aureus and E. coli became infected. The mean numbers of viable bacteria went up to 2.9x10(3) and 95.4x10(3) CFU/ml at 48 h after infusion, respectively; the mean somatic cell counts (SCC) in infected glands reached up to 260.4x10(5) and 622.2x10(5) cells/ml, which were significantly higher than the SCC in uninfected goat glands. In contrast, no bacteria was presented in glands of transgenic goats and PBS-infused controls, and the SSC did not significantly change throughout the period. Moreover, the compositions and protein profiles of milk from transgenic and non-transgenic goats were identical. The present study demonstrated that HBD3 were an effective anti-bacterial protein to enhance the mastitis resistance of dairy animals.	[Liu, Jun; Luo, Yan; Ge, Hengtao; Han, Chengquan; Zhang, Hui; Wang, Yongsheng; Su, Jianmin; Quan, Fusheng; Gao, Mingqing; Zhang, Yong] Northwest A&F Univ, Coll Vet Med, Key Lab Anim Biotechnol, Minist Agr, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Zhang, Y (corresponding author), Northwest A&F Univ, Coll Vet Med, Key Lab Anim Biotechnol, Minist Agr, Yangling, Shaanxi, Peoples R China.	zhangylab@yahoo.com.cn	Zhang, Yong/K-7945-2016	Zhang, Yong/0000-0001-8642-4071	National High Technology Research and Development Program of China (863 Program) [2011AA100303]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development Program of China (863 Program) (No. 2011AA100303) (http://www.863.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An LY, 2012, THERIOGENOLOGY, V78, P1303, DOI 10.1016/j.theriogenology.2012.05.027; Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Dhople V, 2006, BBA-BIOMEMBRANES, V1758, P1499, DOI 10.1016/j.bbamem.2006.07.007; Dunsche A, 2002, EUR J ORAL SCI, V110, P121, DOI 10.1034/j.1600-0722.2002.11186.x; Giraldo AM, 2006, MOL REPROD DEV, V73, P1230, DOI 10.1002/mrd.20558; Goni P, 2004, INT J ANTIMICROB AG, V23, P268, DOI 10.1016/j.ijantimicag.2003.07.016; Gray C, 2005, AUST J EXP AGR, V45, P757, DOI 10.1071/EA05046; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Hoover DM, 2003, ANTIMICROB AGENTS CH, V47, P2804, DOI 10.1128/AAC.47.9.2804-2809.2003; Hyvonen P, 2006, INFECT IMMUN, V74, P6206, DOI 10.1128/IAI.00238-06; Keefer CL, 2001, BIOL REPROD, V64, P849, DOI 10.1095/biolreprod64.3.849; Kerr DE, 2003, J ANIM SCI, V81, P38; Kerr DE, 2001, NAT BIOTECHNOL, V19, P66, DOI 10.1038/83540; Kluver E, 2005, BIOCHEMISTRY-US, V44, P9804, DOI 10.1021/bi050272k; Kong QR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006679; Kuhholzer B, 2001, BIOL REPROD, V64, P1695, DOI 10.1095/biolreprod64.6.1695; Liu J, 2011, THERIOGENOLOGY, V76, P1076, DOI 10.1016/j.theriogenology.2011.05.013; Liu J, 2012, THERIOGENOLOGY, DOI [10.1016/j.theriogenology.2012.11.021, DOI 10.1016/J.THERI0GEN0L0GY.2012.11.021]; Maga EA, 1998, J FOOD PROTECT, V61, P52, DOI 10.4315/0362-028X-61.1.52; Maga EA, 2006, FOODBORNE PATHOG DIS, V3, P384, DOI 10.1089/fpd.2006.3.384; McDougall S, 2009, VET MICROBIOL, V134, P177, DOI 10.1016/j.vetmic.2008.09.026; Niyonsaba F, 2005, J IMMUNOL, V175, P1776, DOI 10.4049/jimmunol.175.3.1776; Rainard P, 2006, VET RES, V37, P369, DOI 10.1051/vetres:2006007; Roosen S, 2004, MAMM GENOME, V15, P834, DOI 10.1007/s00335-004-2387-z; Ross JW, 2010, TRANSGENIC RES, V19, P611, DOI 10.1007/s11248-009-9345-1; Seegers H, 2003, VET RES, V34, P475, DOI 10.1051/vetres:2003027; Swanson K, 2004, INFECT IMMUN, V72, P7311, DOI 10.1128/IAI.72.12.7311-7314.2004; van Berkel PHC, 2002, NAT BIOTECHNOL, V20, P484, DOI 10.1038/nbt0502-484; Wall RJ, 2005, NAT BIOTECHNOL, V23, P445, DOI 10.1038/nbt1078; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017593; Yang PH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003453; Yarus S, 1996, P NATL ACAD SCI USA, V93, P14118, DOI 10.1073/pnas.93.24.14118; Yekta AA, 2013, TRANSGENIC RES, V22, P131, DOI 10.1007/s11248-012-9634-y; Zhang JX, 2007, J DAIRY SCI, V90, P5218, DOI 10.3168/jds.2007-0301; Zhang YL, 2008, THERIOGENOLOGY, V69, P1165, DOI 10.1016/j.theriogenology.2007.10.028	35	12	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65379	10.1371/journal.pone.0065379	http://dx.doi.org/10.1371/journal.pone.0065379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799010	Green Published, gold, Green Submitted			2022-12-25	WOS:000320363300017
J	Shi, SJ; Wang, R; Chen, YT; Song, HZ; Chen, LB; Huang, GC				Shi, Shujing; Wang, Rui; Chen, Yitian; Song, Haizhu; Chen, Longbang; Huang, Guichun			Combining Antiangiogenic Therapy with Adoptive Cell Immunotherapy Exerts Better Antitumor Effects in Non-Small Cell Lung Cancer Models	PLOS ONE			English	Article							INDUCED KILLER-CELLS; TUMOR-ASSOCIATED MACROPHAGES; ANTI-ANGIOGENESIS; VASCULAR NORMALIZATION; GROWTH-FACTOR; IN-VITRO; MICROENVIRONMENT; INHIBITION; EXPRESSION; INFILTRATION	Introduction: Cytokine-induced killer cells (CIK cells) are a heterogeneous subset of ex-vivo expanded T lymphocytes which are characterized with a MHC-unrestricted tumor-killing activity and a mixed T-NK phenotype. Adoptive CIK cells transfer, one of the adoptive immunotherapy represents a promising nontoxic anticancer therapy. However, in clinical studies, the therapeutic activity of adoptive CIK cells transfer is not as efficient as anticipated. Possible explanations are that abnormal tumor vasculature and hypoxic tumor microenvironment could impede the infiltration and efficacy of lymphocytes. We hypothesized that antiangiogenesis therapy could improve the antitumor activity of CIK cells by normalizing tumor vasculature and modulating hypoxic tumor microenvironment. Methods: We combined recombinant human endostatin (rh-endostatin) and CIK cells in the treatment of lung carcinoma murine models. Intravital microscopy, dynamic contrast enhanced magnetic resonance imaging, immunohistochemistry, and flow cytometry were used to investigate the tumor vasculature and hypoxic microenvironment as well as the infiltration of immune cells. Results: Our results indicated that rh-endostatin synergized with adoptive CIK cells transfer to inhibit the growth of lung carcinoma. We found that rh-endostatin normalized tumor vasculature and reduced hypoxic area in the tumor microenvironment. Hypoxia significantly inhibited the proliferation, cytotoxicity and migration of CIK cells in vitro and impeded the homing of CIK cells into tumor parenchyma ex vivo. Furthermore, we found that treatment with rh-endostatin significantly increased the homing of CIK cells and decreased the accumulation of suppressive immune cells in the tumor tissue. In addition, combination therapy produced higher level of tumor-infiltration lymphocytes compared with other treatments. Conclusions: Our results demonstrate that rh-endostatin improves the therapeutic effect of adoptive CIK cells therapy against lung carcinomas and unmask the mechanisms of the synergistic antitumor efficacy, providing a new rationale for combining antiangiogenesis therapy with immunotherapy in the treatment of lung cancer.	[Shi, Shujing; Wang, Rui; Chen, Yitian; Song, Haizhu; Chen, Longbang; Huang, Guichun] Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Oncol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Chen, LB (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Oncol, Nanjing 210008, Jiangsu, Peoples R China.	dr.chenlb@nju.edu.cn; huangguichun@nju.edu.cn			National Natural Science Foundation of China [81101739]; China International Medical Foundation [CIMF-F-H001-023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China International Medical Foundation	The work was supported by National Natural Science Foundation of China (Grant number: 81101739) and China International Medical Foundation (Grant number: CIMF-F-H001-023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsoum IB, 2011, CANCER RES, V71, P7433, DOI 10.1158/0008-5472.CAN-11-2104; Cerniglia GJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006539; Chen J, 2012, CANCER BIOTHER RADIO, V27, P210, DOI 10.1089/cbr.2011.1116; Chinnasamy D, 2010, J CLIN INVEST, V120, P3953, DOI 10.1172/JCI43490; Cortez-Retamozo V, 2012, P NATL ACAD SCI USA, V109, P2491, DOI 10.1073/pnas.1113744109; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Dirkx AEM, 2003, CANCER RES, V63, P2322; Dirkx AEM, 2006, FASEB J, V20, P621, DOI 10.1096/fj.05-4493com; Doublier S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-4; Draghiciu O, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/439053; Feng B, 2012, CANCER-AM CANCER SOC, V118, P3365, DOI 10.1002/cncr.26560; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; George AL, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-80; Griffioen AW, 2008, CANCER IMMUNOL IMMUN, V57, P1553, DOI 10.1007/s00262-008-0524-3; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hasmim M, 2011, J IMMUNOL, V187, P4031, DOI 10.4049/jimmunol.1101011; Hompland T, 2012, ACTA ONCOL, DOI DOI 10.3109/0284186X.2012.737931.ACCEPTED; Hongeng S, 2003, INT J HEMATOL, V77, P175, DOI 10.1007/BF02983217; Huang GC, 2010, J CANCER RES CLIN, V136, P1201, DOI 10.1007/s00432-010-0770-6; Huang KW, 2010, P NATL ACAD SCI USA, V107, P14769, DOI 10.1073/pnas.1009534107; Huang YH, 2012, P NATL ACAD SCI USA, V109, P17561, DOI 10.1073/pnas.1215397109; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Javaherian K, 2011, DOSE-RESPONSE, V9, P369, DOI 10.2203/dose-response.10-020.Javaherian; Jemal A, 2010, CA-CANCER J CLIN, V55, P10, DOI DOI 10.3322/CANJCLIN.55.1.10; Jiang XD, 2011, LUNG CANCER, V72, P165, DOI 10.1016/j.lungcan.2010.09.003; Jin ZJ, 1980, ACTA PHARMACOL SIN, V1, P3; Lee CT, 2010, INT J HYPERTHER, V26, P232, DOI 10.3109/02656731003601745; Lu TY, 2011, J CLIN INVEST, V121, P4015, DOI 10.1172/JCI45862; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Myers AL, 2012, J PEDIATR SURG, V45, P1080; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Naruse T, 2011, ANTICANCER RES, V31, P4429; Noman MZ, 2011, CRIT REV IMMUNOL, V31, P357, DOI 10.1615/CritRevImmunol.v31.i5.10; Ogino T, 2012, CANCER IMMUNOL IMMUN, V61, P409, DOI 10.1007/s00262-011-1112-5; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Ovrebo KM, 2012, ACTA ONCOL, DOI DOI 10.3109/0284186X.2012.689851.ACCESSED; Relf M, 1997, CANCER RES, V57, P963; Rettinger E, 2012, CYTOTHERAPY, V14, P91, DOI 10.3109/14653249.2011.613931; Rosenberg SA, 2008, P NATL ACAD SCI USA, V105, P12643, DOI 10.1073/pnas.0806877105; Sakurai T, 2011, ONCOLOGY-BASEL, V81, P24, DOI 10.1159/000333256; Sangiolo D, 2011, J CANCER, V2, P363, DOI 10.7150/jca.2.363; Sharma R, 2011, CURR RADIOPHARM, V4, P379, DOI 10.2174/1874471011104040379; Shi H, 2011, CHINESE MED J-PEKING, V124, P751, DOI 10.3760/cma.j.issn.0366-6999.2011.05.022; Shrimali RK, 2010, CANCER RES, V70, P6171, DOI 10.1158/0008-5472.CAN-10-0153; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Wei J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016195, 10.1371/journal.pone.0017868]; Wen QL, 2009, CANCER SCI, V100, P1510, DOI 10.1111/j.1349-7006.2009.01193.x; Yu JP, 2011, CANCER BIOTHER RADIO, V26, P485, DOI 10.1089/cbr.2010.0927; Zhang HY, 2005, CANCER BIOL THER, V4, P207; Zhou QY, 2008, CLIN CANCER RES, V14, P1540, DOI 10.1158/1078-0432.CCR-07-4544	51	38	44	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65757	10.1371/journal.pone.0065757	http://dx.doi.org/10.1371/journal.pone.0065757			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799045	gold, Green Published, Green Submitted			2022-12-25	WOS:000320363300040
J	Bordin, AI; Suchodolski, JS; Markel, ME; Weaver, KB; Steiner, JM; Dowd, SE; Pillai, S; Cohen, ND				Bordin, Angela I.; Suchodolski, Jan S.; Markel, Melissa E.; Weaver, Kaytee B.; Steiner, Joerg M.; Dowd, Scot E.; Pillai, Suresh; Cohen, Noah D.			Effects of Administration of Live or Inactivated Virulent Rhodococccus equi and Age on the Fecal Microbiome of Neonatal Foals	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; ORAL IMMUNIZATION; VACCINE STRAIN; PROTECTION; PNEUMONIA; INFECTIONS; IMMUNITY; VAPA; TUBERCULOSIS; INTESTINE	Background: Rhodococcus equi is an important pathogen of foals. Enteral administration of live, virulent R. equi during early life has been documented to protect against subsequent intrabronchial challenge with R. equi, indicating that enteral mucosal immunization may be protective. Evidence exists that mucosal immune responses develop against both live and inactivated micro-organisms. The extent to which live or inactivated R. equi might alter the intestinal microbiome of foals is unknown. This is an important question because the intestinal microbiome of neonates of other species is known to change over time and to influence host development. To our knowledge, changes in the intestinal microbiome of foals during early life have not been reported. Thus, the purpose of this study was to determine whether age (during the first month of life) or administration of either live virulent R. equi (at a dose reported to protect foals against subsequent intrabronchial challenge, viz., 1x10(10) colony forming units [CFU]) or inactivated virulent R. equi (at higher doses, viz., 2x10(10) and 1x10(11) [CFU]) altered the fecal microbiome of foals. Methodology/Principal Findings: Fecal swab samples from 42 healthy foals after vaccination with low-dose inactivated R. equi (n = 9), high-dose inactivated R. equi (n = 10), live R. equi (n = 6), control with cholera toxin B (CTB, n = 9), and control without CTB (n = 8) were evaluated by 454-pyrosequencing of the 16S rRNA gene and by qPCR. No impact of treatment was observed among vaccinated foals; however, marked and significant differences in microbial communities and diversity were observed between foals at 30 days of age relative to 2 days of age. Conclusions: The results suggest age-related changes in the fecal microbial population of healthy foals do occur, however, mucosal vaccination does not result in major changes of the fecal microbiome in foals.	[Bordin, Angela I.; Weaver, Kaytee B.; Cohen, Noah D.] Texas A&M Univ, Dept Large Anim Clin Sci, Equine Infect Dis Lab, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA; [Suchodolski, Jan S.; Markel, Melissa E.; Steiner, Joerg M.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Gastrointestinal Lab, College Stn, TX USA; [Dowd, Scot E.] Mol Res DNA Lab, Shallowater, TX USA; [Pillai, Suresh] Texas A&M Univ, Natl Ctr Elect Beam Res, College Stn, TX USA; [Dowd, Scot E.] Texas A&M Univ, Dept Poultry Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Cohen, ND (corresponding author), Texas A&M Univ, Dept Large Anim Clin Sci, Equine Infect Dis Lab, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA.	ncohen@cvm.tamu.edu	Dowd, Scot E/M-5386-2017	Dowd, Scot E/0000-0002-6296-1427; Suchodolski, Jan/0000-0002-2176-6932; Cohen, Noah/0000-0002-0384-2903	Link Equine Research Endowment at Texas AM University; Gastrointestinal Laboratory at Texas AM University; Boehringer-Ingelheim Vetmedica; Fort Dodge Animal Health/Pfizer Animal Health	Link Equine Research Endowment at Texas AM University; Gastrointestinal Laboratory at Texas AM University; Boehringer-Ingelheim Vetmedica(Boehringer Ingelheim); Fort Dodge Animal Health/Pfizer Animal Health	This work was supported by the Link Equine Research Endowment at Texas A&M University with additional support provided by the Gastrointestinal Laboratory at Texas A&M University and Boehringer-Ingelheim Vetmedica. Dr. Bordin was supported by a fellowship from Fort Dodge Animal Health/Pfizer Animal Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancelet LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045888; Arnold H, 2004, INFECT IMMUN, V72, P6546, DOI 10.1128/IAI.72.11.6546-6553.2004; Buddington RK, 2003, AM J VET RES, V64, P646, DOI 10.2460/ajvr.2003.64.646; Chaffin MK, 2008, JAVMA-J AM VET MED A, V232, P1035, DOI 10.2460/javma.232.7.1035; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; CHIRINOTREJO JM, 1987, CAN J VET RES, V51, P444; Clark SO, 2010, VACCINE, V28, P7109, DOI 10.1016/j.vaccine.2010.07.087; Costa M, 2011, HORSES 2 GENOME META; Daly K, 2001, FEMS MICROBIOL ECOL, V38, P141, DOI 10.1111/j.1574-6941.2001.tb00892.x; Dawson TRMY, 2010, VET IMMUNOL IMMUNOP, V135, P1, DOI 10.1016/j.vetimm.2009.12.004; Dougal K, 2012, FEMS MICROBIOL ECOL, V82, P642, DOI 10.1111/j.1574-6941.2012.01441.x; Fanaro S, 2003, ACTA PAEDIATR, V92, P48; Garcia-Mazcorro JF, 2012, MICROBIOLOGYOPEN, V1, P340, DOI 10.1002/mbo3.36; Garcia-Mazcorro JF, 2011, FEMS MICROBIOL ECOL, V78, P542, DOI 10.1111/j.1574-6941.2011.01185.x; Garrido JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024905; Giguere S, 2011, J VET INTERN MED, V25, P1221, DOI 10.1111/j.1939-1676.2011.00804.x; Giguere S, 2011, J VET INTERN MED, V25, P1209, DOI 10.1111/j.1939-1676.2011.00835.x; Halbert ND, 2005, AM J VET RES, V66, P1380, DOI 10.2460/ajvr.2005.66.1380; Harris SP, 2010, MICROBIOL-SGM, V156, P1836, DOI 10.1099/mic.0.035915-0; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Hooper-McGrevy KE, 2005, VACCINE, V23, P5760, DOI 10.1016/j.vaccine.2005.07.050; Horowitz ML, 2001, J VET INTERN MED, V15, P171, DOI 10.1892/0891-6640(2001)015&lt;0171:AOSMLD&gt;2.3.CO;2; Inman CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033707; Jain S, 2003, MOL MICROBIOL, V50, P115, DOI 10.1046/j.1365-2958.2003.03689.x; Jia J, 2011, FEMS MICROBIOL ECOL, V78, P395, DOI 10.1111/j.1574-6941.2011.01172.x; KuoLee R, 2007, VACCINE, V25, P3781, DOI 10.1016/j.vaccine.2007.02.014; Mashoof S, 2012, MUCOSAL IMMUNOLOGY; Meijer WG, 2004, VET RES, V35, P383, DOI 10.1051/vetres:2004024; Minamoto Yasushi, 2012, Animal Health Research Reviews, V13, P64, DOI 10.1017/S1466252312000060; Mshvildadze M, 2010, EARLY HUM DEV, V86, pS67, DOI 10.1016/j.earlhumdev.2010.01.018; Muscatello G, 2007, EQUINE VET J, V39, P470, DOI 10.2746/042516407X209217; Paillot R, 2013, VET MICROBIOL, V162, P396, DOI 10.1016/j.vetmic.2012.10.019; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Patton KM, 2005, INFECT IMMUN, V73, P2083, DOI 10.1128/IAI.73.4.2083-2093.2005; PRESCOTT JF, 1991, CLIN MICROBIOL REV, V4, P20, DOI 10.1128/CMR.4.1.20-34.1991; Quan FS, 2012, VACCINE, V30, P180, DOI 10.1016/j.vaccine.2011.11.028; Scholtens PAMJ, 2012, ANNU REV FOOD SCI T, V3, P425, DOI 10.1146/annurev-food-022811-101120; Sealy R, 2012, INT IMMUNOL; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shannon C.E., 1963, MATH THEORY COMMUNIC; Shepherd ML, 2012, FEMS MICROBIOL LETT, V326, P62, DOI 10.1111/j.1574-6968.2011.02434.x; Smith PD, 2013, PRINCIPLES OF MUCOSAL IMMUNOLOGY, P1; Suchodolski JS, 2011, J ANIM SCI, V89, P1520, DOI 10.2527/jas.2010-3377; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051907; Takai S, 1997, VET MICROBIOL, V56, P167, DOI 10.1016/S0378-1135(97)00085-0; Tompkins DM, 2013, VACCINE, V31, P893, DOI 10.1016/j.vaccine.2012.12.003; Torrazza RM, 2011, J PERINATOL, V31, pS29, DOI 10.1038/jp.2010.172; van der Geize R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002181; Venturi A, 1999, ALIMENT PHARM THER, V13, P1103; Villena J, 2008, CAN J MICROBIOL, V54, P845, DOI [10.1139/W08-077, 10.1139/w08-077]; Vitali B, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-4; Whitehead AE, 2012, VET IMMUNOL IMMUNOP, V145, P479, DOI 10.1016/j.vetimm.2011.10.011; Willing BP, 2007, J ANIM SCI, V85, P3256, DOI 10.2527/jas.2007-0320	53	17	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66640	10.1371/journal.pone.0066640	http://dx.doi.org/10.1371/journal.pone.0066640			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785508	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800013
J	Castelhano, J; Rebola, J; Leitao, B; Rodriguez, E; Castelo-Branco, M				Castelhano, Joao; Rebola, Jose; Leitao, Bruno; Rodriguez, Eugenio; Castelo-Branco, Miguel			To Perceive or Not Perceive: The Role of Gamma-band Activity in Signaling Object Percepts	PLOS ONE			English	Article							PHASE SYNCHRONY; ELECTROMAGNETIC TOMOGRAPHY; VISUAL RESPONSES; NEURAL ACTIVITY; EYE TRACKING; OSCILLATIONS; FACE; EEG; INVERSION; CORTEX	The relation of gamma-band synchrony to holistic perception in which concerns the effects of sensory processing, high level perceptual gestalt formation, motor planning and response is still controversial. To provide a more direct link to emergent perceptual states we have used holistic EEG/ERP paradigms where the moment of perceptual "discovery'' of a global pattern was variable. Using a rapid visual presentation of short-lived Mooney objects we found an increase of gamma-band activity locked to perceptual events. Additional experiments using dynamic Mooney stimuli showed that gamma activity increases well before the report of an emergent holistic percept. To confirm these findings in a data driven manner we have further used a support vector machine classification approach to distinguish between perceptual vs. non perceptual states, based on time-frequency features. Sensitivity, specificity and accuracy were all above 95%. Modulations in the 30-75 Hz range were larger for perception states. Interestingly, phase synchrony was larger for perception states for high frequency bands. By focusing on global gestalt mechanisms instead of local processing we conclude that gamma-band activity and synchrony provide a signature of holistic perceptual states of variable onset, which are separable from sensory and motor processing.	[Castelhano, Joao; Rebola, Jose; Castelo-Branco, Miguel] Univ Coimbra, Visual Neurosci Lab, Inst Biomed Imaging & Life Sci, Fac Med, Coimbra, Portugal; [Leitao, Bruno] Univ Coimbra, Ctr Informat & Syst, Coimbra, Portugal; [Rodriguez, Eugenio] Max Planck Inst Brain Res, Frankfurt, Germany; [Rodriguez, Eugenio] Pontificia Univ Catolica Chile, Escuela Psicol, Santiago, Chile	Universidade de Coimbra; Universidade de Coimbra; Max Planck Society; Pontificia Universidad Catolica de Chile	Castelo-Branco, M (corresponding author), Univ Coimbra, Visual Neurosci Lab, Inst Biomed Imaging & Life Sci, Fac Med, Coimbra, Portugal.	mcbranco@fmed.uc.pt	Castelo-Branco, Miguel/F-3866-2019; Direito, Bruno/Y-6099-2018; Castelhano, Joao/I-5090-2019; Castelo-Branco, Miguel/E-5689-2010	Castelo-Branco, Miguel/0000-0003-4364-6373; Direito, Bruno/0000-0002-3259-8815; Castelhano, Joao/0000-0002-8996-1515; Rebola, Jose/0000-0002-6963-9414	COMPETE [PIC/IC/82986/2007]; Bial Foundation; Foundation for Science and Technology Portugal [SFRH/BD/65341/2009];  [PTDC/PSI/67381/2006];  [PEst-C/SAU/UI3282/2013];  [CENTRO-07-ST24-FEDER-00205]	COMPETE; Bial Foundation(Bial Foundation); Foundation for Science and Technology Portugal(Portuguese Foundation for Science and Technology); ; ; 	This work was supported by PTDC/PSI/67381/2006 and COMPETE PIC/IC/82986/2007, PEst-C/SAU/UI3282/2013, CENTRO-07-ST24-FEDER-00205, Bial Foundation grants and a PhD fellowship (SFRH/BD/65341/2009) to JC from the Foundation for Science and Technology Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basar E, 1999, NEUROSCI LETT, V259, P165, DOI 10.1016/S0304-3940(98)00934-3; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; Bernardino I, 2013, NEUROPSYCHO IN PRESS; Castelo-Branco M, 1998, J NEUROSCI, V18, P6395; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Delorme A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/130714; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Engel J, 2012, PROGR NEUROBIOLOGY, P38; Ewald A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00166; Ewald A, 2012, NEUROIMAGE, V60, P476, DOI 10.1016/j.neuroimage.2011.11.084; FARAH MJ, 1995, J EXP PSYCHOL HUMAN, V21, P628, DOI 10.1037/0096-1523.21.3.628; Fingelkurts AA, 2003, BRAIN LANG, V85, P297, DOI 10.1016/S0093-934X(03)00059-2; Fries P, 2008, NEURON, V58, P303, DOI 10.1016/j.neuron.2008.04.020; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Golland P, 2005, INF PROC MED IM P C, V18, P330; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Gruber T, 2001, NEUROSCI LETT, V316, P29, DOI 10.1016/S0304-3940(01)02361-8; Gruber T, 2008, NEURON ONLINE COMMEN; Grutzner C, 2010, J NEUROSCI, V30, P8342, DOI 10.1523/JNEUROSCI.5434-09.2010; Herrmann CS, 2004, TRENDS COGN SCI, V8, P347, DOI 10.1016/j.tics.2004.06.006; HOLM S, 1979, SCAND J STAT, V6, P65; Jemel B, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-100; Kaiser J, 2003, NEUROSCIENTIST, V9, P475, DOI 10.1177/1073858403259137; Keil A, 2001, NEUROSCI BIOBEHAV R, V25, P527, DOI 10.1016/S0149-7634(01)00031-8; Keil A, 1999, J NEUROSCI, V19, P7152, DOI 10.1523/JNEUROSCI.19-16-07152.1999; Keren AS, 2010, NEUROIMAGE, V49, P2248, DOI 10.1016/j.neuroimage.2009.10.057; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Melloni L, 2011, J NEUROSCI, V31, P1386, DOI 10.1523/JNEUROSCI.4570-10.2011; MOONEY CM, 1957, CAN J PSYCHOLOGY, V11, P219, DOI 10.1037/h0083717; Mullen T, 2010, SOC NEUROSCIENCE, V1, P2; Nagasawa T, 2011, NEUROIMAGE, V58, P1101, DOI 10.1016/j.neuroimage.2011.07.043; Nasr S, 2009, J VISION, V9, DOI 10.1167/9.5.5; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nolte G, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00209; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pazo-Alvarez P, 2003, BIOL PSYCHOL, V63, P199, DOI 10.1016/S0301-0511(03)00049-8; Pereira Francisco, 2009, Neuroimage, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Plochl M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00278; Pockett S, 2009, CLIN NEUROPHYSIOL, V120, P695, DOI 10.1016/j.clinph.2008.12.044; Rebola J, 2012, NEUROPSYCHOLOGIA, V50, P3693, DOI 10.1016/j.neuropsychologia.2012.06.020; RHODES G, 1993, COGNITION, V47, P25, DOI 10.1016/0010-0277(93)90061-Y; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; Rossion B, 2008, J VISION, V8, DOI 10.1167/8.4.3; Rossion Bruno, 2002, Behav Cogn Neurosci Rev, V1, P63, DOI 10.1177/1534582302001001004; Roux F, 2012, J NEUROSCI, V32, P12411, DOI 10.1523/JNEUROSCI.0421-12.2012; Scheeringa R, 2011, NEURON, V69, P572, DOI 10.1016/j.neuron.2010.11.044; Schiltz C, 2006, NEUROIMAGE, V32, P1385, DOI 10.1016/j.neuroimage.2006.05.037; Schwartzman DJ, 2011, INT J PSYCHOPHYSIOL, V79, P73, DOI 10.1016/j.ijpsycho.2010.10.006; Schyns PG, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001064; SIMSON R, 1977, ELECTROEN CLIN NEURO, V42, P528, DOI 10.1016/0013-4694(77)90216-4; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Strother L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018705; Supp GG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000684; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Tognoli E, 2009, PROG NEUROBIOL, V87, P31, DOI 10.1016/j.pneurobio.2008.09.014; Treisman A, 1996, CURR OPIN NEUROBIOL, V6, P171, DOI 10.1016/S0959-4388(96)80070-5; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; Uhlhaas PJ, 2006, J NEUROSCI, V26, P8168, DOI 10.1523/JNEUROSCI.2002-06.2006; VALENTINE T, 1988, BRIT J PSYCHOL, V79, P471, DOI 10.1111/j.2044-8295.1988.tb02747.x; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; Yovel G, 2005, CURR BIOL, V15, P2256, DOI 10.1016/j.cub.2005.10.072; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027	66	25	27	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66363	10.1371/journal.pone.0066363	http://dx.doi.org/10.1371/journal.pone.0066363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785494	Green Published, gold, Green Submitted			2022-12-25	WOS:000321038800028
J	Ciapa, B; Philippe, L				Ciapa, Brigitte; Philippe, Laetitia			Intracellular and Extracellular pH and Ca Are Bound to Control Mitosis in the Early Sea Urchin Embryo via ERK and MPF Activities	PLOS ONE			English	Article							CELL-CYCLE; PROTEIN-SYNTHESIS; ACTIVATION; KINASE; EGGS; FERTILIZATION; PHOSPHORYLATION; XENOPUS; ENTRY; ACIDIFICATION	Studies aiming to predict the impact on marine life of ocean acidification and of altered salinity have shown altered development in various species including sea urchins. We have analyzed how external Na, Ca, pH and bicarbonate control the first mitotic divisions of sea urchin embryos. Intracellular free Ca (Cai) and pH (pHi) and the activities of the MAP kinase ERK and of MPF regulate mitosis in various types of cells including oocytes and early embryos. We found that intracellular acidification of fertilized eggs by Na-acetate induces a huge activation of ERK at time of mitosis. This also stops the cell cycle and leads to cell death, which can be bypassed by treatment with the MEK inhibitor U0126. Similar intracellular acidification induced in external medium containing low sodium or 5-(N-Methyl-N-isobutyl) amiloride, an inhibitor of the Na+/H+ exchanger, also stops the cell cycle and leads to cell death. In that case, an increase in Cai and in the phosphorylation of tyr-cdc2 occurs during mitosis, modifications that depend on external Ca. Our results indicate that the levels of pHi and Cai determine accurate levels of Ptyr-Cdc2 and P-ERK capable of ensuring progression through the first mitotic cycles. These intracellular parameters rely on external Ca, Na and bicarbonate, alterations of which during climate changes could act synergistically to perturb the early marine life.	[Ciapa, Brigitte; Philippe, Laetitia] Univ Paris 06, CNRS UMR 8195, CNPS, Orsay, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet	Ciapa, B (corresponding author), Univ Paris 06, CNRS UMR 8195, CNPS, Orsay, France.	brigitte.ciapa@u-psud.fr			CNRS	CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirand C, 2000, BIOL CELL, V92, P409, DOI 10.1016/S0248-4900(00)01080-7; ARION D, 1989, EXP CELL RES, V183, P361, DOI 10.1016/0014-4827(89)90397-2; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Carballeira C, 2011, MAR ENVIRON RES, V72, P196, DOI 10.1016/j.marenvres.2011.08.008; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Chiri S, 1998, J CELL SCI, V111, P2519; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; EDGECOMBE M, 1991, EMBO J, V10, P3769, DOI 10.1002/j.1460-2075.1991.tb04946.x; Epel D., 1978, Current Topics in Developmental Biology, V12, P185, DOI 10.1016/S0070-2153(08)60597-9; Fremin C, 2009, HEPATOLOGY, V49, P930, DOI 10.1002/hep.22730; GRAINGER JL, 1979, DEV BIOL, V68, P396, DOI 10.1016/0012-1606(79)90213-6; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HACCARD O, 1993, SCIENCE, V262, P1262, DOI 10.1126/science.8235656; Hamaguchi MS, 2001, DEV GROWTH DIFFER, V43, P447, DOI 10.1046/j.1440-169x.2001.00578.x; Hara M, 2009, DEVELOPMENT, V136, P1687, DOI 10.1242/dev.035261; Harrison PK, 2002, CELL CALCIUM, V31, P289, DOI 10.1016/S0143-4160(02)00057-X; Huang WC, 2009, CELL CALCIUM, V45, P391, DOI 10.1016/j.ceca.2009.01.002; Iwamoto T, 2004, J PHARMACOL SCI, V96, P27, DOI 10.1254/jphs.FMJ04002X6; JOHNSON CH, 1981, J CELL BIOL, V89, P284, DOI 10.1083/jcb.89.2.284; Kishimoto T, 2003, CURR OPIN CELL BIOL, V15, P654, DOI 10.1016/j.ceb.2003.10.010; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; Kumano M, 2001, DEV BIOL, V236, P244, DOI 10.1006/dbio.2001.0328; Kurihara H, 2004, MAR ECOL PROG SER, V274, P161, DOI 10.3354/meps274161; Liu Y, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096826; LOPO A, 1977, NATURE, V269, P590, DOI 10.1038/269590a0; Machaca K, 2007, J CELL PHYSIOL, V213, P331, DOI 10.1002/jcp.21194; Malo ME, 2006, CAN J PHYSIOL PHARM, V84, P1081, DOI 10.1139/Y06-065; Martin S, 2011, J EXP BIOL, V214, P1357, DOI 10.1242/jeb.051169; McCarty MF, 2010, ALTERN MED REV, V15, P264; Mukai S, 2011, ARCH TOXICOL, V85, P149, DOI 10.1007/s00204-010-0556-2; Murakami MS, 1998, DEVELOPMENT, V125, P237; O'Donnell M, 2009, MAR BIOL, V156, P439, DOI 10.1007/s00227-008-1097-6; Patel R, 1999, J BIOL CHEM, V274, P7958, DOI 10.1074/jbc.274.12.7958; PAYAN P, 1983, DEV BIOL, V100, P29, DOI 10.1016/0012-1606(83)90197-5; Philipova R, 2005, J BIOL CHEM, V280, P24957, DOI 10.1074/jbc.M414437200; Place SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034068; Putney LK, 2003, J BIOL CHEM, V278, P44645, DOI 10.1074/jbc.M308099200; REES BB, 1995, DEV BIOL, V169, P683, DOI 10.1006/dbio.1995.1179; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Ruknudin AM, 2007, ANN NY ACAD SCI, V1099, P86, DOI 10.1196/annals.1387.045; Santo-Domingo J, 2007, BRIT J PHARMACOL, V151, P647, DOI 10.1038/sj.bjp.0707260; Sato T, 2006, J PHARMACOL EXP THER, V316, P182, DOI 10.1124/jpet.105.094029; Schreiber R, 2005, J MEMBRANE BIOL, V205, P129, DOI 10.1007/s00232-005-0778-z; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Soliman EM, 2009, CELL CALCIUM, V45, P284, DOI 10.1016/j.ceca.2008.11.006; Stumpp M, 2012, P NATL ACAD SCI USA, V109, P18192, DOI 10.1073/pnas.1209174109; Sunda WG, 2012, ENVIRON SCI TECHNOL, V46, P10651, DOI 10.1021/es300626f; SUPRYNOWICZ FA, 1985, P NATL ACAD SCI USA, V82, P2389, DOI 10.1073/pnas.82.8.2389; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Uhlen P, 2010, BIOCHEM BIOPH RES CO, V396, P28, DOI 10.1016/j.bbrc.2010.02.117; Vaughan-Jones RD, 2009, J MOL CELL CARDIOL, V46, P318, DOI 10.1016/j.yjmcc.2008.10.024; Whitaker M, 2006, CELL CALCIUM, V40, P585, DOI 10.1016/j.ceca.2006.08.018; Wilding M, 1996, J CELL BIOL, V135, P191, DOI 10.1083/jcb.135.1.191; Wu JQ, 2008, J CELL SCI, V121, P3509, DOI 10.1242/jcs.036855; Yue JB, 2004, CURR BIOL, V14, P1581, DOI 10.1016/j.cub.2004.08.056; Zhang WL, 2005, DEV BIOL, V282, P192, DOI 10.1016/j.ydbio.2005.03.008; Zhang WL, 2006, J CELL SCI, V119, P491; ZOREC R, 1993, PFLUG ARCH EUR J PHY, V423, P41, DOI 10.1007/BF00374959	59	18	21	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66113	10.1371/journal.pone.0066113	http://dx.doi.org/10.1371/journal.pone.0066113			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785474	Green Submitted, gold, Green Published			2022-12-25	WOS:000321038800047
J	Stuber, EF; Verpeut, J; Horvat-Gordon, M; Ramachandran, R; Bartell, PA				Stuber, Erica F.; Verpeut, Jessica; Horvat-Gordon, Maria; Ramachandran, Ramesh; Bartell, Paul A.			Differential Regulation of Adipokines May Influence Migratory Behavior in the White-Throated Sparrow (Zonotrichia albicollis)	PLOS ONE			English	Article							FATTY-ACID OXIDATION; CIRCADIAN-RHYTHMS; ADIPOSE-TISSUE; ENDOCRINE ORGAN; ENERGETIC CONDITION; METABOLIC SYNDROME; SKELETAL-MUSCLE; CHICKEN LEPTIN; BIRD MIGRATION; WEIGHT-LOSS	White-throated sparrows increase fat deposits during pre-migratory periods and rely on these fat stores to fuel migration. Adipose tissue produces hormones and signaling factors in a rhythmic fashion and may be controlled by a clock in adipose tissue or driven by a master clock in the brain. The master clock may convey photoperiodic information from the environment to adipose tissue to facilitate pre-migratory fattening, and adipose tissue may, in turn, release adipokines to indicate the extent of fat energy stores. Here, we present evidence that a change in signal from the adipokines adiponectin and visfatin may act to indicate body condition, thereby influencing an individual's decision to commence migratory flight, or to delay until adequate fat stores are acquired. We quantified plasma adiponectin and visfatin levels across the day in captive birds held under constant photoperiod. The circadian profiles of plasma adiponectin in non-migrating birds were approximately inverse the profiles from migrating birds. Adiponectin levels were positively correlated to body fat, and body fat was inversely related to the appearance of nocturnal migratory restlessness. Visfatin levels were constant across the day and did not correlate with fat deposits; however, a reduction in plasma visfatin concentration occurred during the migratory period. The data suggest that a significant change in the biological control of adipokine expression exists between the two migratory conditions and we propose a role for adiponectin, visfatin and adipose clocks in the regulation of migratory behaviors.	[Stuber, Erica F.; Verpeut, Jessica; Horvat-Gordon, Maria; Ramachandran, Ramesh; Bartell, Paul A.] Penn State Univ, Dept Anim Sci, University Pk, PA 16802 USA; [Stuber, Erica F.; Bartell, Paul A.] Penn State Univ, Grad Program Ecol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Bartell, PA (corresponding author), Penn State Univ, Dept Anim Sci, University Pk, PA 16802 USA.	pab43@psu.edu	Stuber, Erica/AAT-2803-2020	Stuber, Erica/0000-0002-2687-6874; Verpeut, Jessica/0000-0003-2941-7697	Pennsylvania State University Dept. of Poultry Science; Pennsylvania State University College of Agricultural Sciences	Pennsylvania State University Dept. of Poultry Science; Pennsylvania State University College of Agricultural Sciences	This project was funded by The Pennsylvania State University Dept. of Poultry Science and College of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamidor SE, 2011, INTEGR COMP BIOL, V51, P385, DOI 10.1093/icb/icr054; Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Ahima RS, 2006, OBESITY, V14, p9S, DOI 10.1038/oby.2006.276; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Alfaro ME, 2006, SYST BIOL, V55, P89, DOI 10.1080/10635150500433565; Arble DM, 2011, PLOS ONE, P6; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Arizaga J, 2011, J ORNITHOL, V152, P991, DOI 10.1007/s10336-011-0685-2; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Attie AD, 2009, J LIPID RES, V50, pS395, DOI 10.1194/jlr.R800057-JLR200; Barnea M, 2009, ENDOCRINOLOGY, V150, P161, DOI 10.1210/en.2008-0944; Bartell PA, 2005, J BIOL RHYTHM, V20, P538, DOI 10.1177/0748730405281826; Bartness TJ, 2007, PHYSIOL BEHAV, V91, P343, DOI 10.1016/j.physbeh.2007.04.002; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; BERTHOLD P, 1984, BIRD STUDY, V31, P19, DOI 10.1080/00063658409476810; BERTHOLD P, 1990, EXPERIENTIA, V46, P363, DOI 10.1007/BF01952169; Bottcher Y, 2006, J CLIN ENDOCR METAB, V91, P2725, DOI 10.1210/jc.2006-0149; Bray MS, 2007, OBES REV, V8, P169, DOI 10.1111/j.1467-789X.2006.00277.x; CAGNACCI A, 1992, J CLIN ENDOCR METAB, V75, P447, DOI 10.1210/jc.75.2.447; Cajochen C, 2003, J NEUROENDOCRINOL, V15, P432, DOI 10.1046/j.1365-2826.2003.00989.x; Calvani M, 2004, DIABETES, V53, P939, DOI 10.2337/diabetes.53.4.939; Cerasale DJ, 2011, GEN COMP ENDOCR, V174, P276, DOI 10.1016/j.ygcen.2011.08.025; Coppack T, 2011, J ORNITHOL, V152, P67, DOI 10.1007/s10336-011-0708-z; Covino KM, 2011, AUK, V128, P313, DOI 10.1525/auk.2011.09225; Del Turco S, 2011, MICROVASC RES, V82, P73, DOI 10.1016/j.mvr.2011.03.003; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; EYSTER MB, 1954, ECOL MONOGR, V24, P1, DOI 10.2307/1943509; FARNER DS, 1957, ANAT REC, V128, P546; Farooqi IS, 2009, AM J CLIN NUTR, V89, p980S, DOI 10.3945/ajcn.2008.26788C; Friedman-Einat M, 1999, GEN COMP ENDOCR, V115, P354, DOI 10.1006/gcen.1999.7322; Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Fusani L, 2009, BIOL LETTERS, V5, P302, DOI 10.1098/rsbl.2008.0755; Gomez-Abellan P, 2010, ENDOCRINOLOGY, V151, P115, DOI 10.1210/en.2009-0647; Goto T, 2012, J NUTR BIOCHEM, V23, P768, DOI 10.1016/j.jnutbio.2011.04.001; Goymann W, 2010, BIOL LETTERS, V6, P478, DOI 10.1098/rsbl.2009.1028; Guglielmo CG, 2010, INTEGR COMP BIOL, V50, P336, DOI 10.1093/icb/icq097; Gwinner E, 1996, IBIS, V138, P47, DOI 10.1111/j.1474-919X.1996.tb04312.x; GWINNER E, 1977, ANNU REV ECOL SYST, V8, P381, DOI 10.1146/annurev.es.08.110177.002121; Gwinner E, 1996, J EXP BIOL, V199, P39; Hendricks GL, 2009, ENDOCRINOLOGY, V150, P3092, DOI 10.1210/en.2008-1558; Hui XY, 2012, BRIT J PHARMACOL, V165, P574, DOI 10.1111/j.1476-5381.2011.01395.x; Hut R, 2007, CIRCWAVE; Janovska A, 2008, MOL CELL ENDOCRINOL, V284, P1, DOI 10.1016/j.mce.2007.12.013; Jenni L, 1998, J AVIAN BIOL, V29, P521, DOI 10.2307/3677171; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; KAISER A, 1992, BIRD STUDY, V39, P96, DOI 10.1080/00063659209477105; KAISER A, 1993, J FIELD ORNITHOL, V64, P246; Kalra SP, 2003, REGUL PEPTIDES, V111, P1, DOI 10.1016/S0167-0115(02)00305-1; Kalsbeek A, 2001, ENDOCRINOLOGY, V142, P2677, DOI 10.1210/en.142.6.2677; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; KING JAMES R., 1963, CONDOR, V65, P200, DOI 10.2307/1365665; Knutson KL, 2008, ANN NY ACAD SCI, V1129, P287, DOI 10.1196/annals.1417.033; Krzysik-Walker SM, 2008, ENDOCRINOLOGY, V149, P1543, DOI 10.1210/en.2007-1301; Kumar V, 2010, PHYSIOL BIOCHEM ZOOL, V83, P827, DOI 10.1086/652243; LABOVITZ S, 1970, AM SOCIOL REV, V35, P515, DOI 10.2307/2092993; Lago F, 2009, TRENDS BIOCHEM SCI, V34, P500, DOI 10.1016/j.tibs.2009.06.008; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Liu QQ, 2012, P NATL ACAD SCI USA, V109, P14568, DOI 10.1073/pnas.1211611109; Maddineni S, 2005, ENDOCRINOLOGY, V146, P4250, DOI 10.1210/en.2005-0254; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Mattevi A, 2006, NAT STRUCT MOL BIOL, V13, P563, DOI 10.1038/nsmb0706-563; McMillan J.P., 1972, Journal Comp Physiol, V79, P105, DOI 10.1007/BF00697766; MCMILLAN JP, 1970, BIOSCIENCE, V20, P1259, DOI 10.2307/1295520; MEIER AH, 1976, AM ZOOL, V16, P649; Mohamed-Ali V, 1998, INT J OBESITY, V22, P1145, DOI 10.1038/sj.ijo.0800770; OBRIEN RM, 1979, AM SOCIOL REV, V44, P851, DOI 10.2307/2094532; Ocon-Grove OM, 2008, REPRODUCTION, V136, P627, DOI 10.1530/REP-07-0446; ODUM EP, 1960, AM J CLIN NUTR, V8, P621, DOI 10.1093/ajcn/8.5.621; Ohkubo T, 2008, J POULT SCI, V45, P233, DOI 10.2141/jpsa.45.233; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Partecke J, 2007, ECOLOGY, V88, P882, DOI 10.1890/06-1105; Penicaud L, 2012, BIOCHIMIE, V94, P2069, DOI 10.1016/j.biochi.2012.04.013; PILO B, 1983, COMP BIOCHEM PHYS A, V74, P601, DOI 10.1016/0300-9629(83)90554-6; Pitel F, 2000, ANIM GENET, V31, P281, DOI 10.1046/j.1365-2052.2000.00610.x; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Salewski V, 2010, J ORNITHOL, V151, P371, DOI 10.1007/s10336-009-0464-5; Sassone-Corsi P, 2012, ENDOCRINOLOGY, V153, P1, DOI 10.1210/en.2011-1535; Schaub M, 2000, OECOLOGIA, V122, P306, DOI 10.1007/s004420050036; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Scheuerlein A, 2001, P ROY SOC B-BIOL SCI, V268, P1575, DOI 10.1098/rspb.2001.1691; Sharp PJ, 2008, GEN COMP ENDOCR, V158, P2, DOI 10.1016/j.ygcen.2008.05.018; SNYDER SH, 1964, LIFE SCI, V3, P1175, DOI 10.1016/0024-3205(64)90137-7; Staiger H, 2003, OBES RES, V11, P368, DOI 10.1038/oby.2003.48; Studds CE, 2005, ECOLOGY, V86, P2380, DOI 10.1890/04-1145; Stutchbury BJM, 2011, P ROY SOC B-BIOL SCI, V278, P131, DOI 10.1098/rspb.2010.1220; te Marvelde L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034090; Team R. D. C., 2008, R LANG ENV STAT COMP; Ukkola O, 2002, J MOL MED, V80, P696, DOI 10.1007/s00109-002-0378-7; Waldstreicher J, 1996, J CLIN ENDOCR METAB, V81, P1483, DOI 10.1210/jc.81.4.1483; WEISE CM, 1956, ECOLOGY, V37, P274, DOI 10.2307/1933139; Xie H, 2007, CALCIFIED TISSUE INT, V80, P201, DOI 10.1007/s00223-006-0155-7; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; YOKOYAMA K, 1976, CELL TISSUE RES, V174, P391; Zajac DM, 2011, GEN COMP ENDOCR, V174, P269, DOI 10.1016/j.ygcen.2011.08.024; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	101	14	14	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e59097	10.1371/journal.pone.0059097	http://dx.doi.org/10.1371/journal.pone.0059097			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785393	Green Submitted, gold, Green Published			2022-12-25	WOS:000321038800124
J	Aiken, CE; Tarry-Adkins, JL; Ozanne, SE				Aiken, Catherine E.; Tarry-Adkins, Jane L.; Ozanne, Susan E.			Suboptimal nutrition in utero causes DNA damage and accelerated aging of the female reproductive tract	FASEB JOURNAL			English	Article						developmental programming; senescence; mitochondrial DNA; reproduction	OXIDATIVE STRESS; PROTEIN RESTRICTION; TELOMERASE ACTIVITY; MATERNAL NUTRITION; POSTNATAL-GROWTH; DEFENSE CAPACITY; COPY NUMBER; FETAL; EXPRESSION; AGE	Early life exposure to adverse environments can lead to a variety of metabolic and cardiovascular diseases in offspring. We hypothesize that female reproductive function may also be affected, with subsequent implications for fertility. We used an established maternal low-protein model where animals are born small but undergo rapid postnatal catch-up growth by suckling a control-fed dam (recuperated offspring). Markers of oxidative stress and cellular aging in reproductive tract tissues were assessed at 3 and 6 mo of age. Recuperated offspring had lower birth weight than controls (P<0.01) but caught up during lactation. 4-Hydroxynonenal (4HNE; an indicator of oxidative stress) was increased in recuperated animals compared with controls in both ovaries and oviducts at 6 mo. At 3 and 6 mo, ovaries and oviducts of recuperated offspring had increased mitochondrial (mt)DNA copy number (P<0.01). By contrast, germ-line cells showed no difference in mtDNA copy number, suggesting they were protected from suboptimal maternal nutrition. Oviduct and somatic ovarian telomere length declined more rapidly with age in recuperated animals. This accelerated cellular aging was associated with a declined ovarian reserve in developmentally programmed animals. These findings have significant clinical implications in light of worldwide trends to delayed childbearing.Aiken, C. E., Tarry-Adkins, J. L., Ozanne, S. E. Suboptimal nutrition in utero causes DNA damage and accelerated aging of the female reproductive tract.	[Aiken, Catherine E.; Tarry-Adkins, Jane L.; Ozanne, Susan E.] Univ Cambridge, Metab Res Labs, Cambridge CB2 OQQ, England; [Aiken, Catherine E.] Addenbrookes Hosp, Med Res Council Metab Dis Unit, Inst Metab Sci, Cambridge, England; [Aiken, Catherine E.] Univ Cambridge, Dept Obstet & Gynaecol, Cambridge CB2 OQQ, England; [Aiken, Catherine E.] Rosie Hosp, Cambridge, England; [Aiken, Catherine E.] Natl Inst Hlth Res Cambridge Comprehens Biomed Re, Cambridge, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Aiken, CE (corresponding author), Univ Cambridge, Metab Res Labs, Inst Metab Sci, Addenbrookes Treatment Ctr,Addenbrookes Hosp, Level 4,Box 289,Hills Rd, Cambridge CB2 OQQ, England.	cema2@cam.ac.uk		Ozanne, Susan/0000-0001-8753-5144	British Maternal Fetal Medicine Society; Gynaecological Cancer Fund; Addenbrooke's Charitable Trust; British Heart Foundation [PG/09/037/27387, FS/09/029/27902] Funding Source: researchfish; Medical Research Council [G0600717, G0600717B, MC_UU_12012/5/B, MC_UU_12012/4] Funding Source: researchfish; MRC [MC_UU_12012/5, G0600717, MC_UU_12012/4] Funding Source: UKRI	British Maternal Fetal Medicine Society; Gynaecological Cancer Fund; Addenbrooke's Charitable Trust; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work reported here was funded jointly by grants from the British Maternal Fetal Medicine Society, the Gynaecological Cancer Fund, and Addenbrooke's Charitable Trust. S.E.O. is a British Heart Foundation Senior Fellow and a member of the University of Cambridge Medical Research Council Metabolic Diseases Unit. The authors declare no conflicts of interest.	Albertini DF, 2012, J ASSIST REPROD GEN, V29, P577, DOI 10.1007/s10815-012-9832-9; Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7; Bentov Y, 2011, J ASSIST REPROD GEN, V28, P773, DOI 10.1007/s10815-011-9588-7; Bernal AB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015558; Botting B, 2000, Popul Trends, P32; Buhi WC, 1997, BIOL REPROD, V57, P7, DOI 10.1095/biolreprod57.1.7; Chen JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004950; Cheong AWY, 2009, BIOL REPROD, V81, P126, DOI 10.1095/biolreprod.108.071449; Chernoff N, 2009, REPROD TOXICOL, V28, P489, DOI 10.1016/j.reprotox.2009.06.006; de Bruin JP, 2004, BIOL REPROD, V70, P419, DOI 10.1095/biolreprod.103.015784; de Bruin JP, 1998, EARLY HUM DEV, V51, P39, DOI 10.1016/S0378-3782(97)00073-X; Arganaraz ME, 2012, ZYGOTE, V20, P53, DOI 10.1017/S0967199410000602; Eisenhauer KM, 1997, BIOL REPROD, V56, P1120, DOI 10.1095/biolreprod56.5.1120; Elias SG, 2003, MENOPAUSE, V10, P399, DOI 10.1097/01.GME.0000059862.93639.C1; Faddy MJ, 2000, MOL CELL ENDOCRINOL, V163, P43, DOI 10.1016/S0303-7207(99)00238-5; GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175; Guzman C, 2006, J PHYSIOL-LONDON, V572, P97, DOI 10.1113/jphysiol.2005.103903; Haussmann MF, 2003, P ROY SOC B-BIOL SCI, V270, P1387, DOI 10.1098/rspb.2003.2385; HIRSHFIELD AN, 1978, BIOL REPROD, V19, P597, DOI 10.1095/biolreprod19.3.597; Ibanez L, 2007, HUM REPROD, V22, P395, DOI 10.1093/humrep/del395; Igosheva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010074; Kawanishi S, 2004, ANN NY ACAD SCI, V1019, P278, DOI 10.1196/annals.1297.047; Knudsen Thomas B, 2004, Birth Defects Res C Embryo Today, V72, P313, DOI 10.1002/bdrc.20028; Lee KF, 2002, BIOCHEM BIOPH RES CO, V292, P564, DOI 10.1006/bbrc.2002.6676; Li Q, 2012, SCI CHINA LIFE SCI, V55, P659, DOI 10.1007/s11427-012-4352-5; Lim J, 2011, BIOL REPROD, V84, P775, DOI 10.1095/biolreprod.110.088583; Liu JP, 2010, REPRODUCTION, V140, P215, DOI 10.1530/REP-10-0008; Meikle D, 2001, REPRODUCTION, V122, P437, DOI 10.1530/rep.0.1220437; Miranda S, 1999, BIOCHEM BIOPH RES CO, V258, P44, DOI 10.1006/bbrc.1999.0580; MURRAY MK, 1995, MICROSC RES TECHNIQ, V31, P497, DOI 10.1002/jemt.1070310606; Nicklas JA, 2004, ENVIRON MOL MUTAGEN, V44, P313, DOI 10.1002/em.20050; Ozanne SE, 2007, NAT CLIN PRACT ENDOC, V3, P539, DOI 10.1038/ncpendmet0531; Rae MT, 2002, ANIM REPROD SCI, V72, P63, DOI 10.1016/S0378-4320(02)00068-4; Rhind SM, 2001, REPRODUCTION, V122, P205, DOI 10.1530/rep.0.1220205; Sloboda DM, 2007, J CLIN ENDOCR METAB, V92, P46, DOI 10.1210/jc.2006-1378; Sloboda DM, 2011, HUM REPROD UPDATE, V17, P210, DOI 10.1093/humupd/dmq048; SNOECK A, 1990, BIOL NEONATE, V57, P107, DOI 10.1159/000243170; Sullivan TM, 2009, REPROD FERT DEVELOP, V21, P773, DOI 10.1071/RD09004; Tarry-Adkins JL, 2008, FASEB J, V22, P2037, DOI 10.1096/fj.07-099523; Tarry-Adkins JL, 2013, FASEB J, V27, P379, DOI 10.1096/fj.12-218685; Tarry-Adkins JL, 2011, AM J CLIN NUTR, V94, p1765S, DOI 10.3945/ajcn.110.000620; Tarry-Adkins JL, 2006, AM J PHYSIOL-RENAL, V290, pF509, DOI 10.1152/ajprenal.00215.2005; Tatone C, 2008, HUM REPROD UPDATE, V14, P131, DOI 10.1093/humupd/dmm048; Tatone C, 2013, FERTIL STERIL, V99, P12, DOI 10.1016/j.fertnstert.2012.11.029; Yamagata Y, 2002, ENDOCR J, V49, P589, DOI 10.1507/endocrj.49.589	46	33	34	1	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					3959	3965		10.1096/fj.13-234484	http://dx.doi.org/10.1096/fj.13-234484			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23792302				2022-12-25	WOS:000329747100011
J	Choi, J; Lin, A; Shrier, E; Lau, LF; Grant, MB; Chaqour, B				Choi, Jinok; Lin, Ann; Shrier, Eric; Lau, Lester F.; Grant, Maria B.; Chaqour, Brahim			Degradome Products of the Matricellular Protein CCN1 as Modulators of Pathological Angiogenesis in the Retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-INDUCED RETINOPATHY; GENE-EXPRESSION; ENDOTHELIAL-CELLS; ADHESION RECEPTOR; CYR61 CCN1; FAMILY; IDENTIFICATION; MUSCLE; ALPHA(6)BETA(1); MECHANISMS	CCN1 is a matricellular protein involved in normal vascular development and tissue repair. CCN1 exhibits cell-and context-dependent activities that are reflective of its tetramodular structure phylogenetically linked to four domains found in various matrix proteins. Here, we show that vitreal fluids from patients with proliferative diabetic retinopathy (PDR) were enriched with a two-module form of CCN1 comprising completely or partially the insulin-like growth factor-binding protein (IGFBP) and von Willebrand factor type C (vWC) domains. The two-and three-module forms comprising, in addition to IGFBP and vWC, the thrombospondin type 1 (TSP1) repeats are CCN1 degradome products by matrix metalloproteinase-2 and -14. The functional significance of CCN1 and its truncated variants was determined in the mouse model of oxygen-induced retinopathy, which simulates neovascular growth associated with PDR and assesses treatment outcomes. In this model, lentivirus-mediated expression of either CCN1 or the IGFBP-vWC-TSP1 form reduced ischemia-induced neovascularization, whereas ectopic expression of the IGFBP-vWC variant exacerbated pathological angiogenesis. The IGFBP-vWC form has potent proangiogenic properties promoting retinal endothelial cell growth, migration, and three-dimensional tubular structure formation, whereas the IGFBP-vWC-TSP1 variant suppressed cell growth and angiogenic gene expression. Both IGFBP-vWC and IGFBP-vWC-TSP1 forms exhibited predictable variations of their domain folding that enhanced their functional potential. These data provide new insights into the formation and activities of CCN1-truncated variants and raise the predictive value of the form containing completely or partially the IGFBP and vWC domains as a surrogate marker of CCN1 activity in PDR distinguishing pathological from physiological angiogenesis.	[Choi, Jinok; Lin, Ann; Chaqour, Brahim] Suny Downstate Med Ctr, Dept Cell Biol, SUNY Eye Inst, Brooklyn, NY 11203 USA; [Shrier, Eric; Chaqour, Brahim] Suny Downstate Med Ctr, Dept Ophthalmol, SUNY Eye Inst, Brooklyn, NY 11203 USA; [Lau, Lester F.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Grant, Maria B.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; State University System of Florida; University of Florida	Chaqour, B (corresponding author), Suny Downstate Med Ctr, 450 Clarkson Ave,Box 5, Brooklyn, NY 11203 USA.	bchaqour@downstate.edu	Shrier, Eric/AAA-3869-2020; Chaqour, Brahim/AEH-1314-2022	Chaqour, Brahim/0000-0002-8516-4324; Lau, Lester/0000-0002-4364-2914	National Institutes of Health from NEI [EY022091-01, EY019387 -01A1, EY01260-12, EY007739-23]; NATIONAL EYE INSTITUTE [R01EY007739, R01EY022091, R29EY007739, R21EY019387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078492] Funding Source: NIH RePORTER	National Institutes of Health from NEI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY022091-01 and EY019387 -01A1 (to B. C.) and EY01260-12 and EY007739-23 from NEI (to M. B. G.).	Athanasopoulos AN, 2007, J BIOL CHEM, V282, P26746, DOI 10.1074/jbc.M705200200; Boosani CS, 2011, PHARMACEUTICALS, V4, P1551, DOI 10.3390/ph4121551; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; Bradley John, 2007, Angiogenesis, V10, P141, DOI 10.1007/s10456-007-9069-x; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Butler GS, 2008, MOL CELL BIOL, V28, P4896, DOI 10.1128/MCB.01775-07; Butler JM, 2005, J CLIN INVEST, V115, P86, DOI 10.1172/JCI200522869; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chintala H, 2012, J BIOL CHEM, V287, P40570, DOI 10.1074/jbc.M112.386565; d'Ortho MP, 1997, EUR J BIOCHEM, V250, P751, DOI 10.1111/j.1432-1033.1997.00751.x; Dean RA, 2007, MOL CELL BIOL, V27, P8454, DOI 10.1128/MCB.00821-07; Elzie CA, 2004, INT J BIOCHEM CELL B, V36, P1090, DOI 10.1016/j.biocel.2003.12.012; Fukushima Y, 2011, J CLIN INVEST, V121, P1974, DOI 10.1172/JCI44900; Gao RP, 2003, HEPATOL RES, V27, P214, DOI 10.1016/S1386-6346(03)00241-9; Grote K, 2007, BLOOD, V110, P877, DOI 10.1182/blood-2006-07-036202; Guillon-Munos A, 2011, J BIOL CHEM, V286, P25505, DOI 10.1074/jbc.M110.213231; Hasan A, 2011, J BIOL CHEM, V286, P9542, DOI 10.1074/jbc.M110.198689; Hilfiker-Kleiner D, 2004, CIRCULATION, V109, P2227, DOI 10.1161/01.CIR.0000127952.90508.9D; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Hughes JM, 2007, DIABETOLOGIA, V50, P1089, DOI 10.1007/s00125-007-0621-4; Huwiler KG, 2002, BIOCHEMISTRY-US, V41, P14329, DOI 10.1021/bi026463u; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Ishida S, 2003, J EXP MED, V198, P483, DOI 10.1084/jem.20022027; Jin Y, 2005, AM J RESP CELL MOL, V33, P297, DOI 10.1165/rcmb.2005-0144OC; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Karagiannis ED, 2008, P NATL ACAD SCI USA, V105, P13775, DOI 10.1073/pnas.0803241105; Kivela R, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-13; Koziol A, 2012, FASEB J, V26, P4481, DOI 10.1096/fj.12-205906; Kubota Satoshi, 2007, Angiogenesis, V10, P1, DOI 10.1007/s10456-006-9058-5; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Leu SJ, 2003, J BIOL CHEM, V278, P33801, DOI 10.1074/jbc.M305862200; Leu SJ, 2002, J BIOL CHEM, V277, P46248, DOI 10.1074/jbc.M209288200; Liu HB, 2008, ENDOCRINOLOGY, V149, P1666, DOI 10.1210/en.2007-1415; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; MacKenzie TC, 2002, MOL THER, V6, P349, DOI 10.1006/mthe.2002.0681; Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282; O'Leary JM, 2004, J BIOL CHEM, V279, P53857, DOI 10.1074/jbc.M409225200; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Pendurthi UR, 2005, CANCER RES, V65, P9705, DOI 10.1158/0008-5472.CAN-05-0982; Perbal B, 2009, J CELL COMMUN SIGNAL, V3, P153, DOI 10.1007/s12079-009-0051-9; Rivera JC, 2011, NEONATOLOGY, V100, P343, DOI 10.1159/000330174; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; SCHLINGEMANN RO, 1991, AM J PATHOL, V138, P1335; Schober JM, 2002, BLOOD, V99, P4457, DOI 10.1182/blood.V99.12.4457; Schutze N, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-45; Scott A, 2010, EYE, V24, P416, DOI 10.1038/eye.2009.306; Segarini PR, 2001, J BIOL CHEM, V276, P40659, DOI 10.1074/jbc.M105180200; Senger DR, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005090; Shi F, 2011, J CELL SCI, V124, P4039, DOI 10.1242/jcs.087858; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Song JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050300; Tamura I, 2001, AM J PHYSIOL-CELL PH, V281, pC1524, DOI 10.1152/ajpcell.2001.281.5.C1524; van Wijngaarden P, 2007, MOL VIS, V13, P1508; Wang H, 2013, EXP EYE RES, V108, P110, DOI 10.1016/j.exer.2012.11.023; Yan LL, 2013, J CELL COMMUN SIGNAL, V7, P253, DOI 10.1007/s12079-013-0206-6; Zhang X, 2012, GRAEF ARCH CLIN EXP, V250, P661, DOI 10.1007/s00417-011-1882-7; Zhou DM, 2005, J APPL PHYSIOL, V98, P2344, DOI 10.1152/japplphysiol.01093.2004; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	59	25	27	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23075	23089		10.1074/jbc.M113.475418	http://dx.doi.org/10.1074/jbc.M113.475418			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23798676	Green Published, hybrid			2022-12-25	WOS:000330598200016
J	Bournier, M; Tissot, N; Mari, S; Boucherez, J; Lacombe, E; Briat, JF; Gaymard, F				Bournier, Marc; Tissot, Nicolas; Mari, Stephane; Boucherez, Jossia; Lacombe, Eric; Briat, Jean-Francois; Gaymard, Frederic			Arabidopsis Ferritin 1 (AtFer1) Gene Regulation by the Phosphate Starvation Response 1 (AtPHR1) Transcription Factor Reveals a Direct Molecular Link between Iron and Phosphate Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR PHR1; DEFICIENCY; PLANTS; IDENTIFICATION; EXPRESSION; THALIANA; STORAGE	A yeast one-hybrid screening allowed the selection of PHR1 as a factor that interacted with the AtFer1 ferritin gene promoter. In mobility shift assays, PHR1 and its close homologue PHL1 (PHR1-like 1) interact with Element 2 of the AtFer1 promoter, containing a P1BS (PHR1 binding site). In a loss of function mutant for genes encoding PHR1 and PHL1 (phr1 phl1 mutant), the response of AtFer1 to phosphate starvation was completely lost, showing that the two transcription factors regulate AtFer1 expression upon phosphate starvation. This regulation does not involve the IDRS (iron-dependent regulatory sequence) present in the AtFer1 promoter and involved in the iron-dependent regulation. The phosphate starvation response of AtFer1 is not linked to the iron status of plants and is specifically initiated by phosphate deficiency. Histochemical localization of iron, visualized by Perls DAB staining, was strongly altered in a phr1 phl1 mutant, revealing that both PHR1 and PHL1 are major factors involved in the regulation of iron homeostasis.	[Bournier, Marc; Tissot, Nicolas; Mari, Stephane; Boucherez, Jossia; Briat, Jean-Francois; Gaymard, Frederic] Univ Montpellier 2, Inst Natl Rech Agron, Agro M CNRS, Lab Biochim & Physiol Mol Plantes,UMR 5004, F-34060 Montpellier 1, France; [Lacombe, Eric] IRD, Dept Plant Resistance Pests, F-34394 Montpellier 5, France	INRAE; Institut Agro; Montpellier SupAgro; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD)	Gaymard, F (corresponding author), 2 Pl Viala, F-34060 Montpellier 1, France.	gaymard@supagro.inra.fr		Lacombe, Eric/0000-0001-5100-4173	Centre National de la Recherche Scientifique (CNRS)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Centre National de la Recherche Scientifique (CNRS) (to M. B.).	Arnaud N, 2006, J BIOL CHEM, V281, P23579, DOI 10.1074/jbc.M602135200; BECKER D, 1990, NUCLEIC ACIDS RES, V18, P203, DOI 10.1093/nar/18.1.203; Bent AF, 2000, PLANT PHYSIOL, V124, P1540, DOI 10.1104/pp.124.4.1540; Briat JF, 2010, BBA-GEN SUBJECTS, V1800, P806, DOI 10.1016/j.bbagen.2009.12.003; Bustos R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001102; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; CUMBUS IP, 1977, PLANT SOIL, V48, P651, DOI 10.1007/BF00145775; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; DEKOCK PC, 1979, ANN BOT-LONDON, V43, P737, DOI 10.1093/oxfordjournals.aob.a085687; Duc C, 2009, J BIOL CHEM, V284, P36271, DOI 10.1074/jbc.M109.059873; Hall A, 2003, PLANT CELL, V15, P2719, DOI 10.1105/tpc.013730; Hilton RJ, 2012, BIOMETALS, V25, P259, DOI 10.1007/s10534-011-9500-z; Hindt MN, 2012, BBA-MOL CELL RES, V1823, P1521, DOI 10.1016/j.bbamcr.2012.03.010; Hirsch J, 2006, BIOCHIMIE, V88, P1767, DOI 10.1016/j.biochi.2006.05.007; Lanquar V, 2005, EMBO J, V24, P4041, DOI 10.1038/sj.emboj.7600864; Mathan K. K., 1977, PLANT SOIL, V48, P413, DOI DOI 10.1007/BF00010097; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Muller R, 2007, PLANT PHYSIOL, V143, P156, DOI 10.1104/pp.106.090167; Nilsson L, 2007, PLANT CELL ENVIRON, V30, P1499, DOI 10.1111/j.1365-3040.2007.01734.x; Nilsson L, 2012, PHYSIOL PLANTARUM, V144, P35, DOI 10.1111/j.1399-3054.2011.01520.x; Oropeza-Aburto A, 2012, J EXP BOT, V63, P2189, DOI 10.1093/jxb/err446; Otegui MS, 2002, PLANT CELL, V14, P1311, DOI 10.1105/tpc.010486; Petit JM, 2001, J BIOL CHEM, V276, P5584, DOI 10.1074/jbc.M005903200; PICH A, 1991, J EXP BOT, V42, P1517, DOI 10.1093/jxb/42.12.1517; Pratt J, 2009, PLANT PHYSIOL, V151, P1646, DOI 10.1104/pp.109.144626; Ravet K, 2012, EMBO J, V31, P175, DOI 10.1038/emboj.2011.341; Ravet K, 2009, PLANT J, V57, P400, DOI 10.1111/j.1365-313X.2008.03698.x; Roschzttardtz H, 2010, PLANT SIGNAL BEHAV, V5, P56, DOI 10.4161/psb.5.1.10159; Roschzttardtz H, 2009, PLANT PHYSIOL, V151, P1329, DOI 10.1104/pp.109.144444; Rouached H, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-19; Rubio V, 2001, GENE DEV, V15, P2122, DOI 10.1101/gad.204401; Schaumloffel D, 2003, J ANAL ATOM SPECTROM, V18, P120, DOI 10.1039/b209819a; Shikanai T, 2003, PLANT CELL, V15, P1333, DOI 10.1105/tpc.011817; Strozycki PM, 2010, MOL BIOL EVOL, V27, P91, DOI 10.1093/molbev/msp196; Thibaud MC, 2010, PLANT J, V64, P775, DOI 10.1111/j.1365-313X.2010.04375.x; Ticconi CA, 2009, P NATL ACAD SCI USA, V106, P14174, DOI 10.1073/pnas.0901778106; VANWUYTSWINKEL O, 1995, BIOCHEM J, V305, P253, DOI 10.1042/bj3050253; WADE VJ, 1993, BIOCHIM BIOPHYS ACTA, V1161, P91, DOI 10.1016/0167-4838(93)90201-2; Ward JT, 2008, PLANT PHYSIOL, V147, P1181, DOI 10.1104/pp.108.118562	39	105	115	7	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22670	22680		10.1074/jbc.M113.482281	http://dx.doi.org/10.1074/jbc.M113.482281			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23788639	Green Published, hybrid			2022-12-25	WOS:000330596300046
J	Berestovsky, N; Nakhleh, L				Berestovsky, Natalie; Nakhleh, Luay			An Evaluation of Methods for Inferring Boolean Networks from Time-Series Data	PLOS ONE			English	Article							GENETIC REGULATORY NETWORKS	Regulatory networks play a central role in cellular behavior and decision making. Learning these regulatory networks is a major task in biology, and devising computational methods and mathematical models for this task is a major endeavor in bioinformatics. Boolean networks have been used extensively for modeling regulatory networks. In this model, the state of each gene can be either 'on' or 'off' and that next-state of a gene is updated, synchronously or asynchronously, according to a Boolean rule that is applied to the current-state of the entire system. Inferring a Boolean network from a set of experimental data entails two main steps: first, the experimental time-series data are discretized into Boolean trajectories, and then, a Boolean network is learned from these Boolean trajectories. In this paper, we consider three methods for data discretization, including a new one we propose, and three methods for learning Boolean networks, and study the performance of all possible nine combinations on four regulatory systems of varying dynamics complexities. We find that employing the right combination of methods for data discretization and network learning results in Boolean networks that capture the dynamics well and provide predictive power. Our findings are in contrast to a recent survey that placed Boolean networks on the low end of the "faithfulness to biological reality'' and "ability to model dynamics'' spectra. Further, contrary to the common argument in favor of Boolean networks, we find that a relatively large number of time points in the time-series data is required to learn good Boolean networks for certain data sets. Last but not least, while methods have been proposed for inferring Boolean networks, as discussed above, missing still are publicly available implementations thereof. Here, we make our implementation of the methods available publicly in open source at http://bioinfo.cs.rice.edu/.	[Berestovsky, Natalie; Nakhleh, Luay] Rice Univ, Dept Comp Sci, Houston, TX 77251 USA	Rice University	Nakhleh, L (corresponding author), Rice Univ, Dept Comp Sci, Houston, TX 77251 USA.	nakhleh@rice.edu			Gulf Coast Center for Computational Cancer Research; John and Ann Doerr Fund for Computational Biomedicine; Alfred P. Sloan Research Fellowship	Gulf Coast Center for Computational Cancer Research; John and Ann Doerr Fund for Computational Biomedicine; Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation)	This work was supported by a Seed Grant from the Gulf Coast Center for Computational Cancer Research, funded by John and Ann Doerr Fund for Computational Biomedicine and and an Alfred P. Sloan Research Fellowship to L.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2008, BOOLEAN NETWORK SIMU, V3; Bachmann J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.50; Bartlett MS., 1953, J ROYAL STAT SOC SER, V2, P44, DOI [10.2307/2985327, DOI 10.2307/2985327]; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Clarke DC, 2006, IEE P SYST BIOL, V153, P412, DOI 10.1049/ip-syb:20050055; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Erkkild T, 2007, IEEE INT WORKSH GEN, P1; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hopfensitz M, 2012, IEEE ACM T COMPUT BI, V9, P487, DOI 10.1109/TCBB.2011.62; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Kauffman S, 2003, P NATL ACAD SCI USA, V100, P14796, DOI 10.1073/pnas.2036429100; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Klipp Edda, 2009, SYSTEMS BIOL TXB; Lahdesmaki H, 2003, MACH LEARN, V52, P147, DOI 10.1023/A:1023905711304; Li C, 2010, BMC SYSTEMS BIOL, V4; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Liang JH, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-113; Liang S, 1998, Pac Symp Biocomput, P18; MacQueen J, 1967, P 5 BERKELEY S MATH, V1, DOI DOI 10.1007/S11665-016-2173-6; Martin S, 2007, BIOINFORMATICS, V23, P866, DOI 10.1093/bioinformatics/btm021; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shmulevich I, 2003, COMP FUNCT GENOM, V4, P601, DOI 10.1002/cfg.342; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308	26	38	38	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66031	10.1371/journal.pone.0066031	http://dx.doi.org/10.1371/journal.pone.0066031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805196	Green Published, gold			2022-12-25	WOS:000320846500024
J	Chu, HL; Tang, YP; Dong, Q				Chu, Heling; Tang, Yuping; Dong, Qiang			Protection of Vascular Endothelial Growth Factor to Brain Edema Following Intracerebral Hemorrhage and Its Involved Mechanisms: Effect of Aquaporin-4	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; BARRIER PERMEABILITY; VEGF; ANGIOGENESIS; RAT; ASTROCYTES; EXPRESSION; INJURY; CELLS; NEURONS	Vascular endothelial growth factor (VEGF) has protective effects on many neurological diseases. However, whether VEGF acts on brain edema following intracerebral hemorrhage (ICH) is largely unknown. Our previous study has shown aquaporin-4 (AQP4) plays an important role in brain edema elimination following ICH. Meanwhile, there is close relationship between VEGF and AQP4. In this study, we aimed to test effects of VEGF on brain edema following ICH and examine whether they were AQP4 dependent. Recombinant human VEGF165 (rhVEGF165) was injected intracerebroventricularly 1 d after ICH induced by microinjecting autologous whole blood into striatum. We detected perihemotomal AQP4 protein expression, then examined the effects of rhVEGF165 on perihemotomal brain edema at 1 d, 3 d, and 7 d after injection in wild type (AQP4(+/+)) and AQP4 knock-out (AQP4(-/-)) mice. Furthermore, we assessed the possible signal transduction pathways activated by VEGF to regulate AQP4 expression via astrocyte cultures. We found perihemotomal AQP4 protein expression was highly increased by rhVEGF165. RhVEGF165 alleviated perihemotomal brain edema in AQP4(+/+) mice at each time point, but had no effect on AQP4(-/-) mice. Perihemotomal EB extravasation was increased by rhVEGF165 in AQP4(-/-) mice, but not AQP4(+/+) mice. RhVEGF165 reduced neurological deficits and increased Nissl's staining cells surrounding hemotoma in both types of mice and these effects were related to AQP4. RhVEGF165 up-regulated phospharylation of C-Jun amino-terminal kinase (p-JNK) and extracellular signal-regulated kinase (p-ERK) and AQP4 protein in cultured astrocytes. The latter was inhibited by JNK and ERK inhibitors. In conclusion, VEGF reduces neurological deficits, brain edema, and neuronal death surrounding hemotoma but has no influence on BBB permeability. These effects are closely related to AQP4 up-regulation, possibly through activating JNK and ERK pathways. The current study may present new insights to treatment of brain edema following ICH.	[Chu, Heling; Tang, Yuping] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [Dong, Qiang] Fudan Univ, State Key Lab Med Neurobiol, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Dong, Q (corresponding author), Fudan Univ, State Key Lab Med Neurobiol, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China.	qiang_dong163@163.com	Chu, Heling/AAG-8255-2019	Chu, Heling/0000-0001-8418-5775				Abumiya T, 2005, BRAIN RES, V1049, P95, DOI 10.1016/j.brainres.2005.05.011; AGRAWAL HC, 1968, J NEUROCHEM, V15, P917, DOI 10.1111/j.1471-4159.1968.tb11633.x; Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Bates DO, 2010, CARDIOVASC RES, V87, P262, DOI 10.1093/cvr/cvq105; Belayev L, 2003, STROKE, V34, P2221, DOI 10.1161/01.STR.0000088061.06656.1E; David L, 2007, J CELL PHYSIOL, V213, P484, DOI 10.1002/jcp.21126; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; Dobrogowska DH, 1998, J NEUROCYTOL, V27, P163, DOI 10.1023/A:1006907608230; Emerich DF, 2010, CELL TRANSPLANT, V19, P1063, DOI 10.3727/096368910X498278; Feng YZ, 2010, BRAIN RES, V1325, P1, DOI 10.1016/j.brainres.2010.02.029; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Habas A, 2006, J NEUROCHEM, V96, P335, DOI 10.1111/j.1471-4159.2005.03543.x; Harrigan MR, 2003, ACTA NEUROCHIR, V145, P49, DOI 10.1007/s00701-002-1035-1; Kaur C, 2006, GLIA, V54, P826, DOI 10.1002/glia.20420; Kawasaki T, 2007, GLIA, V55, P1325, DOI 10.1002/glia.20541; Kaya D, 2005, J CEREBR BLOOD F MET, V25, P1111, DOI 10.1038/sj.jcbfm.9600109; Kilic E, 2006, FASEB J, V20, P1185, DOI 10.1096/fj.05-4829fje; Lee HT, 2010, J NEUROCHEM, V113, P79, DOI 10.1111/j.1471-4159.2010.06584.x; Lee Hyoshin, 2007, Plant Biology (Rockville), V2007, P156; Li Z, 2006, NEUROSCI LETT, V403, P294, DOI 10.1016/j.neulet.2006.05.004; Loreto C, 2010, CURR NEUROPHARMACOL, V8, P105, DOI 10.2174/157015910791233196; Miki Y, 2007, NEUROSURGERY, V61, P586, DOI 10.1227/01.NEU.0000290907.30814.42; Nag S, 2011, NEUROPATH APPL NEURO, V37, P3, DOI 10.1111/j.1365-2990.2010.01138.x; Nakagawa T, 2010, J PHARMACOL SCI, V114, P347, DOI 10.1254/jphs.10R04CP; Nico B, 2001, J CELL SCI, V114, P1297; PETTERSSON CAV, 1990, ACTA NEUROPATHOL, V81, P148, DOI 10.1007/BF00334503; Qi LL, 2011, LIFE SCI, V88, P50, DOI 10.1016/j.lfs.2010.10.025; Rao KVR, 2010, GLIA, V58, P1490, DOI 10.1002/glia.21023; Rite I, 2008, NEUROCHEM INT, V52, P897, DOI 10.1016/j.neuint.2007.10.004; Rite I, 2007, J NEUROCHEM, V101, P1567, DOI 10.1111/j.1471-4159.2007.04567.x; Sanchez A, 2010, NEUROPEPTIDES, V44, P323, DOI 10.1016/j.npep.2010.04.002; Sinke AP, 2008, J NEUROCHEM, V106, P2302, DOI 10.1111/j.1471-4159.2008.05549.x; Sobrino T, 2009, J CEREBR BLOOD F MET, V29, P1968, DOI 10.1038/jcbfm.2009.182; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Sutherland BA, 2009, NEUROSCI RES, V65, P326, DOI 10.1016/j.neures.2009.08.007; Tang T, 2007, BRAIN RES, V1175, P134, DOI 10.1016/j.brainres.2007.08.028; Tang YP, 2010, EXP NEUROL, V223, P485, DOI 10.1016/j.expneurol.2010.01.015; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Vajda Z, 2002, P NATL ACAD SCI USA, V99, P13131, DOI 10.1073/pnas.192457099; Verkman Alan S, 2009, Handb Exp Pharmacol, P359, DOI 10.1007/978-3-540-79885-9_18; Wan YQ, 2007, J NEUROSCI RES, V85, P73, DOI 10.1002/jnr.21091; Wang P, 2011, GENET MOL RES, V10, P2165, DOI 10.4238/vol10-3gmr1212; Wang YF, 2011, BRAIN RES, V1370, P220, DOI 10.1016/j.brainres.2010.11.016; Wang YM, 2006, BRAIN RES, V1115, P186, DOI 10.1016/j.brainres.2006.07.060; Wu GF, 2006, CARDIOVASC RES, V69, P512, DOI 10.1016/j.cardiores.2005.09.019; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Yang CS, 2008, J CELL BIOCHEM, V183, P213; Yang JP, 2010, J INVEST SURG, V23, P149, DOI 10.3109/08941930903469482; Zachary I, 2005, NEUROSIGNALS, V14, P207, DOI 10.1159/000088637; Zador Zsolt, 2009, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-540-79885-9_7; Zeng XN, 2007, MOL CELL NEUROSCI, V34, P34, DOI 10.1016/j.mcn.2006.09.008; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhou JP, 2008, NEUROREPORT, V19, P1, DOI 10.1097/WNR.0b013e3282f2b4eb	53	38	41	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66051	10.1371/journal.pone.0066051	http://dx.doi.org/10.1371/journal.pone.0066051			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805198	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500026
J	Ding, YH; Du, YG; Luo, SK; Li, YX; Li, TM; Yoshina, S; Wang, X; Klage, K; Mitani, S; Ye, KQ; Dong, MQ				Ding, Yue-He; Du, Yun-Guang; Luo, Shukun; Li, Yu-Xin; Li, Tie-Mei; Yoshina, Sawako; Wang, Xing; Klage, Karsten; Mitani, Shohei; Ye, Keqiong; Dong, Meng-Qiu			Characterization of PUD-1 and PUD-2, Two Proteins Up-Regulated in a Long-Lived daf-2 Mutant	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; LIFE-SPAN; C-ELEGANS; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; GENES; LONGEVITY; EXPRESSION; RESISTANCE; MUTATIONS	C. elegans PUD-1 and PUD-2, two proteins up-regulated in daf-2(loss-of-function) (PUD), are homologous 17-kD proteins with a large abundance increase in long-lived daf-2 mutant animals of reduced insulin signaling. In this study, we show that both PUD-1 and PUD-2 are abundantly expressed in the intestine and hypodermis, and form a heterodimer. We have solved their crystal structure to 1.9-angstrom resolution and found that both proteins adopt similar beta-sandwich folds in the V-shaped dimer. In contrast, their homologs PUD-3, PUD-4, PUDL-1 and PUDL-2 are all monomeric proteins with distinct expression patterns in C. elegans. Thus, the PUD-1/PUD-2 heterodimer probably has a function distinct from their family members. Neither overexpression nor deletion of pud-1 and pud-2 affected the lifespan of WT or daf-2 mutant animals, suggesting that their induction in daf-2 worms does not contribute to longevity. Curiously, deletion of pud-1 and pud-2 was associated with a protective effect against paralysis induced by the amyloid beta-peptide (1-42), which further enhanced the protection conferred by daf-2(RNAi) against A beta.	[Ding, Yue-He; Du, Yun-Guang; Luo, Shukun; Li, Yu-Xin; Li, Tie-Mei; Wang, Xing; Ye, Keqiong; Dong, Meng-Qiu] Natl Inst Biol Sci, Beijing, Peoples R China; [Ding, Yue-He; Dong, Meng-Qiu] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China; [Ding, Yue-He; Dong, Meng-Qiu] Peking Union Med Coll, Beijing 100021, Peoples R China; [Yoshina, Sawako; Mitani, Shohei] Tokyo Womens Med Univ, Dept Physiol, Tokyo, Japan; [Klage, Karsten] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tokyo Women's Medical University; Max Planck Society	Ye, KQ (corresponding author), Natl Inst Biol Sci, Beijing, Peoples R China.	yekeqiong@nibs.ac.cn; dongmengqiu@nibs.ac.cn	Luo, Shukun/AAT-8195-2021; Li, yu/HHZ-5236-2022; Luo, Shukun/A-8371-2017; li, Yu/HCI-9086-2022; ding, yuehe/AAZ-6994-2021; li, yu/HGL-9518-2022; Li, yuxin/GSD-1668-2022	Luo, Shukun/0000-0002-2766-3125; Luo, Shukun/0000-0002-2766-3125; 	Ministry of Science and Technology of China (863 grant) [2007AA02Z1A7, 2008AA022310]; Ministry of Science and Technology of China (973 grant) [2010CB835203, 2010CB835402]; municipal government of Beijing	Ministry of Science and Technology of China (863 grant); Ministry of Science and Technology of China (973 grant); municipal government of Beijing	The Ministry of Science and Technology of China (863 grant 2007AA02Z1A7 and 973 grant 2010CB835203 to M-QD; 863 grant 2008AA022310 and 973 grant 2010CB835402 to KY) and the municipal government of Beijing funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantscheff M, 2004, PROTEOMICS, V4, P2283, DOI 10.1002/pmic.200400807; Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; DeLano WL, 2002, PYMOL USERS MANUAL; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Honda Y, 2008, EXP GERONTOL, V43, P520, DOI 10.1016/j.exger.2008.02.009; Johnson TE, 2000, EXP GERONTOL, V35, P687, DOI 10.1016/S0531-5565(00)00138-8; Johnstone I. L, 2007, WORMBOOK; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kirienko NV, 2007, DEV BIOL, V305, P674, DOI 10.1016/j.ydbio.2007.02.021; Kirkwood TBL, 2002, MECH AGEING DEV, V123, P737, DOI 10.1016/S0047-6374(01)00419-5; Krijgsveld J, 2003, NAT BIOTECHNOL, V21, P927, DOI 10.1038/nbt848; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; Murphy CT, 2006, EXP GERONTOL, V41, P910, DOI 10.1016/j.exger.2006.06.040; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paik YK, 2006, EXPERT REV PROTEOMIC, V3, P439, DOI 10.1586/14789450.3.4.439; PARK EC, 1986, GENETICS, V113, P821; Schuster E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.54; Sharabi K, 2009, P NATL ACAD SCI USA, V106, P4024, DOI 10.1073/pnas.0900309106; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SNUTCH TP, 1988, GENE, V64, P241, DOI 10.1016/0378-1119(88)90339-3; Spanier B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006279; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Taubert S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000021; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Weber F, 2000, METH MOL B, V140, P117; Welker NC, 2007, RNA, V13, P1090, DOI 10.1261/rna.542107	45	10	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e67158	10.1371/journal.pone.0067158	http://dx.doi.org/10.1371/journal.pone.0067158			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799143	Green Submitted, Green Published, gold			2022-12-25	WOS:000320363300105
J	Tirumalai, MR; Rastogi, R; Zamani, N; Williams, EO; Allen, S; Diouf, F; Kwende, S; Weinstock, GM; Venkateswaran, KJ; Fox, GE				Tirumalai, Madhan R.; Rastogi, Rajat; Zamani, Nader; Williams, Elisha O'Bryant; Allen, Shamail; Diouf, Fatma; Kwende, Sharon; Weinstock, George M.; Venkateswaran, Kasthuri J.; Fox, George E.			Candidate Genes That May Be Responsible for the Unusual Resistances Exhibited by Bacillus pumilus SAFR-032 Spores	PLOS ONE			English	Article							DNA-REPAIR; SUBTILIS SPORES; SP-NOV.; STRUCTURAL COMPONENTS; PHOTOPRODUCT LYASE; ESCHERICHIA-COLI; UV RESISTANCE; SPACECRAFT; PROTECTION; SURVIVAL	The spores of several Bacillus species, including Bacillus pumilus SAFR-032 and B. safensis FO-36b, which were isolated from the spacecraft assembly facility at NASA's Jet Propulsion Laboratory, are unusually resistant to UV radiation and hydrogen peroxide. In order to identify candidate genes that might be associated with these resistances, the whole genome of B. pumilus SAFR-032, and the draft genome of B. safensis FO-36b were compared in detail with the very closely related type strain B. pumilus ATCC7061(T). 170 genes are considered characteristic of SAFR-032, because they are absent from both FO-36b and ATCC7061(T). Forty of these SAFR-032 characteristic genes are entirely unique open reading frames. In addition, four genes are unique to the genomes of the resistant SAFR-032 and FO-36b. Fifty three genes involved in spore coat formation, regulation and germination, DNA repair, and peroxide resistance, are missing from all three genomes. The vast majority of these are cleanly deleted from their usual genomic context without any obvious replacement. Several DNA repair and peroxide resistance genes earlier reported to be unique to SAFR-032 are in fact shared with ATCC7061 (T) and no longer considered to be promising candidates for association with the elevated resistances. Instead, several SAFR-032 characteristic genes were identified, which along with one or more of the unique SAFR-032 genes may be responsible for the elevated resistances. These new candidates include five genes associated with DNA repair, namely, BPUM_0608 a helicase, BPUM_0652 an ATP binding protein, BPUM_0653 an endonuclease, BPUM_0656 a DNA cytosine-5-methyltransferase, and BPUM_3674 a DNA helicase. Three of these candidate genes are in immediate proximity of two conserved hypothetical proteins, BPUM_0654 and BPUM_0655 that are also absent from both FO-36b and ATCC7061(T). This cluster of five genes is considered to be an especially promising target for future experimental work.	[Tirumalai, Madhan R.; Rastogi, Rajat; Zamani, Nader; Williams, Elisha O'Bryant; Fox, George E.] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA; [Allen, Shamail; Diouf, Fatma; Kwende, Sharon] Texas So Univ, Dept Biol, Houston, TX 77004 USA; [Weinstock, George M.] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA; [Venkateswaran, Kasthuri J.] CALTECH, NASA, Jet Prop Labs, Biotechnol & Planetary Protect Grp, Pasadena, CA 91125 USA	University of Houston System; University of Houston; Texas Southern University; Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Fox, GE (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA.	gefox@central.uh.edu	Willson, richard/AAD-4832-2019; Weinstock, George M/C-6314-2013; Tirumalai, Madhan R/J-4988-2017	Weinstock, George M/0000-0002-2997-4592; Tirumalai, Madhan R/0000-0002-5999-333X	Institute of Space Systems Operations at the University of Houston; Center for Bio-nanotechnology and Environmental Research at Texas Southern University (NASA) [NNX08B4A47A]; Center for Ribosomal Evolution and Adaptation at the Georgia Institute of Technology (NASA) [NNA09DA78A]; National Science Foundation [414410]	Institute of Space Systems Operations at the University of Houston; Center for Bio-nanotechnology and Environmental Research at Texas Southern University (NASA)(National Aeronautics & Space Administration (NASA)); Center for Ribosomal Evolution and Adaptation at the Georgia Institute of Technology (NASA); National Science Foundation(National Science Foundation (NSF))	This work was supported by grants from the Institute of Space Systems Operations at the University of Houston, the Center for Bio-nanotechnology and Environmental Research at Texas Southern University (NASA Cooperative agreement NNX08B4A47A) and the Center for Ribosomal Evolution and Adaptation at the Georgia Institute of Technology (NASA Cooperative Agreement NNA09DA78A) to George E. Fox and National Science Foundation grant -414410 to George M. Weinstock. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benardini JN, 2003, ASTROBIOLOGY, V3, P709, DOI 10.1089/153110703322736033; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Bratlie MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-588; Brown KL, 2000, BRIT MED BULL, V56, P158, DOI 10.1258/0007142001902860; Cahoon LA, 2011, MOL MICROBIOL, V79, P729, DOI 10.1111/j.1365-2958.2010.07481.x; Chang XS, 2010, CURR MICROBIOL, V61, P458, DOI 10.1007/s00284-010-9638-x; Checinska A, 2012, APPL ENVIRON MICROB, V78, P6413, DOI 10.1128/AEM.01211-12; Davidsen T, 2009, NUCL ACIDS RES; de Hoon MJL, 2010, CURR BIOL, V20, pR735, DOI 10.1016/j.cub.2010.06.031; Gardy JL, 2003, NUCLEIC ACIDS RES, V31, P3613, DOI 10.1093/nar/gkg602; Ghosh S, 2010, ASTROBIOLOGY, V10, P325, DOI 10.1089/ast.2009.0396; Gioia J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000928; Henaut A, 1998, ELECTROPHORESIS, V19, P515, DOI 10.1002/elps.1150190411; Horneck G, 2012, ASTROBIOLOGY, V12, P445, DOI 10.1089/ast.2011.0737; Ibarra JR, 2008, J BACTERIOL, V190, P2031, DOI 10.1128/JB.01625-07; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jones DT, 2002, TRENDS BIOCHEM SCI, V27, P161, DOI 10.1016/S0968-0004(01)02039-4; Kempf MJ, 2005, ASTROBIOLOGY, V5, P391, DOI 10.1089/ast.2005.5.391; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; KUNKEL B, 1990, GENE DEV, V4, P525, DOI 10.1101/gad.4.4.525; La Duc MT, 2004, INT J SYST EVOL MICR, V54, P195, DOI [10.1099/ijs.0.02747-0, 10.1099/ijs.0.02747]; Lee KS, 2008, P NATL ACAD SCI USA, V105, P2806, DOI 10.1073/pnas.0708244105; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Link L, 2004, MICROB ECOL, V47, P159, DOI 10.1007/s00248-003-1029-4; Marri PR, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S8; Moeller R, 2007, J BACTERIOL, V189, P3306, DOI 10.1128/JB.00018-07; Moeller R, 2012, APPL ENVIRON MICROB, V78, P8849, DOI 10.1128/AEM.02527-12; Moeller R, 2012, ASTROBIOLOGY, V12, P1069, DOI 10.1089/ast.2012.0890; Mulder Nicola, 2007, V396, P59; Newcombe DA, 2005, APPL ENVIRON MICROB, V71, P8147, DOI 10.1128/AEM.71.12.8147-8156.2005; Ng WO, 2001, MOL GEN GENET, V264, P924, DOI 10.1007/s004380000383; Nicholson WL, 2002, ASTROBIOLOGY, V2, P417, DOI 10.1089/153110702762470518; Norais C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056558; Onodera T, 2013, EXTREMOPHILES, V17, P171, DOI 10.1007/s00792-012-0506-4; PEDRAZAREYES M, 1994, J BACTERIOL, V176, P3983, DOI 10.1128/JB.176.13.3983-3991.1994; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; ROGERS EJ, 1991, J BACTERIOL, V173, P7881, DOI 10.1128/jb.173.24.7881-7886.1991; Rummel J D, 1992, Adv Space Res, V12, P129; Rummel J D, 1989, Adv Space Res, V9, P181, DOI 10.1016/0273-1177(89)90227-5; RUMMEL JD, 1996, ADV SPACE RES-SERIES, V18, P317, DOI 10.1016/0273-1177(95)00822-V; Rummel JD, 2001, ADV SPACE RES-SERIES, V26, P1893; Rummel JD, 2001, P NATL ACAD SCI USA, V98, P2128, DOI 10.1073/pnas.061021398; Satomi M, 2006, INT J SYST EVOL MICR, V56, P1735, DOI 10.1099/ijs.0.64189-0; Schuerger AC, 2003, ICARUS, V165, P253, DOI 10.1016/S0019-1035(03)00200-8; Serizawa M, 2004, GENE, V329, P125, DOI 10.1016/j.gene.2003.12.024; Sghaier H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-297; Vaishampayan P, 2010, INT J SYST EVOL MICR, V60, P1031, DOI 10.1099/ijs.0.008979-0; Vaishampayan PA, 2012, ASTROBIOLOGY, V12, P487, DOI 10.1089/ast.2011.0738; van Hijum SAFT, 2005, NUCLEIC ACIDS RES, V33, pW560, DOI 10.1093/nar/gki356; Venkateswaran K, 2004, ASTROBIOLOGY, V4, P377, DOI 10.1089/ast.2004.4.377; Viswanath L, 2007, SOURCE CODE BIOL MED, V2, DOI 10.1186/1751-0473-2-1; Votava M, 2009, EPIDEMIOL MIKROBI IM, V58, P36; WEINFELD M, 1988, NUCLEIC ACIDS RES, V16, P5693, DOI 10.1093/nar/16.12.5693; Wiedenbeck J, 2011, FEMS MICROBIOL REV, V35, P957, DOI 10.1111/j.1574-6976.2011.00292.x; Williams LE, 2012, GENOME BIOL EVOL, V4, P44, DOI 10.1093/gbe/evr128; Xue YM, 1996, APPL ENVIRON MICROB, V62, P2221, DOI 10.1128/AEM.62.7.2221-2227.1996; Yang YJ, 2010, INT J SYST EVOL MICR, V60, P776, DOI 10.1099/ijs.0.010876-0; You CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-128; Zivanovic Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r70	59	30	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66012	10.1371/journal.pone.0066012	http://dx.doi.org/10.1371/journal.pone.0066012			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799069	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300059
J	Ballesteros, NA; Castro, R; Abos, B; Saint-Jean, SSR; Perez-Prieto, SI; Tafalla, C				Ballesteros, Natalia A.; Castro, Rosario; Abos, Beatriz; Rodriguez Saint-Jean, Sylvia S.; Perez-Prieto, Sara I.; Tafalla, Carolina			The Pyloric Caeca Area Is a Major Site for IgM(+) and IgT(+) B Cell Recruitment in Response to Oral Vaccination in Rainbow Trout	PLOS ONE			English	Article							PANCREATIC NECROSIS VIRUS; CYPRINUS-CARPIO L; POSSIBLE IMMUNOLOGICAL IMPLICATIONS; OMENTAL MILKY SPOTS; ADIPOSE-TISSUE; T-CELLS; TELEOST FISH; PLASMA-CELLS; EXPRESSION; OBESITY	Although previous studies have characterized some aspects of the immune response of the teleost gut in response to diverse pathogens or stimuli, most studies have focused on the posterior segments exclusively. However, there are still many details of how teleost intestinal immunity is regulated that remain unsolved, including the location of IgM(+) and IgT(+) B cells along the digestive tract and their role during the course of a local stimulus. Thus, in the current work, we have studied the B cell response in five different segments of the rainbow trout (Oncorhynchus mykiss) digestive tract in both naive fish and fish orally vaccinated with an alginate-encapsulated DNA vaccine against infectious pancreatic necrosis virus (IPNV). IgM(+) and IgT(+) cells were identified all along the tract with the exception of the stomach in naive fish. While IgM(+) cells were mostly located in the lamina propria (LP), IgT(+) cells were primarily localized as intraepithelial lymphocytes (IELs). Scattered IgM(+) IELs were only detected in the pyloric caeca. In response to oral vaccination, the pyloric caeca region was the area of the digestive tract in which a major recruitment of B cells was demonstrated through both real time PCR and immunohistochemistry, observing a significant increase in the number of both IgM(+) and IgT(+) IELs. Our findings demonstrate that both IgM(+) and IgT(+) respond to oral stimulation and challenge the paradigm that teleost IELs are exclusively T cells. Unexpectedly, we have also detected B cells in the fat tissue associated to the digestive tract that respond to vaccination, suggesting that these cells surrounded by adipocytes also play a role in mucosal defense.	[Ballesteros, Natalia A.; Rodriguez Saint-Jean, Sylvia S.; Perez-Prieto, Sara I.] Ctr Invest Biol, Dpto Microbiol Mol & Biol Infecc, E-28006 Madrid, Spain; [Castro, Rosario; Abos, Beatriz; Tafalla, Carolina] Ctr Invest Sanidad Anim, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Tafalla, C (corresponding author), Ctr Invest Sanidad Anim, Madrid, Spain.	tafalla@inia.es	Tafalla, Carolina/J-8074-2014; Ballesteros, Natalia A./AAD-5766-2019	Tafalla, Carolina/0000-0002-0860-2976; Ballesteros, Natalia A./0000-0003-0797-3107	Starting grant TEBLYM from the European Research Council; Spanish Ministerio de Economia y Competitividad [AGL2010-18454]	Starting grant TEBLYM from the European Research Council; Spanish Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by the Starting grant TEBLYM from the European Research Council and by the project AGL2010-18454 from the Spanish Ministerio de Economia y Competitividad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 1999, ARCH VIROL, V144, P657, DOI 10.1007/s007050050534; Ballesteros NA, 2012, FISH SHELLFISH IMMUN, V33, P1249, DOI 10.1016/j.fsi.2012.09.004; Ballesteros NA, 2012, FISH SHELLFISH IMMUN, V33, P174, DOI 10.1016/j.fsi.2012.03.016; Bedford PA, 2006, J LEUKOCYTE BIOL, V80, P546, DOI 10.1189/jlb.0905501; BEELEN RHJ, 1980, J RETICULOENDOTH SOC, V28, P585; Bengten E, 2006, DEV COMP IMMUNOL, V30, P77, DOI 10.1016/j.dci.2005.06.016; Bernard D, 2006, J IMMUNOL, V176, P3942, DOI 10.4049/jimmunol.176.7.3942; Boyaka PN, 2000, AM J PATHOL, V157, P2023, DOI 10.1016/S0002-9440(10)64841-9; Brandtzaeg P, 2005, IMMUNOL REV, V206, P32, DOI 10.1111/j.0105-2896.2005.00283.x; Castro R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003098; Chaves-Pozo E, 2010, DEV COMP IMMUNOL, V34, P648, DOI 10.1016/j.dci.2010.01.009; Danilova N, 2005, NAT IMMUNOL, V6, P295, DOI 10.1038/ni1166; de las Heras AI, 2010, FISH SHELLFISH IMMUN, V28, P562, DOI 10.1016/j.fsi.2009.12.006; GAUTHIER GF, 1972, ANAT RECORD, V172, P675, DOI 10.1002/ar.1091720408; Gray KS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043196; Hansen JD, 2005, P NATL ACAD SCI USA, V102, P6919, DOI 10.1073/pnas.0500027102; Hayday A, 2001, NAT IMMUNOL, V2, P997, DOI 10.1038/ni1101-997; John BJ, 2006, ALIMENT PHARM THER, V23, P1511, DOI 10.1111/j.1365-2036.2006.02915.x; Jorgensen LV, 2011, J FISH DIS, V34, P749, DOI 10.1111/j.1365-2761.2011.01291.x; Kaminski DA, 2010, TRENDS IMMUNOL, V31, P384, DOI 10.1016/j.it.2010.08.001; Lin KI, 2002, MOL CELL BIOL, V22, P4771, DOI 10.1128/MCB.22.13.4771-4780.2002; LOBB CJ, 1987, DEV COMP IMMUNOL, V11, P727, DOI 10.1016/0145-305X(87)90060-7; Lynch L, 2009, EUR J IMMUNOL, V39, P1893, DOI 10.1002/eji.200939349; Martinez-Alonso S, 2012, DEV COMP IMMUNOL, V36, P378, DOI 10.1016/j.dci.2011.07.010; Mesin L, 2011, J IMMUNOL, V187, P2867, DOI 10.4049/jimmunol.1003181; Olsen MM, 2011, FISH SHELLFISH IMMUN, V30, P859, DOI 10.1016/j.fsi.2011.01.010; Rangel-Moreno J, 2009, IMMUNITY, V30, P731, DOI 10.1016/j.immuni.2009.03.014; Rombout JHWM, 2011, FISH SHELLFISH IMMUN, V31, P616, DOI 10.1016/j.fsi.2010.09.001; ROMBOUT JHWM, 1993, DEV COMP IMMUNOL, V17, P55, DOI 10.1016/0145-305X(93)90015-I; ROMBOUT JHWM, 1985, CELL TISSUE RES, V239, P519, DOI 10.1007/BF00219230; ROMBOUT JHWM, 1985, CELL BIOL INT REP, V9, P516, DOI 10.1016/0309-1651(85)90003-7; Scapigliati G, 2000, FISH SHELLFISH IMMUN, V10, P329, DOI 10.1006/fsim.1999.0243; Tumang JR, 2005, J IMMUNOL, V174, P3173, DOI 10.4049/jimmunol.174.6.3173; vanVugt E, 1996, ANAT REC, V244, P235; Yang YK, 2008, CELL PHYSIOL BIOCHEM, V22, P531, DOI 10.1159/000185527; Zhang YA, 2011, FISH SHELLFISH IMMUN, V31, P627, DOI 10.1016/j.fsi.2011.03.021; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913; Zwollo P, 2005, J IMMUNOL, V174, P6608, DOI 10.4049/jimmunol.174.11.6608; Zwollo P, 2008, DEV COMP IMMUNOL, V32, P1482, DOI 10.1016/j.dci.2008.06.008	39	52	52	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66118	10.1371/journal.pone.0066118	http://dx.doi.org/10.1371/journal.pone.0066118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785475	Green Published, gold			2022-12-25	WOS:000321038800046
J	Emeville, E; Giton, F; Giusti, A; Oliva, A; Fiet, J; Thome, JP; Blanchet, P; Multigner, L				Emeville, Elise; Giton, Frank; Giusti, Arnaud; Oliva, Alejandro; Fiet, Jean; Thome, Jean-Pierre; Blanchet, Pascal; Multigner, Luc			Persistent Organochlorine Pollutants with Endocrine Activity and Blood Steroid Hormone Levels in Middle-Aged Men	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; REPRODUCTIVE HORMONES; DISRUPTING CHEMICALS; PLASMA-LEVELS; SERUM-LEVELS; EXPOSURE; CHLORDECONE; CB-153; DDT; P,P'-DDE	Background: Studies relating long-term exposure to persistent organochlorine pollutants (POPs) with endocrine activities (endocrine disrupting chemicals) on circulating levels of steroid hormones have been limited to a small number of hormones and reported conflicting results. Objective: We examined the relationship between serum concentrations of dehydroepiandrosterone, dehydroepiandrosterone sulphate, androstenedione, androstenediol, testosterone, free and bioavailable testosterone, dihydrotestosterone, estrone, estrone sulphate, estradiol, sex-hormone binding globulin, follicle-stimulating hormone, and luteinizing hormone as a function of level of exposure to three POPs known to interfere with hormone-regulated processes in different way: dichlorodiphenyl dichloroethene (DDE), polychlorinated biphenyl (PCB) congener 153, and chlordecone. Methods: We collected fasting, morning serum samples from 277 healthy, non obese, middle-aged men from the French West Indies. Steroid hormones were determined by gas chromatography-mass spectrometry, except for dehydroepiandrosterone sulphate, which was determined by immunological assay, as were the concentrations of sex-hormone binding globulin, follicle-stimulating hormone and luteinizing hormone. Associations were assessed by multiple linear regression analysis, controlling for confounding factors, in a backward elimination procedure, in multiple bootstrap samples. Results: DDE exposure was negatively associated to dihydrotestosterone level and positively associated to luteinizing hormone level. PCB 153 was positively associated to androstenedione and estrone levels. No association was found for chlordecone. Conclusions: These results suggested that the endocrine response pattern, estimated by determining blood levels of steroid hormones, varies depending on the POPs studied, possibly reflecting differences in the modes of action generally attributed to these compounds. It remains to be investigated whether this response pattern is predictive of the subsequent occurrence of disease.	[Giton, Frank] Hosp Henri Mondor, AP HP CIB GHU Sud, Creteil, France; [Giton, Frank; Fiet, Jean] Ctr Recherches Chirurg, Eq07, Inserm U955, Creteil, France; [Giusti, Arnaud; Thome, Jean-Pierre] Univ Liege, Ctr Analyt Res & Technol, Liege, Belgium; [Oliva, Alejandro] Univ Nacl Rosario, Programa Medio Ambiente & Salud, RA-2000 Rosario, Argentina	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Liege; National University of Rosario		luc.multigner@inserm.fr	Blanchet, Pascal/K-3532-2015; Multigner, Luc/AAA-6214-2020; Multigner, Luc/I-2926-2015	Multigner, Luc/0000-0003-3205-8568; Multigner, Luc/0000-0003-3205-8568; GITON, Frank/0000-0002-4959-1214	French National Health Directorate; Ligue Nationale Contre le Cancer Ph.D. fellowship	French National Health Directorate; Ligue Nationale Contre le Cancer Ph.D. fellowship	This work was supported by the French National Health Directorate. E Emeville is supported by a Ligue Nationale Contre le Cancer Ph.D. fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amory JK, 2003, J STEROID BIOCHEM, V85, P357, DOI 10.1016/S0960-0760(03)00205-X; Asawasinsopon R, 2006, SCI TOTAL ENVIRON, V355, P98, DOI 10.1016/j.scitotenv.2005.03.004; Ayotte P, 2001, EPIDEMIOLOGY, V12, P366, DOI 10.1097/00001648-200105000-00022; Becker K. L., 2001, PRINCIPLES PRACTICE, V3rd; Benachour N, 2007, TOXICOL APPL PHARM, V222, P129, DOI 10.1016/j.taap.2007.03.033; Bernert JT, 2007, CHEMOSPHERE, V68, P824, DOI 10.1016/j.chemosphere.2007.02.043; Blanco-Munoz J, 2012, OCCUP ENVIRON MED, V69, P5, DOI 10.1136/oem.2010.059667; Bonefeld-Jorgensen EC, 2001, TOXICOLOGY, V158, P141, DOI 10.1016/S0300-483X(00)00368-1; Centers for Disease Control and Prevention, 2009, 4 US DEP HLTH HUM SE; COCHRAN RC, 1984, TOXICOL APPL PHARM, V76, P519, DOI 10.1016/0041-008X(84)90356-9; Cohen RA, 2009, 2592009 SAS GLOB FOR, P19; Cooke Paul S., 2001, P257; Dalvie MA, 2004, ENVIRON RES, V96, P9, DOI 10.1016/j.envres.2003.09.003; Danzo BJ, 1997, ENVIRON HEALTH PERSP, V105, P294, DOI 10.2307/3433266; Debier C, 2003, MAR ECOL PROG SER, V247, P237, DOI 10.3354/meps247237; Diamanti-Kandarakis E, 2010, HORM METAB RES, V42, P543, DOI 10.1055/s-0030-1252034; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Dubuisson C, 2007, REGUL TOXICOL PHARM, V49, P5, DOI 10.1016/j.yrtph.2007.04.008; Eriksson AL, 2009, J CLIN ENDOCR METAB, V94, P1033, DOI 10.1210/jc.2008-1283; Ferguson KK, 2012, REPROD TOXICOL, V34, P429, DOI 10.1016/j.reprotox.2012.04.006; Giton F, 2007, CLIN CHEM, V53, P2160, DOI 10.1373/clinchem.2007.087312; Giton F, 2011, EUR J ENDOCRINOL, V165, P917, DOI 10.1530/EJE-11-0551; Giton F, 2010, CLIN CHIM ACTA, V411, P1208, DOI 10.1016/j.cca.2010.04.022; Giwercman A, 2006, ENVIRON HEALTH PERSP, V114, P1348, DOI 10.1289/ehp.8935; Goncharov A, 2009, ENVIRON HEALTH PERSP, V117, P1454, DOI 10.1289/ehp.0800134; Hagmar L, 2001, ARCH ENVIRON HEALTH, V56, P138, DOI 10.1080/00039890109604065; Haugen TB, 2011, REPROD TOXICOL, V32, P261, DOI 10.1016/j.reprotox.2011.06.072; Hsing AW, 2007, CANCER EPIDEM BIOMAR, V16, P1004, DOI 10.1158/1055-9965.EPI-06-0792; HUANG ESR, 1986, TOXICOL APPL PHARM, V82, P62, DOI 10.1016/0041-008X(86)90438-2; Jin Y, 2011, ANN OCCUP HYG, V55, P97, DOI 10.1093/annhyg/meq061; KELCE WR, 1995, NATURE, V375, P581, DOI 10.1038/375581a0; Kelce WR, 1997, TOXICOL APPL PHARM, V142, P192, DOI 10.1006/taap.1996.7966; Kester MHA, 2000, ENDOCRINOLOGY, V141, P1897, DOI 10.1210/en.141.5.1897; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Langer P, 2012, Endocr Regul, V46, P51; Langer P, 2010, Endocr Regul, V44, P109; Lee JG, 2008, TOXICOL APPL PHARM, V233, P193, DOI 10.1016/j.taap.2008.08.011; Lemaire G, 2006, LIFE SCI, V79, P1160, DOI 10.1016/j.lfs.2006.03.023; Lo S, 2007, TOXICOL IN VITRO, V21, P502, DOI 10.1016/j.tiv.2006.10.016; Machala M, 1998, COMP BIOCHEM PHYS A, V120, P65, DOI 10.1016/S1095-6433(98)10011-9; Martin SA, 2002, EPIDEMIOLOGY, V13, P454, DOI 10.1097/00001648-200207000-00014; Multigner L, 2006, EPIDEMIOLOGY, V17, pS372, DOI 10.1097/00001648-200611001-00989; Multigner L, 2010, J CLIN ONCOL, V28, P3457, DOI 10.1200/JCO.2009.27.2153; Oh SM, 2007, ARCH PHARM RES, V30, P199, DOI 10.1007/BF02977695; Owens W, 2007, ENVIRON HEALTH PERSP, V115, P671, DOI 10.1289/ehp.9666; Persky V, 2001, ENVIRON HEALTH PERSP, V109, P1275, DOI 10.2307/3454751; Pliskova M, 2005, ENVIRON HEALTH PERSP, V113, P1277, DOI 10.1289/ehp.7745; Ray S, 2007, ENDOCRINOLOGY, V148, P4774, DOI 10.1210/en.2007-0537; Richthoff J, 2003, ENVIRON HEALTH PERSP, V111, P409, DOI 10.1289/ehp.5767; Rignell-Hydbom A, 2004, HUM REPROD, V19, P2066, DOI 10.1093/humrep/deh362; Rylander L, 2006, CHEMOSPHERE, V65, P375, DOI 10.1016/j.chemosphere.2006.02.012; SAUERBREI W, 1992, STAT MED, V11, P2093, DOI 10.1002/sim.4780111607; Schmidt KL, 2008, GEN COMP ENDOCR, V157, P266, DOI 10.1016/j.ygcen.2008.03.025; Soto AM, 2010, NAT REV ENDOCRINOL, V6, P364, DOI 10.1038/nrendo.2010.87; Stanczyk FZ, 2010, J STEROID BIOCHEM, V121, P491, DOI 10.1016/j.jsbmb.2010.05.001; Thomas P, 2006, J STEROID BIOCHEM, V102, P175, DOI 10.1016/j.jsbmb.2006.09.017; Turyk ME, 2006, ENVIRON RES, V102, P299, DOI 10.1016/j.envres.2006.01.009; Zoeller RT, 2012, ENDOCRINOLOGY, V153, P4097, DOI 10.1210/en.2012-1422	58	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66460	10.1371/journal.pone.0066460	http://dx.doi.org/10.1371/journal.pone.0066460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785499	Green Published, gold, Green Submitted			2022-12-25	WOS:000321038800022
J	Liu, Y; Quang, P; Braggio, E; Ngo, H; Badalian-Very, G; Flores, L; Zhang, Y; Sacco, A; Maiso, P; Azab, AK; Azab, F; Carrasco, R; Rollins, BJ; Roccaro, AM; Ghobrial, IM				Liu, Yang; Phong Quang; Braggio, Esteban; Hai Ngo; Badalian-Very, Gayane; Flores, Ludmila; Zhang, Yong; Sacco, Antonio; Maiso, Patricia; Azab, Abdel Kareem; Azab, Feda; Carrasco, Ruben; Rollins, Barrett J.; Roccaro, Aldo M.; Ghobrial, Irene M.			Novel Tumor Suppressor Function of Glucocorticoid-Induced TNF Receptor GITR in Multiple Myeloma	PLOS ONE			English	Article							NF-KAPPA-B; NK CELLS; T-CELLS; SUPERFAMILY; PATHWAY; ACTIVATION; BIOLOGY; LIGAND; CANCER; NEUROBLASTOMA	Glucocorticoid-induced TNF receptor (GITR) plays a crucial role in modulating immune response and inflammation, however the role of GITR in human cancers is poorly understood. In this study, we demonstrated that GITR is inactivated during tumor progression in Multiple Myeloma (MM) through promoter CpG island methylation, mediating gene silencing in primary MM plasma cells and MM cell lines. Restoration of GITR expression in GITR deficient MM cells led to inhibition of MM proliferation in vitro and in vivo and induction of apoptosis. These findings were supported by the presence of induction of p21 and PUMA, two direct downstream targets of p53, together with modulation of NF-kappa B in GITR-overexpressing MM cells. Moreover, the unbalanced expression of GITR in clonal plasma cells correlated with MM disease progression, poor prognosis and survival. These findings provide novel insights into the pivotal role of GITR in MM pathogenesis and disease progression.	[Liu, Yang; Phong Quang; Hai Ngo; Badalian-Very, Gayane; Flores, Ludmila; Zhang, Yong; Sacco, Antonio; Maiso, Patricia; Azab, Abdel Kareem; Azab, Feda; Carrasco, Ruben; Rollins, Barrett J.; Roccaro, Aldo M.; Ghobrial, Irene M.] Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02114 USA; [Braggio, Esteban] Mayo Clin, Coll Med, Div Haematol, Dept Med, Scottsdale, AZ USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Mayo Clinic; Mayo Clinic Phoenix	Ghobrial, IM (corresponding author), Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02114 USA.	irene_ghobrial@dfci.harvard.edu	Badalian-Very, Gayane/GLN-6049-2022; Dimopoulos, Meletios Athanasios/AAD-4130-2019; Sacco, Antonio/K-4681-2016; Roccaro, Aldo/AAA-8957-2022	Sacco, Antonio/0000-0003-2945-9416; Roccaro, Aldo/0000-0002-1872-5128; Maiso, Patricia/0000-0003-3745-1924	NIH [R01CA125690, R01CA133799]; NATIONAL CANCER INSTITUTE [R01CA133799, R01CA125690] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIHR01CA125690 and R01CA133799	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Baltz KM, 2007, FASEB J, V21, P2442, DOI 10.1096/fj.06-7724com; Berenson JR, 2001, SEMIN ONCOL, V28, P626, DOI 10.1053/sonc.2001.29542; Best CJM, 2005, CLIN CANCER RES, V11, P6823, DOI 10.1158/1078-0432.CCR-05-0585; BIEGEL JA, 1993, AM J HUM GENET, V52, P176; Buechele C, 2012, LEUKEMIA, V26, P991, DOI 10.1038/leu.2011.313; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chauhan D, 2011, CLIN CANCER RES, V17, P5311, DOI 10.1158/1078-0432.CCR-11-0476; Cheng X, 2003, IMMUNOL RES, V27, P287, DOI 10.1385/IR:27:2-3:287; Demchenko YN, 2010, ONCOTARGET, V1, P59, DOI 10.18632/oncotarget.109; Demchenko YN, 2010, BLOOD, V115, P3541, DOI 10.1182/blood-2009-09-243535; Dimberg LY, 2005, BLOOD, V106, P1346, DOI 10.1182/blood-2004-04-1322; Gilmore TD, 2007, CANCER CELL, V12, P95, DOI 10.1016/j.ccr.2007.07.010; Hanabuchi S, 2006, BLOOD, V107, P3617, DOI 10.1182/blood-2005-08-3419; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Katzenberger T, 2009, BLOOD, V113, P1053, DOI 10.1182/blood-2008-07-168682; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kwon B, 2003, EXP MOL MED, V35, P8, DOI 10.1038/emm.2003.2; Liu BY, 2008, J BIOL CHEM, V283, P8202, DOI 10.1074/jbc.M708944200; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mitsiades N, 2002, BLOOD, V99, P4079, DOI 10.1182/blood.V99.11.4079; Nomoto S, 2000, GENE CHROMOSOME CANC, V28, P342, DOI 10.1002/1098-2264(200007)28:3<342::AID-GCC13>3.0.CO;2-A; Poetsch M, 2002, ONCOGENE, V21, P3038, DOI 10.1038/sj.onc.1205457; Rauert H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.78; Ronchetti S, 2002, BLOOD, V100, P350, DOI 10.1182/blood-2001-12-0276; Schultheis B, 1999, LEUKEMIA, V13, P2099, DOI 10.1038/sj.leu.2401609; Shen XJ, 2011, MOL CELL BIOCHEM, V357, P21, DOI 10.1007/s11010-011-0871-9; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Silke J, 2010, CELL DEATH DIFFER, V17, P35, DOI 10.1038/cdd.2009.114; Tai YT, 2003, BLOOD, V101, P2762, DOI 10.1182/blood-2002-09-2813; Tai YT, 2006, CANCER RES, V66, P6675, DOI 10.1158/0008-5472.CAN-06-0190; Tamada K, 2006, CANCER IMMUNOL IMMUN, V55, P355, DOI 10.1007/s00262-005-0081-y; Teodorovic LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031632; Tuyaerts S, 2007, J LEUKOCYTE BIOL, V82, P93, DOI 10.1189/jlb.0906568; Vecchiarelli A, 2009, CELL IMMUNOL, V257, P13, DOI 10.1016/j.cellimm.2009.02.001; WHITE PS, 1995, P NATL ACAD SCI USA, V92, P5520, DOI 10.1073/pnas.92.12.5520; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Zhou T, 2002, IMMUNOL RES, V26, P323, DOI 10.1385/IR:26:1-3:323	38	43	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66982	10.1371/journal.pone.0066982	http://dx.doi.org/10.1371/journal.pone.0066982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785514	Green Submitted, gold, Green Published			2022-12-25	WOS:000321038800009
J	Maggi, U; Consonni, D; Manini, MA; Gatti, S; Cuccaro, F; Donato, F; Conte, G; Bertazzi, PA; Rossi, G				Maggi, Umberto; Consonni, Dario; Manini, Matteo Angelo; Gatti, Stefano; Cuccaro, Francesco; Donato, Francesca; Conte, Grazia; Bertazzi, Pier Alberto; Rossi, Giorgio			Early and Late De Novo Tumors after Liver Transplantation in Adults: The Late Onset of Bladder Tumors in Men	PLOS ONE			English	Article							RISK-FACTORS; CANCER-RISK; MAJOR CAUSE; FOLLOW-UP; MALIGNANCIES; RECIPIENTS; POPULATION; ORGAN; OUTCOMES; COHORT	Background: De novo tumors (DNT) after liver transplantation (LT) represent a growing concern. Patients and Methods: We analyzed the incidence of DNT, type, time of onset, risk factors and mortality (as of 2010) in 494 adult patients transplanted in the last 26 years (1983-2009). Results: DNT occurred in 41 (8.3%) of the patients. The Standardized Incidence Ratio (SIR) compared with the Italian population was 1.8. There was a higher incidence in males (SIR 2.0), an expected extremely high rate of Kaposi's sarcoma (SIR 127.95) and unexpected higher rates of tumors of the bladder in males (SIR 3.3). The incidence of DNT was higher within the first two years of LT (SIR 2.7) for Kaposi's sarcoma (SIR 393.3) and after 10 years (SIR 1.7) for bladder tumors (SIR 10.6). Multivariate analysis identified alcoholic cirrhosis (HR = 3.0, 95% CI = 1.2-7.8) and sclerosing cholangitis (HR = 3.5, 95% CI = 1.1-11.3) in the recipient as main risk factors for the occurrence of DNT. Conclusions: Surveillance protocols for DNT must be specifically oriented to patients transplanted for alcoholic cirrhosis and sclerosing cholangitis. They should focus on early detection of Kaposi's sarcomas, and more remarkably, on late development bladder tumors in men after LT.	[Maggi, Umberto] Fdn IRCCS Ist Ricovero & Cura Carattere Sci Ca Gr, UO Unita Operat Chirurg Gen & Trapianti, Milan, Italy; [Maggi, Umberto] Univ Paris, AP HP, UFR Unite Format & Rech Med, Dept Digest & Hepatobiliary Surg, F-75252 Paris, France; [Gatti, Stefano; Conte, Grazia; Rossi, Giorgio] Fdn IRCCS Ist Ricovero & Cura Carattere Sci Ca Gr, UO Chirurg Gen & Trapianti Fegato, Milan, Italy; [Consonni, Dario; Bertazzi, Pier Alberto] Fdn IRCCS Ist Ricovero & Cura Carattere Sci Ca Gr, UO Epidemiol, Milan, Italy; [Cuccaro, Francesco] Unita Operat Epidemiol & Stat Barletta, Azienda Sanitaria Locale BAT Barletta Andria Tran, Barletta, Italy; [Donato, Francesca] Univ Milan, Fdn IRCCS Ist Ricovero & Cura Carattere Sci Ca Gr, Milan, Italy; [Bertazzi, Pier Alberto] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Rossi, Giorgio] Univ Milan, Dept Surg Sci, Gen Surg & Liver Transplantat Unit, Milan, Italy	Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; University of Milan; University of Milan; University of Milan	Maggi, U (corresponding author), Fdn IRCCS Ist Ricovero & Cura Carattere Sci Ca Gr, UO Unita Operat Chirurg Gen & Trapianti, Milan, Italy.	maggi.umberto@gmail.com	Consonni, Dario/K-7943-2016; Manini, Matteo Angelo/J-3887-2015; bertazzi, pietro alberto/D-5039-2017; maggi, Umberto/M-3074-2015; Consonni, Dario/AAM-2947-2020; Gatti, Stefano/M-1780-2015; Rossi, Giorgio/M-3445-2015; conte, grazia/AAM-4451-2021; Gatti, Stefano/AAE-3281-2022	Consonni, Dario/0000-0002-8935-3843; Manini, Matteo Angelo/0000-0002-2194-5658; bertazzi, pietro alberto/0000-0003-3475-2449; maggi, Umberto/0000-0002-5337-2866; Consonni, Dario/0000-0002-8935-3843; Gatti, Stefano/0000-0003-2209-4338; Rossi, Giorgio/0000-0002-5588-1306; Gatti, Stefano/0000-0003-2209-4338; Cuccaro, Francesco/0000-0002-7012-2885; Conte, Grazia/0000-0002-3877-7355				Aberg F, 2008, LIVER TRANSPLANT, V14, P1428, DOI 10.1002/lt.21475; Adami J, 2003, BRIT J CANCER, V89, P1221, DOI 10.1038/sj.bjc.6601219; Aseni P, 2006, PATHOL INT, V56, P712, DOI 10.1111/j.1440-1827.2006.02035.x; Baccarani U, 2010, DIGEST LIVER DIS, V42, P55, DOI 10.1016/j.dld.2009.04.017; Baccarani U, 2009, TRANSPL P, V41, P1303, DOI 10.1016/j.transproceed.2009.03.079; BenEliyahu S, 1996, NAT MED, V2, P457, DOI 10.1038/nm0496-457; Boin I, 2007, TRANSPL P, V39, P3284, DOI 10.1016/j.transproceed.2007.07.084; Breslow NE., 1987, STAT METHODS CANC RE, P81; Buell JF, 2008, LIVER TRANSPLANT, V14, P1561, DOI 10.1002/lt.21634; Collett D, 2010, AM J TRANSPLANT, V10, P1889, DOI 10.1111/j.1600-6143.2010.03181.x; Delco F, 2006, J HEPATOL, V44, P32, DOI 10.1016/j.jhep.2005.10.011; Di Benedetto F, 2008, J CANCER RES CLIN, V134, P653, DOI 10.1007/s00432-007-0329-3; Fung JJ, 2001, LIVER TRANSPLANT, V7, pS109, DOI 10.1053/jlts.2001.28645; Galve ML, 1999, TRANSPL P, V31, P1275, DOI 10.1016/S0041-1345(98)01994-0; Haagsma EB, 2001, J HEPATOL, V34, P84, DOI 10.1016/S0168-8278(00)00077-5; Hills, 1993, STAT MODELS EPIDEMIO; Herrero JI, 2011, LIVER TRANSPLANT, V17, P402, DOI 10.1002/lt.22247; Jain A, 2008, LIVER TRANSPLANT, V14, P1406, DOI 10.1002/lt.21609; Jimenez C, 2002, TRANSPLANT P, V34, P297, DOI 10.1016/S0041-1345(01)02770-1; Jimenez C, 2007, TRANSPL INT, V20, P57, DOI 10.1111/j.1432-2277.2006.00397.x; Jimenez-Romero C, 2006, TRANSPL P, V38, P2505, DOI 10.1016/j.transproceed.2006.08.065; Kenngott S, 2003, TRANSPLANT INT, V16, P639, DOI 10.1007/s00147-003-0600-8; Lash TL, 2009, J CLIN ONCOL, V27, pE55, DOI 10.1200/JCO.2009.24.1877; LOTZOVA E, 1993, NAT IMMUN, V12, P169; MATHER GG, 1994, IMMUNOBIOLOGY, V190, P333, DOI 10.1016/S0171-2985(11)80606-6; Miao Y, 2009, TRANSPLANTATION, V87, P1347, DOI 10.1097/TP.0b013e3181a238f6; Oo YH, 2005, TRANSPLANTATION, V80, P759, DOI 10.1097/01.TP.0000173775.16579.18; Paul CF, 2003, J INVEST DERMATOL, V120, P211, DOI 10.1046/j.1523-1747.2003.12040.x; Romero-Vargas ME, 2006, TRANSPL P, V38, P2508, DOI 10.1016/j.transproceed.2006.08.028; Sanchez W, 2006, J HEPATOL, V44, P13, DOI 10.1016/j.jhep.2005.10.007; Xiol X, 2001, LIVER TRANSPLANT, V7, P971, DOI 10.1053/jlts.2001.28744; Yao FY, 2006, CLIN TRANSPLANT, V20, P617, DOI 10.1111/j.1399-0012.2006.00527.x	32	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65238	10.1371/journal.pone.0065238	http://dx.doi.org/10.1371/journal.pone.0065238			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785414	Green Published, gold, Green Submitted			2022-12-25	WOS:000321038800106
J	Powers-Fletcher, MV; Feng, XZ; Krishnan, K; Askew, DS				Powers-Fletcher, Margaret V.; Feng, Xizhi; Krishnan, Karthik; Askew, David S.			Deletion of the sec4 Homolog srgA from Aspergillus fumigatus Is Associated with an Impaired Stress Response, Attenuated Virulence and Phenotypic Heterogeneity	PLOS ONE			English	Article							ENCODING SMALL GTPASES; FUNCTIONAL-ANALYSIS; PROTEIN SECRETION; HYPHAL GROWTH; GENE; LOCALIZATION; MUTATION; PATHOGENESIS; REQUIRES; REVEALS	Small GTPases of the Rab family are master regulators of membrane trafficking, responsible for coordinating the sorting, packaging and delivery of membrane-bound vesicles to specific sites within eukaryotic cells. The contribution of these proteins to the biology of the human pathogenic fungus Aspergillus fumigatus has not been explored. In this study, we characterized the srgA gene, encoding a Rab GTPase closely related to Sec4. We found that a GFP-SrgA fusion protein accumulated preferentially at hyphal tips and mature condiophores. The radial growth of a Delta srgA mutant was impaired on both rich and minimal medium, consistent with a role for SrgA in filamentous growth. In addition, the Delta srgA mutant revealed dysmorphic conidiophores that produced conidia with heterogeneous morphology. The Delta srgA mutant was hypersensitive to brefeldin A-mediated inhibition of vesicular trafficking and showed increased temperature sensitivity relative to wild type A. fumigatus. However, the most striking phenotype of this mutant was its phenotypic heterogeneity. Individual colonies isolated from the original Delta srgA mutant showed variable morphology with colony sectoring. In addition, each isolate of the Delta srgA mutant displayed divergent phenotypes with respect to thermotolerance, in vitro stress response and virulence in a Galleria mellonella infection model. Taken together, these results indicate that SrgA contributes to the asexual development and filamentous growth of A. fumigatus. However, the discordant phenotypes observed among individual isolates of the Delta srgA mutant suggest that the absence of srgA exerts selective pressure for the acquisition of compensatory changes, such as second-site suppressor mutations.	[Powers-Fletcher, Margaret V.; Feng, Xizhi; Krishnan, Karthik; Askew, David S.] Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA	University of Cincinnati	Askew, DS (corresponding author), Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA.	David.Askew@uc.edu		Askew, David/0000-0002-6477-2515; Mosur Krishnan, Karthik/0000-0003-4411-4029	National Institutes of Health [R01AI072297]; University of Cincinnati Summer Research Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Cincinnati Summer Research Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institutes of Health grant R01AI072297 to DSA and a University of Cincinnati Summer Research Fellowship to MPF (URL: NIH.gov/grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkowitz RA, 2011, SEMIN CELL DEV BIOL, V22, P806, DOI 10.1016/j.semcdb.2011.08.010; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Bhabhra R, 2004, INFECT IMMUN, V72, P4731, DOI 10.1128/IAI.72.8.4731-4740.2004; Bishop A, 2010, EMBO J, V29, P2930, DOI 10.1038/emboj.2010.158; Calero G, 2003, J BIOL CHEM, V278, P37957, DOI 10.1074/jbc.M301225200; Catlett N.L., 2003, FUNGAL GENET NEWSL, V50, P9, DOI DOI 10.4148/1941-4765.1150; CRAIGHEAD MW, 1993, MOL BIOL CELL, V4, P1069, DOI 10.1091/mbc.4.10.1069; Fallon John, 2012, Methods Mol Biol, V845, P469, DOI 10.1007/978-1-61779-539-8_33; Feng XZ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002330; Frigieri MC, 2008, MOL GENET GENOMICS, V280, P211, DOI 10.1007/s00438-008-0357-y; Georgiev A, 2008, CURR GENET, V53, P235, DOI 10.1007/s00294-008-0183-0; GERASSIMENKO OG, 1994, CURR GENET, V25, P178, DOI 10.1007/BF00309545; HAUBRUCK H, 1990, EMBO J, V9, P1957, DOI 10.1002/j.1460-2075.1990.tb08323.x; Jiang SY, 2006, PHYSIOL GENOMICS, V24, P235, DOI 10.1152/physiolgenomics.00210.2005; Jones LA, 2010, EUKARYOT CELL, V9, P1455, DOI 10.1128/EC.00109-10; Joubert A, 2011, MOL MICROBIOL, V79, P1305, DOI 10.1111/j.1365-2958.2010.07522.x; KABCENELL AK, 1990, J BIOL CHEM, V265, P9366; Krishnan K, 2013, EUKARYOT CELL; Li BJ, 1996, J BIOL CHEM, V271, P16813, DOI 10.1074/jbc.271.28.16813; Mao YX, 1999, J BACTERIOL, V181, P7235, DOI 10.1128/JB.181.23.7235-7242.1999; Momany M, 2002, CURR OPIN MICROBIOL, V5, P580, DOI 10.1016/S1369-5274(02)00368-5; MOUKHA SM, 1993, J GEN MICROBIOL, V139, P969, DOI 10.1099/00221287-139-5-969; Mylonakis E, 2008, MYCOPATHOLOGIA, V165, P1, DOI 10.1007/s11046-007-9082-z; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003; Punt PJ, 2001, MOL MICROBIOL, V41, P513, DOI 10.1046/j.1365-2958.2001.02541.x; Read ND, 2011, MOL MICROBIOL, V81, P4, DOI 10.1111/j.1365-2958.2011.07702.x; Richie DL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000258; Riquelme M, 2011, FUNGAL BIOL-UK, V115, P446, DOI 10.1016/j.funbio.2011.02.008; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; Sapperstein SK, 1996, J CELL BIOL, V132, P755, DOI 10.1083/jcb.132.5.755; Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853; Siriputthaiwan P, 2005, J CELL SCI, V118, P323, DOI 10.1242/jcs.01616; Slater JL, 2011, MED MYCOL, V49, pS107, DOI 10.3109/13693786.2010.523852; Steinberg G, 2007, EUKARYOT CELL, V6, P351, DOI 10.1128/EC.00381-06; Sudbery P, 2011, FUNGAL GENET BIOL, V48, P849, DOI 10.1016/j.fgb.2011.02.004; WOSTEN HAB, 1991, J GEN MICROBIOL, V137, P2017, DOI 10.1099/00221287-137-8-2017; Yamamoto K, 2002, CURR GENET, V42, P85, DOI 10.1007/s00294-002-0336-5; Yoneda A, 2006, MOL BIOL CELL, V17, P5131, DOI 10.1091/mbc.E06-08-0701; Yoo JS, 1999, MOL GEN GENET, V261, P80, DOI 10.1007/s004380050944	40	21	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66741	10.1371/journal.pone.0066741	http://dx.doi.org/10.1371/journal.pone.0066741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785510	Green Published, gold, Green Submitted			2022-12-25	WOS:000321038800012
J	Takata, N; Nagai, T; Ozawa, K; Oe, Y; Mikoshiba, K; Hirase, H				Takata, Norio; Nagai, Terumi; Ozawa, Katsuya; Oe, Yuki; Mikoshiba, Katsuhiko; Hirase, Hajime			Cerebral Blood Flow Modulation by Basal Forebrain or Whisker Stimulation Can Occur Independently of Large Cytosolic Ca2+ Signaling in Astrocytes	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE; NUCLEUS BASALIS; RAT-BRAIN; CELLS; IP3; PLASTICITY; INCREASES; DYNAMICS; RELEASE; CORTEX	We report that a brief electrical stimulation of the nucleus basalis of Meynert (NBM), the primary source of cholinergic projection to the cerebral cortex, induces a biphasic cerebral cortical blood flow (CBF) response in the somatosensory cortex of C57BL/6J mice. This CBF response, measured by laser Doppler flowmetry, was attenuated by the muscarinic type acetylcholine receptor antagonist atropine, suggesting a possible involvement of astrocytes in this type of CBF modulation. However, we find that IP3R2 knockout mice, which lack cytosolic Ca2+ surges in astrocytes, show similar CBF changes. Moreover, whisker stimulation resulted in similar degrees of CBF increase in IP3R2 knockout mice and the background strain C57BL/6J. Our results show that neural activity-driven CBF modulation could occur without large cytosolic increases of Ca2+ in astrocytes.	[Takata, Norio; Nagai, Terumi; Ozawa, Katsuya; Oe, Yuki; Hirase, Hajime] RIKEN Brain Sci Inst, Lab Neuron Glia Circuit, Wako, Saitama, Japan; [Mikoshiba, Katsuhiko] RIKEN Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama, Japan; [Mikoshiba, Katsuhiko] Japan Sci & Technol Agcy, ICORP & SORST, Calcium Oscillat Project, Saitama, Japan; [Hirase, Hajime] Saitama Univ, Brain Sci Inst, Saitama 3388570, Japan	RIKEN; RIKEN; Japan Science & Technology Agency (JST); Saitama University	Takata, N (corresponding author), Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan.	takata@a8.keio.jp; hirase@brain.riken.jp	Hirase, Hajime/A-3709-2012; Mikoshiba, Katsuhiko/N-7943-2015	Hirase, Hajime/0000-0003-3806-6905; 	KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [23700399, 23115522]; RIKEN	KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); RIKEN	This work was supported by KAKENHI grants (23700399, 23115522) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and RIKEN intramural funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badaut J, 2000, NEUROSCI LETT, V292, P75, DOI 10.1016/S0304-3940(00)01364-1; BIESOLD D, 1989, NEUROSCI LETT, V98, P39, DOI 10.1016/0304-3940(89)90370-4; Chen NY, 2012, P NATL ACAD SCI USA, V109, pE2832, DOI 10.1073/pnas.1206557109; DAUPHIN F, 1991, BRAIN RES, V553, P75, DOI 10.1016/0006-8993(91)90232-K; DAWSON TM, 1994, J NEUROSCI, V14, P5147; Di Castro MA, 2011, NAT NEUROSCI, V14, P1276, DOI 10.1038/nn.2929; Filosa JA, 2004, CIRC RES, V95, pE73, DOI 10.1161/01.RES.0000148636.60732.2e; Filosa JA, 2006, NAT NEUROSCI, V9, P1397, DOI 10.1038/nn1779; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Girouard H, 2010, P NATL ACAD SCI USA, V107, P3811, DOI 10.1073/pnas.0914722107; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Gritti I, 1997, J COMP NEUROL, V383, P163; Harder DR, 1998, STROKE, V29, P229, DOI 10.1161/01.STR.29.1.229; He LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042194; Hirase H, 2004, NEUROSCIENCE, V128, P209, DOI 10.1016/j.neuroscience.2004.07.002; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Holtzclaw LA, 2002, GLIA, V39, P69, DOI 10.1002/glia.10085; Hur EE, 2005, J COMP NEUROL, V483, P351, DOI 10.1002/cne.20444; Kanemaru K, 2007, J NEUROSCI, V27, P8957, DOI 10.1523/JNEUROSCI.2276-07.2007; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; LAXMINARAYAN KM, 1994, J BIOL CHEM, V269, P17305; LINDAUER U, 1993, AM J PHYSIOL, V264, pH1223, DOI 10.1152/ajpheart.1993.264.4.H1223; Marpegan L, 2011, J NEUROSCI, V31, P8342, DOI 10.1523/JNEUROSCI.6537-10.2011; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Petzold GC, 2008, NEURON, V58, P897, DOI 10.1016/j.neuron.2008.04.029; Shen ZM, 2012, NAT METHODS, V9, P273, DOI [10.1038/NMETH.1857, 10.1038/nmeth.1857]; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Takata N, 2011, J NEUROSCI, V31, P18155, DOI 10.1523/JNEUROSCI.5289-11.2011; Tanaka M, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-6; Uchiyama T, 2002, J BIOL CHEM, V277, P8106, DOI 10.1074/jbc.M108337200; VANDERZEE EA, 1993, GLIA, V8, P42, DOI 10.1002/glia.440080106; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Wu DM, 2003, AM J PHYSIOL-HEART C, V284, pH2083, DOI 10.1152/ajpheart.01007.2002; Xie Y, 2010, NEUROSCIENCE, V170, P992, DOI 10.1016/j.neuroscience.2010.08.034; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	39	66	68	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66525	10.1371/journal.pone.0066525	http://dx.doi.org/10.1371/journal.pone.0066525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785506	gold, Green Published, Green Submitted			2022-12-25	WOS:000321038800015
J	Chan, SL; Sweet, JG; Cipolla, MJ				Chan, Siu-Lung; Sweet, Julie G.; Cipolla, Marilyn J.			Treatment for cerebral small vessel disease: effect of relaxin on the function and structure of cerebral parenchymal arterioles during hypertension	FASEB JOURNAL			English	Article						blood-brain barrier; inward remodeling; matrix metalloproteinase-2; spontaneous hypertensive rats; vascular endothelial growth factor	WHITE-MATTER LESIONS; ENDOTHELIAL GROWTH-FACTOR; ISCHEMIC VASCULAR-DISEASE; MECHANICAL-PROPERTIES; COGNITIVE DECLINE; NONPREGNANT RATS; FAMILY PEPTIDES; CONSCIOUS RATS; BLOOD-PRESSURE; EXPRESSION	We investigated the effect of hypertension on the function and structure of cerebral parenchymal arterioles (PAs), a major target of cerebral small vessel disease (SVD), and determined whether relaxin is a treatment for SVD during hypertension. PAs were isolated from 18-wk-old female normotensive Wistar-Kyoto (WKY) rats, spontaneous hypertensive rats (SHRs), and SHRs treated with human relaxin 2 for 14 d (4 g/h; n=8/group) and studied using a pressurized arteriograph system. Hypertension reduced PA inner diameter (58 +/- 3 vs. 49 +/- 3 m at 60 mmHg in WKY rats, P<0.05), suggesting inward remodeling that was reversed by relaxin (56 +/- 4 m, P<0.05). Relaxin also increased PA distensibility in SHRs (34 +/- 2 vs. 10 +/- 2% in SHRs, P<0.05). Relaxin was detected in cerebrospinal fluid (110 +/- 30 pg/ml) after systemic administration, suggesting that it crosses the blood-brain barrier (BBB). Relaxin receptors (RXFP1/2) were not detected in cerebral vasculature, but relaxin increased vascular endothelial growth factor (VEGF) and matrix metalloproteinase 2 (MMP-2) expression in brain cortex. Inhibition of VEGF receptor tyrosine kinase (axitinib, 4 mg/kg/d, 14 d) had no effect on increased distensibility with relaxin, but caused outward hypertrophic remodeling of PAs from SHRs. These results suggest that relaxin crosses the BBB and activates MMP-2 in brain cortex, which may interact with PAs to increase distensibility. VEGF appears to be involved in remodeling of PAs, but not relaxin-induced increased distensibility.Chan, S.-L., Sweet, J. G., Cipolla, M. J. Treatment for cerebral small vessel disease: effect of relaxin on the function and structure of cerebral parenchymal arterioles during hypertension.	[Chan, Siu-Lung; Sweet, Julie G.; Cipolla, Marilyn J.] Univ Vermont, Dept Neurol Sci, Burlington, VT 05405 USA; [Cipolla, Marilyn J.] Univ Vermont, Dept Obstet Gynecol & Reprod Sci, Burlington, VT 05405 USA; [Cipolla, Marilyn J.] Univ Vermont, Dept Pharmacol, Burlington, VT 05405 USA	University of Vermont; University of Vermont; University of Vermont	Chan, SL (corresponding author), Univ Vermont, Dept Neurol Sci, 149 Beaumont Ave,HSRF 416, Burlington, VT 05405 USA.	siu-lung.chan@uvm.edu	Chan, Siu-Lung/I-3023-2019	Chan, Siu-Lung/0000-0001-7564-3287	U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke [R01 NSO45940]; NIH National Heart, Lung, and Blood Institute [P01 HL095488]; Totman Medical Research Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL095488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045940] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke; NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Totman Medical Research Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Dr. Dennis Stewart (Corthera, Inc., San Carlos, CA, USA) and Novartis Pharmaceuticals (Basel, Switzerland) for providing recombinant human relaxin 2. The authors also thank Dr. Ernst Rinderknecht (Corthera) for the helpful discussion. The authors thank Timothy Hunter, Mary Lou Shane, Meghann Palermo, and the Vermont Cancer Center DNA Analysis Facility (University of Vermont) for their technical expertise on qPCR studies. The authors thank Nicole Bishop (Microscopy Imaging Center, University of Vermont) for her help with VEGF immunohistochemistry and imaging. The authors also thank Sheila Russell for helping to collect CSF. The authors gratefully acknowledge the continued support from the U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (R01 NSO45940), NIH National Heart, Lung, and Blood Institute (P01 HL095488), and the Totman Medical Research Trust. Recombinant human relaxin 2 was a gift from Corthera and Novartis Phat maceuticals.	Bathgate RAD, 2013, PHYSIOL REV, V93, P405, DOI 10.1152/physrev.00001.2012; Baumbach GL, 1996, HYPERTENSION, V27, P159, DOI 10.1161/01.HYP.27.2.159; BRETELER MMB, 1994, NEUROLOGY, V44, P1246, DOI 10.1212/WNL.44.7.1246; Chan SL, 2012, J IMMUNOASS IMMUNOCH, V33, P314, DOI 10.1080/15321819.2011.647189; Chan SL, 2011, FASEB J, V25, P3229, DOI 10.1096/fj.10-175471; Cipolla MJ, 2009, STROKE, V40, P1451, DOI 10.1161/STROKEAHA.108.535435; Conrad KP, 2011, CURR HYPERTENS REP, V13, P409, DOI 10.1007/s11906-011-0231-x; Conrad KP, 2004, ENDOCRINOLOGY, V145, P3289, DOI 10.1210/en.2003-1612; CORNWELL TL, 1994, AM J PHYSIOL-CELL PH, V267, pC1405, DOI 10.1152/ajpcell.1994.267.5.C1405; Danielson LA, 2003, J APPL PHYSIOL, V95, P1509, DOI 10.1152/japplphysiol.00545.2003; Debrah DO, 2006, ENDOCRINOLOGY, V147, P5126, DOI 10.1210/en.2006-0567; Debrah DO, 2011, J APPL PHYSIOL, V111, P260, DOI 10.1152/japplphysiol.00845.2010; Desouza CV, 2009, VASC PHARMACOL, V51, P162, DOI 10.1016/j.vph.2009.05.001; Dufouil C, 2009, STROKE, V40, P2219, DOI 10.1161/STROKEAHA.108.540633; Fernando MS, 2006, STROKE, V37, P1391, DOI 10.1161/01.STR.0000221308.94473.14; Godin O, 2011, CIRCULATION, V123, P266, DOI 10.1161/CIRCULATIONAHA.110.961052; Gouw AA, 2008, STROKE, V39, P3083, DOI 10.1161/STROKEAHA.108.521807; Gundlach AL, 2009, ANN NY ACAD SCI, V1160, P226, DOI 10.1111/j.1749-6632.2009.03956.x; Guo XX, 2009, HYPERTENSION, V54, P57, DOI 10.1161/HYPERTENSIONAHA.109.129700; HOFFMAN WE, 1981, BRAIN RES, V214, P196, DOI 10.1016/0006-8993(81)90454-6; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Jeyabalan A, 2006, J APPL PHYSIOL, V100, P1955, DOI 10.1152/japplphysiol.01330.2005; Jeyabalan A, 2007, ENDOCRINOLOGY, V148, P189, DOI 10.1210/en.2006-0989; Jokinen H, 2009, CEREBROVASC DIS, V27, P384, DOI 10.1159/000207442; Jokinen H, 2009, CEREBROVASC DIS, V27, P336, DOI 10.1159/000202010; KING GL, 1985, SCIENCE, V227, P1583, DOI 10.1126/science.3883490; Kroll J, 1998, BIOCHEM BIOPH RES CO, V252, P743, DOI 10.1006/bbrc.1998.9719; Lammie GA, 2002, BRAIN PATHOL, V12, P358; Lekgabe ED, 2005, HYPERTENSION, V46, P412, DOI 10.1161/01.HYP.0000171930.00697.2f; Liao DP, 1996, STROKE, V27, P2262, DOI 10.1161/01.STR.27.12.2262; Liu Li, 2008, J Vis Exp, DOI 10.3791/960; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Markus HS, 2000, J NEUROL NEUROSUR PS, V69, P48, DOI 10.1136/jnnp.69.1.48; McGowan BMC, 2010, DIABETES OBES METAB, V12, P1090, DOI 10.1111/j.1463-1326.2010.01302.x; Moran C, 2012, INT J STROKE, V7, P36, DOI 10.1111/j.1747-4949.2011.00725.x; Nishimura N, 2007, P NATL ACAD SCI USA, V104, P365, DOI 10.1073/pnas.0609551104; Pantoni L, 1997, ANN NY ACAD SCI, V826, P92, DOI 10.1111/j.1749-6632.1997.tb48463.x; Tryggvason K, 1992, Matrix Suppl, V1, P45; van Dijk EJ, 2004, HYPERTENSION, V44, P625, DOI 10.1161/01.HYP.0000145857.98904.20; Wang H, 1998, CIRC RES, V83, P832, DOI 10.1161/01.RES.83.8.832; Yan W, 2008, REPRODUCTION, V135, P705, DOI 10.1530/REP-08-0014	41	37	39	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					3917	3927		10.1096/fj.13-230797	http://dx.doi.org/10.1096/fj.13-230797			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23783073	Green Published			2022-12-25	WOS:000329747100007
J	Nilsson, MI; Dobson, JP; Greene, NP; Wiggs, MP; Shimkus, KL; Wudeck, EV; Davis, AR; Laureano, ML; Fluckey, JD				Nilsson, Mats I.; Dobson, Justin P.; Greene, Nicholas P.; Wiggs, Michael P.; Shimkus, Kevin L.; Wudeck, Elyse V.; Davis, Amanda R.; Laureano, Marissa L.; Fluckey, James D.			Abnormal protein turnover and anabolic resistance to exercise in sarcopenic obesity	FASEB JOURNAL			English	Article						fractional synthesis rates; DEPTOR; muscle; diabetes	SKELETAL-MUSCLE; ZUCKER RATS; IN-VIVO; INSULIN STIMULATION; INDUCED HYPERTROPHY; BODY-COMPOSITION; GLUCOSE-UPTAKE; MECHANISM; TISSUES; DEPTOR	Obesity may impair protein synthesis rates and cause anabolic resistance to growth factors, hormones, and exercise, ultimately affecting skeletal muscle mass and function. To better understand muscle wasting and anabolic resistance with obesity, we assessed protein 24-h fractional synthesis rates (24-h FSRs) in selected hind-limb muscles of sedentary and resistance-exercised lean and obese Zucker rats. Despite atrophied hind-limb muscles (-28% vs. lean rats), 24-h FSRs of mixed proteins were significantly higher in quadriceps (+18%) and red or white gastrocnemius (+22 or +38%, respectively) of obese animals when compared to lean littermates. Basal synthesis rates of myofibrillar (+8%) and mitochondrial proteins (-1%) in quadriceps were not different between phenotypes, while manufacture of cytosolic proteins (+12%) was moderately elevated in obese cohorts. Western blot analyses revealed a robust activation of p70S6k (+178%) and a lower expression of the endogenous mTOR inhibitor DEPTOR (-28%) in obese rats, collectively suggesting that there is an obesity-induced increase in net protein turnover favoring degradation. Lastly, the protein synthetic response to exercise of mixed (-7%), myofibrillar (+6%), and cytosolic (+7%) quadriceps subfractions was blunted compared to the lean phenotype (+34, +40, and +17%, respectively), indicating a muscle- and subfraction-specific desensitization to the anabolic stimulus of exercise in obese animals.Nilsson, M. I., Dobson, J. P., Greene, N. P., Wiggs, M. P., Shimkus, K. L., Wudeck, E. V., Davis, A. R., Laureano, M. L., Fluckey, J. D. Abnormal protein turnover and anabolic resistance to exercise in sarcopenic obesity.	[Nilsson, Mats I.; Dobson, Justin P.; Greene, Nicholas P.; Wiggs, Michael P.; Shimkus, Kevin L.; Wudeck, Elyse V.; Davis, Amanda R.; Fluckey, James D.] Texas A&M Univ, Dept Hlth & Kinesiol, Muscle Biol Lab, College Stn, TX 77843 USA; [Laureano, Marissa L.] McMaster Univ Hosp, Dept Pediat & Med, Neuromuscular Clin, Hamilton, ON, Canada	Texas A&M University System; Texas A&M University College Station; McMaster University	Fluckey, JD (corresponding author), Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX 77843 USA.	jfluckey@hlkn.tamu.edu	Nilsson, Mats/AAG-2068-2021; Greene, Nicholas/G-7399-2015; Greene, Nicholas/A-6076-2013	Nilsson, Mats/0000-0001-5656-5578; Greene, Nicholas/0000-0002-9504-9362; Greene, Nicholas/0000-0001-9621-2005	Sydney and J. L. Huffines Institute for Sports Medicine and Human Performance at Texas AM University	Sydney and J. L. Huffines Institute for Sports Medicine and Human Performance at Texas AM University	Funds were provided by the Sydney and J. L. Huffines Institute for Sports Medicine and Human Performance at Texas A&M University. The authors extend their gratitude to Dr. Scot Kimball (Penn State University, State College, PA, USA) for generously providing the eIF2B epsilon antibody.	Adeva MM, 2012, AMINO ACIDS, V43, P171, DOI 10.1007/s00726-011-1088-7; Argiles JM, 1999, J NUTR BIOCHEM, V10, P244, DOI 10.1016/S0955-2863(98)00098-9; Avignon A, 1996, DIABETES, V45, P1396, DOI 10.2337/diabetes.45.10.1396; Bacchi E, 2012, DIABETES CARE, V35, P676, DOI 10.2337/dc11-1655; Baumgartner RN, 2000, ANN NY ACAD SCI, V904, P437; Bell JA, 2006, J NUTR, V136, P1249, DOI 10.1093/jn/136.5.1249; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bolster DR, 2003, J PHYSIOL-LONDON, V553, P213, DOI 10.1113/jphysiol.2003.047019; Cannon Christopher P, 2009, Clin Cornerstone, V9, P55; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; DOMENECH M, 1992, MOL CELL BIOCHEM, V110, P155, DOI 10.1007/BF02454192; Dryden S, 1999, CLIN SCI, V96, P307, DOI [10.1042/CS19980226, 10.1042/cs0960307]; Dufner D, 2003, CURR OPIN CLIN NUTR, V6, P511, DOI 10.1097/00075197-200309000-00004; DURSCHLAG RP, 1983, GROWTH, V47, P282; Evans WJ, 2010, AM J CLIN NUTR, V91, p1123S, DOI 10.3945/ajcn.2010.28608A; Farrell PA, 1999, J APPL PHYSIOL, V87, P1075, DOI 10.1152/jappl.1999.87.3.1075; Farrell PA, 1998, J APPL PHYSIOL, V85, P2291, DOI 10.1152/jappl.1998.85.6.2291; FELIG P, 1969, NEW ENGL J MED, V281, P811, DOI 10.1056/NEJM196910092811503; Fluckey JD, 2000, AM J PHYSIOL-ENDOC M, V279, pE182, DOI 10.1152/ajpendo.2000.279.1.E182; Fluckey JD, 2004, AM J PHYSIOL-ENDOC M, V286, pE753, DOI 10.1152/ajpendo.00155.2003; Fluckey JD, 1999, ACTA PHYSIOL SCAND, V167, P77; Fluckey JD, 1996, J GERONTOL A-BIOL, V51, pB323, DOI 10.1093/gerona/51A.5.B323; Frier BC, 2007, CELL STRESS CHAPERON, V12, P132, DOI 10.1379/CSC-233R.1; GARLICK PJ, 1988, BIOCHEM J, V254, P579, DOI 10.1042/bj2540579; Gasier HG, 2012, METABOLISM, V61, P153, DOI 10.1016/j.metabol.2011.07.001; Gasier HG, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-31; Gasier HG, 2009, COMP BIOCHEM PHYS B, V154, P235, DOI 10.1016/j.cbpb.2009.06.012; Guillet C., OBESITY REV, V13, P51; Guillet C, 2009, J CLIN ENDOCR METAB, V94, P3044, DOI 10.1210/jc.2008-2216; Haasch D, 2006, BIOCHEM BIOPH RES CO, V343, P361, DOI 10.1016/j.bbrc.2006.02.177; Halvatsiotis P, 2002, DIABETES, V51, P2395, DOI 10.2337/diabetes.51.8.2395; Heber D, 1996, AM J CLIN NUTR, V64, P472; Hernandez JM, 2000, J APPL PHYSIOL, V88, P1142, DOI 10.1152/jappl.2000.88.3.1142; Herrero MC, 1997, INT J OBESITY, V21, P698, DOI 10.1038/sj.ijo.0800464; Heshka S, 2008, INT J OBESITY, V32, P780, DOI 10.1038/sj.ijo.0803802; Holloway GP, 2009, AM J PHYSIOL-ENDOC M, V296, pE738, DOI 10.1152/ajpendo.90896.2008; Ibanez J, 2008, J DIABETES COMPLICAT, V22, P112, DOI 10.1016/j.jdiacomp.2007.06.008; Jaleel A, 2008, AM J PHYSIOL-ENDOC M, V295, pE1255, DOI 10.1152/ajpendo.90586.2008; Johnson PR, 1997, AM J CLIN NUTR, V66, P890, DOI 10.1093/ajcn/66.4.890; Katsanos CS, 2011, OBESITY, V19, P469, DOI 10.1038/oby.2010.290; Katta A, 2009, MUSCLE NERVE, V39, P503, DOI 10.1002/mus.21255; Kazi AA, 2011, MOL MED, V17, P925, DOI 10.2119/molmed.2011.00070; Laplante M, 2012, CELL METAB, V16, P202, DOI 10.1016/j.cmet.2012.07.008; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LOBLEY GE, 1978, P NUTR SOC, V37, pA20; Masgrau A, 2012, J PHYSIOL-LONDON, V590, P5199, DOI 10.1113/jphysiol.2012.238576; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Nilsson MI, 2010, AM J PHYSIOL-ENDOC M, V299, pE466, DOI 10.1152/ajpendo.00118.2010; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Oltman CL, 2005, AM J PHYSIOL-ENDOC M, V289, pE113, DOI 10.1152/ajpendo.00594.2004; OTTER T, 1987, ANAL BIOCHEM, V162, P370, DOI 10.1016/0003-2697(87)90406-4; Paturi S, 2010, J APPL PHYSIOL, V108, P7, DOI 10.1152/japplphysiol.00330.2009; Peterson JM, 2008, AM J PHYSIOL-CELL PH, V295, pC521, DOI 10.1152/ajpcell.00073.2008; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Procaccini C, 2012, J IMMUNOL, V189, P2941, DOI 10.4049/jimmunol.1200935; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; Rennie MJ, 2004, ANNU REV PHYSIOL, V66, P799, DOI 10.1146/annurev.physiol.66.052102.134444; Sabatini D. M., 2012, COLD SPRING HARBOR P, V4; Sadiq F, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-23; Sampalis JS, 2004, OBES SURG, V14, P939, DOI 10.1381/0960892041719662; She PX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059443; Simpson S. A., 2011, BMJ, V343; Sitnick M, 2009, J PHYSIOL-LONDON, V587, P5753, DOI 10.1113/jphysiol.2009.180174; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sriwijitkamol A, 2006, AM J PHYSIOL-ENDOC M, V290, pE925, DOI 10.1152/ajpendo.00429.2005; Stenholm S, 2008, CURR OPIN CLIN NUTR, V11, P693, DOI 10.1097/MCO.0b013e328312c37d; Swift J. M., J APPL PHYSL, V109, P1600; TURINSKY J, 1990, J BIOL CHEM, V265, P16880; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang ZW, 2012, AM J PHYSIOL-ENDOC M, V303, pE163, DOI 10.1152/ajpendo.00105.2012; Wang ZW, 2012, NEOPLASIA, V14, P368, DOI 10.1593/neo.12542; Waters DL, 2011, CLIN GERIATR MED, V27, P401, DOI 10.1016/j.cger.2011.03.007; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zamboni M, 2008, NUTR METAB CARDIOVAS, V18, P388, DOI 10.1016/j.numecd.2007.10.002; Zheng YB, 2009, J ENDOCRINOL, V203, P337, DOI 10.1677/JOE-09-0181	76	61	61	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					3905	3916		10.1096/fj.12-224006	http://dx.doi.org/10.1096/fj.12-224006			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23804240				2022-12-25	WOS:000329747100006
J	Tanaka, T; Yamaguchi, J; Higashijima, Y; Nangaku, M				Tanaka, Tetsuhiro; Yamaguchi, Junna; Higashijima, Yoshiki; Nangaku, Masaomi			Indoxyl sulfate signals for rapid mRNA stabilization of Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (CITED2) and suppresses the expression of hypoxia-inducible genes in experimental CKD and uremia	FASEB JOURNAL			English	Article						HIF; cardiorenal anemia syndrome	PROXIMAL TUBULAR CELLS; CHRONIC KIDNEY-DISEASE; TUBULOINTERSTITIAL INJURY; TRANSCRIPTION FACTORS; BINDING-PROTEIN; FUNCTIONAL-ROLE; ERYTHROPOIETIN; IDENTIFICATION; FACTOR-1-ALPHA; DYSFUNCTION	Chronic hypoxia in the tubulointerstitium serves as a final common pathway in progressive renal disease. Circumstantial evidence suggests that hypoxia-inducible factor (HIF)-1 in the ischemic tubules may be functionally inhibited in a chronic kidney disease (CKD) milieu. In this study, we hypothesized that indoxyl sulfate (IS), a uremic toxin, impairs the cellular hypoxic response. In human kidney (HK-2) proximal tubular cells, IS reduced the hypoxic induction of HIF-1 target genes. This effect was not associated with quantitative changes in the HIF-1 protein, but with functional impairment of the HIF-1 C-terminal transactivation domain (CTAD). Among factors that impeded the recruitment of transcriptional coactivators to the HIF-1CTAD, IS markedly up-regulated Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (CITED2) through a mechanism of post-transcriptional mRNA stabilization involving the extracellular signal-regulated kinase (ERK) 1/2 pathway. In vivo, disproportionate expression of HIF target genes was demonstrated in several CKD models, which was offset by an oral adsorbent, AST-120. Furthermore, administration of indole reduced the induction of angiogenic, hypoxia-inducible genes in rats with experimental heart failure. Results of these studies reveal a novel role of IS in modulating the transcriptional response of HIF-1 and provide insight into molecular mechanisms underlying progressive nephropathies as well as cardiovascular complications.Tanaka, T., Yamaguchi, J., Higashijima, Y., Nangaku, M. Indoxyl sulfate signals for rapid mRNA stabilization of Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (CITED2) and suppresses the expression of hypoxia-inducible genes in experimental CKD and uremia.	[Tanaka, Tetsuhiro; Yamaguchi, Junna; Higashijima, Yoshiki; Nangaku, Masaomi] Univ Tokyo, Sch Med, Div Nephrol & Endocrinol, Tokyo 1138655, Japan	University of Tokyo	Tanaka, T (corresponding author), Univ Tokyo, Sch Med, Div Nephrol & Endocrinol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tetsu-tky@umin.ac.jp; mnangaku-tky@umin.ac.jp		Higashijima, Yoshiki/0000-0002-4489-606X	Japan Society for the Promotion of Science [24390213, 22790781]; Takeda Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by grants-in-aid for scientific research from the Japan Society for the Promotion of Science (24390213 to M.N. and 22790781 to T.T.), and a research grant from the Takeda Science Foundation (to T.T.).	Bernhardt WM, 2009, P NATL ACAD SCI USA, V106, P21276, DOI 10.1073/pnas.0903978106; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Braganca J, 2003, J BIOL CHEM, V278, P16021, DOI 10.1074/jbc.M208144200; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Ceradini DJ, 2008, J BIOL CHEM, V283, P10930, DOI 10.1074/jbc.M707451200; Chade AR, 2009, CIRCULATION, V119, P547, DOI 10.1161/CIRCULATIONAHA.108.788653; Chen Y, 2008, DEVELOPMENT, V135, P2939, DOI 10.1242/dev.021097; Chiang CK, 2011, LAB INVEST, V91, P1564, DOI 10.1038/labinvest.2011.114; Chou YT, 2006, ONCOGENE, V25, P5547, DOI 10.1038/sj.onc.1209552; Chou YT, 2006, J BIOL CHEM, V281, P18451, DOI 10.1074/jbc.M601720200; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Du JW, 2012, BLOOD, V119, P2789, DOI 10.1182/blood-2011-10-387902; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Freedman SJ, 2003, NAT STRUCT BIOL, V10, P504, DOI 10.1038/nsb936; Glenn DJ, 1999, J BIOL CHEM, V274, P36159, DOI 10.1074/jbc.274.51.36159; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Huang Y, 2004, FASEB J, V18, P1138, DOI 10.1096/fj.04-1510fje; Ito S, 2010, J BIOL CHEM, V285, P38869, DOI 10.1074/jbc.M110.166686; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Katavetin P, 2006, J AM SOC NEPHROL, V17, P1405, DOI 10.1681/ASN.2005090918; Kawakami T, 2010, AM J PHYSIOL-RENAL, V299, pF568, DOI 10.1152/ajprenal.00659.2009; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Manotham K, 2004, J AM SOC NEPHROL, V15, P1277, DOI 10.1097/01.ASN.0000125614.35046.10; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Matsumoto M, 2004, J AM SOC NEPHROL, V15, P1574, DOI 10.1097/01.ASN.0000128047.13396.48; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Nangaku M, 2013, CLIN EXP PHARMACOL P, V40, P148, DOI 10.1111/1440-1681.12005; Niwa T, 2011, THER APHER DIAL, V15, P120, DOI 10.1111/j.1744-9987.2010.00882.x; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; Palm F, 2010, AM J PHYSIOL-RENAL, V299, pF380, DOI 10.1152/ajprenal.00175.2010; Persson H, 2011, CANCER RES, V71, P78, DOI 10.1158/0008-5472.CAN-10-1869; Qu X, 2007, EMBO J, V26, P4445, DOI 10.1038/sj.emboj.7601883; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Rosenberger C, 2008, KIDNEY INT, V73, P34, DOI 10.1038/sj.ki.5002567; Ruas JL, 2002, J BIOL CHEM, V277, P38723, DOI 10.1074/jbc.M205051200; Sakai M, 2012, NAT MED, V18, P612, DOI 10.1038/nm.2691; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Schmid T, 2004, BIOCHEM J, V380, P289, DOI 10.1042/BJ20031299; SHERIDAN AM, 1993, AM J PHYSIOL, V265, pF342, DOI 10.1152/ajprenal.1993.265.3.F342; Silter M, 2010, PFLUG ARCH EUR J PHY, V459, P569, DOI 10.1007/s00424-009-0748-x; Sun HB, 1998, P NATL ACAD SCI USA, V95, P13555, DOI 10.1073/pnas.95.23.13555; Tanaka S, 2003, PHYSIOL ENTOMOL, V28, P290, DOI 10.1111/j.1365-3032.2003.00346.x; Tanaka T, 2004, AM J PATHOL, V165, P1979, DOI 10.1016/S0002-9440(10)63249-X; Tanaka T, 2012, J BIOL CHEM, V287, P34866, DOI 10.1074/jbc.M112.374587; Tien ES, 2004, J BIOL CHEM, V279, P24053, DOI 10.1074/jbc.M401489200; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Xu B, 2007, DEV BIOL, V301, P130, DOI 10.1016/j.ydbio.2006.08.072; Yan Q, 2007, MOL CELL BIOL, V27, P2092, DOI 10.1128/MCB.01514-06	52	34	35	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					4059	4075		10.1096/fj.13-231837	http://dx.doi.org/10.1096/fj.13-231837			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23792300				2022-12-25	WOS:000329747100019
J	Tang, YQ; Wilmann, PG; Reeve, SB; Coetzer, TH; Smith, AI; Whisstock, JC; Pike, RN; Wijeyewickrema, LC				Tang Yongqing; Wilmann, Pascal G.; Reeve, Shane B.; Coetzer, Theresa H.; Smith, A. Ian; Whisstock, James C.; Pike, Robert N.; Wijeyewickrema, Lakshmi C.			The x-ray crystal structure of mannose-binding lectin-associated serine proteinase-3 reveals the structural basis for enzyme inactivity associated with the Carnevale, Mingarelli, Malpuech, and Michels (3MC) syndrome (vol 288, pg 22399, 2013)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Wijeyewickrema, Lakshmi/A-9676-2015; Coetzer, Theresa/AAM-9193-2021; Coetzer, Theresa/AAE-6207-2019	Wijeyewickrema, Lakshmi/0000-0001-6084-4887; Coetzer, Theresa/0000-0003-0706-3808; Pike, Robert/0000-0002-2083-0269; Smith, Ian/0000-0002-4143-2892; Whisstock, James/0000-0003-4200-5611; Wilmann, Pascal/0000-0002-8376-5150				Tang YQ, 2013, J BIOL CHEM, V288, P28307, DOI 10.1074/jbc.A113.483875	1	20	19	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					28307	28307		10.1074/jbc.M113.483875	http://dx.doi.org/10.1074/jbc.M113.483875			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23792966	Green Published, hybrid			2022-12-25	WOS:000330596300022
J	Zanotti, S; Canalis, E				Zanotti, Stefano; Canalis, Ernesto			Hairy and Enhancer of Split-related with YRPW Motif (HEY)2 Regulates Bone Remodeling in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Interleukin; Notch; Osteoblasts; Osteoclast; HEY2; Bone Remodeling	OSTEOBLAST LINEAGE; OSTEOCLAST DIFFERENTIATION; RECEPTOR ACTIVATOR; CAUSES OSTEOPENIA; GENE-EXPRESSION; STROMAL CELLS; I COLLAGEN; NOTCH; RAT; OSTEOPOROSIS	Notch induces Hairy and Enhancer of Split-related with YRPW motif (Hey)1, Hey2, and HeyL expression in osteoblasts, but the contributions of these genes to the skeletal effects of Notch are not fully understood. HEY1 misexpression has limited skeletal impact, female HeyL null mice display increased bone mass, and Hey2 inactivation is developmentally lethal. To inactivate Hey2 in immature or mature osteoblasts, Hey2(loxP/loxP) mice were crossed with transgenics expressing CRE under the control of the osterix (Osx-Cre) or osteocalcin (Oc-Cre) promoters to generate Osx-Cre(+/-);Hey2(/) or Oc-Cre(+/-);Hey2(/) mice. Trabecular bone volume increased in 3-month-old Osx-Cre(+/-);Hey2(/) and Oc-Cre(+/-);Hey2(/) male mice and in 1-month-old Oc-Cre(+/-);Hey2(/) female mice, although 3-month-old Oc-Cre(+/-);Hey2(/) females developed osteopenia. Alkaline phosphatase liver/bone/kidney (ALPL) expression and activity were suppressed in osteoblasts from Oc-Cre(+/-);Hey2(/) mice of both sexes. To overexpress HEY2 in osteoblasts, transgenic mice where a 3.6-kb fragment of the rat collagen type-I 1 promoter directs HEY2 expression were created. Three-month-old Hey2 transgenic males exhibited decreased osteoblast activity and increased bone resorption and developed osteopenia at 6 months of age. Hey2 transgenic females exhibited reduced osteoblast number and function, but no changes in bone resorption. HEY2 overexpression in osteoblasts from mice of both sexes inhibited ALPL expression and activity and suppressed osteocalcin transcripts in cells from male mice only. HEY2 overexpression in osteoblasts from male mice enhanced bone resorption by co-cultured splenocytes and induced interleukin-6, a molecule that promotes osteoclastogenesis. In conclusion, HEY2 decreases skeletal mass and regulates bone remodeling in male mice.	[Zanotti, Stefano; Canalis, Ernesto] St Francis Hosp & Med Ctr, Dept Res, 114 Woodland St, Hartford, CT 06105 USA; [Zanotti, Stefano; Canalis, Ernesto] Univ Connecticut, Sch Med, Farmington, CT 06030 USA	Saint Francis Hospital & Medical Center; University of Connecticut	Canalis, E (corresponding author), St Francis Hosp & Med Ctr, Dept Res, 114 Woodland St, Hartford, CT 06105 USA.	ecanalis@stfranciscare.org			National Institutes of Health from NIDDK [DK045227]; Arthritis Foundation [5371]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045227] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; Arthritis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK045227 from the NIDDK (to E. C.) and Research Fellowship Award 5371 from the Arthritis Foundation (to S. Z.).	AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; Bai S, 2008, J BIOL CHEM, V283, P6509, DOI 10.1074/jbc.M707000200; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Boban I, 2006, BONE, V39, P1302, DOI 10.1016/j.bone.2006.06.025; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Canalis E, 2007, NEW ENGL J MED, V357, P905, DOI 10.1056/NEJMra067395; Canalis E, 2013, ENDOCRINOLOGY, V154, P623, DOI 10.1210/en.2012-1732; Dong YF, 2010, DEVELOPMENT, V137, P1461, DOI 10.1242/dev.042911; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Fischer A, 2007, CIRC RES, V100, P856, DOI 10.1161/01.RES.0000260913.95642.3b; Fukushima H, 2008, MOL CELL BIOL, V28, P6402, DOI 10.1128/MCB.00299-08; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Garnero P, 2001, CLIN CHEM, V47, P694; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P655, DOI 10.1210/en.2004-0766; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Irwin N., 1989, MOL CLONING LAB MANU; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Iso T, 2001, MOL CELL BIOL, V21, P6080, DOI 10.1128/MCB.21.17.6080-6089.2001; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Kokubo H, 2005, DEV BIOL, V278, P301, DOI 10.1016/j.ydbio.2004.10.025; Kokubo H, 2004, CIRC RES, V95, P540, DOI 10.1161/01.RES.0000141136.85194.f0; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee SK, 2002, J IMMUNOL, V169, P2374, DOI 10.4049/jimmunol.169.5.2374; LIAN J, 1989, P NATL ACAD SCI USA, V86, P1143, DOI 10.1073/pnas.86.4.1143; Manolagas SC, 2002, RECENT PROG HORM RES, V57, P385, DOI 10.1210/rp.57.1.385; MCCARTHY TL, 1990, J BIOL CHEM, V265, P15353; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; O'Brien CA, 2000, J CELL BIOCHEM, V79, P532, DOI 10.1002/1097-4644(20001215)79:4<532::AID-JCB20>3.0.CO;2-U; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Salie R, 2010, BONE, V46, P680, DOI 10.1016/j.bone.2009.10.022; Scheller EL, 2011, CELLS TISSUES ORGANS, V194, P268, DOI 10.1159/000324745; Sethi N, 2011, CANCER CELL, V19, P192, DOI 10.1016/j.ccr.2010.12.022; Sokal R. R, 1981, BIOMETRY; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Tao JN, 2010, J BONE MINER RES, V25, P2175, DOI 10.1002/jbmr.115; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; Tu XL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002577; Wei W, 2011, MOL CELL BIOL, V31, P4692, DOI 10.1128/MCB.05979-11; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Wyzga N, 2004, BONE, V35, P614, DOI 10.1016/j.bone.2004.04.022; Xin M, 2007, P NATL ACAD SCI USA, V104, P7975, DOI 10.1073/pnas.0702447104; Yamada T, 2003, BLOOD, V101, P2227, DOI 10.1182/blood-2002-06-1740; Yoshitake F, 2008, J BIOL CHEM, V283, P11535, DOI 10.1074/jbc.M607999200; Zanotti S, 2008, ENDOCRINOLOGY, V149, P3890, DOI 10.1210/en.2008-0140; Zanotti S, 2011, J BIOL CHEM, V286, P4576, DOI 10.1074/jbc.M110.161893; Zanotti S, 2011, J BIOL CHEM, V286, P2648, DOI 10.1074/jbc.M110.183038; Zanotti S, 2010, MOL CELL BIOL, V30, P886, DOI 10.1128/MCB.01285-09	55	13	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21547	21557		10.1074/jbc.M113.489435	http://dx.doi.org/10.1074/jbc.M113.489435			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23782701	hybrid, Green Published			2022-12-25	WOS:000328841900008
J	Huang, WC; Yang, CC; Chen, IH; Liu, YML; Chang, SJ; Chuang, YJ				Huang, Wei-Chang; Yang, Chung-Chi; Chen, I-Hui; Liu, Yu-Min Lawrence; Chang, Shing-Jyh; Chuang, Yung-Jen			Treatment of Glucocorticoids Inhibited Early Immune Responses and Impaired Cardiac Repair in Adult Zebrafish	PLOS ONE			English	Article							HEART REGENERATION; STEM-CELLS; EXPRESSION; DISEASE; CARDIOMYOCYTES; ANGIOGENESIS; INFLAMMATION; PATHWAYS; THERAPY; SYSTEM	Myocardial injury, such as myocardial infarction (MI), can lead to drastic heart damage. Zebrafish have the extraordinary ability to regenerate their heart after a severe injury. Upon ventricle resection, fibrin clots seal the wound and serve as a matrix for recruiting myeloid-derived phagocytes. Accumulated neutrophils and macrophages not only reduce the risk of infection but also secrete cytokines and growth factors to promote tissue repair. However, the underlying cellular and molecular mechanisms for how immune responses are regulated during the early stages of cardiac repair are still unclear. We investigated the role and programming of early immune responses during zebrafish heart regeneration. We found that zebrafish treated with an anti-inflammatory glucocorticoid had significantly reduced heart regenerative capacities, consistent with findings in other higher vertebrates. Moreover, inhibiting the inflammatory response led to excessive collagen deposition. A microarray approach was used to assess the differential expression profiles between zebrafish hearts with normal or impaired healing. Combining cytokine profiling and immune-staining, our data revealed that impaired heart regeneration could be due to reduced phagocyte recruitment, leading to diminished angiogenesis and cell proliferation post-cardiac injury. Despite their robust regenerative ability, our study revealed that glucocorticoid treatment could effectively hinder cardiac repair in adult zebrafish by interfering with the inflammatory response. Our findings may help to clarify the initiation of cardiac repair, which could be used to develop a therapeutic intervention that may enhance cardiac repair in humans to compensate for the loss of cardiomyocytes after an MI.	[Huang, Wei-Chang; Yang, Chung-Chi; Chen, I-Hui; Liu, Yu-Min Lawrence; Chuang, Yung-Jen] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan; [Huang, Wei-Chang; Yang, Chung-Chi; Chen, I-Hui; Liu, Yu-Min Lawrence; Chuang, Yung-Jen] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Yang, Chung-Chi] Taoyuan Armed Forces Gen Hosp, Div Cardiol, Tao Yuan, Taiwan; [Liu, Yu-Min Lawrence] Mackay Mem Hosp, Hsinchu Branch, Dept Internal Med, Div Cardiol, Hsinchu, Taiwan; [Chang, Shing-Jyh] Mackay Mem Hosp, Hsinchu Branch, Dept Obstet & Gynecol, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University; Mackay Memorial Hospital; Mackay Memorial Hospital	Chuang, YJ (corresponding author), Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan.	yjchuang@life.nthu.edu.tw	Chuang, Yung-Jen/D-2362-2013	Chuang, Yung-Jen/0000-0002-6022-0107	Taiwan National Science Council [101-2325-B-007-004]; Taoyuan Armed Forces General Hospital [9909]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Taoyuan Armed Forces General Hospital	This work was supported by Taiwan National Science Council [http://web1.nsc.gov.tw/mp.aspx grant number: 101-2325-B-007-004] & Taoyuan Armed Forces General Hospital [http://804.mnd.gov.tw/ grant number: 9909]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adcock IM, 2001, PULM PHARMACOL THER, V14, P211, DOI 10.1006/pupt.2001.0283; Bakkers J, 2011, CARDIOVASC RES, V91, P279, DOI 10.1093/cvr/cvr098; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Chen JN, 1996, DEVELOPMENT, V122, P3809; Clements WK, 2011, NATURE, V474, P220, DOI 10.1038/nature10107; CONNOLLY DT, 1991, J CELL BIOCHEM, V47, P219, DOI 10.1002/jcb.240470306; Gaziano TA, 2007, HEALTH AFFAIR, V26, P13, DOI 10.1377/hlthaff.26.1.13; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Huang WC, 2010, ZEBRAFISH, V7, P297, DOI 10.1089/zeb.2010.0653; Hubner G, 1996, CYTOKINE, V8, P548, DOI 10.1006/cyto.1996.0074; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; KNIGHTON DR, 1990, J TRAUMA, V30, pS134; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Kyritsis N, 2012, SCIENCE; Lafontant PJ, 2012, ANAT REC, V295, P234, DOI 10.1002/ar.21492; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mathew LK, 2007, J BIOL CHEM, V282, P35202, DOI 10.1074/jbc.M706640200; MATHEWS MB, 1984, NATURE, V309, P374, DOI 10.1038/309374a0; Mescher AL, 2005, ADV BIOCHEM ENG BIOT, V93, P39, DOI 10.1007/b99966; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Poss KD, 2007, SEMIN CELL DEV BIOL, V18, P36, DOI 10.1016/j.semcdb.2006.11.009; Ptaszek LM, 2012, LANCET, V379, P933, DOI 10.1016/S0140-6736(12)60075-0; Rasmussen TL, 2011, CIRCULATION, V123, P1771, DOI 10.1161/CIRCULATIONAHA.109.858019; Schweitzer J, 2003, GLIA, V41, P301, DOI 10.1002/glia.10192; SEIBERT K, 1995, AGENT ACTION SUPPL, V46, P41; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Sun J, 2009, AM J PHYSIOL-HEART C, V296, pH43, DOI 10.1152/ajpheart.00613.2008; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; WALLNER BP, 1986, NATURE, V320, P77, DOI 10.1038/320077a0; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE	42	59	61	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66613	10.1371/journal.pone.0066613	http://dx.doi.org/10.1371/journal.pone.0066613			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805247	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500075
J	Ingersoll, TE; Sewall, BJ; Amelon, SK				Ingersoll, Thomas E.; Sewall, Brent J.; Amelon, Sybill K.			Improved Analysis of Long-Term Monitoring Data Demonstrates Marked Regional Declines of Bat Populations in the Eastern United States	PLOS ONE			English	Article							WHITE-NOSE SYNDROME; BIG-EARED BAT; MYOTIS-SODALIS; HIBERNATING BATS; FLYING FOXES; BROWN BATS; DISEASE; CONSERVATION; WINTER; PATTERNS	Bats are diverse and ecologically important, but are also subject to a suite of severe threats. Evidence for localized bat mortality from these threats is well-documented in some cases, but long-term changes in regional populations of bats remain poorly understood. Bat hibernation surveys provide an opportunity to improve understanding, but analysis is complicated by bats' cryptic nature, non-conformity of count data to assumptions of traditional statistical methods, and observation heterogeneities such as variation in survey timing. We used generalized additive mixed models (GAMMs) to account for these complicating factors and to evaluate long-term, regional population trajectories of bats. We focused on four hibernating bat species - little brown myotis (Myotis lucifugus), tri-colored bat (Perimyotis subflavus), Indiana myotis (M. sodalis), and northern myotis (M. septentrionalis) - in a four-state region of the eastern United States during 1999-2011. Our results, from counts of nearly 1.2 million bats, suggest that cumulative declines in regional relative abundance by 2011 from peak levels were 71% (with 95% confidence interval of +/- 11%) in M. lucifugus, 34% (+/- 38%) in P. subflavus, 30% (+/- 26%) in M. sodalis, and 31% (+/- 18%) in M. septentrionalis. The M. lucifugus population fluctuated until 2004 before persistently declining, and the populations of the other three species declined persistently throughout the study period. Population trajectories suggest declines likely resulted from the combined effect of multiple threats, and indicate a need for enhanced conservation efforts. They provide strong support for a change in the IUCN Red List conservation status in M. lucifugus from Least Concern to Endangered within the study area, and are suggestive of a need to change the conservation status of the other species. Our modeling approach provided estimates of uncertainty, accommodated non-linearities, and controlled for observation heterogeneities, and thus has wide applicability for evaluating population trajectories in other wildlife species.	[Ingersoll, Thomas E.] Univ Tennessee, Natl Inst Math & Biol Synth, Knoxville, TN 37996 USA; [Sewall, Brent J.] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA; [Amelon, Sybill K.] Univ Missouri, No Res Stn, US Forest Serv, Columbia, MO USA	University of Tennessee System; University of Tennessee Knoxville; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; United States Department of Agriculture (USDA); United States Forest Service; University of Missouri System; University of Missouri Columbia	Ingersoll, TE (corresponding author), Univ Tennessee, Natl Inst Math & Biol Synth, Knoxville, TN 37996 USA.	tomingersoll@yahoo.com; bjsewall@temple.edu	amelon, s/GYQ-7127-2022	Amelon, Sybill/0000-0003-3940-8153	National Science Foundation; U.S. Department of Homeland Security; U.S. Department of Agriculture through NSF Award [EF-0832858]; University of Tennessee, Knoxville; Direct For Biological Sciences [1300426] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); U.S. Department of Agriculture through NSF Award; University of Tennessee, Knoxville; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was conducted while TEI was a Postdoctoral Fellow at the National Institute for Mathematical and Biological Synthesis (http://www.nimbios.org), an Institute sponsored by the National Science Foundation (http://www.nsf.gov), the U.S. Department of Homeland Security (http://www.dhs.gov), and the U.S. Department of Agriculture (http://www.usda.gov) through NSF Award #EF-0832858, with additional support from The University of Tennessee, Knoxville (http://www.utk.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1973, 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Anderson DR, 2001, WILDLIFE SOC B, V29, P1294; Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; Barbour R.W., 1969, BATS AM; Barclay RMR, 2003, BAT ECOLOGY, P209; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Boyles JG, 2006, MAMMAL REV, V36, P267, DOI 10.1111/j.1365-2907.2006.00095.x; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Brack V, 2007, ENVIRON MANAGE, V40, P739, DOI 10.1007/s00267-006-0274-y; BRADY J. T., 1982, GRAY BAT RECOVERY PL; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Butchkoski CM, 2013, WHITE NOSE SYNDROME; Caceres M.C., 2000, MAMMAL SPECIES, V634, P1; Chambers JM., 1992, STAT MODELS S; Clark BS, 2002, J MAMMAL, V83, P590, DOI 10.1644/1545-1542(2002)083<0590:SVIAPO>2.0.CO;2; CLARK DR, 1988, WILDLIFE SOC B, V16, P399; CLAWSON RL, 1980, J MAMMAL, V61, P245, DOI 10.2307/1380045; Clawson RL, 2004, P IND BAT COAL MIN T, P1; Cleveland CJ, 2006, FRONT ECOL ENVIRON, V4, P238, DOI 10.1890/1540-9295(2006)004[0238:EVOTPC]2.0.CO;2; COX PA, 1991, CONSERV BIOL, V5, P448, DOI 10.1111/j.1523-1739.1991.tb00351.x; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Duchamp JE, 2006, WILDLIFE SOC B, V34, P408, DOI 10.2193/0091-7648(2006)34[408:EPODFB]2.0.CO;2; Ellison L.E., 2003, MONITORING BAT POPUL, P127; Fenolio DB, 2006, P ROY SOC B-BIOL SCI, V273, P439, DOI 10.1098/rspb.2005.3341; FENTON M B, 1980, Mammalian Species, P1, DOI 10.2307/3503792; Fenton M.B., 1992, BATS; Fewster RM, 2000, ECOLOGY, V81, P1970, DOI 10.2307/177286; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Foley J, 2011, CONSERV BIOL, V25, P223, DOI 10.1111/j.1523-1739.2010.01638.x; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Frick WF, 2010, J ANIM ECOL, V79, P128, DOI 10.1111/j.1365-2656.2009.01615.x; FUJITA M S, 1984, Mammalian Species, P1, DOI 10.2307/3504021; FUJITA MS, 1991, CONSERV BIOL, V5, P455, DOI 10.1111/j.1523-1739.1991.tb00352.x; Gotelli N.J., 1998, PRIMER ECOLOGY; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; HARDIN JW, 1970, J MAMMAL, V51, P829, DOI 10.2307/1378324; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hein CD, 2012, POTENTIAL IMPACTS SH; Hutson A, 2001, MICROCHIROPTERAN BAT; Ingersoll TE, 2010, J MAMMAL, V91, P1242, DOI 10.1644/09-MAMM-A-288.1; *INT UN CONS NAT, 2012, IUCN RED LIST CAT CR; IUCN, 2022, IUCN RED LIST THREAT; Jones Gareth, 2009, Endangered Species Research, V8, P93, DOI 10.3354/esr00182; Kalka MB, 2008, SCIENCE, V320, P71, DOI 10.1126/science.1153352; Kannan K, 2010, CHEMOSPHERE, V80, P613, DOI 10.1016/j.chemosphere.2010.04.060; Kunz T.H., 2003, MONITORING TRENDS BA, P9; Kunz TH, 2011, STATUS REV LITTLE BR; Kunz TH, 2007, FRONT ECOL ENVIRON, V5, P315, DOI 10.1890/1540-9295(2007)5[315:EIOWED]2.0.CO;2; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Langwig KE, 2012, ECOL LETT, V15, P1050, DOI 10.1111/j.1461-0248.2012.01829.x; Laurance WF, 2009, CONSERV BIOL, V23, P1427, DOI 10.1111/j.1523-1739.2009.01336.x; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Link WA, 1997, BIOMETRICS, V53, P488, DOI 10.2307/2533952; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Magurran AE, 2010, TRENDS ECOL EVOL, V25, P574, DOI 10.1016/j.tree.2010.06.016; Matteson M, 2010, PETITION LIST E SMAL; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; McCullagh P, 1989, GEN LINEAR MODELS; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; Meretsky VJ, 2010, J WILDLIFE MANAGE, V74, P166, DOI 10.2193/2008-306; Mickleburgh S.P., 1992, OLD WORLD FRUIT BATS; Mickleburgh SP, 2002, ORYX, V36, P18, DOI 10.1017/S0030605301000011; Mumma TL, 2011, WIND ENERGY VOLUNTAR; NEILSON AL, 1994, WILDLIFE SOC B, V22, P8; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nichols JD, 2000, AUK, V117, P393, DOI 10.1642/0004-8038(2000)117[0393:ADOAFE]2.0.CO;2; O'Shea TJ, 2003, WILDLIFE SOC B, V31, P16; O'Shea TJ, 2003, USGSBRDITR20030003; Pennsylvania Game Commission, 2012, PENNS B, V42, P5310; Pierson Elizabeth D., 1998, P309; Poulson TL, 2000, ECOSY WORLD, V30, P231; Pruitt L, 2007, INDIANA BAT IN PRESS; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; Rodenhouse NL, 2009, CAN J FOREST RES, V39, P249, DOI 10.1139/X08-160; Rodhouse TJ, 2012, ECOL APPL, V22, P1098, DOI 10.1890/11-1662.1; Royle J. A., 2008, HIERARCHICAL MODELIN; Russell Amy L., 2009, Endangered Species Research, V8, P49, DOI 10.3354/esr00121; Shore R. F., 2001, ECOTOXICOLOGY WILD M; Thomas DW, 1997, FUNCT ECOL, V11, P585, DOI 10.1046/j.1365-2435.1997.00129.x; THOMAS DW, 1990, J MAMMAL, V71, P475, DOI 10.2307/1381967; THOMAS DW, 1995, J MAMMAL, V76, P940, DOI 10.2307/1382764; Thomas L, 1996, ECOLOGY, V77, P49, DOI 10.2307/2265653; THOMSON C E, 1982, Mammalian Species, P1, DOI 10.2307/3504013; Turner Gregory G., 2011, Bat Research News, V52, P13; TUTTLE M. D, 2003, MONITORING TRENDS BA, P31; TUTTLE MD, 1979, J WILDLIFE MANAGE, V43, P1, DOI 10.2307/3800631; U.S. Department of the Interior, 1967, END SPEC 32 FR 4001; U.S. Fish Wildlife Service [USFWS], 2012, N AM BAT DEATH TOLL; US Department of Energy, 2012, WIND POW AM; USFWS, 2007, IND BAT MYOT SOD DRA, P258; WHITAKER JO, 1992, AM MIDL NAT, V127, P52, DOI 10.2307/2426321; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Williams-Guillen K, 2008, SCIENCE, V320, P70, DOI 10.1126/science.1152944; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2008, J R STAT SOC B, V70, P495, DOI 10.1111/j.1467-9868.2007.00646.x; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Zuur Alain F., 2009, P1	99	53	58	2	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e65907	10.1371/journal.pone.0065907	http://dx.doi.org/10.1371/journal.pone.0065907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805192	gold, Green Published, Green Submitted			2022-12-25	WOS:000320846500020
J	Skjot-Arkil, H; Clausen, RE; Rasmussen, LM; Wang, WC; Wang, YG; Zheng, QL; Mickley, H; Saaby, L; Diederichsen, ACP; Lambrechtsen, J; Martinez, FJ; Hogaboam, CM; Han, ML; Larsen, MR; Nawrocki, A; Vainer, B; Krustrup, D; Bjorling-Poulsen, M; Karsdal, MA; Leeming, DJ				Skjot-Arkil, Helene; Clausen, Rikke E.; Rasmussen, Lars M.; Wang, Wanchun; Wang, Yaguo; Zheng, Qinlong; Mickley, Hans; Saaby, Lotte; Diederichsen, Axel C. P.; Lambrechtsen, Jess; Martinez, Fernando J.; Hogaboam, Cory M.; Han, MeiLan; Larsen, Martin R.; Nawrocki, Arkadiusz; Vainer, Ben; Krustrup, Dorrit; Bjorling-Poulsen, Marina; Karsdal, Morten A.; Leeming, Diana J.			Acute Myocardial Infarction and Pulmonary Diseases Result in Two Different Degradation Profiles of Elastin as Quantified by Two Novel ELISAs	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; OSTEOPONTIN-DEFICIENT MICE; MATRIX-METALLOPROTEINASE; BIOCHEMICAL MARKERS; ARTICULAR-CARTILAGE; EX-VIVO; COLLAGEN; CLEAVAGE; PEPTIDE; ATHEROSCLEROSIS	Background: Elastin is a signature protein of the arteries and lungs, thus it was hypothesized that elastin is subject to enzymatic degradation during cardiovascular and pulmonary diseases. The aim was to investigate if different fragments of the same protein entail different information associated to two different diseases and if these fragments have the potential of being diagnostic biomarkers. Methods: Monoclonal antibodies were raised against an identified fragment (the ELM-2 neoepitope) generated at the amino acid position '552 in elastin by matrix metalloproteinase (MMP) -9/-12. A newly identified ELM neoepitope was generated by the same proteases but at amino acid position '441. The distribution of ELM-2 and ELM, in human arterial plaques and fibrotic lung tissues were investigated by immunohistochemistry. A competitive ELISA for ELM-2 was developed. The clinical relevance of the ELM and ELM-2 ELISAs was evaluated in patients with acute myocardial infarction (AMI), no AMI, high coronary calcium, or low coronary calcium. The serological release of ELM-2 in patients with chronic obstructive pulmonary disease (COPD) or idiopathic pulmonary fibrosis (IPF) was compared to controls. Results: ELM and ELM-2 neoepitopes were both localized in diseased carotid arteries and fibrotic lungs. In the cardiovascular cohort, ELM-2 levels were 66% higher in serum from AMI patients compared to patients with no AMI (p<0.01). Levels of ELM were not significantly increased in these patients and no correlation was observed between ELM-2 and ELM. ELM-2 was not elevated in the COPD and IPF patients and was not correlated to ELM. ELM was shown to be correlated with smoking habits (p<0.01). Conclusions: The ELM-2 neoepitope was related to AMI whereas the ELM neoepitope was related to pulmonary diseases. These results indicate that elastin neoepitopes generated by the same proteases but at different amino acid sites provide different tissue-related information depending on the disease in question.	[Skjot-Arkil, Helene; Clausen, Rikke E.; Karsdal, Morten A.; Leeming, Diana J.] Nordic Biosci AS, Herlev, Denmark; [Skjot-Arkil, Helene] Univ Southern Denmark, Sch Endocrinol, Odense, Denmark; [Rasmussen, Lars M.; Bjorling-Poulsen, Marina] Odense Univ Hosp, Inst Clin Res, DK-5000 Odense, Denmark; [Wang, Wanchun; Wang, Yaguo; Zheng, Qinlong] Nordic Biosci Beijing, Beijing, Peoples R China; [Mickley, Hans; Saaby, Lotte; Diederichsen, Axel C. P.] Odense Univ Hosp, Dept Cardiol, DK-5000 Odense, Denmark; [Lambrechtsen, Jess] Svenborg Hosp, Dept Cardiol, Svenborg, Denmark; [Martinez, Fernando J.; Hogaboam, Cory M.; Han, MeiLan] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Martinez, Fernando J.; Hogaboam, Cory M.; Han, MeiLan] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Larsen, Martin R.; Nawrocki, Arkadiusz] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Vainer, Ben; Krustrup, Dorrit] Univ Copenhagen, Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Southern Denmark; Rigshospitalet; University of Copenhagen	Leeming, DJ (corresponding author), Nordic Biosci AS, Herlev, Denmark.	DJL@nordicbioscience.com	Lambrechtsen, Jess/M-3822-2014; Hogaboam, Cory M./AAI-1433-2021; Diederichsen, Axel Cosmus Pyndt/C-3355-2013; ZHENG, Qin/T-2925-2019; hogaboam, cory/M-3578-2014; Skjøt-Arkil, Helene/X-2899-2019; Larsen, Martin Rossel/F-1411-2015	Hogaboam, Cory M./0000-0003-3366-4850; Diederichsen, Axel Cosmus Pyndt/0000-0002-1285-4826; Skjøt-Arkil, Helene/0000-0002-2236-6375; Rasmussen, Lars Melholt/0000-0001-5795-4794; Karsdal, Morten/0000-0001-5026-8740; Larsen, Martin Rossel/0000-0001-6203-0123; Lambrechtsen, Jess/0000-0002-9976-9981	Danish Research Foundation (Den Danske Forskningsfond)	Danish Research Foundation (Den Danske Forskningsfond)	The authors gratefully acknowledge funding from the Danish Research Foundation (Den Danske Forskningsfond) to support this work. The funders had no role in the study design, data collection and analysis, decision to publish, or prepaparation of the manuscript.	Anborgh PH, 2011, J CELL COMMUN SIGNAL, V5, P111, DOI 10.1007/s12079-011-0130-6; Ashworth JL, 1999, BIOCHEM J, V340, P171, DOI 10.1042/0264-6021:3400171; Barascuk N, 2010, CLIN BIOCHEM, V43, P899, DOI 10.1016/j.clinbiochem.2010.03.012; Barroso B, 2006, ANAL BIOCHEM, V358, P216, DOI 10.1016/j.ab.2006.07.011; Bay-Jensen AC, 2011, CLIN BIOCH; Benoit M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008939; Billinghurst RC, 2010, METHODS MOL BIOL, V622, P349, DOI 10.1007/978-1-60327-299-5_21; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Diederichsen ACP, 2012, EUR J PREV CARDIOL, V19, P558, DOI 10.1177/1741826711409172; DILLON TJ, 1992, AM REV RESPIR DIS, V146, P1143, DOI 10.1164/ajrccm/146.5_Pt_1.1143; Donaldson GC, 2010, CHEST, V137, P1091, DOI 10.1378/chest.09-2029; Fritze O, 2012, J VASC RES, V49, P77, DOI 10.1159/000331278; Fuernau G, 2012, INT J CARDIOL; Garnero P, 1998, J BIOL CHEM, V273, P32347, DOI 10.1074/jbc.273.48.32347; GEFTER ML, 1977, SOMAT CELL GENET, V3, P231, DOI 10.1007/BF01551818; Georgiadou P, 2010, EUR J CLIN INVEST, V40, P288, DOI 10.1111/j.1365-2362.2010.02257.x; Gioia M, 2010, J BIOL INORG CHEM, V15, P1219, DOI 10.1007/s00775-010-0680-8; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Heinz A, 2010, FEBS J, V277, P1939, DOI 10.1111/j.1742-4658.2010.07616.x; Hoffmann U, 2003, CIRCULATION, V108, pE50, DOI 10.1161/01.CIR.0000085363.88377.F2; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; JACOB MP, 1992, CR SOC BIOL, V186, P342; Johnson JL, 2005, P NATL ACAD SCI USA, V102, P15575, DOI 10.1073/pnas.0506201102; Joos L, 2002, HUM MOL GENET, V11, P569, DOI 10.1093/hmg/11.5.569; Kai HK, 1998, J AM COLL CARDIOL, V32, P368, DOI 10.1016/S0735-1097(98)00250-2; Karsdal MA, 2011, CLIN BIOCHEM, V44, P1278, DOI 10.1016/j.clinbiochem.2011.08.1135; Karsdal MA, 2009, BIOMARKERS, V14, P181, DOI 10.1080/13547500902777608; Karsdal MA, 2010, CLIN BIOCHEM, V43, P793, DOI 10.1016/j.clinbiochem.2010.03.015; Kielty Cay M., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S146239940600007X; KIELTY CM, 1994, FEBS LETT, V351, P85, DOI 10.1016/0014-5793(94)00818-3; Kielty CM, 2002, J CELL SCI, V115, P2817; Kuznetsova T, 2009, CIRC-HEART FAIL, V2, P105, DOI 10.1161/CIRCHEARTFAILURE.108.822627; Lagente V, 2009, EXPERT OPIN THER TAR, V13, P287, DOI [10.1517/14728220902751632, 10.1517/14728220902751632 ]; Lambert JM, 2008, INT J CARDIOL, V130, P147, DOI 10.1016/j.ijcard.2008.04.059; Leeming DJ, 2010, CLIN BIOCHEM, V43, P1249, DOI 10.1016/j.clinbiochem.2010.07.025; Leeming DJ, 2006, EUR J CLIN PHARM; Lemjabbar H, 1999, AM J RESP CELL MOL, V20, P903, DOI 10.1165/ajrcmb.20.5.3260; Luttun A, 2004, CIRCULATION, V109, P1408, DOI 10.1161/01.CIR.0000121728.14930.DE; Ma SR, 2003, P NATL ACAD SCI USA, V100, P12941, DOI 10.1073/pnas.2235344100; Madsen SH, 2010, BIOMARKERS, V15, P266, DOI 10.3109/13547500903521810; Marciniak SJ, 2009, THORAX, V64, P359, DOI 10.1136/thx.2008.099408; Mouritzen U, 2003, ANN RHEUM DIS, V62, P332, DOI 10.1136/ard.62.4.332; Muehlschlegel JD, 2009, EUR HEART J, V30, P1574, DOI 10.1093/eurheartj/ehp134; O'Rourke MF, 2010, VASC MED, V15, P461, DOI 10.1177/1358863X10382946; Orn S, 2007, J CARD FAIL, V13, P843, DOI 10.1016/j.cardfail.2007.07.006; PARTRIDGE SM, 1955, BIOCHEM J, V61, P11, DOI 10.1042/bj0610011; Petersen E, 2001, EUR J VASC ENDOVASC, V22, P48, DOI 10.1053/ejvs.2001.1404; Rittling SR, 1999, EXP NEPHROL, V7, P103; Rosenberg M, 2008, CIRC-HEART FAIL, V1, P43, DOI 10.1161/CIRCHEARTFAILURE.107.746172; Sato Y, 2012, J CARDIOL; Schaller S, 2005, ASSAY DRUG DEV TECHN, V3, P553, DOI 10.1089/adt.2005.3.553; SCHRIVER EE, 1992, AM REV RESPIR DIS, V145, P762, DOI 10.1164/ajrccm/145.4_Pt_1.762; SENIOR RM, 1982, J CLIN INVEST, V70, P614, DOI 10.1172/JCI110654; Skjot-Arkil H, 2012, CLIN EXP RHEUMATOL, V30, P371; Skjot-Arkil H, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-34; Skjot-Arkil H, 2010, ASSAY DRUG DEV TECHN, V8, P542, DOI 10.1089/adt.2009.0258; Stamatelopoulos KS, 2008, EUR J CARDIOV PREV R, V15, P619, DOI 10.1097/HJR.0b013e32830f95a4; STARCHER BC, 1976, ANAL BIOCHEM, V74, P441, DOI 10.1016/0003-2697(76)90224-4; Sukhova GK, 1999, CIRCULATION, V99, P2503, DOI 10.1161/01.CIR.99.19.2503; Taddese S, 2009, MATRIX BIOL, V28, P84, DOI 10.1016/j.matbio.2008.12.002; Tanner RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023609; Thingholm Tine E., 2009, V527, P57, DOI 10.1007/978-1-60327-834-8_5; Thygesen K, 2007, EUR HEART J, V28, P2525; Turino GM, 2012, COPD, V9, P435, DOI 10.3109/15412555.2012.697753; Turner NA, 2007, J MOL CELL CARDIOL, V43, P168, DOI 10.1016/j.yjmcc.2007.05.006; Umeda H, 2011, BIOCHEM BIOPH RES CO, V411, P281, DOI 10.1016/j.bbrc.2011.06.124; Vassiliadis E, 2012, BIOMARK INSIGHTS, V7, P45, DOI 10.4137/BMI.S9536; Veidal SS, 2010, LIVER INT, V30, P1293, DOI 10.1111/j.1478-3231.2010.02309.x; Venuraju SM, 2010, J AM COLL CARDIOL, V55, P2049, DOI 10.1016/j.jacc.2010.03.013; Warming L, 2002, OSTEOPOROSIS INT, V13, P105, DOI 10.1007/s001980200001; Wendel DP, 2000, AM J RESP CELL MOL, V23, P320, DOI 10.1165/ajrcmb.23.3.3906; Wohlschlaeger J, 2005, PATHOL RES PRACT, V201, P809, DOI 10.1016/j.prp.2005.08.009; Yamada S, 2008, AM J PATHOL, V172, P1419, DOI 10.2353/ajpath.2008.070604; Yoshitake H, 1999, P NATL ACAD SCI USA, V96, P8156, DOI 10.1073/pnas.96.14.8156; Zeng B, 2005, INTERN MED J, V35, P331, DOI 10.1111/j.1445-5994.2005.00822.x; Zhen EY, 2008, ARTHRITIS RHEUM-US, V58, P2420, DOI 10.1002/art.23654	78	15	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e60936	10.1371/journal.pone.0060936	http://dx.doi.org/10.1371/journal.pone.0060936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805173	Green Submitted, Green Published, gold			2022-12-25	WOS:000320846500001
J	Tassano, E; Buttgereit, J; Bader, M; Lerone, M; Divizia, MT; Bocciardi, R; Napoli, F; Pala, G; Sloan-Bena, F; Gimelli, S; Gimelli, G				Tassano, Elisa; Buttgereit, Jens; Bader, Michael; Lerone, Margherita; Divizia, Maria Teresa; Bocciardi, Renata; Napoli, Flavia; Pala, Giovanna; Sloan-Bena, Frederique; Gimelli, Stefania; Gimelli, Giorgio			Genotype-Phenotype Correlation of 2q37 Deletions Including NPPC Gene Associated with Skeletal Malformations	PLOS ONE			English	Article							NATRIURETIC PEPTIDE; OVEREXPRESSION; OVERGROWTH; MUTATIONS; DWARFISM; GROWTH; NPR2; CNP	Coordinated bone growth is controlled by numerous mechanisms which are only partially understood because of the involvement of many hormones and local regulators. The C-type Natriuretic Peptide (CNP), encoded by NPPC gene located on chromosome 2q37.1, is a molecule that regulates endochondral ossification of the cartilaginous growth plate and influences longitudinal bone growth. Two independent studies have described three patients with a Marfan-like phenotype presenting a de novo balanced translocation involving the same chromosomal region 2q37.1 and overexpression of NPPC. We report on two partially overlapping interstitial 2q37 deletions identified by array CGH. The two patients showed opposite phenotypes characterized by short stature and skeletal overgrowth, respectively. The patient with short stature presented a 2q37 deletion causing the loss of one copy of the NPPC gene and the truncation of the DIS3L2 gene with normal CNP plasma concentration. The deletion identified in the patient with a Marfan-like phenotype interrupted the DIS3L2 gene without involving the NPPC gene. In addition, a strongly elevated CNP plasma concentration was found in this patient. A possible role of NPPC as causative of the two opposite phenotypes is discussed in this study.	[Tassano, Elisa; Gimelli, Giorgio] Ist Giannina Gaslini, Lab Citogenet, Genoa, Italy; [Buttgereit, Jens] Joint Inst Max Delbruck Ctr Mol Med MDC, ECRC, Berlin, Germany; [Buttgereit, Jens] Fac Med Charite, Berlin, Germany; [Buttgereit, Jens; Bader, Michael] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Lerone, Margherita; Divizia, Maria Teresa] Ist Giannina Gaslini, Lab Genet Mol, Genoa, Italy; [Bocciardi, Renata] Ist Giannina Gaslini, Dipartimento Neurosci Riabilitaz Oftalmol Genet &, DiNOGMI, Genoa, Italy; [Bocciardi, Renata] Ist Giannina Gaslini, Lab Genet Mol, Genoa, Italy; [Sloan-Bena, Frederique; Gimelli, Stefania] Univ Hosp Geneva, Serv Genet Med, Geneva, Switzerland; [Napoli, Flavia; Pala, Giovanna] Univ Genoa, Ist G Gaslini, Dipartimento Pediat, Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Geneva; University of Genoa; IRCCS Istituto Giannina Gaslini	Tassano, E (corresponding author), Ist Giannina Gaslini, Lab Citogenet, Genoa, Italy.	eli.tassano@gmail.com	lerone, margherita/AAC-1583-2021; Napoli, Flavia/AAA-7624-2020; Tassano, Elisa/AAB-1108-2020; Bader, Michael/K-2124-2013; Bocciardi, Renata/J-8577-2016; Divizia, Maria Teresa/AAC-1622-2021; Divizia, Maria Teresa/AAB-1120-2020	lerone, margherita/0000-0003-0666-4740; Tassano, Elisa/0000-0003-2037-0554; Bocciardi, Renata/0000-0001-8415-3802; Divizia, Maria Teresa/0000-0002-8776-0015; Bader, Michael/0000-0003-4780-4164	Cinque per mille dell'IRPEF-Finanziamento della ricerca sanitaria; Finanziamento Ricerca Corrente, Ministero Salute (contributo per la ricerca intramurale)	Cinque per mille dell'IRPEF-Finanziamento della ricerca sanitaria; Finanziamento Ricerca Corrente, Ministero Salute (contributo per la ricerca intramurale)	This work was supported by "Cinque per mille dell'IRPEF-Finanziamento della ricerca sanitaria'' and "Finanziamento Ricerca Corrente, Ministero Salute (contributo per la ricerca intramurale)''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astuti D, 2012, NAT GENET, V44, P277, DOI 10.1038/ng.1071; Bartels CF, 2004, AM J HUM GENET, V75, P27, DOI 10.1086/422013; Bocciardi R, 2007, HUM MUTAT, V28, P724, DOI 10.1002/humu.20511; Bocciardi R, 2009, ENDOCRIN DEV, V14, P61, DOI 10.1159/000207477; Chusho H, 2001, P NATL ACAD SCI USA, V98, P4016, DOI 10.1073/pnas.071389098; Drake KM, 2009, CLIN CANCER RES, V15, P5985, DOI 10.1158/1078-0432.CCR-09-1065; Estrada K, 2009, HUM MOL GENET, V18, P3516, DOI 10.1093/hmg/ddp296; Higashimoto K, 2013, EUR J HUM GENET, V21, P1316, DOI 10.1038/ejhg.2013.45; Kondo E, 2012, CALCIFIED TISSUE INT, V90, P307, DOI 10.1007/s00223-011-9567-0; Matsukawa N, 1999, P NATL ACAD SCI USA, V96, P7403, DOI 10.1073/pnas.96.13.7403; Moncla A, 2007, HUM MUTAT, V28, P1183, DOI 10.1002/humu.20611; Olney RC, 2006, J CLIN ENDOCR METAB, V91, P1229, DOI 10.1210/jc.2005-1949; Pejchalova K, 2007, MOL GENET METAB, V92, P210, DOI 10.1016/j.ymgme.2007.06.014; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Silberbach M, 2001, CELL SIGNAL, V13, P221, DOI 10.1016/S0898-6568(01)00139-5; Tsuji T, 2005, J BIOL CHEM, V280, P14288, DOI 10.1074/jbc.C500024200; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971; Yasoda A, 1998, J BIOL CHEM, V273, P11695, DOI 10.1074/jbc.273.19.11695	18	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66048	10.1371/journal.pone.0066048	http://dx.doi.org/10.1371/journal.pone.0066048			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805197	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000320846500025
J	Nicastro, A; Bishop, MJ				Nicastro, Andrea; Bishop, Melanie J.			Weak and Habitat-Dependent Effects of Nutrient Pollution on Macrofaunal Communities of Southeast Australian Estuaries	PLOS ONE			English	Article							BENTHIC MACROFAUNA; LAND-USE; ORGANIC ENRICHMENT; WATER-QUALITY; EUTROPHICATION; ASSEMBLAGES; RESPONSES; PATTERNS; NITROGEN; BIOTURBATION	Among the impacts of coastal settlements to estuaries, nutrient pollution is often singled out as a leading cause of modification to the ecological communities of soft sediments. Through sampling of 48 sites, distributed among 16 estuaries of New South Wales, Australia, we tested the hypotheses that (1) anthropogenic nutrient loads would be a better predictor of macrofaunal communities than estuarine geomorphology or local sediment characteristics; and (2) local environmental context, as determined largely by sediment characteristics, would modify the relationship between nutrient loading and community composition. Contrary to the hypothesis, multivariate multiple regression analyses revealed that sediment grain size was the best predictor of macrofaunal assemblage composition. When samples were stratified according to median grain size, relationships between faunal communities and nitrogen loading and latitude emerged, but only among estuaries with sandier sediments. In these estuaries, capitellid and nereid polychaetes and chironomid larvae were the taxa that showed the strongest correlations with nutrient loading. Overall, this study failed to provide evidence of a differential relationship between diffuse nutrient enrichment and benthic macrofauna across a gradient of 7 degrees of latitude and 4 degrees C temperature. Nevertheless, as human population growth continues to place increasing pressure on southeast Australian estuaries, manipulative field studies examining when and where nutrient loading will lead to significant changes in estuarine community structure are needed.	[Nicastro, Andrea; Bishop, Melanie J.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia	Macquarie University	Nicastro, A (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia.	andrea.nicastro@students.mq.edu.au	Bishop, Melanie/AGA-7862-2022	Bishop, Melanie/0000-0001-8210-6500	Macquarie University Higher Degree Research Fund; Australian Research Council Discovery Grant [DP1093444]	Macquarie University Higher Degree Research Fund; Australian Research Council Discovery Grant(Australian Research Council)	The research was funded by the Macquarie University Higher Degree Research Fund (to A. Nicastro) and an Australian Research Council Discovery Grant DP1093444 (to Melanie Bishop). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnio K, 1996, J SEA RES, V36, P311, DOI 10.1016/S1385-1101(96)90798-4; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Biles CL, 2002, HYDROL EARTH SYST SC, V6, P999, DOI 10.5194/hess-6-999-2002; Bilkovic DM, 2006, ESTUAR COAST, V29, P1185, DOI 10.1007/BF02781819; Bishop MJ, 2008, OIKOS, V117, P531, DOI 10.1111/j.0030-1299.2008.16418.x; Bishop MJ, 2007, MAR ECOL PROG SER, V341, P25, DOI 10.3354/meps341025; Bishop MJ, 2006, OECOLOGIA, V149, P701, DOI 10.1007/s00442-006-0481-5; Blott SJ, 2001, EARTH SURF PROC LAND, V26, P1237, DOI 10.1002/esp.261; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chapman MG, 2007, J EXP MAR BIOL ECOL, V343, P96, DOI 10.1016/j.jembe.2006.12.001; Christensen B, 2000, MAR ECOL PROG SER, V192, P203, DOI 10.3354/meps192203; Clarke K., 2001, CHANGES MARINE COMMU, DOI DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Conley DJ, 2007, ECOL APPL, V17, pS165, DOI 10.1890/05-0766.1; Currie DR, 2005, ESTUAR COAST SHELF S, V63, P315, DOI 10.1016/j.ecss.2004.11.023; Davis JR, 2006, HYDROBIOLOGIA, V559, P23, DOI 10.1007/s10750-005-4429-2; Dethier MN, 2006, MAR ECOL PROG SER, V306, P41, DOI 10.3354/meps306041; Diaz RJ, 2001, J ENVIRON QUAL, V30, P275, DOI 10.2134/jeq2001.302275x; Duarte AALS, 2009, ENERGY ENVIRON ENG S, P240; Dugan JE, 2011, ESTUAR COAST, V34, P839, DOI 10.1007/s12237-011-9375-9; Ellis J. I., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P57, DOI 10.1023/A:1009923530894; Fitch JE, 2012, MAR ECOL PROG SER, V461, P59, DOI 10.3354/meps09819; Fukunaga A, 2011, J EXP MAR BIOL ECOL, V396, P244, DOI 10.1016/j.jembe.2010.10.029; GABRIC AJ, 1993, AUST J MAR FRESH RES, V44, P261; Glassom D, 1997, MAR ECOL PROG SER, V149, P1, DOI 10.3354/meps149001; Grant J, 2007, CAN J FISH AQUAT SCI, V64, P387, DOI 10.1139/F07-021; Gray J.S., 1974, Oceanography mar Biol, V12, P223; Griffen BD, 2004, MAR ECOL PROG SER, V269, P223, DOI 10.3354/meps269223; Harris GP, 2001, MAR FRESHWATER RES, V52, P139, DOI 10.1071/MF00031; Hastie BF, 2006, J EXP MAR BIOL ECOL, V330, P356, DOI 10.1016/j.jembe.2005.12.039; Kemp WM, 2005, MAR ECOL PROG SER, V303, P1, DOI 10.3354/meps303001; Lindegarth M, 2001, ESTUAR COAST SHELF S, V52, P237, DOI 10.1006/ecss.2000.0741; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; Morris L, 2003, MAR FRESHWATER RES, V54, P859, DOI 10.1071/MF02157; MORRISEY DJ, 1992, MAR ECOL PROG SER, V81, P197, DOI 10.3354/meps081197; NIXON SW, 1995, OPHELIA, V41, P199, DOI 10.1080/00785236.1995.10422044; O'Brien AL, 2010, MAR FRESHWATER RES, V61, P1388, DOI 10.1071/MF10085; O'Brien AL, 2009, J EXP MAR BIOL ECOL, V371, P51, DOI 10.1016/j.jembe.2009.01.004; Paerl HW, 2006, ECOL ENG, V26, P40, DOI 10.1016/j.ecoleng.2005.09.006; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; Pelletier MC, 2011, ENVIRON TOXICOL CHEM, V30, P538, DOI 10.1002/etc.414; Rabalais NN, 2009, ICES J MAR SCI, V66, P1528, DOI 10.1093/icesjms/fsp047; RHOADS DC, 1970, J MAR RES, V28, P150; Roper T., 2011, ASSESSING CONDITION; Rothenberger MB, 2009, ENVIRON MANAGE, V44, P505, DOI 10.1007/s00267-009-9330-8; Roy PS, 2001, ESTUAR COAST SHELF S, V53, P351, DOI 10.1006/ecss.2001.0796; Savage C, 2002, MAR ECOL PROG SER, V243, P67, DOI 10.3354/meps243067; Scanes P, 2007, ESTUAR COAST SHELF S, V74, P306, DOI 10.1016/j.ecss.2007.04.021; Schuckel U, 2013, HELGOLAND MAR RES, V67, P121, DOI 10.1007/s10152-012-0309-0; SNELGROVE PVR, 1994, OCEANOGR MAR BIOL, V32, P111; Thrush SF, 2003, ECOL APPL, V13, P1433, DOI 10.1890/02-5198; WARWICK RM, 1993, MAR ECOL PROG SER, V92, P221, DOI 10.3354/meps092221; Webb AP, 2004, MAR ECOL PROG SER, V268, P205, DOI 10.3354/meps268205; Wernberg T, 2012, GLOBAL CHANGE BIOL, V18, P1491, DOI 10.1111/j.1365-2486.2012.02656.x; WESTON DP, 1990, MAR ECOL PROG SER, V61, P233, DOI 10.3354/meps061233; Wildsmith MD, 2011, MAR POLLUT BULL, V62, P525, DOI 10.1016/j.marpolbul.2010.11.031; Wildsmith MD, 2009, MAR POLLUT BULL, V58, P1250, DOI 10.1016/j.marpolbul.2009.06.008; York PH, 2012, MAR ECOL PROG SER, V449, P291, DOI 10.3354/meps09541; Ysebaert T, 2002, MAR ECOL PROG SER, V244, P105, DOI 10.3354/meps244105	58	13	14	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65706	10.1371/journal.pone.0065706	http://dx.doi.org/10.1371/journal.pone.0065706			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799037	Green Published, gold, Green Submitted			2022-12-25	WOS:000321397800015
J	Teese, MG; Farnsworth, CA; Li, YQ; Coppin, CW; Devonshire, AL; Scott, C; East, P; Russell, RJ; Oakeshott, JG				Teese, Mark G.; Farnsworth, Claire A.; Li, Yongqiang; Coppin, Chris W.; Devonshire, Alan L.; Scott, Colin; East, Peter; Russell, Robyn J.; Oakeshott, John G.			Heterologous Expression and Biochemical Characterisation of Fourteen Esterases from Helicoverpa armigera	PLOS ONE			English	Article							HUBNER LEPIDOPTERA; MUTANT CARBOXYLESTERASES; METABOLIC RESISTANCE; ACETYLCHOLINESTERASE; INSECTICIDES; PYRETHROIDS; HYDROLYSIS; DNA; AMPLIFICATION; FENVALERATE	Esterases have recurrently been implicated in insecticide resistance in Helicoverpa armigera but little is known about the underlying molecular mechanisms. We used a baculovirus system to express 14 of 30 full-length esterase genes so far identified from midgut cDNA libraries of this species. All 14 produced esterase isozymes after native PAGE and the isozymes for seven of them migrated to two regions of the gel previously associated with both organophosphate and pyrethroid resistance in various strains. Thirteen of the enzymes obtained in sufficient yield for further analysis all showed tight binding to organophosphates and low but measurable organophosphate hydrolase activity. However there was no clear difference in activity between the isozymes from regions associated with resistance and those from elsewhere in the zymogram, or between eight of the isozymes from a phylogenetic clade previously associated with resistance in proteomic and quantitative rtPCR experiments and five others not so associated. By contrast, the enzymes differed markedly in their activities against nine pyrethroid isomers and the enzymes with highest activity for the most insecticidal isomers were from regions of the gel and, in some cases, the phylogeny that had previously been associated with pyrethroid resistance. Phospholipase treatment confirmed predictions from sequence analysis that three of the isozymes were GPI anchored. This unusual feature among carboxylesterases has previously been suggested to underpin an association that some authors have noted between esterases and resistance to the Cry1Ac toxin from Bacillus thuringiensis. However these three isozymes did not migrate to the zymogram region previously associated with Cry1Ac resistance.	[Teese, Mark G.; Farnsworth, Claire A.; Li, Yongqiang; Coppin, Chris W.; Devonshire, Alan L.; Scott, Colin; East, Peter; Russell, Robyn J.; Oakeshott, John G.] CSIRO Ecosyst Sci, Canberra, ACT, Australia; [Teese, Mark G.] Australian Natl Univ, Sch Chem, Canberra, ACT, Australia; [Farnsworth, Claire A.] Australian Natl Univ, Sch Biol Sci, Canberra, ACT, Australia; [Li, Yongqiang] Northwest A&F Univ, Coll Plant Protect, Res & Dev Ctr Biorat Pesticides, Yangling, Peoples R China	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University; Australian National University; Northwest A&F University - China	Oakeshott, JG (corresponding author), CSIRO Ecosyst Sci, Canberra, ACT, Australia.	john.oakeshott@csiro.au	Oakeshott, John G/B-5365-2009; Coppin, Christopher/C-1269-2009; Scott, Colin/A-4682-2009; Russell, Robyn/C-5449-2008; Teese, Mark G/B-4307-2008	Oakeshott, John G/0000-0001-8324-7874; Scott, Colin/0000-0001-6110-6982; Russell, Robyn/0000-0001-5600-3305; Teese, Mark G/0000-0002-8003-4918	Cotton Catchment Cummunities CRC; China Scholarship Council	Cotton Catchment Cummunities CRC; China Scholarship Council(China Scholarship Council)	This study was supported by an Australian Postgraduate Award and Top-up Scholarship from the Cotton Catchment Cummunities CRC to Claire Farnsworth and the China Scholarship Council to Yongqiang Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaleke J, 2009, PEST MANAG SCI, V65, P1147, DOI 10.1002/ps.1807; Alvi AHK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047309; Angelucci C, 2008, INSECT BIOCHEM MOLEC, V38, P685, DOI 10.1016/j.ibmb.2008.03.010; Bass C, 2011, PEST MANAG SCI, V67, P886, DOI 10.1002/ps.2189; Campbell BE, 2001, ROLE ESTERASES AUSTR; Campbell PM, 1998, INSECT BIOCHEM MOLEC, V28, P139, DOI 10.1016/S0965-1748(97)00109-4; Coppin CW, 2012, INSECT BIOCHEM MOLEC, V42, P343, DOI 10.1016/j.ibmb.2012.01.004; Cui F, 2011, INSECT BIOCHEM MOLEC, V41, P1, DOI 10.1016/j.ibmb.2010.09.004; Devonshire AL, 2007, INSECT BIOCHEM MOLEC, V37, P891, DOI 10.1016/j.ibmb.2007.04.011; Devonshire AL, 2003, PESTIC BIOCHEM PHYS, V76, P1, DOI 10.1016/S0048-3575(03)00054-3; ELLIOTT M, 1974, ADV CHEM SER, P80; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Farnsworth CA, 2010, J PESTIC SCI, V35, P275, DOI 10.1584/jpestics.R10-13; Gunning R. V., 2006, Biopesticides International, V2, P129; Gunning RV, 2005, APPL ENVIRON MICROB, V71, P2558, DOI 10.1128/AEM.71.5.2558-2563.2005; Gunning RV, 1999, PESTIC BIOCHEM PHYS, V63, P50, DOI 10.1006/pest.1998.2388; Gunning RV, 1996, PESTIC BIOCHEM PHYS, V54, P12, DOI 10.1006/pest.1996.0004; Gunning RV, 1998, PIPERONYL BUTOXIDE I, P215; Han YC, 2012, PESTIC BIOCHEM PHYS, V104, P243, DOI 10.1016/j.pestbp.2012.09.005; Hartley CJ, 2006, P NATL ACAD SCI USA, V103, P8757, DOI 10.1073/pnas.0509590103; Heidari R, 2005, INSECT BIOCHEM MOLEC, V35, P597, DOI 10.1016/j.ibmb.2005.02.018; Heidari R, 2004, INSECT BIOCHEM MOLEC, V34, P353, DOI 10.1016/j.ibmb.2004.01.001; Heidari R, 2002, KINETIC PROPERTIES E; Horejsi T, 1999, J AM SOC HORTIC SCI, V124, P128, DOI 10.21273/JASHS.124.2.128; Incardona JP, 1996, MOL BIOL CELL, V7, P595, DOI 10.1091/mbc.7.4.595; Jackson CJ, 2010, ANTICHOLINESTERASE PESTICIDES: METABOLISM, NEUROTOXICITY, AND EPIDEMIOLOGY, P57; Joussen N, 2012, P NATL ACAD SCI USA, V109, P15206, DOI 10.1073/pnas.1202047109; Kranthi KR, 2001, B ENTOMOL RES, V91, P37; Li WM, 2005, J BIOL CHEM, V280, P18179, DOI 10.1074/jbc.M411085200; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Massoulie J, 1999, CHEM-BIOL INTERACT, V119, P29, DOI 10.1016/S0009-2797(99)00011-3; MASTROPAOLO W, 1981, ANAL BIOCHEM, V115, P188, DOI 10.1016/0003-2697(81)90544-3; McCaffery AR, 1998, PHILOS T R SOC B, V353, P1735, DOI 10.1098/rstb.1998.0326; MOORES GD, 1994, PESTIC BIOCHEM PHYS, V49, P114, DOI 10.1006/pest.1994.1038; Myers MA, 1996, BIOCHEM GENET, V34, P201, DOI 10.1007/BF02407020; Oakeshott J.G, 2005, COMPREHENSIVE MOL IN, V5, P309, DOI [DOI 10.1016/B0-44-451924-6/00073-9, 10.1016/B0-44-451924-6/00073-9]; OAKESHOTT JG, 1993, GENETICA, V90, P239, DOI 10.1007/BF01435043; Pap L, 1996, J ENVIRON SCI HEAL B, V31, P527, DOI 10.1080/03601239609373015; Teese MG, 2010, INSECT BIOCHEM MOLEC, V40, P1, DOI 10.1016/j.ibmb.2009.12.002; Tsubota T, 2010, INSECT BIOCHEM MOLEC, V40, P100, DOI 10.1016/j.ibmb.2009.12.015; Washington MT, 2003, P NATL ACAD SCI USA, V100, P12093, DOI 10.1073/pnas.2134223100; Wu SW, 2011, INSECT BIOCHEM MOLEC, V41, P14, DOI 10.1016/j.ibmb.2010.09.007; Yang YiHua, 2008, Cotton Science, V20, P249; Young SJ, 2005, PEST MANAG SCI, V61, P397, DOI 10.1002/ps.996	44	18	19	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65951	10.1371/journal.pone.0065951	http://dx.doi.org/10.1371/journal.pone.0065951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799064	Green Submitted, Green Published, gold			2022-12-25	WOS:000321397800021
J	Blanch, A; Robinson, F; Watson, IR; Cheng, LS; Irwin, MS				Blanch, Alvaro; Robinson, Fiona; Watson, Ian R.; Cheng, Lynn S.; Irwin, Meredith S.			Eukaryotic Translation Elongation Factor 1-Alpha 1 Inhibits p53 and p73 Dependent Apoptosis and Chemotherapy Sensitivity	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; FACTOR-I-ALPHA; MOLECULE MDM2 ANTAGONISTS; UBIQUITIN-PROTEIN LIGASE; STRESS-INDUCED APOPTOSIS; SQUAMOUS-CELL CARCINOMA; BREAST-CANCER CELLS; UP-REGULATION; FACTOR EF-1-ALPHA; HOMOLOG P73	The p53 family of transcription factors is a key regulator of cell proliferation and death. In this report we identify the eukaryotic translation elongation factor 1-alpha 1 (eEF1A1) to be a novel p53 and p73 interacting protein. Previous studies have demonstrated that eEF1A1 has translation-independent roles in cancer. We report that overexpression of eEF1A1 specifically inhibits p53-, p73- and chemotherapy-induced apoptosis resulting in chemoresistance. Short-interfering RNA-mediated silencing of eEF1A1 increases chemosensitivity in cell lines bearing wild type p53, but not in p53 null cells. Furthermore, silencing of eEF1A1 partially rescues the chemoresistance observed in response to p53 or p73 knockdown, suggesting that eEF1A1 is a negative regulator of the pro-apoptotic function of p53 and p73. Thus, in the context of p53-family signaling, eEF1A1 has anti-apoptotic properties. These findings identify a novel mechanism of regulation of the p53 family of proteins by eEF1A1 providing additional insight into potential targets to sensitize tumors to chemotherapy.	[Blanch, Alvaro; Robinson, Fiona; Watson, Ian R.; Cheng, Lynn S.; Irwin, Meredith S.] Univ Toronto, Hosp Sick Children, Dept Paediat, Toronto, ON M5G 1X8, Canada; [Blanch, Alvaro; Robinson, Fiona; Watson, Ian R.; Cheng, Lynn S.; Irwin, Meredith S.] Univ Toronto, Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Irwin, Meredith S.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1X8, Canada; [Irwin, Meredith S.] Univ Toronto, Lab Med & Pathobiol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Irwin, MS (corresponding author), Univ Toronto, Hosp Sick Children, Dept Paediat, Toronto, ON M5G 1X8, Canada.	meredith.irwin@sickkids.ca		Watson, Ian/0000-0002-6025-3080	Canadian Cancer Society Research Institute (CCSRI) [2010-700580]; Canada Research Chair in Cancer Biology; Hospital for Sick Children; Ministry of Education and Science (MEC) of Spain	Canadian Cancer Society Research Institute (CCSRI)(Canadian Cancer Society (CCS)); Canada Research Chair in Cancer Biology; Hospital for Sick Children; Ministry of Education and Science (MEC) of Spain(Spanish Government)	This work was supported by Canadian Cancer Society Research Institute (CCSRI #2010-700580) and a Canada Research Chair in Cancer Biology to MSI. AB is a recipient of the Hospital for Sick Children and Ministry of Education and Science (MEC) of Spain Scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Maghrebir M, 2005, ANTICANCER RES, V25, P2573; Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Balint E, 1999, ONCOGENE, V18, P3923, DOI 10.1038/sj.onc.1202781; Borradaile NM, 2006, MOL BIOL CELL, V17, P770, DOI 10.1091/mbc.E05-08-0742; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chen E, 2000, EXP CELL RES, V259, P140, DOI 10.1006/excr.2000.4952; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; Chung J, 2010, EMBO REP, V11, P777, DOI 10.1038/embor.2010.125; Coll-Mulet L, 2006, BLOOD, V107, P4109, DOI 10.1182/blood-2005-08-3273; Collavin L, 2010, CELL DEATH DIFFER, V17, P901, DOI 10.1038/cdd.2010.35; de Wit NJW, 2002, MELANOMA RES, V12, P57, DOI 10.1097/00008390-200202000-00009; Duttaroy A, 1998, EXP CELL RES, V238, P168, DOI 10.1006/excr.1997.3819; Edmonds BT, 1996, J CELL SCI, V109, P2705; Frum R, 2007, J PROTEOME RES, V6, P1410, DOI 10.1021/pr060584p; Gopalkrishnan RV, 1999, INT J BIOCHEM CELL B, V31, P151, DOI 10.1016/S1357-2725(98)00138-1; GRANT AG, 1992, INT J CANCER, V50, P740, DOI 10.1002/ijc.2910500513; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Irwin MS, 2004, CELL CYCLE, V3, P319; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Johnsson A, 2000, BRIT J CANCER, V83, P1047, DOI 10.1054/bjoc.2000.1420; Kato MV, 1997, BLOOD, V90, P1373, DOI 10.1182/blood.V90.4.1373.1373_1373_1378; Khacho M, 2008, MOL BIOL CELL, V19, P5296, DOI 10.1091/mbc.E08-06-0562; Kim J, 2009, LAB INVEST, V89, P867, DOI 10.1038/labinvest.2009.53; Kobayashi Y, 2009, CELL DEATH DIFFER, V16, P139, DOI 10.1038/cdd.2008.136; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lamberti A, 2007, CELL DEATH DIFFER, V14, P952, DOI 10.1038/sj.cdd.4402102; Lamberti A, 2004, AMINO ACIDS, V26, P443, DOI 10.1007/s00726-004-0088-2; Lau L, 2007, ONCOGENE, V26, P1920, DOI 10.1038/sj.onc.1209981; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li BDL, 2002, ANN SURG, V235, P732, DOI 10.1097/00000658-200205000-00016; Marin MC, 1998, MOL CELL BIOL, V18, P6316, DOI 10.1128/MCB.18.11.6316; Mohler JL, 2002, PROSTATE, V51, P247, DOI 10.1002/pros.10086; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Nathan CAO, 2000, CANCER RES, V60, P3599; Ohtsuka T, 2003, ONCOGENE, V22, P1678, DOI 10.1038/sj.onc.1206306; Pecorari L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-58; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Qian YJ, 2012, CELL CYCLE, V11, P3525, DOI 10.4161/cc.21962; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Rosenwald IB, 2001, CANCER-AM CANCER SOC, V92, P2164, DOI 10.1002/1097-0142(20011015)92:8<2164::AID-CNCR1559>3.0.CO;2-A; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Ruest LB, 2002, J BIOL CHEM, V277, P5418, DOI 10.1074/jbc.M110685200; Selga E, 2009, GENOME MED, V1, DOI 10.1186/gm83; Talapatra S, 2002, CELL DEATH DIFFER, V9, P856, DOI 10.1038/sj.cdd.4401078; TATSUKA M, 1992, NATURE, V359, P333, DOI 10.1038/359333a0; Thornton S, 2003, J MOL MED, V81, P536, DOI 10.1007/s00109-003-0461-8; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Van Maerken T, 2006, CANCER RES, V66, P9646, DOI 10.1158/0008-5472.CAN-06-0792; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Watson IR, 2006, J BIOL CHEM, V281, P34096, DOI 10.1074/jbc.M603654200; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; Xie D, 2002, INT J ONCOL, V21, P499; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268	58	48	53	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66436	10.1371/journal.pone.0066436	http://dx.doi.org/10.1371/journal.pone.0066436			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799104	Green Submitted, Green Published, gold			2022-12-25	WOS:000320363300083
J	Kumar, B; Tripathi, C; Kanchan, RK; Tripathi, JK; Ghosh, JK; Ramachandran, R; Bhadauria, S; Tripathi, RK				Kumar, Balawant; Tripathi, Chakrapani; Kanchan, Ranjana K.; Tripathi, Jitendra Kumar; Ghosh, Jimut K.; Ramachandran, Ravishankar; Bhadauria, Smrati; Tripathi, Raj Kamal			Dynamics of Physical Interaction between HIV-1 Nef and ASK1: Identifying the Interacting Motif(S)	PLOS ONE			English	Article							BLOOD-BANK COHORT; SIGNAL-REGULATING KINASE-1; T-CELL DEPLETION; PROTEIN-KINASE; FAS-LIGAND; PROXIMITY LIGATION; INDUCED APOPTOSIS; INFECTED-CELLS; ACTIVATION; DEATH	FasL mediated preferential apoptosis of bystander CTLs while protection of infected CD4(+)T cells remains one of the hallmarks of immune evasion during HIV infection. The property of infected host cells to evade cell-autonomous apoptosis emanates from ability of HIV-1Nef -protein to physically interact with ASK-1 and thereby inhibit its enzymatic activity. The specific domains of HIV-1Nef through which it may interact with ASK1 and thereby impair the ASK1 activity remain unidentified so far and represent a major challenge towards developing clear understanding about the dynamics of this interaction. Using mammalian two hybrid screen in association with site directed mutagenesis and competitive inhibitor peptides, we identified constituent minimal essential domain (152 DEVGEANN 159) through which HIV-1Nef interacts with ASK1 and inhibits its function. Furthermore our study also unravels a novel alternate mechanism underlying HIV-1 Nef mediated ASK1 functional modulation, wherein by potentiating the inhibitory ser(967) phosphorylation of ASK1, HIV-1Nef negatively modulated ASK1function.	[Kumar, Balawant; Tripathi, Chakrapani; Kanchan, Ranjana K.; Bhadauria, Smrati; Tripathi, Raj Kamal] CSIR, Cent Drug Res Inst, Div Toxicol, Jankipuram, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Bhadauria, S (corresponding author), CSIR, Cent Drug Res Inst, Div Toxicol, BS 10-1,Sect 10 Jankipuram Extens, Jankipuram, Uttar Pradesh, India.	smrati_bhadauria@cdri.res.in; rk_tripathi@cdri.res.in	Kumar, Balawant/AAW-9616-2021; Tripathi, Jitendra Kumar/N-2631-2013; Kanchan, Ranjana Kumari/AAD-6218-2022; tripathi, chakrapani/K-5220-2019	Tripathi, Jitendra Kumar/0000-0001-9246-8388; Kanchan, Ranjana Kumari/0000-0002-9649-9488; tripathi, chakrapani/0000-0002-0370-5829; Ramachandran, Ravishankar/0000-0002-0723-9861; kumar, Balawant/0000-0002-8187-3078	CSIR India	CSIR India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by CSIR India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arold ST, 2001, TRENDS BIOCHEM SCI, V26, P356, DOI 10.1016/S0968-0004(01)01846-1; Bentham M, 2006, J GEN VIROL, V87, P563, DOI 10.1099/vir.0.81200-0; Birch MR, 2001, J CLIN VIROL, V22, P263, DOI 10.1016/S1386-6532(01)00198-6; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Dyer WB, 1997, AIDS, V11, P1565, DOI 10.1097/00002030-199713000-00004; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Gao YH, 2010, APOPTOSIS, V15, P822, DOI 10.1007/s10495-010-0495-7; Geleziunas R, 2001, NATURE, V410, P834, DOI 10.1038/35071111; Geyer M, 1999, J MOL BIOL, V289, P123, DOI 10.1006/jmbi.1999.2740; Goldman EH, 2004, J BIOL CHEM, V279, P10442, DOI 10.1074/jbc.M311129200; Gullberg M, 2004, P NATL ACAD SCI USA, V101, P8420, DOI 10.1073/pnas.0400552101; Hyun AS, 2010, J BIOL CHEM, V285, P2397, DOI [10.1074/jbc.M109.064295, DOI 10.1074/JBC.M109.064295.PUBMED:19920149]; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Jean PH, 2005, BLOOD, V105, P2458, DOI [10.1182/blood-2004-08-3058, DOI 10.1182/BL00D-2004-08-3058.PUBMED:15585654]; Karuppiah M, 2005, BLOOD, V106, P6, DOI [10.1182/blood-2005-04-1582, DOI 10.1182/BL00D-2005-04-1582]; Katsikis PD, 1997, J EXP MED, V186, P1365, DOI 10.1084/jem.186.8.1365; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Learmont JC, 1999, NEW ENGL J MED, V340, P1715, DOI 10.1056/NEJM199906033402203; Lixin Z, 1999, P NATL ACAD SCI USA, V96, P8511, DOI [10.1073/pnas.96.15.8511, DOI 10.1073/PNAS.96.15.8511.PUBMED:10411906]; Masao S, 1998, EMBO J, V17, P2596, DOI [DOI 10.1093/EMB0J/17.9.2596.PUBMED:9564042, 10.1093/emboj/17.9.2596]; McCune JM, 2001, NATURE, V410, P974, DOI 10.1038/35073648; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; Mueller YM, 2001, IMMUNITY, V15, P871, DOI 10.1016/S1074-7613(01)00246-1; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Philippe J, 2009, MOL BIOL CELL, V20, P3628, DOI [10.1091/mbc.E09-03-0211, DOI 10.1091/MBC.E09-03-0211.PUBMED:19570911]; Robichaud GA, 2000, AIDS RES HUM RETROV, V16, P1959, DOI 10.1089/088922200750054684; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; SCHULZEOSTHOFF K, 1994, EMBO J, V13, P4587, DOI 10.1002/j.1460-2075.1994.tb06780.x; Silvestris F, 1996, AIDS, V10, P131, DOI 10.1097/00002030-199602000-00002; Singh P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026629; Sloand EM, 1997, BLOOD, V89, P1357, DOI 10.1182/blood.V89.4.1357; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Song JJ, 2002, J BIOL CHEM, V277, P46566, DOI 10.1074/jbc.M206826200; Takizawa T, 2002, EUR J BIOCHEM, V269, P6126, DOI 10.1046/j.1432-1033.2002.03325.x; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Wang XHS, 1996, J BIOL CHEM, V271, P31607; Xu XN, 1997, J EXP MED, V186, P7, DOI 10.1084/jem.186.1.7; Young S, 2004, J GEN VIROL, V85, P1451, DOI [10.1099/vir.0.79803-0, DOI 10.1099/VIR.0.79803-0.PUBMED:15166428]; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511	41	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e67586	10.1371/journal.pone.0067586	http://dx.doi.org/10.1371/journal.pone.0067586			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799149	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300112
J	Lai, CH; Huang, SF; Liao, CT; Chen, IH; Wang, HM; Hsieh, LL				Lai, Chih-Hsiung; Huang, Shiang-Fu; Liao, Chun-Ta; Chen, I-How; Wang, Hung-Ming; Hsieh, Ling-Ling			Clinical Significance in Oral Cavity Squamous Cell Carcinoma of Pathogenic Somatic Mitochondrial Mutations	PLOS ONE			English	Article							BASE EXCISION-REPAIR; DNA MUTATIONS; PROMOTES TUMORIGENESIS; TRANSCRIPTION FACTOR; NECK-CANCER; P53; PROTEIN; BINDING; HEAD; POLYMORPHISMS	Somatic mutations affecting the mitochondrial DNA (mtDNA) have been frequently observed in human cancers and proposed as important oncological biomarkers. However, the clinical significance of mtDNA mutations in cancer remains unclear. This study was therefore performed to explore the possible clinical use in assessing oral squamous cell carcinoma (OSCC) of pathogenic mtDNA mutations. The entire mitochondrial genome of 300 OSCC with their matched control DNAs was screened by direct sequencing and criteria were set to define a pathogenic somatic mutation. The patients' TP53 R72P genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism. The relationships between pathogenic somatic mutations, clinicopathogical features, TP53 R72P genotype and clinical prognosis were analyzed. Overall, 645 somatic mtDNA mutations were identified and 91 of these mutations were defined as pathogenic. About one quarter (74/300) of the OSCC tumor samples contained pathogenic mutations. Individuals with the TP53 R allele had a higher frequency of pathogenic somatic mutation than those with the PP genotype. Kaplan-Meier analysis indicated that TP53 R allele patients with pathogenic somatic mutations demonstrated a significant association with a poorer disease-free survival than other individuals (HR = 1.71; 95% CI, 1.15-2.57; p = 0.009) and this phenomenon still existed after adjusting for mtDNA haplogroup, tumor stage with treatment regimens, differentiation and age at diagnosis (HR = 1.59; 95% CI, 1.06-2.40; p = 0.03). Subgroup analyses showed that this phenomenon was limited to patients who received adjuvant radiotherapy/chemo-radiotherapy after surgery. The results strongly indicated that pathogenic mtDNA mutations are a potential prognostic marker for OSCCs. Furthermore, functional mitochondria may play an active role in cancer development and the patient's response to radiotherapy/chemo-radiotherapy.	[Lai, Chih-Hsiung] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Huang, Shiang-Fu; Liao, Chun-Ta; Chen, I-How] Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Tao Yuan, Taiwan; [Wang, Hung-Ming] Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Tao Yuan, Taiwan; [Hsieh, Ling-Ling] Chang Gung Univ, Coll Med, Dept Publ Hlth, Tao Yuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Hsieh, LL (corresponding author), Chang Gung Univ, Coll Med, Dept Publ Hlth, Tao Yuan, Taiwan.	llhsieh@mail.cgu.edu.tw			National Science Council, Executive Yuan, Taiwan [NSC95-2314-B-182-049-MY3, NSC98-2314-B-182-046-MY3]	National Science Council, Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by Grant NSC95-2314-B-182-049-MY3 and NSC98-2314-B-182-046-MY3 from the National Science Council, Executive Yuan, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bensaad K, 2007, TRENDS CELL BIOL, V17, P286, DOI 10.1016/j.tcb.2007.04.004; Bureau of Health Promotion, 2012, CANC REG ANN REP 200; Carvalho AL, 2005, INT J CANCER, V114, P806, DOI 10.1002/ijc.20740; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chatterjee A, 2011, CANCER PREV RES, V4, P638, DOI 10.1158/1940-6207.CAPR-10-0326; Chen DX, 2006, CANCER RES, V66, P3485, DOI 10.1158/0008-5472.CAN-05-4103; Chen YJ, 2008, CANCER SCI, V99, P1507, DOI 10.1111/j.1349-7006.2008.00863.x; Compton S, 2011, J BIOL CHEM, V286, P20297, DOI 10.1074/jbc.M110.163063; de Souza-Pinto NC, 2004, ONCOGENE, V23, P6559, DOI 10.1038/sj.onc.1207874; Galluzzi L, 2010, MOL ASPECTS MED, V31, P1, DOI 10.1016/j.mam.2009.08.002; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028; Green DR, 2006, CELL, V126, P30, DOI 10.1016/j.cell.2006.06.032; Grochola LF, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001032; Grossman LI, 1996, BIOESSAYS, V18, P983, DOI 10.1002/bies.950181208; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsieh LL, 2005, BRIT J CANCER, V92, P30, DOI 10.1038/sj.bjc.6602271; Hsieh LL, 2003, CANCER EPIDEM BIOMAR, V12, P439; JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007; Koczor CA, 2012, AM J PATHOL, V180, P2276, DOI 10.1016/j.ajpath.2012.01.045; Kulawiec M, 2010, ENVIRON MOL MUTAGEN, V51, P427, DOI 10.1002/em.20582; Kulawiec Mariola, 2009, J Carcinog, V8, P8, DOI 10.4103/1477-3163.50893; Lai CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049684; Larman TC, 2012, P NATL ACAD SCI USA, V109, P14087, DOI 10.1073/pnas.1211502109; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Lievre A, 2005, J CLIN ONCOL, V23, P3517, DOI 10.1200/JCO.2005.07.044; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Park JS, 2009, HUM MOL GENET, V18, P1578, DOI 10.1093/hmg/ddp069; Pereira L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-53; Pim D, 2004, INT J CANCER, V108, P196, DOI 10.1002/ijc.11548; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Ruiz-Pesini E, 2006, HUM MUTAT, V27, P1072, DOI 10.1002/humu.20378; Sanchez-Cespedes M, 2001, CANCER RES, V61, P7015; Sharma LK, 2011, HUM MOL GENET, V20, P4605, DOI 10.1093/hmg/ddr395; Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012; Siddique M, 2006, ONCOGENE, V25, P3489, DOI 10.1038/sj.onc.1209405; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tanaka M, 2004, ANN NY ACAD SCI, V1011, P7, DOI 10.1196/annals.1293.002; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wong TS, 2009, NUCLEIC ACIDS RES, V37, P6765, DOI 10.1093/nar/gkp750; Wong TS, 2009, NUCLEIC ACIDS RES, V37, P568, DOI 10.1093/nar/gkn974; Yoshida Y, 2003, CANCER RES, V63, P3729; Zhou SY, 2007, P NATL ACAD SCI USA, V104, P7540, DOI 10.1073/pnas.0610818104; Zhu F, 2010, CANCER RES, V70, P5851, DOI 10.1158/0008-5472.CAN-09-4646	47	15	18	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65578	10.1371/journal.pone.0065578	http://dx.doi.org/10.1371/journal.pone.0065578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799027	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300027
J	Burton, JP; Wescombe, PA; Macklaim, JM; Chai, MHC; MacDonald, K; Hale, JDF; Tagg, J; Reid, G; Gloor, GB; Cadieux, PA				Burton, Jeremy P.; Wescombe, Philip A.; Macklaim, Jean M.; Chai, Melissa H. C.; MacDonald, Kyle; Hale, John D. F.; Tagg, John; Reid, Gregor; Gloor, Gregory B.; Cadieux, Peter A.			Persistence of the Oral Probiotic Streptococcus salivarius M18 Is Dose Dependent and Megaplasmid Transfer Can Augment Their Bacteriocin Production and Adhesion Characteristics	PLOS ONE			English	Article							INTERFERING ALPHA-STREPTOCOCCI; BETA-HEMOLYTIC STREPTOCOCCI; GRAM-POSITIVE BACTERIA; CELL-SURFACE; CONTROLLED-TRIAL; GENOME SEQUENCE; K12; FIMBRIAE; STRAINS; MODEL	Bacteriocin-producing probiotic Streptococcus salivarius M18 offers beneficial modulatory capabilities within the oral microbiome, apparently through potent inhibitory activity against potentially deleterious bacteria, such as Streptococcus pyogenes. The oral cavity persistence of S. salivarius M18 was investigated in 75 subjects receiving four different doses for 28 days. Sixty per cent of the subjects already had some inhibitor-producing S. salivarius in their saliva prior to probiotic intervention. Strain M18's persistence was dependent upon the dose, but not the period of administration. Culture analysis indicated that in some individuals the introduced strain had almost entirely replaced the indigenous S. salivarius, though the total numbers of the species did not increase. Selected subjects showing either high or low probiotic persistence had their salivary populations profiled using Illumina sequencing of the V6 region of the 16S rRNA gene. Analysis indicated that while certain bacterial phenotypes were markedly modulated, the overall composition of the oral microbiome was not modified by the probiotic treatment. Megaplasmids encoding bacteriocins and adhesion factors were transferred in vitro to generate a transconjugant S. salivarius exhibiting enhanced antimicrobial production and binding capabilities to HEp-2 cells. Since no widespread perturbation of the existing indigenous microbiota was associated with oral instillation and given its antimicrobial activity against potentially pathogenic streptococci, it appears that application of probiotic strain M18 offers potential low impact alternative to classical antibiotic prophylaxis. For candidate probiotic strains having relatively poor antimicrobial or adhesive properties, unique derivatives displaying improved probiotic performance may be engineered in vitro by megaplasmid transfer.	[Burton, Jeremy P.; Reid, Gregor] Lawson Hlth Res Inst, Canadian Res & Dev Ctr Probiot, London, ON, Canada; [Burton, Jeremy P.; Reid, Gregor; Cadieux, Peter A.] Univ Western Ontario, Dept Surg, Div Urol, London, ON N6A 3K7, Canada; [Burton, Jeremy P.; MacDonald, Kyle; Reid, Gregor; Cadieux, Peter A.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Macklaim, Jean M.; Gloor, Gregory B.] Univ Western Ontario, Dept Biochem, Schulich Sch Med & Dent, London, ON, Canada; [Chai, Melissa H. C.; Tagg, John] Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand; [Wescombe, Philip A.; Hale, John D. F.] Univ Otago, Ctr Innovat, BLIS Technol Ltd, Dunedin, New Zealand	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of Otago; University of Otago	Burton, JP (corresponding author), Lawson Hlth Res Inst, Canadian Res & Dev Ctr Probiot, London, ON, Canada.	Jeremy.burton@Lawsonresearch.com	Gloor, Greg B/D-1671-2013; Reid, Gregor/ABE-8327-2020; Burton, Jeremy/AAR-8902-2020; Wescombe, Philip/F-8699-2015	Reid, Gregor/0000-0001-9658-5696; Burton, Jeremy/0000-0002-3591-6436; Wescombe, Philip/0000-0001-8754-6265; Gloor, Gregory/0000-0001-5803-3380	funds for University of Otago Post Graduates; Canadian Research and Development Centre for Probiotics at the Lawson Health Research Institute	funds for University of Otago Post Graduates; Canadian Research and Development Centre for Probiotics at the Lawson Health Research Institute	The study was proposed by BLIS Technologies Ltd to gain further insight into the persistence properties of the organism. The company provided the lozenges for the study but did not fund the analysis of the samples collected at the university or the in vitro components of the study. Analysis and other experiments were supported by funds for University of Otago Post Graduates and by the Canadian Research and Development Centre for Probiotics at the Lawson Health Research Institute. The funders had some role in study design, assisted by providing personnel to collect raw data, but did not have a role in the analysis, decision to publish, or preparation of the manuscript (other than for final proof reading purposes).	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Andersson DI, 1996, P NATL ACAD SCI USA, V93, P906, DOI 10.1073/pnas.93.2.906; BOCHKOV IA, 1981, ZH MIKROB EPID IMMUN, P38; Bron PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038720; Burton JP, 2006, APPL ENVIRON MICROB, V72, P3050, DOI 10.1128/AEM.72.4.3050-3053.2006; Burton JP, 2006, J APPL MICROBIOL, V100, P754, DOI 10.1111/j.1365-2672.2006.02837.x; Burton JP, 2003, APPL ENVIRON MICROB, V69, P97, DOI 10.1128/AEM.69.1.97-101.2003; Caglar E, 2009, INT J PAEDIATR DENT, V19, P377, DOI 10.1111/j.1365-263X.2009.00989.x; Corr SC, 2007, P NATL ACAD SCI USA, V104, P7617, DOI 10.1073/pnas.0700440104; Cosseau C, 2008, INFECT IMMUN, V76, P4163, DOI 10.1128/IAI.00188-08; Daly KM, 2010, J BACTERIOL, V192, P1131, DOI 10.1128/JB.01375-09; Di Pierro F, 2013, EXPERT OPIN BIOL THE; Dierksen K.P., 2000, STREPTOCOCCI STREPTO, P81; Dierksen KP, 2007, FEMS MICROBIOL ECOL, V59, P584, DOI 10.1111/j.1574-6941.2006.00228.x; Dierksen KP, 2000, J CLIN MICROBIOL, V38, P643, DOI 10.1128/JCM.38.2.643-650.2000; Dobson A, 2011, FEMS MICROBIOL ECOL, V76, P602, DOI 10.1111/j.1574-6941.2011.01069.x; Filkins LM, 2012, J BACTERIOL; Foster JS, 2004, APPL ENVIRON MICROB, V70, P4340, DOI 10.1128/AEM.70.7.4340-4348.2004; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Grzeskowiak L, 2011, BRIT J NUTR, V105, P887, DOI 10.1017/S0007114510004496; Guedon E, 2011, J BACTERIOL, V193, P5024, DOI 10.1128/JB.05390-11; Guglielmetti S, 2010, APPL ENV MICROBIOL; Hamada S, 1998, ORAL MICROBIOL IMMUN, V13, P129, DOI 10.1111/j.1399-302X.1998.tb00724.x; HANDLEY PS, 1987, J GEN MICROBIOL, V133, P3207; HANDLEY PS, 1984, J BACTERIOL, V157, P64, DOI 10.1128/JB.157.1.64-72.1984; Heng NCK, 2011, J BACTERIOL, V193, P6402, DOI 10.1128/JB.06001-11; Hummelen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026602; Hyink O, 2007, APPL ENVIRON MICROB, V73, P1107, DOI 10.1128/AEM.02265-06; Ishijima SA, 2012, APPL ENVIRON MICROB, V78, P2190, DOI 10.1128/AEM.07055-11; Jenkinson HF, 1997, MOL MICROBIOL, V23, P183, DOI 10.1046/j.1365-2958.1997.2021577.x; KELSTRUP J, 1981, SCAND J DENT RES, V89, P374; Leblebicioglu B, 2009, ANAEROBE, V15, P82, DOI 10.1016/j.anaerobe.2008.12.005; Levesque C, 2004, MICROBIOL-SGM, V150, P189, DOI 10.1099/mic.0.26592-0; Levesque C, 2003, ORAL MICROBIOL IMMUN, V18, P333, DOI 10.1034/j.1399-302X.2003.00085.x; Masdea L, 2012, ARCH ORAL BIOL, V57, P1041, DOI 10.1016/j.archoralbio.2012.02.011; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; O'Shea EF, 2013, CURR OPIN BIOTECHNOL; Offenbacher S, 2009, J PERIODONTOL, V80, P190, DOI [10.1902/jop.2009.080007, 10.1902/jop.2009.080007 ]; Postollec F, 2006, J DENT RES, V85, P231, DOI 10.1177/154405910608500305; Roos K, 2001, BRIT MED J, V322, P210, DOI 10.1136/bmj.322.7280.210; ROOS K, 1993, SCAND J INFECT DIS, V25, P31, DOI 10.3109/00365549309169666; ROOS K, 1993, INT J PEDIATR OTORHI, V25, P141, DOI 10.1016/0165-5876(93)90047-7; SANDERS CC, 1977, INFECT IMMUN, V16, P599, DOI 10.1128/IAI.16.2.599-603.1977; Sybesma W, 2013, APPL ENV MICROBIOL; TAGG JR, 1976, BACTERIOL REV, V40, P722, DOI 10.1128/MMBR.40.3.722-756.1976; TAGG JR, 1979, J MED MICROBIOL, V12, P397, DOI 10.1099/00222615-12-4-397; Tannock GW, 2000, APPL ENVIRON MICROB, V66, P2578, DOI 10.1128/AEM.66.6.2578-2588.2000; TANZER JM, 1985, INFECT IMMUN, V48, P44, DOI 10.1128/IAI.48.1.44-50.1985; Upton M, 2001, J BACTERIOL, V183, P3931, DOI 10.1128/JB.183.13.3931-3938.2001; van Bokhorst-van de Veen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039053; Wescombe PA, 2006, ANTON LEEUW INT J G, V90, P269, DOI 10.1007/s10482-006-9081-y; Wescombe PA, 2009, FUTURE MICROBIOL, V4, P819, DOI 10.2217/FMB.09.61; Whittaker CJ, 1996, ANNU REV MICROBIOL, V50, P513, DOI 10.1146/annurev.micro.50.1.513	55	46	48	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65991	10.1371/journal.pone.0065991	http://dx.doi.org/10.1371/journal.pone.0065991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785463	Green Submitted, Green Published, gold			2022-12-25	WOS:000321038800059
J	Huang, L; Li, LQ; Klonowski, KD; Tompkins, SM; Tripp, RA; Mellor, AL				Huang, Lei; Li, Lingqian; Klonowski, Kim D.; Tompkins, S. Mark; Tripp, Ralph A.; Mellor, Andrew L.			Induction and Role of Indoleamine 2,3 Dioxygenase in Mouse Models of Influenza A Virus Infection	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; T-CELLS; 2,3-DIOXYGENASE; TRYPTOPHAN; IDO; SUPPRESSION; EXPRESSION; INFLAMMATION; KYNURENINE; SELECTION	Influenza infection stimulates protective host immune responses but paradoxically enhances lung indoleamine 2,3 dioxygenase (IDO) activity, an enzyme that suppresses helper/effector T cells and activates Foxp3-lineage regulatory CD4 T cells (Tregs). Influenza A/PR/8/34 (PR8) infection stimulated rapid elevation of IDO activity in lungs and lung-draining mediastinal lymph nodes (msLNs). Mice lacking intact IDO1 genes (IDO1-KO mice) exhibited significantly lower morbidity after sub-lethal PR8 infection, and genetic or pharmacologic IDO ablation led to much faster recovery after virus clearance. More robust influenza-specific effector CD8 T cell responses manifested in lungs of PR8-infected IDO1-KO mice, though virus clearance rates were unaffected by IDO ablation. Similar outcomes manifested in mice infected with a less virulent influenza A strain (X31). IDO induction in X31-infected lungs was dependent on IFN type II (IFN gamma) signaling and was restricted to non-hematopoietic cells, while redundant IFN type 1 or type II signaling induced IDO exclusively in hematopoietic cells from msLNs. Memory T cells generated in X31-primed IDO1-KO mice protected mice from subsequent challenge with lethal doses of PR8 (100xLD(50)). However recall T cell responses were less robust in lung interstitial tissues, and classic dominance of TCR V beta 8.3 chain usage amongst memory CD8(+) T cells specific for influenza nucleoprotein (NP366) did not manifest in IDO1-KO mice. Thus, influenza induced IDO activity in lungs enhanced morbidity, slowed recovery, restrained effector T cell responses in lungs and shaped memory T cell repertoire generation, but did not attenuate virus clearance during primary influenza A infection.	[Huang, Lei; Li, Lingqian; Mellor, Andrew L.] Georgia Regents Univ, Ctr Canc, Canc Immunol Inflammat & Tolerance Program, Augusta, GA USA; [Huang, Lei] Georgia Regents Univ, Dept Radiol, Augusta, GA USA; [Klonowski, Kim D.] Univ Georgia, Coll Arts & Sci, Dept Cell Biol, Athens, GA 30602 USA; [Tompkins, S. Mark; Tripp, Ralph A.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; [Klonowski, Kim D.; Mellor, Andrew L.] Georgia Regents Univ, Dept Med, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; Augusta University	Mellor, AL (corresponding author), Georgia Regents Univ, Ctr Canc, Canc Immunol Inflammat & Tolerance Program, Augusta, GA USA.	amellor@gru.edu	Tompkins, Stephen/A-3317-2008	Tompkins, Stephen/0000-0002-1523-5588; Tripp, Ralph/0000-0002-2924-9956; huang, lei/0000-0002-1996-944X	National Institutes of Health/National Institute of Allergy and Infectious Diseases Immune Mechanisms of Virus Control (IMVC) Program [AI-83005]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI083005] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases Immune Mechanisms of Virus Control (IMVC) Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding to support this study was provided via a U01 grant (AI-83005) awarded to ALM and RAT from the National Institutes of Health/National Institute of Allergy and Infectious Diseases Immune Mechanisms of Virus Control (IMVC) Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Baban B, 2005, INT IMMUNOL, V17, P909, DOI 10.1093/intimm/dxh271; Baban B, 2004, J REPROD IMMUNOL, V61, P67, DOI 10.1016/j.jri.2003.11.003; Baban B, 2011, J IMMUNOL, V187, P2329, DOI 10.4049/jimmunol.1100276; Baban B, 2009, J IMMUNOL, V183, P2475, DOI 10.4049/jimmunol.0900986; Ball HJ, 2007, GENE, V396, P203, DOI 10.1016/j.gene.2007.04.010; DECKHUT AM, 1993, J IMMUNOL, V151, P2658; Desvignes L, 2009, IMMUNITY, V31, P974, DOI 10.1016/j.immuni.2009.10.007; Divanovic S, 2012, J INFECT DIS, V205, P152, DOI 10.1093/infdis/jir621; Fallarino F, 2006, EUR J IMMUNOL, V36, P8, DOI 10.1002/eji.200535667; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Guillonneau C, 2009, P NATL ACAD SCI USA, V106, P3330, DOI 10.1073/pnas.0813309106; Hoshi M, 2010, J IMMUNOL, V185, P3305, DOI 10.4049/jimmunol.0901150; Huang L, 2012, J IMMUNOL, V188, P4913, DOI 10.4049/jimmunol.1103668; Huang L, 2010, INT REV IMMUNOL, V29, P133, DOI 10.3109/08830180903349669; Johnson BA, 2010, P NATL ACAD SCI USA, V107, P10644, DOI 10.1073/pnas.0914347107; Kochanek K, 2011, NATL VITAL STAT REP, V54, P1; Laich A, 2002, CLIN CHEM, V48, P579; Li LQ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00109; Makala LHC, 2011, J INFECT DIS, V203, P715, DOI 10.1093/infdis/jiq095; McCullers JA, 2002, J INFECT DIS, V186, P341, DOI 10.1086/341462; Mellor AL, 2005, J IMMUNOL, V175, P5601, DOI 10.4049/jimmunol.175.9.5601; Mellor AL, 2008, NAT REV IMMUNOL, V8, P74, DOI 10.1038/nri2233; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; Muller AJ, 2008, P NATL ACAD SCI USA, V105, P17073, DOI 10.1073/pnas.0806173105; Munn David H, 2012, Front Biosci (Elite Ed), V4, P734; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; O'Connor JC, 2009, J IMMUNOL, V182, P3202, DOI 10.4049/jimmunol.0802722; Ou R, 2001, J VIROL, V75, P8407, DOI 10.1128/JVI.75.18.8407-8423.2001; Parker D, 2012, SEMIN IMMUNOPATHOL, V34, P281, DOI 10.1007/s00281-011-0291-7; Price GE, 2005, J VIROL, V79, P8545, DOI 10.1128/JVI.79.13.8545-8559.2005; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; van der Sluijs KF, 2006, J INFECT DIS, V193, P214, DOI 10.1086/498911; Wang YT, 2010, NAT MED, V16, P279, DOI 10.1038/nm.2092; Yeung AWS, 2012, J LEUKOCYTE BIOL, V91, P657, DOI 10.1189/jlb.1011532; YOSHIDA R, 1979, P NATL ACAD SCI USA, V76, P4084, DOI 10.1073/pnas.76.8.4084; Zelante T, 2009, MICROBES INFECT, V11, P133, DOI 10.1016/j.micinf.2008.10.007; Zhong WM, 2004, INT IMMUNOL, V16, P1549, DOI 10.1093/intimm/dxh156; Zhou SH, 2004, J VIROL, V78, P3578, DOI 10.1128/JVI.78.7.3578-3600.2004	41	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66546	10.1371/journal.pone.0066546	http://dx.doi.org/10.1371/journal.pone.0066546			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785507	Green Submitted, gold, Green Published			2022-12-25	WOS:000321038800014
J	Minguez, L; Brule, N; Sohm, B; Devin, S; Giamberini, L				Minguez, Laetitia; Brule, Nelly; Sohm, Benedicte; Devin, Simon; Giamberini, Laure			Involvement of Apoptosis in Host-Parasite Interactions in the Zebra Mussel	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; PROGRAMMED CELL-DEATH; DREISSENA-POLYMORPHA; ANAPLASMA-PHAGOCYTOPHILUM; EHRLICHIA-CHAFFEENSIS; CRASSOSTREA-VIRGINICA; BACTERIAL PATHOGENS; DIGESTIVE GLAND; IMMUNE-SYSTEM; OSTREA-EDULIS	The question of whether cell death by apoptosis plays a biological function during infection is key to understanding host-parasite interactions. We investigated the involvement of apoptosis in several host-parasite systems, using zebra mussels Dreissena polymorpha as test organisms and their micro-and macroparasites. As a stress response associated with parasitism, heat shock proteins (Hsp) can be induced. In this protein family, Hsp70 are known to be apoptosis inhibitors. Mussels were diagnosed for their respective infections by standard histological methods; apoptosis was detected using the TUNEL methods on paraffin sections and Hsp70 by immunohistochemistry on cryosections. Circulating hemocytes were the main cells observed in apoptosis whereas infected tissues displayed no or few apoptotic cells. Parasitism by intracellular bacteria Rickettsiales-like and the trematode Bucephalus polymorphus were associated with the inhibition of apoptosis whereas ciliates Ophryoglena spp. or the trematode Phyllodistomum folium did not involve significant differences in apoptosis. Even if some parasites were able to modulate apoptosis in zebra mussels, we did not see evidence of any involvement of Hsp70 on this mechanism.	[Minguez, Laetitia; Brule, Nelly; Sohm, Benedicte; Devin, Simon; Giamberini, Laure] Univ Lorraine, LIEBE, CNRS UMR 7146, Metz, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Minguez, L (corresponding author), Univ Lorraine, LIEBE, CNRS UMR 7146, Metz, France.	laetitia-minguez@hotmail.fr; laure.giamberini@univ-lorraine.fr	SOHM, Bénédicte/C-1339-2012	Minguez, Laetitia/0000-0003-4840-1607; Devin, Simon/0000-0003-4431-4987; SOHM, Benedicte/0000-0002-7204-5414	CNRS, Region Lorraine	CNRS, Region Lorraine(Region Grand-EstCentre National de la Recherche Scientifique (CNRS))	CNRS, Region Lorraine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMEISEN JC, 1994, AIDS, V8, P1197, DOI 10.1097/00002030-199409000-00001; Lopez-Sanchez JA, 2009, COMP BIOCHEM PHYS A, V154, P425, DOI 10.1016/j.cbpa.2009.07.021; Auffret M, 2006, ECOTOX ENVIRON SAFE, V63, P393, DOI 10.1016/j.ecoenv.2005.10.016; Barcinski MA, 1999, BRAZ J MED BIOL RES, V32, P395, DOI 10.1590/S0100-879X1999000400003; Bayne CJ, 2001, PARASITOLOGY, V123, pS159; Briken V, 2008, CURR DRUG TARGETS, V9, P150, DOI 10.2174/138945008783502449; Bruchhaus I, 2007, TRENDS PARASITOL, V23, P376, DOI 10.1016/j.pt.2007.06.004; Cho SungHwan, 2004, Journal of Asia-Pacific Entomology, V7, P195, DOI 10.1016/S1226-8615(08)60215-0; Creagh EM, 2000, LEUKEMIA, V14, P1161, DOI 10.1038/sj.leu.2401841; da Silva PM, 2002, J INVERTEBR PATHOL, V79, P154, DOI 10.1016/S0022-2011(02)00026-5; David JADO, 2008, MICRON, V39, P329, DOI 10.1016/j.micron.2007.06.002; Fabbri E., 2008, ISJ, V5, P135; Faherty CS, 2008, TRENDS MICROBIOL, V16, P173, DOI 10.1016/j.tim.2008.02.001; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Gao LY, 2000, TRENDS MICROBIOL, V8, P306, DOI 10.1016/S0966-842X(00)01784-4; Giamberini L, 2005, ENVIRON RES, V98, P210, DOI 10.1016/j.envres.2004.11.003; Goedken M, 2005, J SHELLFISH RES, V24, P177; Hacker G, 2006, MED MICROBIOL IMMUN, V195, P11, DOI 10.1007/s00430-005-0239-4; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Hughes FM, 2010, FISH SHELLFISH IMMUN, V29, P247, DOI 10.1016/j.fsi.2010.03.003; James ER, 2004, TRENDS PARASITOL, V20, P280, DOI 10.1016/j.pt.2004.04.004; Kiss T, 2010, APOPTOSIS, V15, P313, DOI 10.1007/s10495-009-0446-3; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Lacoste A, 2002, J CELL SCI, V115, P761; Lancellotti Marcelo, 2006, Brazilian Journal of Morphological Sciences, V23, P75; Lapied E, 2011, ENVIRON INT, V37, P1105, DOI 10.1016/j.envint.2011.01.009; Laruelle F, 2002, J PARASITOL, V88, P856, DOI 10.1645/0022-3395(2002)088[0856:HAOTID]2.0.CO;2; MASTITSKY SE, 2004, THESIS NATL ACAD SCI; Menaker RJ, 2003, MICROBES INFECT, V5, P1149, DOI 10.1016/J.MICINF.2003.08.001; Minguez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034029; Minguez L, 2012, ECOTOXICOLOGY, V21, P538, DOI 10.1007/s10646-011-0814-y; Minguez L, 2012, ENVIRON POLLUT, V162, P234, DOI 10.1016/j.envpol.2011.11.005; Minguez L, 2009, ENVIRON RES, V109, P843, DOI 10.1016/j.envres.2009.07.012; Molloy Daniel P., 1997, Reviews in Fisheries Science, V5, P27; Molloy DP, 2005, DIS AQUAT ORGAN, V65, P237, DOI 10.3354/dao065237; Molloy DP, 2001, DIS AQUAT ORGAN, V44, P203, DOI 10.3354/dao044203; Morga B, 2012, FISH SHELLFISH IMMUN, V32, P958, DOI 10.1016/j.fsi.2012.01.026; Muller A, 2001, INT J MED MICROBIOL, V291, P197, DOI 10.1078/1438-4221-00125; Opferman JT, 2003, NAT IMMUNOL, V4, P410, DOI 10.1038/ni0503-410; OSADA M, 1989, COMP BIOCHEM PHYS C, V93, P171, DOI 10.1016/0742-8413(89)90029-7; Renault T, 2000, DIS AQUAT ORGAN, V42, P173, DOI 10.3354/dao042173; Rikihisa Y, 2010, NAT REV MICROBIOL, V8, P328, DOI 10.1038/nrmicro2318; Rikihisa Y, 2010, VET PARASITOL, V167, P155, DOI 10.1016/j.vetpar.2009.09.017; Rojas V, 2010, J CELL BIOCHEM, V110, P468, DOI 10.1002/jcb.22560; Romero A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017003; Russo J, 2007, CELL TISSUE RES, V328, P431, DOI 10.1007/s00441-006-0353-7; Schmid MC, 2006, PLOS PATHOG, V2, P1083, DOI 10.1371/journal.ppat.0020115; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Singer C, 2005, AQUAT TOXICOL, V75, P65, DOI 10.1016/j.aquatox.2005.07.004; Sokolova IM, 2009, ISJ-INVERT SURVIV J, V6, P49; Sokolova IM, 2004, J EXP BIOL, V207, P3369, DOI 10.1242/jeb.01152; Strahl J, 2010, MAR BIOL, V157, P1283, DOI 10.1007/s00227-010-1408-6; Sunila I, 2003, DIS AQUAT ORGAN, V56, P163, DOI 10.3354/dao056163; Tourari A.L., 1988, Haliotis, V18, P85; Vijayavel K, 2009, FISH SHELLFISH IMMUN, V26, P133, DOI 10.1016/j.fsi.2008.02.015; Walker AJ, 2006, TRENDS PARASITOL, V22, P154, DOI 10.1016/j.pt.2006.02.003; Wei Wang X, 2006, PNAS US, V103, P4204; Xu W, 2009, COMP BIOCHEM PHYS B, V154, P143, DOI 10.1016/j.cbpb.2009.05.012; Zahoor Z, 2010, CELL STRESS CHAPERON, V15, P639, DOI 10.1007/s12192-010-0176-z	59	7	7	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65822	10.1371/journal.pone.0065822	http://dx.doi.org/10.1371/journal.pone.0065822			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785455	Green Published, gold, Green Submitted			2022-12-25	WOS:000321038800067
J	Shoji, M; Takahashi, E; Hatakeyama, D; Iwai, Y; Morita, Y; Shirayama, R; Echigo, N; Kido, H; Nakamura, S; Mashino, T; Okutani, T; Kuzuhara, T				Shoji, Masaki; Takahashi, Etsuhisa; Hatakeyama, Dai; Iwai, Yuma; Morita, Yuka; Shirayama, Riku; Echigo, Noriko; Kido, Hiroshi; Nakamura, Shigeo; Mashino, Tadahiko; Okutani, Takeshi; Kuzuhara, Takashi			Anti-Influenza Activity of C-60 Fullerene Derivatives	PLOS ONE			English	Article							RNA-POLYMERASE; PA SUBUNIT; INFLUENZA; ENDONUCLEASE; OSELTAMIVIR; CELLS	The H1N1 influenza A virus, which originated in swine, caused a global pandemic in 2009, and the highly pathogenic H5N1 avian influenza virus has also caused epidemics in Southeast Asia in recent years. Thus, the threat from influenza A remains a serious global health issue, and novel drugs that target these viruses are highly desirable. Influenza A RNA polymerase consists of the PA, PB1, and PB2 subunits, and the N-terminal domain of the PA subunit demonstrates endonuclease activity. Fullerene (C-60) is a unique carbon molecule that forms a sphere. To identify potential new anti-influenza compounds, we screened 12 fullerene derivatives using an in vitro PA endonuclease inhibition assay. We identified 8 fullerene derivatives that inhibited the endonuclease activity of the PA N-terminal domain or full-length PA protein in vitro. We also performed in silico docking simulation analysis of the C-60 fullerene and PA endonuclease, which suggested that fullerenes can bind to the active pocket of PA endonuclease. In a cell culture system, we found that several fullerene derivatives inhibit influenza A viral infection and the expression of influenza A nucleoprotein and nonstructural protein 1. These results indicate that fullerene derivatives are possible candidates for the development of novel anti-influenza drugs.	[Shoji, Masaki; Hatakeyama, Dai; Iwai, Yuma; Morita, Yuka; Shirayama, Riku; Echigo, Noriko; Okutani, Takeshi; Kuzuhara, Takashi] Tokushima Bunri Univ, Fac Pharmaceut Sci, Biochem Lab, Yamashiro, Tokushima 770, Japan; [Takahashi, Etsuhisa; Kido, Hiroshi] Univ Tokushima, Inst Enzyme Res, Div Enzyme Chem, Tokushima 770, Japan; [Nakamura, Shigeo] Nippon Med Sch, Dept Chem, Nakahara Ku, Kawasaki, Kanagawa, Japan; [Mashino, Tadahiko] Keio Univ, Fac Pharm, Dept Pharmaceut Sci, Minato Ku, Tokyo, Japan	Tokushima Bunri University; Tokushima University; Nippon Medical School; Keio University	Kuzuhara, T (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Biochem Lab, Yamashiro, Tokushima 770, Japan.	kuzuhara@ph.bunri-u.ac.jp	中村, 成夫/R-7695-2019; ハタケヤマ, ダイ/HHS-5095-2022	ハタケヤマ, ダイ/0000-0001-6047-7124; Nakamura, Shigeo/0000-0002-9681-3510; Kuzuhara, Takashi/0000-0003-0565-6060	Japan Society for the Promotion of Science [20890273, 22590422, 22790098, 23780051]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the Japan Society for the Promotion of Science (grant no. 20890273, 22590422, 22790098, and 23780051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D., 1995, FOCUS, V17, P53; Bosi S, 2003, EUR J MED CHEM, V38, P913, DOI 10.1016/j.ejmech.2003.09.005; Chemical Computing Group C, 2004, MOL OP ENV MOE, P0707; Cianci Christopher, 2013, Antiviral Chemistry & Chemotherapy, V23, P77, DOI 10.3851/IMP2235; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; DuBois RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002830; Furuta Y, 2005, ANTIMICROB AGENTS CH, V49, P981, DOI 10.1128/AAC.49.3.981-986.2005; Goto J, 2008, J CHEM INF MODEL, V48, P583, DOI 10.1021/ci700352q; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; Honda A, 1997, BIOL CHEM, V378, P483; Honda A, 2002, P NATL ACAD SCI USA, V99, P13166, DOI 10.1073/pnas.152456799; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Ishikawa Y, 2011, BIOINFORMATION, V6, P221, DOI 10.6026/97320630006221; Iwai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019825; Iwai Y, 2010, BIOORGAN MED CHEM, V18, P5379, DOI 10.1016/j.bmc.2010.05.035; JANKNECHT R, 1991, P NATL ACAD SCI USA, V88, P8972, DOI 10.1073/pnas.88.20.8972; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; Kuzuhara T., 2009, PLOS CURR, V1; Kuzuhara T, 2009, J BIOL CHEM, V284, P6855, DOI 10.1074/jbc.C800224200; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035234; Mashino T, 2005, BIOORG MED CHEM LETT, V15, P1107, DOI 10.1016/j.bmcl.2004.12.030; Mashino T, 2003, BIOORG MED CHEM LETT, V13, P4395, DOI 10.1016/j.bmcl.2003.09.040; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; Nakamura S, 2012, J NIPPON MED SCH, V79, P248, DOI 10.1272/jnms.79.248; NAKAMURA Y, 1991, J BIOCHEM-TOKYO, V110, P395, DOI 10.1093/oxfordjournals.jbchem.a123592; Nakazawa M, 2008, ANTIVIR RES, V78, P194, DOI 10.1016/j.antiviral.2007.12.010; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nishizawa C, 2009, FREE RADICAL RES, V43, P1240, DOI [10.3109/10715760903273849, 10.3109/13814780903260764]; Noble E, 2012, VIROLOGY, V433, P27, DOI 10.1016/j.virol.2012.07.008; Okuda K, 1996, BIOORG MED CHEM LETT, V6, P539, DOI 10.1016/0960-894X(96)00064-9; Reece PA, 2007, J MED VIROL, V79, P1577, DOI 10.1002/jmv.20951; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Sukeguchi D, 2009, BEILSTEIN J ORG CHEM, V5, DOI 10.3762/bjoc.5.7; Tado M, 2001, ANTIVIR CHEM CHEMOTH, V12, P353, DOI 10.1177/095632020101200605; Takahashi E, 2012, J VIROL, V86, P10924, DOI 10.1128/JVI.01207-12; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; TOKUYAMA H, 1993, J AM CHEM SOC, V115, P7918, DOI 10.1021/ja00070a064; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zhao C, 2009, J VIROL, V83, P9024, DOI 10.1128/JVI.00911-09	43	52	58	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66337	10.1371/journal.pone.0066337	http://dx.doi.org/10.1371/journal.pone.0066337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785493	Green Published, gold, Green Submitted			2022-12-25	WOS:000321038800029
J	Jin, R; Yu, SY; Song, ZF; Zhu, XL; Wang, CP; Yan, JC; Wu, FS; Nanda, A; Granger, DN; Li, GH				Jin, Rong; Yu, Shiyong; Song, Zifang; Zhu, Xiaolei; Wang, Cuiping; Yan, Jinchuan; Wu, Fusheng; Nanda, Anil; Granger, D. Neil; Li, Guohong			Soluble CD40 Ligand Stimulates CD40-Dependent Activation of the beta 2 Integrin Mac-1 and Protein Kinase C Zeda (PKC zeta) in Neutrophils: Implications for Neutrophil-Platelet Interactions and Neutrophil Oxidative Burst	PLOS ONE			English	Article							NEOINTIMAL FORMATION; ADHESION MOLECULES; WALL INJURY; P-SELECTIN; EXPRESSION; INFLAMMATION; RESTENOSIS; HYPERPLASIA; RECRUITMENT; SURFACE	Recent work has revealed an essential involvement of soluble CD40L (sCD40L) in inflammation and vascular disease. Activated platelets are the major source of sCD40L, which has been implicated in platelet and leukocyte activation, although its exact functional impact on leukocyte-platelet interactions and the underlying mechanisms remain undefined. We aimed to determine the impact and the mechanisms of sCD40L on neutrophils. We studied neutrophil interactions with activated, surface-adherent platelets as a model for leukocyte recruitment to the sites of injury. Our data show that CD40L contributes to neutrophil firm adhesion to and transmigration across activated surface-adherent platelets, possibly through two potential mechanisms. One involves the direct interaction of ligand-receptor (CD40L-CD40), i.e., platelet surface CD40L interaction with neutrophil CD40; another involves an indirect mechanism, i.e. soluble CD40L stimulates activation of the leukocyte-specific beta 2 integrin Mac-1 in neutrophils and thereby further promotes neutrophil adhesion and migration. Activation of the integrin Mac-1 is known to be critical for mediating neutrophil adhesion and migration. sCD40L activated Mac-1 in neutrophils and enhanced neutrophil-platelet interactions in wild-type neutrophils, but failed to elicit such responses in CD40-deficient neutrophils. Furthermore, our data show that the protein kinase C zeta (PKC zeta) is critically required for sCD40L-induced Mac-1 activation and neutrophil adhesive function. sCD40L strongly stimulated the focal clustering of Mac-1 (CD11b) and the colocalization of Mac-1 with PKC zeta in wild-type neutrophils, but had minimal effect in CD40-deficient neutrophils. Blocking PKC zeta completely inhibited sCD40L-induced neutrophil firm adhesion. Moreover, sCD40L strongly stimulates neutrophil oxidative burst via CD40-dependent activation of PI3K/NF-KB, but independent of Mac-1 and PKC zeta. These findings may contribute to a better understanding of the underlying mechanisms by which sCD40L/CD40 pathway contributes to inflammation and vascular diseases.	[Jin, Rong; Yu, Shiyong; Song, Zifang; Zhu, Xiaolei; Wang, Cuiping; Nanda, Anil; Li, Guohong] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Neurosurg, Vasc Biol & Stroke Res Lab, Shreveport, LA 71105 USA; [Granger, D. Neil; Li, Guohong] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Physiol, Shreveport, LA 71105 USA; [Yu, Shiyong] Third Mil Med Univ, Xinqiao Hosp, Inst Cardiovasc Dis, Chongqing, Peoples R China; [Wang, Cuiping; Yan, Jinchuan] Jiangsu Univ, Affiliated Hosp, Dept Cardiol, Zhenjiang, Jiangsu, Peoples R China; [Wu, Fusheng] Zhejiang Univ, Affiliated Hosp 1, Dept Surg Oncol, Hangzhou 310003, Zhejiang, Peoples R China	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Army Medical University; Jiangsu University; Zhejiang University	Li, GH (corresponding author), Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Neurosurg, Vasc Biol & Stroke Res Lab, Shreveport, LA 71105 USA.	gli@lsuhsc.edu	Song, Zifang/AAA-8467-2022; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	NIH [HL087990, HL026441]; American Heart Association [0530166N]; National Natural Science Foundation of China [81272354]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL026441, R01HL087990] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grant HL087990 (GL) and by a scientist development grant (0530166N, GL) from the American Heart Association, and in part by NIH grant HL026441 (DNG) and by National Natural Science Foundation of China (81272354, FW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2002, CIRCULATION, V106, P896, DOI 10.1161/01.CIR.0000028962.04520.01; Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; Antoniades C, 2009, J AM COLL CARDIOL, V54, P669, DOI 10.1016/j.jacc.2009.03.076; Beland JL, 1998, BLOOD, V92, P4472, DOI 10.1182/blood.V92.11.4472.423k47_4472_4478; Bienvenu JG, 2001, J VASC RES, V38, P153, DOI 10.1159/000051042; Chakrabarti S, 2008, MICROCIRCULATION, V15, P555, DOI 10.1080/10739680801949732; Davidson DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051793; Diacovo TG, 1996, BLOOD, V88, P146; Evangelista V, 1996, BLOOD, V88, P4183, DOI 10.1182/blood.V88.11.4183.bloodjournal88114183; Hassan GS, 2012, IMMUNOBIOLOGY, V217, P521, DOI 10.1016/j.imbio.2011.03.010; Hristov M, 2010, CIRCULATION, V121, P315, DOI 10.1161/CIRCULATIONAHA.109.862771; Inoue T, 2006, THROMB HAEMOSTASIS, V95, P43, DOI 10.1160/TH05-08-0591; Inoue T, 2003, CIRCULATION, V107, P1757, DOI 10.1161/01.CIR.0000060487.15126.56; Inoue T, 1998, CIRCULATION, V97, P2511, DOI 10.1161/01.CIR.97.25.2511; Inoue T, 1996, J AM COLL CARDIOL, V28, P1127, DOI 10.1016/S0735-1097(96)00308-7; Laudanna C, 1998, J BIOL CHEM, V273, P30306, DOI 10.1074/jbc.273.46.30306; Li G, 2008, AM J PATHOL, V172, P1141, DOI 10.2353/ajpath.2008.070633; Lievens D, 2009, THROMB HAEMOSTASIS, V102, P206, DOI 10.1160/TH09-01-0029; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; McDonald PP, 1997, BLOOD, V89, P3421, DOI 10.1182/blood.V89.9.3421; Neumann FJ, 1996, J AM COLL CARDIOL, V27, P819, DOI 10.1016/0735-1097(95)00563-3; Osaka M, 2007, AM J PHYSIOL-HEART C, V292, pH1876, DOI 10.1152/ajpheart.00708.2006; Pamukcu B, 2011, ANN MED, V43, P331, DOI 10.3109/07853890.2010.546362; Roque M, 2000, ARTERIOSCL THROM VAS, V20, P335, DOI 10.1161/01.ATV.20.2.335; Sanguigni V, 2005, J AM COLL CARDIOL, V45, P35, DOI 10.1016/j.jacc.2004.09.047; Sergeant S, 1997, J IMMUNOL, V159, P2877; Shah PK, 2003, CIRCULATION, V107, P2175, DOI 10.1161/01.CIR.0000069943.41206.BD; Simon DI, 2000, J CLIN INVEST, V105, P293, DOI 10.1172/JCI7811; Song ZF, 2012, ARTERIOSCL THROM VAS, V32, P50, DOI 10.1161/ATVBAHA.111.238329; Song ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023239; Sun RH, 2005, CANCER RES, V65, P1433, DOI 10.1158/0008-5472.CAN-04-1163; Tanguay JF, 2003, J ENDOVASC THER, V10, P968, DOI 10.1583/1545-1550(2003)010<0968:CPANAA>2.0.CO;2; Welt FGP, 2002, ARTERIOSCL THROM VAS, V22, P1769, DOI 10.1161/01.ATV.0000037100.44766.5B; Yacoub D, 2010, ARTERIOSCL THROM VAS, V30, P2424, DOI 10.1161/ATVBAHA.110.216143; Zarbock A, 2007, BLOOD REV, V21, P99, DOI 10.1016/j.blre.2006.06.001	36	36	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64631	10.1371/journal.pone.0064631	http://dx.doi.org/10.1371/journal.pone.0064631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23785403	gold, Green Published, Green Submitted			2022-12-25	WOS:000321099000010
J	de Graauw, M; Cao, L; Winkel, L; van Miltenburg, MHAM; le Devedec, SE; Klop, M; Yan, K; Pont, C; Rogkoti, VM; Tijsma, A; Chaudhuri, A; Lalai, R; Price, L; Verbeek, F; van de Water, B				de Graauw, M.; Cao, L.; Winkel, L.; van Miltenburg, M. H. A. M.; le Devedec, S. E.; Klop, M.; Yan, K.; Pont, C.; Rogkoti, V-M; Tijsma, A.; Chaudhuri, A.; Lalai, R.; Price, L.; Verbeek, F.; van de Water, B.			Annexin A2 depletion delays EGFR endocytic trafficking via cofilin activation and enhances EGFR signaling and metastasis formation	ONCOGENE			English	Article						AnxA2; breast cancer; EGFR; endocytosis; metastasis	GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; EARLY ENDOSOMES; PHOSPHORYLATION; INVASION; PATHWAY; ADHESION; RECRUITMENT; EXPRESSION; CARCINOMA	Enhanced epidermal growth factor receptor (EGFR) activity has been strongly linked to breast cancer progression and mediators of EGFR endocytosis may well be involved. We developed a semi-automated high-content fluorescence microscopy-based EGFR endocytosis screen to identify proteins that mediate EGFR endocytosis in human HBL100 breast cancer cells. Knockdown of 172 individual endocytosis and actin-regulatory genes with small interfering RNAs led to the identification of 14 genes of which the contribution to EGFR endocytosis in breast cancer is until now poorly defined, including DNAJC6, GDI2, FGD6, HAX1, NECAP2 and AnxA2. We show that depletion of the actin and endocytosis regulatory protein annexin A2 (AnxA2) in a panel of four triple negative breast cancer (TNBC) cell lines affected EGFR endocytosis. Depletion of AnxA2 in the aggressive and highly metastatic MDA-MB-231 TNBC cell line resulted in the inhibition of EGFR transport beyond the early endosomes. This inhibition coincided with enhanced epidermal growth factor (EGF)-induced cell migration and downstream signaling via c-Jun N-terminal kinase (JNK) and Akt. Moreover, AnxA2 knockdown increased lung metastasis formation in mice. The effect of AnxA2 knockdown on EGFR endocytosis in MDA-MB-231 was related to dephosphorylation/activation of the actin-severing protein cofilin, as re-expression of an inactive S3E-cofilin mutant, but not an active S3A-cofilin mutant, re-established EGFR endocytosis to control levels. Together, our data provide evidence for AnxA2 as a mediator of EGFR endocytosis and signaling in breast cancer via regulation of cofilin activation.	[de Graauw, M.; le Devedec, S. E.; Klop, M.; Pont, C.; Rogkoti, V-M; Tijsma, A.; Chaudhuri, A.; Lalai, R.; Price, L.; van de Water, B.] Leiden Univ, LACDR, Div Toxicol, NL-2300 RA Leiden, Netherlands; [Cao, L.; Yan, K.; Verbeek, F.] Leiden Univ, LIACS, Imaging & Bioinformat Grp, NL-2300 RA Leiden, Netherlands; [Winkel, L.] Erasmus MC, Biomech Lab, Rotterdam, Netherlands; [van Miltenburg, M. H. A. M.] Netherland Canc Inst, Dept Mol Pathol, Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Netherlands Cancer Institute	van de Water, B (corresponding author), Leiden Univ, LACDR, Div Toxicol, Einsteinweg 55,POB 9502, NL-2300 RA Leiden, Netherlands.	m.de.graauw@lacdr.leidenuniv.nl; b.water@lacdr.leidenuniv.nl		Le Devedec, Sylvia/0000-0002-0615-9616; Yan, Kuan/0000-0003-4143-3569	Dutch Cancer Society (KWF) [UL 2006-3538, UL 2007-3860]; EU [201862]; EUFP7 Systems Microscopy NoE [258068]; TI Pharma project [T3-107]; Dutch Organization for Scientific Research [NWO 911-02-022]; Horizon Breakthrough [NWO 93518003]; Centre for Biomedical Genetics	Dutch Cancer Society (KWF)(KWF Kankerbestrijding); EU(European Commission); EUFP7 Systems Microscopy NoE; TI Pharma project; Dutch Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Horizon Breakthrough; Centre for Biomedical Genetics	We thank Dr Erik Danen and Dr Leo Price for critically reading the manuscript. This work was supported by grants from the Dutch Cancer Society (KWF; grant UL 2006-3538 and UL 2007-3860), EU FP7-Metafight (grant no 201862), EUFP7 Systems Microscopy NoE (258068), TI Pharma project T3-107, the Dutch Organization for Scientific Research (NWO 911-02-022), Horizon Breakthrough (NWO 93518003) and Centre for Biomedical Genetics.	Babbin BA, 2007, AM J PATHOL, V170, P951, DOI 10.2353/ajpath.2007.060647; Badovinac-Crnjevic T, 2011, MED ONCOL, V28, pS121, DOI 10.1007/s12032-010-9738-2; Cao L, 2012, P 6 IAPR INT C PATT, P330; Croxtall JD, 2000, BRIT J PHARMACOL, V130, P289, DOI 10.1038/sj.bjp.0703272; de Graauw M, 2005, J BIOL CHEM, V280, P29885, DOI 10.1074/jbc.M412708200; de Graauw M, 2008, MOL CELL BIOL, V28, P1029, DOI 10.1128/MCB.01247-07; de Graauw M, 2010, P NATL ACAD SCI USA, V107, P6340, DOI 10.1073/pnas.0913360107; Eccles SA, 2011, INT J DEV BIOL, V55, P685, DOI 10.1387/ijdb.113396se; Emoto K, 2001, CANCER, V92, P1419, DOI 10.1002/1097-0142(20010915)92:6<1419::AID-CNCR1465>3.0.CO;2-J; Geldner N, 2006, CURR OPIN PLANT BIOL, V9, P589, DOI 10.1016/j.pbi.2006.09.011; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Grandal MV, 2008, J CELL MOL MED, V12, P1527, DOI 10.1111/j.1582-4934.2008.00298.x; Grewal T, 2010, INT J BIOCHEM CELL B, V42, P580, DOI 10.1016/j.biocel.2009.12.020; Grieve Adam G, 2012, Int J Cell Biol, V2012, P852430, DOI 10.1155/2012/852430; HARDER T, 1993, J CELL BIOL, V123, P1119, DOI 10.1083/jcb.123.5.1119; Huigsloot M, 2002, J BIOL CHEM, V277, P35869, DOI 10.1074/jbc.M200378200; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Jost M, 1997, J CELL SCI, V110, P221; Le Devedec SE, 2009, CLIN EXP METASTAS, V26, P673, DOI 10.1007/s10585-009-9267-6; Llado A, 2008, MOL BIOL CELL, V19, P17, DOI 10.1091/mbc.E07-05-0411; Lombaerts M, 2006, BRIT J CANCER, V94, P661, DOI 10.1038/sj.bjc.6602996; Marcoux N, 2005, CELL SIGNAL, V17, P1449, DOI 10.1016/j.cellsig.2005.03.001; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Miyamoto Y, 2003, J BIOL CHEM, V278, P29890, DOI 10.1074/jbc.M301559200; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Nishimura Y, 2006, HISTOCHEM CELL BIOL, V126, P627, DOI 10.1007/s00418-006-0198-x; Okreglak V, 2007, J CELL BIOL, V178, P1251, DOI 10.1083/jcb.200703092; PEPINSKY RB, 1986, NATURE, V321, P81, DOI 10.1038/321081a0; Rescher U, 2008, J CELL SCI, V121, P2177, DOI 10.1242/jcs.028415; Richnau N, 2001, J BIOL CHEM, V276, P35060, DOI 10.1074/jbc.M103540200; Sharma MR, 2006, EXP MOL PATHOL, V81, P146, DOI 10.1016/j.yexmp.2006.03.003; Shetty PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044299; Sidani M, 2007, J CELL BIOL, V179, P777, DOI 10.1083/jcb.200707009; van Roosmalen W, 2011, METHODS MOL BIOL, V769, P435, DOI 10.1007/978-1-61779-207-6_29; Vila de MS, 2009, ONCOGENE, V28, P363; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759; Wu B, 2012, CELL PROLIFERAT, V45, P189, DOI 10.1111/j.1365-2184.2012.00820.x; Zheng L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019390	42	41	41	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 15	2014	33	20					2610	2619		10.1038/onc.2013.219	http://dx.doi.org/10.1038/onc.2013.219			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AH9YT	23792445				2022-12-25	WOS:000336502700007
J	van Diepen, HC; Ramkisoensing, A; Peirson, SN; Foster, RG; Meijer, JH				van Diepen, Hester C.; Ramkisoensing, Ashna; Peirson, Stuart N.; Foster, Russell G.; Meijer, Johanna H.			Irradiance encoding in the suprachiasmatic nuclei by rod and cone photoreceptors	FASEB JOURNAL			English	Article						circadian; melanopsin; light; electrophysiology	RETINAL GANGLION-CELLS; CIRCADIAN RESPONSES; LIGHT; MELANOPSIN; RAT; ILLUMINATION; NEURONS; BIPOLAR	Light information is transmitted to the central clock of the suprachiasmatic nuclei (SCN) for daily synchronization to the external solar cycle. Essential for synchronization is the capacity of SCN neurons to respond in a sustained and irradiance-dependent manner to light. Melanopsin has been considered to mediate this photosensory task of irradiance detection. By contrast, the contribution of the classical photoreceptors in irradiance encoding is less clear. Here we investigate the role of classical photoreceptors by in vivo electrophysiological responses in freely moving animals to specific wavelengths of light (UV, (max) 365 nm; blue, (max) 467 nm; and green, (max) 505 nm) in both melanopsin-deficient (Opn4(-/-)) mice and mice lacking rods and cones (rd/rd cl). Short- and long-wavelength light induced sustained irradiance-dependent responses in congenic wild-type mice (+19.6%). Unexpectedly, sustained responses to light persisted in Opn4(-/-) mice (+18.4%). These results provide unambiguous evidence that classical photoreceptors can transmit irradiance information to the SCN. In addition, at light intensities that would stimulate rod and cone photoreceptors, the SCN of rd/rd cl mice showed greatly reduced sustained responses to light (+7.8%). Collectively, our data demonstrate a role for classical photoreceptors in illuminance detection by the SCN.van Diepen, H. C., Ramkisoensing, A., Peirson, S. N., Foster, R. G., Meijer, J. H. Irradiance encoding in the suprachiasmatic nuclei by rod and cone photoreceptors.	[van Diepen, Hester C.; Ramkisoensing, Ashna; Meijer, Johanna H.] Leiden Univ, Med Ctr, Neurophysiol Lab, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands; [Peirson, Stuart N.; Foster, Russell G.] Univ Oxford, Nuffield Lab Ophthalmol, Nuffield Dept Clin Neurosci, John Radcliffe Hosp, Oxford OX3 9DU, England	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Oxford	Meijer, JH (corresponding author), Leiden Univ, Med Ctr, POB 9600 Mailbox S5-P, NL-2300 RC Leiden, Netherlands.	russell.foster@eye.ox.ac.uk; j.h.meijer@lumc.nl		FOSTER, RUSSELL/0000-0001-6055-2067	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	The authors thank Sanne Verhoeve, Peter Stouten, Jan Janse, Sander van Berloo, Simona di Pretoro, Fred de Boer, and Ben van der Geest for assistance and technical support. The work leading to this paper was supported by a grant to R.G.F., S.N.P., and J.H.M. from the Wellcome Trust.	Aggelopoulos NC, 2000, J PHYSIOL-LONDON, V523, P211, DOI 10.1111/j.1469-7793.2000.t01-1-00211.x; Allen AE, 2011, J NEUROSCI, V31, P16833, DOI 10.1523/JNEUROSCI.2505-11.2011; Altimus CM, 2010, NAT NEUROSCI, V13, P1107, DOI 10.1038/nn.2617; Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brown TM, 2011, J PHYSIOL-LONDON, V589, P1173, DOI 10.1113/jphysiol.2010.199877; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Dkhissi-Benyahya O, 2007, NEURON, V53, P677, DOI 10.1016/j.neuron.2007.02.005; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; Dollet A, 2010, CHRONOBIOL INT, V27, P768, DOI 10.3109/07420521003695704; Drouyer E, 2007, J NEUROSCI, V27, P9623, DOI 10.1523/JNEUROSCI.1391-07.2007; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Gooley JJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000741; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Lall GS, 2010, NEURON, V66, P417, DOI 10.1016/j.neuron.2010.04.037; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 1999, ENDOCRINOLOGY, V140, P1520, DOI 10.1210/en.140.4.1520; Lupi D, 2008, NAT NEUROSCI, V11, P1068, DOI 10.1038/nn.2179; MEIJER JH, 1990, J BIOL RHYTHM, V5, P1, DOI 10.1177/074873049000500101; Meijer JH, 1998, J NEUROSCI, V18, P9078; MEIJER JH, 1986, BRAIN RES, V382, P109, DOI 10.1016/0006-8993(86)90117-4; MOORE RY, 1995, J COMP NEUROL, V352, P351, DOI 10.1002/cne.903520304; Mure LS, 2007, J BIOL RHYTHM, V22, P411, DOI 10.1177/0748730407306043; Nakamura TJ, 2004, NEUROSCI LETT, V371, P244, DOI 10.1016/j.neulet.2004.09.005; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Pang JJ, 2004, J PHYSIOL-LONDON, V558, P897, DOI 10.1113/jphysiol.2003.059543; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Schmidt TM, 2010, J NEUROSCI, V30, P16262, DOI 10.1523/JNEUROSCI.3656-10.2010; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; TERMAN JS, 1980, BEHAV BRAIN RES, V1, P507, DOI 10.1016/S0166-4328(80)80083-0; van Oosterhout F, 2012, CURR BIOL, V22, P1397, DOI 10.1016/j.cub.2012.05.032; Weng S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054625; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Wong KY, 2012, J NEUROSCI, V32, P11478, DOI 10.1523/JNEUROSCI.1423-12.2012	35	42	43	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					4204	4212		10.1096/fj.13-233098	http://dx.doi.org/10.1096/fj.13-233098			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23796782				2022-12-25	WOS:000329747100031
J	Bjorkblom, B; Adilbayeva, A; Maple-Grodem, J; Piston, D; Okvist, M; Xu, XM; Brede, C; Larsen, JP; Moller, SG				Bjorkblom, Benny; Adilbayeva, Altynai; Maple-Grodem, Jodi; Piston, Dominik; Okvist, Mats; Xu, Xiang Ming; Brede, Cato; Larsen, Jan Petter; Moller, Simon Geir			Parkinson Disease Protein DJ-1 Binds Metals and Protects against Metal-induced Cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; DJ-1-DEFICIENT MICE; ANDROGEN RECEPTOR; OXIDATIVE STRESS; MUTATIONS; GENE; ASSOCIATION; STABILITY; EXPOSURE; IRON	The progressive loss of motor control due to reduction of dopamine-producing neurons in the substantia nigra pars compacta and decreased striatal dopamine levels are the classically described features of Parkinson disease (PD). Neuronal damage also progresses to other regions of the brain, and additional non-motor dysfunctions are common. Accumulation of environmental toxins, such as pesticides and metals, are suggested risk factors for the development of typical late onset PD, although genetic factors seem to be substantial in early onset cases. Mutations of DJ-1 are known to cause a form of recessive early onset Parkinson disease, highlighting an important functional role for DJ-1 in early disease prevention. This study identifies human DJ-1 as a metal-binding protein able to evidently bind copper as well as toxic mercury ions in vitro. The study further characterizes the cytoprotective function of DJ-1 and PD-mutated variants of DJ-1 with respect to induced metal cytotoxicity. The results show that expression of DJ-1 enhances the cells' protective mechanisms against induced metal toxicity and that this protection is lost for DJ-1PD mutations A104T and D149A. The study also shows that oxidation site-mutated DJ-1 C106A retains its ability to protect cells. We also show that concomitant addition of dopamine exposure sensitizes cells to metal-induced cytotoxicity. We also confirm that redox-active dopamine adducts enhance metal-catalyzed oxidation of intracellular proteins in vivo by use of live cell imaging of redox-sensitive S3roGFP. The study indicates that even a small genetic alteration can sensitize cells to metal-induced cell death, a finding that may revive the interest in exogenous factors in the etiology of PD.	[Bjorkblom, Benny; Maple-Grodem, Jodi; Piston, Dominik; Xu, Xiang Ming; Larsen, Jan Petter; Moller, Simon Geir] Stavanger Univ Hosp, Norwegian Ctr Movement Disorders, N-4068 Stavanger, Norway; [Bjorkblom, Benny; Adilbayeva, Altynai; Maple-Grodem, Jodi; Piston, Dominik; Xu, Xiang Ming; Moller, Simon Geir] Univ Stavanger, Ctr Organelle Res, N-4036 Stavanger, Norway; [Okvist, Mats] European Synchrotron Radiat Facil, F-38000 Grenoble, France; [Brede, Cato] Stavanger Univ Hosp, Dept Med Biochem, N-4068 Stavanger, Norway; [Moller, Simon Geir] St Johns Univ, Dept Biol Sci, New York, NY 11439 USA	Stavanger University Hospital; Universitetet i Stavanger; European Synchrotron Radiation Facility (ESRF); Stavanger University Hospital; Saint John's University	Bjorkblom, B (corresponding author), Stavanger Univ Hosp, Norwegian Ctr Movement Disorders, N-4068 Stavanger, Norway.	bjorkblom@uis.no	Adilbayeva, Altynai/AAM-7989-2020; Grødem, jodi M/H-5482-2012; Brede, Cato/AGZ-6186-2022	Adilbayeva, Altynai/0000-0003-1636-280X; Brede, Cato/0000-0003-2691-6052; Maple-Grodem, Jodi/0000-0001-7142-0078; Moller, Simon/0000-0002-0460-3592	Western Norway Regional Health Authority Helse Vest Project [911575]	Western Norway Regional Health Authority Helse Vest Project	This work was supported by Western Norway Regional Health Authority Helse Vest Project Grant 911575.	Abou-Sleiman PM, 2003, ANN NEUROL, V54, P283, DOI 10.1002/ana.10675; Akagawa M, 2006, BIOCHEMISTRY-US, V45, P15120, DOI 10.1021/bi0614434; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Ballatori N, 2002, ENVIRON HEALTH PERSP, V110, P689, DOI 10.1289/ehp.02110s5689; Bjorkblom B, 2005, J NEUROSCI, V25, P6350, DOI 10.1523/JNEUROSCI.1517-05.2005; Bjorkblom B, 2008, J BIOL CHEM, V283, P19704, DOI 10.1074/jbc.M707744200; Blackinton J, 2005, MOL BRAIN RES, V134, P76, DOI 10.1016/j.molbrainres.2004.09.004; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Bleackley MR, 2011, BIOMETALS, V24, P785, DOI 10.1007/s10534-011-9451-4; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Bridges CC, 2005, TOXICOL APPL PHARM, V204, P274, DOI 10.1016/j.taap.2004.09.007; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chandran JS, 2008, NEUROBIOL DIS, V29, P505, DOI 10.1016/j.nbd.2007.11.011; Chen J, 2010, HUM MOL GENET, V19, P2395, DOI 10.1093/hmg/ddq113; Ciarimboli G, 2008, XENOBIOTICA, V38, P936, DOI [10.1080/00498250701882482, 10.1080/00498250701882482 ]; Davis SJ, 1998, PLANT MOL BIOL, V36, P521, DOI 10.1023/A:1005991617182; DEXTER DT, 1991, BRAIN, V114, P1953, DOI 10.1093/brain/114.4.1953; Diez S, 2009, REV ENVIRON CONTAM T, V198, P111, DOI 10.1007/978-0-387-09647-6_3; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Gorell JM, 1999, NEUROTOXICOLOGY, V20, P239; Gorner K, 2004, J BIOL CHEM, V279, P6943, DOI 10.1074/jbc.M309204200; Gotz ME, 2004, ANN NY ACAD SCI, V1012, P193, DOI 10.1196/annals.1306.017; Hague S, 2003, ANN NEUROL, V54, P271, DOI 10.1002/ana.10663; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; ITO S, 1988, BIOCHEM PHARMACOL, V37, P1707, DOI 10.1016/0006-2952(88)90432-7; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Leonard GA, 2009, J APPL CRYSTALLOGR, V42, P333, DOI 10.1107/S0021889809001721; Liu B, 2003, ENVIRON HEALTH PERSP, V111, P1065, DOI 10.1289/ehp.6361; Malgieri G, 2008, PROTEIN SCI, V17, P855, DOI 10.1110/ps.073411608; Marsden CD, 1996, OXFORD TXB MED, V3, P3998; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; MARTTILA RJ, 1988, NEUROLOGY, V38, P1217, DOI 10.1212/WNL.38.8.1217; Meulener MC, 2006, P NATL ACAD SCI USA, V103, P12517, DOI 10.1073/pnas.0601891103; Moore DJ, 2003, J NEUROCHEM, V87, P1558, DOI 10.1111/j.1471-4159.2003.02265.x; Moore DJ, 2005, HUM MOL GENET, V14, P71, DOI 10.1093/hmg/ddi007; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; NGIM CH, 1989, NEUROEPIDEMIOLOGY, V8, P128, DOI 10.1159/000110175; Nyholm D, 2002, CLIN NEUROPHARMACOL, V25, P89, DOI 10.1097/00002826-200203000-00006; Okada M, 2002, BIOL PHARM BULL, V25, P853, DOI 10.1248/bpb.25.853; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Park J, 2005, GENE, V361, P133, DOI 10.1016/j.gene.2005.06.040; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Schapira AH, 2011, MOVEMENT DISORD, V26, P1049, DOI 10.1002/mds.23732; SEMCHUK KM, 1992, NEUROLOGY, V42, P1328, DOI 10.1212/WNL.42.7.1328; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Sian-Hulsmann J, 2011, J NEUROCHEM, V118, P939, DOI 10.1111/j.1471-4159.2010.07132.x; Sikk K, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/865319; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Tang BS, 2006, HUM MOL GENET, V15, P1816, DOI 10.1093/hmg/ddl104; Tanner CM, 1999, JAMA-J AM MED ASSOC, V281, P341, DOI 10.1001/jama.281.4.341; Tillman JE, 2007, CANCER RES, V67, P4630, DOI 10.1158/0008-5472.CAN-06-4556; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; WANG JD, 1989, BRIT J IND MED, V46, P856; Werner P., 2007, PARKINSONS DIS MOVEM, P67; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; Wirdefeldt K, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.02.017; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6; Xu XM, 2010, J CELL SCI, V123, P1644, DOI 10.1242/jcs.063222; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	71	56	61	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22809	22820		10.1074/jbc.M113.482091	http://dx.doi.org/10.1074/jbc.M113.482091			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23792957	Green Published, hybrid			2022-12-25	WOS:000330596300058
J	Sirrieh, RE; MacLean, DM; Jayaraman, V				Sirrieh, Rita E.; MacLean, David M.; Jayaraman, Vasanthi			Amino-terminal Domain Tetramer Organization and Structural Effects of Zinc Binding in the N-Methyl-D-aspartate (NMDA) Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL-CHANGES; ALLOSTERIC INTERACTION; SUBUNIT ARRANGEMENT; AMPA RECEPTOR; DYNAMICS; ACTIVATION; MECHANISM; DESENSITIZATION; IDENTIFICATION; INHIBITION	N-Methyl-D-aspartate (NMDA) receptors mediate excitatory neurotransmission in the mammalian central nervous system. An important feature of these receptors is their capacity for allosteric regulation by small molecules, such as zinc, which bind to their amino-terminal domain (ATD). Zinc inhibition through high affinity binding to the ATD has been examined through functional studies; however, there is no direct measurement of associated conformational changes. We used luminescence resonance energy transfer to show that the ATDs undergo a cleft closure-like conformational change upon binding zinc, but no changes are observed in intersubunit distances. Furthermore, we find that the ATDs are more closely packed than the related AMPA receptors. These results suggest that the stability of the upper lobe contacts between ATDs allow for the efficient propagation of the cleft closure conformational change toward the ligand-binding domain and transmembrane segments, ultimately inhibiting the channel.	[Sirrieh, Rita E.; MacLean, David M.; Jayaraman, Vasanthi] Univ Texas Houston, Hlth Sci Ctr, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Jayaraman, V (corresponding author), Univ Texas Houston, Hlth Sci Ctr, Dept Biochem & Mol Biol, Ctr Membrane Biol, MSB 6-174,6431 Fannin St, Houston, TX 77030 USA.	vasanthi.jayaraman@uth.tmc.edu		MacLean, David/0000-0001-8294-6075	Houston Area Molecular Biophysics Training Program National Institutes of Health [2T32GM008280]; American Heart Association; National Institutes of Health [GM094246]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008280, R01GM094246] Funding Source: NIH RePORTER	Houston Area Molecular Biophysics Training Program National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by Houston Area Molecular Biophysics Training Program National Institutes of Health Grant 2T32GM008280.; Supported by an American Heart Association postdoctoral fellowship.; Supported by National Institutes of Health Grant GM094246. To whom correspondence should be addressed: Center for Membrane Biology, Dept. of Biochemistry and Molecular Biology, University of Texas Health Science Center, MSB 6.174, 6431 Fannin St., Houston, TX 77030. Tel.: 713-500-6236; Fax: 713-500-6297; E-mail: vasanthi.jayaraman@uth.tmc.edu.	Amico-Ruvio SA, 2011, BIOPHYS J, V100, P1910, DOI 10.1016/j.bpj.2011.02.042; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; Borschel WF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1512; Brimecombe JC, 1999, J PHARMACOL EXP THER, V291, P785; Burger PB, 2012, MOL PHARMACOL, V82, P344, DOI 10.1124/mol.112.078568; Chazot PL, 1999, METH MOL B, V128, P33; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; Dutta A, 2012, STRUCTURE, V20, P1838, DOI 10.1016/j.str.2012.08.012; Erreger K, 2005, J PHYSIOL-LONDON, V569, P381, DOI 10.1113/jphysiol.2005.095497; Fayyazuddin A, 2000, NEURON, V25, P683, DOI 10.1016/S0896-6273(00)81070-3; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Furukawa H, 2012, J PHYSIOL-LONDON, V590, P63, DOI 10.1113/jphysiol.2011.213850; Gielen M, 2008, NEURON, V57, P80, DOI 10.1016/j.neuron.2007.11.021; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Gonzalez J, 2008, BIOCHEMISTRY-US, V47, P10027, DOI 10.1021/bi800690b; Gonzalez J, 2010, P NATL ACAD SCI USA, V107, P9891, DOI 10.1073/pnas.0911854107; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; Kapanidis AN, 2001, J AM CHEM SOC, V123, P12123, DOI 10.1021/ja017074a; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Landes CF, 2011, NAT CHEM BIOL, V7, P168, DOI 10.1038/NCHEMBIO.523; Maltsev AS, 2008, BIOCHEMISTRY-US, V47, P10600, DOI 10.1021/bi800843c; Maltsev AS, 2010, J BIOL CHEM, V285, P10154, DOI 10.1074/jbc.M109.088641; Masuko T, 1999, MOL PHARMACOL, V55, P957, DOI 10.1124/mol.55.6.957; Meddows E, 2001, J BIOL CHEM, V276, P18795, DOI 10.1074/jbc.M101382200; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Paoletti P, 1997, J NEUROSCI, V17, P5711; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Ramaswamy S, 2012, J BIOL CHEM, V287, P43557, DOI 10.1074/jbc.M112.371815; Rambhadran A, 2011, J BIOL CHEM, V286, P16953, DOI 10.1074/jbc.M111.224576; Rambhadran A, 2010, J BIOL CHEM, V285, P15296, DOI 10.1074/jbc.M109.085035; SELVIN PR, 1994, P NATL ACAD SCI USA, V91, P10024, DOI 10.1073/pnas.91.21.10024; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Suzuki Y, 2013, J BIOL CHEM, V288, P778, DOI 10.1074/jbc.M112.422311; Tang C. M., 2001, CURR PROTOCOLS NEURO, V5; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Zheng F, 2001, NAT NEUROSCI, V4, P894, DOI 10.1038/nn0901-894; Zhu SJ, 2013, NAT STRUCT MOL BIOL, V20, P477, DOI 10.1038/nsmb.2522	38	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22555	22564		10.1074/jbc.M113.482356	http://dx.doi.org/10.1074/jbc.M113.482356			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23792960	Green Published, hybrid			2022-12-25	WOS:000330596300035
J	Arafat, K; Iratni, R; Takahashi, T; Parekh, K; Al Dhaheri, Y; Adrian, TE; Attoub, S				Arafat, Kholoud; Iratni, Rabah; Takahashi, Takashi; Parekh, Khatija; Al Dhaheri, Yusra; Adrian, Thomas E.; Attoub, Samir			Inhibitory Effects of Salinomycin on Cell Survival, Colony Growth, Migration, and Invasion of Human Non-Small Cell Lung Cancer A549 and LNM35: Involvement of NAG-1	PLOS ONE			English	Article							BREAST-CANCER; STEM-CELLS; APOPTOSIS; CYTOKINE-1; INDUCTION; P21	A major challenge for oncologists and pharmacologists is to develop more potent and less toxic drugs that will decrease the tumor growth and improve the survival of lung cancer patients. Salinomycin is a polyether antibiotic used to kill gram-positive bacteria including mycobacteria, protozoans such as plasmodium falciparum, and the parasites responsible for the poultry disease coccidiosis. This old agent is now a serious anti-cancer drug candidate that selectively inhibits the growth of cancer stem cells. We investigated the impact of salinomycin on survival, colony growth, migration and invasion of the differentiated human non-small cell lung cancer lines LNM35 and A549. Salinomycin caused concentration-and time-dependent reduction in viability of LNM35 and A549 cells through a caspase 3/7-associated cell death pathway. Similarly, salinomycin (2.5-5 mu M for 7 days) significantly decreased the growth of LNM35 and A549 colonies in soft agar. Metastasis is the main cause of death related to lung cancer. In this context, salinomycin induced a time-and concentration-dependent inhibition of cell migration and invasion. We also demonstrated for the first time that salinomycin induced a marked increase in the expression of the pro-apoptotic protein NAG-1 leading to the inhibition of lung cancer cell invasion but not cell survival. These findings identify salinomycin as a promising novel therapeutic agent for lung cancer.	[Arafat, Kholoud; Attoub, Samir] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Pharmacol & Therapeut, Al Ain, U Arab Emirates; [Iratni, Rabah; Al Dhaheri, Yusra] United Arab Emirates Univ, Coll Sci, Dept Biol, Al Ain, U Arab Emirates; [Takahashi, Takashi] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Mol Carcinogenesis, Nagoya, Aichi 4648601, Japan; [Parekh, Khatija; Adrian, Thomas E.] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Physiol, Al Ain, U Arab Emirates	United Arab Emirates University; United Arab Emirates University; Nagoya University; United Arab Emirates University	Attoub, S (corresponding author), United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Pharmacol & Therapeut, Al Ain, U Arab Emirates.	samir.attoub@uaeu.ac.ae	Takahashi, Takashi/I-7262-2014; Attoub, Samir/N-6852-2018	Takahashi, Takashi/0000-0003-0615-7001; Adrian, Thomas/0000-0002-5051-1111	Terry Fox fund for Cancer Research; UAEU-National Research Foundation fund	Terry Fox fund for Cancer Research; UAEU-National Research Foundation fund	This study was supported by Terry Fox fund for Cancer Research (SA and TA) and partly by the UAEU-National Research Foundation fund to SA. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dhaheri Y, 2013, BBA-GEN SUBJECTS, V1830, P3121, DOI 10.1016/j.bbagen.2013.01.010; Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Breit SN, 2011, GROWTH FACTORS, V29, P187, DOI 10.3109/08977194.2011.607137; Dempke WCM, 2010, LUNG CANCER, V67, P257, DOI 10.1016/j.lungcan.2009.10.012; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fuchs D, 2009, BIOCHEM BIOPH RES CO, V390, P743, DOI 10.1016/j.bbrc.2009.10.042; Golkar L, 2007, J SURG RES, V138, P163, DOI 10.1016/j.jss.2006.05.037; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hait WN, 2010, NAT REV DRUG DISCOV, V9, P253, DOI 10.1038/nrd3144; Huczynski A, 2012, CHEM BIOL DRUG DES, V79, P235, DOI 10.1111/j.1747-0285.2011.01287.x; Kadara H, 2006, CANCER BIOL THER, V5, P518, DOI 10.4161/cbt.5.5.2602; Ketola K, 2012, BRIT J CANCER, V106, P99, DOI 10.1038/bjc.2011.530; Kim CH, 2008, BIOCHEM PHARMACOL, V75, P1751, DOI 10.1016/j.bcp.2008.02.002; Kim JH, 2011, BRIT J PHARMACOL, V162, P773, DOI 10.1111/j.1476-5381.2010.01089.x; Kim KY, 2011, BIOCHEM BIOPH RES CO, V413, P80, DOI 10.1016/j.bbrc.2011.08.054; Korpanty Grzegorz, 2011, J Thorac Dis, V3, P19, DOI 10.3978/j.issn.2072-1439.2010.11.11; Kozaki K, 2000, CANCER RES, V60, P2535; Lee DH, 2003, CANCER RES, V63, P4648; Liu T, 2003, CANCER RES, V63, P5034; Lu DS, 2011, P NATL ACAD SCI USA, V108, P13253, DOI 10.1073/pnas.1110431108; Mahmoudi N, 2006, J ANTIMICROB CHEMOTH, V57, P489, DOI 10.1093/jac/dki470; Mimeault M, 2010, J CELL PHYSIOL, V224, P626, DOI 10.1002/jcp.22196; MIYAZAKI Y, 1974, J ANTIBIOT, V27, P814, DOI 10.7164/antibiotics.27.814; Naujokat C, 2010, MOL MED REP, V3, P555, DOI 10.3892/mmr_00000296; Oak PS, 2012, INT J CANCER, V131, P2808, DOI 10.1002/ijc.27595; Parajuli B, 2013, CANC EPIDEMIOL; Solier S, 2009, MOL CELL BIOL, V29, P68, DOI 10.1128/MCB.00581-08; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; Tang QL, 2011, CANCER LETT, V311, P113, DOI 10.1016/j.canlet.2011.07.016; Verdoodt B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044132; Wang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050638; Wang Y, 2011, MED CHEM, V7, P106, DOI 10.2174/157340611794859307; Yu YL, 2012, J CELL PHYSIOL, V227, P213, DOI 10.1002/jcp.22719; Zhang GN, 2011, CANCER LETT, V313, P137, DOI 10.1016/j.canlet.2011.05.030; Zhang Y, 2012, BIOMATERIALS, V33, P679, DOI 10.1016/j.biomaterials.2011.09.072	35	41	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66931	10.1371/journal.pone.0066931	http://dx.doi.org/10.1371/journal.pone.0066931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805285	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500113
J	Garofalo, M; Jeon, YJ; Nuovo, GJ; Middleton, J; Secchiero, P; Joshi, P; Alder, H; Nazaryan, N; Di Leva, G; Romano, G; Crawford, M; Nana-Sinkam, P; Croce, CM				Garofalo, Michela; Jeon, Young-Jun; Nuovo, Gerard J.; Middleton, Justin; Secchiero, Paola; Joshi, Pooja; Alder, Hansjuerg; Nazaryan, Natalya; Di Leva, Gianpiero; Romano, Giulia; Crawford, Melissa; Nana-Sinkam, Patrick; Croce, Carlo M.			MiR-34a/c-Dependent PDGFR-alpha/beta Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer	PLOS ONE			English	Article							RECEPTOR-TYROSINE-KINASES; GROWTH-FACTOR; COLORECTAL-CANCER; POOR-PROGNOSIS; EXPRESSION; TUMOR; BETA; MUTATIONS; INVASION; TARGETS	Lung cancer is the leading cause of cancer mortality in the world today. Although some advances in lung cancer therapy have been made, patient survival is still poor. MicroRNAs (miRNAs) can act as oncogenes or tumor-suppressor genes in human malignancy. The miR-34 family consists of tumor-suppressive miRNAs, and its reduced expression has been reported in various cancers, including non-small cell lung cancer (NSCLC). In this study, we found that miR-34a and miR-34c target platelet-derived growth factor receptor alpha and beta (PDGFR-alpha and PDGFR-beta), cell surface tyrosine kinase receptors that induce proliferation, migration and invasion in cancer. MiR-34a and miR-34c were downregulated in lung tumors compared to normal tissues. Moreover, we identified an inverse correlation between PDGFR-alpha/beta and miR-34a/c expression in lung tumor samples. Finally, miR-34a/c overexpression or downregulation of PDGFR-alpha/beta by siRNAs, strongly augmented the response to TNF-related apoptosis inducing ligand (TRAIL) while reducing migratory and invasive capacity of NSCLC cells.	[Garofalo, Michela; Jeon, Young-Jun; Nuovo, Gerard J.; Middleton, Justin; Joshi, Pooja; Alder, Hansjuerg; Nazaryan, Natalya; Di Leva, Gianpiero; Romano, Giulia; Croce, Carlo M.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Nuovo, Gerard J.] Phylogeny Inc, Columbus, OH USA; [Secchiero, Paola] Univ Ferrara, Human Anat Sect, Dept Morphol & Embryol, I-44100 Ferrara, Italy; [Crawford, Melissa; Nana-Sinkam, Patrick] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Ferrara; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Garofalo, M (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	michela.garofalo@osumc.edu; carlo.croce@osumc.edu	secchiero, paola/G-9689-2015; Young, Richard A/F-6495-2012	secchiero, paola/0000-0003-4101-7987; Young, Richard A/0000-0001-8855-8647; , Pooja/0000-0002-1415-1251; Jeon, Young-Jun/0000-0002-5998-9605	National Institutes of Health [CA152758]; Ohio State University Targeted Investment in Excellence Award; Kimmel Scholar Award; NATIONAL CANCER INSTITUTE [U01CA166905] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University Targeted Investment in Excellence Award(Ohio State University); Kimmel Scholar Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health CA152758. The authors are grateful for research support from The Ohio State University Targeted Investment in Excellence Award. MG is a recipient of the Kimmel Scholar Award 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annibali D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040269; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chim CS, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-197; Corless CL, 2005, J CLIN ONCOL, V23, P5357, DOI 10.1200/JCO.2005.14.068; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Dierov J, 2002, BLOOD, V99, P1758, DOI 10.1182/blood.V99.5.1758; Donnem T, 2008, J THORAC ONCOL, V3, P963, DOI 10.1097/JTO.0b013e3181834f52; Feng H, 2012, ONCOGENE, V31, P2691, DOI 10.1038/onc.2011.436; Garofalo M, 2012, NAT MED, V18, P74, DOI 10.1038/nm.2577; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; GAZIT A, 1984, CELL, V39, P89, DOI 10.1016/0092-8674(84)90194-6; Gompelmann D, 2011, RESPIRATION, V82, P111, DOI 10.1159/000329703; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Kaller M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010462; Kim Y, 2012, GENE DEV, V26, P1247, DOI 10.1101/gad.193565.112; Lehman HL, 2012, MOL CANCER RES, V10, P1306, DOI 10.1158/1541-7786.MCR-12-0173; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; Mahalingam D, 2011, CURR DRUG TARGETS, V12, P2079, DOI 10.2174/138945011798829357; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Nishimura J, 2012, ONCOL REP, V28, P2221, DOI 10.3892/or.2012.2059; Nuovo GJ, 2009, NAT PROTOC, V4, P107, DOI 10.1038/nprot.2008.215; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; ROSS R, 1986, CELL, V46, P155, DOI 10.1016/0092-8674(86)90733-6; Rossi G, 2005, J CLIN ONCOL, V23, P8774, DOI 10.1200/JCO.2005.02.8233; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Saxena NK, 2007, CANCER RES, V67, P2497, DOI 10.1158/0008-5472.CAN-06-3075; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shankar Sharmila, 2008, J Mol Signal, V3, P7, DOI 10.1186/1750-2187-3-7; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Silber J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033844; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Thomas GV, 2006, CURR OPIN GENET DEV, V16, P78, DOI 10.1016/j.gde.2005.12.003; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034210; Wang Z, 2011, CANCER BIOL THER, V11, P490, DOI 10.4161/cbt.11.5.14550; Wu KJ, 2012, CELL SIGNAL, V24, P2273, DOI 10.1016/j.cellsig.2012.08.004; Wu NN, 2011, FEBS J, V278, P2044, DOI 10.1111/j.1742-4658.2011.08120.x; Yamashita S, 2012, ONCOLOGY-BASEL, V82, P205, DOI 10.1159/000336809; Yu JH, 2000, J BIOL CHEM, V275, P19076, DOI 10.1074/jbc.M910329199	44	83	88	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67581	10.1371/journal.pone.0067581	http://dx.doi.org/10.1371/journal.pone.0067581			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805317	Green Submitted, Green Published, gold			2022-12-25	WOS:000320846500145
J	Napoleon, C; Raimbault, V; Claquin, P				Napoleon, Camille; Raimbault, Virginie; Claquin, Pascal			Influence of Nutrient Stress on the Relationships between PAM Measurements and Carbon Incorporation in Four Phytoplankton Species	PLOS ONE			English	Article							PHOTOSYNTHETIC ELECTRON-TRANSPORT; REPETITION-RATE FLUOROMETRY; MARINE-PHYTOPLANKTON; DUNALIELLA-TERTIOLECTA; PHOTOSYSTEM-II; FLUORESCENCE MEASUREMENTS; CHLOROPHYLL FLUORESCENCE; INORGANIC PHOSPHORUS; PRIMARY PRODUCTIVITY; OXYGEN EVOLUTION	Two methods of measuring primary production, modulated fluorimetry (PAM) and the traditional carbon incorporation method (C-13), were compared in four phytoplankton species, two diatoms (Pseudo-nitzschia pungens and Asterionellopsis glacialis), and two dinoflagellates (Heterocapsa sp and Karenia mikimotoi), under N (nitrogen), P (phosphorus) and Si (silicon) limited semi-continuous culture. N and Si-limited cultures showed relatively high quantum efficiency of the PSII (F-v/F-m) values, confirming that F-v/F-m is not a good proxy for nutrient stress in balanced systems, whereas P limitation had a drastic effect on many physiological parameters. In all species, the physiological capacity of phytoplankton cells to acclimate to nutrient limitations led to changes in the cellular biochemical composition and the structure of the photosynthetic apparatus. The observed physiological responses were species and nutrient specific. The values of the chlorophyll-specific absorption cross section (a*) increased with nutrient limitation due to package effect, while the carbon/Chl a ratio was higher under N and P limitations. In diatoms, Si limitation did not affect photosynthesis confirming the uncoupling between Si and carbon metabolisms. In all four species and under all treatments, significant relationships were found between photosynthetic activities, ETRChl (electron transport rate) and P-Chl (carbon fixation rate) estimated using PAM measurements and C-13 incorporation, showing that the fluorescence technique can reliably be used to estimate carbon fixation by phytoplankton. The relationship between ETRChl and P-Chl can be described by the shape and the slope of the curve (Phi(C.e)). Linear relationships were found for dinoflagellates and P. pungens under all treatments. A decrease in Phi(C.e). was observed under N and P limitation probably due to structural damage to the photosynthetic apparatus. A. glacialis showed a logarithmic relationship in N and P limited conditions, due to the alternative electron flow which takes place to optimise photosynthetic performances under high light and/or nutrient stress.	[Napoleon, Camille; Raimbault, Virginie; Claquin, Pascal] Univ Caen Basse Normandie, BIOMEA CNRS FRE3484, Caen, France; [Napoleon, Camille; Raimbault, Virginie; Claquin, Pascal] CNRS INEE, BIOMEA FRE3484, Caen, France; [Napoleon, Camille] IFREMER, Lab Environm Ressources Normandie, Port En Bessin, France	Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer	Claquin, P (corresponding author), Univ Caen Basse Normandie, BIOMEA CNRS FRE3484, Caen, France.	pascal.claquin@unicaen.fr		Claquin, Pascal/0000-0002-5183-203X	European project Interreg 4a CHannel Integrated Approach for Marine Resource Management 3 (CHARM3)	European project Interreg 4a CHannel Integrated Approach for Marine Resource Management 3 (CHARM3)	This study was supported by the European project Interreg 4a CHannel Integrated Approach for Marine Resource Management 3 (CHARM3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MX, 2003, FEBS LETT, V537, P128, DOI 10.1016/S0014-5793(03)00109-1; [Anonymous], 1975, CULTURE MARINE INVER; BABIN M, 1994, LIMNOL OCEANOGR, V39, P694, DOI 10.4319/lo.1994.39.3.0694; Barranguet C, 2000, MAR ECOL PROG SER, V204, P39, DOI 10.3354/meps204039; Beardall J, 1996, PHOTOSYNTHESIS LIGHT, P435; Behrenfeld MJ, 2004, J PHYCOL, V40, P4, DOI 10.1046/j.1529-8817.2004.03083.x; BRZEZINSKI MA, 1985, J PHYCOL, V21, P347; Claquin P, 2005, MAR BIOL, V146, P877, DOI 10.1007/s00227-004-1493-5; Claquin P, 2002, J PHYCOL, V38, P922, DOI 10.1046/j.1529-8817.2002.t01-1-01220.x; Claquin P, 2008, AQUAT MICROB ECOL, V51, P1, DOI 10.3354/ame01187; DUBINSKY Z, 1986, PLANT CELL PHYSIOL, V27, P1335, DOI 10.1093/oxfordjournals.pcp.a077232; EILERS PHC, 1988, ECOL MODEL, V42, P199, DOI 10.1016/0304-3800(88)90057-9; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Flameling IA, 1998, LIMNOL OCEANOGR, V43, P284, DOI 10.4319/lo.1998.43.2.0284; Geel C, 1997, PHOTOSYNTH RES, V51, P61, DOI 10.1023/A:1005779112140; Geider RJ, 1998, EUR J PHYCOL, V33, P315, DOI 10.1080/09670269810001736813; Geider RJ, 1997, MAR ECOL PROG SER, V148, P187, DOI 10.3354/meps148187; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gilbert M, 2000, PHOTOSYNTHETICA, V38, P111, DOI 10.1023/A:1026708327185; Guerrini F, 2000, J PHYCOL, V36, P882, DOI 10.1046/j.1529-8817.2000.99070.x; HAMA T, 1983, MAR BIOL, V73, P31, DOI 10.1007/BF00396282; Hancke K, 2008, J PHYCOL, V44, P501, DOI 10.1111/j.1529-8817.2008.00487.x; HEINEKE D, 1989, PLANT PHYSIOL, V91, P221, DOI 10.1104/pp.91.1.221; Johnsen G, 2007, J PHYCOL, V43, P1236, DOI 10.1111/j.1529-8817.2007.00422.x; Juneau P, 2005, PHOTOCHEM PHOTOBIOL, V81, P649, DOI 10.1562/2005-01-13-RA-414.1; Kaiblinger C, 2006, PHOTOSYNTH RES, V88, P19, DOI 10.1007/s11120-005-9018-8; KOLBER Z, 1988, PLANT PHYSIOL, V88, P923, DOI 10.1104/pp.88.3.923; Kromkamp JC, 2008, EUR J PHYCOL, V43, P327, DOI 10.1080/09670260802080895; Kromkamp JC, 2003, EUR J PHYCOL, V38, P103, DOI 10.1080/0967026031000094094; Kruskopf M, 2006, NEW PHYTOL, V169, P525, DOI 10.1111/j.1469-8137.2005.01601.x; LAROCHE J, 1993, J PHYCOL, V29, P767; Lefebvre S, 2007, J PHOTOCH PHOTOBIO B, V86, P131, DOI 10.1016/j.jphotobiol.2006.08.012; Lippemeier S, 1999, J PLANKTON RES, V21, P269, DOI 10.1093/plankt/21.2.269; Lippemeier S, 2001, EUR J PHYCOL, V36, P89, DOI 10.1017/S0967026201003031; Lynn SG, 2000, J PHYCOL, V36, P510, DOI 10.1046/j.1529-8817.2000.98251.x; Marchetti A, 2006, DEEP-SEA RES PT II, V53, P2131, DOI 10.1016/j.dsr2.2006.05.032; Martin-Jezequel V, 2000, J PHYCOL, V36, P821, DOI 10.1046/j.1529-8817.2000.00019.x; Masojidek J, 2001, J PLANKTON RES, V23, P57, DOI 10.1093/plankt/23.1.57; Morris EP, 2003, EUR J PHYCOL, V38, P133, DOI 10.1080/0967026031000085832; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Napoleon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040284; Napoleon C, 2012, J SEA RES, V69, P43, DOI 10.1016/j.seares.2012.01.005; Nielsen E.S., 1952, ICES J MAR SCI, V18, P117; Nogales J, 2012, P NATL ACAD SCI USA, V109, P2678, DOI 10.1073/pnas.1117907109; Pannard A, 2008, ESTUAR COAST SHELF S, V80, P212, DOI 10.1016/j.ecss.2008.08.008; Parkhill JP, 2001, J PHYCOL, V37, P517, DOI 10.1046/j.1529-8817.2001.037004517.x; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Petrou K, 2008, J PHYCOL, V44, P1204, DOI 10.1111/j.1529-8817.2008.00585.x; PREZELIN BB, 1980, MAR BIOL, V58, P85, DOI 10.1007/BF00396119; Redfield A. C, 1963, SEA, P26, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; Rochaix JD, 2011, BBA-BIOENERGETICS, V1807, P878, DOI 10.1016/j.bbabio.2011.05.009; Rychter A., 2005, HDB PHOTOSYNTHESIS, V2nd ed., DOI [10.1201/9781420027877.ch7, DOI 10.1201/9781420027877.CH7]; SAVIDGE G, 1995, DEEP-SEA RES PT I, V42, P599, DOI 10.1016/0967-0637(95)00016-Y; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Spijkerman E, 2010, J PHYCOL, V46, P658, DOI 10.1111/j.1529-8817.2010.00859.x; Wang ZC, 2010, HARMFUL ALGAE, V9, P613, DOI 10.1016/j.hal.2010.04.012; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Wykoff DD, 1998, PLANT PHYSIOL, V117, P129, DOI 10.1104/pp.117.1.129; Young EB, 2003, J PHYCOL, V39, P897, DOI 10.1046/j.1529-8817.2003.03042.x	59	40	42	3	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66423	10.1371/journal.pone.0066423	http://dx.doi.org/10.1371/journal.pone.0066423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805221	Green Published, gold, Green Submitted			2022-12-25	WOS:000320846500049
J	Shin, SW; Park, JS; Park, CS				Shin, Seung-Woo; Park, Jong Sook; Park, Choon-Sik			Elevation of Eosinophil-Derived Neurotoxin in Plasma of the Subjects with Aspirin-Exacerbated Respiratory Disease: A Possible Peripheral Blood Protein Biomarker	PLOS ONE			English	Article							ASSOCIATION ANALYSIS; GENE POLYMORPHISMS; GRANULE PROTEINS; ASTHMA; INTOLERANCE; HYPERSENSITIVITY; SENSITIVITY; SEVERITY; DRUGS	Aspirin-exacerbated respiratory disease (AERD) remains widely underdiagnosed in asthmatics, primarily due to insufficient awareness of the relationship between aspirin ingestion and asthma exacerbation. The identification of aspirin hypersensitivity is therefore essential to avoid serious aspirin complications. The goal of the study was to develop plasma biomarkers to predict AERD. We identified differentially expressed genes in peripheral blood mononuclear cells (PBMC) between subjects with AERD and those with aspirin-tolerant asthma (ATA). The genes were matched with the secreted protein database (http://spd.cbi.pku.edu.cn/) to select candidate proteins in the plasma. Plasma levels of the candidate proteins were then measured in AERD (n = 40) and ATA (n = 40) subjects using an enzyme-linked immunosorbent assay (ELISA). Target genes were validated as AERD biomarkers using an ROC curve analysis. From 175 differentially expressed genes (p-value < 0.0001) that were queried to the secreted protein database, 11 secreted proteins were retrieved. The gene expression patterns were predicted as elevated for 7 genes and decreased for 4 genes in AERD as compared with ATA subjects. Among these genes, significantly higher levels of plasma eosinophil-derived neurotoxin (RNASE2) were observed in AERD as compared with ATA subjects (70(14.62 similar to 311.92) mu g/ml vs. 12(2.55 similar to 272.84) mu g/ml, p-value <0.0003). Based on the ROC curve analysis, the AUC was 0.74 (p-value = 0.0001, asymptotic 95% confidence interval [ lower bound: 0.62, upper bound: 0.83]) with 95% sensitivity, 60% specificity, and a cut-off value of 27.15 mu g/ml. Eosinophil-derived neurotoxin represents a novel biomarker to distinguish AERD from ATA.	[Shin, Seung-Woo; Park, Jong Sook; Park, Choon-Sik] Soonchunhyang Univ, Bucheon Hosp, Div Allergy & Resp Med, Genome Res Ctr Allergy & Resp Dis, Puchon, Gyunggi Do, South Korea	Soonchunhyang University	Park, CS (corresponding author), Soonchunhyang Univ, Bucheon Hosp, Div Allergy & Resp Med, Genome Res Ctr Allergy & Resp Dis, Puchon, Gyunggi Do, South Korea.	mdcspark@unitel.co.kr		Park, Choon-Sik/0000-0003-2977-0255	Soonchunhynahg University	Soonchunhynahg University	This work was supported by a grant from Soonchunhynahg University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUGHAZALEH RI, 1992, J LEUKOCYTE BIOL, V52, P611, DOI 10.1002/jlb.52.6.611; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Chang HS, 2011, ALLERGY ASTHMA IMMUN, V3, P256, DOI 10.4168/aair.2011.3.4.256; Chen YJ, 2005, NUCLEIC ACIDS RES, V33, pD169; De Weck AL, 2010, J INVEST ALLERG CLIN, V20, P39; Devouassoux G, 2008, ALLERGY, V63, P125, DOI 10.1111/j.1398-9995.2007.01558.x; DURACK DT, 1981, P NATL ACAD SCI-BIOL, V78, P5165, DOI 10.1073/pnas.78.8.5165; DURACK DT, 1979, P NATL ACAD SCI USA, V76, P1443, DOI 10.1073/pnas.76.3.1443; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; FUKUDA T, 1985, AM REV RESPIR DIS, V132, P981; Gollapudi RR, 2004, JAMA-J AM MED ASSOC, V292, P3017, DOI 10.1001/jama.292.24.3017; HAMANN KJ, 1987, J PARASITOL, V73, P523, DOI 10.2307/3282130; HAMANN KJ, 1990, J IMMUNOL, V144, P3166; Kim BS, 2010, PHARMACOGENET GENOM, V20, P748, DOI 10.1097/FPC.0b013e3283402155; Kim SH, 2005, CLIN EXP ALLERGY, V35, P585, DOI 10.1111/j.1365-2222.2005.02220.x; Kim TH, 2008, CLIN EXP ALLERGY, V38, P1727, DOI 10.1111/j.1365-2222.2008.03082.x; Lee RU, 2011, ALLERGY ASTHMA IMMUN, V3, P3, DOI 10.4168/aair.2011.3.1.3; Lee SH, 2006, AM J RESP CRIT CARE, V173, P370, DOI 10.1164/rccm.200505-740OC; Lee SH, 2011, ALLERGY ASTHMA IMMUN, V3, P236, DOI 10.4168/aair.2011.3.4.236; MARQUETTE CH, 1992, AM REV RESPIR DIS, V146, P76, DOI 10.1164/ajrccm/146.1.76; Mascia K, 2005, ANN ALLERG ASTHMA IM, V94, P652, DOI 10.1016/S1081-1206(10)61323-3; Mascia K, 2005, J ALLERGY CLIN IMMUN, V116, P970, DOI 10.1016/j.jaci.2005.08.035; Min JW, 2005, CHEST, V128, P3127, DOI 10.1378/chest.128.5.3127; Motojima S, 1995, Arerugi, V44, P1272; Nizankowska-Mogilnicka E, 2007, ALLERGY, V62, P1111, DOI 10.1111/j.1398-9995.2007.01409.x; Oh SH, 2009, ALLERGY ASTHMA IMMUN, V1, P30, DOI 10.4168/aair.2009.1.1.30; Park JS, 2005, PHARMACOGENET GENOM, V15, P483, DOI 10.1097/01.fpc.0000166456.84905.a0; PICADO C, 1989, EUR RESPIR J, V2, P127; Sanak M, 2004, CLIN EXP ALLERGY, V34, P1899, DOI 10.1111/j.1365-2222.2004.02123.x; Shin S, 2012, MOL GENET GENOMICS, V287, P361, DOI 10.1007/s00438-012-0685-9; SLIFMAN NR, 1986, J IMMUNOL, V137, P2913; Stevenson DD, 2001, ANN ALLERG ASTHMA IM, V87, P177, DOI 10.1016/S1081-1206(10)62221-1; Szczeklik A, 2000, EUR RESPIR J, V16, P432, DOI 10.1034/j.1399-3003.2000.016003432.x; Williams AN, 2007, J ALLERGY CLIN IMMUN, V120, P273, DOI 10.1016/j.jaci.2007.03.020	36	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66644	10.1371/journal.pone.0066644	http://dx.doi.org/10.1371/journal.pone.0066644			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805255	Green Published, gold, Green Submitted			2022-12-25	WOS:000320846500083
J	Zhang, YM; Gao, B; Wang, JJ; Sun, XD; Liu, XW				Zhang, Yu-ming; Gao, Bo; Wang, Juan-juan; Sun, Xu-de; Liu, Xi-wen			Effect of Hypotensive Resuscitation with a Novel Combination of Fluids in a Rabbit Model of Uncontrolled Hemorrhagic Shock	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; HYPERTONIC SALINE; LUNG INJURY; INFLAMMATORY RESPONSE; HYPOVOLEMIC SHOCK; OXIDATIVE STRESS; TRAUMA; RATS; STRATEGIES; PREVENTS	Objective: The aim of this study was to compare the effects of hypotensive and normotensive resuscitation with a novel combination of fluids via lactate Ringer's solution (LRS), 6% hydroxyethyl starch 130/0.4 solution (HES), and 7.5% hypertonic saline solution (HSS) at early stage of uncontrolled hemorrhagic shock (UHS) before hemostasis. Methods: New Zealand white rabbits (n = 32) underwent UHS by transecting the splenic parenchyma, followed by blood withdrawal via the femoral artery to target mean arterial pressure (MAP) of 40-45 mmHg. Animals were distributed randomly into 4 groups (n = 8): in group Sham, sham operation was performed; in group HS, UHS was untreated; in group HS-HR, UHS was treated by hypotensive resuscitation with HSS and LRS+HES (ratio of 2:1) to MAP of 50-55 mmHg; in group HS-NR, UHS was treated by normotensive resuscitation with HSS and LRS+HES (ratio of 2:1) to MAP of 75-80 mmHg. Outcomes of hemodynamics, inflammatory and oxidative response, and other metabolic variables were measured and the histopathological studies of heart, lung and kidney were performed at the end of resusucitation. Results: Hypotensive resuscitation with the novel combination of fluids for UHS rabbits decreased blood loss, maintained better stabilization of hemodynamics, and resulted in relatively higher hematocrit and platelet count, superior outcomes of blood gas, and lower plasma lactate concentration. Besides, hypotensive resuscitation attenuated the inflammatory and oxidative response significantly in UHS rabbits. Conclusion: Hypotensive resuscitation with the novel combination of fluids via HSS and LRS+HES (ratio of 2:1) has an effective treatment at early stage of UHS before hemostasis.	[Zhang, Yu-ming; Sun, Xu-de] Fourth Mil Med Univ, Tangdu Hosp, Dept Anesthesiol, Xian 710032, Peoples R China; [Wang, Juan-juan] Yanan Univ, Affiliated Hosp, Dept Surg, Yanan, Peoples R China; [Gao, Bo] Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped Surg, Xian 710032, Peoples R China; [Liu, Xi-wen] Fourth Mil Med Univ, Dept Nursing, Xian 710032, Peoples R China	Air Force Military Medical University; Yanan University; Air Force Military Medical University; Air Force Military Medical University	Sun, XD (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Anesthesiol, Xian 710032, Peoples R China.	sunxude@fmmu.edu.cn; liuwen@fmmu.edu.cn	wang, juanjuan/GYV-5540-2022; liu, xiwen/GSJ-3861-2022		Army Medical Health Research Fund of China [08G109]	Army Medical Health Research Fund of China	This study was supported by the Army Medical Health Research Fund of China 08G109. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahrami S, 2006, SHOCK, V25, P283, DOI 10.1097/01.shk.0000208808.03148.ea; Beer KAS, 2013, JAVMA-J AM VET MED A, V242, P54, DOI 10.2460/javma.242.1.54; Bulger EM, 2008, ARCH SURG-CHICAGO, V143, P139, DOI 10.1001/archsurg.2007.41; Bulger EM, 2007, ANN SURG, V245, P635, DOI 10.1097/01.sla.0000251367.44890.ae; Catrambone JE, 2008, EUR J TRAUMA EMERG S, V34, P397, DOI 10.1007/s00068-007-7068-7; Cherkas David, 2011, Emerg Med Pract, V13, P1; Cotton BA, 2006, SHOCK, V26, P115, DOI 10.1097/01.shk.0000209564.84822.f2; Crimi E, 2006, AM J RESP CRIT CARE, V174, P178, DOI 10.1164/rccm.200507-1178OC; DEFELIPPE J, 1980, LANCET, V2, P1002; Frithiof R, 2011, AM J PHYSIOL-HEART C, V300, pH685, DOI 10.1152/ajpheart.00930.2010; Gecit I, 2011, BIOL TRACE ELEM RES, V144, P1069, DOI 10.1007/s12011-011-9124-8; Hashiguchi N, 2007, J TRAUMA, V62, P299, DOI 10.1097/01.ta.0000222956.88760.33; Hatanaka E, 2007, SHOCK, V27, P32, DOI 10.1097/01.shk.0000238061.69579.a5; Hauser CJ, 2005, SHOCK, V24, P24, DOI 10.1097/01.shk.0000191387.18818.43; Hussmann B, 2011, UNFALLCHIRURG, V114, P705, DOI 10.1007/s00113-010-1842-4; James MFM, 2011, BRIT J ANAESTH, V107, P693, DOI 10.1093/bja/aer229; Klein CL, 2008, KIDNEY INT, V74, P901, DOI 10.1038/ki.2008.314; Li T, 2011, J SURG RES, V169, P76, DOI 10.1016/j.jss.2010.02.001; Li T, 2011, ANESTHESIOLOGY, V114, P111, DOI 10.1097/ALN.0b013e3181fe3fe7; Matsuoka T, 1996, J TRAUMA, V40, P915, DOI 10.1097/00005373-199606000-00009; Montassier E, 2012, AM J EMERG MED, V30, P184, DOI 10.1016/j.ajem.2010.09.033; Moran A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021449; MORITA H, 1987, J AUTONOM NERV SYST, V20, P57, DOI 10.1016/0165-1838(87)90081-6; Morrison CA, 2011, J TRAUMA, V70, P652, DOI 10.1097/TA.0b013e31820e77ea; Park Marcelo, 2006, Clinics, V61, P47, DOI 10.1590/S1807-59322006000100009; Perkins JG, 2009, J TRAUMA, V66, pS77, DOI 10.1097/TA.0b013e31819d8936; Rossaint R, 2010, CRIT CARE, V14, DOI 10.1186/cc8943; Santry HP, 2010, SHOCK, V33, P229, DOI 10.1097/SHK.0b013e3181c30f0c; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Shah SK, 2011, J SURG RES, V166, P120, DOI 10.1016/j.jss.2009.09.010; Solomonov E, 2000, CRIT CARE MED, V28, P749, DOI 10.1097/00003246-200003000-00024; Wang PF, 2009, INT IMMUNOPHARMACOL, V9, P347, DOI 10.1016/j.intimp.2008.12.014; Watters JM, 2006, J TRAUMA, V61, P75, DOI 10.1097/01.ta.0000222723.54559.47; White NJ, 2010, RESUSCITATION, V81, P111, DOI 10.1016/j.resuscitation.2009.09.017; White SA, 1997, ANAESTHESIA, V52, P422, DOI 10.1111/j.1365-2044.1997.090-az0082.x; Wohlauer M, 2012, CRIT CARE MED, V40, P2647, DOI 10.1097/CCM.0b013e3182592006; Wu BU, 2011, CLIN GASTROENTEROL H, V9, P710, DOI 10.1016/j.cgh.2011.04.026; Yu GF, 2012, PULM PHARMACOL THER, V25, P27, DOI 10.1016/j.pupt.2011.10.003; Yu YH, 2009, RESUSCITATION, V80, P1424, DOI 10.1016/j.resuscitation.2009.08.024	40	5	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66916	10.1371/journal.pone.0066916	http://dx.doi.org/10.1371/journal.pone.0066916			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805284	Green Published, gold, Green Submitted			2022-12-25	WOS:000320846500112
J	Lapins, M; Worachartcheewan, A; Spjuth, O; Georgiev, V; Prachayasittikul, V; Nantasenamat, C; Wikberg, JES				Lapins, Maris; Worachartcheewan, Apilak; Spjuth, Ola; Georgiev, Valentin; Prachayasittikul, Virapong; Nantasenamat, Chanin; Wikberg, Jarl E. S.			A Unified Proteochemometric Model for Prediction of Inhibition of Cytochrome P450 Isoforms	PLOS ONE			English	Article							BIOCLIPSE; ENZYMES; QSAR	A unified proteochemometric (PCM) model for the prediction of the ability of drug-like chemicals to inhibit five major drug metabolizing CYP isoforms (i.e. CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4) was created and made publicly available under the Bioclipse Decision Support open source system at www.cyp450model.org. In regards to the proteochemometric modeling we represented the chemical compounds by molecular signature descriptors and the CYP-isoforms by alignment-independent description of composition and transition of amino acid properties of their protein primary sequences. The entire training dataset contained 63 391 interactions and the best PCM model was obtained using signature descriptors of height 1, 2 and 3 and inducing the model with a support vector machine. The model showed excellent predictive ability with internal AUC = 0.923 and an external AUC = 0.940, as evaluated on a large external dataset. The advantage of PCM models is their extensibility making it possible to extend our model for new CYP isoforms and polymorphic CYP forms. A key benefit of PCM is that all proteins are confined in one single model, which makes it generally more stable and predictive as compared with single target models. The inclusion of the model in Bioclipse Decision Support makes it possible to make virtual instantaneous predictions (similar to 100 ms per prediction) while interactively drawing or modifying chemical structures in the Bioclipse chemical structure editor.	[Lapins, Maris; Spjuth, Ola; Georgiev, Valentin; Wikberg, Jarl E. S.] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden; [Worachartcheewan, Apilak; Nantasenamat, Chanin] Mahidol Univ, Ctr Data Min & Biomed Informat, Fac Med Technol, Bangkok 10700, Thailand; [Worachartcheewan, Apilak; Prachayasittikul, Virapong; Nantasenamat, Chanin] Mahidol Univ, Dept Clin Microbiol & Appl Technol, Fac Med Technol, Bangkok 10700, Thailand	Uppsala University; Mahidol University; Mahidol University	Wikberg, JES (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden.	jarl.wikberg@farmbio.uu.se	Nantasenamat, Chanin/AAD-1032-2019; Spjuth, Ola/Q-2638-2019	Nantasenamat, Chanin/0000-0003-1040-663X; Spjuth, Ola/0000-0002-8083-2864; Lapins, Maris/0000-0002-0122-6680; Prachayasittikul, Virapong/0000-0001-7942-1083; Georgiev, Valentin/0000-0002-6064-2684	Swedish Research Links programme [C0610701]; Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative; SNIC-UPPMAX	Swedish Research Links programme; Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative; SNIC-UPPMAX	JESW and CN were supported by a joint grant from the Swedish Research Links programme (no. C0610701). The research was also supported in part by the Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative. Computations were carried out at Uppsala Multidisciplinary Center for Advanced Computational Science (SNIC-UPPMAX) by support of a grant from SNIC-UPPMAX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng FX, 2011, J CHEM INF MODEL, V51, P996, DOI 10.1021/ci200028n; DUBCHAK I, 1995, P NATL ACAD SCI USA, V92, P8700, DOI 10.1073/pnas.92.19.8700; Faulon JL, 2003, J CHEM INF COMP SCI, V43, P707, DOI 10.1021/ci020345w; Hall M., 2009, SIGKDD EXPLOR, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Ingelman-Sundberg M, 2004, N-S ARCH PHARMACOL, V369, P89, DOI 10.1007/s00210-003-0819-z; Kontijevskis A, 2008, J CHEM INF MODEL, V48, P1840, DOI 10.1021/ci8000953; Kumar V, 2006, DRUG METAB DISPOS, V34, P1966, DOI 10.1124/dmd.106.010926; Lapins M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-339; Lapins M, 2009, J CHEM INF MODEL, V49, P1202, DOI 10.1021/ci800453k; Lapinsh M, 2001, BBA-GEN SUBJECTS, V1525, P180, DOI 10.1016/S0304-4165(00)00187-2; Lapinsh M, 2005, BIOINFORMATICS, V21, P4289, DOI 10.1093/bioinformatics/bti703; Lapinsh M, 2003, J MED CHEM, V46, P2572, DOI 10.1021/jm020945m; Lewis DFV, 2010, EXPERT OPIN DRUG MET, V6, P661, DOI 10.1517/17425251003674380; Li ZR, 2006, NUCLEIC ACIDS RES, V34, pW32, DOI 10.1093/nar/gkl305; Novotarskyi S, 2011, J CHEM INF MODEL, V51, P1271, DOI 10.1021/ci200091h; Obach RS, 2006, J PHARMACOL EXP THER, V316, P336, DOI 10.1124/jpet.105.093229; Pelkonen O, 2008, ARCH TOXICOL, V82, P667, DOI 10.1007/s00204-008-0332-8; Pinto N, 2011, CURR DRUG METAB, V12, P487, DOI 10.2174/138920011795495321; Singh D, 2011, DRUG DISCOV TODAY, V16, P793, DOI 10.1016/j.drudis.2011.08.003; Spjuth O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-59; Spjuth O, 2013, BIOINFORMATICS, V29, P286, DOI 10.1093/bioinformatics/bts681; Spjuth O, 2011, J CHEM INF MODEL, V51, P1840, DOI 10.1021/ci200242c; Spjuth O, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-397; Vapnik V., 1998, STAT LEARNING THEORY; Vasanthanathan P, 2009, DRUG METAB DISPOS, V37, P658, DOI 10.1124/dmd.108.023507; Veith H, 2009, NAT BIOTECHNOL, V27, P1050, DOI 10.1038/nbt.1581; Wang YP, 2012, NUCLEIC ACIDS RES, V40, DOI [10.1093/nar/gkr1293, 10.1093/nar/gkr1132]; Wikberg JE., 2012, COMPUTATIONAL APPROA, P57; Wikberg JES, 2011, INTRO PHARM BIOINFOR	29	39	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66566	10.1371/journal.pone.0066566	http://dx.doi.org/10.1371/journal.pone.0066566			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799117	gold, Green Published			2022-12-25	WOS:000321397800038
J	Morroni, M; Marzioni, D; Ragno, M; Di Bella, P; Cartechini, E; Pianese, L; Lorenzi, T; Castellucci, M; Scarpelli, M				Morroni, Manrico; Marzioni, Daniela; Ragno, Michele; Di Bella, Paolo; Cartechini, Elisabetta; Pianese, Luigi; Lorenzi, Teresa; Castellucci, Mario; Scarpelli, Marina			Role of Electron Microscopy in the Diagnosis of Cadasil Syndrome: A Study of 32 Patients	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT ARTERIOPATHY; SUBCORTICAL INFARCTS; NOTCH3 MUTATIONS; SKIN BIOPSY; LEUKOENCEPHALOPATHY CADASIL; RENAL INVOLVEMENT; VASCULAR CHANGES; ITALIAN PATIENTS; MUSCLE; LESIONS	Background and Purpose: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is caused by NOTCH3 gene mutations that result in vascular smooth muscle cell (VSMC) degeneration. Its distinctive feature by electron microscopy (EM) is granular osmiophilic material (GOM) detected in VSMC indentations and/or the extracellular space close to VSMCs. Reports of the sensitivity of EM in detecting GOM in biopsies from CADASIL patients are contradictory. We present data from 32 patients clinically suspected to have CADASIL and discuss the role of EM in its diagnosis in this retrospective study. Methods: Skin, skeletal muscle, kidney and pericardial biopsies were examined by EM; the NOTCH3 gene was screened for mutations. Skin and muscle biopsies from 12 patients without neurological symptoms served as controls. Results and Discussion: All GOM-positive patients exhibited NOTCH3 mutations and vice versa. This study i) confirms that EM is highly specific and sensitive for CADASIL diagnosis; ii) extends our knowledge of GOM distribution in tissues where it has never been described, e.g. pericardium; iii) documents a novel NOTCH3 mutation in exon 3; and iv) shows that EM analysis is critical to highlight the need for comprehensive NOTCH3 analysis. Our findings also confirm the genetic heterogeneity of CADASIL in a small Italian subpopulation and emphasize the difficulties in designing algorithms for molecular diagnosis.	[Morroni, Manrico; Marzioni, Daniela; Lorenzi, Teresa; Castellucci, Mario] Univ Politecn Marche, Sch Med, Sect Anat, Dept Expt & Clin Med, Ancona, Italy; [Morroni, Manrico] United Hosp, Electron Microscopy Unit, Ancona, Italy; [Ragno, Michele] Azienda Sanit Unica Reg, Mazzoni Hosp, Div Neurol, Ascoli Piceno, Italy; [Di Bella, Paolo] Univ Politecn Marche, United Hosp, Sch Med, Dept Neurosci, Ancona, Italy; [Cartechini, Elisabetta] Azienda Sanit Unica Reg, Macerata Hosp, Div Neurol, Macerata, Italy; [Pianese, Luigi] Azienda Sanit Unica Reg, Mazzoni Hosp, Mol Med Lab, Ascoli Piceno, Italy; [Scarpelli, Marina] Univ Politecn Marche, Dept Biomed Sci & Publ Hlth, Sect Pathol Anat, Sch Med,United Hosp, Ancona, Italy	Marche Polytechnic University; Marche Polytechnic University; Marche Polytechnic University	Morroni, M (corresponding author), Univ Politecn Marche, Sch Med, Sect Anat, Dept Expt & Clin Med, Ancona, Italy.	m.morroni@univpm.it; d.marzioni@univpm.it		Lorenzi, Teresa/0000-0002-3723-5378	Universita Politecnica delle Marche	Universita Politecnica delle Marche	The study was supported by a grant from Universita Politecnica delle Marche (2011 FAR, formerly 60%) to M.M. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUDRIMONT M, 1993, STROKE, V24, P122, DOI 10.1161/01.STR.24.1.122; Bergmann M, 1996, ACTA NEUROPATHOL, V92, P341, DOI 10.1007/s004010050528; Brulin P, 2002, ACTA NEUROPATHOL, V104, P241, DOI 10.1007/s00401-002-0530-z; Cappelli A, 2009, NEUROSCI LETT, V462, P176, DOI 10.1016/j.neulet.2009.06.087; Chabriat H, 1998, NEUROLOGY, V51, P452, DOI 10.1212/WNL.51.2.452; CHABRIAT H, 1995, LANCET, V346, P934, DOI 10.1016/S0140-6736(95)91557-5; Dichgans M, 2002, STROKE, V33, P67, DOI 10.1161/hs0102.100885; Dotti MT, 2005, J NEUROL NEUROSUR PS, V76, P736, DOI 10.1136/jnnp.2004.048207; Ebke M, 1997, ACTA NEUROL SCAND, V95, P351, DOI 10.1111/j.1600-0404.1997.tb00224.x; Goebel HH, 1997, MUSCLE NERVE, V20, P625, DOI 10.1002/(SICI)1097-4598(199705)20:5<625::AID-MUS17>3.0.CO;2-V; Guerrot D, 2008, AM J KIDNEY DIS, V52, P340, DOI 10.1053/j.ajkd.2008.04.017; Gustavsen WR, 2006, EUR J NEUROL, V13, P359, DOI 10.1111/j.1468-1331.2006.01243.x; Haritoglou C, 2004, AM J OPHTHALMOL, V138, P302, DOI 10.1016/j.ajo.2004.02.073; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Joutel A, 2001, LANCET, V358, P2049, DOI 10.1016/S0140-6736(01)07142-2; Joutel A, 1997, LANCET, V350, P1511, DOI 10.1016/S0140-6736(97)08083-5; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Joutel A, 2011, BIOESSAYS, V33, P73, DOI 10.1002/bies.201000093; Kalimo H, 2002, BRAIN PATHOL, V12, P371; Kusaba T, 2007, CLIN NEPHROL, V67, P182; Malandrini A, 2007, NEUROLOGY, V68, P1430, DOI 10.1212/01.wnl.0000264018.46335.c8; Markus HS, 2002, NEUROLOGY, V59, P1134, DOI 10.1212/WNL.59.8.1134; Mayer M, 1999, J NEUROL, V246, P526, DOI 10.1007/s004150050398; Miao Q, 2004, BRAIN PATHOL, V14, P358; Oberstein SAJL, 2003, MEDICINE, V82, P251; Oberstein SAJL, 2003, ACTA NEUROPATHOL, V106, P107, DOI 10.1007/s00401-003-0701-6; Ragno M, 2012, HISTOL HISTOPATHOL, V27, P1307, DOI 10.14670/HH-27.1307; Rubio A, 1997, ACTA NEUROPATHOL, V94, P247, DOI 10.1007/s004010050700; Ruchoux MM, 1998, NEUROPATH APPL NEURO, V24, P60; RUCHOUX MM, 1994, STROKE, V25, P2291, DOI 10.1161/01.STR.25.11.2291; RUCHOUX MM, 1995, ACTA NEUROPATHOL, V89, P500; SCHRODER JM, 1995, ACTA NEUROPATHOL, V89, P116, DOI 10.1007/BF00296354; Testi S, 2012, J NEUROL SCI, V319, P37, DOI 10.1016/j.jns.2012.05.025; Tikka S, 2009, BRAIN, V132, P933, DOI 10.1093/brain/awn364; TOURNIERLASSERVE E, 1993, NAT GENET, V3, P256, DOI 10.1038/ng0393-256; van den Boom R, 2002, RADIOLOGY, V224, P791, DOI 10.1148/radiol.2243011123; Wang ZX, 2011, J NEUROL NEUROSUR PS, V82, P534, DOI 10.1136/jnnp.2010.209247	37	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65482	10.1371/journal.pone.0065482	http://dx.doi.org/10.1371/journal.pone.0065482			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799017	Green Published, Green Submitted, gold			2022-12-25	WOS:000321397800009
J	Qi, N; Liu, PP; Zhang, Y; Wu, H; Chen, YM; Han, DS				Qi, Nan; Liu, Peipei; Zhang, Yue; Wu, Hui; Chen, Yongmei; Han, Daishu			Development of a Spontaneous Liver Disease Resembling Autoimmune Hepatitis in Mice Lacking Tyro3, Axl and Mer Receptor Tyrosine Kinases	PLOS ONE			English	Article							TOLL-LIKE-RECEPTORS; INNATE IMMUNE-RESPONSES; TAM RECEPTORS; FAMILY RECEPTORS; ANIMAL-MODELS; CELLS; GAS6; LIPOPOLYSACCHARIDE; IMMUNOBIOLOGY; INFLAMMATION	Autoimmune hepatitis (AIH) is a severe type of chronic liver disease. The lack of appropriate animal models has resulted in a limited understanding regarding the etiology of AIH. Here, we demonstrated that mice deficient in Tyro3, Axl and Mer (TAM) receptor tyrosine kinases (RTKs) developed persistent inflammatory liver damage resembling AIH. Tyro3(-/-) Axl(-/-) Mer(-/-) triple mutant (TAM(-/-)) mice exhibited chronic hepatitis, manifested by progressive appearance of interface hepatitis, immune cell infiltrations and elevated inflammatory cytokine levels in the liver. Accordingly, increased levels of transaminases were observed. Moreover, characteristic autoantibodies and high levels of plasma immunoglobulin G for AIH were detected as TAM(-/-) mice aged. Finally, we provided evidence that the liver damage in TAM(-/-) mice mainly result from bone marrow-derived cells and could be rescued by transplantation of WT bone marrow cells. Results suggest that TAM RTKs play an important role in maintaining immune tolerance of the liver.	[Qi, Nan; Liu, Peipei; Zhang, Yue; Chen, Yongmei; Han, Daishu] Chinese Acad Med Sci, Dept Cell Biol, Inst Basic Med Sci, Sch Basic Med,Peking Union Med Coll, Beijing 100730, Peoples R China; [Qi, Nan] Anhui Med Univ, Dept Biochem & Mol Biol, Sch Basic Med, Hefei, Peoples R China; [Wu, Hui] Navy Gen Hosp, Dept Pathol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Anhui Medical University; Sixth Medical Center of Chinese PLA General Hospital	Han, DS (corresponding author), Chinese Acad Med Sci, Dept Cell Biol, Inst Basic Med Sci, Sch Basic Med,Peking Union Med Coll, Beijing 100730, Peoples R China.	dshan@ibms.pumc.edu.cn			Special Funds for Major State Basic Research Project of China [2007CB947504]; National Supporting Plans of China [2008BAI54B04]; National Natural Science Foundation of China [30971459]	Special Funds for Major State Basic Research Project of China(National Basic Research Program of China); National Supporting Plans of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Special Funds for Major State Basic Research Project of China (Grant No. 2007CB947504), the National Supporting Plans of China (Grant No. 2008BAI54B04) and the National Natural Science Foundation of China (Grant No. 30971459). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amoh Y, 1997, IMMUNOBIOLOGY, V197, P31, DOI 10.1016/S0171-2985(97)80055-1; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Christen U, 2007, AUTOIMMUN REV, V6, P306, DOI 10.1016/j.autrev.2006.04.001; Christen U, 2009, SEMIN LIVER DIS, V29, P262, DOI 10.1055/s-0029-1233536; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; Czaja AJ, 2009, CURR OPIN GASTROEN, V25, P215, DOI 10.1097/MOG.0b013e328324ed06; Czaja MJ, 1989, GROWTH FACTORS, V1, P219, DOI 10.3109/08977198908997998; Deng TT, 2012, IMMUNOLOGY, V135, P40, DOI 10.1111/j.1365-2567.2011.03511.x; Dong ZJ, 2004, WORLD J GASTROENTERO, V10, P1928; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Hafizi S, 2006, CYTOKINE GROWTH F R, V17, P295, DOI 10.1016/j.cytogfr.2006.04.004; Holdener M, 2008, J EXP MED, V205, P1409, DOI 10.1084/jem.20071859; Ichiki Y, 2005, AUTOIMMUN REV, V4, P315, DOI 10.1016/j.autrev.2005.01.005; Iimuro Y, 1997, HEPATOLOGY, V26, P1530; Kunz M, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/979258; KURIKI J, 1983, GASTROENTEROLOGY, V84, P596; Lang KS, 2006, J CLIN INVEST, V116, P2456, DOI 10.1172/JCI28349; Lang KS, 2005, NAT MED, V11, P138, DOI 10.1038/nm1176; Lapierre P, 2004, HEPATOLOGY, V39, P1066, DOI 10.1002/hep.20109; Lemke G, 2003, CURR OPIN IMMUNOL, V15, P31, DOI 10.1016/S0952-7915(02)00016-X; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Lemke G, 2010, ANN NY ACAD SCI, V1209, P23, DOI 10.1111/j.1749-6632.2010.05744.x; Liu Y, 2013, AM J PHYSIOL-GASTR L, V304, pG449, DOI 10.1152/ajpgi.00199.2012; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Manns MP, 2006, HEPATOLOGY, V43, pS132, DOI 10.1002/hep.21059; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Mieli-Vergani G, 2009, J PEDIATR GASTR NUTR, V49, P158, DOI 10.1097/MPG.0b013e3181a1c265; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Pandey S, 2006, IMMUNOL CELL BIOL, V84, P333, DOI 10.1111/j.1440-1711.2006.01444.x; Qingxian Lu, 2010, Front Biol (Beijing), V5, P227; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Sacher T, 2002, EUR J IMMUNOL, V32, P3628, DOI 10.1002/1521-4141(200212)32:12<3628::AID-IMMU3628>3.0.CO;2-E; Sawaki J, 2007, INT IMMUNOL, V19, P311, DOI 10.1093/intimm/dxl148; Schwabe RF, 2006, GASTROENTEROLOGY, V130, P1886, DOI 10.1053/j.gastro.2006.01.038; Seki E, 2001, J IMMUNOL, V166, P2651, DOI 10.4049/jimmunol.166.4.2651; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Shang T, 2011, ENDOCRINOLOGY, V152, P2827, DOI 10.1210/en.2011-0031; SHEN W, 1991, TOXICOL APPL PHARM, V111, P242, DOI 10.1016/0041-008X(91)90028-D; Shu SA, 2007, CLIN EXP IMMUNOL, V149, P335, DOI 10.1111/j.1365-2249.2007.03419.x; Sun B, 2010, ENDOCRINOLOGY, V151, P2886, DOI 10.1210/en.2009-1498; Szabo G, 2006, HEPATOLOGY, V44, P287, DOI 10.1002/hep.21308; Tang HM, 2009, HAEMATOL-HEMATOL J, V94, P326, DOI 10.3324/haematol.13635; Tiegs G, 2010, J AUTOIMMUN, V34, P1, DOI 10.1016/j.jaut.2009.08.008; Uchida Y, 2010, GASTROENTEROLOGY, V139, P2195, DOI 10.1053/j.gastro.2010.07.003; Vergani D, 2009, SEMIN IMMUNOPATHOL, V31, P421, DOI 10.1007/s00281-009-0170-7; Wang HZ, 2005, J HISTOCHEM CYTOCHEM, V53, P1355, DOI 10.1369/jhc.5A6637.2005; Wang J, 2009, MICROBES INFECT, V11, P321, DOI 10.1016/j.micinf.2008.12.011; Wu J, 2007, HEPATOLOGY, V46, P1769, DOI 10.1002/hep.21897; Zachou Kalliopi, 2004, J Autoimmune Dis, V1, P2, DOI 10.1186/1740-2557-1-2; Zheng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039035	53	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66604	10.1371/journal.pone.0066604	http://dx.doi.org/10.1371/journal.pone.0066604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799121	Green Published, Green Submitted, gold			2022-12-25	WOS:000321397800041
J	Rajan, D; Gaston, KA; McCracken, CE; Erdman, DD; Anderson, LJ				Rajan, Devi; Gaston, Kelsey A.; McCracken, Courtney E.; Erdman, Dean D.; Anderson, Larry J.			Response to Rhinovirus Infection by Human Airway Epithelial Cells and Peripheral Blood Mononuclear Cells in an In Vitro Two-Chamber Tissue Culture System	PLOS ONE			English	Article							ASTHMA EXACERBATIONS; MONOCYTIC CELLS; RECEPTOR; CHILDREN; RELEASE; REPLICATION; EXPRESSION; SEROTYPES; CYTOKINES; ALPHA	Human rhinovirus (HRV) infections are associated with the common cold, occasionally with more serious lower respiratory tract illnesses, and frequently with asthma exacerbations. The clinical features of HRV infection and its association with asthma exacerbation suggest that some HRV disease results from virus-induced host immune responses to infection. To study the HRV-infection-induced host responses and the contribution of these responses to disease, we have developed an in vitro model of HRV infection of human airway epithelial cells (Calu-3 cells) and subsequent exposure of human peripheral blood mononuclear cells (PBMCs) to these infected cells in a two-chamber trans-well tissue culture system. Using this model, we studied HRV 14 (species B) and HRV 16 (species A) induced cytokine and chemokine responses with PBMCs from four healthy adults. Infection of Calu-3 cells with either virus induced HRV-associated increases in FGF-Basic, IL-15, IL-6, IL-28A, ENA-78 and IP-10. The addition of PBMCs to HRV 14-infected cells gave significant increases in MIP-1 beta, IL-28A, MCP-2, and IFN-alpha as compared with mock-infected cells. Interestingly, ENA-78 levels were reduced in HRV 14 infected cells that were exposed to PBMCs. Addition of PBMCs to HRV 16-infected cells did not induce MIP-1 beta, IL-28A and IFN-alpha efficiently nor did it decrease ENA-78 levels. Our results demonstrate a clear difference between HRV 14 and HRV 16 and the source of PBMCs, in up or down regulation of several cytokines including those that are linked to airway inflammation. Such differences might be one of the reasons for variation in disease associated with different HRV species including variation in their link to asthma exacerbations as suggested by other studies. Further study of immune responses associated with different HRVs and PBMCs from different patient groups, and the mechanisms leading to these differences, should help characterize pathogenesis of HRV disease and generate novel approaches to its treatment.	[Rajan, Devi; Gaston, Kelsey A.; McCracken, Courtney E.; Anderson, Larry J.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Rajan, Devi; Gaston, Kelsey A.; McCracken, Courtney E.; Anderson, Larry J.] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Erdman, Dean D.] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Emory University; Children's Healthcare of Atlanta (CHOA); Centers for Disease Control & Prevention - USA	Anderson, LJ (corresponding author), Emory Univ, Dept Pediat, Atlanta, GA 30322 USA.	larry.anderson@emory.edu			Children's Healthcare of Atlanta; immunology core of Children's Healthcare of Atlanta	Children's Healthcare of Atlanta; immunology core of Children's Healthcare of Atlanta	This work was supported in part by funding provided by Children's Healthcare of Atlanta and the work partly supported by the immunology core of Children's Healthcare of Atlanta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM G, 1984, J VIROL, V51, P340, DOI 10.1128/JVI.51.2.340-345.1984; Bochkov YA, 2010, MUCOSAL IMMUNOL, V3, P69, DOI 10.1038/mi.2009.109; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Denlinger LC, 2011, AM J RESP CRIT CARE, V184, P1007, DOI 10.1164/rccm.201103-0585OC; Donninger H, 2003, J INFECT DIS, V187, P1809, DOI 10.1086/375246; Forbes RL, 2012, THORAX, V67, P209, DOI 10.1136/thoraxjnl-2011-200708; Garcia C, 2012, PEDIATR INFECT DIS J, V31, P86, DOI 10.1097/INF.0b013e31822dc8c1; Gern JE, 2000, AM J RESP CRIT CARE, V162, P2226, DOI 10.1164/ajrccm.162.6.2003019; Iikura K, 2011, INT ARCH ALLERGY IMM, V155, P27, DOI 10.1159/000327262; Johnston NW, 2005, J ALLERGY CLIN IMMUN, V115, P132, DOI 10.1016/j.jaci.2004.09.025; Johnston SL, 1998, J IMMUNOL, V160, P6172; Khetsuriani N, 2007, J ALLERGY CLIN IMMUN, V119, P314, DOI 10.1016/j.jaci.2006.08.041; Korpi-Steiner NL, 2010, CLIN EXP ALLERGY, V40, P1203, DOI 10.1111/j.1365-2222.2010.03546.x; Korpi-Steiner NL, 2006, J LEUKOCYTE BIOL, V80, P1364, DOI 10.1189/jlb.0606412; Lenarczyk A, 2000, CLIN EXP IMMUNOL, V122, P41, DOI 10.1046/j.1365-2249.2000.01328.x; Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07; Miller EK, 2012, AM J RESP CRIT CARE, V185, P508, DOI 10.1164/rccm.201108-1462OC; Olsson S, 2003, CLIN EXP IMMUNOL, V132, P254, DOI 10.1046/j.1365-2249.2003.02148.x; Papadopoulos N G, 2000, Can Respir J, V7, P409; Papadopoulos NG, 2001, CLIN EXP ALLERGY, V31, P1060, DOI 10.1046/j.1365-2222.2001.01112.x; Persson T, 2003, CLIN EXP ALLERGY, V33, P531, DOI 10.1046/j.1365-2222.2003.01609.x; Saedisomeolia A, 2009, J NUTR BIOCHEM, V20, P577, DOI 10.1016/j.jnutbio.2008.06.001; Saedisomeolia A, 2009, BRIT J NUTR, V101, P533, DOI 10.1017/S0007114508025798; SCHNYDERCANDRIAN S, 1995, J LEUKOCYTE BIOL, V57, P929, DOI 10.1002/jlb.57.6.929; Schroth MK, 1999, AM J RESP CELL MOL, V20, P1220, DOI 10.1165/ajrcmb.20.6.3261; Stokes CA, 2011, J VIROL, V85, P7912, DOI 10.1128/JVI.02649-10; Sykes A, 2012, J ALLERGY CLIN IMMUN, V129, P1506, DOI 10.1016/j.jaci.2012.03.044; Vlasak M, 2005, J VIROL, V79, P7389, DOI 10.1128/JVI.79.12.7389-7395.2005; Vlasak M, 2003, J VIROL, V77, P6923, DOI 10.1128/JVI.77.12.6923-6930.2003; Wark PAB, 2009, RESPIROLOGY, V14, P180, DOI 10.1111/j.1440-1843.2009.01480.x; Watters K, 2011, J VIROL, V85, P10874, DOI 10.1128/JVI.00718-11; Xatzipsalti M, 2008, CLIN EXP ALLERGY, V38, P466, DOI 10.1111/j.1365-2222.2007.02906.x	32	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66600	10.1371/journal.pone.0066600	http://dx.doi.org/10.1371/journal.pone.0066600			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799120	Green Published, Green Submitted, gold			2022-12-25	WOS:000321397800040
J	Hilbe, C; Abou Chakra, M; Altrock, PM; Traulsen, A				Hilbe, Christian; Abou Chakra, Maria; Altrock, Philipp M.; Traulsen, Arne			The Evolution of Strategic Timing in Collective-Risk Dilemmas	PLOS ONE			English	Article							PUBLIC-GOODS; SOCIAL DILEMMA; CLIMATE; GAME; PREVENTION; PROVISION; DYNAMICS; CRISES	In collective-risk dilemmas, a group needs to collaborate over time to avoid a catastrophic event. This gives rise to a coordination game with many equilibria, including equilibria where no one contributes, and thus no measures against the catastrophe are taken. In this game, the timing of contributions becomes a strategic variable that allows individuals to interact and influence one another. Herein, we use evolutionary game theory to study the impact of strategic timing on equilibrium selection. Depending on the risk of catastrophe, we identify three characteristic regimes. For low risks, defection is the only equilibrium, whereas high risks promote equilibria with sufficient contributions. Intermediate risks pose the biggest challenge for cooperation. In this risk regime, the option to interact over time is critical; if individuals can contribute over several rounds, then the group has a higher chance to succeed, and the expected welfare increases. This positive effect of timing is of particular importance in larger groups, where successful coordination becomes increasingly difficult.	[Hilbe, Christian; Abou Chakra, Maria; Altrock, Philipp M.; Traulsen, Arne] Max Planck Inst Evolutionary Biol, Evolutionary Theory Grp, Plon, Germany	Max Planck Society	Hilbe, C (corresponding author), Max Planck Inst Evolutionary Biol, Evolutionary Theory Grp, Plon, Germany.	hilbe@evolbio.mpg.de	Chakra, Maria Abou/K-4735-2013; Traulsen, Arne/A-4955-2009; Hilbe, Christian/K-9412-2013; Altrock, Philipp/X-9063-2018	Chakra, Maria Abou/0000-0002-4895-954X; Traulsen, Arne/0000-0002-0669-5267; Hilbe, Christian/0000-0001-5116-955X; Altrock, Philipp/0000-0001-7731-3345				Abou Chakra M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002652; [Anonymous], 1995, EVOLUTIONARY GAME TH; Archetti M, 2009, J EVOLUTION BIOL, V22, P2192, DOI 10.1111/j.1420-9101.2009.01835.x; Barrett S, 2012, P NATL ACAD SCI USA, V109, P17372, DOI 10.1073/pnas.1208417109; Chen XJ, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/68003; Chen XJ, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036101; Ciccarelli JN, 2009, PSYCHOLOGY; Cookson R., 2000, Experimental Economics, V3, P55, DOI 10.1023/A:1009994008166; DIEKMANN A, 1985, J CONFLICT RESOLUT, V29, P605, DOI 10.1177/0022002785029004003; DRAZEN A, 1993, AM ECON REV, V83, P598; GRADSTEIN M, 1992, J POLIT ECON, V100, P581, DOI 10.1086/261830; Greenwood G, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/40006; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hofbauer J., 1998, EVOLUTIONARY GAMES P; Imhof LA, 2006, J MATH BIOL, V52, P667, DOI 10.1007/s00285-005-0369-8; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Marx LM, 2000, REV ECON STUD, V67, P327; Milinski M, 2006, P NATL ACAD SCI USA, V103, P3994, DOI 10.1073/pnas.0504902103; Milinski M, 2008, P NATL ACAD SCI USA, V105, P2291, DOI 10.1073/pnas.0709546105; Milinski M, 2011, CLIMATIC CHANGE, V109, P807, DOI 10.1007/s10584-011-0319-y; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Palacios-Huerta I, 2009, AM ECON REV, V99, P1619, DOI 10.1257/aer.99.4.1619; Raihani N, 2011, CLIMATIC CHANGE, V108, P47, DOI 10.1007/s10584-010-0014-4; RAPOPORT A, 1989, ORGAN BEHAV HUM DEC, V44, P325, DOI 10.1016/0749-5978(89)90012-5; Romano R, 2001, J PUBLIC ECON, V81, P423, DOI 10.1016/S0047-2727(00)00078-5; Santos FC, 2012, MATH MOD METH APPL S, V22, DOI 10.1142/S0218202511400045; Santos FC, 2011, P NATL ACAD SCI USA, V108, P10421, DOI 10.1073/pnas.1015648108; Schelling TC, 1960, STRATEGY CONICT; Sigmund K, 2010, PRINC SER THEOR COMP, P1; Summers LH, 2000, AM ECON REV, V90, P1, DOI 10.1257/aer.90.2.1; Tavoni A, 2011, P NATL ACAD SCI USA, V108, P11825, DOI 10.1073/pnas.1102493108; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; Wang J, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.016102; Wang J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016101; WEESIE J, 1993, J CONFLICT RESOLUT, V37, P569, DOI 10.1177/0022002793037003008	35	24	24	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66490	10.1371/journal.pone.0066490	http://dx.doi.org/10.1371/journal.pone.0066490			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163UV	23799109	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300087
J	Petsas, N; Tinelli, E; Lenzi, D; Tomassini, V; Sbardella, E; Tona, F; Raz, E; Nucciarelli, V; Pozzilli, C; Pantano, P				Petsas, Nikolaos; Tinelli, Emanuele; Lenzi, Delia; Tomassini, Valentina; Sbardella, Emilia; Tona, Francesca; Raz, Eytan; Nucciarelli, Valter; Pozzilli, Carlo; Pantano, Patrizia			Evidence of Impaired Brain Activity Balance after Passive Sensorimotor Stimulation in Multiple Sclerosis	PLOS ONE			English	Article							FUNCTIONAL MRI; DEFAULT-MODE; HAND MOVEMENT; DEACTIVATION; FMRI; REORGANIZATION; CORTEX; MS; ACTIVATION; DAMAGE	Objectives: Examination of sensorimotor activation alone in multiple sclerosis (MS) patients may not yield a comprehensive view of cerebral response to task stimulation. Additional information may be obtained by examining the negative BOLD response (deactivation). Aim of this work was to characterize activation and deactivation patterns during passive hand movements in MS patients. Methods: 13 relapsing remitting-MS patients (RRMS), 18 secondary progressive-MS patients (SPMS) and 15 healthy controls (HC) underwent an fMRI study during passive right-hand movements. Activation and deactivation contrasts in the three groups were entered into ANOVA, age and gender corrected. Post-hoc analysis was performed with one-sample and two-sample t-tests. For each patient we obtained lesion volume (LV) from both T1- and T2-weighted images. Results: Activations showed a progressive extension to the ipsilateral brain hemisphere according to the group and the clinical form (HC, RRMS, SPMS). Significant deactivation of the ipsilateral cortical sensorimotor areas was reduced in both patient groups with respect to HC. Deactivation of posterior cortical areas belonging to the default mode network (DMN), was increased in RRMS, but not in SPMS, with respect to HC. The amount of activation in the contralateral sensorimotor cortex was significantly correlated with that of deactivation in the DMN in HC and RRMS, but not in SPMS. Both increased activation and decreased deactivation patterns correlated with LV. Conclusion: In RRMS patients, increased cortical activation was associated with increased deactivation of the posterior cortex suggesting a greater resting-state activity in the DMN, probably aimed at facilitating sensorimotor circuit engagement during task performance. In SPMS the coupling between increased sensorimotor activation/increased DMN deactivation was not observed suggesting disorganization between anticorrelated functional networks as a consequence of a higher level of disconnection.	[Petsas, Nikolaos; Tinelli, Emanuele; Lenzi, Delia; Sbardella, Emilia; Tona, Francesca; Raz, Eytan; Nucciarelli, Valter; Pozzilli, Carlo; Pantano, Patrizia] Univ Roma La Sapienza, Dept Neurol & Psychiat, I-00185 Rome, Italy; [Petsas, Nikolaos; Sbardella, Emilia] Univ Roma La Sapienza, Dept Psychol, I-00185 Rome, Italy; [Tomassini, Valentina] Cardiff Univ, Sch Med, Inst Psychol Med & Clin Neurosci, Cardiff CF10 3AX, S Glam, Wales; [Petsas, Nikolaos; Tomassini, Valentina] Santa Lucia Fdn, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Cardiff University; IRCCS Santa Lucia	Petsas, N (corresponding author), Univ Roma La Sapienza, Dept Neurol & Psychiat, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	petsas@gmail.com	Tomassini, Valentina/HGE-0655-2022; Tinelli, Emanuele/AAH-9176-2021; tona, francesca/J-4792-2016; tinelli, emanuele/GSO-0025-2022; Pozzilli, Carlo/AAC-3270-2022; Raz, Eytan/I-5738-2012; Sbardella, Emilia/K-2167-2016; Patrizia, Pantano/C-8214-2009	Tomassini, Valentina/0000-0002-7368-6280; Tinelli, Emanuele/0000-0002-3007-4022; tona, francesca/0000-0001-9802-2248; tinelli, emanuele/0000-0002-3007-4022; Pozzilli, Carlo/0000-0002-6360-4798; Raz, Eytan/0000-0003-2998-8481; Sbardella, Emilia/0000-0002-9129-9065; Patrizia, Pantano/0000-0001-9659-8294	Italian Federation on Multiple Sclerosis (FISM) [2007/R/11]; Sanofi-Aventis; Merck Serono; Bayer Schering; Medical Research Council [G0801418B] Funding Source: researchfish	Italian Federation on Multiple Sclerosis (FISM); Sanofi-Aventis(Sanofi-Aventis); Merck Serono(Merck & Company); Bayer Schering(Bayer AG); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Italian Federation on Multiple Sclerosis (FISM), grant number 2007/R/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; C Pozzilli has received honoraria for consultancy or speaking from Sanofi-Aventis, Biogen Idec, Bayer Schering, Merck Serono, and Novartis and has received research grants from Sanofi-Aventis, Merck Serono, and Bayer Schering. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The following authors have declared that no competing interests exist: N Petsas, E Tinelli, D Lenzi, E Sbardella, F Tona, V Tomassini, E Raz, V Nucciarelli, P Pantano.	Allison JD, 2000, NEUROLOGY, V54, P135, DOI 10.1212/WNL.54.1.135; Brett M., Region of Interest Analysis Using an SPM Toolbox; Ciccarelli O, 2006, J NEUROL, V253, P882, DOI 10.1007/s00415-006-0125-z; Conte A, 2009, J NEUROL, V256, P933, DOI 10.1007/s00415-009-5047-0; Filippi M, 1995, BRAIN, V118, P1601, DOI 10.1093/brain/118.6.1601; Filippi M, 2004, NEUROIMAGE, V21, P1147, DOI 10.1016/j.neuroimage.2003.10.023; Filippi M, 2002, NEUROIMAGE, V15, P537, DOI 10.1006/nimg.2001.1023; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Giorgio A, 2010, NEUROL SCI, V31, P245, DOI 10.1007/s10072-010-0370-x; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Iannetti GD, 2007, MAGN RESON IMAGING, V25, P978, DOI 10.1016/j.mri.2007.03.018; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Lee M, 2000, ANN NEUROL, V47, P606, DOI 10.1002/1531-8249(200005)47:5<606::AID-ANA8>3.3.CO;2-C; Lenzi D, 2007, HUM BRAIN MAPP, V28, P636, DOI 10.1002/hbm.20305; Mainero C, 2004, NEUROIMAGE, V21, P858, DOI 10.1016/j.neuroimage.2003.10.004; Manson SC, 2008, EXP BRAIN RES, V187, P25, DOI 10.1007/s00221-008-1276-1; Manson SC, 2006, EXP BRAIN RES, V174, P728, DOI 10.1007/s00221-006-0517-4; Marchand WR, 2007, NEUROIMAGE, V38, P538, DOI 10.1016/j.neuroimage.2007.07.036; Matthews PM, 2004, RESTOR NEUROL NEUROS, V22, P245; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Mezzapesa DM, 2008, HUM BRAIN MAPP, V29, P562, DOI 10.1002/hbm.20418; Morgen K, 2004, BRAIN, V127, P2506, DOI 10.1093/brain/awh266; Pantano P, 2006, J NEUROIMAGING, V16, P104, DOI 10.1111/j.1552-6569.2006.00029.x; Pantano P, 2005, BRAIN, V128, P2146, DOI 10.1093/brain/awh549; Pantano P, 2002, BRAIN, V125, P1607, DOI 10.1093/brain/awf164; Pantano P, 2011, MULTIPLE SCLEROSIS; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reddy H, 2002, BRAIN, V125, P2646, DOI 10.1093/brain/awf283; Rocca MA, 2005, LANCET NEUROL, V4, P618, DOI 10.1016/S1474-4422(05)70171-X; Rocca MA, 2004, NEUROIMAGE, V23, P141, DOI 10.1016/j.neuroimage.2004.05.005; Rocca MA, 2007, J NEUROIMAGING, V17, p36S, DOI 10.1111/j.1552-6569.2007.00135.x; Sakamoto K, 2009, NEUROSCI LETT, V466, P120, DOI 10.1016/j.neulet.2009.09.038; Tomasi D, 2006, HUM BRAIN MAPP, V27, P694, DOI 10.1002/hbm.20211; Tomassini V, 2012, NEUROREHAB NEURAL RE, V26, P581, DOI 10.1177/1545968311433208; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wegner C, 2008, EUR J NEUROL, V15, P113, DOI 10.1111/j.1468-1331.2007.02027.x; Weiller C, 1996, NEUROIMAGE, V4, P105, DOI 10.1006/nimg.1996.0034	39	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65315	10.1371/journal.pone.0065315	http://dx.doi.org/10.1371/journal.pone.0065315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799005	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000320363300012
J	Chen, W; Jia, WW; Wang, K; Si, XX; Zhu, SC; Duan, T; Kang, JH				Chen, Wen; Jia, Wenwen; Wang, Kai; Si, Xiaoxing; Zhu, Songcheng; Duan, Tao; Kang, Jiuhong			Distinct Roles for CBP and p300 on the RA-Mediated Expression of the Meiosis Commitment Gene Stra8 in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							RETINOIC-ACID; GERM-CELLS; DIFFERENTIAL ROLES; MEIOTIC INITIATION; COACTIVATORS P300; BINDING PROTEIN; INHIBITION; REPRESSION; GENERATION; OVARIES	In mammalian germ cells, meiotic commitment requires the expression of Stimulated by retinoic acid gene 8 (Stra8), which is transcriptionally activated by retinoic acid (RA). However, little is known about the epigenetic mechanism by which RA induces Stra8 expression. Utilizing a chromatin immunoprecipitation assay (ChIP), we showed that RA increases histone acetylation at the Stra8 promoter in murine embryonic stem cells (ESCs), a model for germ cell differentiation. Furthermore, we explored whether two coregulators with histone acetyltransferase (HAT) activity, Creb-binding protein (CBP) and p300, are involved in the activation of Stra8. The lentiviral shRNA knockdown of endogenous CBP led to Stra8 repression, while the overexpression of CBP enhanced Stra8 expression at both the mRNA and protein levels. ChIP analysis confirmed that CBP is the crucial coactivator for RA-mediated Stra8 transcription and that it enhances the level of histone acetylation and recruits RNA polymerase II to establish transcriptionally active chromatin. Furthermore, shRNA of p300 enhanced Stra8 expression, and the overexpression of p300 reduced Stra8 expression, independently of its HAT activity. ChIP showed that the knockdown of p300 significantly increased the level of CBP at the Stra8 promoter. These findings demonstrate that CBP and p300 play distinct roles in RA-mediated Stra8 gene transcription.	[Chen, Wen; Jia, Wenwen; Wang, Kai; Si, Xiaoxing; Zhu, Songcheng; Duan, Tao; Kang, Jiuhong] Tongji Univ, Shanghai Matern & Infant Hlth Hosp 1, Clin & Translat Res Ctr, Sch Life Sci & Technol,Shanghai Key Lab Signaling, Shanghai 200092, Peoples R China; [Duan, Tao] Tongji Univ, Shanghai Matern & Infant Hlth Hosp 1, Sch Med, Dept Obstet, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Duan, T (corresponding author), Tongji Univ, Shanghai Matern & Infant Hlth Hosp 1, Clin & Translat Res Ctr, Sch Life Sci & Technol,Shanghai Key Lab Signaling, Shanghai 200092, Peoples R China.	tduan@yahoo.com; jhkang@tongji.edu.cn			Ministry of Science and Technology [2011CB965100, 2011DFA30480, 2010CB944900, 2010CB945000, 2012CB966603, 2011CBA01100]; National Natural Science Foundation of China [90919028, 31210103905, 31201107, 31101061, 81170499, 31071306, 31000378, 31171432, 30971451]; Science and Technology Commission of Shanghai Municipality [11ZR1438500, 11XD1405300]; Ministry of Education [IRT1168, 20110072110039]; Fundamental Research Funds for the Central Universities [2000219067, 2000219066]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Ministry of Education; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the Ministry of Science and Technology (2011CB965100, 2011DFA30480, 2010CB944900, 2010CB945000, 2012CB966603 and 2011CBA01100), the National Natural Science Foundation of China (90919028, 31210103905, 31201107, 31101061, 81170499, 31071306, 31000378, 31171432, and 30971451), the Science and Technology Commission of Shanghai Municipality (11ZR1438500, 11XD1405300), and IRT1168 and 20110072110039 from Ministry of Education. The work was also supported by Fundamental Research Funds for the Central Universities (2000219067, 2000219066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Baluchamy S, 2003, P NATL ACAD SCI USA, V100, P9524, DOI 10.1073/pnas.1633700100; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Chen W, 2012, BIOCHEM BIOPH RES CO, V418, P571, DOI 10.1016/j.bbrc.2012.01.078; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Giuili G, 2002, EMBO REP, V3, P753, DOI 10.1093/embo-reports/kvf149; Glass CK, 2000, GENE DEV, V14, P121; Ianculescu I, 2012, J BIOL CHEM, V287, P4000, DOI 10.1074/jbc.M111.300194; Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kasper LH, 2005, EMBO J, V24, P3846, DOI 10.1038/sj.emboj.7600846; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Kumar S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1136; Lee S, 2009, NEURON, V62, P641, DOI 10.1016/j.neuron.2009.04.025; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Nayernia K, 2006, DEV CELL, V11, P125, DOI 10.1016/j.devcel.2006.05.010; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Ramos YFM, 2010, NUCLEIC ACIDS RES, V38, P5396, DOI 10.1093/nar/gkq184; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Sangster-Guity N, 2004, CANCER BIOL THER, V3, P1109, DOI 10.4161/cbt.3.11.1190; Shikama N, 2003, EMBO J, V22, P5175, DOI 10.1093/emboj/cdg502; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Wang N, 2010, CELL CYCLE, V9, P339, DOI 10.4161/cc.9.2.10447; Wang ZB, 2010, CELL CYCLE, V9, P2640, DOI 10.4161/cc.9.13.12120	34	10	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66076	10.1371/journal.pone.0066076	http://dx.doi.org/10.1371/journal.pone.0066076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785470	Green Published, gold, Green Submitted			2022-12-25	WOS:000321038800052
J	Gilmore, C; Attridge, N; Clayton, S; Cragg, L; Johnson, S; Marlow, N; Simms, V; Inglis, M				Gilmore, Camilla; Attridge, Nina; Clayton, Sarah; Cragg, Lucy; Johnson, Samantha; Marlow, Neil; Simms, Victoria; Inglis, Matthew			Individual Differences in Inhibitory Control, Not Non-Verbal Number Acuity, Correlate with Mathematics Achievement	PLOS ONE			English	Article							EXECUTIVE FUNCTIONS; NONSYMBOLIC NUMBER; PRESCHOOL-CHILDREN; WORKING-MEMORY; MATH; ABILITY; REPRESENTATIONS; SENSE; PREDICTOR; ADULTS	Given the well-documented failings in mathematics education in many Western societies, there has been an increased interest in understanding the cognitive underpinnings of mathematical achievement. Recent research has proposed the existence of an Approximate Number System (ANS) which allows individuals to represent and manipulate non-verbal numerical information. Evidence has shown that performance on a measure of the ANS (a dot comparison task) is related to mathematics achievement, which has led researchers to suggest that the ANS plays a critical role in mathematics learning. Here we show that, rather than being driven by the nature of underlying numerical representations, this relationship may in fact be an artefact of the inhibitory control demands of some trials of the dot comparison task. This suggests that recent work basing mathematics assessments and interventions around dot comparison tasks may be inappropriate.	[Gilmore, Camilla; Attridge, Nina; Clayton, Sarah; Inglis, Matthew] Univ Loughborough, Math Educ Ctr, Loughborough, Leics, England; [Cragg, Lucy] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England; [Johnson, Samantha; Simms, Victoria] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Marlow, Neil] UCL, Inst Womens Hlth, London WC1E 6BT, England	Loughborough University; University of Nottingham; University of Leicester; University of London; University College London	Gilmore, C (corresponding author), Univ Loughborough, Math Educ Ctr, Loughborough, Leics, England.	c.gilmore@lboro.ac.uk	Clayton, Sarah/I-6294-2018; Marlow, Neil/D-2918-2009; Johnson, Samantha/S-6876-2019; Johnson, Samantha/G-2260-2018; Inglis, Matthew/U-3677-2017; Cragg, Lucy/B-2070-2010	Clayton, Sarah/0000-0002-0193-1443; Marlow, Neil/0000-0001-5890-2953; Johnson, Samantha/0000-0001-8963-7881; Inglis, Matthew/0000-0001-7617-4689; Cragg, Lucy/0000-0001-7523-0204; Attridge, Nina/0000-0001-9586-372X; Simms, Victoria/0000-0001-5664-6810	British Academy Postdoctoral Fellowship; Royal Society Worshipful Company of Actuaries Educational Research Fellowship; Department of Health's NIHR Biomedical Research Centre's funding scheme at UCLH / UCL; Economic and Social Research Council; Action Medical Research; ESRC [ES/G007454/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007454/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10034] Funding Source: researchfish; Action Medical Research [1780] Funding Source: researchfish	British Academy Postdoctoral Fellowship; Royal Society Worshipful Company of Actuaries Educational Research Fellowship; Department of Health's NIHR Biomedical Research Centre's funding scheme at UCLH / UCL; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Action Medical Research; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Action Medical Research	C.G. is supported by a British Academy Postdoctoral Fellowship and M. I. is supported by a Royal Society Worshipful Company of Actuaries Educational Research Fellowship. N.M. receives part funding from the Department of Health's NIHR Biomedical Research Centre's funding scheme at UCLH / UCL. Experiment 1 was funded by a grant from the Economic and Social Research Council and Experiment 2 was funded by a grant from Action Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth H, 2005, P NATL ACAD SCI USA, V102, P14116, DOI 10.1073/pnas.0505512102; Barth H, 2003, COGNITION, V86, P201, DOI 10.1016/S0010-0277(02)00178-6; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Bonny JW, 2013, J EXP CHILD PSYCHOL, V114, P375, DOI 10.1016/j.jecp.2012.09.015; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Castronovo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033832; Cordes S, 2001, PSYCHON B REV, V8, P698, DOI 10.3758/BF03196206; Cragg L, 2008, DEVELOPMENTAL SCI, V11, P819, DOI 10.1111/j.1467-7687.2008.00730.x; Dehaene S., 2011, NUMBER SENSE MIND CR; Desoete A, 2012, BRIT J EDUC PSYCHOL, V82, P64, DOI 10.1348/2044-8279.002002; Espy KA, 2004, DEV NEUROPSYCHOL, V26, P465, DOI 10.1207/s15326942dn2601_6; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Fuhs MW, 2013, DEVELOPMENTAL SCI, V16, P136, DOI 10.1111/desc.12013; Gebuis T, 2011, BEHAV RES METHODS, V43, P981, DOI 10.3758/s13428-011-0097-5; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Halberda J, 2012, P NATL ACAD SCI USA, V109, P11116, DOI 10.1073/pnas.1200196109; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; Inglis M, 2011, PSYCHON B REV, V18, P1222, DOI 10.3758/s13423-011-0154-1; Iuculano T, 2008, DEVELOPMENTAL SCI, V11, P669, DOI 10.1111/j.1467-7687.2008.00716.x; Kolkman ME, 2013, LEARN INSTR, V25, P95, DOI 10.1016/j.learninstruc.2012.12.001; Korkman M., 2007, NEPSY 2 BATERIA NEUR; Kramer P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017378; Libertus ME, 2013, LEARN INDIVID DIFFER, V25, P126, DOI 10.1016/j.lindif.2013.02.001; Libertus ME, 2012, ACTA PSYCHOL, V141, P373, DOI 10.1016/j.actpsy.2012.09.009; Libertus ME, 2011, DEVELOPMENTAL SCI, V14, P1292, DOI 10.1111/j.1467-7687.2011.01080.x; Lourenco SF, 2012, P NATL ACAD SCI USA, V109, P18737, DOI 10.1073/pnas.1207212109; Mazzocco MMM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023749; National Mathematics Advisory Panel, 2008, FDN SUCC FIN REP NAT; Parsons S., 2005, DOES NUMERACY MATTER; Piazza M, 2010, COGNITION, V116, P33, DOI 10.1016/j.cognition.2010.03.012; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; Price GR, 2012, ACTA PSYCHOL, V140, P50, DOI 10.1016/j.actpsy.2012.02.008; Sasanguie D, 2013, J EXP CHILD PSYCHOL, V114, P418, DOI 10.1016/j.jecp.2012.10.012; Sasanguie D, 2012, MIND BRAIN EDUC, V6, P119, DOI 10.1111/j.1751-228X.2012.01147.x; St Clair-Thompson HL, 2006, Q J EXP PSYCHOL, V59, P745, DOI 10.1080/17470210500162854; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Vanbinst K, 2012, MIND BRAIN EDUC, V6, P129, DOI 10.1111/j.1751-228X.2012.01148.x; Vorderman C, 2011, WORLD CLASS MATH ED; Wechsler D., 2009, WECHSLER INDIVIDUAL, V3rd; Wilson AJ, 2006, BEHAV BRAIN FUNCT, V2, DOI [10.86/1744-9081-2-20, DOI 10.1186/1744-9081-2-20.PUBMED:16734906]; Woodcock R. W., 2001, WOODCOCK JOHNSON 3 T	42	293	301	7	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e67374	10.1371/journal.pone.0067374	http://dx.doi.org/10.1371/journal.pone.0067374			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	172XB	23785521	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800003
J	Tahir, H; Bona-Casas, C; Hoekstra, AG				Tahir, Hannan; Bona-Casas, Carles; Hoekstra, Alfons G.			Modelling the Effect of a Functional Endothelium on the Development of In-Stent Restenosis	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELL; NITRIC-OXIDE; STRUT THICKNESS; ELUTING STENTS; INJURY; SIMULATIONS; FLOW; PATHOPHYSIOLOGY; PATHOLOGY; IMPACT	Treatment of stenosed coronary arteries by balloon angioplasty and stenting results in arterial injury including severe damage to the endothelium at the site of treatment and initiates a complex cascade of inflammatory processes that may lead to the development of in-stent restenosis (ISR). Many clinical and biological factors involved in the progression of restenotic lesions have been studied in detail over the past few years but the mystery behind the pathophysiological mechanisms of this disease is still unresolved. In the present work, the effects of re-endothelialization and nitric oxide release on neointimal growth are investigated in-silico using a two dimensional multi-scale model of ISR. The effect of stent deployment depths on the development of ISR is studied as a function of time after stenting. Two dimensional domains were prepared by deploying bare metal stent struts at three different deployment depths into the tissue. Shear stress distribution on endothelial cells, obtained by blood flow simulations, was translated into nitric oxide production that keeps the smooth muscle cells in quiescent state. The cellular growth trends were plotted as a function of time and the data indicate a positive correlation between the neointimal growths and strut deployment depths in the presence of a functional endothelium, in qualitative agreement with in-vivo data. Additionally, no ISR is observed if a functional endothelium appears much earlier.	[Tahir, Hannan; Bona-Casas, Carles; Hoekstra, Alfons G.] Univ Amsterdam, Fac Sci, Inst Informat, Amsterdam, Netherlands	University of Amsterdam	Tahir, H (corresponding author), Univ Amsterdam, Fac Sci, Inst Informat, Amsterdam, Netherlands.	h.tahir@uva.nl	Bona-Casas, Carles/M-1049-2014	Bona-Casas, Carles/0000-0002-3217-5257	European Union [238113]	European Union(European Commission)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 238113 (project 'MeDDiCA' - 'Medical Devices Design in Cardiovascular Applications'; http://www.meddica.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahanchi SS, 2007, J VASC SURG, V45, p64A, DOI 10.1016/j.jvs.2007.02.027; [Anonymous], [No title captured]; Artoli AM, 2006, J BIOMECH, V39, P873, DOI 10.1016/j.jbiomech.2005.01.033; Axner L, 2008, J COMPUT PHYS, V227, P4895, DOI 10.1016/j.jcp.2008.01.013; Axner L, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-23; Baim DS., 2005, GROSSMANS CARDIAC CA; BRETON M, 1986, EXP CELL RES, V166, P416, DOI 10.1016/0014-4827(86)90487-8; Bryan NS, 2006, FREE RADICAL BIO MED, V41, P691, DOI 10.1016/j.freeradbiomed.2006.05.019; Caiazzo A, 2011, J COMPUT SCI-NETH, V2, P9, DOI 10.1016/j.jocs.2010.09.002; Carpenter AW, 2012, CHEM SOC REV; Comerford A, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2838026; Coneski PN, 2012, CHEM SOC REV; De Caterina R, 2007, ENDOTHELIAL DYSFUNCT, P1, DOI DOI 10.1002/9780470988473.CH1; Evans DJW, 2008, PHILOS T R SOC A, V366, P3343, DOI 10.1098/rsta.2008.0081; Finn AV, 2007, ARTERIOSCL THROM VAS, V27, P1500, DOI 10.1161/ATVBAHA.107.144220; Forstermann U, 2011, EUROPEAN HEART J; Gunn J, 2002, HEART, V88, P401, DOI 10.1136/heart.88.4.401; Guo X, 2009, ACTA PHYSIOL, V197, P99, DOI 10.1111/j.1748-1716.2009.01999.x; Hamid Huda, 2007, Mcgill J Med, V10, P105; Harnek J, 1999, CARDIOVASC INTER RAD, V22, P56, DOI 10.1007/s002709900329; Hegewald J, 2010, MULTISCALE COUPLING; Hegewald J, 2008, LECT NOTES COMPUT SC, V5102, P227, DOI 10.1007/978-3-540-69387-1_25; Hsu S, 2011, CELL MOL BIOENG, P1; Inoue T, 2011, JACC-CARDIOVASC INTE, V4, P1057, DOI 10.1016/j.jcin.2011.05.025; Jeremy JY, 1999, CARDIOVASC RES, V43, P580, DOI 10.1016/S0008-6363(99)00171-6; Jukema JW, 2012, NAT REV CARDIOL, V9, P53, DOI 10.1038/nrcardio.2011.132; Kakisis JD, 2004, ENDOTHELIUM-J ENDOTH, V11, P17, DOI 10.1080/10623320490432452; Kastrati A, 2001, CIRCULATION, V103, P2816; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Lehti K, 2009, J CELL SCI, V122, P126, DOI 10.1242/jcs.035279; Louis SF, 2010, EXP CLIN CARDIOL, V15, pE75; Lowe HC, 2002, J AM COLL CARDIOL, V39, P183, DOI 10.1016/S0735-1097(01)01742-9; LUDMER PL, 1986, NEW ENGL J MED, V315, P1046, DOI 10.1056/NEJM198610233151702; McCormick ME, 2011, ARTERIOSCL THROM VAS, V31, P643, DOI 10.1161/ATVBAHA.110.216200; Nakazawa G, 2007, HERZ, V32, P274, DOI 10.1007/s00059-007-2997-9; Nakazawa G, 2010, JACC-CARDIOVASC INTE, V3, P68, DOI 10.1016/j.jcin.2009.09.015; Oncel D, 2008, AM J ROENTGENOL, V191, P56, DOI 10.2214/AJR.07.3560; Otsuka F, 2012, NATURE REV CARDIOLOG; Ozkor MA, 2010, ADVANCES IN VASCULAR MEDICINE, P187, DOI 10.1007/978-1-84882-637-3_11; de Prado AP, 2011, VET PATHOL, V48, P1109, DOI 10.1177/0300985811400446; Perk J, 2012, EUROPEAN HEART J; Pober JS, 2009, ANNU REV PATHOL-MECH, V4, P71, DOI 10.1146/annurev.pathol.4.110807.092155; Redmond EM, 2012, MUSCLE FUNDAMENTAL B, P1231, DOI [10.1016/b978-0-12-381510-1.00092-2, DOI 10.1016/B978-0-12-381510-1.00092-2.1231-1242]; Rittersma SZH, 2004, AM J CARDIOL, V93, P477, DOI 10.1016/j.amjcard.2003.10.049; Sandoo A, 2010, OPEN CARDIOVASC MED, V4, P302, DOI 10.2174/1874192401004010302; Schulz C, 2000, HEART, V83, P462, DOI 10.1136/heart.83.4.462; SCHWARTZ RS, 1992, J AM COLL CARDIOL, V19, P267, DOI 10.1016/0735-1097(92)90476-4; Shi ZD, 2011, ANN BIOMED ENG, V39, P1608, DOI 10.1007/s10439-011-0309-2; Shi ZD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012196; Simons M, 2009, ARTERIOSCL THROM VAS, V29, P439, DOI 10.1161/ATVBAHA.109.183970; Sudano I, 2010, SWISS MED WKLY, V140, P139, DOI [smw-12966, 10.4414/smw.2010.13122]; Tahir H, 2011, INTERFACE FOCUS, V1, P365, DOI 10.1098/rsfs.2010.0024; van Beusekom HMM, 2012, CATHETERIZATION CARD; Vanhoutte PM, 2010, CARDIOVASC DRUG THER, V24, P299, DOI 10.1007/s10557-010-6257-5; Verma S, 2002, CIRCULATION, V105, P546, DOI 10.1161/hc0502.104540; Villalobo A, 2006, FEBS J, V273, P2329, DOI 10.1111/j.1742-4658.2006.05250.x; Wong K, 2006, MED BIOL ENG COMPUT, V44, P971, DOI 10.1007/s11517-006-0113-6; Wong KKL, 2011, COMPUT CARDIOL CONF, V38, P157; Wong KKL, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-7; Wong KKL, 2010, INT CONF BIOMED, P113, DOI 10.1109/BMEI.2010.5639477; Wong KK, 2012, INT P CHEM BIOL ENV, V34, P40	61	46	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66138	10.1371/journal.pone.0066138	http://dx.doi.org/10.1371/journal.pone.0066138			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785479	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800043
J	Mainprize, IL; Bean, JD; Bouwman, C; Kimber, MS; Whitfield, C				Mainprize, Iain L.; Bean, Jordan D.; Bouwman, Catrien; Kimber, Matthew S.; Whitfield, Chris			The UDP-glucose Dehydrogenase of Escherichia coli K-12 Displays Substrate Inhibition by NAD That Is Relieved by Nucleotide Triphosphates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-1 CAPSULAR POLYSACCHARIDES; COLANIC ACID BIOSYNTHESIS; PROTEIN-TYROSINE KINASES; GRAM-NEGATIVE BACTERIA; GROUP-A STREPTOCOCCI; KLEBSIELLA-PNEUMONIAE; BACILLUS-SUBTILIS; K ANTIGENS; EXTRACELLULAR POLYSACCHARIDES; POLYMYXIN RESISTANCE	UDP-glucose dehydrogenase (Ugd) generates UDP-glucuronic acid, an important precursor for the production of many hexuronic acid-containing bacterial surface glycostructures. In Escherichia coli K-12, Ugd is important for biosynthesis of the environmentally regulated exopolysaccharide known as colanic acid, whereas in other E. coli isolates, the same enzyme is required for production of the constitutive group 1 capsular polysaccharides, which act as virulence determinants. Recent studies have implicated tyrosine phosphorylation in the activation of Ugd from E. coli K-12, although it is not known if this is a feature shared by bacterial Ugd proteins. The activities of Ugd from E. coli K-12 and from the group 1 capsule prototype (serotype K30) were compared. Surprisingly, for both enzymes, site-directed Tyr -> Phe mutants affecting the previously proposed phosphorylation site retained similar kinetic properties to the wild-type protein. Purified Ugd from E. coli K-12 had significant levels of NAD substrate inhibition, which could be alleviated by the addition of ATP and several other nucleotide triphosphates. Mutations in a previously identified UDP-glucuronic acid allosteric binding site decreased the binding affinity of the nucleotide triphosphate. Ugd from E. coli serotype K30 was not inhibited by NAD, but its activity still increased in the presence of ATP.	[Mainprize, Iain L.; Bean, Jordan D.; Bouwman, Catrien; Kimber, Matthew S.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca	Kimber, Matthew/Q-8144-2019	Kimber, Matthew/0000-0001-9454-5586; Mainprize, Iain/0000-0002-8872-5350	Canadian Institutes of Health Research [FRN-9623]; National Science and Engineering Research Council of Canada [327280]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institutes of Health Research Operating Grant FRN-9623 (to C. W.) and National Science and Engineering Research Council of Canada Grant 327280 (to M. S. K.).	ALATOSSAVA T, 1985, J BACTERIOL, V162, P413, DOI 10.1128/JB.162.1.413-419.1985; Alvarez D, 2000, INFECT IMMUN, V68, P953, DOI 10.1128/IAI.68.2.953-955.2000; Bechet E, 2010, MOL MICROBIOL, V77, P1315, DOI 10.1111/j.1365-2958.2010.07291.x; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Boels IC, 2001, APPL ENVIRON MICROB, V67, P3033, DOI 10.1128/AEM.67.7.3033-3040.2001; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; Campbell RE, 1997, J BIOL CHEM, V272, P3416, DOI 10.1074/jbc.272.6.3416; Chen YY, 2011, J STRUCT BIOL, V175, P300, DOI 10.1016/j.jsb.2011.04.010; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Clarkin CE, 2011, J CELL PHYSIOL, V226, P749, DOI 10.1002/jcp.22393; Collins RF, 2007, P NATL ACAD SCI USA, V104, P2390, DOI 10.1073/pnas.0607763104; Cuthbertson L, 2009, MICROBIOL MOL BIOL R, V73, P155, DOI 10.1128/MMBR.00024-08; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dhamdhere G, 2010, MOL MICROBIOL, V77, P743, DOI 10.1111/j.1365-2958.2010.07245.x; Dodgson C, 1996, J BACTERIOL, V178, P1895, DOI 10.1128/jb.178.7.1895-1902.1996; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Drummelsmith J, 1999, MOL MICROBIOL, V31, P1321, DOI 10.1046/j.1365-2958.1999.01277.x; Drummelsmith J, 1997, J BACTERIOL, V179, P3232, DOI 10.1128/jb.179.10.3232-3238.1997; Easley KE, 2007, BIOCHEMISTRY-US, V46, P369, DOI 10.1021/bi061537d; Egger S, 2011, J BIOL CHEM, V286, P23877, DOI 10.1074/jbc.M111.234682; Egger S, 2010, BIOCHEM SOC T, V38, P1378, DOI 10.1042/BST0381378; Ferrieres L, 2003, MOL MICROBIOL, V50, P1665, DOI 10.1046/j.1365-2958.2003.03815.x; Grangeasse C, 2003, J BIOL CHEM, V278, P39323, DOI 10.1074/jbc.M305134200; Grangeasse C, 2007, TRENDS BIOCHEM SCI, V32, P86, DOI 10.1016/j.tibs.2006.12.004; Gruszczyk J, 2011, J BIOL CHEM, V286, P17112, DOI 10.1074/jbc.M110.216002; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Ho JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021664; Hung RJ, 2007, J BIOL CHEM, V282, P17738, DOI 10.1074/jbc.M701824200; Ilan O, 1999, EMBO J, V18, P3241, DOI 10.1093/emboj/18.12.3241; JAYARATNE P, 1994, J BACTERIOL, V176, P3126, DOI 10.1128/jb.176.11.3126-3139.1994; Kadirvelraj R, 2011, BIOCHEMISTRY-US, V50, P5780, DOI 10.1021/bi2005637; KEENLEYSIDE WJ, 1992, J BACTERIOL, V174, P8, DOI 10.1128/jb.174.1.8-16.1992; Lacour S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003053; Lee DC, 2008, EMBO J, V27, P1758, DOI 10.1038/emboj.2008.97; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Mijakovic I, 2003, EMBO J, V22, P4709, DOI 10.1093/emboj/cdg458; Mouslim C, 2003, MOL MICROBIOL, V47, P335, DOI 10.1046/j.1365-2958.2003.03318.x; Olivares-Illana V, 2008, PLOS BIOL, V6, P1321, DOI 10.1371/journal.pbio.0060143; Pagni M, 1999, MICROBIOL-UK, V145, P1049, DOI 10.1099/13500872-145-5-1049; Petranovic D, 2009, J MOL MICROB BIOTECH, V17, P83, DOI 10.1159/000206635; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Rahn A, 2003, MOL MICROBIOL, V47, P1045, DOI 10.1046/j.1365-2958.2003.03354.x; Rahn A, 1999, J BACTERIOL, V181, P2307, DOI 10.1128/JB.181.7.2307-2313.1999; Reed MC, 2010, BIOESSAYS, V32, P422, DOI 10.1002/bies.200900167; Reid AN, 2005, J BACTERIOL, V187, P5470, DOI 10.1128/JB.187.15.5470-5481.2005; SCHILLER JG, 1973, BIOCHIM BIOPHYS ACTA, V293, P1, DOI 10.1016/0005-2744(73)90369-0; Shi L, 2010, CURR PROTEOMICS, V7, P188, DOI 10.2174/157016410792928198; Sommer BJ, 2004, J BIOL CHEM, V279, P23590, DOI 10.1074/jbc.M401928200; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; STROMINGER JL, 1954, J AM CHEM SOC, V76, P6411, DOI 10.1021/ja01653a051; Vincent C, 1999, J BACTERIOL, V181, P3472, DOI 10.1128/JB.181.11.3472-3477.1999; WESSELS MR, 1994, INFECT IMMUN, V62, P433, DOI 10.1128/IAI.62.2.433-441.1994; Whitfield C, 2003, CARBOHYD RES, V338, P2491, DOI 10.1016/j.carres.2003.08.010; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wugeditsch T, 2001, J BIOL CHEM, V276, P2361, DOI 10.1074/jbc.M009092200; Xayarath B, 2007, J BACTERIOL, V189, P3369, DOI 10.1128/JB.01938-06; YUASA R, 1969, J BACTERIOL, V100, P433, DOI 10.1128/JB.100.1.433-444.1969	61	13	13	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23064	23074		10.1074/jbc.M113.486613	http://dx.doi.org/10.1074/jbc.M113.486613			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23792965	Green Published, hybrid			2022-12-25	WOS:000330598200015
J	Agarwal, S; Kazi, JU; Ronnstrand, L				Agarwal, Shruti; Kazi, Julhash U.; Ronnstrand, Lars			Phosphorylation of the Activation Loop Tyrosine 823 in c-Kit Is Crucial for Cell Survival and Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR/C-KIT; GASTROINTESTINAL STROMAL TUMORS; PDGF BETA-RECEPTOR; PROTEIN-COUPLED RECEPTORS; MAST-CELLS; TESTICULAR SEMINOMAS; KINASE PATHWAY; EGF RECEPTOR; MUTATIONS; CHEMOTAXIS	The receptor tyrosine kinase c-Kit, also known as the stem cell factor receptor, plays a key role in several developmental processes. Activating mutations in c-Kit lead to alteration of these cellular processes and have been implicated in many human cancers such as gastrointestinal stromal tumors, acute myeloid leukemia, testicular seminomas and mastocytosis. Regulation of the catalytic activity of several kinases is known to be governed by phosphorylation of tyrosine residues in the activation loop of the kinase domain. However, in the case of c-Kit phosphorylation of Tyr-823 has been demonstrated to be a late event that is not required for kinase activation. However, because phosphorylation of Tyr-823 is a ligand-activated event, we sought to investigate the functional consequences of Tyr-823 phosphorylation. By using a tyrosine-to-phenylalanine mutant of tyrosine 823, we investigated the impact of Tyr-823 on c-Kit signaling. We demonstrate here that Tyr-823 is crucial for cell survival and proliferation and that mutation of Tyr-823 to phenylalanine leads to decreased sustained phosphorylation and ubiquitination of c-Kit as compared with the wild-type receptor. Furthermore, the mutated receptor was, upon ligand-stimulation, quickly internalized and degraded. Phosphorylation of the E3 ubiquitin ligase Cbl was transient, followed by a substantial reduction in phosphorylation of downstream signaling molecules such as Akt, Erk, p38, Shc, and Gab2. Thus, we propose that activation loop tyrosine 823 is crucial for activation of both the MAPK and PI3K pathways and that its disruption leads to a destabilization of the c-Kit receptor and decreased survival of cells.	[Agarwal, Shruti; Kazi, Julhash U.; Ronnstrand, Lars] Lund Univ, Skane Univ Hosp, Dept Lab Med, Wallenberg Lab, S-20502 Malmo, Sweden	Lund University; Skane University Hospital	Ronnstrand, L (corresponding author), Lund Univ, Skane Univ Hosp, Dept Lab Med, Wallenberg Lab, S-20502 Malmo, Sweden.	Lars.Ronnstrand@med.lu.se	Kazi, Julhash U./D-9190-2011	Kazi, Julhash U./0000-0002-0719-5336; Ronnstrand, Lars/0000-0003-1275-5809	Swedish Research Council; Swedish Cancer Foundation; Gunnar Nilssons Cancer Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Gunnar Nilssons Cancer Foundation	This work was supported by grants from the Swedish Research Council, the Swedish Cancer Foundation, and the Gunnar Nilssons Cancer Foundation.	Beadling C, 2008, CLIN CANCER RES, V14, P6821, DOI 10.1158/1078-0432.CCR-08-0575; BLUMEJENSEN P, 1993, EMBO J, V12, P4199, DOI 10.1002/j.1460-2075.1993.tb06104.x; Boerner JL, 2005, MOL CARCINOGEN, V44, P262, DOI 10.1002/mc.20138; Boerner JL, 2004, MOL CELL BIOL, V24, P7059, DOI 10.1128/MCB.24.16.7059-7071.2004; Calabuig-Farinas S, 2011, INT J SURG PATHOL, V19, P448, DOI 10.1177/1066896911402327; Carsetti L, 2009, CELL SIGNAL, V21, P1187, DOI 10.1016/j.cellsig.2009.03.007; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; DiNitto JP, 2010, J BIOCHEM, V147, P601, DOI 10.1093/jb/mvq015; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; Goemans BF, 2005, LEUKEMIA, V19, P1536, DOI 10.1038/sj.leu.2403870; Hansen K, 1996, EMBO J, V15, P5299, DOI 10.1002/j.1460-2075.1996.tb00915.x; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; KAMPS MP, 1989, ANAL BIOCHEM, V176, P22, DOI 10.1016/0003-2697(89)90266-2; Kazi JU, 2013, EXP HEMATOL, V41, P585, DOI 10.1016/j.exphem.2013.03.005; Kemmer K, 2004, AM J PATHOL, V164, P305, DOI 10.1016/S0002-9440(10)63120-3; Kitamura Y, 2001, MUTAT RES-FUND MOL M, V477, P165, DOI 10.1016/S0027-5107(01)00117-8; Kulathu Y, 2009, IMMUNOL REV, V232, P286, DOI 10.1111/j.1600-065X.2009.00837.x; Lennartsson J, 2005, STEM CELLS, V23, P16, DOI 10.1634/stemcells.2004-0117; Lennartsson J, 2003, EXP CELL RES, V288, P110, DOI 10.1016/S0014-4827(03)00206-4; Lennartsson J, 1999, ONCOGENE, V18, P5546, DOI 10.1038/sj.onc.1202929; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; Lupher ML, 1996, J BIOL CHEM, V271, P24063, DOI 10.1074/jbc.271.39.24063; Luttrell LM, 1997, J BIOL CHEM, V272, P31648, DOI 10.1074/jbc.272.50.31648; Masson K, 2006, BIOCHEM J, V399, P59, DOI 10.1042/BJ20060464; Masson K, 2009, CELL SIGNAL, V21, P1717, DOI 10.1016/j.cellsig.2009.06.002; Mol CD, 2003, J BIOL CHEM, V278, P31461, DOI 10.1074/jbc.C300186200; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Nishida T, 1998, NAT GENET, V19, P323, DOI 10.1038/1209; Ronnstrand L, 1999, ONCOGENE, V18, P3696, DOI 10.1038/sj.onc.1202705; Samayawardhena LA, 2006, CELL SIGNAL, V18, P1447, DOI 10.1016/j.cellsig.2005.11.005; SERVE H, 1995, EMBO J, V14, P473, DOI 10.1002/j.1460-2075.1995.tb07023.x; Smith JA, 2010, CELL SIGNAL, V22, P427, DOI 10.1016/j.cellsig.2009.10.014; Sun JM, 2008, J BIOL CHEM, V283, P27444, DOI 10.1074/jbc.M709703200; Sun J, 2007, EXP CELL RES, V313, P3935, DOI 10.1016/j.yexcr.2007.08.021; Sun JM, 2009, J BIOL CHEM, V284, P11039, DOI 10.1074/jbc.M808058200; Sundstrom M, 2001, EXP CELL RES, V267, P144, DOI 10.1006/excr.2001.5239; Ueda S, 2002, BLOOD, V99, P3342, DOI 10.1182/blood.V99.9.3342; Wardega P, 2010, CELL SIGNAL, V22, P1363, DOI 10.1016/j.cellsig.2010.05.004; Willmore-Payne C, 2006, MODERN PATHOL, V19, P1164, DOI 10.1038/modpathol.3800623; Zeng S, 2005, BLOOD, V105, P226, DOI 10.1182/blood-2004-05-1768; Zhang J, 2000, J BIOL CHEM, V275, P35442, DOI 10.1074/jbc.M004549200	42	25	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22460	22468		10.1074/jbc.M113.474072	http://dx.doi.org/10.1074/jbc.M113.474072			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23803604	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000330596300027
J	Allerson, MW; Cardona, CJ; Torremorell, M				Allerson, Matt W.; Cardona, Carol J.; Torremorell, Montserrat			Indirect Transmission of Influenza A Virus between Pig Populations under Two Different Biosecurity Settings	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; MYCOPLASMA-HYOPNEUMONIAE; FOMITES BOOTS; SWINE; SURVIVAL	Respiratory disease due to influenza virus is common in both human and swine populations around the world with multiple transmission routes capable of transmitting influenza virus, including indirect routes. The objective of this study was to evaluate the role of fomites in influenza A virus (IAV) transmission between pig populations separated by two different biosecurity settings. Thirty-five pigs were divided into four experimental groups: 10 pigs (1 replicate) were assigned to the infected group (I), 10 pigs (2 replicates of 5 pigs) were assigned to the low biosecurity sentinel group (LB), 10 pigs (2 replicates of 5 pigs) were assigned to the medium biosecurity sentinel group (MB), and 5 pigs (1 replicate) were assigned to the negative control group (NC). Eight of 10 pigs in the infected group were inoculated with IAV and 36 hours following inoculation, personnel movement events took place in order to move potentially infectious clothing and personal protective equipment (PPE) to sentinel pig rooms. Following contact with the infected group, personnel moved to the MB group after designated hygiene measures while personnel moved directly to the LB group. Nasal swabs and blood samples were collected from pigs to assess IAV infection status and fomites were sampled and tested via RRT-PCR. All experimentally inoculated pigs were infected with IAV and 11 of the 144 fomite samples collected following contact with infected pigs were low level positive for IAV genome. One replicate of each sentinel groups LB and MB became infected with IAV and all five pigs were infected over time. This study provides evidence that fomites can serve as an IAV transmission route from infected to sentinel pigs and highlights the need to focus on indirect routes as well as direct routes of transmission for IAV.	[Allerson, Matt W.; Torremorell, Montserrat] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Cardona, Carol J.] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Torremorell, M (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA.	torr0033@umn.edu			NIH, National Institute of Allergy and Infectious Diseases; Department of Health and Human Services [HHSN266200700007C]	NIH, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Health and Human Services	This study was supported in whole or in part with federal funds from the NIH, National Institute of Allergy and Infectious Diseases and Department of Health and Human Services under the contract No. HHSN266200700007C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amass SF, 2003, J SWINE HEALTH PROD, V11, P61; Batista L, 2004, J SWINE HEALTH PROD, V12, P75; BEAN B, 1982, J INFECT DIS, V146, P47, DOI 10.1093/infdis/146.1.47; Boone SA, 2005, J INFECTION, V51, P103, DOI 10.1016/j.jinf.2004.09.011; Bowman AS, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.33; Ciacci-Zanella JR, 2010, J VET DIAGN INVEST, V22, P3, DOI 10.1177/104063871002200102; Forgie SE, 2011, CLIN INFECT DIS, V52, P10, DOI 10.1093/cid/ciq030; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Greatorex JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027932; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3675; Koen J.S., 1919, AM J VET MED ASSOC, V14, P468; MEGURO H, 1979, J CLIN MICROBIOL, V9, P175; Mukherjee DV, 2012, AM J INFECT CONTROL, V40, P590, DOI 10.1016/j.ajic.2011.09.006; Otake S, 2002, J SWINE HEALTH PROD, V10, P59; Pitkin A, 2011, J SWINE HEALTH PROD, V19, P345; Richards Shawn, 2012, Morbidity and Mortality Weekly Report, V61, P619; Slomka MJ, 2010, INFLUENZA OTHER RESP, V4, P277, DOI 10.1111/j.1750-2659.2010.00149.x; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Thomas Y, 2008, APPL ENVIRON MICROB, V74, P3002, DOI 10.1128/AEM.00076-08; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Vincent AL, 2009, VIRUS GENES, V39, P176, DOI 10.1007/s11262-009-0386-6; Zhou NN, 1999, J VIROL, V73, P8851, DOI 10.1128/JVI.73.10.8851-8856.1999	23	31	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67293	10.1371/journal.pone.0067293	http://dx.doi.org/10.1371/journal.pone.0067293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805306	Green Submitted, gold, Green Published			2022-12-25	WOS:000320846500134
J	Fan, Q; Chen, M; Zuo, L; Shang, XY; Huang, MZ; Ciccarelli, M; Raake, P; Brinks, H; Chuprun, KJ; Dorn, GW; Koch, WJ; Gao, EH				Fan, Qian; Chen, Mai; Zuo, Lin; Shang, Xiying; Huang, Maggie Z.; Ciccarelli, Michele; Raake, Philip; Brinks, Henriette; Chuprun, Kurt J.; Dorn, Gerald W., II; Koch, Walter J.; Gao, Erhe			Myocardial Ablation of G Protein-Coupled Receptor Kinase 2 (GRK2) Decreases Ischemia/Reperfusion Injury through an Anti-Intrinsic Apoptotic Pathway	PLOS ONE			English	Article							IMPROVES CARDIAC-FUNCTION; HEART-FAILURE; CYTOCHROME-C; CELL-DEATH; DARBEPOETIN-ALPHA; INFARCTION; ISCHEMIA; MYOCYTES; RELEASE; PHOSPHORYLATION	Studies from our lab have shown that decreasing myocardial G protein-coupled receptor kinase 2 (GRK2) activity and expression can prevent heart failure progression after myocardial infarction. Since GRK2 appears to also act as a pro-death kinase in myocytes, we investigated the effect of cardiomyocyte-specific GRK2 ablation on the acute response to cardiac ischemia/reperfusion (I/R) injury. To do this we utilized two independent lines of GRK2 knockout (KO) mice where the GRK2 gene was deleted in only cardiomyocytes either constitutively at birth or in an inducible manner that occurred in adult mice prior to I/R. These GRK2 KO mice and appropriate control mice were subjected to a sham procedure or 30 min of myocardial ischemia via coronary artery ligation followed by 24 hrs reperfusion. Echocardiography and hemodynamic measurements showed significantly improved post-I/R cardiac function in both GRK2 KO lines, which correlated with smaller infarct sizes in GRK2 KO mice compared to controls. Moreover, there was significantly less TUNEL positive myocytes, less caspase-3, and -9 but not caspase-8 activities in GRK2 KO mice compared to control mice after I/R injury. Of note, we found that lowering cardiac GRK2 expression was associated with significantly lower cytosolic cytochrome C levels in both lines of GRK2 KO mice after I/R compared to corresponding control animals. Mechanistically, the anti-apoptotic effects of lowering GRK2 expression were accompanied by increased levels of Bcl-2, Bcl-xl, and increased activation of Akt after I/R injury. These findings were reproduced in vitro in cultured cardiomyocytes and GRK2 mRNA silencing. Therefore, lowering GRK2 expression in cardiomyocytes limits I/R-induced injury and improves post-ischemia recovery by decreasing myocyte apoptosis at least partially via Akt/Bcl-2 mediated mitochondrial protection and implicates mitochondrial-dependent actions, solidifying GRK2 as a pro-death kinase in the heart.	[Fan, Qian; Chen, Mai; Zuo, Lin; Shang, Xiying; Huang, Maggie Z.; Ciccarelli, Michele; Raake, Philip; Brinks, Henriette; Chuprun, Kurt J.; Koch, Walter J.; Gao, Erhe] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19122 USA; [Dorn, Gerald W., II] Washington Univ, Sch Med, Dept Med, Ctr Pharmacogen, St Louis, MO 63110 USA; [Fan, Qian] Capital Med Univ, Chaoyang Hosp, Beijing, Peoples R China; [Chen, Mai] Fourth Mil Med Univ, Xijing Hosp, Xian 710032, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Washington University (WUSTL); Capital Medical University; Air Force Military Medical University	Gao, EH (corresponding author), Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19122 USA.	erhe.gao@temple.edu	Ciccarelli, Michele/ABC-2826-2021; Ciccarelli, Michele/K-2824-2016	Ciccarelli, Michele/0000-0003-2379-1960; Ciccarelli, Michele/0000-0003-2379-1960; Fan, Qian/0000-0002-8269-3060	National Institutes of Health (NIH) [R37 HL061690, P01 HL075443]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL061690, P01HL075443, R01HL087871] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health (NIH) grants R37 HL061690, P01 HL075443 (Project 2) and P01 HL075443 (Project 1 and Core B) (to WJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Boucher M, 2008, CTS-CLIN TRANSL SCI, V1, P13, DOI 10.1111/j.1752-8062.2008.00008.x; Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004; Brinks H, 2010, CIRC RES, V107, P1140, DOI 10.1161/CIRCRESAHA.110.221010; Chen M, 2013, CIRC RES, V112, P1121, DOI 10.1161/CIRCRESAHA.112.300754; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Gao E, 2007, AM J PHYSIOL-HEART C, V293, pH60, DOI 10.1152/ajpheart.00227.2007; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Hata JA, 2006, J CARD FAIL, V12, P360, DOI 10.1016/j.cardfail.2006.02.011; Kang PM, 2000, CIRC RES, V87, P118, DOI 10.1161/01.RES.87.2.118; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu HR, 2005, CIRCULATION, V111, P90, DOI 10.1161/01.CIR.0000151613.90994.17; Liu SL, 2005, NAT MED, V11, P952, DOI 10.1038/nm1289; Matkovich SJ, 2006, CIRC RES, V99, P996, DOI 10.1161/01.RES.0000247932.71270.2c; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Petrofski JA, 2003, J MOL CELL CARDIOL, V35, P1167, DOI 10.1016/S0022-2828(03)00243-8; Raake PW, 2008, CIRC RES, V103, P413, DOI 10.1161/CIRCRESAHA.107.168336; Ranger AM, 2001, NAT GENET, V28, P113, DOI 10.1038/88815; Rengo G, 2009, CIRCULATION, V119, P89, DOI 10.1161/CIRCULATIONAHA.108.803999; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Theilade J, 2003, BASIC RES CARDIOL, V98, P97, DOI 10.1007/s00395-003-0395-x; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Toth A, 2006, AM J PHYSIOL-HEART C, V291, pH52, DOI 10.1152/ajpheart.01046.2005; Tsuruta F, 2002, J BIOL CHEM, V277, P14040, DOI 10.1074/jbc.M108975200; Uchiyama T, 2004, CIRCULATION, V109, P3042, DOI 10.1161/01.CIR.0000130647.29030.90; Ungerer M, 1996, CIRC RES, V79, P455, DOI 10.1161/01.RES.79.3.455; White DC, 2000, P NATL ACAD SCI USA, V97, P5428, DOI 10.1073/pnas.090091197; Yamamoto S, 2001, J MOL CELL CARDIOL, V33, P1829, DOI 10.1006/jmcc.2001.1446; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	38	45	49	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66234	10.1371/journal.pone.0066234	http://dx.doi.org/10.1371/journal.pone.0066234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805205	Green Submitted, Green Published, gold			2022-12-25	WOS:000320846500033
J	Mallavia, B; Oguiza, A; Lopez-Franco, O; Recio, C; Ortiz-Munoz, G; Lazaro, I; Lopez-Parra, V; Egido, J; Gomez-Guerrero, C				Mallavia, Benat; Oguiza, Ainhoa; Lopez-Franco, Oscar; Recio, Carlota; Ortiz-Munoz, Guadalupe; Lazaro, Iolanda; Lopez-Parra, Virginia; Egido, Jesus; Gomez-Guerrero, Carmen			Gene Deficiency in Activating Fc gamma Receptors Influences the Macrophage Phenotypic Balance and Reduces Atherosclerosis in Mice	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; E KNOCKOUT MICE; CORONARY-ARTERY-DISEASE; SMOOTH-MUSCLE-CELLS; REGULATORY T-CELLS; IMMUNE-COMPLEXES; STEM-CELLS; OXIDIZED LDL; KAPPA-B; INHIBITION	Immunity contributes to arterial inflammation during atherosclerosis. Oxidized low-density lipoproteins induce an autoimmune response characterized by specific antibodies and immune complexes in atherosclerotic patients. We hypothesize that specific Fc gamma receptors for IgG constant region participate in atherogenesis by regulating the inflammatory state of lesional macrophages. In vivo we examined the role of activating Fc gamma receptors in atherosclerosis progression using bone marrow transplantation from mice deficient in gamma-chain (the common signaling subunit of activating Fc gamma receptors) to hyperlipidemic mice. Hematopoietic deficiency of Fc gamma receptors significantly reduced atherosclerotic lesion size, which was associated with decreased number of macrophages and T lymphocytes, and increased T regulatory cell function. Lesions of Fc gamma receptor deficient mice exhibited increased plaque stability, as evidenced by higher collagen and smooth muscle cell content and decreased apoptosis. These effects were independent of changes in serum lipids and antibody response to oxidized low-density lipoproteins. Activating Fc gamma receptor deficiency reduced pro-inflammatory gene expression, nuclear factor-kappa B activity, and M1 macrophages at the lesion site, while increasing anti-inflammatory genes and M2 macrophages. The decreased inflammation in the lesions was mirrored by a reduced number of classical inflammatory monocytes in blood. In vitro, lack of activating Fc gamma receptors attenuated foam cell formation, oxidative stress and pro-inflammatory gene expression, and increased M2-associated genes in murine macrophages. Our study demonstrates that activating Fc gamma receptors influence the macrophage phenotypic balance in the artery wall of atherosclerotic mice and suggests that modulation of Fc gamma receptor-mediated inflammatory responses could effectively suppress atherosclerosis.	[Mallavia, Benat; Oguiza, Ainhoa; Lopez-Franco, Oscar; Recio, Carlota; Ortiz-Munoz, Guadalupe; Lazaro, Iolanda; Lopez-Parra, Virginia; Gomez-Guerrero, Carmen] Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Renal & Vasc Inflammat Lab, Madrid, Spain; [Mallavia, Benat; Oguiza, Ainhoa; Recio, Carlota; Lazaro, Iolanda; Lopez-Parra, Virginia; Egido, Jesus; Gomez-Guerrero, Carmen] Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Dept Nephrol, Madrid, Spain; [Lopez-Franco, Oscar] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Ortiz-Munoz, Guadalupe] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	Autonomous University of Madrid; Fundacion Jimenez Diaz; Autonomous University of Madrid; Fundacion Jimenez Diaz; University of Glasgow; University of California System; University of California San Francisco	Gomez-Guerrero, C (corresponding author), Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Renal & Vasc Inflammat Lab, Madrid, Spain.	cgomez@fjd.es	Recio, Carlota/ABF-5850-2021; munoz, guadalupe ortiz/B-4969-2019; Lopez-Franco, Oscar/AAS-5979-2021; LOPEZ, IOLANDA LAZARO/L-5393-2014; Recio, Carlota/D-2984-2019	munoz, guadalupe ortiz/0000-0002-8928-0576; LOPEZ, IOLANDA LAZARO/0000-0002-6172-9845; Recio, Carlota/0000-0002-8832-2826; Lopez-Franco, Oscar/0000-0001-5069-3763	Spanish Ministry of Science [SAF2009-11794, SAF2012-38830]; Ministry of Health [FIS PI10/00072, RECAVA RD12/0042/0038]; Spanish Society of Nephrology; Fundacion Renal Inigo Alvarez de Toledo; Lilly Foundation	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Health; Spanish Society of Nephrology; Fundacion Renal Inigo Alvarez de Toledo; Lilly Foundation	This work was supported by grants from Spanish Ministry of Science (SAF2009-11794, SAF2012-38830), Ministry of Health (FIS PI10/00072, RECAVA RD12/0042/0038), Spanish Society of Nephrology, Fundacion Renal Inigo Alvarez de Toledo and Lilly Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2010, J EXP MED, V207, P1579, DOI 10.1084/jem.20100155; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; Devaraj S, 2011, ARTERIOSCL THROM VAS, V31, P1397, DOI 10.1161/ATVBAHA.111.225508; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Gavasso S, 2005, ATHEROSCLEROSIS, V180, P277, DOI 10.1016/j.atherosclerosis.2004.12.011; Gomez-Guerrero C, 2002, KIDNEY INT, V62, P2022, DOI 10.1046/j.1523-1755.2002.00653.x; Gomez-Guerrero C, 2012, CARDIOVASC THER, V30, pe189, DOI 10.1111/j.1755-5922.2011.00274.x; Hakkinen T, 2000, VIRCHOWS ARCH, V437, P396, DOI 10.1007/s004280000239; Hernandez-Presa MA, 1999, KIDNEY INT, V55, P209, DOI 10.1046/j.1523-1755.1999.00226.x; Hernandez-Vargas P, 2006, CIRC RES, V99, P1188, DOI 10.1161/01.RES.0000250556.07796.6c; Horkko S, 1999, J CLIN INVEST, V103, P117, DOI 10.1172/JCI4533; Huang Y, 1999, ARTERIOSCL THROM VAS, V19, P1600, DOI 10.1161/01.ATV.19.7.1600; Kelly JA, 2010, CARDIOVASC RES, V85, P224, DOI 10.1093/cvr/cvp300; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Lopes-Virella MF, 2011, DIABETES, V60, P582, DOI 10.2337/db10-0915; Lopez-Franco O, 2006, ARTERIOSCL THROM VAS, V26, P1864, DOI 10.1161/01.ATV.0000229659.94020.53; Lopez-Parra V, 2012, J AM SOC NEPHROL, V23, P1518, DOI 10.1681/ASN.2011080822; MAGGI E, 1994, ARTERIOSCLER THROMB, V14, P1892, DOI 10.1161/01.ATV.14.12.1892; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mineo C, 2005, CIRC RES, V97, P1124, DOI 10.1161/01.RES.0000194323.77203.fe; Mor A, 2007, ARTERIOSCL THROM VAS, V27, P893, DOI 10.1161/01.ATV.0000259365.31469.89; Munder M, 1998, J IMMUNOL, V160, P5347; Ng HP, 2011, J IMMUNOL, V187, P6082, DOI 10.4049/jimmunol.1004133; Nicoletti A, 1998, J CLIN INVEST, V102, P910, DOI 10.1172/JCI119892; Nilsson J, 2008, J INTERN MED, V263, P464, DOI 10.1111/j.1365-2796.2008.01945.x; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Ortiz-Munoz G, 2009, ARTERIOSCL THROM VAS, V29, P525, DOI 10.1161/ATVBAHA.108.173781; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Pello OM, 2011, IMMUNOBIOLOGY, V216, P1172, DOI 10.1016/j.imbio.2011.05.010; Pfeiffer JR, 2001, ATHEROSCLEROSIS, V155, P211, DOI 10.1016/S0021-9150(00)00541-4; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Plutzky J, 2001, AM J CARDIOL, V88, p10K; Raaz D, 2009, ATHEROSCLEROSIS, V205, P512, DOI 10.1016/j.atherosclerosis.2009.01.013; Ratcliffe NR, 2001, IMMUNOL LETT, V77, P169, DOI 10.1016/S0165-2478(01)00217-6; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; Shoenfeld Y, 2004, CIRCULATION, V110, P2552, DOI 10.1161/01.CIR.0000143225.07377.EA; Sironi M, 2006, J LEUKOCYTE BIOL, V80, P342, DOI 10.1189/jlb.1005586; Smook MLF, 2008, CLIN EXP IMMUNOL, V154, P264, DOI 10.1111/j.1365-2249.2008.03746.x; Suzuki Y, 2003, J IMMUNOL, V170, P3243, DOI 10.4049/jimmunol.170.6.3243; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Swirski FK, 2009, ARTERIOSCL THROM VAS, V29, P1424, DOI 10.1161/ATVBAHA.108.180521; Takai T, 2005, J CLIN IMMUNOL, V25, P1, DOI 10.1007/s10875-005-0353-8; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Virella G, 2008, ATHEROSCLEROSIS, V200, P239, DOI 10.1016/j.atherosclerosis.2008.03.025; Xu Y, 2007, BIOCHEM BIOPH RES CO, V363, P782, DOI 10.1016/j.bbrc.2007.09.029; Yan PK, 2011, INT J BIOL SCI, V7, P937, DOI 10.7150/ijbs.7.937; Yan ZQ, 2007, IMMUNOL REV, V219, P187, DOI 10.1111/j.1600-065X.2007.00554.x; Zhao M, 2010, J IMMUNOL, V184, P2253, DOI 10.4049/jimmunol.0902654; Zhou XH, 1998, J CLIN INVEST, V101, P1717, DOI 10.1172/JCI1216; Zhou XH, 2006, ARTERIOSCL THROM VAS, V26, P864, DOI 10.1161/01.ATV.0000206122.61591.ff	53	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66754	10.1371/journal.pone.0066754	http://dx.doi.org/10.1371/journal.pone.0066754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805273	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000320846500101
J	Perraudin, C; Le Vaillant, M; Pelletier-Fleury, N				Perraudin, Clemence; Le Vaillant, Marc; Pelletier-Fleury, Nathalie			Cost-Effectiveness of a Community Pharmacist-Led Sleep Apnea Screening Program - A Markov Model	PLOS ONE			English	Article							RISK-FACTORS; FOLLOW-UP; CARE; POLYSOMNOGRAPHY; PREVALENCE; DISORDERS; DIAGNOSIS; SYMPTOMS; HOME; MEN	Background: Despite the high prevalence and major public health ramifications, obstructive sleep apnea syndrome (OSAS) remains underdiagnosed. In many developed countries, because community pharmacists (CP) are easily accessible, they have been developing additional clinical services that integrate the services of and collaborate with other healthcare providers (general practitioners (GPs), nurses, etc.). Alternative strategies for primary care screening programs for OSAS involving the CP are discussed. Objective: To estimate the quality of life, costs, and cost-effectiveness of three screening strategies among patients who are at risk of having moderate to severe OSAS in primary care. Design: Markov decision model. Data Sources: Published data. Target Population: Hypothetical cohort of 50-year-old male patients with symptoms highly evocative of OSAS. Time Horizon: The 5 years after initial evaluation for OSAS. Perspective: Societal. Interventions: Screening strategy with CP (CP-GP collaboration), screening strategy without CP (GP alone) and no screening. Outcomes measures: Quality of life, survival and costs for each screening strategy. Results of base-case analysis: Under almost all modeled conditions, the involvement of CPs in OSAS screening was cost effective. The maximal incremental cost for "screening strategy with CP" was about 455(sic) per QALY gained. Results of sensitivity analysis: Our results were robust but primarily sensitive to the treatment costs by continuous positive airway pressure, and the costs of untreated OSAS. The probabilistic sensitivity analysis showed that the "screening strategy with CP" was dominant in 80% of cases. It was more effective and less costly in 47% of cases, and within the cost-effective range (maximum incremental cost effectiveness ratio at (sic)6186.67/QALY) in 33% of cases. Conclusions: CP involvement in OSAS screening is a cost-effective strategy. This proposal is consistent with the trend in Europe and the United States to extend the practices and responsibilities of the pharmacist in primary care.	[Perraudin, Clemence] Fac Med Paris Sud Paris 6, Le Kremlin Bicetre, France; [Perraudin, Clemence; Le Vaillant, Marc; Pelletier-Fleury, Nathalie] INSERM, Ctr Rech Med Sci Sante Sante Mentale Soc CERMES3, UMR 8211, U988, Villejuif, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Perraudin, C (corresponding author), Fac Med Paris Sud Paris 6, Le Kremlin Bicetre, France.	clemence.perraudin@gmail.com	Pelletier-Fleury, Nathalie/R-4220-2018	Pelletier-Fleury, Nathalie/0000-0002-4821-4863	Ministry of Higher Education and Research; Ordre National des Pharmaciens	Ministry of Higher Education and Research(Ministry of Higher Education & Scientific Research (MHESR)); Ordre National des Pharmaciens	This study is part of a thesis that is funded by a research allowance from the Ministry of Higher Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the Ordre National des Pharmaciens for their support in this paper.	Albarrak M, 2005, SLEEP, V28, P1306, DOI 10.1093/sleep/28.10.1306; Anderson C, 2000, PATIENT EDUC COUNS, V39, P285, DOI 10.1016/S0738-3991(99)00025-7; Bahammam A, 1999, SLEEP, V22, P740, DOI 10.1093/sleep/22.6.740; Blenkinsopp A, 2003, J PUBLIC HEALTH MED, V25, P144, DOI 10.1093/pubmed/fdg030; Chakravorty I, 2002, EUR RESPIR J, V20, P1233, DOI 10.1183/09031936.00.00014401; Chapman JL, 2004, BRIT J GEN PRACT, V54, P374; Chervin RD, 1999, ANN INTERN MED, V130, P496, DOI 10.7326/0003-4819-130-6-199903160-00006; Christensen DB, 2006, ANN PHARMACOTHER, V40, P1400, DOI 10.1345/aph.1G545; Deutsch PA, 2006, J CLIN SLEEP MED, V2, P145; Dingli K, 2003, EUR RESPIR J, V21, P253, DOI 10.1183/09031936.03.00298103; Engleman HM, 2003, SLEEP MED REV, V7, P81, DOI 10.1053/smrv.2001.0197; Fuhrman C, 2012, SLEEP MED, V13, P852, DOI 10.1016/j.sleep.2012.04.005; Fuller JM, 2011, PATIENT EDUC COUNS, V83, P325, DOI 10.1016/j.pec.2011.05.004; Giles TL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001106.pub2; Gold MR, 1996, COST EFFECTIVENESS H; Hersberger KE, 2006, J CLIN PHARM THER, V31, P35, DOI 10.1111/j.1365-2710.2006.00698.x; Jenkinson C, 1998, QUAL LIFE RES, V7, P95; Jennum P, 2011, THORAX, V66, P560, DOI 10.1136/thx.2010.143958; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; Koshman SL, 2008, ARCH INTERN MED, V168, P687, DOI 10.1001/archinte.168.7.687; Lindberg E, 2001, AM J RESP CRIT CARE, V164, P2031, DOI 10.1164/ajrccm.164.11.2102028; Manolakis Patti Gasdek, 2010, Am J Pharm Educ, V74, pS7; Mar J, 2003, EUR RESPIR J, V21, P515, DOI 10.1183/09031936.03.00040903; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Meslier N, 2007, REV MAL RESPIR, V24, P305, DOI 10.1016/S0761-8425(07)91062-1; *MIN SANT SPORTS, 2006, RAPP THEM SOMM, V2; Mold JW, 2011, J AM BOARD FAM MED, V24, P138, DOI 10.3122/jabfm.2011.02.100095; *NAT INST DEM, 2011, FRENCH LIF TABL 2007; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Noyce PR, 2007, ANN PHARMACOTHER, V41, P861, DOI 10.1345/aph.1K015; Pietzsch JB, 2011, SLEEP, V34, P695, DOI 10.5665/SLEEP.1030; Santschi V, 2011, ARCH INTERN MED, V171, P1441, DOI 10.1001/archinternmed.2011.399; Smith R, 2002, CHEST, V121, P164, DOI 10.1378/chest.121.1.164; TOUSIGNANT P, 1994, SLEEP, V17, P52; Tran A, 2009, PHARM WORLD SCI, V31, P473, DOI 10.1007/s11096-009-9301-4; Tregear S, 2010, SLEEP, V33, P1373, DOI 10.1093/sleep/33.10.1373; WIRRMANN V, 2004, SLEEP MED REV, V8, P269; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Yuksel N, 2010, OSTEOPOROSIS INT, V21, P391, DOI 10.1007/s00198-009-0977-z	39	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e63894	10.1371/journal.pone.0063894	http://dx.doi.org/10.1371/journal.pone.0063894			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	170JP	23805176	gold, Green Published, Green Submitted			2022-12-25	WOS:000320846500004
J	Priemer, G; Balkema-Buschmann, A; Hills, B; Groschup, MH				Priemer, Grit; Balkema-Buschmann, Anne; Hills, Bob; Groschup, Martin H.			Biochemical Characteristics and PrPSc Distribution Pattern in the Brains of Cattle Experimentally Challenged with H-type and L-type Atypical BSE	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; PRION PROTEIN; INTRACEREBRAL INOCULATION; MOLECULAR ANALYSIS; INFECTIVITY; STRAIN; SHEEP; TRANSMISSION; ACCUMULATION	Besides the classical form of bovine spongiform encephalopathy (BSE) that has been known for almost three decades, two atypical forms designated H-type and L-type BSE have recently been described. While the main diagnostic feature of these forms is the altered biochemical profile of the accumulated PrPSc, it was also observed in the initial analysis that L-type BSE displays a distribution pattern of the pathological prion protein (PrPSc), which clearly differs from that observed in classical BSE (C-type). Most importantly, the obex region in the brainstem is not the region with the highest PrPSc concentrations, but PrPSc is spread more evenly throughout the entire brain. A similar distribution pattern has been revealed for H-type BSE by rapid test analysis. Based on these findings, we performed a more detailed Western blot study of the anatomical PrPSc distribution pattern and the biochemical characteristics (molecular mass, glycoprofile as well as PK sensitivity) in ten different anatomical locations of the brain from cattle experimentally challenged with H-or L-type BSE, as compared to cattle challenged with C-type BSE. Results of this study revealed distinct differences in the PrPSc deposition patterns between all three BSE forms, while the biochemical characteristics remained stable for each BSE type among all analysed brain areas.	[Priemer, Grit; Balkema-Buschmann, Anne; Groschup, Martin H.] Friedrich Loeffler Inst, Inst Novel & Emerging Infect Dis, Greifswald, Germany; [Hills, Bob] Hlth Canada, Transmissible Spongiform Encephalopathy Secretari, Ottawa, ON K1A 0L2, Canada	Friedrich Loeffler Institute; Health Canada	Groschup, MH (corresponding author), Friedrich Loeffler Inst, Inst Novel & Emerging Infect Dis, Greifswald, Germany.	martin.groschup@fli.bund.de			Health Canada	Health Canada	Bob Hills, representing Health Canada (which majorly funded this project), played an active role as a scientist in the development and design of the study. No additional external funding was received for this study.	[Anonymous], 2012, REPORT MONITORING RU; Balkema-Buschmann A, 2011, PREV VET MED, V102, P112, DOI 10.1016/j.prevetmed.2011.04.006; Balkema-Buschmann A, 2011, J TOXICOL ENV HEAL A, V74, P103, DOI 10.1080/15287394.2011.529060; Balkema-Buschmann A, 2011, J GEN VIROL, V92, P467, DOI 10.1099/vir.0.025387-0; Baron T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015839; Beringue V, 2007, J NEUROSCI, V27, P6965, DOI 10.1523/JNEUROSCI.0693-07.2007; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Buschmann A, 2006, VET MICROBIOL, V117, P103, DOI 10.1016/j.vetmic.2006.06.016; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Fukuda S, 2012, JPN J INFECT DIS, V65, P37; Gonzalez L, 2005, J GEN VIROL, V86, P827, DOI 10.1099/vir.0.80299-0; Hoffmann C, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-21; Jacobs JG, 2007, J CLIN MICROBIOL, V45, P1821, DOI 10.1128/JCM.00160-07; Kaatz M, 2012, AM J PATHOL, V181, P515, DOI 10.1016/j.ajpath.2012.05.001; Konold T, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-22; Kuczius T, 1998, J INFECT DIS, V178, P693, DOI 10.1086/515337; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Levavasseur E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002786; Lombardi G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000075; McGowan J.P., 1922, SCOTT J AGR, V5, P365; Meloni D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043133; Nickel R, 1992, PAREY, VIV, P68; Okada H, 2012, VET PATHOL, V49, P819, DOI 10.1177/0300985811427150; Okada H, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-79; Parchi P, 2009, ACTA NEUROPATHOL, V118, P659, DOI 10.1007/s00401-009-0585-1; Polak MP, 2012, VET J, V191, P128, DOI 10.1016/j.tvjl.2010.12.019; Siso S, 2009, NEUROPATH APPL NEURO, V35, P247, DOI 10.1111/j.1365-2990.2009.01013.x; Sweeney T, 2000, J GEN VIROL, V81, P1621, DOI 10.1099/0022-1317-81-6-1621; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; Wells GAH, 2005, VET REC, V156, P401, DOI 10.1136/vr.156.13.401	31	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67599	10.1371/journal.pone.0067599	http://dx.doi.org/10.1371/journal.pone.0067599			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805320	Green Submitted, Green Published, gold			2022-12-25	WOS:000320846500148
J	Yu, XM; Liu, Y; Jin, T; Liu, J; Wang, J; Ma, C; Pan, XL				Yu, Xue-Min; Liu, Ying; Jin, Tong; Liu, Jun; Wang, Juan; Ma, Chao; Pan, Xin-Liang			The Expression of SIRT1 and DBC1 in Laryngeal and Hypopharyngeal Carcinomas	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HISTONE DEACETYLASES; POOR-PROGNOSIS; PROTEIN	Rationale and Objective: Sirtuin 1 (SIRT1) plays an important role in tumorigenesis and is increased in many human tumors. DBC1 is a negative regulator of SIRT1 via promotion of p53-mediated apoptosis. It is necessary to investigate the expression of SIRT1 and DBC1 in laryngeal and hypopharyngeal squamous cell carcinomas (LSCC and HSCC) and its correlation with available clinical parameters. Methods: The mRNA levels of SIRT1 and DBC1 were measured in 54 paired LSCC or HSCC tumors and corresponding adjacent noncancerous mucosae using quantitative RT-PCR (qRT-PCR). The protein levels of SIRT1 and DBC1 were also evaluated in 120 cases of patients with LSCC or HSCC using immunohistochemical staining. The correlation between SIRT1 and DBC1 expression and clinical parameters was analyzed with Pearson chi-square test. Results: qRT-PCR assay showed that, compared with the paired adjacent noncancerous mucosae, SIRT1 mRNA was significantly decreased in tumors. The immunohistochemical results indicated that the SIRT1 protein was also downregulated in tumors compared with noncancerous mucosae. Moreover, decreased SIRT1 was significantly correlated with the tumor clinical stage and lymph node metastasis. Additionally, DBC1 mRNA was significantly increased in tumors compared with noncancerous mucosae. The immunohistochemical results indicated that the DBC1 protein was downregulated in tumors, which is inconsistent with the results obtained by qRT-PCR. Finally, decreased DBC1 protein was significantly correlated with tumor differentiation, lymph node metastasis, and p53 expression. Conclusions: SIRT1 and DBC1 might be involved in the pathophysiology of laryngeal and hypopharyngeal squamous cell carcinomas and are associated with lymph node metastasis and p53 positive staining in LSCCs and HSCCs.	[Yu, Xue-Min; Liu, Ying; Jin, Tong; Liu, Jun; Wang, Juan; Ma, Chao; Pan, Xin-Liang] Shandong Univ, Qilu Hosp, Dept Otolaryngol, Jinan 250100, Peoples R China; [Liu, Jun] Sichuan Univ, West China Hosp, Dept Otolaryngol Head & Neck Surg, Chengdu 610064, Peoples R China	Shandong University; Sichuan University	Pan, XL (corresponding author), Shandong Univ, Qilu Hosp, Dept Otolaryngol, Jinan 250100, Peoples R China.	panxinl915@126.com	, 刀客/ABG-3664-2020	Liu, Jun/0000-0003-4800-7749	National Natural Science Foundation of China [30772411, C170702]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (no. 30772411 and no. C170702). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle P, 2005, ANN ONCOL, V16, P481, DOI 10.1093/annonc/mdi098; Bradbury C, 2005, LEUKEMIA, V19, P1751, DOI 10.1038/sj.leu.2403910; Byles V, 2010, INT J BIOL SCI, V6, P599; Cha EJ, 2009, CLIN CANCER RES, V15, P4453, DOI 10.1158/1078-0432.CCR-08-3329; Chen B, 2006, J BIOL CHEM, V281, P2764, DOI 10.1074/jbc.M507330200; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Gu LB, 2009, CANCER CELL, V15, P363, DOI 10.1016/j.ccr.2009.03.002; Hall SF, 2008, LARYNGOSCOPE, V118, P1362, DOI 10.1097/MLG.0b013e318173dc4a; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Hida Y, 2007, ARCH DERMATOL RES, V299, P103, DOI 10.1007/s00403-006-0725-6; Hiraike H, 2011, EXP THER MED, V2, P1105, DOI 10.3892/etm.2011.333; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jain KK, 2007, CURR OPIN MOL THER, V9, P563; Jang KY, 2008, AM J SURG PATHOL, V32, P1523, DOI 10.1097/PAS.0b013e31816b6478; Jang KY, 2009, PATHOLOGY, V41, P366, DOI 10.1080/00313020902884451; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jin QH, 2007, J CELL PHYSIOL, V213, P88, DOI 10.1002/jcp.21091; Kabra N, 2009, J BIOL CHEM, V284, P18210, DOI 10.1074/jbc.M109.000034; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kojima K, 2008, BIOCHEM BIOPH RES CO, V373, P423, DOI 10.1016/j.bbrc.2008.06.045; Kwon HS, 2008, TRENDS BIOCHEM SCI, V33, P517, DOI 10.1016/j.tibs.2008.08.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao Y, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-101; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Noguchi A, 2013, OR SURG OR MED OR PA, V115, P385, DOI 10.1016/j.oooo.2012.12.013; Srinivas PR, 2001, LANCET ONCOL, V2, P698, DOI 10.1016/S1470-2045(01)00560-5; Sung JY, 2010, CANCER SCI, V101, P1738, DOI 10.1111/j.1349-7006.2010.01573.x; Trauernicht AM, 2007, MOL ENDOCRINOL, V21, P1526, DOI 10.1210/me.2007-0064; Voelter-Mahlknecht S, 2006, INT J MOL MED, V17, P59; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wittekindt C., 2012, GMS CURR TOP OTORHIN; Zhang Y, 2013, INT J CLIN ONCOL; Zhao W, 2008, NATURE, V451	36	8	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66975	10.1371/journal.pone.0066975	http://dx.doi.org/10.1371/journal.pone.0066975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805287	gold, Green Submitted, Green Published			2022-12-25	WOS:000320846500115
J	Zhao, H; Chan, SJ; Ng, YK; Wong, PTH				Zhao, Heng; Chan, Su-Jing; Ng, Yee-Kong; Wong, Peter T. -H.			Brain 3-Mercaptopyruvate Sulfurtransferase (3MST): Cellular Localization and Downregulation after Acute Stroke	PLOS ONE			English	Article							CYSTATHIONINE BETA-SYNTHASE; HYDROGEN-SULFIDE; NEUROMODULATOR; HOMOCYSTEINE; CYSTEINE; SYSTEM; RISK; RAT	3-Mercaptopyruvate sulfurtransferase (3MST) is an important enzyme for the synthesis of hydrogen sulfide (H2S) in the brain. We present here data that indicate an exclusively localization of 3MST in astrocytes. Regional distribution of 3MST activities is even and unremarkable. Following permanent middle cerebral artery occlusion (pMCAO), 3MST was down-regulated in both the cortex and striatum, but not in the corpus collosum. It appears that the down-regulation of astrocytic 3MST persisted in the presence of astrocytic proliferation due to gliosis. Our observations indicate that 3MST is probably not responsible for the increased production of H2S following pMCAO. Therefore, cystathionine beta-synthase (CBS), the alternative H2S producing enzyme in the CNS, remains as a more likely potential therapeutic target than 3MST in the treatment of acute stroke through inhibition of H2S production.	[Zhao, Heng; Chan, Su-Jing; Wong, Peter T. -H.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Natl Univ Hlth Syst, Singapore 117595, Singapore; [Ng, Yee-Kong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Natl Univ Hlth Syst, Singapore 117595, Singapore	National University of Singapore; National University of Singapore	Wong, PTH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Natl Univ Hlth Syst, Singapore 117595, Singapore.	peter_wong@nuhs.edu.sg			Biomedical Research Council of Singapore	Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by a Biomedical Research Council of Singapore grant awarded to PTHW (http://www.a-star.edu.sg/bmrc/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, J NEUROSCI, V16, P1066; Boysen G, 2003, STROKE, V34, P1258, DOI 10.1161/01.STR.0000069017.78624.37; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Del Ser T, 2001, CEREBROVASC DIS, V12, P91, DOI 10.1159/000047687; Ishii I, 2004, BIOCHEM J, V381, P113, DOI 10.1042/BJ20040243; Liu YH, 2012, ANTIOXID REDOX SIGN, V17, P141, DOI 10.1089/ars.2011.4005; Mikami Y, 2011, J BIOL CHEM, V286, P39379, DOI 10.1074/jbc.M111.298208; Nagai Y, 2004, FASEB J, V18, P557, DOI 10.1096/fj.03-1052fje; Perna AF, 2013, J CELL BIOCHEM, V114, P1536, DOI 10.1002/jcb.24495; Porter D W, 1995, J Biochem Toxicol, V10, P287, DOI 10.1002/jbt.2570100602; Porter DW, 1995, J BIOCHEM TOXICOL, V10, P45; Qu K, 2008, NEUROCHEM INT, V52, P155, DOI 10.1016/j.neuint.2007.05.016; Qu K, 2006, STROKE, V37, P889, DOI 10.1161/01.STR.0000204184.34946.41; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6; Tan BH, 2010, NEUROCHEM INT, V56, P3, DOI 10.1016/j.neuint.2009.08.008; Westrop GD, 2009, J BIOL CHEM, V284, P33485, DOI 10.1074/jbc.M109.054320; Wong PTH, 2006, J NEUROPATH EXP NEUR, V65, P109, DOI 10.1097/01.jnen.0000199571.96472.c7; Zou CG, 2003, J BIOL CHEM, V278, P16802, DOI 10.1074/jbc.M212376200	21	35	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67322	10.1371/journal.pone.0067322	http://dx.doi.org/10.1371/journal.pone.0067322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805308	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500136
J	Hu, QD; Yuan, YW; Wang, CY				Hu, Qiande; Yuan, Yewen; Wang, Chiayeng			Structural and Functional Studies of FKHR-PAX3, a Reciprocal Fusion Gene of the t(2;13) Chromosomal Translocation in Alveolar Rhabdomyosarcoma	PLOS ONE			English	Article							GROWTH SUPPRESSIVE ACTIVITIES; TRANSCRIPTION FACTOR; PHYSICAL MAP; PAX3; EXPRESSION; ISOFORMS; PROTEIN; TRANSACTIVATION; IDENTIFICATION; LOCALIZATION	Alveolar rhabdomyosarcoma (ARMS) is an aggressive pediatric cancer of skeletal muscle. More than 70% of ARMS tumors carry balanced t(2;13) chromosomal translocation that leads to the production of two novel fusion genes, PAX3-FKHR and FKHR-PAX3. While the PAX3-FKHR gene has been intensely studied, the reciprocal FKHR-PAX3 gene has rarely been described. We report here the cloning and functional characterization of the FKHR-PAX3 gene as the first step towards a better understanding of its potential impact on ARMS biology. From RH30 ARMS cells, we detected and isolated three versions of FKHR-PAX3 cDNAs whose C-terminal sequences corresponded to PAX3c, PAX3d, and PAX3e isoforms. Unlike the nuclear-specific localization of PAX3-FKHR, the reciprocal FKHR-PAX3 proteins stayed predominantly in the cytoplasm. FKHR-PAX3 potently inhibited myogenesis in both non-transformed myoblast cells and ARMS cells. We showed that FKHR-PAX3 was not a classic oncogene but could act as a facilitator in oncogenic pathways by stabilizing PAX3-FKHR expression, enhancing cell proliferation, clonogenicity, anchorage-independent growth, and matrix adhesion in vitro, and accelerating the onset of tumor formation in xenograft mouse model in vivo. In addition to these pro-oncogenic behaviors, FKHR-PAX3 also negatively affected cell migration and invasion in vitro and lung metastasis in vivo. Taken together, these functional characteristics suggested that FKHR-PAX3 might have a critical role in the early stage of ARMS development.	[Hu, Qiande; Yuan, Yewen; Wang, Chiayeng] Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL 60680 USA; [Yuan, Yewen; Wang, Chiayeng] Univ Illinois, Dept Oral Biol, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wang, CY (corresponding author), Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL 60680 USA.	chiayeng@uic.edu			NCI/NIH [CA074907]; NATIONAL CANCER INSTITUTE [R01CA074907, R29CA074907] Funding Source: NIH RePORTER	NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI/NIH (http://m.cancer.gov/) CA074907 to Chiayeng Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber TD, 1999, GENE, V237, P311, DOI 10.1016/S0378-1119(99)00339-X; BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; Barr FG, 1998, CANCER GENET CYTOGEN, V102, P32, DOI 10.1016/S0165-4608(97)00287-2; BARR FG, 1992, GENOMICS, V13, P1150, DOI 10.1016/0888-7543(92)90030-V; BARR FG, 1991, GENOMICS, V11, P941, DOI 10.1016/0888-7543(91)90018-A; Begum S, 2005, ONCOGENE, V24, P1860, DOI 10.1038/sj.onc.1208315; Bernasconi M, 1996, P NATL ACAD SCI USA, V93, P13164, DOI 10.1073/pnas.93.23.13164; Bursen A, 2010, BLOOD, V115, P3570, DOI 10.1182/blood-2009-06-229542; Cao Y, 2000, J BIOL CHEM, V275, P9854, DOI 10.1074/jbc.275.13.9854; Charytonowicz E, 2011, CLIN TRANSL ONCOL, V13, P194, DOI 10.1007/s12094-011-0640-y; De Giovanni C, 2009, FUTURE ONCOL, V5, P1449, DOI 10.2217/fon.09.97; De Pitta C, 2006, INT J CANCER, V118, P2772, DOI 10.1002/ijc.21698; DOUGLASS EC, 1987, CYTOGENET CELL GENET, V45, P148, DOI 10.1159/000132446; Epstein JA, 1998, MOL CELL BIOL, V18, P4118, DOI 10.1128/MCB.18.7.4118; Finckenstein FG, 2008, ONCOGENE, V27, P2004, DOI 10.1038/sj.onc.1210835; Frascella E, 1998, CANCER GENET CYTOGEN, V102, P104, DOI 10.1016/S0165-4608(97)00352-X; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; He LZ, 2000, MOL CELL, V6, P1131, DOI 10.1016/S1097-2765(00)00111-8; Keller C, 2004, GENE DEV, V18, P2614, DOI 10.1101/gad.1244004; Khan J, 1999, P NATL ACAD SCI USA, V96, P13264, DOI 10.1073/pnas.96.23.13264; Kumar AR, 2011, LEUKEMIA RES, V35, P305, DOI 10.1016/j.leukres.2010.08.011; Lam PYP, 1999, MOL CELL BIOL, V19, P594; Marshall AD, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-25; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Mertens F, 2009, SEMIN ONCOL, V36, P312, DOI 10.1053/j.seminoncol.2009.06.004; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Parker CJ, 2004, INT J CANCER, V108, P314, DOI 10.1002/ijc.11527; Picchione F, 2011, CARCINOGENESIS, V32, P452, DOI 10.1093/carcin/bgq273; Pollock JL, 1999, P NATL ACAD SCI USA, V96, P15103, DOI 10.1073/pnas.96.26.15103; Polyak K, 2009, TRENDS GENET, V25, P30, DOI 10.1016/j.tig.2008.10.012; Rego EM, 2002, TRENDS MOL MED, V8, P396, DOI 10.1016/S1471-4914(02)02384-5; Ren YX, 2008, CANCER RES, V68, P6587, DOI 10.1158/0008-5472.CAN-08-0859; Scheidler S, 1996, P NATL ACAD SCI USA, V93, P9805, DOI 10.1073/pnas.93.18.9805; SHAPIRO DN, 1993, CANCER RES, V53, P5108; Sumegi J, 2010, GENE CHROMOSOME CANC, V49, P224, DOI 10.1002/gcc.20731; TURCCAREL C, 1986, CANCER GENET CYTOGEN, V19, P361, DOI 10.1016/0165-4608(86)90069-5; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Wang C, 2012, J DENT RES, V91, P341, DOI 10.1177/0022034511421490; Wang QY, 2006, CANCER RES, V66, P8574, DOI 10.1158/0008-5472.CAN-06-0947; Wang-Wuu S, 1988, Cancer Res, V48, P983; Xia SJ, 2007, LAB INVEST, V87, P318, DOI 10.1038/labinvest.3700521; Xia SJ, 2009, AM J PATHOL, V175, P2600, DOI 10.2353/ajpath.2009.090192; Xia SJJ, 2004, ONCOGENE, V23, P6864, DOI 10.1038/sj.onc.1207850; Zanola A, 2012, J CELL MOL MED, V16, P1377, DOI 10.1111/j.1582-4934.2011.01518.x; Zhang L, 2007, ONCOGENE, V26, P1595, DOI 10.1038/sj.onc.1209958; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Zhang Y, 2011, ONCOGENE, V30, P3549, DOI 10.1038/onc.2011.69; Zhang YB, 2009, INT J CLIN EXP PATHO, V2, P370; Zheng XM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007661	49	3	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e68065	10.1371/journal.pone.0068065	http://dx.doi.org/10.1371/journal.pone.0068065			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799156	Green Published, gold, Green Submitted			2022-12-25	WOS:000320363300118
J	Johnson, FA; Padmadas, SS; Matthews, Z				Johnson, Fiifi Amoako; Padmadas, Sabu S.; Matthews, Zoe			Are Women Deciding against Home Births in Low and Middle Income Countries?	PLOS ONE			English	Article							HEALTH FACILITIES; RURAL BANGLADESH; CARE; CHILDBIRTH	Background: Although there is evidence to tracking progress towards facility births within the UN Millennium Development Goals framework, we do not know whether women are deciding against home birth over their reproductive lives. Using Demographic and Health Surveys (DHS) data from 44 countries, this study aims to investigate the patterns and shifts in childbirth locations and to determine whether these shifts are in favour of home or health settings. Methods and Findings: The analyses considered 108,777 women who had at least two births in the five years preceding the most recent DHS over the period 2000-2010. The vast majority of women opted for the same place of childbirth for their successive births. However, about 14% did switch their place and not all these decisions favoured health facility over home setting. In 24 of the 44 countries analysed, a higher proportion of women switched from a health facility to home. Multilevel regression analyses show significantly higher odds of switching from home to a facility for high parity women, those with frequent antenatal visits and more wealth. However, in countries with high infant mortality rates, low parity women had an increased probability of switching from home to a health facility. Conclusions: There is clear evidence that women do change their childbirth locations over successive births in low and middle income countries. After two decades of efforts to improve maternal health, it might be expected that a higher proportion of women will be deciding against home births in favour of facility births. The results from this analysis show that is not the case.	[Johnson, Fiifi Amoako] Univ Southampton, Ctr Global Hlth Populat Poverty & Policy, Southampton, Hants, England; Univ Southampton, Div Social Stat & Demog, Southampton, Hants, England	University of Southampton; University of Southampton	Johnson, FA (corresponding author), Univ Southampton, Ctr Global Hlth Populat Poverty & Policy, Southampton, Hants, England.	faj100@soton.ac.uk	Amoako Johnson, Fiifi/GWC-1466-2022; Matthews, Zoe/HGD-0506-2022	Padmadas, Sabu/0000-0002-6538-9374; Matthews, Zoe/0000-0003-1533-6618				Achadi E, 2007, TROP MED INT HEALTH, V12, P1490, DOI 10.1111/j.1365-3156.2007.01957.x; Addai I, 2000, J BIOSOC SCI, V32, P1; Chowdhury ME, 2006, LANCET, V367, P327, DOI 10.1016/S0140-6736(06)68070-7; Costello A, 2006, LANCET, V368, P1477, DOI 10.1016/S0140-6736(06)69388-4; Falkingham J, 2003, STUD FAMILY PLANN, V34, P32, DOI 10.1111/j.1728-4465.2003.00032.x; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; Freedman LP, 2005, WHOS GOT POWER TRANS; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Graham W.J., 2001, SAFE MOTHERHOOD STRA, P97; Guseh JS, 2001, AFRICAN STUDIES Q, V5, P1; IBM Corp, 2011, IBM SPSS COMPL SAMPL; Johnson FA, 2009, J COMMUN HEALTH, V34, P64, DOI 10.1007/s10900-008-9120-x; Kesterton AJ, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-30; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Labonte R, 2007, GLOBALIZATION HEALTH, V3, DOI 10.1186/1744-8603-3-6; Lawn JE, 2008, LANCET, V372, P297; Magadi M, 2000, SOC BIOL, V47, P164; Measure DHS, DEM HLTH SURV DAT; Montagu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017155; Paul BK, 2002, SOC SCI MED, V54, P1755, DOI 10.1016/S0277-9536(01)00148-4; Ress P, 2005, BMJ-BRIT MED J, V331, P4742; Rosenfield A, 2007, NEW ENGL J MED, V356, P1395, DOI 10.1056/NEJMp078026; Sharan M, 2010, HLTH SYSTEM READINES; Simwaka BN, 2005, BMJ-BRIT MED J, V331, P708, DOI 10.1136/bmj.331.7519.708; Snijders T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd; Stephenson R, 2006, AM J PUBLIC HEALTH, V96, P84, DOI 10.2105/AJPH.2004.057422; Sychareun V, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-86; Titaley CR, 2010, PREGNANCY CHILD BIRT, V10, P1; UN (United Nations), 2008, UN MILL DEV GOALS; *UNICEF, 2008, COUNTD 2015 TRACK PR; Wall LL, 1998, STUD FAMILY PLANN, V29, P341, DOI 10.2307/172248; WHO, 2010, TRENDS MAT MORT 1990	32	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65527	10.1371/journal.pone.0065527	http://dx.doi.org/10.1371/journal.pone.0065527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163UV	23799022	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000320363300022
J	Yang, JS; Lin, CW; Hsin, CH; Hsieh, MJ; Chang, YC				Yang, Jia-Sin; Lin, Chiao-Wen; Hsin, Chung-Han; Hsieh, Ming-Ju; Chang, Yu-Chao			Selaginella tamariscina Attenuates Metastasis via Akt Pathways in Oral Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; AMENTOFLAVONE INDUCES APOPTOSIS; MATRIX METALLOPROTEINASE-2; INHIBITS MIGRATION; CYCLE ARREST; TUMOR-CELL; IN-VITRO; INVASION; EXPRESSION; CARCINOMA	Background: Crude extracts of Selaginella tamariscina, an oriental medicinal herb, have been evidenced to treat several human diseases. This study investigated the mechanisms by which Selaginella tamariscina inhibits the invasiveness of human oral squamous-cell carcinoma (OSCC) HSC-3 cells. Methodology/Principal Findings: Herein, we demonstrate that Selaginella tamariscina attenuated HSC-3 cell migration and invasion in a dose-dependent manner. The anti-metastatic activities of Selaginella tamariscina occurred at least partially because of the down-regulation of matrix metalloproteinases (MMP)-2 and MMP-9 gelatinase activity and the down-regulation of protein expression. The expression and function of both MMP-2 and MMP-9 were regulated by Selaginella tamariscina at a transcriptional level, as shown by quantitative real-time PCR and reporter assays. Chromatin immunoprecipitation (ChIP) data further indicated that binding of the cAMP response element-binding (CREB) protein and activating protein-1 (AP-1) to the MMP-2 promoter diminished at the highest dosage level of Selaginella tamariscina. The DNA-binding activity of specificity protein 1 (SP-1) to the MMP-9 promoter was also suppressed at the same concentration. Selaginella tamariscina did not affect the mitogen-activated protein kinase signaling pathway, but did inhibit the effects of gelatinase by reducing the activation of serine-threonine kinase Akt. Conclusions: These results demonstrate that Selaginella tamariscina may be a potent adjuvant therapeutic agent in the prevention of oral cancer.	[Yang, Jia-Sin; Hsieh, Ming-Ju] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Lin, Chiao-Wen; Chang, Yu-Chao] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan; [Hsin, Chung-Han] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Hsin, Chung-Han] Chung Shan Med Univ Hosp, Dept Otolaryngol, Taichung, Taiwan; [Chang, Yu-Chao] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University	Chang, YC (corresponding author), Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan.	cyc@csmu.edu.tw	Hsieh, Ming-Ju/GQB-3025-2022	Hsieh, Ming-Ju/0000-0001-9726-3234	National Science Council, Taiwan [NSC100-2632-B-040-001-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a research grant from National Science Council, Taiwan (NSC100-2632-B-040-001-MY3). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chen PN, 2006, J DENT RES, V85, P220, DOI 10.1177/154405910608500303; Chiang YY, 2008, HISTOL HISTOPATHOL, V23, P1213, DOI 10.14670/HH-23.1213; Chien MH, 2012, FOOD CHEM TOXICOL, V50, P558, DOI 10.1016/j.fct.2011.12.016; Fullar A, 2012, EXP CELL RES, V318, P1517, DOI 10.1016/j.yexcr.2012.03.023; Hsieh YS, 2007, CARCINOGENESIS, V28, P977, DOI 10.1093/carcin/bgl221; Hwang IS, 2012, MYCOPATHOLOGIA, V173, P207, DOI 10.1007/s11046-011-9503-x; JUAREZ J, 1993, INT J CANCER, V55, P10, DOI 10.1002/ijc.2910550104; Jung HJ, 2007, BIOL PHARM BULL, V30, P1969, DOI 10.1248/bpb.30.1969; Jung HJ, 2006, ARCH PHARM RES, V29, P746, DOI 10.1007/BF02974074; Kim HS, 2004, ANTICANCER RES, V24, P747; Kuo HP, 2012, J AGR FOOD CHEM, V60, P9649, DOI 10.1021/jf302832n; Kuo YC, 1998, J LAB CLIN MED, V132, P76, DOI 10.1016/S0022-2143(98)90029-4; Lee IS, 1999, CANCER LETT, V144, P93, DOI 10.1016/S0304-3835(99)00202-5; Lee JS, 2009, BIOL PHARM BULL, V32, P1427, DOI 10.1248/bpb.32.1427; Lee J, 2009, J MICROBIOL BIOTECHN, V19, P204, DOI 10.4014/jmb.0810.566; Lee S, 2011, J MED FOOD, V14, P808, DOI 10.1089/jmf.2010.1428; Lu KW, 2011, HUM EXP TOXICOL, V30, P406, DOI 10.1177/0960327110372405; Mao L, 2004, CANCER CELL, V5, P311, DOI 10.1016/S1535-6108(04)00090-X; Massano J, 2006, ORAL SURG ORAL MED O, V102, P67, DOI 10.1016/j.tripleo.2005.07.038; Miao N, 1996, Zhongguo Zhong Yao Za Zhi, V21, P493; Mirzoeva S, 2013, MOL CARCINOG; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Park SY, 2012, INT J ONCOL, V41, P933, DOI 10.3892/ijo.2012.1518; Pei JS, 2012, IN VIVO, V26, P963; Ribatti D, 2008, GENES NUTR, V3, P29, DOI 10.1007/s12263-008-0076-3; Satpathy M, 2009, J BIOL CHEM, V284, P15390, DOI 10.1074/jbc.M808331200; SOPATA I, 1979, BIOCHIM BIOPHYS ACTA, V571, P305, DOI 10.1016/0005-2744(79)90100-1; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sze KMF, 2011, HEPATOLOGY, V53, P1558, DOI 10.1002/hep.24232; Tang SW, 2011, CARCINOGENESIS, V32, P138, DOI 10.1093/carcin/bgq225; VARTIO T, 1981, J BIOL CHEM, V256, P3085; Wang KL, 2013, EXPERT OPIN THER TAR, V17, P337, DOI 10.1517/14728222.2013.756869; Weng CJ, 2008, CARCINOGENESIS, V29, P147, DOI 10.1093/carcin/bgm261; Yang JW, 2006, J ETHNOPHARMACOL, V105, P107, DOI 10.1016/j.jep.2005.10.001; Yang SF, 2007, J ETHNOPHARMACOL, V110, P483, DOI 10.1016/j.jep.2006.10.010; Yeh CB, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/595292; Yu YL, 2011, J BIOL CHEM, V286, P9657, DOI 10.1074/jbc.M110.185124; Yu YL, 2010, J AGR FOOD CHEM, V58, P1630, DOI 10.1021/jf903043r; Zheng XK, 2011, J ETHNOPHARMACOL, V137, P662, DOI 10.1016/j.jep.2011.06.018	41	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e68035	10.1371/journal.pone.0068035	http://dx.doi.org/10.1371/journal.pone.0068035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799155	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300117
J	Chiu, GS; Wu, MA; Lu, L				Chiu, Grace S.; Wu, Margaret A.; Lu, Lin			Model-Based Assessment of Estuary Ecosystem Health Using the Latent Health Factor Index, with Application to the Richibucto Estuary	PLOS ONE			English	Article							MARINE BIOTIC INDEX; HIERARCHICAL-MODELS; QUALITY ASSESSMENT; COMMUNITIES; SIMULATION; VALIDATION; IMPACT; COAST; AMBI	The ability to quantitatively assess ecological health is of great interest to those tasked with monitoring and conserving ecosystems. For decades, biomonitoring research and policies have relied on multimetric health indices of various forms. Although indices are numbers, many are constructed based on qualitative procedures, thus limiting the quantitative rigor of the practical interpretations of such indices. The statistical modeling approach to construct the latent health factor index (LHFI) was recently developed. With ecological data that otherwise are used to construct conventional multimetric indices, the LHFI framework expresses such data in a rigorous quantitative model, integrating qualitative features of ecosystem health and preconceived ecological relationships among such features. This hierarchical modeling approach allows unified statistical inference of health for observed sites (along with prediction of health for partially observed sites, if desired) and of the relevance of ecological drivers, all accompanied by formal uncertainty statements from a single, integrated analysis. Thus far, the LHFI approach has been demonstrated and validated in a freshwater context. We adapt this approach to modeling estuarine health, and illustrate it on the previously unassessed system in Richibucto in New Brunswick, Canada, where active oyster farming is a potential stressor through its effects on sediment properties. Field data correspond to health metrics that constitute the popular AZTI marine biotic index and the infaunal trophic index, as well as abiotic predictors preconceived to influence biota. Our paper is the first to construct a scientifically sensible model that rigorously identifies the collective explanatory capacity of salinity, distance downstream, channel depth, and silt-clay content-all regarded a priori as qualitatively important abiotic drivers-towards site health in the Richibucto ecosystem. This suggests the potential effectiveness of the LHFI approach for assessing not only freshwater systems but aquatic ecosystems in general.	[Chiu, Grace S.] CSIRO, CSIRO Math, Canberra, ACT, Australia; [Wu, Margaret A.] STAT Canada, Business Methods Survey Div, Ottawa, ON, Canada; [Lu, Lin] McGregor GeoSci, Bedford, NS, Canada	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Statistics Canada	Chiu, GS (corresponding author), CSIRO, CSIRO Math, Canberra, ACT, Australia.	grace.chiu@csiro.au	Chiu, Grace/D-1408-2009	Chiu, Grace/0000-0003-4219-1645	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The research of this paper was conducted through research assistantships to MAW at the University of Waterloo funded by an NSERC Strategic Project Grant (http://www.nsercpartnerships.ca/FundingPrograms-ProgrammeDeSubventions/SPG-SPS-eng.asp) to Prof. J. Grant (Dalhousie University) subcontracted to GSC. Funding agency NSERC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee S., 2004, HIERARCHICAL MODELIN; Bazairi H, 2005, CR BIOL, V328, P977, DOI 10.1016/j.crvi.2005.09.006; Bhatt JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046237; BILYARD GR, 1987, MAR POLLUT BULL, V18, P581, DOI 10.1016/0025-326X(87)90277-3; Borja A, 2000, MAR POLLUT BULL, V40, P1100, DOI 10.1016/S0025-326X(00)00061-8; Borja A, 2009, AQUACULTURE, V293, P231, DOI 10.1016/j.aquaculture.2009.04.037; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; [蔡文倩 Cai Wenqian], 2012, [环境科学学报, Acta Scientiae Circumstantiae], V32, P992; Chiu G, 2006, ENVIRONMETRICS, V17, P285, DOI 10.1002/env.744; Chiu GS, 2011, ENVIRONMETRICS, V22, P243, DOI 10.1002/env.1055; Cromey CJ, 2002, AQUACULTURE, V214, P211, DOI 10.1016/S0044-8486(02)00368-X; DAUER DM, 1993, MAR POLLUT BULL, V26, P249, DOI 10.1016/0025-326X(93)90063-P; Deegan LA, 1997, ESTUARIES, V20, P601, DOI 10.2307/1352618; Dey DK, 1998, TEST, V7, P325, DOI 10.1007/BF02565116; Dobbie MJ, 2013, ECOL INDIC, V29, P270, DOI 10.1016/j.ecolind.2012.12.025; Hoff PD, 2009, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-0-387-92407-6_1; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Johnston CA, 2009, ECOL APPL, V19, P1739, DOI 10.1890/08-1290.1; Kennedy R, 2011, MAR POLLUT BULL, V62, P1427, DOI 10.1016/j.marpolbul.2011.04.030; Lopez RD, 2002, ECOL APPL, V12, P487, DOI 10.1890/1051-0761(2002)012[0487:TTFQAI]2.0.CO;2; Lu L, 2008, ESTUAR COAST, V31, P994, DOI 10.1007/s12237-008-9097-9; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Marshall EC, 2007, BAYESIAN ANAL, V2, P409, DOI 10.1214/07-BA218; Medeiros JP, 2012, ECOL INDIC, V19, P79, DOI 10.1016/j.ecolind.2011.09.008; Muniz P, 2012, ECOL INDIC, V19, P89, DOI 10.1016/j.ecolind.2011.07.022; Peet R.K., 1974, Annual Rev Ecol Syst, V5, P285, DOI 10.1146/annurev.es.05.110174.001441; Pla L, 2004, J AGR BIOL ENVIR ST, V9, P42, DOI 10.1198/1085711043136; Rosenberg R, 2004, MAR POLLUT BULL, V49, P728, DOI 10.1016/j.marpolbul.2004.05.013; Schliep EM, 2013, ARXIV12054163; Smith RW, 2001, ECOL APPL, V11, P1073, DOI 10.1890/1051-0761(2001)011[1073:BRIFAI]2.0.CO;2; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Teixeira H, 2012, ECOL INDIC, V12, P84, DOI 10.1016/j.ecolind.2011.05.025; Trebilco R, 2011, BIOL CONSERV, V144, P1758, DOI 10.1016/j.biocon.2011.02.024; Word J. Q., 1980, SO CALIFORNIA COASTA, P103; Wu M, 2009, THESIS U WATERLOO WA	35	2	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65697	10.1371/journal.pone.0065697	http://dx.doi.org/10.1371/journal.pone.0065697			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785443	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800079
J	Ghayee, HK; Bhagwandin, VJ; Stastny, V; Click, A; Ding, LH; Mizrachi, D; Zou, YS; Chari, R; Lam, WL; Bachoo, RM; Smith, AL; Story, MD; Sidhu, S; Robinson, BG; Nwariaku, FE; Gazdar, AF; Auchus, RJ; Shay, JW				Ghayee, Hans K.; Bhagwandin, Vikash J.; Stastny, Victor; Click, Arielle; Ding, Liang-Hao; Mizrachi, Dario; Zou, Ying S.; Chari, Raj; Lam, Wan L.; Bachoo, Robert M.; Smith, Alice L.; Story, Michael D.; Sidhu, Stan; Robinson, Bruce G.; Nwariaku, Fiemu E.; Gazdar, Adi F.; Auchus, Richard J.; Shay, Jerry W.			Progenitor Cell Line (hPheo1) Derived from a Human Pheochromocytoma Tumor	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; EPITHELIAL-CELLS; LUNG-CANCER; GENE; EXPRESSION; PARAGANGLIOMA; TELOMERASE; MUTATIONS; IMMORTALIZATION; SPECIMENS	Background: Pheochromocytomas are rare tumors generally arising in the medullary region of the adrenal gland. These tumors release excessive epinephrine and norepinephrine resulting in hypertension and cardiovascular crises for which surgery is the only definitive treatment. Molecular mechanisms that control tumor development and hormone production are poorly understood, and progress has been hampered by the lack of human cellular model systems. To study pheochromocytomas, we developed a stable progenitor pheochromocytoma cell line derived from a primary human tumor. Methods: After IRB approval and written informed consent, human pheochromocytoma tissue was excised, minced, dispersed enzymatically, and cultured in vitro. Primary pheochromocytoma cells were infected with a lentivirus vector carrying the catalytic subunit of human telomerase reverse transcriptase (hTERT). The hTERT immortalized cells (hPheo1) have been passaged >300 population doublings. The resulting cell line was characterized morphologically, biochemically and for expression of neuroendocrine properties. The expression of marker enzymes and proteins was assessed by immunofluorescence staining and immunoblotting. Telomerase activity was determined by using the telomeric repeat amplification protocol (TRAP) assay. Results: We have established a human pheochromocytoma precursor cell line that expresses the neuroendocrine marker, chromogranin A, when differentiated in the presence of bone morphogenic protein 4 (BMP4), nerve growth factor (NGF), and dexamethasone. Phenylethanolamine N-methyltransferase (PNMT) expression is also detected with this differentiation regimen. CD-56 (also known as NCAM, neural cell adhesion molecule) is expressed in these cells, but CD31 (also known as PECAM-1, a marker of endothelial cells) is negative. Conclusions: We have maintained hTERT-immortalized progenitor cells derived from a pheochromocytoma (hPheo1) in culture for over 300 population doublings. This progenitor human cell line is normal diploid except for a deletion in the p16 region and has inducible neuroendocrine biomarkers. These cells should be a valuable reagent for studying mechanisms of tumor development and for testing novel therapeutic approaches.	[Ghayee, Hans K.] Univ Texas SW Med Ctr Dallas, Div Endocrinol, Dept Internal Med, Dallas, TX 75390 USA; [Bhagwandin, Vikash J.] Univ Calif San Francisco, Hooper Res Fdn, San Francisco, CA 94143 USA; [Stastny, Victor; Smith, Alice L.; Gazdar, Adi F.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol, Dallas, TX 75390 USA; [Stastny, Victor; Smith, Alice L.; Gazdar, Adi F.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Click, Arielle; Shay, Jerry W.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Ding, Liang-Hao; Story, Michael D.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Mizrachi, Dario] Cornell Univ, Ithaca, NY USA; [Zou, Ying S.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Chari, Raj] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Lam, Wan L.] British Columbia Canc Agcy, Dept Integrat Oncol, Vancouver, BC V5Z 4E6, Canada; [Bachoo, Robert M.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Sidhu, Stan; Robinson, Bruce G.] Royal N Shore Hosp, Kolling Inst Med Res, Dept Surg, St Leonards, NSW 2065, Australia; [Nwariaku, Fiemu E.] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Auchus, Richard J.] Univ Michigan, Dept Med, Div Metab Diabet & Endocrinol, Ann Arbor, MI 48109 USA; [Shay, Jerry W.] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21413, Saudi Arabia	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cornell University; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; British Columbia Cancer Agency; University of Texas System; University of Texas Southwestern Medical Center Dallas; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Michigan System; University of Michigan; King Abdulaziz University	Shay, JW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	jerry.shay@utsouthwestern.edu	Story, Michael/AAX-2864-2021; Chari, Raj/G-3285-2019	Story, Michael/0000-0001-6522-4169; Zou, Ying/0000-0003-2787-1917	North American Neuroendocrine Tumor Society; American Cancer Society Institutional Grant; Burroughs Wellcome Fund [1005954]; Canadian Institute of Health Research; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	North American Neuroendocrine Tumor Society; American Cancer Society Institutional Grant(American Cancer Society); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the North American Neuroendocrine Tumor Society, American Cancer Society Institutional Grant, Burroughs Wellcome Fund #1005954, and Canadian Institute of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjalle R, 2009, HORM METAB RES, V41, P687, DOI 10.1055/s-0029-1231025; Aguiar RCT, 1996, CLIN ENDOCRINOL, V45, P93, DOI 10.1111/j.1365-2265.1996.tb02065.x; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Chung KF, 2009, STEM CELLS, V27, P2602, DOI 10.1002/stem.180; Comino-Mendez I, 2011, NAT GENET, V43, P663, DOI 10.1038/ng.861; Ding LH, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn234; Elder EE, 2005, J SURG ONCOL, V89, P193, DOI 10.1002/jso.20177; FRANQUEMONT DW, 1994, AM J CLIN PATHOL, V102, P163, DOI 10.1093/ajcp/102.2.163; Gazdar AF, 2010, JNCI-J NATL CANCER I, V102, P1310, DOI 10.1093/jnci/djq279; GAZDAR AF, 1986, CANCER RES, V46, P6011; Ghayee HK, 2008, J ENDOCRINOL INVEST, V31, P450, DOI 10.1007/BF03346390; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HANING R, 1970, Endocrinology, V87, P1147; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Hofland J, 2007, CLIN ENDOCRINOL, V66, P335, DOI 10.1111/j.1365-2265.2007.02732.x; John H, 1999, UROLOGY, V53, P679, DOI 10.1016/S0090-4295(98)00612-8; Joshua AM, 2009, J CLIN ENDOCR METAB, V94, P5, DOI 10.1210/jc.2008-1836; Lewis CM, 2006, BREAST CANCER RES TR, V99, P103, DOI 10.1007/s10549-006-9189-9; Marian CO, 2010, CLIN CANCER RES, V16, P154, DOI 10.1158/1078-0432.CCR-09-2850; Martiniova L, 2009, CLIN EXP METASTAS, V26, P239, DOI 10.1007/s10585-009-9236-0; Muscarella P, 2008, GENE EXPRESSION, V14, P207, DOI 10.3727/105221608786883825; Pfragner R, 1998, J NEUROCYTOL, V27, P175, DOI 10.1023/A:1006959625068; Powers JF, 2000, CELL TISSUE RES, V302, P309, DOI 10.1007/s004410000290; Qin YJ, 2010, NAT GENET, V42, P229, DOI 10.1038/ng.533; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Ribon V, 1996, J BIOL CHEM, V271, P7375, DOI 10.1074/jbc.271.13.7375; STENSTROM G, 1988, ACTA MED SCAND, V223, P345; TAIT JF, 1974, PROC R SOC SER B-BIO, V185, P375, DOI 10.1098/rspb.1974.0025; Thompson F, 1997, CYTOGENETIC METHODS; van Nederveen FH, 2009, ENDOCR-RELAT CANCER, V16, P505, DOI 10.1677/ERC-08-0241; Vaughan MB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007908; Zhuang ZP, 2012, NEW ENGL J MED, V367, P922, DOI 10.1056/NEJMoa1205119	32	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65624	10.1371/journal.pone.0065624	http://dx.doi.org/10.1371/journal.pone.0065624			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785438	Green Submitted, Green Published, gold			2022-12-25	WOS:000321038800082
J	Hayashi, T; Yoshida, T; Ra, M; Taguchi, R; Mishina, M				Hayashi, Takashi; Yoshida, Tomoyuki; Ra, Moonjin; Taguchi, Ryo; Mishina, Masayoshi			IL1RAPL1 Associated with Mental Retardation and Autism Regulates the Formation and Stabilization of Glutamatergic Synapses of Cortical Neurons through RhoA Signaling Pathway	PLOS ONE			English	Article							ACCESSORY PROTEIN-LIKE; TRANSSYNAPTIC INTERACTION; SPECTRUM DISORDER; MUTATIONS; PLASTICITY; FAMILY; GENE; NEUROLIGINS; RECEPTORS; INSERTION	Interleukin-1 receptor accessory protein-like 1 (IL1RAPL1) is associated with X-linked mental retardation and autism spectrum disorder. We found that IL1RAPL1 regulates synapse formation of cortical neurons. To investigate how IL1RAPL1 controls synapse formation, we here screened IL1RAPL1-interacting proteins by affinity chromatography and mass spectroscopy. IL1RAPL1 interacted with Mcf2-like (Mcf2l), a Rho guanine nucleotide exchange factor, through the cytoplasmic Toll/IL-1 receptor domain. Knockdown of endogenous Mcf2l and treatment with an inhibitor of Rho-associated protein kinase (ROCK), the downstream kinase of RhoA, suppressed IL1RAPL1-induced excitatory synapse formation of cortical neurons. Furthermore, we found that the expression of IL1RAPL1 affected the turnover of AMPA receptor subunits. Insertion of GluA1-containing AMPA receptors to the cell surface was decreased, whereas that of AMPA receptors composed of GluA2/3 was enhanced. Mcf2l knockdown and ROCK inhibitor treatment diminished the IL1RAPL1-induced changes of AMPA receptor subunit insertions. Our results suggest that Mcf2l-RhoA-ROCK signaling pathway mediates IL1RAPL1-dependent formation and stabilization of glutamatergic synapses of cortical neurons.	[Hayashi, Takashi; Yoshida, Tomoyuki; Mishina, Masayoshi] Univ Tokyo, Grad Sch Med, Dept Mol Neurobiol & Pharmacol, Tokyo, Japan; [Ra, Moonjin; Taguchi, Ryo] Univ Tokyo, Grad Sch Med, Dept Metabolome, Tokyo, Japan; [Yoshida, Tomoyuki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Mishina, Masayoshi] Ritsumeikan Univ, Res Org Sci & Technol, Brain Sci Lab, Kusatsu, Shiga, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Ritsumeikan University	Mishina, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mol Neurobiol & Pharmacol, Tokyo, Japan.	mmishina@fc.ritsumei.ac.jp	ra, moonjin/AAK-3816-2021	Hayashi, Takashi/0000-0003-3591-2109; Yoshida, Tomoyuki/0000-0002-8476-3798	Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; Kanae Foundation for the Promotion of Medical Science; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kanae Foundation for the Promotion of Medical Science; Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported in part by the Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Takeda Science Foundation, the Kanae Foundation for the Promotion of Medical Science, and Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Araki Y, 2010, P NATL ACAD SCI USA, V107, P11080, DOI 10.1073/pnas.1006584107; Bahi N, 2003, HUM MOL GENET, V12, P1415, DOI 10.1093/hmg/ddg147; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Bill BR, 2009, CURR OPIN GENET DEV, V19, P271, DOI 10.1016/j.gde.2009.04.004; Bito H, 2003, J BIOCHEM, V134, P315, DOI 10.1093/jb/mvg147; Boda B, 2010, CURR OPIN NEUROBIOL, V20, P519, DOI 10.1016/j.conb.2010.03.012; Born TL, 2000, J BIOL CHEM, V275, P29946, DOI 10.1074/jbc.M004077200; Carrie A, 1999, NAT GENET, V23, P25, DOI 10.1038/12623; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Fombonne E, 1999, PSYCHOL MED, V29, P769, DOI 10.1017/S0033291799008508; Gambino F, 2007, P NATL ACAD SCI USA, V104, P9063, DOI 10.1073/pnas.0701133104; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; HORII Y, 1994, EMBO J, V13, P4776, DOI 10.1002/j.1460-2075.1994.tb06803.x; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Kerr JM, 2012, J NEUROSCI, V32, P658, DOI 10.1523/JNEUROSCI.2927-11.2012; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Laumonnier F, 2010, MOL PSYCHIATR, V15, P767, DOI 10.1038/mp.2009.14; Levy SE, 2009, LANCET, V374, P1627, DOI 10.1016/S0140-6736(09)61376-3; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Loegering D.J., 2011, ENZYME RES; Manchen ST, 2001, BIOCHEM BIOPH RES CO, V287, P1075, DOI 10.1006/bbrc.2001.5701; McCormack SG, 2006, NEURON, V50, P75, DOI 10.1016/j.neuron.2006.02.027; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Pavlowsky A, 2010, CURR BIOL, V20, P103, DOI 10.1016/j.cub.2009.12.030; Piton A, 2011, MOL PSYCHIATR, V16, P867, DOI 10.1038/mp.2010.54; Piton A, 2008, HUM MOL GENET, V17, P3965, DOI 10.1093/hmg/ddn300; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tanaka H, 2012, CELL REPORTS, V1, P291, DOI 10.1016/j.celrep.2012.02.004; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; Valnegri P, 2011, HUM MOL GENET, V20, P4797, DOI 10.1093/hmg/ddr418; Van Aelst L, 2004, CURR OPIN NEUROBIOL, V14, P297, DOI 10.1016/j.conb.2004.05.012; van Bokhoven H, 2011, ANNU REV GENET, V45, P81, DOI 10.1146/annurev-genet-110410-132512; Yoshida T, 2008, MOL CELL NEUROSCI, V39, P218, DOI 10.1016/j.mcn.2008.06.013; Yoshida T, 2011, J NEUROSCI, V31, P13485, DOI 10.1523/JNEUROSCI.2136-11.2011	40	41	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66254	10.1371/journal.pone.0066254	http://dx.doi.org/10.1371/journal.pone.0066254			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785489	Green Published, gold, Green Submitted			2022-12-25	WOS:000321038800033
J	Larsson, HE; Jonsson, I; Lernmark, A; Ivarsson, S; Radtke, JR; Hampe, CS				Larsson, Helena Elding; Jonsson, Ida; Lernmark, Ake; Ivarsson, Sten; Radtke, Jared R.; Hampe, Christiane S.		Diabet Prediction Skane DiPiS; Type 1 Diabet Trial Network	Decline in Titers of Anti-Idiotypic Antibodies Specific to Autoantibodies to GAD65 (GAD65Ab) Precedes Development of GAD65Ab and Type 1 Diabetes	PLOS ONE			English	Article							SYSTEMIC LUPUS-ERYTHEMATOSUS; DECARBOXYLASE; IMMUNIZATION; POPULATION; NETWORK; AGE	The humoral Idiotypic Network consisting of antibodies and their anti-idiotypic antibodies (anti-Id) can be temporarily upset by antigen exposure. In the healthy immune response the original equilibrium is eventually restored through counter-regulatory mechanisms. In certain autoimmune diseases however, autoantibody levels exceed those of their respective anti-Id, indicating a permanent disturbance in the respective humoral Idiotypic Network. We investigated anti-Id directed to a major Type 1 diabetes (T1D)-associated autoantibody (GAD65Ab) in two independent cohorts during progression to disease. Samples taken from participants of the Natural History Study showed significantly lower anti-Id levels in individuals that later progressed to T1D compared to non-progressors (anti-Id antibody index of 0.06 vs. 0.08, respectively, p = 0.02). We also observed a significant inverse correlation between anti-Id levels and age at sampling, but only in progressors (p = 0.014). Finally, anti-Id levels in progressors showed a significant decline during progression as compared to longitudinal anti-Id levels in non-progressors (median rate of change: -0.0004 vs. +0.0004, respectively, p = 0.003), suggesting a loss of anti-Id during progression. Our analysis of the Diabetes Prediction in Skane cohort showed that early in life (age 2) individuals at risk have anti-Id levels indistinguishable from those in healthy controls, indicating that low anti-Id levels are not an innate characteristic of the immune response in individuals at risk. Notably, anti-Id levels declined significantly in individuals that later developed GAD65Ab suggesting that the decline in anti-Id levels precedes the emergence of GAD65Ab (median rate of change: -0.005) compared to matched controls (median rate of change: +0.001) (p = 0.0016). We conclude that while anti-Id are present early in life, their levels decrease prior to the appearance of GAD65Ab and to the development of T1D.	[Larsson, Helena Elding; Jonsson, Ida; Lernmark, Ake] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Ivarsson, Sten] Univ Hosp MAS, Dept Pediat, Malmo, Sweden; [Radtke, Jared R.; Hampe, Christiane S.] Univ Washington, Dept Med, Seattle, WA 98195 USA	Lund University; Lund University; Skane University Hospital; University of Washington; University of Washington Seattle	Hampe, CS (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	champe@u.washington.edu	Hampe, Christiane Susanne/GSD-7679-2022; Lernmark, Åke/F-8140-2015; Toledo, Frederico/G-9071-2013	Lernmark, Åke/0000-0003-1735-0499; Toledo, Frederico/0000-0002-6570-9948; Elding Larsson, Helena/0000-0003-3306-1742; Hampe, Christiane/0000-0001-9111-6671	National Institutes of Health [DK063861, DK26190]; Juvenile Diabetes Research Foundation; Swedish Research Council; Childhood Diabetes Fund; Swedish Diabetesfund; Skane County Council for Research and Development; National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development [U01 DK061010, U01 DK061016, U01 DK061034, U01 DK061036, U01 DK061040, U01 DK061041, U01 DK061042, U01 DK061055, U01 DK061058, U01 DK084565, U01 DK085453, U01 DK085461, U01 DK085463, U01 DK085466, U01 DK085499, U01 DK085505, U01 DK085509, HHSN267200800019C]; National Center for Research Resources, through Clinical Translational Science Awards [UL1 RR024131, UL1 RR024139, UL1 RR024153, UL1 RR024975, UL1 RR024982, UL1 RR025744, UL1 RR025761, UL1 RR025780, UL1 RR029890, UL1 RR031986, P30 DK017047]; General Clinical Research Center Award [M01 RR00400]; Juvenile Diabetes Research Foundation International (JDRF); American Diabetes Association (ADA); Type 1 Diabetes TrialNet Study Group; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085, UL1TR000005, UL1TR000093, UL1TR000130] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153, UL1RR024975, UL1RR031986, UL1RR025780, UL1RR024982, UL1RR025761, UL1RR024139, UL1RR024131, UL1RR029890, M01RR000400, UL1RR025744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK063861, U01DK085509, U01DK085466, R01DK026190, U01DK061036, U01DK085463, U01DK061034, P30DK017047, U01DK085461, U01DK061055, U01DK061041, U01DK061058, U01DK061010, U01DK085499, U01DK085505, UC4DK063861, U01DK061042, U01DK085453, U01DK061040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Childhood Diabetes Fund; Swedish Diabetesfund; Skane County Council for Research and Development; National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Research Resources, through Clinical Translational Science Awards; General Clinical Research Center Award; Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); American Diabetes Association (ADA)(American Diabetes Association); Type 1 Diabetes TrialNet Study Group; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported the National Institutes of Health (DK063861 and DK26190) and a grant of the Juvenile Diabetes Research Foundation to CSH and by the Swedish Research Council (AL), Childhood Diabetes Fund (HEL), Swedish Diabetesfund (AL) and the Skane County Council for Research and Development. The sponsor of the trial was the Type 1 Diabetes TrialNet Study Group. Type 1 Diabetes TrialNet Study Group is a clinical trials network funded by the National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Allergy and Infectious Diseases, and The Eunice Kennedy Shriver National Institute of Child Health and Human Development, through the cooperative agreements U01 DK061010, U01 DK061016, U01 DK061034, U01 DK061036, U01 DK061040, U01 DK061041, U01 DK061042, U01 DK061055, U01 DK061058, U01 DK084565, U01 DK085453, U01 DK085461, U01 DK085463, U01 DK085466, U01 DK085499, U01 DK085505, U01 DK085509, and a contract HHSN267200800019C; the National Center for Research Resources, through Clinical Translational Science Awards UL1 RR024131, UL1 RR024139, UL1 RR024153, UL1 RR024975, UL1 RR024982, UL1 RR025744, UL1 RR025761, UL1 RR025780, UL1 RR029890, UL1 RR031986, P30 DK017047, and General Clinical Research Center Award M01 RR00400; the Juvenile Diabetes Research Foundation International (JDRF); and the American Diabetes Association (ADA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhonen S, 2011, DIABETES CARE, V34, P115, DOI 10.2337/dc10-1091; FALORNI A, 1995, J IMMUNOL METHODS, V186, P89, DOI 10.1016/0022-1759(95)00139-2; GEHA RS, 1985, RES CLIN LAB, V15, P1; GEHA RS, 1983, J IMMUNOL, V130, P1634; GRUBIN CE, 1994, DIABETOLOGIA, V37, P344, DOI 10.1007/BF00408469; Hampe CS, 2012, AUTOIMMUNITY; Harjutsalo V, 2005, DIABETES, V54, P563, DOI 10.2337/diabetes.54.2.563; Hwang WYK, 2005, METHODS, V36, P3, DOI 10.1016/j.ymeth.2005.01.001; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; Larsson HE, 2005, DIABETOLOGIA, V48, P1484, DOI 10.1007/s00125-005-1813-4; Mahon JL, 2009, PEDIATR DIABETES, V10, P97, DOI 10.1111/j.1399-5448.2008.00464.x; Mire-Sluis AR, 2000, DIABETOLOGIA, V43, P1282, DOI 10.1007/s001250051524; Oak S, 2008, P NATL ACAD SCI USA, V105, P5471, DOI 10.1073/pnas.0800578105; Oak S, 2009, J IMMUNOL METHODS, V351, P55, DOI 10.1016/j.jim.2009.09.004; Ortqvist E, 2010, J CLIN ENDOCRINOL ME; Pundziute-Lycka A, 2002, DIABETOLOGIA, V45, P783, DOI 10.1007/s00125-002-0845-2; Rolandsson O, 1999, 59 SCI SESS SAN DIEG; Routsias JG, 2003, J AUTOIMMUN, V21, P17, DOI 10.1016/S0896-8411(03)00063-5; Routsias JG, 2002, MOL MED, V8, pA3, DOI 10.1007/BF03402155; Shoenfeld Y, 2005, ARTHRITIS RHEUM, V52, P2599, DOI 10.1002/art.21252; SHOENFELD Y, 1994, FASEB J, V8, P1296, DOI 10.1096/fasebj.8.15.8001742; SILVESTRIS F, 1984, ARTHRITIS RHEUM, V27, P1387, DOI 10.1002/art.1780271209; Van der Auwera BJ, 2002, HUM IMMUNOL, V63, P40, DOI 10.1016/S0198-8859(01)00362-7; Verge CF, 1998, DIABETES, V47, P1857, DOI 10.2337/diabetes.47.12.1857; WILLIAMS RC, 1995, J RHEUMATOL, V22, P1075; Winter WE, 2011, CLIN CHEM, V57, P168, DOI 10.1373/clinchem.2010.148205; Zivkovic IP, 2010, BIOL RES, V43, P393, DOI [10.4067/S0716-97602010000400003, /S0716-97602010000400003]	27	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65173	10.1371/journal.pone.0065173	http://dx.doi.org/10.1371/journal.pone.0065173			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785410	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800110
J	Manning, AL; Benes, C; Dyson, NJ				Manning, A. L.; Benes, C.; Dyson, N. J.			Whole chromosome instability resulting from the synergistic effects of pRB and p53 inactivation	ONCOGENE			English	Article						heterogeneity; aneuploidy; CIN; retinoblastoma; RB1	GENOMIC INSTABILITY; CLONAL EVOLUTION; GENE-EXPRESSION; HUMAN-CELLS; ANEUPLOIDY; TUMOR; RB; PATHWAY; RETINOBLASTOMA; CANCER	Whole chromosome instability (CIN) is a common feature of cancer cells and has been linked to increased tumor evolution and metastasis. Several studies have shown that the loss of the pRB tumor suppressor causes mitotic defects and chromosome missegregation. pRB is inactivated in many types of cancer and this raises the possibility that the loss of pRB may be a general cause of CIN in tumors. Paradoxically, retinoblastoma tumor cells have a relatively stable karyotype and currently the circumstances in which pRB inactivation causes CIN in human cancers are unclear. Here we utilize a fluorescence in situ hybridization-based approach to score numerical heterogeneity in chromosome copy number as a readout of CIN. Using this technique, we show that high levels of CIN correlate with the combined inactivation of pRB and p53 and that this association is evident in two independent panels of cancer cell lines. Retinoblastoma cell lines characteristically retain a wild-type TP53 gene, providing an opportunity to test the relevance of this functional relationship. We show that retinoblastoma cell lines display mitotic defects similar to those seen when pRB is depleted from non-transformed cells, but that the presence of wild-type p53 suppresses the accumulation of aneuploid cells. A similar synergy between pRB and p53 inactivation was observed in HCT116 cells. These results suggest that the loss of pRB promotes segregation errors, whereas loss of p53 allows tolerance and continued proliferation of the resulting, genomically unstable cancer cells. Hence, it is the cooperative effect of inactivation of both pRB and p53 tumor suppressor pathways that promotes CIN.	[Manning, A. L.; Benes, C.; Dyson, N. J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc Res,Canc Ctr, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Dyson, NJ (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc Res,Canc Ctr, 149 13th St,MB 7330, Charlestown, MA 02129 USA.	dyson@helix.mgh.harvard.edu	Manning, Amity/AAC-8205-2019	Manning, Amity/0000-0003-1332-9086	American Cancer Society Fellowship; NIH [R01 CA155202]; NATIONAL CANCER INSTITUTE [R01CA155202] Funding Source: NIH RePORTER	American Cancer Society Fellowship(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the Lees, Dyer and Pellman labs for sharing cell lines, and Neil Ganem for critical reading of the manuscript. This work was supported by a American Cancer Society Fellowship (A.L.M.) and funding from NIH grant R01 CA155202 (to N.J.D). N.J.D. is the James and Shirley Curvey MGH Research Scholar.	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Bunz F, 2002, CANCER RES, V62, P1129; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Cahill DP, 1999, GENOMICS, V58, P181, DOI 10.1006/geno.1999.5831; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Choi CM, 2009, LUNG CANCER, V64, P66, DOI 10.1016/j.lungcan.2008.07.016; Chung NG, 2012, LEUKEMIA LYMPHOMA, V53, P1234, DOI 10.3109/10428194.2011.645819; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Conklin JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2254; Conkrite K, 2012, J CLIN INVEST, V122, P1726, DOI 10.1172/JCI61403; Corson TW, 2007, GENE CHROMOSOME CANC, V46, P617, DOI 10.1002/gcc.20457; Coschi CH, 2012, CELL MOL LIFE SCI, V69, P2009, DOI 10.1007/s00018-011-0910-4; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Di Leonardo A, 1997, CANCER RES, V57, P1013; Dimaras H, 2008, HUM MOL GENET, V17, P1363, DOI 10.1093/hmg/ddn024; Ertel A, 2010, CELL CYCLE, V9, P4153, DOI 10.4161/cc.9.20.13454; Fuster JJ, 2007, TRENDS MOL MED, V13, P192, DOI 10.1016/j.molmed.2007.03.002; Gao CF, 2007, P NATL ACAD SCI USA, V104, P8995, DOI 10.1073/pnas.0700631104; Gordon GM, 2011, PROTEIN CELL, V2, P864, DOI 10.1007/s13238-011-1117-z; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heilig CE, 2010, J CELL MOL MED, V14, P895, DOI 10.1111/j.1582-4934.2009.00905.x; Herrera RE, 1996, MOL CELL BIOL, V16, P2402; Holland AJ, 2012, EMBO REP, V13, P501, DOI 10.1038/embor.2012.55; Holland EC, 1998, GENE DEV, V12, P3644, DOI 10.1101/gad.12.23.3644; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Kang H, 2004, MOL CELL BIOL, V24, P1188, DOI 10.1128/MCB.24.3.1188-1199.2004; Khan SH, 1998, CANCER RES, V58, P396; Kim MS, 2012, NEOPLASMA, V59, P524, DOI 10.4149/neo_2012_067; Knowlton AL, 2006, CURR BIOL, V16, P1705, DOI 10.1016/j.cub.2006.07.057; KNUDSON AG, 1984, CANCER DETECT PREV, V7, P1; Kuukasjarvi T, 1997, CANCER RES, V57, P1597; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Li M, 2010, P NATL ACAD SCI USA, V107, P14188, DOI 10.1073/pnas.1005960107; Manning AL, 2012, NAT REV CANCER, V12, P220, DOI 10.1038/nrc3216; Manning AL, 2011, TRENDS CELL BIOL, V21, P433, DOI 10.1016/j.tcb.2011.05.003; Manning AL, 2010, EMBO J, V29, P3531, DOI 10.1038/emboj.2010.230; Manning AL, 2010, GENE DEV, V24, P1364, DOI 10.1101/gad.1917310; McClelland SE, 2009, CELL CYCLE, V8, P3262, DOI 10.4161/cc.8.20.9690; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Pfau SJ, 2012, EMBO REP, V13, P515, DOI 10.1038/embor.2012.65; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Randle DH, 2001, P NATL ACAD SCI USA, V98, P9654, DOI 10.1073/pnas.171217498; Roschke AV, 2003, CANCER RES, V63, P8634; Roylance R, 2011, CANCER EPIDEM BIOMAR, V20, P2183, DOI 10.1158/1055-9965.EPI-11-0343; Schvartzman JM, 2011, CANCER CELL, V19, P701, DOI 10.1016/j.ccr.2011.04.017; Swanton C, 2009, P NATL ACAD SCI USA, V106, P8671, DOI 10.1073/pnas.0811835106; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Wang ZH, 2004, CANCER RES, V64, P2998, DOI 10.1158/0008-5472.CAN-04-0587; Weglarz L, 2006, ACTA BIOCHIM POL, V53, P349; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733	62	27	29	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 8	2014	33	19					2487	2494		10.1038/onc.2013.201	http://dx.doi.org/10.1038/onc.2013.201			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AH3OK	23792446	Green Accepted			2022-12-25	WOS:000336033600008
J	Gine-Garriga, M; Martin-Borras, C; Puig-Ribera, A; Martin-Cantera, C; Sola, M; Cuesta-Vargas, A				Gine-Garriga, Maria; Martin-Borras, Carme; Puig-Ribera, Anna; Martin-Cantera, Carlos; Sola, Merce; Cuesta-Vargas, Antonio		PPAF Grp	The Effect of a Physical Activity Program on the Total Number of Primary Care Visits in Inactive Patients: A 15-Month Randomized Controlled Trial	PLOS ONE			English	Article							QUALITY-OF-LIFE; OLDER-ADULTS; HEALTH SURVEY; EXERCISE; WOMEN; INTERVENTIONS; RELIABILITY	Background: Effective promotion of exercise could result in substantial savings in healthcare cost expenses in terms of direct medical costs, such as the number of medical appointments. However, this is hampered by our limited knowledge of how to achieve sustained increases in physical activity. Objectives: To assess the effectiveness of a Primary Health Care (PHC) based physical activity program in reducing the total number of visits to the healthcare center among inactive patients, over a 15-month period. Research Design: Randomized controlled trial. Subjects: Three hundred and sixty-two (n = 362) inactive patients suffering from at least one chronic condition were included. One hundred and eighty-three patients (n = 183; mean (SD); 68.3 (8.8) years; 118 women) were randomly allocated to the physical activity program (IG). One hundred and seventy-nine patients (n = 179; 67.2 (9.1) years; 106 women) were allocated to the control group (CG). The IG went through a three-month standardized physical activity program led by physical activity specialists and linked to community resources. Measures: The total number of medical appointments to the PHC, during twelve months before and after the program, was registered. Self-reported health status (SF-12 version 2) was assessed at baseline (month 0), at the end of the intervention (month 3), and at 12 months follow-up after the end of the intervention (month 15). Results: The IG had a significantly reduced number of visits during the 12 months after the intervention: 14.8 (8.5). The CG remained about the same: 18.2 (11.1) (P = .002). Conclusions: Our findings indicate that a 3-month physical activity program linked to community resources is a short-duration, effective and sustainable intervention in inactive patients to decrease rates of PHC visits.	[Gine-Garriga, Maria; Martin-Borras, Carme] Univ Ramon Llull, FPCEE Blanquerna, Dept Phys Act & Sport Sci, Barcelona, Spain; [Gine-Garriga, Maria] Univ Ramon Llull, FPCEE Blanquerna, Dept Phys Therapy, Barcelona, Spain; [Puig-Ribera, Anna] Univ Vic, Dept Phys Act & Sport Sci, Vic, Spain; [Martin-Cantera, Carlos; Sola, Merce] Primary Healthcare Res Inst IDIAP Jordi Gol, Res Unit Barcelona, Barcelona, Spain; [Martin-Cantera, Carlos] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain; [Cuesta-Vargas, Antonio] Univ Malaga, Dept Phys Therapy, E-29071 Malaga, Spain	Universitat Ramon Llull; Universitat Ramon Llull; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Autonomous University of Barcelona; Universidad de Malaga	Gine-Garriga, M (corresponding author), Univ Ramon Llull, FPCEE Blanquerna, Dept Phys Act & Sport Sci, Barcelona, Spain.	mariagg@blanquerna.url.edu	Giné-Garriga, Maria/AAF-9828-2019; Giné-Garriga, Maria/F-4089-2016; Martin Cantera, Carlos/D-2693-2011; del Val Garcia, Jose Luis/G-6195-2016	Giné-Garriga, Maria/0000-0003-4449-3524; Giné-Garriga, Maria/0000-0003-4449-3524; Martin Cantera, Carlos/0000-0003-0656-8126; del Val Garcia, Jose Luis/0000-0002-0391-9368; Cuesta-Vargas, Antonio I/0000-0002-8880-4315	Catalan Society of General Practice (CAMFIC)	Catalan Society of General Practice (CAMFIC)	This work was supported by a research award from the Catalan Society of General Practice (CAMFIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; Anderson RT, 2005, ANN BEHAV MED, V30, P146, DOI 10.1207/s15324796abm3002_7; Bayliss Elizabeth A, 2003, Ann Fam Med, V1, P15, DOI 10.1370/afm.4; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Department of Health, 2010, 2009 ANN REP CHIEF M; Diari Oficial de la Generalitat de Catalunya, 2009, DIARI OFICIAL GEN CA; Enquesta de Salut de Catalunya, 2012, INF DELS PRINC RES; Fortin M, 2006, QUAL LIFE RES, V15, P83, DOI 10.1007/s11136-005-8661-z; Gine-Garriga M, 2008, ATEN PRIM, V40, P374, DOI 10.1157/13124135; Gine-Garriga M, 2010, J AGING PHYS ACTIV, V18, P401, DOI 10.1123/japa.18.4.401; Gine-Garriga M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-31; Guyton AC, 2007, TRATADO FISIOLOGIA M; Hillsdon M, 2005, Cochrane Database Syst Rev, pCD003180; Hubbard RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006174; Lawton BA, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2509; McCusker J, 2006, J GERONTOL A-BIOL, V61, P53, DOI 10.1093/gerona/61.1.53; Ministerio de Sanidad y Consumo, 2001, ENC NAC SAL; Murphy SL, 2002, J AM GERIATR SOC, V50, P516, DOI 10.1046/j.1532-5415.2002.50119.x; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI 10.1161/CIRCULATIONAHA.107.185650; Orrow G, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1389; Palomo Luis, 2006, Gac Sanit, V20 Suppl 1, P182, DOI 10.1157/13086042; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Prados-Torres A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032190; Ribera AP, 2006, HEALTH EDUC RES, V21, P538, DOI 10.1093/her/cyl008; Ribera AP, 2005, EUR J PUBLIC HEALTH, V15, P569, DOI 10.1093/eurpub/cki045; Robertson R., 2012, MENT HEALTH PHYS ACT, V5, P66, DOI DOI 10.1016/J.MHPA.2012.03.002; Rose Sally B, 2008, N Z Med J, V121, pU2897; Schuch FB, 2011, MENT HEALTH PHYS ACT, V4, p43e48; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Shumaker S. A., 1990, QUALITY LIFE ASSESSM, P95; SKELTON DA, 1995, J AM GERIATR SOC, V43, P1081, DOI 10.1111/j.1532-5415.1995.tb07004.x; Smith K, 2003, CAN J APPL PHYSIOL, V28, P462, DOI 10.1139/h03-034; Spirduso WW, 2001, MED SCI SPORT EXER, V33, pS598, DOI 10.1097/00005768-200106001-00028; Starfield Barbara, 2003, Ann Fam Med, V1, P8, DOI 10.1370/afm.1; van der Bij AK, 2002, AM J PREV MED, V22, P120, DOI 10.1016/S0749-3797(01)00413-5; Vedsted P, 2005, PUBLIC HEALTH, V119, P118, DOI 10.1016/j.puhe.2004.03.007; Ware J. E. J., 2002, SCORE VERSION 2 SF 1; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WHO, 2010, WOR HEALT REP, P1; Williams NH, 2007, BRIT J GEN PRACT, V57, P979, DOI 10.3399/096016407782604866; Wilson T, 2005, BMJ-BRIT MED J, V330, P657, DOI 10.1136/bmj.330.7492.657; Wolfenstetter SB, 2012, ADV PREV MED, V2012, P601, DOI DOI 10.1155/2012/601631	44	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66392	10.1371/journal.pone.0066392	http://dx.doi.org/10.1371/journal.pone.0066392			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	170JP	23805219	Green Published, gold			2022-12-25	WOS:000320846500047
J	Hwang, HS; Shin, JG; Lee, BH; Eom, TJ; Joo, CK				Hwang, Ho Sik; Shin, Jun Geun; Lee, Byeong Ha; Eom, Tae Joong; Joo, Choun-Ki			In Vivo 3D Meibography of the Human Eyelid Using Real Time Imaging Fourier-Domain OCT	PLOS ONE			English	Article							MEIBOMIAN GLAND DYSFUNCTION; OPTICAL COHERENCE TOMOGRAPHY; INTERNATIONAL WORKSHOP; SUBCOMMITTEE; DIAGNOSIS	Recently, we reported obtaining tomograms of meibomian glands from healthy volunteers using commercial anterior segment optical coherence tomography (AS-OCT), which is widely employed in clinics for examination of the anterior segment. However, we could not create 3D images of the meibomian glands, because the commercial OCT does not have a 3D reconstruction function. In this study we report the creation of 3D images of the meibomian glands by reconstructing the tomograms of these glands using high speed Fourier-Domain OCT (FD-OCT) developed in our laboratory. This research was jointly undertaken at the Department of Ophthalmology, Seoul St. Mary's Hospital (Seoul, Korea) and the Advanced Photonics Research Institute of Gwangju Institute of Science and Technology (Gwangju, Korea) with two healthy volunteers and seven patients with meibomian gland dysfunction. A real time imaging FD-OCT system based on a high-speed wavelength swept laser was developed that had a spectral bandwidth of 100 nm at the 1310 nm center wavelength. The axial resolution was 5 mu m and the lateral resolution was 13 mu m in air. Using this device, the meibomian glands of nine subjects were examined. A series of tomograms from the upper eyelid measuring 5 mm (from left to right, B-scan) x 2 mm (from upper part to lower part, C-scan) were collected. Three-D images of the meibomian glands were then reconstructed using 3D "data visualization, analysis, and modeling software''. Established infrared meibography was also performed for comparison. The 3D images of healthy subjects clearly showed the meibomian glands, which looked similar to bunches of grapes. These results were consistent with previous infrared meibography results. The meibomian glands were parallel to each other, and the saccular acini were clearly visible. Here we report the successful production of 3D images of human meibomian glands by reconstructing tomograms of these glands with high speed FD-OCT.	[Hwang, Ho Sik; Joo, Choun-Ki] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Shin, Jun Geun; Lee, Byeong Ha; Eom, Tae Joong] Gwangju Inst Sci & Technol, Adv Photon Res Inst, Kwangju, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Gwangju Institute of Science & Technology (GIST)	Eom, TJ (corresponding author), Gwangju Inst Sci & Technol, Adv Photon Res Inst, Kwangju, South Korea.	eomtj@gist.ac.kr; ckjoo@catholic.ac.kr	Lee, Byeong Ha/T-3397-2019	Lee, Byeong Ha/0000-0003-4544-1232	Technology Innovation Program; Ministry of Trade, Industry & Energy, Republic of Korea [10040121]; National Research Foundation of Korea [2010-0024058]	Technology Innovation Program; Ministry of Trade, Industry & Energy, Republic of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was partially supported by the Technology Innovation Program funded by the Ministry of Trade, Industry & Energy, Republic of Korea (10040121) and the Basic Science Research Program through the National Research Foundation of Korea (2010-0024058). Role of the funding source: development of high speed OCT for meibomian gland imaging.	Arita R, 2008, OPHTHALMOLOGY, V115, P911, DOI 10.1016/j.ophtha.2007.06.031; Arita R, 2010, CORNEA, V29, P980, DOI 10.1097/ICO.0b013e3181cc7b1b; Arita R, 2009, OPHTHALMOLOGY, V116, P2058, DOI 10.1016/j.ophtha.2009.04.037; Arita R, 2009, OPHTHALMOLOGY, V116, P379, DOI 10.1016/j.ophtha.2008.10.012; Bizheva K, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3475957; Bron AJ, 2003, CORNEA, V22, P640, DOI 10.1097/00003226-200310000-00008; Ding HF, 2005, J OPT SOC AM A, V22, P1151, DOI 10.1364/JOSAA.22.001151; Huber R, 2006, OPT EXPRESS, V14, P3225, DOI 10.1364/OE.14.003225; Hwang HS, 2013, CORNEA, V32, P40, DOI 10.1097/ICO.0b013e318247b2fd; Jester BE, 2011, ANAT REC, V294, P185, DOI 10.1002/ar.21305; JESTER JV, 1981, INVEST OPHTH VIS SCI, V20, P537; Knop E, 2011, INVEST OPHTH VIS SCI, V52, P1938, DOI 10.1167/iovs.10-6997c; LeDoux MS, 2001, INVEST OPHTH VIS SCI, V42, P2434; Lemp Michael A., 1995, CLAO Journal, V21, P221; MATHERS WD, 1994, ARCH OPHTHALMOL-CHIC, V112, P448, DOI 10.1001/archopht.1994.01090160022008; Matsumoto Y, 2008, MOL VIS, V14, P1263; Nichols JJ, 2005, CORNEA, V24, P382, DOI 10.1097/01.ico.0000148291.38076.59; Pult H, 2012, OPTOMETRY VISION SCI, V89, pE760, DOI 10.1097/OPX.0b013e3182512ac1; ROBIN JB, 1985, OPHTHALMOLOGY, V92, P1423; Schaumberg DA, 2002, ADV EXP MED BIOL, V506, P989; Seifert P, 1996, GRAEF ARCH CLIN EXP, V234, P648, DOI 10.1007/BF00185300; TIFFANY JM, 1986, CURR EYE RES, V5, P887, DOI 10.3109/02713688609029242; Tomlinson A, 2011, INVEST OPHTH VIS SCI, V52, P2006, DOI 10.1167/iovs.10-6997f; Yokoi N, 2007, JPN J OPHTHALMOL, V51, P53, DOI 10.1007/s10384-006-0397-y	24	42	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67143	10.1371/journal.pone.0067143	http://dx.doi.org/10.1371/journal.pone.0067143			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805297	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500125
J	Jun, JJ; Longtin, A; Maler, L				Jun, James Jaeyoon; Longtin, Andre; Maler, Leonard			Real-Time Localization of Moving Dipole Sources for Tracking Multiple Free-Swimming Weakly Electric Fish	PLOS ONE			English	Article							ORGAN DISCHARGE; SOUND LOCALIZATION; APTERONOTUS-LEPTORHYNCHUS; PASSIVE ELECTROLOCATION; IMAGING TECHNIQUE; SOCIAL-BEHAVIOR; ANIMALS; SIGNALS; SYSTEM; COMMUNICATION	In order to survive, animals must quickly and accurately locate prey, predators, and conspecifics using the signals they generate. The signal source location can be estimated using multiple detectors and the inverse relationship between the received signal intensity (RSI) and the distance, but difficulty of the source localization increases if there is an additional dependence on the orientation of a signal source. In such cases, the signal source could be approximated as an ideal dipole for simplification. Based on a theoretical model, the RSI can be directly predicted from a known dipole location; but estimating a dipole location from RSIs has no direct analytical solution. Here, we propose an efficient solution to the dipole localization problem by using a lookup table (LUT) to store RSIs predicted by our theoretically derived dipole model at many possible dipole positions and orientations. For a given set of RSIs measured at multiple detectors, our algorithm found a dipole location having the closest matching normalized RSIs from the LUT, and further refined the location at higher resolution. Studying the natural behavior of weakly electric fish (WEF) requires efficiently computing their location and the temporal pattern of their electric signals over extended periods. Our dipole localization method was successfully applied to track single or multiple freely swimming WEF in shallow water in real-time, as each fish could be closely approximated by an ideal current dipole in two dimensions. Our optimized search algorithm found the animal's positions, orientations, and tail-bending angles quickly and accurately under various conditions, without the need for calibrating individual-specific parameters. Our dipole localization method is directly applicable to studying the role of active sensing during spatial navigation, or social interactions between multiple WEF. Furthermore, our method could be extended to other application areas involving dipole source localization.	[Jun, James Jaeyoon; Longtin, Andre] Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada; [Jun, James Jaeyoon; Longtin, Andre; Maler, Leonard] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Jun, James Jaeyoon; Longtin, Andre; Maler, Leonard] Univ Ottawa, Ctr Neural Dynam, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa	Jun, JJ (corresponding author), Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada.	jamesjun@gmail.com			Natural Sciences and Engineering Research Council (Canada); Canadian Institutes of Health Research	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors acknowledge funding from Natural Sciences and Engineering Research Council (Canada) (JJJ and AL) as well as from Canadian Institutes of Health Research (AL, LM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aytekin M, 2004, J ACOUST SOC AM, V116, P3594, DOI 10.1121/1.1811412; Babineau D, 2007, PLOS COMPUT BIOL, V3, P402, DOI 10.1371/journal.pcbi.0030038; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Caputi AA, 1999, J EXP BIOL, V202, P1229; Castello ME, 2009, J EXP BIOL, V212, P1351, DOI 10.1242/jeb.022566; Chen L, 2005, J COMP PHYSIOL A, V191, P331, DOI 10.1007/s00359-004-0587-3; Coombs S, 1996, J COMP PHYSIOL A, V178, P359; DAVIS EA, 1988, ANIM BEHAV, V36, P1658, DOI 10.1016/S0003-3472(88)80106-4; Fontaine E, 2008, J EXP BIOL, V211, P1305, DOI 10.1242/jeb.010272; FUZESSERY ZM, 1993, J COMP PHYSIOL A, V171, P767, DOI 10.1007/BF00213073; Goulet J, 2008, J COMP PHYSIOL A, V194, P1, DOI 10.1007/s00359-007-0275-1; HAGEDORN M, 1985, ANIM BEHAV, V33, P254, DOI 10.1016/S0003-3472(85)80139-1; HOPKINS CD, 1974, BEHAVIOUR, V50, P270, DOI 10.1163/156853974X00499; Hopkins CD, 1997, BRAIN BEHAV EVOLUT, V50, P32, DOI 10.1159/000113353; Hupe GJ, 2008, J EXP BIOL, V211, P1657, DOI 10.1242/jeb.013516; Sanguinetti-Scheck JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027470; KNUDSEN EI, 1975, J COMP PHYSIOL, V99, P103, DOI 10.1007/BF00618178; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P13, DOI 10.1007/BF00663106; KRAMER B, 1974, J COMP PHYSIOL, V93, P203, DOI 10.1007/BF00607000; Lewejohann L, 2009, BEHAV RES METHODS, V41, P850, DOI 10.3758/BRM.41.3.850; LISSMANN HW, 1958, J EXP BIOL, V35, P156; LISSMANN HW, 1958, J EXP BIOL, V35, P451; MASCANZONI D, 1986, ECOL ENTOMOL, V11, P387, DOI 10.1111/j.1365-2311.1986.tb00317.x; MOHRES FP, 1957, NATURWISSENSCHAFTEN, V44, P431; Nelson ME, 1999, J EXP BIOL, V202, P1195; Noldus LPJJ, 2001, BEHAV RES METH INS C, V33, P398, DOI 10.3758/BF03195394; O'Neal M. E., 2004, American Entomologist, V50, P212; Rivera-Vicente AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016008; RODRIGUEZCATTAN.A, 2008, PLOS ONE, V0003; Shieh KT, 1996, J EXP BIOL, V199, P2383; SPRUIJT BM, 1992, PHYSIOL BEHAV, V51, P747, DOI 10.1016/0031-9384(92)90111-E; Straw AD, 2011, J R SOC INTERFACE, V8, P395, DOI 10.1098/rsif.2010.0230; Turner CR, 2007, J EXP BIOL, V210, P4104, DOI 10.1242/jeb.007930; Vasserman G, 2012, FRONT BEH NEUR C 10, DOI [10.3389/conf.fnbeh.2012.27. 00026, DOI 10.3389/C0NF.FNBEH.2012.27.00026]; Vatine JJ, 1998, J NEUROSCI METH, V85, P1, DOI 10.1016/S0165-0270(98)00076-4; von der Emde G, 1998, NATURE, V395, P890, DOI 10.1038/27655; WINBERG S, 1993, J EXP BIOL, V179, P213; Windsor SP, 2008, J EXP BIOL, V211, P2950, DOI 10.1242/jeb.020453; Yu N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002564; Zakon H, 2002, J PHYSIOL-PARIS, V96, P451, DOI 10.1016/S0928-4257(03)00012-3; Zupanc GKH, 2002, J PHYSIOLOGY-PARIS, V96, P459, DOI 10.1016/S0928-4257(03)00002-0	41	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66596	10.1371/journal.pone.0066596	http://dx.doi.org/10.1371/journal.pone.0066596			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805244	gold, Green Published, Green Submitted			2022-12-25	WOS:000320846500072
J	Sharman, MJ; Nik, SHM; Chen, MQM; Ong, D; Wijaya, L; Laws, SM; Taddei, K; Newman, M; Lardelli, M; Martins, RN; Verdile, G				Sharman, Mathew J.; Nik, Seyyed H. Moussavi; Chen, Mengqi M.; Ong, Daniel; Wijaya, Linda; Laws, Simon M.; Taddei, Kevin; Newman, Morgan; Lardelli, Michael; Martins, Ralph N.; Verdile, Giuseppe			The Guinea Pig as a Model for Sporadic Alzheimer's Disease (AD): The Impact of Cholesterol Intake on Expression of AD-Related Genes	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; PRESENILIN-2 SPLICE VARIANT; TRANSGENIC MOUSE MODEL; GAMMA-SECRETASE; MESSENGER-RNA; CATALYTIC PORE; TG2576 MICE; TAU-PROTEIN; IN-VITRO; BETA	We investigated the guinea pig, Cavia porcellus, as a model for Alzheimer's disease (AD), both in terms of the conservation of genes involved in AD and the regulatory responses of these to a known AD risk factor - high cholesterol intake. Unlike rats and mice, guinea pigs possess an A beta peptide sequence identical to human A beta. Consistent with the commonality between cardiovascular and AD risk factors in humans, we saw that a high cholesterol diet leads to up-regulation of BACE1 (beta-secretase) transcription and down-regulation of ADAM10 (alpha-secretase) transcription which should increase release of A beta from APP. Significantly, guinea pigs possess isoforms of AD-related genes found in humans but not present in mice or rats. For example, we discovered that the truncated PS2V isoform of human PSEN2, that is found at raised levels in AD brains and that increases gamma-secretase activity and A beta synthesis, is not uniquely human or aberrant as previously believed. We show that PS2V formation is up-regulated by hypoxia and a high-cholesterol diet while, consistent with observations in humans, A beta concentrations are raised in some brain regions but not others. Also like humans, but unlike mice, the guinea pig gene encoding tau, MAPT, encodes isoforms with both three and four microtubule binding domains, and cholesterol alters the ratio of these isoforms. We conclude that AD-related genes are highly conserved and more similar to human than the rat or mouse. Guinea pigs represent a superior rodent model for analysis of the impact of dietary factors such as cholesterol on the regulation of AD-related genes.	[Sharman, Mathew J.; Chen, Mengqi M.; Ong, Daniel; Wijaya, Linda; Laws, Simon M.; Taddei, Kevin; Martins, Ralph N.; Verdile, Giuseppe] Edith Cowan Univ, Sch Med Sci, Ctr Excellence Alzheimers Dis Res & Care, Perth, WA, Australia; [Sharman, Mathew J.] Univ Tasmania, Sch Human Life Sci, Launceston, Tas 7250, Australia; [Nik, Seyyed H. Moussavi; Newman, Morgan; Lardelli, Michael] Univ Adelaide, Sch Mol & Biomed Sci, Discipline Genet, Adelaide, SA, Australia; [Taddei, Kevin; Martins, Ralph N.; Verdile, Giuseppe] Hollywood Private Hosp, Sir James McCusker Alzheimers Dis Res Unit, Nedlands, WA, Australia; [Taddei, Kevin; Martins, Ralph N.; Verdile, Giuseppe] Univ Western Australia, Sch Psychiat & Clin Neurosci, Crawley, WA, Australia	Edith Cowan University; University of Tasmania; University of Adelaide; University of Western Australia; University of Western Australia	Verdile, G (corresponding author), Edith Cowan Univ, Sch Med Sci, Ctr Excellence Alzheimers Dis Res & Care, Perth, WA, Australia.	g.verdile@ecu.edu.au	Sharman, Matt/U-4181-2019; Sharman, Matthew J/I-3788-2014; Wijaya, Linda/CAF-1162-2022; , Morgan/Y-5204-2019; Laws, Simon/C-2858-2014	Sharman, Matt/0000-0003-1005-4793; Sharman, Matthew J/0000-0003-1005-4793; Wijaya, Linda/0000-0003-2603-7074; Laws, Simon/0000-0002-4355-7082; Verdile, Giuseppe/0000-0003-2475-0124; Moussavi Nik, Seyyed Hani/0000-0002-5727-6863; Martins, Ralph/0000-0002-4828-9363; Newman, Morgan/0000-0002-4930-4529; Lardelli, Michael/0000-0002-4289-444X	National Health and Medical Research Council (NHMRC) of Australia [453622]; Edith Cowan University Early Career Research Grant; Edith Cowan University's Strategic Research Grant; McCusker Alzheimer's Disease Research Foundation; NHMRC; West Perth Rotary Club	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Edith Cowan University Early Career Research Grant; Edith Cowan University's Strategic Research Grant; McCusker Alzheimer's Disease Research Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); West Perth Rotary Club	This work was supported by a grant obtained from the National Health and Medical Research Council (NHMRC) of Australia, [ID: 453622 to ML, RM and GV], a Edith Cowan University Early Career Research Grant [to MS] and Edith Cowan University's Strategic Research Grant [to GV]. RM and GV are supported by grants from the McCusker Alzheimer's Disease Research Foundation and NHMRC. MC is supported by a scholarship from the West Perth Rotary Club and the McCusker Alzheimer's Disease Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardiles AO, 2012, P NATL ACAD SCI USA, V109, P13835, DOI 10.1073/pnas.1201209109; Beck M, 1997, BBA-GENE STRUCT EXPR, V1351, P17, DOI 10.1016/S0167-4781(96)00232-1; Beck M, 2003, NEUROCHEM RES, V28, P637, DOI 10.1023/A:1022850113083; Bigl M, 2000, NEUROSCI LETT, V292, P107, DOI 10.1016/S0304-3940(00)01452-X; Connell JW, 2005, MOL BRAIN RES, V137, P104, DOI 10.1016/j.molbrainres.2005.02.014; Conrad C, 2007, J NEUROCHEM, V103, P1228, DOI 10.1111/j.1471-4159.2007.04857.x; Cos E, 2001, LIPIDS, V36, P1209, DOI 10.1007/s11745-001-0834-1; Crestini A, 2006, J MOL NEUROSCI, V30, P311, DOI 10.1385/JMN:30:3:311; Dumanchin C, 1999, HUM MOL GENET, V8, P1263, DOI 10.1093/hmg/8.7.1263; Elder GA, 2010, MT SINAI J MED, V77, P69, DOI 10.1002/msj.20159; Epis R, 2010, EUR J PHARMACOL, V626, P57, DOI 10.1016/j.ejphar.2009.10.020; Espinoza M, 2008, J ALZHEIMERS DIS, V14, P1; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Fernandez ML, 2001, J NUTR, V131, P10, DOI 10.1093/jn/131.1.10; George AJ, 2004, NEUROBIOL DIS, V16, P124, DOI 10.1016/j.nbd.2004.01.009; Ginsberg SD, 2006, J NEUROCHEM, V96, P1401, DOI 10.1111/j.1471-4159.2005.03641.x; Gong P, 2010, J BIOL CHEM, V285, P38042, DOI 10.1074/jbc.M110.132613; Haass C, 2010, CELL, V142, P356, DOI 10.1016/j.cell.2010.07.032; Higashide S, 2004, J NEUROCHEM, V91, P1191, DOI 10.1111/j.1471-4159.2004.02798.x; Howlett DR, 2009, HISTOL HISTOPATHOL, V24, P83, DOI 10.14670/HH-24.83; Irizarry MC, 2001, AM J PATHOL, V158, P173, DOI 10.1016/S0002-9440(10)63955-7; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jung HJ, 2011, EXP NEUROL, V228, P232, DOI 10.1016/j.expneurol.2011.01.012; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Lanz TA, 2005, J PHARMACOL EXP THER, V312, P399, DOI 10.1124/jpet.104.073965; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; Lehman EJH, 2003, HUM MOL GENET, V12, P2949, DOI 10.1093/hmg/ddg322; LIN ECK, 1992, J NUTR, V122, P2019, DOI 10.1093/jn/122.10.2019; Liu H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.05.027; Manabe T, 2003, CELL DEATH DIFFER, V10, P698, DOI 10.1038/sj.cdd.4401221; Matsuzaki S, 2004, J NEUROCHEM, V88, P1345, DOI 10.1111/j.1471-4159.2004.02290.x; Mehta PD, 2000, ARCH NEUROL-CHICAGO, V57, P100, DOI 10.1001/archneur.57.1.100; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Mitterreiter S, 2010, J NEUROSCI, V30, P8974, DOI 10.1523/JNEUROSCI.1199-10.2010; Murphy MP, 2010, J ALZHEIMERS DIS, V22, P135, DOI 10.3233/JAD-2010-100639; Netzer WJ, 2003, P NATL ACAD SCI USA, V100, P12444, DOI 10.1073/pnas.1534745100; Nik SHM, 2011, EXP CELL RES, V317, P1503, DOI 10.1016/j.yexcr.2011.04.004; Petanceska SS, 2000, EXP GERONTOL, V35, P1317, DOI 10.1016/S0531-5565(00)00157-1; Prasanthi RPJ, 2008, MECH AGEING DEV, V129, P649, DOI 10.1016/j.mad.2008.09.002; Refolo LM, 2001, NEUROBIOL DIS, V8, P890, DOI 10.1006/nbdi.2001.0422; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; Ringman JM, 2011, NEUROSCI LETT, V487, P287, DOI 10.1016/j.neulet.2010.10.039; Rogaev EI, 1997, GENOMICS, V40, P415, DOI 10.1006/geno.1996.4523; Rossner S, 2001, J NEUROSCI RES, V64, P437; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato N, 1999, J NEUROCHEM, V72, P2498, DOI 10.1046/j.1471-4159.1999.0722498.x; Sato N, 2001, J BIOL CHEM, V276, P2108, DOI 10.1074/jbc.M006886200; Scheper W, 2004, NEUROGENETICS, V5, P223, DOI 10.1007/s10048-004-0195-y; Schmidt Stephen D., 2004, V299, P279; Sharman MJ, 2008, J NUTR BIOCHEM, V19, P732, DOI 10.1016/j.jnutbio.2007.09.008; Skoog I, 2006, NEUROL RES, V28, P605, DOI 10.1179/016164106X130506; Smith MJ, 2004, MOL BRAIN RES, V127, P128, DOI 10.1016/j.molbrainres.2004.05.019; Smith SKF, 2000, MOL BRAIN RES, V78, P100, DOI 10.1016/S0169-328X(00)00079-6; SPARKS DL, 1994, EXP NEUROL, V126, P88, DOI 10.1006/exnr.1994.1044; Sparks DL, 2000, ANN NY ACAD SCI, V903, P335, DOI 10.1111/j.1749-6632.2000.tb06384.x; Takagi S, 2010, J NEUROSCI, V30, P15943, DOI 10.1523/JNEUROSCI.3318-10.2010; Takuma H, 2003, DEV BRAIN RES, V142, P121, DOI 10.1016/S0165-3806(03)00056-7; Tamagno E, 2008, J NEUROCHEM, V104, P683, DOI 10.1111/j.1471-4159.2007.05072.x; Tanahashi H, 1999, NEUROREPORT, V10, P563, DOI 10.1097/00001756-199902250-00022; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Verdile G, 2004, NEUROLOGY, V63, P1385; Wahjoepramono EJ, 2011, NEUROENDOCRINOLOGY; Wahjoepramono EJ, 2008, J ALZHEIMERS DIS, V15, P129; Wanngren J, 2010, J BIOL CHEM, V285, P8527, DOI 10.1074/jbc.M109.055590; Wu CW, 2003, J NEURAL TRANSM, V110, P641, DOI 10.1007/s00702-002-0809-1; Yasojima K, 2001, BRAIN RES, V919, P115, DOI 10.1016/S0006-8993(01)03008-6; Zern TL, 2003, J NUTR, V133, P2268, DOI 10.1093/jn/133.7.2268; Zetterberg H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028263; Zhang WJ, 1998, J NEUROSCI, V18, P914	70	27	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66235	10.1371/journal.pone.0066235	http://dx.doi.org/10.1371/journal.pone.0066235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805206	Green Published, gold			2022-12-25	WOS:000320846500034
J	Ganem, MB; De Marzi, MC; Fernandez-Lynch, MJ; Jancic, C; Vermeulen, M; Geffner, J; Mariuzza, RA; Fernandez, MM; Malchiodi, EL				Ganem, Maria B.; De Marzi, Mauricio C.; Fernandez-Lynch, Maria J.; Jancic, Carolina; Vermeulen, Monica; Geffner, Jorge; Mariuzza, Roy A.; Fernandez, Marisa M.; Malchiodi, Emilio L.			Uptake and Intracellular Trafficking of Superantigens in Dendritic Cells	PLOS ONE			English	Article							RECEPTOR-BETA-CHAIN; MHC CLASS-II; INNATE IMMUNE-SYSTEM; TOXIC-SHOCK-SYNDROME; CRYSTAL-STRUCTURE; BACTERIAL SUPERANTIGEN; STAPHYLOCOCCAL ENTEROTOXINS; STRUCTURAL BASIS; 3-DIMENSIONAL STRUCTURE; LATE ENDOSOMES	Bacterial superantigens (SAgs) are exotoxins produced mainly by Staphylococcus aureus and Streptococcus pyogenes that can cause toxic shock syndrome (TSS). According to current paradigm, SAgs interact directly and simultaneously with T cell receptor (TCR) on the T cell and MHC class II (MHC-II) on the antigen-presenting cell (APC), thereby circumventing intracellular processing to trigger T cell activation. Dendritic cells (DCs) are professional APCs that coat nearly all body surfaces and are the most probable candidate to interact with SAgs. We demonstrate that SAgs are taken up by mouse DCs without triggering DC maturation. SAgs were found in intracellular acidic compartment of DCs as biologically active molecules. Moreover, SAgs co-localized with EEA1, RAB-7 and LAMP-2, at different times, and were then recycled to the cell membrane. DCs loaded with SAgs are capable of triggering in vitro lymphocyte proliferation and, injected into mice, stimulate T cells bearing the proper TCR in draining lymph nodes. Transportation and trafficking of SAgs in DCs might increase the local concentration of these exotoxins where they will produce the highest effect by promoting their encounter with both MHC-II and TCR in lymph nodes, and may explain how just a few SAg molecules can induce the severe pathology associated with TSS.	[Ganem, Maria B.; De Marzi, Mauricio C.; Fernandez-Lynch, Maria J.; Fernandez, Marisa M.; Malchiodi, Emilio L.] Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Catedra Inmunol, RA-1113 Buenos Aires, DF, Argentina; [Ganem, Maria B.; De Marzi, Mauricio C.; Fernandez-Lynch, Maria J.; Fernandez, Marisa M.; Malchiodi, Emilio L.] Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Inst Estudios Inmunidad Humoral IDEHU, RA-1113 Buenos Aires, DF, Argentina; [De Marzi, Mauricio C.] Univ Nacl Lujan, Dept Ciencias Basicas, Buenos Aires, DF, Argentina; [Jancic, Carolina; Vermeulen, Monica; Geffner, Jorge] Acad Nacl Med Buenos Aires, Inst Invest Hematol, Dept Inmunol, Buenos Aires, DF, Argentina; [Mariuzza, Roy A.] Univ Maryland, Inst Biosci & Biotechnol Res, WM Keck Lab Struct Biol, Rockville, MD USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Universidad Nacional de Lujan; Buenos Aires National Academy of Medicine; IIHEMA - Instituto de Investigaciones Hematologicas	Malchiodi, EL (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Catedra Inmunol, RA-1113 Buenos Aires, DF, Argentina.	emalchio@ffyb.uba.ar		Fernandez, Marisa/0000-0002-7480-5907; Malchiodi, Emilio/0000-0001-7501-3330	University of Buenos Aires; National Research Council of Argentina (CONICET); Agencia Nacional de Promocion Cientifica y Tecnica [PICT-06 450, PICT-10 1139, PICT-08 608]; Fogarty International Center [TW007972]; International Centre for Genetic Engineering and Biotechnology [CRP/ARG09-02]; FOGARTY INTERNATIONAL CENTER [R03TW007972] Funding Source: NIH RePORTER	University of Buenos Aires(University of Buenos Aires); National Research Council of Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnica(ANPCyT); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); International Centre for Genetic Engineering and Biotechnology; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the University of Buenos Aires, the National Research Council of Argentina (CONICET), and Agencia Nacional de Promocion Cientifica y Tecnica, grants PICT-06 450 (to M. M. F.), and PICT-10 1139 and PICT-08 608 (to E. L. M.). E. L. M. is also supported by the Fogarty International Center (TW007972) and International Centre for Genetic Engineering and Biotechnology (CRP/ARG09-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PS, 2002, BIOCHEMISTRY-US, V41, P5177, DOI 10.1021/bi0200209; Arad G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001149; Back J, 2009, IMMUNITY, V31, P598, DOI 10.1016/j.immuni.2009.07.007; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; BOHACH GA, 1990, CRIT REV MICROBIOL, V17, P251, DOI 10.3109/10408419009105728; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Buonpane RA, 2005, J MOL BIOL, V353, P308, DOI 10.1016/j.jmb.2005.08.041; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; CHAKRABORTY P, 1994, METHOD CELL BIOL, V45, P261; Chau TA, 2009, NAT MED, V15, P641, DOI 10.1038/nm.1965; Coutant KD, 1999, TOXICOL SCI, V52, P189, DOI 10.1093/toxsci/52.2.189; De Marzi MC, 2004, EUR J BIOCHEM, V271, P4075, DOI 10.1111/j.1432-1033.2004.04345.x; Dickgreber N, 2009, J IMMUNOL, V182, P1260, DOI 10.4049/jimmunol.182.3.1260; Earhart CA, 1997, SUPERANTIGENS MOL BI, P127; Fernandez MM, 2007, PROTEINS, V68, P389, DOI 10.1002/prot.21388; Fernandez MM, 2006, J BIOL CHEM, V281, P25356, DOI 10.1074/jbc.M603969200; Fernandez MM, 2011, J BIOL CHEM, V286, P1189, DOI 10.1074/jbc.M110.142471; Fernandez MM, 2006, MOL IMMUNOL, V43, P927, DOI 10.1016/j.molimm.2005.06.029; Fields BA, 1996, NATURE, V384, P188, DOI 10.1038/384188a0; Fraser JD, PLOS BIOL, V9, DOI [10.1371/journal.pbio.1001145, DOI 10.1371/J0URNAL.PBI0.1001145]; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; Kato M, 2011, CANCER IMMUNOL IMMUN, V60, P1029, DOI 10.1007/s00262-011-1015-5; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Khandekar SS, 1997, MOL IMMUNOL, V34, P493, DOI 10.1016/S0161-5890(97)00044-8; Lappin E, 2009, LANCET INFECT DIS, V9, P281, DOI 10.1016/S1473-3099(09)70066-0; Le Roux D, 2012, BLOOD, V119, P95, DOI 10.1182/blood-2011-02-336123; Leder L, 1998, J EXP MED, V187, P823, DOI 10.1084/jem.187.6.823; Li HM, 1999, ANNU REV IMMUNOL, V17, P435, DOI 10.1146/annurev.immunol.17.1.435; Li HM, 1998, IMMUNITY, V9, P807, DOI 10.1016/S1074-7613(00)80646-9; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lutz MB, 1996, IMMUNOBIOLOGY, V195, P431, DOI 10.1016/S0171-2985(96)80014-3; Lutz MB, 1997, J IMMUNOL, V159, P3707; MALCHIODI EL, 1995, J EXP MED, V182, P1833, DOI 10.1084/jem.182.6.1833; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; Martinez D, 2007, J IMMUNOL, V179, P1950, DOI 10.4049/jimmunol.179.3.1950; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Michelsen KS, 2001, J BIOL CHEM, V276, P25680, DOI 10.1074/jbc.M011615200; Moza B, 2007, EMBO J, V26, P1187, DOI 10.1038/sj.emboj.7601531; Moza B, 2006, P NATL ACAD SCI USA, V103, P9867, DOI 10.1073/pnas.0600220103; Muraille E, 2002, J IMMUNOL, V168, P4352, DOI 10.4049/jimmunol.168.9.4352; Muralimohan G, 2006, CELL IMMUNOL, V242, P9, DOI 10.1016/j.cellimm.2006.08.007; Niedergang F, 2000, P NATL ACAD SCI USA, V97, P14650, DOI 10.1073/pnas.97.26.14650; Nobile C, 2008, BLOOD, V111, P3579, DOI 10.1182/blood-2007-08-107755; Petersson K, 2001, EMBO J, V20, P3306, DOI 10.1093/emboj/20.13.3306; Platt CD, 2010, P NATL ACAD SCI USA, V107, P4287, DOI 10.1073/pnas.0910609107; Proft T, 2003, CLIN EXP IMMUNOL, V133, P299, DOI 10.1046/j.1365-2249.2003.02203.x; Pumphrey N, 2007, J IMMUNOL, V179, P2700, DOI 10.4049/jimmunol.179.5.2700; Qin ZH, 1997, J IMMUNOL, V159, P770; Rahman AKMNU, 2006, J IMMUNOL, V177, P8595, DOI 10.4049/jimmunol.177.12.8595; Redpath S, 1999, J IMMUNOL, V163, P6; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Rossi RJ, 2004, INT IMMUNOL, V16, P1751, DOI 10.1093/intimm/dxh176; SAHLIN S, 1983, J IMMUNOL METHODS, V60, P115, DOI 10.1016/0022-1759(83)90340-X; Saline M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1117; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; SETH A, 1994, NATURE, V369, P324, DOI 10.1038/369324a0; SOLDATI T, 1995, J BIOL CHEM, V270, P25541, DOI 10.1074/jbc.270.43.25541; Sundberg EJ, 2002, STRUCTURE, V10, P687, DOI 10.1016/S0969-2126(02)00759-1; VANSTRIJP JAG, 1989, J CLIN INVEST, V84, P107, DOI 10.1172/JCI114129; Volz T, 2010, FASEB J, V24, P4089, DOI 10.1096/fj.09-151001; Wang LM, 2007, NAT STRUCT MOL BIOL, V14, P169, DOI 10.1038/nsmb1193; Wang TL, 2011, CELL SIGNAL, V23, P516, DOI 10.1016/j.cellsig.2010.09.012; Wu MS, 2005, EMBO J, V24, P1491, DOI 10.1038/sj.emboj.7600643; Wykes M, 1998, J IMMUNOL, V161, P1313	67	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66244	10.1371/journal.pone.0066244	http://dx.doi.org/10.1371/journal.pone.0066244			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799083	Green Published, gold			2022-12-25	WOS:000320363300068
J	Gero, D; Szoleczky, P; Modis, K; Pribis, JP; Al-Abed, Y; Yang, H; Chevan, S; Billiar, TR; Tracey, KJ; Szabo, C				Geroe, Domokos; Szoleczky, Petra; Modis, Katalin; Pribis, John P.; Al-Abed, Yousef; Yang, Huan; Chevan, Sangeeta; Billiar, Timothy R.; Tracey, Kevin J.; Szabo, Csaba			Identification of Pharmacological Modulators of HMGB1-Induced Inflammatory Response by Cell-Based Screening	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; CYTOKINE RELEASE; SYSTEMIC INFLAMMATION; KAPPA-B; HMGB1; RECEPTOR; ACTIVATION; BINDING; TRANSCRIPTION; SURVIVAL	High mobility group box 1 (HMGB1), a highly conserved, ubiquitous protein, is released into the circulation during sterile inflammation (e. g. arthritis, trauma) and circulatory shock. It participates in the pathogenesis of delayed inflammatory responses andorgandysfunction. While several molecules have been identified that modulate the release of HMGB1, less attention has been paid to identify pharmacological inhibitors of the downstream inflammatory processes elicited by HMGB1 (C23-C45 disulfide C106thiol form). In the current study, a cell-based medium-throughput screening of a 5000+ compound focused library of clinical drugs and drug-like compounds was performed in murine RAW264.7 macrophages, in order to identify modulators of HMGB1-induced tumor-necrosis factor alpha(TNF alpha) production. Clinically used drugs that suppressed HMGB1-induced TNF alpha production included glucocorticoids, beta agonists, and the anti-HIV compound indinavir. A re-screen of the NIH clinical compound library identified beta-agonists and various intracellular cAMP enhancers as compounds that potentiate the inhibitory effect of glucocorticoids on HMGB1-induced TNF alpha production. The molecular pathways involved in this synergistic anti-inflammatory effect are related, at least in part, to inhibition of TNF alpha mRNA synthesis via a synergistic suppression of ERK/IkB activation. Inhibition of TNF alpha production by prednisolone+salbutamol pretreatment was also confirmed in vivo in mice subjected to HMGB1 injection; this effect was more pronounced than the effect of either of the agents administered separately. The current study unveils several drug-like modulators of HMGB1-mediated inflammatory responses and offers pharmacological directions for the therapeutic suppression of inflammatory responses in HMGB1-dependent diseases.	[Geroe, Domokos; Szoleczky, Petra; Modis, Katalin; Szabo, Csaba] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Pribis, John P.; Billiar, Timothy R.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Al-Abed, Yousef; Yang, Huan; Chevan, Sangeeta; Tracey, Kevin J.] Feinstein Inst Med Res, Lab Biomed Sci, Manhasset, NY USA	University of Texas System; University of Texas Medical Branch Galveston; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwell Health	Szabo, C (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	szabocsaba@aol.com	Gero, Domokos/F-7853-2017; Szabo, Csaba/ABG-2644-2021; Szoleczky, Petra/O-4649-2014	Gero, Domokos/0000-0002-3132-3465; Szoleczky, Petra/0000-0003-4921-6673; Tracey, Kevin J/0000-0003-1884-6314; Chavan, Sangeeta S./0000-0002-4822-3356	National Institutes of Health [P50GM060338, GM062508]; University of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM060338, R01GM062508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in part, by grants from the National Institutes of Health (P50GM060338 to C. S., and GM062508 to K. J. T.). M. K. was supported by the James W. McLaughlin Fellowship Fund of the University of Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Barnes PJ, 2002, EUR RESPIR J, V19, P182, DOI 10.1183/09031936.02.00283202; BERTINI R, 1988, J EXP MED, V167, P1708, DOI 10.1084/jem.167.5.1708; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Cai BL, 2009, J CELL MOL MED, V13, P3774, DOI 10.1111/j.1582-4934.2008.00550.x; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Colangelo AM, 2004, MOL BRAIN RES, V124, P97, DOI 10.1016/j.molbrainres.2004.01.011; Ditsworth D, 2007, J BIOL CHEM, V282, P17845, DOI 10.1074/jbc.M701465200; Evankovich J, 2010, J BIOL CHEM, V285, P39888, DOI 10.1074/jbc.M110.128348; Gero D, 2007, INT J MOL MED, V20, P749; Gero D, 2013, DIABETES, V62, P953, DOI 10.2337/db12-0789; Ghio AJ, 1996, AM J RESP CRIT CARE, V154, P783, DOI 10.1164/ajrccm.154.3.8810619; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Kim S, 2013, MOL MED IN PRESS; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Lagathu C, 2004, ANTIVIR THER, V9, P911; Lahat A, 2008, CLIN EXP IMMUNOL, V152, P320, DOI 10.1111/j.1365-2249.2008.03636.x; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; PARK EA, 1993, J BIOL CHEM, V268, P613; Schierbeck H, 2010, MOL MED, V16, P343, DOI 10.2119/molmed.2010.00031; SELYE H, 1971, J PHARM SCI, V60, P1, DOI 10.1002/jps.2600600102; Szabo C, 1997, IMMUNOLOGY, V90, P95, DOI 10.1046/j.1365-2567.1997.00137.x; Szelenyi J, 2007, ANN NY ACAD SCI, V1113, P311, DOI 10.1196/annals.1391.026; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Ulloa L, 2002, P NATL ACAD SCI USA, V99, P12351, DOI 10.1073/pnas.192222999; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Wang HC, 2009, SHOCK, V32, P348, DOI 10.1097/SHK.0b013e3181a551bd; Yang H, 2012, MOL MED, V18, P250, DOI 10.2119/molmed.2011.00389; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yang H, 2010, BBA-GENE REGUL MECH, V1799, P149, DOI 10.1016/j.bbagrm.2009.11.019	31	28	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65994	10.1371/journal.pone.0065994	http://dx.doi.org/10.1371/journal.pone.0065994			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799067	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000320363300057
J	Maciejewska-Karlowska, A; Sawczuk, M; Cieszczyk, P; Zarebska, A; Sawczyn, S				Maciejewska-Karlowska, Agnieszka; Sawczuk, Marek; Cieszczyk, Pawel; Zarebska, Aleksandra; Sawczyn, Stanislaw			Association between the Pro12Ala Polymorphism of the Peroxisome Proliferator-Activated Receptor Gamma Gene and Strength Athlete Status	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; BODY-MASS INDEX; PPAR-GAMMA; INSULIN SENSITIVITY; PPAR-GAMMA-2 GENE; ALANINE SUBSTITUTION; BONE-FORMATION; PROMOTER; EXPRESSION; VARIANT	Background: The 12Ala allele of the Peroxisome Proliferator-Activated Receptor gamma gene ( PPARG) Pro12Ala polymorphism produces a decreased binding affinity of the PPAR gamma 2 protein, resulting in low activation of the target genes. The 12Ala allele carriers display a significantly improved insulin sensitivity that may result in better glucose utilisation in working skeletal muscles. We hypothesise that the PPARG 12Ala allele could be associated with strength athlete status in Polish athletes. Methodology: The genotype distribution of PPARG Pro12Ala was examined in 660 Polish athletes. The athletes were stratified into four subgroups: endurance, strength-endurance, sprint-strength and strength. Control samples were prepared from 684 unrelated sedentary volunteers. A chi(2) test was used to compare the PPARG Pro12Ala allele and genotype frequencies between the different groups of athletes and control subjects. Bonferroni's correction for multiple testing was applied. Results: A statistically significant higher frequency of PPARG 12Ala alleles was observed in the subgroup of strength athletes performing short-term and very intense exertion characterised by predominant anaerobic energy production (13.2% vs. 7.5% in controls; P = 0.0007). Conclusion: The PPARG 12Ala allele may be a relevant genetic factor favouring strength abilities in professional athletes, especially in terms of insulin-dependent metabolism, a shift of the energy balance towards glucose utilisation and the development of a favourable weight-to-strength ratio.	[Maciejewska-Karlowska, Agnieszka; Sawczuk, Marek] Tech Univ Szczecin, Fac Phys Educ & Hlth Promot, Dept Biol Bases Phys Culture, Szczecin, Poland; [Maciejewska-Karlowska, Agnieszka; Sawczuk, Marek] Tech Univ Szczecin, Dept Genet, Fac Biol, Szczecin, Poland; [Cieszczyk, Pawel; Zarebska, Aleksandra; Sawczyn, Stanislaw] Acad Phys Educ & Sport, Dept Sport, Fac Tourism & Recreat, Gdansk, Poland	West Pomeranian University of Technology; West Pomeranian University of Technology; Gdansk University of Physical Education & Sport	Maciejewska-Karlowska, A (corresponding author), Tech Univ Szczecin, Fac Phys Educ & Hlth Promot, Dept Biol Bases Phys Culture, Szczecin, Poland.	maciejewska.us@wp.pl	Cieszczyk, Pawel/AFK-4645-2022; Sawczuk, Marek/S-3609-2017; Cieszczyk, Pawel/AAG-3328-2022	Cieszczyk, Pawel/0000-0002-7735-7580; Cieszczyk, Pawel/0000-0002-7735-7580; Maciejewska-Skrendo, Agnieszka/0000-0003-4587-2411; sawczyn, stanislaw/0000-0002-1974-3248; Jazdzewska, Aleksandra/0000-0002-7518-855X; Sawczuk, Marek/0000-0002-5730-5249	Polish Ministry of Science and Higher Education [N 404166334]; Faculty of Biology, University of Szczecin [504-1000-240-849]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Faculty of Biology, University of Szczecin	This work was partly supported by grant N 404166334 founded by Polish Ministry of Science and Higher Education (www.nauka.gov.pl) and by grant 504-1000-240-849 for young researchers founded by Faculty of Biology, University of Szczecin (wb.univ.szczecin.pl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Ahmetov II, 2008, B EXP BIOL MED+, V146, P630, DOI 10.1007/s10517-009-0364-y; Akhmetov I I, 2007, Ross Fiziol Zh Im I M Sechenova, V93, P837; Ali AA, 2005, ENDOCRINOLOGY, V146, P1226, DOI 10.1210/en.2004-0735; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Beamer BA, 1998, DIABETES, V47, P1806, DOI 10.2337/diabetes.47.11.1806; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Cieszczyk P, 2011, EUR J SPORT SCI, V11, P119, DOI 10.1080/17461391.2010.487120; Cock TA, 2004, EMBO REP, V5, P1007, DOI 10.1038/sj.embor.7400254; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Doney A, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-21; Douglas JA, 2001, DIABETES, V50, P886, DOI 10.2337/diabetes.50.4.886; Druzhevskaya AM, 2008, EUR J APPL PHYSIOL, V103, P631, DOI 10.1007/s00421-008-0763-1; Ek J, 2001, DIABETOLOGIA, V44, P1170, DOI 10.1007/s001250100629; Evangelisti L, 2009, ATHEROSCLEROSIS, V205, P186, DOI 10.1016/j.atherosclerosis.2008.11.009; Fajas L, 1998, FEBS LETT, V438, P55, DOI 10.1016/S0014-5793(98)01273-3; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Franks PW, 2004, METABOLISM, V53, P11, DOI 10.1016/j.metabol.2003.08.005; Frederiksen L, 2002, J CLIN ENDOCR METAB, V87, P3989, DOI 10.1210/jc.87.8.3989; Gabbasov RT, 2013, J STRENGTH COND RES, V27, P2055, DOI 10.1519/JSC.0b013e31827f06ae; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Honka MJ, 2009, METABOLISM, V58, P541, DOI 10.1016/j.metabol.2008.11.015; Hsueh WC, 2001, DIABETES CARE, V24, P672, DOI 10.2337/diacare.24.4.672; Kawaguchi H, 2005, J BONE MINER METAB, V23, P275, DOI 10.1007/s00774-005-0599-2; Koch M, 1999, DIABETOLOGIA, V42, P758, DOI 10.1007/s001250051225; Little J, 2009, HUM GENET, V125, P131, DOI 10.1007/s00439-008-0592-7; Luan J, 2001, DIABETES, V50, P686, DOI 10.2337/diabetes.50.3.686; Maciejewska A, 2012, J SPORT SCI, V30, P101, DOI 10.1080/02640414.2011.623709; Maciejewska A, 2011, J SCI MED SPORT, V14, P58, DOI 10.1016/j.jsams.2010.05.006; Masud S, 2003, J MED GENET, V40, P773, DOI 10.1136/jmg.40.10.773; Masugi J, 2000, BIOCHEM BIOPH RES CO, V268, P178, DOI 10.1006/bbrc.2000.2096; Meirhaeghe A, 2003, ARTERIOSCL THROM VAS, V23, P289, DOI 10.1161/01.ATV.0000051382.28752.FE; Meirhaeghe A, 2004, MOL GENET METAB, V83, P93, DOI 10.1016/j.ymgme.2004.08.014; Ogawa S, 1999, BIOCHEM BIOPH RES CO, V260, P122, DOI 10.1006/bbrc.1999.0896; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Sawczuk M, 2013, J SPORT SCI, V31, P1535, DOI 10.1080/02640414.2013.786184; Schneider J, 2002, DIABETES, V51, P867, DOI 10.2337/diabetes.51.3.867; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Simon I, 2002, HORM RES, V58, P143, DOI 10.1159/000064490; Stumvoll M, 2002, DIABETES, V51, P2341, DOI 10.2337/diabetes.51.8.2341; Stumvoll M, 2001, DIABETES, V50, P876, DOI 10.2337/diabetes.50.4.876; Sundvold H, 2001, BIOCHEM BIOPH RES CO, V287, P383, DOI 10.1006/bbrc.2001.5602; Thamer C, 2002, HORM METAB RES, V34, P132, DOI 10.1055/s-2002-23196; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Vanttinen M, 2005, J CLIN ENDOCR METAB, V90, P4249, DOI 10.1210/jc.2005-0101; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Werman A, 1997, J BIOL CHEM, V272, P20230, DOI 10.1074/jbc.272.32.20230; Yamamoto Y, 2002, METABOLISM, V51, P1407, DOI 10.1053/meta.2002.35586; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; Yen CJ, 1997, BIOCHEM BIOPH RES CO, V241, P270, DOI 10.1006/bbrc.1997.7798	50	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e67172	10.1371/journal.pone.0067172	http://dx.doi.org/10.1371/journal.pone.0067172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799144	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300106
J	Murakami, K; Kurihara, C; Oka, T; Shimoike, T; Fujii, Y; Takai-Todaka, R; Park, Y; Wakita, T; Matsuda, T; Hokari, R; Miura, S; Katayama, K				Murakami, Kosuke; Kurihara, Chie; Oka, Tomoichiro; Shimoike, Takashi; Fujii, Yoshiki; Takai-Todaka, Reiko; Park, YoungBin; Wakita, Takaji; Matsuda, Tsukasa; Hokari, Ryota; Miura, Soichiro; Katayama, Kazuhiko			Norovirus Binding to Intestinal Epithelial Cells Is Independent of Histo-Blood Group Antigens	PLOS ONE			English	Article							GENOGROUP-II NOROVIRUSES; NORWALK VIRUS-INFECTION; LINE CACO-2; DIFFERENTIATION; PARTICLES; STRAIN; CLASSIFICATION; ATTACHMENT; EXPRESSION; DIVERSITY	Human noroviruses (NoVs) are a major cause of non-bacterial gastroenteritis. Although histo-blood group antigens (HBGAs) have been implicated in the initial binding of NoV, the mechanism of that binding before internalization is not clear. To determine the involvement of NoVs and HBGAs in cell binding, we examined the localization of NoV virus-like particles (VLPs) and HBGAs in a human intestinal cell line and the human ileum biopsy specimens by immunofluorescence microscopy. The localizations of Ueno 7k VLPs (genogroup II.6) and each HBGA (type H1-, H2- and Le(b)-HBGAs) on the human intestinal cell line, Caco-2, were examined by confocal laser-scanning microscopy. To explore any interactions of NoVs and HBGAs in vivo, fresh biopsy specimens from human ileum were directly incubated with NoV VLPs and examined by immunofluorescence microscopy. We found that VLP binding depended on the state of cell differentiation, but not on the presence of HBGAs. In differentiated Caco-2 cells, we detected no type H1 HBGAs, but VLPs bound to the cells anyway. We incubated fresh biopsies of human ileum directly with VLPs, a model that better replicates the in vivo environment. VLPs mainly bound epithelial cells and goblet cells. Although the incubations were performed at 4 degrees C to hinder internalization, VLPs were still detected inside cells. Our results suggest that VLPs utilize molecule(s) other than HBGAs during binding and internalization into cells.	[Murakami, Kosuke; Oka, Tomoichiro; Shimoike, Takashi; Fujii, Yoshiki; Takai-Todaka, Reiko; Park, YoungBin; Wakita, Takaji; Katayama, Kazuhiko] Natl Inst Infect Dis, Dept Virol 2, Musashimurayama, Tokyo, Japan; [Kurihara, Chie; Hokari, Ryota; Miura, Soichiro] Natl Def Med Coll, Dept Internal Med, Tokorozawa, Saitama 359, Japan; [Matsuda, Tsukasa] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	National Institute of Infectious Diseases (NIID); National Defense Medical College - Japan; Nagoya University	Katayama, K (corresponding author), Natl Inst Infect Dis, Dept Virol 2, Musashimurayama, Tokyo, Japan.	katayama@nih.go.jp	Fujii, Yoshiki/GOE-3566-2022	Katayama, Kazuhiko/0000-0002-7692-1151	Japan Society for the Promotion of Science (JSPS KAKENHI) [20380184, 24380069, 23590556]; Ministry of Health, Labor and Welfare of Japan [11103251, 12103310]	Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS KAKENHI Grand numbers 20380184, 24380069 and 23590556, http://www.jsps.go.jp/english/e-grants/index.html), by Grants-in-Aid from the Ministry of Health, Labor and Welfare of Japan (Research on Emerging and Re-emerging Infectious Diseases Grand numbers 11103251 and 12103310, http://www.mhlw.go.jp/english/policy/other/research-projects/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano J, 1999, J BIOL CHEM, V274, P21209, DOI 10.1074/jbc.274.30.21209; Bok K, 2011, P NATL ACAD SCI USA, V108, P325, DOI 10.1073/pnas.1014577107; Buhrke T, 2011, DEV GROWTH DIFFER, V53, P411, DOI 10.1111/j.1440-169X.2011.01258.x; Chan MCW, 2011, J VIROL, V85, P8427, DOI 10.1128/JVI.05016-11; Cheetham S, 2007, J VIROL, V81, P3535, DOI 10.1128/JVI.01306-06; Choi JM, 2008, P NATL ACAD SCI USA, V105, P9175, DOI 10.1073/pnas.0803275105; Farkas T, 2010, J VIROL, V84, P8617, DOI 10.1128/JVI.00630-10; Gerondopoulos A, 2010, J GEN VIROL, V91, P1428, DOI 10.1099/vir.0.016717-0; Guix S, 2007, J VIROL, V81, P12238, DOI 10.1128/JVI.01489-07; Hansman GS, 2012, J VIROL, V86, P3635, DOI 10.1128/JVI.06868-11; Hansman GS, 2006, J GEN VIROL, V87, P909, DOI 10.1099/vir.0.81532-0; Harrington PR, 2004, J VIROL, V78, P3035, DOI 10.1128/JVI.78.6.3035-3045.2004; Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005; Hutson AM, 2003, J VIROL, V77, P405, DOI 10.1128/JVI.77.1.405-415.2003; Hutson AM, 2002, J INFECT DIS, V185, P1335, DOI 10.1086/339883; Kageyama T, 2004, J CLIN MICROBIOL, V42, P2988, DOI 10.1128/JCM.42.7.2988-2995.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Marionneau S, 2002, GASTROENTEROLOGY, V122, P1967, DOI 10.1053/gast.2002.33661; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Murakami K, 2010, BIOSCI BIOTECH BIOCH, V74, P541, DOI 10.1271/bbb.90729; ORIOL R, 1990, J IMMUNOGENET, V17, P235; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; PINTO M, 1983, BIOL CELL, V47, P323; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Ruvoen-Clouet N, 2000, J VIROL, V74, P11950, DOI 10.1128/JVI.74.24.11950-11954.2000; Sestak K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037973; Shirato H, 2008, J VIROL, V82, P10756, DOI 10.1128/JVI.00802-08; Stuart AD, 2006, J VIROL, V80, P7500, DOI 10.1128/JVI.02452-05; Tamura M, 2004, J VIROL, V78, P3817, DOI 10.1128/JVI.78.8.3817-3826.2004; Tamura M, 2000, J VIROL, V74, P11589, DOI 10.1128/JVI.74.24.11589-11597.2000; Tan M, 2003, J VIROL, V77, P12562, DOI 10.1128/JVI.77.23.12562-12571.2003; Tian P, 2007, RES VET SCI, V83, P410, DOI 10.1016/j.rvsc.2007.01.017; WALTER E, 1995, EUR J PHARM SCI, V3, P215, DOI 10.1016/0928-0987(95)00010-B; White LJ, 1996, J VIROL, V70, P6589, DOI 10.1128/JVI.70.10.6589-6597.1996; XI JA, 1992, J VIROL, V66, P6527, DOI 10.1128/JVI.66.11.6527-6532.1992; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	37	33	36	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66534	10.1371/journal.pone.0066534	http://dx.doi.org/10.1371/journal.pone.0066534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799113	gold, Green Published, Green Submitted			2022-12-25	WOS:000320363300089
J	Smirnova, E; Shanbhag, R; Kurabi, A; Mobli, M; Kwan, JJ; Donaldson, LW				Smirnova, Ekaterina; Shanbhag, Riya; Kurabi, Arwa; Mobli, Mehdi; Kwan, Jamie J.; Donaldson, Logan W.			Solution Structure and Peptide Binding of the PTB Domain from the AIDA1 Postsynaptic Signaling Scaffolding Protein	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; INTRACELLULAR DOMAIN; SUGGESTS; COMPLEX; MODEL	AIDA1 links persistent chemical signaling events occurring at the neuronal synapse with global changes in gene expression. Consistent with its role as a scaffolding protein, AIDA1 is composed of several protein-protein interaction domains. Here we report the NMR structure of the carboxy terminally located phosphotyrosine binding domain (PTB) that is common to all AIDA1 splice variants. A comprehensive survey of peptides identified a consensus sequence around an NxxY motif that is shared by a number of related neuronal signaling proteins. Using peptide arrays and fluorescence based assays, we determined that the AIDA1 PTB domain binds amyloid protein precursor (APP) in a similar manner to the X11/Mint PTB domain, albeit at reduced affinity (similar to 10 mu M) that may allow AIDA1 to effectively sample APP, as well as other protein partners in a variety of cellular contexts.	[Smirnova, Ekaterina; Shanbhag, Riya; Kurabi, Arwa; Kwan, Jamie J.; Donaldson, Logan W.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Mobli, Mehdi] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	York University - Canada; University of Queensland	Donaldson, LW (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.	logand@yorku.ca	Mobli, Mehdi/O-7244-2014	Mobli, Mehdi/0000-0003-2420-4262; Donaldson, Logan/0000-0001-5034-2699	Canadian Institutes of Health Research [MOP-81250]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research MOP-81250 to L.W.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya A, 2008, PROTEINS, V70, P105, DOI 10.1002/prot.21466; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emaduddin Muhammad, 2008, Cell Commun Signal, V6, P7, DOI 10.1186/1478-811X-6-7; Fogh RH, 2006, J BIOMOL NMR, V36, P147, DOI 10.1007/s10858-006-9076-z; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Ghersi E, 2004, J BIOL CHEM, V279, P49105, DOI 10.1074/jbc.M405329200; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hoch JC, 1996, NMR DATA PROCESSING; Jordan BA, 2004, MOL CELL PROTEOMICS, V3, P857, DOI 10.1074/mcp.M400045-MCP200; Jordan BA, 2007, NAT NEUROSCI, V10, P427, DOI 10.1038/nn1867; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kurabi A, 2009, J MOL BIOL, V392, P1168, DOI 10.1016/j.jmb.2009.08.004; Li L, 2006, NEUROSCIENCE, V142, P391, DOI 10.1016/j.neuroscience.2006.06.018; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Margolis B, 1999, KIDNEY INT, V56, P1230, DOI 10.1046/j.1523-1755.1999.00700.x; Matos MF, 2012, P NATL ACAD SCI USA, V109, P3802, DOI 10.1073/pnas.1119075109; Mulvihill MM, 2011, BIOCHEMISTRY-US, V50, P6208, DOI 10.1021/bi200508f; Radzimanowski J, 2008, EMBO REP, V9, P1134, DOI 10.1038/embor.2008.188; Raveh B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018934; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141	25	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65605	10.1371/journal.pone.0065605	http://dx.doi.org/10.1371/journal.pone.0065605			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799029	Green Submitted, Green Published, gold			2022-12-25	WOS:000320363300029
J	Kawamoto, R; Tabara, Y; Kohara, K; Kusunoki, T; Abe, M; Miki, T				Kawamoto, Ryuichi; Tabara, Yasuharu; Kohara, Katsuhiko; Kusunoki, Tomo; Abe, Masanori; Miki, Tetsuro			Serum Uric Acid Is More Strongly Associated with Impaired Fasting Glucose in Women than in Men from a Community-Dwelling Population	PLOS ONE			English	Article							HYPERTENSION; INSULIN; STRESS; RISK	Serum uric acid (SUA) levels are associated with metabolic syndrome (MetS) and its components such as glucose intolerance and type 2 diabetes. It is unknown whether there are gender-specific differences regarding the relationship between SUA levels, impaired fasting glucose (IFG) and newly detected diabetes. We recruited 1,209 men aged 60 +/- 15 (range, 19-89) years and 1,636 women aged 63 +/- 12 (range, 19-89) years during their annual health examination from a single community. We investigated the association between SUA levels and six categories according to fasting plasma glucose (FPG) level {normal fasting glucose (NFG), <100 mg/dL; high NFG-WHO, 100 to 109 mg/dL; IFG-WHO, 110 to 125 mg/dL; IFG-ADA, 100 to 125 mg/dL; newly detected diabetes, >= 126 mg/dL; known diabetes} SUA levels were more strongly associated with the different FPG categories in women compared with men. In women, the associations remained significant for IFG-WHO (OR, 1.23, 95% CI, 1.00-1.50) and newly detected diabetes (OR, 1.33, 95% CI, 1.03-1.72) following multivariate adjustment. However, in men all the associations were not significant. Thus, there was a significant interaction between gender and SUA level for newly detected diabetes (P = 0.005). SUA levels are associated with different categories of impaired fasting glucose in participants from community-dwelling persons, particularly in women.	[Kawamoto, Ryuichi; Kusunoki, Tomo; Abe, Masanori] Ehime Univ, Grad Sch Med, Dept Community Med, Matsuyama, Ehime 790, Japan; [Tabara, Yasuharu] Kyoto Univ, Ctr Genom Med, Grad Sch Med, Kyoto, Japan; [Miki, Tetsuro] Ehime Univ, Grad Sch Med, Dept Geriatr Med, Matsuyama, Ehime 790, Japan	Ehime University; Kyoto University; Ehime University	Kawamoto, R (corresponding author), Ehime Univ, Grad Sch Med, Dept Community Med, Matsuyama, Ehime 790, Japan.	rykawamo@m.ehime-u.ac.jp			Foundation for Development of Community; Grants-in-Aid for Scientific Research [23390188] Funding Source: KAKEN	Foundation for Development of Community; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for Scientific Research from the Foundation for Development of Community (2012). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker SD, 2003, CIRCULATION, V107, P1991, DOI 10.1161/01.CIR.0000065637.10517.A0; Chiou WK, 2010, J EPIDEMIOL, V20, P219, DOI 10.2188/jea.JE20090078; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; GALVAN AQ, 1995, AM J PHYSIOL-ENDOC M, V268, pE1, DOI 10.1152/ajpendo.1995.268.1.E1; Glantzounis GK, 2005, CURR PHARM DESIGN, V11, P4145, DOI 10.2174/138161205774913255; GORDON T, 1983, ARCH INTERN MED, V143, P1366, DOI 10.1001/archinte.143.7.1366; Hotamisligil GS, 2003, INT J OBESITY, V27, pS53, DOI 10.1038/sj.ijo.0802502; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Johnson RJ, 2009, ENDOCR REV, V30, P96, DOI 10.1210/er.2008-0033; Kawamoto R, 2006, INTERNAL MED, V45, P605, DOI 10.2169/internalmedicine.45.1661; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Lin KC, 2004, J RHEUMATOL, V31, P1159; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; Meisinger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037180; Nakanishi N, 2003, EUR J EPIDEMIOL, V18, P523, DOI 10.1023/A:1024600905574; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Savage PJ, 1998, ARCH INTERN MED, V158, P741, DOI 10.1001/archinte.158.7.741; Taniguchi Y, 2001, J HYPERTENS, V19, P1209, DOI 10.1097/00004872-200107000-00005; Wang TG, 2011, ENDOCRINE, V40, P109, DOI 10.1007/s12020-011-9449-2	20	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65886	10.1371/journal.pone.0065886	http://dx.doi.org/10.1371/journal.pone.0065886			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785457	Green Submitted, Green Published, gold			2022-12-25	WOS:000321038800065
J	Zhao, X; Zhou, XH; Feng, ZJ; Guo, PF; He, HY; Zhang, T; Duan, L; Li, XS				Zhao, Xing; Zhou, Xiao-Hua; Feng, Zijian; Guo, Pengfei; He, Hongyan; Zhang, Tao; Duan, Lei; Li, Xiaosong			A Scan Statistic for Binary Outcome Based on Hypergeometric Probability Model, with an Application to Detecting Spatial Clusters of Japanese Encephalitis	PLOS ONE			English	Article							P-VALUES; EVENT DETECTION; TESTS; LIKELIHOOD; HYPOTHESIS; ALGORITHM	As a useful tool for geographical cluster detection of events, the spatial scan statistic is widely applied in many fields and plays an increasingly important role. The classic version of the spatial scan statistic for the binary outcome is developed by Kulldorff, based on the Bernoulli or the Poisson probability model. In this paper, we apply the Hypergeometric probability model to construct the likelihood function under the null hypothesis. Compared with existing methods, the likelihood function under the null hypothesis is an alternative and indirect method to identify the potential cluster, and the test statistic is the extreme value of the likelihood function. Similar with Kulldorff's methods, we adopt Monte Carlo test for the test of significance. Both methods are applied for detecting spatial clusters of Japanese encephalitis in Sichuan province, China, in 2009, and the detected clusters are identical. Through a simulation to independent benchmark data, it is indicated that the test statistic based on the Hypergeometric model outweighs Kulldorff's statistics for clusters of high population density or large size; otherwise Kulldorff's statistics are superior.	[Zhao, Xing; Guo, Pengfei; He, Hongyan; Zhang, Tao; Li, Xiaosong] Sichuan Univ, West China Sch Publ Hlth, Dept Biostat, Chengdu 610064, Sichuan, Peoples R China; [Zhao, Xing; Zhou, Xiao-Hua] Univ Washington, Sch Publ Hlth & Community Med, Dept Biostat, Seattle, WA 98195 USA; [Feng, Zijian] Chinese Ctr Dis Control & Prevent China CDC, Off Dis Control & Emergency Response, Beijing, Peoples R China; [Duan, Lei] Sichuan Univ, Sch Comp Sci, Chengdu 610064, Sichuan, Peoples R China; [Duan, Lei] Wuhan Univ, State Key Lab Software Engn, Wuhan 430072, Hubei, Peoples R China	Sichuan University; University of Washington; University of Washington Seattle; Chinese Center for Disease Control & Prevention; Sichuan University; Wuhan University	Li, XS (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Dept Biostat, Chengdu 610064, Sichuan, Peoples R China.	lixiaosong1101@126.com	Guo, Peng/GWC-0572-2022; guo, peng/AAG-4052-2019	Zhou, Xiaohua/0000-0001-7935-1222; Zhang, Tao/0000-0001-7279-8929	Natural Science Foundation of China [30571618, 61103042]; Ministry of Health, China [200802133]; Research Fund for the Doctoral Program of Higher Education of China [20100181120029]; State Key Laboratory of Software Engineering of China [SKLSE2012-09-32]; China Scholarship Council	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health, China; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); State Key Laboratory of Software Engineering of China; China Scholarship Council(China Scholarship Council)	This work was supported by Natural Science Foundation of China (No. 30571618 and No. 61103042), Grants of the Ministry of Health, China (No. 200802133), Research Fund for the Doctoral Program of Higher Education of China (No. 20100181120029), State Key Laboratory of Software Engineering of China (No. SKLSE2012-09-32), and China Scholarship Council (http://en.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assuncao R, 2006, STAT MED, V25, P723, DOI 10.1002/sim.2411; BERGER JO, 1987, J AM STAT ASSOC, V82, P112, DOI 10.2307/2289131; Berkson J, 1942, J AM STAT ASSOC, V37, P325, DOI 10.2307/2279000; Cao M, 2009, THESIS SICHUAN U; Christiansen LE, 2006, J AGR BIOL ENVIR ST, V11, P411, DOI 10.1198/108571106X154858; Cook AJ, 2007, BIOMETRICS, V63, P540, DOI 10.1111/j.1541-0420.2006.00714.x; Costa MA, 2005, ENVIRON ECOL STAT, V12, P301, DOI 10.1007/s10651-005-1515-6; Diagana M, 2007, J NEUROL SCI, V262, P165, DOI 10.1016/j.jns.2007.06.041; Duarte AR, 2010, ENVIRON ECOL STAT, V17, P203, DOI 10.1007/s10651-010-0139-7; Duczmal L, 2006, STAT MED, V25, P743, DOI 10.1002/sim.2403; Duczmal L, 2004, COMPUT STAT DATA AN, V45, P269, DOI 10.1016/S0167-9473(02)00302-X; Duczmal L, 2007, COMPUT STAT DATA AN, V52, P43, DOI 10.1016/j.csda.2007.01.016; DWASS M, 1957, ANN MATH STAT, V28, P181, DOI 10.1214/aoms/1177707045; Gangnon RE, 2001, STAT MED, V20, P2977, DOI 10.1002/sim.917; GIBBONS JD, 1975, AM STAT, V29, P20, DOI 10.2307/2683674; GOODMAN SN, 1993, AM J EPIDEMIOL, V137, P485, DOI 10.1093/oxfordjournals.aje.a116700; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; Hjalmars U, 1996, STAT MED, V15, P707, DOI 10.1002/(SICI)1097-0258(19960415)15:7/9<707::AID-SIM242>3.3.CO;2-W; Huang L, 2009, J AM STAT ASSOC, V104, P886, DOI 10.1198/jasa.2009.ap07613; Huang XL, 2006, BIOMETRICS, V62, P901, DOI 10.1111/j.1541-0420.2005.00520.x; Jung I, 2007, STAT MED, V26, P1594, DOI 10.1002/sim.2607; Jung I, 2010, STAT MED, V29, P1910, DOI 10.1002/sim.3951; Kulldorff M, 1997, AM J EPIDEMIOL, V146, P161; Kulldorff M, 2001, J ROY STAT SOC A STA, V164, P61, DOI 10.1111/1467-985X.00186; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M, 2003, COMPUT STAT DATA AN, V42, P665, DOI 10.1016/S0167-9473(02)00160-3; Kulldorff M, 2007, STAT MED, V26, P1824, DOI 10.1002/sim.2818; Kulldorff M, 2006, STAT MED, V25, P3929, DOI 10.1002/sim.2490; Kulldorff M, 2006, J AM STAT ASSOC, V101, P1289, DOI 10.1198/016214506000000618; Kulldorff M, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-58; LEHMANN EL, 1993, J AM STAT ASSOC, V88, P1242; Li XZ, 2011, MATH BIOSCI, V233, P135, DOI 10.1016/j.mbs.2011.07.004; Loh JM, 2007, ANN APPL STAT, V1, P560, DOI 10.1214/07-AOAS129; Neill DB, 2011, STAT MED, V30, P455, DOI 10.1002/sim.3881; Neill DB, 2010, MACH LEARN, V79, P261, DOI 10.1007/s10994-009-5144-4; Neill DB, 2006, THESIS CARNEGIE MELL; Patil GP, 2004, ENVIRON ECOL STAT, V11, P183, DOI 10.1023/B:EEST.0000027208.48919.7e; Schervish MJ, 1996, AM STAT, V50, P203, DOI 10.2307/2684655; Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263; Song C, 2006, STAT MED, V25, P825, DOI 10.1002/sim.2430; Song C, 2003, INT J HEALTH GEOGR, V2, P9, DOI [10.1186/1476-072X-2-9, DOI 10.1186/1476-072X-2-9]; Tango T, 2010, STAT METHODS DIS CLU; Tango T, 2011, BIOMETRICS, V67, P106, DOI 10.1111/j.1541-0420.2010.01412.x; Tango Toshiro, 2005, Int J Health Geogr, V4, P11, DOI 10.1186/1476-072X-4-11; Viel JF, 2005, ENVIRON ECOL STAT, V12, P289, DOI 10.1007/s10651-005-1514-7; Wen SH, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-73; Wong WK, 2005, J MACH LEARN RES, V6, P1961; Yang Z, 2008, MODERN PREVENTIVE ME, V10, P003; Zhang Z, 2010, J PROBABILITY STAT	50	1	2	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65419	10.1371/journal.pone.0065419	http://dx.doi.org/10.1371/journal.pone.0065419			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785424	Green Published, gold, Green Submitted			2022-12-25	WOS:000321038800096
J	Brown, AC; Balashova, NV; Epand, RM; Epand, RF; Bragin, A; Kachlany, SC; Walters, MJ; Du, YR; Boesze-Battaglia, K; Lally, ET				Brown, Angela C.; Balashova, Nataliya V.; Epand, Richard M.; Epand, Raquel F.; Bragin, Alvina; Kachlany, Scott C.; Walters, Michael J.; Du, Yurong; Boesze-Battaglia, Kathleen; Lally, Edward T.			Aggregatibacter actinomycetemcomitans Leukotoxin Utilizes a Cholesterol Recognition/Amino Acid Consensus Site for Membrane Association	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATE-CYCLASE TOXIN; ESCHERICHIA-COLI HEMOLYSIN; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; LIPID RAFTS; BENZODIAZEPINE-RECEPTOR; BORDETELLA-PERTUSSIS; ALPHA-HEMOLYSIN; UNILAMELLAR VESICLES; SIGNAL-TRANSDUCTION; FATTY-ACYLATION	Aggregatibacter actinomycetemcomitans produces a repeats-in-toxin (RTX) leukotoxin (LtxA) that selectively kills human immune cells. Binding of LtxA to its beta(2) integrin receptor (lymphocyte function-associated antigen-1 (LFA-1)) results in the clustering of the toxin.receptor complex in lipid rafts. Clustering occurs only in the presence of LFA-1 and cholesterol, and LtxA is unable to kill cells lacking either LFA-1 or cholesterol. Here, the interaction of LtxA with cholesterol was measured using surface plasmon resonance and differential scanning calorimetry. The binding of LtxA to phospholipid bilayers increased by 4 orders of magnitude in the presence of 40% cholesterol relative to the absence of cholesterol. The affinity was specific to cholesterol and required an intact secondary structure. LtxA contains two cholesterol recognition/amino acid consensus (CRAC) sites; CRAC(336) ((LEEYSKR339)-L-333) is highly conserved among RTX toxins, whereas CRAC(503) ((VDYLK505)-V-501) is unique to LtxA. A peptide corresponding to CRAC(336) inhibited the ability of LtxA to kill Jurkat (Jn.9) cells. Although peptides corresponding to both CRAC(336) and CRAC(503) bind cholesterol, only CRAC(336) competitively inhibited LtxA binding to this sterol. A panel of full-length LtxA CRAC mutants demonstrated that an intact CRAC(336) site was essential for LtxA cytotoxicity. The conservation of CRAC(336) among RTX toxins suggests that this mechanism may be conserved among RTX toxins.	[Brown, Angela C.; Walters, Michael J.; Du, Yurong; Lally, Edward T.] Univ Penn, Dept Pathol, Sch Dent Med, Philadelphia, PA 19104 USA; [Bragin, Alvina; Boesze-Battaglia, Kathleen] Univ Penn, Dept Biochem, Sch Dent Med, Philadelphia, PA 19104 USA; [Balashova, Nataliya V.; Kachlany, Scott C.] Univ Med & Dent New Jersey, Dept Oral Biol, Newark, NJ 07103 USA; [Epand, Richard M.; Epand, Raquel F.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada	University of Pennsylvania; University of Pennsylvania; Rutgers State University New Brunswick; Rutgers State University Medical Center; McMaster University	Lally, ET (corresponding author), Univ Penn, Dept Pathol, Sch Dent Med, 240 S 40th St,317 Levy Bldg, Philadelphia, PA 19104 USA.	lally@toxin.dental.upenn.edu	, Richard/R-2316-2019	, Richard/0000-0002-9602-9558	National Institutes of Health [R01DE009517, F32DE020950, K99DE022795, R01EY018705, R01EY10420]; Canadian Institutes of Health Research [MOP 86608]; NATIONAL EYE INSTITUTE [R21EY018705, R01EY010420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F32DE020950, K99DE022795, R01DE009517] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DE009517 (to E. T. L.), F32DE020950 and K99DE022795 (to A. C. B.), and R01EY018705 and R01EY10420 (to K. B.-B.). This work was also supported by Canadian Institutes of Health Research Grant MOP 86608 (to R. M. E.).	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Ahn A, 2002, J VIROL, V76, P3267, DOI 10.1128/JVI.76.7.3267-3275.2002; ALMEIDA PFF, 1992, BIOCHEMISTRY-US, V31, P6739, DOI 10.1021/bi00144a013; ALOIA RC, 1993, P NATL ACAD SCI USA, V90, P5181, DOI 10.1073/pnas.90.11.5181; Atapattu DN, 2007, INFECT IMMUN, V75, P4719, DOI 10.1128/IAI.00534-07; Bakas L, 1996, BIOPHYS J, V71, P1869, DOI 10.1016/S0006-3495(96)79386-4; Balashova NV, 2009, GENE, V443, P42, DOI 10.1016/j.gene.2009.05.002; Bauer ME, 1996, INFECT IMMUN, V64, P4665, DOI 10.1128/IAI.64.11.4665-4672.1996; BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; Besenicar MP, 2010, METHODS MOL BIOL, V627, P191, DOI 10.1007/978-1-60761-670-2_12; Bini L, 2003, BIOCHEM J, V369, P301, DOI 10.1042/BJ20020503; BOEHM DF, 1990, INFECT IMMUN, V58, P1959, DOI 10.1128/IAI.58.6.1959-1964.1990; Boesze-Battaglia K, 2009, J BIOL CHEM, V284, P10650, DOI 10.1074/jbc.M809094200; Boyd AP, 2005, J IMMUNOL, V175, P730, DOI 10.4049/jimmunol.175.2.730; BROGAN JM, 1994, INFECT IMMUN, V62, P501, DOI 10.1128/IAI.62.2.501-508.1994; Brown AC, 2007, LANGMUIR, V23, P11180, DOI 10.1021/la700633b; Brown AC, 2012, CELL MICROBIOL, V14, P869, DOI 10.1111/j.1462-5822.2012.01762.x; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; BRYANT M, 1990, P NATL ACAD SCI USA, V87, P523, DOI 10.1073/pnas.87.2.523; Bumba L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000901; BUSS JE, 1986, J VIROL, V58, P468, DOI 10.1128/JVI.58.2.468-474.1986; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Cherry LK, 2001, J IMMUNOL, V167, P6171, DOI 10.4049/jimmunol.167.11.6171; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Crosby JA, 2007, GENE, V388, P83, DOI 10.1016/j.gene.2006.10.004; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Epand RM, 2000, BIOPHYS J, V78, P866, DOI 10.1016/S0006-3495(00)76644-6; Fine DH, 1999, MICROBIOL-SGM, V145, P1335, DOI 10.1099/13500872-145-6-1335; Fong KP, 2011, MOL ORAL MICROBIOL, V26, P262, DOI 10.1111/j.2041-1014.2011.00617.x; Fong KP, 2006, CELL MICROBIOL, V8, P1753, DOI 10.1111/j.1462-5822.2006.00746.x; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; HACKETT M, 1994, SCIENCE, V266, P433, DOI 10.1126/science.7939682; HACKETT M, 1995, J BIOL CHEM, V270, P20250, DOI 10.1074/jbc.270.35.20250; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; HARDIE KR, 1991, MOL MICROBIOL, V5, P1669, DOI 10.1111/j.1365-2958.1991.tb01914.x; Herlax V, 2003, CHEM PHYS LIPIDS, V122, P185, DOI 10.1016/S0009-3084(02)00191-3; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Isberg Ralph R., 1994, Trends in Microbiology, V2, P10, DOI 10.1016/0966-842X(94)90338-7; ISSARTEL JP, 1991, NATURE, V351, P759, DOI 10.1038/351759a0; Jamin N, 2005, MOL ENDOCRINOL, V19, P588, DOI 10.1210/me.2004-0308; JARCHAU T, 1994, MOL GEN GENET, V245, P53, DOI 10.1007/BF00279750; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LALLY ET, 1991, J PERIODONTAL RES, V26, P268, DOI 10.1111/j.1600-0765.1991.tb01655.x; LALLY ET, 1991, MICROB PATHOGENESIS, V11, P111, DOI 10.1016/0882-4010(91)90004-T; LALLY ET, 1989, J BIOL CHEM, V264, P15451; Lally ET, 1997, J BIOL CHEM, V272, P30463, DOI 10.1074/jbc.272.48.30463; Lear JD, 2000, BBA-PROTEIN STRUCT M, V1476, P350, DOI 10.1016/S0167-4838(99)00241-1; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Li H, 2001, P NATL ACAD SCI USA, V98, P1267, DOI 10.1073/pnas.031461598; Lilie H, 2000, FEBS LETT, V470, P173, DOI 10.1016/S0014-5793(00)01308-9; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Marwali MR, 2003, BLOOD, V102, P215, DOI 10.1182/blood-2002-10-3195; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Norkin LC, 1999, IMMUNOL REV, V168, P13, DOI 10.1111/j.1600-065X.1999.tb01279.x; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; SCHULTZ AM, 1989, J VIROL, V63, P2370, DOI 10.1128/JVI.63.5.2370-2373.1989; Shin JS, 2000, SCIENCE, V289, P785, DOI 10.1126/science.289.5480.785; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Soloaga A, 1996, EUR J BIOCHEM, V238, P418, DOI 10.1111/j.1432-1033.1996.0418z.x; Stanley P, 1998, MICROBIOL MOL BIOL R, V62, P309, DOI 10.1128/MMBR.62.2.309-333.1998; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; Taichman N S, 1987, Oral Microbiol Immunol, V2, P97, DOI 10.1111/j.1399-302X.1987.tb00270.x; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Walters M. J., 2013, MOL ORAL MI IN PRESS; WEAVER TA, 1990, J VIROL, V64, P3995, DOI 10.1128/JVI.64.8.3995-4001.1990; WELCH RA, 1991, MOL MICROBIOL, V5, P521, DOI 10.1111/j.1365-2958.1991.tb00723.x; Wooldridge KG, 1996, MICROB PATHOGENESIS, V21, P299, DOI 10.1006/mpat.1996.0063; Zitzer A, 2001, J BIOL CHEM, V276, P14628, DOI 10.1074/jbc.M100241200	75	35	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23607	23621		10.1074/jbc.M113.486654	http://dx.doi.org/10.1074/jbc.M113.486654			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23792963	Green Published, hybrid			2022-12-25	WOS:000330598200064
J	Nakamura, H; Moriyama, Y; Makiyama, T; Emori, S; Yamashita, H; Yamazaki, R; Murayama, T				Nakamura, Hiroyuki; Moriyama, Yuta; Makiyama, Tomohiko; Emori, Shunsuke; Yamashita, Hisahiro; Yamazaki, Risa; Murayama, Toshihiko			Lactosylceramide Interacts with and Activates Cytosolic Phospholipase A(2)alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; C2 DOMAIN; INTERFACIAL BINDING; ENDOTHELIAL-CELLS; CATALYTIC DOMAIN; L929 CELLS; A(2); INHIBITION; EXPRESSION; ADHESION	Lactosylceramide (LacCer) is a member of the glycosphingolipid family and is known to be a bioactive lipid in various cell physiological processes. However, the direct targets of LacCer and cellular events mediated by LacCer are largely unknown. In this study, we examined the effect of LacCer on the release of arachidonic acid (AA) and the activity of cytosolic phospholipase A(2)alpha (cPLA(2)alpha). In CHO-W11A cells, treatment with 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol (PPMP), an inhibitor of glucosylceramide synthase, reduced the glycosphingolipid level, and the release of AA induced by A23187 or platelet-activating factor was inhibited. The addition of LacCer reversed the PPMP effect on the stimulus-induced AA release. Exogenous LacCer stimulated the release of AA, which was decreased by treatment with an inhibitor of cPLA(2)alpha or silencing of the enzyme. Treatment of CHO-W11A cells with LacCer induced the translocation of full-length cPLA(2)alpha and its C2 domain from the cytosol to the Golgi apparatus. LacCer also induced the translocation of the D43N mutant of cPLA(2)alpha. Treatment of L929 cells with TNF-alpha induced LacCer generation and mediated the translocation of cPLA(2)alpha and AA release, which was attenuated by treatment with PPMP. In vitro studies were then conducted to test whether LacCer interacts directly with cPLA(2)alpha. Phosphatidylcholine vesicles containing LacCer increased cPLA(2)alpha activity. LacCer bound to cPLA(2)alpha and its C2 domain in a Ca2+-independent-manner. Thus, we propose that LacCer is a direct activator of cPLA(2)alpha.	[Nakamura, Hiroyuki; Moriyama, Yuta; Makiyama, Tomohiko; Emori, Shunsuke; Yamashita, Hisahiro; Yamazaki, Risa; Murayama, Toshihiko] Chiba Univ, Lab Chem Pharmacol, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan	Chiba University	Nakamura, H (corresponding author), Chiba Univ, Lab Chem Pharmacol, Grad Sch Pharmaceut Sci, Chuo Ku, Inohana 1-8-1, Chiba 2608675, Japan.	nakahiro@faculty.chiba-u.jp	Nakamura, Hiroyuki/AFV-2078-2022; Nakamura, Hiroyuki/B-4089-2015	Nakamura, Hiroyuki/0000-0001-6328-9727; Nakamura, Hiroyuki/0000-0001-6328-9727; Makiyama, Tomohiko/0000-0001-6636-2897; Yamazaki, Risa/0000-0001-9717-6763	Ministry of Education, Culture, Sports, Science and Technology of Japan [22790056]; Grants-in-Aid for Scientific Research [24790066] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Young Scientists (B) 22790056 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Bhunia AK, 1998, J BIOL CHEM, V273, P34349, DOI 10.1074/jbc.273.51.34349; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buton X, 2002, BIOCHEMISTRY-US, V41, P13106, DOI 10.1021/bi020385t; CHATTERJEE S, 1991, BIOCHEM BIOPH RES CO, V181, P554, DOI 10.1016/0006-291X(91)91225-2; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Das S, 2002, J BIOL CHEM, V277, P23838, DOI 10.1074/jbc.M202322200; Eckford PDW, 2005, BIOCHEM J, V389, P517, DOI 10.1042/BJ20050047; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; Gijon MA, 1999, J CELL BIOL, V145, P1219, DOI 10.1083/jcb.145.6.1219; Gong NL, 2004, P NATL ACAD SCI USA, V101, P6490, DOI 10.1073/pnas.0308684101; Hayter HL, 2001, FEBS LETT, V507, P151, DOI 10.1016/S0014-5793(01)02967-2; Hirabayashi T, 2004, BIOL PHARM BULL, V27, P1168, DOI 10.1248/bpb.27.1168; Hixon MS, 1998, BIOCHEMISTRY-US, V37, P8516, DOI 10.1021/bi980416d; Jayadev S, 1997, J BIOL CHEM, V272, P17196, DOI 10.1074/jbc.272.27.17196; Jenkins RW, 2010, J BIOL CHEM, V285, P35706, DOI 10.1074/jbc.M110.125609; Martin SF, 2006, GLYCOCONJUGATE J, V23, P147, DOI 10.1007/s10719-006-7920-8; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Nakamura H, 2006, BIOCHEM PHARMACOL, V71, P850, DOI 10.1016/j.bcp.2005.12.027; Nakamura H, 2004, EUR J PHARMACOL, V484, P9, DOI 10.1016/j.ejphar.2003.10.053; Nakamura H, 2010, J LIPID RES, V51, P720, DOI 10.1194/jlr.M002428; Nalefski EA, 1998, J BIOL CHEM, V273, P1365, DOI 10.1074/jbc.273.3.1365; Pannu R, 2005, J BIOL CHEM, V280, P13742, DOI 10.1074/jbc.M411959200; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; Sharma DK, 2005, CANCER RES, V65, P8233, DOI 10.1158/0008-5472.CAN-05-0803; Shimizu M, 2008, BIOCHEM PHARMACOL, V75, P1358, DOI 10.1016/j.bcp.2007.11.020; Singh RD, 2006, J BIOL CHEM, V281, P30660, DOI 10.1074/jbc.M606194200; Six DA, 2003, J BIOL CHEM, V278, P23842, DOI 10.1074/jbc.M301386200; Stahelin RV, 2007, J BIOL CHEM, V282, P20467, DOI 10.1074/jbc.M701396200; Subramanian P, 2007, J LIPID RES, V48, P2701, DOI 10.1194/jlr.M700356-JLR200; Tucker DE, 2009, J BIOL CHEM, V284, P9596, DOI 10.1074/jbc.M807299200	30	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23264	23272		10.1074/jbc.M113.491431	http://dx.doi.org/10.1074/jbc.M113.491431			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23801329	Green Published, hybrid			2022-12-25	WOS:000330598200033
J	Mendez, DL; Mandt, RE; Elgin, SCR				Mendez, Deanna L.; Mandt, Rebecca E.; Elgin, Sarah C. R.			Heterochromatin Protein 1a (HP1a) Partner Specificity Is Determined by Critical Amino Acids in the Chromo Shadow Domain and C-terminal Extension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITION-EFFECT VARIEGATION; DROSOPHILA-MELANOGASTER; GENE; EXPRESSION; MUTATIONS; MECHANISM; SUGGESTS; ISOFORM; BINDING; HINGE	Drosophila melanogaster Heterochromatin Protein 1a (HP1a) is an essential protein critical for heterochromatin assembly and regulation. Its chromo shadow domain (CSD) homodimerizes, a requirement for binding protein partners that contain a PXVXL motif. How does HP1a select among its many different PXVXL-containing partners? HP1a binds tightly to Heterochromatin Protein 2 (HP2), but weakly to PIWI. We investigated differences in homodimerization and the impact of the C-terminal extension (CTE) by contrasting HP1a to its paralogue, HP1b. HP1a and HP1b differ in the dimerization interface, with HP1a having an Arg at position 188 rather than Glu. We find that while this substitution reduces the dimerization constant, it does not impact the binding surface as demonstrated by unchanged partner binding affinities. However, the CTE (only 4 residues in HP1a as compared with 87 residues in HP1b) is critical; the charged residues in HP1a are necessary for tight peptide binding. Examining a panel of amino acid substitutions in the HP1a CSD, we find that Leu-165 in HP1a interacts with HP2 but not PIWI, supporting the conclusion that different sites in the binding surface provide discrimination for partner selection. Partner sequence is also critical for affinity, as the remaining difference in binding between HP2 and PIWI polypeptides is eliminated by swapping the PXVXL motifs between the two. Taken together, these studies indicate that the binding surface of the HP1a CSD plus its short CTE provide the needed discrimination among HP1a's partners, and that the CTE is important for differentiating the interactions of the Drosophila HP1 paralogs.	[Mendez, Deanna L.; Elgin, Sarah C. R.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Mandt, Rebecca E.] Grinnell Coll, Grinnell, IA 50112 USA	Washington University (WUSTL)	Elgin, SCR (corresponding author), Washington Univ, Dept Biol, Campus Box 1137,1 Brookings Dr, St Louis, MO 63130 USA.	selgin@biology.wustl.edu		Mendez, Deanna/0000-0002-0481-4816; Elgin, Sarah C. R./0000-0002-5176-2510	National Institutes of Health [GM068388]; National Science Foundation [0852037]; Washington University, St Louis; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Washington University, St Louis; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health Grant GM068388 (to S. C. R. E.), the National Science Foundation under Grant No. 0852037-Cellular and Developmental Biology Research Apprenticeship Program (CD-BioRAP) at Washington University, St. Louis, and by Washington University, St Louis.	Abel J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005089; Badugu R, 2005, CHROMOSOMA, V113, P370, DOI 10.1007/s00412-004-0324-2; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Canzio D, 2011, MOL CELL, V41, P67, DOI 10.1016/j.molcel.2010.12.016; Cleard F, 1997, EMBO J, V16, P5280, DOI 10.1093/emboj/16.17.5280; Demeler B., 2005, ULTRASCAN COMPREHENS; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Font-Burgada J, 2008, GENE DEV, V22, P3007, DOI 10.1101/gad.481408; Huang Y, 2006, STRUCTURE, V14, P703, DOI 10.1016/j.str.2006.01.007; Jacobs SA, 2004, METHOD ENZYMOL, V376, P131; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Li YH, 2002, P NATL ACAD SCI USA, V99, P16462, DOI 10.1073/pnas.162371699; Lu BY, 2000, GENETICS, V155, P699; Mendez D. L., 2012, KEY FACTORS DROSOPHI; Mendez DL, 2011, CHEMBIOCHEM, V12, P1084, DOI 10.1002/cbic.201000598; Riddle NC, 2011, GENOME RES, V21, P147, DOI 10.1101/gr.110098.110; Shaffer CD, 2002, P NATL ACAD SCI USA, V99, P14332, DOI 10.1073/pnas.212458899; Shaffer CD, 2006, GENETICS, V174, P1189, DOI 10.1534/genetics.106.057604; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Smothers JF, 2001, MOL CELL BIOL, V21, P2555, DOI 10.1128/MCB.21.7.2555-2569.2001; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Vermaak D, 2005, PLOS GENET, V1, P96, DOI 10.1371/journal.pgen.0010009; Vermaak D, 2009, ANNU REV GENET, V43, P467, DOI 10.1146/annurev-genet-102108-134802; Wang SH, 2011, P NATL ACAD SCI USA, V108, P21164, DOI 10.1073/pnas.1107892109; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03	27	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22315	22323		10.1074/jbc.M113.468413	http://dx.doi.org/10.1074/jbc.M113.468413			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23793104	Green Published, hybrid			2022-12-25	WOS:000330596300013
J	Bosch, T; Verkade, E; van Luit, M; Pot, B; Vauterin, P; Burggrave, R; Savelkoul, P; Kluytmans, J; Schouls, L				Bosch, Thijs; Verkade, Erwin; van Luit, Martijn; Pot, Bruno; Vauterin, Paul; Burggrave, Ronald; Savelkoul, Paul; Kluytmans, Jan; Schouls, Leo			High Resolution Typing by Whole Genome Mapping Enables Discrimination of LA-MRSA (CC398) Strains and Identification of Transmission Events	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; FIELD GEL-ELECTROPHORESIS; METHICILLIN-RESISTANT; ST398	After its emergence in 2003, a livestock-associated (LA-)MRSA clade (CC398) has caused an impressive increase in the number of isolates submitted for the Dutch national MRSA surveillance and now comprises 40% of all isolates. The currently used molecular typing techniques have limited discriminatory power for this MRSA clade, which hampers studies on the origin and transmission routes. Recently, a new molecular analysis technique named whole genome mapping was introduced. This method creates high-resolution, ordered whole genome restriction maps that may have potential for strain typing. In this study, we assessed and validated the capability of whole genome mapping to differentiate LA- MRSA isolates. Multiple validation experiments showed that whole genome mapping produced highly reproducible results. Assessment of the technique on two well-documented MRSA outbreaks showed that whole genome mapping was able to confirm one outbreak, but revealed major differences between the maps of a second, indicating that not all isolates belonged to this outbreak. Whole genome mapping of LA-MRSA isolates that were epidemiologically unlinked provided a much higher discriminatory power than spa-typing or MLVA. In contrast, maps created from LA-MRSA isolates obtained during a proven LA-MRSA outbreak were nearly indistinguishable showing that transmission of LA-MRSA can be detected by whole genome mapping. Finally, whole genome maps of LA-MRSA isolates originating from two unrelated veterinarians and their household members showed that veterinarians may carry and transmit different LA-MRSA strains at the same time. No such conclusions could be drawn based spa-typing and MLVA. Although PFGE seems to be suitable for molecular typing of LA-MRSA, WGM provides a much higher discriminatory power. Furthermore, whole genome mapping can provide a comparison with other maps within 2 days after the bacterial culture is received, making it suitable to investigate transmission events and outbreaks caused by LA-MRSA.	[Bosch, Thijs; van Luit, Martijn; Schouls, Leo] Natl Inst Publ Hlth & Environm RIVM, Lab Infect Dis & Screening, Bilthoven, Netherlands; [Verkade, Erwin; Kluytmans, Jan] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [van Luit, Martijn; Kluytmans, Jan] St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [Pot, Bruno; Vauterin, Paul] Appl Maths, Sint Martens Latem, Belgium; [Burggrave, Ronald] Piext BV, Rosmalen, Netherlands; [Savelkoul, Paul] Univ Limburg, Acad Hosp Maastricht, Dept Med Microbiol, Maastricht, Netherlands; [Savelkoul, Paul; Kluytmans, Jan] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; Amphia Hospital; Elisabeth-TweeSteden Ziekenhuis (ETZ); Hasselt University; Maastricht University; Maastricht University Medical Centre (MUMC); Vrije Universiteit Amsterdam	Bosch, T (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Lab Infect Dis & Screening, Bilthoven, Netherlands.	thijs.bosch@rivm.nl	Pot, Bruno DF/I-6645-2012	Vauterin, Paul/0000-0003-3665-4519	Food & Nutrition Delta program of the Dutch Ministry of Economic Affairs; Dutch Ministry of Health, Welfare and Sport	Food & Nutrition Delta program of the Dutch Ministry of Economic Affairs; Dutch Ministry of Health, Welfare and Sport	This work was partially funded by a grant in the Food & Nutrition Delta program of the Dutch Ministry of Economic Affairs and partially by the Dutch Ministry of Health, Welfare and Sport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argudin MA, 2010, LETT APPL MICROBIOL, V50, P127, DOI 10.1111/j.1472-765X.2009.02742.x; Bens CCPM, 2006, J CLIN MICROBIOL, V44, P1875, DOI 10.1128/JCM.44.5.1875-1876.2006; Bosch T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-40; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; Diep BA, 2013, LANCET INFECT DIS, V13, P99, DOI 10.1016/S1473-3099(12)70276-1; EMORI TG, 1993, CLIN MICROBIOL REV, V6, P428, DOI 10.1128/CMR.6.4.428-442.1993; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; Guardabassi L, 2007, VET MICROBIOL, V122, P384, DOI 10.1016/j.vetmic.2007.03.021; Haenen APJ, 2011, INFECTIEZIEKTEN B, V22, P250; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Harris SR, 2013, LANCET INFECT DIS, V13, P130, DOI 10.1016/S1473-3099(12)70268-2; Huijsdens XW, 2008, EMERG INFECT DIS, V14, P1797, DOI 10.3201/eid1411.071297; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Kotewicz ML, 2007, MICROBIOL-SGM, V153, P1720, DOI 10.1099/mic.0.2006/004507-0; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Melles D C, 2004, Ned Tijdschr Geneeskd, V148, P1038; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; Neely RK, 2011, BIOPOLYMERS, V95, P298, DOI 10.1002/bip.21579; Nemati M, 2008, ANTIMICROB AGENTS CH, V52, P3817, DOI 10.1128/AAC.00613-08; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; Reuter S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002175; Riley MC, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-252; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; Schouls LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005082; Shukla SK, 2012, J CLIN MICROBIOL, V50, P3526, DOI 10.1128/JCM.01168-12; Shukla SK, 2009, J BACTERIOL, V191, P5717, DOI 10.1128/JB.00325-09; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Steinberg JP, 1996, CLIN INFECT DIS, V23, P255, DOI 10.1093/clinids/23.2.255; van Wamel WJB, 2010, EUR J CLIN MICROBIOL, V29, P119, DOI 10.1007/s10096-009-0816-3; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3	31	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66493	10.1371/journal.pone.0066493	http://dx.doi.org/10.1371/journal.pone.0066493			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805225	Green Published, gold, Green Submitted			2022-12-25	WOS:000320846500053
J	Jonsson, JE; Gardarsson, A; Gill, JA; Petursdottir, UK; Petersen, A; Gunnarsson, TG				Jonsson, Jon Einar; Gardarsson, Arnthor; Gill, Jennifer A.; Petursdottir, Una Kristin; Petersen, Aevar; Gunnarsson, Tomas Gretar			Relationships between Long-Term Demography and Weather in a Sub-Arctic Population of Common Eider	PLOS ONE			English	Article							SOMATERIA-MOLLISSIMA; CLIMATE-CHANGE; CLUTCH SIZE; BREEDING SUCCESS; NESTING SUCCESS; ICE CONDITIONS; SEA-ICE; SURVIVAL; DYNAMICS; SITE	Effects of local weather on individuals and populations are key drivers of wildlife responses to climatic changes. However, studies often do not last long enough to identify weather conditions that influence demographic processes, or to capture rare but extreme weather events at appropriate scales. In Iceland, farmers collect nest down of wild common eider Somateria mollissima and many farmers count nests within colonies annually, which reflects annual variation in the number of breeding females. We collated these data for 17 colonies. Synchrony in breeding numbers was generally low between colonies. We evaluated 1) demographic relationships with weather in nesting colonies of common eider across Iceland during 1900-2007; and 2) impacts of episodic weather events (aberrantly cold seasons or years) on subsequent breeding numbers. Except for episodic events, breeding numbers within a colony generally had no relationship to local weather conditions in the preceding year. However, common eider are sexually mature at 2-3 years of age and we found a 3-year time lag between summer weather and breeding numbers for three colonies, indicating a positive effect of higher pressure, drier summers for one colony, and a negative effect of warmer, calmer summers for two colonies. These findings may represent weather effects on duckling production and subsequent recruitment. Weather effects were mostly limited to a few aberrant years causing reductions in breeding numbers, i.e. declines in several colonies followed severe winters (1918) and some years with high NAO (1992, 1995). In terms of life history, adult survival generally is high and stable and probably only markedly affected by inclement weather or aberrantly bad years. Conversely, breeding propensity of adults and duckling production probably do respond more to annual weather variations; i.e. unfavorable winter conditions for adults increase probability of death or skipped breeding, whereas favorable summers can promote boom years for recruitment.	[Jonsson, Jon Einar; Petursdottir, Una Kristin; Gunnarsson, Tomas Gretar] Univ Iceland, Res Ctr Snaefellsnes, Stykkisholmur, Iceland; [Gardarsson, Arnthor] Univ Iceland, Inst Biol, Reykjavik, Iceland; [Gill, Jennifer A.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Petersen, Aevar] Iceland Inst Nat Hist, Garoabaer, Iceland; [Gunnarsson, Tomas Gretar] Univ Iceland, South Iceland Res Ctr, Selfoss, Iceland; [Gunnarsson, Tomas Gretar] Univ Iceland, South Iceland Res Ctr, Gunnarsholt Hella, Iceland	University of Iceland; University of Iceland; University of East Anglia; University of Iceland; University of Iceland	Jonsson, JE (corresponding author), Univ Iceland, Res Ctr Snaefellsnes, Stykkisholmur, Iceland.	joneinar@hi.is	Jónsson, Jón Einar/K-7482-2015; Gunnarsson, Tomas G/L-9783-2015; Gill, Jennifer A/A-7759-2008	Jónsson, Jón Einar/0000-0003-1198-786X; Gunnarsson, Tomas Gretar/0000-0001-7692-0637	Icelandic Research Council (RANNIS); Icelandic Agricultural Productivity fund (Framleionisjoour landbunaoarins); Icelandic eider-down farmers association (AEoarraektarfelag Islands); University of Iceland	Icelandic Research Council (RANNIS); Icelandic Agricultural Productivity fund (Framleionisjoour landbunaoarins); Icelandic eider-down farmers association (AEoarraektarfelag Islands); University of Iceland	This study was supported financially by the Icelandic Research Council (RANNIS), the Icelandic Agricultural Productivity fund (Framleionisjoour landbunaoarins), the Icelandic eider-down farmers association (AEoarraektarfelag Islands) and the University of Iceland. The funders had no involvement in study design, data collation or analysis, decision to publish, or manuscript preparation.	ACIA, 2005, IMP WARM CLIM ARCT C; Anders AD, 2006, J ANIM ECOL, V75, P221, DOI 10.1111/j.1365-2656.2006.01034.x; BAILLIE SR, 1989, IBIS, V131, P321, DOI 10.1111/j.1474-919X.1989.tb02782.x; BEUKEMA JJ, 1993, NETH J SEA RES, V31, P395, DOI 10.1016/0077-7579(93)90056-X; Bjornsson H., 2008, HNATTRAENAR LOFTSLAG; Bolduc F, 2005, WILDLIFE BIOL, V11, P273, DOI 10.2981/0909-6396(2005)11[273:NSOCES]2.0.CO;2; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2010, P ROY SOC B-BIOL SCI, V277, P1259, DOI 10.1098/rspb.2009.1525; BOX GEP, 1975, J AM STAT ASSOC, V70, P70, DOI 10.2307/2285379; BUSTNES JO, 1993, ORNIS FENNICA, V70, P11; COULSON JC, 1984, IBIS, V126, P525, DOI 10.1111/j.1474-919X.1984.tb02078.x; Coulson JC, 2010, BIRD STUDY, V57, P1; D'Alba L, 2010, IBIS, V152, P19, DOI 10.1111/j.1474-919X.2009.00978.x; Descamps S, 2010, OIKOS, V119, P1526, DOI 10.1111/j.1600-0706.2010.18508.x; Descamps S, 2009, BIOL LETTERS, V5, P278, DOI 10.1098/rsbl.2008.0704; Einarsson M.A., 1984, WORLD SURV CLIMATOL, V15, P673; Ekroos J, 2012, ORNIS FENNICA, V89, P81; ERIKSTAD KE, 1995, OECOLOGIA, V103, P270, DOI 10.1007/BF00328614; Frederiksen M, 2008, J ANIM ECOL, V77, P1020, DOI 10.1111/j.1365-2656.2008.01422.x; Gardarsson A, 1997, J ANIM ECOL, V66, P439, DOI 10.2307/5939; GARDARSSON A, 1994, HYDROBIOLOGIA, V279, P15, DOI 10.1007/BF00027837; Gardarsson Arnthor, 2009, Bliki (Reykjavik), V30, P49; Gjerdrum C, 2003, P NATL ACAD SCI USA, V100, P9377, DOI 10.1073/pnas.1133383100; Gordo O, 2007, CLIM RES, V35, P37, DOI 10.3354/cr00713; Grosbois V, 2005, OIKOS, V109, P273, DOI 10.1111/j.0030-1299.2005.13774.x; Gunnarsson TG, 2006, J ANIM ECOL, V75, P1119, DOI 10.1111/j.1365-2656.2006.01131.x; Hanna E, 2004, INT J CLIMATOL, V24, P1193, DOI 10.1002/joc.1051; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Hario M, 2009, ORNIS FENNICA, V86, P81; Hario M, 2009, OECOLOGIA, V159, P747, DOI 10.1007/s00442-008-1265-x; Hurrell JW, 2001, SCIENCE, V291, P603, DOI 10.1126/science.1058761; Iles D. T., 2012, THESIS UTAH STATE U; Iles DT, 2013, J ANIM ECOL, V82, P683, DOI 10.1111/1365-2656.12038; Institute of Natural History, 2000, VAL 2 BIRDS; Jiguet F, 2010, P ROY SOC B-BIOL SCI, V277, P3601, DOI 10.1098/rspb.2010.0796; Jonsson J, 2001, POLAR BIOL; Jonsson J. E., 2001, Wildfowl, V52, P55; Jonsson JE, 2012, ORNIS FENNICA, V89; Jonsson JE, 2009, CLIM RES, V38, P237, DOI 10.3354/cr00790; Jonsson T, 2010, ISLAND NAO FYRIRBRIG; Jonsson T., 2006, HITAFAR ISLANDI EFTI; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; Klaassen M, 2006, ARDEA, V94, P371; Koenig WD, 1999, TRENDS ECOL EVOL, V14, P22, DOI 10.1016/S0169-5347(98)01533-X; Lehikoinen A, 2006, GLOBAL CHANGE BIOL, V12, P1355, DOI 10.1111/j.1365-2486.2006.01162.x; Lepage D, 2000, J ANIM ECOL, V69, P414, DOI 10.1046/j.1365-2656.2000.00404.x; Liebhold A, 2004, ANNU REV ECOL EVOL S, V35, P467, DOI 10.1146/annurev.ecolsys.34.011802.132516; Love OP, 2010, OECOLOGIA, V164, P277, DOI 10.1007/s00442-010-1678-1; Marra PP, 2005, OECOLOGIA, V142, P307, DOI 10.1007/s00442-004-1725-x; Mehlum F, 2012, POLAR SCI, V6, P143, DOI 10.1016/j.polar.2012.03.004; MENDENHALL VM, 1985, IBIS, V127, P148, DOI 10.1111/j.1474-919X.1985.tb05051.x; Moe B, 2009, MAR ECOL PROG SER, V393, P235, DOI 10.3354/meps08222; Newton I., 1998, POPULATION LIMITATIO; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Pike N, 2011, METHODS ECOL EVOL, V2, P278, DOI 10.1111/j.2041-210X.2010.00061.x; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; Ranta E, 1997, OIKOS, V78, P136, DOI 10.2307/3545809; Robert A, 2012, ECOLOGY, V93, P1944, DOI 10.1890/11-1840.1; ROBERTSON GJ, 1995, IBIS, V137, P109, DOI 10.1111/j.1474-919X.1995.tb03226.x; Robinson SA, 2009, GLOBAL CHANGE BIOL, V15, P1615, DOI 10.1111/j.1365-2486.2009.01977.x; Saether BE, 2004, ADV ECOL RES, V35, P185, DOI 10.1016/S0065-2504(04)35009-9; *SAS I INC, 2001, SAS SYSTAT US GUID V; Senechal E, 2011, BEHAV ECOL, V22, P162, DOI 10.1093/beheco/arq189; SWENNEN C, 1990, ORNIS SCAND, V21, P17, DOI 10.2307/3676374; SWENNEN C, 1991, J ORNITHOL, V132, P427, DOI 10.1007/BF01640382; Thompson PM, 2001, NATURE, V413, P417, DOI 10.1038/35096558; Tiedemann R, 1999, BEHAVIOUR, V136, P1145; Tranquilla LM, 2010, ESTUAR COAST SHELF S, V89, P97, DOI 10.1016/j.ecss.2010.06.003; Traylor JJ, 2006, AUK, V123, P67, DOI 10.1642/0004-8038(2006)123[0067:EOIAEF]2.0.CO;2; van de Pol M, 2010, J APPL ECOL, V47, P720, DOI 10.1111/j.1365-2664.2010.01842.x; WAKELEY JS, 1976, J WILDLIFE MANAGE, V40, P15, DOI 10.2307/3800151; Watanuki Y, 2009, MAR ECOL PROG SER, V393, P259, DOI 10.3354/meps08264; Wilson HM, 2007, J WILDLIFE MANAGE, V71, P403, DOI 10.2193/2005-776; Yaffee R.A., 2000, INTRO TIME SERIES AN	75	17	19	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67093	10.1371/journal.pone.0067093	http://dx.doi.org/10.1371/journal.pone.0067093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805292	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500120
J	Raikkonen, J; Vucetich, JA; Vucetich, LM; Peterson, RO; Nelson, MP				Raikkonen, Jannikke; Vucetich, John A.; Vucetich, Leah M.; Peterson, Rolf O.; Nelson, Michael P.			What the Inbred Scandinavian Wolf Population Tells Us about the Nature of Conservation	PLOS ONE			English	Article							LUMBOSACRAL TRANSITIONAL VERTEBRAE; FOX VULPES-VULPES; INBREEDING DEPRESSION; DENTAL ANOMALIES; CANIS-LUPUS; LARGE CARNIVORE; WOLVES; DOG; WILD; CRYPTORCHIDISM	The genetic aspects of population health are critical, but frequently difficult to assess. Of concern has been the genetic constitution of Scandinavian wolves (Canis lupus), which represent an important case in conservation. We examined the incidence of different congenital anomalies for 171 Scandinavian wolves, including the immigrant founder female, born during a 32-year period between 1978 and 2010. The incidence of anomalies rose from 13% to 40% throughout the 32-year study period. Our ability to detect this increase was likely facilitated by having considered multiple kinds of anomaly. Many of the found anomalies are likely associated with inbreeding or some form of genetic deterioration. These observations have implications for understanding the conservation needs of Scandinavian wolves. Moreover, these observations and the history of managing Scandinavian wolves focus attention on a broader question, whether conservation is merely about avoiding extinction of remnant populations, or whether conservation also entails maintaining genetic aspects of population health.	[Raikkonen, Jannikke] Swedish Museum Nat Hist, Dept Contaminant Res, S-10405 Stockholm, Sweden; [Vucetich, John A.; Vucetich, Leah M.; Peterson, Rolf O.] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA; [Nelson, Michael P.] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA	Swedish Museum of Natural History; Michigan Technological University; Oregon State University	Raikkonen, J (corresponding author), Swedish Museum Nat Hist, Dept Contaminant Res, S-10405 Stockholm, Sweden.	jannikke.raikkonen@gmail.com	Nelson, Michael Shawn/GXF-4934-2022		United States National Science Foundation [DEB-0424562]; Swedish Environmental Protection Agency	United States National Science Foundation(National Science Foundation (NSF)); Swedish Environmental Protection Agency	Funding was provided by the United States National Science Foundation (DEB-0424562) and by a grant from the Swedish Environmental Protection Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JR, 2011, P ROY SOC B-BIOL SCI, V278, P3336, DOI 10.1098/rspb.2011.0261; Akesson M, 2010, 235369710 DNR NAT; Amann RP, 2007, REPRODUCTION, V133, P541, DOI 10.1530/REP-06-0272; Andersone Z, 2000, ACTA THERIOL, V45, P549; Bergstrom BJ, 2009, BIOSCIENCE, V59, P991, DOI 10.1525/bio.2009.59.11.11; Birchard SJ, 2008, COMPENDIUM, V30, P325; BOUWMEESTER J, 1989, J ZOOL, V219, P123, DOI 10.1111/j.1469-7998.1989.tb02571.x; Breit S, 2002, ANAT EMBRYOL, V205, P125, DOI 10.1007/s00429-002-0234-0; Burnham K. P., 1998, MODEL SELECTION INFE; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CARO TM, 1994, SCIENCE, V263, P485, DOI 10.1126/science.8290956; Carpenter Len H., 2000, Human Dimensions of Wildlife, V5, P5; DECKER DJ, 1988, WILDLIFE SOC B, V16, P53; Dunbar MR, 1996, J WILDLIFE DIS, V32, P661, DOI 10.7589/0090-3558-32.4.661; Echegaray J, 2010, ANIM CONSERV, V13, P157, DOI 10.1111/j.1469-1795.2009.00315.x; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fluckiger MA, 2006, VET RADIOL ULTRASOUN, V47, P39, DOI 10.1111/j.1740-8261.2005.00103.x; Forslund P, 2009, 429858508 DNR EPA; Frankham R, 2010, HEREDITY, V104, P124, DOI 10.1038/hdy.2009.155; Hale FA, 2005, VET CLIN N AM-SMALL, V35, P789, DOI 10.1016/j.cvsm.2005.02.003; Hedrick PW, 2001, TRENDS ECOL EVOL, V16, P629, DOI 10.1016/S0169-5347(01)02282-0; HELL P, 1990, Z JAGDWISS, V36, P266, DOI 10.1007/BF02242401; Kojola I, 2009, J WILDLIFE MANAGE, V73, P309, DOI 10.2193/2007-539; Lacy RC, 1996, EVOLUTION, V50, P2187, DOI 10.1111/j.1558-5646.1996.tb03609.x; Laikre L, 2013, CONSERV BIOL, V27, P248, DOI 10.1111/j.1523-1739.2012.01965.x; Landon DB, 1998, J WILDLIFE MANAGE, V62, P674, DOI 10.2307/3802343; Lauck T, 1998, ECOL APPL, V8, pS72, DOI 10.1890/1051-0761(1998)8[S72:ITPPIF]2.0.CO;2; Legendre L, 2008, J VET DENT, V25, P216; Liberg O, 2005, BIOL LETT-UK, V1, P17, DOI 10.1098/rsbl.2004.0266; Liberg O, 2009, REGULATING HARVEST S; Liberg O, 2012, P ROY SOC B-BIOL SCI, V279, P910, DOI 10.1098/rspb.2011.1275; Lihotop RI, 1994, VESTNIK ZOOLOGII, V3, P45; LYNCH M, 1988, GENETICS, V120, P791; Mech D, 2010, BIOL CONSERV, V143, P535, DOI 10.1016/j.biocon.2009.10.019; Mills L. S., 2007, CONSERVATION WILDLIF; MORGAN JP, 1993, J AM VET MED ASSOC, V202, P1877; MORGAN JP, 1968, J AM VET RADIOL SOC, V9, P21; Naturvardsverket, 2012, NAT FORV VARG 2012 2; Naturvardsverket Statens Jordbruksverk & Statens veterinarmedicinska anstalt, 2010, GEN FORST SVENSK VAR; Nelson M.P., 2011, WILDLIFE PROFESSIONA, V5, P58; Nentvichova M, 2008, ACTA THERIOL, V53, P217, DOI 10.1007/BF03193118; Raikkonen J, 2006, MAMM BIOL, V71, P65, DOI 10.1016/j.mambio.2005.12.002; Raikkonen J, 2009, BIOL CONSERV, V142, P1025, DOI 10.1016/j.biocon.2009.01.014; ROELKE ME, 1993, CURR BIOL, V3, P340, DOI 10.1016/0960-9822(93)90197-V; Shaffer Mark L., 2000, P301; Steffen F, 2004, J AM ANIM HOSP ASSOC, V40, P338, DOI 10.5326/0400338; Tear TH, 2005, BIOSCIENCE, V55, P835, DOI 10.1641/0006-3568(2005)055[0835:HMIETR]2.0.CO;2; Tidholm A, 1997, J SMALL ANIM PRACT, V38, P94, DOI 10.1111/j.1748-5827.1997.tb03326.x; Traill LW, 2010, BIOL CONSERV, V143, P28, DOI 10.1016/j.biocon.2009.09.001; Treves A, 2009, J APPL ECOL, V46, P1350, DOI 10.1111/j.1365-2664.2009.01729.x; Vila C, 2003, P ROY SOC B-BIOL SCI, V270, P91, DOI 10.1098/rspb.2002.2184; VILA C, 1993, CAN J ZOOL, V71, P968, DOI 10.1139/z93-127; Vucetich JA, 2012, IGNORING NA IN PRESS; Wabakken P, 2001, CAN J ZOOL, V79, P710, DOI 10.1139/cjz-79-4-710; Wabakken P, 2011, 1 HOGSK HEDM; Wabakken P, 2010, 4 HOGSK HEDM; Wigger A, 2009, TIERAERZTL PRAX K H, V37, P7; WOBESER G, 1992, J WILDLIFE DIS, V28, P268, DOI 10.7589/0090-3558-28.2.268	58	27	27	1	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67218	10.1371/journal.pone.0067218	http://dx.doi.org/10.1371/journal.pone.0067218			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805301	gold, Green Published			2022-12-25	WOS:000320846500129
J	Raju, I; Kannan, K; Abraham, EC				Raju, Ilangovan; Kannan, Krishnaswamy; Abraham, Edathara C.			FoxO3a Serves as a Biomarker of Oxidative Stress in Human Lens Epithelial Cells under Conditions of Hyperglycemia	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; DIABETIC-RAT; DOWNSTREAM; MODULATION; MECHANISMS; CATARACT; PROTEINS; AKT	Background: Forkhead box 'O' transcription factors (FoxOs) are implicated in the pathogenesis of type2 diabetes and other metabolic diseases. Abnormal activity of FoxOs was reported in the glucose and insulin metabolism. Expression of FoxO proteins was reported in ocular tissues; however their function under hyperglycemic conditions was not examined. Methods: Human lens epithelial cell line was used to study the function of FoxO proteins. Immunofluorescence, flow cytometry and Western blotting were employed to detect the FoxO proteins under the conditions of hyperglycemia. Results: In this study we examined the role of FoxO3a in hyperglycemia-induced oxidative stress in human lens epithelial cells. FoxO3a protein expression was elevated in a dose- and time-dependent fashion after high glucose treatment. Antioxidant defense mechanisms of the lens epithelial cells were diminished as evidenced from loss of mitochondrial membrane integrity and lowered MnSOD after 72 h treatment with high glucose. Taken together, FoxO3a acts as a sensitive indicator of oxidative stress and cell homeostasis in human lens epithelial cells during diabetic conditions. Conclusion: FoxO3a is an early stress response protein to glucose toxicity in diabetic conditions.	[Raju, Ilangovan; Abraham, Edathara C.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Kannan, Krishnaswamy] Univ Arkansas Med Sci, Div Rheumatol, Dept Internal Med, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Abraham, EC (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	AbrahamEdatharaC@uams.edu			National Institutes of Health [EY11352]; Sturgis Diabetes Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sturgis Diabetes Foundation	This study was supported by National Institutes of Health grant #EY11352. Research grant money provided by Sturgis Diabetes Foundation to Dr. Kannan is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argirova M, 2002, J BIOCHEM MOL TOXIC, V16, P140, DOI 10.1002/jbt.10031; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; CHERIAN M, 1995, BIOCHEM BIOPH RES CO, V212, P184, DOI 10.1006/bbrc.1995.1954; Choi SW, 2008, FREE RADICAL BIO MED, V44, P1217, DOI 10.1016/j.freeradbiomed.2007.12.005; Dansen TB, 2011, ANTIOXID REDOX SIGN, V14, P559, DOI 10.1089/ars.2010.3778; de Keizer PLJ, 2011, ANTIOXID REDOX SIGN, V14, P1093, DOI 10.1089/ars.2010.3403; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851; Kim DH, 2013, J DIABETES; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kousteni S, 2012, BONE, V50, P437, DOI 10.1016/j.bone.2011.06.034; Kowluru A, 2012, BIOCHEM PHARMACOL, V84, P591, DOI 10.1016/j.bcp.2012.05.003; Kumar PA, 2005, MOL VIS, V11, P561; Kumar PA, 2009, J NUTR BIOCHEM, V20, P553, DOI 10.1016/j.jnutbio.2008.05.015; Li GR, 2011, INVEST OPHTH VIS SCI, V52, P4395, DOI 10.1167/iovs.10-6652; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nakae J, 2008, FEBS LETT, V582, P54, DOI 10.1016/j.febslet.2007.11.025; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Ni YG, 2007, P NATL ACAD SCI USA, V104, P20517, DOI 10.1073/pnas.0610290104; Obrosova IG, 2010, DIABETES-METAB RES, V26, P172, DOI 10.1002/dmrr.1075; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pollreisz A, 2010, J OPHTHALMOL, V2010, DOI 10.1155/2010/608751; Ponugoti B, 2012, EXP DIABETES RES, DOI 10.1155/2012/939751; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Singh A, 2010, MOL BIOL CELL, V21, P1140, DOI 10.1091/mbc.E09-09-0795; Srivastava S K, 1990, Lens Eye Toxic Res, V7, P161; Thampi P, 2002, MOL CELL BIOCHEM, V229, P113, DOI 10.1023/A:1017980713089; Tran Hien, 2003, Sci STKE, V2003, pRE5, DOI 10.1126/stke.2003.172.re5; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Ughade Suresh N., 1998, Indian Journal of Ophthalmology, V46, P221; Zheng TY, 2011, CURR EYE RES, V36, P449, DOI 10.3109/02713683.2011.559301	34	18	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67126	10.1371/journal.pone.0067126	http://dx.doi.org/10.1371/journal.pone.0067126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805295	Green Published, gold, Green Submitted			2022-12-25	WOS:000320846500123
J	Jemon, K; Young, V; Wilson, M; McKee, S; Ward, V; Baird, M; Young, S; Hibma, M				Jemon, Khairunadwa; Young, Vivienne; Wilson, Michelle; McKee, Sara; Ward, Vernon; Baird, Margaret; Young, Sarah; Hibma, Merilyn			An Enhanced Heterologous Virus-Like Particle for Human Papillomavirus Type 16 Tumour Immunotherapy	PLOS ONE			English	Article							REGULATORY T-CELLS; HEMORRHAGIC-DISEASE VIRUS; CERVICAL-CANCER; DNA VACCINE; ANTIGEN-4 BLOCKADE; IMMUNE-RESPONSES; CAPSID PROTEIN; COMBINATION IMMUNOTHERAPY; ANTI-CD25 ANTIBODY; ANTITUMOR IMMUNITY	Cervical cancer is caused by high-risk, cancer-causing human papillomaviruses (HPV) and is the second highest cause of cancer deaths in women globally. The majority of cervical cancers express well-characterized HPV oncogenes, which are potential targets for immunotherapeutic vaccination. Here we develop a rabbit haemorrhagic disease virus (RHDV) virus-like particle (VLP)-based vaccine designed for immunotherapy against HPV16 positive tumours. An RHDV-VLP, modified to contain the universal helper T cell epitope PADRE and decorated with an MHC I-restricted peptide (aa 48-57) from the HPV16 E6, was tested for its immunotherapeutic efficacy against the TC-1 HPV16 E6 and E7-expressing tumour in mice. The E6-RHDV-VLP-PADRE was administered therapeutically for the treatment of a pre-existing TC-1 tumour and was delivered with antibodies either to deplete regulatory T cells (anti-CD25) or to block T cell suppression mediated through CTLA-4. As a result, the tumour burden was reduced by around 50% and the median survival time of mice to the humane endpoint was almost doubled the compared to controls. The incorporation of PADRE into the RHDV-VLP was necessary for an E6-specific enhancement of the anti-tumour response and the co-administration of the immune modifying antibodies contributed to the overall efficacy of the immunotherapy. The E6-RHDV-VLP-PADRE shows immunotherapeutic efficacy, prolonging survival for HPV tumour-bearing mice. This was enhanced by the systemic administration of immune-modifying antibodies that are commercially available for use in humans. There is potential to further modify these particles for even greater efficacy in the path to development of an immunotherapeutic treatment for HPV precancerous and cancer stages.	[Jemon, Khairunadwa; Young, Vivienne; Wilson, Michelle; McKee, Sara; Ward, Vernon; Baird, Margaret; Hibma, Merilyn] Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand; [McKee, Sara; Young, Sarah] Univ Otago, Dept Pathol, Dunedin, New Zealand	University of Otago; University of Otago	Hibma, M (corresponding author), Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand.	merilyn.hibma@otago.ac.nz	McKee, Sara/R-7810-2016; Jemon, Khairunadwa/N-2401-2013	McKee, Sara/0000-0002-3513-2906; Jemon, Khairunadwa/0000-0002-6966-3406; Ward, Vernon/0000-0001-8692-5116; Young, Vivienne/0000-0002-9216-5552; Young, Sarah/0000-0003-0374-2221	Health Research Council of New Zealand; Genesis Oncology Trust (New Zealand)	Health Research Council of New Zealand(Health Research Council of New Zealand); Genesis Oncology Trust (New Zealand)	Funding for this study was provided by the Health Research Council of New Zealand and the Genesis Oncology Trust (New Zealand). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Chen YL, 2008, WORLD J GASTROENTERO, V14, P5797, DOI 10.3748/wjg.14.5797; Chuang CM, 2009, VACCINE, V27, P684, DOI 10.1016/j.vaccine.2008.11.042; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dawar M, 2007, CAN MED ASSOC J, V177, P456, DOI 10.1503/cmaj.070771; Greenstone HL, 1998, P NATL ACAD SCI USA, V95, P1800, DOI 10.1073/pnas.95.4.1800; Gromadzka B, 2006, ACTA BIOCHIM POL, V53, P371; Hamilton DH, 2008, CANCER IMMUNOL IMMUN, V57, P1125, DOI 10.1007/s00262-007-0442-9; Hildesheim A, 2007, JAMA-J AM MED ASSOC, V298, P743, DOI 10.1001/jama.298.7.743; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hsu FJ, 2002, J IMMUNOTHER, V25, P455, DOI 10.1097/00002371-200211000-00002; Huang CH, 2005, GENE THER, V12, P1180, DOI 10.1038/sj.gt.3302519; Hung CF, 2007, MOL THER, V15, P1211, DOI 10.1038/sj.mt.6300121; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; Hurwitz AA, 2000, CANCER RES, V60, P2444; HUSMANN LA, 1988, ANN NY ACAD SCI, V532, P158, DOI 10.1111/j.1749-6632.1988.tb36335.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Katpally U, 2010, J VIROL, V84, P5836, DOI 10.1128/JVI.00314-10; KEENE JA, 1982, J EXP MED, V155, P768, DOI 10.1084/jem.155.3.768; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Laurent S, 2002, ARCH VIROL, V147, P1559, DOI 10.1007/s00705-002-0825-3; LAURENT S, 1994, J VIROL, V68, P6794, DOI 10.1128/JVI.68.10.6794-6798.1994; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Lenz P, 2003, CLIN IMMUNOL, V106, P231, DOI 10.1016/S1521-6616(02)00039-6; Leong CM, 2010, J INVEST DERMATOL, V130, P472, DOI 10.1038/jid.2009.266; Li KY, 2013, J IMMUNOTHER, V36, P11, DOI 10.1097/CJI.0b013e3182787f5e; Li YL, 2010, ONCOL REP, V24, P1323, DOI 10.3892/or_00000989; Lin KY, 1996, CANCER RES, V56, P21; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Loddenkemper C, 2009, CANCER SCI, V100, P1112, DOI 10.1111/j.1349-7006.2009.01153.x; May KF, 2005, BLOOD, V105, P1114, DOI 10.1182/blood-2004-07-2561; McKee SJ, 2012, J CONTROL RELEASE; Molling JW, 2007, INT J CANCER, V121, P1749, DOI 10.1002/ijc.22894; MOUSSA A, 1992, VET MICROBIOL, V33, P375, DOI 10.1016/0378-1135(92)90065-2; NAGESHA HS, 1995, ARCH VIROL, V140, P1095, DOI 10.1007/BF01315418; Ohlinger V F, 1991, Rev Sci Tech, V10, P311; Okita R, 2009, INT J ONCOL, V34, P563, DOI 10.3892/ijo_00000182; Olsson SE, 2007, VACCINE, V25, P4931, DOI 10.1016/j.vaccine.2007.03.049; Oosterhuis K, 2011, INT J CANCER, V129, P397, DOI 10.1002/ijc.25894; PANINABORDIGNON P, 1989, EUR J IMMUNOL, V19, P2237, DOI 10.1002/eji.1830191209; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peacey M, 2008, VACCINE, V26, P5334, DOI 10.1016/j.vaccine.2008.07.074; Peacey M, 2007, BIOTECHNOL BIOENG, V98, P968, DOI 10.1002/bit.21518; Pedersen AE, 2006, CANCER LETT, V235, P229, DOI 10.1016/j.canlet.2005.04.012; Peng S, 2008, GENE THER, V15, P1156, DOI 10.1038/gt.2008.53; Peng SW, 2004, J VIROL, V78, P8468, DOI 10.1128/JVI.78.16.8468-8476.2004; Persson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022303; Raghunandan R, 2011, EXPERT REV VACCINES, V10, P409, DOI [10.1586/erv.11.37, 10.1586/ERV.11.37]; Rambout L, 2007, CAN MED ASSOC J, V177, P469, DOI 10.1503/cmaj.070948; Rech AJ, 2009, ANN NY ACAD SCI, V1174, P99, DOI 10.1111/j.1749-6632.2009.04939.x; Saha A, 2010, SCAND J IMMUNOL, V71, P70, DOI 10.1111/j.1365-3083.2009.02355.x; Schwarz K, 2003, EUR J IMMUNOL, V33, P1465, DOI 10.1002/eji.200323919; Soutter WP, 1997, LANCET, V349, P978, DOI 10.1016/S0140-6736(96)08295-5; Stanley Margaret, 2003, Expert Rev Vaccines, V2, P615, DOI 10.1586/14760584.2.5.615; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Tuve S, 2007, CANCER RES, V67, P5929, DOI 10.1158/0008-5472.CAN-06-4296; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; Visser J, 2007, CLIN EXP IMMUNOL, V150, P199, DOI 10.1111/j.1365-2249.2007.03468.x; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Welters MJP, 2008, CLIN CANCER RES, V14, P178, DOI 10.1158/1078-0432.CCR-07-1880; Wick DA, 2011, VACCINE, V29, P7857, DOI 10.1016/j.vaccine.2011.07.090; Win SJ, 2011, IMMUNOL CELL BIOL, V89, P681, DOI 10.1038/icb.2010.161; Woo EY, 2002, J IMMUNOL, V168, P4272, DOI 10.4049/jimmunol.168.9.4272; Wu A, 2011, GENE THER, V18, P304, DOI 10.1038/gt.2010.151; Zhang Y, 2007, INT IMMUNOL, V19, P151, DOI 10.1093/intimm/dxl132; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	68	25	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66866	10.1371/journal.pone.0066866	http://dx.doi.org/10.1371/journal.pone.0066866			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799135	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300100
J	Lin, SC; Jan, JT; Dionne, B; Butler, M; Huang, MH; Wu, CY; Wong, CH; Wu, SC				Lin, Shih-Chang; Jan, Jia-Tsrong; Dionne, Ben; Butler, Michael; Huang, Ming-Hsi; Wu, Chung-Yi; Wong, Chi-Huey; Wu, Suh-Chin			Different Immunity Elicited by Recombinant H5N1 Hemagglutinin Proteins Containing Pauci-Mannose, High-Mannose, or Complex Type N-Glycans	PLOS ONE			English	Article							INFLUENZA-VIRUS H5N1; AVIAN INFLUENZA; VIRAL HEMAGGLUTININ; CHALLENGE INFECTION; RECEPTOR-BINDING; INSECT CELLS; CHO-CELLS; GLYCOSYLATION; CULTURE; TRANSMISSION	Highly pathogenic avian influenza H5N1 viruses can result in poultry and occasionally in human mortality. A safe and effective H5N1 vaccine is urgently needed to reduce the pandemic potential. Hemagglutinin (HA), a major envelope protein accounting for approximately 80% of spikes in influenza virus, is often used as a major antigen for subunit vaccine development. In this study, we conducted a systematic study of the immune response against influenza virus infection following immunization with recombinant HA proteins expressed in insect (Sf9) cells, insect cells that contain exogenous genes for elaborating N-linked glycans (Mimic) and mammalian cells (CHO). While the antibody titers are higher with the insect cell derived HA proteins, the neutralization and HA inhibition titers are much higher with the mammalian cell produced HA proteins. Recombinant HA proteins containing tri- or tetra-antennary complex, terminally sialylated and asialyated-galactose type N-glycans induced better protective immunity in mice to lethal challenge. The results are highly relevant to issues that should be considered in the production of fragment vaccines.	[Lin, Shih-Chang; Wu, Suh-Chin] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Jan, Jia-Tsrong; Wu, Chung-Yi; Wong, Chi-Huey] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Dionne, Ben; Butler, Michael] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada; [Huang, Ming-Hsi] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan	National Tsing Hua University; Academia Sinica - Taiwan; University of Manitoba; National Health Research Institutes - Taiwan	Wu, SC (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan.	scwu@mx.nthu.edu.tw	Butler, Michael/AAP-7439-2021; Wu, Chung-Yi/K-8334-2018; Wu, Suh-Chin/AAV-6233-2021; Huang, Ming-Hsi/E-3872-2010; Butler, Michael/I-8167-2012	Huang, Ming-Hsi/0000-0002-9670-3821; Butler, Michael/0000-0002-4907-3652	National Science Council of Taiwan [NSC101-2321-B-007-002, NSC99-2311-B-007-005-MY3]; National Health Research Institutes; Academia Sinica Short-term Visitor Program	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan); Academia Sinica Short-term Visitor Program	This project was supported by the National Science Council of Taiwan (NSC101-2321-B-007-002 and NSC99-2311-B-007-005-MY3), the National Health Research Institutes, and the Academia Sinica Short-term Visitor Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EW, 2008, CHEMBIOCHEM, V9, P294, DOI 10.1002/cbic.200700310; Berns KI, 2012, SCIENCE, V335, P660, DOI 10.1126/science.1217994; Biesova Z, 2009, VACCINE, V27, P6234, DOI 10.1016/j.vaccine.2009.07.107; Bjorkman C, 1999, J VET DIAGN INVEST, V11, P41; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Buszewski B, 2012, ANAL BIOANAL CHEM, V402, P231, DOI 10.1007/s00216-011-5308-5; Chen WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049224; Chiu FF, 2009, BIOCHEM BIOPH RES CO, V383, P27, DOI 10.1016/j.bbrc.2009.03.106; Cornelissen LAHM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010645; de Souza VAUF, 2004, J CLIN MICROBIOL, V42, P1782, DOI 10.1128/JCM.42.4.1782-1784.2004; de Vries RP, 2012, J VIROL, V86, P11735, DOI 10.1128/JVI.01084-12; de Vries RP, 2010, VIROLOGY, V403, P17, DOI 10.1016/j.virol.2010.03.047; Fouchier RAM, 2012, SCIENCE, V335, P662, DOI 10.1126/science.1218376; Guile GR, 1996, ANAL BIOCHEM, V240, P210, DOI 10.1006/abio.1996.0351; Hanson SR, 2009, P NATL ACAD SCI USA, V106, P3131, DOI 10.1073/pnas.0810318105; Hart ML, 2002, AIDS RES HUM RETROV, V18, P1311, DOI 10.1089/088922202320886352; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hollister J, 2002, BIOCHEMISTRY-US, V41, P15093, DOI 10.1021/bi026455d; Huang MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012279; Hutter J, 2013, J IMMUNOL, V190, P220, DOI 10.4049/jimmunol.1201060; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jarvis DL, 1998, CURR OPIN BIOTECH, V9, P528, DOI 10.1016/S0958-1669(98)80041-4; Kalthoff D, 2010, J VIROL, V84, P12002, DOI 10.1128/JVI.00940-10; Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336; Khurana S, 2011, J VIROL, V85, P1246, DOI 10.1128/JVI.02107-10; Lin SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039075; Lin SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020052; Lin SC, 2010, BIOTECHNOL PROGR, V26, P1733, DOI 10.1002/btpr.480; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Restelli V, 2006, BIOTECHNOL BIOENG, V94, P481, DOI 10.1002/bit.20875; Rodriguez J, 2005, BIOTECHNOL PROGR, V21, P22, DOI 10.1021/bp049807b; Rodriguez J, 2010, J BIOTECHNOL, V150, P509, DOI 10.1016/j.jbiotec.2010.09.959; Schwarzer J, 2009, VACCINE, V27, P4325, DOI 10.1016/j.vaccine.2009.04.076; Shan MM, 2007, PLOS PATHOG, V3, P1637, DOI 10.1371/journal.ppat.0030169; Shen S, 2008, J MED VIROL, V80, P1972, DOI 10.1002/jmv.21298; Shoji Y, 2009, VACCINE, V27, P1087, DOI 10.1016/j.vaccine.2008.11.108; Song L, 2009, VACCINE, V27, P5875, DOI 10.1016/j.vaccine.2009.07.060; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; Webster RG, 2012, MBIO, V3, DOI 10.1128/mBio.00005-12; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; Wei HJ, 2011, VACCINE, V29, P7163, DOI 10.1016/j.vaccine.2011.05.077; World Health Organization, CUMULATIVE NUMBER CO; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932	44	25	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66719	10.1371/journal.pone.0066719	http://dx.doi.org/10.1371/journal.pone.0066719			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799128	Green Published, gold			2022-12-25	WOS:000320363300093
J	Brolund, A; Franzen, O; Melefors, O; Tegmark-Wisell, K; Sandegren, L				Brolund, Alma; Franzen, Oscar; Melefors, Ojar; Tegmark-Wisell, Karin; Sandegren, Linus			Plasmidome-Analysis of ESBL-Producing Escherichia coli Using Conventional Typing and High-Throughput Sequencing	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASE; RESISTANCE; GENOME; ENTEROBACTERIACEAE; IDENTIFICATION; INFECTIONS; SELECTION; CARRIAGE; STRAINS; SCHEME	Infections caused by Extended spectrum beta-lactamase (ESBL)-producing E. coli are an emerging global problem, threatening the effectiveness of the extensively used beta-lactam antibiotics. ESBL dissemination is facilitated by plasmids, transposons, and other mobile elements. We have characterized the plasmid content of ESBL-producing E. coli from human urinary tract infections. Ten diverse isolates were selected; they had unrelated pulsed-field gel electrophoresis (PFGE) types (<90% similarity), were from geographically dispersed locations and had diverging antibiotic resistance profiles. Three isolates belonged to the globally disseminated sequence type ST131. ESBL-genes of the CTX-M-1 and CTX-M-9 phylogroups were identified in all ten isolates. The plasmid content (plasmidome) of each strain was analyzed using a combination of molecular methods and high-throughput sequencing. Hidden Markov Model-based analysis of unassembled sequencing reads was used to analyze the genetic diversity of the plasmid samples and to detect resistance genes. Each isolate contained between two and eight distinct plasmids, and at least 22 large plasmids were identified overall. The plasmids were variants of pUTI89, pKF3-70, pEK499, pKF3-140, pKF3-70, p1ESCUM, pEK204, pHK17a, p083CORR, R64, pLF82, pSFO157, and R721. In addition, small cryptic high copy-number plasmids were frequent, containing one to seven open reading frames per plasmid. Three clustered groups of such small cryptic plasmids could be distinguished based on sequence similarity. Extrachromosomal prophages were found in three isolates. Two of them resembled the E. coli P1 phage and one was previously unknown. The present study confirms plasmid multiplicity in multi-resistant E. coli. We conclude that high-throughput sequencing successfully provides information on the extrachromosomal gene content and can be used to generate a genetic fingerprint of possible use in epidemiology. This could be a valuable tool for tracing plasmids in outbreaks.	[Brolund, Alma; Melefors, Ojar; Tegmark-Wisell, Karin] Swedish Inst Communicable Dis Control, Solna, Sweden; [Brolund, Alma; Melefors, Ojar; Tegmark-Wisell, Karin] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Franzen, Oscar] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Sandegren, Linus] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden	Swedish Institute for Infectious Disease Control; Karolinska Institutet; Karolinska Institutet; Uppsala University	Brolund, A (corresponding author), Swedish Inst Communicable Dis Control, Solna, Sweden.	alma.brolund@smi.se	Sandegren, Linus/K-4638-2013; Melefors, Öjar/N-6164-2015	Sandegren, Linus/0000-0001-7382-9782; Melefors, Öjar/0000-0003-4115-1190	NSCMID - Nordic Society of Clinical Microbiology and Infectious Diseases; Swedish Research Council (VR-MH); Carl Tryggers Foundation	NSCMID - Nordic Society of Clinical Microbiology and Infectious Diseases; Swedish Research Council (VR-MH)(Swedish Research Council); Carl Tryggers Foundation	Part of this work was supported with grants from NSCMID - Nordic Society of Clinical Microbiology and Infectious Diseases (to AB), and the Swedish Research Council (VR-MH) and Carl Tryggers Foundation (to LS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; [Anonymous], 2011, J ANTIMICROB CHEMOTH; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bengtsson S, 2012, J ANTIMICROB CHEMOTH, V67, P69, DOI 10.1093/jac/dkr421; Brolund A, 2010, J MICROBIOL METH, V83, P224, DOI 10.1016/j.mimet.2010.09.004; Brolund A, 2010, J MICROBIOL METH, V82, P229, DOI 10.1016/j.mimet.2010.06.006; Brolund A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009233; Burian J, 1997, PLASMID, V37, P2, DOI 10.1006/plas.1996.1273; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2011, INT J MED MICROBIOL, V301, P654, DOI 10.1016/j.ijmm.2011.09.003; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Eddy Sean R, 2009, Genome Inform, V23, P205; Garcia-Fernandez A, 2008, J ANTIMICROB CHEMOTH, V61, P1229, DOI 10.1093/jac/dkn131; Garcia-Fernandez A, 2010, J ANTIMICROB CHEMOTH, V65, P1155, DOI 10.1093/jac/dkq101; Giske CG, 2009, J ANTIMICROB CHEMOTH, V63, P1, DOI 10.1093/jac/dkn444; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Johnson JR, 2010, CLIN INFECT DIS, V51, P286, DOI 10.1086/653932; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lobocka MB, 2004, J BACTERIOL, V186, P7032, DOI 10.1128/JB.186.21.7032-7068.2004; Miquel S, 2010, PLOS ONE, P5; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Pitout JDD, 2010, DRUGS, V70, P313, DOI 10.2165/11533040-000000000-00000; Ripoll A, 2011, ANTIMICROB AGENTS CH, V55, P4530, DOI 10.1128/AAC.00178-11; Sherley M, 2003, PLASMID, V49, P79, DOI 10.1016/S0147-619X(02)00107-5; Smet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011202; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tofteland S, 2007, J CLIN MICROBIOL, V45, P199, DOI 10.1128/JCM.01319-06; Wilkins BM, 2002, ENVIRON MICROBIOL, V4, P495, DOI 10.1046/j.1462-2920.2002.00332.x; Woodford N, 2009, ANTIMICROB AGENTS CH, V53, P4472, DOI 10.1128/AAC.00688-09; Yi HG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008601	37	31	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65793	10.1371/journal.pone.0065793	http://dx.doi.org/10.1371/journal.pone.0065793			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785449	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800073
J	Coley, W; Rayavarapu, S; van der Meulen, JH; Duba, AS; Nagaraju, K				Coley, William; Rayavarapu, Sree; van der Meulen, Jack H.; Duba, Ayyappa S.; Nagaraju, Kanneboyina			Daily Supplementation of D-ribose Shows No Therapeutic Benefits in the MHC-I Transgenic Mouse Model of Inflammatory Myositis	PLOS ONE			English	Article							MYOADENYLATE DEAMINASE DEFICIENCY; ENDOPLASMIC-RETICULUM STRESS; HUMAN SKELETAL-MUSCLE; AUTOIMMUNE MYOSITIS; INTENSE EXERCISE; UP-REGULATION; METABOLISM; CAPACITY; DAMAGE	Background: Current treatments for idiopathic inflammatory myopathies (collectively called myositis) focus on the suppression of an autoimmune inflammatory response within the skeletal muscle. However, it has been observed that there is a poor correlation between the successful suppression of muscle inflammation and an improvement in muscle function. Some evidence in the literature suggests that metabolic abnormalities in the skeletal muscle underlie the weakness that continues despite successful immunosuppression. We have previously shown that decreased expression of a purine nucleotide cycle enzyme, adenosine monophosphate deaminase (AMPD1), leads to muscle weakness in a mouse model of myositis and may provide a mechanistic basis for muscle weakness. One of the downstream metabolites of this pathway, D-ribose, has been reported to alleviate symptoms of myalgia in patients with a congenital loss of AMPD1. Therefore, we hypothesized that supplementing exogenous D-ribose would improve muscle function in the mouse model of myositis. We treated normal and myositis mice with daily doses of D-ribose (4 mg/kg) over a 6-week time period and assessed its effects using a battery of behavioral, functional, histological and molecular measures. Results: Treatment with D-ribose was found to have no statistically significant effects on body weight, grip strength, open field behavioral activity, maximal and specific forces of EDL, soleus muscles, or histological features. Histological and gene expression analysis indicated that muscle tissues remained inflamed despite treatment. Gene expression analysis also suggested that low levels of the ribokinase enzyme in the skeletal muscle might prevent skeletal muscle tissue from effectively utilizing D-ribose. Conclusions: Treatment with daily oral doses of D-ribose showed no significant effect on either disease progression or muscle function in the mouse model of myositis.	[Coley, William; Rayavarapu, Sree; van der Meulen, Jack H.; Duba, Ayyappa S.; Nagaraju, Kanneboyina] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Nagaraju, Kanneboyina] George Washington Univ, Sch Med, Dept Integrat Syst Biol, Washington, DC USA	Children's National Health System; George Washington University	Nagaraju, K (corresponding author), Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA.	knagaraju@childrensnational.org	Nagaraju, Kanneboyina/AAV-7684-2021; Nagaraju, Kanneboyina/ABA-6525-2021		Association Francaise Contre les Myopathies	Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies)	Sree Rayavarapu is supported by a pre-doctoral fellowship from the Association Francaise Contre les Myopathies. William Coley is a predoctoral student in the Microbiology and Immunology Program of the Institute for Biomedical Sciences at the George Washington University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alger HM, 2011, ARTHRITIS RHEUM-US, V63, P3448, DOI 10.1002/art.30530; Berardi JM, 2003, J STRENGTH COND RES, V17, P47; Coley W, 2012, ARTHRITIS RHEUM-US, V64, P3750, DOI 10.1002/art.34625; Englund P, 2001, AM J PATHOL, V159, P1263, DOI 10.1016/S0002-9440(10)62513-8; FISHBEIN WN, 1985, BIOCHEM MED METAB B, V33, P158, DOI 10.1016/0006-2944(85)90024-9; GROSS M, 1989, KLIN WOCHENSCHR, V67, P1205, DOI 10.1007/BF01716208; Hellsten Y, 1999, J PHYSIOL-LONDON, V520, P909, DOI 10.1111/j.1469-7793.1999.00909.x; Kerksick C, 2005, INT J SPORT NUTR EXE, V15, P653, DOI 10.1123/ijsnem.15.6.653; LECKY BRF, 1983, LANCET, V1, P193; Li CKC, 2004, J RHEUMATOL, V31, P605; Nagaraju K, 2005, ARTHRITIS RHEUM, V52, P1824, DOI 10.1002/art.21103; Nagaraju K, 2000, P NATL ACAD SCI USA, V97, P9209, DOI 10.1073/pnas.97.16.9209; Rozen S, 2000, Methods Mol Biol, V132, P365; SABINA RL, 1991, ADV EXP MED BIOL, V309, P203; SABINA RL, 1984, J CLIN INVEST, V73, P720, DOI 10.1172/JCI111265; SABINA RL, 1992, NEUROLOGY, V42, P170, DOI 10.1212/WNL.42.1.170; Sabina RL, 2000, NEUROL CLIN, V18, P185, DOI 10.1016/S0733-8619(05)70184-5; Salomonsson S, 2009, MUSCLE NERVE, V39, P674, DOI 10.1002/mus.21129; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; Steele IC, 1996, J NEUROL SCI, V136, P174, DOI 10.1016/0022-510X(95)00320-2; TULLSON PC, 1995, J APPL PHYSIOL, V78, P146, DOI 10.1152/jappl.1995.78.1.146; Vattemi G, 2004, AM J PATHOL, V164, P1, DOI 10.1016/S0002-9440(10)63089-1; Vitadello M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2963; WAGNER DR, 1991, ANN NUTR METAB, V35, P297, DOI 10.1159/000177660; ZOLLNER N, 1986, KLIN WOCHENSCHR, V64, P1281, DOI 10.1007/BF01785710	25	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65970	10.1371/journal.pone.0065970	http://dx.doi.org/10.1371/journal.pone.0065970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785461	Green Published, gold, Green Submitted			2022-12-25	WOS:000321038800061
J	Pakradouni, J; Le Goff, W; Calmel, C; Antoine, B; Villard, E; Frisdal, E; Abifadel, M; Tordjman, J; Poitou, C; Bonnefont-Rousselot, D; Bittar, R; Bruckert, E; Clement, K; Feve, B; Martinerie, C; Guerin, M				Pakradouni, Jihane; Le Goff, Wilfried; Calmel, Claire; Antoine, Benedicte; Villard, Elise; Frisdal, Eric; Abifadel, Marianne; Tordjman, Joan; Poitou, Christine; Bonnefont-Rousselot, Dominique; Bittar, Randa; Bruckert, Eric; Clement, Karine; Feve, Bruno; Martinerie, Cecile; Guerin, Maryse			Plasma NOV/CCN3 Levels Are Closely Associated with Obesity in Patients with Metabolic Disorders	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; ADIPOSE-TISSUE; GENDER-DIFFERENCES; NERVOUS-SYSTEM; EXPRESSION; GENE; NOV; ATHEROSCLEROSIS; GROWTH; MICE	Objective: Evidence points to a founder of the multifunctional CCN family, NOV/CCN3, as a circulating molecule involved in cardiac development, vascular homeostasis and inflammation. No data are available on the relationship between plasma NOV/CCN3 levels and cardiovascular risk factors in humans. This study investigated the possible relationship between plasma NOV levels and cardiovascular risk factors in humans. Methods: NOV levels were measured in the plasma from 594 adults with a hyperlipidemia history and/or with lipid-lowering therapy and/or a body mass index (BMI) >30 kg/m(2). Correlations were measured between NOV plasma levels and various parameters, including BMI, fat mass, and plasma triglycerides, cholesterol, glucose, and C-reactive protein. NOV expression was also evaluated in adipose tissue from obese patients and rodents and in primary cultures of adipocytes and macrophages. Results: After full multivariate adjustment, we detected a strong positive correlation between plasma NOV and BMI (r = 0.36 p<0.0001) and fat mass (r = 0.33 p<0.0005). According to quintiles, this relationship appeared to be linear. NOV levels were also positively correlated with C-reactive protein but not with total cholesterol, LDL-C or blood glucose. In patients with drastic weight loss induced by Roux-en-Y bariatric surgery, circulating NOV levels decreased by 28% (p<0.02) and 48% (p<0.0001) after 3 and 6 months, respectively, following surgery. In adipose tissue from obese patients, and in human primary cultures NOV protein was detected in adipocytes and macrophages. In mice fed a high fat diet NOV plasma levels and its expression in adipose tissue were also significantly increased compared to controls fed a standard diet. Conclusion: Our results strongly suggest that in obese humans and mice plasma NOV levels positively correlated with NOV expression in adipose tissue, and support a possible contribution of NOV to obesity-related inflammation.	[Pakradouni, Jihane; Calmel, Claire; Antoine, Benedicte; Feve, Bruno; Martinerie, Cecile] Hop St Antoine, St Antoine Res Ctr, UMR S938, INSERM, F-75571 Paris, France; [Pakradouni, Jihane; Calmel, Claire; Antoine, Benedicte; Feve, Bruno; Martinerie, Cecile] Univ Paris 06, UMR S938, Paris, France; [Pakradouni, Jihane] Sisene SAS, Paris, France; [Le Goff, Wilfried; Villard, Elise; Frisdal, Eric; Bittar, Randa; Bruckert, Eric; Guerin, Maryse] Hop La Pitie Salpetriere, INSERM, UMR S939, Paris, France; [Tordjman, Joan; Poitou, Christine; Clement, Karine] Cordelier Res Ctr, Nutri Team 7, INSERM, U872, Paris, France; [Tordjman, Joan; Poitou, Christine; Clement, Karine] Univ Paris 06, AP HP, Pitie Salpetriere Hosp, Human Nutr Res Ctr CRNH, Paris, France; [Le Goff, Wilfried; Villard, Elise; Frisdal, Eric; Guerin, Maryse] Univ Paris 06, UMR S939, Paris, France; [Bruckert, Eric] Hop La Pitie Salpetriere, AP HP, Dept Endocrinol, Paris, France; [Bonnefont-Rousselot, Dominique; Bittar, Randa] Hop La Pitie Salpetriere, AP HP, Metab Biochem Dept, Paris, France; [Le Goff, Wilfried; Villard, Elise; Frisdal, Eric; Bruckert, Eric; Clement, Karine; Guerin, Maryse] ICAN, Cardiometab & Nutr Inst, Paris, France; [Abifadel, Marianne] Bichat Claude Bernard Hosp, INSERM, UMR S698, Paris, France; [Abifadel, Marianne] St Joseph Univ, Fac Pharm, Beirut, Lebanon	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Martinerie, C (corresponding author), Hop St Antoine, St Antoine Res Ctr, UMR S938, INSERM, F-75571 Paris, France.	cecile.martinerie@inserm.fr	Clément, karine/R-1120-2017; Abifadel, Marianne/ABH-5370-2020; Le Goff, Wilfried/N-6326-2017; Guerin, Maryse/N-5794-2017; Le Goff, Wilfried/N-7593-2019; Rousselot, Bonnefont/U-7434-2019; Poitou, Christine/GVT-6117-2022	Le Goff, Wilfried/0000-0002-7611-9644; Le Goff, Wilfried/0000-0002-7611-9644; Poitou, Christine/0000-0001-7769-6331; Pakradouni, Jihane/0000-0003-0400-6007; Bonnefont-Rousselot, Dominique/0000-0003-4689-9202; CALMEL, Claire/0000-0001-7215-7910; ABIFADEL, Marianne/0000-0001-7645-8323; Feve, Bruno/0000-0001-6577-9009; GUERIN, Maryse/0000-0003-0150-1360	Institut National de la Sante et de la Recherche Medicale (INSERM); Institut National du Cancer (INCA); Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC); ANRT (Association National Recherche et Technologie), CIFRE; Assistance Publique-Hopitaux de Paris (APHP); Direction of Clinical Research (CRC) [CRC NCT 0047658]; PHRC [0702]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France); Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC); ANRT (Association National Recherche et Technologie), CIFRE; Assistance Publique-Hopitaux de Paris (APHP); Direction of Clinical Research (CRC); PHRC	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), and by grants from the Institut National du Cancer (INCA) and the Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC). JP was a recipient of financial support from the ANRT (Association National Recherche et Technologie), CIFRE. The authors acknowledge support from the Assistance Publique-Hopitaux de Paris (APHP) and the Direction of Clinical Research (CRC), which promoted and supported our clinical investigation (CRC NCT 0047658) and PHRC 0702. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Maksoud M, 2008, J CARDIOVASC PHARM, V51, P331, DOI 10.1097/FJC.0b013e318165e2e7; Benini S, 2005, ONCOGENE, V24, P4349, DOI 10.1038/sj.onc.1208620; Bouloumie A, 2005, CURR OPIN CLIN NUTR, V8, P347, DOI 10.1097/01.mco.0000172571.41149.52; Braunersreuther V, 2007, ARTERIOSCL THROM VAS, V27, P373, DOI 10.1161/01.ATV.0000253886.44609.ae; Breland UM, 2008, ARTERIOSCL THROM VAS, V28, P1005, DOI 10.1161/ATVBAHA.108.162305; Bruun JM, 2005, J CLIN ENDOCR METAB, V90, P2282, DOI 10.1210/jc.2004-1696; Burren CP, 1999, J CLIN ENDOCR METAB, V84, P1096; Calhabeu F, 1876, EXP CELL RES; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chevalier G, 1998, AM J PATHOL, V152, P1563; Christiansen T, 2005, INT J OBESITY, V29, P146, DOI 10.1038/sj.ijo.0802839; Couillard C, 1997, DIABETOLOGIA, V40, P1178, DOI 10.1007/s001250050804; Dalmas E, 2011, AM J CLIN NUTR, V94, P450, DOI 10.3945/ajcn.111.013771; Divoux A, 2011, OBES REV, V12, pe494, DOI 10.1111/j.1467-789X.2010.00811.x; Doghman M, 2007, J CLIN ENDOCR METAB, V92, P3253, DOI 10.1210/jc.2007-0342; Fukunaga-Kalabis M, 2008, ONCOGENE, V27, P2552, DOI 10.1038/sj.onc.1210896; Heath E, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-18; Hellstrom L, 2000, J INTERN MED, V247, P457, DOI 10.1046/j.1365-2796.2000.00678.x; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Inoue S, 2002, CIRCULATION, V106, P2700, DOI 10.1161/01.CIR.0000038140.80105.AD; JOLIOT V, 1992, MOL CELL BIOL, V12, P10, DOI 10.1128/MCB.12.1.10; Kimura A, 2010, J BIOL CHEM, V285, P32704, DOI 10.1074/jbc.M110.141804; Kular L, 2011, BIOCHIMIE, V93, P377, DOI 10.1016/j.biochi.2010.11.010; Larrede S, 2009, ARTERIOSCL THROM VAS, V29, P1930, DOI 10.1161/ATVBAHA.109.194548; Le Dreau G, 2010, GLIA, V58, P1510, DOI 10.1002/glia.21025; Libby P, 2010, CIRC J, V74, P213, DOI 10.1253/circj.CJ-09-0706; Lin ZY, 2010, J CELL COMMUN SIGNAL, V4, P141, DOI 10.1007/s12079-010-0095-x; Manara MC, 2002, AM J PATHOL, V160, P849, DOI 10.1016/S0002-9440(10)64908-5; Martinerie C, 2001, J CLIN ENDOCR METAB, V86, P3929, DOI 10.1210/jc.86.8.3929; McCallum L, 2009, J CELL COMMUN SIGNAL, V3, P115, DOI 10.1007/s12079-009-0058-2; Niu ZH, 2005, J UROLOGY, V174, P1460, DOI 10.1097/01.ju.0000173008.73741.80; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poitou C, 2011, ARTERIOSCL THROM VAS, V31, P2322, DOI 10.1161/ATVBAHA.111.230979; Poitou C, 2009, J CLIN ENDOCR METAB, V94, P1810, DOI 10.1210/jc.2008-2040; Rydziel S, 2007, J BIOL CHEM, V282, P19762, DOI 10.1074/jbc.M700212200; Samad F, 1997, MOL MED, V3, P37, DOI 10.1007/BF03401666; Shimoyama T, 2010, ARTERIOSCL THROM VAS, V30, P675, DOI 10.1161/ATVBAHA.110.203356; Su BY, 2001, J CLIN PATHOL-MOL PA, V54, P184, DOI 10.1136/mp.54.3.184; Thibout H, 2003, J CLIN ENDOCR METAB, V88, P327, DOI 10.1210/jc.2002-020304; Vendrell JA, 2004, J MOL ENDOCRINOL, V32, P397, DOI 10.1677/jme.0.0320397	40	35	36	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66788	10.1371/journal.pone.0066788	http://dx.doi.org/10.1371/journal.pone.0066788			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785511	Green Published, gold, Green Submitted			2022-12-25	WOS:000321038800011
J	Cetinbas, N; Huang-Hobbs, H; Tognon, C; Leprivier, G; An, JH; McKinney, S; Bowden, M; Chow, C; Gleave, M; McIntosh, LP; Sorensen, PH				Cetinbas, Naniye; Huang-Hobbs, Helen; Tognon, Cristina; Leprivier, Gabriel; An, Jianghong; McKinney, Steven; Bowden, Mary; Chow, Connie; Gleave, Martin; McIntosh, Lawrence P.; Sorensen, Poul H.			Mutation of the Salt Bridge-forming Residues in the ETV6-SAM Domain Interface Blocks ETV6-NTRK3-induced Cellular Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; CHRONIC MYELOMONOCYTIC LEUKEMIA; GENE FUSION; SAM DOMAIN; CHROMOSOMAL TRANSLOCATION; CONGENITAL FIBROSARCOMA; TERMINAL SEQUENCE; TEL GENE; RECEPTOR; ACTIVATION	The ETV6-NTRK3 (EN) chimeric oncogene is expressed in diverse tumor types. EN is generated by a t(12;15) translocation, which fuses the N-terminal SAM (sterile alpha-motif) domain of the ETV6 (or TEL) transcription factor to the C-terminal PTK (protein-tyrosine kinase) domain of the neurotrophin-3 receptor NTRK3. SAM domain-mediated polymerization of EN leads to constitutive activation of the PTK domain and constitutive signaling of the Ras-MAPK and PI3K-Akt pathways, which are essential for EN oncogenesis. Here we show through complementary biophysical and cellular biological techniques that mutation of Lys-99, which participates in a salt bridge at the SAM polymer interface, reduces self-association of the isolated SAM domain as well as high molecular mass complex formation of EN and abrogates the transformation activity of EN. We also show that mutation of Asp-101, the intermolecular salt bridge partner of Lys-99, similarly blocks transformation of NIH3T3 cells by EN, reduces EN tyrosine phosphorylation, inhibits Akt and Mek1/2 signaling downstream of EN, and abolishes tumor formation in nude mice. In contrast, mutations of Glu-100 and Arg-103, residues in the vicinity of the interdomain Lys-99-Asp-101 salt bridge, have little or no effect on these oncogenic characteristics of EN. Our results underscore the importance of specific electrostatic interactions for SAM polymerization and EN transformation.	[Cetinbas, Naniye; Tognon, Cristina; Leprivier, Gabriel; Chow, Connie; Sorensen, Poul H.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; [Cetinbas, Naniye; Tognon, Cristina; Leprivier, Gabriel; McKinney, Steven; Sorensen, Poul H.] BC Canc Res Ctr, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada; [Huang-Hobbs, Helen; McIntosh, Lawrence P.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z3, Canada; [Huang-Hobbs, Helen; McIntosh, Lawrence P.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [An, Jianghong] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Bowden, Mary; Gleave, Martin] Univ British Columbia, Dept Urol Sci, Vancouver, BC V6H 3Z6, Canada; [Bowden, Mary; Gleave, Martin] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC V6H 3Z6, Canada	University of British Columbia; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; University of British Columbia	Sorensen, PH (corresponding author), BC Canc Res Ctr, Dept Mol Oncol, 675 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	psor@mail.ubc.ca		Gleave, Martin/0000-0003-4235-0167	Canadian Institutes for Health Research [MOP119599]; British Columbia Cancer Foundation; Canadian Cancer Society Research Institute [017308]; Canadian Institutes for Health Research Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); British Columbia Cancer Foundation; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institutes for Health Research Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes for Health Research Grant MOP119599 and funds from the British Columbia Cancer Foundation through generous donations from Team Finn and Ride to Conquer Cancer (to P. H. S.) and Canadian Cancer Society Research Institute Grant 017308 (to L. P. M.).; Supported by a Canadian Institutes for Health Research Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award.	An JH, 2005, MOL CELL PROTEOMICS, V4, P752, DOI 10.1074/mcp.M400159-MCP200; Bohlander SK, 2005, SEMIN CANCER BIOL, V15, P162, DOI 10.1016/j.semcancer.2005.01.008; Carroll M, 1996, P NATL ACAD SCI USA, V93, P14845, DOI 10.1073/pnas.93.25.14845; Chakrabarti SR, 2000, P NATL ACAD SCI USA, V97, P13281, DOI 10.1073/pnas.240315897; De Braekeleer E, 2012, LEUKEMIA RES, V36, P945, DOI 10.1016/j.leukres.2012.04.010; Eguchi M, 1999, BLOOD, V93, P1355, DOI 10.1182/blood.V93.4.1355; Forghieri F, 2011, EUR J HAEMATOL, V86, P352, DOI 10.1111/j.1600-0609.2011.01576.x; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; Golub TR, 1996, MOL CELL BIOL, V16, P4107; GOLUB TR, 1995, P NATL ACAD SCI USA, V92, P4917, DOI 10.1073/pnas.92.11.4917; Jousset C, 1997, EMBO J, V16, P69, DOI 10.1093/emboj/16.1.69; Kazakov DV, 2010, AM J SURG PATHOL, V34, P1226, DOI 10.1097/PAS.0b013e3181e4f49d; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; Knezevich SR, 1998, NAT GENET, V18, P184, DOI 10.1038/ng0298-184; Knezevich SR, 1998, CANCER RES, V58, P5046; Kuno Y, 2001, BLOOD, V97, P1050, DOI 10.1182/blood.V97.4.1050; Kyba M, 1998, DEV GENET, V22, P74, DOI 10.1002/(SICI)1520-6408(1998)22:1<74::AID-DVG8>3.3.CO;2-V; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Lannon CL, 2005, SEMIN CANCER BIOL, V15, P215, DOI 10.1016/j.semcancer.2005.01.003; Lannon CL, 2004, J BIOL CHEM, V279, P6225, DOI 10.1074/jbc.M307388200; Macauley MS, 2006, J BIOL CHEM, V281, P4164, DOI 10.1074/jbc.M510488200; Martin MJ, 2006, MOL CELL BIOL, V26, P1754, DOI 10.1128/MCB.26.5.1754-1769.2006; Morrison KB, 2002, ONCOGENE, V21, P5684, DOI 10.1038/sj.onc.1205669; Ng TL, 2012, CELL DEATH DIFFER, V19, P501, DOI 10.1038/cdd.2011.119; PAPADOPOULOS P, 1995, CANCER RES, V55, P34; Peterson AJ, 1997, MOL CELL BIOL, V17, P6683, DOI 10.1128/MCB.17.11.6683; Poirel H, 1997, ONCOGENE, V14, P349, DOI 10.1038/sj.onc.1200829; PONTING CP, 1995, PROTEIN SCI, V4, P1928, DOI 10.1002/pro.5560040927; Qiao F, 2004, CELL, V118, P163, DOI 10.1016/j.cell.2004.07.010; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Roukens MG, 2008, MOL CELL BIOL, V28, P2342, DOI 10.1128/MCB.01159-07; Schultz J, 1997, PROTEIN SCI, V6, P249; Skalova A, 2010, AM J SURG PATHOL, V34, P599, DOI 10.1097/PAS.0b013e3181d9efcc; Tognon C, 2001, CANCER RES, V61, P8909; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0; Tognon CE, 2004, MOL CELL BIOL, V24, P4636, DOI 10.1128/MCB.24.11.4636-4650.2004; Tran Hoang H, 2002, BMC Struct Biol, V2, P5, DOI 10.1186/1472-6807-2-5; Wai DH, 2000, ONCOGENE, V19, P906, DOI 10.1038/sj.onc.1203396; Wood LD, 2003, P NATL ACAD SCI USA, V100, P3257, DOI 10.1073/pnas.0637114100; Yagasaki F, 2001, CANCER RES, V61, P8371; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	42	12	12	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27940	27950		10.1074/jbc.M113.475301	http://dx.doi.org/10.1074/jbc.M113.475301			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23798677	Green Published, hybrid			2022-12-25	WOS:000330612800021
J	Pallesen, LJ; Solodovnikova, N; Sharma, AK; Walden, WE				Pallesen, Leif J.; Solodovnikova, Natalia; Sharma, Anil K.; Walden, William E.			Interaction with Cfd1 Increases the Kinetic Lability of FeS on the Nbp35 Scaffold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTER; SACCHAROMYCES-CEREVISIAE; PROTEIN BIOGENESIS; REGULATORY PROTEIN-1; CFD1-NBP35 COMPLEX; 4FE-4S CLUSTER; MITOCHONDRIA; MATURATION; MUTATIONS; CYTOSOL	P-loop NTPases of the ApbC/Nbp35 family are involved in FeS protein maturation in nearly all organisms and are proposed to function as scaffolds for initial FeS cluster assembly. In yeast and animals, Cfd1 and Nbp35 are homologous P-loop NTPases that form a heterotetrameric complex essential for FeS protein maturation through the cytosolic FeS cluster assembly (CIA) pathway. Cfd1 is conserved in animals, fungi, and several archaeal species, but in many organisms, only Nbp35 is present, raising the question of the unique roles played by Cfd1 and Nbp35. To begin to investigate this issue, we examined Cfd1 and Nbp35 function in budding yeast. About half of each protein was detected in a heterocomplex in logarithmically growing yeast. Nbp35 readily bound Fe-55 when fed to cells, whereas Fe-55 binding by free Cfd1 could not be detected. Rapid Fe-55 binding to and release from Nbp35 was impaired by Cfd1 deficiency. A Cfd1 mutation that caused a defect in heterocomplex stability supported iron binding to Nbp35 but impaired iron release. Our results suggest a model in which Cfd1-Nbp35 interaction increases the lability of assembled FeS on the Nbp35 scaffold for transfer to target apo-FeS proteins.	[Pallesen, Leif J.; Solodovnikova, Natalia; Sharma, Anil K.; Walden, William E.] Rush Med Coll, Dept Microbiol & Immunol, Chicago, IL 60612 USA	Rush University	Walden, WE (corresponding author), Rush Med Coll, Dept Microbiol & Immunol MC 790, 835 S Wolcott Ave, Chicago, IL 60612 USA.	wwalden@uic.edu	Sharma, Anil K./AAP-1909-2020	Sharma, Anil K./0000-0002-9768-1644	National Institutes of Health [DK047281]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK047281 (to W. E. W.).	Angelaccio S, 2002, ANAL BIOCHEM, V306, P346, DOI 10.1006/abio.2002.5689; Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Balk J, 2011, TRENDS PLANT SCI, V16, P218, DOI 10.1016/j.tplants.2010.12.006; Boyd JM, 2008, BIOCHEMISTRY-US, V47, P8195, DOI 10.1021/bi800551y; Boyd JM, 2009, J BACTERIOL, V191, P1490, DOI 10.1128/JB.01469-08; Brown NM, 1998, P NATL ACAD SCI USA, V95, P15235, DOI 10.1073/pnas.95.26.15235; Bych K, 2008, J BIOL CHEM, V283, P35797, DOI 10.1074/jbc.M807303200; EIDE D, 1992, J BIOL CHEM, V267, P20774; GROVES WE, 1968, ANAL BIOCHEM, V22, P195, DOI 10.1016/0003-2697(68)90307-2; Hassett RF, 1998, J BIOL CHEM, V273, P7628, DOI 10.1074/jbc.273.13.7628; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; KOHLHAW GB, 1988, METHOD ENZYMOL, V166, P423; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lezhneva L, 2004, PLANT J, V37, P174, DOI 10.1046/j.1365-313X.2003.01952.x; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Narahari J, 2000, J BIOL CHEM, V275, P16227, DOI 10.1074/jbc.M910450199; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Netz DJA, 2012, J BIOL CHEM, V287, P12365, DOI 10.1074/jbc.M111.328914; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; Schwenkert S, 2010, BIOCHEM J, V425, P207, DOI 10.1042/BJ20091290; Sharma AK, 2010, J BIOL CHEM, V285, P26745, DOI 10.1074/jbc.R110.122218; Sheftel A, 2010, TRENDS ENDOCRIN MET, V21, P302, DOI 10.1016/j.tem.2009.12.006; Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Tong WH, 2003, P NATL ACAD SCI USA, V100, P9762, DOI 10.1073/pnas.1732541100; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08	37	26	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23358	23367		10.1074/jbc.M113.486878	http://dx.doi.org/10.1074/jbc.M113.486878			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23798678	Green Published, hybrid			2022-12-25	WOS:000330598200040
J	Sato, M; Murakami, K; Uno, M; Nakagawa, Y; Katayama, S; Akagi, K; Masuda, Y; Takegoshi, K; Irie, K				Sato, Mizuho; Murakami, Kazuma; Uno, Mayumi; Nakagawa, Yu; Katayama, Sumie; Akagi, Ken-ichi; Masuda, Yuichi; Takegoshi, Kiyonori; Irie, Kazuhiro			Site-specific Inhibitory Mechanism for Amyloid beta 42 Aggregation by Catechol-type Flavonoids Targeting the Lys Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; ALZHEIMERS-DISEASE; FIBRIL FORMATION; A-BETA; OXIDATIVE STRESS; PROTEIN OLIGOMERIZATION; SECONDARY STRUCTURE; MOLECULAR TWEEZERS; PLAQUE BURDEN; MOUSE MODEL	The aggregation of the 42-residue amyloid beta-protein (A beta 42) is involved in the pathogenesis of Alzheimer disease (AD). Numerous flavonoids exhibit inhibitory activity against A beta 42 aggregation, but their mechanism remains unclear in the molecular level. Here we propose the site-specific inhibitory mechanism of (+)-taxifolin, a catechol-type flavonoid, whose 3',4'-dihydroxyl groups of the B-ring plays a critical role. Addition of sodium periodate, an oxidant, strengthened suppression of A beta 42 aggregation by (+)-taxifolin, whereas no inhibition was observed under anaerobic conditions, suggesting the inhibition to be associated with the oxidation to form o-quinone. Because formation of the A beta 42-taxifolin adduct was suggested by mass spectrometry, A beta 42 mutants substituted at Arg(5), Lys(16), and/or Lys(28) with norleucine (Nle) were prepared to identify the residues involved in the conjugate formation. (+)-Taxifolin did not suppress the aggregation of A beta 42 mutants at Lys(16) and/or Lys(28) except for the mutant at Arg(5). In addition, the aggregation of A beta 42 was inhibited by other catechol-type flavonoids, whereas that of K16Nle-A beta 42 was not. In contrast, some non-catechol-type flavonoids suppressed the aggregation of K16Nle-A beta 42 as well as A beta 42. Furthermore, interaction of (+)-taxifolin with the beta-sheet region in A beta 42 was not observed using solid-state NMR unlike curcumin of the non-catechol-type. These results demonstrate that catechol-type flavonoids could specifically suppress A beta 42 aggregation by targeting Lys residues. Although the anti-AD activity of flavonoids has been ascribed to their antioxidative activity, the mechanism that the o-quinone reacts with Lys residues of A beta 42 might be more intrinsic. The Lys residues could be targets for Alzheimer disease therapy.	[Sato, Mizuho; Murakami, Kazuma; Uno, Mayumi; Nakagawa, Yu; Irie, Kazuhiro] Kyoto Univ, Div Food Sci & Biotechnol, Grad Sch Agr, Kyoto 6068502, Japan; [Masuda, Yuichi; Takegoshi, Kiyonori] Kyoto Univ, Dept Chem, Grad Sch Sci, Kyoto 6068502, Japan; [Nakagawa, Yu] RIKEN Adv Sci Inst, Synthet Cellular Chem Lab, Wako, Saitama 3510198, Japan; [Katayama, Sumie; Akagi, Ken-ichi] Natl Inst Biomed Innovat, Osaka 5670085, Japan; [Masuda, Yuichi] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan	Kyoto University; Kyoto University; RIKEN; National Institute of Health Sciences - Japan; Tohoku University	Irie, K (corresponding author), Kitashirakawa Oiwake Cho,Sakyo Ku, Kyoto 6068502, Japan.	irie@kais.kyoto-u.ac.jp	Murakami, Kazuma/GQA-7062-2022; Irie, Kazuhiro/A-6121-2014	Murakami, Kazuma/0000-0003-3152-1784; Irie, Kazuhiro/0000-0001-7109-8568; Takegoshi, Kiyonori/0000-0002-4613-2987; AKAGI, Ken-ichi/0000-0002-7051-4598	Ministry of Education, Culture, Sports, Science and Technology, Japan [21248015, 22603006, 22.4068]; Asahi Beer Science Promotion Foundation; Kato Memorial Bioscience Foundation; Grants-in-Aid for Scientific Research [21248015] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Asahi Beer Science Promotion Foundation; Kato Memorial Bioscience Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research (A) 21248015 (to K. I.) and (C) 22603006 (to K. M.), and Promotion of Science for Young Scientists Grant 22.4068 (to M. S.) from The Ministry of Education, Culture, Sports, Science and Technology, Japan, and by funds from the Asahi Beer Science Promotion Foundation (to K. I.) and Kato Memorial Bioscience Foundation (to K.M.).	Abelein A, 2012, BIOCHEMISTRY-US, V51, P126, DOI 10.1021/bi201745g; Akaishi T, 2008, NEUROSCI LETT, V444, P280, DOI 10.1016/j.neulet.2008.08.052; Attar A, 2012, BRAIN, V135, P3735, DOI 10.1093/brain/aws289; BOOTH AN, 1958, J AM PHARM ASSOC, V47, P183, DOI 10.1002/jps.3030470310; Bruschweiler R, 2004, J CHEM PHYS, V121, P409, DOI 10.1063/1.1755652; FIELDS CG, 1989, INT J PEPT PROT RES, V33, P298; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GRAHAM DG, 1977, J BIOL CHEM, V252, P5729; Gravitz L, 2011, NATURE, V475, pS9, DOI 10.1038/475S9a; Grill JD, 2010, EXPERT REV NEUROTHER, V10, P711, DOI [10.1586/ern.10.29, 10.1586/ERN.10.29]; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; Hou LM, 2002, J BIOL CHEM, V277, P40173, DOI 10.1074/jbc.C200338200; Irie K, 1998, J AM CHEM SOC, V120, P9159, DOI 10.1021/ja981087f; Ishii T, 2008, FREE RADICAL BIO MED, V45, P1384, DOI 10.1016/j.freeradbiomed.2008.07.023; Jeon SH, 2008, ARCH PHARM RES, V31, P978, DOI 10.1007/s12272-001-1255-9; Keshet B, 2010, PROTEIN SCI, V19, P2291, DOI 10.1002/pro.509; Kiehlmann E, 2003, J NAT PROD, V66, P1562, DOI 10.1021/np034005w; Kim NC, 2003, ORG BIOMOL CHEM, V1, P1684, DOI 10.1039/b300099k; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Kostyuk VA, 2003, FEBS LETT, V537, P146, DOI 10.1016/S0014-5793(03)00113-3; Kulic L, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.109; KUROYANAGI M, 1982, CHEM PHARM BULL, V30, P1602; LeVine H, 2012, BIOCHEMISTRY-US, V51, P307, DOI 10.1021/bi201288x; Li F, 2004, J NEUROCHEM, V89, P1308, DOI 10.1111/j.1471-4159.2004.02455.x; Lopez del Amo JM, 2012, J MOL BIOL, V421, P517, DOI 10.1016/j.jmb.2012.01.013; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Masuda Y, 2011, BIOORGAN MED CHEM, V19, P5967, DOI 10.1016/j.bmc.2011.08.052; Masuda Y, 2009, CHEMBIOCHEM, V10, P287, DOI 10.1002/cbic.200800411; Mecocci P, 2012, BBA-MOL BASIS DIS, V1822, P631, DOI 10.1016/j.bbadis.2011.10.006; MORAZZONI P, 1993, EUR J DRUG METAB PH, V18, P289, DOI 10.1007/BF03188811; Morimoto A, 2004, J BIOL CHEM, V279, P52781, DOI 10.1074/jbc.M406262200; Murakami K, 2002, BIOCHEM BIOPH RES CO, V294, P5, DOI 10.1016/S0006-291X(02)00430-8; Murakami K, 2005, J AM CHEM SOC, V127, P15168, DOI 10.1021/ja054041c; Murakami K, 2003, J BIOL CHEM, V278, P46179, DOI 10.1074/jbc.M301874200; Murakami K, 2011, J BIOL CHEM, V286, P44557, DOI 10.1074/jbc.M111.279208; Murakami K, 2010, ACS CHEM NEUROSCI, V1, P747, DOI 10.1021/cn100072e; Murata N, 2010, BIOSCI BIOTECH BIOCH, V74, P2299, DOI 10.1271/bbb.100524; Naiki H, 1999, METHOD ENZYMOL, V309, P305; Ono K, 2006, BBA-MOL BASIS DIS, V1762, P575, DOI 10.1016/j.bbadis.2006.03.002; Ono K, 2012, J BIOL CHEM, V287, P14631, DOI 10.1074/jbc.M111.325456; Palhano FL, 2013, J AM CHEM SOC, V135, P7503, DOI 10.1021/ja3115696; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Roschek B, 2009, PHYTOCHEMISTRY, V70, P1255, DOI 10.1016/j.phytochem.2009.06.003; Rossi L, 2008, NEUROCHEM RES, V33, P2390, DOI 10.1007/s11064-008-9696-7; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Sato M, 2013, BIOSCI BIOTECH BIOCH, V77, P1100, DOI 10.1271/bbb.120925; Sayre LM, 2008, CHEM RES TOXICOL, V21, P172, DOI 10.1021/tx700210j; Sinha S, 2012, ACS CHEM NEUROSCI, V3, P473, DOI 10.1021/cn3000247; Sinha S, 2011, J AM CHEM SOC, V133, P16958, DOI 10.1021/ja206279b; Soejima N, 2013, CURR ALZHEIMER RES, V10, P11; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Trbovic N, 2004, J MAGN RESON, V171, P277, DOI 10.1016/j.jmr.2004.08.007; Ushikubo H, 2012, NEUROSCI LETT, V513, P51, DOI 10.1016/j.neulet.2012.02.006; VALENZUELA A, 1985, BIOCHEM BIOPH RES CO, V126, P712, DOI 10.1016/0006-291X(85)90243-8; Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274; Vega-Villa KR, 2009, BIOMED CHROMATOGR, V23, P638, DOI 10.1002/bmc.1165; Vu TH, 2010, J BIOSCI BIOENG, V109, P629, DOI 10.1016/j.jbiosc.2009.11.010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wiejak S, 1999, CHEM PHARM BULL, V47, P1489; Williams RJ, 2012, FREE RADICAL BIO MED, V52, P35, DOI 10.1016/j.freeradbiomed.2011.09.010; Yanagisawa D, 2010, BIOMATERIALS, V31, P4179, DOI 10.1016/j.biomaterials.2010.01.142; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Youdim KA, 2004, FREE RADICAL BIO MED, V37, P1683, DOI 10.1016/j.freeradbiomed.2004.08.002; Zhu M, 2004, J BIOL CHEM, V279, P26846, DOI 10.1074/jbc.M403129200	66	157	161	1	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23212	23224		10.1074/jbc.M113.464222	http://dx.doi.org/10.1074/jbc.M113.464222			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23792961	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000330598200028
J	Florencio, DF; Marins, A; Rosa, CS; Cristaldo, PF; Araujo, PA; Silva, IR; DeSouza, O				Florencio, Daniela Faria; Marins, Alessandra; Rosa, Cassiano Sousa; Cristaldo, Paulo Fellipe; Araujo, Paula Albano; Silva, Ivo Ribeiro; DeSouza, Og			Diet Segregation between Cohabiting Builder and Inquiline Termite Species	PLOS ONE			English	Article							CORNITERMES-CUMULANS ISOPTERA; NATIONAL-PARK; ECOLOGY; COMMUNITIES; COEXISTENCE; COMPETITION; EVOLUTION; ISOTOPES; POSITION; SAVANNA	How do termite inquilines manage to cohabit termitaria along with the termite builder species? With this in mind, we analysed one of the several strategies that inquilines could use to circumvent conflicts with their hosts, namely, the use of distinct diets. We inspected overlapping patterns for the diets of several cohabiting Neotropical termite species, as inferred from carbon and nitrogen isotopic signatures for termite individuals. Cohabitant communities from distinct termitaria presented overlapping diet spaces, indicating that they exploited similar diets at the regional scale. When such communities were split into their components, full diet segregation could be observed between builders and inquilines, at regional (environment-wide) and local (termitarium) scales. Additionally, diet segregation among inquilines themselves was also observed in the vast majority of inspected termitaria. Inquiline species distribution among termitaria was not random. Environmental-wide diet similarity, coupled with local diet segregation and deterministic inquiline distribution, could denounce interactions for feeding resources. However, inquilines and builders not sharing the same termitarium, and thus not subject to potential conflicts, still exhibited distinct diets. Moreover, the areas of the builder's diet space and that of its inquilines did not correlate negatively. Accordingly, the diet areas of builders which hosted inquilines were in average as large as the areas of builders hosting no inquilines. Such results indicate the possibility that dietary partitioning by these cohabiting termites was not majorly driven by current interactive constraints. Rather, it seems to be a result of traits previously fixed in the evolutionary past of cohabitants.	[Florencio, Daniela Faria; Marins, Alessandra; Rosa, Cassiano Sousa; Cristaldo, Paulo Fellipe; DeSouza, Og] Univ Fed Vicosa, Dept Entomol, Lab Termitol, Vicosa, MG, Brazil; [Florencio, Daniela Faria] Univ Fed Santa Catarina, Dept Bioquim, Curitibanos, Santa Catarina, Brazil; [Marins, Alessandra] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Rosa, Cassiano Sousa] Univ Estado Minas Gerais, Fac Engn, Joao Monlevade, MG, Brazil; [Araujo, Paula Albano] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Infochem Res Team, Prague, Czech Republic; [Araujo, Paula Albano] Univ Fed Sergipe, Sao Cristovao, Sergipe, Brazil; [Silva, Ivo Ribeiro] Univ Fed Vicosa, Dept Solos, Lab Isotopos Estaveis, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Santa Catarina (UFSC); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universidade do Estado de Minas Gerais; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Universidade Federal de Sergipe; Universidade Federal de Vicosa	DeSouza, O (corresponding author), Univ Fed Vicosa, Dept Entomol, Lab Termitol, Vicosa, MG, Brazil.	og.souza@ufv.br	DeSouza, Og/A-7140-2008; Rosa, Cassiano S/A-1780-2011; Cristaldo, Paulo/A-1247-2013; Marins, Alessandra/G-1334-2014	DeSouza, Og/0000-0002-7108-0242; Rosa, Cassiano S/0000-0003-3294-5677; Cristaldo, Paulo/0000-0003-4939-0487; Marins, Alessandra/0000-0002-6233-110X; Albano Araujo, Ana P./0000-0001-7853-8001	Brazilian National Council for Research (CNPq) [140085/2010-6, 142551/2008-2, 150362/2012-9, 302486/2010-0, PQ-2, 200271/2010, PQ-1D]; Coordination for the Improvement of Higher Education Personnel (CAPES) [PDSE 9669/11-6]; Minas Gerais State Foundation for Research Support (FAPEMIG) [CRA-APQ-02124-09, BPD-00135-10, CRA-APQ-01519-11, BPV-00055-11]	Brazilian National Council for Research (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Minas Gerais State Foundation for Research Support (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	The Brazilian National Council for Research (CNPq) provided financial support to the following coauthors: AM (SwB posdoctoral grant), PFC (doctoral grant 140085/2010-6), CSR (doctoral grant 142551/2008-2 and posdoctoral grant 150362/2012-9), ODS (fellowship 302486/2010-0, PQ-2 and grant 200271/2010), IRS (fellowship PQ-1D). The Coordination for the Improvement of Higher Education Personnel (CAPES) supported PFC (PDSE 9669/11-6) and DFF (CAPES/REUNI). The Minas Gerais State Foundation for Research Support (FAPEMIG) supported AM (doctoral grand) and funded significant parts of field and lab work through grants CRA-APQ-02124-09, BPD-00135-10, CRA-APQ-01519-11, and BPV-00055-11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agritempo, 2009, SIST MON AGR; Araujo R. L., 1970, P527; Bouillon A., 1970, P153; Bourguignon T, 2011, ECOL ENTOMOL, V36, P261, DOI 10.1111/j.1365-2311.2011.01265.x; Bourguignon T, 2009, SOIL BIOL BIOCHEM, V41, P2038, DOI 10.1016/j.soilbio.2009.07.005; Brightsmith DJ, 2000, CONDOR, V102, P529, DOI 10.1650/0010-5422(2000)102[0529:UOATBN]2.0.CO;2; Chase J.M., 2009, ECOLOGICAL NICHES LI; COLES HR, 1980, THESIS U SOUTHAMPTON; CONNELL JH, 1980, OIKOS, V35, P131, DOI 10.2307/3544421; CONSTANTINO R., 2002, ZOOTAXA, V67, P1, DOI [10.11646/zootaxa.67.1.1, DOI 10.11646/zootaxa.67.1.1, DOI 10.11646/ZOOTAXA.67.1.1]; Costa Cleide, 2010, Psyche (Cambridge), V2010, P1; Costa DA, 2009, SOCIOBIOLOGY, V53, P443; COUTINHO LM, 1990, ECOL STU AN, V84, P82; Crawley MJ., 2007, R BOOK; Cristaldo PF, 2012, INSECT SOC, V59, P541, DOI 10.1007/s00040-012-0249-3; Darlington JPEC, 2012, INSECT SOC, V59, P159, DOI 10.1007/s00040-011-0199-1; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; De Visser SN, 2008, ECOL ENTOMOL, V33, P758, DOI 10.1111/j.1365-2311.2008.01029.x; Dechmann DKN, 2004, EVOL ECOL RES, V6, P1037; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DeSouza O, 2003, SOCIOBIOLOGY, V42, P639; DeSouza O, 2009, B ENTOMOL RES, V99, P603, DOI 10.1017/S000748530900666X; Eggers T, 2000, TRENDS ECOL EVOL, V15, P265, DOI 10.1016/S0169-5347(00)01877-2; Fargione J, 2005, OECOLOGIA, V143, P598, DOI 10.1007/s00442-005-0010-y; Fry B., 2006, STABLE ISOTOPE ECOLO; Grasse P, 1986, TERMITOLOGIA, VIII, P235; HARRIS RN, 1995, ANIM BEHAV, V50, P1309, DOI 10.1016/0003-3472(95)80046-8; Hines HM, 2010, INSECT SOC, V57, P379, DOI 10.1007/s00040-010-0094-1; Hubbell Stephen P., 2001, V32, pi; Inward D, 2007, BIOL LETTERS, V3, P331, DOI 10.1098/rsbl.2007.0102; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jouquet P, 2002, INSECT SOC, V49, P1, DOI 10.1007/s00040-002-8269-z; Junqueira Domingos Denize, 1996, Revista Brasileira de Biologia, V56, P717; Kalshoven LGE, 1954, INSECT SOC, V1, P319; KISTNER DH, 1990, SOCIOBIOLOGY, V17, P191; Kneitel JM, 2004, ECOL LETT, V7, P69, DOI 10.1046/j.1461-0248.2003.00551.x; Korb J, 2002, INSECT SOC, V49, P264, DOI 10.1007/s00040-002-8312-0; Korb J, 2001, OECOLOGIA, V127, P324, DOI 10.1007/s004420000597; Korb J, 2001, AFR J ECOL, V39, P257, DOI 10.1046/j.1365-2028.2001.00312.x; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Kronland WJ, 2007, WILSON J ORNITHOL, V119, P486, DOI 10.1676/05-139.1; LEE K. E., 1971, TERMITES AND SOIL; Lo N, 2007, BIOL LETTERS, V3, P562, DOI 10.1098/rsbl.2007.0264; Mason NWH, 2008, J ANIM ECOL, V77, P661, DOI 10.1111/j.1365-2656.2008.01379.x; Mathews A. G. A., 1977, STUDIES TERMITES MAT; Noirot C., 1970, P73; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Perdereau E, 2011, BIOL INVASIONS, V13, P1457, DOI 10.1007/s10530-010-9906-5; Pierce NE, 2002, ANNU REV ENTOMOL, V47, P733, DOI 10.1146/annurev.ento.47.091201.145257; R Development Core Team, 2012, R LANG ENV STAT COMP; REDFORD KH, 1984, BIOTROPICA, V16, P112, DOI 10.2307/2387842; Sarty M, 2007, INSECT SOC, V54, P166, DOI 10.1007/s00040-007-0927-8; Schonrogge K, 2006, ECOL LETT, V9, P1032, DOI 10.1111/j.1461-0248.2006.00957.x; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Tillberg CV, 2007, P NATL ACAD SCI USA, V104, P20856, DOI 10.1073/pnas.0706903105; Vander Zanden MJ, 2000, CAN J FISH AQUAT SCI, V57, P725, DOI 10.1139/cjfas-57-4-725; Vasconcellos A, 2007, NEOTROP ENTOMOL, V36, P693, DOI 10.1590/S1519-566X2007000500009	57	26	26	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66535	10.1371/journal.pone.0066535	http://dx.doi.org/10.1371/journal.pone.0066535			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805229	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500057
J	Kavanaugh, DW; O'Callaghan, J; Butto, LF; Slattery, H; Lane, J; Clyne, M; Kane, M; Joshi, L; Hickey, RM				Kavanaugh, Devon W.; O'Callaghan, John; Butto, Ludovica F.; Slattery, Helen; Lane, Jonathan; Clyne, Marguerite; Kane, Marian; Joshi, Lokesh; Hickey, Rita M.			Exposure of Bifidobacterium longum subsp infantis to Milk Oligosaccharides Increases Adhesion to Epithelial Cells and Induces a Substantial Transcriptional Response	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; BOTTLE-FED INFANTS; IN-VITRO; HELICOBACTER-PYLORI; CACO-2 CELLS; INTESTINAL MICROFLORA; HAEMOPHILUS-DUCREYI; BACTERIAL ADHESION; HUMAN ENTEROCYTE; STRAINS	In this study, we tested the hypothesis that milk oligosaccharides may contribute not only to selective growth of bifidobacteria, but also to their specific adhesive ability. Human milk oligosaccharides (3'sialyllactose and 6'sialyllactose) and a commercial prebiotic (Beneo Orafti P95; oligofructose) were assayed for their ability to promote adhesion of Bifidobacterium longum subsp. infantis ATCC 15697 to HT-29 and Caco-2 human intestinal cells. Treatment with the commercial prebiotic or 3'sialyllactose did not enhance adhesion. However, treatment with 6'sialyllactose resulted in increased adhesion (4.7 fold), while treatment with a mixture of 3'- and 6'-sialyllactose substantially increased adhesion (9.8 fold) to HT-29 intestinal cells. Microarray analyses were subsequently employed to investigate the transcriptional response of B. longum subsp. infantis to the different oligosaccharide treatments. This data correlated strongly with the observed changes in adhesion to HT-29 cells. The combination of 3'- and 6'-sialyllactose resulted in the greatest response at the genetic level (both in diversity and magnitude) followed by 6'sialyllactose, and 3'sialyllactose alone. The microarray data was further validated by means of real-time PCR. The current findings suggest that the increased adherence phenotype of Bifidobacterium longum subsp. infantis resulting from exposure to milk oligosaccharides is multi-faceted, involving transcription factors, chaperone proteins, adhesion-related proteins, and a glycoside hydrolase. This study gives additional insight into the role of milk oligosaccharides within the human intestine and the molecular mechanisms underpinning host-microbe interactions.	[Kavanaugh, Devon W.; O'Callaghan, John; Slattery, Helen; Lane, Jonathan; Hickey, Rita M.] Teagasc Food Res Ctr, Dept Biosci, Cork, Ireland; [Kavanaugh, Devon W.; Clyne, Marguerite; Kane, Marian; Joshi, Lokesh; Hickey, Rita M.] Natl Univ Ireland, Glycosci Grp, Natl Ctr Biomed Engn Sci, Galway, Ireland; [Butto, Ludovica F.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Butto, Ludovica F.] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Clyne, Marguerite] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland	Teagasc; Ollscoil na Gaillimhe-University of Galway; University College Cork; University College Cork; University College Dublin	Hickey, RM (corresponding author), Teagasc Food Res Ctr, Dept Biosci, Moorepk, Cork, Ireland.	rita.hickey@teagasc.ie	O'Callaghan, John/G-6242-2014; Hickey, Rita/AAY-7875-2021; Clyne, Marguerite M/H-4179-2012; Butto, Ludovica/P-1882-2019	O'Callaghan, John/0000-0002-1522-4512; Clyne, Marguerite M/0000-0003-2547-9129; Kavanaugh, Devon/0000-0001-8831-8248; Joshi, Lokesh/0000-0002-3612-0747	Teagasc Walsh Fellowship; Science Foundation Ireland [08/SRC/B1393]; Alimentary Glycoscience Research Cluster (AGRC)	Teagasc Walsh Fellowship; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Alimentary Glycoscience Research Cluster (AGRC)(Science Foundation Ireland)	Devon Kavanaugh is in receipt of a Teagasc Walsh Fellowship. The authors would also like to acknowledge the support of Science Foundation Ireland under Grant No. 08/SRC/B1393 and the Alimentary Glycoscience Research Cluster (AGRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali QS, 2009, P WORLD ACAD SCI ENG, V9, P149; Asakuma S, 2007, BIOSCI BIOTECH BIOCH, V71, P1447, DOI 10.1271/bbb.60529; BENNO Y, 1984, MICROBIOL IMMUNOL, V28, P975, DOI 10.1111/j.1348-0421.1984.tb00754.x; Bergonzelli GE, 2006, INFECT IMMUN, V74, P425, DOI 10.1128/IAI.74.1.425-434.2006; BERNET MF, 1993, APPL ENVIRON MICROB, V59, P4121, DOI 10.1128/AEM.59.12.4121-4128.1993; Bezirtzoglou E, 1997, ANAEROBE, V3, P173, DOI 10.1006/anae.1997.0102; Boehm G, 2007, J NUTR, V137, p847S, DOI 10.1093/jn/137.3.847S; Brentjens RJ, 1996, J BACTERIOL, V178, P808, DOI 10.1128/jb.178.3.808-816.1996; Candela M, 2005, RES MICROBIOL, V156, P887, DOI 10.1016/j.resmic.2005.04.006; Candela M, 2010, MICROBIOL-SGM, V156, P1609, DOI 10.1099/mic.0.038307-0; Charlebois RL, 2004, GENOME RES, V14, P2469, DOI 10.1101/gr.3024704; Chichlowski M, 2012, J PEDIATR GASTR NUTR, V55, P321, DOI 10.1097/MPG.0b013e31824fb899; Chopra DP, 2010, STEM CELLS DEV, V19, P131, DOI 10.1089/scd.2009.0109; COCONNIER MH, 1992, APPL ENVIRON MICROB, V58, P2034, DOI 10.1128/AEM.58.6.2034-2039.1992; Cooksley C, 2003, J MED MICROBIOL, V52, P461, DOI 10.1099/jmm.0.05070-0; CROCIANI J, 1995, LETT APPL MICROBIOL, V21, P146, DOI 10.1111/j.1472-765X.1995.tb01027.x; Del Re B, 2000, LETT APPL MICROBIOL, V31, P438, DOI 10.1046/j.1365-2672.2000.00845.x; Dunn BE, 1997, INFECT IMMUN, V65, P1181, DOI 10.1128/IAI.65.4.1181-1188.1997; Dussurget O, 2005, FEMS MICROBIOL LETT, V250, P253, DOI 10.1016/j.femsle.2005.07.015; Engfer MB, 2000, AM J CLIN NUTR, V71, P1589; Foroni E, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S16; Frisk A, 1998, INFECT IMMUN, V66, P1252, DOI 10.1128/IAI.66.3.1252-1257.1998; Garrido D, 2012, ANAEROBE, V18, P430, DOI 10.1016/j.anaerobe.2012.04.012; Garrido D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017315; GILLIS TP, 1985, INFECT IMMUN, V49, P371, DOI 10.1128/IAI.49.2.371-377.1985; Gleinser M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-80; Gnoth MJ, 2000, J NUTR, V130, P3014, DOI 10.1093/jn/130.12.3014; Gonzalez R, 2008, APPL ENVIRON MICROB, V74, P4686, DOI 10.1128/AEM.00122-08; Halsey TA, 2004, INFECT IMMUN, V72, P1155, DOI 10.1128/IAI.72.2.1155-1158.2004; Hennequin C, 2001, MICROBIOL-UK, V147, P87, DOI 10.1099/00221287-147-1-87; Kiyohara M, 2009, BIOSCI BIOTECH BIOCH, V73, P1175, DOI 10.1271/bbb.80697; Lane JI, 2010, TEMPORAL BONE, P1, DOI 10.1007/978-3-642-02210-4_1; Langerholc T, 2011, TRENDS FOOD SCI TECH, V22, pS11, DOI 10.1016/j.tifs.2011.03.010; Laparra JM, 2009, LETT APPL MICROBIOL, V49, P695, DOI 10.1111/j.1472-765X.2009.02729.x; Leahy SC, 2005, J APPL MICROBIOL, V98, P1303, DOI 10.1111/j.1365-2672.2005.02600.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locascio RG, 2007, J AGR FOOD CHEM, V55, P8914, DOI 10.1021/jf0710480; LoCascio RG, 2010, APPL ENVIRON MICROB, V76, P7373, DOI 10.1128/AEM.00675-10; Marcobal A, 2010, J AGR FOOD CHEM, V58, P5334, DOI 10.1021/jf9044205; MEVISSENVERHAGE EAE, 1987, J CLIN MICROBIOL, V25, P285, DOI 10.1128/JCM.25.2.285-289.1987; Moss AC, 2007, GUT, V56, P1210, DOI 10.1136/gut.2006.110668; Motherway MO, 2011, P NATL ACAD SCI USA, V108, P11217, DOI 10.1073/pnas.1105380108; Mukai T, 1997, CURR MICROBIOL, V34, P326, DOI 10.1007/s002849900190; Preising J, 2010, APPL ENVIRON MICROB, V76, P3048, DOI 10.1128/AEM.03127-09; Remus DM, 2013, J BACTERIOL, V195, P502, DOI 10.1128/JB.01321-12; Riedel CU, 2006, INT J FOOD MICROBIOL, V110, P62, DOI 10.1016/j.ijfoodmicro.2006.01.040; Savage DC, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P19, DOI 10.1016/B978-012491543-5/50006-1; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Sela DA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193359; Sela DA, 2011, INT J FOOD MICROBIOL, V149, P58, DOI 10.1016/j.ijfoodmicro.2011.01.025; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Tomich M, 2007, NAT REV MICROBIOL, V5, P363, DOI 10.1038/nrmicro1636; van Pijkeren JP, 2006, APPL ENVIRON MICROB, V72, P4143, DOI 10.1128/AEM.03023-05; Ventura M, 2004, APPL ENVIRON MICROB, V70, P6197, DOI 10.1128/AEM.70.10.6197-6209.2004; Ward RE, 2007, MOL NUTR FOOD RES, V51, P1398, DOI 10.1002/mnfr.200700150; Ward RE, 2006, APPL ENVIRON MICROB, V72, P4497, DOI 10.1128/AEM.02515-05; Zivkovic AM, 2011, P NATL ACAD SCI USA, V108, P4653, DOI 10.1073/pnas.1000083107; Zocco MA, 2007, DIGEST LIVER DIS, V39, P707, DOI 10.1016/j.dld.2007.04.003	58	69	71	5	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67224	10.1371/journal.pone.0067224	http://dx.doi.org/10.1371/journal.pone.0067224			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805302	Green Submitted, Green Published, gold			2022-12-25	WOS:000320846500130
J	Lin, XW; Xu, WC; Luo, JG; Guo, XJ; Sun, T; Zhao, XL; Fu, ZJ				Lin, Xiao-Wen; Xu, Wei-Cheng; Luo, Jian-Gang; Guo, Xue-Jiao; Sun, Tao; Zhao, Xu-Li; Fu, Zhi-Jian			WW Domain Containing E3 Ubiquitin Protein Ligase 1 (WWP1) Negatively Regulates TLR4-Mediated TNF-alpha and IL-6 Production by Proteasomal Degradation of TNF Receptor Associated Factor 6 (TRAF6)	PLOS ONE			English	Article							NF-KAPPA-B; SIGNALING PATHWAYS; ADAPTER PROTEIN; BREAST-CANCER; FAMILY; IMMUNITY; ACTIVATION; EXPRESSION; TARGETS; TLR4	Background: Toll-like receptors (TLRs) play a pivotal role in the defense against invading pathogens by detecting pathogen-associated molecular patterns (PAMPs). TLR4 recognizes lipopolysaccharides (LPS) in the cell walls of Gram-negative bacteria, resulting in the induction and secretion of proinflammatory cytokines such as TNF-alpha and IL-6. The WW domain containing E3 ubiquitin protein ligase 1 (WWP1) regulates a variety of cellular biological processes. Here, we investigated whether WWP1 acts as an E3 ubiquitin ligase in TLR-mediated inflammation. Methodology/Results: Knocking down WWP1 enhanced the TNF-alpha and IL-6 production induced by LPS, and overexpression of WWP1 inhibited the TNF-alpha and IL-6 production induced by LPS, but not by TNF-alpha. WWP1 also inhibited the I kappa B-alpha, NF-kappa B, and MAPK activation stimulated by LPS. Additionally, WWP1 could degrade TRAF6, but not IRAK1, in the proteasome pathway, and knocking down WWP1 reduced the LPS-induced K48-linked, but not K63-linked, polyubiquitination of endogenous TRAF6. Conclusions/Significance: We identified WWP1 as an important negative regulator of TLR4-mediated TNF-alpha and IL-6 production. We also showed that WWP1 functions as an E3 ligase when cells are stimulated with LPS by binding to TRAF6 and promoting K48-linked polyubiquitination. This results in the proteasomal degradation of TRAF6.	[Lin, Xiao-Wen; Luo, Jian-Gang; Guo, Xue-Jiao; Sun, Tao; Zhao, Xu-Li; Fu, Zhi-Jian] Shandong Univ, Dept Pain Management, Prov Hosp, Jinan 250100, Peoples R China; [Xu, Wei-Cheng] Shandong Univ, Dept Orthoped, Prov Hosp, Jinan 250100, Peoples R China	Shandong University; Shandong University	Fu, ZJ (corresponding author), Shandong Univ, Dept Pain Management, Prov Hosp, Jinan 250100, Peoples R China.	zhijian_fu@163.com			National Natural Science Foundation of China [81271346, 30972844]; Independent Innovation Foundation of Shandong University [21300072613161]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Innovation Foundation of Shandong University	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 81271346, 30972844) and the Independent Innovation Foundation of Shandong University (21300072613161). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Chen C, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00429.x; Chen C, 2007, ONCOGENE, V26, P2386, DOI 10.1038/sj.onc.1210021; Chen C, 2007, INT J CANCER, V121, P2834; Chen C, 2007, CANCER METAST REV, V26, P587, DOI 10.1007/s10555-007-9091-x; Edwards TL, 2009, BIOCHEM J, V423, P31, DOI 10.1042/BJ20082398; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fukuchi M, 2002, CANCER RES, V62, P7162; Hoshino K, 1999, J IMMUNOL, V162, P3749; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Kawai T, 2011, EMBO MOL MED, V3, P513, DOI 10.1002/emmm.201100160; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lee JO, 2013, J BIOL CHEM, V288, P4673, DOI 10.1074/jbc.M112.406009; Li Y, 2008, CELL DEATH DIFFER, V15, P1941, DOI 10.1038/cdd.2008.134; Li Y, 2009, ONCOGENE, V28, P2948, DOI 10.1038/onc.2009.162; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Roach JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054156; Shembade N, 2007, EMBO J, V26, P3910, DOI 10.1038/sj.emboj.7601823; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Subik K, 2012, BONE, V50, P813, DOI 10.1016/j.bone.2011.12.022; Suzuki A, 2008, CANCER SCI, V99, P986, DOI 10.1111/j.1349-7006.2008.00779.x; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Yang Y, 2013, P NATL ACAD SCI USA, V110, P5115, DOI 10.1073/pnas.1220271110; Zhang XL, 2004, BIOCHEM BIOPH RES CO, V316, P139, DOI 10.1016/j.bbrc.2004.02.033; Zhi X, 2012, CELL MOL LIFE SCI, V69, P1425, DOI 10.1007/s00018-011-0871-7	33	22	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e67633	10.1371/journal.pone.0067633	http://dx.doi.org/10.1371/journal.pone.0067633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799152	Green Submitted, gold, Green Published			2022-12-25	WOS:000321397800050
J	Liu, Y; Wang, L; Long, ZY; Wu, YM; Wan, Q; Jiang, JX; Wang, ZG				Liu, Yuan; Wang, Li; Long, Zai-yun; Wu, Ya-min; Wan, Qi; Jiang, Jian-xin; Wang, Zheng-guo			Inhibiting PTEN Protects Hippocampal Neurons against Stretch Injury by Decreasing Membrane Translocation of AMPA Receptor GluR2 Subunit	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; IN-VITRO; SYNAPTIC-TRANSMISSION; GLUTAMATE; PLASTICITY; MECHANISMS; ISCHEMIA; SUSCEPTIBILITY; PERMEABILITY; INCREASES	The AMPA type of glutamate receptors (AMPARs)-mediated excitotoxicity is involved in the secondary neuronal death following traumatic brain injury (TBI). But the underlying cellular and molecular mechanisms remain unclear. In this study, the role of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) in GluR2-lacking AMPARs mediated neuronal death was investigated through an in vitro stretch injury model of neurons. It was indicated that both the mRNA and protein levels of PTEN were increased in cultured hippocampal neurons after stretch injury, which was associated with the decreasing expression of GluR2 subunits on the surface of neuronal membrane. Inhibition of PTEN activity by its inhibitor can promote the survival of neurons through preventing reduction of GluR2 on membrane. Moreover, the effect of inhibiting GluR2-lacking AMPARs was similar to PTEN suppression-mediated neuroprotective effect in stretch injury-induced neuronal death. Further evidence identified that the total GluR2 protein of neurons was not changed in all groups. So inhibition of PTEN or blockage of GluR2-lacking AMPARs may attenuate the death of hippocampal neurons post injury through decreasing the translocation of GluR2 subunit on the membrane effectively.	[Liu, Yuan; Wang, Li; Long, Zai-yun; Wu, Ya-min; Jiang, Jian-xin; Wang, Zheng-guo] Third Mil Med Univ, Daping Hosp, State Key Lab Trauma Burns & Combined Injury, Dept Res Inst Surg, Chongqing, Peoples R China; [Wan, Qi] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA	Army Medical University; Nevada System of Higher Education (NSHE); University of Nevada Reno	Wang, ZG (corresponding author), Third Mil Med Univ, Daping Hosp, State Key Lab Trauma Burns & Combined Injury, Dept Res Inst Surg, Chongqing, Peoples R China.	zhengguowang1212@sina.com			National Natural Science Foundation of China [30728026]; Science funds of Chongqing [csct2012jjA10131]; funds of State Key Laboratory [SKLKF201109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science funds of Chongqing; funds of State Key Laboratory	This work was supported by a grant from the National Natural Science Foundation of China (#30728026), Science funds of Chongqing (csct2012jjA10131) and funds of State Key Laboratory (SKLKF201109). The National Natural Science Foundation of China (#30728026) had role in study design, data collection; Science funds of Chongqing (csct2012jjA10131) had role in data analysis; Funds of State Key Laboratory (SKLKF201109) had role in preparation of the manuscript.	Akimoto T, 2005, BIOCHEM BIOPH RES CO, V329, P381, DOI 10.1016/j.bbrc.2005.01.136; Alessandri B, 1998, PROG BRAIN RES, V116, P303, DOI 10.1016/S0079-6123(08)60445-8; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Bell JD, 2007, BRAIN, V130, P2528, DOI 10.1093/brain/awm164; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; Gary DS, 2002, NEUROMOL MED, V2, P261, DOI 10.1385/NMM:2:3:261; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Gorter JA, 1997, J NEUROSCI, V17, P6179; Greger IH, 2007, CURR OPIN NEUROBIOL, V17, P289, DOI 10.1016/j.conb.2007.04.007; Krassioukov AV, 2002, BRAIN RES PROTOC, V10, P60, DOI 10.1016/S1385-299X(02)00180-0; Kwak S, 2006, CURR OPIN NEUROBIOL, V16, P281, DOI 10.1016/j.conb.2006.05.004; Liu BS, 2006, J NEUROSCI, V26, P5309, DOI 10.1523/JNEUROSCI.0567-06.2006; Liu BS, 2010, STROKE, V41, P1018, DOI 10.1161/STROKEAHA.110.579011; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; Ning K, 2004, J NEUROSCI, V24, P4052, DOI 10.1523/JNEUROSCI.5449-03.2004; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Zhang QG, 2007, FEBS LETT, V581, P495, DOI 10.1016/j.febslet.2006.12.055	25	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65431	10.1371/journal.pone.0065431	http://dx.doi.org/10.1371/journal.pone.0065431			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799014	Green Published, Green Submitted, gold			2022-12-25	WOS:000321397800006
J	Meynard, CN; Migeon, A; Navajas, M				Meynard, Christine N.; Migeon, Alain; Navajas, Maria			Uncertainties in Predicting Species Distributions under Climate Change: A Case Study Using Tetranychus evansi (Acari: Tetranychidae), a Widespread Agricultural Pest	PLOS ONE			English	Article							GLOBAL FOOD SECURITY; PRESENCE-ONLY DATA; DISTRIBUTION MODELS; EVOLUTIONARY; PERFORMANCE; CHALLENGES; IMPACTS; THREATS; PLANT; BIODIVERSITY	Many species are shifting their distributions due to climate change and to increasing international trade that allows dispersal of individuals across the globe. In the case of agricultural pests, such range shifts may heavily impact agriculture. Species distribution modelling may help to predict potential changes in pest distributions. However, these modelling strategies are subject to large uncertainties coming from different sources. Here we used the case of the tomato red spider mite (Tetranychus evansi), an invasive pest that affects some of the most important agricultural crops worldwide, to show how uncertainty may affect forecasts of the potential range of the species. We explored three aspects of uncertainty: (1) species prevalence; (2) modelling method; and (3) variability in environmental responses between mites belonging to two invasive clades of T. evansi. Consensus techniques were used to forecast the potential range of the species under current and two different climate change scenarios for 2080, and variance between model projections were mapped to identify regions of high uncertainty. We revealed large predictive variations linked to all factors, although prevalence had a greater influence than the statistical model once the best modelling strategies were selected. The major areas threatened under current conditions include tropical countries in South America and Africa, and temperate regions in North America, the Mediterranean basin and Australia. Under future scenarios, the threat shifts towards northern Europe and some other temperate regions in the Americas, whereas tropical regions in Africa present a reduced risk. Analysis of niche overlap suggests that the current differential distribution of mites of the two clades of T. evansi can be partially attributed to environmental niche differentiation. Overall this study shows how consensus strategies and analysis of niche overlap can be used jointly to draw conclusions on invasive threat considering different sources of uncertainty in species distribution modelling.	[Meynard, Christine N.; Migeon, Alain; Navajas, Maria] UMR CBGP INRA IRD Cirad Montpellier SupAgro, INRA, Montferrier Sur Lez, France	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD)	Meynard, CN (corresponding author), UMR CBGP INRA IRD Cirad Montpellier SupAgro, INRA, Campus Int Baillarguet, Montferrier Sur Lez, France.	cnmeynard@gmail.com	NAVAJAS, Maria/AAM-2294-2020; Meynard, Christine N/B-2082-2010	NAVAJAS, Maria/0000-0002-0702-4238; Meynard, Christine N/0000-0002-5983-6289	INRA AAP-SPE project [470338]; Agence National de la Recherche [2010 BLAN 1715 02]; Programme BLANC-SVE7	INRA AAP-SPE project; Agence National de la Recherche(French National Research Agency (ANR)); Programme BLANC-SVE7	This work was partially funded by an INRA AAP-SPE project no470338 to CNM and by a grant from the Agence National de la Recherche (ID 2010 BLAN 1715 02) to MN, Programme BLANC-SVE7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; BAKER EDWARD W., 1960, HILGARDIA, V29, P455; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Barry S, 2006, J APPL ECOL, V43, P413, DOI 10.1111/j.1365-2664.2006.01136.x; Beale CM, 2012, PHILOS T R SOC B, V367, P247, DOI 10.1098/rstb.2011.0178; Boubou A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035601; Boubou A, 2011, BIOL INVASIONS, V13, P81, DOI 10.1007/s10530-010-9791-y; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Doledec S, 2000, ECOLOGY, V81, P2914, DOI 10.1890/0012-9658(2000)081[2914:NSICAA]2.0.CO;2; Duverney C, 2005, ESSAIS PRELIMINAIRES; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Garcia RA, 2012, GLOBAL CHANGE BIOL, V18, P1253, DOI 10.1111/j.1365-2486.2011.02605.x; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gotoh T, 2009, INT J ACAROL, V35, P485, DOI 10.1080/01647950903431156; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Howden SM, 2007, P NATL ACAD SCI USA, V104, P19691, DOI 10.1073/pnas.0701890104; Knapp M, 2003, AFR ENTOMOL, V11, P300; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Lenzen M, 2012, NATURE, V486, P109, DOI 10.1038/nature11145; Li WK, 2011, ECOGRAPHY, V34, P1096, DOI 10.1111/j.1600-0587.2011.06888.x; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobell D., 2007, ENV RES LETT; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lobo JM, 2011, J NAT CONSERV, V19, P1, DOI 10.1016/j.jnc.2010.03.002; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Marmion M, 2009, ECOL MODEL, V220, P3512, DOI 10.1016/j.ecolmodel.2008.10.019; Meynard CN, 2007, J BIOGEOGR, V34, P1455, DOI 10.1111/j.1365-2699.2007.01720.x; Meynard CN, 2013, J BIOGEOGR, V40, P1, DOI 10.1111/jbi.12006; Meynard CN, 2012, ECOL EVOL, V2, P1008, DOI 10.1002/ece3.219; Meynard CN, 2012, ECOGRAPHY, V35, P499, DOI 10.1111/j.1600-0587.2011.07157.x; Migeon A., 2006, SPIDER MITES WEB COM; Migeon A, 2009, EXP APPL ACAROL, V48, P199, DOI 10.1007/s10493-008-9229-8; Navajas M, 2012, EXPT APPL ACAROLOGY, P1; Navarro M, 2010, BIOTECH AGR IND MED, P149; Palevsky E, 2003, PHYTOPARASITICA, V31, P144, DOI 10.1007/BF02980784; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips S, 2012, ECOGRAPHY, V35, P385, DOI 10.1111/j.1600-0587.2011.07285.x; Phillips SJ, 2010, ECOLOGY, V91, P2476, DOI 10.1890/09-0760.1; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roques A, 2012, INTEGR ZOOL, V7, P227, DOI 10.1111/j.1749-4877.2012.00311.x; Rosegrant MW, 2003, SCIENCE, V302, P1917, DOI 10.1126/science.1092958; Santika T, 2011, GLOBAL ECOL BIOGEOGR, V20, P181, DOI 10.1111/j.1466-8238.2010.00581.x; Schmidhuber J, 2007, P NATL ACAD SCI USA, V104, P19703, DOI 10.1073/pnas.0701976104; Sibanda T, 2000, CROP PROT, V19, P807, DOI 10.1016/S0261-2194(00)00108-3; Silva P., 1954, Boletim do Instituto Biologico da Bahia, V1, P1; Simelton E, 2012, FOOD SECUR, V4, P163, DOI 10.1007/s12571-012-0173-4; Thomson LJ, 2010, BIOL CONTROL, V52, P296, DOI 10.1016/j.biocontrol.2009.01.022; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Thuiller W, 2004, ECOLOGY, V85, P1688, DOI 10.1890/03-0148; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Ward G, 2009, BIOMETRICS, V65, P554, DOI 10.1111/j.1541-0420.2008.01116.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zurell D, 2012, DIVERS DISTRIB, V18, P628, DOI 10.1111/j.1472-4642.2012.00887.x	67	29	29	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66445	10.1371/journal.pone.0066445	http://dx.doi.org/10.1371/journal.pone.0066445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799105	gold, Green Published, Green Submitted			2022-12-25	WOS:000321397800033
J	Ota, H; Katanosaka, K; Murase, S; Kashio, M; Tominaga, M; Mizumura, K				Ota, Hiroki; Katanosaka, Kimiaki; Murase, Shiori; Kashio, Makiko; Tominaga, Makoto; Mizumura, Kazue			TRPV1 and TRPV4 Play Pivotal Roles in Delayed Onset Muscle Soreness	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; CATION CHANNEL TRPV4; MUSCULAR MECHANICAL HYPERALGESIA; N-ARACHIDONOYL-DOPAMINE; POTENTIAL VANILLOID 1; CAPSAICIN-RECEPTOR; ION-CHANNEL; NEUROPATHIC PAIN; SKELETAL-MUSCLE; SPINAL-CORD	Unaccustomed strenuous exercise that includes lengthening contraction (LC) often causes tenderness and movement related pain after some delay (delayed-onset muscle soreness, DOMS). We previously demonstrated that nerve growth factor (NGF) and glial cell line-derived neurotrophic factor (GDNF) are up-regulated in exercised muscle through upregulation of cyclooxygenase (COX)-2, and they sensitized nociceptors resulting in mechanical hyperalgesia. There is also a study showing that transient receptor potential (TRP) ion channels are involved in DOMS. Here we examined whether and how TRPV1 and/or TRPV4 are involved in DOMS. We firstly evaluated a method to measure the mechanical withdrawal threshold of the deep tissues in wild-type (WT) mice with a modified Randall-Selitto apparatus. WT, TRPV1-/- and TRPV4-/- mice were then subjected to LC. Another group of mice received injection of murine NGF-2.5S or GDNF to the lateral gastrocnemius (LGC) muscle. Before and after these treatments the mechanical withdrawal threshold of LGC was evaluated. The change in expression of NGF, GDNF and COX-2 mRNA in the muscle was examined using real-time RT-PCR. In WT mice, mechanical hyperalgesia was observed 6-24 h after LC and 1-24 h after NGF and GDNF injection. LC induced mechanical hyperalgesia neither in TRPV1-/- nor in TRPV4-/- mice. NGF injection induced mechanical hyperalgesia in WT and TRPV4-/- mice but not in TRPV1-/- mice. GDNF injection induced mechanical hyperalgesia in WT but neither in TRPV1-/- nor in TRPV4-/- mice. Expression of NGF and COX-2 mRNA was significantly increased 3 h after LC in all genotypes. However, GDNF mRNA did not increase in TRPV4-/- mice. These results suggest that TRPV1 contributes to DOMS downstream (possibly at nociceptors) of NGF and GDNF, while TRPV4 is located downstream of GDNF and possibly also in the process of GDNF up-regulation.	[Ota, Hiroki] Nagoya Univ, Grad Sch Med, Dept Neural Regulat, Nagoya, Aichi 4648601, Japan; [Ota, Hiroki; Murase, Shiori; Mizumura, Kazue] Chubu Univ, Coll Life & Hlth Sci, Dept Phys Therapy, Kasugai, Aichi 487, Japan; [Katanosaka, Kimiaki] Nagoya Univ, Environm Med Res Inst, Dept Neurosci 2, Nagoya, Aichi 464, Japan; [Kashio, Makiko; Tominaga, Makoto] Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Okazaki, Aichi 444, Japan	Nagoya University; Chubu University; Nagoya University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB)	Mizumura, K (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Dept Phys Therapy, Kasugai, Aichi 487, Japan.	mizu@isc.chubu.ac.jp	Ota, Hiroki/O-6777-2019	Ota, Hiroki/0000-0002-4746-8845; Kashio, Makiko/0000-0001-6404-2339	Japan Society for the Promotion of Sciences [23390154]; Ministry of Education, Culture, Sports, Science and Technology, Japan [21026015]	Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Financial support for this study was provided by a Grant-in Aid for Scientific Research (B) (number 23390154) from Japan Society for the Promotion of Sciences and a Grant-in Aid for Scientific Research on Priority areas (number 21026015) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandri-Haber N, 2009, J NEUROSCI, V29, P6217, DOI 10.1523/JNEUROSCI.0893-09.2009; AMANO T, 1991, NEUROSCI LETT, V132, P5, DOI 10.1016/0304-3940(91)90418-S; Andersen H, 2006, SOMATOSENS MOT RES, V23, P97, DOI 10.1080/08990220600856255; ARMSTRONG RB, 1984, MED SCI SPORT EXER, V16, P529; Asai H, 2005, PAIN, V117, P19, DOI 10.1016/j.pain.2005.05.010; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; BJERRING P, 1990, BRIT J ANAESTH, V64, P173, DOI 10.1093/bja/64.2.173; Boucher TJ, 2000, SCIENCE, V290, P124, DOI 10.1126/science.290.5489.124; Brierley SM, 2008, GASTROENTEROLOGY, V134, P2059, DOI 10.1053/j.gastro.2008.01.074; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Everaerts W, 2010, P NATL ACAD SCI USA, V107, P19084, DOI 10.1073/pnas.1005333107; Fang M, 2003, NEUROSCIENCE, V117, P503, DOI 10.1016/S0306-4522(02)00958-2; Fernandes J, 2008, J CELL BIOL, V181, P143, DOI 10.1083/jcb.200712058; Fujii Y, 2008, PAIN, V140, P292, DOI 10.1016/j.pain.2008.08.013; Guler AD, 2002, J NEUROSCI, V22, P6408; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Jones RCW, 2005, J NEUROSCI, V25, P10981, DOI 10.1523/JNEUROSCI.0703-05.2005; Kim YH, 2012, NEURON, V74, P640, DOI 10.1016/j.neuron.2012.02.039; Kruger J, 2008, NEUROMUSCULAR DISORD, V18, P501, DOI 10.1016/j.nmd.2008.04.003; Kubo A, 2012, J PHYSIOL-LONDON, V590, P2995, DOI 10.1113/jphysiol.2012.229153; Kusudo T, 2012, J APPL PHYSIOL, V112, P1223, DOI 10.1152/japplphysiol.01070.2011; Lechner SG, 2011, NEURON, V69, P332, DOI 10.1016/j.neuron.2010.12.028; Lee RHK, 2006, J NEUROSCI RES, V83, P80, DOI 10.1002/jnr.20701; LEVIMONTALCINI R, 1985, P NATL ACAD SCI USA, V82, P7111, DOI 10.1073/pnas.82.20.7111; LEWIN GR, 1993, TRENDS NEUROSCI, V16, P353, DOI 10.1016/0166-2236(93)90092-Z; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Malin S, 2011, J NEUROSCI, V31, P10516, DOI 10.1523/JNEUROSCI.2992-10.2011; Mann MK, 2006, J OROFAC PAIN, V20, P325; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Mihara H, 2011, J PHYSIOL-LONDON, V589, P3471, DOI 10.1113/jphysiol.2011.207829; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Murase S., 2012, 35 ANN M JAP NEUR SO; Murase S, 2013, J PHYSL IN PRESS; Murase S, 2010, J NEUROSCI, V30, P3752, DOI 10.1523/JNEUROSCI.3803-09.2010; Nasu T, 2010, EUR J PAIN, V14, P236, DOI 10.1016/j.ejpain.2009.05.009; Ota HMK, 2012, PAIN RES, V27, P97; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Phillips E, 2004, J BIOL CHEM, V279, P17165, DOI 10.1074/jbc.M313328200; Pomonis JD, 2003, J PHARMACOL EXP THER, V306, P387, DOI 10.1124/jpet.102.046268; Pritschow BW, 2011, PFLUG ARCH EUR J PHY, V461, P115, DOI 10.1007/s00424-010-0883-4; Radhakrishnan R, 2003, PAIN, V104, P567, DOI 10.1016/S0304-3959(03)00114-3; Ravnefjord A, 2009, EUR J PHARMACOL, V611, P85, DOI 10.1016/j.ejphar.2009.03.058; Rong WF, 2004, J PHYSIOL-LONDON, V560, P867, DOI 10.1113/jphysiol.2004.071746; Sagar DR, 2004, EUR J NEUROSCI, V20, P175, DOI 10.1111/j.1460-9568.2004.03481.x; Sharkey KA, 2007, EUR J NEUROSCI, V25, P2773, DOI 10.1111/j.1460-9568.2007.05521.x; Shinoda M, 2011, J NEUROSCI, V31, P7145, DOI 10.1523/JNEUROSCI.0481-11.2011; Shu X, 2001, J NEUROPHYSIOL, V86, P2931, DOI 10.1152/jn.2001.86.6.2931; Spicarova D, 2009, J NEUROPHYSIOL, V102, P234, DOI 10.1152/jn.00024.2009; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Svensson P, 2003, PAIN, V104, P241, DOI 10.1016/S0304-3959(03)00012-5; Szolcsanyi J, 2004, NEUROSCI LETT, V361, P155, DOI 10.1016/j.neulet.2003.12.025; Taguchi T, 2005, J PHYSIOL-LONDON, V564, P259, DOI 10.1113/jphysiol.2004.079483; Takahashi K, 2004, JPN J PHYSL, V54, pS175; Takasu K, 2011, J PAIN, V12, P1130, DOI 10.1016/j.jpain.2011.04.003; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Troidl C, 2010, J MOL CELL CARDIOL, V49, P142, DOI 10.1016/j.yjmcc.2010.03.021; Turrini P, 2002, NEUROSCI LETT, V323, P109, DOI 10.1016/S0304-3940(02)00090-3; Urban L, 2011, CURR PHARM BIOTECHNO, V12, P115, DOI 10.2174/138920111793937934; Vellani V, 2001, J PHYSIOL-LONDON, V534, P813, DOI 10.1111/j.1469-7793.2001.00813.x; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Walder RY, 2012, PAIN, V153, P1664, DOI 10.1016/j.pain.2012.04.034; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; WOOLF CJ, 1994, NEUROSCIENCE, V62, P327, DOI 10.1016/0306-4522(94)90366-2; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhou Y, 2011, RESP PHYSIOL NEUROBI, V177, P327, DOI 10.1016/j.resp.2011.05.011	70	42	42	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65751	10.1371/journal.pone.0065751	http://dx.doi.org/10.1371/journal.pone.0065751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799042	Green Submitted, Green Published, gold			2022-12-25	WOS:000321397800016
J	Sriwiriyanont, P; Lynch, KA; McFarland, KL; Supp, DM; Boyce, ST				Sriwiriyanont, Penkanok; Lynch, Kaari A.; McFarland, Kevin L.; Supp, Dorothy M.; Boyce, Steven T.			Characterization of Hair Follicle Development in Engineered Skin Substitutes	PLOS ONE			English	Article							BETA-CATENIN; SEBACEOUS GLAND; TERMINAL DIFFERENTIATION; MOUSE EPIDERMIS; CANAL FORMATION; GROWTH-FACTOR; HUMAN EMBRYOS; ATHYMIC MICE; IN-VIVO; CELLS	Generation of skin appendages in engineered skin substitutes has been limited by lack of trichogenic potency in cultured postnatal cells. To investigate the feasibility and the limitation of hair regeneration, engineered skin substitutes were prepared with chimeric populations of cultured human keratinocytes from neonatal foreskins and cultured murine dermal papilla cells from adult GFP transgenic mice and grafted orthotopically to full-thickness wounds on athymic mice. Non-cultured dissociated neonatal murine-only skin cells, or cultured human-only skin keratinocytes and fibroblasts without dermal papilla cells served as positive and negative controls respectively. In this study, neonatal murine-only skin substitutes formed external hairs and sebaceous glands, chimeric skin substitutes formed pigmented hairs without sebaceous glands, and human-only skin substitutes formed no follicles or glands. Although chimeric hair cannot erupt readily, removal of upper skin layer exposed keratinized hair shafts at the skin surface. Development of incomplete pilosebaceous units in chimeric hair corresponded with upregulation of hair-related genes, LEF1 and WNT10B, and downregulation of a marker of sebaceous glands, Steroyl-CoA desaturase. Transepidermal water loss was normal in all conditions. This study demonstrated that while sebaceous glands may be involved in hair eruption, they are not required for hair development in engineered skin substitutes.	[Sriwiriyanont, Penkanok; Boyce, Steven T.] Univ Cincinnati, Sch Energy Environm Biol & Med Engn, Cincinnati, OH 45221 USA; [Lynch, Kaari A.; Supp, Dorothy M.; Boyce, Steven T.] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45267 USA; [McFarland, Kevin L.; Supp, Dorothy M.; Boyce, Steven T.] Shriners Hosp Children, Res Dept, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Boyce, ST (corresponding author), Univ Cincinnati, Sch Energy Environm Biol & Med Engn, Cincinnati, OH 45221 USA.	steven.boyce@uc.edu	Supp, Dorothy/ABQ-7999-2022	Supp, Dorothy/0000-0002-2429-6630	NIH [GM079542]; Shriners Hospitals for Children grant [84050]; Aderans Research Institute (ARI); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079542] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children grant; Aderans Research Institute (ARI); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by NIH grant GM079542, and Shriners Hospitals for Children grant #84050. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Boyce is the named inventor on patents and patent applications assigned to the University of Cincinnati and Shriners Hospitals for Children according to their intellectual property policies. Patents, patent applications and other intellectual property pertaining to engineered skin substitutes are licensed to Cutanogen Corporation which was founded by Dr. Boyce, and in which he has past and present financial interests. Dr. Boyce resigned as an officer of Cutanogen in 2006, and he has no authority or responsibility for Cutanogen's current activities. Dr. Boyce also is a paid consultant for Aderans Research Institute (ARI). No funding for the reported studies was provided by ARI, and ARI has no rights to any technologies invented by Dr. Boyce. Other authors declare no conflict of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aki R, 2010, J CELL BIOCHEM, V110, P80, DOI 10.1002/jcb.22512; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; BOYCE ST, 1991, SURGERY, V110, P866; Boyce ST, 2001, METHODS TISSUE ENG, P365; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Cawthorn WP, 2011, BONE; Choi EH, 2002, BRIT J DERMATOL, V147, P244, DOI 10.1046/j.1365-2133.2002.04918.x; Enshell-Seijffers D, 2010, DEV CELL, V18, P633, DOI 10.1016/j.devcel.2010.01.016; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; Fehrenschild D, 2011, J INVESTIGATIVE DERM; Gagnon V, 2011, J INVEST DERMATOL, V131, P1375, DOI 10.1038/jid.2011.34; Garza LA, 2011, J CLIN INVEST, V121, P613, DOI 10.1172/JCI44478; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; HASHIMOT.K, 1970, DERMATOLOGICA, V141, P49, DOI 10.1159/000252435; HASHIMOTO K, 1970, ARCH KLIN EXP DERM, V238, P333, DOI 10.1007/BF00525727; HOLBROOK KA, 1978, J INVEST DERMATOL, V71, P385, DOI 10.1111/1523-1747.ep12556818; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Ideta R, 2002, J DERMATOL SCI, V28, P48, DOI 10.1016/S0923-1811(01)00145-1; Jordan SA, 2000, DEV BIOL, V225, P424, DOI 10.1006/dbio.2000.9856; Klingenberg JM, 2010, J INVEST DERMATOL, V130, P587, DOI 10.1038/jid.2009.295; Kloepper JE, 2008, EXP DERMATOL, V17, P592, DOI 10.1111/j.1600-0625.2008.00720.x; Lee LF, 2011, TISSUE ENG PART C-ME, V17, P391, DOI [10.1089/ten.tec.2010.0477, 10.1089/ten.TEC.2010.0477]; Lo Celso C, 2008, STEM CELLS, V26, P1241, DOI 10.1634/stemcells.2007-0651; LYNE A. G., 1957, AUSTRALIAN JOUR BIOL SCI, V10, P390; Magnusdottir E, 2007, P NATL ACAD SCI USA, V104, P14988, DOI 10.1073/pnas.0707323104; Niemann C, 2012, SEMIN CELL DEV BIOL, V23, P928, DOI 10.1016/j.semcdb.2012.08.010; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Petersson M, 2011, EMBO J, V30, P3004, DOI 10.1038/emboj.2011.199; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sellheyer K, 2010, J CUTAN PATHOL, V37, P362, DOI 10.1111/j.1600-0560.2009.01434.x; Sharov AA, 2011, J INVEST DERMATOL, V131, P257, DOI 10.1038/jid.2010.279; Sundberg JP, 2000, AM J PATHOL, V156, P2067, DOI 10.1016/S0002-9440(10)65078-X; Supp DM, 2000, J INVEST DERMATOL, V114, P5, DOI 10.1046/j.1523-1747.2000.00824.x; Supp Dorothy M., 2002, Journal of Burn Care & Rehabilitation, V23, P10, DOI 10.1097/00004630-200201000-00004; Takakura N, 1996, J INVEST DERMATOL, V107, P770, DOI 10.1111/1523-1747.ep12371802; Tanabe A, 2006, J DERMATOL SCI, V43, P210, DOI 10.1016/j.jdermsci.2006.04.004; WEINBERG WC, 1993, J INVEST DERMATOL, V100, P229, DOI 10.1111/1523-1747.ep12468971; Zheng Y, 2005, J INVEST DERMATOL, V124, P867, DOI 10.1111/j.0022-202X.2005.23716.x	39	28	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65664	10.1371/journal.pone.0065664	http://dx.doi.org/10.1371/journal.pone.0065664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799033	Green Submitted, Green Published, gold			2022-12-25	WOS:000321397800012
J	Hatashita, S; Yamasaki, H				Hatashita, Shizuo; Yamasaki, Hidetomo			Diagnosed Mild Cognitive Impairment Due to Alzheimer's Disease with PET Biomarkers of Beta Amyloid and Neuronal Dysfunction	PLOS ONE			English	Article							PITTSBURGH COMPOUND-B; CONVERSION; PREDICTION; DEPOSITION; MCI	The aim of this study is to identify mild cognitive impairment (MCI) due to Alzheimer's disease (AD) using amyloid imaging of beta amyloid (A beta) deposition and FDG imaging of reflecting neuronal dysfunction as PET biomarkers. Sixty-eight MCI patients underwent cognitive testing, [11C]-PIB PET and [18F]-FDG PET at baseline and follow-up. Regions of interest were defined on co-registered MRI. PIB distribution volume ratio (DVR) was calculated using Logan graphical analysis, and the standardized uptake value ratio (SUVR) on the same regions was used as quantitative analysis for [18F]-FDG. Thirty (44.1%) of all 68 MCI patients converted to AD over 19.2 +/- 7.1 months. The annual rate of MCI conversion was 23.4%. A positive A beta PET biomarker significantly identified MCI due to AD in individual MCI subjects with a sensitivity (SS) of 96.6% and specificity (SP) of 42.1%. The positive predictive value (PPV) was 56.8%. A positive A beta biomarker in APOE epsilon 4/4 carriers distinguished with a SS of 100%. In individual MCI subjects who had a prominent impairment in episodic memory and aged older than 75 years, an A beta biomarker identified MCI due to AD with a greater SS of 100%, SP of 66.6% and PPV of 80%, compared to FDG biomarker alone or both PET biomarkers combined. In contrast, when assessed in precuneus, both A beta and FDG biomarkers had the greatest level of certainty for MCI due to AD with a PPV of 87.8%. The A beta PET biomarker primarily defines MCI due to AD in individual MCI subjects. Furthermore, combined FDG biomarker in a cortical region of precuneus provides an added diagnostic value in predicting AD over a short period.	[Hatashita, Shizuo; Yamasaki, Hidetomo] Shonan Atsugi Hosp, Atsugi, Kanagawa, Japan		Hatashita, S (corresponding author), Shonan Atsugi Hosp, Atsugi, Kanagawa, Japan.	hatashita@shonan-atsugi.jp						Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Drzezga A, 2005, J NUCL MED, V46, P1625; Drzezga A, 2003, EUR J NUCL MED MOL I, V30, P1104, DOI 10.1007/s00259-003-1194-1; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Ewers M, 2012, NEUROBIOL AGING, V33, P1203, DOI 10.1016/j.neurobiolaging.2010.10.019; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forsberg A, 2008, NEUROBIOL AGING, V29, P1456, DOI 10.1016/j.neurobiolaging.2007.03.029; Hatashita S, 2010, J ALZHEIMERS DIS, V21, P995, DOI 10.3233/JAD-2010-100222; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Landau SM, 2010, NEUROLOGY, V75, P230, DOI 10.1212/WNL.0b013e3181e8e8b8; Lopresti BJ, 2005, J NUCL MED, V46, P1959; Mathis CA, 2003, J MED CHEM, V46, P2740, DOI 10.1021/jm030026b; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Okello A, 2009, NEUROLOGY, V73, P754, DOI 10.1212/WNL.0b013e3181b23564; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Villemagne VL, 2011, ANN NEUROL, V69, P181, DOI 10.1002/ana.22248; Wechsler D, 1987, WMS R WECHSLER MEMOR; Zhang S, 2012, INT J CLIN PRACT, V66, P185, DOI 10.1111/j.1742-1241.2011.02845.x	20	41	46	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66877	10.1371/journal.pone.0066877	http://dx.doi.org/10.1371/journal.pone.0066877			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799136	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300101
J	Liu, P; Wang, YY; Qi, X; Gu, QQ; Geng, MY; Li, J				Liu, Ping; Wang, Yuan-yuan; Qi, Xin; Gu, QianQun; Geng, Meiyu; Li, Jing			Undecylprodigiosin Induced Apoptosis in P388 Cancer Cells Is Associated with Its Binding to Ribosome	PLOS ONE			English	Article							CYCLOPRODIGIOSIN HYDROCHLORIDE; H+/CL-SYMPORTER; PRODIGIOSIN; PROLIFERATION; INHIBITION; GROWTH; PHASE	Prodigiosins (PGs) are a family of natural red pigments with anticancer activity, and one member of the family has entered clinical phase II trials. However, the anticancer mechanisms of PGs remain largely unclear. This study was designed to investigate the molecular basis of anticancer activity of UP, a derivative of PGs, in P388 cells. By introducing pharmacological inhibitors and utilizing a variety of analytical approaches including western blotting, flow cytometry and confocal laser microscopy, we found that UP inhibited proliferation of P388 via arresting cells at G2/M phase and inducing cells apoptosis, which was related to the activation of P38, JNK rather than ERK1/2 signaling. ROS regeneration and acidification in cells appear not involved in UP induced apoptosis. Furthermore, utilizing mass spectrometry, sucrose density gradient fractionation and immunofluorescence staining, we discovered that UP was apparently located at ribosome. These results together indicate that ribosome may be the potential target of UP in cancer cells, which opened a new avenue in delineating the anticancer mechanism of PGs.	[Liu, Ping; Wang, Yuan-yuan; Qi, Xin; Gu, QianQun; Li, Jing] Ocean Univ China, Sch Med & Pharm, Minist Educ, Key Lab Marine Drugs, Qingdao, Peoples R China; [Liu, Ping] Chinese Acad Sci, Anal & Testing Ctr, Yantai Inst Coastal Zone Res, Yantai, Peoples R China; [Geng, Meiyu] Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Drug Res, Shanghai 200031, Peoples R China	Ocean University of China; Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Geng, MY (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Drug Res, Shanghai 200031, Peoples R China.	mygeng@mail.shcnc.ac.cn; lijing_ouc@ouc.edu.cn	Lv, Yuanjie/AER-0767-2022		National High-tech R&D Program of China [2011AA09070104]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0944]	National High-tech R&D Program of China(National High Technology Research and Development Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the grants from National High-tech R&D Program (2011AA09070104) of China and Program for Changjiang Scholars and Innovative Research Team in University (IRT0944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae HK, 2009, TOXICOL APPL PHARM, V237, P137, DOI 10.1016/j.taap.2009.03.006; Baldino CM, 2006, BIOORG MED CHEM LETT, V16, P701, DOI 10.1016/j.bmcl.2005.10.027; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Chen F W, 1999, Int Rev Immunol, V18, P429, DOI 10.3109/08830189909088492; Davis W, 2001, J PHARMACOL EXP THER, V296, P1; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Diaz-Ruiz C, 2001, HISTOL HISTOPATHOL, V16, P415, DOI 10.14670/HH-16.415; Esper RJ, 2008, ADV CARDIOL, V45, P17, DOI 10.1159/000115120; Espona-Fiedler M, 2012, BIOCHEM PHARMACOL, V83, P489, DOI 10.1016/j.bcp.2011.11.027; Francisco R, 2007, EUR J PHARMACOL, V572, P111, DOI 10.1016/j.ejphar.2007.06.054; Hsu PC, 2008, LEUKEMIA RES, V32, P1530, DOI 10.1016/j.leukres.2008.01.017; Johnson CR, 2003, LEUKEMIA, V17, P2140, DOI 10.1038/sj.leu.2403132; Lee SR, 2005, J CELL PHYSIOL, V205, P270, DOI 10.1002/jcp.20395; Liu R, 2005, ARCH PHARM RES, V28, P1341, DOI 10.1007/BF02977899; MELLMAN I, 1989, SCIENCE, V244, P853, DOI 10.1126/science.244.4906.853; Miao BC, 2005, MOL PHARMACOL, V68, P1716, DOI 10.1124/mol.105.015412; Montaner B, 2005, TOXICOL SCI, V85, P870, DOI 10.1093/toxsci/kfi149; Montaner B, 2002, TOXICOL LETT, V129, P93, DOI 10.1016/S0378-4274(01)00477-5; OHKUMA S, 1993, IN VITRO CELL DEV-AN, V29A, P862; Pandey R, 2003, INT IMMUNOPHARMACOL, V3, P159, DOI 10.1016/S1567-5769(02)00114-5; Parikh SA, 2010, CL LYMPH MYELOM LEUK, V10, P285, DOI 10.3816/CLML.2010.n.059; Ruiz-Ramos R, 2005, TOXICOLOGY, V209, P279, DOI 10.1016/j.tox.2004.12.035; Sauer H, 2001, CELL PHYSIOL BIOCHEM, V11, P173, DOI 10.1159/000047804; Shenoy N, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-32; Shieh WY, 2003, INT J SYST EVOL MICR, V53, P479, DOI 10.1099/ijs.0.02307-0; Shrode LD, 1997, J BIOENERG BIOMEMBR, V29, P393, DOI 10.1023/A:1022407116339; Soto-Cerrato V, 2007, MOL CANCER THER, V6, P362, DOI 10.1158/1535-7163.MCT-06-0266; Yamamoto C, 2001, ONCOL REP, V8, P821; Yamamoto D, 2000, J CANCER RES CLIN, V126, P191, DOI 10.1007/s004320050032; Yamamoto D, 2000, INT J CANCER, V88, P121, DOI 10.1002/1097-0215(20001001)88:1<121::AID-IJC19>3.0.CO;2-C; Yamamoto Y, 1999, HUM REPROD, V14, P3041, DOI 10.1093/humrep/14.12.3041; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhang J, 2005, MED CHEM RES, V14, P181, DOI 10.1007/s00044-005-0133-z	33	18	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65381	10.1371/journal.pone.0065381	http://dx.doi.org/10.1371/journal.pone.0065381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799011	gold, Green Submitted, Green Published			2022-12-25	WOS:000320363300018
J	Ness, D; Ren, Z; Gardai, S; Sharpnack, D; Johnson, VJ; Brennan, RJ; Brigham, EF; Olaharski, AJ				Ness, Daniel; Ren, Zhao; Gardai, Shyra; Sharpnack, Douglas; Johnson, Victor J.; Brennan, Richard J.; Brigham, Elizabeth F.; Olaharski, Andrew J.			Leucine-Rich Repeat Kinase 2 (LRRK2)-Deficient Rats Exhibit Renal Tubule Injury and Perturbations in Metabolic and Immunological Homeostasis	PLOS ONE			English	Article							PARKINSONS-DISEASE; OXIDATIVE STRESS; ALPHA-SYNUCLEIN; PEROXIREDOXIN 3; LRRK2; PROTEIN; MUTATIONS; AUTOPHAGY; PATHWAY; GENE	Genetic evidence links mutations in the LRRK2 gene with an increased risk of Parkinson's disease, for which no neuroprotective or neurorestorative therapies currently exist. While the role of LRRK2 in normal cellular function has yet to be fully described, evidence suggests involvement with immune and kidney functions. A comparative study of LRRK2-deficient and wild type rats investigated the influence that this gene has on the phenotype of these rats. Significant weight gain in the LRRK2 null rats was observed and was accompanied by significant increases in insulin and insulin-like growth factors. Additionally, LRRK2-deficient rats displayed kidney morphological and histopathological alterations in the renal tubule epithelial cells of all animals assessed. These perturbations in renal morphology were accompanied by significant decreases of lipocalin-2, in both the urine and plasma of knockout animals. Significant alterations in the cellular composition of the spleen between LRRK2 knockout and wild type animals were identified by immunophenotyping and were associated with subtle differences in response to dual infection with rat-adapted influenza virus (RAIV) and Streptococcus pneumoniae. Ontological pathway analysis of LRRK2 across metabolic and kidney processes and pathological categories suggested that the thioredoxin network may play a role in perturbing these organ systems. The phenotype of the LRRK2 null rat is suggestive of a complex biology influencing metabolism, immune function and kidney homeostasis. These data need to be extended to better understand the role of the kinase domain or other biological functions of the gene to better inform the development of pharmacological inhibitors.	[Ness, Daniel; Olaharski, Andrew J.] Elan Pharmaceut Inc, Nonclin Safety Evaluat, San Francisco, CA USA; [Ren, Zhao] Elan Pharmaceut Inc, Assay Dev, San Francisco, CA USA; [Gardai, Shyra] Elan Pharmaceut Inc, Exploratory Biol, San Francisco, CA USA; [Brigham, Elizabeth F.] Elan Pharmaceut Inc, Pharmacol, San Francisco, CA USA; [Brennan, Richard J.] Thomson Reuters Inc, Carlsbad, CA USA; [Sharpnack, Douglas] Vet Path Serv Inc, Mason, OH USA; [Johnson, Victor J.] Burleson Res Technol Inc BRT, Morrisville, NC USA		Olaharski, AJ (corresponding author), Elan Pharmaceut Inc, Nonclin Safety Evaluat, San Francisco, CA USA.	andrew.olaharski@gmail.com		Johnson, Victor J./0000-0002-3471-6483	Elan Pharmaceuticals	Elan Pharmaceuticals	Daniel Ness, Zhao Ren, Shyra Gardai, Elizabeth F. Brigham, and Andrew J. Olaharski were employees of Elan Pharmaceutical where the work was conducted. Elan Pharmaceuticals funded this study. Richard J. Brennan is employed by Thomson Reuters Inc., Douglas Sharpnack by Vet Path Services Inc., and Victor J. Johnson by Burleson Research Technologies, Inc. Some work was outsourced to contract research organizations, such as Vet Path Services (Douglas Sharpnack for histopathology), Burleson Research Technologies (Victor J. Johnson for the host resistance study), and Thomson Reuters (Richard J. Brennan for pathway analysis). There are no patents, products in development or marketed products to declare. This does not alter their adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Angeles DC, 2011, HUM MUTAT, V32, P1390, DOI 10.1002/humu.21582; Blouet C, 2012, J NEUROSCI, V32, P9870, DOI 10.1523/JNEUROSCI.0353-12.2012; Blouet C, 2011, J NEUROSCI, V31, P6019, DOI 10.1523/JNEUROSCI.6498-10.2011; Boverhof DR, 2011, TOXICOL SCI, V121, P207, DOI 10.1093/toxsci/kfr075; Bravo-San Pedro JM, 2012, CELL MOL LIFE SCI; Chen CY, 2012, CELL DEATH DIFFER, V19, P1623, DOI 10.1038/cdd.2012.42; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Danoy P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001195; Das SK, 2011, J CLIN ENDOCR METAB, V96, pE1308, DOI 10.1210/jc.2011-0101; Dawson TM, 2009, BBA-MOL BASIS DIS, V1792, P585, DOI 10.1016/j.bbadis.2009.06.001; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Dezso Z, 2009, GENOMICS FUNDAMENTAL, P269; Dodson MW, 2012, HUM MOL GENET, V21, P1350, DOI 10.1093/hmg/ddr573; Ekins S, 2010, SYSTEMS BIOL APPL DR; Gaig C, 2006, ARCH NEUROL-CHICAGO, V63, P377, DOI 10.1001/archneur.63.3.377; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Gillardon F, 2012, NEUROSCIENCE, V208, P41, DOI 10.1016/j.neuroscience.2012.02.001; Gomez-Suaga P, 2012, HUM MOL GENET, V21, P511, DOI 10.1093/hmg/ddr481; Greggio E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-94; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Herzig MC, 2011, HUM MOL GENET, V20, P4209, DOI 10.1093/hmg/ddr348; Hinkle KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-25; Ho CCY, 2009, J NEUROSCI, V29, P1011, DOI 10.1523/JNEUROSCI.5175-08.2009; Huh JY, 2012, ANTIOXID REDOX SIGN, V16, P229, DOI [10.1089/ars.2010.3766, 10.1089/ars.2011.3952]; Ikegami H, 2008, ANN NY ACAD SCI, V1150, P103, DOI 10.1196/annals.1447.060; Inzelberg R, 2012, NEUROLOGY, V78, P781, DOI 10.1212/WNL.0b013e318249f673; Kim B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034693; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lichtenberg M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.81; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; Mellor HR, 2011, TOXICOL SCI, V120, P14, DOI 10.1093/toxsci/kfq378; Moehle MS, 2012, J NEUROSCI, V32, P1602, DOI 10.1523/JNEUROSCI.5601-11.2012; Myshkin E, 2012, CHEM BIOL DRUG DES, V80, P406, DOI 10.1111/j.1747-0285.2012.01411.x; Nikolsky Y, 2005, DRUG DISCOV TODAY, V10, P653, DOI 10.1016/S1359-6446(05)03420-3; Nikonova EV, 2012, HUM MOL GENET, V21, P163, DOI 10.1093/hmg/ddr451; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Ramonet D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018568; Tong YR, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-2; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Tsigou E, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/361078; Wang EJ, 2008, TOXICOLOGY, V246, P91, DOI 10.1016/j.tox.2007.12.031; Wang XL, 2012, HUM MOL GENET, V21, P1931, DOI 10.1093/hmg/dds003; Waxman EA, 2009, J NEUROPATH EXP NEUR, V68, P785, DOI 10.1097/NEN.0b013e3181aaf4fd; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	46	73	73	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66164	10.1371/journal.pone.0066164	http://dx.doi.org/10.1371/journal.pone.0066164			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799078	gold, Green Published			2022-12-25	WOS:000320363300063
J	Nishi, H; Tyagi, M; Teng, SL; Shoemaker, BA; Hashimoto, K; Alexov, E; Wuchty, S; Panchenko, AR				Nishi, Hafumi; Tyagi, Manoj; Teng, Shaolei; Shoemaker, Benjamin A.; Hashimoto, Kosuke; Alexov, Emil; Wuchty, Stefan; Panchenko, Anna R.			Cancer Missense Mutations Alter Binding Properties of Proteins and Their Interaction Networks	PLOS ONE			English	Article							HOT-SPOTS; PHOSPHORYLATION SITES; SIGNALING PATHWAYS; CRYSTAL-STRUCTURE; DRIVER MUTATIONS; PREDICTION; STABILITY; DISEASE; SERVER; IDENTIFICATION	Many studies have shown that missense mutations might play an important role in carcinogenesis. However, the extent to which cancer mutations might affect biomolecular interactions remains unclear. Here, we map glioblastoma missense mutations on the human protein interactome, model the structures of affected protein complexes and decipher the effect of mutations on protein-protein, protein-nucleic acid and protein-ion binding interfaces. Although some missense mutations over-stabilize protein complexes, we found that the overall effect of mutations is destabilizing, mostly affecting the electrostatic component of binding energy. We also showed that mutations on interfaces resulted in more drastic changes of amino acid physico-chemical properties than mutations occurring outside the interfaces. Analysis of glioblastoma mutations on interfaces allowed us to stratify cancer-related interactions, identify potential driver genes, and propose two dozen additional cancer biomarkers, including those specific to functions of the nervous system. Such an analysis also offered insight into the molecular mechanism of the phenotypic outcomes of mutations, including effects on complex stability, activity, binding and turnover rate. As a result of mutated protein and gene network analysis, we observed that interactions of proteins with mutations mapped on interfaces had higher bottleneck properties compared to interactions with mutations elsewhere on the protein or unaffected interactions. Such observations suggest that genes with mutations directly affecting protein binding properties are preferably located in central network positions and may influence critical nodes and edges in signal transduction networks.	[Nishi, Hafumi; Shoemaker, Benjamin A.; Wuchty, Stefan; Panchenko, Anna R.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; [Tyagi, Manoj] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Teng, Shaolei; Alexov, Emil] Clemson Univ, Dept Phys, Clemson, SC USA; [Hashimoto, Kosuke] RIKEN, Omics Sci Ctr, Yokohama, Kanagawa, Japan	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Washington University (WUSTL); Clemson University; RIKEN	Panchenko, AR (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	panch@ncbi.nlm.nih.gov	Hashimoto, Kosuke/C-3675-2017; Tyagi, Manoj/K-8438-2014	Hashimoto, Kosuke/0000-0003-3031-0635; Nishi, Hafumi/0000-0002-0846-0330; Teng, Shaolei/0000-0001-8326-9889	National Library of Medicine at the U.S. National Institutes of Health; JSPS Research Fellowship from the Japan Society for the Promotion of Science; National Institutes of Health, National Institute of General Medical Sciences [R01GM093937]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093937] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM090313] Funding Source: NIH RePORTER	National Library of Medicine at the U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); JSPS Research Fellowship from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the Intramural Research Program of the National Library of Medicine at the U.S. National Institutes of Health. K. H. in part was supported by a JSPS Research Fellowship from the Japan Society for the Promotion of Science. EA was supported in part by National Institutes of Health, National Institute of General Medical Sciences, grant number R01GM093937. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Asleson EN, 2003, GENETICS, V163, P91; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Brock K, 2007, BIOPHYS J, V93, P3340, DOI 10.1529/biophysj.107.112367; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; David A, 2012, HUM MUTAT, V33, P359, DOI 10.1002/humu.21656; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dinkel H, 2011, NUCLEIC ACIDS RES, V39, pD261, DOI 10.1093/nar/gkq1104; Dong WJ, 2011, CANCER SCI, V102, P361, DOI 10.1111/j.1349-7006.2010.01804.x; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hosur R, 2011, J MOL BIOL, V405, P1295, DOI 10.1016/j.jmb.2010.11.025; Huang YPJ, 2008, MOL CELL PROTEOMICS, V7, P2048, DOI 10.1074/mcp.M700550-MCP200; Jonsson PF, 2006, BIOINFORMATICS, V22, P2291, DOI 10.1093/bioinformatics/btl390; Kar G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000601; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kim YA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001095; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar S, 2009, GENOME RES, V19, P1562, DOI 10.1101/gr.091991.109; Kuzu G, 2012, CURR OPIN STRUC BIOL, V22, P367, DOI 10.1016/j.sbi.2012.04.004; LOEB LA, 1991, CANCER RES, V51, P3075; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nishi H, 2011, STRUCTURE, V19, P1807, DOI 10.1016/j.str.2011.09.021; Ohgaki H, 2009, CANCER SCI, V100, P2235, DOI 10.1111/j.1349-7006.2009.01308.x; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; PONDER JW, 1999, TINKER SOFTWARE TOOL; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Radivojac P, 2008, BIOINFORMATICS, V24, pI241, DOI 10.1093/bioinformatics/btn267; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schuster-Bockler B, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r9; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; Sharan R, 2006, NAT BIOTECHNOL, V24, P427, DOI 10.1038/nbt1196; Shoemaker BA, 2012, NUCLEIC ACIDS RES, V40, pD834, DOI 10.1093/nar/gkr997; Shoemaker BA, 2010, NUCLEIC ACIDS RES, V38, pD518, DOI 10.1093/nar/gkp842; Stitziel NO, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-227; Teng Shaolei, 2010, International Journal of Computational Biology and Drug Design, V3, P334, DOI 10.1504/IJCBDD.2010.038396; Teng SL, 2009, BIOPHYS J, V96, P2178, DOI 10.1016/j.bpj.2008.12.3904; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Torkamani A, 2009, GENOME RES, V19, P1570, DOI 10.1101/gr.092833.109; Torkamani A, 2009, CANCER LETT, V281, P117, DOI 10.1016/j.canlet.2008.11.008; Tuncbag N, 2009, BIOINFORMATICS, V25, P1513, DOI 10.1093/bioinformatics/btp240; Tyagi M, 2012, EMBO REP, V13, P266, DOI 10.1038/embor.2011.261; Tyagi M, 2009, PROTEIN SCI, V18, P1674, DOI 10.1002/pro.181; Vitkup D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r72; Wang JX, 2012, IEEE ACM T COMPUT BI, V9, P1070, DOI 10.1109/TCBB.2011.147; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106; Wei QO, 2010, PROTEINS, V78, P2058, DOI 10.1002/prot.22722; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2008, CANCER RES, V68, P3086; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Xiang ZX, 2001, J MOL BIOL, V311, P421, DOI 10.1006/jmbi.2001.4865; Xie XL, 1998, STRUCTURE, V6, P983, DOI 10.1016/S0969-2126(98)00100-2; Xu HE, 1999, GENE DEV, V13, P1263, DOI 10.1101/gad.13.10.1263; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Youn A, 2011, BIOINFORMATICS, V27, P175, DOI 10.1093/bioinformatics/btq630; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Zhang Y, 2009, CURR OPIN STRUC BIOL, V19, P145, DOI 10.1016/j.sbi.2009.02.005; Zhang Z, 2010, HUM MUTAT, V31, P1043, DOI 10.1002/humu.21310; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	75	66	66	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66273	10.1371/journal.pone.0066273	http://dx.doi.org/10.1371/journal.pone.0066273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799087	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300071
J	Caballero, JN; Frenette, G; Belleannee, C; Sullivan, R				Caballero, Julieta N.; Frenette, Gilles; Belleannee, Clemence; Sullivan, Robert			CD9-Positive Microvesicles Mediate the Transfer of Molecules to Bovine Spermatozoa during Epididymal Maturation	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; PROTEOMIC ANALYSIS; MEMBRANE-VESICLES; ALDOSE REDUCTASE; SPERM PROTEINS; EXOSOMES; TETRASPANINS; PROSTASOME; CD9; IDENTIFICATION	Acquisition of fertilization ability by spermatozoa during epididymal transit occurs in part by the transfer of molecules from membranous vesicles called epididymosomes. Epididymosomes are heterogeneous in terms of both size and molecular composition. Exosomes and other related small membranous vesicles (30-120 nm) containing tetraspanin proteins on their surface are found in many biological fluids. In this study, we demonstrate that these vesicles are present in bovine cauda epididymal fluid as a subpopulation of epididymosomes. They contain tetraspanin CD9 in addition to other proteins involved in sperm maturation such as P25b, GliPr1L1, and MIF. In order to study the mechanism of protein transfer to sperm, DilC12-labeled unfractionated epididymosomes or CD9-positive microvesicles were coincubated with epididymal spermatozoa, and their transfer was evaluated by flow cytometry. CD9-positive microvesicles from epididymal fluid specifically transferred molecules to spermatozoa, whereas those prepared from blood were unable to do so. The CD9-positive microvesicles transferred molecules to the same sperm regions (acrosome and midpiece) as epididymosomes, with the same kinetics; however, the molecules were preferentially transferred to live sperm and, in contrast to epididymosomes, Zn2+ did not demonstrate potentiated transfer. Tetraspanin CD9 was associated with other proteins on the membrane surface of CD9-positive microvesicles according to coimmunoprecipitation experiments. CD26 cooperated with CD9 in the molecular transfer to sperm since the amount of molecules transferred was significantly reduced in the presence of specific antibodies. In conclusion, CD9-positive microvesicles are present in bovine cauda epididymal fluid and transfer molecules to live maturing sperm in a tissue-specific manner that involves CD9 and CD26.	[Caballero, Julieta N.; Frenette, Gilles; Belleannee, Clemence; Sullivan, Robert] Univ Laval, CRCHU Quebec, Quebec City, PQ, Canada; [Sullivan, Robert] Univ Laval, Ctr Rech Biol Reprod, Dept Obstet Gynecol & Reprod, Quebec City, PQ, Canada	Laval University; Laval University	Sullivan, R (corresponding author), Univ Laval, CRCHU Quebec, Quebec City, PQ, Canada.	robert.sullivan@crchul.ulaval.ca		Caballero, Julieta/0000-0002-5466-3614; Belleannee, Clemence/0000-0001-9284-9420	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by grants from the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada to RS. The funders had no role in study design, data collection and analysis, decision to publish, or prepartion of the manuscript.	[Anonymous], 2002, EPIDIDYMIS MOL CLIN, P377; Arienti G, 1997, BBA-GEN SUBJECTS, V1336, P533, DOI 10.1016/S0304-4165(97)00071-8; Bard MP, 2004, AM J RESP CELL MOL, V31, P114, DOI 10.1165/rcmb.2003-0238OC; Caballero J, 2012, J CELL PHYSIOL, V227, P3876, DOI 10.1002/jcp.24099; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Chaput N, 2005, BLOOD CELL MOL DIS, V35, P111, DOI 10.1016/j.bcmd.2005.05.009; Chikhi N, 1999, COMP BIOCHEM PHYS B, V122, P367, DOI 10.1016/S0305-0491(99)00013-9; D'Amours O, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100990; D'Amours O, 2010, REPRODUCTION, V139, P545, DOI 10.1530/REP-09-0375; Dacheux J. -L., 2002, EPIDIDYMIS MOL CLIN, P151, DOI [10.1007/978-1-4615-0679-9_9, DOI 10.1007/978-1-4615-0679-9_9]; Eickhoff R, 2004, MOL HUM REPROD, V10, P605, DOI 10.1093/molehr/gah075; Engering A, 2003, EUR J BIOCHEM, V270, P2412, DOI 10.1046/j.1432-1033.2003.03609.x; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fanaei M, 2011, BIOCHEM SOC T, V39, P524, DOI 10.1042/BST0390524; Florek M, 2007, CELL TISSUE RES, V328, P31, DOI 10.1007/s00441-006-0324-z; Frenette G, 2003, BIOL REPROD, V69, P1586, DOI 10.1095/biolreprod.103.019216; Frenette G, 2002, BIOL REPROD, V67, P308, DOI 10.1095/biolreprod67.1.308; Girouard J, 2011, INT J ANDROL, V34, pE475, DOI 10.1111/j.1365-2605.2011.01203.x; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Gonzalez-Begne M, 2009, J PROTEOME RES, V8, P1304, DOI 10.1021/pr800658c; GOYAL HO, 1985, AM J ANAT, V172, P155, DOI 10.1002/aja.1001720205; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hermo L, 2002, MOL REPROD DEV, V63, P394, DOI 10.1002/mrd.90023; Jones R., 2002, EPIDIDYMIS MOL CLIN, P405, DOI 10.1007/978-1-4615-0679-9_23; Le Naour F, 2006, MOL CELL PROTEOMICS, V5, P845, DOI 10.1074/mcp.M500330-MCP200; Madore E, 2003, J BIOL CHEM, V278, P11205, DOI 10.1074/jbc.M208318200; Mallegol J, 2007, GASTROENTEROLOGY, V132, P1866, DOI 10.1053/j.gastro.2007.02.043; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Minelli A, 1998, J REPROD FERTIL, V114, P237, DOI 10.1530/jrf.0.1140237; Parent S, 1999, MOL REPROD DEV, V52, P57, DOI 10.1002/(SICI)1098-2795(199901)52:1&lt;57::AID-MRD8&gt;3.0.CO;2-U; Parolini I, 2009, J BIOL CHEM, V284, P34211, DOI 10.1074/jbc.M109.041152; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Rejraji H, 2006, BIOL REPROD, V74, P1104, DOI 10.1095/biolreprod.105.049304; Reyes-Moreno C, 2002, BIOL REPROD, V66, P159, DOI 10.1095/biolreprod66.1.159; Reyes-Moreno C, 2008, MOL REPROD DEV, V75, P512, DOI 10.1002/mrd.20751; Rubinstein E, 2006, DEV BIOL, V290, P351, DOI 10.1016/j.ydbio.2005.11.031; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; Seigneuret M, 2001, J BIOL CHEM, V276, P40055, DOI 10.1074/jbc.M105557200; Sullivan R, 2007, ASIAN J ANDROL, V9, P483, DOI 10.1111/j.1745-7262.2007.00281.x; Tachibana I, 1999, J CELL BIOL, V146, P893, DOI 10.1083/jcb.146.4.893; Takeda Y, 2003, J CELL BIOL, V161, P945, DOI 10.1083/jcb.200212031; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Turner TT, 2002, EPIDIDYMIS MOL CLIN, P131, DOI DOI 10.1007/978-1-4615-0679-9_8; Wang HX, 2011, J CELL SCI, V124, P2702, DOI 10.1242/jcs.085449; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	47	84	87	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65364	10.1371/journal.pone.0065364	http://dx.doi.org/10.1371/journal.pone.0065364			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785420	Green Submitted, gold, Green Published			2022-12-25	WOS:000321038800100
J	Du, JK; Xiao, K; Li, L; Ding, X; Liu, HL; Lu, YJ; Zhou, SN				Du, Jikun; Xiao, Kai; Li, Li; Ding, Xian; Liu, Helu; Lu, Yongjun; Zhou, Shining			Temporal and Spatial Diversity of Bacterial Communities in Coastal Waters of the South China Sea	PLOS ONE			English	Article							BACTERIOPLANKTON COMMUNITIES; MICROBIAL DIVERSITY; SEQUENCE ALIGNMENT; OCEAN; DYNAMICS; ATLANTIC; PACIFIC; ENVIRONMENTS; BIODIVERSITY; BIOSPHERE	Bacteria are recognized as important drivers of biogeochemical processes in all aquatic ecosystems. Temporal and geographical patterns in ocean bacterial communities have been observed in many studies, but the temporal and spatial patterns in the bacterial communities from the South China Sea remained unexplored. To determine the spatiotemporal patterns, we generated 16S rRNA datasets for 15 samples collected from the five regularly distributed sites of the South China Sea in three seasons (spring, summer, winter). A total of 491 representative sequences were analyzed by MOTHUR, yielding 282 operational taxonomic units (OTUs) grouped at 97% stringency. Significant temporal variations of bacterial diversity were observed. Richness and diversity indices indicated that summer samples were the most diverse. The main bacterial group in spring and summer samples was Alphaproteobacteria, followed by Cyanobacteria and Gammaproteobacteria, whereas Cyanobacteria dominated the winter samples. Spatial patterns in the samples were observed that samples collected from the coastal (D151, D221) waters and offshore (D157, D1512, D224) waters clustered separately, the coastal samples harbored more diverse bacterial communities. However, the temporal pattern of the coastal site D151 was contrary to that of the coastal site D221. The LIBSHUFF statistics revealed noticeable differences among the spring, summer and winter libraries collected at five sites. The UPGMA tree showed there were temporal and spatial heterogeneity of bacterial community composition in coastal waters of the South China Sea. The water salinity (P=0.001) contributed significantly to the bacteria-environment relationship. Our results revealed that bacterial community structures were influenced by environmental factors and community-level changes in 16S-based diversity were better explained by spatial patterns than by temporal patterns.	[Du, Jikun; Xiao, Kai; Lu, Yongjun; Zhou, Shining] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Li] Guangdong Med Coll, Dept Pharmacol, Dongguan, Peoples R China; [Du, Jikun; Liu, Helu] Guangzhou Med Univ, Dept Clin Lab, Shenzhen Shajing Affiliated Hosp, Shenzhen, Peoples R China; [Ding, Xian] Chinese Acad Fishery Sci, South China Sea Fisheries Res Inst, Guangzhou, Peoples R China	Sun Yat Sen University; Guangdong Medical University; Guangzhou Medical University; Chinese Academy of Fishery Sciences; South China Sea Fisheries Research Institute, CAFS	Li, L (corresponding author), Guangdong Med Coll, Dept Pharmacol, Dongguan, Peoples R China.	lsszsl@mail.sysu.edu.cn; china_lovelylily@hotmail.com	du, jikun/G-3990-2013		China Marine Commonweal Research Project [201005022-2]; Guangdong Provincial Science and Technique Major Project [2011A080403006]	China Marine Commonweal Research Project; Guangdong Provincial Science and Technique Major Project	This research was supported by grants from China Marine Commonweal Research Project (201005022-2) and Guangdong Provincial Science and Technique Major Project (2011A080403006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers E, 2013, ISME J, V7, P256, DOI 10.1038/ismej.2012.108; Andersson AF, 2010, ISME J, V4, P171, DOI 10.1038/ismej.2009.108; Azam F, 2001, NATURE, V414, P495, DOI 10.1038/35107174; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Briee C, 2007, RES MICROBIOL, V158, P213, DOI 10.1016/j.resmic.2006.12.012; Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86; CONNELL JH, 1964, AM NAT, V98, P399, DOI 10.1086/282335; Copley J, 2002, NATURE, V415, P572, DOI 10.1038/415572a; Crump BC, 1999, APPL ENVIRON MICROB, V65, P3192; Danovaro R, 2007, ESTUAR COAST SHELF S, V75, P4, DOI 10.1016/j.ecss.2007.02.030; Du HL, 2006, FEMS MICROBIOL ECOL, V57, P92, DOI 10.1111/j.1574-6941.2006.00090.x; Du JK, 2011, ANTON LEEUW INT J G, V100, P317, DOI 10.1007/s10482-011-9587-9; Feingersch R, 2010, ISME J, V4, P78, DOI 10.1038/ismej.2009.92; Feng BW, 2009, FEMS MICROBIOL ECOL, V70, P236, DOI 10.1111/j.1574-6941.2009.00772.x; Field KG, 1997, APPL ENVIRON MICROB, V63, P63, DOI 10.1128/AEM.63.1.63-70.1997; Fuhrman JA, 1995, APPL ENVIRON MICROB, V59, P1294; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Gao Z, 2010, ISME J, V4, P111, DOI 10.1038/ismej.2009.87; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Gilbert JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015545; GIOVANNONI SJ, 2000, MICROBIAL ECOLOGY OC, P47; Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Grasshoff K, 1999, METHODS SEAWATER ANA; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Jari O., 2013, MULTIVARIATE ANAL EC; Kanokratana P, 2004, J BASIC MICROB, V44, P430, DOI 10.1002/jobm.200410388; Karl DM, 2002, NATURE, V415, P590, DOI 10.1038/415590b; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lai XT, 2007, ISME J, V1, P756, DOI 10.1038/ismej.2007.51; Madigan MT, 1997, SCI AM, V276, P82, DOI 10.1038/scientificamerican0497-82; Magalhaes C, 2008, MICROB ECOL, V55, P259, DOI 10.1007/s00248-007-9273-7; Manini E, 2003, OCEANOL ACTA, V26, P27, DOI 10.1016/S0399-1784(02)01227-6; Morris RM, 2005, LIMNOL OCEANOGR, V50, P1687, DOI 10.4319/lo.2005.50.5.1687; Mou XZ, 2008, NATURE, V451, P708, DOI 10.1038/nature06513; Mueller-Spitz SR, 2009, FEMS MICROBIOL ECOL, V67, P511, DOI 10.1111/j.1574-6941.2008.00639.x; Muller-Navarra DC, 2000, NATURE, V403, P74, DOI 10.1038/47469; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; Newell RC, 1982, OCEANOL ACTA, P347; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; POMEROY LR, 1974, BIOSCIENCE, V24, P499, DOI 10.2307/1296885; Pomeroy LR, 2007, J OCEANOGR, V20; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwarz JIK, 2007, SYST APPL MICROBIOL, V30, P239, DOI 10.1016/j.syapm.2006.05.004; Silveira CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017789; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Treusch AH, 2009, ISME J, V3, P1148, DOI 10.1038/ismej.2009.60; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Ward DM, 1998, MICROBIOL MOL BIOL R, V62, P1353, DOI 10.1128/MMBR.62.4.1353-1370.1998; Wright David H., 1993, P66; Xie SP, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001867; Yeo SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056207	56	26	30	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66968	10.1371/journal.pone.0066968	http://dx.doi.org/10.1371/journal.pone.0066968			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785512	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800010
J	Reverdatto, S; Rai, V; Xue, J; Burz, DS; Schmidt, AM; Shekhtman, A				Reverdatto, Sergey; Rai, Vivek; Xue, Jing; Burz, David S.; Schmidt, Ann Marie; Shekhtman, Alexander			Combinatorial Library of Improved Peptide Aptamers, CLIPs to Inhibit RAGE Signal Transduction in Mammalian Cells	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; ESCHERICHIA-COLI THIOREDOXIN; PHAGE DISPLAY LIBRARIES; SECONDARY STRUCTURE; STRUCTURAL BASIS; DNA-POLYMERASE; RECEPTOR; PROTEIN; SELECTION; LIGANDS	Peptide aptamers are small proteins containing a randomized peptide sequence embedded into a stable protein scaffold, such as Thioredoxin. We developed a robust method for building a Combinatorial Library of Improved Peptide aptamers (CLIPs) of high complexity, containing >= 3 x 10(10) independent clones, to be used as a molecular tool in the study of biological pathways. The Thioredoxin scaffold was modified to increase solubility and eliminate aggregation of the peptide aptamers. The CLIPs was used in a yeast two-hybrid screen to identify peptide aptamers that bind to various domains of the Receptor for Advanced Glycation End products (RAGE). NMR spectroscopy was used to identify interaction surfaces between the peptide aptamers and RAGE domains. Cellular functional assays revealed that in addition to directly interfering with known binding sites, peptide aptamer binding distal to ligand sites also inhibits RAGE ligand-induced signal transduction. This finding underscores the potential of using CLIPs to select allosteric inhibitors of biological targets.	[Reverdatto, Sergey; Xue, Jing; Burz, David S.; Shekhtman, Alexander] SUNY Albany, Dept Chem, Albany, NY 12222 USA; [Rai, Vivek; Schmidt, Ann Marie] NYU, Langone Med Ctr, New York, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; New York University; NYU Langone Medical Center	Shekhtman, A (corresponding author), SUNY Albany, Dept Chem, Albany, NY 12222 USA.	ashekhtman@albany.edu		Shekhtman, Alexander/0000-0003-2649-2675	National Institutes of Health grant [RO1GM085006]; Juvenile Diabetes Research Foundation grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085006] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation grant(Juvenile Diabetes Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant RO1GM085006 and Juvenile Diabetes Research Foundation grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed H., 2004, PRINCIPLES REACTIONS; [Anonymous], 1991, FEBS LETT, V284, P178; [Anonymous], 1990, CURRENT RES PROTEIN, P449; [Anonymous], 1980, BLOOD VESSELS, V17, P110; Baines IC, 2006, DRUG DISCOV TODAY, V11, P334, DOI 10.1016/j.drudis.2006.02.007; Bickle MBT, 2006, NAT PROTOC, V1, P1066, DOI 10.1038/nprot.2006.32; Borghouts C, 2008, MOL CANCER RES, V6, P267, DOI 10.1158/1541-7786.MCR-07-0245; BRETT J, 1993, AM J PATHOL, V143, P1699; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brown CJ, 2010, J MOL BIOL, V395, P871, DOI 10.1016/j.jmb.2009.10.069; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Cavanagh J., 1996, PROTEIN NMR SPECTROS; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Christ D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl605; Cohen BA, 1998, P NATL ACAD SCI USA, V95, P14272, DOI 10.1073/pnas.95.24.14272; Colas P, 1996, NATURE, V380, P548, DOI 10.1038/380548a0; Colas P, 2000, CURR OPIN CHEM BIOL, V4, P54, DOI 10.1016/S1367-5931(99)00051-4; Crawford Margaret, 2003, Briefings in Functional Genomics & Proteomics, V2, P72, DOI 10.1093/bfgp/2.1.72; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Derda R, 2011, MOLECULES, V16, P1776, DOI 10.3390/molecules16021776; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Dyson HJ, 1997, BIOCHEMISTRY-US, V36, P2622, DOI 10.1021/bi961801a; DYSON HJ, 1989, BIOCHEMISTRY-US, V28, P7074, DOI 10.1021/bi00443a044; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fritz G, 2011, TRENDS BIOCHEM SCI, V36, P625, DOI 10.1016/j.tibs.2011.08.008; Georgiou G, 1997, NAT BIOTECHNOL, V15, P29, DOI 10.1038/nbt0197-29; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Huber D, 2005, P NATL ACAD SCI USA, V102, P18872, DOI 10.1073/pnas.0509583102; James P, 1996, GENETICS, V144, P1425; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Kislinger T, 2001, ARTERIOSCL THROM VAS, V21, P905, DOI 10.1161/01.ATV.21.6.905; Klevenz B, 2002, CELL MOL LIFE SCI, V59, P1993, DOI 10.1007/PL00012521; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; LANGSETMO K, 1991, BIOCHEMISTRY-US, V30, P7603, DOI 10.1021/bi00244a032; LANGSETMO K, 1991, BIOCHEMISTRY-US, V30, P7609, DOI 10.1021/bi00244a033; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Masse JE, 2005, J MAGN RESON, V174, P133, DOI 10.1016/j.jmr.2005.01.017; MATTHEAKIS LC, 1994, P NATL ACAD SCI USA, V91, P9022, DOI 10.1073/pnas.91.19.9022; Menendez A, 2005, ANAL BIOCHEM, V336, P145, DOI 10.1016/j.ab.2004.09.048; Newton-Northup J. R., 2012, J MOL IMAGING DYNAM, V2, P1; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Pedone E, 1999, BIOCHEM J, V339, P309, DOI 10.1042/0264-6021:3390309; Reichelt P, 2006, PROTEIN EXPRES PURIF, V46, P483, DOI 10.1016/j.pep.2005.09.027; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Rodi DJ, 2002, J MOL BIOL, V322, P1039, DOI 10.1016/S0022-2836(02)00844-6; Shi H, 2007, P NATL ACAD SCI USA, V104, P3742, DOI 10.1073/pnas.0607805104; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; TAKESAKO K, 1991, J ANTIBIOT, V44, P919, DOI 10.7164/antibiotics.44.919; Thomas WD, 2010, ANAL BIOCHEM, V407, P237, DOI 10.1016/j.ab.2010.07.037; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vodnik M, 2011, MOLECULES, V16, P790, DOI 10.3390/molecules16010790; Walters KJ, 2001, METHOD ENZYMOL, V339, P238, DOI 10.1016/S0076-6879(01)39316-3; Worthington MT, 2001, ANAL BIOCHEM, V294, P169, DOI 10.1006/abio.2001.5162; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Xue J, 2011, STRUCTURE, V19, P722, DOI 10.1016/j.str.2011.02.013; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0	69	24	26	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65180	10.1371/journal.pone.0065180	http://dx.doi.org/10.1371/journal.pone.0065180			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785412	gold, Green Published, Green Submitted			2022-12-25	WOS:000321038800108
J	Teramoto, S; Shimura, H; Tanaka, R; Shimada, Y; Miyamoto, N; Arai, H; Urabe, T; Hattori, N				Teramoto, Shinichiro; Shimura, Hideki; Tanaka, Ryota; Shimada, Yoshiaki; Miyamoto, Nobukazu; Arai, Hajime; Urabe, Takao; Hattori, Nobutaka			Human-Derived Physiological Heat Shock Protein 27 Complex Protects Brain after Focal Cerebral Ischemia in Mice	PLOS ONE			English	Article							CHAPERONE FUNCTION; OXIDATIVE STRESS; DRUG-RESISTANCE; NEURONAL INJURY; CELL-DEATH; HSP27; HEAT-SHOCK-PROTEIN-27; PHOSPHORYLATION; NEUROPROTECTION; OVEREXPRESSION	Although challenging, neuroprotective therapies for ischemic stroke remain an interesting strategy for countering ischemic injury and suppressing brain tissue damage. Among potential neuroprotective molecules, heat shock protein 27 (HSP27) is a strong cell death suppressor. To assess the neuroprotective effects of HSP27 in a mouse model of transient middle cerebral artery occlusion, we purified a "physiological" HSP27 (hHSP27) from normal human lymphocytes. hHSP27 differed from recombinant HSP27 in that it formed dimeric, tetrameric, and multimeric complexes, was phosphorylated, and contained small amounts of ab-crystallin and HSP20. Mice received intravenous injections of hHSP27 following focal cerebral ischemia. Infarct volume, neurological deficit scores, physiological parameters, and immunohistochemical analyses were evaluated 24 h after reperfusion. Intravenous injections of hHSP27 1 h after reperfusion significantly reduced infarct size and improved neurological deficits. Injected hHSP27 was localized in neurons on the ischemic side of the brain. hHSP27 suppressed neuronal cell death resulting from cytochrome c-mediated caspase activation, oxidative stress, and inflammatory responses. Recombinant HSP27 (rHSP27), which was artificially expressed and purified from Escherichia coli, and dephosphorylated hHSP27 did not have brain protective effects, suggesting that the phosphorylation of hHSP27 may be important for neuroprotection after ischemic insults. The present study suggests that hHSP27 with posttranslational modifications provided neuroprotection against ischemia/reperfusion injury and that the protection was mediated through the inhibition of apoptosis, oxidative stress, and inflammation. Intravenously injected human HSP27 should be explored for the treatment of acute ischemic strokes.	[Teramoto, Shinichiro; Tanaka, Ryota; Shimada, Yoshiaki; Miyamoto, Nobukazu; Hattori, Nobutaka] Juntendo Univ, Sch Med, Dept Neurol, Tokyo 113, Japan; [Teramoto, Shinichiro; Arai, Hajime] Juntendo Univ, Sch Med, Dept Neurosurg, Tokyo 113, Japan; [Shimura, Hideki; Tanaka, Ryota; Urabe, Takao] Juntendo Univ, Sch Med, Urayasu Hosp, Dept Neurol, Chiba, Japan; [Shimura, Hideki; Tanaka, Ryota] Juntendo Univ, Grad Sch Med, Inst Environm & Gender Specif Med, Chiba, Japan	Juntendo University; Juntendo University; Juntendo University; Juntendo University	Shimura, H (corresponding author), Juntendo Univ, Sch Med, Urayasu Hosp, Dept Neurol, Chiba, Japan.	hshimura@juntendo-urayasu.jp; nhattori@juntendo.ac.jp	shimura, hideki/AAA-2864-2020; Hattori, Nobutaka/ACR-0069-2022		High Technology Research Center; Ministry of Education, Culture, Sports, Science and Technology in Japan; Japan Society for the Promotion of Science [21700395, 21500338]; Takeda Science Foundation	High Technology Research Center; Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This study was partly supported by a High Technology Research Center grant and a Grant-in-Aid for exploratory research from the Ministry of Education, Culture, Sports, Science and Technology in Japan and by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (21700395, H. Shimura; 21500338, T. Urabe) and from the Takeda Science Foundation (H. Shimura). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abisambra JF, 2010, J NEUROSCI, V30, P15374, DOI 10.1523/JNEUROSCI.3155-10.2010; Akbar MT, 2003, J BIOL CHEM, V278, P19956, DOI 10.1074/jbc.M207073200; An JJ, 2008, FEBS J, V275, P1296, DOI 10.1111/j.1742-4658.2008.06291.x; Andrabi SA, 2004, FASEB J, V18, P869, DOI 10.1096/fj.03-1031fje; Assimakopoulou M, 1997, ANTICANCER RES, V17, P2677; Badin RA, 2006, J CEREBR BLOOD F MET, V26, P371, DOI 10.1038/sj.jcbfm.9600190; Badin RA, 2009, J CEREBR BLOOD F MET, V29, P254, DOI 10.1038/jcbfm.2008.106; Bukach OV, 2009, BBA-PROTEINS PROTEOM, V1794, P486, DOI 10.1016/j.bbapap.2008.11.010; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; Currie RW, 2000, BRAIN RES, V863, P169, DOI 10.1016/S0006-8993(00)02133-8; Dhodda VK, 2004, J NEUROCHEM, V89, P73, DOI 10.1111/j.1471-4159.2004.02316.x; DUDICH IV, 1995, BBA-PROTEIN STRUCT M, V1253, P163, DOI 10.1016/0167-4838(95)00135-X; Efthymiou CA, 2004, BASIC RES CARDIOL, V99, P392, DOI 10.1007/s00395-004-0483-6; Faden AI, 2007, ARCH NEUROL-CHICAGO, V64, P794, DOI 10.1001/archneur.64.6.794; FUQUA SAW, 1994, BREAST CANCER RES TR, V32, P67, DOI 10.1007/BF00666207; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; Hayes D, 2009, J BIOL CHEM, V284, P18801, DOI 10.1074/jbc.M109.011353; Hollander JM, 2004, CIRCULATION, V110, P3544, DOI 10.1161/01.CIR.0000148825.99184.50; Huang QJ, 2010, CLIN CHEM LAB MED, V48, P263, DOI 10.1515/CCLM.2010.043; KATO H, 1995, NEUROSCIENCE, V68, P65, DOI 10.1016/0306-4522(95)00141-5; KATO K, 1994, J BIOL CHEM, V269, P11274; KATO K, 1994, J BIOL CHEM, V269, P15302; Lambert H, 1999, J BIOL CHEM, V274, P9378, DOI 10.1074/jbc.274.14.9378; Lelj-Garolla B, 2005, J MOL BIOL, V345, P631, DOI 10.1016/j.jmb.2004.10.056; Love S, 1999, BRAIN PATHOL, V9, P119; Miyamoto N, 2008, NEUROSCI RES, V61, P249, DOI 10.1016/j.neures.2008.03.003; Phan TG, 2002, CLIN EXP PHARMACOL P, V29, P1, DOI 10.1046/j.1440-1681.2002.03609.x; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; Sharp P, 2006, EXP NEUROL, V198, P511, DOI 10.1016/j.expneurol.2005.12.031; Sharp PS, 2008, NEUROBIOL DIS, V30, P42, DOI 10.1016/j.nbd.2007.12.002; Shimura H, 2004, J BIOL CHEM, V279, P17957, DOI 10.1074/jbc.M400351200; Spencer BJ, 2007, P NATL ACAD SCI USA, V104, P7594, DOI 10.1073/pnas.0702170104; Stetler RA, 2009, CURR MOL MED, V9, P863, DOI 10.2174/156652409789105561; Stetler RA, 2012, J NEUROSCI, V32, P2667, DOI 10.1523/JNEUROSCI.5169-11.2012; Stetler RA, 2010, PROG NEUROBIOL, V92, P184, DOI 10.1016/j.pneurobio.2010.05.002; Stetler RA, 2008, J NEUROSCI, V28, P13038, DOI 10.1523/JNEUROSCI.4407-08.2008; Tureyen K, 2004, J NEUROSCI METH, V139, P203, DOI 10.1016/j.jneumeth.2004.04.029; van der Weerd L, 2010, J CEREBR BLOOD F MET, V30, P849, DOI 10.1038/jcbfm.2009.249; Vargas-Roig LM, 1998, INT J CANCER, V79, P468, DOI 10.1002/(SICI)1097-0215(19981023)79:5<468::AID-IJC4>3.0.CO;2-Z; Wagstaff MJD, 1999, J BIOL CHEM, V274, P5061, DOI 10.1074/jbc.274.8.5061; Warner DS, 2004, J EXP BIOL, V207, P3221, DOI 10.1242/jeb.01022	45	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66001	10.1371/journal.pone.0066001	http://dx.doi.org/10.1371/journal.pone.0066001			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785464	Green Submitted, Green Published, gold			2022-12-25	WOS:000321038800058
J	Tolani, B; Gopalakrishnan, R; Punj, V; Matta, H; Chaudhary, PM				Tolani, B.; Gopalakrishnan, R.; Punj, V.; Matta, H.; Chaudhary, P. M.			Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors	ONCOGENE			English	Article						Myc; PEL; BET; bromodomain; KSHV	SARCOMA-ASSOCIATED HERPESVIRUS; C-MYC; NUCLEAR ANTIGEN; SELECTIVE-INHIBITION; RNA INTERFERENCE; TERMINAL REPEAT; LATENCY; EXPRESSION; CANCER; BRD4	Primary effusion lymphoma (PEL) is an aggressive form of non-Hodgkin's B-cell lymphoma associated with infection by Kaposi's sarcoma-associated herpes virus (KSHV). (+)-JQ1 and I-BET151 are two recently described novel small-molecule inhibitors of BET bromodomain chromatin-associated proteins that have shown impressive preclinical activity in cancers in which MYC is overexpressed at the transcriptional level due to chromosomal translocations that bring the MYC gene under the control of a super-enhancer. PEL cells, in contrast, lack structural alterations in the MYC gene, but have deregulated Myc protein due to the activity of KSHV-encoded latent proteins. We report that PEL cell lines are highly sensitive to bromodomain and extra-terminal (BET) bromodomain inhibitors-induced growth inhibition and undergo G(0)/G(1) cell-cycle arrest, apoptosis and cellular senescence, but without the induction of lytic reactivation, upon treatment with these drugs. Treatment of PEL cell lines with BET inhibitors suppressed the expression of MYC and resulted in a genome-wide perturbation of MYC-dependent genes. Silencing of BRD4 and MYC expression blocked cell proliferation and cell-cycle progression, while ectopic expression of MYC from a retroviral promoter rescued cells from (+)-JQ1-induced growth arrest. In a xenograft model of PEL, (+)-JQ1 significantly reduced tumor growth and improved survival. Taken collectively, our results demonstrate that the utility of BET inhibitors may not be limited to cancers in which genomic alterations result in extremely high expression of MYC and they may have equal or perhaps greater activity against cancers in which the MYC genomic locus is structurally intact and c-Myc protein is deregulated at the post-translational level and is only modestly overexpressed.	[Chaudhary, P. M.] Univ So Calif, Keck Sch Med, Jane Anne Nohl Div Hematol, Los Angeles, CA 90033 USA; [Chaudhary, P. M.] Univ So Calif, Keck Sch Med, Ctr Study Blood Dis, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Chaudhary, PM (corresponding author), Univ So Calif, Keck Sch Med, Jane Anne Nohl Div Hematol, Los Angeles, CA 90033 USA.	preet.chaudhary@med.usc.edu	Gopalakrishnan, Ramakrishnan/N-3454-2015; Chaudhary, Preet/E-1970-2018	Gopalakrishnan, Ramakrishnan/0000-0002-5068-6886; Tolani, Bhairavi/0000-0001-9076-866X	National Institutes of Health [CA139119, DE019811, P30CA014089]; STOP Cancer Foundations; National Cancer Institute Cancer Center Shared Grant [P30CA014089]; USC Provost Office Dean's Development Funds; NATIONAL CANCER INSTITUTE [R01CA139119, P30CA014089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); STOP Cancer Foundations; National Cancer Institute Cancer Center Shared Grant; USC Provost Office Dean's Development Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank Dr James Bradner (Dana-Farber Cancer Institute, Boston, MA, USA) for his generous contribution of (+)-JQ1 and (-)-JQ1, Dr Peter Howley (Harvard University) for BRD4 antibody, Gary Hayward (Johns Hopkins University) for RTA antibody, and Drs Lossos and Ramos from the University of Miami for UM-PEL-1 and UM-PEL-3 cells, respectively. This work was supported by grants from the National Institutes of Health (CA139119, DE019811 and P30CA014089) and STOP Cancer Foundations. Flow cytometry was performed in the USC Flow Cytometry Core Facility that is supported in part by the National Cancer Institute Cancer Center Shared Grant award P30CA014089 and the USC Provost Office Dean's Development Funds.	Ballestas ME, 2001, J VIROL, V75, P3250, DOI 10.1128/JVI.75.7.3250-3258.2001; Bartholomeeusen K, 2012, J BIOL CHEM, V287, P36609, DOI 10.1074/jbc.M112.410746; Bhatt S, 2011, 53 ASH ANN M EXP; Boulanger E, 2004, AM J HEMATOL, V76, P88, DOI 10.1002/ajh.20048; Boulanger E, 2003, AM J HEMATOL, V73, P143, DOI 10.1002/ajh.10341; Bubman D, 2007, ONCOGENE, V26, P4979, DOI 10.1038/sj.onc.1210299; Chung CW, 2011, J BIOMOL SCREEN, V16, P1170, DOI 10.1177/1087057111421372; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Garber AC, 2002, J BIOL CHEM, V277, P27401, DOI 10.1074/jbc.M203489200; Li XD, 2010, J VIROL, V84, P8945, DOI 10.1128/JVI.00244-10; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Liu JY, 2007, J VIROL, V81, P10451, DOI 10.1128/JVI.00804-07; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lubyova B, 2007, J BIOL CHEM, V282, P31944, DOI 10.1074/jbc.M706430200; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Morris K, 2003, LANCET ONCOL, V4, P5, DOI 10.1016/S1470-2045(03)00969-0; Nador RG, 1996, BLOOD, V88, P645, DOI 10.1182/blood.V88.2.645.bloodjournal882645; Nakamura H, 2003, J VIROL, V77, P4205, DOI 10.1128/JVI.77.7.4205-4220.2003; Nicholas J, 2007, FRONT BIOSCI-LANDMRK, V12, P265, DOI 10.2741/2063; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Ott CJ, 2012, BLOOD, V120, P2843, DOI 10.1182/blood-2012-02-413021; Ottinger M, 2006, J VIROL, V80, P10772, DOI 10.1128/JVI.00804-06; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Sarosiek KA, 2010, P NATL ACAD SCI USA, V107, P13069, DOI 10.1073/pnas.1002985107; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Shou YP, 2000, P NATL ACAD SCI USA, V97, P228, DOI 10.1073/pnas.97.1.228; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; WABINGA HR, 1993, INT J CANCER, V54, P26, DOI 10.1002/ijc.2910540106; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; You JX, 2006, J VIROL, V80, P8909, DOI 10.1128/JVI.00502-06; Zhao Hong, 2013, Methods Mol Biol, V965, P83, DOI 10.1007/978-1-62703-239-1_5; Zhao JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001067; Zhu XC, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-98; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	38	73	77	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 29	2014	33	22					2928	2937		10.1038/onc.2013.242	http://dx.doi.org/10.1038/onc.2013.242			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EI	23792448	Green Accepted			2022-12-25	WOS:000337231800012
J	Rojko, N; Kristan, KC; Viero, G; Zerovnik, E; Macek, P; Dalla Serra, M; Anderluh, G				Rojko, Nejc; Kristan, Katarina C.; Viero, Gabriella; Zerovnik, Eva; Macek, Peter; Dalla Serra, Mauro; Anderluh, Gregor			Membrane Damage by an alpha-Helical Pore-forming Protein, Equinatoxin II, Proceeds through a Succession of Ordered Steps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANEMONE STICHODACTYLA-HELIANTHUS; N-TERMINAL REGION; SEA-ANEMONE; LIPID-MEMBRANES; STICHOLYSIN-I; ACTINIA-EQUINA; TOXIN; MECHANISM; MUTANTS; PREPORE	Actinoporin equinatoxin II (EqtII) is an archetypal example of alpha-helical pore-forming toxins that porate cellular membranes by the use of alpha-helices. Previous studies proposed several steps in the pore formation: binding of monomeric protein onto the membrane, followed by oligomerization and insertion of the N-terminal alpha-helix into the lipid bilayer. We studied these separate steps with an EqtII triple cysteine mutant. The mutant was engineered to monitor the insertion of the N terminus into the lipid bilayer by labeling Cys-18 with a fluorescence probe and at the same time to control the flexibility of the N-terminal region by the disulfide bond formed between cysteines introduced at positions 8 and 69. The insertion of the N terminus into the membrane proceeded shortly after the toxin binding and was followed by oligomerization. The oxidized, non-lytic, form of the mutant was still able to bind to membranes and oligomerize at the same level as the wild-type or the reduced form. However, the kinetics of the N-terminal helix insertion, the release of calcein from erythrocyte ghosts, and hemolysis of erythrocytes was much slower when membrane-bound oxidized mutant was reduced by the addition of the reductant. Results show that the N-terminal region needs to be inserted in the lipid membrane before the oligomerization into the final pore and imply that there is no need for a stable prepore formation. This is different from beta-pore-forming toxins that often form beta-barrel pores via a stable prepore complex.	[Rojko, Nejc; Kristan, Katarina C.; Macek, Peter; Anderluh, Gregor] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana 1000, Slovenia; [Viero, Gabriella; Dalla Serra, Mauro] CNR, Ist Biofis, I-38123 Trento, Italy; [Viero, Gabriella; Dalla Serra, Mauro] Fdn Bruno Kessler, I-38123 Trento, Italy; [Zerovnik, Eva] Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, Ljubljana 1000, Slovenia; [Anderluh, Gregor] Natl Inst Chem, Ljubljana 1000, Slovenia; [Anderluh, Gregor] En Fist Ctr Excellence, Ljubljana 1000, Slovenia	University of Ljubljana; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Fondazione Bruno Kessler; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; National Institute of Chemistry - Slovenia	Anderluh, G (corresponding author), Natl Inst Chem, Lab Mol Biol & Nanobiotechnol, Hajdrihova 19, Ljubljana 1000, Slovenia.	gregor.anderluh@ki.si	Maček, Peter/U-4662-2017; Serra, Mauro Dalla/AAK-9299-2021; Zerovnik, Eva/AAB-6498-2022; Viero, Gabriella/G-2096-2012; Anderluh, Gregor/C-6905-2014; Maček, Peter/Y-9877-2019; Serra, Mauro Dalla/A-6218-2010	Maček, Peter/0000-0001-6470-7759; Serra, Mauro Dalla/0000-0003-1048-2739; Viero, Gabriella/0000-0002-6755-285X; Anderluh, Gregor/0000-0002-9916-8465; Maček, Peter/0000-0001-6470-7759; Serra, Mauro Dalla/0000-0003-1048-2739	Slovenian Research Agency	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by grants from the Slovenian Research Agency.	Alegre-Cebollada J, 2008, J MOL BIOL, V382, P920, DOI 10.1016/j.jmb.2008.07.053; Anderluh G, 2003, J BIOL CHEM, V278, P45216, DOI 10.1074/jbc.M305916200; Anderluh G, 1999, EUR J BIOCHEM, V263, P128, DOI 10.1046/j.1432-1327.1999.00477.x; Anderluh G, 1998, BIOCHEM BIOPH RES CO, V242, P187, DOI 10.1006/bbrc.1997.7944; Anderluh G, 1996, BIOCHEM BIOPH RES CO, V220, P437, DOI 10.1006/bbrc.1996.0391; Anderluh G, 2002, TOXICON, V40, P111, DOI 10.1016/S0041-0101(01)00191-X; Anderluh G, 2008, TRENDS BIOCHEM SCI, V33, P482, DOI 10.1016/j.tibs.2008.07.004; Anderluh G, 2005, PROTEIN-LIPID INTERACTIONS: FROM MEMBRANE DOMAINS TO CELLULAR NETWORKS, P141; Athanasiadis A, 2001, STRUCTURE, V9, P341, DOI 10.1016/S0969-2126(01)00592-5; Bakrac B, 2008, J BIOL CHEM, V283, P18665, DOI 10.1074/jbc.M708747200; BELMONTE G, 1993, J MEMBRANE BIOL, V131, P11, DOI 10.1007/BF02258530; Castrillo I, 2010, PROTEINS, V78, P1959, DOI 10.1002/prot.22712; Comai M, 2002, MOL MICROBIOL, V44, P1251, DOI 10.1046/j.1365-2958.2002.02943.x; Dalla Serra M, 2000, METH MOL B, V145, P171; Dalla Serra M, 2001, ELS, DOI [10.1002/9780470015902.a0002655.pub2, DOI 10.1002/9780470015902.A0002655.PUB2]; Drechsler A, 2006, BIOCHEMISTRY-US, V45, P1818, DOI 10.1021/bi052166o; Fang Y, 1997, BIOCHEMISTRY-US, V36, P9518, DOI 10.1021/bi970600j; Garcia-Ortega L, 2011, BBA-BIOMEMBRANES, V1808, P2275, DOI 10.1016/j.bbamem.2011.05.012; Gutierrez-Aguirre I, 2004, BIOCHEM J, V384, P421, DOI 10.1042/BJ20040601; Heuck AP, 2000, MOL CELL, V6, P1233, DOI 10.1016/S1097-2765(00)00119-2; Heuck AP, 2003, J BIOL CHEM, V278, P31218, DOI 10.1074/jbc.M303151200; Heuck AP, 2001, BIOCHEMISTRY-US, V40, P9065, DOI 10.1021/bi0155394; Hinds MG, 2002, J MOL BIOL, V315, P1219, DOI 10.1006/jmbi.2001.5321; Hong Q, 2002, J BIOL CHEM, V277, P41916, DOI 10.1074/jbc.M204625200; Jimenez-Juarez N, 2008, PEPTIDES, V29, P318, DOI 10.1016/j.peptides.2007.09.026; Kristan K, 2004, J BIOL CHEM, V279, P46509, DOI 10.1074/jbc.M406193200; Kristan K, 2007, FEBS J, V274, P539, DOI 10.1111/j.1742-4658.2006.05608.x; Kristan KC, 2009, TOXICON, V54, P1125, DOI 10.1016/j.toxicon.2009.02.026; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; MACEK P, 1995, EUR J BIOCHEM, V234, P329, DOI 10.1111/j.1432-1033.1995.329_c.x; Malovrh P, 2000, BIOCHEM J, V346, P223, DOI 10.1042/0264-6021:3460223; Malovrh P, 2003, J BIOL CHEM, V278, P22678, DOI 10.1074/jbc.M300622200; Mancheno JM, 2003, STRUCTURE, V11, P1319, DOI 10.1016/j.str.2003.09.019; Mechaly AE, 2011, STRUCTURE, V19, P181, DOI 10.1016/j.str.2010.11.013; Miller CJ, 1999, BIOCHEMISTRY-US, V38, P10432, DOI 10.1021/bi990792d; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Pardo-Cea MA, 2011, FEBS J, V278, P2080, DOI 10.1111/j.1742-4658.2011.08123.x; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Tejuca M, 2001, J MEMBRANE BIOL, V183, P125, DOI 10.1007/s00232-001-0060-y; Tejuca M, 1996, BIOCHEMISTRY-US, V35, P14947, DOI 10.1021/bi960787z; THANNHAUSER TW, 1984, ANAL BIOCHEM, V138, P181, DOI 10.1016/0003-2697(84)90786-3; Valcarcel CA, 2001, BIOPHYS J, V80, P2761, DOI 10.1016/S0006-3495(01)76244-3; Viero G, 2008, CELL MOL LIFE SCI, V65, P312, DOI 10.1007/s00018-007-7491-2; Whitson KB, 2004, ANAL BIOCHEM, V324, P227, DOI 10.1016/j.ab.2003.09.023	45	66	66	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23704	23715		10.1074/jbc.M113.481572	http://dx.doi.org/10.1074/jbc.M113.481572			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23803608	Green Published, hybrid			2022-12-25	WOS:000330611400011
J	Santa Maria, SR; Kwon, Y; Sung, P; Klein, HL				Santa Maria, Sergio R.; Kwon, YoungHo; Sung, Patrick; Klein, Hannah L.			Characterization of the Interaction between the Saccharomyces cerevisiae Rad51 Recombinase and the DNA Translocase Rdh54	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Remodeling; DNA Damage Response; DNA Recombination; DNA Repair; Genomic Instability; DNA Recombinases; DNA Translocases; DNA-Protein Interactions; Rad51	PROTEIN TID1P; YEAST RAD51; DMC1; HOMOLOG; REPAIR; CHROMATIN	The Saccharomyces cerevisiae Rdh54 protein is a member of the Swi2/Snf2 family of DNA translocases required for meiotic and mitotic recombination and DNA repair. Rdh54 interacts with the general recombinases Rad51 and Dmc1 and promotes D-loop formation with either recombinase. Rdh54 also mediates the removal of Rad51 from undamaged chromatin in mitotic cells, which prevents formation of nonrecombinogenic complexes that can otherwise become toxic for cell growth. To determine which of the mitotic roles of Rdh54 are dependent on Rad51 complex formation, we finely mapped the Rad51 interaction domain in Rdh54, generated N-terminal truncation variants, and characterized their attributes biochemically and in cells. Here, we provide evidence suggesting that the N-terminal region of Rdh54 is not necessary for the response to the DNA-damaging agent methyl methanesulfonate. However, truncation variants missing 75-200 residues at the N terminus are sensitive to Rad51 overexpression. Interestingly, a hybrid protein containing the N-terminal region of Rad54, responsible for Rad51 interaction, fused to the Swi2/Snf2 core of Rdh54 is able to effectively complement the sensitivity to both methyl methanesulfonate and excess Rad51 in rdh54 null cells. Altogether, these results reveal a distinction between damage sensitivity and Rad51 removal with regard to Rdh54 interaction with Rad51.	[Santa Maria, Sergio R.; Klein, Hannah L.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Kwon, YoungHo; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	New York University; Yale University	Klein, HL (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA.	hannah.klein@nyumc.org		Klein, Hannah/0000-0003-4228-8535	National Institutes of Health [CA146940]; American Cancer Society Postdoctoral Fellowship [PF-11088-01-DMC]; NATIONAL CANCER INSTITUTE [R01CA146940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Postdoctoral Fellowship(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA146940 (to H. L. K. and P. S.). Supported by American Cancer Society Postdoctoral Fellowship PF-11088-01-DMC.	Chi P, 2006, J BIOL CHEM, V281, P26268, DOI 10.1074/jbc.M602983200; Dresser ME, 1997, GENETICS, V147, P533; Ferrari M, 2013, DNA REPAIR, V12, P347, DOI 10.1016/j.dnarep.2013.02.004; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Holzen TM, 2006, GENE DEV, V20, P2593, DOI 10.1101/gad.1447106; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; Jiang H, 1996, J BIOL CHEM, V271, P33181, DOI 10.1074/jbc.271.52.33181; Kateneva AV, 2005, J CELL BIOL, V171, P241, DOI 10.1083/jcb.200505020; Klein HL, 1997, GENETICS, V147, P1533; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Kwon YH, 2008, J BIOL CHEM, V283, P10445, DOI 10.1074/jbc.M800082200; Lee SE, 2001, CURR BIOL, V11, P1053, DOI 10.1016/S0960-9822(01)00296-2; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Nimonkar AV, 2012, J BIOL CHEM, V287, P28727, DOI 10.1074/jbc.M112.373290; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Petukhova G, 2000, GENE DEV, V14, P2206, DOI 10.1101/gad.826100; Prasad TK, 2007, J MOL BIOL, V369, P940, DOI 10.1016/j.jmb.2007.04.005; Raschle M, 2004, J BIOL CHEM, V279, P51973, DOI 10.1074/jbc.M410101200; Shah PP, 2010, MOL CELL, V39, P862, DOI 10.1016/j.molcel.2010.08.028; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; Shinohara M, 1997, GENETICS, V147, P1545; Shinohara M, 2003, GENETICS, V163, P1273; Tanaka K, 2002, NUCLEIC ACIDS RES, V30, P1346, DOI 10.1093/nar/30.6.1346; Thompson LH, 2002, MUTAT RES-FUND MOL M, V509, P49, DOI 10.1016/S0027-5107(02)00224-5	24	8	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21999	10.1074/jbc.M113.480475	http://dx.doi.org/10.1074/jbc.M113.480475			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23798704	Green Published, hybrid			2022-12-25	WOS:000328841900046
J	Benhaim, D; Begout, ML; Lucas, G; Chatain, B				Benhaim, David; Begout, Marie-Laure; Lucas, Gael; Chatain, Beatrice			First Insight into Exploration and Cognition in Wild Caught and Domesticated Sea Bass (Dicentrarchus labrax) in a Maze	PLOS ONE			English	Article							ONCORHYNCHUS-MYKISS; ATLANTIC SALMON; ANTIPREDATOR BEHAVIOR; PIMEPHALES-PROMELAS; FATHEAD MINNOWS; FISH; GROWTH; HATCHERY; TROUT; SIZE	European sea bass aquaculture is so recent that very little is known on the effects of the early steps of its domestication. Behavioural parameters are sensitive indicators of the domestication process since they are generally impacted as soon as the first generation. The present work compared wild-caught and domesticated sea bass juvenile swimming activity, exploration and ability to learn to discriminate between two 2-D objects associated to a simple spatial task that enabled the tested individual to visually interact with an unfamiliar congener (the reward) located behind a transparent wall at the end of one of the two arms of a maze. Ten fish from each origin were individually tested 3 times in a row during 3 days (9 trials in total). Fish were placed in a start box closed by a transparent wall located in front of two 2-D objects. Fish were filmed during 10 min after the removal of the start box wall. Different swimming variables including angular velocity, total distance travelled and velocity mean, were analyzed from videos as well as the time spent in each of 6 virtual zones including the reward zone near the congener (Cong) and the zone opposite to the reward zone (OpCong). Two learning criteria were chosen: the number of successful turns and time to reach Cong. Behavioural differences were found between domesticated and wild fish. Angular velocity was higher in wild fish while the distance travelled and the velocity mean were higher in domesticated ones. Wild and domesticated fish spent most of the time in Cong and in OpCong. No differences were seen in learning ability between wild and domesticated fish. However, our findings for learning require confirmation by further studies with larger numbers of learning sessions and experiments designed to minimise stress. This study therefore demonstrated an impact of domestication on swimming behaviour but not on spatial learning.	[Benhaim, David; Lucas, Gael] INTECHMER CNAM, LERMA, Cherbourg, France; [Begout, Marie-Laure] IFREMER, Lab Ressources Halieut, Lhoumeau, France; [Chatain, Beatrice] Stn Expt Aquaculture Ifremer, Lab Rech Piscicole Mediterrane, Palavas Les Flots, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); Ifremer	Benhaim, D (corresponding author), INTECHMER CNAM, LERMA, BP 324, Cherbourg, France.	david.benhaim@cnam.fr	Begout, Marie-Laure/L-7730-2019; Benhaim, David/A-9991-2019	Begout, Marie-Laure/0000-0003-1416-3479; 				ABBOTT JC, 1985, BEHAVIOUR, V92, P241; Allen PJ, 2009, J FISH BIOL, V74, P90, DOI 10.1111/j.1095-8649.2008.02112.x; Alves C, 2007, ANIM COGN, V10, P29, DOI 10.1007/s10071-006-0027-6; Anthouard M., 1993, ICHTYOPHYSIOL ACTA, V16, P59; Balon EK, 2004, J FISH BIOL, V65, P1, DOI 10.1111/j.0022-1112.2004.00563.x; Barnabe G., 1989, AQUACULTURE, P675; Beamish F.W.H., 1978, FISH PHYSIOL, V7, P101; Begout-Anras ML, 2004, INRA PROD ANIM, V7, P211; Benhaim D., 2013, Journal of Aquaculture Research and Development, V4, P169; Benhaim D, 2012, APPL ANIM BEHAV SCI, V141, P79, DOI 10.1016/j.applanim.2012.07.002; Benhaim D, 2012, APPL ANIM BEHAV SCI, V136, P63, DOI 10.1016/j.applanim.2011.11.010; Benhaim D, 2011, AQUAT LIVING RESOUR, V24, P391, DOI 10.1051/alr/2011140; Berejikian BA, 1995, CAN J FISH AQUAT SCI, V52, P2476, DOI 10.1139/f95-838; Brown C, 2005, BEHAV ECOL, V16, P482, DOI 10.1093/beheco/ari016; Brown C, 2001, J FISH BIOL, V59, P471, DOI [10.1006/jfbi.2001.1689, 10.1111/j.1095-8649.2001.tb02354.x]; Brown C, 2007, FISH COGNITION BEHAV; Brown GE, 2007, LEARNING DANGER CHEM; Burns JG, 2009, ETHOLOGY, V115, P122, DOI 10.1111/j.1439-0310.2008.01585.x; CHIVERS DP, 1994, ANIM BEHAV, V48, P597, DOI 10.1006/anbe.1994.1279; Coves D, 2006, AQUACULTURE, V253, P385, DOI 10.1016/j.aquaculture.2005.08.015; Coves D, 1998, AQUAT LIVING RESOUR, V11, P395, DOI 10.1016/S0990-7440(99)80005-9; Dellefors Claes, 1995, Nordic Journal of Freshwater Research, V70, P31; Di-Poi C, 2007, PHYSIOL BEHAV, V90, P559, DOI 10.1016/j.physbeh.2006.11.005; Di-Poi C., 2008, THESIS SAINT ETIENNE; Duarte CM, 2007, SCIENCE, V316, P382, DOI 10.1126/science.1138042; Dudchenko PA, 2001, BEHAV NEUROSCI, V115, P850, DOI 10.1037//0735-7044.115.4.850; Dupont-Nivet M, 2008, AQUACULTURE, V275, P81, DOI 10.1016/j.aquaculture.2007.12.032; Einum S, 1997, J FISH BIOL, V50, P634, DOI 10.1006/jfbi.1996.0330; Ferno A, 2007, ROLE FISH LEARNING S; Ferno Anders, 1998, Nordic Journal of Freshwater Research, V0, P95; Fontaine P, 2003, CAHIERS AGR, V19, P119; Gibson BM, 2005, BEHAV NEUROSCI, V119, P567, DOI 10.1037/0735-7044.119.2.567; Gross MR, 1998, CAN J FISH AQUAT SCI, V55, P131, DOI 10.1139/cjfas-55-S1-131; Huntingford FA, 2004, J FISH BIOL, V65, P122, DOI 10.1111/j.0022-1112.2004.00562.x; JOHNSSON JI, 1991, CAN J FISH AQUAT SCI, V48, P243, DOI 10.1139/f91-033; Johnsson JI, 1996, CAN J FISH AQUAT SCI, V53, P1546, DOI 10.1139/cjfas-53-7-1546; Johnsson JI, 2001, CAN J FISH AQUAT SCI, V58, P788, DOI 10.1139/cjfas-58-4-788; Kieffer J.D., 1992, Reviews in Fish Biology and Fisheries, V2, P125, DOI 10.1007/BF00042881; KLEEREKOPER H, 1974, ANIM BEHAV, V22, P124, DOI 10.1016/S0003-3472(74)80061-8; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Kotrschal K, 1998, REV FISH BIOL FISHER, V8, P373, DOI 10.1023/A:1008839605380; L?pez JC., 1999, ANIM COGN, V2, P109, DOI 10.1007/s100710050031; MAGURRAN AE, 1989, ETHOLOGY, V82, P216, DOI 10.1111/j.1439-0310.1989.tb00501.x; Malavasi S, 2004, J FISH BIOL, V65, P143, DOI 10.1111/j.0022-1112.2004.00545.x; Malavasi S, 2008, AQUAC RES, V39, P276, DOI 10.1111/j.1365-2109.2007.01894.x; Marchetti MP, 2003, ENVIRON BIOL FISH, V66, P9, DOI 10.1023/A:1023269221678; MATHIS A, 1993, ANIM BEHAV, V46, P645, DOI 10.1006/anbe.1993.1241; Matthews KR, 1990, ENVIRON BIOL FISH, V29, P141; Millot S, 2008, AQUACULTURE, V274, P87, DOI 10.1016/j.aquaculture.2007.11.004; Millot S, 2009, APPL ANIM BEHAV SCI, V119, P108, DOI 10.1016/j.applanim.2009.03.009; Odling-Smee L, 2003, FISH FISH, V4, P235, DOI 10.1046/j.1467-2979.2003.00127.x; Odling-Smee L, 2007, ROLE LEARNING FISH O; PEUHKURI N, 1995, J FISH BIOL, V46, P221, DOI 10.1111/j.1095-8649.1995.tb05963.x; POYSA H, 1994, ANIM BEHAV, V48, P921, DOI 10.1006/anbe.1994.1317; RANTA E, 1993, AM NAT, V142, P42, DOI 10.1086/285528; REESE ES, 1989, ENVIRON BIOL FISH, V25, P79, DOI 10.1007/BF00002202; RESTLE F, 1957, PSYCHOL REV, V64, P217, DOI 10.1037/h0040678; Roberts G, 1996, ANIM BEHAV, V51, P1077, DOI 10.1006/anbe.1996.0109; RUSSELL EM, 1967, ANIM BEHAV, V15, P586, DOI 10.1016/0003-3472(67)90062-0; Siebeck UE, 2009, J EXP BIOL, V212, P2112, DOI 10.1242/jeb.028936; Sovrano VA, 2008, ANIM COGN, V11, P161, DOI 10.1007/s10071-007-0100-9; STIRLING HP, 1977, MAR BIOL, V40, P173, DOI 10.1007/BF00396264; Vandeputte M, 2009, AQUACULTURE, V286, P20, DOI 10.1016/j.aquaculture.2008.09.008; Waples RS, 1999, FISHERIES, V24, P12, DOI 10.1577/1548-8446(1999)024<0012:DSMAH>2.0.CO;2; Warburton K, 2007, LEARNING FORAGING SK; Ward AJW, 2011, P NATL ACAD SCI USA, V108, P2312, DOI 10.1073/pnas.1007102108	66	16	16	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e65872	10.1371/journal.pone.0065872	http://dx.doi.org/10.1371/journal.pone.0065872			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805190	Green Published, gold			2022-12-25	WOS:000320846500018
J	Gilat, M; Shine, JM; Bolitho, SJ; Matar, E; Kamsma, YPT; Naismith, SL; Lewis, SJG				Gilat, Moran; Shine, James M.; Bolitho, Samuel J.; Matar, Elie; Kamsma, Yvo P. T.; Naismith, Sharon L.; Lewis, Simon J. G.			Variability of Stepping during a Virtual Reality Paradigm in Parkinson's Disease Patients with and without Freezing of Gait	PLOS ONE			English	Article								Background: Freezing of gait is a common and debilitating symptom affecting many patients with advanced Parkinson's disease. Although the pathophysiology of freezing of gait is not fully understood, a number of observations regarding the pattern of gait in patients with this symptom have been made. Increased 'Stride Time Variability' has been one of the most robust of these features. In this study we sought to identify whether patients with freezing of gait demonstrated similar fluctuations in their stepping rhythm whilst performing a seated virtual reality gait task that has recently been used to demonstrate the neural correlate of the freezing phenomenon. Methods: Seventeen patients with freezing and eleven non-freezers performed the virtual reality task twice, once whilst 'On' their regular Parkinsonian medication and once in their practically defined 'Off' state. Results: All patients displayed greater step time variability during their 'Off' state assessment compared to when medicated. Additionally, in the 'Off' state, patients with freezing of gait had greater step time variability compared to non-freezers. The five steps leading up to a freezing episode in the virtual reality environment showed a significant increase in step time variability although the final three steps preceding the freeze were not characterized by a progressive shortening of latency. Conclusions: The results of this study suggest that characteristic features of gait disturbance observed in patients with freezing of gait can also be demonstrated with a virtual reality paradigm. These findings suggest that virtual reality may offer the potential to further explore the freezing phenomenon in Parkinson's disease.	[Gilat, Moran; Shine, James M.; Bolitho, Samuel J.; Matar, Elie; Naismith, Sharon L.; Lewis, Simon J. G.] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [Gilat, Moran; Kamsma, Yvo P. T.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands	University of Sydney; University of Groningen	Lewis, SJG (corresponding author), Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia.	simonl@med.usyd.edu.au	Lewis, Simon/R-9469-2016	Lewis, Simon/0000-0002-4093-7071; Gilat, Moran/0000-0002-0072-4637; Shine, James/0000-0003-1762-5499; Naismith, Sharon/0000-0001-9076-2778; Matar, Elie/0000-0002-4994-0488	Michael J. Fox Foundation; National Health and Medical Research Council Practitioner Fellowship [1003007]; National Health and Medical Research Council [1008117]; 'het Prinses Beatrix Fonds', The Netherlands	Michael J. Fox Foundation; National Health and Medical Research Council Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); 'het Prinses Beatrix Fonds', The Netherlands(Netherlands Government)	This work is supported by the Michael J. Fox Foundation (www.michaeljfox.org). A/Prof Lewis is supported by the National Health and Medical Research Council Practitioner Fellowship No. 1003007; A/Prof Naismith is supported by the National Health and Medical Research Council Career Development Award No. 1008117; and Moran Gilat MSc. is supported by a scholarship from 'het Prinses Beatrix Fonds', The Netherlands (www.prinsesbeatrixspierfonds.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLIN O, 1990, J NEUROL SCI, V98, P91, DOI 10.1016/0022-510X(90)90184-O; Cowie D, 2012, MOVEMENT DISORD, V27, P492, DOI 10.1002/mds.23990; Espay AJ, 2012, NEUROLOGY, V78, P454, DOI 10.1212/WNL.0b013e3182477ec0; FAHN S, 1995, ADV NEUROL, V67, P53; Giladi N, 2001, J NEURAL TRANSM, V108, P53, DOI 10.1007/s007020170096; Giladi N, 2001, NEUROLOGY, V56, P1712, DOI 10.1212/WNL.56.12.1712; Giladi N, 2008, MOVEMENT DISORD, V23, pS423, DOI 10.1002/mds.21927; Gray P, 2000, J Neurosci Nurs, V32, P222; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; Hausdorff JM, 2003, EXP BRAIN RES, V149, P187, DOI 10.1007/s00221-002-1354-8; Iansek R, 2006, MOVEMENT DISORD, V21, P1419, DOI 10.1002/mds.20998; Ijmker T, 2012, GAIT POSTURE, V35, P126, DOI 10.1016/j.gaitpost.2011.08.022; Lord S, 2011, J NEUROL, V258, P566, DOI 10.1007/s00415-010-5789-8; Moore ST, 2008, J NEUROSCI METH, V167, P340, DOI 10.1016/j.jneumeth.2007.08.023; Moreau C, 2008, J NEURAL TRANSM, V115, P1431, DOI 10.1007/s00702-008-0099-3; Morris TR, 2012, PARKINSONISM RELAT D, V18, P572, DOI 10.1016/j.parkreldis.2012.03.001; Morris TR, 2012, GAIT POSTUR IN PRESS; Naismith SL, 2010, J CLIN NEUROSCI, V17, P984, DOI 10.1016/j.jocn.2009.12.006; Nieuwboer A, 2001, MOVEMENT DISORD, V16, P1066, DOI 10.1002/mds.1206; Plotnik M, 2008, MOVEMENT DISORD, V23, pS444, DOI 10.1002/mds.21984; Spildooren J, 2010, MOVEMENT DISORD, V25, P2563, DOI 10.1002/mds.23327	21	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66718	10.1371/journal.pone.0066718	http://dx.doi.org/10.1371/journal.pone.0066718			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805270	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500098
J	Ikeda, T; Kumagai, E; Iwata, S; Yamakawa, A				Ikeda, Tetsurou; Kumagai, Emi; Iwata, Satoshi; Yamakawa, Akio			Soluble CD26/Dipeptidyl Peptidase IV Enhances the Transcription of IL-6 and TNF-alpha in THP-1 Cells and Monocytes	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; IMMUNE-RESPONSE; CD26; ACTIVATION; PHOSPHORYLATION; EXPRESSION; CAVEOLIN-1; ANTIBODY; CLONING; RANTES	CD26 is a 110-kDa multifunctional molecule having dipeptidyl peptidase IV (DPPIV) enzyme activity and is present on the surface of human T cells. Soluble CD26 (sCD26) exists in human blood and enhances the proliferation of peripheral T lymphocytes induced by tetanus toxoid (TT). The mechanisms by which CD26 enhances the activation of T cells and monocytes remain to be fully elucidated. In this study, we compared the stimulation of THP-1 cells and isolated human monocytes with a combination of recombinant sCD26 and lipopolysaccharide (LPS) and the stimulation of these cells with LPS alone. We found that addition of sCD26 increased TNF-alpha and IL-6 mRNA and protein expression and enhanced ERK1/2 levels in the cytosol as well as c-Fos, NF-kappa B p50, NF-kappa B p65, and CUX1 levels in the nuclei of these cells. On the other hand, the selective DPPIV inhibitor sitagliptin inhibited the increase in TNF-alpha mRNA and protein expression as well as the increase in ERK, c-Fos, NF-kappa B p50, NF-kappa B p65, and CUX1 levels. However, it did not inhibit the increase in IL-6 mRNA and protein expression. We then demonstrated that sCD26 enhanced binding of transcription factors to the TNF- and IL-6 promoters and used reporter assays to demonstrate that transcription factor binding enhanced promoter activity. Once again, we observed differential activities at the TNF- and IL-6 promoters. Finally, we demonstrated that CUX-1 overexpression enhanced TNF- production on sCD26/LPS stimulation, while CUX-1 depletion had no effect. Neither CUX-1 overexpression nor CUX-1 depletion had an effect on IL-6 stimulation. These results are discussed in the context of a model that describes the mechanisms by which stimulation of monocytic cells by sCD26 and LPS leads to elevation of TNF- and IL-6 expression. CUX-1 is identified as a new transcription factor that differently regulates the activities of the TNF- and IL-6 promoters.	[Ikeda, Tetsurou; Kumagai, Emi; Iwata, Satoshi; Yamakawa, Akio] Univ Tokyo, Inst Med Sci, Tokyo, Japan	University of Tokyo	Ikeda, T (corresponding author), Univ Tokyo, Inst Med Sci, Tokyo, Japan.	ikedate4@ims.u-tokyo.ac.jp			Global COE Program "Center of Education and Research for Advanced Genome-Based Medicine for personalized medicine and the control of worldwide infectious disease", MEXT Japan	Global COE Program "Center of Education and Research for Advanced Genome-Based Medicine for personalized medicine and the control of worldwide infectious disease", MEXT Japan	The Global COE Program "Center of Education and Research for Advanced Genome-Based Medicine for personalized medicine and the control of worldwide infectious disease", MEXT Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Casrouge A, 2011, J CLIN INVEST, V121, P308, DOI 10.1172/JCI40594; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FLEISCHER B, 1994, IMMUNOL TODAY, V15, P180, DOI 10.1016/0167-5699(94)90316-6; FOX DA, 1984, J IMMUNOL, V133, P1250; Hegen M, 1997, IMMUNOLOGY, V90, P257, DOI 10.1046/j.1365-2567.1997.00053.x; Ikushima H, 2000, P NATL ACAD SCI USA, V97, P8439, DOI 10.1073/pnas.97.15.8439; Kahne T, 1998, CELL IMMUNOL, V189, P60, DOI 10.1006/cimm.1998.1355; Koga K, 2009, IMMUNITY, V30, P372, DOI 10.1016/j.immuni.2008.12.021; Korom S, 1997, TRANSPLANTATION, V63, P1495, DOI 10.1097/00007890-199705270-00021; KUBOTA T, 1992, CLIN EXP IMMUNOL, V89, P192; Manickasingham SP, 1998, J IMMUNOL, V161, P3827; Morimoto C, 1998, IMMUNOL REV, V161, P55, DOI 10.1111/j.1600-065X.1998.tb01571.x; NANUS DM, 1993, P NATL ACAD SCI USA, V90, P7069, DOI 10.1073/pnas.90.15.7069; Ohnuma K, 2005, MOL CELL BIOL, V25, P7743, DOI 10.1128/MCB.25.17.7743-7757.2005; Ohnuma K, 2004, P NATL ACAD SCI USA, V101, P14186, DOI 10.1073/pnas.0405266101; Oravecz T, 1997, J EXP MED, V186, P1865, DOI 10.1084/jem.186.11.1865; Ponticos M, 2009, NUCLEIC ACIDS RES, V37, P5378, DOI 10.1093/nar/gkp544; Proost P, 1998, J BIOL CHEM, V273, P7222, DOI 10.1074/jbc.273.13.7222; Sinclair AM, 2001, BLOOD, V98, P3658, DOI 10.1182/blood.V98.13.3658; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; TANAKA T, 1994, P NATL ACAD SCI USA, V91, P3082, DOI 10.1073/pnas.91.8.3082; TANAKA T, 1993, P NATL ACAD SCI USA, V90, P4586, DOI 10.1073/pnas.90.10.4586; TANAKA T, 1992, J IMMUNOL, V149, P481	23	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66520	10.1371/journal.pone.0066520	http://dx.doi.org/10.1371/journal.pone.0066520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805228	Green Submitted, Green Published, gold			2022-12-25	WOS:000320846500056
J	Seltmann, A; Majolo, B; Schulke, O; Ostner, J				Seltmann, Anne; Majolo, Bonaventura; Schuelke, Oliver; Ostner, Julia			The Organization of Collective Group Movements in Wild Barbary Macaques (Macaca sylvanus): Social Structure Drives Processes of Group Coordination in Macaques	PLOS ONE			English	Article							DECISION-MAKING; CONSENSUS DECISION; JAPANESE MACAQUES; DOMINANCE; PROPITHECUS; LEADERSHIP; STEEPNESS; DEPARTURE; BEHAVIOR; SIGNALS	Social animals have to coordinate activities and collective movements to benefit from the advantages of group living. Animals in large groups maintain cohesion by self-organization processes whereas in smaller groups consensus decisions can be reached. Where consensus decisions are relevant leadership may emerge. Variation in the organization of collective movements has been linked to variation in female social tolerance among macaque species ranging from despotic to egalitarian. Here we investigated the processes underlying group movements in a wild macaque species characterized by a degree of social tolerance intermediate to previously studied congeneric species. We focused on processes before, during and after the departure of the first individual. To this end, we observed one group of wild Barbary macaques (Macaca sylvanus) in the Middle Atlas, Morocco using all-occurrence behaviour sampling of 199 collective movements. We found that initiators of a collective movement usually chose the direction in which more individuals displayed pre-departure behavior. Dominant individuals contributed to group movements more than subordinates, especially juveniles, measured as frequencies of successful initiations and pre-departure behaviour. Joining was determined by affiliative relationships and the number of individuals that already joined the movement (mimetism). Thus, in our study group partially shared consensus decisions mediated by selective mimetism seemed to be prevalent, overall supporting the suggestion that a species' social style affects the organization of group movements. As only the most tolerant species show equally shared consensus decisions whereas in others the decision is partially shared with a bias to dominant individuals the type of consensus decisions seems to follow a stepwise relation. Joining order may also follow a stepwise, however opposite, relationship, because dominance only determined joining in highly despotic, but not in intermediate and tolerant species.	[Seltmann, Anne; Ostner, Julia] Univ Gottingen, Courant Res Ctr Evolut Social Behav, Primate Social Evolut Grp, Kellnerweg, Germany; [Majolo, Bonaventura] Lincoln Univ, Sch Psychol, Lincoln, England; [Schuelke, Oliver] Univ Gottingen, Courant Res Ctr Evolut Social Behav, Kellnerweg, Germany	University of Gottingen; University of Lincoln; University of Gottingen	Seltmann, A (corresponding author), Univ Gottingen, Courant Res Ctr Evolut Social Behav, Primate Social Evolut Grp, Kellnerweg, Germany.	anne.seltmann@stud.uni-goettingen.de		Majolo, Bonaventura/0000-0002-0235-3040	German Initiative of Excellence	German Initiative of Excellence	The study was supported by funds from the German Initiative of Excellence to Georg August University Gottingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Balasubramaniam KN, 2012, ANIM BEHAV, V83, P1207, DOI 10.1016/j.anbehav.2012.02.012; Berghanel A, 2011, ANIM BEHAV, V81, P1109, DOI 10.1016/j.anbehav.2011.02.009; Berghanel A, 2010, ANIM BEHAV, V80, P675, DOI 10.1016/j.anbehav.2010.07.002; BLACK JM, 1988, ETHOLOGY, V79, P143, DOI 10.1111/j.1439-0310.1988.tb00707.x; Bourjade M, 2010, BEHAV PROCESS, V84, P648, DOI 10.1016/j.beproc.2010.02.027; Bourjade M, 2009, ETHOLOGY, V115, P321, DOI 10.1111/j.1439-0310.2009.01614.x; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Conradt L, 2009, AM NAT, V173, P304, DOI 10.1086/596532; Conradt L, 2009, PHILOS T R SOC B, V364, P719, DOI 10.1098/rstb.2008.0276; De Vries H, 2006, ANIM BEHAV, V71, P585, DOI 10.1016/j.anbehav.2005.05.015; DEVRIES H, 1995, ANIM BEHAV, V50, P1375, DOI 10.1016/0003-3472(95)80053-0; Erhart EM, 1999, INT J PRIMATOL, V20, P927, DOI 10.1023/A:1020830703012; Fichtel C, 2011, COORDINATION IN HUMAN AND PRIMATE GROUPS, P37, DOI 10.1007/978-3-642-15355-6_3; Fischer J, 2011, COORDINATION IN HUMAN AND PRIMATE GROUPS, P229, DOI 10.1007/978-3-642-15355-6_13; Fischhoff IR, 2007, ANIM BEHAV, V73, P825, DOI 10.1016/j.anbehav.2006.10.012; Furrer RD, 2012, ANIM BEHAV, V84, P205, DOI 10.1016/j.anbehav.2012.04.034; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Hockings KJ, 2006, CURR BIOL, V16, pR668, DOI 10.1016/j.cub.2006.08.019; Jacobs A, 2011, INT J PRIMATOL, V32, P1311, DOI 10.1007/s10764-011-9554-3; Kaplan BS, 2011, INT J PRIMATOL, V32, P1397, DOI 10.1007/s10764-011-9541-8; King AJ, 2011, ANIM BEHAV, V82, P1337, DOI 10.1016/j.anbehav.2011.09.017; King AJ, 2011, INT J PRIMATOL, V32, P1245, DOI 10.1007/s10764-011-9526-7; King AJ, 2009, CURR BIOL, V19, pR911, DOI 10.1016/j.cub.2009.07.027; King AJ, 2008, CURR BIOL, V18, P1833, DOI 10.1016/j.cub.2008.10.048; Krause J, 2002, LIVING GROUPS; Kummer H., 1968, SOCIAL ORG HAMADRYAS; Leca JB, 2003, ANIM BEHAV, V66, P1045, DOI 10.1006/anbe.2003.2276; Menard N., 2004, MACAQUE SOC MODEL ST, P117; Pannozzo PL, 2007, ETHOLOGY, V113, P881, DOI 10.1111/j.1439-0310.2007.01392.x; Petit O, 2008, DEV PSYCHOBIOL, V50, P399, DOI 10.1002/dev.20305; Petit O, 2011, INT J PRIMATOL, V32, P1433, DOI 10.1007/s10764-011-9545-4; Prins H.H.T., 1996, ECOLOGY BEHAV AFRICA, P218; Pyritz L, 2010, BEHAV PROCESS, V84, P681, DOI 10.1016/j.beproc.2010.02.025; Pyritz LW, 2011, INT J PRIMATOL, V32, P1325, DOI 10.1007/s10764-011-9549-0; Pyritz LW, 2011, INT J PRIMATOL, V32, P1268, DOI 10.1007/s10764-011-9524-9; Reinhart C.J., 2010, INT J COMP PSYCHOL, V23, P166; Sapolsky RM, 1997, ARCH GEN PSYCHIAT, V54, P1137; Schulke O, 2010, CURR BIOL, V20, P2207, DOI 10.1016/j.cub.2010.10.058; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Silk JB, 2006, BEHAV ECOL SOCIOBIOL, V61, P183, DOI 10.1007/s00265-006-0249-2; STEWART KJ, 1994, BEHAVIOUR, V130, P29, DOI 10.1163/156853994X00127; Stueckle S, 2008, ANIM BEHAV, V75, P1995, DOI 10.1016/j.anbehav.2007.12.012; Sueur C, 2008, BEHAV PROCESS, V78, P84, DOI 10.1016/j.beproc.2008.01.004; Sueur C, 2009, ANIM BEHAV, V78, P1087, DOI 10.1016/j.anbehav.2009.07.029; Sueur C., 2010, P R SOC B, V278, P1697; Sueur C, 2012, COMPL SYST IN PRESS; Sueur C, 2008, INT J PRIMATOL, V29, P1085, DOI 10.1007/s10764-008-9262-9; Sueur C, 2011, INT J PRIMATOL, V32, P1413, DOI 10.1007/s10764-011-9520-0; Sueur C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000917; Sueur C, 2010, BEHAV ECOL SOCIOBIOL, V64, P1875, DOI 10.1007/s00265-010-0999-8; Thierry B, 2008, ANIM BEHAV, V75, P847, DOI 10.1016/j.anbehav.2007.07.006; Thierry B, 2007, EVOL ANTHROPOL, V16, P224, DOI 10.1002/evan.20147; Thierry Bernard, 2004, Cambridge Studies in Biological and Evolutionary Anthropology, V41, P267; Thierry Bernard, 2004, Cambridge Studies in Biological and Evolutionary Anthropology, V41, P3; Trillmich J, 2004, BEHAVIOUR, V141, P1103, DOI 10.1163/1568539042664579; WASER PM, 1985, INT J PRIMATOL, V6, P569, DOI 10.1007/BF02692289; Young C, 2013, HORM BEHAV, V63, P32, DOI 10.1016/j.yhbeh.2012.11.004	58	17	17	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67285	10.1371/journal.pone.0067285	http://dx.doi.org/10.1371/journal.pone.0067285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805305	Green Published, Green Accepted, gold			2022-12-25	WOS:000320846500133
J	D'Haene, N; Sauvage, S; Maris, C; Adanja, I; Le Mercier, M; Decaestecker, C; Baum, L; Salmon, I				D'Haene, Nicky; Sauvage, Sebastien; Maris, Calliope; Adanja, Ivan; Le Mercier, Marie; Decaestecker, Christine; Baum, Linda; Salmon, Isabelle			VEGFR1 and VEGFR2 Involvement in Extracellular Galectin-1-and Galectin-3-Induced Angiogenesis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR ANGIOGENESIS; CELL-GROWTH; EXPRESSION; RECEPTORS; BINDING; PROTEIN; PLGF	Aim: Accumulating evidence suggests that extracellular galectin-1 and galectin-3 promote angiogenesis. Increased expression of galectin-1 and/or galectin-3 has been reported to be associated with tumour progression. Thus, it is critical to identify their influence on angiogenesis. Methods: We examined the individual and combined effects of galectin-1 and galectin-3 on endothelial cell (EC) growth and tube formation using two EC lines, EA.hy926 and HUVEC. The activation of vascular endothelial growth factor receptors (VEGFR1 and VEGFR2) was determined by ELISA and Western blots. We evaluated the VEGFR1 and VEGFR2 levels in endosomes by proximity ligation assay. Results: We observed different responses to exogenous galectins depending on the EC line. An enhanced effect on EA. hy926 cell growth and tube formation was observed when both galectins were added together. Focusing on this enhanced effect, we observed that together galectins induced the phosphorylation of both VEGFR1 and VEGFR2, whereas galectin-1 and -3 alone induced VEGFR2 phosphorylation only. In the same way, the addition of a blocking VEGFR1 antibody completely abolished the increase in tube formation induced by the combined addition of both galectins. In contrast, the addition of a blocking VEGFR2 antibody only partially inhibited this effect. Finally, the addition of both galectins induced a decrease in the VEGFR1 and VEGFR2 endocytic pools, with a significantly enhanced effect on the VEGFR1 endocytic pool. These results suggest that the combined action of galectin-1 and galectin-3 has an enhanced effect on angiogenesis via VEGFR1 activation, which could be related to a decrease in receptor endocytosis.	[D'Haene, Nicky; Sauvage, Sebastien; Maris, Calliope; Le Mercier, Marie; Salmon, Isabelle] Free Univ Brussels, Erasme Hosp, Dept Pathol, B-1050 Brussels, Belgium; [Adanja, Ivan; Decaestecker, Christine] Univ Libre Bruxelles, Lab Image Synth & Anal, Brussels Sch Engn, Ecole polytech Bruxelles, Brussels, Belgium; [Decaestecker, Christine; Salmon, Isabelle] ULB, DIAPATH Ctr Microscopy & Mol Imaging CMMI, Gosselies, Belgium; [Baum, Linda] Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Salmon, I (corresponding author), Free Univ Brussels, Erasme Hosp, Dept Pathol, B-1050 Brussels, Belgium.	isabelle.salmon@erasme.ulb.ac.be		Decaestecker, Christine/0000-0002-5495-1931	Fonds Erasme; Fonds Yvonne Boel (Brussels, Belgium); FNRS	Fonds Erasme; Fonds Yvonne Boel (Brussels, Belgium); FNRS(Fonds de la Recherche Scientifique - FNRS)	This work was performed with the support of grants awarded by the Fonds Erasme and the Fonds Yvonne Boel (Brussels, Belgium). C.D. is a Senior Research Associate with the "Fonds National de la Recherche Scientifique'' (FNRS), Brussels, Belgium. I.A. benefits from a Televie grant from the FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2004, GLYCOBIOLOGY, V14, P817, DOI 10.1093/glycob/cwh095; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Chi JT, 2003, P NATL ACAD SCI USA, V100, P10623, DOI 10.1073/pnas.1434429100; Clausse N, 1999, Angiogenesis, V3, P317, DOI 10.1023/A:1026584523789; D'Haene N, 2005, INT J IMMUNOPATH PH, V18, P431, DOI 10.1177/039463200501800304; D'Haene N, 2008, BRIT J HAEMATOL, V140, P402, DOI 10.1111/j.1365-2141.2007.06929.x; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Ebos JML, 2009, CLIN CANCER RES, V15, P5020, DOI 10.1158/1078-0432.CCR-09-0095; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Garner OB, 2008, BIOCHEM SOC T, V36, P1472, DOI 10.1042/BST0361472; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsieh SH, 2008, ONCOGENE, V27, P3746, DOI 10.1038/sj.onc.1211029; Imoukhuede PI, 2011, EXP CELL RES, V317, P955, DOI 10.1016/j.yexcr.2010.12.014; Jia JH, 2010, PROTEOMICS, V10, P224, DOI 10.1002/pmic.200900607; Kopitz J, 2001, J BIOL CHEM, V276, P35917, DOI 10.1074/jbc.M105135200; Leys C, 2010, J EXP SOC PSYCHOL, V46, P684, DOI 10.1016/j.jesp.2010.02.007; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Luttun A, 2004, BBA-REV CANCER, V1654, P79, DOI 10.1016/j.bbcan.2003.09.002; Markowska AI, 2011, J BIOL CHEM, V286, P29913, DOI 10.1074/jbc.M111.226423; Markowska AI, 2010, J EXP MED, V207, P1981, DOI 10.1084/jem.20090121; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Rorive S, 2008, GLIA, V56, P1679, DOI 10.1002/glia.20719; Scott A, 2009, BIOCHEM SOC T, V37, P1184, DOI 10.1042/BST0371184; Shtivelband MI, 2003, J THROMB HAEMOST, V1, P2225, DOI 10.1046/j.1538-7836.2003.00446.x; St Croix B, 2000, SCIENCE, V289, P1197; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Thijssen VLJL, 2007, BLOOD, V110, P2819, DOI 10.1182/blood-2007-03-077792; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; Thijssen VL, CANC RES, V70, P6216; Ulyatt C, 2011, BIOCHEM BIOPH RES CO, V404, P774, DOI 10.1016/j.bbrc.2010.12.057; Zar J., 2010, BIOSTATISCTICAL ANAL; Zhang Z, 2010, CELL DEATH DIFFER, V17, P499, DOI 10.1038/cdd.2009.152	36	83	83	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e67029	10.1371/journal.pone.0067029	http://dx.doi.org/10.1371/journal.pone.0067029			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799140	Green Submitted, Green Published, gold			2022-12-25	WOS:000321397800049
J	Tsai, CP; Lee, CTC				Tsai, Ching-Piao; Lee, Charles Tzu-Chi			Multiple Sclerosis Incidence Associated with the Soil Lead and Arsenic Concentrations in Taiwan	PLOS ONE			English	Article							ENVIRONMENTAL-FACTORS; RISK; PREVALENCE; POPULATION; ACIDS	Background: Few studies in the world have assessed the incidence of multiple sclerosis (MS) with soil heavy metal concentrations. We explored the association of soil heavy metal factors and the MS incidence in Taiwan. Methods: There were 1240 new MS cases from the National Health Insurance Research Database and were verified with serious disabling disease certificates, 1997-2008. Soil heavy metal factors records included arsenic, mercury, cadmium, chromium, copper, nickel, lead and zinc in Taiwan from 1986 to 2002. Spatial regression was used to reveal the association of soil heavy metals and age- and gender-standardized incidence ratios for townships by controlling sunlight exposure hours, smoking prevalence and spatial autocorrelation. Results: The lead (Pb) concentration in the soil positively correlated with the township incidence; on the other hand, the arsenic (As) concentration in soil negatively correlated with the township incidence and when found together controlled each other. The positive correlation of lead (Pb) predominated in males, whereas the negative correlation of arsenic (As) in soil predominated in females. Conclusions: We conclude that exposure to lead (Pb) in soil positive associated with incidence of MS in Taiwan, especially in males. Exposure to arsenic (As) in soil negative associated with MS in Taiwan, especially in females.	[Tsai, Ching-Piao] Taipei Vet Gen Hosp, Neurol Inst, Taipei, Taiwan; [Tsai, Ching-Piao] Natl Yang Ming Univ, Taipei 112, Taiwan; [Lee, Charles Tzu-Chi] Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Kaohsiung Medical University	Lee, CTC (corresponding author), Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung, Taiwan.	charles@kmu.edu.tw			Ching-Ling Foundation of Taipei Veterans General Hospital	Ching-Ling Foundation of Taipei Veterans General Hospital	This research was supported by Ching-Ling Foundation of Taipei Veterans General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aelion CM, 2009, SCI TOTAL ENVIRON, V407, P2216, DOI 10.1016/j.scitotenv.2008.11.033; Ammatuna E, 2009, LEUKEMIA LYMPHOMA, V50, P1217, DOI 10.1080/10428190902912486; Benito-Leon J, 2011, NEUROEPIDEMIOLOGY, V36, P148, DOI 10.1159/000325368; Boffetta P, 2003, BRIT MED BULL, V68, P71, DOI 10.1093/bmp/ldg023; Chiang CT, 2010, INT J ENV RES PUB HE, V7, P3916, DOI 10.3390/ijerph7113916; Conradi S, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-123; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Elhami SR, 2011, NEUROEPIDEMIOLOGY, V36, P141, DOI 10.1159/000324708; Fisher AA, 2000, J NEUROL NEUROSUR PS, V69, P687, DOI 10.1136/jnnp.69.5.687; Giovannoni G, 2007, CURR OPIN NEUROL, V20, P261, DOI 10.1097/WCO.0b013e32815610c2; Hirst C, 2009, J NEUROL NEUROSUR PS, V80, P386, DOI 10.1136/jnnp.2008.144667; Hwang BF, 2008, ENVIRON HEALTH PERSP, V116, P1411, DOI 10.1289/ehp.11311; Johnson S, 2000, MED HYPOTHESES, V55, P239, DOI 10.1054/mehy.2000.1051; KLEIN D, 1994, BIOL REPROD, V50, P802, DOI 10.1095/biolreprod50.4.802; Koutsouraki E, 2010, INT REV PSYCHIATR, V22, P2, DOI 10.3109/09540261003589216; Lauer K, 2010, EXPERT REV NEUROTHER, V10, P421, DOI [10.1586/ern.10.7, 10.1586/ERN.10.7]; Lindberg AL, 2007, ENVIRON HEALTH PERSP, V115, P1081, DOI 10.1289/ehp.10026; Medade MS, 2000, MED GEOGRAPHY; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; POSKANZER DC, 1981, NEUROLOGY, V31, P708, DOI 10.1212/WNL.31.6.708; ROBERTSON DAF, 1983, BRIT MED J, V286, P605, DOI 10.1136/bmj.286.6365.605-a; Turabelidze G, 2008, J NEUROL SCI, V269, P158, DOI 10.1016/j.jns.2008.01.008; Wingerchuk DM, 2011, MT SINAI J MED, V78, P221, DOI 10.1002/msj.20240; Zhao HR, 2012, SCI TOTAL ENVIRON, V417, P45, DOI 10.1016/j.scitotenv.2011.12.047	24	24	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65911	10.1371/journal.pone.0065911	http://dx.doi.org/10.1371/journal.pone.0065911			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799061	Green Submitted, Green Published, gold			2022-12-25	WOS:000321397800020
J	Colle, D; Santos, DB; Moreira, ELG; Hartwig, JM; dos Santos, AA; Zimmermann, LT; Hort, MA; Farina, M				Colle, Dirleise; Santos, Danubia Bonfanti; Gasnhar Moreira, Eduardo Luiz; Hartwig, Juliana Montagna; dos Santos, Alessandra Antunes; Zimmermann, Luciana Teixeira; Hort, Mariana Appel; Farina, Marcelo			Probucol Increases Striatal Glutathione Peroxidase Activity and Protects against 3-Nitropropionic Acid-Induced Pro-Oxidative Damage in Rats	PLOS ONE			English	Article							INDUCED HUNTINGTONS-DISEASE; TRANSGENIC MOUSE MODEL; INDUCED NEUROTOXICITY; IN-VITRO; MITOCHONDRIAL DYSFUNCTION; SUPEROXIDE-DISMUTASE; COENZYME Q(10); ENERGY-METABOLISM; ANIMAL-MODEL; VITAMIN-E	Huntington's disease (HD) is an autosomal dominantly inherited neurodegenerative disease characterized by symptoms attributable to the death of striatal and cortical neurons. The molecular mechanisms mediating neuronal death in HD involve oxidative stress and mitochondrial dysfunction. Administration of 3-nitropropionic acid (3-NP), an irreversible inhibitor of the mitochondrial enzyme succinate dehydrogenase, in rodents has been proposed as a useful experimental model of HD. This study evaluated the effects of probucol, a lipid-lowering agent with anti-inflammatory and antioxidant properties, on the biochemical parameters related to oxidative stress, as well as on the behavioral parameters related to motor function in an in vivo HD model based on 3-NP intoxication in rats. Animals were treated with 3.5 mg/kg of probucol in drinking water daily for 2 months and, subsequently, received 3-NP (25 mg/kg i.p.) once a day for 6 days. At the end of the treatments, 3- NP-treated animals showed a significant decrease in body weight, which corresponded with impairment on motor ability, inhibition of mitochondrial complex II activity and oxidative stress in the striatum. Probucol, which did not rescue complex II inhibition, protected against behavioral and striatal biochemical changes induced by 3-NP, attenuating 3-NP-induced motor impairments and striatal oxidative stress. Importantly, probucol was able to increase activity of glutathione peroxidase (GPx), an enzyme important in mediating the detoxification of peroxides in the central nervous system. The major finding of this study was that probucol protected against 3-NP-induced behavioral and striatal biochemical changes without affecting 3-NP-induced mitochondrial complex II inhibition, indicating that long-term probucol treatment resulted in an increased resistance against neurotoxic events (i.e., increased oxidative damage) secondary to mitochondrial dysfunction. These data appeared to be of great relevance when extrapolated to human neurodegenerative processes involving mitochondrial dysfunction and indicates that GPx is an important molecular target involved in the beneficial effects of probucol.	[Colle, Dirleise; Santos, Danubia Bonfanti; Gasnhar Moreira, Eduardo Luiz; Hartwig, Juliana Montagna; dos Santos, Alessandra Antunes; Zimmermann, Luciana Teixeira; Hort, Mariana Appel; Farina, Marcelo] Univ Fed Santa Catarina, Dept Bioquim, Ctr Ciencias Biol, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC)	Colle, D (corresponding author), Univ Fed Santa Catarina, Dept Bioquim, Ctr Ciencias Biol, Florianopolis, SC, Brazil.	dirleise@yahoo.com.br; marcelo.farina@.ufsc.br	dos Santos, Alessandra Antunes/F-3484-2019; Hort, Mariana/T-7377-2019; Moreira, Eduardo/S-6205-2016; Farina, Marcelo/HFZ-8788-2022; Farina, Marcelo/AAH-2005-2019; Teixeira Zimmermann, Luciana/F-5284-2013	Hort, Mariana/0000-0001-5877-3506; Moreira, Eduardo/0000-0003-2306-2207; Farina, Marcelo/0000-0001-8255-8515; Teixeira Zimmermann, Luciana/0000-0002-6992-2148; Colle, Dirleise/0000-0003-2345-5297	FINEP Research Grant "Rede Instituto Brasileiro de Neurociencia (IBN-Net) [01.06.0842-00]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Apoio a Pesquisa do Estado de Santa Catarina (FAPESC) [TO 1346/2010-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); INCT-CNPq-Excitotoxicity and Neuroprotection; CNPq	FINEP Research Grant "Rede Instituto Brasileiro de Neurociencia (IBN-Net)(Financiadora de Inovacao e Pesquisa (Finep)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio a Pesquisa do Estado de Santa Catarina (FAPESC)(Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); INCT-CNPq-Excitotoxicity and Neuroprotection; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The financial supports by (i) FINEP Research Grant "Rede Instituto Brasileiro de Neurociencia (IBN-Net)" #01.06.0842-00, (ii) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), (iii) Fundacao de Apoio a Pesquisa do Estado de Santa Catarina (FAPESC - TO 1346/2010-3), (iv) Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and (v) INCT-CNPq-Excitotoxicity and Neuroprotection are gratefully acknowledged. MF is the recipient of a CNPq fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1974, EUR J BIOCHEM, V48, P137, DOI 10.1111/j.1432-1033.1974.tb03751.x; Al Mutairy A, 2010, NEUROTOXICOL TERATOL, V32, P226, DOI 10.1016/j.ntt.2009.09.003; ARCHER J, 1973, ANIM BEHAV, V21, P205, DOI 10.1016/S0003-3472(73)80065-X; Asiri YA, 2010, OXID MED CELL LONGEV, V3, P308, DOI 10.4161/oxim.3.5.13107; Avila DS, 2010, TOXICOL SCI, V115, P194, DOI 10.1093/toxsci/kfq036; Bhateja DK, 2012, EUR J PHARMACOL, V674, P33, DOI 10.1016/j.ejphar.2011.10.029; Borlongan CV, 1997, NEUROSCI BIOBEHAV R, V21, P289, DOI 10.1016/S0149-7634(96)00027-9; Borlongan CV, 1997, BRAIN RES PROTOC, V1, P253, DOI 10.1016/S1385-299X(96)00037-2; Browne SE, 2006, ANTIOXID REDOX SIGN, V8, P2061, DOI 10.1089/ars.2006.8.2061; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Chen CM, 2007, BIOCHEM BIOPH RES CO, V359, P335, DOI 10.1016/j.bbrc.2007.05.093; Chen Chiung-Mei, 2011, Chang Gung Med J, V34, P135; Cirillo G, 2010, NEUROCHEM INT, V56, P152, DOI 10.1016/j.neuint.2009.09.013; Colle D, 2013, MITOCHONDRION, V13, P125, DOI 10.1016/j.mito.2013.01.005; Colle D, 2012, BRAIN RES BULL, V87, P397, DOI 10.1016/j.brainresbull.2012.01.003; Dringen R, 2003, BIOL CHEM, V384, P505, DOI 10.1515/BC.2003.059; Drose S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6; Du YY, 2012, NEUROSCI LETT, V509, P110, DOI 10.1016/j.neulet.2011.12.054; Farina M, 2009, TOXICOL SCI, V112, P416, DOI 10.1093/toxsci/kfp219; FISCHER JC, 1985, CLIN CHIM ACTA, V153, P23, DOI 10.1016/0009-8981(85)90135-4; Franco JL, 2007, CHEM RES TOXICOL, V20, P1919, DOI 10.1021/tx7002323; Franco JL, 2009, FREE RADICAL BIO MED, V47, P449, DOI 10.1016/j.freeradbiomed.2009.05.013; Gopinath K, 2012, NEUROSCIENCE, V227, P134, DOI 10.1016/j.neuroscience.2012.07.060; Gu M, 1996, ANN NEUROL, V39, P385, DOI 10.1002/ana.410390317; Han I, 2010, J NEUROCHEM, V113, P1073, DOI 10.1111/j.1471-4159.2010.06672.x; Hands S, 2011, J BIOL CHEM, V286, P44512, DOI 10.1074/jbc.M111.307587; HASSEL B, 1995, J NEUROCHEM, V65, P1184; HEINSEN H, 1994, ACTA NEUROPATHOL, V88, P320, DOI 10.1007/BF00310376; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Hyson HC, 2010, MOVEMENT DISORD, V25, P1924, DOI 10.1002/mds.22408; Johri A, 2012, J PHARMACOL EXP THER, V342, P619, DOI 10.1124/jpet.112.192138; Jung KA, 2010, MOLECULES, V15, P7266, DOI 10.3390/molecules15107266; Kasparova S, 2006, NEUROCHEM INT, V48, P93, DOI 10.1016/j.neuint.2005.09.002; Klivenyi P, 2000, J NEUROSCI, V20, P1; Kumar P, 2007, FUND CLIN PHARMACOL, V21, P297, DOI 10.1111/j.1472-8206.2007.00485.x; Kumar P, 2011, BRIT J PHARMACOL, V164, P644, DOI 10.1111/j.1476-5381.2011.01418.x; Kumar P, 2010, PHARMACOL REP, V62, P1; Kumar P, 2009, EUR J PHARMACOL, V615, P91, DOI 10.1016/j.ejphar.2009.04.058; Kumar P, 2009, PROG NEURO-PSYCHOPH, V33, P100, DOI 10.1016/j.pnpbp.2008.10.013; Latini A, 2005, MOL GENET METAB, V86, P188, DOI 10.1016/j.ymgme.2005.05.002; Liot G, 2009, CELL DEATH DIFFER, V16, P899, DOI 10.1038/cdd.2009.22; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lubos E, 2011, ANTIOXID REDOX SIGN, V15, P1957, DOI 10.1089/ars.2010.3586; MCDOWELL IFW, 1994, EUR J CLIN INVEST, V24, P759, DOI 10.1111/j.1365-2362.1994.tb01073.x; Menze ET, 2012, NEUROTOXICOLOGY, V33, P1265, DOI 10.1016/j.neuro.2012.07.007; Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Mochel F, 2011, J CLIN INVEST, V121, P493, DOI 10.1172/JCI45691; Montilla P, 2004, J PHYSIOL BIOCHEM, V60, P259, DOI 10.1007/BF03167071; Moreira ELG, 2010, J PHARM PHARMACOL, V62, P1061, DOI 10.1111/j.2042-7158.2010.01124.x; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Perez-Severiano F, 2004, NEUROCHEM INT, V45, P1175, DOI 10.1016/j.neuint.2004.06.008; Perez-Severiano F, 2000, BRAIN RES, V862, P234, DOI 10.1016/S0006-8993(00)02082-5; Roos RAC, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-40; Sandhir R, 2012, NEURODEGENER DIS, V9, P145, DOI 10.1159/000334273; Santamaria A, 2003, J NEUROCHEM, V86, P479, DOI 10.1046/j.1471-4159.2003.01857.x; Santamaria A, 2001, NEUROCHEM RES, V26, P419, DOI 10.1023/A:1010911417383; Santos DB, 2012, EXP NEUROL, V233, P767, DOI 10.1016/j.expneurol.2011.11.036; Schilling G, 2001, NEUROSCI LETT, V315, P149, DOI 10.1016/S0304-3940(01)02326-6; Shimano Y, 1995, OBES RES, V3, pS779, DOI 10.1002/j.1550-8528.1995.tb00499.x; Sorolla MA, 2008, FREE RADICAL BIO MED, V45, P667, DOI 10.1016/j.freeradbiomed.2008.05.014; Stack EC, 2008, ANN NY ACAD SCI, V1147, P79, DOI 10.1196/annals.1427.008; Steinert JR, 2010, NEUROSCIENTIST, V16, P435, DOI 10.1177/1073858410366481; Stoy N, 2005, J NEUROCHEM, V93, P611, DOI 10.1111/j.1471-4159.2005.03070.x; Sudati JH, 2013, NEUROTOXICOLOGY, V37, P118, DOI 10.1016/j.neuro.2013.04.006; Tabrizi SJ, 2000, ANN NEUROL, V47, P80; Tardif JC, 2003, CIRCULATION, V107, P552, DOI 10.1161/01.CIR.0000047525.58618.3C; Tardif Jean-Claude, 2002, Am J Cardiovasc Drugs, V2, P323, DOI 10.2165/00129784-200202050-00005; Tariq M, 2005, BRAIN RES BULL, V67, P161, DOI 10.1016/j.brainresbull.2005.06.024; Tunez I, 2010, MOLECULES, V15, P878, DOI 10.3390/molecules15020878; Villaran RE, 2008, NEUROTOXICOLOGY, V29, P244, DOI 10.1016/j.neuro.2007.11.001; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wendel A, 1981, Methods Enzymol, V77, P325; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Yamashita S, 2009, ATHEROSCLEROSIS, V207, P16, DOI 10.1016/j.atherosclerosis.2009.04.002; Yamashita S, 2008, J ATHEROSCLER THROMB, V15, P292, DOI 10.5551/jat.E610; Yang LC, 2009, J NEUROCHEM, V109, P1427, DOI 10.1111/j.1471-4159.2009.06074.x; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	78	49	49	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e67658	10.1371/journal.pone.0067658	http://dx.doi.org/10.1371/journal.pone.0067658			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799154	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300116
J	Eldridge-Thomas, B; Rubin, GJ				Eldridge-Thomas, Buffy; Rubin, G. James			Idiopathic Environmental Intolerance Attributed to Electromagnetic Fields: A Content Analysis of British Newspaper Reports	PLOS ONE			English	Article							MEDIA WARNINGS; HYPERSENSITIVITY; PROVOCATION; SYMPTOMS; EXPOSURE; SENSITIVITY; MEDICINE	Idiopathic environmental intolerance attributed to electromagnetic fields (IEI-EMF) is a controversial condition in which people describe symptoms following exposure to electromagnetic fields from everyday electrical devices. However, double-blind experiments have found no convincing evidence that electromagnetic fields cause these symptoms. In this study, we assessed whether recent newspaper reporting in the UK reflected this scientific evidence. We searched a database of newspaper articles to identify all those that contained IEI-EMF related keywords and selected a random sample of 60 for content analysis. For our primary outcomes, we assessed how many articles mainly or wholly presented an electromagnetic cause for IEI-EMF and how many discussed unproven treatments for the condition such as strategies intended to reduce exposure to electromagnetic fields or the use of complementary and alternative therapies. We also assessed whether the type of information source used by a newspaper article (e. g. scientist, person with IEI-EMF, politician) or the type of newspaper (broadsheet, tabloid, local or regional) was associated with either outcome. Of the 60 articles, 43 (71.7%) presented a mainly electromagnetic cause, compared to 13 (21.7%) which presented mainly non-electromagnetic causes and 4 (6.7%) which did not discuss a cause. 29 (48.3%) did not mention any potential treatment, while 24 (40.0%) mentioned eletromagnetic field related strategies and 12 (20.0%) mentioned complementary or alternative therapies. Articles which quoted someone with IEI-EMF were significantly more likely to report an electromagnetic cause and to present unproven treatments. Those which used a scientist as a source were more likely to present a non-electromagnetic cause for the condition. The widespread poor reporting we identified is disappointing and has the potential for to encourage more people to misattribute their symptoms to electromagnetic fields. Scientists should remain engaged with the media to counteract this effect.	[Eldridge-Thomas, Buffy; Rubin, G. James] Kings Coll London, Dept Psychol Med, London WC2R 2LS, England	University of London; King's College London	Rubin, GJ (corresponding author), Kings Coll London, Dept Psychol Med, London WC2R 2LS, England.	Gideon.rubin@kcl.ac.uk		Eldridge-Thomas, Buffy/0000-0003-4070-2827	Church of England; UK's Mobile Telecommunications and Health Research programme	Church of England; UK's Mobile Telecommunications and Health Research programme	The authors have read the journal's policy and have the following conflicts to disclose: Dr Rubin has received payment from the Church of England for expert testimony relating to the installation of wifi equipment on Church premises and has previously received funding from the UK's Mobile Telecommunications and Health Research programme. He sits on the UK's Advisory Group for Non Ionising Radiation, and is an external expert for the European Commission's Scientific Committee on Emerging and Newly Identified Health Risks. He was interviewed in some of the articles analysed in this study. These potential conflicts do not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Advisory Group on Non-Ionising Radiation (AGNIR), 2012, HLTH EFF RAD EL FIEL; BEGG N, 1998, BRIT MED J, V316, P561, DOI DOI 10.1136/BMJ.316.7130.561; Bergqvist U, 1997, ARBETE HALSA, V19, P1; Boyd I, 2012, J ROY SOC MED, V105, P523, DOI 10.1258/jrsm.2012.120060; Dougall AL, 2005, PSYCHIATRY, V68, P28, DOI 10.1521/psyc.68.1.28.64188; Eltiti S, 2007, ENVIRON HEALTH PERSP, V115, P1603, DOI 10.1289/ehp.10286; Eltiti S, 2007, BIOELECTROMAGNETICS, V28, P137, DOI 10.1002/bem.20279; Faasse K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5613; Hansson Mild K, 2004, P INT WORKSH EMF HYP; Knudsen AK, 2011, J ROYAL SOC MED SHOR, V2, DOI [10.1258/shorts.2011.011016, DOI 10.1258/SH0RTS.2011.011016]; Lemal M, 2009, PREV MED, V48, P189, DOI 10.1016/j.ypmed.2008.11.011; Manjunatha N, 2011, NATL MED J INDIA, V24, P314; Mortazavi SMJ, 2007, BIOELECTROMAGNETICS, V28, P326, DOI 10.1002/bem.20305; Rubin GJ, 2010, HEALTH TECHNOL ASSES, V14, P183, DOI 10.3310/hta14340-03; Rubin GJ, 2008, J PSYCHOSOM RES, V64, P1, DOI 10.1016/j.jpsychores.2007.05.006; Rubin GJ, 2011, BIOELECTROMAGNETICS, V32, P593, DOI 10.1002/bem.20690; Rubin GJ, 2010, BIOELECTROMAGNETICS, V31, P1, DOI 10.1002/bem.20536; Rubin GJ, 2005, PSYCHOSOM MED, V67, P224, DOI 10.1097/01.psy.0000155664.13300.64; Rubin GJ, 2006, PSYCHOTHER PSYCHOSOM, V75, P12, DOI 10.1159/000089222; Seitz H, 2005, SCI TOTAL ENVIRON, V349, P45, DOI 10.1016/j.scitotenv.2005.05.009; STEWART DE, 1990, PSYCHOSOMATICS, V31, P153, DOI 10.1016/S0033-3182(90)72188-3; WHO, 2005, EL FIELDS PUBL HLTH; Winters W, 2003, PSYCHOSOM MED, V65, P332, DOI 10.1097/01.PSY.0000041468.75064.BE; Witthoft M, 2013, J PSYCHOSOM RES, V74, P206, DOI 10.1016/j.jpsychores.2012.12.002; Young ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003552	25	25	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65713	10.1371/journal.pone.0065713	http://dx.doi.org/10.1371/journal.pone.0065713			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799038	gold, Green Published, Green Submitted			2022-12-25	WOS:000320363300034
J	Perez-Aguilar, JM; Xi, J; Matsunaga, F; Cui, X; Selling, B; Saven, JG; Liu, RY				Perez-Aguilar, Jose Manuel; Xi, Jin; Matsunaga, Felipe; Cui, Xu; Selling, Bernard; Saven, Jeffery G.; Liu, Renyu			A Computationally Designed Water-Soluble Variant of a G-Protein-Coupled Receptor: The Human Mu Opioid Receptor	PLOS ONE			English	Article							ANGSTROM CRYSTAL-STRUCTURE; MEMBRANE-PROTEINS; BINDING-SITE; COMBINATORIAL LIBRARIES; CIRCULAR-DICHROISM; STATISTICAL-THEORY; LIGAND-BINDING; NUCLEIC-ACIDS; CHANNEL; CHOLESTEROL	G-protein-coupled receptors (GPCRs) play essential roles in various physiological processes, and are widely targeted by pharmaceutical drugs. Despite their importance, studying GPCRs has been problematic due to difficulties in isolating large quantities of these membrane proteins in forms that retain their ligand binding capabilities. Creating water-soluble variants of GPCRs by mutating the exterior, transmembrane residues provides a potential method to overcome these difficulties. Here we present the first study involving the computational design, expression and characterization of water-soluble variant of a human GPCR, the human mu opioid receptor (MUR), which is involved in pain and addiction. An atomistic structure of the transmembrane domain was built using comparative (homology) modeling and known GPCR structures. This structure was highly similar to the subsequently determined structure of the murine receptor and was used to computationally design 53 mutations of exterior residues in the transmembrane region, yielding a variant intended to be soluble in aqueous media. The designed variant expressed in high yield in Escherichia coli and was water soluble. The variant shared structural and functionally related features with the native human MUR, including helical secondary structure and comparable affinity for the antagonist naltrexone (K-d = 65 nM). The roles of cholesterol and disulfide bonds on the stability of the receptor variant were also investigated. This study exemplifies the potential of the computational approach to produce water-soluble variants of GPCRs amenable for structural and functionally related characterization in aqueous solution.	[Perez-Aguilar, Jose Manuel; Saven, Jeffery G.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Xi, Jin; Matsunaga, Felipe; Cui, Xu; Liu, Renyu] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Cui, Xu] Capital Med Univ, Beijing Tongren Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Selling, Bernard] Impact Biol Inc, Swarthmore, PA USA	University of Pennsylvania; University of Pennsylvania; Capital Medical University	Saven, JG (corresponding author), Univ Penn, Dept Chem, Philadelphia, PA 19104 USA.	saven@sas.upenn.edu; liur@uphs.upenn.edu		Matsunaga, Felipe/0000-0002-0798-7632; Perez-Aguilar, Jose Manuel/0000-0002-9893-5992	Foundation for Anesthesia Education and Research (FAER); National Institutes of Health (NIH) [K08-GM-093115-01]; GROFF; Department of Anesthesiology and Critical Care at the University of Pennsylvania; Penn Nano/Bio Interface Center through the National Science Foundation (NSF) [NSEC DMR-0425780]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM093115] Funding Source: NIH RePORTER	Foundation for Anesthesia Education and Research (FAER); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GROFF; Department of Anesthesiology and Critical Care at the University of Pennsylvania; Penn Nano/Bio Interface Center through the National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Foundation for Anesthesia Education and Research (FAER) (PI, RL), National Institutes of Health (NIH) K08 (K08-GM-093115-01) (PI, RL), GROFF (PI, RL), the Department of Anesthesiology and Critical Care at the University of Pennsylvania (PI, RL), and the Penn Nano/Bio Interface Center through the National Science Foundation (NSF) NSEC DMR-0425780 (PI, JGS). NSF MRSEC DMR-1120901 (JGS) provided infrastructural support related to protein computational work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Beuming T, 2004, BIOINFORMATICS, V20, P1822, DOI 10.1093/bioinformatics/bth143; Bronson J, 2006, BIOPHYS J, V90, P1156, DOI 10.1529/biophysj.105.068965; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cherezov V, 2010, METHODS MOL BIOL, V654, P141, DOI 10.1007/978-1-60761-762-4_8; Cui TX, 2012, BBA-BIOMEMBRANES, V1818, P617, DOI 10.1016/j.bbamem.2011.11.021; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Illergard K, 2011, PROTEINS, V79, P79, DOI 10.1002/prot.22859; Inturrisi CE, 2002, CLIN J PAIN, V18, pS3, DOI 10.1097/00002508-200207001-00002; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Kono H, 2001, J MOL BIOL, V306, P607, DOI 10.1006/jmbi.2000.4422; Krepkiy D, 2006, PROTEIN EXPRES PURIF, V49, P60, DOI 10.1016/j.pep.2006.03.002; Kuehn BM, 2007, JAMA-J AM MED ASSOC, V297, P249, DOI 10.1001/jama.297.3.249; Liu RY, 2012, ACTA CRYSTALLOGR D, V68, P497, DOI 10.1107/S0907444912002740; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Ma DJ, 2008, P NATL ACAD SCI USA, V105, P16537, DOI 10.1073/pnas.0805501105; Manchikanti L, 2008, PAIN PHYSICIAN, V11, pS63; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Muller I, 2008, J MEMBRANE BIOL, V223, P49, DOI 10.1007/s00232-008-9112-x; Muller I, 2010, APPL BIOCHEM BIOTECH, V160, P2175, DOI 10.1007/s12010-009-8715-8; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Oates J, 2012, BBA-BIOMEMBRANES, V1818, P2228, DOI 10.1016/j.bbamem.2012.04.010; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Perez-Aguilar Jose Manuel, 2012, J Anesth Clin Res, V3, P218; Perez-Aguilar JM, 2012, STRUCTURE, V20, P5, DOI 10.1016/j.str.2011.12.003; Poschner BC, 2007, ANAL BIOCHEM, V363, P306, DOI 10.1016/j.ab.2007.01.021; REES DC, 1989, SCIENCE, V245, P510, DOI 10.1126/science.2667138; Rousseau B, 2007, HEPATOLOGY, V46, P1108, DOI 10.1002/hep.21770; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samish I, 2011, ANNU REV PHYS CHEM, V62, P129, DOI 10.1146/annurev-physchem-032210-103509; Sarramegna V, 2005, PROTEIN EXPRES PURIF, V43, P85, DOI 10.1016/j.pep.2005.05.007; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Slovic AM, 2004, P NATL ACAD SCI USA, V101, P1828, DOI 10.1073/pnas.0306417101; Stanasila L, 1999, EUR J BIOCHEM, V260, P430, DOI 10.1046/j.1432-1327.1999.00187.x; Subramanian G, 2000, J MED CHEM, V43, P381, DOI 10.1021/jm9903702; Surratt CK, 2005, CURR TOP MED CHEM, V5, P315, DOI 10.2174/1568026053544533; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P1299, DOI 10.1001/jama.2011.401; Wallin E, 1997, PROTEIN SCI, V6, P808; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Zhang PS, 1999, MOL BRAIN RES, V72, P195, DOI 10.1016/S0169-328X(99)00241-7; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zou JM, 2000, J MOL BIOL, V296, P281, DOI 10.1006/jmbi.1999.3426; Zwier JM, 2010, J BIOMOL SCREEN, V15, P1248, DOI 10.1177/1087057110384611	56	33	39	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66009	10.1371/journal.pone.0066009	http://dx.doi.org/10.1371/journal.pone.0066009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799068	Green Submitted, Green Published, gold			2022-12-25	WOS:000320363300058
J	Zhang, HP; Wang, F; Kranzler, HR; Zhao, HY; Gelernter, J				Zhang, Huiping; Wang, Fan; Kranzler, Henry R.; Zhao, Hongyu; Gelernter, Joel			Profiling of Childhood Adversity-Associated DNA Methylation Changes in Alcoholic Patients and Healthy Controls	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MESSENGER-RNA EXPRESSION; NICOTINE DEPENDENCE; GENE-EXPRESSION; ANXIETY DISORDERS; HUMAN BRAIN; RISK; HYPERMETHYLATION; SCHIZOPHRENIA; GENOTYPE	The increased vulnerability to alcohol dependence (AD) seen in individuals with childhood adversity (CA) may result in part from CA-induced epigenetic changes. To examine CA-associated DNA methylation changes in AD patients, we examined peripheral blood DNA methylation levels of 384 CpGs in promoter regions of 82 candidate genes in 279 African Americans [AAs; 88 with CA (70.5% with AD) and 191 without CA (38.2% with AD)] and 239 European Americans [EAs; 61 with CA (86.9% with AD) and 178 without CA (46.6% with AD)] using Illumina GoldenGate Methylation Array assays. The effect of CA on methylation of individual CpGs and overall methylation in promoter regions of genes was evaluated using a linear regression analysis (with consideration of sex, age, and ancestry proportion of subjects) and a principal components-based analysis, respectively. In EAs, hypermethylation of 10 CpGs in seven genes (ALDH1A1, CART, CHRNA5, HTR1B, OPRL1, PENK, and RGS19) were cross validated in AD patients and healthy controls who were exposed to CA. P values of two CpGs survived Bonferroni correction when all EA samples were analyzed together to increase statistical power [CHRNA5_cg17108064: P-adjust = 2.54 x 10(-5); HTR1B_cg06031989: P-adjust = 8.98 x 10(-5)]. Moreover, overall methylation levels in the promoter regions of three genes (ALDH1A1, OPRL1 and RGS19) were elevated in both EA case and control subjects who were exposed to CA. However, in AAs, CA-associated DNA methylation changes in AD patients were not validated in healthy controls. Our findings suggest that CA could induce population-specific methylation alterations in the promoter regions of specific genes, thus leading to changes in gene transcription and an increased risk for AD and other disorders.	[Zhang, Huiping; Wang, Fan; Gelernter, Joel] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Gelernter, Joel] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Gelernter, Joel] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Zhao, Hongyu] Yale Univ, Sch Publ Hlth, Div Biostat, New Haven, CT USA; [Zhang, Huiping; Wang, Fan; Gelernter, Joel] VA Connecticut Healthcare Syst, West Haven, CT USA; [Kranzler, Henry R.] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kranzler, Henry R.] Philadelphia VAMC, MIRECC VISN4, Philadelphia, PA USA	Yale University; Yale University; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; University of Pennsylvania; Pennsylvania Medicine	Zhang, HP (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA.	huiping.zhang@yale.edu	kranzler, henry/AAS-1113-2020	kranzler, henry/0000-0002-1018-0450; WANG, FAN/0000-0001-9806-5037; Gelernter, Joel/0000-0002-4067-1859; Zhang, Huiping/0000-0002-4902-0104	National Institutes of Health (NIH) [K99/R00 DA022891, R01 DA12690, R01 AA11330, R01 DA12849, R01 DA018432]; Veteran's Affairs Connecticut Mental Illness Research, Education and Clinical Center (MIRECC); Alcoholic Beverage Medical Research Foundation (ABMRF); Alkermes; Lilly; Lundbeck; Pfizer; Roche; Abbott; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018432, K99DA022891, R01DA012690, R01DA012849] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran's Affairs Connecticut Mental Illness Research, Education and Clinical Center (MIRECC); Alcoholic Beverage Medical Research Foundation (ABMRF); Alkermes; Lilly(Eli Lilly); Lundbeck(Lundbeck Corporation); Pfizer(Pfizer); Roche(Roche Holding); Abbott(Abbott Laboratories); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the National Institutes of Health (NIH) Grants K99/R00 DA022891 (to H. Zhang), R01 DA12690 (to JG), R01 AA11330 (to JG), R01 DA12849 (to JG), R01 DA018432 (to HRK), and grants from the Veteran's Affairs Connecticut Mental Illness Research, Education and Clinical Center (MIRECC) to JG and the Alcoholic Beverage Medical Research Foundation (ABMRF) to H. Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The co-author Dr. Kranzler has been a paid consultant or advisory board member for the following pharmaceutical companies: Alkermes, Lilly, Lundbeck, Pfizer, and Roche. Dr. Kranzler has also received honoraria from the Alcohol Clinical Trials Initiative (ACTIVE), which is supported by Abbott, Lilly, Lundbeck, and Pfizer. However, this does not alter his adherence to all the PLOS ONE policies on sharing data and materials. The corresponding author Dr. Zhang is currently the academic editor for PLOS ONE. However, this does not alter his adherence to all the PLOS ONE policies on sharing data and materials.	Adkins RM, 2011, BIRTH DEFECTS RES A, V91, P728, DOI 10.1002/bdra.20770; Afifi TO, 2008, AM J PUBLIC HEALTH, V98, P946, DOI 10.2105/AJPH.2007.120253; Afifi TO, 2011, J PSYCHIATR RES, V45, P814, DOI 10.1016/j.jpsychires.2010.11.008; American Psychiatric Association, 1994, DSM 4 DIAGNOSTIC STA; Angst J, 2011, EUR ARCH PSY CLIN N, V261, P21, DOI 10.1007/s00406-010-0120-3; Beach SRH, 2010, AM J MED GENET B, V153B, P710, DOI 10.1002/ajmg.b.31028; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Bleich S, 2006, ALCOHOL CLIN EXP RES, V30, P587, DOI 10.1111/j.1530-0277.2006.00068.x; Bock C, 2012, NAT REV GENET, V13, P705, DOI 10.1038/nrg3273; Bonsch D, 2006, J NEURAL TRANSM, V113, P1299, DOI 10.1007/s00702-005-0413-2; Borghol N, 2012, INT J EPIDEMIOL, V41, P62, DOI 10.1093/ije/dyr147; Douglas KR, 2010, ADDICT BEHAV, V35, P7, DOI 10.1016/j.addbeh.2009.07.004; Franklin TB, 2010, NEUROBIOL DIS, V39, P61, DOI 10.1016/j.nbd.2009.11.012; Gibney ER, 2010, HEREDITY, V105, P4, DOI 10.1038/hdy.2010.54; Grucza RA, 2008, BIOL PSYCHIAT, V64, P922, DOI 10.1016/j.biopsych.2008.04.018; Hodson C, 2006, CHILD ABUSE NEGLECT, V30, P1017, DOI 10.1016/j.chiabu.2005.10.017; Jewkes RK, 2010, CHILD ABUSE NEGLECT, V34, P833, DOI 10.1016/j.chiabu.2010.05.002; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kramer DA, 2005, J AM ACAD CHILD PSY, V44, P19, DOI 10.1097/01.chi.0000145804.30112.6b; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee R, 2005, AM J PSYCHIAT, V162, P995, DOI 10.1176/appi.ajp.162.5.995; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; McGowan PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014739; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Philibert Robert A., 2012, Frontiers in Genetics, V3, P54, DOI 10.3389/fgene.2012.00054; Pierucci-Lagha A, 2005, DRUG ALCOHOL DEPEN, V80, P303, DOI 10.1016/j.drugalcdep.2005.04.005; Piyathilake CJ, 2003, CANCER CAUSE CONTROL, V14, P37, DOI 10.1023/A:1022573630082; Pritchard JK, 2000, GENETICS, V155, P945; Read J, 2010, AM J PSYCHIAT, V167, P717, DOI 10.1176/appi.ajp.2010.10010105; Rosenberg SD, 2007, PSYCHIAT SERV, V58, P245, DOI 10.1176/appi.ps.58.2.245; Shannon C, 2011, SCHIZOPHRENIA BULL, V37, P531, DOI 10.1093/schbul/sbp096; Shen GQ, 2009, METHODS MOL BIOL, V578, P293, DOI 10.1007/978-1-60327-411-1_19; Sherva R, 2010, NEUROPSYCHOPHARMACOL, V35, P1921, DOI 10.1038/npp.2010.64; Shoemaker R, 2010, GENOME RES, V20, P883, DOI 10.1101/gr.104695.109; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tyrka AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030148; van der Vegt EJM, 2010, BIOL PSYCHIAT, V68, P1048, DOI 10.1016/j.biopsych.2010.07.027; van Eijk KR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-636; van Ijzendoorn MH, 2010, BIOL PSYCHIAT, V68, P405, DOI 10.1016/j.biopsych.2010.05.008; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Wang JC, 2009, MOL PSYCHIATR, V14, P501, DOI 10.1038/mp.2008.42; WANG RYH, 1980, NUCLEIC ACIDS RES, V8, P4777, DOI 10.1093/nar/8.20.4777; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wilkinson PO, 2011, DEV PSYCHOPATHOL, V23, P1017, DOI 10.1017/S0954579411000472; Xie PX, 2012, NEUROPSYCHOPHARMACOL, V37, P669, DOI 10.1038/npp.2011.240; Xie P, 2010, NEUROPSYCHOPHARMACOL, V35, P1684, DOI 10.1038/npp.2010.37; Xie PX, 2009, ARCH GEN PSYCHIAT, V66, P1201, DOI 10.1001/archgenpsychiatry.2009.153; Yang BZ, 2005, GENET EPIDEMIOL, V28, P302, DOI 10.1002/gepi.20070; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005; Zhang H, 2012, ALCOHOL CLIN EXP RES; Zhang HP, 2013, ALCOHOL CLIN EXP RES, V37, pE108, DOI 10.1111/j.1530-0277.2012.01928.x	53	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65648	10.1371/journal.pone.0065648	http://dx.doi.org/10.1371/journal.pone.0065648			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799031	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300031
J	Sengupta, B; Pahari, B; Blackmon, L; Sengupta, PK				Sengupta, Bidisha; Pahari, Biswapathik; Blackmon, Laura; Sengupta, Pradeep K.			Prospect of Bioflavonoid Fisetin as a Quadruplex DNA Ligand: A Biophysical Approach	PLOS ONE			English	Article							FLUORESCENCE ANISOTROPY DECAY; STATE PROTON-TRANSFER; FLAVONOID FISETIN; BINDING; 3-HYDROXYFLAVONE; TELOMERASE; MODE	Quadruplex (G(4)) forming sequences in telomeric DNA and c-myc promoter regions of human DNA are associated with tumorogenesis. Ligands that can facilitate or stabilize the formation and increase the stabilization of G(4) can prevent tumor cell proliferation and have been regarded as potential anti-cancer drugs. In the present study, steady state and time-resolved fluorescence measurements provide important structural and dynamical insights into the free and bound states of the therapeutically potent plant flavonoid fisetin (3,3',4',7-tetrahydroxyflavone) in a G(4) DNA matrix. The excited state intramolecular proton transfer (ESPT) of fisetin plays an important role in observing and understanding the binding of fisetin with the G(4) DNA. Differential absorption spectra, thermal melting, and circular dichroism spectroscopic studies provide evidences for the formation of G(4) DNA and size exclusion chromatography (SEC) proves the binding and 1:1 stoichiometry of fisetin in the DNA matrix. Comparative analysis of binding in the presence of EtBr proves that fisetin favors binding at the face of the G-quartet, mostly along the diagonal loop. Time resolved fluorescence anisotropy decay analysis indicates the increase in the restrictions in motion from the free to bound fisetin. We have also investigated the fingerprints of the binding of fisetin in the antiparallel quadruplex using Raman spectroscopy. Preliminary results indicate fisetin to be a prospective candidate as a G(4) ligand.	[Sengupta, Bidisha; Blackmon, Laura] Tougaloo Coll, Dept Chem, Tougaloo, MS USA; [Pahari, Biswapathik; Sengupta, Pradeep K.] Saha Inst Nucl Phys, Div Biophys, Kolkata, W Bengal, India	Tougaloo College; Saha Institute of Nuclear Physics	Sengupta, B (corresponding author), Tougaloo Coll, Dept Chem, Tougaloo, MS USA.	bsengupta@tougaloo.edu; pradeepsinp@yahoo.co.in		Sengupta, Bidisha/0000-0003-4624-9998	AAAS WIRC @ MSIs; National Science Foundation (NSF); National Institutes of Health/National Center on Minority Health and Health Disparities/Research Infrastructure in Minority Institutions [1P20MD002725]; Epscor seed grant [MS- EPS-0903787]; HBCU-UP Grant; NSF [0811638]; CSIR, India [21(0864)/11/EMR-II]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER; EPSCoR [0903787] Funding Source: National Science Foundation	AAAS WIRC @ MSIs; National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health/National Center on Minority Health and Health Disparities/Research Infrastructure in Minority Institutions; Epscor seed grant; HBCU-UP Grant; NSF(National Science Foundation (NSF)); CSIR, India(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	BSG is thankful to the travel award by AAAS WIRC @ MSIs which is funded by National Science Foundation (NSF), for allowing her to initiate the international collaboration, as is described in the present study. BSG also likes to acknowledge the financial support from National Institutes of Health/National Center on Minority Health and Health Disparities/Research Infrastructure in Minority Institutions grant number 1P20MD002725, Epscor seed grant MS- EPS-0903787 and research support from HBCU-UP Grant, NSF ID: 0811638 at Tougaloo College. PKS gratefully acknowledges CSIR, India for the award of a grant under CSIR Emeritus scientist scheme, sanction number 21(0864)/11/EMR-II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2006, RSC BIOMOL SCI, pV; Bang I, 1910, BIOCHEM Z, V26, P293; Baral A, 2012, NUCLEIC ACIDS RES, V40, P3800, DOI 10.1093/nar/gkr1258; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Fernando H, 2006, BIOCHEMISTRY-US, V45, P7854, DOI 10.1021/bi0601510; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Giri B, 2011, NUCLEIC ACIDS RES, V39, P7161, DOI 10.1093/nar/gkr234; Gomez D, 2002, CANCER RES, V62, P3365; Guharay J, 1999, SPECTROCHIM ACTA A, V55, P1091, DOI 10.1016/S1386-1425(98)00280-7; Huppert JL, 2007, PHILOS T R SOC A, V365, P2969, DOI 10.1098/rsta.2007.0011; Jana B, 2012, J PHYS CHEM B, V116, P639, DOI 10.1021/jp2094824; Ji XH, 2012, NUCLEIC ACID THER, V22, P127, DOI 10.1089/nat.2012.0342; Khan N, 2008, CANCER RES, V68, P8555, DOI 10.1158/0008-5472.CAN-08-0240; Koeppel F, 2001, NUCLEIC ACIDS RES, V29, P1087, DOI 10.1093/nar/29.5.1087; Kumbhakar M, 2005, PHOTOCHEM PHOTOBIOL, V81, P588, DOI 10.1562/2004-10-12-RA-341.1; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, DOI [10.1007/978-0-387-46312-4, DOI 10.1007/978-0-387-46312-4]; Maher P, 2006, P NATL ACAD SCI USA, V103, P16568, DOI 10.1073/pnas.0607822103; Markovic JMD, 2011, SPECTROCHIM ACTA A, V83, P120, DOI 10.1016/j.saa.2011.08.001; Masiero S, 2010, ORG BIOMOL CHEM, V8, P2683, DOI 10.1039/c003428b; Mergny JL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni134; Neault JF, 1996, J BIOL CHEM, V271, P8140, DOI 10.1074/jbc.271.14.8140; Neidle S, 2009, CURR OPIN STRUC BIOL, V19, P239, DOI 10.1016/j.sbi.2009.04.001; Pagba CV, 2011, BIOMED OPT EXPRESS, V2, P207, DOI 10.1364/BOE.2.000207; Pahari B, 2013, J PHOTOCH PHOTOBIO B, V118, P33, DOI 10.1016/j.jphotobiol.2012.10.010; Phosrithong N, 2010, MED CHEM RES, V19, P817, DOI 10.1007/s00044-009-9233-5; Rachwal PA, 2007, METHODS, V43, P291, DOI 10.1016/j.ymeth.2007.05.004; Sacca B, 2005, NUCLEIC ACIDS RES, V33, P1182, DOI 10.1093/nar/gki257; Sahoo D, 2010, J PHYS CHEM B, V114, P2044, DOI 10.1021/jp910766q; Selvam S, 2011, PHOTOCH PHOTOBIO SCI, V10, P66, DOI 10.1039/c0pp00120a; Sen S, 2001, J PHYS CHEM A, V105, P7495, DOI 10.1021/jp004275c; Sengupta B, 2004, FEBS LETT, V570, P77, DOI 10.1016/j.febslet.2004.06.027; Sengupta B, 2009, J PHYS CHEM C, V113, P19518, DOI 10.1021/jp906522u; SENGUPTA PK, 1979, CHEM PHYS LETT, V68, P382, DOI 10.1016/0009-2614(79)87221-8; Shida T, 1996, NUCLEOS NUCLEOT, V15, P599, DOI 10.1080/07328319608002408; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Sun HX, 2006, BIOORG MED CHEM LETT, V16, P3586, DOI 10.1016/j.bmcl.2006.03.087; Sun XG, 1999, SCI CHINA SER B, V42, P62, DOI 10.1007/BF02883038; Touil YS, 2011, CANCER CHEMOTH PHARM, V68, P445, DOI 10.1007/s00280-010-1505-8; Vogel SS, 2009, FLIM MICROSCOPY BIOL, P245; Xu NS, 2012, CHINESE J CHEM, V30, P1433, DOI 10.1002/cjoc.201100641	41	31	31	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65383	10.1371/journal.pone.0065383	http://dx.doi.org/10.1371/journal.pone.0065383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785423	Green Submitted, Green Published, gold			2022-12-25	WOS:000321038800097
J	Kirkby, NS; Chan, MV; Lundberg, MH; Massey, KA; Edmands, WMB; MacKenzie, LS; Holmes, E; Nicolaou, A; Warner, TD; Mitchell, JA				Kirkby, Nicholas S.; Chan, Melissa V.; Lundberg, Martina H.; Massey, Karen A.; Edmands, William M. B.; MacKenzie, Louise S.; Holmes, Elaine; Nicolaou, Anna; Warner, Timothy D.; Mitchell, Jane A.			Aspirin-triggered 15-epi-lipoxin A(4) predicts cyclooxygenase-2 in the lungs of LPS-treated mice hut not in the circulation: implications for a clinical test	FASEB JOURNAL			English	Article						15-HETE; COX-2 biomarker; vascular inflammation; nonsteroidal anti-inflammatory drugs	ARACHIDONIC-ACID; GENE DISRUPTION; INFLAMMATION; INHIBITION; 5-LIPOXYGENASE; PROSTACYCLIN; EICOSANOIDS; THROMBOXANE; LIPOXINS; SYNTHASE	Inhibition of cyclooxygenase (COX)-2 increases cardiovascular deaths. Identifying a biomarker of COX-2 is desirable but difficult, since COX-1 and COX-2 ordinarily catalyze formation of an identical product, prostaglandin H-2. When acetylated by aspirin, however, COX-2 (but not COX-1) can form 15(R)-HETE, which is metabolized to aspirin-triggered lipoxin (ATL), 15-epi-lipoxin A(4). Here we have used COX-1- and COX-2-knockout mice to establish whether plasma ATL could be used as a biomarker of vascular COX-2 in vivo. Vascular COX-2 was low but increased by LPS (10 mg/kg; i.p). Aspirin (10 mg/kg; i.v.) inhibited COX-1, measured as blood thromboxane and COX-2, measured as lung PGE(2). Aspirin also increased the levels of ATL in the lungs of LPS-treated wild-type C57Bl6 mice (vehicle: 25.5 +/- 9.3 ng/ml; 100 mg/kg: 112.0 +/- 7.4 ng/ml; P<0.05). Despite this, ATL was unchanged in plasma after LPS and aspirin. This was true in wild-type as well as COX-1(-/-) and COX-2(-/-) mice. Thus, in mice in which COX-2 has been induced by LPS treatment, aspirin triggers detectable 15-epi-lipoxin A(4) in lung tissue, but not in plasma. This important study is the first to demonstrate that while ATL can be measured in tissue, plasma ATL is not a biomarker of vascular COX-2 expression.Kirkby, N. S., Chan, M. V., Lundberg, M. H., Massey, K. A., Edmands, W. M. B., MacKenzie, L. S., Holmes, E., Nicolaou, A., Warner, T. D., Mitchell, J. A. Aspirin-triggered 15-epi-lipoxin A(4) predicts cyclooxygenase-2 in the lungs of LPS-treated mice but not in the circulation: implications for a clinical test.	[Kirkby, Nicholas S.; Lundberg, Martina H.; Edmands, William M. B.; MacKenzie, Louise S.; Holmes, Elaine; Mitchell, Jane A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England; [Kirkby, Nicholas S.; Chan, Melissa V.; Lundberg, Martina H.; Warner, Timothy D.] Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London, England; [Massey, Karen A.; Nicolaou, Anna] Univ Bradford, Sch Pharm, Bradford BD7 1DP, W Yorkshire, England; [MacKenzie, Louise S.] Univ Hertfordshire, Sch Life & Med Sci, Hatfield AL10 9AB, Herts, England	Imperial College London; University of London; Queen Mary University London; University of Bradford; University of Hertfordshire	Kirkby, NS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dovehouse St, London SW3 6LY, England.	n.kirkby@imperial.ac.uk; j.a.mitchell@imperial.ac.uk	Nicolaou, Anna/D-4025-2018; Holmes, Elaine/A-2189-2015; Warner, Timothy D/A-1980-2009; Holmes, Elaine/ABE-6606-2020; Mackenzie, Louise/AAY-7585-2020; Slingsby, Martina H/B-1476-2015	Nicolaou, Anna/0000-0002-1314-413X; Warner, Timothy D/0000-0003-3988-4408; Holmes, Elaine/0000-0002-0556-8389; Mackenzie, Louise/0000-0003-4271-379X; Lundberg, Martina H/0000-0001-6369-3041; Chan, Melissa/0000-0003-2154-1386; Slingsby, Martina H/0000-0002-2620-7582; Kirkby, Nicholas/0000-0003-3509-8549	Wellcome Trust [0852551Z108/Z]; British Heart Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation)	This research was supported by a program grant from the Wellcome Trust (0852551Z108/Z) and a pilot study grant from the British Heart Foundation. The authors declare no conflicts of interest.	Armstrong PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020062; Botting RM, 2010, PHARMACOL REP, V62, P518, DOI 10.1016/S1734-1140(10)70308-X; CAPDEVILA J, 1986, BIOCHEM BIOPH RES CO, V141, P1007, DOI 10.1016/S0006-291X(86)80144-9; Chiang N, 2004, P NATL ACAD SCI USA, V101, P15178, DOI 10.1073/pnas.0405445101; Chiang N, 1998, J PHARMACOL EXP THER, V287, P779; CLARIA J, 1995, P NATL ACAD SCI USA, V92, P9475, DOI 10.1073/pnas.92.21.9475; Claria J, 1996, MOL MED, V2, P583, DOI 10.1007/BF03401642; Fiorucci S, 2003, BRIT J PHARMACOL, V139, P1351, DOI 10.1038/sj.bjp.0705356; Flavahan NA, 2007, TRENDS PHARMACOL SCI, V28, P106, DOI 10.1016/j.tips.2007.01.003; FRIDOVICH SE, 1981, J BIOL CHEM, V256, P260; HOLTZMAN MJ, 1992, J BIOL CHEM, V267, P21438; Kirkby NS, 2012, P NATL ACAD SCI USA, V109, P17597, DOI 10.1073/pnas.1209192109; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Liu B, 2012, EXP PHYSIOL, V97, P895, DOI 10.1113/expphysiol.2011.063784; Massey K. A., 2012, FREE RADIC BIOL MED; McGettigan P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001098; MEADE EA, 1993, J BIOL CHEM, V268, P6610; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; ONEILL GP, 1994, MOL PHARMACOL, V45, P245; Paul-Clark MJ, 2004, J EXP MED, V200, P69, DOI 10.1084/jem.20040566; Planaguma A, 2010, MUCOSAL IMMUNOL, V3, P270, DOI 10.1038/mi.2009.141; Serhan CN, 2005, PROSTAG LEUKOTR ESS, V73, P141, DOI 10.1016/j.plefa.2005.05.002; Smith JP, 2012, HYPERTENSION, V59, P719, DOI 10.1161/HYPERTENSIONAHA.111.181404; Warner TD, 2004, FASEB J, V18, P790, DOI 10.1096/fj.03-0645rev; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Ye YM, 2008, J IMMUNOL, V181, P3515, DOI 10.4049/jimmunol.181.5.3515	26	14	15	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					3938	3946		10.1096/fj.12-215533	http://dx.doi.org/10.1096/fj.12-215533			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23792301	Green Published			2022-12-25	WOS:000329747100009
J	Cavallini, A; Brewerton, S; Bell, A; Sargent, S; Glover, S; Hardy, C; Moore, R; Calley, J; Ramachandran, D; Poidinger, M; Karran, E; Davies, P; Hutton, M; Szekeres, P; Bose, S				Cavallini, Annalisa; Brewerton, Suzanne; Bell, Amanda; Sargent, Samantha; Glover, Sarah; Hardy, Clare; Moore, Roger; Calley, John; Ramachandran, Devaki; Poidinger, Michael; Karran, Eric; Davies, Peter; Hutton, Michael; Szekeres, Philip; Bose, Suchira			An Unbiased Approach to Identifying Tau Kinases That Phosphorylate Tau at Sites Associated with Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; HYPERPHOSPHORYLATION; TANGLES; AGGREGATION; EIF2-ALPHA; FILAMENTS; DOMAINS; PATHWAY	Neurofibrillary tangles, one of the hallmarks of Alzheimer disease (AD), are composed of paired helical filaments of abnormally hyperphosphorylated tau. The accumulation of these proteinaceous aggregates in AD correlates with synaptic loss and severity of dementia. Identifying the kinases involved in the pathological phosphorylation of tau may identify novel targets for AD. We used an unbiased approach to study the effect of 352 human kinases on their ability to phosphorylate tau at epitopes associated with AD. The kinases were overexpressed together with the longest form of human tau in human neuroblastoma cells. Levels of total and phosphorylated tau (epitopes Ser(P)-202, Thr(P)-231, Ser(P)-235, and Ser(P)-396/404) were measured in cell lysates using AlphaScreen assays. GSK3 alpha, GSK3 beta, and MAPK13 were found to be the most active tau kinases, phosphorylating tau at all four epitopes. We further dissected the effects of GSK3 alpha and GSK3 beta using pharmacological and genetic tools in hTau primary cortical neurons. Pathway analysis of the kinases identified in the screen suggested mechanisms for regulation of total tau levels and tau phosphorylation; for example, kinases that affect total tau levels do so by inhibition or activation of translation. A network fishing approach with the kinase hits identified other key molecules putatively involved in tau phosphorylation pathways, including the G-protein signaling through the Ras family of GTPases (MAPK family) pathway. The findings identify novel tau kinases and novel pathways that may be relevant for AD and other tauopathies.	[Cavallini, Annalisa; Brewerton, Suzanne; Bell, Amanda; Sargent, Samantha; Glover, Sarah; Hardy, Clare; Moore, Roger; Hutton, Michael; Szekeres, Philip; Bose, Suchira] Eli Lilly & Co Ltd, Erl Wood Manor, Windlesham GU20 6PH, Surrey, England; [Calley, John] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA; [Ramachandran, Devaki; Poidinger, Michael] Eli Lilly & Co Ltd, Singapore Ctr Drug Discovery, Lilly Singapore, Singapore 237994, Singapore; [Karran, Eric] Alzheimers Res UK, Cambridge CB21 6AD, England; [Davies, Peter] Albert Einstein Coll Med, Einstein Inst Med Res, Manhasset, NY 11030 USA	Eli Lilly; Eli Lilly; Yeshiva University	Bose, S (corresponding author), Eli Lilly & Co Ltd, Erl Wood Manor, Sunninghill Rd, Windlesham GU20 6PH, Surrey, England.	bose_suchira@lilly.com		Poidinger, Michael/0000-0002-1047-2277				Allen B, 2002, J NEUROSCI, V22, P9340; Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Atzori C, 2001, J NEUROPATH EXP NEUR, V60, P1190, DOI 10.1093/jnen/60.12.1190; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Azorsa DO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-25; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Buee-Scherrer V, 2002, FEBS LETT, V515, P151, DOI 10.1016/S0014-5793(02)02460-2; Bullido MJ, 2008, NEUROBIOL AGING, V29, P1160, DOI 10.1016/j.neurobiolaging.2007.02.023; Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011; Cho JH, 2003, J BIOL CHEM, V278, P187, DOI 10.1074/jbc.M206236200; Dijkstra E. W., 1959, NUMER MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Eidenmuller J, 2000, BIOCHEMISTRY-US, V39, P13166, DOI 10.1021/bi001290z; Ferrer I, 2001, J NEURAL TRANSM, V108, P1397, DOI 10.1007/s007020100016; Goedert M, 1997, FEBS LETT, V409, P57, DOI 10.1016/S0014-5793(97)00483-3; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Hanger DP, 2009, EXPERT REV NEUROTHER, V9, P1647, DOI 10.1586/ERN.09.104; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Harper SJ, 2003, EXPERT OPIN THER TAR, V7, P187, DOI 10.1517/14728222.7.2.187; Hernandez F, 2003, NEUROBIOL AGING, V24, P1087, DOI 10.1016/j.neurobiolaging.2003.04.002; Higuchi M, 2002, NEUROMOL MED, V2, P131, DOI 10.1385/NMM:2:2:131; Higuchi M, 2012, FASEB J, V26, P1204, DOI 10.1096/fj.11-187740; Hurtado DE, 2012, J NEUROSCI, V32, P7392, DOI 10.1523/JNEUROSCI.0889-12.2012; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Johnson GVW, 2003, EXP NEUROL, V183, P263, DOI 10.1016/S0014-4886(03)00268-1; Kimura T, 1996, DEMENTIA, V7, P177, DOI 10.1159/000106875; Le Corre S, 2006, P NATL ACAD SCI USA, V103, P9673, DOI 10.1073/pnas.0602913103; Lee VHL, 2011, INT J PHARMACEUT, V415, P1, DOI 10.1016/j.ijpharm.2011.03.035; Lee YM, 2010, ARCH PHARM RES, V33, P231, DOI 10.1007/s12272-010-0207-4; Maas T, 2000, J BIOL CHEM, V275, P15733, DOI 10.1074/jbc.M000389200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Nuss J. M., 2002, U. S. Patent, Patent No. [20,020,156,087, 20020156087]; Pooler AM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.01.005; Reynolds CH, 2008, J BIOL CHEM, V283, P18177, DOI 10.1074/jbc.M709715200; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; Sergeant N, 2008, EXPERT REV PROTEOMIC, V5, P207, DOI 10.1586/14789450.5.2.207; Shahpasand K, 2012, J NEUROSCI, V32, P2430, DOI 10.1523/JNEUROSCI.5927-11.2012; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; Wen Y, 2008, J NEUROSCI, V28, P2624, DOI 10.1523/JNEUROSCI.5245-07.2008	41	74	75	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23331	23347		10.1074/jbc.M113.463984	http://dx.doi.org/10.1074/jbc.M113.463984			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23798682	Green Published, hybrid			2022-12-25	WOS:000330598200038
J	Smith, AM; Harrison, JS; Sprague, KM; Roy, H				Smith, Angela M.; Harrison, Jesse S.; Sprague, Kevin M.; Roy, Herve			A Conserved Hydrolase Responsible for the Cleavage of Aminoacylphosphatidylglycerol in the Membrane of Enterococcus faecium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS; LYSYL-PHOSPHATIDYLGLYCEROL; ANTIMICROBIAL PEPTIDES; IV SECRETION; RESISTANCE; VIRULENCE; PROTEIN; MPRF; SUSCEPTIBILITY; DAPTOMYCIN	Aminoacylphosphatidylglycerol synthases (aaPGSs) are enzymes that transfer amino acids from aminoacyl-tRNAs (aa-tRNAs) to phosphatidylglycerol (PG) to form aa-PG in the cytoplasmic membrane of bacteria. aa-PGs provide bacteria with resistance to a range of antimicrobial compounds and stress conditions. Enterococcus faecium encodes a triple-specific aaPGS (RakPGS) that utilizes arginine, alanine, and lysine as substrates. Here we identify a novel hydrolase (AhyD), encoded immediately adjacent to rakPGS in E. faecium, which is responsible for the hydrolysis of aa-PG. The genetic synteny of aaPGS and ahyD is conserved in >60 different bacterial species. Deletion of ahyD in E. faecium resulted in increased formation of Ala-PG and Lys-PG and increased sensitivity to bacitracin. Our results suggest that AhyD and RakPGS act together to maintain optimal levels of aa-PG in the bacterial membrane to confer resistance to certain antimicrobial compounds and stress conditions.	[Smith, Angela M.; Harrison, Jesse S.; Sprague, Kevin M.; Roy, Herve] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32826 USA	State University System of Florida; University of Central Florida	Roy, H (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, 12722 Res Pkwy, Orlando, FL 32826 USA.	herve.roy@ucf.edu						Arendt W, 2012, J BACTERIOL, V194, P1401, DOI 10.1128/JB.06576-11; Atmakuri K, 2003, MOL MICROBIOL, V49, P1699, DOI 10.1046/j.1365-2958.2003.03669.x; Bao YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038458; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; den Kamp JA O P, 1965, Biochim Biophys Acta, V106, P438; DITTMER JC, 1964, J LIPID RES, V5, P126; Ernst CM, 2011, MOL MICROBIOL, V80, P290, DOI 10.1111/j.1365-2958.2011.07576.x; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; FRIESENEGGER A, 1991, FEMS MICROBIOL LETT, V79, P323, DOI 10.1016/0378-1097(91)90106-K; GOULD RM, 1970, J BACTERIOL, V104, P1135, DOI 10.1128/JB.104.3.1135-1144.1970; Hachmann AB, 2009, ANTIMICROB AGENTS CH, V53, P1598, DOI 10.1128/AAC.01329-08; HAEST CWM, 1972, BIOCHIM BIOPHYS ACTA, V255, P720, DOI 10.1016/0005-2736(72)90385-9; Jones T, 2008, ANTIMICROB AGENTS CH, V52, P269, DOI 10.1128/AAC.00719-07; Kahm M., 2010, J STAT SOFTW, V33, pi07; KALOGERAKI VS, 1995, J BACTERIOL, V177, P892, DOI 10.1128/jb.177.4.892-897.1995; KANG HW, 1994, BIOSCI BIOTECH BIOCH, V58, P2024, DOI 10.1271/bbb.58.2024; Klein S, 2009, MOL MICROBIOL, V71, P551, DOI 10.1111/j.1365-2958.2008.06562.x; Maloney E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000534; Mishra NN, 2009, ANTIMICROB AGENTS CH, V53, P2312, DOI 10.1128/AAC.01682-08; Nallapareddy SR, 2006, APPL ENVIRON MICROB, V72, P334, DOI 10.1128/AEM.72.1.334-345.2006; Nishi H, 2004, ANTIMICROB AGENTS CH, V48, P4800, DOI 10.1128/AAC.48.12.4800-4807.2004; ODONOVAN CA, 1994, DIAGN MICR INFEC DIS, V18, P105, DOI 10.1016/0732-8893(94)90074-4; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; OPDENKAMP JA, 1969, J BACTERIOL, V99, P298, DOI 10.1128/JB.99.1.298-303.1969; Pantoja M, 2002, MOL MICROBIOL, V45, P1325, DOI 10.1046/j.1365-2958.2002.03098.x; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Peschel A, 2001, PEPTIDES, V22, P1651, DOI 10.1016/S0196-9781(01)00500-9; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Roy H, 2008, P NATL ACAD SCI USA, V105, P4667, DOI 10.1073/pnas.0800006105; Roy H, 2008, METHODS, V44, P164, DOI 10.1016/j.ymeth.2007.09.002; Roy H, 2009, J BIOL CHEM, V284, P29677, DOI 10.1074/jbc.M109.046367; Roy H, 2009, IUBMB LIFE, V61, P940, DOI 10.1002/iub.240; RUBIN HE, 1982, J DAIRY SCI, V65, P197, DOI 10.3168/jds.S0022-0302(82)82177-2; Samant S, 2009, J BACTERIOL, V191, P1311, DOI 10.1128/JB.01345-08; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sohlenkamp C, 2007, MOL PLANT MICROBE IN, V20, P1421, DOI 10.1094/MPMI-20-11-1421; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; STONE KJ, 1971, P NATL ACAD SCI USA, V68, P3223, DOI 10.1073/pnas.68.12.3223; Thedieck K, 2006, MOL MICROBIOL, V62, P1325, DOI 10.1111/j.1365-2958.2006.05452.x; Vaas LAI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034846; Vinuesa P, 2003, MOL PLANT MICROBE IN, V16, P159, DOI 10.1094/MPMI.2003.16.2.159; Weidenmaier C, 2005, INFECT IMMUN, V73, P8033, DOI 10.1128/IAI.73.12.8033-8038.2005	44	14	14	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22768	22776		10.1074/jbc.M113.484402	http://dx.doi.org/10.1074/jbc.M113.484402			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23793054	Green Published, hybrid			2022-12-25	WOS:000330596300054
J	Greer, AL; Schanzer, D				Greer, Amy L.; Schanzer, Dena			Using a Dynamic Model to Consider Optimal Antiviral Stockpile Size in the Face of Pandemic Influenza Uncertainty	PLOS ONE			English	Article							CLINICAL PREDICTORS; EPIDEMIC; CHILDREN; IMPACT; CANADA; TRANSMISSIBILITY; SEASONALITY; MORTALITY; ILLNESS; VACCINE	Background: The Canadian National Antiviral Stockpile (NAS) contains treatment for 17.5% of Canadians. This assumes no concurrent intervention strategies and no wastage due to non-influenza respiratory infections. A dynamic model can provide a mechanism to consider complex scenarios to support decisions regarding the optimal NAS size under uncertainty. Methods: We developed a dynamic model for pandemic influenza in Canada that is structured by age and risk to calculate the demand for antivirals to treat persons with pandemic influenza under a wide-range of scenarios that incorporated transmission dynamics, disease severity, and intervention strategies. The anticipated per capita number of acute respiratory infections due to viruses other than influenza was estimated for the full pandemic period from surveys based on criteria to identify potential respiratory infections. Results: Our results demonstrate that up to two thirds of the population could develop respiratory symptoms as a result of infection with a pandemic strain. In the case of perfect antiviral allocation, up to 39.8% of the population could request antiviral treatment. As transmission dynamics, severity and timing of the emergence of a novel influenza strain are unknown, the sensitivity analysis produced considerable variation in potential demand (median: 11%, IQR: 2-21%). If the next pandemic strain emerges in late spring or summer and a vaccine is available before the anticipated fall wave, the median prediction was reduced to 6% and IQR to 0.7-14%. Under the strategy of offering empirical treatment to all patients with influenza like symptoms who present for care, demand could increase to between 65 and 144%. Conclusions: The demand for antivirals during a pandemic is uncertain. Unless an accurate, timely and cost-effective test is available to identify influenza cases, demand for antivirals from persons infected with other respiratory viruses will be substantial and have a significant impact on the NAS.	[Greer, Amy L.; Schanzer, Dena] Publ Hlth Agcy Canada, Ctr Communicable Dis & Infect Control, Profess Guidelines & Publ Hlth Practice Div, Modelling & Project Sect, Ottawa, ON, Canada; [Greer, Amy L.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada	Public Health Agency of Canada; University of Toronto	Greer, AL (corresponding author), Publ Hlth Agcy Canada, Ctr Communicable Dis & Infect Control, Profess Guidelines & Publ Hlth Practice Div, Modelling & Project Sect, Ottawa, ON, Canada.	amy.greer@phac-aspc.gc.ca	Schanzer, Dena/G-1593-2011	Schanzer, Dena/0000-0001-7093-4309	Public Health Agency of Canada	Public Health Agency of Canada	This work was funded internally by the Public Health Agency of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki FY, 2010, USE ANTIVIRAL DRUGS, P1; Azziz-Baumgartner E, 2009, INFLUENZA OTHER RESP, V3, P189, DOI 10.1111/j.1750-2659.2009.00091.x; Becker NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017764; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; Carrasco LR, 2011, J ROYAL SOC INTERFAC, P1; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P37; Chowell G, 2006, J THEOR BIOL, V241, P193, DOI 10.1016/j.jtbi.2005.11.026; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; D'Aoust MA, 2008, PLANT BIOTECHNOL J, V6, P930, DOI 10.1111/j.1467-7652.2008.00384.x; Dimitrov NB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016094; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Friedman MJ, 2004, ARCH PEDIAT ADOL MED, V158, P391, DOI 10.1001/archpedi.158.4.391; Gani R, 2005, EMERG INFECT DIS, V11, P1355; Glass K, 2009, J R SOC INTERFACE, V6, P695, DOI 10.1098/rsif.2008.0404; Glezen WP, 2011, LANCET; Hall IM, 2007, EPIDEMIOL INFECT, V135, P372, DOI 10.1017/S0950268806007084; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kelso JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013797; Kwong JC, 2008, PLOS MED, V5, P1440, DOI 10.1371/journal.pmed.0050211; Lee S, 2010, J THEOR BIOL, V265, P136, DOI 10.1016/j.jtbi.2010.04.003; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; LONGINI IM, 1984, INT J EPIDEMIOL, V13, P496, DOI 10.1093/ije/13.4.496; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; McVernon J, 2010, AUST NZ J PUBL HEAL, V34, P113, DOI 10.1111/j.1753-6405.2010.00493.x; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Moghadas SM, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-73; MONTO AS, 1994, EPIDEMIOL REV, V16, P351, DOI 10.1093/oxfordjournals.epirev.a036158; Monto AS, 2002, AM J MED, V112, p4S; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Moran K, 2009, VACCINE, V27, P2350, DOI 10.1016/j.vaccine.2009.02.017; Moss R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014505; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Nuno M, 2007, J R SOC INTERFACE, V4, P505, DOI 10.1098/rsif.2006.0186; Ohmit SE, 2006, CLIN INFECT DIS, V43, P564, DOI 10.1086/506352; Potter CW, 2001, J APPL MICROBIOL, V91, P572, DOI 10.1046/j.1365-2672.2001.01492.x; Public Health Agency of Canada, 2008, FLUWATCH REP; Schanzer DL, 2008, INFLUENZA OTHER RESP, V2, P1, DOI 10.1111/j.1750-2659.2008.00035.x; Schanzer DL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-90; Schanzer DL, 2010, INFLUENZA OTHER RESP, V4, P295, DOI 10.1111/j.1750-2659.2010.00154.x; Schanzer DL, 2012, INFLUENZA OTHER RESP; Shaman J, 2011, AM J EPIDEMIOL, V173, P127, DOI 10.1093/aje/kwq347; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Siddiqui MR, 2008, EMERG INFECT DIS, V14, P267, DOI 10.3201/eid1402.070478; Skowronski DM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7297; Socan M, 2010, CENT EUR J MED, V5, P41, DOI 10.2478/s11536-009-0089-3; Statistics Canada, 2009, PREGN OUTC AG GROUP; Statistics Canada, 2007, AG SEX HIGHL TABL 20; Statistics Canada, 2007, CAN COMM HLTH SURV C; Tam T, 2005, CAN J PUBLIC HEALTH, V96, P406, DOI 10.1007/BF03405177; The Public Health Agency of Canada, 2006, CAN PAND INFL PLAN H; Thursky K, 2003, J CLIN VIROL, V27, P170, DOI 10.1016/S1386-6532(02)00172-5; Tsalik EL, 2010, J CLIN VIROL, V47, P286, DOI 10.1016/j.jcv.2009.12.012; Tuite A, 2009, PLOS CURRENTS INFLUE; Tuite A. R., 2010, PLOS ONE, V5, P1; TUITE AR, 2009, CMAJ, V182, P131, DOI DOI 10.1503/CMAJ.091807; Viboud C, 2006, VACCINE, V24, P6701, DOI 10.1016/j.vaccine.2006.05.067; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P166, DOI 10.1017/S0950268807008369; Webster P, 2004, LANCET, V363, P628, DOI 10.1016/S0140-6736(04)15635-3; Zhang XZ, 2006, MED DECIS MAKING, V26, P617, DOI 10.1177/0272989X06295359	60	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67253	10.1371/journal.pone.0067253	http://dx.doi.org/10.1371/journal.pone.0067253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805303	Green Published, gold, Green Submitted			2022-12-25	WOS:000320846500131
J	Kato, M; Kumasaka, MY; Ohnuma, S; Furuta, A; Kato, Y; Shekhar, HU; Kojima, M; Koike, Y; Thang, ND; Ohgami, N; Ly, TB; Jia, XF; Yetti, H; Naito, H; Ichihara, G; Yajima, I				Kato, Masashi; Kumasaka, Mayuko Y.; Ohnuma, Shoko; Furuta, Akio; Kato, Yoko; Shekhar, Hossain U.; Kojima, Michiyo; Koike, Yasuko; Dinh Thang, Nguyen; Ohgami, Nobutaka; Ly, Thuy Bich; Jia, Xiaofang; Yetti, Husna; Naito, Hisao; Ichihara, Gaku; Yajima, Ichiro			Comparison of Barium and Arsenic Concentrations in Well Drinking Water and in Human Body Samples and a Novel Remediation System for These Elements in Well Drinking Water	PLOS ONE			English	Article							SKIN-LESIONS; GROUNDWATER; EXPOSURE; CONTAMINATION; BANGLADESH; POPULATION; SAMTA	Health risk for well drinking water is a worldwide problem. Our recent studies showed increased toxicity by exposure to barium alone (<= 700 mu g/L) and coexposure to barium (137 mu g/L) and arsenic (225 mu g/L). The present edition of WHO healthbased guidelines for drinking water revised in 2011 has maintained the values of arsenic (10 mu g/L) and barium (700 mu g/L), but not elements such as manganese, iron and zinc. Nevertheless, there have been very few studies on barium in drinking water and human samples. This study showed significant correlations between levels of arsenic and barium, but not its homologous elements (magnesium, calcium and strontium), in urine, toenail and hair samples obtained from residents of Jessore, Bangladesh. Significant correlation between levels of arsenic and barium in well drinking water and levels in human urine, toenail and hair samples were also observed. Based on these results, a high-performance and low-cost adsorbent composed of a hydrotalcite-like compound for barium and arsenic was developed. The adsorbent reduced levels of barium and arsenic from well water in Bangladesh and Vietnam to <7 mu g/L within 1 min. Thus, we have showed levels of arsenic and barium in humans and propose a novel remediation system.	[Kato, Masashi; Kumasaka, Mayuko Y.; Furuta, Akio; Kato, Yoko; Ohgami, Nobutaka; Yajima, Ichiro] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Unit Environm Hlth Sci, Kasugai, Aichi 487, Japan; [Kato, Masashi; Kumasaka, Mayuko Y.; Ohnuma, Shoko; Kato, Yoko; Ohgami, Nobutaka; Yajima, Ichiro] Chubu Univ, Kasugai, Aichi 487, Japan; [Kato, Masashi; Kumasaka, Mayuko Y.; Jia, Xiaofang; Yetti, Husna; Naito, Hisao; Ichihara, Gaku; Yajima, Ichiro] Nagoya Univ, Grad Sch Med, Dept Occupat & Environm Hlth, Showa Ku, Nagoya, Aichi 4648601, Japan; [Shekhar, Hossain U.] Univ Dhaka, Dept Biochem, Dhaka 1000, Bangladesh; [Shekhar, Hossain U.] Univ Dhaka, Dept Mol Biol, Dhaka 1000, Bangladesh; [Kojima, Michiyo; Koike, Yasuko] Aichi Prefectural Inst Publ Hlth, Nagoya, Aichi 462, Japan; [Dinh Thang, Nguyen] Vietnam Natl Univ Sci, Dept Biochem & Plant Physiol, Fac Biol, Hanoi, Vietnam; [Ly, Thuy Bich] Hanoi Univ Sci & Technol, Inst Environm Sci & Technol, Hanoi, Vietnam	Chubu University; Chubu University; Nagoya University; University of Dhaka; University of Dhaka; Vietnam National University Hanoi; Hanoi University of Science & Technology	Kato, M (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Unit Environm Hlth Sci, Kasugai, Aichi 487, Japan.	katomasa@med.nagoya-u.ac.jp	KATO, Masashi/I-7250-2014; Ohgami, Nobutaka/I-4572-2014; YAJIMA, Ichiro/I-7467-2014	Ichihara, Gaku/0000-0001-5707-5300; Ly, Bich Thuy/0000-0002-1961-9175; Naito, Hisao/0000-0003-4228-637X; Shekhar, Hossain/0000-0002-8960-0840	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [24108001]; COE Project (Health Science Hills) for Private Universities form MEXT; Chubu University [S0801055]; Tokyo Biochemical Research Foundation (TBRF); Naito Foundation Natural Science Scholarship; Uehara Memorial Foundation; AEON Environmental Foundation; Cosmetology Research Foundation;  [20406003];  [24390157];  [24406002];  [23650241]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); COE Project (Health Science Hills) for Private Universities form MEXT; Chubu University; Tokyo Biochemical Research Foundation (TBRF); Naito Foundation Natural Science Scholarship; Uehara Memorial Foundation(Uehara Memorial Foundation); AEON Environmental Foundation; Cosmetology Research Foundation; ; ; ; 	This work was supported in part by Grants-in-Aid for Scientific Research (B) (No. 20406003, 24390157 and 24406002), Grant-in-Aid for Challenging Exploratory Research (No. 23650241), Grant-in-Aid for Scientific Research on Innovative Areas (No. 24108001) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); COE Project (Health Science Hills) for Private Universities form MEXT and Chubu University (No. S0801055); AA Science Platform Program from the Japan Society for the Promotion of Science (JSPS); Research Grant from the Tokyo Biochemical Research Foundation (TBRF); the Naito Foundation Natural Science Scholarship; the Uehara Memorial Foundation; AEON Environmental Foundation and the Cosmetology Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argos M, 2011, AM J EPIDEMIOL, V174, P185, DOI 10.1093/aje/kwr062; Berg M, 2007, SCI TOTAL ENVIRON, V372, P413, DOI 10.1016/j.scitotenv.2006.09.010; Chakraborti D, 2003, ENVIRON HEALTH PERSP, V111, P1194, DOI 10.1289/ehp.5966; Chowdhury UK, 2000, ENVIRON HEALTH PERSP, V108, P393, DOI 10.2307/3454378; Frisbie SH, 2009, ENVIRON HEALTH PERSP, V117, P410, DOI 10.1289/ehp.11886; Frisbie SH, 2002, ENVIRON HEALTH PERSP, V110, P1147, DOI 10.1289/ehp.021101147; Gillman GP, 2006, SCI TOTAL ENVIRON, V366, P926, DOI 10.1016/j.scitotenv.2006.01.036; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC Monogr Eval Carcinog Risks Hum, V84, P1; Kato M, 2011, CANCER EPIDEM BIOMAR, V20, P1622, DOI 10.1158/1055-9965.EPI-11-0228; Kato M, 2010, J CELL BIOCHEM, V110, P399, DOI 10.1002/jcb.22550; Kumasaka MY, 2013, ARCH TOXICOL, V87, P439, DOI 10.1007/s00204-012-0964-6; Kurokawa M, 2001, ARCH DERMATOL, V137, P102; Maddison D, 2004, EFFECTS ARSENIC CONT; Mahata J, 2004, MUTAGENESIS, V19, P223, DOI 10.1093/mutage/geh022; Marchiset-Ferlay N, 2012, ENVIRON INT, V39, P150, DOI 10.1016/j.envint.2011.07.015; Nermell B, 2008, ENVIRON RES, V106, P212, DOI 10.1016/j.envres.2007.08.005; Thang ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025636; Nguyen VA, 2009, ENVIRON INT, V35, P466, DOI 10.1016/j.envint.2008.07.014; Ohgami N, 2012, NEUROTOXICOLOGY, V33, P1276, DOI 10.1016/j.neuro.2012.07.008; Ohno K, 2005, WATER SCI TECHNOL, V52, P87, DOI 10.2166/wst.2005.0233; Parvez F, 2006, ENVIRON HEALTH PERSP, V114, P355, DOI 10.1289/ehp.7903; Seow WJ, 2012, ENVIRON HEALTH PERSP, V120, P1733, DOI 10.1289/ehp.1205381; Singh Amrit Pal, 2011, Toxicol Int, V18, P87, DOI 10.4103/0971-6580.84258; Sun GF, 2006, J HEALTH POPUL NUTR, V24, P176; Tokar EJ, 2010, CRIT REV TOXICOL, V40, P912, DOI 10.3109/10408444.2010.506641; Turk T, 2009, J HAZARD MATER, V171, P665, DOI 10.1016/j.jhazmat.2009.06.052; WU MM, 1989, AM J EPIDEMIOL, V130, P1123, DOI 10.1093/oxfordjournals.aje.a115439; Yajima I, 2012, ARCH TOXICOL, V86, P961, DOI 10.1007/s00204-012-0848-9; Yokota H, 2002, WATER SCI TECHNOL, V46, P375, DOI 10.2166/wst.2002.0765	29	30	30	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66681	10.1371/journal.pone.0066681	http://dx.doi.org/10.1371/journal.pone.0066681			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805262	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000320846500090
J	Mohr, W; Vagner, T; Kuypers, MMM; Ackermann, M; LaRoche, J				Mohr, Wiebke; Vagner, Tomas; Kuypers, Marcel M. M.; Ackermann, Martin; LaRoche, Julie			Resolution of Conflicting Signals at the Single-Cell Level in the Regulation of Cyanobacterial Photosynthesis and Nitrogen Fixation	PLOS ONE			English	Article							LIGHT-GROWN CULTURES; SP PCC 6909; GENE-EXPRESSION; DIAZOTROPHIC CYANOBACTERIUM; TRANSLATIONAL REGULATION; STRAIN; DARK; METABOLISM; CARBON; IRON	Unicellular, diazotrophic cyanobacteria temporally separate dinitrogen (N-2) fixation and photosynthesis to prevent inactivation of the nitrogenase by oxygen. This temporal segregation is regulated by a circadian clock with oscillating activities of N-2 fixation in the dark and photosynthesis in the light. On the population level, this separation is not always complete, since the two processes can overlap during transitions from dark to light. How do single cells avoid inactivation of nitrogenase during these periods? One possibility is that phenotypic heterogeneity in populations leads to segregation of the two processes. Here, we measured N-2 fixation and photosynthesis of individual cells using nanometer-scale secondary ion mass spectrometry (nanoSIMS) to assess both processes in a culture of the unicellular, diazotrophic cyanobacterium Crocosphaera watsonii during a dark-light and a continuous light phase. We compared single-cell rates with bulk rates and gene expression profiles. During the regular dark and light phases, C. watsonii exhibited the temporal segregation of N-2 fixation and photosynthesis commonly observed. However, N-2 fixation and photosynthesis were concurrently measurable at the population level during the subjective dark phase in which cells were kept in the light rather than returned to the expected dark phase. At the single-cell level, though, cells discriminated against either one of the two processes. Cells that showed high levels of photosynthesis had low nitrogen fixing activities, and vice versa. These results suggest that, under ambiguous environmental signals, single cells discriminate against either photosynthesis or nitrogen fixation, and thereby might reduce costs associated with running incompatible processes in the same cell.	[Mohr, Wiebke; LaRoche, Julie] Helmholtz Ctr Ocean Res GEOMAR, Dept Biogeochem, Kiel, Germany; [Vagner, Tomas; Kuypers, Marcel M. M.] Max Planck Inst Marine Microbiol, Dept Biogeochem, Bremen, Germany; [Ackermann, Martin] Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland; [Ackermann, Martin] Eawag, Dept Environm Microbiol, Dubendorf, Switzerland	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Mohr, W (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	wmohr@fas.harvard.edu	LaRoche, Julie/A-1109-2010; Ackermann, Martin/V-4554-2017	Ackermann, Martin/0000-0003-0087-4819; LaRoche, Julie/0000-0003-4809-6411; Mohr, Wiebke/0000-0002-1126-1455	SOPRAN project; German Federal Ministry of Education and Research (BMBF); Max-Planck-Society; Swiss National Science Foundation; NSERC discovery grant	SOPRAN project; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Max-Planck-Society(Max Planck SocietyFoundation CELLEX); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NSERC discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported through the SOPRAN project (http://sopran.pangaea.de) funded by the German Federal Ministry of Education and Research (BMBF). The authors thank the Max-Planck-Society for financial support (http://www.mpg.de). MA was supported by a grant from the Swiss National Science Foundation (http://www.snf.ch). Julie LaRoche was supported by a NSERC discovery grant. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capone D.G., 1993, HDB METHODS AQUATIC, P621, DOI 10.1201/9780203752746-74; Cerveny J, 2009, J BIOL RHYTHM, V24, P295, DOI 10.1177/0748730409338367; Chen YB, 1996, J PHYCOL, V32, P916, DOI 10.1111/j.0022-3646.1996.00916.x; Chen YB, 1998, J BACTERIOL, V180, P3598, DOI 10.1128/JB.180.14.3598-3605.1998; CHOU HM, 1989, BOT BULL ACAD SINICA, V30, P291; CHOW TJ, 1994, J BACTERIOL, V176, P6281, DOI 10.1128/jb.176.20.6281-6285.1994; Colon-Lopez MS, 1998, J BACTERIOL, V180, P519; ColonLopez M, 1997, J BACTERIOL, V179, P4319, DOI 10.1128/jb.179.13.4319-4327.1997; Compaore J, 2010, ENVIRON MICROBIOL, V12, P54, DOI 10.1111/j.1462-2920.2009.02034.x; Davidson CJ, 2008, ANNU REV GENET, V42, P253, DOI 10.1146/annurev.genet.42.110807.091601; Dron A, 2012, ENVIRON MICROBIOL, V14, P967, DOI 10.1111/j.1462-2920.2011.02675.x; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; FAY P, 1992, MICROBIOL REV, V56, P340, DOI 10.1128/MMBR.56.2.340-373.1992; GALLON JR, 1992, NEW PHYTOL, V122, P571; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kelly CD, 1932, J BACTERIOL, V23, P147, DOI 10.1128/JB.23.2.147-153.1932; Lechene CP, 2007, SCIENCE, V317, P1563, DOI 10.1126/science.1145557; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis Matthieu, 2002, Sci STKE, V2002, ppe33, DOI 10.1126/stke.2002.143.pe33; Mackey SR, 2011, ADV GENET, V74, P13, DOI 10.1016/B978-0-12-387690-4.00002-7; MARYAN PS, 1986, J GEN MICROBIOL, V132, P789; Mohr W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012583; Mohr W, 2010, ENVIRON MICROBIOL, V12, P412, DOI 10.1111/j.1462-2920.2009.02078.x; Montoya JP, 1996, APPL ENVIRON MICROB, V62, P986, DOI 10.1128/AEM.62.3.986-993.1996; ORTEGA-CALVO JJ, 1991, J GEN MICROBIOL, V137, P1789; Pennebaker K, 2010, ENVIRON MICROBIOL, DOI [10.1111/j.1462-2920.2009.02144.x., DOI 10.1111/J.1462-2920.2009.02144.X]; Ploug H, 2011, ISME J, V5, P1549, DOI 10.1038/ismej.2011.20; Popa R, 2007, ISME J, V1, P354, DOI 10.1038/ismej.2007.44; Rust MJ, 2011, SCIENCE, V331, P220, DOI 10.1126/science.1197243; Ryall B, 2012, MICROBIOL MOL BIOL R, V76, P597, DOI 10.1128/MMBR.05028-11; Saito MA, 2011, P NATL ACAD SCI USA, V108, P2184, DOI 10.1073/pnas.1006943108; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHNEEGURT MA, 1994, J BACTERIOL, V176, P1586, DOI 10.1128/jb.176.6.1586-1597.1994; Shi T, 2007, ENVIRON MICROBIOL, V9, P2945, DOI 10.1111/j.1462-2920.2007.01406.x; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Strovas TJ, 2007, J BACTERIOL, V189, P7127, DOI 10.1128/JB.00746-07; Taniuchi Y, 2008, MICROBIOL-SGM, V154, P1859, DOI 10.1099/mic.0.2008/018689-0; Taniuchi Y, 2007, PHYCOL RES, V55, P249, DOI 10.1111/j.1440-1835.2007.00470.x; Toepel J, 2008, J BACTERIOL, V190, P3904, DOI 10.1128/JB.00206-08; Tuit C, 2004, LIMNOL OCEANOGR, V49, P978, DOI 10.4319/lo.2004.49.4.0978	40	20	20	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66060	10.1371/journal.pone.0066060	http://dx.doi.org/10.1371/journal.pone.0066060			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805199	gold, Green Published, Green Accepted			2022-12-25	WOS:000320846500027
J	Pinter-Kubler, B; Ferenczi, S; Nunez, C; Zelei, E; Polyak, A; Milanes, MV; Kovacs, KJ				Pinter-Kuebler, Bernadett; Ferenczi, Szilamer; Nunez, Cristina; Zelei, Edina; Polyak, Agnes; Victoria Milanes, M.; Kovacs, Krisztina J.			Differential Changes in Expression of Stress- and Metabolic-Related Neuropeptides in the Rat Hypothalamus during Morphine Dependence and Withdrawal	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; MESSENGER-RNA EXPRESSION; C-FOS EXPRESSION; GENE-EXPRESSION; UROCORTIN-II; BRAIN; ACTIVATION; RESPONSES; SYSTEM; VASOPRESSIN	Chronic morphine treatment and naloxone precipitated morphine withdrawal activates stress-related brain circuit and results in significant changes in food intake, body weight gain and energy metabolism. The present study aimed to reveal hypothalamic mechanisms underlying these effects. Adult male rats were made dependent on morphine by subcutaneous implantation of constant release drug pellets. Pair feeding revealed significantly smaller weight loss of morphine treated rats compared to placebo implanted animals whose food consumption was limited to that eaten by morphine implanted pairs. These results suggest reduced energy expenditure of morphine-treated animals. Chronic morphine exposure or pair feeding did not significantly affect hypothalamic expression of selected stress-and metabolic related neuropeptides - corticotropin-releasing hormone (CRH), urocortin 2 (UCN2) and proopiomelanocortin (POMC) compared to placebo implanted and pair fed animals. Naloxone precipitated morphine withdrawal resulted in a dramatic weight loss starting as early as 15-30 min after naloxone injection and increased adrenocorticotrophic hormone, prolactin and corticosterone plasma levels in morphine dependent rats. Using real-time quantitative PCR to monitor the time course of relative expression of neuropeptide mRNAs in the hypothalamus we found elevated CRH and UCN2 mRNA and dramatically reduced POMC expression. Neuropeptide Y (NPY) and arginine vasopressin (AVP) mRNA levels were transiently increased during opiate withdrawal. These data highlight that morphine withdrawal differentially affects expression of stress-and metabolic-related neuropeptides in the rat hypothalamus, while relative mRNA levels of these neuropeptides remain unchanged either in rats chronically treated with morphine or in their pair-fed controls.	[Pinter-Kuebler, Bernadett; Ferenczi, Szilamer; Zelei, Edina; Polyak, Agnes; Kovacs, Krisztina J.] Hungarian Acad Sci, Inst Expt Med, Lab Mol Neuroendocrinol, Budapest, Hungary; [Nunez, Cristina; Victoria Milanes, M.] Univ Murcia, Fac Med, Grp Cellular & Mol Pharmacol, Murcia, Spain	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of Murcia	Kovacs, KJ (corresponding author), Hungarian Acad Sci, Inst Expt Med, Lab Mol Neuroendocrinol, Budapest, Hungary.	kovacs.krisztina@koki.mta.hu	Milanés, M. Victoria/AGB-4075-2022; Milanés, M Victoria/K-6591-2017; Núñez, Cristina/O-8288-2015	Milanés, M. Victoria/0000-0002-0984-2218; Milanés, M Victoria/0000-0002-0984-2218; Núñez, Cristina/0000-0002-0773-4950	Hungarian Research Fund, OTKA grant (International Research Collaboration grant) [68574, 76697]; Ministerio de Ciencia e Innovacion, Spain [2009-07178]; Red de Trastornos Adictivos, Spain [RD06/0001/1006, RD06/0001/1001]	Hungarian Research Fund, OTKA grant (International Research Collaboration grant)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Red de Trastornos Adictivos, Spain	This work was supported by the following grants: Hungarian Research Fund, OTKA grants, 68574 and 76697 (International Research Collaboration grant) to KJK and Ministerio de Ciencia e Innovacion (Grant 2009-07178 to MVM), Spain and Red de Trastornos Adictivos (RD06/0001/1006 and RD06/0001/1001), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 1999, ENDOCRINOLOGY, V140, P4923, DOI 10.1210/en.140.11.4923; Anghel A, 2010, NEUROSCIENCE, V167, P554, DOI 10.1016/j.neuroscience.2010.01.043; ARASE K, 1988, AM J PHYSIOL, V255, pE255, DOI 10.1152/ajpendo.1988.255.3.E255; Befort K, 2008, ANN NY ACAD SCI, V1129, P175, DOI 10.1196/annals.1417.028; BRONSTEIN DM, 1990, BRAIN RES, V519, P102, DOI 10.1016/0006-8993(90)90066-K; CICERO TJ, 1973, J PHARMACOL EXP THER, V184, P404; Clausen TR, 2001, J NEUROSCI RES, V64, P410, DOI 10.1002/jnr.1092; Dallman MF, 2003, P NATL ACAD SCI USA, V100, P11696, DOI 10.1073/pnas.1934666100; De Fanti BA, 2002, BRAIN RES, V930, P37, DOI 10.1016/S0006-8993(01)03401-1; DELLE M, 1990, J PHARMACOL EXP THER, V253, P646; DEYEBENES EG, 1993, NEUROPEPTIDES, V25, P91, DOI 10.1016/0143-4179(93)90087-Q; DHATT RK, 1988, PHYSIOL BEHAV, V43, P553, DOI 10.1016/0031-9384(88)90208-9; Ferenczi S, 2010, NEUROCHEM INT, V57, P323, DOI 10.1016/j.neuint.2010.06.011; Frenois F, 2002, EUR J NEUROSCI, V16, P1377, DOI 10.1046/j.1460-9568.2002.02187.x; George O, 2007, P NATL ACAD SCI USA, V104, P17198, DOI 10.1073/pnas.0707585104; Hamlin AS, 2004, NEUROSCI LETT, V362, P39, DOI 10.1016/j.neulet.2004.02.033; Houshyar H, 2004, J NEUROSCI, V24, P9414, DOI 10.1523/JNEUROSCI.1641-04.2004; Houshyar H, 2003, NEUROPSYCHOPHARMACOL, V28, P1960, DOI 10.1038/sj.npp.1300271; Hsu SY, 2001, NAT MED, V7, P605, DOI 10.1038/87936; IKONOMOV OC, 1984, ACTA PHYSIOL HUNG, V63, P137; JANSEN ASP, 1995, SCIENCE, V270, P644, DOI 10.1126/science.270.5236.644; Kas MJH, 2005, J MOL ENDOCRINOL, V35, P159, DOI 10.1677/jme.1.01819; KAUPPILA T, 1992, PHARMACOL TOXICOL, V71, P173, DOI 10.1111/j.1600-0773.1992.tb00540.x; Kiefer F, 2004, ADDICT BIOL, V9, P205, DOI 10.1111/j.1369-1600.2004.tb00534.x; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; KOOB GF, 1992, TRENDS NEUROSCI, V15, P186, DOI 10.1016/0166-2236(92)90171-4; Kovacs KJ, 1996, J NEUROSCI, V16, P262; KOVACS KJ, 1988, BRAIN RES, V474, P205, DOI 10.1016/0006-8993(88)90435-0; Kuperman Y, 2008, TRENDS ENDOCRIN MET, V19, P122, DOI 10.1016/j.tem.2007.12.002; la Fleur SE, 2005, P NATL ACAD SCI USA, V102, P7647, DOI 10.1073/pnas.0408531102; LIGHTMAN SL, 1988, J PHYSIOL-LONDON, V403, P511, DOI 10.1113/jphysiol.1988.sp017261; MALDONADO R, 1992, N-S ARCH PHARMACOL, V345, P466; MANSOUR A, 1995, TRENDS NEUROSCI, V18, P22, DOI 10.1016/0166-2236(95)93946-U; Martin F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031119; Martinez V, 2004, J PHYSIOL-LONDON, V556, P221, DOI 10.1113/jphysiol.2003.059659; Milanes MV, 1998, J PHARMACOL EXP THER, V285, P700; Navarro-Zaragoza J, 2011, BRIT J PHARMACOL, V162, P851, DOI 10.1111/j.1476-5381.2010.01090.x; Navarro-Zaragoza J, 2010, MOL PHARMACOL, V77, P864, DOI 10.1124/mol.109.062463; Nijsen MJMA, 2000, NEUROPSYCHOPHARMACOL, V22, P388, DOI 10.1016/S0893-133X(99)00126-8; Nunez C, 2007, J NEUROCHEM, V101, P1060, DOI 10.1111/j.1471-4159.2006.04421.x; Nunez C, 2010, J NEUROCHEM, V114, P475, DOI 10.1111/j.1471-4159.2010.06765.x; Papaleo F, 2008, NEUROPSYCHOPHARMACOL, V33, P2878, DOI 10.1038/npp.2008.8; Pennock RL, 2011, J NEUROSCI, V31, P281, DOI 10.1523/JNEUROSCI.4654-10.2011; Reyes TM, 2001, P NATL ACAD SCI USA, V98, P2843, DOI 10.1073/pnas.051626398; Schank JR, 2012, NEURON, V76, P192, DOI 10.1016/j.neuron.2012.09.026; STORNETTA RL, 1993, BRAIN RES, V624, P19, DOI 10.1016/0006-8993(93)90055-R; Szilamer F, 2010, MOL CELL ENDOCRINOL, V321, P138, DOI 10.1016/j.mce.2010.02.036; Tanaka Y, 2003, NEUROENDOCRINOLOGY, V78, P1, DOI 10.1159/000071700; Uehara Y, 1998, DIABETES, V47, P890, DOI 10.2337/diabetes.47.6.890; Williams CL, 1997, J PHARMACOL EXP THER, V280, P656; Williams KW, 2012, NAT NEUROSCI, V15, P1350, DOI 10.1038/nn.3217; Woldbye DPD, 1998, J PHARMACOL EXP THER, V284, P633; Zelena D, 2003, AM J PHYSIOL-ENDOC M, V285, pE1110, DOI 10.1152/ajpendo.00219.2003; Zhang R, 2009, P NATL ACAD SCI USA, V106, P5913, DOI 10.1073/pnas.0808716106	54	16	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67027	10.1371/journal.pone.0067027	http://dx.doi.org/10.1371/journal.pone.0067027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805290	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000320846500118
J	Zhuo, DX; Zhang, XW; Jin, B; Zhang, Z; Xie, BS; Wu, CL; Gong, K; Mao, ZB				Zhuo, De-Xiang; Zhang, Xiao-Wei; Jin, Bo; Zhang, Zheng; Xie, Bu-Shan; Wu, Cheng-Lin; Gong, Kan; Mao, Ze-Bin			CSTP1, a Novel Protein Phosphatase, Blocks Cell Cycle, Promotes Cell Apoptosis, and Suppresses Tumor Growth of Bladder Cancer by Directly Dephosphorylating Akt at Ser473 Site	PLOS ONE			English	Article							KINASE-B; FGFR3 MUTATIONS; GENE-MUTATIONS; ACTIVATION; PHOSPHORYLATION; PTEN/MMAC1; PATHWAYS; PHLPP; PTEN	Akt/protein kinase B is a pivotal component downstream of phosphatidylinositol 3-kinase (PI3K) pathway, whose activity regulates the balance between cell survival and apoptosis. Phosphorylation of Akt occurs at two key sites either at Thr308 site in the activation loop or at Ser473 site in the hydrophobic motif. The phosphorylated form of Akt (pAkt) is activated to promote cell survival. The mechanisms of pAkt dephosphorylation and how the signal transduction of Akt pathway is terminated are still largely unknown. In this study, we identified a novel protein phosphatase CSTP1(complete s transactivated protein 1), which interacts and dephosphorylates Akt specifically at Ser473 site in vivo and in vitro, blocks cell cycle progression and promotes cell apoptosis. The effects of CSTP1 on cell survival and cell cycle were abrogated by depletion of phosphatase domain of CSTP1 or by expression of a constitutively active form of Akt (S473D), suggesting Ser473 site of Akt as a primary cellular target of CSTP1. Expression profile analysis showed that CSTP1 expression is selectively down-regulated in non-invasive bladder cancer tissues and over-expression of CSTP1 suppressed the size of tumors in nude mice. Kaplan-Meier curves revealed that decreased expression of CSTP1 implicated significantly reduced recurrence-free survival in patients suffered from non-invasive bladder cancers.	[Zhuo, De-Xiang; Zhang, Xiao-Wei; Jin, Bo; Xie, Bu-Shan; Wu, Cheng-Lin; Mao, Ze-Bin] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; [Zhang, Zheng; Gong, Kan] Peking Univ, Hosp 1, Dept Urol, Beijing 100871, Peoples R China; [Zhang, Zheng; Gong, Kan] Peking Univ, Inst Urol, Beijing 100871, Peoples R China; [Zhuo, De-Xiang] Fujian Med Univ, Hosp Sanming 1, Dept Lab Med, Sanming, Fujian, Peoples R China	Peking University; Peking University; Peking University; Fujian Medical University	Gong, K (corresponding author), Peking Univ, Hosp 1, Dept Urol, Beijing 100871, Peoples R China.	gongkan2004@yahoo.com.cn; zbmao@bjmu.edu.cn	Gong, Kan/AAA-5915-2020	Gong, Kan/0000-0001-7195-677X	National Science Foundation of China [81272827, 30971627]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China grants 81272827 and 30971627. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Askham JM, 2010, ONCOGENE, V29, P150, DOI 10.1038/onc.2009.315; Aveyard JS, 1999, BRIT J CANCER, V80, P904, DOI 10.1038/sj.bjc.6690439; Bai GQ, 2005, WORLD J GASTROENTERO, V11, P3893; Bakkar AA, 2003, CANCER RES, V63, P8108; Billerey C, 2001, AM J PATHOL, V158, P1955, DOI 10.1016/S0002-9440(10)64665-2; Broach JR, 1997, CURR OPIN GENET DEV, V7, P1, DOI 10.1016/S0959-437X(97)80102-5; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Cairns P, 1998, ONCOGENE, V16, P3215, DOI 10.1038/sj.onc.1201855; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cappellen D, 1997, ONCOGENE, V14, P3059, DOI 10.1038/sj.onc.1201154; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Jebar AH, 2005, ONCOGENE, V24, P5218, DOI 10.1038/sj.onc.1208705; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Knowles MA, 2008, SCAND J UROL NEPHROL, V42, P116, DOI 10.1080/03008880802284605; Knowles MA, 2009, CANCER METAST REV, V28, P305, DOI 10.1007/s10555-009-9198-3; Kramer MW, 2007, SCAND J UROL NEPHROL, V41, P478, DOI 10.1080/00365590701430737; Liu J, 2009, ONCOGENE, V28, P994, DOI 10.1038/onc.2008.450; Lopez-Knowles E, 2006, CANCER RES, V66, P7401, DOI 10.1158/0008-5472.CAN-06-1182; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mitra AP, 2006, J CLIN ONCOL, V24, P5552, DOI 10.1200/JCO.2006.08.2073; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Platt FM, 2009, CLIN CANCER RES, V15, P6008, DOI 10.1158/1078-0432.CCR-09-0898; Ploeg M, 2009, WORLD J UROL, V27, P289, DOI 10.1007/s00345-009-0383-3; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shu LL, 2009, MOL CELL BIOL, V29, P4691, DOI 10.1128/MCB.00764-09; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Wang DS, 2000, INT J CANCER, V88, P620, DOI 10.1002/1097-0215(20001115)88:4<620::AID-IJC16>3.0.CO;2-Z; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Yamada T, 2001, J BIOL CHEM, V276, P5339, DOI 10.1074/jbc.M005685200; Zhang ZT, 2001, ONCOGENE, V20, P1973, DOI 10.1038/sj.onc.1204315	37	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65679	10.1371/journal.pone.0065679	http://dx.doi.org/10.1371/journal.pone.0065679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799035	Green Published, Green Submitted, gold			2022-12-25	WOS:000321397800014
J	Gomes, C; Osorio, H; Pinto, MT; Campos, D; Oliveira, MJ; Reis, CA				Gomes, Catarina; Osorio, Hugo; Pinto, Marta Teixeira; Campos, Diana; Oliveira, Maria Jose; Reis, Celso A.			Expression of ST3GAL4 Leads to SLe(x) Expression and Induces c-Met Activation and an Invasive Phenotype in Gastric Carcinoma Cells	PLOS ONE			English	Article							BREAST-CANCER CELLS; SIALYL LEWIS(X) ANTIGEN; COLORECTAL-CARCINOMA; ACTIN CYTOSKELETON; THERAPEUTIC TARGET; PROGNOSTIC MARKER; G(D3) SYNTHASE; CDC42 GTPASES; RHO GTPASES; P-SELECTIN	Sialyl-Lewis X (SLe(x)) is a sialylated glycan antigen expressed on the cell surface during malignant cell transformation and is associated with cancer progression and poor prognosis. The increased expression of sialylated glycans is associated with alterations in the expression of sialyltransferases (STs). In this study we determined the capacity of ST3GAL3 and ST3GAL4 sialyltransferases to synthesize the SLe(x) antigen in MKN45 gastric carcinoma cells and evaluated the effect of SLe(x) overexpression in cancer cell behavior both in vitro and in vivo using the chicken chorioallantoic membrane (CAM) model. The activation of tyrosine kinase receptors and their downstream molecular targets was also addressed. Our results showed that the expression of ST3GAL4 in MKN45 gastric cancer cells leads to the synthesis of SLe(x) antigens and to an increased invasive phenotype both in vitro and in the in vivo CAM model. Analysis of phosphorylation of tyrosine kinase receptors showed a specific increase in c-Met activation. The characterization of downstream molecular targets of c-Met activation, involved in the invasive phenotype, revealed increased phosphorylation of FAK and Src proteins and activation of Cdc42, Rac1 and RhoA GTPases. Inhibition of c-Met and Src activation abolished the observed increased cell invasive phenotype. In conclusion, the expression of ST3GAL4 leads to SLe(x) antigen expression in gastric cancer cells which in turn induces an increased invasive phenotype through the activation of c-Met, in association with Src, FAK and Cdc42, Rac1 and RhoA GTPases activation.	[Gomes, Catarina; Osorio, Hugo; Pinto, Marta Teixeira; Campos, Diana; Reis, Celso A.] Univ Porto, IPATIMUP, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Oliveira, Maria Jose] Univ Porto, INEB, Inst Engn Biomed, P-4100 Oporto, Portugal; [Osorio, Hugo; Oliveira, Maria Jose; Reis, Celso A.] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Reis, Celso A.] ICBAS, Inst Biomed Sci Abel Salazar, Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto	Reis, CA (corresponding author), Univ Porto, IPATIMUP, Inst Mol Pathol & Immunol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	celsor@ipatimup.pt	Gomes, Catarina/AAU-4636-2020; REIS, Celso A/B-9969-2008; Pinto, Marta T/J-2519-2013; Osorio, Hugo/A-7847-2012; Gomes, Catarina/AAC-3325-2021; Oliveira, Maria Jose/K-3275-2013	REIS, Celso A/0000-0002-0286-6639; Pinto, Marta T/0000-0002-8521-2904; Osorio, Hugo/0000-0002-6362-8255; Gomes, Catarina/0000-0002-0352-6783; Campos, Diana/0000-0003-0762-7124; Oliveira, Maria Jose/0000-0002-0724-0272	Portuguese Foundation for Science and Technology FCT [PTDC/BBB-EBI/0786/2012]; Portuguese Foundation for Science and Technology;  [SFRH/BD/44236/2008]	Portuguese Foundation for Science and Technology FCT(Portuguese Foundation for Science and Technology); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); 	This work was partially supported by Portuguese Foundation for Science and Technology FCT (PTDC/BBB-EBI/0786/2012) financiado no ambito do Programa Operacional Tematico de Fatores de Competitividade (COMPETE) e do Quadro de Referencia Estrategia Nacional QREN. FCT supports CG (PhD grant SFRH/BD/44236/2008), and HO and MTP (Ciencia 2007 program). IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by the Portuguese Foundation for Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado M, 1998, GASTROENTEROLOGY, V114, P462, DOI 10.1016/S0016-5085(98)70529-3; Aubert M, 2000, CANCER RES, V60, P1449; Baldus SE, 1998, TUMOR BIOL, V19, P445, DOI 10.1159/000030036; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Borsig L, 2002, P NATL ACAD SCI USA, V99, P2193, DOI 10.1073/pnas.261704098; Carvalho AS, 2010, INT J BIOCHEM CELL B, V42, P80, DOI 10.1016/j.biocel.2009.09.010; Cazet A, 2012, GLYCOBIOLOGY, V22, P806, DOI 10.1093/glycob/cws049; Cazet A, 2010, CARBOHYD RES, V345, P1377, DOI 10.1016/j.carres.2010.01.024; Cazet A, 2009, BIOL CHEM, V390, P601, DOI 10.1515/BC.2009.054; Colomb F, 2012, BIOCHIMIE, V94, P2045, DOI 10.1016/j.biochi.2012.05.030; de Curtis I, 2012, J CELL SCI; Drake PM, 2010, CLIN CHEM, V56, P223, DOI 10.1373/clinchem.2009.136333; Dua R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015932; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Ellies LG, 2002, BLOOD, V100, P3618, DOI 10.1182/blood-2002-04-1007; Evers EE, 2000, EUR J CANCER, V36, P1269, DOI 10.1016/S0959-8049(00)00091-5; Fukuoka K, 1998, LUNG CANCER, V20, P109, DOI 10.1016/S0169-5002(98)00016-6; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Grabowski P, 2000, INT J CANCER, V88, P281, DOI 10.1002/1097-0215(20001015)88:2<281::AID-IJC21>3.0.CO;2-2; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Hall A, 1999, BRIT J CANCER, V80, P25; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Harduin-Lepers Anne, 2012, Front Biosci (Elite Ed), V4, P499; Hill CAS, 2011, CANCER-AM CANCER SOC, V117, P4493, DOI 10.1002/cncr.26059; Ichikawa D, 2000, J SURG ONCOL, V75, P98, DOI 10.1002/1096-9098(200010)75:2<98::AID-JSO5>3.0.CO;2-R; Inoue T, 2004, CANCER SCI, V95, P803, DOI 10.1111/j.1349-7006.2004.tb02185.x; Kamai T, 2004, CLIN CANCER RES, V10, P4799, DOI 10.1158/1078-0432.CCR-0436-03; Kannagi R, 2004, CANCER SCI, V95, P377, DOI 10.1111/j.1349-7006.2004.tb03219.x; Kannagi R, 1997, GLYCOCONJUGATE J, V14, P577, DOI 10.1023/A:1018532409041; Kim YJ, 1998, P NATL ACAD SCI USA, V95, P9325, DOI 10.1073/pnas.95.16.9325; KITAGAWA H, 1993, BIOCHEM BIOPH RES CO, V194, P375, DOI 10.1006/bbrc.1993.1830; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; Kono M, 1997, GLYCOBIOLOGY, V7, P469, DOI 10.1093/glycob/7.4.469; Lee J, 2011, ONCOL REP, V25, P1517, DOI 10.3892/or.2011.1219; Leve F, 2011, EUR J PHARMACOL, V671, P7, DOI 10.1016/j.ejphar.2011.09.006; Li J, 2012, MED ONCOL, V29, P84, DOI 10.1007/s12032-010-9771-1; Lim SK, 2012, CLIN EXP METASTASIS; Liu XD, 2010, TRENDS MOL MED, V16, P37, DOI 10.1016/j.molmed.2009.11.005; Machesky LM, 1999, J CELL BIOL, V146, P267, DOI 10.1083/jcb.146.2.267; Nakamori S, 1997, DIS COLON RECTUM, V40, P420, DOI 10.1007/BF02258386; Nakamori S, 1999, J EXP CLIN CANC RES, V18, P425; NAKAMORI S, 1993, CANCER RES, V53, P3632; Okajima T, 1999, J BIOL CHEM, V274, P11479, DOI 10.1074/jbc.274.17.11479; Organ Shawna Leslie, 2011, Ther Adv Med Oncol, V3, pS7, DOI 10.1177/1758834011422556; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Peng L, 2009, CARCINOGENESIS, V30, P1660, DOI 10.1093/carcin/bgp178; Pertz O, 2010, J CELL SCI, V123, P1841, DOI 10.1242/jcs.064345; Petretti T, 1999, BBA-GEN SUBJECTS, V1428, P209, DOI 10.1016/S0304-4165(99)00080-X; Sanchez-Bailon MP, 2012, CELL SIGNAL, V24, P1276, DOI 10.1016/j.cellsig.2012.02.011; Reis CA, 2010, J CLIN PATHOL, V63, P322, DOI 10.1136/jcp.2009.071035; Seales EC, 2005, J BIOL CHEM, V280, P37610, DOI 10.1074/jbc.M508476200; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Shen J, 2012, CANCER LETT, V318, P106, DOI 10.1016/j.canlet.2011.12.008; Sierra J Rafael, 2011, Ther Adv Med Oncol, V3, pS21, DOI 10.1177/1758834011422557; Singh R, 2006, GLYCOBIOLOGY, V16, P594, DOI 10.1093/glycob/cwj108; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; SOMAN NR, 1991, P NATL ACAD SCI USA, V88, P4892, DOI 10.1073/pnas.88.11.4892; Sperandio M, 2006, EUR J IMMUNOL, V36, P3207, DOI 10.1002/eji.200636157; TAKADA A, 1993, CANCER RES, V53, P354; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Tatsumi M, 1998, CLIN EXP METASTAS, V16, P743, DOI 10.1023/A:1006584829246; VARKI A, 1994, P NATL ACAD SCI USA, V91, P7390, DOI 10.1073/pnas.91.16.7390; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Wessler S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-27; Yu J, 2000, CANCER-AM CANCER SOC, V88, P1801, DOI 10.1002/(SICI)1097-0142(20000415)88:8<1801::AID-CNCR7>3.0.CO;2-U	66	74	75	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66737	10.1371/journal.pone.0066737	http://dx.doi.org/10.1371/journal.pone.0066737			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799130	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300095
J	Hill, J; Dellicour, S; Bruce, J; Ouma, P; Smedley, J; Otieno, P; Ombock, M; Kariuki, S; Desai, M; Hamel, MJ; ter Kuile, FO; Webster, J				Hill, Jenny; Dellicour, Stephanie; Bruce, Jane; Ouma, Peter; Smedley, James; Otieno, Peter; Ombock, Maurice; Kariuki, Simon; Desai, Meghna; Hamel, Mary J.; ter Kuile, Feiko O.; Webster, Jayne			Effectiveness of Antenatal Clinics to Deliver Intermittent Preventive Treatment and Insecticide Treated Nets for the Control of Malaria in Pregnancy in Kenya	PLOS ONE			English	Article							SULFADOXINE-PYRIMETHAMINE; PRESUMPTIVE TREATMENT; BIRTH-WEIGHT; WOMEN; POLICY; ANTIMALARIAL; KNOWLEDGE; COVERAGE; TANZANIA; THERAPY	Background: Malaria in pregnancy can have devastating consequences for mother and baby. Coverage with the WHO prevention strategy for sub-Saharan Africa of intermittent-preventive-treatment (IPTp) with two doses of sulphadoxine-pyrimethamine (SP) and insecticide-treated-nets (ITNs) in pregnancy is low. We analysed household survey data to evaluate the effectiveness of antenatal clinics (ANC) to deliver IPTp and ITNs to pregnant women in Nyando district, Kenya. Methods: We assessed the systems effectiveness of ANC to deliver IPTp and ITNs to pregnant women and the impact on low birthweight (LBW). Logistic regression was used to identify predictors of receipt of IPTp and ITN use during pregnancy. Results: Among 89% of recently pregnant women who attended ANC at least once between 4-9 months gestation, 59% reported receiving one dose of SP and 90% attended ANC again, of whom 57% received a second dose, resulting in a cumulative effectiveness for IPTp of 27%, most of whom used an ITN (96%). Overall ITN use was 89%, and ANC the main source (76%). Women were less likely to receive IPTp if they had low malaria knowledge (0.26, 95% CI 0.08-0.83), had a child who had died (OR 0.36, 95% CI 0.14-0.95), or if they first attended ANC late (OR 0.20, 95% CI 0.06-0.67). Women who experienced side effects to SP (OR 0.18, CI 0.03-0.90) or had low malaria knowledge (OR 0.78, 95% CI 0.11-5.43) were less likely to receive IPTp by directly observed therapy. Ineffective delivery of IPTp reduced its potential impact by 231 LBW cases averted (95% CI 64-359) per 10,000 pregnant women. Conclusion: IPTp presents greater challenges to deliver through ANC than ITNs in this setting. The reduction in public health impact on LBW resulting from ineffective delivery of IPTp is estimated to be substantial. Urgent efforts are required to improve service delivery of this important intervention.	[Hill, Jenny; Dellicour, Stephanie; Smedley, James; ter Kuile, Feiko O.] Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England; [Dellicour, Stephanie; Ouma, Peter; Otieno, Peter; Ombock, Maurice; Kariuki, Simon; Desai, Meghna] Ctr Dis Control Res & Publ Hlth Collaborat, Kenya Med Res Inst, Kisumu, Kenya; [Bruce, Jane; Webster, Jayne] London Sch Trop Med & Hyg, Dis Control Dept, London, England; [Desai, Meghna; Hamel, Mary J.] Ctr Dis Control & Prevent, Atlanta, GA USA	Liverpool School of Tropical Medicine; University of Liverpool; Kenya Medical Research Institute; University of London; London School of Hygiene & Tropical Medicine; Centers for Disease Control & Prevention - USA	Hill, J (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England.	j.hill@liv.ac.uk	Kariuki, Simon/AFT-6596-2022; Hill, Jenny/C-3839-2017; Kuile, Feiko ter/ABD-6681-2020	Hill, Jenny/0000-0003-1588-485X; Kuile, Feiko ter/0000-0003-3663-5617; Webster, Jayne/0000-0002-0498-8883	Malaria in Pregnancy (MiP) Consortium; Bill & Melinda Gates Foundation	Malaria in Pregnancy (MiP) Consortium; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Malaria in Pregnancy (MiP) Consortium, which is funded through a grant from the Bill & Melinda Gates Foundation to the Liverpool School of Tropical Medicine, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000397; ALTMAN DG, 1991, NEPHRON, V59, P522, DOI 10.1159/000186630; Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; Anders K, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-79; [Anonymous], 2008, GLOB MAL ACT PLAN; Ashwood-Smith Hannah, 2002, Malawi Med J, V14, P8; Baiden F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028944; Beer N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-173; Huynh BT, 2011, AM J TROP MED HYG, V85, P214, DOI 10.4269/ajtmh.2011.11-0103; CHANDRAMOHAN D, 2007, TROP MED INT HEALTH, V12, P1; Chico RM, 2011, TROP MED INT HLTH; Crawley J, 2007, LANCET INFECT DIS, V7, P145, DOI 10.1016/S1473-3099(07)70026-9; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Division of Malaria Control MoH Republic of Kenya, 2001, NAT MAL STRAT 2001 2; Eisele TP, 2009, AM J TROP MED HYG, V80, P209, DOI 10.4269/ajtmh.2009.80.209; Eisele TP, 2012, LANCET INFECT DIS; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; Gamble C, 2007, PLOS MED, V4, P506, DOI 10.1371/journal.pmed.0040107; Gikandi PW, 2008, TROP MED INT HEALTH, V13, P208, DOI 10.1111/j.1365-3156.2007.01992.x; Gross K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-140; Guyatt HL, 2004, TROP MED INT HEALTH, V9, P255, DOI 10.1046/j.1365-3156.2003.01193.x; Hill J, 2006, TROP MED INT HEALTH, V11, P409, DOI 10.1111/j.1365-3156.2006.01585.x; Hill J, 2013, FACTORS AFFECT UNPUB; Kayentao K, 2013, JAMA-J AM MED ASSOC, V309, P594, DOI 10.1001/jama.2012.216231; Kenya Ministry of Health and Sanitation Health MoP, 2010, NAT GUID DIAGN TREAT; [Kenya National Bureau of Statistics ICF Macro], 2003, KEN DEM HLTH SURV 20; Kenya National Bureau of Statistics and ICF Macro, 2010, KEN DEM HLTH SURV 20; Marchant T, 2010, CAN MED ASSOC J, V182, P152, DOI 10.1503/cmaj.090268; Marchant T, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-260; McGready R, 2012, LANCET INFECT DIS, V12, P388, DOI 10.1016/S1473-3099(11)70339-5; Menendez C, 2007, LANCET INFECT DIS, V7, P126, DOI 10.1016/S1473-3099(07)70024-5; Mubyazi G, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-31; Ndyomugyenyi R, 2010, T ROY SOC TROP MED H, V104, P536, DOI 10.1016/j.trstmh.2010.02.003; Nganda RY, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-42; Ouma PO, 2007, TROP MED INT HEALTH, V12, P953, DOI 10.1111/j.1365-3156.2007.01876.x; Paintain LS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024035; Pell C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053747; [Roll Back Malaria MEASURE Evaluation USAID UNICEF World Health Organization], 2009, RBMWG2009TP1 USAID U; Roll Back Malaria Partnership, 2011, RBM REF UPD GLOB MAL; Sangare LR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015066; Smith LA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-333; Smith LA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-18; Tagbor H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014425; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; van Eijk AM, 2013, COVERAGE INTER UNPUB; van Eijk AM, 2011, LANCET INFECT DIS, V11, P190, DOI 10.1016/S1473-3099(10)70295-4; VLASSOFF C, 1992, HEALTH POLICY PLANN, V7, P1, DOI 10.1093/heapol/7.1.1; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Webster J, 2011, THESIS LONDON SCH HY; Webster J, 2010, AM J TROP MED HYG, V82, P672, DOI 10.4269/ajtmh.2010.09-0473; WHO, 2004, STRAT FRAM MAL PREV; World Health Organisation, 2006, MAL PREGN GUID MEAS; World Health Organisation Global Malaria Programme, 2007, POS STAT ITNS; World Health Organization, 2012, UPD WHO POL REC OCT; Worrall E, 2007, LANCET INFECT DIS, V7, P156, DOI 10.1016/S1473-3099(07)70027-0	56	41	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e64913	10.1371/journal.pone.0064913	http://dx.doi.org/10.1371/journal.pone.0064913			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23798997	Green Published, gold, Green Accepted			2022-12-25	WOS:000320363300006
J	Lin, PC; Lin, HJ; Guo, HR; Chen, KT				Lin, Pei-Chen; Lin, Hung-Jung; Guo, How-Ran; Chen, Kuo-Tai			Epidemiological Characteristics of Lower Extremity Cellulitis after a Typhoon Flood	PLOS ONE			English	Article							INFECTIONS; WATERBORNE; DISEASES; SKIN	Objective: The flood after a typhoon may lead to increase in patients with cellulitis of lower limbs. However, the microbiological features of these cases are rarely reported. We conducted a study of patients with lower extremity cellulitis after a typhoon followed in southern Taiwan to study the risk factors of cellulitis and the bacteriological features of the patients. Methods: We reviewed all the medical records of cellulitis at emergency departments of two teaching hospitals in southern Taiwan 30 days before and after the landing of Typhoon Morakot and collected data on the demographic and bacteriological characteristics. In addition, we evaluated the relationship between the daily number of patients and the rainfall in the Tainan area. Results: The number of cellulitis patients increased from 183 to 344 during the 30-day period after the typhoon. The number peaked in the third and fourth days and lasted for 3 weeks. The proportion of patients with water immersion of the affected limb was higher after the typhoon (6% vs. 37%, odds ratio [OR]: 9.0, 95% Confidence interval [CI]: 4.7-17.2). We found cultures from the infected limbs with immersion had more polymicrobial (73% vs. 26%, OR: 7.8, 95% CI: 3.2-19.2) and Gram-negative bacilli infection (86% vs. 34%, OR: 11.8, 95% CI: 4.1-34.5). Conclusions: Flood arose from Typhoon Morakot caused increases in cellulitis patients, which lasted for 3 weeks. Antibiotic treatment that were effective to both Gram-positive cocci and Gram-negative bacilli are recommended for patients with limbs emerged in the water.	[Lin, Pei-Chen; Lin, Hung-Jung; Chen, Kuo-Tai] Chi Mei Med Ctr, Emergency Dept, Tainan, Taiwan; [Lin, Hung-Jung] Southern Tainan Univ Technol, Dept Biotechnol, Tainan, Taiwan; [Guo, How-Ran] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Chen, Kuo-Tai] Taipei Med Univ, Dept Emergency Med, Taipei, Taiwan	Chi Mei Hospital; Southern Taiwan University of Science & Technology; National Cheng Kung University; Taipei Medical University	Chen, KT (corresponding author), Chi Mei Med Ctr, Emergency Dept, Tainan, Taiwan.	890502@mail.chimei.org.tw	Guo, How-Ran/AAK-9063-2020	Guo, How-Ran/0000-0003-3343-3446				[Anonymous], 2005, CLIN INFECT DIS; Auld H, 2004, J TOXICOL ENV HEAL A, V67, P1879, DOI 10.1080/15287390490493475; BURKE V, 1984, APPL ENVIRON MICROB, V48, P361, DOI 10.1128/AEM.48.2.361-366.1984; Chiller K, 2001, J INVEST DERM SYMP P, V6, P170, DOI 10.1046/j.0022-202x.2001.00043.x; Greer A, 2008, CAN MED ASSOC J, V178, P715, DOI 10.1503/cmaj.081325; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Ki V, 2008, CAN J INFECT DIS MED, V19, P173, DOI 10.1155/2008/846453; Landis S.J., 2008, ADV SKIN WOUND CARE, V21, P531, DOI DOI 10.1097/01.ASW.0000323578.87700.A5; Lin HJ, 2007, EPIDEMIOLOGY, V18, P410, DOI 10.1097/01.ede.0000259989.77630.77; McNeil K. M., 2006, Morbidity and Mortality Weekly Report, V55, P231; Rose JB, 2001, ENVIRON HEALTH PERSP, V109, P211, DOI 10.2307/3435011; Sharpe AH, 2005, ROBBINS COTRAN PATHO, P371; Willams W., 2005, Morbidity and Mortality Weekly Report, V54, P1018	13	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65655	10.1371/journal.pone.0065655	http://dx.doi.org/10.1371/journal.pone.0065655			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785441	Green Published, gold, Green Submitted			2022-12-25	WOS:000321038800080
J	Nickel, KF; Laux, V; Heumann, R; von Degenfeld, G				Nickel, Katrin F.; Laux, Volker; Heumann, Rolf; von Degenfeld, Georges			Thrombin Has Biphasic Effects on the Nitric Oxide-cGMP Pathway in Endothelial Cells and Contributes to Experimental Pulmonary Hypertension	PLOS ONE			English	Article							SOLUBLE GUANYLATE-CYCLASE; CLINICAL-PRACTICE GUIDELINES; ARTERIAL-HYPERTENSION; FACTOR-XA; ACTIVATED RECEPTORS; MEDICAL THERAPY; L-ARGININE; COAGULATION; EXPRESSION; INHIBITION	Background: A potential role for coagulation factors in pulmonary arterial hypertension has been recently described, but the mechanism of action is currently not known. Here, we investigated the interactions between thrombin and the nitric oxide-cGMP pathway in pulmonary endothelial cells and experimental pulmonary hypertension. Principal Findings: Chronic treatment with the selective thrombin inhibitor melagatran (0.9 mg/kg daily via implanted minipumps) reduced right ventricular hypertrophy in the rat monocrotaline model of experimental pulmonary hypertension. In vitro, thrombin was found to have biphasic effects on key regulators of the nitric oxide-cGMP pathway in endothelial cells (HUVECs). Acute thrombin stimulation led to increased expression of the cGMP-elevating factors endothelial nitric oxide synthase (eNOS) and soluble guanylate cyclase (sGC) subunits, leading to increased cGMP levels. By contrast, prolonged exposition of pulmonary endothelial cells to thrombin revealed a characteristic pattern of differential expression of the key regulators of the nitric oxide-cGMP pathway, in which specifically the factors contributing to cGMP elevation (eNOS and sGC) were reduced and the cGMP-hydrolyzing PDE5 was elevated (qPCR and Western blot). In line with the differential expression of key regulators of the nitric oxide-cGMP pathway, a reduction of cGMP by prolonged thrombin stimulation was found. The effects of prolonged thrombin exposure were confirmed in endothelial cells of pulmonary origin (HPAECs and HPMECs). Similar effects could be induced by activation of protease-activated receptor-1 (PAR-1). Conclusion: These findings suggest a link between thrombin generation and cGMP depletion in lung endothelial cells through negative regulation of the nitric oxide-cGMP pathway, possibly mediated via PAR-1, which could be of relevance in pulmonary arterial hypertension.	[Nickel, Katrin F.; Laux, Volker] Bayer HealthCare, Cardiol Res, Wuppertal, Germany; [Nickel, Katrin F.] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Nickel, Katrin F.] Univ Hosp, Stockholm, Sweden; [Heumann, Rolf] Ruhr Univ Bochum, Bochum, Germany; [Heumann, Rolf] Bayer HealthCare, Common Mech Res, Wuppertal, Germany; [von Degenfeld, Georges] Univ Witten Herdecke, Inst Res Operat Med, Cologne, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals; Karolinska Institutet; Ruhr University Bochum; Bayer AG; Bayer Healthcare Pharmaceuticals; Witten Herdecke University	von Degenfeld, G (corresponding author), Bayer HealthCare, Common Mech Res, Wuppertal, Germany.	georges.vondegenfeld@bayer.com	Heumann, Rolf/AAK-4390-2020; Heumann, Rolf/ABB-9675-2021	Heumann, Rolf/0000-0003-4364-2655	Bayer Pharma AG; Bayer Pharma; Bayer HealthCare AG	Bayer Pharma AG; Bayer Pharma; Bayer HealthCare AG(Bayer AGBayer Healthcare Pharmaceuticals)	Katrin Nickel received funding from Bayer Pharma AG. Volker Laux and Georges v. Degenfeld are employees of Bayer Pharma AG. Bayer Pharma provided funding for the in vivo studies and took part in the design, data aquisition and analysis of the in vivo experiments. Bayer Pharma had no role in the interpretation of the data and decision to publish. The authors declare that funding by Bayer Pharma does not influence their adherence to the PLOS ONE policies on sharing data and materials.; The authors have read the journal's policy and have the following conflicts. Bayer HealthCare AG funded this study and is an employer of: Volker Laux and Georges von Degenfeld. Katrin F. Nickel has received funding from Bayer HealthCare AG. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ahluwalia A, 2004, P NATL ACAD SCI USA, V101, P1386, DOI 10.1073/pnas.0304264101; Badesch DB, 2007, CHEST, V131, P1917, DOI 10.1378/chest.06-2674; Badesch DB, 2004, CHEST, V126, p35S, DOI 10.1378/chest.126.1_suppl.35S; Berger G, 2009, ISR MED ASSOC J, V11, P376; BJORNSSON J, 1985, MAYO CLIN PROC, V60, P16, DOI 10.1016/S0025-6196(12)65277-X; Boerrigter G, 2007, CARDIOVASC DRUG REV, V25, P30, DOI 10.1111/j.1527-3466.2007.00003.x; Borensztajn K, 2008, TRENDS MOL MED, V14, P429, DOI 10.1016/j.molmed.2008.08.001; Borensztajn K, 2008, AM J PATHOL, V172, P309, DOI 10.2353/ajpath.2008.070347; Borissoff JI, 2009, CARDIOVASC RES, V82, P392, DOI 10.1093/cvr/cvp066; Budhiraja R, 2004, CIRCULATION, V109, P159, DOI 10.1161/01.CIR.0000102381.57477.50; Butenas S, 2002, BIOCHEMISTRY-MOSCOW+, V67, P3; CHEN J, 1994, J BIOL CHEM, V269, P16041; Cheung WM, 1999, ARTERIOSCL THROM VAS, V19, P3014, DOI 10.1161/01.ATV.19.12.3014; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Corbin JD, 2005, BIOCHEM BIOPH RES CO, V334, P930, DOI 10.1016/j.bbrc.2005.06.183; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; Delbeck M, 2011, CARDIOVASC RES, V92, P159, DOI 10.1093/cvr/cvr168; DEMEY JG, 1982, J PHARMACOL EXP THER, V222, P166; Dorfmuller P, 2003, SARCOIDOSIS VASC DIF, V20, P9; Eto M, 2001, CIRC RES, V89, P583, DOI 10.1161/hh1901.097084; Friebe A, 2003, CIRC RES, V93, P96, DOI 10.1161/01.RES.0000082524.34487.31; Giordano D, 2001, BBA-MOL CELL RES, V1539, P16, DOI 10.1016/S0167-4889(01)00086-6; Grimminger F, 2009, EUR RESPIR J, V33, P785, DOI 10.1183/09031936.00039808; Grunig E, 2008, Hamostaseologie, V28, P225; Hassell KL, 1998, BLOOD COAGUL FIBRIN, V9, P107, DOI 10.1097/00001721-199803000-00001; Huang J, 2010, EXP LUNG RES, V36, P57, DOI 10.3109/01902140903104793; Johnson SR, 2006, EUR RESPIR J, V28, P999, DOI 10.1183/09031936.06.00015206; Jurasz P, 2010, PHARMACOL THERAPEUT, V126, P1, DOI 10.1016/j.pharmthera.2009.12.006; Kemp-Harper Barbara, 2009, V191, P447, DOI 10.1007/978-3-540-68964-5_19; Klein M, 2008, CIRCULATION, V118, P2081, DOI 10.1161/CIRCULATIONAHA.108.779751; Kodama K, 1999, J PHARMACOL EXP THER, V290, P748; Krupiczojc MA, 2008, INT J BIOCHEM CELL B, V40, P1228, DOI 10.1016/j.biocel.2008.02.026; Kwapiszewska G, 2012, CIRC RES, V110, P1179, DOI 10.1161/CIRCRESAHA.111.257568; Lange U, 2003, PATHOPHYSIOL HAEMO T, V33, P184, DOI 10.1159/000081506; Levin YD, 2011, DRUG TODAY, V47, P145, DOI 10.1358/dot.2011.47.2.1544337; Licari LG, 2009, J VET EMERG CRIT CAR, V19, P11, DOI 10.1111/j.1476-4431.2009.00383.x; LUSCHER TF, 1988, NEW ENGL J MED, V319, P462, DOI 10.1056/NEJM198808253190802; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Maki J, 2010, BRIT J PHARMACOL, V159, P919, DOI 10.1111/j.1476-5381.2009.00591.x; Mann KG, 2003, J THROMB HAEMOST, V1, P1504, DOI 10.1046/j.1538-7836.2003.00298.x; Mason NA, 1998, J PATHOL, V185, P313, DOI 10.1002/(SICI)1096-9896(199807)185:3<313::AID-PATH93>3.0.CO;2-8; Mathew Rajamma, 2002, Heart Dis, V4, P152, DOI 10.1097/00132580-200205000-00004; MEHTA S, 1995, CIRCULATION, V92, P1539, DOI 10.1161/01.CIR.92.6.1539; Mittendorf J, 2009, CHEMMEDCHEM, V4, P853, DOI 10.1002/cmdc.200900014; Motley ED, 2007, HYPERTENSION, V49, P577, DOI 10.1161/01.HYP.0000255954.80025.34; Nagaya N, 2001, AM J RESP CRIT CARE, V163, P887, DOI 10.1164/ajrccm.163.4.2007116; O'Brien PJ, 2000, J BIOL CHEM, V275, P13502, DOI 10.1074/jbc.275.18.13502; Papapetropoulos A, 1998, P NATL ACAD SCI USA, V95, P4738, DOI 10.1073/pnas.95.8.4738; PEPKEZABA J, 1991, LANCET, V338, P1173, DOI 10.1016/0140-6736(91)92033-X; PIETRA GG, 1989, CIRCULATION, V80, P1198, DOI 10.1161/01.CIR.80.5.1198; Ramani GV, 2010, DRUG DES DEV THER, V4, P61; Sawamura F, 2009, J PHARMACOL SCI, V111, P235, DOI 10.1254/jphs.09110FP; Schermuly RT, 2008, EUR RESPIR J, V32, P881, DOI 10.1183/09031936.00114407; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Schermuly RT, 2004, AM J RESP CRIT CARE, V169, P39, DOI 10.1164/rccm.200302-282OC; Schultze AE, 1998, J TOXICOL ENV HEAL B, V1, P271, DOI 10.1080/10937409809524557; Scotton CJ, 2009, J CLIN INVEST, V119, P2550, DOI 10.1172/JCI33288; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738; Stasch Johannes-Peter, 2009, V191, P277, DOI 10.1007/978-3-540-68964-5_13; Steiner MK, 2005, CURR OPIN PHARMACOL, V5, P245, DOI 10.1016/j.coph.2004.12.008; Stephens RS, 2010, AM J PHYSIOL-LUNG C, V299, pL323, DOI 10.1152/ajplung.00442.2009; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; Wharton J, 2005, AM J RESP CRIT CARE, V172, P105, DOI 10.1164/rccm.200411-1587OC; White TA, 2010, AM J RESP CELL MOL, V43, P35, DOI 10.1165/rcmb.2009-0144OC; Wilkins MR, 2008, EUR RESPIR J, V32, P198, DOI 10.1183/09031936.00124007	66	17	17	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e63504	10.1371/journal.pone.0063504	http://dx.doi.org/10.1371/journal.pone.0063504			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785394	gold, Green Published, Green Submitted			2022-12-25	WOS:000321038800123
J	Song, MM; Chen, DF; Lu, BY; Wang, CL; Zhang, JX; Huang, LL; Wang, XY; Timmons, CL; Hu, J; Liu, BD; Wu, XJ; Wang, L; Wang, JP; Liu, HL				Song, Minmin; Chen, Defeng; Lu, Biyan; Wang, Chenliang; Zhang, Junxiao; Huang, Lanlan; Wang, Xiaoyan; Timmons, Christine L.; Hu, Jun; Liu, Bindong; Wu, Xiaojian; Wang, Lei; Wang, Jianping; Liu, Huanliang			PTEN Loss Increases PD-L1 Protein Expression and Affects the Correlation between PD-L1 Expression and Clinical Parameters in Colorectal Cancer	PLOS ONE			English	Article							B7-H1 EXPRESSION; CLINICOPATHOLOGICAL SIGNIFICANCE; CARCINOMA; CELLS; LIGANDS; LYMPHOCYTES; METASTASIS; VALIDATION; APOPTOSIS; PATHWAY	Background: Programmed death ligand-1 (PD-L1) has been identified as a factor associated with poor prognosis in a range of cancers, and was reported to be mainly induced by PTEN loss in gliomas. However, the clinical effect of PD-L1 and its regulation by PTEN has not yet been determined in colorectal cancer (CRC). In the present study, we verified the regulation of PTEN on PD-L1 and further determined the effect of PTEN on the correlation between PD-L1 expression and clinical parameters in CRC. Methods/Results: RNA interference approach was used to down-regulate PTEN expression in SW480, SW620 and HCT116 cells. It was showed that PD-L1 protein, but not mRNA, was significantly increased in cells transfected with siRNA PTEN compared with the negative control. Moreover, the capacity of PTEN to regulate PD-L1 expression was not obviously affected by IFN-gamma, the main inducer of PD-L1. Tissue microarray immunohistochemistry was used to detect PD-L1 and PTEN in 404 CRC patient samples. Overexpression of PD-L1 was significantly correlated with distant metastasis (P<0.001), TNM stage (P<0.01), metastatic progression (P<0.01) and PTEN expression (P<0.001). Univariate analysis revealed that patients with high PD-L1 expression had a poor overall survival (P<0.001). However, multivariate analysis did not support PD-L1 as an independent prognostic factor (P = 0.548). Univariate (P<0.001) and multivariate survival (P<0.001) analysis of 310 located CRC patients revealed that high level of PD-L1 expression was associated with increased risks of metastatic progression. Furthermore, the clinical effect of PD-L1 on CRC was not statistically significant in a subset of 39 patients with no PTEN expression (distant metastasis: P = 0.102; TNM stage: P = 0.634, overall survival: P = 0.482). Conclusions: PD-L1 can be used to identify CRC patients with high risk of metastasis and poor prognosis. This clinical manifestation may be partly associated with PTEN expression.	[Song, Minmin; Chen, Defeng; Lu, Biyan; Wang, Chenliang; Zhang, Junxiao; Huang, Lanlan; Wang, Xiaoyan; Hu, Jun; Wu, Xiaojian; Wang, Lei; Wang, Jianping; Liu, Huanliang] Sun Yat Sen Univ, Inst Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China; [Song, Minmin; Chen, Defeng; Lu, Biyan; Wang, Chenliang; Zhang, Junxiao; Huang, Lanlan; Wang, Xiaoyan; Hu, Jun; Wu, Xiaojian; Wang, Lei; Wang, Jianping; Liu, Huanliang] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou 510275, Guangdong, Peoples R China; [Song, Minmin; Lu, Biyan; Wang, Chenliang; Zhang, Junxiao; Huang, Lanlan; Wang, Xiaoyan; Liu, Huanliang] Sun Yat Sen Univ, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China; [Song, Minmin; Lu, Biyan; Wang, Chenliang; Zhang, Junxiao; Huang, Lanlan; Wang, Xiaoyan; Liu, Huanliang] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China; [Lu, Biyan] Dongguan Hlth Sch, Dongguan, Guangdong, Peoples R China; [Wang, Chenliang; Timmons, Christine L.; Liu, Bindong] Meharry Med Coll, Dept Microbiol & Immunol, Ctr AIDS Hlth Dispar Res, Nashville, TN 37208 USA	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Meharry Medical College	Wang, JP (corresponding author), Sun Yat Sen Univ, Inst Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China.	wangjply@yahoo.com.cn; huanliang.liu@gmail.com	Wang, Xiaoyan/AAU-6258-2021	Wang, Xiaoyan/0000-0002-5140-676X; Liu, Huanliang/0000-0002-1006-6666; wang, chenliang/0000-0003-4388-681X	Sun Yat-sen University "100 Talents Program"; Guangdong Innovative Research Team Program [2009010058]; Science and Information Technology Bureau of Guangzhou, Guangdong [2011J5200009]; Guangdong Provincial Department of Science and Technology [2012B050500004]; "985 Project" of Sun Yat-sen University and Guangdong Translational Medicine Public Platform [4202037]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140] Funding Source: NIH RePORTER	Sun Yat-sen University "100 Talents Program"; Guangdong Innovative Research Team Program; Science and Information Technology Bureau of Guangzhou, Guangdong; Guangdong Provincial Department of Science and Technology; "985 Project" of Sun Yat-sen University and Guangdong Translational Medicine Public Platform; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by Sun Yat-sen University "100 Talents Program"; Guangdong Innovative Research Team Program (2009010058); Science and Information Technology Bureau of Guangzhou, Guangdong (2011J5200009); Guangdong Provincial Department of Science and Technology (2012B050500004); and "985 Project" of Sun Yat-sen University and Guangdong Translational Medicine Public Platform (4202037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma T, 2008, BLOOD, V111, P3635, DOI 10.1182/blood-2007-11-123141; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Bretthauer M, 2010, BEST PRACT RES CL GA, V24, P417, DOI 10.1016/j.bpg.2010.06.005; Colakoglu T, 2008, AM J SURG, V195, P719, DOI 10.1016/j.amjsurg.2007.05.061; Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030; Davies MA, 1999, CANCER RES, V59, P2551; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Ghebeh H, 2006, NEOPLASIA, V8, P190, DOI 10.1593/neo.05733; Gillett CE, 2000, J PATHOL, V192, P549; Goel A, 2004, CANCER RES, V64, P3014, DOI 10.1158/0008-5472.CAN-2401-2; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Hoos A, 2001, AM J PATHOL, V158, P1245, DOI 10.1016/S0002-9440(10)64075-8; Inman BA, 2007, CANCER-AM CANCER SOC, V109, P1499, DOI 10.1002/cncr.22588; Jang KS, 2010, HISTOPATHOLOGY, V56, P229, DOI 10.1111/j.1365-2559.2009.03468.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Konishi J, 2004, CLIN CANCER RES, V10, P5094, DOI 10.1158/1078-0432.CCR-04-0428; Langlois MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015742; Liu JZ, 2007, BLOOD, V110, P296, DOI 10.1182/blood-2006-10-051482; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Ramsay AJ, 2008, J BIOL CHEM, V283, P12293, DOI 10.1074/jbc.M709493200; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; Sawai H, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-56; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Snietura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033396; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Thompson RH, 2006, CANCER RES, V66, P3381, DOI 10.1158/0008-5472.CAN-05-4303; Wu CP, 2006, ACTA HISTOCHEM, V108, P19, DOI 10.1016/j.acthis.2006.01.003; Xavier LL, 2005, BRAIN RES PROTOC, V16, P58, DOI 10.1016/j.brainresprot.2005.10.002; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Zeng Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023621; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	36	148	158	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65821	10.1371/journal.pone.0065821	http://dx.doi.org/10.1371/journal.pone.0065821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785454	gold, Green Published, Green Submitted			2022-12-25	WOS:000321038800068
J	Umeshappa, CS; Xie, YF; Xu, SL; Nanjundappa, RH; Freywald, A; Deng, YL; Ma, H; Xiang, J				Umeshappa, Channakeshava Sokke; Xie, Yufeng; Xu, Shulin; Nanjundappa, Roopa Hebbandi; Freywald, Andrew; Deng, Yulin; Ma, Hong; Xiang, Jim			Th Cells Promote CTL Survival and Memory via Acquired pMHC-I and Endogenous IL-2 and CD40L Signaling and by Modulating Apoptosis-Controlling Pathways	PLOS ONE			English	Article							NF-KAPPA-B; ANTIGEN PRESENTASOME APS; MHC/COSTIMULATORY COMPLEX; SECONDARY EXPANSION; IMMUNE-RESPONSES; PRESENTING CELLS; RECALL RESPONSES; FAS LIGAND; HELP; LYMPHOCYTES	Involvement of CD4(+) helper T (Th) cells is crucial for CD8(+) cytotoxic T lymphocyte (CTL)-mediated immunity. However, CD4(+) Th's signals that govern CTL survival and functional memory are still not completely understood. In this study, we assessed the role of CD4+ Th cells with acquired antigen-presenting machineries in determining CTL fates. We utilized an adoptive co-transfer into CD4(+) T cell-sufficient or -deficient mice of OTI CTLs and OTII Th cells or Th cells with various gene deficiencies pre-stimulated in vitro by ovalbumin (OVA)-pulsed dendritic cell (DCova). CTL survival was kinetically assessed in these mice using FITC-anti-CD8 and PE-H-2K(b)/OVA(257-264) tetramer staining by flow cytometry. We show that by acting via endogenous CD40L and IL-2, and acquired peptide-MHC-I (pMHC-I) complex signaling, CD4(+) Th cells enhance survival of transferred effector CTLs and their differentiation into the functional memory CTLs capable of protecting against highly-metastasizing tumor challenge. Moreover, RT-PCR, flow cytometry and Western blot analysis demonstrate that increased survival of CD4(+) Th cell-helped CTLs is matched with enhanced Akt1/NF-kappa B activation, down-regulation of TRAIL, and altered expression profiles with up-regulation of prosurvival (Bcl-2) and down-regulation of proapoptotic (Bcl-10, Casp-3, Casp-4, Casp-7) molecules. Taken together, our results reveal a previously unexplored mechanistic role for CD4(+) Th cells in programming CTL survival and memory recall responses. This knowledge could also aid in the development of efficient adoptive CTL cancer therapy.	[Umeshappa, Channakeshava Sokke; Xie, Yufeng; Xu, Shulin; Nanjundappa, Roopa Hebbandi; Xiang, Jim] Saskatchewan Canc Agcy, Canc Res Unit, Saskatoon, SK, Canada; [Freywald, Andrew] Univ Saskatchewan, Dept Pathol, Saskatoon, SK S7N 0W0, Canada; [Deng, Yulin; Ma, Hong] Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China	University of Saskatchewan; University of Saskatchewan; Beijing Institute of Technology	Xiang, J (corresponding author), Saskatchewan Canc Agcy, Canc Res Unit, Saskatoon, SK, Canada.	jim.xiang@saskcancer.ca			Canadian Institutes of Health Research (CIHR) [MOP 79415]; Beijing Science and Technology Foundation [5121002]; Dean's Scholarship of the University of Saskatchewan; Vanier Canada Graduate Scholarship of CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Beijing Science and Technology Foundation; Dean's Scholarship of the University of Saskatchewan; Vanier Canada Graduate Scholarship of CIHR	This study was supported by research grants from the Canadian Institutes of Health Research (CIHR) (MOP 79415) and the Beijing Science and Technology Foundation (5121002). Umeshappa was supported by Dean's Scholarship of the University of Saskatchewan and Vanier Canada Graduate Scholarship of CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KA, 2008, CELL MOL IMMUNOL, V5, P261, DOI 10.1038/cmi.2008.32; Ahmed KA, 2012, J LEUKOCYTE BIOL, V92, P289, DOI 10.1189/jlb.1211631; ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Arnold PY, 1997, EUR J IMMUNOL, V27, P3198, DOI 10.1002/eji.1830271217; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Brenner MK, 2010, CURR OPIN IMMUNOL, V22, P251, DOI 10.1016/j.coi.2010.01.020; Chen M, 2007, MOL IMMUNOL, V44, P2558, DOI 10.1016/j.molimm.2006.12.020; Cox JH, 2007, J IMMUNOL, V179, P830, DOI 10.4049/jimmunol.179.2.830; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; de Herve MGD, 2010, J IMMUNOL, V185, P1028, DOI 10.4049/jimmunol.0904209; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Droin NM, 2003, MOL CELL BIOL, V23, P7638, DOI 10.1128/MCB.23.21.7638-7647.2003; Fischer UB, 2007, P NATL ACAD SCI USA, V104, P7181, DOI 10.1073/pnas.0608299104; Fuse S, 2009, J IMMUNOL, V182, P4244, DOI 10.4049/jimmunol.0802041; Hao SG, 2008, J IMMUNOL, V181, P2428, DOI 10.4049/jimmunol.181.4.2428; Helft J, 2008, BLOOD, V112, P1249, DOI 10.1182/blood-2007-09-114389; HoWangYin KY, 2011, J IMMUNOL, V186, P2210, DOI 10.4049/jimmunol.1000547; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Huang H, 2007, IMMUNOLOGY, V120, P148, DOI 10.1111/j.1365-2567.2006.02452.x; Hwang ML, 2007, J IMMUNOL, V179, P5829, DOI 10.4049/jimmunol.179.9.5829; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kennedy R, 2006, J IMMUNOL, V177, P2862, DOI 10.4049/jimmunol.177.5.2862; Kim EY, 2009, J IMMUNOL, V183, P6051, DOI 10.4049/jimmunol.0803482; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; LeMaoult J, 2007, BLOOD, V109, P2040, DOI 10.1182/blood-2006-05-024547; Li ZG, 2009, BLOOD, V114, P4486, DOI 10.1182/blood-2009-04-218123; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Mostbock S, 2007, BLOOD, V109, P2488, DOI 10.1182/blood-2006-09-047290; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Nguyen P, 2003, GENE THER, V10, P594, DOI 10.1038/sj.gt.3301932; Novy P, 2007, J IMMUNOL, V179, P8243, DOI 10.4049/jimmunol.179.12.8243; Novy P, 2011, J IMMUNOL, V186, P2729, DOI 10.4049/jimmunol.1003009; Obar JJ, 2010, P NATL ACAD SCI USA, V107, P193, DOI 10.1073/pnas.0909945107; Rapetti L, 2008, J IMMUNOL, V181, P299, DOI 10.4049/jimmunol.181.1.299; REES MA, 1990, P NATL ACAD SCI USA, V87, P2765, DOI 10.1073/pnas.87.7.2765; Rosenberg SA, 2009, CURR OPIN IMMUNOL, V21, P233, DOI 10.1016/j.coi.2009.03.002; Ryu SJ, 2009, BLOOD, V113, P4273, DOI 10.1182/blood-2008-09-181263; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shi MQ, 2006, J LEUKOCYTE BIOL, V80, P1354, DOI 10.1189/jlb.0506321; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Tsang JYS, 2003, BLOOD, V101, P2704, DOI 10.1182/blood-2002-04-1230; Umeshappa CS, 2011, IMMUNOL CELL BIOL, V89, P578, DOI 10.1038/icb.2011.28; Umeshappa CS, 2010, CELL MOL LIFE SCI, V67, P4107, DOI 10.1007/s00018-010-0553-x; Umeshappa CS, 2009, J IMMUNOL, V182, P193, DOI 10.4049/jimmunol.182.1.193; Wang L, 2001, J BIOL CHEM, V276, P21405, DOI 10.1074/jbc.M102488200; Wang LX, 2007, BLOOD, V109, P4865, DOI 10.1182/blood-2006-09-045245; Wang ZW, 2010, J CELL BIOCHEM, V109, P726, DOI 10.1002/jcb.22451; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wong SBJ, 2008, J IMMUNOL, V180, P3122, DOI 10.4049/jimmunol.180.5.3122; Xia DJ, 2006, J IMMUNOL, V177, P2976, DOI 10.4049/jimmunol.177.5.2976; Xiang J, 2005, J IMMUNOL, V174, P7497, DOI 10.4049/jimmunol.174.12.7497; Zhou G, 2011, J IMMUNOL, V186, P2148, DOI 10.4049/jimmunol.1002917; Zhou J, 2005, BLOOD, V105, P3238, DOI 10.1182/blood-2004-08-3236; Zhou JH, 2005, J IMMUNOTHER, V28, P53, DOI 10.1097/00002371-200501000-00007; Zhou JH, 2004, J IMMUNOL, V173, P7622, DOI 10.4049/jimmunol.173.12.7622	64	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e64787	10.1371/journal.pone.0064787	http://dx.doi.org/10.1371/journal.pone.0064787			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785406	Green Submitted, Green Published, gold			2022-12-25	WOS:000321038800113
J	Osmakov, DI; Kozlov, SA; Andreev, YA; Koshelev, SG; Sanamyan, NP; Sanamyan, KE; Dyachenko, IA; Bondarenko, DA; Murashev, AN; Mineev, KS; Arseniev, AS; Grishin, EV				Osmakov, Dmitry I.; Kozlov, Sergey A.; Andreev, Yaroslav A.; Koshelev, Sergey G.; Sanamyan, Nadezhda P.; Sanamyan, Karen E.; Dyachenko, Igor A.; Bondarenko, Dmitry A.; Murashev, Arkadii N.; Mineev, Konstantin S.; Arseniev, Alexander S.; Grishin, Eugene V.			Sea Anemone Peptide with Uncommon beta-Hairpin Structure Inhibits Acid-sensing Ion Channel 3 (ASIC3) and Reveals Analgesic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESIDUE DISTRIBUTION ANALYSIS; GATED NA+ CHANNELS; ANTIMICROBIAL PEPTIDE; INFLAMMATORY PAIN; SPIDER VENOM; INSECTICIDAL PEPTIDES; POLYPEPTIDE INHIBITOR; SENSITIVE CHANNEL; SENSORY NEURONS; TOXINS	Three novel peptides were isolated from the venom of the sea anemone Urticina grebelnyi. All of them are 29 amino acid peptides cross-linked by two disulfide bridges, with a primary structure similar to other sea anemone peptides belonging to structural group 9a. The structure of the gene encoding the shared precursor protein of the identified peptides was determined. One peptide, pi-AnmTX Ugr 9a-1 (short name Ugr 9-1), produced a reversible inhibition effect on both the transient and the sustained current of human ASIC3 channels expressed in Xenopus laevis oocytes. It completely blocked the transient component (IC50 10 +/- 0.6 mu M) and partially (48 +/- 2%) inhibited the amplitude of the sustained component (IC50 1.44 +/- 0.19 mu M). Using in vivo tests in mice, Ugr 9-1 significantly reversed inflammatory and acid-induced pain. The other two novel peptides, AnmTX Ugr 9a-2 (Ugr 9-2) and AnmTX Ugr 9a-3 (Ugr 9-3), did not inhibit the ASIC3 current. NMR spectroscopy revealed that Ugr 9-1 has an uncommon spatial structure, stabilized by two S-S bridges, with three classical beta-turns and twisted beta-hairpin without interstrand disulfide bonds. This is a novel peptide spatial structure that we propose to name boundless beta-hairpin.	[Osmakov, Dmitry I.; Kozlov, Sergey A.; Andreev, Yaroslav A.; Koshelev, Sergey G.; Mineev, Konstantin S.; Arseniev, Alexander S.; Grishin, Eugene V.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Sanamyan, Nadezhda P.; Sanamyan, Karen E.] Russian Acad Sci, Kamchatka Branch, Pacific Inst Geog, Far Eastern Branch, Petropavlovsk Kamchatski 683000, Russia; [Dyachenko, Igor A.; Bondarenko, Dmitry A.; Murashev, Arkadii N.] Russian Acad Sci, Branch Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 142290, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Pacific Geographical Institute of the Far Eastern Branch of the Russian Academy of Sciences; Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Andreev, YA (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Ul Miklukho Maklaya 16-10, Moscow 117997, Russia.	ay@land.ru	Kozlov, Sergey A/D-1548-2012; Mineev, Konstantin/E-4151-2010; DI Igor, Dyachenko/K-9060-2017; Mineev, Konstantin S/Q-3948-2018; Osmakov, Dmitry/H-5560-2019; Mineev, Konstantin/AAC-6662-2019; Andreev, Yaroslav A/C-6627-2012; Bondarenko, Dmitry A/T-9356-2017	Kozlov, Sergey A/0000-0002-0242-4240; Mineev, Konstantin/0000-0002-2418-9421; Mineev, Konstantin S/0000-0002-2418-9421; Mineev, Konstantin/0000-0002-2418-9421; Bondarenko, Dmitry A/0000-0002-8055-0066; Sanamyan, Nadya/0000-0002-9987-0668; Andreev, Yaroslav/0000-0002-7628-0980; Osmakov, Dmitry/0000-0001-6588-5012	Russian Academy of Sciences; Ministry of Education and Science of the Russian Federation [8063]; Russian Foundation for Basic Research [12-04-33151, 12-04-90442, 12-04-01068]	Russian Academy of Sciences(Russian Academy of Sciences); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by the Programs of the Russian Academy of Sciences "Molecular and Cell Biology" and "Fundamental Sciences for Medicine," the Federal Program of The Ministry of Education and Science of the Russian Federation (Agreement 8063), and Russian Foundation for Basic Research Grants 12-04-33151, 12-04-90442, and 12-04-01068.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anangi R, 2012, MAR DRUGS, V10, P1605, DOI 10.3390/md10071605; Andreev YA, 2009, DOKL BIOCHEM BIOPHYS, V424, P46, DOI 10.1134/S160767290901013X; Andreev YA, 2008, J BIOL CHEM, V283, P23914, DOI 10.1074/jbc.M800776200; Andreev YA, 2012, RECENT PATENTS INFLA, V6, P35, DOI 10.2174/187221312798889266; Andreev YA, 2010, ANAL BIOCHEM, V407, P144, DOI 10.1016/j.ab.2010.07.023; Bosmans F, 2007, TOXICON, V49, P550, DOI 10.1016/j.toxicon.2006.11.029; Carli A, 1996, TOXICON, V34, P496, DOI 10.1016/0041-0101(95)00157-3; Castaneda O, 2009, TOXICON, V54, P1119, DOI 10.1016/j.toxicon.2009.02.032; Corzo G, 2009, BBA-PROTEINS PROTEOM, V1794, P1190, DOI 10.1016/j.bbapap.2009.04.004; Delaglio F, 2001, J MAGN RESON, V149, P276, DOI 10.1006/jmre.2001.2297; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; Dubinnyi MA, 2012, J BIOL CHEM, V287, P32993, DOI 10.1074/jbc.M112.366427; EFREMOV RG, 1995, J PHYS CHEM-US, V99, P10658, DOI 10.1021/j100026a033; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Fahrner RL, 1996, CHEM BIOL, V3, P543, DOI 10.1016/S1074-5521(96)90145-3; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Grishin EV, 2010, ANN NEUROL, V67, P680, DOI 10.1002/ana.21949; Honma T, 2005, TOXICON, V45, P33, DOI 10.1016/j.toxicon.2004.09.013; Honma T, 2008, PEPTIDES, V29, P536, DOI 10.1016/j.peptides.2007.12.010; Hwang PM, 1998, BIOCHEMISTRY-US, V37, P4288, DOI 10.1021/bi972323m; Karczewski J, 2010, BRIT J PHARMACOL, V161, P950, DOI 10.1111/j.1476-5381.2010.00918.x; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kozlov S, 2005, TOXICON, V46, P672, DOI 10.1016/j.toxicon.2005.07.009; Kozlov S, 2005, PROTEINS, V59, P131, DOI 10.1002/prot.20390; Kozlov SA, 2012, RUSS J BIOORG CHEM+, V38, P578, DOI 10.1134/S1068162012060064; Kozlov S, 2012, PEPTIDES, V33, P240, DOI 10.1016/j.peptides.2011.12.008; Kozlov S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-88; Kozlov SA, 2007, TOXICON, V49, P721, DOI 10.1016/j.toxicon.2006.11.007; Kozlov SA, 2006, J BIOL CHEM, V281, P20983, DOI 10.1074/jbc.M602168200; Lai R, 2002, PEPTIDES, V23, P427, DOI 10.1016/S0196-9781(01)00641-6; Lovelace ES, 2006, J MED CHEM, V49, P6561, DOI 10.1021/jm060299h; Marino A, 2004, COMP BIOCHEM PHYS C, V139, P295, DOI 10.1016/j.cca.2004.12.008; Molliver DC, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-35; Salinas M, 2009, J BIOL CHEM, V284, P31851, DOI 10.1074/jbc.M109.043984; Sanamyan NP, 2006, J NAT HIST, V40, P359, DOI 10.1080/00222930600703532; Shenkarev ZO, 2011, BIOCHEMISTRY-US, V50, P6255, DOI 10.1021/bi200746t; Shiomi K, 2009, TOXICON, V54, P1112, DOI 10.1016/j.toxicon.2009.02.031; Shlyapnikov YM, 2008, PROTEIN EXPRES PURIF, V60, P89, DOI 10.1016/j.pep.2008.03.011; TERRY AS, 1988, J BIOL CHEM, V263, P5745; Umetsu Y, 2009, J BIOL CHEM, V284, P29625, DOI 10.1074/jbc.M109.011148; Vassilevski AA, 2008, RECENT PATENTS INFLA, V2, P58, DOI 10.2174/187221308783399261; Vetter I, 2011, AMINO ACIDS, V40, P15, DOI 10.1007/s00726-010-0516-4; Voilley N, 2001, J NEUROSCI, V21, P8026, DOI 10.1523/JNEUROSCI.21-20-08026.2001; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yen YT, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-1; Zaharenko AJ, 2008, COMP BIOCHEM PHYS D, V3, P219, DOI 10.1016/j.cbd.2008.04.002	49	54	68	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23116	23127		10.1074/jbc.M113.485516	http://dx.doi.org/10.1074/jbc.M113.485516			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23801332	Green Published, hybrid			2022-12-25	WOS:000330598200019
J	Hales, EC; Orr, SM; Gedman, AL; Taub, JW; Matherly, LH				Hales, Eric C.; Orr, Steven M.; Gedman, Amanda Larson; Taub, Jeffrey W.; Matherly, Larry H.			Notch1 Receptor Regulates AKT Protein Activation Loop (Thr(308)) Dephosphorylation through Modulation of the PP2A Phosphatase in Phosphatase and Tensin Homolog (PTEN)-null T-cell Acute Lymphoblastic Leukemia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYC; SIGNALING PATHWAY; GENE IEX-1; PTEN; MUTATIONS; 2A; INHIBITION; SUBUNIT; PHOSPHORYLATION; HOLOENZYME	Notch1 activating mutations occur in more than 50% of T-cell acute lymphoblastic leukemia (T-ALL) cases and increase expression of Notch1 target genes, some of which activate AKT. HES1 transcriptionally silences phosphatase and tensin homolog (PTEN), resulting in AKT activation, which is reversed by Notch1 inhibition with gamma-secretase inhibitors (GSIs). Mutational loss of PTEN is frequent in T-ALL and promotes resistance to GSIs due to AKT activation. GSI treatments increased AKT-Thr(308) phosphorylation and signaling in PTEN-deficient, GSI-resistant T-ALL cell lines (Jurkat, CCRF-CEM, and MOLT3), suggesting that Notch1 represses AKT independent of its PTEN transcriptional effects. AKT-Thr(308) phosphorylation and downstream signaling were also increased by knocking down Notch1 in Jurkat (N1KD) cells. This was blocked by treatment with the AKT inhibitor perifosine. The PI3K inhibitor wortmannin and the protein phosphatase type 2A (PP2A) inhibitor okadaic acid both impacted AKT-Thr(308) phosphorylation to a greater extent in nontargeted control than N1KD cells, suggesting decreased dephosphorylation of AKT-Thr(308) by PP2A in the latter. Phosphorylations of AMP-activated protein kinase alpha (AMPK alpha)-Thr(172) and p70S6K-Thr(389), both PP2A substrates, were also increased in both N1KD and GSI-treated cells and responded to okadaic acid treatment. A transcriptional regulatory mechanism was implied because ectopic expression of dominant-negative mastermind-like protein 1 increased and wild-type HES1 decreased phosphorylation of these PP2A targets. This was independent of changes in PP2A subunit levels or in vitro PP2A activity, but was accompanied by decreased association of PP2A with AKT in N1KD cells. These results suggest that Notch1 can regulate PP2A dephosphorylation of critical cellular regulators including AKT, AMPK alpha, and p70S6K.	[Hales, Eric C.; Orr, Steven M.; Gedman, Amanda Larson; Matherly, Larry H.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48201 USA; [Matherly, Larry H.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Taub, Jeffrey W.] Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA; [Matherly, Larry H.] Barbara Ann Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI 48201 USA; [Taub, Jeffrey W.] Childrens Hosp Michigan, Detroit, MI 48201 USA	Wayne State University; Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Children's Hospital of Michigan	Matherly, LH (corresponding author), Barbara Ann Karmanos Canc Inst, Mol Therapeut Program, 110 E Warren Ave,Rm 3120, Detroit, MI 48201 USA.	matherly@karmanos.org			Herrick Foundation; Wayne State University; Ring Screw Textron Endowed Chair for Pediatric Research; National Institutes of Health Training Grant from the NCI [T32 CA009531]; NATIONAL CANCER INSTITUTE [T32CA009531] Funding Source: NIH RePORTER	Herrick Foundation; Wayne State University; Ring Screw Textron Endowed Chair for Pediatric Research; National Institutes of Health Training Grant from the NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Herrick Foundation and Wayne State University and the Ring Screw Textron Endowed Chair for Pediatric Research (to J. W. T.).; Supported by National Institutes of Health Training Grant T32 CA009531 from the NCI.	Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Aster JC, 2008, ANNU REV PATHOL-MECH, V3, P587, DOI 10.1146/annurev.pathmechdis.3.121806.154300; Bonnet M, 2011, BLOOD, V117, P6650, DOI 10.1182/blood-2011-02-336842; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Calzavara E, 2008, J CELL BIOCHEM, V103, P1405, DOI 10.1002/jcb.21527; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chan SM, 2007, BLOOD, V110, P278, DOI 10.1182/blood-2006-08-039883; Coustan-Smith E, 2009, LANCET ONCOL, V10, P147, DOI 10.1016/S1470-2045(08)70314-0; Cristobal I, 2011, LEUKEMIA, V25, P606, DOI 10.1038/leu.2010.294; DAMUNI Z, 1994, FEBS LETT, V352, P311, DOI 10.1016/0014-5793(94)00981-3; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; Dey-Guha I, 2011, P NATL ACAD SCI USA, V108, P12845, DOI 10.1073/pnas.1109632108; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Gallagher Sean R, 2006, Curr Protoc Mol Biol, VChapter 10, DOI 10.1002/0471142727.mb1002as75; Gallay N, 2009, LEUKEMIA, V23, P1029, DOI 10.1038/leu.2008.395; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gedman AL, 2009, LEUKEMIA, V23, P1417, DOI 10.1038/leu.2009.64; Gonzalez-Garcia S, 2009, J EXP MED, V206, P779, DOI 10.1084/jem.20081922; Guo DM, 2009, LEUKEMIA RES, V33, P678, DOI 10.1016/j.leukres.2008.10.026; Hahn K, 2010, CELL METAB, V11, P438, DOI 10.1016/j.cmet.2010.03.015; Ikehara T, 2007, BIOCHEM BIOPH RES CO, V354, P1052, DOI 10.1016/j.bbrc.2007.01.085; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jackson JB, 2012, NEOPLASIA, V14, P585, DOI 10.1593/neo.12768; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Kageyama R, 2000, MOL CELLS, V10, P1, DOI 10.1007/s10059-000-0001-0; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kim KY, 2009, CANCER RES, V69, P4018, DOI 10.1158/0008-5472.CAN-08-2641; Koch U, 2011, TRENDS IMMUNOL, V32, P434, DOI 10.1016/j.it.2011.06.005; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kox C, 2010, LEUKEMIA, V24, P2005, DOI 10.1038/leu.2010.203; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; LERGA A, 1995, BIOCHEM BIOPH RES CO, V215, P889, DOI 10.1006/bbrc.1995.2547; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Liao Y, 2010, AM J TRANSL RES, V2, P19; Medyouf H, 2011, J EXP MED, V208, P1809, DOI 10.1084/jem.20110121; Meijerink JPP, 2010, BEST PRACT RES CL HA, V23, P307, DOI 10.1016/j.beha.2010.08.002; Nagase H, 2011, CURR STEM CELL RES T, V6, P131, DOI 10.2174/157488811795495459; Ni YG, 2007, P NATL ACAD SCI USA, V104, P20517, DOI 10.1073/pnas.0610290104; Ning JY, 2011, ENDOCRINOLOGY, V152, P3143, DOI 10.1210/en.2011-0155; Nyakern M, 2006, MOL CANCER THER, V5, P1559, DOI 10.1158/1535-7163.MCT-06-0076; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pui CH, 2010, LEUKEMIA, V24, P371, DOI 10.1038/leu.2009.252; Pui CH, 2010, J FORMOS MED ASSOC, V109, P777, DOI 10.1016/S0929-6646(10)60123-4; Qin L, 2011, J BIOCHEM, V150, P151, DOI 10.1093/jb/mvr066; Rocher G, 2007, J BIOL CHEM, V282, P5468, DOI 10.1074/jbc.M609712200; Rodgers JT, 2011, MOL CELL, V41, P471, DOI 10.1016/j.molcel.2011.02.007; Sade H, 2004, J BIOL CHEM, V279, P2937, DOI 10.1074/jbc.M309924200; Sang LY, 2010, TRENDS MOL MED, V16, P17, DOI 10.1016/j.molmed.2009.11.001; Silva A, 2008, J CLIN INVEST, V118, P3762, DOI 10.1172/JCI34616; Silva A, 2010, HAEMATOL-HEMATOL J, V95, P674, DOI 10.3324/haematol.2009.011999; Sulis ML, 2008, BLOOD, V112, P733, DOI 10.1182/blood-2007-12-130096; Tallen G, 2010, J CLIN ONCOL, V28, P2339, DOI 10.1200/JCO.2009.25.1983; Wang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013096; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Yamamoto N, 2001, J BIOL CHEM, V276, P45031, DOI 10.1074/jbc.M105245200	61	36	39	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22836	22848		10.1074/jbc.M113.451625	http://dx.doi.org/10.1074/jbc.M113.451625			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23788636	hybrid, Green Published			2022-12-25	WOS:000330596300060
J	Bakre, A; Andersen, LE; Meliopoulos, V; Coleman, K; Yan, XZ; Brooks, P; Crabtree, J; Tompkins, SM; Tripp, RA				Bakre, Abhijeet; Andersen, Lauren E.; Meliopoulos, Victoria; Coleman, Keegan; Yan, Xiuzhen; Brooks, Paula; Crabtree, Jackelyn; Tompkins, S. Mark; Tripp, Ralph A.			Identification of Host Kinase Genes Required for Influenza Virus Replication and the Regulatory Role of MicroRNAs	PLOS ONE			English	Article							NF-KAPPA-B; RESPIRATORY SYNCYTIAL VIRUS; CELL-CYCLE ARREST; A VIRUS; AVIAN INFLUENZA; PROTEIN-KINASE; IN-VIVO; SIGNAL-TRANSDUCTION; RESISTANT INFLUENZA; ANTIVIRAL THERAPY	Human protein kinases (HPKs) have profound effects on cellular responses. To better understand the role of HPKs and the signaling networks that influence influenza virus replication, a small interfering RNA (siRNA) screen of 720 HPKs was performed. From the screen, 17 HPKs (NPR2, MAP3K1, DYRK3, EPHA6, TPK1, PDK2, EXOSC10, NEK8, PLK4, SGK3, NEK3, PANK4, ITPKB, CDC2L5 (CDK13), CALM2, PKN3, and HK2) were validated as essential for A/WSN/33 influenza virus replication, and 6 HPKs (CDK13, HK2, NEK8, PANK4, PLK4 and SGK3) were identified as vital for both A/WSN/33 and A/New Caledonia/20/99 influenza virus replication. These HPKs were found to affect multiple host pathways and regulated by miRNAs induced during infection. Using a panel of miRNA agonists and antagonists, miR-149* was found to regulate NEK8 expression, miR-548d-3p was found to regulate MAPK1 transcript expression, and miRs -1228 and -138 to regulate CDK13 expression. Up-regulation of miR-34c induced PLK4 transcript and protein expression and enhanced influenza virus replication, while miR-34c inhibition reduced viral replication. These findings identify HPKs important for influenza viral replication and show the miRNAs that govern their expression.	[Bakre, Abhijeet; Andersen, Lauren E.; Meliopoulos, Victoria; Coleman, Keegan; Yan, Xiuzhen; Brooks, Paula; Crabtree, Jackelyn; Tompkins, S. Mark; Tripp, Ralph A.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Tripp, RA (corresponding author), Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.	ratripp@uga.edu	Tompkins, Stephen/A-3317-2008; Bakre, Abhijeet A./A-4632-2013	Tompkins, Stephen/0000-0002-1523-5588; Bakre, Abhijeet A./0000-0002-6755-5233; Tripp, Ralph/0000-0002-2924-9956	National Institute of Allergy and Infectious Diseases Center of Excellence for Influenza Research and Surveillance [HHSN266200700006C]	National Institute of Allergy and Infectious Diseases Center of Excellence for Influenza Research and Surveillance	The authors acknowledge National Institute of Allergy and Infectious Diseases Center of Excellence for Influenza Research and Surveillance, contract # HHSN266200700006C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamares-Sapuay JG, 2013, J VIROL, V87, P6020, DOI 10.1128/JVI.01258-12; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arora DJS, 1998, ARCH VIROL, V143, P2029, DOI 10.1007/s007050050439; Bakre A, 2012, J GEN VIROL, V93, P2346, DOI 10.1099/vir.0.044255-0; Beigel J, 2008, ANTIVIR RES, V78, P91, DOI 10.1016/j.antiviral.2008.01.003; Berro R, 2008, J VIROL, V82, P7155, DOI 10.1128/JVI.02543-07; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Buggele WA, 2012, J BIOL CHEM, V287, P31027, DOI 10.1074/jbc.M112.387670; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cannell IG, 2010, CELL CYCLE, V9, P2726, DOI 10.4161/cc.9.14.12182; Cannell IG, 2010, P NATL ACAD SCI USA, V107, P5375, DOI 10.1073/pnas.0910015107; Chang WLW, 2007, J IMMUNOL, V178, P1457, DOI 10.4049/jimmunol.178.3.1457; Chen HH, 2007, BIOCHEM BIOPH RES CO, V354, P735, DOI 10.1016/j.bbrc.2007.01.049; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; Conly Jm, 2006, Can J Infect Dis Med Microbiol, V17, P11; Cottey R, 2001, CURR PROTOC IMMUNOL, V19; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Dove BK, 2012, PROTEOMICS, V12, P1431, DOI 10.1002/pmic.201100470; Droebner K, 2011, ANTIVIR RES, V92, P195, DOI 10.1016/j.antiviral.2011.08.002; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Esau CC, 2008, METHODS, V44, P55, DOI 10.1016/j.ymeth.2007.11.001; Fang JL, 2012, J VIROL, V86, P1010, DOI 10.1128/JVI.06169-11; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flory E, 2000, J BIOL CHEM, V275, P8307, DOI 10.1074/jbc.275.12.8307; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ghosh T, 2008, NUCLEIC ACIDS RES, V36, P6318, DOI 10.1093/nar/gkn624; Guan ZH, 2012, BIOCHEM BIOPH RES CO, V425, P662, DOI 10.1016/j.bbrc.2012.07.114; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Haney SA, 2007, PHARMACOGENOMICS, V8, P1037, DOI 10.2217/14622416.8.8.1037; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; He YA, 2010, J VIROL, V84, P12832, DOI 10.1128/JVI.01216-10; Heynisch B, 2010, VACCINE, V28, P8210, DOI 10.1016/j.vaccine.2010.07.076; Hirst GK, 1942, J EXP MED, V76, P195, DOI 10.1084/jem.76.2.195; Holland AJ, 2012, GENE DEV, V26, P2684, DOI 10.1101/gad.207027.112; Holland AJ, 2012, MOL BIOL CELL, V23, P1838, DOI 10.1091/mbc.E11-12-1043; Holland PM, 2002, J BIOL CHEM, V277, P16229, DOI 10.1074/jbc.M108662200; Hsieh HP, 2007, CURR PHARM DESIGN, V13, P3531, DOI 10.2174/138161207782794248; Hsu CW, 2008, PROTEOMICS, V8, P1975, DOI 10.1002/pmic.200701004; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jiang W, 2013, J VIROL, V87, P3039, DOI 10.1128/JVI.03176-12; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kang HW, 2012, FEBS LETT, V586, P897, DOI 10.1016/j.febslet.2012.02.020; Karlas A, 2010, NATURE; Karlas A, NATURE; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Kroeker AL, 2012, J PROTEOME RES, V11, P4132, DOI 10.1021/pr300239r; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kumar N, 2008, J VIROL, V82, P9880, DOI 10.1128/JVI.00909-08; Kunzelmann K, 2000, P NATL ACAD SCI USA, V97, P10282, DOI 10.1073/pnas.160041997; Labuda T, 2006, EUR J IMMUNOL, V36, P2076, DOI 10.1002/eji.200535163; Lackenby A, 2008, CURR OPIN INFECT DIS, V21, P626, DOI 10.1097/QCO.0b013e3283199797; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lee SMY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008072; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Y, 2011, VIROLOGY; Li YK, 2013, PROTEIN CELL, V4, P130, DOI 10.1007/s13238-012-2081-y; Liang TM, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/679563; Lietzen N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001340; Lin RJ, 2010, MOL CARCINOGEN, V49, P719, DOI 10.1002/mc.20647; Liu He, 2010, Weishengwu Xuebao, V50, P1399; Liu L, 2012, J PROTEOME RES, V11, P4091, DOI 10.1021/pr3001332; Liu M, 2012, HEPATOLOGY, V55, P1754, DOI 10.1002/hep.25584; Loveday EK, 2012, J VIROL, V86, P6109, DOI 10.1128/JVI.06892-11; Lu H, 2010, CARDIOVASC RES, V86, P410, DOI 10.1093/cvr/cvq010; Ludwig S, 2006, CELL MICROBIOL, V8, P375, DOI 10.1111/j.1462-5822.2005.00678.x; Ludwig S, 2004, FEBS LETT, V561, P37, DOI 10.1016/S0014-5793(04)00108-5; Ludwig S, 2008, BIOL CHEM, V389, P1307, DOI 10.1515/BC.2008.148; Majde JA, 2000, J INTERF CYTOK RES, V20, P259, DOI 10.1089/107999000312397; Marjuki H, 2006, J BIOL CHEM, V281, P16707, DOI 10.1074/jbc.M510233200; Mata MA, 2011, NAT CHEM BIOL, V7, P712, DOI [10.1038/NCHEMBIO.645, 10.1038/nchembio.645]; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Meliopoulos VA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037169; Min JY, 2010, NAT BIOTECHNOL, V28, P239, DOI 10.1038/nbt0310-239; MMWR, 2010, EST DEATHS ASS SEAS; Munding JB, 2012, INT J CANCER, V131, pE86, DOI 10.1002/ijc.26466; Munoz-Fontela C, 2011, J IMMUNOL, V187, P6428, DOI 10.4049/jimmunol.1101459; Murray James L., 2012, Antiviral Chemistry & Chemotherapy, V22, P205, DOI 10.3851/IMP2080; Nimmerjahn F, 2004, J GEN VIROL, V85, P2347, DOI 10.1099/vir.0.79958-0; Osterhaus A, 2011, PHILOS T R SOC B, V366, P2766, DOI 10.1098/rstb.2011.0102; PAHL HL, 1995, J VIROL, V69, P1480, DOI 10.1128/JVI.69.3.1480-1484.1995; Palese P., 2007, FIELDS VIROLOGY; Parnell G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023162; Pauli EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000196; Perwitasari O, 2013, ANTIMICROB AGENTS CH, V57, P475, DOI 10.1128/AAC.01532-12; Pinto R, 2011, ANTIVIR RES, V92, P45, DOI 10.1016/j.antiviral.2011.05.009; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Pleschka S, 2008, BIOL CHEM, V389, P1273, DOI 10.1515/BC.2008.145; REED L. J., 1938, AMER JOUR HYG, V27, P493; Regoes RR, 2006, SCIENCE, V312, P389, DOI 10.1126/science.1122947; Scaria V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-68; Schultz-Cherry S, 2010, ADV VIRUS RES, V77, P63, DOI 10.1016/S0065-3527(10)77003-2; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Sigoillot FD, 2011, ACS CHEM BIOL, V6, P47, DOI 10.1021/cb100358f; Sillibourne JE, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-25; Sillibourne JE, 2010, MOL BIOL CELL, V21, P547, DOI 10.1091/mbc.E09-06-0505; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Straka M, 2010, CURRENT TOPICS RNAI; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Truesdell SS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00842; Turpin E, 2005, J VIROL, V79, P8802, DOI 10.1128/JVI.79.14.8802-8811.2005; Vasudevan S, 2012, WIRES RNA, V3, P311, DOI 10.1002/wrna.121; Vermeulen A, 2007, RNA, V13, P723, DOI 10.1261/rna.448107; Wang XD, 2010, BIOCHEM BIOPH RES CO, V395, P141, DOI 10.1016/j.bbrc.2010.03.160; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Wei L, 2006, J BIOL CHEM, V281, P11678, DOI 10.1074/jbc.M513286200; Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033; Woolcock Peter R., 2008, V436, P35, DOI 10.1007/978-1-59745-279-3_6; Xiao JN, 2007, J CELL PHYSIOL, V212, P285, DOI 10.1002/jcp.21062; Xu Y, 2010, SCHIZOPHR RES, V119, P219, DOI 10.1016/j.schres.2010.02.1070; Yamauchi Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002316; Yeung ML, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-81; Yoshida R, 2008, J BIOL CHEM, V283, P36211, DOI 10.1074/jbc.M806576200; Zalli D, 2012, HUM MOL GENET, V21, P1155, DOI 10.1093/hmg/ddr544; Zhang Lijun, 2010, Genomics Proteomics & Bioinformatics, V8, P139, DOI 10.1016/S1672-0229(10)60016-2; Zhe JP, 2012, J PROTEOMICS, V75, P1732, DOI 10.1016/j.jprot.2011.12.012; Zheng SQ, 2005, ANTIVIR RES, V89, P219	119	44	44	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66796	10.1371/journal.pone.0066796	http://dx.doi.org/10.1371/journal.pone.0066796			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805279	Green Published, gold, Green Submitted			2022-12-25	WOS:000320846500107
J	Chen, MW; Lohkamp, B; Schnell, R; Lescar, J; Schneider, G				Chen, Ming Wei; Lohkamp, Bernhard; Schnell, Robert; Lescar, Julien; Schneider, Gunter			Substrate Channel Flexibility in Pseudomonas aeruginosa MurB Accommodates Two Distinct Substrates	PLOS ONE			English	Article							N-ACETYLENOLPYRUVYLGLUCOSAMINE REDUCTASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; METHYLENETETRAHYDROFOLATE REDUCTASE; PROTEIN-STRUCTURE; NADP(+) BINDING; DOMAIN MOTIONS; S229A MUTANT; WILD-TYPE; ENZYME	Biosynthesis of UDP-N-acetylmuramic acid in bacteria is a committed step towards peptidoglycan production. In an NADPH- and FAD-dependent reaction, the UDP-N-acetylglucosamine-enolpyruvate reductase (MurB) reduces UDP-N-acetylglucosamine-enolpyruvate to UDP-N-acetylmuramic acid. We determined the three-dimensional structures of the ternary complex of Pseudomonas aeruginosa MurB with FAD and NADP(+) in two crystal forms to resolutions of 2.2 and 2.1 angstrom, respectively, to investigate the structural basis of the first half-reaction, hydride transfer from NADPH to FAD. The nicotinamide ring of NADP(+) stacks against the si face of the isoalloxazine ring of FAD, suggesting an unusual mode of hydride transfer to flavin. Comparison with the structure of the Escherichia coli MurB complex with UDP-Nacetylglucosamine-enolpyruvate shows that both substrates share the binding site located between two lobes of the substrate-binding domain III, consistent with a ping pong mechanism with sequential substrate binding. The nicotinamide and the enolpyruvyl moieties are strikingly well-aligned upon superimposition, both positioned for hydride transfer to and from FAD. However, flexibility of the substrate channel allows the non-reactive parts of the two substrates to bind in different conformations. A potassium ion in the active site may assist in substrate orientation and binding. These structural models should help in structure-aided drug design against MurB, which is essential for cell wall biogenesis and hence bacterial survival.	[Chen, Ming Wei; Lohkamp, Bernhard; Schnell, Robert; Schneider, Gunter] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Chen, Ming Wei; Lescar, Julien] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Karolinska Institutet; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Schneider, G (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	Gunter.Schneider@ki.se		Chen, Ming Wei/0000-0003-0718-866X; Lohkamp, Bernhard/0000-0002-5646-2090; Schneider, Gunter/0000-0003-0622-5713; SCHNELL, ROBERT/0000-0001-7530-3629	European Commission [HEALTH-F3-2008-223461]; Swedish Science Council; Clas Groschinskys Foundation	European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Science Council; Clas Groschinskys Foundation	This work was supported by the European Commission through the 7th Framework program, grant agreement HEALTH-F3-2008-223461, the Swedish Science Council (www.vr.se) and by the Clas Groschinskys Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axley MJ, 1997, BIOCHEMISTRY-US, V36, P812, DOI 10.1021/bi962260s; Bae E, 2008, PROTEINS, V70, P303, DOI 10.1002/prot.21678; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BENSON TE, 1995, NAT STRUCT BIOL, V2, P644, DOI 10.1038/nsb0895-644; Benson TE, 1997, BIOCHEMISTRY-US, V36, P806, DOI 10.1021/bi962221g; Benson TE, 1996, STRUCTURE, V4, P47, DOI 10.1016/S0969-2126(96)00008-1; BENSON TE, 1993, BIOCHEMISTRY-US, V32, P2024, DOI 10.1021/bi00059a019; Benson TE, 2001, BIOCHEMISTRY-US, V40, P2340, DOI 10.1021/bi002162d; Benson TE, 1997, BIOCHEMISTRY-US, V36, P796, DOI 10.1021/bi962220o; BROWN ED, 1995, J BACTERIOL, V177, P4194, DOI 10.1128/jb.177.14.4194-4197.1995; Constantine KL, 1997, J MOL BIOL, V267, P1223, DOI 10.1006/jmbi.1997.0915; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DHALLA AM, 1995, BIOCHEMISTRY-US, V34, P5390, DOI 10.1021/bi00016a010; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Gautam A, 2011, CRIT REV BIOTECHNOL, V31, P295, DOI 10.3109/07388551.2010.525498; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Harris MS, 2001, ACTA CRYSTALLOGR D, V57, P1032, DOI 10.1107/S0907444901006552; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hayward S, 1997, PROTEINS, V27, P425, DOI 10.1002/(SICI)1097-0134(199703)27:3<425::AID-PROT10>3.0.CO;2-N; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kim MK, 2007, PROTEINS, V66, P751, DOI 10.1002/prot.21174; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Mansour TS, 2007, CHEMMEDCHEM, V2, P1414, DOI 10.1002/cmdc.200700094; Mattevi A, 1997, STRUCTURE, V5, P907, DOI 10.1016/S0969-2126(97)00245-1; Moynie L, 2013, ACTA CRYSTALLOGR F, V69, P25, DOI 10.1107/S1744309112044739; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pejchal R, 2005, BIOCHEMISTRY-US, V44, P11447, DOI 10.1021/bi050533q; Shabala L, 2009, ENVIRON MICROBIOL, V11, P137, DOI 10.1111/j.1462-2920.2008.01748.x; SUMNER JS, 1992, J AM CHEM SOC, V114, P6949, DOI 10.1021/ja00044a001; TAKU A, 1973, J BIOL CHEM, V248, P4971; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Heijenoort J, 1998, CELL MOL LIFE SCI, V54, P300, DOI 10.1007/s000180050155; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	46	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66936	10.1371/journal.pone.0066936	http://dx.doi.org/10.1371/journal.pone.0066936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805286	Green Published, gold			2022-12-25	WOS:000320846500114
J	Lemme, F; Doyle, AM; Changalucha, J; Andreasen, A; Baisley, K; Maganja, K; Watson-Jones, D; Kapiga, S; Hayes, RJ; Ross, DA				Lemme, Francesca; Doyle, Aoife M.; Changalucha, John; Andreasen, Aura; Baisley, Kathy; Maganja, Kaballa; Watson-Jones, Deborah; Kapiga, Saidi; Hayes, Richard J.; Ross, David A.			HIV Infection among Young People in Northwest Tanzania: The Role of Biological, Behavioural and Socio-Demographic Risk Factors	PLOS ONE			English	Article							SEXUAL HEALTH INTERVENTION; SIMPLEX-VIRUS TYPE-2; COMMUNITY-RANDOMIZED-TRIAL; MALE CIRCUMCISION; RURAL TANZANIA; MWANZA REGION; PREVENTION; WOMEN; TRANSMISSION; IMPACT	Background: Young people are at high risk of HIV and developing appropriate prevention programmes requires an understanding of the risk factors for HIV in this age group. We investigated factors associated with HIV among participants aged 15-30 years in a 2007-8 cross-sectional survey nested within a community-randomised trial of the MEMA kwa Vijana intervention in 20 rural communities in northwest Tanzania. Methods: We analysed data for 7259(53%) males and 6476(47%) females. Using a proximate-determinant conceptual framework and conditional logistic regression, we obtained sex-specific Odds Ratios (ORs) for the association of HIV infection with socio-demographic, knowledge, behavioural and biological factors. Results: HSV-2 infection was strongly associated with HIV infection (females: adjOR 4.4, 95%CI 3.2-6.1; males: adjOR 4.2, 95%CI 2.8-6.2). Several socio-demographic factors (such as age, marital status and mobility), behavioural factors (condom use, number and type of sexual partnerships) and biological factors (blood transfusion, lifetime pregnancies, genital ulcers, Neisseria gonorrhoeae) were also associated with HIV infection. Among females, lifetime sexual partners (linear trend, p<0.001), >= 2 partners in the past year (adjOR 2.0, 95%CI 1.4-2.8), >= 2 new partners in the past year (adjOR 1.9 95%CI 1.2, 3.3) and concurrent partners in the past year (adjOR 1.6 95%CI 1.1, 2.4) were all associated with HIV infection. Conclusions: Efforts must be intensified to find effective interventions to reduce HSV-2. Effective behavioural interventions focusing on reducing the number of sexual partnerships and risk behaviour within partnerships are also needed. An increase in risky sexual behaviour may occur following marriage dissolution or when a young woman travels outside of her community and interventions addressing the needs of these subgroups of vulnerable women may be important.	[Lemme, Francesca; Doyle, Aoife M.; Andreasen, Aura; Baisley, Kathy; Watson-Jones, Deborah; Kapiga, Saidi; Hayes, Richard J.; Ross, David A.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Lemme, Francesca; Doyle, Aoife M.; Andreasen, Aura; Maganja, Kaballa; Watson-Jones, Deborah; Kapiga, Saidi] Natl Inst Med Res, Mwanza Intervent Trials Unit, Mwanza, Tanzania; [Changalucha, John] Natl Inst Med Res, Mwanza, Tanzania	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research; National Institute of Medical Research	Ross, DA (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	ross@lshtm.ac.uk	Doyle, Aoife/AAX-3525-2020	Doyle, Aoife/0000-0002-3305-7738; Andreasen, Aura/0000-0003-0664-7342; Kapiga, Saidi/0000-0003-1753-4060; Hayes, Richard/0000-0002-1729-9892	European Commission; United Kingdom Department for International Development; Medical Research Council of Great Britain; United Nations Joint Programme on HIV/AIDS (UNAIDS); Irish Aid; MRC [G0902121, G0700837, G0901756] Funding Source: UKRI; Medical Research Council [G0902121, G0700837, G0901756] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); United Kingdom Department for International Development; Medical Research Council of Great Britain(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United Nations Joint Programme on HIV/AIDS (UNAIDS); Irish Aid(CGIAR); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded through grants from the European Commission, and the United Kingdom Department for International Development and Irish Aid. Additional funding was received from the Medical Research Council of Great Britain and The United Nations Joint Programme on HIV/AIDS (UNAIDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Barnabas RV, 2012, CURR HIV RES, V10, P228, DOI 10.2174/157016212800618156; BARONGO LR, 1992, AIDS, V6, P1521, DOI 10.1097/00002030-199212000-00016; Bloom SS, 2002, SEX TRANSM INFECT, V78, P261, DOI 10.1136/sti.78.4.261; Blum, 2004, RISK PROTECTIVE FACT; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Doyle AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024866; Doyle AM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000287; Forbes HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040507; Gray RH, 2007, AIDS, V21, P845, DOI 10.1097/QAD.0b013e3280187544; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Hargreaves JR, 2010, AIDS, V24, P754, DOI 10.1097/QAD.0b013e328336672e; Hayes R, 2010, AIDS, V24, pS15, DOI 10.1097/01.aids.0000390704.35642.47; Hayes RJ, 2005, CONTEMP CLIN TRIALS, V26, P430, DOI 10.1016/j.cct.2005.04.006; Kapiga SH, 2007, J INFECT DIS, V195, P1260, DOI 10.1086/513566; Kishamawe C, 2006, AIDS, V20, P601, DOI 10.1097/01.aids.0000210615.83330.b2; Msisha WM, 2008, INT J EPIDEMIOL, V37, P1297, DOI 10.1093/ije/dyn186; Obasi AI, 2006, AIDS CARE, V18, P311, DOI 10.1080/09540120500161983; Parkhurst JO, 2010, B WORLD HEALTH ORGAN, P17; Plummer M.L., 2012, PROMOTING ABSTINENCE; Plummer ML, 2011, YOUNG PEOPLES LIVES; Quigley M, 1997, AIDS, V11, P237, DOI 10.1097/00002030-199702000-00015; Remes P, 2009, CULT HEALTH SEX, V1; Rodriguez MDM, 2002, AIDS, V16, P451; Ross DA, 2007, AIDS, V21, P1943, DOI 10.1097/QAD.0b013e3282ed3cf5; Senkoro KP, 2000, J ACQ IMMUN DEF SYND, V23, P194; TACAIDS/Tanzania ZAC/Tanzania NBS/Tanzania OCGS/Tanzania and Macro International, 2008, TANZ HIV AIDS MAL IN; Todd J, 2006, J INFECT DIS, V193, P458, DOI 10.1086/499313; UNAIDS, 2012, WORLD AIDS DAY REP 2; UNAIDS, 2010, OUTL BREAK NEWS YOUN; United Nations, 2001, UNGASS GOALS; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Watson-Jones D, 2009, AIDS, V23, P415, DOI 10.1097/QAD.0b013e32831ef523; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Weiss HA, 2001, AIDS, V15, pS97, DOI 10.1097/00002030-200108004-00011; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Weiss Helen, 2004, Herpes, V11 Suppl 1, p24A; Weiss HA, 2008, AIDS, V22, P567, DOI 10.1097/QAD.0b013e3282f3f406; Wight D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-788	42	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66287	10.1371/journal.pone.0066287	http://dx.doi.org/10.1371/journal.pone.0066287			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805209	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000320846500037
J	Nassim, R; Mansure, JJ; Chevalier, S; Cury, F; Kassouf, W				Nassim, Roland; Mansure, Jose Joao; Chevalier, Simone; Cury, Fabio; Kassouf, Wassim			Combining mTOR Inhibition with Radiation Improves Antitumor Activity in Bladder Cancer Cells In Vitro and In Vivo: A Novel Strategy for Treatment	PLOS ONE			English	Article							CONCURRENT CISPLATIN; IONIZING-RADIATION; MAMMALIAN TARGET; KINASE-ACTIVITY; BREAST-CANCER; DNA-DAMAGE; HELA-CELLS; X-RAY; PATHWAY; CYCLE	Purpose: Radiation therapy for invasive bladder cancer allows for organ preservation but toxicity and local control remain problematic. As such, improving efficacy of treatment requires radiosensitization of tumor cells. The aim of study is to investigate if the mammalian Target of Rapamycin (mTOR), a downstream kinase of the phosphatidylinositol 3-kinase (PI3K)/AKT survival pathway, may be a target for radiation sensitization. Experimental Design: Clonogenic assays were performed using 6 bladder cancer cell lines (UM-UC3, UM-UC5, UM-UC6, KU7, 253J-BV, and 253-JP) in order to examine the effects of ionizing radiation (IR) alone and in combination with RAD001, an mTOR inhibitor. Cell cycle analysis was performed using flow cytometry. In vivo, athymic mice were subcutaneously injected with 2 bladder cancer cell lines. Treatment response with RAD001 (1.5 mg/kg, daily), fractionated IR (total 9Gy = 3Gyx3), and combination of RAD001 and IR was followed over 4 weeks. Tumor weight was measured at experimental endpoint. Results: Clonogenic assays revealed that in all bladder cell lines tested, an additive effect was observed in the combined treatment when compared to either treatment alone. Our data indicates that this effect is due to arrest in both G1 and G2 phases of cell cycle when treatments are combined. Furthermore, our data show that this arrest is primarily regulated by changes in levels of cyclin D1, p27 and p21 following treatments. In vivo, a significant decrease in tumor weight was observed in the combined treatment compared to either treatment alone or control. Conclusions: Altering cell cycle by inhibiting the mTOR signaling pathway in combination with radiation have favorable outcomes and is a promising therapeutic modality for bladder cancer.	[Nassim, Roland; Mansure, Jose Joao; Chevalier, Simone; Kassouf, Wassim] McGill Univ, Div Urol, McGill Urol Oncol Res, Montreal, PQ, Canada; [Cury, Fabio] McGill Univ, Ctr Hlth, Med Phys Unit, Montreal, PQ, Canada; [Cury, Fabio] Res Inst, Montreal, PQ, Canada	McGill University; McGill University	Kassouf, W (corresponding author), McGill Univ, Div Urol, McGill Urol Oncol Res, Montreal, PQ, Canada.	wassim.kassouf@muhc.mcgill.ca	Cury, Fabio L./AAW-5633-2020	Cury, Fabio L./0000-0003-1293-0822	Canadian Institute of Health Research (CIHR) [MOP 89796]; Fonds de recherche du Quebec-Sante (FRSQ)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec-Sante (FRSQ)	This project is being funded by a grant from the Canadian Institute of Health Research (CIHR) grant MOP 89796. Dr. W. Kassouf is a recipient of a clinical research scholar award from the Fonds de recherche du Quebec-Sante (FRSQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JM, 2006, MOL CANCER THER, V5, P1183, DOI 10.1158/1535-7163.MCT-05-0400; Brugarolas J, 1999, P NATL ACAD SCI USA, V96, P1002, DOI 10.1073/pnas.96.3.1002; Bussink J, 2008, LANCET ONCOL, V9, P288, DOI 10.1016/S1470-2045(08)70073-1; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cao C, 2006, CANCER RES, V66, P10040, DOI 10.1158/0008-5472.CAN-06-0802; Cayrol C, 1998, ONCOGENE, V16, P311, DOI 10.1038/sj.onc.1201543; Chen WC, 2003, INT J RADIAT ONCOL, V56, P726, DOI 10.1016/S0360-3016(03)00124-X; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Deng R, 2011, ONCOGENE, V30, P944, DOI 10.1038/onc.2010.467; Diaz De Stahl T, 2008, Minerva Urol Nefrol, V60, P205; DINNEY CPN, 1995, J UROLOGY, V154, P1532, DOI 10.1016/S0022-5347(01)66923-4; Gao N, 2004, AM J PHYSIOL-CELL PH, V287, pC281, DOI 10.1152/ajpcell.00422.2003; Gorshtein A, 2009, ENDOCR RELAT CANC; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; HUI Z, 1993, MOL BIOL CELL, V4, P897, DOI 10.1091/mbc.4.9.897; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Jones JM, 1999, CELL GROWTH DIFFER, V10, P213; Kaufmann WK, 1996, FASEB J, V10, P238, DOI 10.1096/fasebj.10.2.8641557; Konety BR, 2007, J UROLOGY, V177, P1636, DOI 10.1016/j.juro.2007.01.055; Law M, 2006, CANCER RES, V66, P1070, DOI 10.1158/0008-5472.CAN-05-1672; Li HF, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-43; Lieberman HB, 2008, CURR MED CHEM, V15, P360, DOI 10.2174/092986708783497328; Mansure JJ, 2009, CANCER BIOL THER, V8, P2339, DOI 10.4161/cbt.8.24.9987; MATTSSON A, 1993, J NATL CANCER I, V85, P1679, DOI 10.1093/jnci/85.20.1679; Milosevic M, 2007, UROLOGY, V69, P80, DOI 10.1016/j.urology.2006.05.060; Morgensztern D, 2005, ANTI-CANCER DRUG, V16, P797, DOI 10.1097/01.cad.0000173476.67239.3b; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Ram R, 2009, CLIN CANCER RES, V15, P914, DOI 10.1158/1078-0432.CCR-08-0792; Rho JK, 2009, ONCOL REP, V21, P801, DOI 10.3892/or_00000287; Ron E, 2003, HEALTH PHYS, V85, P47, DOI 10.1097/00004032-200307000-00011; Sabichi A, 2006, J UROLOGY, V175, P1133, DOI 10.1016/S0022-5347(05)00323-X; Samuel T, 2002, CELL CYCLE, V1, P162, DOI 10.4161/cc.1.3.118; Shinohara ET, 2005, ONCOGENE, V24, P5414, DOI 10.1038/sj.onc.1208715; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SINCLAIR WK, 1968, RADIAT RES, V33, P620, DOI 10.2307/3572419; SINCLAIR WK, 1965, BIOPHYS J, V5, P1, DOI 10.1016/S0006-3495(65)86700-5; TERASIMA T, 1963, BIOPHYS J, V3, P11, DOI 10.1016/S0006-3495(63)86801-0; Toulany M, 2006, CLIN CANCER RES, V12, P4119, DOI 10.1158/1078-0432.CCR-05-2454; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Xia S, 2010, CANCER BIOTHER RADIO, V25, P317, DOI 10.1089/cbr.2009.0707; Zhan M, 2004, HISTOL HISTOPATHOL, V19, P915, DOI 10.14670/HH-19.915; Zietman AL, 1998, J UROLOGY, V160, P1673, DOI 10.1016/S0022-5347(01)62379-6	42	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65257	10.1371/journal.pone.0065257	http://dx.doi.org/10.1371/journal.pone.0065257			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799002	Green Published, Green Submitted, gold			2022-12-25	WOS:000321397800003
J	Johnson, I; Liu, HN				Johnson, Ian; Liu, Huinan			A Study on Factors Affecting the Degradation of Magnesium and a Magnesium-Yttrium Alloy for Biomedical Applications	PLOS ONE			English	Article							IN-VITRO EVALUATION; CORROSION; BEHAVIOR; DISSOLUTION; CHLORIDE	Controlling degradation of magnesium or its alloys in physiological saline solutions is essential for their potential applications in clinically viable implants. Rapid degradation of magnesium-based materials reduces the mechanical properties of implants prematurely and severely increases alkalinity of the local environment. Therefore, the objective of this study is to investigate the effects of three interactive factors on magnesium degradation, specifically, the addition of yttrium to form a magnesium-yttrium alloy versus pure magnesium, the metallic versus oxide surfaces, and the presence versus absence of physiological salt ions in the immersion solution. In the immersion solution of phosphate buffered saline (PBS), the magnesium-yttrium alloy with metallic surface degraded the slowest, followed by pure magnesium with metallic or oxide surfaces, and the magnesium-yttrium alloy with oxide surface degraded the fastest. However, in deionized (DI) water, the degradation rate showed a different trend. Specifically, pure magnesium with metallic or oxide surfaces degraded the slowest, followed by the magnesium-yttrium alloy with oxide surface, and the magnesium-yttrium alloy with metallic surface degraded the fastest. Interestingly, only magnesium-yttrium alloy with metallic surface degraded slower in PBS than in DI water, while all the other samples degraded faster in PBS than in DI water. Clearly, the results showed that the alloy composition, presence or absence of surface oxide layer, and presence or absence of physiological salt ions in the immersion solution all influenced the degradation rate and mode. Moreover, these three factors showed statistically significant interactions. This study revealed the complex interrelationships among these factors and their respective contributions to degradation for the first time. The results of this study not only improved our understanding of magnesium degradation in physiological environment, but also presented the key factors to consider in order to satisfy the degradation requirements for next-generation biodegradable implants and devices.	[Johnson, Ian; Liu, Huinan] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA	University of California System; University of California Riverside	Liu, HN (corresponding author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.	huinan.liu@ucr.edu	Liu, Huinan H/N-2891-2015	Liu, Huinan H/0000-0001-9366-6204	U.S. National Science Foundation [CBET BRIGE 1125801]; Hellman Faculty Fellowship; Burroughs Wellcome Fund; University of California Regent's Faculty Fellowship	U.S. National Science Foundation(National Science Foundation (NSF)); Hellman Faculty Fellowship; Burroughs Wellcome Fund(Burroughs Wellcome Fund); University of California Regent's Faculty Fellowship(University of California System)	The authors thank the U.S. National Science Foundation (CBET BRIGE 1125801), Hellman Faculty Fellowship, Burroughs Wellcome Fund, and the University of California Regent's Faculty Fellowship for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghion E, 2008, J MATER SCI, V43, P4870, DOI 10.1007/s10853-008-2708-9; Ambat R, 2000, J APPL ELECTROCHEM, V30, P865, DOI 10.1023/A:1004011916609; Brar HS, 2009, JOM-US, V61, P31, DOI 10.1007/s11837-009-0129-0; Davenport AJ, 2007, ELECTROCHEM SOLID ST, V10, pC5, DOI 10.1149/1.2400727; FERRANDO WA, 1989, J MATER ENG, V11, P299, DOI 10.1007/BF02834140; Ghali E, 2004, J MATER ENG PERFORM, V13, P7, DOI 10.1361/10599490417533; Guan RG, 2012, J BIOMED MATER RES A, V100A, P999, DOI 10.1002/jbm.a.34042; Gunde P, 2010, J BIOMED MATER RES A, V92A, P409, DOI 10.1002/jbm.a.32350; Hanzi AC, 2009, ACTA BIOMATER, V5, P162, DOI 10.1016/j.actbio.2008.07.034; He WW, 2010, MAT SCI ENG C-MATER, V30, P167, DOI 10.1016/j.msec.2009.09.014; Heakal FET, 2009, ELECTROCHIM ACTA, V54, P1545, DOI 10.1016/j.electacta.2008.09.055; Janning C, 2010, ACTA BIOMATER, V6, P1861, DOI 10.1016/j.actbio.2009.12.037; Johnson I, 2012, J BIOMED MATER RES A, V100A, P477, DOI 10.1002/jbm.a.33290; Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004; Lindstrom R, 2004, CORROS SCI, V46, P1141, DOI 10.1016/j.corsci.2003.09.010; Liu M, 2010, CORROS SCI, V52, P3687, DOI 10.1016/j.corsci.2010.07.019; MILLER PL, 1995, CORROSION, V51, P922, DOI 10.5006/1.3293568; Mueller WD, 2009, J BIOMED MATER RES A, V90A, P487, DOI 10.1002/jbm.a.32106; Rettig R, 2009, J BIOMED MATER RES A, V88A, P359, DOI 10.1002/jbm.a.31887; Socjusz-Podosek M, 2003, MATER CHEM PHYS, V80, P472, DOI 10.1016/S0254-0584(02)00549-7; Song G, 1997, CORROS SCI, V39, P1981, DOI 10.1016/S0010-938X(97)00090-5; Song GL, 2005, ADV ENG MATER, V7, P563, DOI 10.1002/adem.200500013; Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405; Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028; Wu BL, 2010, MAT SCI ENG A-STRUCT, V527, P4334, DOI 10.1016/j.msea.2010.03.054; Xin YC, 2008, ACTA BIOMATER, V4, P2008, DOI 10.1016/j.actbio.2008.05.014; Yamasaki Y, 2003, BIOMATERIALS, V24, P4913, DOI 10.1016/S0142-9612(03)00414-9; Yao HB, 2003, ELECTROCHIM ACTA, V48, P4197, DOI 10.1016/S0013-4686(03)00605-4; Zhang JH, 2009, J ALLOY COMPD, V471, P322, DOI 10.1016/j.jallcom.2008.03.089	29	53	54	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65603	10.1371/journal.pone.0065603	http://dx.doi.org/10.1371/journal.pone.0065603			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799028	Green Submitted, Green Published, gold			2022-12-25	WOS:000320363300028
J	Thwe, AA; Kim, JK; Li, XH; Kim, YB; Uddin, MR; Kim, SJ; Suzuki, T; Park, NI; Park, SU				Thwe, Aye Aye; Kim, Jae Kwang; Li, Xiaohua; Kim, Yeon Bok; Uddin, Md Romij; Kim, Sun Ju; Suzuki, Tatsuro; Park, Nam Il; Park, Sang Un			Metabolomic Analysis and Phenylpropanoid Biosynthesis in Hairy Root Culture of Tartary Buckwheat Cultivars	PLOS ONE			English	Article							AGROBACTERIUM-RHIZOGENES; FLAVONOID BIOSYNTHESIS; HIGHER-PLANTS; GROWTH; RUTIN; ACCUMULATION; ACID; TRANSFORMATION; METABOLITES; EXPRESSION	Buckwheat, Fagopyrum tataricum Gaertn., is an important medicinal plant, which contains several phenolic compounds, including one of the highest content of rutin, a phenolic compound with anti-inflammatory properties. An experiment was conducted to investigate the level of expression of various genes in the phenylpropanoid biosynthetic pathway to analyze in vitro production of anthocyanin and phenolic compounds from hairy root cultures derived from 2 cultivars of tartary buckwheat (Hokkai T8 and T10). A total of 47 metabolites were identified by gas chromatography-time-of-flight mass spectrometry (GC-TOFMS) and subjected to principal component analysis (PCA) in order to fully distinguish between Hokkai T8 and T10 hairy roots. The expression levels of phenylpropanoid biosynthetic pathway genes, through qRT-PCR, showed higher expression for almost all the genes in T10 than T8 hairy root except for FtF3'H-2 and FtFLS-2. Rutin, quercetin, gallic acid, caffeic acid, ferulic acid, 4-hydroxybenzoic acid, and 2 anthocyanin compounds were identified in Hokkai T8 and T10 hairy roots. The concentration of rutin and anthocyanin in Hokkai T10 hairy roots of tartary buckwheat was several-fold higher compared with that obtained from Hokkai T8 hairy root. This study provides useful information on the molecular and physiological dynamic processes that are correlated with phenylpropanoid biosynthetic gene expression and phenolic compound content in F. tataricum species.	[Thwe, Aye Aye; Li, Xiaohua; Kim, Yeon Bok; Uddin, Md Romij; Park, Sang Un] Chungnam Natl Univ, Dept Crop Sci, Taejon, South Korea; [Kim, Jae Kwang] Rural Dev Adm, Natl Acad Agr Sci, Suwon, South Korea; [Kim, Sun Ju] Chungnam Natl Univ, Dept Bio Environm Chem, Taejon, South Korea; [Suzuki, Tatsuro] Natl Agr Res Ctr Hokkaido Reg, Sapporo, Hokkaido, Japan; [Park, Nam Il] Wildlife Genet Resources Ctr, Natl Inst Biol Resources, Inchon, South Korea	Chungnam National University; Rural Development Administration (RDA); Chungnam National University; National Agriculture & Food Research Organization - Japan; National Institute of Biological Resources	Park, NI (corresponding author), Wildlife Genet Resources Ctr, Natl Inst Biol Resources, Inchon, South Korea.	parknamil@korea.kr; supark@cnu.ac.kr		Kim, Sun-Ju/0000-0003-4872-9637	Korea Institute of Oriental Medicine (KIOM) [K11101]; Korea government	Korea Institute of Oriental Medicine (KIOM); Korea government(Korean Government)	This work (K11101) was supported by the Korea Institute of Oriental Medicine (KIOM) grant funded by the Korea government. The funder took part in the role of conceiving and designing the experiment.	Bettini P, 2003, THEOR APPL GENET, V107, P831, DOI 10.1007/s00122-003-1322-0; Christey MC, 2005, METH MOL B, V286, P47; Christey MC, 2001, IN VITRO CELL DEV-PL, V37, P687; FILETICI P, 1987, PLANT MOL BIOL, V9, P19, DOI 10.1007/BF00017983; Fraser Christopher M, 2011, Arabidopsis Book, V9, pe0152, DOI 10.1199/tab.0152; Gaberscik A, 2002, J PHOTOCH PHOTOBIO B, V66, P30, DOI 10.1016/S1011-1344(01)00272-X; Georgiev MI, 2007, APPL MICROBIOL BIOT, V74, P1175, DOI 10.1007/s00253-007-0856-5; Giri A, 2000, BIOTECHNOL ADV, V18, P1, DOI 10.1016/S0734-9750(99)00016-6; Gong GH, 2010, EUR J PHARMACOL, V628, P27, DOI 10.1016/j.ejphar.2009.11.028; Guillon S, 2006, TRENDS BIOTECHNOL, V24, P403, DOI 10.1016/j.tibtech.2006.07.002; Guillon S, 2006, CURR OPIN PLANT BIOL, V9, P341, DOI 10.1016/j.pbi.2006.03.008; Guo X, 2007, J AGR FOOD CHEM, V55, P6958, DOI 10.1021/jf071032+; Gupta N, 2011, J PLANT PHYSIOL, V168, P2117, DOI 10.1016/j.jplph.2011.06.018; Hagels H, 1995, CURR ADV BUCKWHEAT R, V115, P801; HAMILL JD, 1987, BIO-TECHNOL, V5, P800, DOI 10.1038/nbt0887-800; Kayashita J, 1997, J NUTR, V127, P1395, DOI 10.1093/jn/127.7.1395; Kim JK, 2013, J CEREAL SCI, V57, P14, DOI 10.1016/j.jcs.2012.09.012; Kim JK, 2013, PLANT BIOTECHNOL REP, V7, P121, DOI 10.1007/s11816-012-0231-6; Kim Yong Kyoung, 2009, Journal of Crop Science and Biotechnology, V12, P53; Kobayashi S, 2012, J BIOSCI BIOENG, V114, P86, DOI 10.1016/j.jbiosc.2012.02.015; Kok EJ, 2008, REGUL TOXICOL PHARM, V50, P98, DOI 10.1016/j.yrtph.2007.09.007; Kuntic V, 2011, MOLECULES, V16, P1378, DOI 10.3390/molecules16021378; Lachman J., 2000, Scientia Agriculturae Bohemica, V31, P89; Landberg R, 2011, J NUTR, V141, P618, DOI 10.3945/jn.110.133843; Lee SY, 2007, PREP BIOCHEM BIOTECH, V37, P239, DOI 10.1080/10826060701386729; Li XH, 2010, J AGR FOOD CHEM, V58, P12176, DOI 10.1021/jf103310g; Liu CL, 2008, J AGR FOOD CHEM, V56, P173, DOI 10.1021/jf072347s; Mandal S, 2008, BIOTECHNOL LETT, V30, P1253, DOI 10.1007/s10529-008-9666-9; Messerli G, 2007, PLANT PHYSIOL, V143, P1484, DOI 10.1104/pp.106.090795; Moriguchi K, 2001, J MOL BIOL, V307, P771, DOI 10.1006/jmbi.2001.4488; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Park NI, 2011, J AGR FOOD CHEM, V59, P2356, DOI 10.1021/jf200020b; PETIT A, 1983, MOL GEN GENET, V190, P204, DOI 10.1007/BF00330641; Pongsuwan W, 2007, J AGR FOOD CHEM, V55, P231, DOI 10.1021/jf062330u; RUSSELL DW, 1971, J BIOL CHEM, V246, P3870; Sircar D, 2007, J PLANT PHYSIOL, V164, P1358, DOI 10.1016/j.jplph.2006.08.002; Srivastava S, 2007, CRIT REV BIOTECHNOL, V27, P29, DOI 10.1080/07388550601173918; Suzuki T, 2009, J AGR FOOD CHEM, V57, P259, DOI 10.1021/jf802731d; Tarachiwin L, 2008, J AGR FOOD CHEM, V56, P5827, DOI 10.1021/jf800418u; TEPFER D, 1984, CELL, V37, P959, DOI 10.1016/0092-8674(84)90430-6; Timotijevic GS, 2010, J PLANT PHYSIOL, V167, P61, DOI 10.1016/j.jplph.2009.06.017; TSUZUKI E, 1987, Bulletin of the Faculty of Agriculture Miyazaki University, V34, P289; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Yao Y, 2008, J AGR FOOD CHEM, V56, P10027, DOI 10.1021/jf801879m	45	38	41	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65349	10.1371/journal.pone.0065349	http://dx.doi.org/10.1371/journal.pone.0065349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799007	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300014
J	Zhang, Z; Xu, YW; Liu, J; Wong, DWK; Kwoh, CK; Saw, SM; Wong, TY				Zhang, Zhuo; Xu, Yanwu; Liu, Jiang; Wong, Damon Wing Kee; Kwoh, Chee Keong; Saw, Seang-Mei; Wong, Tien Yin			Automatic Diagnosis of Pathological Myopia from Heterogeneous Biomedical Data	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; POPULATION; BLINDNESS; LINKAGE; PREVALENCE; REGION; SCAN; EYE	Pathological myopia is one of the leading causes of blindness worldwide. The condition is particularly prevalent in Asia. Unlike myopia, pathological myopia is accompanied by degenerative changes in the retina, which if left untreated can lead to irrecoverable vision loss. The accurate diagnosis of pathological myopia will enable timely intervention and facilitate better disease management to slow down the progression of the disease. Current methods of assessment typically consider only one type of data, such as that from retinal imaging. However, different kinds of data, including that of genetic, demographic and clinical information, may contain different and independent information, which can provide different perspectives on the visually observable, genetic or environmental mechanisms for the disease. The combination of these potentially complementary pieces of information can enhance the understanding of the disease, providing a holistic appreciation of the multiple risks factors as well as improving the detection outcomes. In this study, we propose a computer-aided diagnosis framework for Pathological Myopia diagnosis through Biomedical and Image Informatics(PM-BMII). Through the use of multiple kernel learning (MKL) methods, PM-BMII intelligently fuses heterogeneous biomedical information to improve the accuracy of disease diagnosis. Data from 2,258 subjects of a population-based study, in which demographic and clinical information, retinal fundus imaging data and genotyping data were collected, are used to evaluate the proposed framework. The experimental results show that PM-BMII achieves an AUC of 0.888, outperforming the detection results from the use of demographic and clinical information 0.607 (increase 46.3%, p < 0.005), genotyping data 0.774 (increase 14.7%, p < 0.005) or imaging data 0.852 (increase 4.2%, p = 0.19) alone. The accuracy of the results obtained demonstrates the feasibility of using heterogeneous data for improved disease diagnosis through our proposed PM-BMII framework.	[Zhang, Zhuo; Xu, Yanwu; Liu, Jiang; Wong, Damon Wing Kee] Agcy Sci Technol & Res, Inst Infocomm Res, Singapore, Singapore; [Zhang, Zhuo; Kwoh, Chee Keong] Nanyang Technol Univ, Sch Comp Engn, Singapore 639798, Singapore; [Saw, Seang-Mei] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Wong, Tien Yin] Singapore Eye Res Inst, Dept Ophthalmol, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore; Singapore National Eye Center	Zhang, Z (corresponding author), Agcy Sci Technol & Res, Inst Infocomm Res, Singapore, Singapore.	zzhang@i2r.a-star.edu.sg	Xu, Yanwu/AAK-8156-2020; Wong, Tien Yin/AAC-9724-2020	Xu, Yanwu/0000-0002-1779-931X; Wong, Tien Yin/0000-0002-8448-1264; liu, jiang/0000-0001-6281-6505; Wong, Damon/0000-0003-4601-9121	Agency for Science, Technology and Research, Singapore, under Science and Engineering Research Council [092-148-0073]	Agency for Science, Technology and Research, Singapore, under Science and Engineering Research Council	This work was supported in part by the Agency for Science, Technology and Research, Singapore, under Science and Engineering Research Council grant 092-148-0073. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ONL MEND INH MAN OM; Bach F.R., 2004, P 21 INT C MACH LEAR, P6, DOI DOI 10.1145/1015330.1015424; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Buch H, 2004, OPHTHALMOLOGY, V111, P53, DOI 10.1016/j.ophtha.2003.05.010; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Cheng J, 2011, LECT NOTES COMPUT SC, V6893, P91, DOI 10.1007/978-3-642-23626-6_12; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Curtin BJ, 1985, MYOPIAS BASIC SCI CL; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Fan Q, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002753; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Fei-Fei L, 2005, PROC CVPR IEEE, P524; Foong AWP, 2007, OPHTHAL EPIDEMIOL, V14, P25, DOI 10.1080/09286580600878844; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GREEN JS, 1986, BRIT J OPHTHALMOL, V70, P696, DOI 10.1136/bjo.70.9.696; Hindorff LA, CATALOG PUBLISHED GE; Iwase A, 2006, OPHTHALMOLOGY, V113, P1354, DOI 10.1016/j.ophtha.2006.04.022; Krumpaszky HG, 1999, OPHTHALMOLOGICA, V213, P176, DOI 10.1159/000027415; Lanckriet GRG, 2004, J MACH LEARN RES, V5, P27; Lanckriet GRG, 2004, BIOINFORMATICS, V20, P2626, DOI 10.1093/bioinformatics/bth294; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Li YJ, 2011, OPHTHALMOLOGY, V118, P368, DOI 10.1016/j.ophtha.2010.06.016; Li ZQ, 2011, HUM MOL GENET, V20, P2861, DOI 10.1093/hmg/ddr169; Liu J, 2010, J HEALTHC ENG, V1, P1, DOI 10.1260/2040-2295.1.1.1; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Mikolajczyk K, 2005, INT J COMPUT VISION, V65, P43, DOI 10.1007/s11263-005-3848-x; Nakanishi H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000660; Rakotomamonjy A, 2008, J MACH LEARN RES, V9, P2491; Saw SM, 1996, EPIDEMIOL REV, V18, P175, DOI 10.1093/oxfordjournals.epirev.a017924; Shih YF, 2006, BRIT J OPHTHALMOL, V90, P546, DOI 10.1136/bjo.2005.081992; Solouki AM, 2010, NAT GENET, V42, P897, DOI 10.1038/ng.663; Stambolian D, 2004, AM J HUM GENET, V75, P448, DOI 10.1086/423789; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wojciechowski R, 2006, HUM GENET, V119, P389, DOI 10.1007/s00439-006-0153-x; Xu YW, 2012, LECT NOTES COMPUT SC, V7510, P58, DOI 10.1007/978-3-642-33415-3_8; Xu YW, 2011, LECT NOTES COMPUT SC, V6893, P1, DOI 10.1007/978-3-642-23626-6_1; Xu Z., 2010, P 27 INT C MACHINE L, P1175; Young TL, 2004, ARCH OPHTHALMOL-CHIC, V122, P897, DOI 10.1001/archopht.122.6.897; Zhuo Zhang, 2012, 2012 7th IEEE Conference on Industrial Electronics and Applications (ICIEA 2012). Proceedings, P1742, DOI 10.1109/ICIEA.2012.6361007	39	9	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65736	10.1371/journal.pone.0065736	http://dx.doi.org/10.1371/journal.pone.0065736			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799040	Green Published, gold			2022-12-25	WOS:000320363300036
J	Inoue, Y; Hasegawa, S; Yamada, T; Date, Y; Mizutani, H; Nakata, S; Akamatsu, H				Inoue, Yu; Hasegawa, Seiji; Yamada, Takaaki; Date, Yasushi; Mizutani, Hiroshi; Nakata, Satoru; Akamatsu, Hirohiko			Lignin Induces ES Cells to Differentiate into Neuroectodermal Cells through Mediation of the Wnt Signaling Pathway	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DOPAMINERGIC-NEURONS; RETINOIC ACID; GENERATION; CULTURE; MOUSE; MOLECULE; MODEL; LIF	Embryonic stem cells (ES cells) are characterized by their pluripotency and infinite proliferation potential. Ever since ES cells were first established in 1981, there have been a growing number of studies aimed at clinical applications of ES cells. In recent years, various types of differentiation inducement systems using ES cells have been established. Further studies have been conducted to utilize differentiation inducement systems in the field of regenerative medicine. For cellular treatments using stem cells including ES cells, differentiation induction should be performed in a sufficient manner to obtain the intended cell lineages. Lignin is a high-molecular amorphous material that forms plants together with cellulose and hemicelluloses, in which phenylpropane fundamental units are complexly condensed. Lignin derivatives have been shown to have several bioactive functions. In spite of these findings, few studies have focused on the effects of lignin on stem cells. Our study aimed to develop a novel technology using lignin to effectively induce ES cells to differentiate into neuroectodermal cells including ocular cells and neural cells. Since lignin can be produced at a relatively low cost in large volumes, its utilization is expected for more convenient differentiation induction technologies and in the field of regenerative medicine in the future.	[Inoue, Yu; Hasegawa, Seiji; Yamada, Takaaki; Date, Yasushi; Mizutani, Hiroshi; Nakata, Satoru] Nippon Menard Cosmet Co Ltd, Res Labs, Aichi, Japan; [Hasegawa, Seiji; Yamada, Takaaki] Fujita Hlth Univ, Sch Med, Dept Dermatol, Aichi, Japan; [Akamatsu, Hirohiko] Fujita Hlth Univ, Sch Med, Dept Appl Cell & Regenerat Med, Aichi, Japan	Fujita Health University; Fujita Health University	Inoue, Y (corresponding author), Nippon Menard Cosmet Co Ltd, Res Labs, Aichi, Japan.	inoue.yuu@menard.co.jp	Date, Yasushi/C-5349-2016; Hasegawa, Seiji/A-3514-2016	Hasegawa, Seiji/0000-0001-9797-1900; Inoue, Yu/0000-0002-7540-6940	Nippon Menard Cosmetic Co., Ltd.	Nippon Menard Cosmetic Co., Ltd.	This work was supported by Nippon Menard Cosmetic Co., Ltd. (http://www.menard.co.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests. Yu Inoue, Seiji Hasegawa, Takaaki Yamada, Yasushi Date, Hiroshi Mizutani and Satoru Nakata are employed by Nippon Menard Cosmetic Co., Ltd, the funder of this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Bellmeyer A, 2003, DEV CELL, V4, P827, DOI 10.1016/S1534-5807(03)00160-6; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Doi D, 2012, STEM CELLS, V30, P935, DOI 10.1002/stem.1060; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GOUGH NM, 1989, REPROD FERT DEVELOP, V1, P281, DOI 10.1071/RD9890281; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Hirami Y, 2009, NEUROSCI LETT, V458, P126, DOI 10.1016/j.neulet.2009.04.035; Hirano M, 2003, DEV DYNAM, V228, P664, DOI 10.1002/dvdy.10425; Inoue Y, 2012, PIGM CELL MELANOMA R, V25, P299, DOI 10.1111/j.1755-148X.2012.00988.x; Ito Y, 2006, J PHARMACOL SCI, V102, P196, DOI 10.1254/jphs.FP0060711; Kawasaki H, 2002, P NATL ACAD SCI USA, V99, P1580, DOI 10.1073/pnas.032662199; Kim YY, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/167376; Lu JF, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-57; O'Shea KS, 1999, ANAT RECORD, V257, P32, DOI 10.1002/(SICI)1097-0185(19990215)257:1<32::AID-AR6>3.0.CO;2-2; Prelle K, 2002, ANAT HISTOL EMBRYOL, V31, P169, DOI 10.1046/j.1439-0264.2002.00388.x; Reynertson KA, 2011, EXP CELL RES, V317, P82, DOI 10.1016/j.yexcr.2010.10.010; Swistowska AM, 2010, STEM CELLS DEV, V19, P71, DOI 10.1089/scd.2009.0107; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013; Teraoka ME, 2009, DEV BIOL, V330, P389, DOI 10.1016/j.ydbio.2009.04.008; Ulloa-Montoya F, 2005, J BIOSCI BIOENG, V100, P12, DOI 10.1263/jbb.100.12; Vazin T, 2008, STEM CELLS, V26, P1517, DOI 10.1634/stemcells.2008-0039; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Yamane T, 1999, DEV DYNAM, V216, P450, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<450::AID-DVDY13>3.0.CO;2-0	24	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66376	10.1371/journal.pone.0066376	http://dx.doi.org/10.1371/journal.pone.0066376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805217	gold, Green Published, Green Submitted			2022-12-25	WOS:000320846500045
J	Jiang, Y; Li, BQ; Zhang, Y; Feng, YM; Gao, YF; Zhang, N; Cai, YD				Jiang, Yang; Li, Bi-Qing; Zhang, Yuchao; Feng, Yuan-Ming; Gao, Yu-Fei; Zhang, Ning; Cai, Yu-Dong			Prediction and Analysis of Post-Translational Pyruvoyl Residue Modification Sites from Internal Serines in Proteins	PLOS ONE			English	Article							S-ADENOSYLMETHIONINE DECARBOXYLASE; TARGETING POLYAMINE METABOLISM; ACID PAIRING PREFERENCES; ARGININE DECARBOXYLASE; BETA-STRANDS; PHOSPHORYLATION; GLYCOSYLATION; DISORDER; CANCER; IDENTIFICATION	Most of pyruvoyl-dependent proteins observed in prokaryotes and eukaryotes are critical regulatory enzymes, which are primary targets of inhibitors for anti-cancer and anti-parasitic therapy. These proteins undergo an autocatalytic, intramolecular self-cleavage reaction in which a covalently bound pyruvoyl group is generated on a conserved serine residue. Traditional detections of the modified serine sites are performed by experimental approaches, which are often labor-intensive and time-consuming. In this study, we initiated in an attempt for the computational predictions of such serine sites with Feature Selection based on a Random Forest. Since only a small number of experimentally verified pyruvoyl-modified proteins are collected in the protein database at its current version, we only used a small dataset in this study. After removing proteins with sequence identities >60%, a non-redundant dataset was generated and was used, which contained only 46 proteins, with one pyruvoyl serine site for each protein. Several types of features were considered in our method including PSSM conservation scores, disorders, secondary structures, solvent accessibilities, amino acid factors and amino acid occurrence frequencies. As a result, a pretty good performance was achieved in our dataset. The best 100.00% accuracy and 1.0000 MCC value were obtained from the training dataset, and 93.75% accuracy and 0.8441 MCC value from the testing dataset. The optimal feature set contained 9 features. Analysis of the optimal feature set indicated the important roles of some specific features in determining the pyruvoyl-group-serine sites, which were consistent with several results of earlier experimental studies. These selected features may shed some light on the in-depth understanding of the mechanism of the post-translational self-maturation process, providing guidelines for experimental validation. Future work should be made as more pyruvoyl-modified proteins are found and the method should be evaluated on larger datasets. At last, the predicting software can be downloaded from http://www.nkbiox.com/sub/pyrupred/index.html.	[Jiang, Yang; Gao, Yu-Fei] Jilin Univ, China Japan Union Hosp, Dept Surg, Changchun 130023, Peoples R China; [Li, Bi-Qing] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Zhang, Yuchao] Shanghai Jiao Tong Univ, Sch Med, Inst Hlth Sci, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Zhang, Yuchao] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Feng, Yuan-Ming; Zhang, Ning] Tianjin Univ, Dept Biomed Engn, Tianjin Key Lab Biomed Engn Measurement, Tianjin 300072, Peoples R China; [Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China	Jilin University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tianjin University; Shanghai University	Gao, YF (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Surg, Changchun 130023, Peoples R China.	gaoyufei1975@sina.cn; zhni@tju.edu.cn; cai_yud@yahoo.com.cn		Zhang, Ning/0000-0002-1559-111X; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101]; National Science Foundation of China [81171342, 81201148]; Innovation Program of Shanghai Municipal Education Commission [12YZ120, 12ZZ087]; grant of "The First-class Discipline of Universities in Shanghai''; Natural science fund projects of Jilin province [201215059]; development of science and technology plan projects of Jilin province [20100733, 201101074]; SRF for ROCS; SEM [2009-36]; Scientific Research Foundation (Jilin Department of Science Technology) [20100733, 200705314, 20090175]; Scientific Research Foundation (Jilin Department of Health) [2010Z068]; SRF for ROCS (Jilin Department of Human Resource & Social Security)	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); grant of "The First-class Discipline of Universities in Shanghai''; Natural science fund projects of Jilin province; development of science and technology plan projects of Jilin province; SRF for ROCS(Scientific Research Foundation for the Returned Overseas Chinese Scholars); SEM; Scientific Research Foundation (Jilin Department of Science Technology); Scientific Research Foundation (Jilin Department of Health); SRF for ROCS (Jilin Department of Human Resource & Social Security)	This contribution is supported by National Basic Research Program of China (2011CB510102, 2011CB510101), National Science Foundation of China (81171342, 81201148), Innovation Program of Shanghai Municipal Education Commission (No. 12YZ120, No. 12ZZ087), the grant of "The First-class Discipline of Universities in Shanghai''. Natural science fund projects of Jilin province (201215059), development of science and technology plan projects of Jilin province (20100733, 201101074), SRF for ROCS, SEM (2009-36), Scientific Research Foundation (Jilin Department of Science & Technology, 200705314, 20090175, 20100733), Scientific Research Foundation (Jilin Department of Health, 2010Z068), SRF for ROCS (Jilin Department of Human Resource & Social Security, 2012-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert A, 1998, NAT STRUCT BIOL, V5, P289, DOI 10.1038/nsb0498-289; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Bale S, 2010, AMINO ACIDS, V38, P451, DOI 10.1007/s00726-009-0404-y; Basu S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-210; Bednarski B, 2001, EUR J BIOCHEM, V268, P3538, DOI 10.1046/j.1432-1327.2001.02257.x; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Ekstrom JL, 2001, BIOCHEMISTRY-US, V40, P9495, DOI 10.1021/bi010736o; Fairlie DP, 2000, J MED CHEM, V43, P1271, DOI 10.1021/jm990315t; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Fooks HM, 2006, J MOL BIOL, V356, P32, DOI 10.1016/j.jmb.2005.11.008; GALLAGHER T, 1989, J BIOL CHEM, V264, P12737; Gerner EW, 2007, AMINO ACIDS, V33, P189, DOI 10.1007/s00726-007-0515-2; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Giles TN, 2008, J BIOL CHEM, V283, P25829, DOI 10.1074/jbc.M802674200; Graham DE, 2002, J BIOL CHEM, V277, P23500, DOI 10.1074/jbc.M203467200; Hamby SE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-500; He B, 2009, CELL RES, V19, P929, DOI 10.1038/cr.2009.87; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; HUGO ER, 1993, BIOCHEM J, V295, P203, DOI 10.1042/bj2950203; Jia SC, 2011, PROTEIN PEPTIDE LETT, V18, P609, DOI 10.2174/092986611795222777; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045854; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039308; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033393; Li BQ, 2012, J PROTEOMICS, V75, P1654, DOI 10.1016/j.jprot.2011.12.003; LI QX, 1990, J BIOL CHEM, V265, P4111; Li SL, 2009, PROTEIN PEPTIDE LETT, V16, P977, DOI 10.2174/092986609788923338; Lonvaud-Funel A, 2001, FEMS MICROBIOL LETT, V199, P9, DOI 10.1016/S0378-1097(01)00157-4; Noivirt-Brik O, 2009, PROTEINS, V77, P210, DOI 10.1002/prot.22586; Pegg AE, 1998, BIOCHEM SOC T, V26, P580, DOI 10.1042/bst0260580; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Rogers J, 2006, LECT NOTES COMPUT SC, V3940, P173; Schmitzberger F, 2003, EMBO J, V22, P6193, DOI 10.1093/emboj/cdg575; Shameer K, 2011, PROTEIN PEPTIDE LETT, V18, P1010, DOI 10.2174/092986611796378729; Shao JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004920; Smith CB, 2008, J BACTERIOL, V190, P7431, DOI 10.1128/JB.00652-08; Toms AV, 2004, J BIOL CHEM, V279, P33837, DOI 10.1074/jbc.M403369200; Trip H, 2011, MOL MICROBIOL, V79, P861, DOI 10.1111/j.1365-2958.2010.07492.x; Tyndall JDA, 2005, CHEM REV, V105, P973, DOI 10.1021/cr040669e; Wada M, 2010, BIOL PHARM BULL, V33, P891, DOI 10.1248/bpb.33.891; Webb ME, 2012, ACTA CRYSTALLOGR F, V68, P414, DOI 10.1107/S1744309112009487; WITTEN IH, 2005, DATA MINING PRACTICA; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Xue Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-163; You Liwen, 2006, Comput Syst Bioinformatics Conf, P249; Zhang N, 2012, MOL BIOSYST, V8, P2946, DOI 10.1039/c2mb25185j; Zhang N, 2010, J THEOR BIOL, V263, P360, DOI 10.1016/j.jtbi.2009.12.019; Zhang N, 2009, BIOCHEM BIOPH RES CO, V386, P537, DOI 10.1016/j.bbrc.2009.06.072	56	1	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66678	10.1371/journal.pone.0066678	http://dx.doi.org/10.1371/journal.pone.0066678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805260	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500088
J	Lee, HJ; Jang, M; Kim, H; Kwak, W; Park, W; Hwang, JY; Lee, CK; Jang, GW; Park, MN; Kim, HC; Jeong, JY; Seo, KS; Kim, H; Cho, S; Lee, BY				Lee, Hyun-Jeong; Jang, Mi; Kim, Hyeongmin; Kwak, Woori; Park, WonCheoul; Hwang, Jae Yeon; Lee, Chang-Kyu; Jang, Gul Won; Park, Mi Na; Kim, Hyeong-Cheol; Jeong, Jin Young; Seo, Kang Seok; Kim, Heebal; Cho, Seoae; Lee, Bo-Young			Comparative Transcriptome Analysis of Adipose Tissues Reveals that ECM-Receptor Interaction Is Involved in the Depot-Specific Adipogenesis in Cattle	PLOS ONE			English	Article							INTRAMUSCULAR FAT-CONTENT; GENE-EXPRESSION; PREADIPOCYTE DIFFERENTIATION; PROMOTES ADIPOGENESIS; LONGISSIMUS-LUMBORUM; KEY REGULATOR; UP-REGULATION; HIGH-STARCH; PPAR-GAMMA; SITE	Adipocytes mainly function as energy storage and endocrine cells. Adipose tissues showed the biological and genetic difference based on their depots. The difference of adipocytes between depots might be influenced by the inherent genetic programing for adipogenesis. We used RNA-seq technique to investigate the transcriptomes in 3 adipose tissues of omental (O), subcutaneous (S) and intramuscular (I) fats in cattle. Sequence reads were obtained from Illumina HiSeq2000 and mapped to the bovine genome using Tophat2. Differentially expressed genes (DEG) between adipose tissues were detected by EdgeR. We identified 5797, 2156, and 5455 DEGs in the comparison between OI, OS, and IS respectively and also found 5657 DEGs in the comparison between the intramuscular and the combined omental and subcutaneous fats (C) (FDR<0.01). Depot specifically up-and down-regulated DEGs were 853 in S, 48 in I, and 979 in O. The numbers of DEGs and functional annotation studies suggested that I had the different genetic profile compared to other two adipose tissues. In I, DEGs involved in the developmental process (eg. EGR2, FAS, and KLF7) were up-regulated and those in the immune system process were down-regulated. Many DEGs from the adipose tissues were enriched in the various GO terms of developmental process and KEGG pathway analysis showed that the ECM-receptor interaction was one of commonly enriched pathways in all of the 3 adipose tissues and also functioned as a sub-pathway of other enriched pathways. However, genes involved in the ECM-receptor interaction were differentially regulated depending on the depots. Collagens, main ECM constituents, were significantly up-regulated in S and integrins, transmembrane receptors, were up-regulated in I. Different laminins were up-regulated in the different depots. This comparative transcriptome analysis of three adipose tissues suggested that the interactions between ECM components and transmembrane receptors of fat cells depend on the depot specific adipogenesis.	[Lee, Hyun-Jeong; Jang, Mi; Jang, Gul Won; Park, Mi Na; Kim, Hyeong-Cheol; Jeong, Jin Young] Rural Dev Adm, Natl Inst Anim Sci, Div Anim Genom & Bioinformat, Suwon, South Korea; [Kim, Hyeongmin; Park, WonCheoul; Hwang, Jae Yeon; Lee, Chang-Kyu; Kim, Heebal; Lee, Bo-Young] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Hyeongmin; Park, WonCheoul; Hwang, Jae Yeon; Lee, Chang-Kyu; Kim, Heebal; Lee, Bo-Young] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Kwak, Woori] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Kwak, Woori; Cho, Seoae] Seoul Natl Univ Res Pk, C&K Genom, Seoul, South Korea; [Jang, Mi; Seo, Kang Seok] Sunchon Natl Univ, Coll Life Sci & Nat Resources, Dept Anim Sci & Technol, Jeollanam Do, South Korea	National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Sunchon National University	Cho, S (corresponding author), Seoul Natl Univ Res Pk, C&K Genom, Seoul, South Korea.	seoae@cnkgenomics.com; bylee613@snu.ac.kr	Kim, Heebal/A-8889-2016	Kim, Heebal/0000-0003-3064-1303; Hwang, Jae Yeon/0000-0002-6493-4182; Park, WonCheoul/0000-0003-3140-5628	National Livestock Research Institute [PJ008487]; BioGreen 21 Project of Rural Development Administration, Republic of Korea [PJ00819101]	National Livestock Research Institute; BioGreen 21 Project of Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This study was supported by Project (PJ008487) of the National Livestock Research Institute and BioGreen 21 Project (PJ00819101) of Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Akerblad P, 2002, MOL CELL BIOL, V22, P8015, DOI 10.1128/MCB.22.22.8015-8025.2002; Alterovitz G., 2011, KNOWL BAS BIOINF AN; Ament Z, 2012, GENOME MED, V4, DOI 10.1186/gm331; Arner P, 1997, J ENDOCRINOL, V155, P191, DOI 10.1677/joe.0.1550191; Basu U, 2012, J GENOMICS, V1, P22; Beale EG, 2007, CELL BIOCHEM BIOPHYS, V48, P89, DOI 10.1007/s12013-007-0025-6; Billon N, 2008, BIOL CELL, V100, P563, DOI 10.1042/BC20080011; Brooks MA, 2011, J ANIM SCI, V89, P2556, DOI 10.2527/jas.2010-3369; Caserta F, 2001, AM J PHYSIOL-ENDOC M, V280, pE238, DOI 10.1152/ajpendo.2001.280.2.E238; Chen Z, 2005, CELL METAB, V1, P93, DOI 10.1016/j.cmet.2004.12.009; Chui PC, 2005, J CLIN INVEST, V115, P2244, DOI 10.1172/JCI24130; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhar M, 2008, J LIPID RES, V49, P612, DOI 10.1194/jlr.M700450-JLR200; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Ditlecadet D, 2011, AM J PHYSIOL-REG I, V300, pR674, DOI 10.1152/ajpregu.00700.2010; DJIAN P, 1983, J CLIN INVEST, V72, P1200, DOI 10.1172/JCI111075; Dodson MV, 2010, J FOOD SCI, V75, pR1, DOI 10.1111/j.1750-3841.2009.01396.x; Dube E, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.098095; EDENS NK, 1993, AM J PHYSIOL, V265, pE374, DOI 10.1152/ajpendo.1993.265.3.E374; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; FRIED SK, 1993, J CLIN INVEST, V92, P2191, DOI 10.1172/JCI116821; Gardan D, 2006, AM J PHYSIOL-ENDOC M, V291, pE372, DOI 10.1152/ajpendo.00482.2005; Gondret F, 2008, J ANIM SCI, V86, P2115, DOI 10.2527/jas.2007-0750; Graugnard DE, 2010, BRIT J NUTR, V103, P953, DOI 10.1017/S0007114509992789; Graugnard DE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-142; HARTMAN AD, 1985, LIPIDS, V20, P255, DOI 10.1007/BF02534256; HAUNER H, 1991, INT J OBESITY, V15, P121; Helledie T, 2002, MOL CELL BIOCHEM, V239, P157, DOI 10.1023/A:1020538404612; Hocquette JF, 2010, ANIMAL, V4, P303, DOI 10.1017/S1751731109991091; Hong YH, 2005, BIOSCI BIOTECH BIOCH, V69, P2117, DOI 10.1271/bbb.69.2117; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Houten SM, 2012, J LIPID RES, V53, P1296, DOI 10.1194/jlr.M024463; Huang H, 2005, BIOCHEMISTRY-US, V44, P10282, DOI 10.1021/bi0477891; Hube F, 1996, HORM METAB RES, V28, P690, DOI 10.1055/s-2007-979879; Hutley L, 2004, DIABETES, V53, P3097, DOI 10.2337/diabetes.53.12.3097; Jeong J, 2012, J ANIM SCI, V90, P2044, DOI 10.2527/jas.2011-4753; Jin W, 2012, J ANIM SCI, V90, P171, DOI 10.2527/jas.2011-4229; Joe AWB, 2009, STEM CELLS, V27, P2563, DOI 10.1002/stem.190; Kanazawa A, 2005, BIOCHEM BIOPH RES CO, V330, P505, DOI 10.1016/j.bbrc.2005.03.007; Kanazawa A, 2004, AM J HUM GENET, V75, P832, DOI 10.1086/425340; Kanazawa A, 2005, DIABETOLOGIA, V48, P1315, DOI 10.1007/s00125-005-1797-0; Kawaguchi N, 1998, P NATL ACAD SCI USA, V95, P1062, DOI 10.1073/pnas.95.3.1062; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kirkland J. L., 1997, OBESITY RES S1, V5, p22S; KIRKLAND JL, 1984, J AM GERIATR SOC, V32, P219, DOI 10.1111/j.1532-5415.1984.tb02006.x; Kirkland JL, 1996, INT J OBESITY, V20, pS102; Kunej T, 2007, OBESITY, V15, P2896, DOI 10.1038/oby.2007.344; LEE YB, 1974, J ANIM SCI, V38, P532, DOI 10.2527/jas1974.383532x; Li D, 2005, J BIOL CHEM, V280, P26941, DOI 10.1074/jbc.M500463200; Li P, 2012, J DAIRY SCI, V95, P1759, DOI 10.3168/jds.2011-4580; Li RW, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-114; Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobo S., 2007, NOVART FDN SYMP, V286, P196; Lobo Sandra, 2007, Novartis Found Symp, V286, P113; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; Mariman ECM, 2010, CELL MOL LIFE SCI, V67, P1277, DOI 10.1007/s00018-010-0263-4; Michal JJ, 2006, ANIM GENET, V37, P400, DOI 10.1111/j.1365-2052.2006.01464.x; MILLER MF, 1991, J ANIM SCI, V69, P162; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Niesler CU, 1998, DIABETES, V47, P1365, DOI 10.2337/diabetes.47.8.1365; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Radler U, 2011, ANN NUTR METAB, V58, P133, DOI 10.1159/000327150; Randhawa M, 2009, FASEB J, V23, P835, DOI 10.1096/fj.08-116327; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sarruf DA, 2005, MOL CELL BIOL, V25, P9985, DOI 10.1128/MCB.25.22.9985-9995.2005; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Toyoda M, 2009, CELL BIOCHEM FUNCT, V27, P440, DOI 10.1002/cbf.1591; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; Wang YH, 2009, J ANIM SCI, V87, P119, DOI 10.2527/jas.2008-1082; Wang Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S5; Yang YZ, 2004, BIOCHEM BIOPH RES CO, V320, P1204, DOI 10.1016/j.bbrc.2004.06.069	79	39	46	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66267	10.1371/journal.pone.0066267	http://dx.doi.org/10.1371/journal.pone.0066267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805208	gold, Green Published, Green Submitted			2022-12-25	WOS:000320846500036
J	Belonogova, NM; Svishcheva, GR; van Duijn, CM; Aulchenko, YS; Axenovich, TI				Belonogova, Nadezhda M.; Svishcheva, Gulnara R.; van Duijn, Cornelia M.; Aulchenko, Yurii S.; Axenovich, Tatiana I.			Region-Based Association Analysis of Human Quantitative Traits in Related Individuals	PLOS ONE			English	Article							MISSING HERITABILITY; HUMAN HEIGHT; KERNEL; REGRESSION; VARIANTS; TESTS; LOCI	Regional-based association analysis instead of individual testing of each SNP was introduced in genome-wide association studies to increase the power of gene mapping, especially for rare genetic variants. For regional association tests, the kernel machine-based regression approach was recently proposed as a more powerful alternative to collapsing-based methods. However, the vast majority of existing algorithms and software for the kernel machine-based regression are applicable only to unrelated samples. In this paper, we present a new method for the kernel machine-based regression association analysis of quantitative traits in samples of related individuals. The method is based on the GRAMMAR+ transformation of phenotypes of related individuals, followed by use of existing kernel machine-based regression software for unrelated samples. We compared the performance of kernel-based association analysis on the material of the Genetic Analysis Workshop 17 family sample and real human data by using our transformation, the original untransformed trait, and environmental residuals. We demonstrated that only the GRAMMAR+ transformation produced type I errors close to the nominal value and that this method had the highest empirical power. The new method can be applied to analysis of related samples by using existing software for kernel-based association analysis developed for unrelated samples.	[Belonogova, Nadezhda M.; Svishcheva, Gulnara R.; Aulchenko, Yurii S.; Axenovich, Tatiana I.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia; [van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Erasmus University Rotterdam; Erasmus MC	Axenovich, TI (corresponding author), Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia.	aks@bionet.nsc.ru	Svishcheva, Gulnara/AAD-2881-2022; Aulchenko, Yurii/M-8270-2013; Axenovich, Tatiana I/AAD-2595-2022	Svishcheva, Gulnara/0000-0001-9478-267X; Aulchenko, Yurii/0000-0002-7899-1575; Axenovich, Tatiana I/0000-0002-4318-4458; Van Duijn, Cornelia/0000-0002-2374-9204	Russian Foundation for Basic Research [11-04-00098-a, 12-04-33182]; Programs of Russian Academy of Sciences and RFBR-Helmholtz Joint Research Groups program [12-04-91322-CHGamma_ a]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Programs of Russian Academy of Sciences and RFBR-Helmholtz Joint Research Groups program	This work was supported by grants from the Russian Foundation for Basic Research (11-04-00098-a, 12-04-33182), Programs of Russian Academy of Sciences and RFBR-Helmholtz Joint Research Groups program (12-04-91322-CH Gamma_ a). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abney M, 2002, AM J HUM GENET, V70, P920, DOI 10.1086/339705; Almasy L, 2011, BMC P S9; Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2009, EUR J HUM GENET, V17, P1070, DOI 10.1038/ejhg.2009.5; Beyene J, 2009, GENET EPIDEMIOL, V33, pS105, DOI 10.1002/gepi.20481; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Gao QS, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-75; Gianola D, 2008, GENETICS, V178, P2289, DOI 10.1534/genetics.107.084285; Kwee LC, 2008, AM J HUM GENET, V82, P386, DOI 10.1016/j.ajhg.2007.10.010; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li Lun, 2011, BMC Proc, V5 Suppl 9, pS117, DOI 10.1186/1753-6561-5-S9-S117; Liu D, 2007, BIOMETRICS, V63, P1079, DOI 10.1111/j.1541-0420.2007.00799.x; Liu DW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-292; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Pardo LM, 2005, ANN HUM GENET, V69, P288, DOI 10.1046/j.1529-8817.2005.00162.x; Perola M, 2011, BEST PRACT RES CL EN, V25, P19, DOI 10.1016/j.beem.2010.10.013; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Schifano ED, 2012, GENET EPIDEMIOL, DOI [10.1002/gepi.21676, DOI 10.1002/GEPI.21676.[]; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Svishcheva GR, 2012, NAT GENET, V44, P1166, DOI 10.1038/ng.2410; Vineis P, 2010, NAT REV GENET, V11, DOI 10.1038/nrg2809-c2; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Zhang DW, 2003, BIOSTATISTICS, V4, P57, DOI 10.1093/biostatistics/4.1.57; Zhang Qunyuan, 2011, BMC Proc, V5 Suppl 9, pS35, DOI 10.1186/1753-6561-5-S9-S35; Zhu HJ, 2012, BIOINFORMATICS, V28, pI375, DOI 10.1093/bioinformatics/bts406	34	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65395	10.1371/journal.pone.0065395	http://dx.doi.org/10.1371/journal.pone.0065395			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799013	Green Published, Green Submitted, gold			2022-12-25	WOS:000321397800005
J	Gatschenberger, H; Azzami, K; Tautz, J; Beier, H				Gaetschenberger, Heike; Azzami, Klara; Tautz, Juergen; Beier, Hildburg			Antibacterial Immune Competence of Honey Bees (Apis mellifera) Is Adapted to Different Life Stages and Environmental Risks	PLOS ONE			English	Article							PAENIBACILLUS-LARVAE; DEVELOPMENTAL-STAGES; BACTERIAL-INFECTION; AMERICAN FOULBROOD; DEFENSE-MECHANISMS; INSECT IMMUNITY; PARALYSIS VIRUS; PROTEINS; PEPTIDE; GENES	The development of all honey bee castes proceeds through three different life stages all of which encounter microbial infections to a various extent. We have examined the immune strength of honey bees across all developmental stages with emphasis on the temporal expression of cellular and humoral immune responses upon artificial challenge with viable Escherichia coli bacteria. We employed a broad array of methods to investigate defence strategies of infected individuals: (a) fate of bacteria in the haemocoel; (b) nodule formation and (c) induction of antimicrobial peptides (AMPs). Newly emerged adult worker bees and drones were able to activate efficiently all examined immune reactions. The number of viable bacteria circulating in the haemocoel of infected bees declined rapidly by more than two orders of magnitude within the first 4-6 h post-injection (p.i.), coinciding with the occurrence of melanised nodules. Antimicrobial activity, on the other hand, became detectable only after the initial bacterial clearance. These two temporal patterns of defence reactions very likely represent the constitutive cellular and the induced humoral immune response. A unique feature of honey bees is that a fraction of worker bees survives the winter season in a cluster mostly engaged in thermoregulation. We show here that the overall immune strength of winter bees matches that of young summer bees although nodulation reactions are not initiated at all. As expected, high doses of injected viable E. coli bacteria caused no mortality in larvae or adults of each age. However, drone and worker pupae succumbed to challenge with E. coli even at low doses, accompanied by a premature darkening of the pupal body. In contrast to larvae and adults, we observed no fast clearance of viable bacteria and no induction of AMPs but a rapid proliferation of E. coli bacteria in the haemocoel of bee pupae ultimately leading to their death.	[Gaetschenberger, Heike; Azzami, Klara; Tautz, Juergen; Beier, Hildburg] Univ Wurzburg, BEEgrp, Bioctr, D-97070 Wurzburg, Germany	University of Wurzburg	Beier, H (corresponding author), Univ Wurzburg, BEEgrp, Bioctr, D-97070 Wurzburg, Germany.	h.beier@biozentrum.uni-wuerzburg.de			Bundesministerium fur Bildung und Forschung, BMBF [FKZ 0315125B]; Deutsche Forschungsgemeinschaft [SFB 567, Part A9]	Bundesministerium fur Bildung und Forschung, BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This project was financially supported by Bundesministerium fur Bildung und Forschung, BMBF, FKZ 0315125B (Fugapis) to JT and HG and by a grant from the "Deutsche Forschungsgemeinschaft'', SFB 567, Part A9 to HB, JT, KA and HG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert S, 2011, INSECT BIOCHEM MOLEC, V41, P968, DOI 10.1016/j.ibmb.2011.09.006; Aumeier P, 2001, APIDOLOGIE, V32, P491; Azzami K, 2009, APIDOLOGIE, V40, P660; Azzami K, 2012, ARCH VIROL, V157, P689, DOI 10.1007/s00705-012-1223-0; BAMRICK JF, 1961, J INSECT PATHOL, V3, P381; Barchuk AR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-70; Becher MA, 2009, J COMP PHYSIOL A, V195, P673, DOI 10.1007/s00359-009-0442-7; Bedick JC, 2001, COMP BIOCHEM PHYS C, V130, P107, DOI 10.1016/S1532-0456(01)00226-5; Behrends A, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00015; Bilikova K, 2001, APIDOLOGIE, V32, P275, DOI 10.1051/apido:2001129; BOMAN HG, 1974, INFECT IMMUN, V10, P136, DOI 10.1128/IAI.10.1.136-145.1974; Brodsgaard CJ, 1998, APIDOLOGIE, V29, P569, DOI 10.1051/apido:19980609; Bujok B, 2002, NATURWISSENSCHAFTEN, V89, P299, DOI 10.1007/s00114-002-0338-7; CASTEELS P, 1989, EMBO J, V8, P2387, DOI 10.1002/j.1460-2075.1989.tb08368.x; CASTEELS P, 1990, EUR J BIOCHEM, V187, P381, DOI 10.1111/j.1432-1033.1990.tb15315.x; CASTEELS P, 1993, J BIOL CHEM, V268, P7044; CASTEELSJOSSON K, 1994, J BIOL CHEM, V269, P28569; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Doums C, 2002, ECOL ENTOMOL, V27, P138, DOI 10.1046/j.1365-2311.2002.00388.x; DUNN PE, 1983, J INVERTEBR PATHOL, V41, P77, DOI 10.1016/0022-2011(83)90238-0; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2004, J INVERTEBR PATHOL, V85, P105, DOI 10.1016/j.jip.2004.02.004; FAYE I, 1975, INFECT IMMUN, V12, P1426, DOI 10.1128/IAI.12.6.1426-1438.1975; Fedorova AA, 2011, ANTIVIR RES, V91, P267, DOI 10.1016/j.antiviral.2011.06.011; FLURI P, 1977, EXPERIENTIA, V33, P1240, DOI 10.1007/BF01922354; Fluri P, 1993, SCHWEIZ BIENENZEIT, V116, P624; Fujita T, 2013, J PROTEOME RES, V12, P404, DOI 10.1021/pr300700e; FUJIWARA S, 1990, J BIOL CHEM, V265, P11333; Gaetschenberger H, 2012, J EXP BIOL, V215, P1313, DOI 10.1242/jeb.065276; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; GILLIAM M, 1987, J INVERTEBR PATHOL, V49, P70, DOI 10.1016/0022-2011(87)90127-3; Gregory PG, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.7; Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265; Haine ER, 2008, J INSECT PHYSIOL, V54, P1090, DOI 10.1016/j.jinsphys.2008.04.013; HOROHOV DW, 1983, J INVERTEBR PATHOL, V41, P203, DOI 10.1016/0022-2011(83)90220-3; Hrassnigg N, 2005, APIDOLOGIE, V36, P255, DOI 10.1051/apido:2005015; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Huszart T, 2008, ADV VIRUS RES, V72, P227, DOI 10.1016/S0065-3527(08)00406-5; Ivanova E., 2007, J CELL MOL BIOL, V6, P129; JAY S. CAMERON, 1962, BEE WORLD, V43, P119; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; Kanbar G, 2003, PARASITOL RES, V90, P349, DOI 10.1007/s00436-003-0827-4; Klaudiny J, 2005, INSECT BIOCHEM MOLEC, V35, P11, DOI 10.1016/j.ibmb.2004.09.007; Korner P, 2004, J INVERTEBR PATHOL, V87, P59, DOI 10.1016/j.jip.2004.07.004; Kralj J, 2007, J COMP PHYSIOL A, V193, P363, DOI 10.1007/s00359-006-0192-8; Kraus FB, 2003, J EVOLUTION BIOL, V16, P914, DOI 10.1046/j.1420-9101.2003.00593.x; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laughton AM, 2011, J INSECT PHYSIOL, V57, P1023, DOI 10.1016/j.jinsphys.2011.04.020; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; MICHELETTE ERD, 1993, APIDOLOGIE, V24, P431, DOI 10.1051/apido:19930410; Moret Y, 2001, NATURE, V414, P506, DOI 10.1038/35107138; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; Munch D, 2008, FUNCT ECOL, V22, P407, DOI 10.1111/j.1365-2435.2008.01419.x; Page RE, 2001, EXP GERONTOL, V36, P695, DOI 10.1016/S0531-5565(00)00236-9; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; Randolt K, 2008, ARCH INSECT BIOCHEM, V69, P155, DOI 10.1002/arch.20269; REMBOLD H, 1980, APIDOLOGIE, V11, P29, DOI 10.1051/apido:19800104; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schluns H, 2007, INSECT MOL BIOL, V16, P753, DOI 10.1111/j.1365-2583.2007.00768.x; Schmid MR, 2008, J INSECT PHYSIOL, V54, P439, DOI 10.1016/j.jinsphys.2007.11.002; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Seeley TD, 1985, HONEYBEE ECOLOGY STU; Siede R, 2012, J APICULT RES, V51, P320, DOI 10.3896/IBRA.1.51.4.05; Stabentheiner A, 2003, J EXP BIOL, V206, P353, DOI 10.1242/jeb.00082; Stanley D, 2011, J APPL ENTOMOL, V135, P534, DOI 10.1111/j.1439-0418.2010.01612.x; Stanley DW, 2006, ENTOMOL EXP APPL, V119, P1, DOI 10.1111/j.1570-7458.2006.00406.x; STANLEYSAMUELSON DW, 1991, P NATL ACAD SCI USA, V88, P1064, DOI 10.1073/pnas.88.3.1064; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Strand Michael R., 2008, Insect Science, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; Szymas B, 2003, APIDOLOGIE, V34, P97, DOI 10.1051/apido:2003012; Tautz J, 2003, P NATL ACAD SCI USA, V100, P7343, DOI 10.1073/pnas.1232346100; Tautz J, 2008, BUZZ BEES; Trenczek T, 1998, ZOOL-ANAL COMPLEX SY, V101, P298; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wheeler DE, 2006, INSECT MOL BIOL, V15, P597, DOI 10.1111/j.1365-2583.2006.00681.x; Wilson-Rich N, 2008, J INSECT PHYSIOL, V54, P1392, DOI 10.1016/j.jinsphys.2008.07.016; Winston M.L., 1991, BIOL HONEY BEE; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; Yue D, 2008, ENVIRON MICROBIOL, V10, P1612, DOI 10.1111/j.1462-2920.2008.01579.x	83	62	63	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66415	10.1371/journal.pone.0066415	http://dx.doi.org/10.1371/journal.pone.0066415			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799099	Green Published, gold, Green Submitted			2022-12-25	WOS:000321397800031
J	Yang, WP; Li, Q; Ochi, T; Yang, JJ; Gao, YL; Tang, XY; Takahashi, S; Wu, JL				Yang, Weiping; Li, Qi; Ochi, Tatsuya; Yang, Jingjing; Gao, Yulin; Tang, Xiaoyu; Takahashi, Satoshi; Wu, Jinglong			Effects of Auditory Stimuli in the Horizontal Plane on Audiovisual Integration: An Event-Related Potential Study	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; VISUAL INTERACTIONS; SELECTIVE ATTENTION; SPEECH-PERCEPTION; HUMANS; CORTEX; SOUND; ACTIVATION; DYNAMICS; SIGNALS	This article aims to investigate whether auditory stimuli in the horizontal plane, particularly originating from behind the participant, affect audiovisual integration by using behavioral and event-related potential (ERP) measurements. In this study, visual stimuli were presented directly in front of the participants, auditory stimuli were presented at one location in an equidistant horizontal plane at the front (0 degrees, the fixation point), right (90 degrees), back (180 degrees), or left (270 degrees) of the participants, and audiovisual stimuli that include both visual stimuli and auditory stimuli originating from one of the four locations were simultaneously presented. These stimuli were presented randomly with equal probability; during this time, participants were asked to attend to the visual stimulus and respond promptly only to visual target stimuli (a unimodal visual target stimulus and the visual target of the audiovisual stimulus). A significant facilitation of reaction times and hit rates was obtained following audiovisual stimulation, irrespective of whether the auditory stimuli were presented in the front or back of the participant. However, no significant interactions were found between visual stimuli and auditory stimuli from the right or left. Two main ERP components related to audiovisual integration were found: first, auditory stimuli from the front location produced an ERP reaction over the right temporal area and right occipital area at approximately 160-200 milliseconds; second, auditory stimuli from the back produced a reaction over the parietal and occipital areas at approximately 360-400 milliseconds. Our results confirmed that audiovisual integration was also elicited, even though auditory stimuli were presented behind the participant, but no integration occurred when auditory stimuli were presented in the right or left spaces, suggesting that the human brain might be particularly sensitive to information received from behind than both sides.	[Yang, Weiping; Ochi, Tatsuya; Yang, Jingjing; Gao, Yulin; Tang, Xiaoyu; Takahashi, Satoshi; Wu, Jinglong] Okayama Univ, Biomed Engn Lab, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Li, Qi] Changchun Univ Sci & Technol, Sch Comp Sci & Technol, Changchun, Peoples R China	Okayama University; Changchun University of Science & Technology	Wu, JL (corresponding author), Okayama Univ, Biomed Engn Lab, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan.	wu@mech.okayama-u.ac.jp	Takahashi, Satoshi/ABG-8262-2021; Yang, Wei/HIA-0360-2022	Takahashi, Satoshi/0000-0002-3535-1535; Yang, Weiping/0000-0001-8839-2173	National Natural Science Foundation of China [61203362]; JSPS; VINNOVA under the Japan-Sweden Research Cooperative Program; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry;  [25303013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); VINNOVA under the Japan-Sweden Research Cooperative Program; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); 	A part of this work was supported by the Grant-in-Aid for Scientific Research (B) 25303013 and JSPS and VINNOVA under the Japan-Sweden Research Cooperative Program. A part of the study was also financially supported by the National Natural Science Foundation of China (61203362) and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTH DS, 1995, BRAIN RES, V678, P177, DOI 10.1016/0006-8993(95)00182-P; Bernstein LE, 2008, NEUROIMAGE, V39, P423, DOI 10.1016/j.neuroimage.2007.08.035; Berryhill M, 2007, PERCEPT PSYCHOPHYS, V69, P628, DOI 10.3758/BF03193920; Besle J, 2004, EUR J NEUROSCI, V20, P2225, DOI 10.1111/j.1460-9568.2004.03670.x; Besle J, 2004, COGN PROCESS, V5, P189, DOI DOI 10.1007/S10339-004-0026-Y; Callan A, 2013, NEUROIMAGE, V66, P22, DOI 10.1016/j.neuroimage.2012.10.057; Colonius H, 2009, BRAIN TOPOGR, V21, P177, DOI 10.1007/s10548-009-0091-8; Fort A, 2002, COGNITIVE BRAIN RES, V14, P20, DOI 10.1016/S0926-6410(02)00058-7; Fort A, 2002, CEREB CORTEX, V12, P1031, DOI 10.1093/cercor/12.10.1031; Frassinetti F, 2002, EXP BRAIN RES, V147, P332, DOI 10.1007/s00221-002-1262-y; FRENS MA, 1995, PERCEPT PSYCHOPHYS, V57, P802, DOI 10.3758/BF03206796; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Gondan M, 2005, PERCEPT PSYCHOPHYS, V67, P713, DOI 10.3758/BF03193527; Harrington LK, 1998, EXP BRAIN RES, V122, P247, DOI 10.1007/s002210050512; Jones JA, 2006, EXP BRAIN RES, V174, P588, DOI 10.1007/s00221-006-0634-0; Koelewijn T, 2010, ACTA PSYCHOL, V134, P372, DOI 10.1016/j.actpsy.2010.03.010; Lewald J, 2003, COGNITIVE BRAIN RES, V16, P468, DOI 10.1016/S0926-6410(03)00074-0; Li Q, 2010, NEUROREPORT, V21, P173, DOI 10.1097/WNR.0b013e3283345f08; Lippert M, 2007, BRAIN RES, V1173, P102, DOI 10.1016/j.brainres.2007.07.050; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; MILLER J, 1986, ATTEN PERCEPT PSYCHO, V40, P331, DOI DOI 10.3758/BF03203025; Miller LM, 2005, J NEUROSCI, V25, P5884, DOI 10.1523/JNEUROSCI.0896-05.2005; Molholm S, 2002, COGNITIVE BRAIN RES, V14, P115, DOI 10.1016/S0926-6410(02)00066-6; Morimoto M, 2001, J ACOUST SOC AM, V109, P1596, DOI 10.1121/1.1352084; MUSICANT AD, 1984, J ACOUST SOC AM, V75, P1195, DOI 10.1121/1.390770; PAULESU E, 1995, BRAIN, V118, P661, DOI 10.1093/brain/118.3.661; Raij T, 2000, NEURON, V28, P617, DOI 10.1016/S0896-6273(00)00138-0; RUGG MD, 1995, J COGNITIVE NEUROSCI, V7, P209, DOI 10.1162/jocn.1995.7.2.209; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; Stein BE, 1993, J COGNITIVE NEUROSCI, V5, P373; Stevenson RA, 2012, EXP BRAIN RES, V219, P121, DOI 10.1007/s00221-012-3072-1; Stevenson RA, 2010, NEUROIMAGE, V49, P3308, DOI 10.1016/j.neuroimage.2009.12.001; Talsma D, 2005, J COGNITIVE NEUROSCI, V17, P1098, DOI 10.1162/0898929054475172; Talsma D, 2007, CEREB CORTEX, V17, P679, DOI 10.1093/cercor/bhk016; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; Teder-Salejarvi WA, 2005, J COGNITIVE NEUROSCI, V17, P1396, DOI 10.1162/0898929054985383; Teder-Salejarvi WA, 2002, COGNITIVE BRAIN RES, V14, P106, DOI 10.1016/S0926-6410(02)00065-4; Tuomainen J, 2005, COGNITION, V96, pB13, DOI 10.1016/j.cognition.2004.10.004; Turatto M, 2005, COGNITION, V96, pB55, DOI 10.1016/j.cognition.2004.12.001; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; WIGHTMAN FL, 1995, PERCEPTION SPACE MOT, P365; Woldorff MG, 1999, HUM BRAIN MAPP, V7, P49, DOI 10.1002/(SICI)1097-0193(1999)7:1<49::AID-HBM5>3.3.CO;2-A; Wu JL, 2009, J CLIN NEUROPHYSIOL, V26, P407, DOI 10.1097/WNP.0b013e3181c298b1; Wyk BCV, 2010, BRAIN COGNITION, V74, P97, DOI 10.1016/j.bandc.2010.07.002; Zampini M, 2007, NEUROPSYCHOLOGIA, V45, P1869, DOI 10.1016/j.neuropsychologia.2006.12.004	47	11	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66402	10.1371/journal.pone.0066402	http://dx.doi.org/10.1371/journal.pone.0066402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799097	gold, Green Published, Green Submitted			2022-12-25	WOS:000321397800029
J	Barrs, VR; van Doorn, TM; Houbraken, J; Kidd, SE; Martin, P; Pinheiro, MD; Richardson, M; Varga, J; Samson, RA				Barrs, Vanessa R.; van Doorn, Tineke M.; Houbraken, Jos; Kidd, Sarah E.; Martin, Patricia; Pinheiro, Maria Dolores; Richardson, Malcolm; Varga, Janos; Samson, Robert A.			Aspergillus felis sp nov., an Emerging Agent of Invasive Aspergillosis in Humans, Cats, and Dogs	PLOS ONE			English	Article							EPIDEMIOLOGIC CUTOFF VALUES; SPECIES RECOGNITION; POLYPHASIC TAXONOMY; MIC DISTRIBUTIONS; SECTION FUMIGATI; INFECTIONS; UDAGAWAE; LENTULUS; PATIENT	We describe a novel heterothallic species in Aspergillus section Fumigati, namely A. felis (neosartorya-morph) isolated from three host species with invasive aspergillosis including a human patient with chronic invasive pulmonary aspergillosis, domestic cats with invasive fungal rhinosinusitis and a dog with disseminated invasive aspergillosis. Disease in all host species was often refractory to aggressive antifungal therapeutic regimens. Four other human isolates previously reported as A. viridinutans were identified as A. felis on comparative sequence analysis of the partial beta-tubulin and/or calmodulin genes. A. felis is a heterothallic mold with a fully functioning reproductive cycle, as confirmed by mating-type analysis, induction of teleomorphs within 7 to 10 days in vitro and ascospore germination. Phenotypic analyses show that A. felis can be distinguished from the related species A. viridinutans by its ability to grow at 45 degrees C and from A. fumigatus by its inability to grow at 50 degrees C. Itraconazole and voriconazole cross-resistance was common in vitro.	[Barrs, Vanessa R.; Martin, Patricia] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [van Doorn, Tineke M.; Houbraken, Jos; Samson, Robert A.] Cent Bur Schimmelcultures Koninklijke Nederlandse, Dept Appl & Ind Mycol, Utrecht, Netherlands; [Kidd, Sarah E.] Womens & Childrens Hosp, Mycol Unit, SA Pathol, Adelaide, SA, Australia; [Pinheiro, Maria Dolores] Hosp Sao Joao, Microbiol Lab, Serv Clin Pathol, Oporto, Portugal; [Richardson, Malcolm] Univ S Manchester Hosp, Educ & Res Ctr, Mycol Reference Ctr Manchester, Manchester M20 8LR, Lancs, England; [Richardson, Malcolm] Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Varga, Janos] Univ Szeged, Fac Sci, Dept Microbiol, Szeged, Hungary	University of Sydney; SA Pathology; Sao Joao Hospital; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; Szeged University	Barrs, VR (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	vanessa.barrs@sydney.edu.au	Kidd, Sarah E./A-1731-2009; Houbraken, Jos/AAE-7955-2019; Samson, Robert/ABE-6704-2020; Barrs, Vanessa/K-3755-2012	Kidd, Sarah E./0000-0002-5957-4178; Houbraken, Jos/0000-0003-4893-4438; Barrs, Vanessa/0000-0001-6761-8022; Richardson, Malcolm/0000-0001-5672-9552; Pinheiro, Dolores/0000-0002-5525-0213; Samson, Robert A./0000-0002-2979-3097	Endeavour Research Fellowship; Australian Government; Australian Companion Animal Health Foundation; Centraalbureau voor Schimmelcultures-Koninklijke Nederlandse Akademie van Wetenschappen (CBS-KNAW) Fungal Biodiversity Centre, Utrecht, The Netherlands	Endeavour Research Fellowship; Australian Government(Australian GovernmentCGIAR); Australian Companion Animal Health Foundation; Centraalbureau voor Schimmelcultures-Koninklijke Nederlandse Akademie van Wetenschappen (CBS-KNAW) Fungal Biodiversity Centre, Utrecht, The Netherlands(Netherlands Government)	This study was funded by an Endeavour Research Fellowship awarded by the Australian Government to one of the authors (VRB) (http://www.australiaawards.gov.au/), The Australian Companion Animal Health Foundation and the Centraalbureau voor Schimmelcultures-Koninklijke Nederlandse Akademie van Wetenschappen (CBS-KNAW) Fungal Biodiversity Centre, Utrecht, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar-Fuoli L, 2008, ANTIMICROB AGENTS CH, V52, P1244, DOI 10.1128/AAC.00942-07; Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Balajee SA, 2006, EUKARYOT CELL, V5, P1705, DOI 10.1128/EC.00162-06; Balajee SA, 2005, J CLIN MICROBIOL, V43, P5996, DOI 10.1128/JCM.43.12.5996-5999.2005; Balajee SA, 2005, EUKARYOT CELL, V4, P625, DOI 10.1128/EC.4.3.625-632.2005; Barrs VR, 2012, VET J, V191, P58, DOI 10.1016/j.tvjl.2011.02.009; Castro C, 2004, J CLIN MICROBIOL, V42, P4358, DOI 10.1128/JCM.42.9.4358-4360.2004; Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI, V3rd; Coelho D, 2011, MED MYCOL, V49, P755, DOI 10.3109/13693786.2011.556672; Day MJ, 2009, MED MYCOL, V47, pS315, DOI 10.1080/13693780802056038; Dyer PS, 2011, CURR OPIN MICROBIOL, V14, P649, DOI 10.1016/j.mib.2011.10.001; Espinel-Ingroff A, 2011, ANTIMICROB AGENTS CH, V55, P5150, DOI 10.1128/AAC.00686-11; Espinel-Ingroff A, 2011, ANTIMICROB AGENTS CH, V55, P2855, DOI 10.1128/AAC.01730-10; Garcia-Solache MA, 2010, MBIO, V1, DOI 10.1128/mBio.00061-10; Geiser DM, 2007, STUD MYCOL, P1, DOI 10.3114/sim.2007.59.01; Geiser DM, 1998, MYCOLOGIA, V90, P831, DOI 10.2307/3761325; Giordano C, 2010, J FELINE MED SURG, V12, P714, DOI 10.1016/j.jfms.2010.07.015; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Hawksworth DL, 2011, IMA FUNGUS, V2, P105, DOI 10.5598/imafungus.2011.02.01.14; Hong SB, 2005, MYCOLOGIA, V97, P1316, DOI 10.3852/mycologia.97.6.1316; Houbraken J, 2011, STUD MYCOL, P1, DOI 10.3114/sim.2011.70.01; Kano R, 2013, J VET MED SCI, V75, P7, DOI 10.1292/jvms.12-0119; Katz ME, 2005, J CLIN MICROBIOL, V43, P551, DOI 10.1128/JCM.43.2.551-555.2005; Lass-Florl C, 2005, BRIT J HAEMATOL, V131, P201, DOI 10.1111/j.1365-2141.2005.05763.x; Montenegro G, 2009, J MED MICROBIOL, V58, P391, DOI 10.1099/jmm.0.005942-0; Nei M., 2000, MOL EVOLUTION PHYLOG; Norvell LL, 2011, MYCOTAXON, V116, P481, DOI 10.5248/116.481; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Pelaez T, 2013, J MED MICROBIOL, V62, P474, DOI 10.1099/jmm.0.044867-0; Pfaller MA, 2009, J CLIN MICROBIOL, V47, P3142, DOI 10.1128/JCM.00940-09; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Samson RA, 2007, STUD MYCOL, P147, DOI 10.3114/sim.2007.59.14; Samson R. A., 2010, CBS LAB MANUAL SERIE, V2; Sugui JA, 2010, J CLIN MICROBIOL, V48, P220, DOI 10.1128/JCM.01556-09; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Van Der Linden JWM, 2011, MED MYCOL, V49, pS82, DOI 10.3109/13693786.2010.499916; Vinh DC, 2009, CLIN INFECT DIS, V49, P102, DOI 10.1086/599345; Vinh DC, 2009, EMERG INFECT DIS, V15, P1292, DOI 10.3201/eid1508.090251; Yaguchi Takashi, 2007, Nihon Ishinkin Gakkai Zasshi, V48, P37, DOI 10.3314/jjmm.48.37	40	74	75	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e64871	10.1371/journal.pone.0064871	http://dx.doi.org/10.1371/journal.pone.0064871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23798996	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300005
J	McGahon, MK; Yarham, JM; Daly, A; Guduric-Fuchs, J; Ferguson, LJ; Simpson, DA; Collins, A				McGahon, Mary K.; Yarham, Janet M.; Daly, Aideen; Guduric-Fuchs, Jasenka; Ferguson, Lyndsey J.; Simpson, David A.; Collins, Anthony			Distinctive Profile of IsomiR Expression and Novel MicroRNAs in Rat Heart Left Ventricle	PLOS ONE			English	Article							TRANSIENT OUTWARD CURRENT; MICROVASCULAR ENDOTHELIAL-CELLS; CARDIAC-HYPERTROPHY; MYOCARDIAL-INFARCTION; TRANSMURAL HETEROGENEITY; REGIONAL DIFFERENCES; CANINE VENTRICLE; ANGIOTENSIN-II; ELECTRICAL HETEROGENEITY; DIFFERENTIAL EXPRESSION	MicroRNAs (miRNAs) are single-stranded non-coding RNAs that negatively regulate target gene expression through mRNA cleavage or translational repression. There is mounting evidence that they play critical roles in heart disease. The expression of known miRNAs in the heart has been studied at length by microarray and quantitative PCR but it is becoming evident that microRNA isoforms (isomiRs) are potentially physiologically important. It is well known that left ventricular (patho)physiology is influenced by transmural heterogeneity of cardiomyocyte phenotype, and this likely reflects underlying heterogeneity of gene expression. Given the significant role of miRNAs in regulating gene expression, knowledge of how the miRNA profile varies across the ventricular wall will be crucial to better understand the mechanisms governing transmural physiological heterogeneity. To determinine miRNA/isomiR expression profiles in the rat heart we investigated tissue from different locations across the left ventricular wall using deep sequencing. We detected significant quantities of 145 known rat miRNAs and 68 potential novel orthologs of known miRNAs, in mature, mature* and isomiR formation. Many isomiRs were detected at a higher frequency than their canonical sequence in miRBase and have different predicted targets. The most common miR-133a isomiR was more effective at targeting a construct containing a sequence from the gelsolin gene than was canonical miR-133a, as determined by dual-fluorescence assay. We identified a novel rat miR-1 homolog from a second miR-1 gene; and a novel rat miRNA similar to miR-676. We also cloned and sequenced the rat miR-486 gene which is not in miRBase (v18). Signalling pathways predicted to be targeted by the most highly detected miRNAs include Ubiquitin-mediated Proteolysis, Mitogen-Activated Protein Kinase, Regulation of Actin Cytoskeleton, Wnt signalling, Calcium Signalling, Gap junctions and Arrhythmogenic Right Ventricular Cardiomyopathy. Most miRNAs are not expressed in a gradient across the ventricular wall, with exceptions including miR-10b, miR-21, miR-99b and miR-486.	[McGahon, Mary K.; Yarham, Janet M.; Daly, Aideen; Guduric-Fuchs, Jasenka; Ferguson, Lyndsey J.; Simpson, David A.; Collins, Anthony] Queens Univ Belfast, Ctr Vis & Vasc Sci, Belfast, Antrim, North Ireland	Queens University Belfast	Collins, A (corresponding author), Queens Univ Belfast, Ctr Vis & Vasc Sci, Belfast, Antrim, North Ireland.	anthony.collins@qub.ac.uk	Daly, Aideen/AAF-3537-2021	Daly, Aideen/0000-0001-5003-9630; Simpson, David/0000-0003-0157-1211	British Heart Foundation (BHF) [PG110/039/28365]; Biotechnology and Biological Sciences Research Council (BBSRC [BB/H005498/1]; Science Foundation Ireland; Trinity Centre for High Performance Computing; BBSRC [BB/H005498/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H005498/1] Funding Source: researchfish; British Heart Foundation [PG/10/39/28365] Funding Source: researchfish	British Heart Foundation (BHF)(British Heart Foundation); Biotechnology and Biological Sciences Research Council (BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Trinity Centre for High Performance Computing; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	This research was partly supported by a British Heart Foundation (BHF; http://www.bhf.org.uk) grant to AC (PI) and DAS (Co-I) (PG110/039/28365); and partly supported by a Biotechnology and Biological Sciences Research Council (BBSRC; http://www.bbsrc.ac.uk) grant to DAS (BB/H005498/1). The Trinity Genome Sequencing Laboratory is a core facility funded by Science Foundation Ireland and supported by the Trinity Centre for High Performance Computing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bierhuizen MFA, 2008, J MOL CELL CARDIOL, V45, P373, DOI 10.1016/j.yjmcc.2008.06.011; Bostjancic E, 2010, CARDIOLOGY, V115, P163, DOI 10.1159/000268088; Bryant SM, 1997, CARDIOVASC RES, V35, P315, DOI 10.1016/S0008-6363(97)00111-9; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P4586, DOI 10.1073/pnas.072647999; Busk PK, 2010, BIOCHEM BIOPH RES CO, V396, P989, DOI 10.1016/j.bbrc.2010.05.039; Cardin S, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1027, DOI 10.1161/CIRCEP.112.973214; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Carrillo ED, 2011, J CARDIOVASC PHARM, V58, P470, DOI 10.1097/FJC.0b013e31822a789b; Castoldi G, 2012, J CELL PHYSIOL, V227, P850, DOI 10.1002/jcp.22939; Chan YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058169; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Cheng YH, 2010, CARDIOVASC RES, V87, P431, DOI 10.1093/cvr/cvq082; Chinchilla A, 2011, CARDIOVASC RES, V89, P98, DOI 10.1093/cvr/cvq264; CLARK RB, 1993, CARDIOVASC RES, V27, P1795, DOI 10.1093/cvr/27.10.1795; Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126; Cordeiro JM, 2008, AM J PHYSIOL-HEART C, V295, pH154, DOI 10.1152/ajpheart.01327.2007; Cordeiro JM, 2004, AM J PHYSIOL-HEART C, V286, pH1471, DOI 10.1152/ajpheart.00748.2003; Costantini DL, 2005, CELL, V123, P347, DOI 10.1016/j.cell.2005.08.004; D'Alessandra Y, 2012, CURR OPIN CARDIOL, V27, P228, DOI 10.1097/HCO.0b013e3283522052; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Da Silva ND, 2012, MED SCI SPORT EXER, V44, P1453, DOI 10.1249/MSS.0b013e31824e8a36; Das S, 2012, CIRC RES, V110, P1596, DOI 10.1161/CIRCRESAHA.112.267732; Dong D, 2003, CARDIOVASC RES, V57, P320, DOI 10.1016/S0008-6363(02)00661-2; Dong SM, 2009, J BIOL CHEM, V284, P29514, DOI 10.1074/jbc.M109.027896; Dosenko VE, 2012, EXP CLIN CARDIOL, V17, P84; Du GW, 2006, FEBS J, V273, P5421, DOI 10.1111/j.1742-4658.2006.05534.x; Duan X, 2012, CARDIOLOGY, V122, P36, DOI 10.1159/000338149; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Fang J, 2012, APOPTOSIS, V17, P410, DOI 10.1007/s10495-011-0683-0; FEDIDA D, 1991, J PHYSIOL-LONDON, V442, P191, DOI 10.1113/jphysiol.1991.sp018789; Fernandes T, 2012, HYPERTENSION, V59, P513, DOI 10.1161/HYPERTENSIONAHA.111.185801; Fernandes T, 2011, HYPERTENSION, V58, P182, DOI 10.1161/HYPERTENSIONAHA.110.168252; Frank D, 2012, J MOL CELL CARDIOL, V52, P711, DOI 10.1016/j.yjmcc.2011.12.001; Fu J, 2012, ENVIRON TOXICOL PHAR, V33, P312, DOI 10.1016/j.etap.2011.12.023; Fu MG, 1999, HEART VESSELS, V14, P283, DOI 10.1007/BF03257240; FURUKAWA T, 1990, CIRC RES, V67, P1287, DOI 10.1161/01.RES.67.5.1287; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Ge YZ, 2013, BBA-MOL BASIS DIS, V1832, P1, DOI 10.1016/j.bbadis.2012.09.004; Giunta Simona, 2009, Acta Biomed, V80, P187; Gladka MM, 2012, J MOL CELL CARDIOL, V52, P74, DOI 10.1016/j.yjmcc.2011.09.015; Glukhov AV, 2010, CIRC RES, V106, P981, DOI 10.1161/CIRCRESAHA.109.204891; Glukhov AV, CIRC RES, V106, P981; Goldoni D, 2012, BIOCHEM J, V448, P103, DOI 10.1042/BJ20120578; Gong NL, 2006, J BIOL CHEM, V281, P38498, DOI 10.1074/jbc.M607774200; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grubb S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00118; Guduric-Fuchs J, 2012, J CELL BIOCHEM, V113, P2098, DOI 10.1002/jcb.24084; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Han BW, 2011, CURR BIOL, V21, P1878, DOI 10.1016/j.cub.2011.09.034; Hatcher CJ, 2000, DEV DYNAM, V219, P90, DOI 10.1002/1097-0177(200009)219:1<90::AID-DVDY1033>3.0.CO;2-L; He B, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-22; He W, 2009, CARDIOVASC RES, V81, P64, DOI 10.1093/cvr/cvn259; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Honen BN, 2002, CLIN EXP PHARMACOL P, V29, P161, DOI 10.1046/j.1440-1681.2002.03620.x; Hou YL, 2012, MED SCI MONITOR, V18, pBR309, DOI 10.12659/MSM.883263; Humphreys DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030933; Katanosaka Y, 2005, J BIOL CHEM, V280, P5764, DOI 10.1074/jbc.M410240200; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Kumarswamy R, 2012, EUR HEART J, V33, P1067, DOI 10.1093/eurheartj/ehs043; Kumarswamy R, 2012, ARTERIOSCL THROM VAS, V32, P361, DOI 10.1161/ATVBAHA.111.234286; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Laurita KR, 2003, CIRC RES, V92, P668, DOI 10.1161/01.RES.0000062468.25308.27; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Li GH, 2009, CIRC RES, V104, P896, DOI 10.1161/CIRCRESAHA.108.172882; Li Q, 2010, J CELL SCI, V123, P2444, DOI 10.1242/jcs.067165; Li RT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044907; Li SC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S13; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Linsen SEV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-249; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; LITOVSKY SH, 1988, CIRC RES, V62, P116, DOI 10.1161/01.RES.62.1.116; LIU DW, 1995, CIRC RES, V76, P351, DOI 10.1161/01.RES.76.3.351; Liu HB, 2010, TRENDS CARDIOVAS MED, V20, P148, DOI 10.1016/j.tcm.2010.12.003; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019139; Liu N, 2011, CURR BIOL, V21, P1888, DOI 10.1016/j.cub.2011.10.006; Llorens F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-104; MacDonnell SM, 2009, CIRC RES, V105, P316, DOI 10.1161/CIRCRESAHA.109.194035; Maier LS, 2011, HEART RHYTHM, V8, P474, DOI 10.1016/j.hrthm.2010.09.080; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Marti E, 2010, NUCLEIC ACIDS RES, V38, P7219, DOI 10.1093/nar/gkq575; Matkovich SJ, 2010, CIRC RES, V106, P166, DOI 10.1161/CIRCRESAHA.109.202176; Matkovich SJ, 2009, CIRCULATION, V119, P1263, DOI 10.1161/CIRCULATIONAHA.108.813576; Mishra PK, 2010, CELL BIOCHEM BIOPHYS, V57, P67, DOI 10.1007/s12013-010-9084-1; Montgomery RL, 2011, CIRCULATION, V124, P1537, DOI 10.1161/CIRCULATIONAHA.111.030932; Mukhopadhyay P, 2012, J CELL MOL MED, V16, P2504, DOI 10.1111/j.1582-4934.2011.01480.x; Mukhopadhyay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015705; Munch G, 2002, J MOL CELL CARDIOL, V34, P321, DOI 10.1006/jmcc.2001.1515; Nabauer M, 1996, CIRCULATION, V93, P168, DOI 10.1161/01.CIR.93.1.168; Nishi H, 2010, J BIOL CHEM, V285, P4920, DOI 10.1074/jbc.M109.082610; Ohanian M, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-18; Pan ZW, 2012, CIRCULATION, V126, P840, DOI 10.1161/CIRCULATIONAHA.112.094524; Pan ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032571; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poelzing S, 2004, AM J PHYSIOL-HEART C, V286, pH2001, DOI 10.1152/ajpheart.00987.2003; Portbury AL, 2012, J MOL CELL CARDIOL, V52, P526, DOI 10.1016/j.yjmcc.2011.10.023; Prasad AM, 2011, AM J PHYSIOL-HEART C, V300, pH173, DOI 10.1152/ajpheart.00841.2010; Qin YJ, 2012, INT J MED SCI, V9, P413, DOI 10.7150/ijms.4514; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Rosati B, 2006, J MOL CELL CARDIOL, V40, P295, DOI 10.1016/j.yjmcc.2005.11.002; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Rossow CF, 2006, CIRC RES, V98, P1306, DOI 10.1161/01.RES.0000222028.92993.10; Sabatel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016979; Schipper MEI, 2008, J HEART LUNG TRANSPL, V27, P1282, DOI 10.1016/j.healun.2008.09.005; Shan HL, 2009, BRIT J PHARMACOL, V158, P1227, DOI 10.1111/j.1476-5381.2009.00377.x; Shan ZX, 2010, FEBS LETT, V584, P3592, DOI 10.1016/j.febslet.2010.07.027; Sharma S, 2012, EMBO MOL MED, V4, P617, DOI 10.1002/emmm.201200234; Shi B, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-11; Shigekawa M, 2007, ANN NY ACAD SCI, V1099, P53, DOI 10.1196/annals.1387.059; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Soltysinska E, 2009, PFLUG ARCH EUR J PHY, V459, P11, DOI 10.1007/s00424-009-0718-3; Song XW, 2010, J CELL PHYSIOL, V225, P437, DOI 10.1002/jcp.22217; Sorefan Karim, 2012, Silence, V3, P4, DOI 10.1186/1758-907X-3-4; Starega-Roslan J, 2011, NUCLEIC ACIDS RES, V39, P257, DOI 10.1093/nar/gkq727; Stelzer JE, 2008, J PHYSIOL-LONDON, V586, P5203, DOI 10.1113/jphysiol.2008.160390; Stones R, 2008, PROG BIOPHYS MOL BIO, V97, P268, DOI 10.1016/j.pbiomolbio.2008.02.010; Sucharov C, 2008, J MOL CELL CARDIOL, V45, P185, DOI 10.1016/j.yjmcc.2008.04.014; Suh JH, 2012, BIOCHEM BIOPH RES CO, V423, P404, DOI 10.1016/j.bbrc.2012.05.138; Szabo G, 2005, PFLUG ARCH EUR J PHY, V450, P307, DOI 10.1007/s00424-005-1445-z; Tan JHC, 2004, EXP PHYSIOL, V89, P237, DOI 10.1113/expphysiol.2003.027052; Tang YH, 2009, INT HEART J, V50, P377, DOI 10.1536/ihj.50.377; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Vacchi-Suzzi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052442; Vacchi-Suzzi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040395; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Voellenkle C, 2012, RNA, V18, P472, DOI 10.1261/rna.027615.111; Waldenstrom A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034653; Wang J, 2012, CELL RES, V22, P516, DOI 10.1038/cr.2011.132; Wang K, 2010, J BIOL CHEM, V285, P11903, DOI 10.1074/jbc.M109.098004; Wang XH, 2009, CLIN EXP PHARMACOL P, V36, P181, DOI 10.1111/j.1440-1681.2008.05057.x; White Michel, 2012, Ther Adv Cardiovasc Dis, V6, P5, DOI 10.1177/1753944711432901; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Xiao J, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-35; Xiong W, 2005, CIRC RES, V97, P207, DOI 10.1161/01.RES.0000175935.08283.27; Xu L, 2012, MOL BIOL REP, V39, P3847, DOI 10.1007/s11033-011-1163-x; Xu L, 2011, MOL CELL BIOCHEM, V352, P239, DOI 10.1007/s11010-011-0759-8; Xu M, 2012, CIRC RES, V111, P837, DOI 10.1161/CIRCRESAHA.112.277418; Xu XD, 2012, J CELL PHYSIOL, V227, P1391, DOI 10.1002/jcp.22852; Yang KC, 2012, J MOL CELL CARDIOL, V53, P101, DOI 10.1016/j.yjmcc.2012.04.012; Yang ZK, 1996, J PHYSIOL-LONDON, V492, P789, DOI 10.1113/jphysiol.1996.sp021346; Zhang Y, 2010, CELL PHYSIOL BIOCHEM, V26, P991, DOI 10.1159/000324012; Zhou HJ, 2012, NUCLEIC ACIDS RES, V40, P5864, DOI 10.1093/nar/gks247; Zhu WL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014736; Zuker M., 1999, RNA BIOCH BIOTECHNOL; Zygmunt AC, 2001, AM J PHYSIOL-HEART C, V281, pH689, DOI 10.1152/ajpheart.2001.281.2.H689; Zygmunt AC, 2000, AM J PHYSIOL-HEART C, V278, pH1671, DOI 10.1152/ajpheart.2000.278.5.H1671	154	27	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65809	10.1371/journal.pone.0065809	http://dx.doi.org/10.1371/journal.pone.0065809			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799049	Green Published, gold, Green Submitted			2022-12-25	WOS:000320363300044
J	Rangel, DE; Marin-Medina, N; Castro, JE; Gonzalez-Mancera, A; Forero-Shelton, M				Rangel, Dilia E.; Marin-Medina, Nathaly; Castro, Jaime E.; Gonzalez-Mancera, Andres; Forero-Shelton, Manu			Observation of Bacterial Type I Pili Extension and Contraction under Fluid Flow	PLOS ONE			English	Article							COLI P-PILI; FIMBRIATED ESCHERICHIA-COLI; URINARY-TRACT INFECTIONS; MUSSEL BYSSAL THREAD; OPTICAL TWEEZERS; MECHANICAL-PROPERTIES; PHYSICAL-PROPERTIES; FORCE SPECTROSCOPY; ADHESION; FIMH	Type I pili are proteinaceous tethers that mediate bacterial adhesion of uropathogenic Escherichia coli to surfaces and are thought to help bacteria resist drag forces imparted by fluid flow via uncoiling of their quaternary structure. Uncoiling and recoiling have been observed in force spectroscopy experiments, but it is not clear if and how this process occurs under fluid flow. Here we developed an assay to study the mechanical properties of pili in a parallel plate flow chamber. We show that pili extend when attached E. coli bacteria are exposed to increasing shear stresses, that pili can help bacteria move against moderate fluid flows, and characterize two dynamic regimes of this displacement. The first regime is consistent with entropic contraction as modeled by a freely jointed chain, and the second with coiling of the quaternary structure of pili. These results confirm that coiling and uncoiling happen under flow but the observed dynamics are different from those reported previously. Using these results and those from previous studies, we review the mechanical properties of pili in the context of other elastic proteins such as the byssal threads of mussels. It has been proposed that the high extensibility of pili may help recruit more pili into tension and lower the force acting on each one by damping changes in force due to fluid flow. Our analysis of the mechanical properties suggests additional functions of pili; in particular, their extensibility may reduce tension by aligning pili with the direction of flow, and the uncoiled state of pili may complement uncoiling in regulating the force of the terminal adhesin.	[Rangel, Dilia E.; Castro, Jaime E.; Gonzalez-Mancera, Andres] Univ Los Andes, Dept Mech Engn, Bogota, Colombia; [Marin-Medina, Nathaly; Forero-Shelton, Manu] Univ Los Andes, Dept Phys, Bogota, Colombia	Universidad de los Andes (Colombia); Universidad de los Andes (Colombia)	Forero-Shelton, M (corresponding author), Univ Los Andes, Dept Phys, Bogota, Colombia.	anforero@uniandes.edu.co		Forero-Shelton, Manu/0000-0002-7989-0311; Gonzalez-Mancera, Andres/0000-0002-0663-2653	Faculty of Sciences (Fondo de Investigaciones); Faculty of Engineering (CIFI)	Faculty of Sciences (Fondo de Investigaciones); Faculty of Engineering (CIFI)	Funding for this project was obtained from two internal research grants of the Faculty of Sciences (Fondo de Investigaciones - DER and NM), one internal research grant of the Faculty of Engineering (CIFI) and an inter-faculties research grant, all of them at Universidad de los Andes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2006, BIOPHYS J, V90, P1521, DOI 10.1529/biophysj.105.074674; Andersson M, 2008, CHEMPHYSCHEM, V9, P221, DOI 10.1002/cphc.200700389; Andersson M, 2007, BIOPHYS J, V93, P3008, DOI 10.1529/biophysj.107.110643; Andersson M, 2006, BIOPHYS J, V91, P2717, DOI 10.1529/biophysj.106.087429; Aprikian P, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000617; Axner O, 2011, ADV EXP MED BIOL, V715, P301, DOI 10.1007/978-94-007-0940-9_19; Axner O, 2010, SPRINGER SER CHEM PH, V96, P337, DOI 10.1007/978-3-642-02597-6_18; Bell EC, 1996, J EXP BIOL, V199, P1005; Bjornham O, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3148027; Bjornham O, 2010, BIOPHYS J, V99, P1331, DOI 10.1016/j.bpj.2010.06.003; BULLITT E, 1995, NATURE, V373, P164, DOI 10.1038/373164a0; Carrington E, 2004, AM MALACOL BULL, V18, P135; Carrington E, 2002, INTEGR COMP BIOL, V42, P846, DOI 10.1093/icb/42.4.846; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Connell I, 1996, P NATL ACAD SCI USA, V93, P9827, DOI DOI 10.1073/PNAS.93.18.9827; De la Fuente L, 2007, APPL ENVIRON MICROB, V73, P2690, DOI 10.1128/AEM.02649-06; DOMINGUE GJ, 1985, J UROLOGY, V133, P983, DOI 10.1016/S0022-5347(17)49341-4; EDEN CS, 1977, INFECT IMMUN, V18, P767, DOI 10.1128/IAI.18.3.767-774.1977; Fallman E, 2004, PROC SPIE, V5514, P763, DOI 10.1117/12.579893; Forero M, 2006, PLOS BIOL, V4, P1509, DOI 10.1371/journal.pbio.0040298; GOLDMAN AJ, 1967, CHEM ENG SCI, V22, P653, DOI 10.1016/0009-2509(67)80048-4; Gonzalez R. C., 2013, DIGITAL IMAGE PROCES, V2nd; Gosline J, 2002, PHILOS T R SOC B, V357, P121, DOI 10.1098/rstb.2001.1022; Gossert AD, 2008, J MOL BIOL, V375, P752, DOI 10.1016/j.jmb.2007.10.059; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; Haralick R. M., 2002, COMPUTER ROBOT VISIO; Howard J., 2001, MECH MOTOR PROTEINS; Jass J, 2004, BIOPHYS J, V87, P4271, DOI 10.1529/biophysj.104.044867; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80, DOI 10.1128/CMR.4.1.80-128.1991; KALLENIUS G, 1981, LANCET, V2, P1369; KLEMM P, 1984, EUR J BIOCHEM, V143, P395, DOI 10.1111/j.1432-1033.1984.tb08386.x; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; KROGFELT KA, 1990, INFECT IMMUN, V58, P1995, DOI 10.1128/IAI.58.6.1995-1998.1990; Le Trong I, 2010, CELL, V141, P645, DOI 10.1016/j.cell.2010.03.038; Miller E, 2006, BIOPHYS J, V91, P3848, DOI 10.1529/biophysj.106.088989; Moeser GM, 2006, J EXP BIOL, V209, P1996, DOI 10.1242/jeb.02234; Nilsson LM, 2006, J BIOL CHEM, V281, P16656, DOI 10.1074/jbc.M511496200; Puorger C, 2008, STRUCTURE, V16, P631, DOI 10.1016/j.str.2008.01.013; Tchesnokova V, 2010, MOL MICROBIOL, V76, P489, DOI 10.1111/j.1365-2958.2010.07116.x; Thomas W, 2006, BIOPHYS J, V90, P753, DOI 10.1529/biophysj.105.066548; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Trong IL, 2010, J STRUCT BIOL, V172, P380, DOI [10.1016/j.jsb.2010.06.002, DOI 10.1016/J.JSB.2010.06.002]; Vaccaro E, 2001, BIOMACROMOLECULES, V2, P906, DOI 10.1021/bm0100514; Vahidi B, 2012, J THEOR BIOL, V298, P42, DOI 10.1016/j.jtbi.2011.12.019; Whitfield M, 2010, BIOPHYS J, V99, P2470, DOI 10.1016/j.bpj.2010.08.045; Yakovenko O, 2008, J BIOL CHEM, V283, P11596, DOI 10.1074/jbc.M707815200; Zakrisson J., 2012, EUR BIOPHYS J, P1	47	16	16	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65563	10.1371/journal.pone.0065563	http://dx.doi.org/10.1371/journal.pone.0065563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799025	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300024
J	Vashist, P; Gupta, N; Rathore, AS; Shah, A; Singh, S				Vashist, Praveen; Gupta, Noopur; Rathore, Abhilakh S.; Shah, Anita; Singh, Suman			Rapid Assessment of Trachoma in Underserved Population of Car-Nicobar Island, India	PLOS ONE			English	Article							RISK-FACTORS; PREVALENCE; DISTRICT	Purpose: To determine the burden of trachoma and its related risk factors amongst the native population of Car-Nicobar Island in India. Methods: Rapid assessment for trachoma was conducted in ten villages of Car-Nicobar Island according to standard WHO guidelines. An average of 50 children aged 1-9 years were assessed clinically for signs of active trachoma and facial cleanliness in each village. Additionally, all adults above 15 years of age in these households were examined for evidence of trachomatous trichiasis and corneal opacity. Environmental risk factors contributing to trachoma like limited access to potable water & functional latrine, presence of animal pen and garbage within the Nicobari hut were also noted in all villages. Results: Out of a total of fifteen villages in Car-Nicobar Island, ten villages were selected for trachoma survey depending on evidence of socio-developmental indicators like poverty and decreased access to water, sanitation and healthcare facilities. The total population of the selected clusters was 7277 in the ten villages. Overall, 251 of 516 children (48.6%; CI: 46.5-55.1) had evidence of follicular stage of trachoma and 11 children (2.1%; CI: 1.0-3.4) had evidence of inflammatory stage of trachoma. Nearly 15%(CI: 12.1-18.3) children were noted to have unclean faces in the ten villages. Trachomatous trichiasis was noted in 73 adults (1.0%; CI: 0.8-1.2). The environmental sanitation was not found to be satisfactory in the surveyed villages mainly due to the co-habitance of Nicobari people with domestic animals like pigs, hens, goats, dogs, cats etc in most (96.4%) of the households. Conclusion: Active trachoma and trachomatous trichiasis was observed in all the ten villages surveyed, wherein trachoma control measures are needed.	[Vashist, Praveen; Gupta, Noopur] All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, Dept Community Ophthalmol, New Delhi 110029, India; [Rathore, Abhilakh S.; Singh, Suman] Govt India, Minist Hlth & Family Welf, Directorate Gen Hlth Serv, New Delhi, India; [Shah, Anita] Govind Ballabh Pant Hosp, Port Blair, Andaman & Nicob, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Dr. Rajendra Prasad Centre for Ophthalmic Sciences; Govind Ballabh Pant Institute of Postgraduate Medical Education & Research	Vashist, P (corresponding author), All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, Dept Community Ophthalmol, New Delhi 110029, India.	praveenvashist@yahoo.com	GUPTA, NOOPUR/AAX-5043-2021	GUPTA, NOOPUR/0000-0001-8022-6656	Ministry of Health & Family Welfare, Govt of India	Ministry of Health & Family Welfare, Govt of India	Funding was provided by the Ministry of Health & Family Welfare, Govt of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amza A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001586; Baggaley RF, 2006, TROP MED INT HEALTH, V11, P220, DOI 10.1111/j.1365-3156.2005.01553.x; Census of India, 2011, PROV POP TOT FIG GLA; Emerson PM, 2001, MED VET ENTOMOL, V15, P314, DOI 10.1046/j.0269-283x.2001.00318.x; Goldschmidt P, 2006, OPHTHAL EPIDEMIOL, V13, P335, DOI 10.1080/09286580600943796; Harding-Esch EM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000861; Kalua K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009067; Mabey DCW, 2003, LANCET, V362, P223, DOI 10.1016/S0140-6736(03)13914-1; Mariotti SP, 2009, BRIT J OPHTHALMOL, V93, P563, DOI 10.1136/bjo.2008.148494; Mariotti SP, 2003, AM J TROP MED HYG, V69, P33; Mariotti SP, 2000, 136WHOPBDGET007, V1, P36; Mpyet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040421; Negrel A D, 1999, Community Eye Health, V12, P51; Negrel AD, 2001, WHOPBDGET008, P1; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Polack S, 2003, B WORLD HEALTH ORGAN, V83, P913; PREOBRAGENSKI V V, 1964, J All India Ophthalmol Soc, V12, P68; Pruss A, 2000, B WORLD HEALTH ORGAN, V78, P258; Rabiu M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004003.pub4; Rapid Assessment of Trachoma in India, 2006, RAPID ASSESSMENT TRA, P1; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; *WHO, 2007, 11 M WHO ALL GLOB EL	22	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65918	10.1371/journal.pone.0065918	http://dx.doi.org/10.1371/journal.pone.0065918			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799063	Green Submitted, Green Published, gold			2022-12-25	WOS:000320363300054
J	Quinlivan, EP; Crider, KS; Zhu, JH; Maneval, DR; Hao, L; Li, Z; Rasmussen, SA; Berry, RJ; Bailey, LB				Quinlivan, Eoin P.; Crider, Krista S.; Zhu, Jiang-Hui; Maneval, David R.; Hao, Ling; Li, Zhu; Rasmussen, Sonja A.; Berry, R. J.; Bailey, Lynn B.			Hypomethylation of Serum Blood Clot DNA, but Not Plasma EDTA-Blood Cell Pellet DNA, from Vitamin B12-Deficient Subjects	PLOS ONE			English	Article							METHIONINE SYNTHASE ACTIVITY; MODERATE FOLATE-DEPLETION; COLORECTAL-CANCER RISK; S-ADENOSYLMETHIONINE; METHYLENETETRAHYDROFOLATE REDUCTASE; METHYLTRANSFERASES DNMT3A; CPG METHYLATION; MAMMALIAN DNA; X-CHROMOSOME; HOMOCYSTEINE	Vitamin B12, a co-factor in methyl-group transfer, is important in maintaining DNA (deoxycytidine) methylation. Using two independent assays we examined the effect of vitamin B12-deficiency (plasma vitamin B12<148 pmol/L) on DNA methylation in women of childbearing age. Coagulated blood clot DNA from vitamin B12-deficient women had significantly (p<0.001) lower percentage deoxycytidine methylation (3.23 +/- 0.66%; n = 248) and greater [3 H]methyl-acceptance (42,859 +/- 9,699 cpm; n = 17) than DNA from B12-replete women (4.44 +/- 0.18%; n = 128 and 26,049 +/- 2,814 cpm; n = 11) [correlation between assays: r = -0.8538; p<0.001; n = 28]. In contrast, uncoagulated EDTA-blood cell pellet DNA from vitamin B12-deficient and B12-replete women exhibited similar percentage methylation (4.45 +/- 0.15%; n = 77 vs. 4.47 +/- 0.15%; n = 47) and [3 H]methyl-acceptance (27,378 +/- 4,094 cpm; n = 17 vs. 26,610 +/- 2,292 cpm; n = 11). Therefore, in simultaneously collected paired blood samples, vitamin B12-deficiency was associated with decreased DNA methylation only in coagulated samples. These findings highlight the importance of sample collection methods in epigenetic studies, and the potential impact biological processes can have on DNA methylation during collection.	[Quinlivan, Eoin P.] Univ Florida, Clin & Translat Sci Inst, Biomed Mass Spectrometry Lab, Gainesville, FL 32610 USA; [Crider, Krista S.; Rasmussen, Sonja A.; Berry, R. J.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA; [Zhu, Jiang-Hui] China Natl Ctr Food Safety Risk Assessment, Dept Surveillance Program & Risk Assessment, Beijing, Peoples R China; [Maneval, David R.] Univ Florida, Food Sci & Human Nutr Dept, Gainesville, FL USA; [Hao, Ling] China Off, Ctr Dis Control & Prevent, Global Aids Program, Beijing, Peoples R China; [Li, Zhu] Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Bailey, Lynn B.] Univ Georgia, Dept Foods & Nutr, Athens, GA 30602 USA	State University System of Florida; University of Florida; Centers for Disease Control & Prevention - USA; State University System of Florida; University of Florida; Chinese Center for Disease Control & Prevention; Peking University; University System of Georgia; University of Georgia	Quinlivan, EP (corresponding author), Univ Florida, Clin & Translat Sci Inst, Biomed Mass Spectrometry Lab, Gainesville, FL 32610 USA.	epq@ufl.edu	Quinlivan, Eoin/AAJ-1979-2021; Quinlivan, Eoin P/B-8454-2008	Quinlivan, Eoin/0000-0002-0908-1762; Quinlivan, Eoin P/0000-0002-0908-1762; Crider, Krista/0000-0001-6997-5955; Berry, Robert/0000-0002-7162-5046	BDB/DBDDD/NCBDDD/CDC (Birth Defects Branch, Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention); NIH/NCATS Clinical and Translational Science Award [UL1 TR000064]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	BDB/DBDDD/NCBDDD/CDC (Birth Defects Branch, Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention); NIH/NCATS Clinical and Translational Science Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding for this study was provided by a cooperative agreement from BDB/DBDDD/NCBDDD/CDC (Birth Defects Branch, Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention). This work was supported in part by the NIH/NCATS Clinical and Translational Science Award to the University of Florida (UL1 TR000064). As a part of a public health scientific agency, CDC employees were directly involved in the study design, analysis, decision to publish and preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, INT PSYCHOGERIATR, P1; [Anonymous], 2012, NUCL ACIDS RES; [Anonymous], 2012, EUR J OBSTET GYNECOL; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; BALAGHI M, 1993, BIOCHEM BIOPH RES CO, V193, P1184, DOI 10.1006/bbrc.1993.1750; Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; Batra V, 2010, CHEM-BIOL INTERACT, V183, P425, DOI 10.1016/j.cbi.2009.11.010; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Brena RM, 2007, HUM MOL GENET, V16, pR96, DOI 10.1093/hmg/ddm073; Brunaud L, 2003, DIGESTION, V68, P133, DOI 10.1159/000075307; Brunaud L, 2003, CLIN CHEM LAB MED, V41, P1012, DOI 10.1515/CCLM.2003.155; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; CANNON SV, 1988, BIOCHEM BIOPH RES CO, V151, P1173, DOI 10.1016/S0006-291X(88)80489-3; Cervoni N, 1999, J BIOL CHEM, V274, P8363, DOI 10.1074/jbc.274.13.8363; Chen CC, 2012, J BIOL CHEM, V287, P33116, DOI 10.1074/jbc.C112.406975; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Choi SW, 2004, J NUTR, V134, P750, DOI 10.1093/jn/134.4.750; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Crider KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028144; Crider KS, 2011, AM J CLIN NUTR, V93, P1365, DOI 10.3945/ajcn.110.004671; DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P11450, DOI 10.1073/pnas.88.24.11450; DIETZ AA, 1977, CANCER RES, V37, P419; DOI T, 1989, J NUTR SCI VITAMINOL, V35, P1, DOI 10.3177/jnsv.35.1; Eckhardt F, 2004, EXPERT REV MOL DIAGN, V4, P609, DOI 10.1586/14737159.4.5.609; Finkelstein JD, 1998, EUR J PEDIATR, V157, pS40, DOI 10.1007/PL00014300; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; HALLAM LJ, 1987, BLOOD, V69, P1128; Hammoud SS, 2011, HUM REPROD, V26, P2558, DOI 10.1093/humrep/der192; Hao L, 2008, AM J CLIN NUTR, V88, P448, DOI 10.1093/ajcn/88.2.448; Hao L, 2007, J NUTR, V137, P407, DOI 10.1093/jn/137.2.407; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Hodges E, 2009, GENOME RES, V19, P1593, DOI 10.1101/gr.095190.109; Holz-Schietinger C, 2010, J BIOL CHEM, V285, P29091, DOI 10.1074/jbc.M110.142513; HSIEH CL, 1994, MOL CELL BIOL, V14, P5487, DOI 10.1128/MCB.14.8.5487; Hughes LAE, 2010, INT J EPIDEMIOL, V39, P1333, DOI 10.1093/ije/dyq062; Hughes LAE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007951; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jacob RA, 1998, J NUTR, V128, P1204, DOI 10.1093/jn/128.7.1204; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Juriloff DM, 2000, HUM MOL GENET, V9, P993, DOI 10.1093/hmg/9.6.993; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; KENNEDY DG, 1992, J NUTR, V122, P1384, DOI 10.1093/jn/122.7.1384; KOTB M, 1985, J BIOL CHEM, V260, P3923; Kress C, 2006, P NATL ACAD SCI USA, V103, P11112, DOI 10.1073/pnas.0601793103; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; LeGros HL, 1997, J BIOL CHEM, V272, P16040, DOI 10.1074/jbc.272.25.16040; Lenth RV., 2006, JAVA APPLETS POWER S; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu Zhenhua, 2006, Proceedings of the American Association for Cancer Research Annual Meeting, V47, P916; Liutkeviciute Z, 2009, NAT CHEM BIOL, V5, P400, DOI 10.1038/nchembio.172; MALINOW MR, 1994, J LAB CLIN MED, V123, P421; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Melnyk S, 2000, CLIN CHEM, V46, P265; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Neddermann P, 1996, J BIOL CHEM, V271, P12767, DOI 10.1074/jbc.271.22.12767; OBROIN S, 1992, J CLIN PATHOL, V45, P344, DOI 10.1136/jcp.45.4.344; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Patra SK, 2002, MOL CARCINOGEN, V33, P163, DOI 10.1002/mc.10033; Quinlivan EP, 2008, ANAL BIOCHEM, V373, P383, DOI 10.1016/j.ab.2007.09.031; Quinlivan EP, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn534; Quinlivan EP, 2005, J NUTR, V135, P389, DOI 10.1093/jn/135.3.389; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Ramchandani S, 1999, P NATL ACAD SCI USA, V96, P6107, DOI 10.1073/pnas.96.11.6107; Rampersaud GC, 2000, AM J CLIN NUTR, V72, P998; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; RUSSELL GJ, 1976, J MOL BIOL, V108, P1, DOI 10.1016/S0022-2836(76)80090-3; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Shelnutt KP, 2004, J NUTR BIOCHEM, V15, P554, DOI 10.1016/j.jnutbio.2004.04.003; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Smulders YM, 2006, BRIT J HAEMATOL, V132, P623, DOI 10.1111/j.1365-2141.2005.05913.x; STEINBERG RA, 1995, NUCLEIC ACIDS RES, V23, P1621, DOI 10.1093/nar/23.9.1621; Suetake I, 2003, J BIOCHEM, V133, P737, DOI 10.1093/jb/mvg095; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; Vairapandi M, 2004, J CELL BIOCHEM, V91, P572, DOI 10.1002/jcb.10749; Vairapandi M, 2000, J CELL BIOCHEM, V79, P249, DOI 10.1002/1097-4644(20001101)79:2<249::AID-JCB80>3.0.CO;2-Z; Van Emburgh BO, 2011, NUCL ACIDS RES; Villalpando S, 2008, FOOD NUTR BULL, V29, pS112, DOI 10.1177/15648265080292S115; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; WOLF SF, 1984, P NATL ACAD SCI-BIOL, V81, P2806, DOI 10.1073/pnas.81.9.2806; Wu HC, 2011, EPIGENETICS-US, V6, P76, DOI 10.4161/epi.6.1.13391; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Xu MQ, 2009, SCHIZOPHRENIA BULL, V35, P568, DOI 10.1093/schbul/sbn168; Yamada K, 2000, J NUTR, V130, P1894, DOI 10.1093/jn/130.8.1894; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zhang Z, 2012, GENOMICS, V99, P209, DOI 10.1016/j.ygeno.2012.01.002; Zhou YP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-123; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	102	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65241	10.1371/journal.pone.0065241	http://dx.doi.org/10.1371/journal.pone.0065241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785415	Green Submitted, Green Published, gold			2022-12-25	WOS:000321038800105
J	Wilcox, CL; Terry, NA; Walp, ER; Lee, RA; May, CL				Wilcox, Crystal L.; Terry, Natalie A.; Walp, Erik R.; Lee, Randall A.; May, Catherine Lee			Pancreatic alpha-Cell Specific Deletion of Mouse Arx Leads to alpha-Cell Identity Loss	PLOS ONE			English	Article							BETA-CELLS; ENDOCRINE PANCREAS; PROGENITOR CELLS; IDENTIFICATION; PAX4; DIFFERENTIATION; PLASTICITY; MICE; PP	The specification and differentiation of pancreatic endocrine cell populations (alpha-, beta-, delta, PP-and epsilon-cells) is orchestrated by a combination of transcriptional regulators. In the pancreas, Aristaless-related homeobox gene (Arx) is expressed first in the endocrine progenitors and then restricted to glucagon-producing alpha-cells. While the functional requirement of Arx in early alpha-cell specification has been investigated, its role in maintaining alpha-cell identity has yet to be explored. To study this later role of Arx, we have generated mice in which the Arx gene has been ablated specifically in glucagon-producing alpha-cells. Lineage-tracing studies and immunostaining analysis for endocrine hormones demonstrate that ablation of Arx in neonatal alpha-cells results in an alpha-to-beta-like conversion through an intermediate bihormonal state. Furthermore, these Arx-deficient converted cells express beta-cell markers including Pdx1, MafA, and Glut2. Surprisingly, short-term ablation of Arx in adult mice does not result in a similar alpha-to-beta-like conversion. Taken together, these findings reveal a potential temporal requirement for Arx in maintaining alpha-cell identity.	[Wilcox, Crystal L.; Walp, Erik R.; Lee, Randall A.; May, Catherine Lee] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Terry, Natalie A.] Childrens Hosp Philadelphia, Dept Pediat, Div Gastroenterol, Philadelphia, PA 19104 USA; [May, Catherine Lee] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	May, CL (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	catheril@mail.med.upenn.edu			Center for Molecular Studies in Digestive and Liver Disease [P30-DK050306]; Penn Institute for Diabetes, Obesity, and Metabolism [DERC: P30-DK19525]; National Institutes of Health [DK078606, NIH-DK019525, JDRF2-2007-730]; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney [T32-DK007066, NIH-5K12HD043245]; CHOP Foerderer Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK078606, P30DK019525, P30DK050306, R01DK078606, T32DK007066] Funding Source: NIH RePORTER	Center for Molecular Studies in Digestive and Liver Disease; Penn Institute for Diabetes, Obesity, and Metabolism; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Institute of Diabetes and Digestive and Kidney; CHOP Foerderer Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Part of these studies were supported by the Center for Molecular Studies in Digestive and Liver Disease (P30-DK050306) and Penn Institute for Diabetes, Obesity, and Metabolism (DERC: P30-DK19525). CLM is supported by National Institutes of Health-DK078606, NIH-DK019525 and JDRF2-2007-730. NAT is supported by National Institutes of Health/National Institute of Diabetes and Digestive and Kidney T32-DK007066 and NIH-5K12HD043245. These studies were also supported by the CHOP Foerderer Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borowiak M, 2009, CURR OPIN CELL BIOL, V21, P727, DOI 10.1016/j.ceb.2009.08.006; Bramswig NC, 2011, DIABETES OBES METAB, V13, P13, DOI 10.1111/j.1463-1326.2011.01440.x; Bramswig NC, 2013, J CLIN INVEST, V123, P1275, DOI 10.1172/JCI66514; Chao CS, 2007, DEV BIOL, V312, P523, DOI 10.1016/j.ydbio.2007.09.057; Collombat P, 2005, DEVELOPMENT, V132, P2969, DOI 10.1242/dev.01870; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Collombat P, 2006, MECH DEVELOP, V123, P501, DOI 10.1016/j.mod.2006.05.006; Du AP, 2012, DEV BIOL, V365, P175, DOI 10.1016/j.ydbio.2012.02.024; Fulp CT, 2008, HUM MOL GENET, V17, P3740, DOI 10.1093/hmg/ddn271; Hancock AS, 2010, MOL ENDOCRINOL, V24, P1605, DOI 10.1210/me.2010-0120; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Itoh M, 2010, DIFFERENTIATION, V80, P118, DOI 10.1016/j.diff.2010.05.003; Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; Juhl K, 2010, CURR OPIN ORGAN TRAN, V15, P79, DOI 10.1097/MOT.0b013e3283344932; Lee SH, 2011, ISLETS, V3, P188, DOI 10.4161/isl.3.4.16338; Li WC, 2010, J CELL SCI, V123, P2792, DOI 10.1242/jcs.065268; Lu JL, 2010, GASTROENTEROLOGY, V138, P1954, DOI 10.1053/j.gastro.2010.01.046; Mastracci TL, 2011, DEV BIOL; Prado CL, 2004, P NATL ACAD SCI USA, V101, P2924, DOI 10.1073/pnas.0308604100; Quoix N, 2007, FEBS LETT, V581, P4235, DOI 10.1016/j.febslet.2007.07.068; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sussel L, 1998, DEVELOPMENT, V125, P2213; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Yang YP, 2011, GENE DEV, V25, P1680, DOI 10.1101/gad.16875711	27	59	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66214	10.1371/journal.pone.0066214	http://dx.doi.org/10.1371/journal.pone.0066214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785486	Green Published, gold, Green Submitted			2022-12-25	WOS:000321038800035
J	Harrison, W; Cochrane, B; Neill, G; Philpott, M				Harrison, W.; Cochrane, B.; Neill, G.; Philpott, M.			The oncogenic GLI transcription factors facilitate keratinocyte survival and transformation upon exposure to genotoxic agents	ONCOGENE			English	Article						Hedgehog; GLI; Genotoxic; Transformation; Keratinocyte	BASAL-CELL CARCINOMAS; EPITHELIAL-MESENCHYMAL TRANSITIONS; GENE-EXPRESSION; HUMAN HOMOLOG; E-CADHERIN; FACTOR SNAIL; DNA-DAMAGE; STEM-CELLS; ACTIVATION; APOPTOSIS	Ultraviolet B (UVB) light is the principal aetiological factor associated with non-melanoma skin cancer, the most prevalent group of malignancies in the Caucasian population. Exposure to environmental chemicals has also been shown to promote skin carcinogenesis and, as for UVB, this is associated with the acquisition of genomic DNA damage. Cells respond to DNA damage by inducing cell cycle arrest to facilitate DNA repair, although apoptosis will occur if the damage is excessive. Oncogenes may drive carcinogenesis by disrupting the balanced control of cell cycle progression, DNA repair and apoptosis, allowing for the propagation of cells with damaged DNA. The transcription factors GLI1 and GLI2 have been implicated in both the initiation and progression of several cancers, including basal cell carcinoma. Here we show that GLI1 and an active mutant of GLI2 (Delta NGLI2) promote apoptotic resistance in N/TERT human keratinocytes upon exposure to UVB and the DNA-alkylating chemicals such as methyl methanesulphonate (MMS) and N-ethyl-N-nitrosurea. Compared with control and untreated N/TERT-GLI1 and -GLI2 cells, those that survived genotoxic insult formed significantly more colonies in soft agar and were significantly more invasive when grown in three-dimensional organotypic collagen gel cultures. Indeed, surviving N/TERT-GLI1 and -GLI2 cells expressed higher levels of the epithelial-to-mesenchymal transition markers Snail and vimentin, and a subpopulation of MMS-treated cells displayed an elongated fibroblast-like morphology with decreased levels of E-cadherin. Finally, whereas Bcl2 was strongly increased in N/TERT-GLI2 cells, the level of induction was weak in N/TERT-GLI1 cells, indicating that GLI1 may activate anti-apoptotic mechanisms(s) independently of Bcl2. In summary, our results show that GLI1 and GLI2 facilitate the propagation of cells with damaged DNA, and thus their expression may be naturally higher in cells that form the earliest precursor tumour lesions.	[Harrison, W.; Neill, G.; Philpott, M.] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, Ctr Cutaneous Res, London E1 2AT, England; [Cochrane, B.] Unilever, Safety & Environm Assurance Ctr, Bedford, England	University of London; Queen Mary University London; Unilever	Philpott, M (corresponding author), Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, Ctr Cutaneous Res, 4 Newark St, London E1 2AT, England.	m.p.philpott@qmul.ac.uk		Philpott, Michael/0000-0002-1255-4612	Dr Hadwen Trust for Humane Research and Unilever Research	Dr Hadwen Trust for Humane Research and Unilever Research(Unilever)	This work was funded by a basic science grants from the Dr Hadwen Trust for Humane Research and Unilever Research to Professor Mike Philpott and Dr Graham Neill.	Ahmadian A, 1998, ONCOGENE, V17, P1837, DOI 10.1038/sj.onc.1202080; Alexaki VI, 2010, JNCI-J NATL CANCER I, V102, P1148, DOI 10.1093/jnci/djq257; Almahroos Mona, 2004, Skinmed, V3, P132; Armstrong BK, 2001, J PHOTOCH PHOTOBIO B, V63, P8, DOI 10.1016/S1011-1344(01)00198-1; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Biddle A, 2011, CANCER RES, V71, P5317, DOI 10.1158/0008-5472.CAN-11-1059; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chen XL, 2010, ARCH MED RES, V41, P315, DOI 10.1016/j.arcmed.2010.06.003; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Fan L, 2004, ENDOCRINOLOGY, V145, P3961, DOI 10.1210/en.2004-0079; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Grachtchouk M, 2011, J CLIN INVEST, V121, P1768, DOI 10.1172/JCI46307; Han G, 2005, J CLIN INVEST, V115, P1714, DOI 10.1172/JCI24399; Hoot KE, 2008, J CLIN INVEST, V118, P2722, DOI 10.1172/JCI33713; Hudson LG, 2009, J DERMATOL SCI, V56, P19, DOI 10.1016/j.jdermsci.2009.06.009; Ikram MS, 2004, J INVEST DERMATOL, V122, P1503, DOI 10.1111/j.0022-202X.2004.22612.x; Javelaud D, 2011, CANCER RES, V71, P5606, DOI 10.1158/0008-5472.CAN-11-1194; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kaina B, 1998, MUTAT RES-FUND MOL M, V404, P119, DOI 10.1016/S0027-5107(98)00103-1; Kandala PK, 2012, J BIOL CHEM, V287, P28745, DOI 10.1074/jbc.M112.351379; Kump E, 2008, ONCOGENE, V27, P3856, DOI 10.1038/onc.2008.5; Lear W, 2007, J CUTAN MED SURG, V11, P19, DOI 10.2310/7750.2007.00011; Leonard JM, 2008, J CELL BIOL, V183, P385, DOI 10.1083/jcb.200804042; Li X, 2007, ONCOGENE, V26, P4489, DOI 10.1038/sj.onc.1210241; Li X, 2006, ONCOGENE, V25, P609, DOI 10.1038/sj.onc.1209077; Louro ID, 2002, CANCER RES, V62, P5867; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Mazumdar T, 2011, CANCER RES, V71, P5904, DOI 10.1158/0008-5472.CAN-10-4173; McCalla-Martin AC, 2010, TRANSGENIC RES, V19, P869, DOI 10.1007/s11248-010-9362-0; Nakamura M, 2011, J DERMATOL SCI, V61, P7, DOI 10.1016/j.jdermsci.2010.11.015; Neill GW, 2008, CARCINOGENESIS, V29, P738, DOI 10.1093/carcin/bgn037; Newkirk KM, 2007, AM J PATHOL, V171, P1629, DOI 10.2353/ajpath.2007.070221; Nilsson M, 2000, P NATL ACAD SCI USA, V97, P3438, DOI 10.1073/pnas.050467397; Nystrom ML, 2005, J PATHOL, V205, P468, DOI 10.1002/path.1716; Papanikolaou S, 2010, HISTOPATHOLOGY, V56, P799, DOI 10.1111/j.1365-2559.2010.03556.x; Patil MA, 2006, CANCER BIOL THER, V5, P111, DOI 10.4161/cbt.5.1.2379; Perrot CY, 2013, PHARMACOL THERAPEUT, V137, P183, DOI 10.1016/j.pharmthera.2012.10.002; Ping XL, 2001, J INVEST DERMATOL, V116, P614, DOI 10.1046/j.1523-1747.2001.01301.x; Raj D, 2006, J INVEST DERMATOL, V126, P243, DOI 10.1038/sj.jid.5700008; Regl G, 2004, CANCER RES, V64, P7724, DOI 10.1158/0008-5472.CAN-04-1085; Regl G, 2002, ONCOGENE, V21, P5529, DOI 10.1038/sj.onc.1205748; Reichrath J, 2006, MED INTELL UNIT, P10, DOI 10.1007/0-387-35098-5_2; Rittie L, 2009, AGING CELL, V8, P738, DOI 10.1111/j.1474-9726.2009.00526.x; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sarasin A, 1999, MUTAT RES-FUND MOL M, V428, P5, DOI 10.1016/S1383-5742(99)00025-3; Savagner P, 2005, J CELL PHYSIOL, V202, P858, DOI 10.1002/jcp.20188; Schnidar H, 2009, CANCER RES, V69, P1284, DOI 10.1158/0008-5472.CAN-08-2331; Sheng H, 2002, CANCER RES, V62, P5308; Teh MT, 2002, CANCER RES, V62, P4773; Teh MT, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-45; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thomas ZI, 2011, BRIT J CANCER, V104, P1575, DOI 10.1038/bjc.2011.133; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Vorechovsky I, 1997, ONCOGENE, V15, P361, DOI 10.1038/sj.onc.1201340; Wong CSM, 2003, BMJ-BRIT MED J, V327, P794, DOI 10.1136/bmj.327.7418.794; Yoon JW, 2002, J BIOL CHEM, V277, P5548, DOI 10.1074/jbc.M105708200; Yu M, 2008, J INVEST DERMATOL, V128, P1797, DOI 10.1038/sj.jid.5701243; Yuan JS, 2010, FEBS LETT, V584, P3717, DOI 10.1016/j.febslet.2010.05.021; Zheng X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049581	60	16	16	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 8	2014	33	19					2432	2440		10.1038/onc.2013.199	http://dx.doi.org/10.1038/onc.2013.199			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AH3OK	23792444				2022-12-25	WOS:000336033600003
J	Yang, SF; Gao, ZQ; Li, TT; Yang, M; Zhang, TY; Dong, YH; He, ZG				Yang, Shifan; Gao, Zengqiang; Li, Tingting; Yang, Min; Zhang, Tianyi; Dong, Yuhui; He, Zheng-Guo			Structural Basis for Interaction between Mycobacterium smegmatis Ms6564, a TetR Family Master Regulator, and Its Target DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; TAL EFFECTORS; TRANSCRIPTIONAL REGULATION; RESPONSE REGULATOR; ESCHERICHIA-COLI; RECOGNITION; REPRESSOR; TUBERCULOSIS; BINDING; NARL	Master regulators, which broadly affect expression of diverse genes, play critical roles in bacterial growth and environmental adaptation. However, the underlying mechanism by which such regulators interact with their cognate DNA remains to be elucidated. In this study, we solved the crystal structure of a broad regulator Ms6564 in Mycobacterium smegmatis and its protein-operator complex at resolutions of 1.9 and 2.5 angstrom, respectively. Similar to other typical TetR family regulators, two dimeric Ms6564 molecules were found to bind to opposite sides of target DNA. However, the recognition helix of Ms6564 inserted only slightly into the DNA major groove. Unexpectedly, 11 disordered water molecules bridged the interface of TetR family regulator DNA. Although the DNA was deformed upon Ms6564 binding, it still retained the conformation of B-form DNA. Within the DNA-binding domain of Ms6564, only two amino acids residues directly interacted with the bases of cognate DNA. Lys-47 was found to be essential for the specific DNA binding ability of Ms6564. These data indicate that Ms6564 can bind DNA with strong affinity but makes flexible contacts with DNA. Our study suggests that Ms6564 might slide more easily along the genomic DNA and extensively regulate the expression of diverse genes in M. smegmatis.	[Yang, Shifan; Li, Tingting; Yang, Min; He, Zheng-Guo] Huazhong Agr Univ, Coll Life Sci & Technol, Ctr Prote Res, Natl Key Lab Agr Microbiol, Wuhan 430070, Peoples R China; [Gao, Zengqiang; Zhang, Tianyi; Dong, Yuhui] Chinese Acad Sci, Inst High Energy Phys, Beijing 100049, Peoples R China	Huazhong Agricultural University; Chinese Academy of Sciences; Institute of High Energy Physics, CAS	Dong, YH (corresponding author), Chinese Acad Sci, Inst High Energy Phys, Beijing 100049, Peoples R China.	dongyh@ihep.ac.cn; he.zhengguo@hotmail.com	He, Zheng-Guo/P-3647-2014	Dong, Yuhui/0000-0002-4422-4685; Yang, Min/0000-0003-2924-5717	National Natural Science Foundation of China [31121004, 31025002, 30930003]; Fundamental Research Funds for the Central Universities [2011PY140]; Creative Research Groups of Hubei; Hubei Chutian Scholar Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Creative Research Groups of Hubei; Hubei Chutian Scholar Program	This work was supported by National Natural Science Foundation of China Grants 31121004, 31025002, and 30930003; Fundamental Research Funds for the Central Universities Grant 2011PY140; the Creative Research Groups of Hubei; and the Hubei Chutian Scholar Program (to H.Z.-G.).	Baikalov I, 1998, BIOCHEMISTRY-US, V37, P3665, DOI 10.1021/bi972365a; Baikalov I, 1996, BIOCHEMISTRY-US, V35, P11053, DOI 10.1021/bi960919o; Bellinzoni M, 2009, J BACTERIOL, V191, P7531, DOI 10.1128/JB.00631-09; Bolla JR, 2012, NUCLEIC ACIDS RES, V40, P9340, DOI 10.1093/nar/gks677; Carette X, 2012, NUCLEIC ACIDS RES, V40, P3018, DOI 10.1093/nar/gkr1113; Coulocheri SA, 2007, BIOCHIMIE, V89, P1291, DOI 10.1016/j.biochi.2007.07.020; Deng D, 2012, CELL RES, V22, P1502, DOI 10.1038/cr.2012.127; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6; Gu RY, 2007, J MOL BIOL, V372, P583, DOI 10.1016/j.jmb.2007.06.072; Itou H, 2010, J MOL BIOL, V403, P174, DOI 10.1016/j.jmb.2010.07.042; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Kim Y, 2010, J BIOL CHEM, V285, P14020, DOI 10.1074/jbc.M109.100248; Le TBK, 2011, NUCLEIC ACIDS RES, V39, P9433, DOI 10.1093/nar/gkr640; Maris AE, 2002, NAT STRUCT BIOL, V9, P771, DOI 10.1038/nsb845; Miller DJ, 2010, NAT STRUCT MOL BIOL, V17, P971, DOI 10.1038/nsmb.1847; Muller CW, 2001, CURR OPIN STRUC BIOL, V11, P26, DOI 10.1016/S0959-440X(00)00163-9; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Orth P, 2000, NAT STRUCT BIOL, V7, P215; OTWINOWSKI Z, 1988, NATURE, V335, P321, DOI 10.1038/335321a0; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Sawai H, 2012, J BIOL CHEM, V287, P30755, DOI 10.1074/jbc.M112.370916; Schumacher MA, 2002, EMBO J, V21, P1210, DOI 10.1093/emboj/21.5.1210; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Shen A, 2009, STRUCTURE, V17, P769, DOI 10.1016/j.str.2009.02.018; Yang M, 2012, NUCLEIC ACIDS RES, V40, P1009, DOI 10.1093/nar/gkr830; Yin P, 2012, CELL REP, V2, P707, DOI 10.1016/j.celrep.2012.09.001	31	15	15	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23687	23695		10.1074/jbc.M113.468694	http://dx.doi.org/10.1074/jbc.M113.468694			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23803605	Green Published, hybrid			2022-12-25	WOS:000330611400009
J	Jiang, L; Xu, LL; Song, YX; Li, JZ; Mao, JH; Zhao, AZ; He, WC; Yang, JW; Dai, CS				Jiang, Lei; Xu, Lingling; Song, Yuxian; Li, Jianzhong; Mao, Junhua; Zhao, Allan Zijian; He, Weichun; Yang, Junwei; Dai, Chunsun			Calmodulin-dependent Protein Kinase II/cAMP Response Element-binding Protein/Wnt/beta-Catenin Signaling Cascade Regulates Angiotensin II-induced Podocyte Injury and Albuminuria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; NEPHRIN EXPRESSION; CONVERTING ENZYME; CALCIUM ACTIVITY; BLOOD-PRESSURE; GROWTH-FACTOR; ACTIVATION; SYSTEM; GLOMERULOSCLEROSIS; BLOCKADE	Angiotensin II (Ang II) plays a pivotal role in promoting podocyte dysfunction and albuminuria, however, the underlying mechanisms have not been fully delineated. In this study, we found that Ang II induced Wnt1 expression and beta-catenin nuclear translocation in cultured mouse podocytes. Blocking Wnt signaling with Dickkopf-1 (Dkk1) or beta-catenin siRNA attenuated Ang II-induced podocyte injury. Ang II could also induce the phosphorylation of calmodulin-dependent protein kinase (CaMK) II and cAMP response element-binding protein (CREB) in cultured podocytes. Blockade of this pathway with CK59 or CREB siRNA could significantly inhibit Ang II-induced Wnt/beta-catenin signaling and podocyte injury. In in vivo studies, administration of Ang II promoted Wnt/beta-catenin signaling, aggregated podocyte damage, and albuminuria in mice. CK59 could remarkably ameliorate Ang II-induced podocyte injury and albuminuria. Furthermore, ectopic expression of exogenous Dkk1 also attenuated Ang II-induced podocytopathy in mice. Taken together, this study demonstrates that the CaMK II/CREB/Wnt/beta-catenin signaling cascade plays an important role in regulating Ang II-induced podocytopathy. Targeting this signaling pathway may offer renal protection against the development of proteinuric kidney diseases.	[Jiang, Lei; Xu, Lingling; Song, Yuxian; Li, Jianzhong; Mao, Junhua; He, Weichun; Yang, Junwei; Dai, Chunsun] Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, Nanjing 210003, Jiangsu, Peoples R China; [Zhao, Allan Zijian] Nanjing Med Univ, Ctr Metab Dis Res, Nanjing 210029, Jiangsu, Peoples R China; [Zhao, Allan Zijian; Dai, Chunsun] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Yang, JW (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, 262 North Zhongshan Rd, Nanjing 210003, Jiangsu, Peoples R China.	jwyang@njmu.edu.cn; daichunsun@njmu.edu.cn			National Basic Research Program of China 973 Program [2012CB517601, 2011CB504005]; National Science Foundation of China [81070550/H0503, 3171093/C1102]; National Natural Science Foundation of China, General Program [81170780]; Ph.D. Programs Foundation of Ministry of Education of China [20113234110005]	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China, General Program(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported by National Basic Research Program of China 973 Program Grant 2012CB517601, National Science Foundation of China Grant 81070550/H0503 (to C. D.), National Basic Research Program of China 973 Program Grant 2011CB504005, and National Science Foundation of China Grant 3171093/C1102 (to J.W.Y.), National Natural Science Foundation of China, General Program Grant 81170780, and Ph.D. Programs Foundation of Ministry of Education of China Grant 20113234110005 (to A.Z.Z.).	Attia DM, 2004, J AM SOC NEPHROL, V15, P949, DOI 10.1097/01.ASN.0000118528.00817.8E; Benigni A, 2004, SEMIN NEPHROL, V24, P131, DOI 10.1016/j.semnephrol.2003.11.005; Benigni A, 2001, J AM SOC NEPHROL, V12, P941, DOI 10.1681/ASN.V125941; Benigni A, 2011, AM J PATHOL, V179, P628, DOI 10.1016/j.ajpath.2011.04.003; Bensman A, 2010, PEDIATR NEPHROL, V25, P1197, DOI 10.1007/s00467-010-1469-2; BIANCHI C, 1986, AM J PHYSIOL, V251, pF594, DOI 10.1152/ajprenal.1986.251.4.F594; Blanco S, 2005, KIDNEY INT, V67, pS10, DOI 10.1111/j.1523-1755.2005.09303.x; Campbell KN, 2011, CURR DIABETES REV, V7, P3, DOI 10.2174/157339911794273973; Crowley SD, 2009, J CLIN INVEST, V119, P943, DOI 10.1172/JCI34862; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Durvasula RV, 2008, AM J PHYSIOL-RENAL, V294, pF830, DOI 10.1152/ajprenal.00266.2007; Durvasula RV, 2006, CURR HYPERTENS REP, V8, P132, DOI 10.1007/s11906-006-0009-8; Durvasula RV, 2004, KIDNEY INT, V65, P30, DOI 10.1111/j.1523-1755.2004.00362.x; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Fox KE, 2008, J BIOL CHEM, V283, P35096, DOI 10.1074/jbc.M806423200; Fukuda A, 2012, KIDNEY INT, V81, P40, DOI 10.1038/ki.2011.306; He WC, 2011, J AM SOC NEPHROL, V22, P90, DOI 10.1681/ASN.2009121236; Heikkila E, 2010, NEPHROL DIAL TRANSPL, V25, P2437, DOI 10.1093/ndt/gfq076; Henger A, 1997, KIDNEY INT, V52, P687, DOI 10.1038/ki.1997.383; Herman-Edelstein M, 2011, DIABETES, V60, P1779, DOI 10.2337/db10-1110; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Hiramatsu N, 2007, J AM SOC NEPHROL, V18, P515, DOI 10.1681/ASN.2006030217; Hoffmann S, 2004, J AM SOC NEPHROL, V15, P1475, DOI 10.1097/01.ASN.0000127988.42710.A7; Hsu HH, 2011, KIDNEY INT, V80, P959, DOI 10.1038/ki.2011.250; Hsu HH, 2008, J MOL MED, V86, P1379, DOI 10.1007/s00109-008-0399-y; Izuhara Y, 2005, J AM SOC NEPHROL, V16, P3631, DOI 10.1681/ASN.2005050522; Kang YS, 2006, J MOL ENDOCRINOL, V36, P377, DOI 10.1677/jme.1.02033; Kato H, 2011, J BIOL CHEM, V286, P26003, DOI 10.1074/jbc.M111.223164; Kim J, 2012, J IMMUNOL, V188, P182, DOI 10.4049/jimmunol.1102297; Lai KN, 2011, CONTRIB NEPHROL, V170, P135, DOI 10.1159/000325649; Lemley KV, 2012, KIDNEY INT, V81, P9, DOI 10.1038/ki.2011.329; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Lu TC, 2008, MOL CELL BIOL, V28, P5785, DOI 10.1128/MCB.00245-08; Matsui I, 2007, LAB INVEST, V87, P273, DOI 10.1038/labinvest.3700518; Moeller MJ, 2010, NEPHROL DIAL TRANSPL, V25, P2101, DOI 10.1093/ndt/gfq182; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Naito T, 2010, AM J PHYSIOL-RENAL, V298, pF683, DOI 10.1152/ajprenal.00503.2009; Naves MA, 2012, J NEPHROL, V25, P401, DOI 10.5301/jn.5000017; Nitschke R, 2000, KIDNEY INT, V57, P41, DOI 10.1046/j.1523-1755.2000.00810.x; Palomeque J, 2009, CIRC RES, V105, P1204, DOI 10.1161/CIRCRESAHA.109.204172; Reiser J, 2007, CURR HYPERTENS REP, V9, P403, DOI 10.1007/s11906-007-0074-7; Ruster C, 2011, AM J NEPHROL, V34, P309, DOI 10.1159/000329321; Saito T, 2003, J MOL CELL CARDIOL, V35, P1153, DOI 10.1016/S0022-2828(03)00234-7; Saneyoshi T, 2002, NATURE, V417, P295, DOI 10.1038/417295a; Semenov MV, 2008, J BIOL CHEM, V283, P21427, DOI 10.1074/jbc.M800014200; Shkreli M, 2012, NAT MED, V18, P111, DOI 10.1038/nm.2550; Sofue T, 2012, AM J HYPERTENS, V25, P604, DOI 10.1038/ajh.2012.1; Takano Y, 2007, AM J PHYSIOL-RENAL, V292, pF1573, DOI 10.1152/ajprenal.00423.2006; Velez JCQ, 2007, AM J PHYSIOL-RENAL, V293, pF398, DOI 10.1152/ajprenal.00050.2007; Wang D, 2011, KIDNEY INT, V80, P1159, DOI 10.1038/ki.2011.255; Wang L, 2003, J LAB CLIN MED, V142, P313, DOI 10.1016/S0022-2143(03)00139-2; Wang YQ, 2010, J AM SOC NEPHROL, V21, P1657, DOI 10.1681/ASN.2009121253; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Ye MH, 2006, J AM SOC NEPHROL, V17, P3067, DOI 10.1681/ASN.2006050423; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	56	32	35	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23368	23379		10.1074/jbc.M113.460394	http://dx.doi.org/10.1074/jbc.M113.460394			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23803607	Green Published, hybrid			2022-12-25	WOS:000330598200041
J	Kasahara, AK; Singh, RJ; Noymer, A				Kasahara, Amy K.; Singh, Ravinder J.; Noymer, Andrew			Vitamin D (25OHD) Serum Seasonality in the United States	PLOS ONE			English	Article							25-HYDROXYVITAMIN D; D DEFICIENCY; CIRCULATING 25-HYDROXYVITAMIN-D; SOLAR-RADIATION; HIGH PREVALENCE; BREAST-CANCER; SUN EXPOSURE; ASSOCIATION; POPULATION; PREVENTION	Background: Vitamin D is an important micronutrient for health. Hypovitaminosis D is thought to play a role in the seasonality of a number of diseases and adverse health conditions. To refine hypotheses about the links between vitamin D and seasonal diseases, good estimates of the cyclicality of serum vitamin D are necessary. Objectives: The objective of this study is to describe quantitatively the cyclicality of 25-hydroxyvitamin D (25OHD) in the United States. We provide a statistical analysis with weekly time resolution, in comparison to the quarterly (winter/spring/summer/fall) estimates already in the literature. Methods: We analyzed time series data on 25OHD, spanning 287 consecutive weeks. The pooled data set comes from 3.44 million serum samples from the United States. We statistically analyzed the proportion of sera that were vitamin D sufficient, defined as 25OHD >= 25 ng/mL, as a function of date. Results: In the United States, serum 25OHD follows a lagged pattern relative to the astronomical seasons, peaking in late summer (August) and troughing in late winter (February). Airmass, which is a function of solar altitude, fits the 25OHD data very well when lagged by 8 weeks. Conclusions: Serum vitamin D levels can be modeled as a function of date, working through a double-log transformation of minimal solar airmass (easily calculated from solar altitude, retrievable from an online solar altitude/azimuth table).	[Kasahara, Amy K.] Univ Calif Irvine, Program Publ Hlth, Irvine, CA USA; [Singh, Ravinder J.] Mayo Clin, Div Clin Biochem & Immunol, Rochester, MN USA; [Noymer, Andrew] Univ Calif Irvine, Dept Populat Hlth & Dis Prevent, Irvine, CA 92717 USA	University of California System; University of California Irvine; Mayo Clinic; University of California System; University of California Irvine	Noymer, A (corresponding author), Univ Calif Irvine, Dept Populat Hlth & Dis Prevent, Irvine, CA 92717 USA.	noymer@uci.edu						Aghajafari F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1169; Antico A, 2012, CLIN REV ALLERG IMMU, V42, P355, DOI 10.1007/s12016-011-8255-1; Azizi E, 2009, PHOTOCHEM PHOTOBIOL, V85, P1240, DOI 10.1111/j.1751-1097.2009.00569.x; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Baeke F, 2010, PEDIATR NEPHROL, V25, P1597, DOI 10.1007/s00467-010-1452-y; Bloomfield P., 2000, FOURIER ANAL TIME SE, P261; Bozzetto S, 2012, ALLERGY, V67, P10, DOI 10.1111/j.1398-9995.2011.02711.x; Calvo MS, 2005, J NUTR, V135, P310, DOI 10.1093/jn/135.2.310; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; DEVGUN MS, 1981, AM J CLIN NUTR, V34, P1501, DOI 10.1093/ajcn/34.8.1501; DEVGUN MS, 1983, CLIN PHYSIOL BIOCH, V1, P300; Garland CF, 2007, J STEROID BIOCHEM, V103, P708, DOI 10.1016/j.jsbmb.2006.12.007; Gorham ED, 2007, AM J PREV MED, V32, P210, DOI 10.1016/j.amepre.2006.11.004; Harris SS, 1998, AM J CLIN NUTR, V67, P1232, DOI 10.1093/ajcn/67.6.1232; Holick MF, 2006, MAYO CLIN PROC, V81, P353, DOI 10.4065/81.3.353; Holick MF, 1977, VITAMIN D BIOCH CHEM, P135; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollis BW, 2004, J CLIN ENDOCR METAB, V89, P3149, DOI 10.1210/jc.2004-0682; Itoh H, 2011, IND HEALTH, V49, P475, DOI 10.2486/indhealth.MS1255; John EM, 2007, AM J EPIDEMIOL, V166, P1409, DOI 10.1093/aje/kwm259; Juzeniene A, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/6/066701; Juzeniene A, 2010, INT J INFECT DIS, V14, pE1099, DOI 10.1016/j.ijid.2010.09.002; Looker AC, 2008, AM J CLIN NUTR, V88, P1519, DOI 10.3945/ajcn.2008.26182; MAXWELL JD, 1994, P NUTR SOC, V53, P533, DOI 10.1079/PNS19940063; McCullagh P, 1989, GEN LINEAR MODELS; McNally JD, 2012, PEDIATRICS, V130, P429, DOI 10.1542/peds.2011-3059; Modarres R, 2012, BONE, V50, P909, DOI 10.1016/j.bone.2012.01.004; Moore C, 2004, J AM DIET ASSOC, V104, P980, DOI 10.1016/j.jada.2004.03.028; National Weather Service, 2012, OC NIN IND ONI DAT; Paul G, 2012, AM J RESP CRIT CARE, V185, P124, DOI 10.1164/rccm.201108-1502CI; Persson LJP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038934; Reusch J, 2009, HORM METAB RES, V41, P402, DOI 10.1055/s-0028-1128131; Schwartz GG, 2007, CURR OPIN CLIN NUTR, V10, P6; Shaman J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020743; Shaw WN, 1901, P R SOC LONDON, V69, P61, DOI 10.1098/rspl.1901.0084; Singh RJ, 2006, J CLIN ENDOCR METAB, V91, P3055, DOI 10.1210/jc.2006-0710; Tucker MA, 2007, NUTR REV, V65, pS84, DOI 10.1111/j.1753-4887.2007.tb00347.x; Tukey JW, 1977, EXPLORATORY DATA ANA; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094; US Naval Observatory, 2012, SUN MOON ALT AZ TABL; Wayse V, 2004, EUR J CLIN NUTR, V58, P563, DOI 10.1038/sj.ejcn.1601845; WEBB AR, 1990, AM J CLIN NUTR, V51, P1075, DOI 10.1093/ajcn/51.6.1075; YOUNG AT, 1994, APPL OPTICS, V33, P1108, DOI 10.1364/AO.33.001108; Zerwekh JE, 2004, ANN CLIN BIOCHEM, V41, P272, DOI 10.1258/0004563041201464; Zhu ZW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-126	45	100	103	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e65785	10.1371/journal.pone.0065785	http://dx.doi.org/10.1371/journal.pone.0065785			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805188	Green Published, gold			2022-12-25	WOS:000320846500016
J	Vinogradova, MV; Malanina, GG; Waitzman, JS; Rice, SE; Fletterick, RJ				Vinogradova, Maia V.; Malanina, Galina G.; Waitzman, Joshua S.; Rice, Sarah E.; Fletterick, Robert J.			Plant Kinesin-Like Calmodulin Binding Protein Employs Its Regulatory Domain for Dimerization	PLOS ONE			English	Article							TRICHOME MORPHOGENESIS; CRYSTAL-STRUCTURE; MOTOR; ARABIDOPSIS; MICROTUBULES; MOTILITY	Kinesin-like calmodulin binding protein (KCBP), a Kinesin-14 family motor protein, is involved in the structural organization of microtubules during mitosis and trichome morphogenesis in plants. The molecular mechanism of microtubule bundling by KCBP remains unknown. KCBP binding to microtubules is regulated by Ca2+ - binding proteins that recognize its C-terminal regulatory domain. In this work, we have discovered a new function of the regulatory domain. We present a crystal structure of an Arabidopsis KCBP fragment showing that the C-terminal regulatory domain forms a dimerization interface for KCBP. This dimerization site is distinct from the dimerization interface within the N-terminal domain. Side chains of hydrophobic residues of the calmodulin binding helix of the regulatory domain form the C-terminal dimerization interface. Biochemical experiments show that another segment of the regulatory domain located beyond the dimerization interface, its negatively charged coil, is unexpectedly and absolutely required to stabilize the dimers. The strong microtubule bundling properties of KCBP are unaffected by deletion of the C-terminal regulatory domain. The slow minus-end directed motility of KCBP is also unchanged in vitro. Although the C-terminal domain is not essential for microtubule bundling, we suggest that KCBP may use its two independent dimerization interfaces to support different types of bundled microtubule structures in cells. Two distinct dimerization sites may provide a mechanism for microtubule rearrangement in response to Ca2+ signaling since Ca2+- binding proteins can disengage KCBP dimers dependent on its C-terminal dimerization interface.	[Vinogradova, Maia V.; Malanina, Galina G.; Fletterick, Robert J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Waitzman, Joshua S.; Rice, Sarah E.] Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA	University of California System; University of California San Francisco; Northwestern University	Fletterick, RJ (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	Robert.Fletterick@ucsf.edu	Gelfand, Vladimir I/D-2545-2013	Gelfand, Vladimir I/0000-0002-6361-2798; Waitzman, Joshua/0000-0003-3364-6281	NIH [R01GM072656]; Myhrvold Family Fellowship from the Fannie and John Hertz Foundation; Malkin Scholars Program from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Northwestern's Cellular and Molecular Basis of Disease training grant [GM08061]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072656] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Myhrvold Family Fellowship from the Fannie and John Hertz Foundation; Malkin Scholars Program from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Northwestern's Cellular and Molecular Basis of Disease training grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The following funds partially supported this work: NIH grant R01GM072656 awarded to Sarah E. Rice; Myhrvold Family Fellowship from the Fannie and John Hertz Foundation, the Malkin Scholars Program from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and Northwestern's Cellular and Molecular Basis of Disease training grant (GM08061) awarded to Joshua Waitzman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2005, PLANT PHYSIOL, V138, P1711, DOI 10.1104/pp.105.060913; Bowser J, 1997, PLANT J, V12, P1429, DOI 10.1046/j.1365-313x.1997.12061429.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Kao YL, 2000, BIOCHEM BIOPH RES CO, V267, P201, DOI 10.1006/bbrc.1999.1896; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Larson AG, 2009, PHYS CHEM CHEM PHYS, V11, P4890, DOI 10.1039/b900968j; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Naber N, 2011, J MOL BIOL, V408, P628, DOI 10.1016/j.jmb.2011.01.001; Oppenheimer DG, 1997, P NATL ACAD SCI USA, V94, P6261, DOI 10.1073/pnas.94.12.6261; Preuss ML, 2003, PLANT PHYSIOL, V132, P154, DOI 10.1104/pp.103.020339; Reddy ASN, 1996, J BIOL CHEM, V271, P7052, DOI 10.1074/jbc.271.12.7052; Reddy VS, 1999, BIOINFORMATICS, V15, P1055; Reddy VS, 2004, PLANT CELL, V16, P185, DOI 10.1105/tpc.016600; Sablin EP, 1998, NATURE, V395, P813, DOI 10.1038/27463; Song H, 1997, P NATL ACAD SCI USA, V94, P322, DOI 10.1073/pnas.94.1.322; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vinogradova MV, 2008, J STRUCT BIOL, V163, P76, DOI 10.1016/j.jsb.2008.04.004; Vinogradova MV, 2009, P NATL ACAD SCI USA, V106, P8175, DOI 10.1073/pnas.0811131106; Vinogradova MV, 2004, J BIOL CHEM, V279, P23504, DOI 10.1074/jbc.M400741200; Vos JW, 2000, PLANT CELL, V12, P979, DOI 10.1105/tpc.12.6.979; WALKER RA, 1990, NATURE, V347, P780, DOI 10.1038/347780a0	21	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66669	10.1371/journal.pone.0066669	http://dx.doi.org/10.1371/journal.pone.0066669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805258	Green Submitted, Green Published, gold			2022-12-25	WOS:000320846500086
J	de Oliveira, APL; Peron, JPS; Franco, ALS; Golega, BA; Vieira, RP; Ibanez, OCM; Ribeiro, OG; Cabrera, WHK; De Franco, M; Oliveira, RM; Rizzo, LV; Vargaftig, BB; de Lima, WT				Ligeiro de Oliveira, Ana Paula; Schatzmann Peron, Jean Pierre; Santos Franco, Adriana Lino; Golega, Beatriz Acceturi; Vieira, Rodolfo Paula; Martinez Ibanez, Olga Celia; Ribeiro, Orlando Garcia; Koury Cabrera, Wafa Hanna; De Franco, Marcelo; Oliveira-Filho, Ricardo Martins; Rizzo, Luiz Vicente; Vargaftig, Bernardo Boris; de Lima, Wothan Tavares			Ovariectomized OVA-Sensitized Mice Display Increased Frequency of CD4(+)Foxp3(+) T Regulatory Cells in the Periphery	PLOS ONE			English	Article							ROR-GAMMA-T; MENSTRUAL-CYCLE; TH17 CELLS; DIFFERENTIATION; ASTHMA; CD4(+)CD25(+); T(H)17; PHASE; INFLAMMATION; LYMPHOCYTES	It is well established that female sex hormones have a pivotal role in inflammation. For instance, our group has previously reported that estradiol has proinflammatory actions during allergic lung response in animal models. Based on these findings, we have decided to further investigate whether T regulatory cells are affected by female sex hormones absence after ovariectomy. We evaluated by flow cytometry the frequencies of CD4(+) Foxp3(+) T regulatory cells (Tregs) in central and peripheral lymphoid organs, such as the thymus, spleen and lymph nodes. Moreover, we have also used the murine model of allergic lung inflammation a to evaluate how female sex hormones would affect the immune response in vivo. To address that, ovariectomized or sham operated female Balb/c mice were sensitized or not with ovalbumin 7 and 14 days later and subsequently challenged twice by aerosolized ovalbumin on day 21. Besides the frequency of CD4(+) Foxp3(+) T regulatory cells, we also measured the cytokines IL-4, IL-5, IL-10, IL-13 and IL-17 in the bronchoalveolar lavage from lungs of ovalbumine challenged groups. Our results demonstrate that the absence of female sex hormones after ovariectomy is able to increase the frequency of Tregs in the periphery. As we did not observe differences in the thymus-derived natural occurring Tregs, our data may indicate expansion or conversion of peripheral adaptive Tregs. In accordance with Treg suppressive activity, ovariectomized and ovalbumine-sensitized and challenged animals had significantly reduced lung inflammation. This was observed after cytokine analysis of lung explants showing significant reduction of pro-inflammatory cytokines, such as IL-4, IL-5, IL-13 and IL-17, associated to increased amount of IL-10. In summary, our data clearly demonstrates that OVA sensitization 7 days after ovariectomy culminates in reduced lung inflammation, which may be directly correlated with the expansion of Tregs in the periphery and further higher IL-10 secretion in the lungs.	[Ligeiro de Oliveira, Ana Paula; Vieira, Rodolfo Paula] Univ Nove de Julho UNINOVE, Programa Posgrad Biofoton Aplicada Ciencias Saude, Sao Paulo, Brazil; [Schatzmann Peron, Jean Pierre] ICB USP, Dept Immunol, Sao Paulo, Brazil; [Santos Franco, Adriana Lino; Golega, Beatriz Acceturi; Oliveira-Filho, Ricardo Martins; Vargaftig, Bernardo Boris; de Lima, Wothan Tavares] ICB USP, Dept Pharmacol, Sao Paulo, Brazil; [Martinez Ibanez, Olga Celia; Ribeiro, Orlando Garcia; Koury Cabrera, Wafa Hanna; De Franco, Marcelo] Butantan Inst, Immunogenet Lab, Sao Paulo, Brazil; [Rizzo, Luiz Vicente] HIAE, Inst Ensino & Pesquisa, Sao Paulo, Brazil	Universidade Nove de Julho; Instituto Butantan; Hospital Israelita Albert Einstein	de Lima, WT (corresponding author), ICB USP, Dept Pharmacol, Sao Paulo, Brazil.	wtavares@usp.br	Cabrera, Wafa HK/F-7189-2016; Oliveira-Filho, Ricardo/F-9287-2015; Ribeiro, Orlando Garcia/AAY-9424-2020; Ibañez, Olga CM/B-9627-2015; Ribeiro, Orlando Garcia/B-5241-2016; Vargaftig, Bernardo Boris B.B.J./C-3323-2013; Rizzo, Luiz Vicente/B-4458-2009; Peron, Jean Pierre S/F-9248-2012; Franco, Adriana Lino dos Santos/AAA-7081-2019; DE FRANCO, MARCELO/S-5870-2019; de Paula Vieira, Rodolfo/E-9315-2011	Ribeiro, Orlando Garcia/0000-0003-2117-2402; Ibañez, Olga CM/0000-0002-2672-4758; Franco, Adriana Lino dos Santos/0000-0002-7854-2833; DE FRANCO, MARCELO/0000-0002-0417-8215; de Paula Vieira, Rodolfo/0000-0001-6379-1143; Ligeiro de Oliveira, Ana Paula/0000-0001-6089-5107	CAPES (PNPD) [02610/09-4, 0188085]; FAPESP [09/07208-0, 09/51886-3, 2006/5595-0, 2007/55631, 2011/18703-2]	CAPES (PNPD)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by CAPES (PNPD number 02610/09-4 and 0188085) and FAPESP ( number 09/07208-0, 09/51886-3, 2006/5595-0, 2007/55631 and 2011/18703-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Andre S, 2009, AM J PATHOL, V174, P1575, DOI 10.2353/ajpath.2009.080987; Arruvito L, 2007, J IMMUNOL, V178, P2572, DOI 10.4049/jimmunol.178.4.2572; Battaglia M, 2009, ANN NY ACAD SCI, V1029, P142; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Chen ML, 2008, J IMMUNOL, V180, P7327, DOI 10.4049/jimmunol.180.11.7327; Chhabra S K, 2005, Indian J Chest Dis Allied Sci, V47, P109; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dardalhon V, 2008, J AUTOIMMUN, V31, P252, DOI 10.1016/j.jaut.2008.04.017; de Oliveira APL, 2004, NEUROIMMUNOMODULAT, V11, P20, DOI 10.1159/000072965; Derbinski G, 2005, JEM, V202, P33; Fitzgerald DC, 2007, J IMMUNOL, V179, P3268, DOI 10.4049/jimmunol.179.5.3268; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Huang TJ, 2001, J IMMUNOL, V166, P207, DOI 10.4049/jimmunol.166.1.207; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jamieson PM, 1999, J ENDOCRINOL, V160, P103, DOI 10.1677/joe.0.1600103; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Keller AC, 2006, J ALLERGY CLIN IMMUN, V117, P283, DOI 10.1016/j.jaci.2005.10.019; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Krug N, 1996, AM J RESP CELL MOL, V14, P319, DOI 10.1165/ajrcmb.14.4.8600935; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Lewkowich IP, 2005, AM J RESP CELL MOL, V25, P125; de Oliveira APL, 2007, AM J PHYSIOL-CELL PH, V293, pC1120, DOI 10.1152/ajpcell.00286.2006; Matthews J, 2007, BIOCHEM J, V406, P343, DOI 10.1042/BJ20070585; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; Mellor AL, 2003, J IMMUNOL, V171, P1652, DOI 10.4049/jimmunol.171.4.1652; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Murphy VE, 2006, THORAX, V61, P169, DOI 10.1136/thx.2005.049718; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Rhodes L, 2005, J ASTHMA, V42, P777, DOI 10.1080/02770900500308387; Riffo-Vasquez Y, 2007, CLIN EXP ALLERGY, V37, P459, DOI 10.1111/j.1365-2222.2007.02670.x; Scariano JK, 2008, J RECEPT SIG TRANSD, V28, P285, DOI [10.1080/10799890802084614, 10.1080/10799890802084614 ]; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Shevach E, 2002, J IMMUNOL, V188, P287; Siracusa MC, 2008, J IMMUNOL, V180, P1423, DOI 10.4049/jimmunol.180.3.1423; Song CW, 2008, J IMMUNOL, V181, P6117, DOI 10.4049/jimmunol.181.9.6117; Stanford KI, 2006, EUR J APPL PHYSIOL, V96, P703, DOI 10.1007/s00421-005-0067-7; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Takeda K, 2009, CURR OPIN IMMUNOL, V21, P660, DOI 10.1016/j.coi.2009.09.005; Wong CK, 2009, IMMUNOL INVEST, V38, P652, DOI 10.1080/08820130903062756; Yang KY, 2009, J AUTOIMMUN, V32, P94, DOI 10.1016/j.jaut.2008.12.004; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhou L., 2007, NAT IMMUNOL, V8, P1	47	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65674	10.1371/journal.pone.0065674	http://dx.doi.org/10.1371/journal.pone.0065674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799034	Green Published, gold, Green Submitted			2022-12-25	WOS:000321397800013
J	Liu, X; Zhu, RX; Li, L; Deng, SM; Li, Q; He, ZY				Liu, Xu; Zhu, Ruixia; Li, Lei; Deng, Shumin; Li, Qu; He, Zhiyi			Genetic Polymorphism in PDE4D Gene and Risk of Ischemic Stroke in Chinese Population: A Meta-Analysis	PLOS ONE			English	Article							PHOSPHODIESTERASE 4D GENE; ASSOCIATION; SURVIVAL; NEURONS; SUSCEPTIBILITY; DEFINITIONS; PROMOTE	Background: Stroke is the second most common cause of death and major cause of disability worldwide. The SNP 83 in PDE4D gene has been suggested as a risk factor in ischemic stroke, but direct evidence from genetic association studies remains inconclusive even in Chinese population. Methods: Meta-analysis of case-control studies on the relationship between SNP 83 in PDE4D gene and susceptibility to ischemic stroke in Chinese population published domestically and abroad from January 2003 to September 2012. Results: 9 case-control studies were selected. Meta-analysis results showed that the significant association between SNP 83 and ischemic stroke was found under the dominant model (OR = 1.34, 95% CI: 1.20-1.49) and recessive model (OR = 1.45, 95% CI: 1.19-1.76) in Chinese population. In subgroup meta-analysis, SNP 83 and atherothrombotic stroke, rather than lacunar stroke, showed the significant association under the dominant model (OR = 1.69, 95% CI: 1.41-2.01) and recessive model (OR = 1.47, 95% CI: 1.04-2.06). Conclusions: The results suggest that SNP 83 in PDE4D gene is significantly associated with susceptibility to ischemic stroke in Chinese population.	[Liu, Xu; Zhu, Ruixia; Li, Lei; Deng, Shumin; Li, Qu; He, Zhiyi] China Med Univ, Affiliated Hosp 1, Dept Neurol, Shenyang, Peoples R China	China Medical University	He, ZY (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Neurol, Shenyang, Peoples R China.	hezhiyi0301@sina.com		Liu, Xu/0000-0002-3956-946X	National Natural Science Foundation of China [30971018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant Number: 30971018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Bevan S, 2008, STROKE, V39, P1966, DOI 10.1161/STROKEAHA.107.509992; Cheng H, 2011, NEURAL REGEN RES, V6, P935, DOI 10.3969/j.issn.1673-5374.2011.12.010; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Flossmann E, 2004, STROKE, V35, P212, DOI 10.1161/01.STR.0000107187.84390.AA; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gulcher JR, 2005, TRENDS MOL MED, V11, P217, DOI 10.1016/j.molmed.2005.03.001; Hanson MG, 1998, J NEUROSCI, V18, P7361; Kuhlenbaumer G, 2006, J NEUROL NEUROSUR PS, V77, P521, DOI 10.1136/jnnp.2005.073577; Li C, 2012, ACTA ACAD MED QINDAO, V48, P304; Li N, 2010, BRAIN RES BULL, V81, P38, DOI 10.1016/j.brainresbull.2009.09.009; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lin HF, 2007, J THROMB HAEMOST, V5, P436, DOI 10.1111/j.1538-7836.2007.02350.x; Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755; Matsushita T, 2009, STROKE, V40, P1245, DOI 10.1161/STROKEAHA.108.527408; Meschia JF, 2011, NAT REV NEUROL, V7, P369, DOI 10.1038/nrneurol.2011.80; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Munshi A, 2008, INT J STROKE, V3, P188, DOI 10.1111/j.1747-4949.2008.00199.x; Munshi A, 2009, J NEUROL SCI, V285, P142, DOI 10.1016/j.jns.2009.06.024; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Nakayama T, 2007, CURR MED CHEM, V14, P3171, DOI 10.2174/092986707782793871; Quarta G, 2009, EUR J HUM GENET, V17, P1448, DOI 10.1038/ejhg.2009.71; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; Saleheen D, 2005, STROKE, V36, P2275, DOI 10.1161/01.STR.0000182242.59466.ee; Sasaki T, 2007, STROKE, V38, P1597, DOI 10.1161/STROKEAHA.106.476754; Staton JM, 2006, J NEUROL NEUROSUR PS, V77, P1067, DOI 10.1136/jnnp.2006.092106; Sun Y, 2009, CLIN SCI, V117, P265, DOI 10.1042/CS20080471; Thrift AG, 2001, STROKE, V32, P1732, DOI 10.1161/01.STR.32.8.1732; Wang HM, 2012, J MED RES, V41, P134; Xu SL, 2008, J CLIN NEUROL, V21, P249; Xu XW, 2010, NEUROGENETICS, V11, P327, DOI 10.1007/s10048-010-0235-8; Xue H, 2009, CLIN SCI, V116, P335, DOI 10.1042/CS20080162; Zhang HL, 2009, J CHIN MICROCIRC, V13, P624	33	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66374	10.1371/journal.pone.0066374	http://dx.doi.org/10.1371/journal.pone.0066374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799094	Green Published, gold, Green Submitted			2022-12-25	WOS:000321397800028
J	Komatsu, S; Makino, T; Yasue, H				Komatsu, Setsuko; Makino, Takahiro; Yasue, Hiroshi			Proteomic and Biochemical Analyses of the Cotyledon and Root of Flooding-Stressed Soybean Plants	PLOS ONE			English	Article							CALCIUM-OXALATE; SEEDLINGS; TOLERANCE; MECHANISM	Background: Flooding significantly reduces the growth and grain yield of soybean plants. Proteomic and biochemical techniques were used to determine whether the function of cotyledon and root is altered in soybean under flooding stress. Results: Two-day-old soybean plants were flooded for 2 days, after which the proteins from root and cotyledon were extracted for proteomic analysis. In response to flooding stress, the abundance of 73 and 28 proteins was significantly altered in the root and cotyledon, respectively. The accumulation of only one protein, 70 kDa heat shock protein (HSP70) (Glyma17g08020.1), increased in both organs following flooding. The ratio of protein abundance of HSP70 and biophoton emission in the cotyledon was higher than those detected in the root under flooding stress. Computed tomography and elemental analyses revealed that flooding stress decreases the number of calcium oxalate crystal the cotyledon, indicating calcium ion was elevated in the cotyledon under flooding stress. Conclusion: These results suggest that calcium might play one role through HSP70 in the cotyledon under flooding stress.	[Komatsu, Setsuko] NARO, Natl Inst Crop Sci, Tsukuba, Ibaraki, Japan; [Makino, Takahiro] Grad Sch Creat New Photon Ind, Hamamatsu, Shizuoka, Japan; [Yasue, Hiroshi] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Agrobiological Sciences - Japan	Komatsu, S (corresponding author), NARO, Natl Inst Crop Sci, Tsukuba, Ibaraki, Japan.	skomatsu@affrc.go.jp			Japan Society for the Promotion of Science [23658063]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-In-Aid for Challenging Exploratory Research (23658063) from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Bennett M, 2005, MOL PLANT MICROBE IN, V18, P95, DOI 10.1094/MPMI-18-0095; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAPLAN AJ, 1993, MOL BIOL CELL, V4, P555, DOI 10.1091/mbc.4.6.555; Cha JY, 2012, PLANT PHYSIOL BIOCH, V58, P29, DOI 10.1016/j.plaphy.2012.06.006; Chiera JM, 2007, J EXP BOT, V58, P2261, DOI 10.1093/jxb/erm101; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; Githiri SM, 2006, PLANT BREEDING, V125, P613, DOI 10.1111/j.1439-0523.2006.01291.x; Hashiguchi A, 2009, J PROTEOME RES, V8, P2058, DOI 10.1021/pr801051m; Hossain Z, 2012, J PROTEOMICS, V75, P4151, DOI 10.1016/j.jprot.2012.05.037; Ilarslan H, 2001, ANN BOT-LONDON, V88, P243, DOI 10.1006/anbo.2001.1453; Kausar R, 2012, MOL BIOL REP, V39, P10573, DOI 10.1007/s11033-012-1945-9; Khatoon A, 2012, AMINO ACIDS, V43, P2513, DOI 10.1007/s00726-012-1333-8; Khatoon A, 2012, J PROTEOMICS, V75, P5706, DOI 10.1016/j.jprot.2012.07.031; Kobayashi M, 1997, PHOTOCHEM PHOTOBIOL, V65, P535, DOI 10.1111/j.1751-1097.1997.tb08600.x; Komatsu S, 2013, J PROTEOMICS; Komatsu S, 2013, J PROTEOMICS, V79, P231, DOI 10.1016/j.jprot.2012.12.023; Komatsu S, 2012, J PROTEOME RES, V11, P68, DOI 10.1021/pr2008863; Komatsu S, 2011, PLANT MOL BIOL, V77, P309, DOI 10.1007/s11103-011-9812-y; Komatsu S, 2011, J PROTEOME RES, V10, P3993, DOI 10.1021/pr2001918; Komatsu S, 2009, J PROTEOME RES, V8, P4766, DOI 10.1021/pr900460x; Komatsu S, 2010, AMINO ACIDS, V38, P729, DOI 10.1007/s00726-009-0277-0; Makino T, 1996, PHOTOCHEM PHOTOBIOL, V64, P953, DOI 10.1111/j.1751-1097.1996.tb01860.x; Mathesius U, 2011, PROTEOMICS, V11, P1707, DOI 10.1002/pmic.201000619; Nanjo Y, 2011, PLANT MOL BIOL, V77, P129, DOI 10.1007/s11103-011-9799-4; Nanjo Y, 2010, J PROTEOME RES, V9, P3989, DOI 10.1021/pr100179f; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Setter TL, 2003, PLANT SOIL, V253, P1, DOI 10.1023/A:1024573305997; Subbaiah CC, 2003, ANN BOT-LONDON, V91, P119, DOI 10.1093/aob/mcf210; Suri SS, 2008, PLANT CELL ENVIRON, V31, P218, DOI 10.1111/j.1365-3040.2007.01754.x; Webb MA, 1999, PLANT CELL, V11, P751, DOI 10.1105/tpc.11.4.751; Yanagawa Y, 2012, PLANT SCI, V185, P250, DOI 10.1016/j.plantsci.2011.11.014	33	38	41	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65301	10.1371/journal.pone.0065301	http://dx.doi.org/10.1371/journal.pone.0065301			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799004	Green Published, gold, Green Submitted			2022-12-25	WOS:000320363300011
J	Richter, S; Morrison, S; Connor, T; Su, JC; Print, CG; Ronimus, RS; Mcgee, SL; Wilson, WR				Richter, Susan; Morrison, Shona; Connor, Tim; Su, Jiechuang; Print, Cristin G.; Ronimus, Ron S.; Mcgee, Sean L.; Wilson, William R.			Zinc Finger Nuclease Mediated Knockout of ADP-Dependent Glucokinase in Cancer Cell Lines: Effects on Cell Survival and Mitochondrial Oxidative Metabolism	PLOS ONE			English	Article							GENE KNOCKOUT; GENOME; HYPOXIA; HEXOKINASE; GENERATION; PHOSPHORYLATION; IDENTIFICATION; ACTIVATION; GLYCOLYSIS; EXPRESSION	Zinc finger nucleases (ZFN) are powerful tools for editing genes in cells. Here we use ZFNs to interrogate the biological function of ADPGK, which encodes an ADP-dependent glucokinase (ADPGK), in human tumour cell lines. The hypothesis we tested is that ADPGK utilises ADP to phosphorylate glucose under conditions where ATP becomes limiting, such as hypoxia. We characterised two ZFN knockout clones in each of two lines (H460 and HCT116). All four clones had frameshift mutations in all alleles at the target site in exon 1 of ADPGK, and were ADPGK-null by immunoblotting. ADPGK knockout had little or no effect on cell proliferation, but compromised the ability of H460 cells to survive siRNA silencing of hexokinase-2 under oxic conditions, with clonogenic survival falling from 21 +/- 3% for the parental line to 6.4 +/- 0.8% (p = 0.002) and 4.3 +/- 0.8% (p = 0.001) for the two knockouts. A similar increased sensitivity to clonogenic cell killing was observed under anoxia. No such changes were found when ADPGK was knocked out in HCT116 cells, for which the parental line was less sensitive than H460 to anoxia and to hexokinase-2 silencing. While knockout of ADPGK in HCT116 cells caused few changes in global gene expression, knockout of ADPGK in H460 cells caused notable up-regulation of mRNAs encoding cell adhesion proteins. Surprisingly, we could discern no consistent effect on glycolysis as measured by glucose consumption or lactate formation under anoxia, or extracellular acidification rate (Seahorse XF analyser) under oxic conditions in a variety of media. However, oxygen consumption rates were generally lower in the ADPGK knockouts, in some cases markedly so. Collectively, the results demonstrate that ADPGK can contribute to tumour cell survival under conditions of high glycolytic dependence, but the phenotype resulting from knockout of ADPGK is cell line dependent and appears to be unrelated to priming of glycolysis in these lines.	[Richter, Susan; Su, Jiechuang; Wilson, William R.] Univ Auckland, Auckland Canc Soc Res Ctr, Auckland 1, New Zealand; [Print, Cristin G.] Univ Auckland, Fac Med & Hlth Sci, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Print, Cristin G.] Univ Auckland, New Zealand Bioinformat Inst, Auckland 1, New Zealand; [Morrison, Shona; Connor, Tim; Mcgee, Sean L.] Deakin Univ, Sch Med, Metab Res Unit, Geelong, Vic 3217, Australia; [Ronimus, Ron S.] AgResearch, Palmerston North, New Zealand	University of Auckland; University of Auckland; University of Auckland; Deakin University; AgResearch - New Zealand	Wilson, WR (corresponding author), Univ Auckland, Auckland Canc Soc Res Ctr, Auckland 1, New Zealand.	wr.wilson@auckland.ac.nz	Richter, Susan/AAP-1767-2020	Richter, Susan/0000-0002-3549-2477; Ronimus, Ron/0000-0001-8669-5840; Print, Cristin/0000-0001-8345-7812; McGee, Sean/0000-0001-6953-106X	Royal Society of New Zealand Marsden Fund; National Health and Medical Research Council (NHMRC) [1027226, 1027227]	Royal Society of New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the Royal Society of New Zealand Marsden Fund (www.royalsociety.org.nz/programmes/funds/marsden/). SLM is supported by a National Health and Medical Research Council (NHMRC) Career Development Fellowship and project grants from the NHMRC (1027226 and 1027227). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki H, 2012, FEBS OPEN B IN PRESS; Beumer K, 2006, GENETICS, V172, P2391, DOI 10.1534/genetics.105.052829; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Carroll D, 2011, CURR GENE THER, V11, P2, DOI 10.2174/156652311794520076; Cost GJ, 2010, BIOTECHNOL BIOENG, V105, P330, DOI 10.1002/bit.22541; Doberstein K, 2011, CARCINOGENESIS, V32, P262, DOI 10.1093/carcin/bgq249; Fan LC, 2012, BIOTECHNOL BIOENG, V109, P1007, DOI 10.1002/bit.24365; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Isalan M, 2012, NAT METHODS, V9, P32, DOI 10.1038/nmeth.1805; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kaminski MM, 2012, CELL REP, V2, P1300, DOI 10.1016/j.celrep.2012.10.009; KENGEN SWM, 1994, J BIOL CHEM, V269, P17537; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Kurtoglu M, 2007, ANTIOXID REDOX SIGN, V9, P1383, DOI 10.1089/ars.2007.1714; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Li K, 2009, WORLD J GASTROENTERO, V15, P697, DOI 10.3748/wjg.15.697; Liu PQ, 2010, BIOTECHNOL BIOENG, V106, P97, DOI 10.1002/bit.22654; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; MacLeod RAF, 2007, NAT PROTOC, V2, P372, DOI 10.1038/nprot.2007.29; Mailloux RJ, 2011, BIOCHEM J, V437, P301, DOI 10.1042/BJ20110571; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; Monahan TS, 2007, J VASC SURG, V45, P581, DOI 10.1016/j.jvs.2006.12.016; Nelson EA, 2006, J BIOL CHEM, V281, P26216, DOI 10.1074/jbc.M605001200; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Palpant NJ, 2012, GENE THER, pe1; Papandreou I, 2005, CANCER RES, V65, P3171, DOI 10.1158/0008-5472.CAN-04-3395; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Pruett-Miller SM, 2008, MOL THER, V16, P707, DOI 10.1038/mt.2008.20; Pruett-Miller SM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000376; Qiu P, 2004, BIOTECHNIQUES, V36, P702, DOI 10.2144/04364PF01; Richter S, 2012, MOL CELL BIOCHEM, V364, P131, DOI 10.1007/s11010-011-1212-8; Ronimus RS, 2004, BIOCHEM BIOPH RES CO, V315, P652, DOI 10.1016/j.bbrc.2004.01.103; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; SEABRIGHT M, 1972, CHROMOSOMA, V36, P204; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/NMETH.1731, 10.1038/nmeth.1731]; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Warburg O, 1924, BIOCHEM Z, V152, P309; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Wong AW, 2010, BIOTECHNOL BIOENG, V106, P751, DOI 10.1002/bit.22749; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yoneda M, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-27; Zhang PQ, 2012, GLYCOBIOLOGY, V22, P897, DOI 10.1093/glycob/cws064	55	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65267	10.1371/journal.pone.0065267	http://dx.doi.org/10.1371/journal.pone.0065267			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799003	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300010
J	Viswanathan, S; Muthu, V; Iqbal, N; Remalayam, B; George, T				Viswanathan, Stalin; Muthu, Vivekanandan; Iqbal, Nayyar; Remalayam, Bhavith; George, Tarun			Scrub Typhus Meningitis in South India - A Retrospective Study	PLOS ONE			English	Article							TUBERCULOUS MENINGITIS; ORIENTIA-TSUTSUGAMUSHI; CLINICAL-MANIFESTATIONS; ADENOSINE-DEAMINASE; LABORATORY FINDINGS; RISK-FACTORS; DIAGNOSIS; MENINGOENCEPHALITIS; OUTBREAK; PALSY	Background: Scrub typhus is prevalent in India although definite statistics are not available. There has been only one study on scrub typhus meningitis 20 years ago. Most reports of meningitis/meningoencephalitis in scrub typhus are case reports Methods: A retrospective study done in Pondicherry to extract cases of scrub typhus admitted to hospital between February 2011 and January 2012. Diagnosis was by a combination of any one of the following in a patient with an acute febrile illness-a positive scrub IgM ELISA, Weil-Felix test, and an eschar. Lumbar puncture was performed in patients with headache, nuchal rigidity, altered sensorium or cranial nerve deficits. Results: Sixty five cases of scrub typhus were found, and 17 (17/65) had meningitis. There were 33 males and 32 females. Thirteen had an eschar. Median cerebrospinal fluid (CSF) cell count, lymphocyte percentage, CSF protein, CSF glucose/blood glucose, CSF ADA were 54 cells/mu L, 98%, 88 mg/dL, 0.622 and 3.5 U/mL respectively. Computed tomography was normal in patients with altered sensorium and cranial nerve deficits. Patients with meningitis had lesser respiratory symptoms and signs and higher urea levels. All patients had received doxycycline except one who additionally received chloramphenicol. Conclusion: Meningitis in scrub typhus is mild with quick and complete recovery. Clinical features and CSF findings can mimic tuberculous meningitis, except for ADA levels. In the Indian context where both scrub typhus and tuberculosis are endemic, ADA and scrub IgM may be helpful in identifying patients with scrub meningitis and in avoiding prolonged empirical antituberculous therapy in cases of lymphocytic meningitis.	[Viswanathan, Stalin; Muthu, Vivekanandan] Indira Gandhi Med Coll, Dept Gen Med, Pondicherry, India; [Iqbal, Nayyar; Remalayam, Bhavith; George, Tarun] Pondicherry Inst Med Sci, Dept Internal Med, Pondicherry, India	Pondicherry Institute of Medical Sciences	Viswanathan, S (corresponding author), Indira Gandhi Med Coll, Dept Gen Med, Pondicherry, India.	stalinviswanathan@ymail.com	Viswanathan, Stalin/H-3019-2019	Viswanathan, Stalin/0000-0001-5861-5161				Boorugu Harikishan, 2010, J Assoc Physicians India, V58, P520; Chen Pei-Hao, 2006, Acta Neurol Taiwan, V15, P251; Garg RK, 2010, ACTA NEUROL SCAND, V122, P75, DOI 10.1111/j.1600-0404.2009.01316.x; Harden V.A., 1993, CAMBRIDGE WORLD HIST, V153, P355; Hayakawa K, 2012, J MED MICROBIOL, V61, P291, DOI 10.1099/jmm.0.034678-0; Iqbal N, 2012, TROPICAL MED HLTH, V40; Isaac R, 2004, CLIN INFECT DIS, V39, P1395, DOI 10.1086/424748; Jeong YJ, 2007, RADIOGRAPHICS, V27, P161, DOI 10.1148/rg.271065074; Jim WT, 2009, PEDIATR NEONATOL, V50, P96, DOI 10.1016/S1875-9572(09)60043-7; Kamarasu K, 2007, INDIAN J MED RES, V126, P128; Kang JI, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-173; Khan SA, 2012, INT J INFECT DIS; Kim DM, 2011, DIAGN MICR INFEC DIS, V69, P271, DOI 10.1016/j.diagmicrobio.2010.10.005; Kim DM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-108; Kim JH, 2008, J CLIN NEUROL, V4, P36, DOI 10.3988/jcn.2008.4.1.36; Koh GCKW, 2010, AM J TROP MED HYG, V82, P368, DOI 10.4269/ajtmh.2010.09-0233; Kularatne SA, 2012, INT J INFECT DIS; Lai CH, 2009, EMERG INFECT DIS, V15, P1659, DOI 10.3201/eid1510.090007; Lee CS, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-216; Lee CS, 2009, AM J TROP MED HYG, V81, P484, DOI 10.4269/ajtmh.2009.81.484; Lee KL, 2008, DIAGN MICR INFEC DIS, V60, P237, DOI 10.1016/j.diagmicrobio.2007.09.015; Lee SH, 2007, SCAND J INFECT DIS, V39, P826, DOI 10.1080/00365540701266755; Lee YH, 2010, J AAPOS, V14, P460, DOI 10.1016/j.jaapos.2010.06.016; Lin WR, 2011, KAOHSIUNG J MED SCI, V27, P573, DOI 10.1016/j.kjms.2011.10.003; Liu YX, 2006, EMERG INFECT DIS, V12, P1109; Liu YX, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-82; Mahajan SK, 2010, EMERG INFECT DIS, V16, P1641, DOI 10.3201/eid1610.100456; Mathai E, 2003, ANN NY ACAD SCI, V990, P359, DOI 10.1111/j.1749-6632.2003.tb07391.x; Moghtaderi A, 2009, SCAND J INFECT DIS, V41, P188, DOI 10.1080/00365540902721384; Murthy JMK, 2010, NEUROL INDIA, V58, P716, DOI 10.4103/0028-3886.72178; Oaks JSC, 1983, BULLETIN, P1; PAPEZ JW, 1949, ARCH NEURO PSYCHIATR, V61, P545, DOI 10.1001/archneurpsyc.1949.02310110080004; Parola P, 2006, CLIN DERMATOL, V24, P191, DOI 10.1016/j.clindermatol.2005.11.007; Premaratna R, 2006, CLIN INFECT DIS, V42; Rajapakse S, 2012, ASIAN PAC J TROP MED, V5, P261, DOI 10.1016/S1995-7645(12)60036-4; Remalayam B, 2011, J POSTGRAD MED, V57, P262, DOI 10.4103/0022-3859.85231; Saifudheen K, 2012, ANN INDIAN ACAD NEUR, V15, P141, DOI 10.4103/0972-2327.95002; Seong SY, 2001, MICROBES INFECT, V3, P11, DOI 10.1016/S1286-4579(00)01352-6; Sharma PK, 2009, T ROY SOC TROP MED H, V103, P1153, DOI 10.1016/j.trstmh.2009.02.006; SILPAPOJAKUL K, 1991, ARCH INTERN MED, V151, P1753, DOI 10.1001/archinte.151.9.1753; Silpapojakul K, 2004, T ROY SOC TROP MED H, V98, P354, DOI 10.1016/j.trstmh.2003.10.011; Sittiwangkul R, 2008, ANN TROP PAEDIATR, V28, P149, DOI 10.1179/146532808X302189; Sun Q, 2012, AM J MED SCI, V344, P116, DOI 10.1097/MAJ.0b013e318238fee3; Suntharasaj T, 1997, J Obstet Gynaecol Res, V23, P75; Thakur JS, 2011, J LARYNGOL OTOL, V125, P567, DOI 10.1017/S0022215111000107; Thwaites GE, 2002, LANCET, V360, P1287, DOI 10.1016/S0140-6736(02)11318-3; Ting K S, 1992, J Formos Med Assoc, V91, P110; Tsay RW, 2002, QJM-INT J MED, V95, P126, DOI 10.1093/qjmed/95.2.126; Tuon FF, 2010, SCAND J INFECT DIS, V42, P198, DOI 10.3109/00365540903428158; Varghese GM, 2006, J INFECTION, V52, P56, DOI 10.1016/j.jinf.2005.02.001; Vivekanandan M, 2010, J Assoc Physicians India, V58, P24; Yang S-H, 2005, TZU CHI MED J, V17, P111; Yum KS, 2011, CLIN NEUROL NEUROSUR, V113, P250, DOI 10.1016/j.clineuro.2010.11.007	53	75	79	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66595	10.1371/journal.pone.0066595	http://dx.doi.org/10.1371/journal.pone.0066595			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799119	Green Published, gold, Green Submitted			2022-12-25	WOS:000320363300091
J	Cen, JR; Shi, MS; Yang, YF; Fu, YX; Zhou, HL; Wang, MQ; Su, ZY; Wei, Q				Cen, Juren; Shi, Mingshu; Yang, Yanfang; Fu, Yanxia; Zhou, Hailing; Wang, Mengqi; Su, Zhenyi; Wei, Qun			Isogarcinol Is a New Immunosuppressant	PLOS ONE			English	Article							CYCLOSPORINE-A; BENZOPHENONE DERIVATIVES; ORGAN-TRANSPLANTATION; MEDICINAL PROPERTIES; CARDIAC GROWTH; CALCINEURIN; INHIBITION; KAEMPFEROL; MECHANISM; FRUIT	Calcineurin (CN), a unique protein phosphatase, plays an important role in immune regulation. In this study we used CN as a target enzyme to investigate the immunosuppressive properties of a series of natural compounds from Garcinia mangostana L., and discovered an active compound, isogarcinol. Enzymatic assays showed that isogarcinol inhibited CN in a dose-dependent manner. At concentrations resulting in relatively low cytotoxicity isogarcinol significantly inhibited proliferation of murine spleen T-lymphocytes induced by concanavalin A (ConA) and the mixed lymphocyte reaction (MLR). In addition, it performed much better in acute toxicity tests and via oral administration in mice than cyclosporin A (CsA), with few adverse reactions and low toxicity in experimental animals. Oral administration of isogarcinol in mice resulted in a dose-dependent decrease in delayed type hypersensitivity (DTH) and prolonged graft survival in allogeneic skin transplantation. These findings suggest that isogarcinol could serve as a new oral immunomodulatory drug for preventing transplant rejection, and for long-term medication in autoimmune diseases.	[Cen, Juren; Shi, Mingshu; Fu, Yanxia; Zhou, Hailing; Wang, Mengqi; Su, Zhenyi; Wei, Qun] Beijing Normal Univ, Gene Engn & Biotechnol Beijing Key Lab, Dept Biochem & Mol Biol, Beijing 100875, Peoples R China; [Yang, Yanfang] Hubei Univ Chinese Med, Prov & Minist Established Key Lab Resource & Comp, Wuhan, Peoples R China	Beijing Normal University; Hubei University of Chinese Medicine	Wei, Q (corresponding author), Beijing Normal Univ, Gene Engn & Biotechnol Beijing Key Lab, Dept Biochem & Mol Biol, Beijing 100875, Peoples R China.	weiq@bnu.edu.cn	Su, Zhenyi/AHC-5959-2022		National Natural Science Foundation of China; National Important Novel Medicine Research Project; International Cooperation Project; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Important Novel Medicine Research Project; International Cooperation Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The work was supported by grants from the National Natural Science Foundation of China, the National Important Novel Medicine Research Project, the International Cooperation Project and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baksh S, 2000, SEMIN IMMUNOL, V12, P405, DOI 10.1006/smim.2000.0221; BENNETT WM, 1986, ANNU REV MED, V37, P215; BIERER BE, 1993, CURR OPIN IMMUNOL, V5, P763, DOI 10.1016/0952-7915(93)90135-F; Cardenas ME, 1998, TRENDS BIOTECHNOL, V16, P427, DOI 10.1016/S0167-7799(98)01239-6; CLIPSTONE NA, 1993, ANN NY ACAD SCI, V696, P20; Cuesta-Rubio O, 2005, STUD NAT PROD CHEM, V32, P671; Cui JH, 2010, PHARMACOL BIOCHEM BE, V95, P166, DOI 10.1016/j.pbb.2009.12.021; Feng YH, 2002, ACTA PHARMACOL SIN, V23, P893; Gonsette RE, 2004, J NEUROL SCI, V223, P87, DOI 10.1016/j.jns.2004.04.025; Ho S, 1996, CLIN IMMUNOL IMMUNOP, V80, pS40, DOI 10.1006/clin.1996.0140; Hong JC, 2000, SEMIN NEPHROL, V20, P108; Iinuma M, 1996, BIOL PHARM BULL, V19, P311, DOI 10.1248/bpb.19.311; Issa F, 2010, EXPERT REV CLIN IMMU, V6, P155, DOI 10.1586/ECI.09.64; Ito C, 2003, J NAT PROD, V66, P206, DOI 10.1021/np020372g; Jorgensen KA, 2003, SCAND J IMMUNOL, V57, P93, DOI 10.1046/j.1365-3083.2003.01221.x; Kobayashi K, 2001, MICROSC RES TECHNIQ, V53, P241, DOI 10.1002/jemt.1090; Lechler RI, 2005, NAT MED, V11, P605, DOI 10.1038/nm1251; Lei H, 2011, FOOD CHEM, V127, P1169, DOI 10.1016/j.foodchem.2011.01.119; Lei H, 2009, BBA-PROTEINS PROTEOM, V1794, P1269, DOI 10.1016/j.bbapap.2009.04.014; Li JY, 2010, PHARM BIOL, V48, P1177, DOI 10.3109/13880200903573169; Li X, 2012, INT IMMUNOPHARMACOLO; Liang QR, 2003, EMBO J, V22, P5079, DOI 10.1093/emboj/cdg474; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Mantelingu K, 2007, CHEM BIOL, V14, P645, DOI 10.1016/j.chembiol.2007.04.011; Marti G, 2010, MOLECULES, V15, P7106, DOI 10.3390/molecules15107106; Matsumoto K, 2003, BIOL PHARM BULL, V26, P569, DOI 10.1248/bpb.26.569; Moussay E, 2010, RES DETERMINATION GE; Pedraza-Chaverri J, 2008, FOOD CHEM TOXICOL, V46, P3227, DOI 10.1016/j.fct.2008.07.024; Peng LQ, 2011, IUBMB LIFE, V63, P14, DOI 10.1002/iub.408; Rathee P, 2012, PHARM INNOVATION J, V1, P90; Roy J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2100re9; Rukachaisirikul V, 2005, CHEM PHARM BULL, V53, P342, DOI 10.1248/cpb.53.342; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Salem ML, 2005, INT IMMUNOPHARMACOL, V5, P1749, DOI 10.1016/j.intimp.2005.06.008; Shen J, 2006, STUDIES CHEM CONSTIT; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; STALLARD N, 1995, HUM EXP TOXICOL, V14, P315, DOI 10.1177/096032719501400401; THOMSON AW, 1984, AGENTS ACTIONS, V15, P307, DOI 10.1007/BF01972366; Vega RB, 2003, J BIOL CHEM, V278, P36981, DOI 10.1074/jbc.R300023200; Wang HL, 2007, IUBMB LIFE, V59, P388, DOI 10.1080/15216540701370721; Wang H, 2008, IUBMB LIFE, V60, P549, DOI 10.1002/iub.94; Wang H, 2010, J BIOCHEM, V147, P185, DOI 10.1093/jb/mvp163; Yu LM, 2007, FOOD CHEM, V104, P176, DOI 10.1016/j.foodchem.2006.11.018; Zhou R, 2005, INT IMMUNOPHARMACOL, V5, P1895, DOI 10.1016/j.intimp.2005.06.009	44	96	102	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66503	10.1371/journal.pone.0066503	http://dx.doi.org/10.1371/journal.pone.0066503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785505	gold, Green Published, Green Submitted			2022-12-25	WOS:000321038800016
J	Martin, B; Chesnel, F; Delcros, JG; Jouan, F; Couturier, A; Dugay, F; Le Goff, X; Patard, JJ; Fergelot, P; Vigneau, C; Rioux-Leclercq, N; Arlot-Bonnemains, Y				Martin, Benedicte; Chesnel, Franck; Delcros, Jean-Guy; Jouan, Florence; Couturier, Anne; Dugay, Frederic; Le Goff, Xavier; Patard, Jean-Jacques; Fergelot, Patricia; Vigneau, Cecile; Rioux-Leclercq, Nathalie; Arlot-Bonnemains, Yannick			Identification of pVHL as a Novel Substrate for Aurora-A in Clear Cell Renal Cell Carcinoma (ccRCC)	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; EXPRESSION; CANCER; KINASES; CLASSIFICATION; DROSOPHILA; TISSUES; BREAST; GRADE	Clear cell renal cell carcinoma (ccRCC) is the most common histological subtype of kidney cancer and is often characterized by mutations or deletions of the Von Hippel Lindau (VHL) tumour suppressor gene. Aurora gene family members are implicated in proper mitotic progression and spindle checkpoint function and play a crucial role in cancer progression. In the present study, we assessed the expression of Aurora-A in a cohort of 30 ccRCC with fully characterized VHL status (wt/wt or mut/del) and Fuhrman grade. Aurora-A transcript and protein levels were significantly increased in high Fuhrman grade tumours and in VHLwt/wt tumours. These results suggest that Aurora-A and VHL interact in the ccRCC. We demonstrated that the two proteins interact in vivo and identified the Ser72 on the sequence of VHL as the unique site phosphorylated by Aurora-A.	[Martin, Benedicte; Chesnel, Franck; Jouan, Florence; Couturier, Anne; Dugay, Frederic; Le Goff, Xavier; Vigneau, Cecile; Rioux-Leclercq, Nathalie; Arlot-Bonnemains, Yannick] Univ Rennes 1, BIOSIT, CNRS, IGDR,UMR 6290, Rennes, France; [Delcros, Jean-Guy] Ctr Leon Berard, Ctr Rech Cancerol Lyon, UMR INSERM CNRS U1052 5286, Lyon, France; [Patard, Jean-Jacques] CHU Bordeaux, Serv Genet Mol, Bordeaux, France; [Fergelot, Patricia] Hop Bicetre, AP HP, Serv Chirurg Urol, Le Kremlin Bicetre, France; [Rioux-Leclercq, Nathalie] CHU Pontchaillou, Dept Pathol, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; CHU Rennes	Arlot-Bonnemains, Y (corresponding author), Univ Rennes 1, BIOSIT, CNRS, IGDR,UMR 6290, Rennes, France.	Yannick.arlot@univ-rennes1.fr	FERGELOT, Patricia/M-4493-2014; delcros, jean-guy/N-5813-2017; vigneau, cecile/I-3178-2015; DUGAY, Frédéric/L-9198-2015	delcros, jean-guy/0000-0002-9593-4046; LE GOFF, Xavier/0000-0002-5297-2421; MARTIN, Benedicte/0000-0003-0897-5884	CNRS, the Ligue Nationale Contre le Cancer	CNRS, the Ligue Nationale Contre le Cancer	This work was supported by the CNRS, the Ligue Nationale Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampofo E, 2010, INT J BIOCHEM CELL B, V42, P1729, DOI 10.1016/j.biocel.2010.07.008; Arlot-Bonnemains Y, 2001, FEBS LETT, V508, P149, DOI 10.1016/S0014-5793(01)03048-4; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bodmer D, 2002, CANCER GENET CYTOGEN, V134, P6, DOI 10.1016/S0165-4608(01)00585-4; Bufo P, 2010, HISTOL HISTOPATHOL, V25, P1371, DOI 10.14670/HH-25.1371; Buschhorn HM, 2005, PROSTATE, V64, P341, DOI 10.1002/pros.20247; CHEN F, 1995, CANCER RES, V55, P4804; CROSSEY PA, 1994, HUM MOL GENET, V3, P1303; Ehara H, 2003, UROL RES, V31, P382, DOI 10.1007/s00240-003-0354-x; FOSTER K, 1994, BRIT J CANCER, V69, P230, DOI 10.1038/bjc.1994.44; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Hergovich A, 2006, MOL CELL BIOL, V26, P5784, DOI 10.1128/MCB.00232-06; Hoque A, 2003, CANCER EPIDEM BIOMAR, V12, P1518; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Kimura M, 1997, J BIOL CHEM, V272, P13766, DOI 10.1074/jbc.272.21.13766; Klotzbucher Andrea, 2002, Biological Procedures Online, V4, P62, DOI 10.1251/bpo35; Kovacs G, 1997, J PATHOL, V183, P131, DOI 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G; Kurahashi T, 2007, UROL ONCOL-SEMIN ORI, V25, P128, DOI 10.1016/j.urolonc.2006.06.001; Lei Y, 2011, ACTA HISTOCHEM, V113, P514, DOI 10.1016/j.acthis.2010.05.004; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; Patard JJ, 2009, BRIT J CANCER, V101, P1417, DOI 10.1038/sj.bjc.6605298; Patard JJ, 2009, CURR OPIN UROL, V19, P454, DOI 10.1097/MOU.0b013e32832f0ccd; Pause A, 1998, P NATL ACAD SCI USA, V95, P993, DOI 10.1073/pnas.95.3.993; Royce ME, 2004, CANCER, V100, P12, DOI 10.1002/cncr.11879; Seagroves T, 2002, CANCER CELL, V1, P211, DOI 10.1016/S1535-6108(02)00048-X; SEIZINGER BR, 1988, NATURE, V332, P268, DOI 10.1038/332268a0; THOENES W, 1986, PATHOL RES PRACT, V181, P125, DOI 10.1016/S0344-0338(86)80001-2; Thoma CR, 2009, NAT CELL BIOL, V11, P994, DOI 10.1038/ncb1912; Ulisse S, 2007, ENDOCR-RELAT CANCER, V14, P827, DOI 10.1677/ERC-07-0053; Ulisse S, 2006, INT J CANCER, V119, P275, DOI 10.1002/ijc.21842	32	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e67071	10.1371/journal.pone.0067071	http://dx.doi.org/10.1371/journal.pone.0067071			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785518	gold, Green Published			2022-12-25	WOS:000321038800006
J	Zhang, ZZ; Matos, SC; Jego, S; Adamantidis, A; Seguela, P				Zhang, Zizhen; Matos, Steven Cordeiro; Jego, Sonia; Adamantidis, Antoine; Seguela, Philippe			Norepinephrine Drives Persistent Activity in Prefrontal Cortex via Synergistic alpha 1 and alpha 2 Adrenoceptors	PLOS ONE			English	Article							LOCUS-COERULEUS NEURONS; SPATIAL WORKING-MEMORY; PROTEIN-KINASE-C; POSTTRAUMATIC-STRESS-DISORDER; AXONAL GABA(A) RECEPTORS; HUMAN FRONTAL-CORTEX; PYRAMIDAL NEURONS; COGNITIVE FUNCTION; RAT-BRAIN; ALPHA-1-ADRENERGIC ANTAGONIST	Optimal norepinephrine levels in the prefrontal cortex (PFC) increase delay-related firing and enhance working memory, whereas stress-related or pathologically high levels of norepinephrine are believed to inhibit working memory via alpha 1 adrenoceptors. However, it has been shown that activation of Gq-coupled and phospholipase C-linked receptors can induce persistent firing, a cellular correlate of working memory, in cortical pyramidal neurons. Therefore, despite its importance in stress and cognition, the exact role of norepinephrine in modulating PFC activity remains elusive. Using electrophysiology and optogenetics, we report here that norepinephrine induces persistent firing in pyramidal neurons of the PFC independent of recurrent fast synaptic excitation. This persistent excitatory effect involves presynaptic alpha 1 adrenoceptors facilitating glutamate release and subsequent activation of postsynaptic mGluR5 receptors, and is enhanced by postsynaptic alpha 2 adrenoceptors inhibiting HCN channel activity. Activation of alpha 2 adrenoceptors or inhibition of HCN channels also enhances cholinergic persistent responses in pyramidal neurons, providing a mechanism of crosstalk between noradrenergic and cholinergic inputs. The present study describes a novel cellular basis for the noradrenergic control of cortical information processing and supports a synergistic combination of intrinsic and network mechanisms for the expression of mnemonic properties in pyramidal neurons.	[Zhang, Zizhen; Matos, Steven Cordeiro; Seguela, Philippe] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Alan Edwards Ctr Res Pain, Montreal, PQ H3A 2B4, Canada; [Jego, Sonia; Adamantidis, Antoine] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada	McGill University; McGill University	Zhang, ZZ (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Alan Edwards Ctr Res Pain, Montreal, PQ H3A 2B4, Canada.	zizzhang@ucalgary.ca; philippe.seguela@mcgill.ca	Core, Vector/CAF-4832-2022	Adamantidis, Antoine/0000-0003-2531-5175	CIHR [NRF 77566, NRF 86527]; Savoy Foundation for Epilepsy	CIHR(Canadian Institutes of Health Research (CIHR)); Savoy Foundation for Epilepsy	Supported by CIHR (NRF 77566, NRF 86527) and The Savoy Foundation for Epilepsy. Antoine Adamantidis holds a Canada Research Chair in Neural Circuits and Optogenetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRADE R, 1991, BRAIN RES, V548, P81, DOI 10.1016/0006-8993(91)91109-E; Arnsten AFT, 1999, BIOL PSYCHIAT, V45, P26, DOI 10.1016/S0006-3223(98)00296-0; ARNSTEN AFT, 1985, SCIENCE, V230, P1273, DOI 10.1126/science.2999977; Arnsten AFT, 2011, INT J DEV NEUROSCI, V29, P215, DOI 10.1016/j.ijdevneu.2011.02.006; Arnsten AFT, 2010, TRENDS COGN SCI, V14, P365, DOI 10.1016/j.tics.2010.05.003; ASTONJONES G, 1981, J NEUROSCI, V1, P876; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Birnbaum S, 1999, BIOL PSYCHIAT, V46, P1266, DOI 10.1016/S0006-3223(99)00138-9; Birnbaum SG, 2004, SCIENCE, V306, P882, DOI 10.1126/science.1100021; Birnbaum SG, 2000, PHARMACOL BIOCHEM BE, V67, P397, DOI 10.1016/S0091-3057(00)00306-3; Bondi CO, 2010, PROG NEURO-PSYCHOPH, V34, P913, DOI 10.1016/j.pnpbp.2010.04.016; Boudaba C, 2003, J NEUROENDOCRINOL, V15, P803, DOI 10.1046/j.1365-2826.2003.01063.x; Carr DB, 2007, J PHYSIOL-LONDON, V584, P437, DOI 10.1113/jphysiol.2007.141671; Carr DB, 2007, J NEUROPHYSIOL, V97, P3432, DOI 10.1152/jn.00828.2006; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; CONSTANTI A, 1991, NEUROSCI LETT, V131, P27, DOI 10.1016/0304-3940(91)90329-R; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; Day HEW, 1997, J CHEM NEUROANAT, V13, P115, DOI 10.1016/S0891-0618(97)00042-2; Day M, 2005, J NEUROSCI, V25, P8776, DOI 10.1523/JNEUROSCI.2650-05.2005; Dembrow NC, 2010, J NEUROSCI, V30, P16922, DOI 10.1523/JNEUROSCI.3644-10.2010; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; FINLAY JM, 1995, NEUROSCIENCE, V64, P619, DOI 10.1016/0306-4522(94)00331-X; FOOTE SL, 1980, P NATL ACAD SCI-BIOL, V77, P3033, DOI 10.1073/pnas.77.5.3033; Fowler MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000573; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; FUSTER JM, 1973, BRAIN RES, V61, P79, DOI 10.1016/0006-8993(73)90517-9; Garcia-Sainz JA, 2004, BIOCHEM PHARMACOL, V67, P1853, DOI 10.1016/j.bcp.2004.01.025; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Goldstein LE, 1996, J NEUROSCI, V16, P4787; Gordon GRJ, 2005, J NEUROSCI, V25, P11385, DOI 10.1523/JNEUROSCI.2378-05.2005; Gordon GRJ, 2003, J NEUROSCI, V23, P6223; GREENE CC, 1994, J NEUROPHYSIOL, V72, P693, DOI 10.1152/jn.1994.72.2.693; Homayoun H, 2004, NEUROPSYCHOPHARMACOL, V29, P1259, DOI 10.1038/sj.npp.1300417; Huang CH, 2010, J NEUROSCI, V30, P11994, DOI 10.1523/JNEUROSCI.2381-10.2010; Huang Z, 2011, NAT NEUROSCI, V14, P478, DOI 10.1038/nn.2757; Kaouane N, 2012, SCIENCE, V335, P1510, DOI 10.1126/science.1207615; Karreman M, 1996, BRAIN RES, V716, P180, DOI 10.1016/0006-8993(96)00015-7; KRNJEVIC K, 1971, J PHYSIOL-LONDON, V215, P247, DOI 10.1113/jphysiol.1971.sp009467; Krueger DD, 2011, ANNU REV MED, V62, P411, DOI 10.1146/annurev-med-061109-134644; Krystal JH, 1996, J CLIN PSYCHIAT, V57, P23; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Kullmann DM, 2005, PROG BIOPHYS MOL BIO, V87, P33, DOI 10.1016/j.pbiomolbio.2004.06.003; Lapiz MDS, 2006, NEUROSCIENCE, V137, P1039, DOI 10.1016/j.neuroscience.2005.09.031; LEWIS DA, 1989, J COMP NEUROL, V282, P317, DOI 10.1002/cne.902820302; LI BM, 1994, BEHAV NEURAL BIOL, V62, P134, DOI 10.1016/S0163-1047(05)80034-2; Li BM, 1999, NEUROPSYCHOPHARMACOL, V21, P601, DOI 10.1016/S0893-133X(99)00070-6; Lindeberg J, 2004, GENESIS, V40, P67, DOI 10.1002/gene.20065; Locchi F, 2007, NEUROSCI LETT, V422, P213, DOI 10.1016/j.neulet.2007.06.023; Marek GJ, 1999, EUR J PHARMACOL, V367, P197, DOI 10.1016/S0014-2999(98)00945-5; Matzel LD, 2010, NEUROSCI BIOBEHAV R, V34, P23, DOI 10.1016/j.neubiorev.2009.07.002; Melendez RI, 2004, NEUROPSYCHOPHARMACOL, V29, P1980, DOI 10.1038/sj.npp.1300507; MORROW AL, 1986, MOL PHARMACOL, V29, P321; Murai Y, 2005, NEUROSCI RES, V51, P55, DOI 10.1016/j.neures.2004.09.005; Nakadate K, 2006, NEUROSCIENCE, V141, P1783, DOI 10.1016/j.neuroscience.2006.05.031; Navaroli VL, 2012, HIPPOCAMPUS, V22, P1392, DOI 10.1002/hipo.20975; PIERIBONE VA, 1994, J NEUROSCI, V14, P4252; Postle BR, 2000, J COGNITIVE NEUROSCI, V12, P2, DOI 10.1162/089892900564028; Rahman J, 2011, EUR J NEUROSCI, V34, P22, DOI 10.1111/j.1460-9568.2011.07736.x; Ramos BP, 2005, BIOL PSYCHIAT, V58, P894, DOI 10.1016/j.biopsych.2005.05.022; Ramos BP, 2008, NEUROBIOL AGING, V29, P1060, DOI 10.1016/j.neurobiolaging.2007.02.003; Ramos BP, 2007, PHARMACOL THERAPEUT, V113, P523, DOI 10.1016/j.pharmthera.2006.11.006; Ramos BP, 2006, LEARN MEMORY, V13, P770, DOI 10.1101/lm.298006; Raskind MA, 2003, AM J PSYCHIAT, V160, P371, DOI 10.1176/appi.ajp.160.2.371; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rommelfanger KS, 2009, NEUROSCIENCE, V158, P1530, DOI 10.1016/j.neuroscience.2008.11.019; Ruiz A, 2010, NAT NEUROSCI, V13, P431, DOI 10.1038/nn.2512; SCHWINDT PC, 1988, J NEUROPHYSIOL, V59, P450, DOI 10.1152/jn.1988.59.2.450; SEGUELA P, 1990, NEUROSCIENCE, V35, P249, DOI 10.1016/0306-4522(90)90079-J; Sidiropoulou K, 2009, NAT NEUROSCI, V12, P190, DOI 10.1038/nn.2245; Simpson TL, 2009, ALCOHOL CLIN EXP RES, V33, P255, DOI 10.1111/j.1530-0277.2008.00807.x; Southwick SM, 1997, ANN NY ACAD SCI, V821, P125, DOI 10.1111/j.1749-6632.1997.tb48274.x; Taylor F, 2002, J CLIN PSYCHOPHARM, V22, P82, DOI 10.1097/00004714-200202000-00013; Trigo FF, 2008, EUR J NEUROSCI, V28, P841, DOI 10.1111/j.1460-9568.2008.06404.x; TROVERO F, 1992, NEUROSCIENCE, V47, P69, DOI 10.1016/0306-4522(92)90121-H; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Venkatachalam K, 2003, J BIOL CHEM, V278, P29031, DOI 10.1074/jbc.M302751200; Villalobos C, 2005, EUR J NEUROSCI, V22, P1120, DOI 10.1111/j.1460-9568.2005.04307.x; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; Winterfeld KT, 1998, J NEUROSCI RES, V52, P201, DOI 10.1002/(SICI)1097-4547(19980415)52:2<201::AID-JNR8>3.0.CO;2-E; Yan HD, 2009, J NEUROSCI, V29, P10038, DOI 10.1523/JNEUROSCI.1042-09.2009; Yoshida M, 2008, EUR J NEUROSCI, V28, P1116, DOI 10.1111/j.1460-9568.2008.06409.x; Yoshida M, 2009, J NEUROSCI, V29, P4945, DOI 10.1523/JNEUROSCI.5154-08.2009; Zarahn E, 1999, COGNITIVE BRAIN RES, V7, P255, DOI 10.1016/S0926-6410(98)00029-9; Zhang ZZ, 2011, HIPPOCAMPUS, V21, P386, DOI 10.1002/hipo.20755; Zhang ZZ, 2010, CEREB CORTEX, V20, P2948, DOI 10.1093/cercor/bhq043; Zhu MH, 2005, AM J PHYSIOL-CELL PH, V289, pC591, DOI 10.1152/ajpcell.00440.2004	87	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66122	10.1371/journal.pone.0066122	http://dx.doi.org/10.1371/journal.pone.0066122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785477	gold, Green Submitted, Green Published			2022-12-25	WOS:000321038800045
J	Giri, A; Bajpai, S; Trenton, N; Jayatilaka, H; Longmore, GD; Wirtz, D				Giri, Anjil; Bajpai, Saumendra; Trenton, Nicholaus; Jayatilaka, Hasini; Longmore, Gregory D.; Wirtz, Denis			The Arp2/3 complex mediates multigeneration dendritic protrusions for efficient 3-dimensional cancer cell migration	FASEB JOURNAL			English	Article						3D environment; collagen I matrix; matrix deformation	N-WASP; CORTACTIN; ACTIVATION; LAMELLIPODIA; INVADOPODIA; COLLAGEN; PROTEIN; GTPASES; ROLES; CYTOSKELETON	Arp2/3 is a protein complex that nucleates actin filament assembly in the lamellipodium in adherent cells crawling on planar 2-dimensional (2D) substrates. However, in physiopathological situations, cell migration typically occurs within a 3-dimensional (3D) environment, and little is known about the role of Arp2/3 and associated proteins in 3D cell migration. Using time resolved live-cell imaging and HT1080, a fibrosarcoma cell line commonly used to study cell migration, we find that the Arp2/3 complex and associated proteins N-WASP, WAVE1, cortactin, and Cdc42 regulate 3D cell migration. We report that this regulation is caused by formation of multigeneration dendritic protrusions, which mediate traction forces on the surrounding matrix and effective cell migration. The primary protrusions emanating directly from the cell body and prolonging the nucleus forms independent of Arp2/3 and dependent on focal adhesion proteins FAK, talin, and p130Cas. The Arp2/3 complex, N-WASP, WAVE1, cortactin, and Cdc42 regulate the secondary protrusions branching off from the primary protrusions. In 3D matrices, fibrosarcoma cells as well as migrating breast, pancreatic, and prostate cancer cells do not display lamellipodial structures. This study characterizes the unique topology of protrusions made by cells in a 3D matrix and show that these dendritic protrusions play a critical role in 3D cell motility and matrix deformation. The relative contribution of these proteins to 3D migration is significantly different from their role in 2D migration.Giri, A., Bajpai, S., Trenton, N., Jayatilaka, H., Longmore, G. D., Wirtz, D. The Arp2/3 complex mediates multigeneration dendritic protrusions for efficient 3-dimensional cancer cell migration.	[Giri, Anjil; Bajpai, Saumendra; Trenton, Nicholaus; Jayatilaka, Hasini; Wirtz, Denis] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Giri, Anjil; Bajpai, Saumendra; Longmore, Gregory D.; Wirtz, Denis] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD 21218 USA; [Longmore, Gregory D.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Longmore, Gregory D.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Longmore, Gregory D.] Washington Univ, Sch Med, Bridging Res Imaging Genom & High Throughput BRIG, St Louis, MO 63110 USA	Johns Hopkins University; Johns Hopkins University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Wirtz, D (corresponding author), Johns Hopkins Univ, 3400 North Charles St,Croft Hall, Baltimore, MD 21218 USA.	glongmor@dom.wustl.edu; wirtz@jhu.edu	Bajpai, Saumendra/B-8120-2014	Bajpai, Saumendra/0000-0002-9397-2102	U.S. National Institutes of Health (NIH) [GM084204, CA143868, CA85839]; NATIONAL CANCER INSTITUTE [R01CA085839, U54CA143868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084204] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health (NIH) grants GM084204, CA143868, and CA85839. D.W. acknowledges fruitful discussions with Dr. Sean X. Sun (Johns Hopkins Physical Sciences-Oncology Center, Johns Hopkins University). A.G. and D.W. designed the experiments; A.G., S.B.K., NT., H.J., and D.W. conducted the experiments and analyzed the data; A.G. and D.W. wrote the article; A.G., D.W., and G.D.L. edited the article. The authors declare no conflicts of interest.	Bloom RJ, 2008, BIOPHYS J, V95, P4077, DOI 10.1529/biophysj.108.132738; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Buccione R, 2009, CANCER METAST REV, V28, P137, DOI 10.1007/s10555-008-9176-1; Chan AY, 2005, ONCOGENE, V24, P7821, DOI 10.1038/sj.onc.1208909; Christiansen DL, 2000, MATRIX BIOL, V19, P409, DOI 10.1016/S0945-053X(00)00089-5; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Fraley SI, 2011, NAT CELL BIOL, V13, P5, DOI 10.1038/ncb0111-5; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Grinnell F, 2003, MOL BIOL CELL, V14, P384, DOI 10.1091/mbc.E02-08-0493; Huttenlocher A., 2011, COLD SPRING HARBOR P, V3; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Khatau SB, 2012, SCI REP-UK, V2, DOI 10.1038/srep00488; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Konstantopoulos K, 2013, BIOPHYS J, V104, P279, DOI 10.1016/j.bpj.2012.12.016; Kowalski JR, 2005, J CELL SCI, V118, P79, DOI 10.1242/jcs.01586; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Raub CB, 2007, BIOPHYS J, V92, P2212, DOI 10.1529/biophysj.106.097998; Rhee S, 2007, P NATL ACAD SCI USA, V104, P5425, DOI 10.1073/pnas.0608030104; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Shakir MA, 2008, GENETICS, V179, P1957, DOI 10.1534/genetics.108.088963; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Weaver AM, 2008, CURR BIOL, V18, pR362, DOI 10.1016/j.cub.2008.02.028; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317; Yu XZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030605; Zhou XM, 2008, GENE DEV, V22, P1231, DOI 10.1101/gad.1643308	45	48	49	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					4089	4099		10.1096/fj.12-224352	http://dx.doi.org/10.1096/fj.12-224352			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23796785	Green Published			2022-12-25	WOS:000329747100021
J	Gu, W; Fukuda, T; Isaji, T; Hashimoto, H; Wang, YQ; Gu, JG				Gu, Wei; Fukuda, Tomohiko; Isaji, Tomoya; Hashimoto, Hirokazu; Wang, Yuqin; Gu, Jianguo			alpha 1,6-Fucosylation regulates neurite formation via the activin/phospho-Smad2 pathway in PC12 cells: the implicated dual effects of Fut8 for TGF-beta/activin-mediated signaling	FASEB JOURNAL			English	Article						N-glycosylation; glycosyltransferase; cell differentiation	GROWTH-FACTOR-BETA; CORE FUCOSYLATION; ALPHA-1,6-FUCOSYL-TRANSFERASE-DEFICIENT MICE; ALPHA-3-BETA-1 INTEGRIN; N-ACETYLGLUCOSAMINE; NERVOUS-SYSTEM; EXPRESSION; PHENOTYPE; FUCOSE; DIFFERENTIATION	It is well known that 1,6-fucosyltransferase (Fut8) and its products, 1,6-fucosylated N-glycans, are highly expressed in brain tissue. Recently, we reported that Fut8-knockout mice exhibited multiple behavioral abnormalities with a schizophrenia-like phenotype, suggesting that 1,6-fucosylation plays important roles in the brain and neuron system. In the present study, we screened several neural cell lines and found that PC12 cells express the highest levels of 1,6-fucosylation. The knockdown (KD) of Fut8 promoted a significant enhancement of neurite formation and induction of neurofilament expression. Surprisingly, the levels of phospho-Smad2 were greatly increased in the KD cells. Finally, we found that the activin-mediated signal pathway was essential for these changes in KD cells. Exogenous activin, not TGF-1, induced neurite outgrowth and phospho-Smad2. In addition, the 1,6-fucosylation level on the activin receptors was greatly decreased in KD cells, while the total expression level was unchanged, suggesting that 1,6-fucosylation negatively regulated activin-mediated signaling. Furthermore, inhibition of activin receptor-mediated signaling or restoration of Fut8 expression rescued cell morphology and phospho-Smad2 levels, which were enhanced in KD cells. Considering the fact that 1,6-fucosylation is important for TGF--mediated signaling, the results of this study strongly suggest that Fut8 plays a dual role in TGF-/activin-mediated signaling.Gu, W., Fukuda, T., Isaji, T., Hashimoto, H., Wang, Y., Gu, J. 1,6-Fucosylation regulates neurite formation via the activin/phospho-Smad2 pathway in PC12 cells: the implicated dual effects of Fut8 for TGF-/activin-mediated signaling.	[Gu, Wei; Fukuda, Tomohiko; Isaji, Tomoya; Hashimoto, Hirokazu; Wang, Yuqin; Gu, Jianguo] Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Sendai, Miyagi 9818558, Japan	Tohoku Medical & Pharmaceutical University	Gu, JG (corresponding author), Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-pharm.ac.jp	Isaji, Tomoya/ABC-9285-2021; Gu, Jianguo/ABC-9257-2020		Japan Society for the Promotion of Science [21370059, 23651196]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [23110002, 24590087]; Mizutani Foundation for Glycoscience; Grants-in-Aid for Scientific Research [24570169] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mizutani Foundation for Glycoscience; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by grants-in-aid for scientific cesearch (21370059 to J.G.) and challenging exploratory research (23651196 to J.G.) from the Japan Society for the Promotion of Science; by a grant from the Scientific Research on Innovative Areas (23110002 to J.G.; 24590087 to T.F.) and the Strategic Research Foundation grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and by the Mizutani Foundation for Glycoscience. The authors acknowledge James L. McDonald of Scientific Editorial Services for editing this manuscript.	Abe K, 1996, BRAIN RES, V723, P206, DOI 10.1016/0006-8993(96)00253-3; ANDREASSON K, 1995, NEUROSCIENCE, V69, P781, DOI 10.1016/0306-4522(95)00245-E; Bao YL, 2005, J ENDOCRINOL, V184, P493, DOI 10.1677/joe.1.05978; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Buss A, 2008, SPINAL CORD, V46, P364, DOI 10.1038/sj.sc.3102148; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dow AL, 2005, J NEUROSCI, V25, P4908, DOI 10.1523/JNEUROSCI.5155-04.2005; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Finnson Kenneth W, 2012, Front Biosci (Schol Ed), V4, P251; FLANDERS KC, 1991, DEVELOPMENT, V113, P183; Fukuda T, 2011, J BIOL CHEM, V286, P18434, DOI 10.1074/jbc.M110.172536; GIRI SN, 1993, THORAX, V48, P959, DOI 10.1136/thx.48.10.959; Hagedorn HG, 2001, INT J ONCOL, V18, P669; Heupel K, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-25; Isaji T, 2009, J BIOL CHEM, V284, P12207, DOI 10.1074/jbc.M807920200; Ishikawa M, 2010, J BIOL CHEM, V285, P32734, DOI 10.1074/jbc.M110.118745; JAEKEN J, 1994, ARCH DIS CHILD, V71, P123, DOI 10.1136/adc.71.2.123; Krieglstein K, 2011, TRENDS NEUROSCI, V34, P421, DOI 10.1016/j.tins.2011.06.002; Li WZ, 2006, GLYCOBIOLOGY, V16, P1007, DOI 10.1093/glycob/cwl023; Li WZ, 2012, J BIOL CHEM, V287, P2500, DOI 10.1074/jbc.M111.303123; Lutz M, 2004, EUR J BIOCHEM, V271, P920, DOI 10.1111/j.1432-1033.2004.03994.x; Pinho SS, 2011, CELL MOL LIFE SCI, V68, P1011, DOI 10.1007/s00018-010-0595-0; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; UNSICKER K, 1991, NEUROSCIENCE, V44, P613, DOI 10.1016/0306-4522(91)90082-Y; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Wang XC, 2006, METHOD ENZYMOL, V417, P11, DOI 10.1016/S0076-6879(06)17002-0; Wang Y, 2001, GLYCOBIOLOGY, V11, P1051, DOI 10.1093/glycob/11.12.1051; WILSON JR, 1976, BIOCHEM BIOPH RES CO, V72, P909, DOI 10.1016/S0006-291X(76)80218-5; Zhao YY, 2006, J BIOL CHEM, V281, P38343, DOI 10.1074/jbc.M608764200; Zheng F, 2009, MOL PSYCHIATR, V14, P332, DOI 10.1038/sj.mp.4002131	35	23	24	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					3947	3958		10.1096/fj.12-225805	http://dx.doi.org/10.1096/fj.12-225805			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23796784				2022-12-25	WOS:000329747100010
J	Cheung, KL; Lee, JH; Shu, L; Kim, JH; Sacks, DB; Kong, ANT				Cheung, Ka Lung; Lee, Jong Hun; Shu, Limin; Kim, Jung-Hwan; Sacks, David B.; Kong, Ah-Ng Tony			The Ras GTPase-activating-like Protein IQGAP1 Mediates Nrf2 Protein Activation via the Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase (ERK) Kinase (MEK)-ERK Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT RESPONSE ELEMENT; BINDING PROTEIN; NUCLEAR TRANSLOCATION; OXIDATIVE STRESS; HEME OXYGENASE-1; GENE-EXPRESSION; HEPG2 CELLS; CALMODULIN; INDUCTION; IDENTIFICATION	Nrf2 plays a critical role in the regulation of cellular oxidative stress. MEK-ERK activation has been shown to be one of the major pathways resulting in the activation of Nrf2 and induction of Nrf2 downstream targets, including phase II detoxifying/antioxidant genes in response to oxidative stress and xenobiotics. In this study, IQGAP1 (IQ motif-containing GTPase-activating protein 1), a new Nrf2 interaction partner that we have published previously, was found to modulate MEK-ERK-mediated Nrf2 activation and induction of phase II detoxifying/antioxidant genes. Nrf2 binds directly to the IQ domain (amino acids 699-905) of IQGAP1. Knockdown of IQGAP1 significantly attenuated phenethyl isothiocyanate-or MEK-mediated activation of the MEK-ERK-Nrf2 pathway. Knockdown of IQGAP1 also attenuated MEK-mediated increased stability of Nrf2, which in turn was associated with a decrease in the nuclear translocation of Nrf2 and a decrease in the expression of phase II detoxifying/antioxidant genes. In the aggregate, these results suggest that IQGAP1 may play an important role in the MEK-ERK-Nrf2 signaling pathway.	[Cheung, Ka Lung] Rutgers State Univ, Ernest Mario Sch Pharm, Grad Program Pharmaceut Sci, Piscataway, NJ 08854 USA; [Cheung, Ka Lung; Lee, Jong Hun; Shu, Limin; Kim, Jung-Hwan; Kong, Ah-Ng Tony] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmaceut, Piscataway, NJ 08854 USA; [Sacks, David B.] NIH, Dept Lab Med, Bethesda, MD 20892 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; National Institutes of Health (NIH) - USA	Kong, ANT (corresponding author), Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmaceut, 160 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	kongt@pharmacy.rutgers.edu	Kong, Ah-Ng Tony/AAX-2828-2020	Sacks, David/0000-0003-3100-0735; Lee, Jong Hun/0000-0002-3083-7595; Kim, Jung Hwan/0000-0002-2975-4899	CLINICAL CENTER [ZIACL080017] Funding Source: NIH RePORTER	CLINICAL CENTER		Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Brill S, 1996, MOL CELL BIOL, V16, P4869; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; Dreger H, 2010, CARDIOVASC RES, V85, P395, DOI 10.1093/cvr/cvp279; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Higgins LG, 2009, TOXICOL APPL PHARM, V237, P267, DOI 10.1016/j.taap.2009.03.005; Huang HC, 2000, P NATL ACAD SCI USA, V97, P12475, DOI 10.1073/pnas.220418997; Jaaro H, 1997, P NATL ACAD SCI USA, V94, P3742, DOI 10.1073/pnas.94.8.3742; Keum YS, 2006, PHARM RES, V23, P2586, DOI 10.1007/s11095-006-9094-2; Keum YS, 2006, CANCER RES, V66, P8804, DOI 10.1158/0008-5472.CAN-05-3513; Kim JH, 2013, ANTIOXID REDOX SIGN, V19, P89, DOI 10.1089/ars.2012.4586; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Manandhar S, 2007, EUR J PHARMACOL, V577, P17, DOI 10.1016/j.ejphar.2007.08.018; Mbele GO, 2002, J BIOL CHEM, V277, P49998, DOI 10.1074/jbc.M205363200; McCallum SJ, 1996, J BIOL CHEM, V271, P21732, DOI 10.1074/jbc.271.36.21732; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Shen GX, 2004, J BIOL CHEM, V279, P23052, DOI 10.1074/jbc.M401368200; Tsubota A, 2010, CARCINOGENESIS, V31, P504, DOI 10.1093/carcin/bgp313; Usatyuk PV, 2009, J BIOL CHEM, V284, P15339, DOI 10.1074/jbc.M109.005439; Wakabayashi N, 2010, ANTIOXID REDOX SIGN, V13, P1649, DOI 10.1089/ars.2010.3216; Wang XJ, 2008, TOXICOL APPL PHARM, V230, P383, DOI 10.1016/j.taap.2008.03.003; Weissbach L, 1998, BIOCHEM BIOPH RES CO, V251, P269, DOI 10.1006/bbrc.1998.9371; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517; Xu CJ, 2006, MOL CANCER THER, V5, P1918, DOI 10.1158/1535-7163.MCT-05-0497; Xu CJ, 2006, CARCINOGENESIS, V27, P437, DOI 10.1093/carcin/bgi251; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60; Yamaoka-Tojo M, 2006, ARTERIOSCL THROM VAS, V26, P1991, DOI 10.1161/01.ATV.0000231524.14873.e7; Yuan XL, 2006, MOL CARCINOGEN, V45, P841, DOI 10.1002/mc.20234	35	33	36	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22378	22386		10.1074/jbc.M112.444182	http://dx.doi.org/10.1074/jbc.M112.444182			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23788642	Green Published, hybrid			2022-12-25	WOS:000330596300019
J	Lai, JB; Linder, ME				Lai, Jianbin; Linder, Maurine E.			Oligomerization of DHHC Protein S-Acyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGF RECEPTOR; SACCHAROMYCES-CEREVISIAE; MEDIATED PALMITOYLATION; DOMAIN; IDENTIFICATION; LOCALIZATION; TRANSFERASE; ACTIVATION; MECHANISM; ENZYMES	The formation of dimers or higher-order oligomers is a property of numerous integral membrane proteins, including ion channels, transporters, and receptors. In this study, we examined whether members of the DHHC-S-acyltransferase family oligomerize in intact cells and in vitro. DHHC-S-acyltransferases are integral membrane proteins that catalyze the addition of palmitate to cysteine residues on proteins at the cytoplasmic face of cell membranes. Bioluminescence resonance energy transfer (BRET) experiments revealed that DHHC2 or DHHC3 (Golgi-specific DHHC zinc finger protein (GODZ)) self-associate when expressed in HEK-293 cells. Homomultimer formation was confirmed by coimmunoprecipitation. Purified DHHC3 resolved predominately as a monomer and dimer on blue native polyacrylamide gels. In intact cells and in vitro, catalytically inactive DHHC proteins displayed a greater propensity to form dimers. BRET signals were higher for the catalytically inactive DHHC2 or DHHC3 than their wild-type counterparts. DHHC3 BRET in cell membranes was decreased by the addition of its lipid substrate palmitoyl-CoA, a treatment that results in autoacylation of the enzyme. Enzyme activity of a covalently linked DHHC3 dimer was less than that of the monomeric form, suggesting that enzyme activity may be modulated by the oligomerization status of the protein.	[Lai, Jianbin; Linder, Maurine E.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University	Linder, ME (corresponding author), Cornell Univ, CVM Box 41, Ithaca, NY 14853 USA.	mel237@cornell.edu	Linder, Maurine/AAU-9999-2021	Linder, Maurine/0000-0003-2202-9712	National Institutes of Health [RO1GM51466]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051466] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM51466 (to M. E. L.).	Achour L, 2011, METHODS MOL BIOL, V756, P183, DOI 10.1007/978-1-61779-160-4_9; Batistic O, 2012, PLANT PHYSIOL, V160, P1597, DOI 10.1104/pp.112.203968; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Endres NF, 2011, CURR OPIN STRUC BIOL, V21, P777, DOI 10.1016/j.sbi.2011.07.007; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Hamdan Fadi F, 2006, Curr Protoc Neurosci, VChapter 5, DOI 10.1002/0471142301.ns0523s34; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Jennings BC, 2012, J BIOL CHEM, V287, P7236, DOI 10.1074/jbc.M111.337246; Jennings BC, 2009, J LIPID RES, V50, P233, DOI 10.1194/jlr.M800270-JLR200; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Lambert NA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115pe12; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Misumi Y, 2001, J BIOL CHEM, V276, P6867, DOI 10.1074/jbc.M010121200; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Mitchell DA, 2010, J BIOL CHEM, V285, P38104, DOI 10.1074/jbc.M110.169102; MUMBY SM, 1994, METHOD ENZYMOL, V237, P254; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Ohno Y, 2012, MOL BIOL CELL, V23, P4543, DOI 10.1091/mbc.E12-05-0336; Politis EG, 2005, J BIOL CHEM, V280, P10156, DOI 10.1074/jbc.M411946200; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Young FB, 2012, PROG NEUROBIOL, V97, P220, DOI 10.1016/j.pneurobio.2011.11.002; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411	29	28	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22862	22870		10.1074/jbc.M113.458794	http://dx.doi.org/10.1074/jbc.M113.458794			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23793055	Green Published, hybrid			2022-12-25	WOS:000330596300062
J	Vakili, H; Jin, Y; Menticoglou, S; Cattini, PA				Vakili, Hana; Jin, Yan; Menticoglou, Savas; Cattini, Peter A.			CCAAT-enhancer-binding Protein beta (C/EBP beta) and Downstream Human Placental Growth Hormone Genes Are Targets for Dysregulation in Pregnancies Complicated by Maternal Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCUS-CONTROL REGION; TISSUE-SPECIFIC EXPRESSION; INSULIN-SECRETION; CYTOLOGICAL LOCALIZATION; TRANSCRIPTIONAL ENHANCER; CHORIONIC-GONADOTROPIN; LACTOGENIC HORMONES; B ENHANCER; CELL MASS; PITUITARY	Human chorionic somatomammotropin (CS) and placental growth hormone variant (GH-V) act as metabolic adaptors in response to maternal insulin resistance, which occurs in "normal" pregnancy. Maternal obesity can exacerbate this "resistance," suggesting that CS, GH-V, or transcription factors that regulate their production might be targets. The human CS genes, hCS-A and hCS-B, flank the GH-V gene. A significant decrease in pre-term placental CS/GH-V RNA levels was observed in transgenic mice containing the CS/GH-V genes in a model of high fat diet (HFD)-induced maternal obesity. Similarly, a decrease in CS/GH-V RNA levels was detected in term placentas from obese (body mass index (BMI) >= 35 kg/m(2)) versus lean (BMI 20-25 kg/m(2)) women. Aspecific decrease in transcription factor CCAAT-enhancer-binding protein beta (C/EBP beta) RNA levels was also seen with obesity; C/EBP beta is required for mouse placenta development and is expressed, like CS and GH-V, in syncytiotrophoblasts. Binding of C/EBP beta to the CS gene downstream enhancer regions, which by virtue of their position distally flank the GH-V gene, was reduced in placenta chromatin from mice on a HFD and in obese women; a corresponding decrease in RNA polymerase II associated with CS/GH-V promoters was also observed. Detection of decreased endogenous CS/GH-V RNA levels in human placental tumor cells treated with C/EBP beta siRNA is consistent with a direct effect. These data provide evidence for CS/GH-V dysregulation in acute HFD-induced obesity in mouse pregnancy and chronic obesity in human pregnancy and implicate C/EBP beta, a factor associated with CS regulation and placental development.	[Vakili, Hana; Jin, Yan; Cattini, Peter A.] Univ Manitoba, Dept Physiol, Div Endocrinol & Metab Dis, Winnipeg, MB R3E 0J9, Canada; [Menticoglou, Savas] Univ Manitoba, Dept Obstet Gynecol & Reprod Sci, Fac Med, Winnipeg, MB R3E 0J9, Canada	University of Manitoba; University of Manitoba	Cattini, PA (corresponding author), Univ Manitoba, Dept Physiol, 745 Bannatyne Ave, Winnipeg, MB R3E 0J9, Canada.	peter_cattini@umanitoba.ca			Canadian Institutes of Health Research [MT-10853, RPA-12495]; Manitoba Institute of Child Health; Manitoba Health Research Council	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Manitoba Institute of Child Health; Manitoba Health Research Council	This work was supported by Canadian Institutes of Health Research Grants MT-10853 and RPA-12495 and a studentship from the Manitoba Institute of Child Health and Manitoba Health Research Council and Canadian Institutes of Health Research.	Alsat E, 1997, AM J OBSTET GYNECOL, V177, P1526, DOI 10.1016/S0002-9378(97)70103-0; Bamberger AM, 2004, VIRCHOWS ARCH, V444, P149, DOI 10.1007/s00428-003-0935-7; Begay V, 2004, MOL CELL BIOL, V24, P9744, DOI 10.1128/MCB.24.22.9744-9751.2004; BIRKENMEIER EH, 1989, GENE DEV, V3, P1146, DOI 10.1101/gad.3.8.1146; BOIME I, 1982, BIOL REPROD, V26, P73, DOI 10.1095/biolreprod26.1.73; BRELJE TC, 1993, ENDOCRINOLOGY, V132, P879, DOI 10.1210/en.132.2.879; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Butler AE, 2010, DIABETOLOGIA, V53, P2167, DOI 10.1007/s00125-010-1809-6; CHEN HW, 1995, DNA CELL BIOL, V14, P681, DOI 10.1089/dna.1995.14.681; COLOSI P, 1982, P NATL ACAD SCI-BIOL, V79, P771, DOI 10.1073/pnas.79.3.771; Cross JC, 2005, PLACENTA, V26, pS3, DOI 10.1016/j.placenta.2005.01.015; Day INM, 2004, J CLIN ENDOCR METAB, V89, P5569, DOI 10.1210/jc.2004-0152; Denison FC, 2010, REPRODUCTION, V140, P373, DOI 10.1530/REP-10-0074; Dubois SG, 2006, OBESITY, V14, P1543, DOI 10.1038/oby.2006.178; Elefant F, 2000, EMBO J, V19, P6814, DOI 10.1093/emboj/19.24.6814; Farley D, 2009, PLACENTA, V30, P752, DOI 10.1016/j.placenta.2009.06.007; GOOSSENS M, 1986, ANN ENDOCRINOL-PARIS, V47, P363; GORDON YB, 1977, BRIT J OBSTET GYNAEC, V84, P642; Gunasekharan V, 2012, J VIROL, V86, P5393, DOI 10.1128/JVI.07239-11; Haig D, 2008, PLACENTA, V29, pS36, DOI 10.1016/j.placenta.2007.09.010; Handwerger S., 2009, GROWTH GENET HORM, V25, P1; Harju S, 2002, EXP BIOL MED, V227, P683, DOI 10.1177/153537020222700902; Heslehurst N, 2007, BJOG-INT J OBSTET GY, V114, P334, DOI 10.1111/j.1471-0528.2006.01230.x; Heslehurst N, 2007, BJOG-INT J OBSTET GY, V114, P187, DOI 10.1111/j.1471-0528.2006.01180.x; Holland MP, 2004, ENDOCRINOLOGY, V145, P1096, DOI 10.1210/en.2003-0777; HOSHINA M, 1982, J CELL BIOL, V93, P190, DOI 10.1083/jcb.93.1.190; Hoshina M, 1984, Nihon Sanka Fujinka Gakkai Zasshi, V36, P397; Huang C, 2009, ENDOCRINOLOGY, V150, P1618, DOI 10.1210/en.2008-1003; JACQUEMIN P, 1994, DNA CELL BIOL, V13, P1037, DOI 10.1089/dna.1994.13.1037; Jacquemin P, 1997, J BIOL CHEM, V272, P12928, DOI 10.1074/jbc.272.20.12928; JACQUEMIN P, 1994, MOL CELL BIOL, V14, P93, DOI 10.1128/MCB.14.1.93; Jiang SW, 1999, MOL ENDOCRINOL, V13, P879, DOI 10.1210/me.13.6.879; JIANG SW, 1994, J BIOL CHEM, V269, P10384; Jin Y, 1999, MOL ENDOCRINOL, V13, P1249, DOI 10.1210/me.13.8.1249; Jin Y, 2009, PLACENTA, V30, P226, DOI 10.1016/j.placenta.2008.12.011; JONES BK, 1995, MOL CELL BIOL, V15, P7010; Kannan A, 2010, REPROD SCI, V17, P434, DOI 10.1177/1933719110361384; Kawai M, 1999, EUR J ENDOCRINOL, V141, P419, DOI 10.1530/eje.0.1410419; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kimura AP, 2007, MOL CELL BIOL, V27, P6555, DOI 10.1128/MCB.00273-07; KLASSEN ME, 1989, PLACENTA, V10, P321, DOI 10.1016/0143-4004(89)90015-5; Kondegowda NG, 2012, DIABETOLOGIA, V55, P1721, DOI 10.1007/s00125-012-2501-9; Lacroix MC, 2002, ENDOCRINE, V19, P73, DOI 10.1385/ENDO:19:1:73; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Lepercq J, 1998, DIABETES, V47, P847, DOI 10.2337/diabetes.47.5.847; Liang XH, 2010, ENDOCRINOLOGY, V151, P5007, DOI 10.1210/en.2010-0170; LYTRAS A, 1994, MOL ENDOCRINOL, V8, P478, DOI 10.1210/me.8.4.478; Lytras A, 1996, MOL CELL ENDOCRINOL, V119, P1, DOI 10.1016/0303-7207(96)03777-X; Lytras A, 2011, J MOL ENDOCRINOL, V47, P179, DOI 10.1530/JME-11-0025; MATT DW, 1985, BIOL REPROD, V32, P969, DOI 10.1095/biolreprod32.4.969; MCWILLIAMS D, 1980, ENDOCRINOLOGY, V107, P761, DOI 10.1210/endo-107-3-761; Millward CA, 2007, DIABETES, V56, P161, DOI 10.2337/db06-0310; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; NACHTIGAL MW, 1992, PLACENTA, V13, P371, DOI 10.1016/0143-4004(92)90061-W; NICKEL BE, 1991, ENDOCRINOLOGY, V128, P2353, DOI 10.1210/endo-128-5-2353; Nielsen JH, 2001, DIABETES, V50, pS25, DOI 10.2337/diabetes.50.2007.S25; Norquay LD, 2003, MOL ENDOCRINOL, V17, P1027, DOI 10.1210/me.2003-0025; Norquay LD, 2001, BIOCHEM J, V354, P387, DOI 10.1042/0264-6021:3540387; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; Radde J, 2004, INT J GYNECOL PATHOL, V23, P373, DOI 10.1097/01.pgp.0000139645.32997.e1; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Roberts KA, 2011, PLACENTA, V32, P247, DOI 10.1016/j.placenta.2010.12.023; ROGERS BL, 1986, NUCLEIC ACIDS RES, V14, P7647, DOI 10.1093/nar/14.19.7647; SAXENA BN, 1969, NEW ENGL J MED, V281, P225, DOI 10.1056/NEJM196907312810501; Schafer-Graf UM, 1998, J PERINAT MED, V26, P27, DOI 10.1515/jpme.1998.26.1.27; Schroeder-Gloeckler JM, 2007, J BIOL CHEM, V282, P15717, DOI 10.1074/jbc.M701329200; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; Steinberg XP, 2012, BIOCHEMISTRY-US, V51, P952, DOI 10.1021/bi201593q; Su YH, 2000, J BIOL CHEM, V275, P7902, DOI 10.1074/jbc.275.11.7902; Vakili H, 2012, J BIOL CHEM, V287, P33282, DOI 10.1074/jbc.M112.380949; Vakili N, 2011, MOL CELL ENDOCRINOL, V345, P48, DOI 10.1016/j.mce.2011.07.010; Vickers MH, 2009, AM J PHYSIOL-ENDOC M, V297, pE629, DOI 10.1152/ajpendo.00221.2009; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; WALKER WH, 1990, J BIOL CHEM, V265, P12940; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; Zeck W, 2008, PEDIATR RES, V63, P353, DOI 10.1203/01.pdr.0000304935.19183.07	77	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22849	22861		10.1074/jbc.M113.474999	http://dx.doi.org/10.1074/jbc.M113.474999			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23782703	hybrid, Green Published			2022-12-25	WOS:000330596300061
J	Zhang, HW; Wu, CW; Matesic, LE; Li, X; Wang, ZY; Boyce, BF; Xing, LP				Zhang, Hengwei; Wu, Chengwu; Matesic, Lydia E.; Li, Xing; Wang, Zhiyu; Boyce, Brendan F.; Xing, Lianping			Ubiquitin E3 Ligase Itch Negatively Regulates Osteoclast Formation by Promoting Deubiquitination of Tumor Necrosis Factor (TNF) Receptor-associated Factor 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; EDITING ENZYME A20; MEDIATED REGULATION; BONE-RESORPTION; TGF-BETA; C-FMS; MICE; DIFFERENTIATION; EXPRESSION; RESPONSES	Itch is a ubiquitin E3 ligase that regulates protein stability. Itch(-/-) mice develop an autoimmune disease phenotype characterized by itchy skin and multiorgan inflammation. The role of Itch in the regulation of osteoclast function has not been examined. We report that Itch(-/-) bone marrow and spleen cells formed more osteoclasts than cells from WT littermates in response to receptor activator of NF-kappa B ligand (RANKL) and was associated with increased expression of the osteoclastogenic transcription factors c-fos and Nfatc1. Overexpression of Itch in Itch(-/-) cells rescued increased osteoclastogenesis. RANKL increased Itch expression, which can be blocked by a NF-kappa B inhibitor. The murine Itch promoter contains NF-kappa B binding sites. Overexpression of NF-kappa B p65 increased Itch expression, and RANKL promoted the binding of p65 onto the NF-kappa B binding sites in the Itch promoter. Itch(-/-) osteoclast precursors had prolonged RANKL-induced NF-kappa B activation and delayed TNF receptor-associated factor 6 (TRAF6) deubiquitination. In WT osteoclast precursors, Itch bound to TRAF6 and the deubiquitinating enzyme cylindromatosis. Adult Itch(-/-) mice had normal bone volume, but they had significantly increased LPS-induced osteoclastogenesis and bone resorption. Thus, Itch is a new RANKL target gene that is induced during osteoclastogenesis. Itch interacts with the deubiquitinating enzyme and is required for deubiquitination of TRAF6, thus limiting RANKL-induced osteoclast formation.	[Zhang, Hengwei; Wu, Chengwu; Li, Xing; Boyce, Brendan F.; Xing, Lianping] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Matesic, Lydia E.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Li, Xing; Wang, Zhiyu] Hebei Med Univ, Hosp 4, Dept Biotherapy, Shijiazhuang 050011, Hebei, Peoples R China	University of Rochester; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Hebei Medical University	Xing, LP (corresponding author), Univ Rochester, Med Ctr, Dept Pathol & Lab Med, 601 Elmwood Ave,Box 626, Rochester, NY 14642 USA.	lianping_xing@urmc.rochester.edu			National Institutes of Health [AR48697, AR53586, AR43510]; United States Public Health Service; National Natural Science Foundation of China [81202037]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043510, R21AR053586, R01AR048697] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR48697 and AR53586 (to L. X.) and AR43510 (to B. F. B.) from the United States Public Health Service.; Supported by National Natural Science Foundation of China Grant 81202037 (to Z. W.)	Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Bai YL, 2004, MOL CELL, V15, P825, DOI 10.1016/j.molcel.2004.07.021; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Boyce BF, 2010, ANN NY ACAD SCI, V1192, P367, DOI 10.1111/j.1749-6632.2009.05315.x; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chiang CY, 1999, INFECT IMMUN, V67, P4231, DOI 10.1128/IAI.67.8.4231-4236.1999; Darzynkiewick Z., 2004, CYTOMETRY, V75; Duran A, 2004, DEV CELL, V6, P303, DOI 10.1016/S1534-5807(03)00403-9; Durrington HJ, 2010, J BIOL CHEM, V285, P37641, DOI 10.1074/jbc.M110.132415; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Guo R, 2008, J BIOL CHEM, V283, P23084, DOI 10.1074/jbc.M709848200; Hengwei Z., 2013, STEM CELLS IN PRESS; Hughes DE, 1996, NAT MED, V2, P1132, DOI 10.1038/nm1096-1132; Jacome-Galarza CE, 2013, J BONE MINER RES, V28, P1203, DOI 10.1002/jbmr.1822; Jensen LE, 2003, FEBS LETT, V553, P190, DOI 10.1016/S0014-5793(03)00998-0; Jin W, 2008, J CLIN INVEST, V118, P1858, DOI 10.1172/JCI34257; Katz EJ, 2010, BIOCHEM SOC T, V38, P21, DOI 10.1042/BST0380021; Kurihara N, 2007, J CLIN INVEST, V117, P133, DOI 10.1172/JCI28267; LAHERTY CD, 1993, J BIOL CHEM, V268, P5032; Lamothe B, 2007, BIOCHEM BIOPH RES CO, V359, P1044, DOI 10.1016/j.bbrc.2007.06.017; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Li P, 2004, ARTHRITIS RHEUM, V50, P265, DOI 10.1002/art.11419; Lohr NJ, 2010, AM J HUM GENET, V86, P447, DOI 10.1016/j.ajhg.2010.01.028; Mabilleau G, 2011, J BIOL CHEM, V286, P3242, DOI 10.1074/jbc.M110.150300; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Shembade N, 2009, EMBO J, V28, P513, DOI 10.1038/emboj.2008.285; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tao MF, 2009, CURR BIOL, V19, P1255, DOI 10.1016/j.cub.2009.06.038; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164; Wullaert A, 2006, TRENDS IMMUNOL, V27, P533, DOI 10.1016/j.it.2006.09.003; Xing LP, 2003, J BONE MINER RES, V18, P260, DOI 10.1359/jbmr.2003.18.2.260; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Yao ZQ, 2008, J BIOL CHEM, V283, P9917, DOI 10.1074/jbc.M706415200; Yao ZQ, 2006, J BIOL CHEM, V281, P11846, DOI 10.1074/jbc.M512624200; Zhang HW, 2010, J BONE MINER RES, V25, P640, DOI 10.1359/jbmr.090812	43	22	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22359	22368		10.1074/jbc.M112.442459	http://dx.doi.org/10.1074/jbc.M112.442459			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23782702	Green Published, hybrid			2022-12-25	WOS:000330596300017
J	Groen, B; Links, TP; Lefrandt, JD; van den Berg, PP; de Vos, P; Faas, MM				Groen, Bart; Links, Thera P.; Lefrandt, Joop D.; van den Berg, Paul P.; de Vos, Paul; Faas, Marijke M.			Aberrant Pregnancy Adaptations in the Peripheral Immune Response in Type 1 Diabetes: A Rat Model	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; RECURRENT SPONTANEOUS-ABORTION; RHEUMATOID-ARTHRITIS; CYTOKINE PRODUCTION; T-CELLS; BB RATS; WOMEN; PREECLAMPSIA; LYMPHOCYTES; MONOCYTES	Introduction: Despite tight glycemic control, pregnancy complication rate in type 1 diabetes patients is higher than in normal pregnancy. Other etiological factors may be responsible for the development of adverse pregnancy outcome. Acceptance of the semi-allogeneic fetus is accompanied by adaptations in the maternal immune-response. Maladaptations of the immune-response has been shown to contribute to pregnancy complications. We hypothesized that type 1 diabetes, as an autoimmune disease, may be associated with maladaptations of the immune-response to pregnancy, possibly resulting in pregnancy complications. Methods: We studied pregnancy outcome and pregnancy-induced immunological adaptations in a normoglycemic rat-model of type 1 diabetes, i.e. biobreeding diabetes-prone rats (BBDP; 5 non-pregnant rats, 7 pregnant day 10 rats and 6 pregnant day 18 rats), versus non-diabetic control rats (i.e. congenic non-diabetic biobreeding diabetes-resistant (BBDR; 6 non-pregnant rats, 6 pregnant day 10 rats and 6 pregnant day 18 rats) and Wistar-rats (6 non-pregnant, 6 pregnant day 10 rats and 5 pregnant day 18 rats)). Results: We observed reduced litter size, lower fetal weight of viable fetuses and increased numbers of resorptions versus control rats. These complications are accompanied by various differences in the immune-response between BBDP and control rats in both pregnant and non-pregnant animals. The immune-response in non-pregnant BBDP-rats was characterized by decreased percentages of lymphocytes, increased percentages of effector T-cells, regulatory T-cells and natural killer cells, an increased Th1/Th2-ratio and activated monocytes versus Wistar and BBDR-rats. Furthermore, pregnancy-induced adaptations in BBDP-rats coincided with an increased Th1/Th2-ratio, a decreased mean fluorescence intensity CD161a/NKR-P1b ratio and no further activation of monocytes versus non-diabetic control rats. Conclusion: This study suggests that even in the face of strict normoglycemia, pregnancy complications still occur in type 1 diabetic pregnancies. This adverse pregnancy outcome may be related to the aberrant immunological adaptations to pregnancy in diabetic rats.	[Groen, Bart; Links, Thera P.] Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Groen, Bart; Links, Thera P.; Lefrandt, Joop D.; van den Berg, Paul P.; de Vos, Paul; Faas, Marijke M.] Univ Groningen, NL-9700 AB Groningen, Netherlands; [Lefrandt, Joop D.] Univ Groningen, Univ Med Ctr Groningen, Div Vasc Med, Dept Internal Med, Groningen, Netherlands; [van den Berg, Paul P.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands; [de Vos, Paul; Faas, Marijke M.] Univ Groningen, Univ Med Ctr Groningen, Div Med Biol, Dept Pathol & Med Biol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Faas, MM (corresponding author), Univ Med Ctr Groningen, Div Med Biol, Dept Pathol & Med Biol, Groningen, Netherlands.	m.m.faas@umcg.nl	de Vos, Paul/A-3170-2013	de vos, paul/0000-0001-9618-2408				AHUJA V, 1995, CELL IMMUNOL, V163, P59, DOI 10.1006/cimm.1995.1099; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Baer AN, 2011, OBSTET GYNECOL SURV, V66, P639, DOI 10.1097/OGX.0b013e318239e1ee; Csorba TR, 2010, CRIT REV CL LAB SCI, V47, P51, DOI 10.3109/10408361003787171; Darmochwal-Kolarz D, 2012, J REPROD IMMUNOL, V93, P75, DOI 10.1016/j.jri.2012.01.006; de Man YA, 2009, ARTHRITIS RHEUM-US, V60, P3196, DOI 10.1002/art.24914; Devaraj S, 2006, DIABETES, V55, P774, DOI 10.2337/diabetes.55.03.06.db05-1417; Diabet Control Complications Trial Res Grp, 1996, AM J OBSTET GYNECOL, V174, P1343; Evers IN, 2004, BMJ-BRIT MED J, V328, P915, DOI 10.1136/bmj.38043.583160.EE; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gustafsson C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002078; Hawthorne G, 1997, BRIT MED J, V315, P279, DOI 10.1136/bmj.315.7103.279; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; Hillebrands JL, 2006, J IMMUNOL, V177, P7820, DOI 10.4049/jimmunol.177.11.7820; HUSSAIN MJ, 1987, DIABETOLOGIA, V30, P907, DOI 10.1007/BF00295872; Karami N, 2012, J REPROD IMMUNOL, V95, P87, DOI 10.1016/j.jri.2012.06.005; KNOPP RH, 1986, BIOL NEONATE, V50, P297, DOI 10.1159/000242614; Kuhnert M, 1998, EUR J OBSTET GYN R B, V76, P147, DOI 10.1016/S0301-2115(97)00180-2; Laresgoiti-Servitje E, 2010, HUM REPROD UPDATE, V16, P510, DOI 10.1093/humupd/dmq007; Lee SK, 2012, AM J REPROD IMMUNOL, V67, P311, DOI 10.1111/j.1600-0897.2012.01116.x; Leibowitz A, 2011, CURR HYPERTENS REP, V13, P465, DOI 10.1007/s11906-011-0224-9; Li J, 2003, INT IMMUNOL, V15, P411, DOI 10.1093/intimm/dxg046; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Loke YW, 2000, J REPROD FERTIL, P83; Lopez-Soldado Iliana, 2003, Exp Diabesity Res, V4, P107, DOI 10.1155/EDR.2003.107; Mahmoud Fadia, 2003, J Obstet Gynaecol, V23, P20, DOI 10.1080/0144361021000043163; Melgert BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045229; Mordes JP, 2004, ILAR J, V45, P278, DOI 10.1093/ilar.45.3.278; Murphy HR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1680; Norgaard M, 2010, J INTERN MED, V268, P329, DOI 10.1111/j.1365-2796.2010.02239.x; Orsi NM, 2008, J NEUROENDOCRINOL, V20, P462, DOI 10.1111/j.1365-2826.2008.01668.x; Poehlmann H, 2009, CRIT CARE, V13, DOI 10.1186/cc7969; Poussier P, 2005, J IMMUNOL, V174, P4081, DOI 10.4049/jimmunol.174.7.4081; Raghupathy R, 2000, HUM REPROD, V15, P713, DOI 10.1093/humrep/15.3.713; Raghupathy R, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/734865; Rossol M, 2012, ARTHRITIS RHEUM-US, V64, P671, DOI 10.1002/art.33418; Sacks G, 1999, IMMUNOL TODAY, V20, P114, DOI 10.1016/S0167-5699(98)01393-0; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; Saito S, 2007, J REPROD IMMUNOL, V76, P30, DOI 10.1016/j.jri.2007.08.002; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Sargent Ian L, 2007, Reprod Biomed Online, V14 Spec No 1, P111, DOI 10.1016/S1472-6483(10)61465-4; Scriba A, 1997, J LEUKOCYTE BIOL, V62, P741, DOI 10.1002/jlb.62.6.741; Soares MJ, 2012, PLACENTA, V33, P233, DOI 10.1016/j.placenta.2011.11.026; Taylor R, 2007, BMJ-BRIT MED J, V334, P742, DOI 10.1136/bmj.39154.700417.BE; van Nieuwenhoven ALV, 2003, HUM REPROD UPDATE, V9, P347, DOI 10.1093/humupd/dmg026; van Nieuwenhoven ALV, 2002, FERTIL STERIL, V77, P1032, DOI 10.1016/S0015-0282(02)02976-X; van Nieuwenhoven ALV, 2008, HYPERTENS PREGNANCY, V27, P207, DOI 10.1080/10641950701885006; Visser J, 2004, LAB ANIM-UK, V38, P371, DOI 10.1258/0023677041958936; WILSON RG, 1986, BRIT MED J, V293, P244, DOI 10.1136/bmj.293.6541.244; Zhang JH, 2011, CELL MOL IMMUNOL, V8, P1, DOI 10.1038/cmi.2010.38; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510	51	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e65490	10.1371/journal.pone.0065490	http://dx.doi.org/10.1371/journal.pone.0065490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805184	Green Published, gold			2022-12-25	WOS:000320846500012
J	Bijar, A; Khayati, R; Benavent, AP				Bijar, Ahmad; Khayati, Rasoul; Penalver Benavent, Antonio			Increasing the Contrast of the Brain MR FLAIR Images Using Fuzzy Membership Functions and Structural Similarity Indices in Order to Segment MS Lesions	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS LESIONS; FULLY-AUTOMATIC SEGMENTATION; PROBABILISTIC SEGMENTATION	Segmentation is an important step for the diagnosis of multiple sclerosis (MS). This paper presents a new approach to the fully automatic segmentation of MS lesions in Fluid Attenuated Inversion Recovery (FLAIR) Magnetic Resonance (MR) images. With the aim of increasing the contrast of the FLAIR MR images with respect to the MS lesions, the proposed method first estimates the fuzzy memberships of brain tissues (i.e., the cerebrospinal fluid (CSF), the normal-appearing brain tissue (NABT), and the lesion). The procedure for determining the fuzzy regions of their member functions is performed by maximizing fuzzy entropy through Genetic Algorithm. Research shows that the intersection points of the obtained membership functions are not accurate enough to segment brain tissues. Then, by extracting the structural similarity (SSIM) indices between the FLAIR MR image and its lesions membership image, a new contrast-enhanced image is created in which MS lesions have high contrast against other tissues. Finally, the new contrast-enhanced image is used to segment MS lesions. To evaluate the result of the proposed method, similarity criteria from all slices from 20 MS patients are calculated and compared with other methods, which include manual segmentation. The volume of segmented lesions is also computed and compared with Gold standard using the Intraclass Correlation Coefficient (ICC) and paired samples t test. Similarity index for the patients with small lesion load, moderate lesion load and large lesion load was 0.7261, 0.7745 and 0.8231, respectively. The average overall similarity index for all patients is 0.7649. The t test result indicates that there is no statistically significant difference between the automatic and manual segmentation. The validated results show that this approach is very promising.	[Bijar, Ahmad; Khayati, Rasoul] Shahed Univ, Dept Biomed Engn, Tehran, Iran; [Penalver Benavent, Antonio] Miguel Hernandez Univ Elche, Ctr Operat Res Univ Inst, Elche, Spain	Shahed University; Universidad Miguel Hernandez de Elche	Bijar, A (corresponding author), Shahed Univ, Dept Biomed Engn, Tehran, Iran.	bijar@shahed.ac.ir		Penalver Benavent, Antonio/0000-0002-3775-2623				Admasu F, 2003, 2003 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL 2, PROCEEDINGS, P1081; Admiraal-Behloul F, 2005, NEUROIMAGE, V28, P607, DOI 10.1016/j.neuroimage.2005.06.061; Akselrod-Ballin A, 2009, IEEE T BIO-MED ENG, V56, P2461, DOI 10.1109/TBME.2008.926671; Alfano B, 2000, J MAGN RESON IMAGING, V12, P799, DOI 10.1002/1522-2586(200012)12:6<799::AID-JMRI2>3.0.CO;2-#; Anbeek P, 2005, NEUROIMAGE, V27, P795, DOI 10.1016/j.neuroimage.2005.05.046; Anbeek P, 2004, NEUROIMAGE, V21, P1037, DOI 10.1016/j.neuroimage.2003.10.012; Anbeek P, 2008, MIDAS J, P1; BARTKO JJ, 1991, SCHIZOPHRENIA BULL, V17, P483, DOI 10.1093/schbul/17.3.483; Bedell BJ, 1998, MAGNET RESON MED, V39, P935, DOI 10.1002/mrm.1910390611; Bijar A., 2011, J BIOMED SCI ENG, V4, P552, DOI DOI 10.4236/JBISE.2011.48071; Boudraa AO, 2000, COMPUT BIOL MED, V30, P23, DOI 10.1016/S0010-4825(99)00019-0; Bricq S, 2008, GRAND CHALLENGE WORK, P1; Datta S, 2006, NEUROIMAGE, V29, P467, DOI 10.1016/j.neuroimage.2005.07.042; Datta S, 2007, J MAGN RESON IMAGING, V25, P932, DOI 10.1002/jmri.20896; Edelman RR, 2006, CLIN MAGNETIC RESONA, P1571; Freifeld O, 2007, I S BIOMED IMAGING, P596, DOI 10.1109/ISBI.2007.356922; Garcia-Lorenzo D., 2008, MICCAI WORKSH MED IM, P82; Garcia-Lorenzo D, 2008, GOURMET HLTH PROMOTI, P1; Garcia-Lorenzo D., 2008, WORK MED IM AN MULT, P104; Garcia-Lorenzo D, 2011, IEEE T MED IMAGING, V30, P1455, DOI 10.1109/TMI.2011.2114671; Gawne-Cain ML, 1998, J NEUROL NEUROSUR PS, V64; Goldberg-Zimring D, 1998, MAGN RESON IMAGING, V16, P311, DOI 10.1016/S0730-725X(97)00300-7; Goodman A., 2001, CNS NEWS SPECIAL EDI; He RJ, 2002, MED PHYS, V29, P1536, DOI 10.1118/1.1487422; Holland J.H., 1992, ADAPTATION NATURAL A; KAMBER M, 1995, IEEE T MED IMAGING, V14, P442, DOI 10.1109/42.414608; Khayati R, 2006, THESIS AMIRKBIR U TE; Khayati R, 2008, COMPUT BIOL MED, V38, P379, DOI 10.1016/j.compbiomed.2007.12.005; Lecoeur J, 2009, WORK MED IMAGE ANAL, P5; Li S. Z., 2001, COMP SCI W; Llado X, 2012, INFORM SCIENCES, V186, P164, DOI 10.1016/j.ins.2011.10.011; Martinez WL., 2002, COMPUTATIONAL STAT H; Morra J, 2008, GRAND CHALLENGE WORK, P1; Mortazavi D, 2012, NEURORADIOLOGY, V54, P299, DOI 10.1007/s00234-011-0886-7; Pahm DL, 1999, IEEE T MED IMAGING, V18, P731; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Prastawa M., 2008, GRAND CHALLENGE WORK, P1; Saha S, 2009, INFORM SCIENCES, V179, P3230, DOI 10.1016/j.ins.2009.06.013; Sahraian M. A., 2008, MRI ATLAS MS LESIONS; Sajja BR, 2006, ANN BIOMED ENG, V34, P142, DOI 10.1007/s10439-005-9009-0; Shiee N, 2008, WORK MED IMAGE ANAL, P71; Shiee N, 2010, NEUROIMAGE, V49, P1524, DOI 10.1016/j.neuroimage.2009.09.005; Shiee Navid, 2008, GRAND CHALLENGE WORK, P1; Slump K., 2008, GRAND CHALLENGE WORK, P1; Souplet JC, 2008, GRAND CHALLENGE WORK, P1; Stokking R, 2000, NEUROIMAGE, V12, P726, DOI 10.1006/nimg.2000.0661; Styner M., 2008, MIDAS J, P1; Subbanna N, 2009, MS LESION SEGMENTATI, P15; Tao WB, 2003, PATTERN RECOGN LETT, V24, P3069, DOI 10.1016/S0167-8655(03)00166-1; Tomas X, 2009, WORK MED IMAGE ANAL, P5; Van Leemput K, 2001, IEEE T MED IMAGING, V20, P677, DOI 10.1109/42.938237; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wellner PD., 1993, EPC1993110, pp. 1; Wells WM, 1996, IEEE T MED IMAGING, V15, P429, DOI 10.1109/42.511747; Wu Y, 2006, NEUROIMAGE, V32, P1205, DOI 10.1016/j.neuroimage.2006.04.211; Zavaljevski A, 2000, COMPUT MED IMAG GRAP, V24, P87, DOI 10.1016/S0895-6111(99)00042-7; Zijdenbos AP, 2002, IEEE T MED IMAGING, V21, P1280, DOI 10.1109/TMI.2002.806283; ZIJDENBOS AP, 1994, IEEE T MED IMAGING, V13, P716, DOI 10.1109/42.363096	58	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65469	10.1371/journal.pone.0065469	http://dx.doi.org/10.1371/journal.pone.0065469			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799015	gold, Green Submitted, Green Published			2022-12-25	WOS:000321397800007
J	Hu, T; Hu, LX; Zhang, XZ; Zhang, PP; Zhao, ZJ; Fu, JM				Hu, Tao; Hu, Longxing; Zhang, Xunzhong; Zhang, Pingping; Zhao, Zhuangjun; Fu, Jinmin			Differential Responses of CO2 Assimilation, Carbohydrate Allocation and Gene Expression to NaCl Stress in Perennial Ryegrass with Different Salt Tolerance	PLOS ONE			English	Article							SUCROSE-FRUCTAN 6-FRUCTOSYLTRANSFERASE; SIGNAL-TRANSDUCTION; PHOTOSYSTEM-II; PHOTOSYNTHETIC CAPACITY; STOMATAL CONDUCTANCE; SEEDLING GROWTH; SOLUBLE SUGAR; KEY ENZYME; IN-VIVO; SALINITY	Little is known about the effects of NaCl stress on perennial ryegrass (Lolium perenne L.) photosynthesis and carbohydrate flux. The objective of this study was to understand the carbohydrate metabolism and identify the gene expression affected by salinity stress. Seventy-four days old seedlings of two perennial ryegrass accessions (salt-sensitive 'PI 538976' and salt-tolerant 'Overdrive') were subjected to three levels of salinity stress for 5 days. Turf quality in all tissues (leaves, stems and roots) of both grass accessions negatively and significantly correlated with GFS (Glu+Fru+Suc) content, except for 'Overdrive' stems. Relative growth rate (RGR) in leaves negatively and significantly correlated with GFS content in 'Overdrive' (P < 0.01) and 'PI 538976' (P < 0.05) under salt stress. 'Overdrive' had higher CO2 assimilation and F-v/F-m than 'PI 538976'. Intercellular CO2 concentration, however, was higher in 'PI 538976' treated with 400 mM NaCl relative to that with 200 mM NaCl. GFS content negatively and significantly correlated with RGR in 'Overdrive' and 'PI 538976' leaves and in 'PI 538976' stems and roots under salt stress. In leaves, carbohydrate allocation negatively and significantly correlated with RGR (r(2) = 0.83, P < 0.01) and turf quality (r(2) = 0.88, P < 0.01) in salt-tolerant 'Overdrive', however, the opposite trend for salt-sensitive 'PI 538976' (r(2) = 0.71, P < 0.05 for RGR; r(2) = 0.62, P > 0.05 for turf quality). A greater up-regulation in the expression of SPS, SS, SI, 6-SFT gene was observed in 'Overdrive' than 'PI 538976'. A higher level of SPS and SS expression in leaves was found in 'PI 538976' relative to 'Overdrive'. Accumulation of hexoses in roots, stems and leaves can induce a feedback repression to photosynthesis in salt-stressed perennial ryegrass and the salt tolerance may be changed with the carbohydrate allocation in leaves and stems.	[Hu, Tao; Hu, Longxing; Zhang, Pingping; Zhao, Zhuangjun; Fu, Jinmin] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Peoples R China; [Zhang, Xunzhong] Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Virginia Polytechnic Institute & State University	Fu, JM (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Peoples R China.	jfu@wbgcas.cn	Campos, Gustavo R C Ribeiro/O-3981-2017; Hu, Longxing/AAS-8287-2020		National Natural Science Foundation of China [31071822/C150302]; Chinese Academy of Sciences [KSCX2-YW-N-068]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was financially supported by National Natural Science Foundation of China (Grant: 31071822/C150302) and Innovative Program of The Chinese Academy of Sciences (Project #: KSCX2-YW-N-068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdiev SI, 2008, PHOTOSYNTH RES, V98, P529, DOI 10.1007/s11120-008-9334-x; Amiard V, 2003, PLANT PHYSIOL, V132, P2218, DOI 10.1104/pp.103.022335; BAKER NR, 1991, PHYSIOL PLANTARUM, V81, P563, DOI 10.1111/j.1399-3054.1991.tb05101.x; BALL MC, 1988, AUST J PLANT PHYSIOL, V15, P447, DOI 10.1071/PP9880447; Bernstein N, 2010, FREE RADICAL BIO MED, V49, P1161, DOI 10.1016/j.freeradbiomed.2010.06.032; BETHKE PC, 1992, PLANT PHYSIOL, V99, P219, DOI 10.1104/pp.99.1.219; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; BRUGNOLI E, 1991, PLANT PHYSIOL, V95, P628, DOI 10.1104/pp.95.2.628; BURCHETT MD, 1989, PHYSIOL PLANTARUM, V75, P299, DOI 10.1111/j.1399-3054.1989.tb06185.x; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Debez A, 2004, PLANT SOIL, V262, P179, DOI 10.1023/B:PLSO.0000037034.47247.67; Delfine S, 1999, PLANT PHYSIOL, V119, P1101, DOI 10.1104/pp.119.3.1101; Dionisio-Sese ML, 2000, J PLANT PHYSIOL, V157, P54, DOI 10.1016/S0176-1617(00)80135-2; DUCHATEAU N, 1995, PLANT PHYSIOL, V107, P1249, DOI 10.1104/pp.107.4.1249; ELSE MA, 1995, PLANT PHYSIOL, V109, P1017, DOI 10.1104/pp.109.3.1017; EVERARD JD, 1994, PLANT PHYSIOL, V106, P281, DOI 10.1104/pp.106.1.281; Farrar J, 2000, PLANT SCI, V154, P1, DOI 10.1016/S0168-9452(99)00260-5; Felix J. de M., 2009, Tropical Plant Biology, V2, P98, DOI 10.1007/s12042-009-9031-8; Flexas J, 2007, PLANT CELL ENVIRON, V30, P1284, DOI 10.1111/j.1365-3040.2007.01700.x; FOYER C, 1990, PHOTOSYNTH RES, V25, P83, DOI 10.1007/BF00035457; Fu JM, 2010, J AM SOC HORTIC SCI, V135, P506, DOI 10.21273/JASHS.135.6.506; GOLDSCHMIDT EE, 1992, PLANT PHYSIOL, V99, P1443, DOI 10.1104/pp.99.4.1443; GREEN PB, 1968, PLANT PHYSIOL, V43, P1169, DOI 10.1104/pp.43.8.1169; Griffin KL, 1996, CHEM BIOL, V3, P245, DOI 10.1016/S1074-5521(96)90104-0; Gutierrez D, 2009, PHYSIOL PLANTARUM, V137, P86, DOI 10.1111/j.1399-3054.2009.01256.x; Han S, 2009, PLANT SCI, V176, P143, DOI 10.1016/j.plantsci.2008.10.004; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; HAVAUX M, 1992, PLANT PHYSIOL, V100, P424, DOI 10.1104/pp.100.1.424; Ho SL, 2001, PLANT PHYSIOL, V125, P877, DOI 10.1104/pp.125.2.877; Hoagland DR, 1950, 247 CAL AGR EXP, V247; Hu T, 2011, ECOTOX ENVIRON SAFE, V74, P2050, DOI 10.1016/j.ecoenv.2011.07.013; Jang JC, 1997, PLANT CELL, V9, P5, DOI 10.1105/tpc.9.1.5; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; KOCH KE, 1992, PLANT CELL, V4, P59, DOI 10.1105/tpc.4.1.59; Larcher W, 2003, PHYSL PLANT ECOLOGY; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; Liu H, 2008, PLANT CELL ENVIRON, V31, P1325, DOI 10.1111/j.1365-3040.2008.01838.x; Lu CM, 1999, NEW PHYTOL, V141, P231, DOI 10.1046/j.1469-8137.1999.00340.x; Lutts S, 1996, PLANT GROWTH REGUL, V19, P207, DOI 10.1007/BF00037793; Macias-Rodriguez L, 2002, J AGR FOOD CHEM, V50, P3317, DOI 10.1021/jf011491p; MARCAR NE, 1987, AUST J AGR RES, V38, P297, DOI 10.1071/AR9870297; Meloni DA, 2003, ENVIRON EXP BOT, V49, P69, DOI 10.1016/S0098-8472(02)00058-8; MOING A, 1992, PLANT PHYSIOL, V100, P1878, DOI 10.1104/pp.100.4.1878; MORALES F, 1992, PHYSIOL PLANTARUM, V86, P419, DOI 10.1111/j.1399-3054.1992.tb01338.x; Morvan-Bertrand A, 2001, PLANTA, V213, P109, DOI 10.1007/s004250000478; Moya JL, 2003, J EXP BOT, V54, P825, DOI 10.1093/jxb/erg064; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; MUNNS R, 1986, AUST J PLANT PHYSIOL, V13, P143, DOI 10.1071/PP9860143; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Neves-Piestun BG, 2001, PLANT PHYSIOL, V125, P1419, DOI 10.1104/pp.125.3.1419; NIU XM, 1995, PLANT PHYSIOL, V109, P735, DOI 10.1104/pp.109.3.735; Nizam I, 2011, AFR J BIOTECHNOL, V10, P10418; Parida AK, 2003, PHOTOSYNTHETICA, V41, P191, DOI 10.1023/B:PHOT.0000011951.37231.69; Pego JV, 2000, J EXP BOT, V51, P407, DOI 10.1093/jexbot/51.suppl_1.407; Pollock C, 2003, J EXP BOT, V54, P489, DOI 10.1093/jxb/erg037; Prado FE, 2000, BOT BULL ACAD SINICA, V41, P27; Ramon M., 2008, ARABIDOPSIS BOOK; RHOADES J D, 1990, P1089; Roitsch T, 1999, CURR OPIN PLANT BIOL, V2, P198, DOI 10.1016/S1369-5266(99)80036-3; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Sade N, 2010, PLANT PHYSIOL, V152, P245, DOI 10.1104/pp.109.145854; Savitch LV, 2002, PLANT CELL ENVIRON, V25, P761, DOI 10.1046/j.1365-3040.2002.00861.x; Seckin B, 2010, ENVIRON EXP BOT, V69, P76, DOI 10.1016/j.envexpbot.2010.02.013; SEEMANN JR, 1986, PLANT PHYSIOL, V82, P555, DOI 10.1104/pp.82.2.555; SEEMANN JR, 1985, PLANTA, V164, P151, DOI 10.1007/BF00396077; Shabala S, 2008, PHYSIOL PLANTARUM, V133, P651, DOI 10.1111/j.1399-3054.2007.01008.x; Smeekens S, 1997, PLANT PHYSIOL, V115, P7, DOI 10.1104/pp.115.1.7; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; SMILLIE RM, 1982, PLANT PHYSIOL, V70, P1049, DOI 10.1104/pp.70.4.1049; SPRENGER N, 1995, P NATL ACAD SCI USA, V92, P11652, DOI 10.1073/pnas.92.25.11652; STOREY R, 1995, AUST J PLANT PHYSIOL, V22, P101, DOI 10.1071/PP9950101; Sudhir PR, 2005, J BIOCHEM MOL BIOL, V38, P481; Takemura T, 2000, AQUAT BOT, V68, P15, DOI 10.1016/S0304-3770(00)00106-6; Trapp S, 2004, ENVIRON SCI POLLUT R, V11, P327, DOI 10.1007/BF02979647; Turgeon A.J., 2002, TURFGRASS MANAGEMENT; Wei JZ, 2001, J PLANT PHYSIOL, V158, P1203, DOI 10.1078/0176-1617-00241; Wu W, 2005, BIOCHEM SYST ECOL, V33, P1141, DOI 10.1016/j.bse.2005.02.010; Xiong YW, 2007, MOL BREEDING, V19, P125, DOI 10.1007/s11032-006-9050-1; Ye Y, 2005, AQUAT BOT, V83, P193, DOI 10.1016/j.aquabot.2005.06.006; Yu XZ, 2008, ECOTOX ENVIRON SAFE, V71, P609, DOI 10.1016/j.ecoenv.2008.05.007; Zhang T, 2010, J PLANT PHYSIOL, V167, P951, DOI 10.1016/j.jplph.2009.12.020; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	82	26	27	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66090	10.1371/journal.pone.0066090	http://dx.doi.org/10.1371/journal.pone.0066090			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799072	Green Published, gold, Green Submitted			2022-12-25	WOS:000320363300061
J	Shen, CP; Liu, ST; Zhou, WZ; Lin, FS; Lam, AYY; Sung, HY; Chen, W; Lin, JW; Chiu, MJ; Pan, MK; Kao, JH; Wu, JM; Lai, FP				Shen, Chia-Ping; Liu, Shih-Ting; Zhou, Wei-Zhi; Lin, Feng-Seng; Lam, Andy Yan-Yu; Sung, Hsiao-Ya; Chen, Wei; Lin, Jeng-Wei; Chiu, Ming-Jang; Pan, Ming-Kai; Kao, Jui-Hung; Wu, Jin-Ming; Lai, Feipei			A Physiology- Based Seizure Detection System for Multichannel EEG	PLOS ONE			English	Article							AUTOMATIC SPIKE DETECTION; NEURAL-NETWORK; POLARITY; EPILEPSY	Background: Epilepsy is a common chronic neurological disorder characterized by recurrent unprovoked seizures. Electroencephalogram (EEG) signals play a critical role in the diagnosis of epilepsy. Multichannel EEGs contain more information than do single-channel EEGs. Automatic detection algorithms for spikes or seizures have traditionally been implemented on single-channel EEG, and algorithms for multichannel EEG are unavailable. Methodology: This study proposes a physiology-based detection system for epileptic seizures that uses multichannel EEG signals. The proposed technique was tested on two EEG data sets acquired from 18 patients. Both unipolar and bipolar EEG signals were analyzed. We employed sample entropy (SampEn), statistical values, and concepts used in clinical neurophysiology (e.g., phase reversals and potential fields of a bipolar EEG) to extract the features. We further tested the performance of a genetic algorithm cascaded with a support vector machine and post-classification spike matching. Principal Findings: We obtained 86.69% spike detection and 99.77% seizure detection for Data Set I. The detection system was further validated using the model trained by Data Set I on Data Set II. The system again showed high performance, with 91.18% detection of spikes and 99.22% seizure detection. Conclusion: We report a de novo EEG classification system for seizure and spike detection on multichannel EEG that includes physiology-based knowledge to enhance the performance of this type of system.	[Shen, Chia-Ping; Liu, Shih-Ting; Zhou, Wei-Zhi; Lam, Andy Yan-Yu; Chen, Wei; Kao, Jui-Hung; Wu, Jin-Ming; Lai, Feipei] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Lin, Feng-Seng; Sung, Hsiao-Ya; Lai, Feipei] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei 10764, Taiwan; [Lin, Jeng-Wei] Tunghai Univ, Dept Informat Management, Taichung 40704, Taiwan; [Chiu, Ming-Jang; Pan, Ming-Kai] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Neurol, Taipei 10764, Taiwan; [Chiu, Ming-Jang; Pan, Ming-Kai] Natl Taiwan Univ, Grad Inst Brain & Mind Sci, Taipei 10764, Taiwan; [Chiu, Ming-Jang; Pan, Ming-Kai] Natl Taiwan Univ, Coll Sci, Dept Psychol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; Tunghai University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Chiu, MJ (corresponding author), Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Neurol, Taipei 10764, Taiwan.	mjchiu@ntu.edu.tw	Chiu, Ming-Jang/AAR-3940-2020; Wu, Jin-Ming/D-9370-2013	Chiu, Ming-Jang/0000-0002-4158-4423; Wu, Jin-Ming/0000-0002-1821-239X; Pan, Ming-Kai/0000-0003-1485-3154; Pan, Ming-Kai/0000-0001-5535-2714				Acir N, 2004, COMPUT BIOL MED, V34, P561, DOI 10.1016/j.compbiomed.2003.08.003; Blume WT, 2001, EPILEPSIA, V42, P508, DOI 10.1046/j.1528-1157.2001.02700.x; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chaovalitwongse WA, 2011, IEEE T SYST MAN CY A, V41, P977, DOI 10.1109/TSMCA.2011.2106118; Chen L, 2009, IEEE T INF TECHNOL B, V13, P405, DOI 10.1109/TITB.2008.2012164; Chia-Ping Shen, 2011, 2011 IEEE 11th International Conference on Bioinformatics & Bioengineering, P39, DOI 10.1109/BIBE.2011.13; Cortes C., 1995, SUPPORT VECTOR NETWO; DAVEY BLK, 1989, MED BIOL ENG COMPUT, V27, P365, DOI 10.1007/BF02441427; De Lucia M, 2008, MED BIOL ENG COMPUT, V46, P263, DOI 10.1007/s11517-007-0289-4; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Fitzpatrick W, 2007, CAN J NEUROL SCI, V34, P443, DOI 10.1017/S0317167100007332; Ghosh-Dastidar S, 2008, IEEE T BIO-MED ENG, V55, P512, DOI 10.1109/TBME.2007.905490; Guler I, 2005, J NEUROSCI METH, V148, P113, DOI 10.1016/j.jneumeth.2005.04.013; Holland J.H., 1992, ADAPTATION NATURAL A; Inan ZH, 2007, COMPUT BIOL MED, V37, P1160, DOI 10.1016/j.compbiomed.2006.10.010; Indiradevi KP, 2008, COMPUT BIOL MED, V38, P805, DOI 10.1016/j.compbiomed.2008.04.010; Ji ZF, 2011, IEEE T BIO-MED ENG, V58, P2478, DOI 10.1109/TBME.2011.2157917; KNOTT JR, 1985, J CLIN NEUROPHYSIOL, V2, P63, DOI 10.1097/00004691-198501000-00004; Ko CW, 2000, CLIN NEUROPHYSIOL, V111, P477, DOI 10.1016/S1388-2457(99)00284-9; LESSER RP, 1985, J CLIN NEUROPHYSIOL, V2, P45, DOI 10.1097/00004691-198501000-00003; Logesparan L, 2011, IEEE T BIO-MED ENG, V58, P2825, DOI 10.1109/TBME.2011.2160639; Nonclercq A, 2009, NEUROPHYSIOL CLIN, V39, P123, DOI 10.1016/j.neucli.2008.12.001; Oikonomou VP, 2007, COMPUT METH PROG BIO, V85, P101, DOI 10.1016/j.cmpb.2006.10.003; Olejniczak P, 2006, J CLIN NEUROPHYSIOL, V23, P186, DOI 10.1097/01.wnp.0000220079.61973.6c; Pedley T. A., 1980, American Journal of EEG Technology, V20, P101; Sackellares JC, 2012, EPILEPSY BEHAV, V22, P69; Shen CP, 2013, CLIN EEG NE IN PRESS; Shen CP, 2012, INT S NETW EN HLTH I, P797; Tzallas AT, 2009, IEEE T INF TECHNOL B, V13, P703, DOI 10.1109/TITB.2009.2017939; Ubeyli ED, 2007, PATTERN RECOGN LETT, V28, P592, DOI 10.1016/j.patrec.2006.10.004; Valderrama M, 2012, BIOMED SIGNAL PROCES, V7, P237, DOI 10.1016/j.bspc.2011.05.005; Witte H, 2003, IEEE T BIO-MED ENG, V50, P537, DOI 10.1109/TBME.2003.810708; Xia YS, 2006, IEEE T NEURAL NETWOR, V17, P975, DOI 10.1109/TNN.2006.875985; Yadav R, 2012, IEEE T BIO-MED ENG, V59, P1419, DOI 10.1109/TBME.2012.2188399; Yang JH, 1998, IEEE INTELL SYST APP, V13, P44, DOI 10.1109/5254.671091	35	21	22	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65862	10.1371/journal.pone.0065862	http://dx.doi.org/10.1371/journal.pone.0065862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799053	Green Submitted, Green Published, gold			2022-12-25	WOS:000320363300047
J	Beckers, P; Loesel, R; Bartolomaeus, T				Beckers, Patrick; Loesel, Rudi; Bartolomaeus, Thomas			The Nervous Systems of Basally Branching Nemertea (Palaeonemertea)	PLOS ONE			English	Article							RIBBON WORM RELATIONSHIPS; NEREIS-DIVERSICOLOR; ULTRASTRUCTURE; RECONSTRUCTION; POLYCHAETA; PREDATORS; MOLLUSCA; ORGANS	In recent years, a lot of studies have been published dealing with the anatomy of the nervous system in different spiralian species. The only nemertean species investigated in this context probably shows derived characters and thus the conditions found there are not useful in inferring the relationship between nemerteans and other spiralian taxa. Ingroup relationships within Nemertea are still unclear, but there is some agreement that the palaeonemerteans form a basal, paraphyletic grade. Thus, palaeonemertean species are likely the most informative when comparing with other invertebrate groups. We therefore analyzed the nervous system of several palaeonemertean species by combining histology and immunostaining. 3D reconstructions based on the aligned slices were performed to get an overall impression of the central nervous system, and immunohistochemistry was chosen to reveal fine structures and to be able to compare the data with recently published results. The insights presented here permit a first attempt to reconstruct the primary organization of the nemertean nervous system. This comparative analysis allows substantiating homology hypotheses for nerves of the peripheral nervous system. This study also provides evidence that the nemertean brain primarily consists of two lobes connected by a strong ventral commissure and one to several dorsal commissures. During nemertean evolution, the brain underwent continuous compartmentalization into a pair of dorsal and ventral lobes interconnected by commissures and lateral tracts. Given that this conclusion can be corroborated by cladistic analyses, nemerteans should share a common ancestor with spiralians that primarily have a simple brain consisting of paired medullary, frontally commissurized and reinforced cords. Such an organization resembles the situation found in presumably basally branching annelids or mollusks.	[Beckers, Patrick; Bartolomaeus, Thomas] Univ Bonn, Inst Evolutionary Biol & Ecol, Bonn, Germany; [Loesel, Rudi] Rhein Westfal TH Aachen, Inst Biol 2, Unit Dev Biol & Morphol Anim, Aachen, Germany	University of Bonn; RWTH Aachen University	Beckers, P (corresponding author), Univ Bonn, Inst Evolutionary Biol & Ecol, Bonn, Germany.	pbeckers@evolution.uni-bonn.de	Beckers, Patrick/AAO-7757-2020		German Research Council [BA 1520/11-2]	German Research Council(German Research Foundation (DFG))	Funding provided by the German Research Council BA 1520/11-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMERONGEN HM, 1982, J EXP MAR BIOL ECOL, V64, P11, DOI 10.1016/0022-0981(82)90065-X; Andrade SCS, 2012, CLADISTICS, V28, P141, DOI 10.1111/j.1096-0031.2011.00376.x; AX P, 1996, MULTICELLULAR ANIMAL, V1; Beckers P, 2012, THESIS FRIEDRICH WIL; Beckers P, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-17; BIANCHI S, 1969, GEN COMP ENDOCR, V12, P541, DOI 10.1016/0016-6480(69)90172-5; Brusca R. C., 2004, INVERTEBRATES; BULLOCK TH, 1965, STRUCTURE FUNCTION N, V2, P1719; Burger O., 1895, FAUNA FLORA GOLFES N; Burger O, 1921, MITTHEILUNGEN ZOOLOG, P206; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; Coe Wesley R., 1943, TRANS CONNECTICUT ACAD ARTS AND SCI, V35, P129; Coe WR, 1905, B MUS COMP ZOOL HARV, V47, P1, DOI DOI 10.1038/199121D0; Coulon J, 1997, CELL TISSUE RES, V1, P95; Edgecombe GD, 2011, ORG DIVERS EVOL, V11, P151, DOI 10.1007/s13127-011-0044-4; Eernisse Douglas J., 1994, P55; Faller S, 2008, J MORPHOL, V269, P1482; FERRARIS JD, 1985, AM ZOOL, V25, P73; Friedrich H, 1956, LUNDS U ARSSKR, V2, P3; FRIEDRICH HERMANN, 1935, ZOOL ANZ, V109, P64; Gibson R., 1982, SYNOPSES BRIT FAUNA, V24; Gibson R, 1972, NEMERTEANS; Gibson R, 1986, P 2 INT MAR BIOL WOR, P33; Golding David W., 1992, P153; HAREL R, 1993, FASEB J, V7, P1115, DOI 10.1096/fasebj.7.12.8375610; HASZPRUNAR G, 1987, PHILOS T R SOC B, V315, P37, DOI 10.1098/rstb.1987.0002; Herrmann Karl, 1997, P207; Heuer CM, 2008, CELL TISSUE RES, V331, P713, DOI 10.1007/s00441-007-0535-y; Heuer CM, 2009, ZOOMORPHOLOGY, V128, P219, DOI 10.1007/s00435-008-0063-7; Heuer CM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-13; Hyman L. H., 1967, INVERTEBRATES MOLLUS, VVI; Iwata F., 1954, Journal of the Faculty of Science Hokkaido University Zoology, V11, P126; Iwata F, 1963, PUBL AKKESHI MAR BIO, V10, P1; IWATA FUMIO, 1954, JOUR FAC SCI HOKKAIDO UNIV SER VI ZOOL, V12, P1; James MA, 1997, MICROSCOPIC ANATOMY, V13, P297; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Loesel R, 2010, ACTA ZOOL-STOCKHOLM, V91, P29, DOI 10.1111/j.1463-6395.2009.00422.x; Maslakova SA, 2004, DEV BIOL, V267, P342, DOI 10.1016/j.ydbio.2003.10.022; MOROZ L, 1994, CELL TISSUE RES, V275, P277, DOI 10.1007/BF00319425; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Nielsen Claus, 1997, P13; NORDHAUSEN W, 1988, HYDROBIOLOGIA, V156, P39, DOI 10.1007/BF00027976; Purschke G, 1997, ACTA ZOOL-STOCKHOLM, V78, P123, DOI 10.1111/j.1463-6395.1997.tb01133.x; Reuter M., 1995, Experientia Supplementum (Basel), V72, P25; Rhode B, 1990, J MORPHOL, V1, P167; Rice Mary E., 1993, P237; Richter S, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-29; RODRIGUEZ J, 1960, VIROLOGY, V12, P316, DOI 10.1016/0042-6822(60)90205-1; Rothe Birgen H., 2008, Meiofauna Marina, V16, P175; Rouse GW, 1997, ZOOL SCR, V26, P139, DOI 10.1111/j.1463-6409.1997.tb00412.x; Ruppert E.E., 2003, INVERTEBRATE ZOOLOGY; RUTKA JT, 1988, J NEUROSURG, V69, P155, DOI 10.3171/jns.1988.69.2.0155; Scharrer B, 1941, J COMP NEUROL, V74, P109, DOI 10.1002/cne.900740109; Scheltema Amelie H., 1994, P13; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Senz W., 2000, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V102B, P321; Senz W, 1997, SITZUNGSBER AKAD W 1, V204, P3; Senz W, 1990, ANN NATURHISTORISCHE, P47; SENZ W, 1997, SITZUNGSBER ABT 1, V204, P63; Struck TH, 2011, NATURE, V471, P95, DOI 10.1038/nature09864; Sundberg P, 2001, MOL PHYLOGENET EVOL, V20, P327, DOI 10.1006/mpev.2001.0982; Thiel M, 2001, HYDROBIOLOGIA, V456, P21, DOI 10.1023/A:1013005814145; Thiel M, 1998, HYDROBIOLOGIA, V365, P241; Thollesson M, 2003, P ROY SOC B-BIOL SCI, V270, P407, DOI 10.1098/rspb.2002.2254; Todt C, 2008, MAR BIOL RES, V4, P290, DOI 10.1080/17451000801922830; TURBEVILLE JM, 1985, AM ZOOL, V25, P53; Turbeville JM, 1991, MICROSCOPIC ANATOMY, V3, P258; Wang HY, 2006, J EXP MAR BIOL ECOL, V336, P146, DOI 10.1016/j.jembe.2006.05.008; WHITTLE AC, 1974, J MORPHOL, V144, P167, DOI 10.1002/jmor.1051440204; Wijnhoff G., 1910, (Anatom Teil) Zool Jahrb Jena Abt f Anat, V30; Wollesen T, 2008, ACTA BIOL HUNG, V59, P111, DOI 10.1556/ABiol.59.2008.Suppl.18	72	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66137	10.1371/journal.pone.0066137	http://dx.doi.org/10.1371/journal.pone.0066137			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785478	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800044
J	Cernilogar, FM; Burroughs, AM; Lanzuolo, C; Breiling, A; Imhof, A; Orlando, V				Cernilogar, Filippo M.; Burroughs, A. Maxwell; Lanzuolo, Chiara; Breiling, Achim; Imhof, Axel; Orlando, Valerio			RNA-Interference Components Are Dispensable for Transcriptional Silencing of the Drosophila Bithorax-Complex	PLOS ONE			English	Article							NONCODING RNAS; METHYLTRANSFERASE ACTIVITY; HETEROCHROMATIN FORMATION; ARGONAUTE PROTEINS; DISTINCT ROLES; POLYCOMB; ELEMENTS; CHROMATIN; PATHWAY; METHYLATION	Background: Beyond their role in post-transcriptional gene silencing, Dicer and Argonaute, two components of the RNA interference (RNAi) machinery, were shown to be involved in epigenetic regulation of centromeric heterochromatin and transcriptional gene silencing. In particular, RNAi mechanisms appear to play a role in repeat induced silencing and some aspects of Polycomb-mediated gene silencing. However, the functional interplay of RNAi mechanisms and Polycomb group (PcG) pathways at endogenous loci remains to be elucidated. Principal Findings: Here we show that the endogenous Dicer-2/Argonaute-2 RNAi pathway is dispensable for the PcG mediated silencing of the homeotic Bithorax Complex (BX-C). Although Dicer-2 depletion triggers mild transcriptional activation at Polycomb Response Elements (PREs), this does not induce transcriptional changes at PcG-repressed genes. Moreover, Dicer-2 is not needed to maintain global levels of methylation of lysine 27 of histone H3 and does not affect PRE-mediated higher order chromatin structures within the BX-C. Finally bioinformatic analysis, comparing published data sets of PcG targets with Argonaute-2-bound small RNAs reveals no enrichment of these small RNAs at promoter regions associated with PcG proteins. Conclusions: We conclude that the Dicer-2/Argonaute-2 RNAi pathway, despite its role in pairing sensitive gene silencing of transgenes, does not have a role in PcG dependent silencing of major homeotic gene cluster loci in Drosophila.	[Cernilogar, Filippo M.; Lanzuolo, Chiara; Orlando, Valerio] IRCCS Fdn Santa Lucia, Epigenet & Genome Reprogramming Lab, Rome, Italy; [Cernilogar, Filippo M.; Imhof, Axel] Univ Munich, Adolf Butenandt Inst, Munich, Germany; [Breiling, Achim] German Canc Res Ctr, DKFZ ZMBH Alliance, Div Epigenet, Heidelberg, Germany; [Lanzuolo, Chiara] IRCCS Fdn Santa Lucia, Inst Neurobiol & Mol Med, CNR, Rome, Italy; [Burroughs, A. Maxwell] RIKEN Yokohama Inst, RIKEN Om Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Imhof, Axel] Univ Munich, Munich Ctr Integrated Prot Sci, Munich, Germany	IRCCS Santa Lucia; University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Consiglio Nazionale delle Ricerche (CNR); IRCCS Santa Lucia; RIKEN; University of Munich	Cernilogar, FM (corresponding author), IRCCS Fdn Santa Lucia, Epigenet & Genome Reprogramming Lab, Rome, Italy.	filippo.cernilogar@med.uni-muenchen.de	Imhof, Axel/AAU-5313-2021; Lanzuolo, Chiara/AAB-1037-2019; Cernilogar, Filippo/AAC-3243-2021	Imhof, Axel/0000-0003-2993-8249; Cernilogar, Filippo/0000-0003-2814-3436; Burroughs, A. Max/0000-0002-2229-8771; Lanzuolo, Chiara/0000-0003-2649-6334; Breiling, Achim/0000-0002-7928-299X	European Union [EpiGeneSys 257082]; Fondazione Telethon [S00094TELA]; Epigenome Network of Excellence (NoE); Progetto Bandiera EPIGEN	European Union(European Commission); Fondazione Telethon(Fondazione TelethonEuropean Commission); Epigenome Network of Excellence (NoE); Progetto Bandiera EPIGEN	Funding was provided by grants from the European Union to A.I. (EpiGeneSys 257082), and by the Fondazione Telethon (S00094TELA), The Epigenome Network of Excellence (NoE), the Progetto Bandiera EPIGEN to V.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M., 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002; Bantignies F, 2003, GENE DEV, V17, P2406, DOI 10.1101/gad.269503; Bantignies F, 2011, TRENDS GENET, V27, P454, DOI 10.1016/j.tig.2011.06.008; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bonaldi T, 2004, PROTEOMICS, V4, P1382, DOI 10.1002/pmic.200300743; Bonaldi T, 2004, METHOD ENZYMOL, V377, P111; Breiling A, 2004, EMBO REP, V5, P976, DOI 10.1038/sj.embor.7400260; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Burroughs AM, 2011, RNA BIOL, V8, P158, DOI 10.4161/rna.8.1.14300; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cernilogar FM, 2011, NATURE, V480, P391, DOI 10.1038/nature10492; Cleard F, 2006, NAT GENET, V38, P931, DOI 10.1038/ng1833; Comet I, 2006, DEV CELL, V11, P117, DOI 10.1016/j.devcel.2006.05.009; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Deshpande G, 2005, GENE DEV, V19, P1680, DOI 10.1101/gad.1316805; Enderle D, 2011, GENOME RES, V21, P216, DOI 10.1101/gr.114348.110; Fagegaltier D, 2009, P NATL ACAD SCI USA, V106, P21258, DOI 10.1073/pnas.0809208105; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Greiner D, 2005, NAT CHEM BIOL, V1, P143, DOI 10.1038/nchembio721; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hekimoglu B, 2009, RNA BIOL, V6, P129, DOI 10.4161/rna.6.2.8178; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Lanzuolo C, 2012, ANNU REV GENET, V46, P561, DOI 10.1146/annurev-genet-110711-155603; Lanzuolo C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002370; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo Sardo F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003283; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; MARTIN CH, 1995, P NATL ACAD SCI USA, V92, P8398, DOI 10.1073/pnas.92.18.8398; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; MESSMER S, 1992, GENE DEV, V6, P1241, DOI 10.1101/gad.6.7.1241; Mihaly J, 1997, DEVELOPMENT, V124, P1809; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Moshkovich N, 2011, GENE DEV, V25, P1686, DOI 10.1101/gad.16651211; Moshkovich N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000880; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; PalBhadra M, 1997, CELL, V90, P479, DOI 10.1016/S0092-8674(00)80508-5; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rank G, 2002, MOL CELL BIOL, V22, P8026, DOI 10.1128/MCB.22.22.8026-8034.2002; Saito K, 2010, DEV CELL, V19, P687, DOI 10.1016/j.devcel.2010.10.011; Sanchez-Elsner T, 2006, SCIENCE, V311, P1118, DOI 10.1126/science.1117705; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016	69	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65740	10.1371/journal.pone.0065740	http://dx.doi.org/10.1371/journal.pone.0065740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785447	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800075
J	Kibbe, C; Chen, JQ; Xu, GL; Jing, G; Shalev, A				Kibbe, Carly; Chen, Junqin; Xu, Guanlan; Jing, Gu; Shalev, Anath			FOXO1Competes with Carbohydrate Response Element-binding Protein (ChREBP) and Inhibits Thioredoxin-interacting Protein (TXNIP) Transcription in Pancreatic Beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UP-REGULATED PROTEIN-1; GLUCOSE REGULATION; OXIDATIVE STRESS; GENE-EXPRESSION; FOXO1; PATHWAY; MASS; IDENTIFICATION; APOPTOSIS; FAILURE	Thioredoxin-interacting protein (TXNIP) has emerged as an important factor in pancreatic beta cell biology, and tight regulation of TXNIP levels is necessary for beta cell survival. However, the mechanisms regulating TXNIP expression have only started to be elucidated. The forkhead boxO1 transcription factor (FOXO1) has been reported to up-regulate TXNIP expression in neurons and endothelial cells but to down-regulate TXNIP in liver, and the effects on beta cells have remained unknown. We now have found that FOXO1 binds to the TXNIP promoter in vivo in human islets and INS-1 beta cells and significantly decreases TXNIP expression. TXNIP promoter deletion analyses revealed that an E-box motif conferring carbohydrate response element-binding protein (ChREBP)-mediated, glucose-induced TXNIP expression is necessary and sufficient for this effect, and electromobility shift assays confirmed FOXO1 binding to this site. Moreover, FOXO1 blocked glucose-induced TXNIP expression and reduced glucose-induced ChREBP binding at the TXNIP promoter without affecting ChREBP expression or nuclear localization, suggesting that FOXO1 may compete with ChREBP for binding to the TXNIP promoter. In fact, a FOXO1 DNA-binding mutant (FOXO1-H215R) failed to inhibit TXNIP transcription, and the effects were not restricted to TXNIP as FOXO1 also inhibited transcription of other ChREBP target genes such as liver pyruvate kinase. Together, these results demonstrate that FOXO1 inhibits beta cell TXNIP transcription and suggest that FOXO1 confers this inhibition by interfering with ChREBP DNA binding at target gene promoters. Our findings thereby reveal a novel gene regulatory mechanism and a previously unappreciated cross-talk between FOXO1 and ChREBP, two major metabolic signaling pathways.	[Kibbe, Carly; Chen, Junqin; Xu, Guanlan; Jing, Gu; Shalev, Anath] Univ Alabama Birmingham, Comprehens Diabet Ctr, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA; [Kibbe, Carly; Chen, Junqin; Xu, Guanlan; Jing, Gu; Shalev, Anath] Univ Alabama Birmingham, Dept Med, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA; [Kibbe, Carly] Univ Wisconsin, Dept Pharmacol, Madison, WI 53792 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Wisconsin System; University of Wisconsin Madison	Shalev, A (corresponding author), Univ Alabama Birmingham, 1825 Univ Blvd,SHEL 1206, Birmingham, AL 35294 USA.	shalev@uab.edu			National Institutes of Health [R01DK-078752]; American Diabetes Association [7-07-CD-22, 7-12-BS-167]; Juvenile Diabetes Research Foundation/JNJSI [40-2011-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation/JNJSI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK-078752. This work was also supported by American Diabetes Association Grants 7-07-CD-22 and 7-12-BS-167 and Juvenile Diabetes Research Foundation/JNJSI Grant 40-2011-1.	Al-Mubarak B, 2009, CHANNELS, V3, P233; Boergesen M, 2011, J BIOL CHEM, V286, P13214, DOI 10.1074/jbc.M110.215467; Buteau J, 2007, DIABETES OBES METAB, V9, P140, DOI 10.1111/j.1463-1326.2007.00782.x; Buteau J, 2006, DIABETES, V55, P1190, DOI 10.2337/db05-0825; Cha-Molstad H, 2009, J BIOL CHEM, V284, P16898, DOI 10.1074/jbc.M109.010504; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9; de Candia P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001670; Glauser DA, 2007, J ENDOCRINOL, V193, P195, DOI 10.1677/JOE-06-0191; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura T, 2007, ENDOCR J, V54, P507, DOI 10.1507/endocrj.KR-109; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Li XN, 2009, BIOCHEM BIOPH RES CO, V381, P660, DOI 10.1016/j.bbrc.2009.02.132; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Maiese K, 2009, ADV EXP MED BIOL, V665, P242; Masson E, 2009, AM J PHYSIOL-ENDOC M, V296, pE1251, DOI 10.1152/ajpendo.90619.2008; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Minn AH, 2005, BIOCHEM BIOPH RES CO, V336, P770, DOI 10.1016/j.bbrc.2005.08.161; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Nishiyama A, 2001, IUBMB LIFE, V52, P29, DOI 10.1080/15216540252774739; O'Callaghan BL, 2001, J BIOL CHEM, V276, P16033, DOI 10.1074/jbc.M101557200; Okamoto H, 2006, J CLIN INVEST, V116, P775, DOI 10.1172/JCI24967; Poungvarin N, 2012, DIABETOLOGIA, V55, P1783, DOI 10.1007/s00125-012-2506-4; Rufo C, 2001, J BIOL CHEM, V276, P21969, DOI 10.1074/jbc.M100461200; Shalev A, 2002, ENDOCRINOLOGY, V143, P3695, DOI 10.1210/en.2002-220564; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Wang HY, 2002, J BIOL CHEM, V277, P32746, DOI 10.1074/jbc.M201635200; Yamanaka H, 2000, BIOCHEM BIOPH RES CO, V271, P796, DOI 10.1006/bbrc.2000.2699	33	58	61	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23194	23202		10.1074/jbc.M113.473082	http://dx.doi.org/10.1074/jbc.M113.473082			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23803610	Green Published, hybrid			2022-12-25	WOS:000330598200026
J	Silvestri, C; Martella, A; Poloso, NJ; Piscitelli, F; Capasso, R; Izzo, A; Woodward, DF; Di Marzo, V				Silvestri, Cristoforo; Martella, Andrea; Poloso, Neil J.; Piscitelli, Fabiana; Capasso, Raffaele; Izzo, Angelo; Woodward, David F.; Di Marzo, Vincenzo			Anandamide-derived Prostamide F-2 alpha Negatively Regulates Adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITIVE FEEDBACK LOOP; TOPICAL BIMATOPROST; ADIPOSE-TISSUE; PROSTAGLANDIN-ETHANOLAMIDES; MOLECULAR CHARACTERIZATION; ADIPOCYTE DIFFERENTIATION; PPAR-GAMMA; LID SULCUS; CYCLOOXYGENASE-2 EXPRESSION; TRANSCRIPTIONAL CONTROL	Lipid mediators variedly affect adipocyte differentiation. Anandamide stimulates adipogenesis via CB1 receptors and peroxisome proliferator-activated receptor gamma. Anandamide may be converted by PTGS2 (COX2) and prostaglandin F synthases, such as prostamide/prostaglandin F synthase, to prostaglandin F-2 alpha ethanolamide (PGF(2 alpha)EA), of which bimatoprost is a potent synthetic analog. PGF(2 alpha)EA/bimatoprost act via prostaglandin F2 alpha FP receptor/FP alt4 splicing variant heterodimers. We investigated whether prostamide signaling occurs in preadipocytes and controls adipogenesis. Exposure of mouse 3T3-L1 or human preadipocytes to PGF(2 alpha)EA/bimatoprost during early differentiation inhibits adipogenesis. PGF(2 alpha)EA is produced from anandamide in preadipocytes and much less so in differentiating adipocytes, which express much less PTGS2, FP, and its alt4 splicing variant. Selective antagonism of PGF(2 alpha)EA receptors counteracts prostamide effects on adipogenesis, as does inhibition of ERK1/2 phosphorylation. Selective inhibition of PGF(2 alpha)EA versus prostaglandin F-2 alpha biosynthesis accelerates adipogenesis. PGF(2 alpha)EA levels are reduced in the white adipose tissue of high fat diet-fed mice where there is a high requirement for new adipocytes. Prostamides also inhibit zebrafish larval adipogenesis in vivo. We propose that prostamide signaling in preadipocytes is a novel anandamide-derived antiadipogenic mechanism.	[Silvestri, Cristoforo; Martella, Andrea; Piscitelli, Fabiana; Di Marzo, Vincenzo] CNR, Endocannabinoid Res Grp, Inst Biomol Chem, I-80078 Pozzuoli, Italy; [Poloso, Neil J.; Woodward, David F.] Allergan Pharmaceut Inc, Irvine, CA 92612 USA; [Capasso, Raffaele; Izzo, Angelo] Univ Naples Federico II, Endocannabinoid Res Grp, Dept Pharm, I-80131 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); AbbVie; Allergan; University of Naples Federico II	Woodward, DF (corresponding author), Allergan Pharmaceut Inc, Irvine, CA 92612 USA.	Woodward_David@Allergan.com; vincenzo.dimarzo@icb.cnr.it	Di Marzo, Vincenzo/AAD-7742-2019; Piscitelli, Fabiana/A-7100-2014; Silvestri, Cristoforo/Y-2504-2019	Di Marzo, Vincenzo/0000-0002-1490-3070; Silvestri, Cristoforo/0000-0001-5635-1545; Capasso, Raffaele/0000-0002-3335-1822; Piscitelli, Fabiana/0000-0001-9343-4622; Izzo, Angelo/0000-0002-8557-2133; Martella, Andrea/0000-0002-4680-7702	Allergan	Allergan(AbbVieAllergan)	Recipients of an Allergan research grant.	Aydin S, 2010, CUTAN OCUL TOXICOL, V29, P212, DOI 10.3109/15569521003796860; Bensaid M, 2003, MOL PHARMACOL, V63, P908, DOI 10.1124/mol.63.4.908; Blaho VA, 2009, J BIOL CHEM, V284, P21599, DOI 10.1074/jbc.M109.003822; Bouaboula M, 2005, EUR J PHARMACOL, V517, P174, DOI 10.1016/j.ejphar.2005.05.032; Chen J, 2005, BRIT J PHARMACOL, V144, P493, DOI 10.1038/sj.bjp.0706044; Choi HY, 2012, J OCUL PHARMACOL TH, V28, P146, DOI 10.1089/jop.2011.0160; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Crofford LJ, 2001, GASTROENTEROL CLIN N, V30, P863, DOI 10.1016/S0889-8553(05)70217-X; D'Eon TM, 2008, DIABETES, V57, P1262, DOI 10.2337/db07-1186; DEASUA LJ, 1977, NATURE, V265, P450, DOI 10.1038/265450a0; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di Marzo V, 2011, NAT NEUROSCI, V14, P9, DOI 10.1038/nn.2720; Drolet R, 2008, INT J OBESITY, V32, P283, DOI 10.1038/sj.ijo.0803708; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Fajas L, 1998, CURR OPIN CELL BIOL, V10, P165, DOI 10.1016/S0955-0674(98)80138-5; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; FAUST IM, 1984, AM J PHYSIOL, V247, P1038; Filippopoulos T, 2008, OPHTHAL PLAST RECONS, V24, P302, DOI 10.1097/IOP.0b013e31817d81df; FLIER JS, 1995, CELL, V80, P15, DOI 10.1016/0092-8674(95)90445-X; Flynn EJ, 2009, J LIPID RES, V50, P1641, DOI 10.1194/jlr.M800590-JLR200; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; Fujimori K, 2010, PROSTAG OTH LIPID M, V93, P52, DOI 10.1016/j.prostaglandins.2010.06.005; Fujimori K, 2010, J BIOL CHEM, V285, P8880, DOI 10.1074/jbc.M109.077164; Garber AJ, 2004, MED CLIN N AM, V88, P837, DOI 10.1016/j.mcna.2004.04.001; Gatta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031111; GOETZL EJ, 1995, FASEB J, V9, P1051, DOI 10.1096/fasebj.9.11.7649404; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Grosser T, 2002, P NATL ACAD SCI USA, V99, P8418, DOI 10.1073/pnas.112217799; Hall LM, 1998, J AM SOC MASS SPECTR, V9, P527, DOI 10.1016/S1044-0305(98)00013-0; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Hutley LJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE1037, DOI 10.1152/ajpendo.2001.281.5.E1037; Imrie D, 2010, DEV DYNAM, V239, P3013, DOI 10.1002/dvdy.22443; Jabbour HN, 2005, ENDOCRINOLOGY, V146, P4657, DOI 10.1210/en.2005-0804; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Karaliota S, 2009, OBESITY, V17, P1830, DOI 10.1038/oby.2009.177; Koda N, 2004, ARCH BIOCHEM BIOPHYS, V424, P128, DOI 10.1016/j.abb.2004.02.009; Kwok AHY, 2012, GEN COMP ENDOCR, V178, P216, DOI 10.1016/j.ygcen.2012.05.002; Liang Y, 2008, BRIT J PHARMACOL, V154, P1079, DOI 10.1038/bjp.2008.142; Liu L, 2007, J CELL BIOCHEM, V100, P161, DOI 10.1002/jcb.21044; Maccarrone M, 2004, EUR J BIOCHEM, V271, P4666, DOI 10.1111/j.1432-1033.2004.04427.x; Matias I, 2004, J PHARMACOL EXP THER, V309, P745, DOI 10.1124/jpet.103.061705; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Matsuoka T, 2007, THESCIENTIFICWORLDJO, V7, P1329, DOI 10.1100/tsw.2007.182; Miller CW, 1996, ENDOCRINOLOGY, V137, P5641, DOI 10.1210/en.137.12.5641; Moriuchi H, 2008, J BIOL CHEM, V283, P792, DOI 10.1074/jbc.M705638200; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Ouchi N, 2012, NAGOYA J MED SCI, V74, P19; Park J, 2011, JPN J OPHTHALMOL, V55, P22, DOI 10.1007/s10384-010-0904-z; Peplinski LS, 2004, OPTOMETRY VISION SCI, V81, P574, DOI 10.1097/01.opx.0000141791.16683.4a; REBUFFESCRIVE M, 1993, METABOLISM, V42, P1405, DOI 10.1016/0026-0495(93)90190-Y; Reginato MJ, 1998, J BIOL CHEM, V273, P1855, DOI 10.1074/jbc.273.4.1855; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; SANDOUK T, 1993, AM J PHYSIOL, V264, pC1600, DOI 10.1152/ajpcell.1993.264.6.C1600; SERRERO G, 1992, ENDOCRINOLOGY, V131, P2545, DOI 10.1210/en.131.6.2545; Serrero G, 1997, BIOCHEM BIOPH RES CO, V233, P200, DOI 10.1006/bbrc.1997.6433; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Tanaka A, 2011, AM J PHYSIOL-CELL PH, V301, pC1360, DOI 10.1152/ajpcell.00514.2010; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Taniguchi K, 2010, REPRODUCTION, V140, P885, DOI 10.1530/REP-10-0240; TAYLOR L, 1987, ATHEROSCLEROSIS, V65, P227, DOI 10.1016/0021-9150(87)90038-4; Tchoukalova YD, 2010, P NATL ACAD SCI USA, V107, P18226, DOI 10.1073/pnas.1005259107; Tsuboi K, 2002, PROSTAG OTH LIPID M, V68-9, P535, DOI 10.1016/S0090-6980(02)00054-0; Ueno T, 2011, FEBS J, V278, P2901, DOI 10.1111/j.1742-4658.2011.08213.x; Weber A, 2004, J LIPID RES, V45, P757, DOI 10.1194/jlr.M300475-JLR200; Woodward DF, 2008, PHARMACOL THERAPEUT, V120, P71, DOI 10.1016/j.pharmthera.2008.08.001; Woodward DF, 2008, BRIT J PHARMACOL, V153, P410, DOI 10.1038/sj.bjp.0707434; Woodward DF, 2007, BRIT J PHARMACOL, V150, P342, DOI 10.1038/sj.bjp.0706989; Woodward DF, 2004, CARDIOVASC DRUG REV, V22, P103; Woodward DF, 2001, SURV OPHTHALMOL, V45, pS337, DOI 10.1016/S0039-6257(01)00224-7; Woodward JA, 2010, J COSMET DERMATOL-US, V9, P96, DOI 10.1111/j.1473-2165.2010.00487.x; Yam JCS, 2009, J OCUL PHARMACOL TH, V25, P471, DOI 10.1089/jop.2009.0019; Yan HY, 2003, J LIPID RES, V44, P424, DOI 10.1194/jlr.M200357-JLR200	76	43	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23307	23321		10.1074/jbc.M113.489906	http://dx.doi.org/10.1074/jbc.M113.489906			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23801328	Green Published, hybrid			2022-12-25	WOS:000330598200036
J	Sun, QA; Wang, BL; Miyagi, M; Hess, DT; Stamler, JS				Sun, Qi-An; Wang, Benlian; Miyagi, Masaru; Hess, Douglas T.; Stamler, Jonathan S.			Oxygen-coupled Redox Regulation of the Skeletal Muscle Ryanodine Receptor/Ca2+ Release Channel (RyR1) SITES AND NATURE OF OXIDATIVE MODIFICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE 1B; CALCIUM-RELEASE; S-NITROSYLATION; MASS-SPECTROMETRY; FKBP12 BINDING; NITRIC-OXIDE; GLUTATHIONYLATION; IDENTIFICATION; NITROSOGLUTATHIONE; O-2	In mammalian skeletal muscle, Ca2+ release from the sarcoplasmic reticulum (SR) through the ryanodine receptor/Ca2+-release channel RyR1 can be enhanced by S-oxidation or S-nitrosylation of separate Cys residues, which are allosterically linked. S-Oxidation of RyR1 is coupled to muscle oxygen tension (pO(2)) through O-2-dependent production of hydrogen peroxide by SR-resident NADPH oxidase 4. In isolated SR (SR vesicles), an average of six to eight Cys thiols/RyR1 monomer are reversibly oxidized at high (21% O-2) versus low pO(2) (1% O-2), but their identity among the 100 Cys residues/RyR1 monomer is unknown. Here we use isotope-coded affinity tag labeling and mass spectrometry (yielding 93% coverage of RyR1 Cys residues) to identify 13 Cys residues subject to pO(2)-coupled S-oxidation in SR vesicles. Eight additional Cys residues are oxidized at high versus low pO(2) only when NADPH levels are supplemented to enhance NADPH oxidase 4 activity. pO(2)-sensitive Cys residues were largely non-overlapping with those identified previously as hyperreactive by administration of exogenous reagents (three of 21) or as S-nitrosylated. Cys residues subject to pO(2)-coupled oxidation are distributed widely within the cytoplasmic domain of RyR1 in multiple functional domains implicated in RyR1 activity-regulating interactions with the L-type Ca2+ channel (dihydropyridine receptor) and FK506-binding protein 12 as well as in "hot spot" regions containing sites of mutation implicated in malignant hyperthermia and central core disease. pO(2)-coupled disulfide formation was identified, whereas neither S-glutathionylated nor sulfenamide-modified Cys residues were observed. Thus, physiological redox regulation of RyR1 by endogenously generated hydrogen peroxide is exerted through dynamic disulfide formation involving multiple Cys residues.	Case Western Reserve Univ, Inst Transformat Mol Med, Cleveland, OH 44106 USA; Univ Hosp, Cleveland, OH 44106 USA; [Sun, Qi-An; Hess, Douglas T.; Stamler, Jonathan S.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Miyagi, Masaru] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Wang, Benlian; Miyagi, Masaru] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Stamler, Jonathan S.] Univ Hosp Case Med Ctr, Harrington Discovery Inst, Cleveland, OH 44106 USA	Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital	Stamler, JS (corresponding author), Inst Transformat Mol Med, Wolstein Res Bldg 4129,2103 Cornell Rd, Cleveland, OH 44106 USA.	jonathan.stamler@case.edu		Stamler, Jonathan/0000-0002-6866-1572	National Institutes of Health [RO1 HL0591130]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 HL0591130 (to J. S. S.).	ANDERSON K, 1994, AM J PHYSIOL, V266, pC462, DOI 10.1152/ajpcell.1994.266.2.C462; Andersson DC, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-9; Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014; Aracena P, 2005, ANTIOXID REDOX SIGN, V7, P870, DOI 10.1089/ars.2005.7.870; Aracena P, 2003, J BIOL CHEM, V278, P42927, DOI 10.1074/jbc.M306969200; Aracena-Parks P, 2006, J BIOL CHEM, V281, P40354, DOI 10.1074/jbc.M600876200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Beigi F, 2012, P NATL ACAD SCI USA, V109, P4314, DOI 10.1073/pnas.1113319109; Burgoyne JR, 2011, BIOCHEM SOC T, V39, P1260, DOI 10.1042/BST0391260; Chung HS, 2013, CIRC RES, V112, P382, DOI 10.1161/CIRCRESAHA.112.268680; Espinosa A, 2006, J CELL PHYSIOL, V209, P379, DOI 10.1002/jcp.20745; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; Eu JP, 2003, P NATL ACAD SCI USA, V100, P15229, DOI 10.1073/pnas.2433468100; Gaburjakova M, 2001, J BIOL CHEM, V276, P16931, DOI 10.1074/jbc.M100856200; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hidalgo C, 2006, J BIOL CHEM, V281, P26473, DOI 10.1074/jbc.M600451200; Hwang JH, 2012, TRENDS MOL MED, V18, P644, DOI 10.1016/j.molmed.2012.09.006; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; Lobo PA, 2009, STRUCTURE, V17, P1505, DOI 10.1016/j.str.2009.08.016; Lynch PJ, 1997, ANESTHESIOLOGY, V86, P620, DOI 10.1097/00000542-199703000-00014; Ostman A, 2011, J BIOCHEM, V150, P345, DOI 10.1093/jb/mvr104; Paul BD, 2012, NAT REV MOL CELL BIO, V13, P499, DOI 10.1038/nrm3391; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; Pessah IN, 2000, ANTIOXID REDOX SIGN, V2, P17, DOI 10.1089/ars.2000.2.1-17; Ruse CI, 2002, ANAL CHEM, V74, P1658, DOI 10.1021/ac0157122; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Sheridan DC, 2006, P NATL ACAD SCI USA, V103, P19760, DOI 10.1073/pnas.0609473103; Sun JH, 2003, J BIOL CHEM, V278, P8184, DOI 10.1074/jbc.M211940200; Sun JH, 2001, J BIOL CHEM, V276, P15625, DOI 10.1074/jbc.M100083200; Sun JH, 2001, P NATL ACAD SCI USA, V98, P11158, DOI 10.1073/pnas.201289098; Sun JH, 2008, BIOCHEMISTRY-US, V47, P13985, DOI 10.1021/bi8012627; Svoboda LK, 2012, CIRC RES, V111, P842, DOI 10.1161/CIRCRESAHA.111.263525; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Voss AA, 2004, J BIOL CHEM, V279, P34514, DOI 10.1074/jbc.M404290200; Xu H, 2008, J PROTEOME RES, V7, P138, DOI 10.1021/pr070363z	37	42	42	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					22961	22971		10.1074/jbc.M113.480228	http://dx.doi.org/10.1074/jbc.M113.480228			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23798702	Green Published, hybrid			2022-12-25	WOS:000330598200007
J	Chiang, HL; Ngo, ST; Chen, CJ; Hu, CK; Li, MS				Chiang, Hsin-Lin; Ngo, Son Tung; Chen, Chun-Jung; Hu, Chin-Kun; Li, Mai Suan			Oligomerization of Peptides LVEALYL and RGFFYT and Their Binding Affinity to Insulin	PLOS ONE			English	Article							EXCHANGE MOLECULAR-DYNAMICS; AMYLOID PEPTIDES; PROTEIN; AGGREGATION; MECHANISM; DISEASE; INHIBITION; FIBRILS; FIBRILLATION; SIMULATIONS	Recently it has been proposed a model for fibrils of human insulin in which the fibril growth proceeds via stacking LVEALYL (fragment 11-17 from chain B of insulin) into pairs of tightly interdigitated beta-sheets. The experiments have also shown that LVEALYL has high propensity to self-assembly and binding to insulin. This necessitates study of oligomerization of LVEALYL and its binding affinity to full-length insulin. Using the all-atom simulations with Gromos96 43a1 force field and explicit water it is shown that LVEALYL can aggregate. Theoretical estimation of the binding free energy of LVEALYL to insulin by the molecular mechanic Poisson-Boltzmann surface area method reveals its strong binding affinity to chain B, implying that, in agreement with the experiments, LVEALYL can affect insulin aggregation via binding mechanism. We predict that, similar to LVEALYL, peptide RGFFYT (fragment B22-27) can self-assemble and bind to insulin modulating its fibril growth process. The binding affinity of RGFFYT is shown to be comparable with that of LVEALYL.	[Chiang, Hsin-Lin; Chen, Chun-Jung] Natl Tsing Hua Univ, Dept Phys, Hsinchu, Taiwan; [Chiang, Hsin-Lin; Hu, Chin-Kun] Acad Sinica, Inst Phys, Taipei, Taiwan; [Ngo, Son Tung] Inst Computat Sci & Technol, Ho Chi Minh City, Vietnam; [Ngo, Son Tung; Li, Mai Suan] Polish Acad Sci, Inst Phys, Warsaw, Poland; [Chen, Chun-Jung] Natl Synchrotron Radiat Res Ctr, Life Sci Grp, Sci Res Div, Hsinchu, Taiwan; [Chen, Chun-Jung] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 70101, Taiwan	National Tsing Hua University; Academia Sinica - Taiwan; Polish Academy of Sciences; Institute of Physics - Polish Academy of Sciences; National Synchrotron Radiation Research Center; National Cheng Kung University	Hu, CK (corresponding author), Acad Sinica, Inst Phys, Taipei, Taiwan.	huck@phys.sinica.edu.tw; masli@ifpan.edu.pl	Chen, Chun-Jung/A-6880-2011; Li, Mai Suan/D-6304-2015; Ngo, Son Tung/M-4518-2014; Ngo, Son Tung/F-8964-2013	Chen, Chun-Jung/0000-0002-5157-4288; Li, Mai Suan/0000-0001-7021-7916; Ngo, Son Tung/0000-0003-1034-1768; Ngo, Son Tung/0000-0003-1034-1768; Hu, Chin-Kun/0000-0002-3620-8319	Narodowe Centrum Nauki in Poland [2011/01/B/NZ1/01622]; Department of Science and Technology at Ho Chi Minh city, Vietnam; Poland-Taiwan NSC [100-2911-I-001-507]; National Science Council in Taiwan [NSC-100-2923-M-001-003-MY3]; National Center for Theoretical Sciences in Taiwan	Narodowe Centrum Nauki in Poland; Department of Science and Technology at Ho Chi Minh city, Vietnam; Poland-Taiwan NSC; National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); National Center for Theoretical Sciences in Taiwan	The work was supported by Narodowe Centrum Nauki in Poland (grant No 2011/01/B/NZ1/01622), Department of Science and Technology at Ho Chi Minh city, Vietnam, and Poland-Taiwan NSC grant 100-2911-I-001-507. CKH and HLC are also supported by National Science Council in Taiwan under grant number NSC-100-2923-M-001-003-MY3 and National Center for Theoretical Sciences in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong AH, 2011, BIOCHEMISTRY-US, V50, P4058, DOI 10.1021/bi200268w; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BERENDSEN HJC, 1996, INTERMOLECULAR FORCE; BLUNDELL TL, 1971, NATURE, V231, P506, DOI 10.1038/231506a0; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cecchini M, 2004, J CHEM PHYS, V121, P10748, DOI 10.1063/1.1809588; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Devlin GL, 2006, J MOL BIOL, V360, P497, DOI 10.1016/j.jmb.2006.05.007; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Favrin G, 2004, BIOPHYS J, V87, P3657, DOI 10.1529/biophysj.104.046839; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOCKNEY RW, 1974, J COMPUT PHYS, V14, P148, DOI 10.1016/0021-9991(74)90010-2; Hong DP, 2005, BIOCHEMISTRY-US, V44, P16701, DOI 10.1021/bi051658y; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ivanova MI, 2009, P NATL ACAD SCI USA, V106, P18990, DOI 10.1073/pnas.0910080106; Ivanova MI, 2006, P NATL ACAD SCI USA, V103, P4079, DOI 10.1073/pnas.0511298103; Klimov DK, 2003, STRUCTURE, V11, P295, DOI 10.1016/S0969-2126(03)00031-5; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Li MS, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.218101; Lin YF, 2011, J TAIWAN INST CHEM E, V42, P394, DOI 10.1016/j.jtice.2010.08.010; MacDonald ME, 1996, CURR OPIN NEUROBIOL, V6, P638, DOI 10.1016/S0959-4388(96)80097-3; Viet MH, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4730410; Viet MH, 2011, J PHYS CHEM B, V115, P7433, DOI 10.1021/jp1116728; Matthes D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019129; Nam HB, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3415372; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nguyen PH, 2005, PROTEINS, V61, P795, DOI 10.1002/prot.20696; Nguyen PH, 2007, P NATL ACAD SCI USA, V104, P111, DOI 10.1073/pnas.0607440104; Nguyen PH, 2011, PHYS CHEM CHEM PHYS, V13, P9778, DOI 10.1039/c1cp20323a; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Pease LF, 2010, BIOPHYS J, V99, P3979, DOI 10.1016/j.bpj.2010.10.010; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schrodinger L., 2020, PYMOL; Sgourakis NG, 2007, J MOL BIOL, V368, P1448, DOI 10.1016/j.jmb.2007.02.093; SHANNO DF, 1970, MATH COMPUT, V24, P647, DOI 10.2307/2004840; SNYDER SW, 1994, BIOPHYS J, V67, P1216, DOI 10.1016/S0006-3495(94)80591-0; STORKEL S, 1983, LAB INVEST, V48, P108; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Timofeev VI, 2010, ACTA CRYSTALLOGR F, V66, P259, DOI 10.1107/S1744309110000461; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tzotzos S, 2010, PROTEIN SCI, V19, P327, DOI 10.1002/pro.314; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Vestergaard B, 2007, PLOS BIOL, V5, P1089, DOI 10.1371/journal.pbio.0050134; Weyer C, 2001, DIABETES CARE, V24, P89, DOI 10.2337/diacare.24.1.89; Whittingham JL, 2002, J MOL BIOL, V318, P479, DOI 10.1016/S0022-2836(02)00021-9; Wilhelm KR, 2007, EUR J NEUROL, V14, P327, DOI 10.1111/j.1468-1331.2006.01667.x; Yang MF, 2008, J MOL BIOL, V384, P450, DOI 10.1016/j.jmb.2008.09.039	58	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e65358	10.1371/journal.pone.0065358	http://dx.doi.org/10.1371/journal.pone.0065358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805182	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500010
J	Nakamura, Y; Ishii, J; Kondo, A				Nakamura, Yasuyuki; Ishii, Jun; Kondo, Akihiko			Rapid, Facile Detection of Heterodimer Partners for Target Human G-Protein-Coupled Receptors Using a Modified Split-Ubiquitin Membrane Yeast Two-Hybrid System	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; TIME-RESOLVED FRET; IN-VIVO; GPCR OLIGOMERIZATION; TERMINAL DOMAIN; DRUG DISCOVERY; COMPLEXES; HOMODIMERS; CEREVISIAE; SUBTYPE-5	Potentially immeasurable heterodimer combinations of human G-protein-coupled receptors (GPCRs) result in a great deal of physiological diversity and provide a new opportunity for drug discovery. However, due to the existence of numerous combinations, the sets of GPCR dimers are almost entirely unknown and thus their dominant roles are still poorly understood. Thus, the identification of GPCR dimer pairs has been a major challenge. Here, we established a specialized method to screen potential heterodimer partners of human GPCRs based on the split-ubiquitin membrane yeast two-hybrid system. We demonstrate that the mitogen-activated protein kinase (MAPK) signal-independent method can detect ligand-induced conformational changes and rapidly identify heterodimer partners for target GPCRs. Our data present the abilities to apply for the intermolecular mapping of interactions among GPCRs and to uncover potential GPCR targets for the development of new therapeutic agents.	[Nakamura, Yasuyuki; Kondo, Akihiko] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Kobe, Hyogo 657, Japan; [Ishii, Jun] Kobe Univ, Org Adv Sci & Technol, Kobe, Hyogo 657, Japan	Kobe University; Kobe University	Kondo, A (corresponding author), Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Kobe, Hyogo 657, Japan.	akondo@kobe-u.ac.jp	Ishii, Jun/D-7670-2016; Kondo, Akihiko/A-2130-2015	Ishii, Jun/0000-0003-2568-515X; Nakamura, Yasuyuki/0000-0002-0093-3754	Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science; Naito Foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science, the Naito Foundation, and Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe; iBioK) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akada R, 2006, YEAST, V23, P399, DOI 10.1002/yea.1365; Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/nchembio.396, 10.1038/NCHEMBIO.396]; Ayoub MA, 2004, MOL PHARMACOL, V66, P312, DOI 10.1124/mol.104.000398; Barki-Harrington L, 2003, CIRCULATION, V108, P1611, DOI 10.1161/01.CIR.0000092166.30360.78; Brown AJ, 2000, YEAST, V16, P11, DOI 10.1002/(SICI)1097-0061(20000115)16:1<11::AID-YEA502>3.0.CO;2-K; ELION EA, 1993, MOL BIOL CELL, V4, P495, DOI 10.1091/mbc.4.5.495; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gehret AU, 2006, J BIOL CHEM, V281, P20698, DOI 10.1074/jbc.M513642200; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Iguchi Y, 2010, J BIOCHEM, V147, P875, DOI 10.1093/jb/mvq023; Ishii J, 2008, J BIOCHEM, V143, P667, DOI 10.1093/jb/mvn018; Ishii J, 2006, BIOTECHNOL PROGR, V22, P954, DOI 10.1021/bp0601387; Ishii J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037136; Ishii J, 2010, FEBS J, V277, P1982, DOI 10.1111/j.1742-4658.2010.07625.x; Ishii J, 2009, J BIOCHEM, V145, P701, DOI 10.1093/jb/mvp028; Iyer K., 2005, SCI STKE, V2005, P13; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kittanakom S, 2009, METHODS MOL BIOL, V548, P247, DOI 10.1007/978-1-59745-540-4_14; Kokkola T, 1998, BIOCHEM BIOPH RES CO, V249, P531, DOI 10.1006/bbrc.1998.9182; KONOPKA JB, 1988, CELL, V54, P609, DOI 10.1016/S0092-8674(88)80005-9; Li B, 2007, NAT METHODS, V4, P169, DOI 10.1038/nmeth990; Lyngso C, 2009, MOL CELL ENDOCRINOL, V302, P203, DOI 10.1016/j.mce.2008.09.018; Matsushita S, 2010, J BIOL CHEM, V285, P10291, DOI 10.1074/jbc.M109.077990; Maurel D, 2004, ANAL BIOCHEM, V329, P253, DOI 10.1016/j.ab.2004.02.013; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Overton MC, 2000, CURR BIOL, V10, P341, DOI 10.1016/S0960-9822(00)00386-9; Overton MC, 2002, J BIOL CHEM, V277, P41463, DOI 10.1074/jbc.M205368200; Panetta R, 2008, DRUG DISCOV TODAY, V13, P1059, DOI 10.1016/j.drudis.2008.09.002; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Pfleger KDG, 2005, BIOCHEM J, V385, P625, DOI 10.1042/BJ20041361; Porrello ER, 2011, CELL SIGNAL, V23, P1767, DOI 10.1016/j.cellsig.2011.06.011; Prezeau L, 2010, CURR OPIN PHARMACOL, V10, P6, DOI 10.1016/j.coph.2009.10.009; Rivero-Muller A, 2010, P NATL ACAD SCI USA, V107, P2319, DOI 10.1073/pnas.0906695106; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Togawa S, 2010, J BIOCHEM, V147, P867, DOI 10.1093/jb/mvq022	36	12	12	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66793	10.1371/journal.pone.0066793	http://dx.doi.org/10.1371/journal.pone.0066793			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805278	Green Submitted, Green Published, gold			2022-12-25	WOS:000320846500106
J	Tyler, AF; Mendoza, JP; Firan, M; Karandikar, NJ				Tyler, Andrew F.; Mendoza, Jason P.; Firan, Mihail; Karandikar, Nitin J.			CD8(+) T Cells Are Required For Glatiramer Acetate Therapy in Autoimmune Demyelinating Disease	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MHC CLASS-I; MULTIPLE-SCLEROSIS; DENDRITIC CELLS; TRYPTOPHAN CATABOLISM; INTERFERON-GAMMA; MEDICAL PROGRESS; COPOLYMER 1; IFN-GAMMA; ENCEPHALOMYELITIS	The exact mechanism of glatiramer acetate (GA, Copaxone (R)), an FDA-approved immunomodulatory therapy for multiple sclerosis (MS), remains unclear after decades of research. Previously, we have shown that GA therapy of MS induces CD8(+) T cell responses that can potentially suppress pathogenic CD4(+) T cell responses. Using a murine model of MS, experimental autoimmune encephalomyelitis (EAE), we now demonstrate that CD8(+) T cells are necessary in mediating the therapeutic effects of GA. Further, adoptive transfer of GA-induced CD8(+) T cells resulted in amelioration of EAE, establishing a role as a viable immunotherapy in demyelinating disease. Generation of these cells required indoleamine-2,3-dioxygenase (IDO), while suppressive function depended on non-classical MHC class I, IFN-gamma, and perforin expression. GA-induced regulatory myeloid cells, previously shown to activate CD4(+) regulatory T cells in an antigen-independent manner, required CD8(+) T cells for disease suppression in vivo. These studies demonstrate an essential role for CD8(+) T cells in GA therapy and identify their potential as an adoptive immunotherapeutic agent.	[Tyler, Andrew F.; Mendoza, Jason P.; Firan, Mihail; Karandikar, Nitin J.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Karandikar, NJ (corresponding author), Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA.	nitin-karandikar@uiowa.edu		Karandikar, Nitin/0000-0002-6867-6950; Mendoza, Jason/0000-0003-2526-5542	NIH [F31, R01, K24]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092106, K24AI079272] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in part, by grant awards from the NIH (Ruth L. Kirschstein National Research Service F31 Award to AT and R01 and K24 awards to NK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aharoni R, 2005, INT IMMUNOPHARMACOL, V5, P23, DOI 10.1016/j.intimp.2004.09.007; Aharoni R, 2000, P NATL ACAD SCI USA, V97, P11472, DOI 10.1073/pnas.97.21.11472; Aharoni R, 1998, J NEUROIMMUNOL, V91, P135, DOI 10.1016/S0165-5728(98)00166-0; Baughman EJ, 2011, J AUTOIMMUN, V36, P115, DOI 10.1016/j.jaut.2010.12.003; Baxter AG, 2007, NAT REV IMMUNOL, V7, P904, DOI 10.1038/nri2190; Beeston T, 2010, J NEUROIMMUNOL, V229, P91, DOI 10.1016/j.jneuroim.2010.07.007; Biegler BW, 2006, J NEUROIMMUNOL, V180, P159, DOI 10.1016/j.jneuroim.2006.07.015; Braud VM, 1999, CURR OPIN IMMUNOL, V11, P100, DOI 10.1016/S0952-7915(99)80018-1; Burger D, 2009, P NATL ACAD SCI USA, V106, P4355, DOI 10.1073/pnas.0812183106; Farina C, 2001, BRAIN, V124, P705, DOI 10.1093/brain/124.4.705; Fridkis-Hareli M, 1998, P NATL ACAD SCI USA, V95, P12528, DOI 10.1073/pnas.95.21.12528; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Gajewski TF, 2006, J IMMUNOTHER, V29, P233, DOI 10.1097/01.cji.0000199193.29048.56; Gianfrani C, 2006, J IMMUNOL, V177, P4178, DOI 10.4049/jimmunol.177.6.4178; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Hong J, 2005, P NATL ACAD SCI USA, V102, P6449, DOI 10.1073/pnas.0502187102; Hurgin V, 2007, P NATL ACAD SCI USA, V104, P5044, DOI 10.1073/pnas.0611608104; Hwu P, 2000, J IMMUNOL, V164, P3596, DOI 10.4049/jimmunol.164.7.3596; Illes Z, 2005, EUR J IMMUNOL, V35, P3683, DOI 10.1002/eji.200526121; Jee Y, 2006, INT IMMUNOL, V18, P537, DOI 10.1093/intimm/dxh394; Jung S, 2004, J NEUROIMMUNOL, V148, P63, DOI 10.1016/j.jneuroim.2003.11.014; Kala M, 2010, EXP NEUROL, V221, P136, DOI 10.1016/j.expneurol.2009.10.015; Karandikar NJ, 2002, J CLIN INVEST, V109, P641, DOI 10.1172/JCI200214380; Kim HJ, 2010, NATURE; Li JF, 2001, J IMMUNOL, V167, P3800, DOI 10.4049/jimmunol.167.7.3800; Lu LR, 2008, P NATL ACAD SCI USA, V105, P19420, DOI 10.1073/pnas.0810383105; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Miller S. D., 2010, CURR PROTOC IMMUNOL; Mitne S, 2011, CLIN OPHTHALMOL, V5, P991, DOI 10.2147/OPTH.S22964; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Najafian N, 2003, J CLIN INVEST; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Sand KL, 2009, CELL MOL LIFE SCI, V66, P1446, DOI 10.1007/s00018-009-8726-1; Sarantopoulos S, 2004, J CLIN INVEST, V114, P1218, DOI 10.1172/JCI200423152; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Sellebjerg F, 2012, MULT SCLER; Seo SK, 2004, NAT MED, V10, P1088, DOI 10.1038/nm1107; TEITELBAUM D, 1971, European Journal of Immunology, V1, P242, DOI 10.1002/eji.1830010406; Tennakoon DK, 2006, J IMMUNOL, V176, P7119, DOI 10.4049/jimmunol.176.11.7119; Theil DJ, 2008, J NEUROIMMUNOL, V204, P92, DOI 10.1016/j.jneuroim.2008.07.005; Toker A, 2011, SCAND J IMMUNOL, V74, P235, DOI 10.1111/j.1365-3083.2011.02575.x; Tonkin DR, 2009, EUR J IMMUNOL, V39, P1313, DOI 10.1002/eji.200838916; Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; York NR, 2010, J AUTOIMMUN, V35, P33, DOI 10.1016/j.jaut.2010.01.003; Ziemssen T, 2007, INT REV NEUROBIOL, V79, P537, DOI 10.1016/S0074-7742(07)79024-4	48	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66772	10.1371/journal.pone.0066772	http://dx.doi.org/10.1371/journal.pone.0066772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805274	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500102
J	Tan, WH; Popel, AS; Mac Gabhann, F				Wan Hua Tan; Popel, Aleksander S.; Mac Gabhann, Feilim			Computational Model of Gab1/2-Dependent VEGFR2 Pathway to Akt Activation	PLOS ONE			English	Article							ENDOTHELIAL-CELL MIGRATION; SIGNAL-TRANSDUCTION; CROSS-TALK; SENSITIVITY-ANALYSIS; QUANTITATIVE MODEL; SYSTEMS BIOLOGY; GAB2; PHOSPHORYLATION; SURVIVAL; QUANTIFICATION	Vascular endothelial growth factor (VEGF) signal transduction is central to angiogenesis in development and in pathological conditions such as cancer, retinopathy and ischemic diseases. However, no detailed mass-action models of VEGF receptor signaling have been developed. We constructed and validated the first computational model of VEGFR2 trafficking and signaling, to study the opposing roles of Gab1 and Gab2 in regulation of Akt phosphorylation in VEGF-stimulated endothelial cells. Trafficking parameters were optimized against 5 previously published in vitro experiments, and the model was validated against six independent published datasets. The model showed agreement at several key nodes, involving scaffolding proteins Gab1, Gab2 and their complexes with Shp2. VEGFR2 recruitment of Gab1 is greater in magnitude, slower, and more sustained than that of Gab2. As Gab2 binds VEGFR2 complexes more transiently than Gab1, VEGFR2 complexes can recycle and continue to participate in other signaling pathways. Correspondingly, the simulation results show a log-linear relationship between a decrease in Akt phosphorylation and Gab1 knockdown while a linear relationship was observed between an increase in Akt phosphorylation and Gab2 knockdown. Global sensitivity analysis demonstrated the importance of initial-concentration ratios of antagonistic molecular species (Gab1/Gab2 and PI3K/Shp2) in determining Akt phosphorylation profiles. It also showed that kinetic parameters responsible for transient Gab2 binding affect the system at specific nodes. This model can be expanded to study multiple signaling contexts and receptor crosstalk and can form a basis for investigation of therapeutic approaches, such as tyrosine kinase inhibitors (TKIs), overexpression of key signaling proteins or knockdown experiments.	[Wan Hua Tan; Popel, Aleksander S.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Mac Gabhann, Feilim] Johns Hopkins Univ, Inst Computat Med, Baltimore, MD 21218 USA; [Mac Gabhann, Feilim] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Mac Gabhann, F (corresponding author), Johns Hopkins Univ, Inst Computat Med, Baltimore, MD 21218 USA.	feilim@jhu.edu	Popel, Aleksander S/A-6724-2009	Popel, Aleksander/0000-0002-6706-9235	National Institutes of Health (NIH) [R01 HL101200, R01 CA138264, U54 CA143868, R00 HL093219]; NATIONAL CANCER INSTITUTE [U54CA143868, R01CA138264] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101200, R00HL093219] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (NIH) grants R01 HL101200, R01 CA138264, and U54 CA143868 (ASP) and R00 HL093219 (FMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksamitiene E, 2012, BIOCHEM SOC T, V40, P139, DOI 10.1042/BST20110609; Andersen J, 2010, DANCING TIMES, V100, P55; [Anonymous], 2012, BLOOD PREPUBLICA; Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; Birtwistle MR, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100188; Borisov N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.19; Brummer T, 2006, J BIOL CHEM, V281, P626, DOI 10.1074/jbc.M509567200; Brummer T, 2008, EMBO J, V27, P2305, DOI 10.1038/emboj.2008.159; Bruns AF, 2010, TRAFFIC, V11, P161, DOI 10.1111/j.1600-0854.2009.01001.x; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Caron C, 2009, CELL SIGNAL, V21, P943, DOI 10.1016/j.cellsig.2009.02.004; Chabot C, 2009, MOL CELL BIOL, V29, P241, DOI 10.1128/MCB.01374-08; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Cirit M, 2010, J BIOL CHEM, V285, P36736, DOI 10.1074/jbc.M110.148759; Dance M, 2006, J BIOL CHEM, V281, P23285, DOI 10.1074/jbc.M600987200; Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204; Dougher M, 1999, ONCOGENE, V18, P1619, DOI 10.1038/sj.onc.1202478; Funahashi A, 2008, P IEEE, V96, P1254, DOI 10.1109/JPROC.2008.925458; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Horst B, 2009, AM J PATHOL, V174, P1524, DOI 10.2353/ajpath.2009.080543; Imoukhuede PI, 2011, EXP CELL RES, V317, P955, DOI 10.1016/j.yexcr.2010.12.014; Jain HV, 2009, MOL CANCER THER, V8, P2926, DOI 10.1158/1535-7163.MCT-08-1223; Jayson GC, 2012, NAT REV CLIN ONCOL; Jopling HM, 2011, BIOCHEM BIOPH RES CO, V410, P170, DOI 10.1016/j.bbrc.2011.04.093; Kaur H, 2006, BIOCHEM J, V393, P235, DOI 10.1042/BJ20051022; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kitano H, 2005, NAT BIOTECHNOL, V23, P961, DOI 10.1038/nbt1111; Kiyatkin A, 2006, J BIOL CHEM, V281, P19925, DOI 10.1074/jbc.M600482200; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Kumar N, 2007, PLOS COMPUT BIOL, V3, P35, DOI 10.1371/journal.pcbi.0030004; Lamalice L, 2006, J BIOL CHEM, V281, P34009, DOI 10.1074/jbc.M603928200; Lanahan AA, 2010, DEV CELL, V18, P713, DOI 10.1016/j.devcel.2010.02.016; Laramee M, 2007, J BIOL CHEM, V282, P7758, DOI 10.1074/jbc.M611327200; Lynch DK, 2002, EMBO J, V21, P72, DOI 10.1093/emboj/21.1.72; Mac Gabhann F, 2007, AM J PHYSIOL-HEART C, V292, pH459, DOI 10.1152/ajpheart.00637.2006; Mac Gabhann F, 2007, BIOPHYS CHEM, V128, P125, DOI 10.1016/j.bpc.2007.03.010; Mac Gabhann F, 2010, WIRES SYST BIOL MED, V2, P694, DOI 10.1002/wsbm.92; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Meng SS, 2005, BIOCHEM J, V391, P143, DOI 10.1042/BJ20050229; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Park CS, 2003, J BIOL CHEM, V278, P37064, DOI 10.1074/jbc.M304968200; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Saltelli A, 1999, TECHNOMETRICS, V41, P39, DOI 10.2307/1270993; Saltelli A, 1998, COMPUT STAT DATA AN, V26, P445, DOI 10.1016/S0167-9473(97)00043-1; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Schneeweis C, 2010, J ATHEROSCLER THROMB, V17, P203, DOI 10.5551/jat.3004; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Schoeberl B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000352; Scott A, 2009, BIOCHEM SOC T, V37, P1184, DOI 10.1042/BST0371184; Stefanini MO, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000622; Stuible M, 2010, TRENDS CELL BIOL, V20, P672, DOI 10.1016/j.tcb.2010.08.013; Tugues S, 2011, MOL ASPECTS MED, V32, P88, DOI 10.1016/j.mam.2011.04.004; Wang CC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.4; Wohrle FU, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-22; Zhang SQ, 2002, MOL CELL BIOL, V22, P4062, DOI 10.1128/MCB.22.12.4062-4072.2002; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200; Zhang Z, 2010, CELL DEATH DIFFER, V17, P499, DOI 10.1038/cdd.2009.152	59	26	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67438	10.1371/journal.pone.0067438	http://dx.doi.org/10.1371/journal.pone.0067438			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805312	gold, Green Submitted, Green Published			2022-12-25	WOS:000320846500140
J	Zhang, C; Ni, J; Li, BL; Gao, F; Liu, H; Liu, W; Huang, YJ; Cai, JM				Zhang, Chao; Ni, Jin; Li, Bai-Long; Gao, Fu; Liu, Hu; Liu, Wen; Huang, Yi-Juan; Cai, Jian-Ming			CpG-Oligodeoxynucleotide Treatment Protects against Ionizing Radiation-Induced Intestine Injury	PLOS ONE			English	Article								Background: the bone marrow and the intestine are the major sites of ionizing radiation (IR)-induced injury. Our previous study demonstrated that CpG-oligodeoxynucleotide (ODN) treatment mitigated IR-induced bone marrow injury, but its effect on the intestine is not known. In this study, we sought to determine if CpG-ODN have protective effect on IR-induced intestine injury, and if so, to determine the mechanism of its effect. Methods and Findings: Mice were treated with CpG-ODN after IR. The body weight and survival were daily monitored for 30 days consecutively after exposure. The number of surviving intestinal crypt was assessed by the microcolony survival assay. The number and the distribution of proliferating cell in crypt were evaluated by TUNEL assay and BrdU assay. The expression of Bcl-2, Bax and caspase-3 in crypt were analyzed by Immunohistochemistry assay. The findings showed that the treatment for irradiated mice with CpG-ODN diminished body weight loss, improved 30 days survival, enhanced intestinal crypts survival and maintained proliferating cell population and regeneration in crypt. The reason might involve that CpG-ODN up-regulated the expression of Bcl-2 protein and down-regulated the expression of Bax protein and caspase-3 protein. Conclusion: CpG-ODN was effective in protection of IR-induced intestine injury by enhancing intestinal crypts survival and maintaining proliferating cell population and regeneration in crypt. The mechanism might be that CpG-ODN inhibits proliferating cell apoptosis through regulating the expression of apoptosis-related protein, such as Bax, Bcl-2 and caspase-3.	[Zhang, Chao; Ni, Jin; Li, Bai-Long; Gao, Fu; Liu, Hu; Liu, Wen; Huang, Yi-Juan; Cai, Jian-Ming] Second Mil Med Univ, Sect Radiat Med, Dept Naval Med, Shanghai, Peoples R China	Naval Medical University	Cai, JM (corresponding author), Second Mil Med Univ, Sect Radiat Med, Dept Naval Med, Shanghai, Peoples R China.	cjm882003@gmail.com	li, bz/GVR-7133-2022		National Natural Science Foundation of China [31070762]; National Natural Science Foundation of Shanghai [10ZR1437500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Shanghai	This work is supported in part by the National Natural Science Foundation of China (No.31070762) and the National Natural Science Foundation of Shanghai (No. 10ZR1437500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SC, 2005, HISTOCHEM CELL BIOL, V123, P249, DOI 10.1007/s00418-005-0765-6; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Ciorba MA, 2012, GUT, V61, P829, DOI 10.1136/gutjnl-2011-300367; Coopersmith CM, 1997, ONCOGENE, V15, P131, DOI 10.1038/sj.onc.1201176; Diego A, 2001, DIGEST DIS SCI, V46, P2608; Eric JH, 2012, RADIOBIOLOGY RADIOLO; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Jurk M, 2004, IMMUNOBIOLOGY, V209, P141, DOI 10.1016/j.imbio.2004.02.006; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Krieg AM, 2007, J CLIN INVEST, V117, P1184, DOI 10.1172/JCI31414; Lee JD, 2007, CURR OPIN GASTROEN, V23, P27, DOI 10.1097/MOG.0b013e3280118272; Luka M., 2004, CANCER RES, V64, P5074; Mason KA, 2006, RADIOTHER ONCOL, V80, P192, DOI 10.1016/j.radonc.2006.07.024; Monti PWJ, 2005, BJR S27, P27; Payel B, 2009, PLOS ONE, V4, P8041; Pedersen G, 2005, CLIN EXP IMMUNOL, V141, P298, DOI 10.1111/j.1365-2249.2005.02848.x; Pritchard DM, 1999, ONCOGENE, V18, P7287, DOI 10.1038/sj.onc.1203150; Przemeck SMC, 2006, AM J PHYSIOL-GASTR L, V292, P620; Riehl T, 2000, GASTROENTEROLOGY, V118, P1106, DOI 10.1016/S0016-5085(00)70363-5; Salakou S, 2007, IN VIVO, V21, P123; Subhrajit S, 2012, PLOS ONE, V7, P29357; Vijay-Kumar M, 2008, J IMMUNOL, V180, P8280, DOI 10.4049/jimmunol.180.12.8280; Wang YH, 2008, J BIOL CHEM, V283, P9454, DOI 10.1074/jbc.M707962200; WITHERS HR, 1970, INT J RADIAT BIOL RE, V17, P261, DOI 10.1080/09553007014550291; Zhang C, 2011, BASIC CLIN PHARMACOL, V109, P11, DOI 10.1111/j.1742-7843.2011.00695.x	25	9	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66586	10.1371/journal.pone.0066586	http://dx.doi.org/10.1371/journal.pone.0066586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805241	Green Submitted, gold, Green Published			2022-12-25	WOS:000320846500069
J	Yi, J; Zheng, YJ; Miao, CH; Tang, JG; Zhu, B				Yi, Juan; Zheng, Yijun; Miao, Changhong; Tang, Jianguo; Zhu, Biao			Desflurane Preconditioning Induces Oscillation of NF-kappa B in Human Umbilical Vein Endothelial Cells	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; REDUCES INFLAMMATION; MYOCARDIAL-ISCHEMIA; SIGNALING PATHWAY; RENAL ISCHEMIA; INHIBITION; ACTIVATION; PROTECTION; ISOFLURANE; MECHANISM	Background: Nuclear factor kappa B (NF-kappa B) has been implicated in anesthetic preconditioning (APC) induced protection against anoxia and reoxygenation (A/R) injury. The authors hypothesized that desflurane preconditioning would induce NF kappa B oscillation and prevent endothelial cells apoptosis. Methods: A human umbilical vein endothelial cells (HUVECs) A/R injury model was used. A 30 minute desflurane treatment was initiated before anoxia. NF-kappa B inhibitor BAY11-7082 was administered in some experiments before desflurane preconditioning. Cells apoptosis was analyzed by flow cytometry using annexin V-fluorescein isothiocyanate staining and cell viability was evaluated by modified tertrozalium salt (MTT) assay. The cellular superoxide dismutases (SOD) activitiy were tested by water-soluble tetrazolium salt (WST-1) assay. NF-kappa B p65 subunit nuclear translocation was detected by immunofluorescence staining. Expression of inhibitor of NF-kappa B-alpha (IkB alpha), NF-kappa B p65 and cellular inhibitor of apoptosis 1 (c-IAP1), B-cell leukemia/lymphoma 2 (Bcl-2), cysteine containing aspartate specific protease 3 (caspases-3) and second mitochondrial-derived activator of caspase (SMAC/DIABLO) were determined by western blot. Results: Desflurane preconditioning caused phosphorylation and nuclear translocation of NF-kappa B before anoxia, on the contrary, induced the synthesis of I kappa B alpha and inhibition of NF-kappa B after reoxygenation. Desflurane preconditioning upregulated the expression of c-IAP1 and Bcl-2, blocked the cleavage of caspase-3 and reduced SMAC release, and decreased the cell death of HUVECs after A/R. The protective effect was abolished by BAY11-7082 administered before desflurane. Conclusions: The results demonstrated that desflurane activated NF-kappa B during the preconditioning period and inhibited excessive activation of NF-kappa B in reperfusion. And the oscillation of NF-kappa B induced by desflurane preconditioning finally upregulated antiapoptotic proteins expression and protected endothelial cells against A/R.	[Yi, Juan; Zheng, Yijun; Zhu, Biao] Fudan Univ, Zhongshan Hosp, Dept Anesthesiol & Crit Care, Shanghai 200433, Peoples R China; [Miao, Changhong] Fudan Univ, Shanghai Canc Hosp, Dept Anesthesiol, Shanghai 200433, Peoples R China; [Tang, Jianguo] Fudan Univ, Peoples Hosp Shanghai 5, Dept Emergency, Shanghai 200433, Peoples R China; [Tang, Jianguo] Fudan Univ, Peoples Hosp Shanghai 5, Crit Care Unit, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Zhu, B (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Anesthesiol & Crit Care, Shanghai 200433, Peoples R China.	zhubiaozs@gmail.com			National Natural Science Foundation of China [30972838/C160201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding game from the National Natural Science Foundation of China Grant number:30972838/C160201 http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amour J, 2009, ANESTHESIOLOGY, V110, P317, DOI 10.1097/ALN.0b013e3181942cb4; Annecke T, 2010, BRIT J ANAESTH, V104, P414, DOI 10.1093/bja/aeq019; Baudin B, 2007, NAT PROTOC, V2, P481, DOI 10.1038/nprot.2007.54; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Chen CH, 2008, SHOCK, V30, P241, DOI [10.1097/SHK.0b013e318162ad19, 10.1097/SHK.0b013e31816ad19]; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Donnahoo KK, 2000, J UROLOGY, V163, P1328, DOI 10.1016/S0022-5347(05)67772-5; Espinosa I, 2008, HISTOPATHOLOGY, V53, P441, DOI 10.1111/j.1365-2559.2008.03139.x; Feng JF, 2011, J PHARM PHARMACOL, V63, P106, DOI 10.1111/j.2042-7158.2010.01198.x; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; Hunter AL, 2005, VASC PHARMACOL, V43, P213, DOI 10.1016/j.vph.2005.07.005; Kalita MK, 2011, J BIOL CHEM, V286, P37741, DOI 10.1074/jbc.M111.280925; Kandilci HB, 2006, LIFE SCI, V79, P2172, DOI 10.1016/j.lfs.2006.07.011; Kersten JR, 1996, ANESTHESIOLOGY, V85, P794, DOI 10.1097/00000542-199610000-00015; Kim YS, 2010, INT HEART J, V51, P348, DOI 10.1536/ihj.51.348; Lee HT, 2004, ANESTHESIOLOGY, V101, P1313; Li Y, 2008, ANESTH ANALG, V106, P1473, DOI 10.1213/ane.0b013e318168b3f2; Lu XY, 2009, AM J PHYSIOL-HEART C, V296, pH1296, DOI 10.1152/ajpheart.01282.2008; Lucchinetti E, 2007, ANESTHESIOLOGY, V106, P262, DOI 10.1097/00000542-200702000-00013; Lucchinetti E, 2009, ANESTH ANALG, V109, P1117, DOI 10.1213/ANE.0b013e3181b5a277; Maier CM, 2006, ANN NEUROL, V59, P929, DOI 10.1002/ana.20850; Masini E, 2002, BRIT J PHARMACOL, V136, P905, DOI 10.1038/sj.bjp.0704774; Mengel B, 2010, CURR OPIN GENET DEV, V20, P656, DOI 10.1016/j.gde.2010.08.008; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Sun Jun, 2009, J Mol Signal, V4, P4, DOI 10.1186/1750-2187-4-4; Sun SX, 2011, CELL BIOCHEM BIOPHYS, V61, P123, DOI 10.1007/s12013-011-9168-6; Tsung A, 2005, J IMMUNOL, V175, P7661, DOI 10.4049/jimmunol.175.11.7661; Wang C, 2010, EUR J ANAESTH, V27, P747, DOI 10.1097/EJA.0b013e32833bb3ba; Wang PH, 1998, P NATL ACAD SCI USA, V95, P4556, DOI 10.1073/pnas.95.8.4556; Wang YJ, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-23; Wei Z, 2009, TRANSPL P, V41, P4120, DOI 10.1016/j.transproceed.2009.09.054; Zhong CY, 2004, ANESTHESIOLOGY, V100, P540, DOI 10.1097/00000542-200403000-00012	33	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66576	10.1371/journal.pone.0066576	http://dx.doi.org/10.1371/journal.pone.0066576			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799118	Green Submitted, Green Published, gold			2022-12-25	WOS:000321397800039
J	Bromke, MA; Giavalisco, P; Willmitzer, L; Hesse, H				Bromke, Mariusz A.; Giavalisco, Patrick; Willmitzer, Lothar; Hesse, Holger			Metabolic Analysis of Adaptation to Short-Term Changes in Culture Conditions of the Marine Diatom Thalassiosira pseudonana	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; TROPICAL AUSTRALIAN MICROALGAE; FATTY-ACID-COMPOSITION; PHAEODACTYLUM-TRICORNUTUM; CHEMICAL-COMPOSITION; BATCH CULTURES; HIGHER-PLANTS; WORLD OCEAN; NUTRIENT; PHYTOPLANKTON	This report describes the metabolic and lipidomic profiling of 97 low-molecular weight compounds from the primary metabolism and 124 lipid compounds of the diatom Thalassiosira pseudonana. The metabolic profiles were created for diatoms perturbed for 24 hours with four different treatments: (I) removal of nitrogen, (II) lower iron concentration, (III) addition of sea salt, (IV) addition of carbonate to their growth media. Our results show that as early as 24 hours after nitrogen depletion significant qualitative and quantitative change in lipid composition as well as in the primary metabolism of Thalassiosira pseudonana occurs. So we can observe the accumulation of several storage lipids, namely triacylglycerides, and TCA cycle intermediates, of which citric acid increases more than 10-fold. These changes are positively correlated with expression of TCA enzymes genes. Next to the TCA cycle intermediates and storage lipid changes, we have observed decrease in N-containing lipids and primary metabolites such as amino acids. As a measure of counteracting nitrogen starvation, we have observed elevated expression levels of nitrogen uptake and amino acid biosynthetic genes. This indicates that diatoms can fast and efficiently adapt to changing environment by altering the metabolic fluxes and metabolite abundances. Especially, the accumulation of proline and the decrease of dimethylsulfoniopropionate suggest that the proline is the main osmoprotectant for the diatom in nitrogen rich conditions.	[Bromke, Mariusz A.; Giavalisco, Patrick; Willmitzer, Lothar; Hesse, Holger] Max Planck Inst Mol Plant Physiol, Dept Mol Physiol, Potsdam, Germany	Max Planck Society	Bromke, MA (corresponding author), Max Planck Inst Mol Plant Physiol, Dept Mol Physiol, Potsdam, Germany.	bromke@mpimp-golm.mpg.de	Bromke, Mariusz A./AAZ-4519-2020	Bromke, Mariusz A./0000-0002-0806-6608	DFG;  [HE3088/4-1]	DFG(German Research Foundation (DFG)); 	This work was supported by grant number HE3088/4-1, funded by DFG (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2008, P NATL ACAD SCI USA, V105, P10438, DOI 10.1073/pnas.0711370105; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Bender SJ, 2012, PROTIST, V163, P232, DOI 10.1016/j.protis.2011.07.008; BERGES JA, 1995, J PHYCOL, V31, P85, DOI 10.1111/j.0022-3646.1995.00085.x; Bolling C, 2005, PLANT PHYSIOL, V139, P1995, DOI 10.1104/pp.105.071589; Cuadros-Inostroza A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-428; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; DORTCH Q, 1990, MAR ECOL PROG SER, V61, P183, DOI 10.3354/meps061183; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Gage DA, 1997, NATURE, V387, P891, DOI 10.1038/43160; Gaude N, 2007, PLANT J, V49, P729, DOI 10.1111/j.1365-313X.2006.02992.x; Giavalisco P, 2011, PLANT J, V68, P364, DOI 10.1111/j.1365-313X.2011.04682.x; Granum E, 2005, CAN J BOT, V83, P898, DOI 10.1139/B05-077; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hockin NL, 2012, PLANT PHYSIOL, V158, P299, DOI 10.1104/pp.111.184333; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Hummel J, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00054; Keller MD, 1999, MAR BIOL, V135, P237, DOI 10.1007/s002270050621; KLOPFENSTEIN WE, 1983, J AM OIL CHEM SOC, V60, P1596, DOI 10.1007/BF02666592; Kustka AB, 2007, J PHYCOL, V43, P715, DOI 10.1111/j.1529-8817.2007.00359.x; Li YT, 2011, BIORESOURCE TECHNOL, V102, P123, DOI 10.1016/j.biortech.2010.06.036; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Milligan AJ, 2000, J PHYCOL, V36, P78, DOI 10.1046/j.1529-8817.2000.99013.x; Mock T, 2008, P NATL ACAD SCI USA, V105, P1579, DOI 10.1073/pnas.0707946105; Moore JK, 2001, DEEP-SEA RES PT II, V49, P463; MOREL FMM, 1987, J PHYCOL, V23, P137; Nappo M, 2009, J APPL PHYCOL, V21, P295, DOI 10.1007/s10811-008-9367-8; Niki T, 2004, J OCEANOGR, V60, P913, DOI 10.1007/s10872-005-5783-4; ORCUTT DM, 1975, COMP BIOCHEM PHYS B, V50, P579, DOI 10.1016/0305-0491(75)90093-0; Otte ML, 2004, J EXP BOT, V55, P1919, DOI 10.1093/jxb/erh178; PAASCHE E, 1973, MAR BIOL, V19, P117, DOI 10.1007/BF00353582; Parker MS, 2008, ANNU REV GENET, V42, P619, DOI 10.1146/annurev.genet.42.110807.091417; Renaud SM, 1999, AQUACULTURE, V170, P147, DOI 10.1016/S0044-8486(98)00399-8; Renaud SM, 2002, AQUACULTURE, V211, P195, DOI 10.1016/S0044-8486(01)00875-4; ROBERTS BA, 1986, CAN J BOT, V64, P455, DOI 10.1139/b86-060; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schuster J, 2006, PLANT CELL, V18, P2664, DOI 10.1105/tpc.105.039339; Simo R, 2001, TRENDS ECOL EVOL, V16, P287, DOI 10.1016/S0169-5347(01)02152-8; Strong AL, 2009, OCEANOGRAPHY, V22, P236, DOI 10.5670/oceanog.2009.83; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; Team RC, 2012, R LANG ENV STAT COMP; Tonon T, 2002, PHYTOCHEMISTRY, V61, P15, DOI 10.1016/S0031-9422(02)00201-7; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; Vidoudez C, 2012, METABOLOMICS, V8, P654, DOI 10.1007/s11306-011-0356-6; Zendejas FJ, 2012, BIOTECHNOL BIOENG, V109, P1146, DOI 10.1002/bit.24395	47	43	43	3	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e67340	10.1371/journal.pone.0067340	http://dx.doi.org/10.1371/journal.pone.0067340			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799147	Green Submitted, gold, Green Published			2022-12-25	WOS:000320363300110
J	Cunneen, MM; Liu, B; Wang, L; Reeves, PR				Cunneen, Monica M.; Liu, Bin; Wang, Lei; Reeves, Peter R.			Biosynthesis of UDP-GlcNAc, UndPP-GlcNAc and UDP-GlcNAcA Involves Three Easily Distinguished 4-Epimerase Enzymes, Gne, Gnu and GnaB	PLOS ONE			English	Article							N-ACETYLGLUCOSAMINE 4-EPIMERASE; ANTIGEN GENE CLUSTERS; PSEUDOMONAS-AERUGINOSA; SUBSTRATE-SPECIFICITY; BIOCHEMICAL-CHARACTERIZATION; POLYSACCHARIDE SYNTHESIS; GALACTOSE 4-EPIMERASE; STRUCTURAL-ANALYSIS; C4 EPIMERASE; VIRULENCE	We have undertaken an extensive survey of a group of epimerases originally named Gne, that were thought to be responsible for inter-conversion of UDP-N-acetylglucosamine (UDP-GlcNAc) and UDP-N-acetylgalactosamine (UDP-GalNAc). The analysis builds on recent work clarifying the specificity of some of these epimerases. We find three well defined clades responsible for inter-conversion of the gluco- and galacto-configuration at C4 of different N-acetylhexosamines. Their major biological roles are the formation of UDP-GalNAc, UDP-N-acetylgalactosaminuronic acid (UDP-GalNAcA) and undecaprenyl pyrophosphate-N-acetylgalactosamine (UndPP-GalNAc) from the corresponding glucose forms. We propose that the clade of UDP-GlcNAcA epimerase genes be named gnaB and the clade of UndPP-GlcNAc epimerase genes be named gnu, while the UDP-GlcNAc epimerase genes retain the name gne. The Gne epimerases, as now defined after exclusion of those to be named GnaB or Gnu, are in the same clade as the GalE 4-epimerases for inter-conversion of UDP-glucose (UDP-Glc) and UDP-galactose (UDP-Gal). This work brings clarity to an area that had become quite confusing. The identification of distinct enzymes for epimerisation of UDP-GlcNAc, UDP-GlcNAcA and UndPP-GlcNAc will greatly facilitate allocation of gene function in polysaccharide gene clusters, including those found in bacterial genome sequences. A table of the accession numbers for the 295 proteins used in the analysis is provided to enable the major tree to be regenerated with the inclusion of additional proteins of interest. This and other suggestions for annotation of 4-epimerase genes will facilitate annotation.	[Cunneen, Monica M.; Reeves, Peter R.] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; [Liu, Bin; Wang, Lei] Nankai Univ, TEDA, TEDA Sch Biol Sci & Biotechnol, Tianjin 300071, Peoples R China; [Liu, Bin; Wang, Lei] TEDA, Tianjin Res Ctr Funct Genom & Biochip, Tianjin, Peoples R China; [Wang, Lei] Nankai Univ, Tianjin Key Lab Microbial Funct Genom, Tianjin 300071, Peoples R China	University of Sydney; Nankai University; Nankai University	Reeves, PR (corresponding author), Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia.	peter.reeves@sydney.edu.au	Reeves, Peter R/A-6064-2008; Wang, Lei/C-5176-2009	Reeves, Peter R/0000-0003-4479-7974; Wang, Lei/0000-0003-4427-0881	National Natural Science Foundation of China (NSFC) Key Program Grant [31030002]; National 973 program of China [2011CB504900]; Australian Research Council	National Natural Science Foundation of China (NSFC) Key Program Grant(National Natural Science Foundation of China (NSFC)); National 973 program of China(National Basic Research Program of China); Australian Research Council(Australian Research Council)	The work for this paper was supported in part by the National Natural Science Foundation of China (NSFC) Key Program Grant 31030002 and the National 973 program of China (2011CB504900), and preliminary work in the area was supported by grants from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER DC, 1994, J BACTERIOL, V176, P7079, DOI 10.1128/JB.176.22.7079-7084.1994; Allard STM, 2001, CELL MOL LIFE SCI, V58, P1650, DOI 10.1007/PL00000803; Bengoechea JA, 2002, J BACTERIOL, V184, P4277, DOI 10.1128/JB.184.15.4277-4287.2002; Bhatt VS, 2011, PROTEIN SCI, V20, P856, DOI 10.1002/pro.611; Canals R, 2007, J BACTERIOL, V189, P540, DOI 10.1128/JB.01260-06; Creuzenet C, 2000, J BIOL CHEM, V275, P19060, DOI 10.1074/jbc.M001171200; Cunneen MM, 2011, GLYCOBIOLOGY, V21, P1140, DOI 10.1093/glycob/cwr010; De Castro C, 2013, GLYCOBIOLOGY, V23, P346, DOI 10.1093/glycob/cws145; De Castro C, 2011, INNATE IMMUN-LONDON, V17, P183, DOI 10.1177/1753425910364425; De Castro C, 2009, INNATE IMMUN-LONDON, V15, P351, DOI 10.1177/1753425909105319; deHenestrosa ARF, 1997, FEMS MICROBIOL LETT, V154, P311, DOI 10.1016/S0378-1097(97)00347-9; ESTRELA AI, 1991, J GEN MICROBIOL, V137, P943, DOI 10.1099/00221287-137-4-943; Guo HJ, 2007, BIOCHEM BIOPH RES CO, V356, P604, DOI 10.1016/j.bbrc.2007.03.015; Hao YA, 2011, BACTERIAL LIPOPOLYSACCHARIDES: STRUCTURE, CHEMICAL SYNTHESIS, BIOGENESIS AND INTERACTION WITH HOST CELLS, P195, DOI 10.1007/978-3-7091-0733-1_7; HASHIMOTO Y, 1993, J BACTERIOL, V175, P4456, DOI 10.1128/JB.175.14.4456-4465.1993; Ishiyama N, 2004, J BIOL CHEM, V279, P22635, DOI 10.1074/jbc.M401642200; Knirel YA, 2011, BACTERIAL LIPOPOLYSACCHARIDES: STRUCTURE, CHEMICAL SYNTHESIS, BIOGENESIS AND INTERACTION WITH HOST CELLS, P41, DOI 10.1007/978-3-7091-0733-1_3; Lopez AB, 2007, J EUKARYOT MICROBIOL, V54, P154, DOI 10.1111/j.1550-7408.2007.00246.x; METZGER M, 1994, J BACTERIOL, V176, P450, DOI 10.1128/JB.176.2.450-459.1994; Miller WL, 2008, J BIOL CHEM, V283, P3507, DOI 10.1074/jbc.M708894200; Reeves PR, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P319; Reeves PR, 2003, ADV EXP MED BIOL, V529, P199; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Roodt Y, 2007, DNA SEQUENCE, V18, P265, DOI 10.1080/10425170701207067; Rush JS, 2010, J BIOL CHEM, V285, P1671, DOI 10.1074/jbc.M109.061630; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; Schulz JM, 2004, J BIOL CHEM, V279, P32796, DOI 10.1074/jbc.M405005200; Thoden JB, 2002, J BIOL CHEM, V277, P27528, DOI 10.1074/jbc.M204413200; Thoden JB, 2001, J BIOL CHEM, V276, P20617, DOI 10.1074/jbc.M101304200; Wang L, 2002, J BACTERIOL, V184, P2620, DOI 10.1128/JB.184.10.2620-2625.2002; Wetter M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045609; Woodward R, 2010, NAT CHEM BIOL, V6, P418, DOI 10.1038/nchembio.351; Zhao X, 2000, J BIOL CHEM, V275, P33252, DOI 10.1074/jbc.M004191200	33	32	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e67646	10.1371/journal.pone.0067646	http://dx.doi.org/10.1371/journal.pone.0067646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799153	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300115
J	Moisello, C; Meziane, HB; Kelly, S; Perfetti, B; Kvint, S; Voutsinas, N; Blanco, D; Quartarone, A; Tononi, G; Ghilardi, MF				Moisello, Clara; Meziane, Hadj Boumediene; Kelly, Simon; Perfetti, Bernardo; Kvint, Svetlana; Voutsinas, Nicholas; Blanco, Daniella; Quartarone, Angelo; Tononi, Giulio; Ghilardi, Maria Felice			Neural Activations during Visual Sequence Learning Leave a Trace in Post-Training Spontaneous EEG	PLOS ONE			English	Article							WORKING-MEMORY TASK; PARKINSONS-DISEASE; PHASE SYNCHRONIZATION; ALPHA OSCILLATIONS; THETA OSCILLATIONS; MOTOR CORTEX; PERFORMANCE; MODULATION; SLEEP; INHIBITION	Recent EEG studies have shown that implicit learning involving specific cortical circuits results in an enduring local trace manifested as local changes in spectral power. Here we used a well characterized visual sequence learning task and high density-(hd-)EEG recording to determine whether also declarative learning leaves a post-task, local change in the resting state oscillatory activity in the areas involved in the learning process. Thus, we recorded hd-EEG in normal subjects before, during and after the acquisition of the order of a fixed spatial target sequence (VSEQ) and during the presentation of targets in random order (VRAN). We first determined the temporal evolution of spectral changes during VSEQ and compared it to VRAN. We found significant differences in the alpha and theta bands in three main scalp regions, a right occipito-parietal (ROP), an anterior-frontal (AFr), and a right frontal (RFr) area. The changes in frontal theta power during VSEQ were positively correlated with the learning rate. Further, post-learning EEG recordings during resting state revealed a significant increase in alpha power in ROP relative to a pre-learning baseline. We conclude that declarative learning is associated with alpha and theta changes in frontal and posterior regions that occur during the task, and with an increase of alpha power in the occipito-parietal region after the task. These post-task changes may represent a trace of learning and a hallmark of use-dependent plasticity.	[Moisello, Clara; Meziane, Hadj Boumediene; Perfetti, Bernardo; Kvint, Svetlana; Voutsinas, Nicholas; Blanco, Daniella; Ghilardi, Maria Felice] CUNY, Sch Med, Dept Physiol Pharmacol & Neurosci, New York, NY 10031 USA; [Kelly, Simon] CUNY, Dept Biomed Engn, New York, NY 10021 USA; [Quartarone, Angelo] Univ Messina, Dept Neurosci Psychiat & Anaesthesiol Sci, Messina, Italy; [Tononi, Giulio] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA	City University of New York (CUNY) System; City University of New York (CUNY) System; University of Messina; University of Wisconsin System; University of Wisconsin Madison	Ghilardi, MF (corresponding author), CUNY, Sch Med, Dept Physiol Pharmacol & Neurosci, New York, NY 10031 USA.	lice.mg79@gmail.com	; QUARTARONE, Angelo/G-3264-2017	Meziane, Hadj Boumediene/0000-0001-9284-5016; QUARTARONE, Angelo/0000-0003-1485-6590; Kelly, Simon/0000-0001-9983-3595	McDonnell Foundation; National Parkinson Foundation; National Institute of Health [NS-054864, NS-055185]; Rudin Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054864, R01NS055185] Funding Source: NIH RePORTER	McDonnell Foundation; National Parkinson Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rudin Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	McDonnell Foundation to MFG and GT, National Parkinson Foundation to MFG, National Institute of Health (NS-054864 to MFG, NS-055185 to GT) and Rudin Fellowship to SvK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastiaansen MCM, 2002, CLIN NEUROPHYSIOL, V113, P1882, DOI 10.1016/S1388-2457(02)00303-6; BEATTY J, 1974, SCIENCE, V183, P871, DOI 10.1126/science.183.4127.871; BRASILNETO J, 1993, EXP BRAIN RES, V93, P181; Buschkuehl M, 2012, DEV COGN NEUROS-NETH, V2, pS167, DOI 10.1016/j.dcn.2011.10.001; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Cooper NR, 2003, INT J PSYCHOPHYSIOL, V47, P65, DOI 10.1016/S0167-8760(02)00107-1; Crupi D, 2013, J MOTOR BEHAV, V45, P127, DOI 10.1080/00222895.2012.760514; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dien J., 2005, EVENT RELATED POTENT, P189, DOI DOI 10.1212/01.WNL.0000217365.45426.9A; Gallasch E, 2009, EUR J APPL PHYSIOL, V105, P47, DOI 10.1007/s00421-008-0871-y; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Ghilardi MF, 2007, PARKINSONISM RELAT D, V13, P146, DOI 10.1016/j.parkreldis.2006.08.006; Ghilardi MF, 2003, ANN NEUROL, V54, P102, DOI 10.1002/ana.10610; Ghilardi MF, 2000, BRAIN RES, V871, P127, DOI 10.1016/S0006-8993(00)02365-9; Ghilardi MF, 2003, NEUROLOGY, V60, P1313, DOI 10.1212/01.WNL.0000059545.69089.EE; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Hung CS, 2013, SLEEP, V36, P59, DOI 10.5665/sleep.2302; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Keller A, 2002, TRENDS NEUROSCI, V25, P541, DOI 10.1016/S0166-2236(02)02260-9; Kim SJ, 2007, NEURON, V56, P582, DOI 10.1016/j.neuron.2007.10.030; Klimesch W, 1997, INT J PSYCHOPHYSIOL, V26, P319, DOI 10.1016/S0167-8760(97)00773-3; KLIMESCH W, 1994, ELECTROEN CLIN NEURO, V91, P428, DOI 10.1016/0013-4694(94)90164-3; Klimesch W., 1993, Brain Topography, V5, P241, DOI 10.1007/BF01128991; Klimesch W, 1996, NEUROREPORT, V7, P1235, DOI 10.1097/00001756-199605170-00002; Klimesch W, 1997, PSYCHOPHYSIOLOGY, V34, P169, DOI 10.1111/j.1469-8986.1997.tb02128.x; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2008, BRAIN RES, V1235, P31, DOI 10.1016/j.brainres.2008.06.049; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Klimesch W, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00118; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Kvint S, 2011, ARCH ITAL BIOL, V149, P303, DOI 10.4449/aib.v149i3.1244; Landsness EC, 2011, CLIN NEUROPHYSIOL, V122, P2418, DOI 10.1016/j.clinph.2011.05.001; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Mima T, 2001, J NEUROSCI, V21, P3942, DOI 10.1523/JNEUROSCI.21-11-03942.2001; Moisello C, 2009, EXP BRAIN RES, V194, P143, DOI 10.1007/s00221-008-1681-5; Nakamura T, 2001, HUM BRAIN MAPP, V12, P42, DOI 10.1002/1097-0193(200101)12:1<42::AID-HBM40>3.0.CO;2-D; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Perfetti B, 2010, ARCH ITAL BIOL, V148, P279; Perfetti B, 2011, J NEUROSCI, V31, P14810, DOI 10.1523/JNEUROSCI.1319-11.2011; Perfetti B, 2011, J NEUROPHYSIOL, V105, P18, DOI 10.1152/jn.00778.2010; Pignatelli M, 2012, J PHYSIOL-PARIS, V106, P81, DOI 10.1016/j.jphysparis.2011.09.007; Sauseng P, 2005, HUM BRAIN MAPP, V26, P148, DOI 10.1002/hbm.20150; Sauseng P, 2005, INT J PSYCHOPHYSIOL, V57, P97, DOI 10.1016/j.ijpsycho.2005.03.018; Sederberg PB, 2003, J NEUROSCI, V23, P10809; Tanaka S, 2011, NEUROPSYCHOL REHABIL, V21, P650, DOI 10.1080/09602011.2011.605589; Vanni S, 1997, J NEUROSCI, V17, P7141; Vyazovskiy VV, 2011, PROG BRAIN RES, V193, P17, DOI 10.1016/B978-0-444-53839-0.00002-8; White T.P, 2012, HUM BRAIN MAPP	50	24	25	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65882	10.1371/journal.pone.0065882	http://dx.doi.org/10.1371/journal.pone.0065882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799058	gold, Green Published			2022-12-25	WOS:000320363300050
J	Schwarzinger, M; Sagaon-Teyssier, L; Cabaret, O; Bretagne, S; Cordonnier, C				Schwarzinger, Michael; Sagaon-Teyssier, Luis; Cabaret, Odile; Bretagne, Stephane; Cordonnier, Catherine		PREVERT Investigators	Performance of Serum Biomarkers for the Early Detection of Invasive Aspergillosis in Febrile, Neutropenic Patients: A Multi-State Model	PLOS ONE			English	Article								Background: The performance of serum biomarkers for the early detection of invasive aspergillosis expectedly depends on the timing of test results relative to the empirical administration of antifungal therapy during neutropenia, although a dynamic evaluation framework is lacking. Methods: We developed a multi-state model describing simultaneously the likelihood of empirical antifungal therapy and the risk of invasive aspergillosis during neutropenia. We evaluated whether the first positive test result with a biomarker is an independent predictor of invasive aspergillosis when both diagnostic information used to treat and risk factors of developing invasive aspergillosis are taken into account over time. We applied the multi-state model to a homogeneous cohort of 185 high-risk patients with acute myeloid leukemia. Patients were prospectively screened for galactomannan antigenemia twice a week for immediate treatment decision; 2,214 serum samples were collected on the same days and blindly assessed for (1->3)- beta-D-glucan antigenemia and a quantitative PCR assay targeting a mitochondrial locus. Results: The usual evaluation framework of biomarker performance was unable to distinguish clinical benefits of beta-glucanor PCR assays. The multi-state model evidenced that the risk of invasive aspergillosis is a complex time function of neutropenia duration and risk management. The quantitative PCR assay accelerated the early detection of invasive aspergillosis (P = .010), independently of other diagnostic information used to treat, while beta-glucan assay did not (P = .53). Conclusions: The performance of serum biomarkers for the early detection of invasive aspergillosis is better apprehended by the evaluation of time-varying predictors in a multi-state model. Our results provide strong rationale for prospective studies testing a preemptive antifungal therapy, guided by clinical, radiological, and bi-weekly blood screening with galactomannan antigenemia and a standardized quantitative PCR assay.	[Schwarzinger, Michael] INSERM, UMR 738, Equipe ATIP AVENIR, Paris, France; [Schwarzinger, Michael] Univ Paris Diderot, Sorbonne Paris Cite, UMR 738, Paris, France; [Schwarzinger, Michael] Translat Hlth Econ Network, Paris, France; [Schwarzinger, Michael] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Sagaon-Teyssier, Luis] INSERM, SESSTIM UMR912, Marseille, France; [Sagaon-Teyssier, Luis] Univ Aix Marseille, UMR S912, IRD, Marseille, France; [Sagaon-Teyssier, Luis] Observ Reg Sante Provence Alpes Cote Azur, ORS PACA, Marseille, France; [Cabaret, Odile; Bretagne, Stephane] Henri Mondor Teaching Hosp, AP HP, Parasitol Mycol Dept, Creteil, France; [Bretagne, Stephane; Cordonnier, Catherine] Univ Paris Est Creteil, UMR 956, Creteil, France; [Bretagne, Stephane] Inst Pasteur, Ctr Natl Reference Mycoses Invas & Antifong, Paris, France; [Cordonnier, Catherine] Henri Mondor Teaching Hosp, AP HP, Hematol Dept, Creteil, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Stanford University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Schwarzinger, M (corresponding author), INSERM, UMR 738, Equipe ATIP AVENIR, Paris, France.	michael.schwarzinger@inserm.fr	BRETAGNE, Stephane/H-6655-2019; maury, sebastien/Q-6573-2018; Cornet, Muriel/M-6563-2014; Schwarzinger, Michael/F-7367-2011; BRETAGNE, Stephane/GLT-8879-2022	BRETAGNE, Stephane/0000-0001-6870-3800; maury, sebastien/0000-0002-1170-8683; Cornet, Muriel/0000-0003-4155-3675; Schwarzinger, Michael/0000-0002-0573-6856; Paugam, Andre/0000-0003-1451-3029; Goldhaber-Fiebert, Jeremy/0000-0002-4007-5192; Sagaon-Teyssier, Luis/0000-0001-7318-6596	French Ministry of Health [PHRC 2002 AOR02028]	French Ministry of Health	Financial support French Ministry of Health (PHRC 2002 AOR02028). The study sponsor had no involvement in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Alberti C, 2001, J HOSP INFECT, V48, P198, DOI 10.1053/jhin.2001.0998; Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Barnes RA, 2009, J CLIN PATHOL, V62, P64, DOI 10.1136/jcp.2008.058354; Botterel F, 2008, TRANSPL INFECT DIS, V10, P333, DOI 10.1111/j.1399-3062.2008.00323.x; Cordonnier C, 2009, CLIN INFECT DIS, V48, P1042, DOI 10.1086/597395; Cornely OA, 2007, NEW ENGL J MED, V356, P348, DOI 10.1056/NEJMoa061094; Cornet M, 1999, INFECT CONT HOSP EP, V20, P508, DOI 10.1086/501661; Costa C, 2002, J CLIN MICROBIOL, V40, P2224, DOI 10.1128/JCM.40.6.2224-2227.2002; Costa JM, 2001, PRENATAL DIAG, V21, P85, DOI 10.1002/1097-0223(200102)21:2&lt;85::AID-PD18&gt;3.0.CO;2-1; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Desmet S, 2009, J CLIN MICROBIOL, V47, P3871, DOI 10.1128/JCM.01756-09; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; GERSON SL, 1984, ANN INTERN MED, V100, P345, DOI 10.7326/0003-4819-100-3-345; Gotzsche PC, 1997, BMJ-BRIT MED J, V314, P1238, DOI 10.1136/bmj.314.7089.1238; Heckman J J, 1994, Stat Methods Med Res, V3, P279, DOI 10.1177/096228029400300306; Kami M, 2001, CLIN INFECT DIS, V33, P1504, DOI 10.1086/323337; Karageorgopoulos DE, 2011, CLIN INFECT DIS, V52, P750, DOI 10.1093/cid/ciq206; Kawazu M, 2004, J CLIN MICROBIOL, V42, P2733, DOI 10.1128/JCM.42.6.2733-2741.2004; Koo S, 2009, CLIN INFECT DIS, V49, P1650, DOI 10.1086/647942; Lamoth F, 2012, CLIN INFECT DIS, V54, P633, DOI 10.1093/cid/cir897; Leeflang MM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007394; Maertens J, 2005, CLIN INFECT DIS, V41, P1242, DOI 10.1086/496927; Maertens J, 2011, BONE MARROW TRANSPL, V46, P709, DOI 10.1038/bmt.2010.175; Maertens J, 2001, BLOOD, V97, P1604, DOI 10.1182/blood.V97.6.1604; Marchetti O, 2012, BONE MARROW TRANSPL, V47, P846, DOI 10.1038/bmt.2011.178; Marino P, 2013, J CLIN ONCOL, V31, P1277, DOI 10.1200/JCO.2011.38.5401; Marr KA, 2005, CLIN INFECT DIS, V41, pS381, DOI 10.1086/430920; Marr KA, 2005, CLIN INFECT DIS, V40, P1762, DOI 10.1086/429921; Marr KA, 2004, J INFECT DIS, V190, P641, DOI 10.1086/422009; Mengoli C, 2009, LANCET INFECT DIS, V9, P89, DOI 10.1016/S1473-3099(09)70019-2; MEYER BD, 1990, ECONOMETRICA, V58, P757, DOI 10.2307/2938349; Miceli MH, 2008, CLIN INFECT DIS, V46, P1412, DOI 10.1086/528714; Muhlemann K, 2005, LEUKEMIA, V19, P545, DOI 10.1038/sj.leu.2403674; Nouer SA, 2011, CLIN INFECT DIS, V53, P671, DOI 10.1093/cid/cir441; Pfeiffer CD, 2006, CLIN INFECT DIS, V42, P1417, DOI 10.1086/503427; Segal BH, 2007, CLIN INFECT DIS, V44, P402, DOI 10.1086/510677; Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853; White PL, 2011, J CLIN MICROBIOL, V49, P3842, DOI 10.1128/JCM.05316-11; White PL, 2010, J CLIN MICROBIOL, V48, P1231, DOI 10.1128/JCM.01767-09; Yokoe D, 2009, BONE MARROW TRANSPL, V44, P495, DOI 10.1038/bmt.2009.261	40	24	29	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65776	10.1371/journal.pone.0065776	http://dx.doi.org/10.1371/journal.pone.0065776			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V71EU	23799048	gold, Green Published, Green Submitted			2022-12-25	WOS:000211558300001
J	Wong, KS; Cheung, MK; Au, CH; Kwan, HS				Wong, Kin-Sing; Cheung, Man-Kit; Au, Chun-Hang; Kwan, Hoi-Shan			A Novel Lentinula edodes Laccase and Its Comparative Enzymology Suggest Guaiacol-Based Laccase Engineering for Bioremediation	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; CRYSTAL-STRUCTURE; DIRECTED EVOLUTION; FUNGAL LACCASES; EXPRESSION; OXIDATION; BIODEGRADATION; DEGRADATION; DYES; THERMOSTABILITY	Laccases are versatile biocatalysts for the bioremediation of various xenobiotics, including dyes and polyaromatic hydrocarbons. However, current sources of new enzymes, simple heterologous expression hosts and enzymatic information (such as the appropriateness of common screening substrates on laccase engineering) remain scarce to support efficient engineering of laccase for better "green'' applications. To address the issue, this study began with cloning the laccase family of Lentinula edodes. Three laccases perfectio sensu stricto (Lcc4A, Lcc5, and Lcc7) were then expressed from Pichia pastoris, characterized and compared with the previously reported Lcc1A and Lcc1B in terms of kinetics, stability, and degradation of dyes and polyaromatic hydrocarbons. Lcc7 represented a novel laccase, and it exhibited both the highest catalytic efficiency (assayed with 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) [ABTS]) and thermostability. However, its performance on "green'' applications surprisingly did not match the activity on the common screening substrates, namely, ABTS and 2,6-dimethoxyphenol. On the other hand, correlation analyses revealed that guaiacol is much better associated with the decolorization of multiple structurally different dyes than are the two common screening substrates. Comparison of the oxidation chemistry of guaiacol and phenolic dyes, such as azo dyes, further showed that they both involve generation of phenoxyl radicals in laccase-catalyzed oxidation. In summary, this study concluded a robust expression platform of L. edodes laccases, novel laccases, and an indicative screening substrate, guaiacol, which are all essential fundamentals for appropriately driving the engineering of laccases towards more efficient "green'' applications.	[Wong, Kin-Sing; Cheung, Man-Kit; Au, Chun-Hang; Kwan, Hoi-Shan] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Kwan, HS (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	hoishankwan@cuhk.edu.hk	Cheung, Man Kit/E-5696-2012; Kwan, Hoi Shan/GOV-6863-2022; Cheung, Man Kit/M-6972-2019	Cheung, Man Kit/0000-0002-2764-2113; Cheung, Man Kit/0000-0002-2764-2113; Kwan, Hoi Shan/0000-0002-7943-2513	Innovation & Technology Fund in Hong Kong [ITS/047/08]; GeneHarbor (Hong Kong) Technologies Limited [ITS/047/08]; Research Grants Council of Hong Kong [CUHK467810]	Innovation & Technology Fund in Hong Kong; GeneHarbor (Hong Kong) Technologies Limited; Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by Innovation & Technology Fund in Hong Kong (ITS/047/08; http://www.itf.gov.hk/) and GeneHarbor (Hong Kong) Technologies Limited (ITS/047/08; http://www.geneharbortech.com/), and was partially supported by the Research Grants Council of Hong Kong (CUHK467810; http://www.ugc.edu.hk/eng/rgc/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcalde M, 2002, J BIOMOL SCREEN, V7, P547, DOI 10.1177/1087057102238629; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Bertrand T, 2002, BIOCHEMISTRY-US, V41, P7325, DOI 10.1021/bi0201318; Call HP, 1997, J BIOTECHNOL, V53, P163, DOI 10.1016/S0168-1656(97)01683-0; Camarero S, 2012, APPL ENVIRON MICROB, V78, P1370, DOI 10.1128/AEM.07530-11; Campos R, 2001, J BIOTECHNOL, V89, P131, DOI 10.1016/S0168-1656(01)00303-0; Canas AI, 2010, BIOTECHNOL ADV, V28, P694, DOI 10.1016/j.biotechadv.2010.05.002; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chhabra M, 2009, J BIOTECHNOL, V143, P69, DOI 10.1016/j.jbiotec.2009.06.011; CHIVUKULA M, 1995, APPL ENVIRON MICROB, V61, P4374, DOI 10.1128/AEM.61.12.4374-4377.1995; Daly R, 2005, J MOL RECOGNIT, V18, P119, DOI 10.1002/jmr.687; Doerge DR, 1997, ANAL BIOCHEM, V250, P10, DOI 10.1006/abio.1997.2191; Enguita FJ, 2003, J BIOL CHEM, V278, P19416, DOI 10.1074/jbc.M301251200; Farinas ET, 2001, CURR OPIN BIOTECH, V12, P545, DOI 10.1016/S0958-1669(01)00261-0; Festa G, 2008, PROTEINS, V72, P25, DOI 10.1002/prot.21889; Garcia-Ruiz E, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-17; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hadibarata T, 2012, WATER AIR SOIL POLL, V223, P933, DOI 10.1007/s11270-011-0914-6; Haritash AK, 2009, J HAZARD MATER, V169, P1, DOI 10.1016/j.jhazmat.2009.03.137; Hilden K, 2009, BIOTECHNOL LETT, V31, P1117, DOI 10.1007/s10529-009-9998-0; Hoegger PJ, 2006, FEBS J, V273, P2308, DOI 10.1111/j.1742-4658.2006.05247.x; Hu XK, 2009, BIORESOURCE TECHNOL, V100, P4963, DOI 10.1016/j.biortech.2009.03.089; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kimata K, 2012, J BIOSCI BIOENG, V113, P154, DOI 10.1016/j.jbiosc.2011.10.007; Kumar SVS, 2003, BIOTECHNOL BIOENG, V83, P386, DOI 10.1002/bit.10681; Levasseur A, 2008, FUNGAL GENET BIOL, V45, P638, DOI 10.1016/j.fgb.2008.01.004; Li KC, 1999, APPL ENVIRON MICROB, V65, P2654; Majeau JA, 2010, BIORESOURCE TECHNOL, V101, P2331, DOI 10.1016/j.biortech.2009.10.087; Mate D, 2010, CHEM BIOL, V17, P1030, DOI 10.1016/j.chembiol.2010.07.010; Miele A, 2010, MOL BIOTECHNOL, V46, P149, DOI 10.1007/s12033-010-9289-y; Nagai M, 2003, MICROBIOL-SGM, V149, P2455, DOI 10.1099/mic.0.26414-0; Nagai M, 2002, APPL MICROBIOL BIOT, V60, P327, DOI 10.1007/s00253-002-1109-2; Pardo I, 2012, BIOTECHNOL BIOENG, V109, P2978, DOI 10.1002/bit.24588; Pereira L, 2009, ADV SYNTH CATAL, V351, P1857, DOI 10.1002/adsc.200900271; Piontek K, 2002, J BIOL CHEM, V277, P37663, DOI 10.1074/jbc.M204571200; Piscitelli Alessandra, 2010, Bioeng Bugs, V1, P252, DOI 10.4161/bbug.1.4.11438; Riva S, 2006, TRENDS BIOTECHNOL, V24, P219, DOI 10.1016/j.tibtech.2006.03.006; Rodgers CJ, 2010, TRENDS BIOTECHNOL, V28, P63, DOI 10.1016/j.tibtech.2009.11.001; Sakamoto Y, 2008, APPL MICROBIOL BIOT, V79, P971, DOI 10.1007/s00253-008-1507-1; Simmons KE, 1987, ENVIRON SCI TECHNOL, V23, P115; SRINIVASAN C, 1995, APPL ENVIRON MICROB, V61, P4274, DOI 10.1128/AEM.61.12.4274-4277.1995; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; Strong PJ, 2011, CRIT REV ENV SCI TEC, V41, P373, DOI 10.1080/10643380902945706; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tilli S, 2011, ENZYME MICROB TECH, V49, P465, DOI 10.1016/j.enzmictec.2011.08.002; Wong KS, 2012, BIORESOURCE TECHNOL, V104, P157, DOI 10.1016/j.biortech.2011.10.097; Xu F, 2000, APPL ENVIRON MICROB, V66, P2052, DOI 10.1128/AEM.66.5.2052-2056.2000; Yano A, 2009, MICROBIOL RES, V164, P642, DOI 10.1016/j.micres.2008.12.001; Zhao D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038817; Zhao J, 1999, APPL ENVIRON MICROB, V65, P4908	51	24	27	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66426	10.1371/journal.pone.0066426	http://dx.doi.org/10.1371/journal.pone.0066426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799101	gold, Green Published, Green Submitted			2022-12-25	WOS:000320363300080
J	Wu, CW; Ivanova, E; Zhang, Y; Pan, ZH				Wu, Chaowen; Ivanova, Elena; Zhang, Yi; Pan, Zhuo-Hua			rAAV-Mediated Subcellular Targeting of Optogenetic Tools in Retinal Ganglion Cells In Vivo	PLOS ONE			English	Article							RESTORES VISUAL RESPONSES; ECTOPIC EXPRESSION; PHOTORECEPTOR DEGENERATION; CONGENITAL AMAUROSIS; HIPPOCAMPAL-NEURONS; MAMMALIAN RETINA; GENE-TRANSFER; DENDRITES; CHANNELS; RESTORATION	Expression of optogenetic tools in surviving inner retinal neurons to impart retinal light sensitivity has been a new strategy for restoring vision after photoreceptor degeneration. One potential approach for restoring retinal light sensitivity after photoreceptor degeneration is to express optogenetic tools in retinal ganglion cells (RGCs). For this approach, restoration of ON and OFF center-surround receptive fields in RGCs, a key feature of visual information processing, may be important. A possible solution is to differentially express depolarizing and hyperpolarizing optogenetic tools, such as channelrhodopsin-2 and halorhodopsin, to the center and peripheral regions of the RGC dendritic field by using protein targeting motifs. Recombinant adeno-associated virus (rAAV) vectors have proven to be a powerful vehicle for in vitro and in vivo gene delivery, including in the retina. Therefore, the search for protein targeting motifs that can achieve rAAV-mediated subcellular targeted expression would be particularly valuable for developing therapeutic applications. In this study, we identified two protein motifs that are suitable for rAAV-mediated subcellular targeting for generating center-surround receptive fields while reducing the axonal expression in RGCs. Resulting morphological dendritic field and physiological response field by center-targeting were significantly smaller than those produced by surround-targeting. rAAV motif-mediated protein targeting could also be a valuable tool for studying physiological function and clinical applications in other areas of the central nervous system.	[Wu, Chaowen; Ivanova, Elena; Zhang, Yi; Pan, Zhuo-Hua] Wayne State Univ, Sch Med, Dept Anat Cell Biol, Detroit, MI 48202 USA; [Pan, Zhuo-Hua] Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI USA	Wayne State University; Wayne State University	Pan, ZH (corresponding author), Wayne State Univ, Sch Med, Dept Anat Cell Biol, Detroit, MI 48202 USA.	zhpan@med.wayne.edu			NIH [EY17130]; Wayne State University (WSU);  [EY04068]; NATIONAL EYE INSTITUTE [R01EY017130, P30EY004068] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wayne State University (WSU); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grant EY17130 (Z.-H. P.), the Wayne State University (WSU) MD/PhD program (C. W.), and core grant EY04068 to Department of Anatomy and Cell Biology at Wayne State University, the Ligon Research Center of Vision, and Research to Prevent Blindness to Department of Ophthalmology at Wayne State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P299, DOI 10.1113/jphysiol.1978.sp012234; Caporale N, 2011, MOL THER, V19, P1212, DOI 10.1038/mt.2011.103; Chow BY, 2012, PROG BRAIN RES, V196, P49, DOI 10.1016/B978-0-444-59426-6.00003-3; Doroudchi MM, 2011, MOL THER, V19, P1220, DOI 10.1038/mt.2011.69; Flotte TR, 2004, GENE THER, V11, P805, DOI 10.1038/sj.gt.3302233; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Geething NC, 2007, J BIOL CHEM, V282, P21518, DOI 10.1074/jbc.M701932200; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Greenberg KP, 2011, NEURON, V69, P713, DOI 10.1016/j.neuron.2011.01.024; Grubb MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013761; Ivanova E, 2010, NEUROSCIENCE, V165, P233, DOI 10.1016/j.neuroscience.2009.10.021; Ivanova E, 2013, J COMP NEUROL, V521, P2165, DOI 10.1002/cne.23279; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Lewis TL, 2009, NAT NEUROSCI, V12, P568, DOI 10.1038/nn.2318; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; MANGEL SC, 1991, J PHYSIOL-LONDON, V442, P211, DOI 10.1113/jphysiol.1991.sp018790; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Mitsui S, 2005, J NEUROSCI, V25, P1122, DOI 10.1523/JNEUROSCI.3853-04.2005; PEICHL L, 1979, J PHYSIOL-LONDON, V291, P117, DOI 10.1113/jphysiol.1979.sp012803; Polosukhina A, 2012, NEURON, V75, P271, DOI 10.1016/j.neuron.2012.05.022; Prigge M, 2012, J BIOL CHEM, V287, P31804, DOI 10.1074/jbc.M112.391185; Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020; Rosales CR, 2005, EUR J NEUROSCI, V22, P2381, DOI 10.1111/j.1460-9568.2005.04400.x; Ruberti F, 2000, J NEUROSCI, V20, part. no.; Sucrace E, 2003, PROG RETIN EYE RES, V22, P705; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Tomita H, 2007, INVEST OPHTH VIS SCI, V48, P3821, DOI 10.1167/iovs.06-1501; Tomita H, 2010, EXP EYE RES, V90, P429, DOI 10.1016/j.exer.2009.12.006; Van Wart A, 2006, J NEUROSCI, V26, P7172, DOI 10.1523/JNEUROSCI.1101-06.2006; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WERBLIN FS, 1972, SCIENCE, V175, P1008, DOI 10.1126/science.175.4025.1008; Xu J, 2006, J NEUROSCI, V26, P9780, DOI 10.1523/JNEUROSCI.0840-06.2006; Zhang Y, 2009, J NEUROSCI, V29, P9186, DOI 10.1523/JNEUROSCI.0184-09.2009	42	44	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66332	10.1371/journal.pone.0066332	http://dx.doi.org/10.1371/journal.pone.0066332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799092	gold, Green Published, Green Submitted			2022-12-25	WOS:000320363300076
J	Barik, S; Banerjee, S; Mallick, A; Goswami, KK; Roy, S; Bose, A; Baral, R				Barik, Subhasis; Banerjee, Saptak; Mallick, Atanu; Goswami, Kuntal Kanti; Roy, Soumyabrata; Bose, Anamika; Baral, Rathindranath			Normalization of Tumor Microenvironment by Neem Leaf Glycoprotein Potentiates Effector T Cell Functions and Therapeutically Intervenes in the Growth of Mouse Sarcoma	PLOS ONE			English	Article							MURINE EHRLICH CARCINOMA; AZADIRACHTA-INDICA; DENDRITIC CELLS; B16 MELANOMA; ADOPTIVE IMMUNOTHERAPY; ANTIGEN PRESENTATION; IMMUNE-RESPONSES; NK CELLS; CANCER; INHIBITION	We have observed restriction of the murine sarcoma growth by therapeutic intervention of neem leaf glycoprotein (NLGP). In order to evaluate the mechanism of tumor growth restriction, here, we have analyzed tumor microenvironment (TME) from sarcoma bearing mice with NLGP therapy (NLGP-TME, in comparison to PBS-TME). Analysis of cytokine milieu within TME revealed IL-10, TGF beta, IL-6 rich type 2 characters was switched to type 1 microenvironment with dominance of IFN gamma secretion within NLGP-TME. Proportion of CD8(+) T cells was increased within NLGP-TME and these T cells were protected from TME-induced anergy by NLGP, as indicated by higher expression of rho NFAT and inhibit related downstream signaling. Moreover, low expression of FasR(+) cells within CD8(+) T cell population denotes prevention from activation induced cell death. Using CFSE as a probe, better migration of T cells was noted within TME from NLGP treated mice than PBS cohort. CD8(+) T cells isolated from NLGP-TME exhibited greater cytotoxicity to sarcoma cells in vitro and these cells show higher expression of cytotoxicity related molecules, perforin and granzyme B. Adoptive transfer of NLGP-TME exposed T cells, but not PBS-TME exposed cells in mice, is able to significantly inhibit the growth of sarcoma in vivo. Such tumor growth inhibition by NLGP-TME exposed T cells was not observed when mice were depleted for CD8(+) T cells. Accumulated evidences strongly suggest NLGP mediated normalization of TME allows T cells to perform optimally to inhibit the tumor growth.	[Barik, Subhasis; Banerjee, Saptak; Mallick, Atanu; Goswami, Kuntal Kanti; Roy, Soumyabrata; Baral, Rathindranath] CNCI, Dept Immunoregulat & Immunodiagnost, Kolkata, India; [Bose, Anamika] CIT Scheme, Bose Inst, Dept Mol Med, Kolkata, India	Department of Science & Technology (India); Bose Institute	Baral, R (corresponding author), CNCI, Dept Immunoregulat & Immunodiagnost, Kolkata, India.	baralrathin@hotmail.com	Banerjee, Dr Saptak/HDO-6987-2022	Banerjee, Dr Saptak/0000-0001-9211-2074; Barik, Subhasis/0000-0002-0488-0434	Council of Scientific and Industrial Research, New Delhi [09/030(0063)/2011-EMR-I, 09/030(0050)/2008-EMR-I, 8463A, 37(1524)/12/EMR-II]; Indian Council of Medical Research, New Delhi [59/6/2011/BMS/TRM]	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	This work was partially supported by Council of Scientific and Industrial Research, New Delhi, Grant 09/030(0063)/2011-EMR-I to S Barik, 09/030(0050)/2008-EMR-I to S Banerjee, Scientists's Pool Scheme No: 8463A to AB, 37(1524)/12/EMR-II and Indian Council of Medical Research, New Delhi, Grant- 59/6/2011/BMS/TRM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JL, 1967, TECHNIQUES PROTEIN C, P340; Baral R, 2005, INT IMMUNOPHARMACOL, V5, P1343, DOI 10.1016/j.intimp.2005.03.008; Baral R, 2004, INT IMMUNOPHARMACOL, V4, P355, DOI 10.1016/j.intimp.2003.09.006; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Biswas K, 2002, CURR SCI INDIA, V82, P1336; Bose A, 2009, HUM IMMUNOL, V70, P6, DOI 10.1016/j.humimm.2008.09.004; Bose A, 2009, J IMMUNOTHER, V32, P42, DOI 10.1097/CJI.0b013e31818e997d; Chakraborty K, 2008, INT IMMUNOPHARMACOL, V8, P330, DOI 10.1016/j.intimp.2007.10.015; Chakraborty K, 2010, CELL MOL IMMUNOL, V7, P396, DOI 10.1038/cmi.2010.29; Chakraborty T, 2011, IMMUNOTHERAPY-UK, V3, P949, DOI [10.2217/IMT.11.81, 10.2217/imt.11.81]; Ebert LA, 2005, MOL IMMUNOL, V42, P799, DOI 10.1016/j.molimm.2004.06.040; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; FUJIWARA T, 1982, CHEM PHARM BULL, V30, P4025; Goswami S, 2010, VACCINE, V28, P1241, DOI 10.1016/j.vaccine.2009.11.018; Haque E, 2006, IMMUNOBIOLOGY, V211, P721, DOI 10.1016/j.imbio.2006.02.005; Hayashi RJ, 1998, J IMMUNOL, V160, P33; Hinrichs CS, 2008, BLOOD, V111, P5326, DOI 10.1182/blood-2007-09-113050; KERBEL RS, 1991, BIOESSAYS, V13, P31, DOI 10.1002/bies.950130106; Komita H, 2008, CANC RES; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Lu B, 2008, CELL DEATH DIFFER, V15, P70, DOI 10.1038/sj.cdd.4402274; Mallick A, 2013, PLOS ONE, V8; Mallick A, 2013, INT IMMUNOPHARMACOL, V15, P73, DOI 10.1016/j.intimp.2012.11.006; Mbeunkui F, 2009, CANCER CHEMOTH PHARM, V63, P571, DOI 10.1007/s00280-008-0881-9; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Paul R, 2011, CANCER BIOL THER, V12, P467, DOI 10.4161/cbt.12.6.16850; Prager GW, 2012, TRANSL LUNG CANCER R, V1, P14, DOI 10.3978/j.issn.2218-6751.2011.11.02; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; ROSENBERG SA, 1986, SCIENCE, V233, P1318, DOI 10.1126/science.3489291; Sarkar K, 2008, VACCINE, V26, P4352, DOI 10.1016/j.vaccine.2008.06.048; Sarkar K, 2010, INT IMMUNOPHARMACOL, V10, P865, DOI 10.1016/j.intimp.2010.04.024; Sarkar K, 2009, INT IMMUNOPHARMACOL, V9, P753, DOI 10.1016/j.intimp.2009.02.016; Stadler WM, 1998, J CLIN ONCOL, V16, P1820, DOI 10.1200/JCO.1998.16.5.1820; Whiteside TL, 2006, SEMIN CANCER BIOL, V16, P3, DOI 10.1016/j.semcancer.2005.07.008; Witz IP, 2009, CANCER MICROENVIRON, V2, pS9, DOI 10.1007/s12307-009-0025-8; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Xu L, 2010, CLIN IMMUNOL, V135, P466, DOI 10.1016/j.clim.2010.01.014; Yamanaka R, 2003, BRIT J CANCER, V89, P1172, DOI 10.1038/sj.bjc.6601268; Yu JY, 2009, INT J BIOL SCI, V5, P135; Zamarron BF, 2011, INT J BIOL SCI, V7, P651, DOI 10.7150/ijbs.7.651; Zheng Y, 2008, EMBO REP, V9, P50, DOI 10.1038/sj.embor.7401138	41	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66501	10.1371/journal.pone.0066501	http://dx.doi.org/10.1371/journal.pone.0066501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785504	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800017
J	Bottos, KM; Oliveira, AG; Bersanetti, PA; Nogueira, RF; Lima, AAS; Cardillo, JA; Schor, P; Chamon, W				Bottos, Katia M.; Oliveira, Anselmo G.; Bersanetti, Patricia A.; Nogueira, Regina F.; Lima-Filho, Acacio A. S.; Cardillo, Jose A.; Schor, Paulo; Chamon, Wallace			Corneal Absorption of a New Riboflavin-Nanostructured System for Transepithelial Collagen Cross-Linking	PLOS ONE			English	Article							ULTRAVIOLET-A; BENZALKONIUM CHLORIDE; OCULAR SURFACE; CONTACT-LENS; IN-VITRO; KERATITIS; MICROEMULSIONS; NANOEMULSIONS; BACTERIAL; PORCINE	Corneal collagen cross-linking (CXL) has been described as a promising therapy for keratoconus. According to standard CXL protocol, epithelium should be debrided before treatment to allow penetration of riboflavin into the corneal stroma. However, removal of the epithelium can increase procedure risks. In this study we aim to evaluate stromal penetration of a biocompatible riboflavin-based nanoemulsion system (riboflavin-5-phosphate and riboflavin-base) in rabbit corneas with intact epithelium. Two riboflavin nanoemulsions were developed. Transmittance and absorption coefficient were measured on corneas with intact epithelia after 30, 60, 120, 180, and 240 minutes following exposure to either the nanoemulsions or standard 0.1% or 1% riboflavin-dextran solutions. For the nanoemulsions, the epithelium was removed after measurements to assure that the riboflavin had passed through the hydrophobic epithelium and retained within the stroma. Results were compared to de-epithelialized corneas exposed to 0.1% riboflavin solution and to the same riboflavin nanoemulsions for 30 minutes (standard protocol). Mean transmittance and absorption measured in epithelialized corneas receiving the standard 0.1% riboflavin solution did not reach the levels found on the debrided corneas using the standard technique. Neither increasing the time of exposure nor the concentration of the riboflavin solution from 0.1% to 1% improved riboflavin penetration through the epithelium. When using riboflavin-5-phosphate nanoemulsion for 240 minutes, we found no difference between the mean absorption coefficients to the standard cross-linking protocol (p = 0.54). Riboflavin nanoemulsion was able to penetrate the corneal epithelium, achieving, after 240 minutes, greater stromal concentration when compared to debrided corneas with the standard protocol (p = 0.002). The riboflavin-5-phosphate nanoemulsion diffused better into the stroma than the riboflavin-base nanoemulsion.	[Bottos, Katia M.; Lima-Filho, Acacio A. S.; Cardillo, Jose A.; Schor, Paulo; Chamon, Wallace] Fed Univ Sao Paulo UNIFESP, Paulista Sch Med, Dept Ophthalmol, Sao Paulo, Brazil; [Oliveira, Anselmo G.] Sao Paulo State Univ, UNESP, Sch Pharmaceut Sci, Dept Pharmaceut, Araraquara, SP, Brazil; [Bersanetti, Patricia A.; Nogueira, Regina F.] Fed Univ Sao Paulo UNIFESP, Paulista Sch Med, Dept Ophthalmol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP)	Bersanetti, PA (corresponding author), Fed Univ Sao Paulo UNIFESP, Paulista Sch Med, Dept Ophthalmol, Sao Paulo, Brazil.	bersanetti@unifesp.br	Oliveira, Anselmo/B-8284-2013; Chamon, Wallace/A-5400-2010; de Souza Lima Filho, Acácio Alves/C-7189-2012; Bersanetti, Patrícia A/B-9703-2012; Schor, Paulo/C-6555-2012	Oliveira, Anselmo/0000-0002-0107-9940; Chamon, Wallace/0000-0002-2528-0526; de Souza Lima Filho, Acácio Alves/0000-0003-1802-9592; Bersanetti, Patrícia A/0000-0002-9262-2151; Schor, Paulo/0000-0002-3999-4706; Cardillo, Jose Augusto/0000-0002-5791-3201	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [BEX 1325-09-4]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported in part by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) BEX 1325-09-4. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar DA, 2010, ADV THER, V27, P837, DOI 10.1007/s12325-010-0070-1; Ammar HO, 2009, AAPS PHARMSCITECH, V10, P808, DOI 10.1208/s12249-009-9268-4; Badawi AA, 2008, ARCH PHARM RES, V31, P1040, DOI 10.1007/s12272-001-1266-6; Baiocchi S, 2009, J CATARACT REFR SURG, V35, P893, DOI 10.1016/j.jcrs.2009.01.009; Bottos KM, 2008, J REFRACT SURG, V24, pS715, DOI 10.3928/1081597X-20080901-14; Bottos KM, 2011, ARQ BRAS OFTALMOL, V74, P348, DOI 10.1590/S0004-27492011000500008; Calvo P, 1996, J PHARM SCI, V85, P530, DOI 10.1021/js950474+; Caporossi A, 2012, EUR J OPHTHALMOL, V22, pS81, DOI 10.5301/ejo.5000125; Chan CCK, 2007, J CATARACT REFR SURG, V33, P75, DOI 10.1016/j.jcrs.2006.09.012; Formariz TP, 2008, COLLOID SURFACE B, V63, P287, DOI 10.1016/j.colsurfb.2007.12.021; Formariz TP, 2010, COLLOID SURFACE B, V77, P47, DOI 10.1016/j.colsurfb.2010.01.004; Franzini CM, 2012, J BIOMED NANOTECHNOL, V8, P350, DOI 10.1166/jbn.2012.1435; Goldich Y, 2010, CORNEA, V29, P409, DOI 10.1097/ICO.0b013e3181bd9f8c; Hayes S, 2008, J CATARACT REFR SURG, V34, P657, DOI 10.1016/j.jcrs.2008.02.002; Jankov MR, 2008, ARQ BRAS OFTALMOL, V71, P813, DOI 10.1590/S0004-27492008000600009; Kanellopoulos AJ, 2009, J REFRACT SURG, V25, P1034, DOI 10.3928/1081597X-20090901-02; Kim JR, 2011, JPN J OPHTHALMOL, V55, P283, DOI 10.1007/s10384-011-0008-4; Kolozsvari L, 2002, INVEST OPHTH VIS SCI, V43, P2165; Koppen C, 2010, EYE CONTACT LENS, V36, P77, DOI 10.1097/ICL.0b013e3181d0b74b; Krueger RR, 2008, J REFRACT SURG, V24, pS730, DOI 10.3928/1081597X-20080901-17; Kymionis GD, 2007, J CATARACT REFR SURG, V33, P2135, DOI 10.1016/j.jcrs.2007.06.070; Kymionis GD, 2007, J CATARACT REFR SURG, V33, P1982, DOI 10.1016/j.jcrs.2007.06.036; Leccisotti A, 2010, J REFRACT SURG, V26, P942, DOI 10.3928/1081597X-20100212-09; Loch C, 2012, EUR J PHARM SCI, V47, P131, DOI 10.1016/j.ejps.2012.05.007; Martins SAR, 2008, INVEST OPHTH VIS SCI, V49, P3402, DOI 10.1167/iovs.07-1592; Mason TG, 2006, J PHYS-CONDENS MAT, V18, pR635, DOI 10.1088/0953-8984/18/41/R01; Morrison PWJ, 2013, MOL PHARMACEUT, V10, P756, DOI 10.1021/mp3005963; Oliveira AG, 2010, COLLOID SURFACE B, V79, P372, DOI 10.1016/j.colsurfb.2010.04.020; OLIVEIRA AG, 1991, J PHYS ORG CHEM, V4, P19, DOI 10.1002/poc.610040105; Paganelli F, 2010, EXPERT OPIN DRUG DEL, V7, P955, DOI 10.1517/17425247.2010.498817; Pestana KC, 2008, COLLOID SURFACE B, V66, P253, DOI 10.1016/j.colsurfb.2008.06.016; Pollhammer M, 2009, J CATARACT REFR SURG, V35, P588, DOI 10.1016/j.jcrs.2008.09.029; Rama P, 2009, J CATARACT REFR SURG, V35, P788, DOI 10.1016/j.jcrs.2008.09.035; Samaras K, 2009, J REFRACT SURG, V25, P771, DOI 10.3928/1081597X-20090813-03; Sarkar J, 2012, INVEST OPHTH VIS SCI, V53, P1792, DOI 10.1167/iovs.11-8775; Shigeyasu C, 2012, CORNEA, V31, P59, DOI 10.1097/ICO.0b013e318218237e; Spoerl E, 2007, CORNEA, V26, P385, DOI 10.1097/ICO.0b013e3180334f78; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1; Wollensak G, 2010, J CATARACT REFR SURG, V36, P114, DOI 10.1016/j.jcrs.2009.07.044; Wollensak G, 2009, J CATARACT REFR SURG, V35, P540, DOI 10.1016/j.jcrs.2008.11.036; Zamora KV, 2009, CORNEA, V28, P474, DOI 10.1097/ICO.0b013e31818d381a; Zhang YT, 2012, INVEST OPHTH VIS SCI, V53, P2620, DOI 10.1167/iovs.12-9537	42	34	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66408	10.1371/journal.pone.0066408	http://dx.doi.org/10.1371/journal.pone.0066408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785497	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800025
J	Briet, OJT; Amerasinghe, PH; Vounatsou, P				Briet, Olivier J. T.; Amerasinghe, Priyanie H.; Vounatsou, Penelope			Generalized Seasonal Autoregressive Integrated Moving Average Models for Count Data with Application to Malaria Time Series with Low Case Numbers	PLOS ONE			English	Article							POISSON REGRESSION; DISEASE; PREDICTION; RISK	Introduction: With the renewed drive towards malaria elimination, there is a need for improved surveillance tools. While time series analysis is an important tool for surveillance, prediction and for measuring interventions' impact, approximations by commonly used Gaussian methods are prone to inaccuracies when case counts are low. Therefore, statistical methods appropriate for count data are required, especially during "consolidation" and "pre-elimination" phases. Methods: Generalized autoregressive moving average (GARMA) models were extended to generalized seasonal autoregressive integrated moving average (GSARIMA) models for parsimonious observation-driven modelling of non Gaussian, non stationary and/or seasonal time series of count data. The models were applied to monthly malaria case time series in a district in Sri Lanka, where malaria has decreased dramatically in recent years. Results: The malaria series showed long-term changes in the mean, unstable variance and seasonality. After fitting negative-binomial Bayesian models, both a GSARIMA and a GARIMA deterministic seasonality model were selected based on different criteria. Posterior predictive distributions indicated that negative-binomial models provided better predictions than Gaussian models, especially when counts were low. The G(S)ARIMA models were able to capture the autocorrelation in the series. Conclusions: G(S)ARIMA models may be particularly useful in the drive towards malaria elimination, since episode count series are often seasonal and non-stationary, especially when control is increased. Although building and fitting GSARIMA models is laborious, they may provide more realistic prediction distributions than do Gaussian methods and may be more suitable when counts are low.	[Briet, Olivier J. T.] Int Water Management Inst, Colombo, Sri Lanka; [Briet, Olivier J. T.; Vounatsou, Penelope] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Briet, Olivier J. T.; Vounatsou, Penelope] Univ Basel, Basel, Switzerland; [Amerasinghe, Priyanie H.] Int Water Management Inst, Sub Reg Off South Asia, Patancheru, Andhra Pradesh, India	CGIAR; International Water Management Institute (IWMI); University of Basel; Swiss Tropical & Public Health Institute; University of Basel; CGIAR; International Water Management Institute (IWMI)	Briet, OJT (corresponding author), Int Water Management Inst, Colombo, Sri Lanka.	olivier.briet@unibas.ch	Briët, Olivier/K-1917-2015	Briët, Olivier/0000-0003-1186-2688; Vounatsou, Penelope/0000-0002-4904-5352	National Oceanic and Atmospheric Administration (NOAA); National Science Foundation (NSF); Environmental Protection Agency (EPA); Electric Power Research Institute (EPRI) Joint Program on Climate Variability and Human Health	National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Environmental Protection Agency (EPA)(United States Environmental Protection Agency); Electric Power Research Institute (EPRI) Joint Program on Climate Variability and Human Health	This study was funded through the National Oceanic and Atmospheric Administration (NOAA), National Science Foundation (NSF), Environmental Protection Agency (EPA) and Electric Power Research Institute (EPRI) Joint Program on Climate Variability and Human Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALZAID AA, 1993, ANN I STAT MATH, V45, P223, DOI 10.1007/BF00775809; [Anonymous], 2000, MALARIA SRI LANKA CU; Benjamin MA, 2003, J AM STAT ASSOC, V98, P214, DOI 10.1198/016214503388619238; BERNARDINELLI L, 1995, STAT MED, V14, P2433, DOI 10.1002/sim.4780142112; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Briet O. J. T., 2006, Malaria Journal, V5; Briet Olivier J T, 2008, Malar J, V7, P77, DOI 10.1186/1475-2875-7-77; Briet OJT, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-76; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Chen Y., 2002, ECON BULL, V3, P1; Chris Chatfield, 2004, ANAL TIME SERIES INT; COX DR, 1981, SCAND J STAT, V8, P93; Czado C, 2007, APPL STOCH MODEL BUS, V23, P1, DOI 10.1002/asmb.634; Davis RA, 2003, BIOMETRIKA, V90, P777, DOI 10.1093/biomet/90.4.777; Dunn KP, 1996, J COMPUTATIONAL GRAP, V5, P1, DOI DOI 10.2307/1390802; Gamerman D, 1998, BIOMETRIKA, V85, P215, DOI 10.1093/biomet/85.1.215; Gomez-Elipe A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-129; Grunwald GK, 2000, AUST NZ J STAT, V42, P479, DOI 10.1111/1467-842X.00143; Heinen, 2003, MODELLING TIME SERIE; Hu WN, 2007, ANN EPIDEMIOL, V17, P679, DOI 10.1016/j.annepidem.2007.03.020; Hu WB, 2010, OCCUP ENVIRON MED, V67, P307, DOI 10.1136/oem.2008.044966; Jackman S, 1998, TIME SERIES MODELS D; JONES MC, 1987, APPL STAT-J ROY ST C, V36, P134, DOI 10.2307/2347544; Jung RC, 2006, COMPUT STAT DATA AN, V51, P2350, DOI 10.1016/j.csda.2006.08.001; Jung RC, 2006, STAT MODEL, V6, P81, DOI 10.1191/1471082X06st114oa; KING G, 1988, AM J POLIT SCI, V32, P838, DOI 10.2307/2111248; Kleinschmidt I, 2002, AM J EPIDEMIOL, V155, P257, DOI 10.1093/aje/155.3.257; Knorr-Held L, 1998, STAT MED, V17, P2045, DOI 10.1002/(SICI)1097-0258(19980930)17:18<2045::AID-SIM943>3.0.CO;2-P; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207; Mabaso M. L. H., 2006, International Journal of Health Geographics, V5; MCKENZIE E, 1988, ADV APPL PROBAB, V20, P822, DOI 10.2307/1427362; Morina D, 2011, STAT MED, V30, P3125, DOI 10.1002/sim.4336; Nobre AA, 2005, ENVIRONMETRICS, V16, P291, DOI 10.1002/env.704; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; Ravines RR, 2006, APPL STOCH MODEL BUS, V22, P193, DOI 10.1002/asmb.628; SAID SE, 1984, BIOMETRIKA, V71, P599; Stefani A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-246; Teklehaimanot HD, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-44; Waller LA, 1997, J AM STAT ASSOC, V92, P607, DOI 10.2307/2965708; Wangdi K, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-251; West M., 2006, BAYESIAN FORECASTING; WHO, 2012, WORLD MALARIA REPORT 2012, P1; ZEGER SL, 1988, BIOMETRICS, V44, P1019, DOI 10.2307/2531732; ZEGER SL, 1988, BIOMETRIKA, V75, P621; Zinszer K, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001992	45	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65761	10.1371/journal.pone.0065761	http://dx.doi.org/10.1371/journal.pone.0065761			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785448	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800074
J	Hasegawa, A; Iwamura, C; Kitajima, M; Hashimoto, K; Otsuyama, K; Ogino, H; Nakayama, T; Shirai, M				Hasegawa, Akihiro; Iwamura, Chiaki; Kitajima, Masayuki; Hashimoto, Kahoko; Otsuyama, Ken-ichiro; Ogino, Hidetaka; Nakayama, Toshinori; Shirai, Mutsunori			Crucial Role for CD69 in the Pathogenesis of Dextran Sulphate Sodium-Induced Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ALLERGIC AIRWAY INFLAMMATION; C-X-C; ULCERATIVE-COLITIS; CROHNS-DISEASE; T-CELLS; CHEMOKINE EXPRESSION; MUCOSAL IMMUNITY; INTESTINAL INFLAMMATION; RECEPTOR EXPRESSION	CD69 is a membrane molecule transiently expressed on activated lymphocytes, and its selective expression in inflammatory infiltrates suggests that it plays a role in the pathogenesis of inflammatory diseases. In this study, we used CD69-deficient (CD69 KO) mice to assess the role of CD69 in the pathogenesis of dextran sulphate sodium (DSS)-induced acute and chronic colitis. The severity of colitis was assessed by the survival rate, clinical signs, colon length, histological examination and the expression of cytokines and chemokines in the large intestines. Both acute and chronic colitis were attenuated in the CD69 KO mice, as reflected by the lower lethality, weight loss, clinical signs, and improved histological findings. CD69(+) cells infiltrated extensively into the inflamed mucosa of the colon in WT mice after DSS treatment. Experiments with the transfer of WT CD4 T cells into CD69 KO mice restored the induction of colitis. The administration of an anti-CD69 antibody also inhibited the induction of the DSS-induced colitis. These results indicate that CD69 expressed on CD4 T cells plays an important role in the pathogenesis of DSS-induced acute and chronic colitis, and that CD69 could be a possible therapeutic target for colitis.	[Hasegawa, Akihiro; Otsuyama, Ken-ichiro; Ogino, Hidetaka; Shirai, Mutsunori] Yamaguchi Univ, Grad Sch Med, Dept Microbiol & Immunol, Ube, Yamaguchi 755, Japan; [Iwamura, Chiaki; Kitajima, Masayuki; Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan; [Hashimoto, Kahoko] Chiba Inst Technol, Dept Life & Environm Sci, Narashino, Chiba 275, Japan; [Hashimoto, Kahoko] Chiba Inst Technol, High Technol Res Ctr, Narashino, Chiba 275, Japan; [Nakayama, Toshinori] CREST, JST, Chiba, Japan	Yamaguchi University; Chiba University; Chiba Institute of Technology; Chiba Institute of Technology; Japan Science & Technology Agency (JST)	Nakayama, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan.	tnakayama@faculty.chiba-u.jp	Nakayama, Toshinori/E-1067-2017	Nakayama, Toshinori/0000-0002-1434-2007	JSPS KAKENHI (Japan) [22591093]; MEXT KAKENHI (Japan) [23111520]; Grants-in-Aid for Scientific Research [24791024] Funding Source: KAKEN	JSPS KAKENHI (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (Japan) (http://www.jsps.go.jp/english/index.html) Grant Number 22591093 and MEXT KAKENHI (Japan) (http://www.mext.go.jp/english/) Grant Number 23111520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuebor MN, 1999, J IMMUNOL, V162, P1685; Andres PG, 2000, J IMMUNOL, V164, P6303, DOI 10.4049/jimmunol.164.12.6303; Annunziato F, 1999, J LEUKOCYTE BIOL, V65, P691, DOI 10.1002/jlb.65.5.691; Aranda R, 1997, J IMMUNOL, V158, P3464; Banks C, 2003, J PATHOL, V199, P28, DOI 10.1002/path.1245; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Brandtzaeg P, 1997, SPRINGER SEMIN IMMUN, V18, P555, DOI 10.1007/BF00824058; Cobrin GM, 2005, IMMUNOL REV, V206, P277, DOI 10.1111/j.0105-2896.2005.00293.x; Cong YZ, 1998, J EXP MED, V187, P855, DOI 10.1084/jem.187.6.855; Connor SJ, 2004, GUT, V53, P1287, DOI 10.1136/gut.2003.028225; COOPER HS, 1993, LAB INVEST, V69, P238; Cruz-Adalia A, 2010, CIRCULATION, V122, P1396, DOI 10.1161/CIRCULATIONAHA.110.952820; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Esplugues E, 2005, BLOOD, V105, P4399, DOI 10.1182/blood-2004-10-3854; Esplugues E, 2003, J EXP MED, V197, P1093, DOI 10.1084/jem.20021337; Feng CG, 2002, INT IMMUNOL, V14, P535, DOI 10.1093/intimm/dxf020; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Grimm MC, 1996, GUT, V38, P90, DOI 10.1136/gut.38.1.90; Guehler SR, 1999, GASTROENTEROLOGY, V116, P327, DOI 10.1016/S0016-5085(99)70129-0; Hasegawa A, 2006, J IMMUNOL, V176, P2546, DOI 10.4049/jimmunol.176.4.2546; Jugde F, 2001, EUR CYTOKINE NETW, V12, P468; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kolios G, 1999, EUR J IMMUNOL, V29, P530, DOI 10.1002/(SICI)1521-4141(199902)29:02<530::AID-IMMU530>3.0.CO;2-Y; Maaser C, 2002, Z GASTROENTEROL, V40, P525, DOI 10.1055/s-2002-32808; Martin P, 2010, J ALLERGY CLIN IMMUN, V126, P355, DOI 10.1016/j.jaci.2010.05.010; MATSUSHIMA K, 1989, J EXP MED, V169, P1485, DOI 10.1084/jem.169.4.1485; Mazzucchelli L, 1996, J PATHOL, V178, P201, DOI 10.1002/(SICI)1096-9896(199602)178:2<201::AID-PATH440>3.0.CO;2-4; McCormack G, 2001, INFLAMM RES, V50, P491, DOI 10.1007/PL00000223; McKay DM, 1999, CAN J GASTROENTEROL, V13, P509, DOI 10.1155/1999/680206; Miki-Hosokawa T, 2009, J IMMUNOL, V183, P8203, DOI 10.4049/jimmunol.0900646; Murata K, 2003, INT IMMUNOL, V15, P987, DOI 10.1093/intimm/dxg102; NAKAYAMA T, 1990, SCIENCE, V249, P1558, DOI 10.1126/science.2120773; Nakayama T, 2002, J IMMUNOL, V168, P87, DOI 10.4049/jimmunol.168.1.87; Nigo YI, 2006, P NATL ACAD SCI USA, V103, P2286, DOI 10.1073/pnas.0510685103; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Radulovic K, 2012, J IMMUNOL, V188, P2001, DOI 10.4049/jimmunol.1100765; REINECKER HC, 1993, CLIN EXP IMMUNOL, V94, P174; Sancho D, 2003, J CLIN INVEST, V112, P872, DOI 10.1172/JCI200319112; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Sartor RB, 1997, RES IMMUNOL, V148, P567, DOI 10.1016/S0923-2494(98)80151-X; Schrum S, 1996, J IMMUNOL, V157, P3598; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Targan SR, 2005, IMMUNOL REV, V206, P296, DOI 10.1111/j.0105-2896.2005.00286.x; TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7; Tsuchiya T, 2003, J IMMUNOL, V171, P5507, DOI 10.4049/jimmunol.171.10.5507; Uguccioni M, 1999, AM J PATHOL, V155, P331, DOI 10.1016/S0002-9440(10)65128-0; Yamashita M, 1999, P NATL ACAD SCI USA, V96, P1024, DOI 10.1073/pnas.96.3.1024; Yang SK, 1997, GASTROENTEROLOGY, V113, P1214, DOI 10.1053/gast.1997.v113.pm9322516; ZIEGLER SF, 1993, EUR J IMMUNOL, V23, P1643, DOI 10.1002/eji.1830230737	52	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65494	10.1371/journal.pone.0065494	http://dx.doi.org/10.1371/journal.pone.0065494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785429	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800092
J	Rosty, C; Young, JP; Walsh, MD; Clendenning, M; Sanderson, K; Walters, RJ; Parry, S; Jenkins, MA; Win, AK; Southey, MC; Hopper, JL; Giles, GG; Williamson, EJ; English, DR; Buchanan, DD				Rosty, Christophe; Young, Joanne P.; Walsh, Michael D.; Clendenning, Mark; Sanderson, Kristy; Walters, Rhiannon J.; Parry, Susan; Jenkins, Mark A.; Win, Aung Ko; Southey, Melissa C.; Hopper, John L.; Giles, Graham G.; Williamson, Elizabeth J.; English, Dallas R.; Buchanan, Daniel D.			PIK3CA Activating Mutation in Colorectal Carcinoma: Associations with Molecular Features and Survival	PLOS ONE			English	Article							RECEPTOR INHIBITOR CETUXIMAB; ISLAND METHYLATOR PHENOTYPE; BRAF V600E MUTATION; COLON-CANCER CELLS; POOR SURVIVAL; GROWTH; GENE; KRAS; POPULATION; PREVALENCE	Mutations in PIK3CA are present in 10 to 15% of colorectal carcinomas. We aimed to examine how PIK3CA mutations relate to other molecular alterations in colorectal carcinoma, to pathologic phenotype and survival. PIK3CA mutation testing was carried out using direct sequencing on 757 incident tumors from the Melbourne Collaborative Cohort Study. The status of O-6-methylguanine-DNA methyltransferase (MGMT) was assessed using both immunohistochemistry and methyLight techniques. Microsatellite instability, CpG island phenotype (CIMP), KRAS and BRAF V600E mutation status, and pathology review features were derived from previous reports. PIK3CA mutation was observed in 105 of 757 (14%) of carcinomas, characterized by location in the proximal colon (54% vs. 34%; P<0.001) and an increased frequency of KRAS mutation (48% vs. 25%; P<0.001). High-levels of CIMP were more frequently found in PIK3CA-mutated tumors compared with PIK3CA wildtype tumors (22% vs. 11%; P = 0.004). There was no difference in the prevalence of BRAF V600E mutation between these two tumor groups. PIK3CA-mutated tumors were associated with loss of MGMT expression (35% vs. 20%; P = 0.001) and the presence of tumor mucinous differentiation (54% vs. 32%; P<0.001). In patients with wild-type BRAF tumors, PIK3CA mutation was associated with poor survival (HR 1.51 95% CI 1.04-2.19, P = 0.03). In summary, PIK3CA-mutated colorectal carcinomas are more likely to develop in the proximal colon, to demonstrate high levels of CIMP, KRAS mutation and loss of MGMT expression. PIK3CA mutation also contributes to significantly decreased survival for patients with wild-type BRAF tumors.	[Rosty, Christophe; Young, Joanne P.; Walsh, Michael D.; Clendenning, Mark; Sanderson, Kristy; Walters, Rhiannon J.; Buchanan, Daniel D.] Queensland Inst Med Res, Canc & Populat Studies Grp, Herston, Qld 4006, Australia; [Rosty, Christophe; Young, Joanne P.] Univ Queensland, Sch Med, Herston, Qld, Australia; [Rosty, Christophe] Envoi Pathol, Herston, Qld, Australia; [Walsh, Michael D.] Sullivan & Nicolaides Pathol, Taringa, Australia; [Parry, Susan] Middlemore Hosp, Dept Gastroenterol & Hepatol, Auckland 6, New Zealand; [Parry, Susan] Auckland Hosp, New Zealand Familial Gastrointestinal Canc Serv, Auckland, New Zealand; [Jenkins, Mark A.; Win, Aung Ko; Hopper, John L.; Giles, Graham G.; Williamson, Elizabeth J.; English, Dallas R.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Parkville, Vic 3052, Australia; [Southey, Melissa C.] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Parkville, Vic 3052, Australia; [Giles, Graham G.; English, Dallas R.] Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; Auckland City Hospital; University of Melbourne; University of Melbourne; Cancer Council Victoria	Rosty, C (corresponding author), Queensland Inst Med Res, Canc & Populat Studies Grp, Bramston Terrace, Herston, Qld 4006, Australia.	c.rosty@uq.edu.au	Jenkins, Mark/P-7803-2015; Young, Joanne P/H-7774-2014; Rosty, Christophe/F-1796-2010; Win, Aung K./J-6204-2015; English, Dallas/AAH-5005-2019; Williamson, Elizabeth/H-3876-2019	Jenkins, Mark/0000-0002-8964-6160; Win, Aung K./0000-0002-2794-5261; English, Dallas/0000-0001-7828-8188; Williamson, Elizabeth/0000-0001-6905-876X; Southey, Melissa/0000-0002-6313-9005; Young, Joanne/0000-0002-1514-1522; Rosty, Christophe/0000-0001-7671-2651; Giles, Graham/0000-0003-4946-9099; Buchanan, Daniel/0000-0003-2225-6675	National Health and Medical Research Council [509348 209057]; Cancer Council Victoria	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria)	This work was supported by the National Health and Medical Research Council (509348 209057) and Cancer Council Victoria. MAJ is a NHMRC Senior Research Fellow and JLH is a NHMRC Australia Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubaker J, 2008, ONCOGENE, V27, P3539, DOI 10.1038/sj.onc.1211013; Baba Y, 2011, CANCER-AM CANCER SOC, V117, P1399, DOI 10.1002/cncr.25630; Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Benvenuti S, 2008, HUM MUTAT, V29, P284, DOI 10.1002/humu.20648; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; English DR, 2008, CANCER EPIDEM BIOMAR, V17, P1774, DOI 10.1158/1055-9965.EPI-08-0091; Furnari FB, 1998, CANCER RES, V58, P5002; Garrido-Laguna I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038033; Guo XN, 2007, CANCER RES, V67, P5851, DOI 10.1158/0008-5472.CAN-07-0049; Herreros-Villanueva M, 2011, MOL BIOL REP, V38, P1347, DOI 10.1007/s11033-010-0236-6; Hsieh LL, 2012, CLIN CHIM ACTA, V413, P1605, DOI 10.1016/j.cca.2012.04.029; Iida S, 2012, ONCOL LETT, V3, P565, DOI 10.3892/ol.2011.544; Janku F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022769; Janku F, 2011, MOL CANCER THER, V10, P558, DOI 10.1158/1535-7163.MCT-10-0994; Jehan Z, 2009, J PATHOL, V219, P337, DOI 10.1002/path.2601; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Kato S, 2007, INT J CANCER, V121, P1771, DOI 10.1002/ijc.22890; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Liao XY, 2012, CLIN CANCER RES, V18, P2257, DOI 10.1158/1078-0432.CCR-11-2410; Loboda A, 2009, CLIN PHARMACOL THER, V86, P92, DOI 10.1038/clpt.2009.48; Mao C, 2012, ANN ONCOL, V23, P1518, DOI 10.1093/annonc/mdr464; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Miyaki M, 2007, INT J CANCER, V121, P1627, DOI 10.1002/ijc.22829; Naguib A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-123; Nosho K, 2008, NEOPLASIA, V10, P534, DOI 10.1593/neo.08336; Ogino S, 2006, MODERN PATHOL, V19, P59, DOI 10.1038/modpathol.3800482; Ogino S, 2009, J CLIN ONCOL, V27, P1477, DOI 10.1200/JCO.2008.18.6544; Prenen H, 2009, CLIN CANCER RES, V15, P3184, DOI 10.1158/1078-0432.CCR-08-2961; Rosty C, 2013, MODERN PATHOL, DOI [10.1038/mod-pathol.2012.1240, DOI 10.1038/M0D-PATH0L.2012.1240]; Rosty C, 2012, AM J SURG PATHOL, V36, P876, DOI 10.1097/PAS.0b013e31824e133f; Samowitz WS, 2005, CANCER RES, V65, P6063, DOI 10.1158/0008-5472.CAN-05-0404; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sarasqueta AF, 2011, CELL ONCOL, V34, P523, DOI 10.1007/s13402-011-0054-4; Tian S, 2013, GUT, V62, P540, DOI 10.1136/gutjnl-2012-302423; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Velho S, 2005, EUR J CANCER, V41, P1649, DOI 10.1016/j.ejca.2005.04.022; Walsh MD, 2008, CLIN CANCER RES, V14, P1692, DOI 10.1158/1078-0432.CCR-07-1849; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Whitehall VLJ, 2012, INT J CANCER, V131, P813, DOI 10.1002/ijc.26440; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865; Zhao L, 2010, CELL CYCLE, V9, P596, DOI 10.4161/cc.9.3.10599	43	104	107	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65479	10.1371/journal.pone.0065479	http://dx.doi.org/10.1371/journal.pone.0065479			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785428	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000321038800093
J	Suta, D; Popelar, J; Burianova, J; Syka, J				Suta, Daniel; Popelar, Jiri; Burianova, Jana; Syka, Josef			Cortical Representation of Species-Specific Vocalizations in Guinea Pig	PLOS ONE			English	Article							PRIMARY AUDITORY-CORTEX; PHASE-LOCKED RESPONSES; MEDIAL GENICULATE-BODY; INFERIOR COLLICULUS; NEURONAL RESPONSES; PURE-TONES; AMPLITUDE; MARMOSET; THALAMUS; STIMULI	We investigated the representation of four typical guinea pig vocalizations in the auditory cortex (AI) in anesthetized guinea pigs with the aim to compare cortical data to the data already published for identical calls in subcortical structures - the inferior colliculus (IC) and medial geniculate body (MGB). Like the subcortical neurons also cortical neurons typically responded to many calls with a time-locked response to one or more temporal elements of the calls. The neuronal response patterns in the AI correlated well with the sound temporal envelope of chirp (an isolated short phrase), but correlated less well in the case of chutter and whistle (longer calls) or purr (a call with a fast repetition rate of phrases). Neuronal rate vs. characteristic frequency profiles provided only a coarse representation of the calls' frequency spectra. A comparison between the activity in the AI and those of subcortical structures showed a different transformation of the neuronal response patterns from the IC to the AI for individual calls: i) while the temporal representation of chirp remained unchanged, the representations of whistle and chutter were transformed at the thalamic level and the response to purr at the cortical level; ii) for the wideband calls (whistle, chirp) the rate representation of the call spectra was preserved in the AI and MGB at the level present in the IC, while in the case of low-frequency calls (chutter, purr), the representation was less precise in the AI and MGB than in the IC; iii) the difference in the response strength to natural and time-reversed whistle was found to be smaller in the AI than in the IC or MGB.	[Suta, Daniel; Popelar, Jiri; Burianova, Jana; Syka, Josef] Acad Sci Czech Republic, Inst Expt Med, Dept Auditory Neurosci, Prague, Czech Republic; [Suta, Daniel] Charles Univ Prague, Fac Med 3, Dept Med Biophys & Informat, Prague, Czech Republic	Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague	Suta, D (corresponding author), Acad Sci Czech Republic, Inst Expt Med, Dept Auditory Neurosci, Prague, Czech Republic.	suta@biomed.cas.cz	Svobodová Burianová, Jana/AHB-9055-2022; Syka, Josef/H-3103-2014; Popelar, Jiri/H-2558-2014; Suta, Daniel/AAL-7768-2021	Svobodová Burianová, Jana/0000-0002-8927-2381; Suta, Daniel/0000-0002-6178-7770	Grant Agency of the Czech Republic [GACR P303/12/1347, P304/12/G069]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This work was supported by research grants from Grant Agency of the Czech Republic (GACR P303/12/1347 and P304/12/G069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astl J, 1996, AUDIOLOGY, V35, P335; Barbour DL, 2002, J NEUROPHYSIOL, V88, P2684, DOI 10.1152/jn.00253.2002; BERRYMAN JC, 1976, Z TIERPSYCHOL, V41, P80; CREUTZFELDT O, 1980, EXP BRAIN RES, V39, P87; DOUPE AJ, 1991, P NATL ACAD SCI USA, V88, P11339, DOI 10.1073/pnas.88.24.11339; Esser KH, 1997, P NATL ACAD SCI USA, V94, P14019, DOI 10.1073/pnas.94.25.14019; GAESE BH, 1995, EUR J NEUROSCI, V7, P438, DOI 10.1111/j.1460-9568.1995.tb00340.x; Gehr DD, 2000, HEARING RES, V150, P27, DOI 10.1016/S0378-5955(00)00170-2; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; Grimsley JMS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051646; Holmstrom LA, 2010, J NEUROSCI, V30, P802, DOI 10.1523/JNEUROSCI.1964-09.2010; Huetz C, 2009, J NEUROSCI, V29, P334, DOI 10.1523/JNEUROSCI.3269-08.2009; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; Kvasnak E, 2000, PHYSIOL RES, V49, P369; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; Nagarajan SS, 2002, J NEUROPHYSIOL, V87, P1723, DOI 10.1152/jn.00632.2001; Pasley BN, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001251; Philibert B, 2005, HEARING RES, V209, P97, DOI 10.1016/j.heares.2005.07.004; REES A, 1989, J ACOUST SOC AM, V85, P1978, DOI 10.1121/1.397851; Sadagopan S, 2009, J NEUROSCI, V29, P11192, DOI 10.1523/JNEUROSCI.1286-09.2009; Suta D, 2003, J NEUROPHYSIOL, V90, P3794, DOI 10.1152/jn.01175.2002; Suta D, 2008, PHYSIOL RES, V57, pS149, DOI 10.33549/physiolres.931608; Suta Daniel, 2004, Acta Medica (Hradec Kralove), V47, P339; Suta D, 2007, EXP BRAIN RES, V183, P377, DOI 10.1007/s00221-007-1056-3; Syka J, 2005, HEARING RES, V206, P177, DOI 10.1016/j.heares.2005.01.013; Syka J, 1997, ACOUSTICAL SIGNAL PROCESSING IN THE CENTRAL AUDITORY SYSTEM, P431, DOI 10.1007/978-1-4419-8712-9_39; Syka J, 2000, EXP BRAIN RES, V133, P254, DOI 10.1007/s002210000426; Wallace MN, 2008, EXP BRAIN RES, V184, P179, DOI 10.1007/s00221-007-1092-z; Wallace MN, 2009, EXP BRAIN RES, V194, P395, DOI 10.1007/s00221-009-1714-8; Wallace MN, 2007, J NEUROPHYSIOL, V98, P1941, DOI 10.1152/jn.00697.2007; Wallace MN, 2005, NEUROREPORT, V16, P2001, DOI 10.1097/00001756-200512190-00006; Wallace MN, 2005, HEARING RES, V204, P115, DOI 10.1016/j.heares.2005.01.007; Wallace MN, 2002, HEARING RES, V172, P160, DOI 10.1016/S0378-5955(02)00580-4; Wang X, 2008, NEUROSCIENCE, V154, P294, DOI 10.1016/j.neuroscience.2008.03.065; Wang XQ, 1995, J NEUROPHYSIOL, V74, P2685, DOI 10.1152/jn.1995.74.6.2685; Wang XQ, 2001, J NEUROPHYSIOL, V86, P2616, DOI 10.1152/jn.2001.86.5.2616; YOUNG ED, 1979, J ACOUST SOC AM, V66, P1381, DOI 10.1121/1.383532	37	10	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65432	10.1371/journal.pone.0065432	http://dx.doi.org/10.1371/journal.pone.0065432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785425	Green Published, gold, Green Submitted			2022-12-25	WOS:000321038800095
J	Dolmer, K; Campos, A; Gettins, PGW				Dolmer, Klavs; Campos, Andres; Gettins, Peter G. W.			Quantitative Dissection of the Binding Contributions of Ligand Lysines of the Receptor-associated Protein (RAP) to the Low Density Lipoprotein Receptor-related Protein (LRP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR SOLUTION STRUCTURE; LDL RECEPTOR; HUMAN ALPHA(2)-MACROGLOBULIN; PLASMINOGEN-ACTIVATOR; DOMAIN; RESIDUES; AFFINITY; COMPLEX; SITE; IDENTIFICATION	Although lysines are known to be critical for ligand binding to LDL receptor family receptors, relatively small reductions in affinity have been found when such lysines have been mutated. To resolve this paradox, we have examined the specific binding contributions of four lysines, Lys-253, Lys-256, Lys-270, and Lys-289, in the third domain (D3) of receptor-associated protein (RAP), by eliminating all other lysine residues. Using D3 variants containing lysine subsets, we examined binding to the high affinity fragment CR56 from LRP1. With this simplification, we found that elimination of the lysine pairs Lys-253/Lys-256 and Lys-270/Lys-289 resulted in increases in K-d of 1240- and 100,000-fold, respectively. Each pair contributed additively to overall affinity, with 61% from Lys-270/Lys-289 and 39% from Lys-253/Lys-256. Furthermore, the Lys-270/Lys-289 pair alone could bind different single CR domains with similar affinity. Within the pairs, binding contributions of Lys-270 >> Lys-256 > Lys-253 similar to Lys-289 were deduced. Importantly, however, Lys-289 could significantly compensate for the loss of Lys-270, thus explaining how previous studies have underestimated the importance of Lys-270. Calorimetry showed that favorable enthalpy, from Lys-256 and Lys-270, overwhelmingly drives binding, offset by unfavorable entropy. Our findings support a mode of ligand binding in which a proximal pair of lysines engages the negatively charged pocket of a CR domain, with two such pairs of interactions (requiring two CR domains), appropriately separated, being alone sufficient to provide the low nanomolar affinity found for most protein ligands of LDL receptor family members.	[Dolmer, Klavs; Campos, Andres; Gettins, Peter G. W.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gettins, PGW (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, M-C 669,900 S Ashland, Chicago, IL 60607 USA.	pgettins@uic.edu			National Institutes of Health [GM54414]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054414] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54414.	Andersen OS, 2001, J GEN PHYSIOL, V117, P1; Arandjelovic S, 2005, ARCH BIOCHEM BIOPHYS, V438, P29, DOI 10.1016/j.abb.2005.03.019; Beglova N, 2001, BIOCHEMISTRY-US, V40, P2808, DOI 10.1021/bi0027276; Dolmer K, 2000, J BIOL CHEM, V275, P3264, DOI 10.1074/jbc.275.5.3264; Dolmer K, 2006, J BIOL CHEM, V281, P34189, DOI 10.1074/jbc.M604389200; Estrada K, 2008, BIOCHEMISTRY-US, V47, P1532, DOI 10.1021/bi702076y; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Gettins PGW, 2012, BIOCHEM J, V443, P65, DOI 10.1042/BJ20111867; Guttman M, 2011, BIOCHEMISTRY-US, V50, P11001, DOI 10.1021/bi2014486; Guttman M, 2010, J MOL BIOL, V398, P306, DOI 10.1016/j.jmb.2010.03.022; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Horn IR, 1998, THROMB HAEMOSTASIS, V80, P822; Huang W, 1999, J BIOL CHEM, V274, P14130, DOI 10.1074/jbc.274.20.14130; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; Jensen JK, 2009, J BIOL CHEM, V284, P17989, DOI 10.1074/jbc.M109.009530; Jensen JK, 2009, BIOCHEM J, V421, P273, DOI 10.1042/BJ20090175; Lazic A, 2006, ARCH BIOCHEM BIOPHYS, V450, P167, DOI 10.1016/j.abb.2006.04.007; Lee D, 2006, MOL CELL, V22, P423, DOI 10.1016/j.molcel.2006.04.011; Migliorini MM, 2003, J BIOL CHEM, V278, P17986, DOI 10.1074/jbc.M212592200; Nielsen KL, 1996, J BIOL CHEM, V271, P12909, DOI 10.1074/jbc.271.22.12909; Sarafanov AG, 2006, BIOCHEMISTRY-US, V45, P1829, DOI 10.1021/bi0520380; Simonovic M, 2001, BIOCHEMISTRY-US, V40, P15127, DOI 10.1021/bi015688m; van den Biggelaar M, 2011, INT J BIOCHEM CELL B, V43, P431, DOI 10.1016/j.biocel.2010.11.017; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; Yasui N, 2010, STRUCTURE, V18, P320, DOI 10.1016/j.str.2010.01.010	26	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24081	24090		10.1074/jbc.M113.473728	http://dx.doi.org/10.1074/jbc.M113.473728			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23798683	hybrid, Green Published			2022-12-25	WOS:000330611400044
J	Kottom, TJ; Limper, AH				Kottom, Theodore J.; Limper, Andrew H.			The Pneumocystis Ace2 Transcription Factor Regulates Cell Wall-remodeling Genes and Organism Virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG EPITHELIAL-CELLS; INDUCE EXPRESSION; CARINII; PNEUMONIA; ATTACHMENT; KINASE; GROWTH; FIBRONECTIN; MUTATIONS; PARASITE	Pneumocystis carinii (Pc) beta-glucans are major components of the organism cell wall; yet, the regulation of Pc cell wall genesis and remodeling is not well understood. Ace2 transcription factors, which are present in many fungi, regulate glucanases and other enzymes needed for cell wall remodeling. The cloning and heterologous expression of PcAce2 in ace2 Delta Saccharomyces cerevisiae demonstrated that PcAce2 can restore the defective glucanase and endochitinase gene expression of the mutant as well as regulate cell wall beta-glucan biosynthetic genes. Furthermore, when a reconstructed yeast system was used, PcAce2 activated the transcription of the Pneumocystis gsc1 beta-glucan synthetase, confirming the activity of a Pc transcription factor on a native Pneumocystis promoter and gene for the first time. We further observed that Pneumocystis binding to host extracellular matrix proteins and lung epithelial cells induced the phosphorylation (activation) of the PcAce2 transcription factor. Finally, we present a novel method that confirms the role of PcAce2 in modulating organism virulence using ace2 Delta Candida glabrata infection in neutropenic mice. Together, these results indicate that the adherence of Pc to lung matrix proteins and epithelial cells leads to the activation of the Ace2 transcription factor, which regulates cell wall degradation and biosynthesis genes that are required for cell wall remodeling.	Mayo Clin, Dept Med, Thorac Dis Res Unit, Rochester, MN 55905 USA; Mayo Clin, Dept Biochem, Thorac Dis Res Unit, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Limper, AH (corresponding author), Mayo Clin, 8-24 Stabile, Rochester, MN 55905 USA.	limper.andrew@mayo.edu			National Institutes of Health [R01-HL62150, R01-HL55934]; Mayo Foundation; Walter and Leonore Annenberg Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055934, R01HL062150] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; Walter and Leonore Annenberg Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL62150 and R01-HL55934 (to A. H. L.). This work was also supported by the Mayo Foundation and the Walter and Leonore Annenberg Foundation.	ANDRIANOPOULOS A, 1994, MOL CELL BIOL, V14, P2503, DOI 10.1128/MCB.14.4.2503; Burgess JW, 2008, INFECT IMMUN, V76, P417, DOI 10.1128/IAI.00986-07; Burgess JW, 2009, AM J RESP CELL MOL, V41, P714, DOI 10.1165/rcmb.2008-0098OC; Crothers K, 2005, AIDS, V19, P801, DOI 10.1097/01.aids.0000168974.67090.70; CUSHION MT, 1984, INFECT IMMUN, V44, P245, DOI 10.1128/IAI.44.2.245-251.1984; Huang L, 2004, EMERG INFECT DIS, V10, P1721, DOI 10.3201/eid1010.030994; Huang Laurence, 2006, Proc Am Thorac Soc, V3, P655, DOI 10.1513/pats.200602-015MS; ITATANI CA, 1988, J PARASITOL, V74, P700, DOI 10.2307/3282193; Kamran M, 2004, EUKARYOT CELL, V3, P546, DOI 10.1128/EC.3.2.546-552.2004; Kottom TJ, 2008, MOL MICROBIOL, V67, P747, DOI 10.1111/j.1365-2958.2007.06093.x; Kottom TJ, 2011, INFECT IMMUN, V79, P4157, DOI 10.1128/IAI.05066-11; Kottom TJ, 2004, INFECT IMMUN, V72, P4628, DOI 10.1128/IAI.72.8.4628-4636.2004; Kottom TJ, 2003, INFECT IMMUN, V71, P6463, DOI 10.1128/IAI.71.11.6463-6471.2003; Kottom TJ, 2000, J BIOL CHEM, V275, P40628, DOI 10.1074/jbc.M002103200; Krajicek BJ, 2010, AM J PHYSIOL-LUNG C, V298, pL252, DOI 10.1152/ajplung.00191.2009; LIMPER AH, 1993, INFECT IMMUN, V61, P4302, DOI 10.1128/IAI.61.10.4302-4309.1993; LIMPER AH, 1990, J CLIN INVEST, V85, P391, DOI 10.1172/JCI114451; Limper AH, 1997, J LAB CLIN MED, V130, P132, DOI 10.1016/S0022-2143(97)90089-5; MacCallum DM, 2006, INFECT IMMUN, V74, P5244, DOI 10.1128/IAI.00817-06; Maccallum Donna M, 2012, Int J Microbiol, V2012, P363764, DOI 10.1155/2012/363764; McBride HJ, 1999, J BIOL CHEM, V274, P21029, DOI 10.1074/jbc.274.30.21029; POTTRATZ ST, 1990, J CLIN INVEST, V85, P351, DOI 10.1172/JCI114445; Saputo S, 2012, EUKARYOT CELL, V11, P708, DOI 10.1128/EC.00044-12; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; Thomas CF, 1998, AM J RESP CELL MOL, V18, P297, DOI 10.1165/ajrcmb.18.3.3122; Thomas CF, 2007, NAT REV MICROBIOL, V5, P298, DOI 10.1038/nrmicro1621; Voth WP, 2005, EUKARYOT CELL, V4, P1018, DOI 10.1128/EC.4.6.1018-1028.2005; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	28	5	5	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23893	23902		10.1074/jbc.M113.471243	http://dx.doi.org/10.1074/jbc.M113.471243			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23801335	Green Published, hybrid			2022-12-25	WOS:000330611400029
J	Dalghi, MG; Fernandez, MM; Ferreira-Gomes, M; Mangialavori, IC; Malchiodi, EL; Strehler, EE; Rossi, JPFC				Dalghi, Marianela G.; Fernandez, Marisa M.; Ferreira-Gomes, Mariela; Mangialavori, Irene C.; Malchiodi, Emilio L.; Strehler, Emanuel E.; Rossi, Juan Pablo F. C.			Plasma Membrane Calcium ATPase Activity Is Regulated by Actin Oligomers through Direct Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALMODULIN-BINDING DOMAIN; EPITHELIAL SODIUM-CHANNELS; SEA-URCHIN EGGS; ERYTHROCYTE CA-2+-ATPASE; HIGH-AFFINITY; PHOSPHOINOSITIDE-BINDING; SELF-ASSOCIATION; CA-2+ PUMP; CA2+ PUMP; F-ACTIN	As recently described by our group, plasma membrane calcium ATPase (PMCA) activity can be regulated by the actin cytoskeleton. In this study, we characterize the interaction of purified G-actin with isolated PMCA and examine the effect of G-actin during the first polymerization steps. As measured by surface plasmon resonance, G-actin directly interacts with PMCA with an apparent 1: 1 stoichiometry in the presence of Ca2+ with an apparent affinity in the micromolar range. As assessed by the photoactivatable probe 1-O-hexadecanoyl-2-O-[9-[[[2-[I-125] iodo-4-(trifluoromethyl-3H-diazirin-3-yl)benzyl]oxy]carbonyl]nonanoyl]-sn-glycero-3-phosphocholine, the association of PMCA to actin produced a shift in the distribution of the conformers of the pump toward a calmodulin-activated conformation. G-actin stimulates Ca2+ ATPase activity of the enzyme when incubated under polymerizing conditions, displaying a cooperative behavior. The increase in the Ca2+-ATPase activity was related to an increase in the apparent affinity for Ca2+ and an increase in the phosphoenzyme levels at steady state. Although surface plasmon resonance experiments revealed only one binding site for G-actin, results clearly indicate that more than one molecule of G-actin was needed for a regulatory effect on the pump. Polymerization studies showed that the experimental conditions are compatible with the presence of actin in the first stages of assembly. Altogether, these observations suggest that the stimulatory effect is exerted by short oligomers of actin. The functional interaction between actin oligomers and PMCA represents a novel regulatory pathway by which the cortical actin cytoskeleton participates in the regulation of cytosolic Ca2+ homeostasis.	[Dalghi, Marianela G.; Ferreira-Gomes, Mariela; Mangialavori, Irene C.; Rossi, Juan Pablo F. C.] Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Inst Quim & Fis Quim Biol, RA-1113 Buenos Aires, DF, Argentina; [Fernandez, Marisa M.; Malchiodi, Emilio L.] Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Inst Estudios Immunidad Humoral,Catedra Inmunol, RA-1113 Buenos Aires, DF, Argentina; [Strehler, Emanuel E.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Mayo Clinic	Malchiodi, EL (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Junin 956, RA-1113 Buenos Aires, DF, Argentina.	emalchiodi@ffyb.uba.ar; jprossi@retina.ar	Mangialavori, Irene/GLU-8182-2022	Mangialavori, Irene/0000-0003-3187-3130; Rossi, Juan Pablo/0000-0001-7087-844X; Malchiodi, Emilio/0000-0001-7501-3330; Fernandez, Marisa/0000-0002-7480-5907	Agencia Nacional de Promocion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Universidad de Buenos Aires Ciencia y Tecnica (Argentina)	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires Ciencia y Tecnica (Argentina)	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica, Consejo Nacional de Investigaciones Cientificas y Tecnicas, and Universidad de Buenos Aires Ciencia y Tecnica (Argentina).	Berdiev BK, 1996, J BIOL CHEM, V271, P17704, DOI 10.1074/jbc.271.30.17704; Billadeau DD, 2006, TRAFFIC, V7, P1451, DOI 10.1111/j.1600-0854.2006.00491.x; BONDER EM, 1989, DEV BIOL, V134, P327, DOI 10.1016/0012-1606(89)90105-X; Bozulic LD, 2007, THROMB HAEMOSTASIS, V97, P587, DOI 10.1160/TH06-08-0438; Bredeston LM, 2002, BIOCHEM J, V361, P355, DOI 10.1042/0264-6021:3610355; BRETSCHER A, 1980, CELL, V20, P839, DOI 10.1016/0092-8674(80)90330-X; Brozinick JT, 2007, CURR DIABETES REV, V3, P111, DOI 10.2174/157339907780598199; CANTIELLO HF, 1995, AM J PHYSIOL-RENAL, V269, pF637, DOI 10.1152/ajprenal.1995.269.5.F637; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.biochem.56.1.395; Carlier MF, 1991, CURR OPIN CELL BIOL, V3, P12, DOI 10.1016/0955-0674(91)90160-Z; CARLIER MF, 1986, J BIOL CHEM, V261, P785; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Echarte MM, 2001, ANAL BIOCHEM, V289, P267, DOI 10.1006/abio.2000.4950; ENYEDI A, 1989, J BIOL CHEM, V264, P12313; FECHHEIMER M, 1993, J CELL BIOL, V123, P1, DOI 10.1083/jcb.123.1.1; Fernandez MM, 2006, MOL IMMUNOL, V43, P927, DOI 10.1016/j.molimm.2005.06.029; Filomatori CV, 2003, J BIOL CHEM, V278, P22265, DOI 10.1074/jbc.M302657200; FILOTEO AG, 1992, J BIOL CHEM, V267, P11800; FRIEDERICH E, 1992, CELL, V70, P81, DOI 10.1016/0092-8674(92)90535-K; FUJIMOTO T, 1993, J CELL BIOL, V120, P1147, DOI 10.1083/jcb.120.5.1147; GERSHMAN LC, 1991, J BIOL CHEM, V266, P76; GOLDSCHMIDTCLERMONT PJ, 1990, SCIENCE, V247, P1575, DOI 10.1126/science.2157283; Guerini D, 2003, J BIOL CHEM, V278, P38141, DOI 10.1074/jbc.M302400200; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Huang YP, 2007, J CELL SCI, V120, P723, DOI 10.1242/jcs.000786; Ismailov II, 1997, AM J PHYSIOL-CELL PH, V272, pC1077, DOI 10.1152/ajpcell.1997.272.4.C1077; JAMES P, 1988, J BIOL CHEM, V263, P2905; JAMES P, 1989, J BIOL CHEM, V264, P8289; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; KATZ S, 1975, BIOCHIM BIOPHYS ACTA, V389, P314, DOI 10.1016/0005-2736(75)90324-7; Khurana S, 2000, J MEMBRANE BIOL, V178, P73, DOI 10.1007/s002320010016; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; KOSKKOSICKA D, 1988, J BIOL CHEM, V263, P18184; KOSKKOSICKA D, 1989, J BIOL CHEM, V264, P19495; KOSKKOSICKA D, 1990, BIOCHEMISTRY-US, V29, P3772, DOI 10.1021/bi00467a025; KOSKKOSICKA D, 1990, BIOCHEMISTRY-US, V29, P1875, DOI 10.1021/bi00459a030; KOSKKOSICKA D, 1985, FEBS LETT, V189, P67, DOI 10.1016/0014-5793(85)80843-7; KRATJE RB, 1983, BIOCHIM BIOPHYS ACTA, V731, P40, DOI 10.1016/0005-2736(83)90395-4; Kueh HY, 2008, J CELL BIOL, V182, P341, DOI 10.1083/jcb.200801027; Kurashima K, 1999, J BIOL CHEM, V274, P29843, DOI 10.1074/jbc.274.42.29843; Kusano K, 1999, MOL CELL BIOCHEM, V190, P133, DOI 10.1023/A:1006962210692; LICHTNER R, 1980, BIOCHIM BIOPHYS ACTA, V598, P486, DOI 10.1016/0005-2736(80)90029-2; MALCHIODI EL, 1995, J EXP MED, V182, P1833, DOI 10.1084/jem.182.6.1833; Mandato CA, 2000, CELL MOTIL CYTOSKEL, V45, P87, DOI 10.1002/(SICI)1097-0169(200002)45:2<87::AID-CM1>3.0.CO;2-0; Mangialavori I, 2011, J BIOL CHEM, V286, P18397, DOI 10.1074/jbc.M110.210088; Mangialavori I, 2010, J BIOL CHEM, V285, P123, DOI 10.1074/jbc.M109.076679; Mangialavori I, 2009, J BIOL CHEM, V284, P4823, DOI 10.1074/jbc.M806912200; Mangialavori Irene C, 2011, Curr Chem Biol, V5, P118; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Navratilova I, 2006, ANAL BIOCHEM, V355, P132, DOI 10.1016/j.ab.2006.04.021; NEYSES L, 1985, J BIOL CHEM, V260, P283; NIGGLI V, 1981, J BIOL CHEM, V256, P395; NIGGLI V, 1979, J BIOL CHEM, V254, P9955; NIGGLI V, 1981, J BIOL CHEM, V256, P8588; Noda Y, 2004, BIOCHEM BIOPH RES CO, V322, P740, DOI 10.1016/j.bbrc.2004.07.195; Penniston JT, 1998, J MEMBRANE BIOL, V165, P101, DOI 10.1007/s002329900424; Pike LJ, 1996, J BIOL CHEM, V271, P26453, DOI 10.1074/jbc.271.43.26453; POLLARD TD, 1984, FEBS LETT, V170, P94, DOI 10.1016/0014-5793(84)81376-9; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Rega A. F., 1986, CA2 PLUS PUMP PLASMA, P77; RICHARDS DE, 1978, BIOCHIM BIOPHYS ACTA, V511, P194, DOI 10.1016/0005-2736(78)90313-9; Ridley A, 2000, J CELL BIOL, V150, pF107, DOI 10.1083/jcb.150.4.F107; Roman I, 2006, BBA-BIOMEMBRANES, V1758, P479, DOI 10.1016/j.bbamem.2006.03.019; Sackett DL, 1996, J BIOL CHEM, V271, P9987, DOI 10.1074/jbc.271.17.9987; SAFER D, 1991, J BIOL CHEM, V266, P4029; SARKADI B, 1986, J BIOL CHEM, V261, P9552; SARKADI B, 1980, BIOCHIM BIOPHYS ACTA, V598, P326, DOI 10.1016/0005-2736(80)90010-3; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Scita G, 2008, TRENDS CELL BIOL, V18, P52, DOI 10.1016/j.tcb.2007.12.002; Shaul PW, 1996, J BIOL CHEM, V271, P6518, DOI 10.1074/jbc.271.11.6518; Sheterline P, 1998, ACTIN; SPUDICH A, 1988, CELL MOTIL CYTOSKEL, V9, P85, DOI 10.1002/cm.970090109; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; STOSSEL TP, 1989, J BIOL CHEM, V264, P18261; Straub F. B., 1943, MED CHEM U SZEGED, V3, P23; Strehler EE, 2004, CURR MOL MED, V4, P323, DOI 10.2174/1566524043360735; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; TOBACMAN LS, 1983, J BIOL CHEM, V258, P3207; Valentijn JA, 2000, P NATL ACAD SCI USA, V97, P1091, DOI 10.1073/pnas.97.3.1091; Vanagas L, 2007, BBA-BIOMEMBRANES, V1768, P1641, DOI 10.1016/j.bbamem.2007.03.012; Vanagas L, 2013, CELL BIOCHEM BIOPHYS, V66, P187, DOI 10.1007/s12013-012-9467-6; VORHERR T, 1991, J BIOL CHEM, V266, P22; VORHERR T, 1990, BIOCHEMISTRY-US, V29, P355, DOI 10.1021/bi00454a008; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; WEGNER A, 1975, BIOPHYS CHEM, V3, P215, DOI 10.1016/0301-4622(75)80013-5; Xian WJ, 1995, BIOPHYS J, V69, P2695, DOI 10.1016/S0006-3495(95)80140-2; Xu JY, 1998, BIOPHYS J, V74, P2731, DOI 10.1016/S0006-3495(98)77979-2; YAMAMOTO K, 1991, J MOL BIOL, V217, P229, DOI 10.1016/0022-2836(91)90535-E; YIN HL, 1981, J BIOL CHEM, V256, P9693; YONEZAWA N, 1989, EUR J BIOCHEM, V183, P235, DOI 10.1111/j.1432-1033.1989.tb14918.x; Zylinska L, 1998, BBA-MOL CELL RES, V1448, P99, DOI 10.1016/S0167-4889(98)00128-1	95	19	19	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23380	23393		10.1074/jbc.M113.470542	http://dx.doi.org/10.1074/jbc.M113.470542			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23803603	Green Published, hybrid			2022-12-25	WOS:000330598200042
J	Wolters, M; Boyle, EC; Lardong, K; Trulzsch, K; Steffen, A; Rottner, K; Ruckdeschel, K; Aepfelbacher, M				Wolters, Manuel; Boyle, Erin C.; Lardong, Kerstin; Truelzsch, Konrad; Steffen, Anika; Rottner, Klemens; Ruckdeschel, Klaus; Aepfelbacher, Martin			Cytotoxic Necrotizing Factor-Y Boosts Yersinia Effector Translocation by Activating Rac Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III SECRETION SYSTEM; MOUSE INFECTION MODEL; ESCHERICHIA-COLI; RHO GTPASES; VIRULENCE FACTOR; PROTEASOMAL DEGRADATION; SIGNALING RESPONSES; KINASE ACTIVATION; ENDOTHELIAL-CELLS; ACTIN-BINDING	Pathogenic Yersinia spp. translocate the effectors YopT, YopE, and YopO/YpkA into target cells to inactivate Rho family GTP-binding proteins and block immune responses. Some Yersinia spp. also secrete the Rho protein activator cytotoxic necrotizing factor-Y (CNF-Y), but it has been unclear how the bacteria may benefit from Rho protein activation. We show here that CNF-Y increases Yop translocation in Yersinia enterocolitica-infected cells up to 5-fold. CNF-Y strongly activated RhoA and also delayed in time Rac1 and Cdc42, but when individually expressed, constitutively active mutants of Rac1, but not of RhoA, increased Yop translocation. Consistently, knock-out or knockdown of Rac1 but not of RhoA, -B, or -C inhibited Yersinia effector translocation in CNF-Y-treated and control cells. Activation or knockdown of Cdc42 also affected Yop translocation but much less efficiently than Rac. The increase in Yop translocation induced by CNF-Y was essentially independent of the presence of YopE, YopT, or YopO in the infecting Yersinia strain, indicating that none of the Yops reported to inhibit translocation could reverse the CNF-Y effect. In summary, the CNF-Y activity of Yersinia strongly enhances Yop translocation through activation of Rac.	[Wolters, Manuel; Boyle, Erin C.; Lardong, Kerstin; Ruckdeschel, Klaus; Aepfelbacher, Martin] Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, D-20246 Hamburg, Germany; [Truelzsch, Konrad] Univ Munich, Max von Pettenkofer Inst Hyg & Med Microbiol, D-80336 Munich, Germany; [Steffen, Anika; Rottner, Klemens] Univ Bonn, Inst Genet, D-53127 Bonn, Germany; [Rottner, Klemens] Helmholtz Ctr Infect Res HZI, D-38124 Braunschweig, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; University of Bonn; Helmholtz Association; Helmholtz-Center for Infection Research	Aepfelbacher, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, Martinistr 52, D-20246 Hamburg, Germany.	m.aepfelbacher@uke.de		Rottner, Klemens/0000-0003-4244-4198; Boyle, Erin C./0000-0002-5963-3633; Steffen, Anika/0000-0002-2933-0543	German Research Council	German Research Council(German Research Foundation (DFG))	This work was supported in part by a grant from the German Research Council (to K. R.).	Aepfelbacher M, 2003, J BIOL CHEM, V278, P33217, DOI 10.1074/jbc.M303349200; Aepfelbacher M, 2007, THROMB HAEMOSTASIS, V98, P521, DOI 10.1160/TH07-03-0173; Aepfelbacher M, 2011, EUR J CELL BIOL, V90, P951, DOI 10.1016/j.ejcb.2010.12.004; Aili M, 2006, CELL MICROBIOL, V8, P1020, DOI 10.1111/j.1462-5822.2005.00684.x; Aktories K, 2003, TRENDS MICROBIOL, V11, P152, DOI 10.1016/S0966-842X(03)00042-8; Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; Alli M, 2008, INT J MED MICROBIOL, V298, P183, DOI 10.1016/j.ijmm.2007.04.007; Alonso A, 2004, J BIOL CHEM, V279, P4922, DOI 10.1074/jbc.M308978200; Andor A, 2001, CELL MICROBIOL, V3, P301, DOI 10.1046/j.1462-5822.2001.00114.x; BOLIN I, 1982, INFECT IMMUN, V37, P506; Brodsky IE, 2010, CELL HOST MICROBE, V7, P376, DOI 10.1016/j.chom.2010.04.009; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Chrostek A, 2006, MOL CELL BIOL, V26, P6957, DOI 10.1128/MCB.00075-06; Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932; Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x; Dewoody R, 2011, MOL MICROBIOL, V79, P1445, DOI 10.1111/j.1365-2958.2011.07534.x; Doye A, 2006, METHOD ENZYMOL, V406, P447, DOI 10.1016/S0076-6879(06)06033-2; Essler M, 2003, INFECT IMMUN, V71, P5188, DOI 10.1128/IAI.71.9.5188-5193.2003; Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973; Flatau G, 1997, NATURE, V387, P729, DOI 10.1038/42743; Gaus K, 2011, INFECT IMMUN, V79, P1166, DOI 10.1128/IAI.00694-10; GEMSKI P, 1980, INFECT IMMUN, V28, P1044; Gerke C, 2005, J EXP MED, V201, P361, DOI 10.1084/jem.20041120; Groves E, 2010, J BIOL CHEM, V285, P4087, DOI 10.1074/jbc.M109.071035; Harris KP, 2010, TRAFFIC, V11, P1272, DOI 10.1111/j.1600-0854.2010.01102.x; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heesemann J, 2006, CURR OPIN MICROBIOL, V9, P55, DOI 10.1016/j.mib.2005.10.018; HEESEMANN J, 1983, J BACTERIOL, V155, P761, DOI 10.1128/JB.155.2.761-767.1983; Hentschke M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013165; Hoffmann C, 2004, J BIOL CHEM, V279, P16026, DOI 10.1074/jbc.M313556200; Holmstrom A, 1997, MOL MICROBIOL, V24, P73, DOI 10.1046/j.1365-2958.1997.3211681.x; Holmstrom A, 1995, CONTRIB TO MICROBIOL, V13, P239; Humphreys D, 2012, CELL HOST MICROBE, V11, P129, DOI 10.1016/j.chom.2012.01.006; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997; Koberle M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000551; Koronakis V, 2011, P NATL ACAD SCI USA, V108, P14449, DOI 10.1073/pnas.1107666108; Lerm M, 2002, INFECT IMMUN, V70, P4053, DOI 10.1128/IAI.70.8.4053-4058.2002; Lockman HA, 2002, INFECT IMMUN, V70, P2708, DOI 10.1128/IAI.70.5.2708-2714.2002; McCoy MW, 2010, INFECT IMMUN, V78, P2584, DOI 10.1128/IAI.00141-10; McDonald C, 2003, J BIOL CHEM, V278, P18514, DOI 10.1074/jbc.M301226200; McPhee JB, 2010, INFECT IMMUN, V78, P3529, DOI 10.1128/IAI.00269-10; Mejia E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040003; Melendez J, 2011, J BIOL CHEM, V286, P15132, DOI 10.1074/jbc.C111.229336; Mills E, 2008, CELL HOST MICROBE, V3, P104, DOI 10.1016/j.chom.2007.11.007; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Mukherjee S, 2008, METHOD ENZYMOL, V438, P343, DOI 10.1016/S0076-6879(07)38024-5; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Navarro L, 2005, CURR OPIN MICROBIOL, V8, P21, DOI 10.1016/j.mib.2004.12.014; Nordfelth R, 2001, INFECT IMMUN, V69, P3516, DOI 10.1128/IAI.69.5.3516-3518.2001; Persson C, 1997, EMBO J, V16, P2307, DOI 10.1093/emboj/16.9.2307; Peters KN, 2012, ADV EXP MED BIOL, V954, P229, DOI 10.1007/978-1-4614-3561-7_29; Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231; Prehna G, 2006, CELL, V126, P869, DOI 10.1016/j.cell.2006.06.056; Prentice MB, 2007, LANCET, V369, P1196, DOI 10.1016/S0140-6736(07)60566-2; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Schmidt G, 2011, EUR J CELL BIOL, V90, P955, DOI 10.1016/j.ejcb.2010.12.005; Schotte P, 2004, J BIOL CHEM, V279, P25134, DOI 10.1074/jbc.M401245200; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Trasak C, 2007, J BIOL CHEM, V282, P2268, DOI 10.1074/jbc.M610071200; Trulzsch K, 2007, ADV EXP MED BIOL, V603, P279; Trulzsch K, 2004, INFECT IMMUN, V72, P5227, DOI 10.1128/IAI.72.9.5227-5234.2004; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Viboud GI, 2001, EMBO J, V20, P5373, DOI 10.1093/emboj/20.19.5373; Viboud GI, 2006, CELL MICROBIOL, V8, P1504, DOI 10.1111/j.1462-5822.2006.00729.x; Wong KW, 2005, PLOS PATHOG, V1, P125, DOI 10.1371/journal.ppat.0010016; Yao T, 1999, J EXP MED, V190, P1343, DOI 10.1084/jem.190.9.1343; Zumbihl R, 1999, J BIOL CHEM, V274, P29289, DOI 10.1074/jbc.274.41.29289	68	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23543	23553		10.1074/jbc.M112.448662	http://dx.doi.org/10.1074/jbc.M112.448662			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23803609	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000330598200058
J	Hillian, AD; McMullen, MR; Sebastian, BM; Rowchowdhury, S; Kashyap, SR; Schauer, PR; Kirwan, JP; Feldstein, AE; Nagy, LE				Hillian, Antoinette D.; McMullen, Megan R.; Sebastian, Becky M.; Rowchowdhury, Sanjoy; Kashyap, Sangeeta R.; Schauer, Philip R.; Kirwan, John P.; Feldstein, Ariel E.; Nagy, Laura E.			Mice Lacking C1q Are Protected from High Fat Diet-induced Hepatic Insulin Resistance and Impaired Glucose Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYLATION STIMULATING PROTEIN; DECAY-ACCELERATING FACTOR; OMENTAL ADIPOSE-TISSUE; COMPLEMENT ACTIVATION; LIVER-DISEASE; IN-VITRO; EXPRESSION; ADIPOCYTE; OBESITY; C3A	Complement activation is implicated in the development of obesity and insulin resistance, and loss of signaling by the anaphylatoxin C3a prevents obesity-induced insulin resistance in mice. Here we have identified C1q in the classical pathway as required for activation of complement in response to high fat diets. After 8 weeks of high fat diet, wild-type mice became obese and developed glucose intolerance. This was associated with increased apoptotic cell death and accumulation of complement activation products (C3b/iC3b/C3c) in liver and adipose tissue. Previous studies have shown that high fat diet-induced apoptosis is dependent on Bid; here we report that Bid-mediated apoptosis was required for complement activation in adipose and liver. Although C1qa deficiency had no effect on high fat diet-induced apoptosis, accumulation of complement activation products and the metabolic complications of high fat diet-induced obesity were dependent on C1q. When wild-type mice were fed a high fat diet for only 3 days, hepatic insulin resistance was associated with the accumulation of C3b/iC3b/C3c in the liver. Mice deficient in C3a receptor were protected against this early high fat diet-induced hepatic insulin resistance, whereas mice deficient in the negative complement regulator CD55/DAF were more sensitive to the high fat diet. C1qa(-/-) mice were also protected from high fat diet-induced hepatic insulin resistance and complement activation. Evidence of complement activation was also detected in adipose tissue of obese women compared with lean women. Together, these studies reveal an important role for C1q in the classical pathway of complement activation in the development of high fat diet-induced insulin resistance.	[Hillian, Antoinette D.; McMullen, Megan R.; Sebastian, Becky M.; Rowchowdhury, Sanjoy; Kirwan, John P.; Nagy, Laura E.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA; [Kashyap, Sangeeta R.] Cleveland Clin, Dept Endocrinol Diabet & Metab, Cleveland, OH 44195 USA; [Schauer, Philip R.] Cleveland Clin, Bariatr Metab Inst, Cleveland, OH 44195 USA; [Kirwan, John P.; Nagy, Laura E.] Cleveland Clin, Dept Gastroenterol & Hepatol, Cleveland, OH 44195 USA; [Feldstein, Ariel E.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of California System; University of California San Diego	Nagy, LE (corresponding author), Cleveland Clin, Dept Pathobiol, 9500 Euclid Ave NE40, Cleveland, OH 44195 USA.	nagyL3@ccf.org	Kirwan, John P/G-6942-2012	Schauer, Philip/0000-0002-4029-7537; Kashyap, Sangeeta/0000-0002-7489-6650	National Institutes of Health (NIH) [5R01AA016399, 5R37 AA011876, RO1DK089547, RO1 DK076853, RO1DK082451]; NIH, NCRR [CTSA UL1RR024989];  [T32DK07319]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007319, R01DK082451, R01DK089547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016399, R37AA011876] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants 5R01AA016399 and 5R37 AA011876 (to L. E. N.), RO1DK089547 (to J. P. K.), RO1 DK076853 and RO1DK082451 (to A. E. F.), support from Grant T32DK07319 (to A. D. H.), and NIH, NCRR, Grant CTSA UL1RR024989 (Case Western Reserve University/Cleveland Clinic).	Alkhouri N, 2010, J BIOL CHEM, V285, P3428, DOI 10.1074/jbc.M109.074252; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Bieghs V, 2012, HEPATOLOGY, V56, P894, DOI 10.1002/hep.25660; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Cohen JI, 2010, GASTROENTEROLOGY, V139, P664, DOI 10.1053/j.gastro.2010.04.041; DiScipio RG, 1999, J IMMUNOL, V162, P1127; Elward K, 2005, J BIOL CHEM, V280, P36342, DOI 10.1074/jbc.M506579200; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Flyvbjerg A, 2010, NAT REV ENDOCRINOL, V6, P94, DOI 10.1038/nrendo.2009.266; Galvan MD, 2012, J IMMUNOL, V188, P3716, DOI 10.4049/jimmunol.1102920; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; Gornicka A, 2012, AM J PHYSIOL-ENDOC M, V303, pE597, DOI 10.1152/ajpendo.00022.2012; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Jauneau AC, 2003, FEBS LETT, V537, P17, DOI 10.1016/S0014-5793(03)00060-7; Kelly KR, 2010, OBESITY, V18, P663, DOI 10.1038/oby.2009.328; Khashab Mouen A, 2008, Curr Gastroenterol Rep, V10, P73, DOI 10.1007/s11894-008-0012-0; Kildsgaard J, 2000, J IMMUNOL, V165, P5406, DOI 10.4049/jimmunol.165.10.5406; Korb LC, 1997, J IMMUNOL, V158, P4525; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Lim J, 2013, FASEB J, V27, P822, DOI 10.1096/fj.12-220582; Lin F, 2001, IMMUNOLOGY, V104, P215, DOI 10.1046/j.1365-2567.2001.01287.x; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; MacLaren RE, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-3; Maher JJ, 2008, HEPATOLOGY, V48, P670, DOI 10.1002/hep.22399; Mamane Y, 2009, DIABETES, V58, P2006, DOI 10.2337/db09-0323; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Monsinjon T, 2003, FASEB J, V17, P1003, DOI 10.1096/fj.02-0737com; Muscari A, 2007, DIABETES CARE, V30, P2362, DOI 10.2337/dc07-0637; Musso G, 2010, OBES REV, V11, P430, DOI 10.1111/j.1467-789X.2009.00657.x; Ostergaard J, 2005, CLIN CHIM ACTA, V361, P10, DOI 10.1016/j.cccn.2005.04.028; Paidassi H, 2008, J IMMUNOL, V180, P2329, DOI 10.4049/jimmunol.180.4.2329; Pattrick M, 2009, MOL IMMUNOL, V46, P755, DOI 10.1016/j.molimm.2008.09.013; Pritchard MT, 2007, GASTROENTEROLOGY, V132, P1117, DOI 10.1053/j.gastro.2007.01.053; Rensen SS, 2009, HEPATOLOGY, V50, P1809, DOI 10.1002/hep.23228; Rivera CA, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-52; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Schieferdecker HL, 2001, INT IMMUNOPHARMACOL, V1, P469, DOI 10.1016/S1567-5769(00)00038-2; Sebastian BM, 2011, J BIOL CHEM, V286, P35989, DOI 10.1074/jbc.M111.254201; SUNDSMO JS, 1985, CLIN IMMUNOL IMMUNOP, V35, P211, DOI 10.1016/0090-1229(85)90067-4; Tilg H, 2010, DIGEST DIS, V28, P179, DOI 10.1159/000282083; Trauner M, 2010, BBA-MOL CELL BIOL L, V1801, P299, DOI 10.1016/j.bbalip.2009.10.007; Trouw LA, 2008, MOL IMMUNOL, V45, P1199, DOI 10.1016/j.molimm.2007.09.008; Valenti L, 2009, SEMIN IMMUNOPATHOL, V31, P359, DOI 10.1007/s00281-009-0152-9; Vallerie SN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001007; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wang HJ, 2012, ANNU REV NUTR, V32, P343, DOI 10.1146/annurev-nutr-072610-145138; Weyer C, 2000, DIABETES CARE, V23, P779, DOI 10.2337/diacare.23.6.779; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Yang Y, 2006, INT J OBESITY, V30, P439, DOI 10.1038/sj.ijo.0803173; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zhong H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000932	54	25	27	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22565	22575		10.1074/jbc.M113.465674	http://dx.doi.org/10.1074/jbc.M113.465674			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23788643	Green Published, hybrid			2022-12-25	WOS:000330596300036
J	Bunprajun, T; Henriksen, TI; Scheele, C; Pedersen, BK; Green, CJ				Bunprajun, Tipwadee; Henriksen, Tora Ida; Scheele, Camilla; Pedersen, Bente Klarlund; Green, Charlotte Jane			Lifelong Physical Activity Prevents Aging-Associated Insulin Resistance in Human Skeletal Muscle Myotubes via Increased Glucose Transporter Expression	PLOS ONE			English	Article							NATURAL-HISTORY; SATELLITE CELL; EXERCISE; PROTEIN; GLUT4; ACTIVATION; TOLERANCE; DIFFERENTIATION; HYPERTROPHY; PROGRESSION	Both aging and physical inactivity are associated with increased development of insulin resistance whereas physical activity has been shown to promote increased insulin sensitivity. Here we investigated the effects of physical activity level on aging-associated insulin resistance in myotubes derived from human skeletal muscle satellite cells. Satellite cells were obtained from young (22 yrs) normally active or middle-aged (56.6 yrs) individuals who were either lifelong sedentary or lifelong active. Both middle-aged sedentary and middle-aged active myotubes had increased p21 and myosin heavy chain protein expression. Interestingly MHCIIa was increased only in myotubes from middle-aged active individuals. Middle-aged sedentary cells had intact insulin-stimulated Akt phosphorylation however, the same cell showed ablated insulin-stimulated glucose uptake and GLUT4 translocation to the plasma membrane. On the other hand, middle-aged active cells retained both insulin-stimulated increases in glucose uptake and GLUT4 translocation to the plasma membrane. Middle-aged active cells also had significantly higher mRNA expression of GLUT1 and GLUT4 compared to middle-aged sedentary cells, and significantly higher GLUT4 protein. It is likely that physical activity induces a number of stable adaptations, including increased GLUT4 expression that are retained in cells ex vivo and protect, or delay the onset of middle-aged-associated insulin resistance. Additionally, a sedentary lifestyle has an impact on the metabolism of human myotubes during aging and may contribute to aging-associated insulin resistance through impaired GLUT4 localization.	[Bunprajun, Tipwadee; Henriksen, Tora Ida; Scheele, Camilla; Pedersen, Bente Klarlund; Green, Charlotte Jane] Univ Copenhagen, Rigshosp, Fac Hlth Sci, Dept Infect Dis,Ctr Inflammat & Metab, DK-2100 Copenhagen, Denmark; [Bunprajun, Tipwadee] Mahidol Univ, Fac Sci, Dept Physiol, Bangkok 10700, Thailand	Rigshospitalet; University of Copenhagen; Mahidol University	Green, CJ (corresponding author), Univ Copenhagen, Rigshosp, Fac Hlth Sci, Dept Infect Dis,Ctr Inflammat & Metab, DK-2100 Copenhagen, Denmark.	cjgreen30@gmail.com	Pedersen, Bente Klarlund/AGR-3217-2022; Scheele, Camilla/S-6401-2017; Scheele, Camilla/AAA-3599-2020; GREEN, Charlotte/B-9742-2014; Henriksen, Tora/AGK-6018-2022	Pedersen, Bente Klarlund/0000-0001-6508-6288; Scheele, Camilla/0000-0002-6055-9709; Scheele, Camilla/0000-0002-6055-9709; GREEN, Charlotte/0000-0003-1631-3186; Henriksen, Tora/0000-0003-1568-8920; Bunprajun, Tipwadee/0000-0003-4972-7246	Danish National Research Foundation [02-512-55]; Danish Council for Independent Research - Medical Sciences; Commission of the European Communities [223576 - MYOAGE]; Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program [PHD/0042/2550]	Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Council for Independent Research - Medical Sciences(Det Frie Forskningsrad (DFF)); Commission of the European Communities(European Commission); Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Centre of Inflammation and Metabolism (CIM) is supported by a grant from the Danish National Research Foundation (#02-512-55). This study was supported by the Danish Council for Independent Research - Medical Sciences, the Commission of the European Communities (Grant Agreement no. 223576 - MYOAGE) and by the Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program (Grant PHD/0042/2550).	Alfaro LAS, 2011, STEM CELLS, V29, P2030, DOI 10.1002/stem.759; Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Balagopal P, 2001, AM J PHYSIOL-ENDOC M, V280, pE203, DOI 10.1152/ajpendo.2001.280.2.E203; Bamman MM, 2003, J GERONTOL A-BIOL, V58, P108; Booth FW, 2011, J APPL PHYSIOL, V111, P1497, DOI 10.1152/japplphysiol.00420.2011; Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; Broholm C, 2012, AM J PHYSIOL-ENDOC M, V303, pE283, DOI 10.1152/ajpendo.00586.2011; CARMELI E, 1994, P SOC EXP BIOL MED, V206, P103; Carrascosa JM, 2011, CURR PROTEIN PEPT SC, V12, P305; Christ-Roberts CY, 2004, METABOLISM, V53, P1233, DOI 10.1016/j.metabol.2004.03.022; Ciaraldi TP, 2005, J CLIN ENDOCR METAB, V90, P352, DOI 10.1210/jc.2004-0516; DELA F, 1994, DIABETES, V43, P862, DOI 10.2337/diabetes.43.7.862; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908; Gaster M, 2002, DIABETES, V51, P921, DOI 10.2337/diabetes.51.4.921; Gaster M, 2001, APMIS, V109, P735, DOI 10.1034/j.1600-0463.2001.d01-140.x; Gaster M, 2000, AM J PHYSIOL-ENDOC M, V279, pE1191, DOI 10.1152/ajpendo.2000.279.5.E1191; Gjovaag TF, 2009, MED SCI SPORT EXER, V41, P129, DOI 10.1249/MSS.0b013e3181844e42; GOODYEAR LJ, 1992, DIABETES, V41, P1091, DOI 10.2337/diabetes.41.9.1091; Graveleau C, 2005, J BIOL CHEM, V280, P31679, DOI 10.1074/jbc.M504008200; Green CJ, 2011, DIABETES, V60, P2810, DOI 10.2337/db11-0263; GUILLETDENIAU I, 1994, J CELL SCI, V107, P487; GUO K, 1995, MOL CELL BIOL, V15, P3823; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Harber MP, 2012, J APPL PHYSIOL, V113, P1495, DOI 10.1152/japplphysiol.00786.2012; Holloszy J O, 2000, Mayo Clin Proc, V75 Suppl, pS3; KAHN SE, 1990, AM J PHYSIOL, V258, pE937, DOI 10.1152/ajpendo.1990.258.6.E937; Liu Y, 2008, BRIT J SPORT MED, V42, P989, DOI 10.1136/bjsm.2007.045518; MacKrell JG, 2012, J GERONTOL A-BIOL, V67, P1286, DOI 10.1093/gerona/gls194; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Meigs JB, 2003, DIABETES, V52, P1475, DOI 10.2337/diabetes.52.6.1475; Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534; NAGATA Y, 1974, J BIOL CHEM, V249, P3116; Nakatani A, 1997, J APPL PHYSIOL, V82, P711, DOI 10.1152/jappl.1997.82.2.711; Nichols GA, 2007, DIABETES CARE, V30, P228, DOI 10.2337/dc06-1392; Robson LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027116; RODNICK KJ, 1990, DIABETES, V39, P1425, DOI 10.2337/diabetes.39.11.1425; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Scheele C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039657; SEALS DR, 1984, J APPL PHYSIOL, V56, P1521, DOI 10.1152/jappl.1984.56.6.1521; Stuart CA, 2010, MED SCI SPORT EXER, V42, P96, DOI 10.1249/MSS.0b013e3181ad7f36; Thyfault JP, 2011, CURR OPIN CLIN NUTR, V14, P374, DOI 10.1097/MCO.0b013e3283468e69; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Welle S, 2004, EXP GERONTOL, V39, P369, DOI 10.1016/j.exger.2003.11.011; Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231	46	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66628	10.1371/journal.pone.0066628	http://dx.doi.org/10.1371/journal.pone.0066628			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805253	Green Submitted, Green Published, gold			2022-12-25	WOS:000320846500081
J	Haussig, JM; Matuschewski, K; Kooij, TWA				Haussig, Joana M.; Matuschewski, Kai; Kooij, Taco W. A.			Experimental Genetics of Plasmodium berghei NFU in the Apicoplast Iron-Sulfur Cluster Biogenesis Pathway	PLOS ONE			English	Article							MALARIA PARASITE; FOSMIDOMYCIN-CLINDAMYCIN; PROTEIN; FE; SUFB; TRANSFECTION; EVOLUTION; SYSTEM	Eukaryotic pathogens of the phylum Apicomplexa contain a non-photosynthetic plastid, termed apicoplast. Within this organelle distinct iron-sulfur [Fe-S] cluster proteins are likely central to biosynthesis pathways, including generation of isoprenoids and lipoic acid. Here, we targeted a nuclear-encoded component of the apicoplast [Fe-S] cluster biosynthesis pathway by experimental genetics in the murine malaria parasite Plasmodium berghei. We show that ablation of the gene encoding a nitrogen fixation factor U (NifU)-like domain containing protein (NFUapi) resulted in parasites that were able to complete the entire life cycle indicating redundant or non-essential functions. nfu(-) parasites displayed reduced merosome formation in vitro, suggesting that apicoplast NFUapi plays an auxiliary role in establishing a blood stage infection. NFUapi fused to a combined fluorescent protein-epitope tag delineates the Plasmodium apicoplast and was tested to revisit inhibition of liver stage development by azithromycin and fosmidomycin. We show that the branched apicoplast signal is entirely abolished by azithromycin treatment, while fosmidomycin had no effect on apicoplast morphology. In conclusion, our experimental genetics analysis supports specialized and/or redundant role(s) for NFUapi in the [Fe-S] cluster biosynthesis pathway in the apicoplast of a malarial parasite.	[Haussig, Joana M.; Matuschewski, Kai; Kooij, Taco W. A.] Max Planck Inst Infect Biol, Parasitol Unit, Berlin, Germany	Max Planck Society	Kooij, TWA (corresponding author), Max Planck Inst Infect Biol, Parasitol Unit, Berlin, Germany.	kooij@mpiib-berlin.mpg.de	Kooij, Taco W.A./L-5623-2015	Kooij, Taco W.A./0000-0002-8547-7523; Matuschewski, Kai/0000-0001-6147-8591; Haussig, Joana M./0000-0002-5216-3472	Max Planck Society; European Union [242095]	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Union(European Commission)	This work was supported by the Max Planck Society and partly by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no242095: EVIMalaR - Towards the establishment of a permanent European Virtual Institute dedicated to Malaria Research (EVIMalaR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balk J, 2011, TRENDS PLANT SCI, V16, P218, DOI 10.1016/j.tplants.2010.12.006; Baumeister S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019334; Bender A, 2003, MOL BIOCHEM PARASIT, V132, P59, DOI 10.1016/j.molbiopara.2003.07.001; Borrmann S, 2005, ANTIMICROB AGENTS CH, V49, P3749, DOI 10.1128/AAC.49.9.3749-3754.2005; Borrmann S, 2004, J INFECT DIS, V190, P1534, DOI 10.1086/424603; Borrmann S, 2004, J INFECT DIS, V189, P901, DOI 10.1086/381785; Borrmann S, 2006, ANTIMICROB AGENTS CH, V50, P2713, DOI 10.1128/AAC.00392-06; Chahal HK, 2012, J INORG BIOCHEM, V116, P126, DOI 10.1016/j.jinorgbio.2012.06.008; Chahal HK, 2009, BIOCHEMISTRY-US, V48, P10644, DOI 10.1021/bi901518y; Cilingir G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036598; CLAROS MG, 1995, COMPUT APPL BIOSCI, V11, P441; Ellis KES, 2001, MOL MICROBIOL, V41, P973, DOI 10.1046/j.1365-2958.2001.02588.x; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Friesen J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001058; Haussig JM, 2011, MOL MICROBIOL, V81, P1511, DOI 10.1111/j.1365-2958.2011.07787.x; JACOBSON MR, 1989, MOL GEN GENET, V219, P49, DOI 10.1007/BF00261156; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Kenthirapalan S, 2012, INT J PARASITOL, V42, P1185, DOI 10.1016/j.ijpara.2012.10.006; Kooij TWA, 2012, MOL BIOCHEM PARASIT, V185, P19, DOI 10.1016/j.molbiopara.2012.06.001; Kumar B, 2011, INT J PARASITOL, V41, P991, DOI 10.1016/j.ijpara.2011.05.006; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Missinou MA, 2002, LANCET, V360, P1941, DOI 10.1016/S0140-6736(02)11860-5; Nachin L, 2003, EMBO J, V22, P427, DOI 10.1093/emboj/cdg061; Nair SC, 2011, J EXP MED, V208, P1547, DOI 10.1084/jem.20110039; Py B, 2012, MOL MICROBIOL, V86, P155, DOI 10.1111/j.1365-2958.2012.08181.x; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Rangachari K, 2002, FEBS LETT, V514, P225, DOI 10.1016/S0014-5793(02)02369-4; Seeber F, 2002, INT J PARASITOL, V32, P1207, DOI 10.1016/S0020-7519(02)00022-X; Seeber F, 2010, INT REV CEL MOL BIO, V281, P161, DOI 10.1016/S1937-6448(10)81005-6; Sharma AK, 2010, J BIOL CHEM, V285, P26745, DOI 10.1074/jbc.R110.122218; Sheiner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002392; Silvie O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000086; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; Tarun AS, 2008, P NATL ACAD SCI USA, V105, P305, DOI 10.1073/pnas.0710780104; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; Vaidya AB, 2009, ANNU REV MICROBIOL, V63, P249, DOI 10.1146/annurev.micro.091208.073424; VANDERBERG JP, 1975, J PARASITOL, V61, P43, DOI 10.2307/3279102; Vinella D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000497; Wiesner J, 2003, PARASITOL RES, V90, pS71, DOI 10.1007/s00436-002-0770-9; Xu XM, 2011, ANTIOXID REDOX SIGN, V15, P271, DOI 10.1089/ars.2010.3259; Xu XM, 2005, J BIOL CHEM, V280, P6648, DOI 10.1074/jbc.M413082200	44	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67269	10.1371/journal.pone.0067269	http://dx.doi.org/10.1371/journal.pone.0067269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805304	Green Submitted, Green Published, gold			2022-12-25	WOS:000320846500132
J	Pajon, R; Fergus, AM; Granoff, DM				Pajon, Rolando; Fergus, Andrew M.; Granoff, Dan M.			Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa	PLOS ONE			English	Article							H-BINDING-PROTEIN; NEISSERIA-MENINGITIDIS; GLYCOCONJUGATE VACCINE; BACTERICIDAL ANTIBODY; GROUP-A; MONOCLONAL-ANTIBODIES; CONTROLLED-TRIAL; IMMUNE MEMORY; PORA GENE; IMMUNOGENICITY	Background: The meningococcal serogroup A (MenA) polysaccharide conjugate vaccine used in Sub-Saharan Africa does not prevent disease caused by MenW or MenX strains, which also cause epidemics in the region. We investigated the vaccine-potential of native outer membrane vesicles with over-expressed factor H-binding protein (NOMV-fHbp), which targeted antigens in African meningococcal strains, and was combined with a MenA polysaccharide conjugate vaccine. Methodology/Principal Findings: The NOMV-fHbp vaccine was prepared from a mutant African MenW strain with PorA P1.5,2, attenuated endotoxin (Delta LpxL1), deleted capsular genes, and over-expressed fHbp in variant group 1. The NOMV-fHbp was adsorbed with Al(OH)(3) and used to reconstitute a lyophilized MenA conjugate vaccine, which normally is reconstituted with liquid MenC, Y and W conjugates in a meningococcal quadrivalent conjugate vaccine (MCV4-CRM, Novartis). Mice immunized with the NOMV-fHbp vaccine alone developed serum bactericidal (human complement) activity against 13 of 15 African MenA strains tested; 10 of 10 African MenX strains, 7 of 7 African MenW strains, and 6 of 6 genetically diverse MenB strains with fHbp variant group 1 (including 1 strain from The Gambia). The combination NOMV-fHbp/MenA conjugate vaccine elicited high serum bactericidal titers against the two MenA strains tested that were resistant to bactericidal antibodies elicited by the NOMV-fHbp alone; the combination elicited higher titers against the MenA and MenW strains than those elicited by a control MCV4-CRM vaccine (P<0.05); and high titers against MenX and MenB strains. For most strains, the titers elicited by a control NOMV-fHbp knock out vaccine were <1:10 except when the strain PorA matched the vaccine (titers >1:000). Conclusion/Significance: The NOMV-fHbp/MenA conjugate vaccine provided similar or higher coverage against MenA and MenW strains than a quadrivalent meningococcal conjugate vaccine, and extended protection against MenX strains responsible for epidemics in Africa, and MenB strains with fHbp in variant group 1.	[Pajon, Rolando; Fergus, Andrew M.; Granoff, Dan M.] Childrens Hosp, Oakland Res Inst, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA	Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Granoff, DM (corresponding author), Childrens Hosp, Oakland Res Inst, Ctr Immunobiol & Vaccine Dev, 747 52nd St, Oakland, CA 94609 USA.	dgranoff@chori.org			Public Health Service from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [R01 AI 046464, AI 082263]; Clorox Company; Research Facilities Improvement Program from the National Center for Research Resources, NIH [C06 RR 016226]; Novartis Vaccines and Diagnostics; Sanofi Pasteur; Novartis; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046464] Funding Source: NIH RePORTER	Public Health Service from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH); Clorox Company; Research Facilities Improvement Program from the National Center for Research Resources, NIH; Novartis Vaccines and Diagnostics; Sanofi Pasteur; Novartis(Novartis); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grants R01 AI 046464 and AI 082263 (to D.M.G.) from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH). D.M.G. also is supported in part by an endowment established by the Clorox Company. The laboratory work at Children's Hospital Oakland Research Institute was performed in a facility funded by Research Facilities Improvement Program grant C06 RR 016226 from the National Center for Research Resources, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Dan M. Granoff is principal investigator of laboratory research conducted on behalf of Children's Hospital Oakland Research Institute that is funded by grants from Novartis Vaccines and Diagnostics, and Sanofi Pasteur. D.M.G. is also supported in part by an endowment established by the Clorox Company. He also held a paid consultancy from Novartis. DMG and Rolando Pajon are inventors on patents or patent applications in the area of meningococcal vaccine. The patent applications relevant to the vaccine described in the manuscript are listed below. Andrew Fergus declares no conflicts. These competing interests do not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. Ctr : US Publication Number : 20120288517 Title : Factor H Binding proteins (FHBP) with altered properties and methods of use thereof Pub Date: Nov. 15, 2012 Organization : Children's Hospital Oakland California Inventor : Peter Beernink, Rolando Pajon and Dan M Granoff link: http://www.patentbuddy.com/Patent/20120288517 Ctr : US Publication Number : 20120093867 Title : GNA1870-Based Vesicle Vaccines for Broad Protection Against Diseases Caused by Neisseria meningitidis Pub Date: Apr. 19, 2012 Organization: Children's Hospital Oakland California Inventor : Dan M Granoff and Victor Hou link: http://patent.ipexl.com/U2S/20120093867.html	Beernink PT, 2009, J INFECT DIS, V199, P1360, DOI 10.1086/597806; Beernink PT, 2008, INFECT IMMUN, V76, P2568, DOI 10.1128/IAI.00033-08; Beernink PT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002688; Beernink PT, 2011, J IMMUNOL, V186, P3606, DOI 10.4049/jimmunol.1003470; Beernink PT, 2009, MOL IMMUNOL, V46, P1647, DOI 10.1016/j.molimm.2009.02.021; Ibarz-Pavon AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019717; Bishai DM, 2011, HEALTH AFFAIR, V30, P1058, DOI 10.1377/hlthaff.2011.0295; Boisier P, 2007, CLIN INFECT DIS, V44, P657, DOI 10.1086/511646; Broker M, 2009, VACCINE, V27, P5574, DOI 10.1016/j.vaccine.2009.07.036; Brunelli B, 2011, VACCINE, V29, P1072, DOI 10.1016/j.vaccine.2010.11.064; Caugant DA, 2007, VACCINE, V25, pA8, DOI 10.1016/j.vaccine.2007.04.033; Caugant DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046019; Chiavolini D, 2008, CLIN VACCINE IMMUNOL, V15, P1322, DOI 10.1128/CVI.00125-08; Cohn AC, 2010, CLIN INFECT DIS, V50, P184, DOI 10.1086/649209; Dagan R, 2010, VACCINE, V28, P5513, DOI 10.1016/j.vaccine.2010.06.026; DEMPSEY JAF, 1995, J BACTERIOL, V177, P6390, DOI 10.1128/jb.177.22.6390-6400.1995; Djingarey MH, 2012, VACCINE, V30, pB40, DOI 10.1016/j.vaccine.2011.12.073; FEAVERS IM, 1992, MOL MICROBIOL, V6, P489, DOI 10.1111/j.1365-2958.1992.tb01493.x; Ferrari G, 2006, PROTEOMICS, V6, P1856, DOI 10.1002/pmic.200500164; Findlow H, 2011, CLIN VACCINE IMMUNOL, V18, P1492, DOI 10.1128/CVI.05020-11; Findlow J, 2010, CLIN INFECT DIS, V51, P1127, DOI 10.1086/656741; FINNE J, 1983, LANCET, V2, P355; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; Galloway Y, 2009, INT J EPIDEMIOL, V38, P413, DOI 10.1093/ije/dyn228; Gasparini R, 2011, HUM VACCINES, V7, P170, DOI 10.4161/hv.7.2.13717; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Giuntini S, 2011, INFECT IMMUN, V79, P3751, DOI 10.1128/IAI.05182-11; Granoff DM, 2013, PEDIATR INFECT DIS J, V32, P372, DOI 10.1097/INF.0b013e318282942f; Granoff DM, 1998, CLIN DIAGN LAB IMMUN, V5, P479, DOI 10.1128/CDLI.5.4.479-485.1998; Gray-Owen SD, 2003, SCAND J INFECT DIS, V35, P614, DOI 10.1080/00365540310016042; Greenwood B, 2007, EPIDEMIOL INFECT, V135, P703, DOI 10.1017/S0950268807008825; Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2; Halperin SA, 2012, VACCINE, V30, pB26, DOI 10.1016/j.vaccine.2011.12.032; Harrison LH, 2008, JAMA-J AM MED ASSOC, V299, P217, DOI 10.1001/jama.2007.57-c; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Harrison LH, 2010, NAT REV DRUG DISCOV, V9, P429, DOI 10.1038/nrd3194; Harrison LH, 2010, CLIN INFECT DIS, V50, pS37, DOI 10.1086/648963; Jackson LA, 2009, PEDIATR INFECT DIS J, V28, P86, DOI 10.1097/INF.0b013e31818a0237; Jelfs J, 2000, CLIN DIAGN LAB IMMUN, V7, P390, DOI 10.1128/CDLI.7.3.390-395.2000; Jiang HQ, 2010, VACCINE, V28, P6086, DOI 10.1016/j.vaccine.2010.06.083; Jodar L, 2003, LANCET, V361, P1902, DOI 10.1016/S0140-6736(03)13494-0; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Keiser PB, 2011, VACCINE, V29, P1413, DOI 10.1016/j.vaccine.2010.12.039; Keyserling H, 2005, ARCH PEDIAT ADOL MED, V159, P907, DOI 10.1001/archpedi.159.10.907; Koeberling O, 2008, J INFECT DIS, V198, P262, DOI 10.1086/589308; Koeberling O, 2011, VACCINE, V29, P4728, DOI 10.1016/j.vaccine.2011.04.095; Koeberling O, 2011, CLIN VACCINE IMMUNOL, V18, P736, DOI 10.1128/CVI.00542-10; Koeberling O, 2009, CLIN VACCINE IMMUNOL, V16, P156, DOI 10.1128/CVI.00403-08; Kogan G, 1997, CARBOHYD RES, V298, P191, DOI 10.1016/S0008-6215(96)00305-9; Kristiansen PA, 2013, CLIN INFECT DIS, V56, P354, DOI 10.1093/cid/cis892; LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016/j.vaccine.2007.04.049; LaForce FM, 2009, VACCINE, V27, pB13, DOI 10.1016/j.vaccine.2009.04.062; Lee CH, 2009, VACCINE, V27, P726, DOI 10.1016/j.vaccine.2008.11.065; Lewis LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001027; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Marshall HS, 2012, PEDIATR INFECT DIS J, V31, P1061, DOI 10.1097/INF.0b013e31826327e4; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; Mothibeli KM, 2011, VACCINE, V29, P2187, DOI 10.1016/j.vaccine.2010.11.072; Mueller JE, 2006, EXPERT REV VACCINES, V5, P319, DOI 10.1586/14760584.5.3.319; Murphy E, 2009, J INFECT DIS, V200, P379, DOI 10.1086/600141; Nicolas P, 2005, J CLIN MICROBIOL, V43, P5129, DOI 10.1128/JCM.43.10.5129-5135.2005; Nokleby H, 2007, VACCINE, V25, P3080, DOI 10.1016/j.vaccine.2007.01.022; Norheim G, 2006, J CLIN MICROBIOL, V44, P861, DOI 10.1128/JCM.44.3.861-871.2006; Norheim G, 2012, SCAND J IMMUNOL, V76, P99, DOI 10.1111/j.1365-3083.2012.02709.x; Novak RT, 2012, LANCET INFECT DIS, V12, P757, DOI 10.1016/S1473-3099(12)70168-8; Pace D, 2009, CURR OPIN MOL THER, V11, P692; Pajon R, 2012, INFECT IMMUN, V80, P2667, DOI 10.1128/IAI.00103-12; Pajon R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001302; Pajon R, 2010, VACCINE, V28, P2122, DOI 10.1016/j.vaccine.2009.12.027; Perrett KP, 2009, PEDIATR INFECT DIS J, V28, P186, DOI 10.1097/INF.0b013e31818e037d; POOLMAN JT, 1995, CLIN DIAGN LAB IMMUN, V2, P69, DOI 10.1128/CDLI.2.1.69-72.1995; Popp A, 1999, CELL MICROBIOL, V1, P169, DOI 10.1046/j.1462-5822.1999.00017.x; Richmond PC, 2012, VACCINE, V30, P6163, DOI 10.1016/j.vaccine.2012.07.065; Richmond PC, 2012, LANCET INFECT DIS, V12, P597, DOI 10.1016/S1473-3099(12)70087-7; Scarselli M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002234; Seib KL, 2011, INFECT IMMUN, V79, P970, DOI 10.1128/IAI.00891-10; SIERRA G V G, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P195; Smith H, 1995, MICROB PATHOGENESIS, V19, P365, DOI 10.1006/mpat.1995.0071; Snape MD, 2010, PEDIATR INFECT DIS J, V29, pE71, DOI 10.1097/INF.0b013e3181f59f6d; Sow SO, 2011, NEW ENGL J MED, V364, P2293, DOI 10.1056/NEJMoa1003812; Steeghs L, 2004, J ENDOTOXIN RES, V10, P113, DOI 10.1179/096805104225004059; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; SUKER J, 1994, MOL MICROBIOL, V12, P253, DOI 10.1111/j.1365-2958.1994.tb01014.x; Tappero JW, 1999, JAMA-J AM MED ASSOC, V281, P1520, DOI 10.1001/jama.281.16.1520; Tsang RSW, 2001, FEMS MICROBIOL LETT, V199, P203, DOI 10.1111/j.1574-6968.2001.tb10675.x; Vu DM, 2011, VACCINE, V29, P1968, DOI 10.1016/j.vaccine.2010.12.075; WANG JF, 1992, INFECT IMMUN, V60, P5267, DOI 10.1128/IAI.60.12.5267-5282.1992; Welsch JA, 2004, J IMMUNOL, V172, P5606, DOI 10.4049/jimmunol.172.9.5606; Welsch JA, 2008, VACCINE, V26, pI40, DOI 10.1016/j.vaccine.2008.11.060; Wetzler LM, 2010, FUTURE MICROBIOL, V5, P749, DOI 10.2217/FMB.10.41; Xie O, 2012, VACCINE, V30, P5812, DOI 10.1016/j.vaccine.2012.07.032; Zollinger WD, 2010, VACCINE, V28, P5057, DOI 10.1016/j.vaccine.2010.05.006; Zughaier S, 2007, VACCINE, V25, P4401, DOI 10.1016/j.vaccine.2007.03.029	94	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66536	10.1371/journal.pone.0066536	http://dx.doi.org/10.1371/journal.pone.0066536			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805230	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500058
J	Bao, W; Jin, L; Fu, HJ; Shen, YN; Lu, GX; Mei, H; Cao, XZ; Wang, HS; Liu, WD				Bao, Wei; Jin, Lei; Fu, Hai-jing; Shen, Yong-nian; Lu, Gui-xia; Mei, Huan; Cao, Xin-zhi; Wang, Hong-sheng; Liu, Wei-da			Interleukin-22 Mediates Early Host Defense against Rhizomucor pusilluscan Pathogens	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; ROR-GAMMA-T; CANDIDA-ALBICANS; IMMUNITY; CELLS; DIFFERENTIATION; IL-22; CYTOKINE; MICE; TH17	Background: In recent years, the fungal infectious disease zygomycosis has increased in incidence worldwide, especially among the immunodeficient population. Despite the rates of zygomycosis-related death and deformation being very high, the mechanism(s) by which the fungal pathogens cause these severe manifestations remain unknown. Methods: Using the associated Rhizomucor variabilis species, which can selectively induce cutaneous zygomycosis in otherwise healthy individuals, we investigated the host mechanisms of infection-related responses, including cytokine and chemokine expression as well as contributions of particular T cell subsets. siRNA specifically targeting IL-22, IL-17 and IFN-gamma were used to down-regulate expression of those molecules. Results: In mouse models of infection, IL-22 was implicated in development of Rhizomucor spp.-induced skin lesions. In cultured human peripheral blood monocytes, R. pusilluscan, which is often found in immunodeficient patients, induced the production of IL-22, while R. variabilis did not. Moreover, Rhizomucor spp.-induced secretion of Il-22 from CCR6(+)CCR4(+)CCR10(+) cells was down-regulated by knockdown of IL-22 related signaling receptors, RORC and ARH. Conclusion: Our data strongly suggest that avoidance of IL-22 may be one mechanism by which mucor species produce morbidity and mortality in infected individuals.	[Bao, Wei; Shen, Yong-nian; Lu, Gui-xia; Mei, Huan; Wang, Hong-sheng; Liu, Wei-da] Chinese Acad Med Sci, Inst Dermatol, Jiangsu Key Lab Mol Biol Skin Dis & STIs, Dept Mycol, Nanjing, Jiangsu, Peoples R China; [Bao, Wei; Shen, Yong-nian; Lu, Gui-xia; Mei, Huan; Wang, Hong-sheng; Liu, Wei-da] Peking Union Med Coll, Nanjing, Jiangsu, Peoples R China; [Jin, Lei] Nanjing Univ, Jinling Hosp, Dept Stomatol, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Bao, Wei] Nanjing Univ, Jinling Hosp, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Fu, Hai-jing] Nanjing Univ, Jinling Hosp, Sch Med, Dept Med Oncol, Nanjing 210008, Jiangsu, Peoples R China; [Bao, Wei] Bayi Hosp, Nanjing, Jiangsu, Peoples R China; [Cao, Xin-zhi] Nanjing Univ, Jinling Hosp, Sch Clin, Dept Med Imaging,Med Coll, Nanjing 210008, Jiangsu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Nanjing University; Nanjing University; Nanjing University; Nanjing University of Chinese Medicine; Nanjing University	Liu, WD (corresponding author), Chinese Acad Med Sci, Inst Dermatol, Jiangsu Key Lab Mol Biol Skin Dis & STIs, Dept Mycol, Nanjing, Jiangsu, Peoples R China.	liumyco@hotmail.com			Ministry of Science and Technology of Major Projects [2008ZX1004-002]; Clinical Subjects' Key Project of the Ministry of Health [125]; National Natural Sciences Foundation of China [81000717]; China Postdoctoral Science Special Foundation [201104072]; China Postdoctoral Science Foundation [20100480233]; Natural Sciences Foundation of Jiangsu [BK2010134]	Ministry of Science and Technology of Major Projects; Clinical Subjects' Key Project of the Ministry of Health; National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Special Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Sciences Foundation of Jiangsu	This work was supported by grants from the Ministry of Science and Technology of Major Projects (No. 2008ZX1004-002), the 2010-2012 Clinical Subjects' Key Project of the Ministry of Health (No. 125), the National Natural Sciences Foundation of China (No. 81000717), the China Postdoctoral Science Special Foundation (No. 201104072), the China Postdoctoral Science Foundation (No. 20100480233), and the Natural Sciences Foundation of Jiangsu (No. BK2010134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cavani A, 2012, CHEM IMMUNOL ALLERGY, V96, P39, DOI 10.1159/000331870; De Luca A, 2010, MUCOSAL IMMUNOL, V3, P361, DOI 10.1038/mi.2010.22; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Eberl G, 2012, IMMUNOL REV, V245, P177, DOI 10.1111/j.1600-065X.2011.01071.x; Enoch DA, 2011, INT J ANTIMICROB AG, V38, P465, DOI 10.1016/j.ijantimicag.2011.05.010; Eyerich S, 2011, EUR J IMMUNOL, V41, P1894, DOI 10.1002/eji.201041197; Gessner MA, 2012, INFECT IMMUN, V80, P410, DOI 10.1128/IAI.05939-11; Gurney AL, 2004, INT IMMUNOPHARMACOL, V4, P669, DOI 10.1016/j.intimp.2004.01.016; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kaushik R, 2012, SURG INFECT, V13, P125, DOI 10.1089/sur.2010.078; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kontoyiannis DP, 2012, AM J MED, V125, pS25, DOI 10.1016/j.amjmed.2011.10.009; Lewis DL, 2002, NAT GENET, V32, P107, DOI 10.1038/ng944; Liu Y, 2009, EUR J IMMUNOL, V39, P1472, DOI 10.1002/eji.200838811; Lu XL, 2009, CLIN INFECT DIS, V49, pE39, DOI 10.1086/600817; Malley R, 2006, INFECT IMMUN, V74, P2187, DOI 10.1128/IAI.74.4.2187-2195.2006; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; McAleer JP, 2011, J LEUKOCYTE BIOL, V90, P263, DOI 10.1189/jlb.0211099; Muhl H, 2011, CELL MICROBIOL, V13, P340, DOI 10.1111/j.1462-5822.2010.01559.x; Page AV, 2008, TRANSPL INFECT DIS, V10, P419, DOI 10.1111/j.1399-3062.2008.00324.x; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Wincent E, 2009, J BIOL CHEM, V284, P2690, DOI 10.1074/jbc.M808321200; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Xiong N, 2012, PROTEIN CELL, V3, P571, DOI 10.1007/s13238-012-2927-3; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	30	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65065	10.1371/journal.pone.0065065	http://dx.doi.org/10.1371/journal.pone.0065065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23798999	Green Submitted, Green Published, gold			2022-12-25	WOS:000321397800002
J	Boudarham, J; Roche, N; Pradon, D; Bonnyaud, C; Bensmail, D; Zory, R				Boudarham, Julien; Roche, Nicolas; Pradon, Didier; Bonnyaud, Celine; Bensmail, Djamel; Zory, Raphael			Variations in Kinematics during Clinical Gait Analysis in Stroke Patients	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; STIFF-LEGGED GAIT; OLDER-ADULTS; COMMUNITY AMBULATION; RECTUS FEMORIS; CAUTIOUS GAIT; FATIGUE; PEOPLE; INDIVIDUALS; FALLS	In addition to changes in spatio-temporal and kinematic parameters, patients with stroke exhibit fear of falling as well as fatigability during gait. These changes could compromise interpretation of data from gait analysis. The aim of this study was to determine if the gait of hemiplegic patients changes significantly over successive gait trials. Forty two stroke patients and twenty healthy subjects performed 9 gait trials during a gait analysis session. The mean and variability of spatio-temporal and kinematic joint parameters were analyzed during 3 groups of consecutive gait trials (1-3, 4-6 and 7-9). Principal component analysis was used to reduce the number of variables from the joint kinematic waveforms and to identify the parts of the gait cycle which changed during the gait analysis session. The results showed that i) spontaneous gait velocity and the other spatio-temporal parameters significantly increased, and ii) gait variability decreased, over the last 6 gait trials compared to the first 3, for hemiplegic patients but not healthy subjects. Principal component analysis revealed changes in the sagittal waveforms of the hip, knee and ankle for hemiplegic patients after the first 3 gait trials. These results suggest that at the beginning of the gait analysis session, stroke patients exhibited phase of adaptation, characterized by a "cautious gait'' but no fatigue was observed.	[Boudarham, Julien; Roche, Nicolas; Pradon, Didier; Bonnyaud, Celine; Bensmail, Djamel; Zory, Raphael] CHU Raymond Poincare, GRCTH, EA4497, CIC IT 805, Garches, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP	Boudarham, J (corresponding author), CHU Raymond Poincare, GRCTH, EA4497, CIC IT 805, Garches, France.	julien.boudarham@yahoo.fr	roche, nicolas/R-6080-2018; Bonnyaud, Celine/AGK-7246-2022; Bensmail, Djamel/R-6035-2018	Bensmail, Djamel/0000-0001-9360-9330				Balash Y, 2007, J NEURAL TRANSM, V114, P1309, DOI 10.1007/s00702-007-0771-z; Barak Y, 2006, PHYS THER, V86, P1501, DOI 10.2522/ptj.20050387; Bautmans I, 2011, GAIT POSTURE, V33, P366, DOI 10.1016/j.gaitpost.2010.12.003; BOHANNON RW, 1987, ARCH PHYS MED REHAB, V68, P777; Callisaya ML, 2011, AGE AGEING, V40, P481, DOI 10.1093/ageing/afr055; Carin-Levy G, 2006, CEREBROVASC DIS, V21, P201, DOI 10.1159/000090792; Carriero A, 2009, GAIT POSTURE, V29, P71, DOI 10.1016/j.gaitpost.2008.06.011; Chen G, 2005, GAIT POSTURE, V22, P51, DOI 10.1016/j.gaitpost.2004.06.009; Deluzio KJ, 2007, GAIT POSTURE, V25, P86, DOI 10.1016/j.gaitpost.2006.01.007; Duncan F, 2012, INT J STROKE, V7, P157, DOI 10.1111/j.1747-4949.2011.00741.x; Eng JJ, 2002, ARCH PHYS MED REHAB, V83, P1138, DOI 10.1053/apmr.2002.33644; Giladi N, 2005, J NEUROL, V252, P300, DOI 10.1007/s00415-005-0641-2; Goldberg SR, 2003, J BIOMECH, V36, P1111, DOI 10.1016/S0021-9290(03)00106-4; Harris JE, 2005, PHYS THER, V85, P150, DOI 10.1093/ptj/85.2.150; Hausdorff J. M., 2005, J NEUROENG REHABIL, V2, P2; Helbostad JL, 2007, J GERONTOL A-BIOL, V62, P1010, DOI 10.1093/gerona/62.9.1010; Herman T, 2005, GAIT POSTURE, V21, P178, DOI 10.1016/j.gaitpost.2004.01.014; Hill Keith, 1997, Aust J Physiother, V43, P173; Hsu AL, 2003, ARCH PHYS MED REHAB, V84, P1185, DOI 10.1016/S0003-9993(03)00030-3; Hutin E, 2012, GAIT POSTURE, V36, P205, DOI 10.1016/j.gaitpost.2012.02.016; Hutin E, 2010, NEUROREHAB NEURAL RE, V24, P442, DOI 10.1177/1545968309354535; Hyngstrom AS, 2012, AM J PHYS MED REHAB, V91, P33, DOI 10.1097/PHM.0b013e31823caac0; Iosa M, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/810415; JACKSON JE, 1991, USERS GUIDE PRINCIPL; Jonkers I, 2009, GAIT POSTURE, V29, P129, DOI 10.1016/j.gaitpost.2008.07.010; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Kavanagh JJ, 2008, GAIT POSTURE, V28, P1, DOI 10.1016/j.gaitpost.2007.10.010; KERRIGAN DC, 1991, AM J PHYS MED REHAB, V70, P294; Kesar TM, 2011, GAIT POSTURE, V33, P314, DOI 10.1016/j.gaitpost.2010.11.024; Kirkwood RN, 2011, BRAZ J PHYS THER, V15, P52, DOI 10.1590/S1413-35552011000100007; Lam R, 2011, CAN FAM PHYSICIAN, V57, P765; Lerdal A, 2009, J PAIN SYMPTOM MANAG, V38, P928, DOI 10.1016/j.jpainsymman.2009.04.028; Lewis SJ, 2011, ARCH PHYS MED REHAB, V92, P295, DOI 10.1016/j.apmr.2010.10.030; Lord SE, 2005, STROKE, V36, P1457, DOI 10.1161/01.STR.0000170698.20376.2e; Lord SE, 2004, ARCH PHYS MED REHAB, V85, P234, DOI 10.1016/j.apmr.2003.05.002; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Maynard V, 2003, GAIT POSTURE, V17, P59, DOI 10.1016/S0966-6362(02)00051-6; McGinley JL, 2009, GAIT POSTURE, V29, P360, DOI 10.1016/j.gaitpost.2008.09.003; Morris ME, 2002, J NEUROL NEUROSUR PS, V72, P361, DOI 10.1136/jnnp.72.3.361; Muniz AMS, 2009, GAIT POSTURE, V29, P31, DOI 10.1016/j.gaitpost.2008.05.015; Nagai K, 2012, AGING CLIN EXP RES, V24, P157, DOI 10.3275/7716; Niechwiej-Szwedo E, 2007, GAIT POSTURE, V25, P70, DOI 10.1016/j.gaitpost.2006.01.002; Oken O, 2008, GAIT POSTURE, V27, P506, DOI 10.1016/j.gaitpost.2007.06.007; OLNEY SJ, 1994, PHYS THER, V74, P872, DOI 10.1093/ptj/74.9.872; Patla AE, 1999, J AGING PHYS ACTIV, V7, P7, DOI 10.1123/japa.7.1.7; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; Perry J., 1992, GAIT ANAL NORMAL PAT; Reid SM, 2010, GAIT POSTURE, V31, P197, DOI 10.1016/j.gaitpost.2009.10.005; Robertson JVG, 2009, GAIT POSTURE, V29, P108, DOI 10.1016/j.gaitpost.2008.07.005; Schmid AA, 2011, AM J OCCUP THER, V65, P125, DOI 10.5014/ajot.2011.000737; Schwartz MH, 2004, GAIT POSTURE, V20, P196, DOI 10.1016/j.gaitpost.2003.09.011; Sehle A, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-59; Sibley KM, 2008, GAIT POSTURE, V27, P387, DOI 10.1016/j.gaitpost.2007.05.007; Sibley KM, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-27; Straudi S, 2009, EUR J PHYS REHAB MED, V45, P341; Sung DH, 2000, ARCH PHYS MED REHAB, V81, P910, DOI 10.1053/apmr.2000.5615; Weerdesteyn V, 2008, J REHABIL RES DEV, V45, P1195, DOI 10.1682/JRRD.2007.09.0145; WINTER DA, 1974, J BIOMECH, V7, P157, DOI 10.1016/0021-9290(74)90056-6; Yavuzer G, 2008, GAIT POSTURE, V27, P31, DOI 10.1016/j.gaitpost.2006.12.016	59	85	92	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66421	10.1371/journal.pone.0066421	http://dx.doi.org/10.1371/journal.pone.0066421			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799100	Green Published, Green Submitted, gold			2022-12-25	WOS:000321397800032
J	Gu, L; Bai, WL; Li, S; Zhang, YQ; Han, Y; Gu, Y; Meng, GL; Xie, LP; Wang, J; Xiao, YJ; Shan, LY; Zhou, SM; Wei, L; Ferro, A; Ji, Y				Gu, Lei; Bai, Wenli; Li, Sha; Zhang, Yuqing; Han, Yi; Gu, Yue; Meng, Guoliang; Xie, Liping; Wang, Jing; Xiao, Yujiao; Shan, Liyang; Zhou, Suming; Wei, Lei; Ferro, Albert; Ji, Yong			Celastrol Prevents Atherosclerosis via Inhibiting LOX-1 and Oxidative Stress	PLOS ONE			English	Article							NF-KAPPA-B; LOW-DENSITY-LIPOPROTEIN; FOAM CELL-FORMATION; NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE-CELLS; APOE KNOCKOUT MICE; OXIDIZED-LDL; RECEPTOR LOX-1; UP-REGULATION; NUDE-MICE	Celastrol is a triterpenoid compound extracted from the Chinese herb Tripterygium wilfordii Hook F. Previous research has revealed its anti-oxidant, anti-inflammatory, anti-cancer and immunosuppressive properties. Here, we investigated whether celastrol inhibits oxidized low-density lipoprotein (oxLDL) induced oxidative stress in RAW 264.7 cells. In addition, the effect of celastrol on atherosclerosis in vivo was assessed in apolipoprotein E knockout (apoE(-/-)) mouse fed a high-fat/high-cholesterol diet (HFC). We found that celastrol significantly attenuated oxLDL-induced excessive expression of lectin-like oxidized low density lipoprotein receptor-1(LOX-1) and generation of reactive oxygen species (ROS) in cultured RAW264.7 macrophages. Celastrol also decreased I kappa B phosphorylation and degradation and reduced production of inducible nitric oxide synthase (iNOS), nitric oxide (NO) and proinflammatory cytokines such as tumor necrosis factor (TNF)-alpha and IL-6. Celastrol reduced atherosclerotic plaque size in apoE(-/-) mice. The expression of LOX-1 within the atherosclerotic lesions and generation of superoxide in mouse aorta were also significantly reduced by celastrol while the lipid profile was not improved. In conclusion, our results show that celastrol inhibits atherosclerotic plaque developing in apoE(-/-) mice via inhibiting LOX-1 and oxidative stress.	[Gu, Lei; Bai, Wenli; Li, Sha; Gu, Yue; Meng, Guoliang; Xie, Liping; Wang, Jing; Xiao, Yujiao; Shan, Liyang; Ji, Yong] Nanjing Med Univ, Atherosclerosis Res Ctr, State Key Lab Reprod Med, Lab Cardiovasc Dis & Mol Intervent, Nanjing, Jiangsu, Peoples R China; [Zhang, Yuqing; Zhou, Suming] Nanjing Med Univ, Affiliated Jiangning Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Han, Yi] Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Nanjing, Jiangsu, Peoples R China; [Wei, Lei] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Nanjing, Jiangsu, Peoples R China; [Ferro, Albert] Kings Coll London, Dept Clin Pharmacol, Div Cardiovasc, London WC2R 2LS, England	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; University of London; King's College London	Ji, Y (corresponding author), Nanjing Med Univ, Atherosclerosis Res Ctr, State Key Lab Reprod Med, Lab Cardiovasc Dis & Mol Intervent, Nanjing, Jiangsu, Peoples R China.	yongji@njmu.edu.cn	Gu, Lei/GWQ-6785-2022	Ferro, Albert/0000-0002-5486-9145; Shan, Liyang/0000-0003-0431-4376	National Basic Research Program (973) [2011CB503903]; National Natural Science Foundation of China [81170083, 81200196]; Universities Natural Science Research Project of Jiangsu Province [10KJA310033]; PAPD	National Basic Research Program (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Universities Natural Science Research Project of Jiangsu Province; PAPD	This work was supported by grants from National Basic Research Program (973) (No. 2011CB503903), the National Natural Science Foundation of China (No. 81170083, 81200196), Universities Natural Science Research Project of Jiangsu Province (No. 10KJA310033) and PAPD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti A, 2004, THORAX, V59, P483, DOI 10.1136/thx.2003.017640; Aoyama T, 2000, FEBS LETT, V467, P217, DOI 10.1016/S0014-5793(00)01154-6; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Buttery LDK, 1996, LAB INVEST, V75, P77; Cheng J, 2011, AFR J PHARM PHARMACO, V5, P1247, DOI 10.5897/AJPP11.458; Cominacini L, 2000, J BIOL CHEM, V275, P12633, DOI 10.1074/jbc.275.17.12633; Dhar A, 2003, MOL CANCER THER, V2, P1285; DI MASCIO P, 1991, AM J CLIN NUTR, V53, pS194, DOI 10.1093/ajcn/53.1.194S; Feng XY, 2010, ATHEROSCLEROSIS, V208, P396, DOI 10.1016/j.atherosclerosis.2009.07.035; Fortuno A, 2005, EXP PHYSIOL, V90, P457, DOI 10.1113/expphysiol.2005.030098; GAMBLE W, 1978, J LIPID RES, V19, P1068; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Gutteridge JMC, 2000, ANN NY ACAD SCI, V899, P136, DOI 10.1111/j.1749-6632.2000.tb06182.x; Hashizume M, 2012, CYTOKINE, V58, P424, DOI 10.1016/j.cyto.2012.02.010; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hofnagel O, 2006, ARTERIOSCL THROM VAS, V26, P604, DOI 10.1161/01.ATV.0000201073.45862.8b; Huang YL, 2008, CANCER LETT, V264, P101, DOI 10.1016/j.canlet.2008.01.043; Inoue K, 2005, CIRC RES, V97, P176, DOI 10.1161/01.RES.0000174286.73200.d4; Ishiyama J, 2010, ATHEROSCLEROSIS, V209, P118, DOI 10.1016/j.atherosclerosis.2009.09.004; Itabe H, 2003, BIOL PHARM BULL, V26, P1, DOI 10.1248/bpb.26.1; Jang SY, 2011, CANCER LETT, V300, P57, DOI 10.1016/j.canlet.2010.09.006; Jung HW, 2007, EXP MOL MED, V39, P715, DOI 10.1038/emm.2007.78; Kataoka H, 1999, CIRCULATION, V99, P3110, DOI 10.1161/01.CIR.99.24.3110; Kim DH, 2009, EUR J CLIN INVEST, V39, P819, DOI 10.1111/j.1365-2362.2009.02186.x; Lee JH, 2006, BIOCHEM PHARMACOL, V72, P1311, DOI 10.1016/j.bcp.2006.08.014; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Li DY, 2001, CARDIOVASC RES, V52, P130, DOI 10.1016/S0008-6363(01)00371-6; Li L, 2004, CIRC RES, V94, P892, DOI 10.1161/01.RES.0000124920.09738.26; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; Makarov SS, 2001, ARTHRITIS RES, V3, P200, DOI 10.1186/ar300; MARLETTA MA, 1988, BIOCHEMISTRY-US, V27, P8706, DOI 10.1021/bi00424a003; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Musiek ES, 2005, J BIOL CHEM, V280, P35562, DOI 10.1074/jbc.M504785200; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; OHARA Y, 1993, J CLIN INVEST, V91, P2546, DOI 10.1172/JCI116491; Poli G, 2004, CURR MED CHEM, V11, P1163, DOI 10.2174/0929867043365323; Pueyo ME, 2000, ARTERIOSCL THROM VAS, V20, P645, DOI 10.1161/01.ATV.20.3.645; SASSA H, 1990, BIOCHEM BIOPH RES CO, V172, P890, DOI 10.1016/0006-291X(90)90759-G; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Schmitz G, 2007, ANTIOXID REDOX SIGN, V9, P1499, DOI 10.1089/ars.2007.1663; Scott J, 2007, NEW ENGL J MED, V357, P2195, DOI 10.1056/NEJMcibr075951; SIES H, 1989, NATURWISSENSCHAFTEN, V76, P57, DOI 10.1007/BF00396705; Stein S, 2010, EUR HEART J, V31, P2301, DOI 10.1093/eurheartj/ehq107; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; Sukhanov S, 2006, CIRC RES, V99, P191, DOI 10.1161/01.RES.0000232319.02303.8c; Taye A, 2010, EUR J PHARMACOL, V627, P42, DOI 10.1016/j.ejphar.2009.10.045; Wang YF, 2009, ARTERIOSCL THROM VAS, V29, P173, DOI 10.1161/ATVBAHA.108.179333; Wang Y, 2011, BIOCHEM BIOPH RES CO, V411, P543, DOI 10.1016/j.bbrc.2011.06.177; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; White SJ, 2011, CARDIOVASC PATHOL, V20, P369, DOI 10.1016/j.carpath.2010.08.007; Xu XB, 2007, ARTERIOSCL THROM VAS, V27, P871, DOI 10.1161/01.ATV.0000259358.31234.37; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yu XA, 2010, AM J HYPERTENS, V23, P895, DOI 10.1038/ajh.2010.75	55	70	74	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65477	10.1371/journal.pone.0065477	http://dx.doi.org/10.1371/journal.pone.0065477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799016	gold, Green Published, Green Submitted			2022-12-25	WOS:000321397800008
J	Heinrichs, D; Berres, ML; Nellen, A; Fischer, P; Scholten, D; Trautwein, C; Wasmuth, HE; Sahin, H				Heinrichs, Daniel; Berres, Marie-Luise; Nellen, Andreas; Fischer, Petra; Scholten, David; Trautwein, Christian; Wasmuth, Hermann E.; Sahin, Hacer			The Chemokine CCL3 Promotes Experimental Liver Fibrosis in Mice	PLOS ONE			English	Article							T-CELLS; LYMPHOCYTES; CHEMOTAXIS; EXPRESSION; PROTEIN-1; HEPATITIS; RECEPTOR; DISEASE; INJURY; GAMMA	Liver fibrosis is associated with infiltrating immune cells and activation of hepatic stellate cells. We here aimed to investigate the effects of the CC chemokine CCL3, also known as macrophage inflammatory protein-1a, in two different fibrosis models. To this end, we treated mice either with carbon tetrachloride or with a methionine-and choline-deficient diet to induce fibrosis in CCL3 deficient and wild-type mice. The results show that the protein expression of CCL3 is increased in wild-type mice after chronic liver injury. Deletion of CCL3 exhibited reduced liver fibrosis compared to their wild-type counterparts. We could validate these results by treating the two mouse groups with either carbon tetrachloride or by feeding a methionine-and choline-deficient diet. In these models, lack of CCL3 is functionally associated with reduced stellate cell activation and liver immune cell infiltration. In vitro, we show that CCL3 leads to increased proliferation and migration of hepatic stellate cells. In conclusion, our results define the chemokine CCL3 as a mediator of experimental liver fibrosis. Thus, therapeutic modulation of CCL3 might be a promising target for chronic liver diseases.	[Heinrichs, Daniel; Berres, Marie-Luise; Nellen, Andreas; Fischer, Petra; Scholten, David; Trautwein, Christian; Wasmuth, Hermann E.; Sahin, Hacer] Univ Hosp Aachen, Dept Med 3, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital	Sahin, H (corresponding author), Univ Hosp Aachen, Dept Med 3, Aachen, Germany.	hasahin@ukaachen.de	Berres, Marie-Luise/AAN-5351-2021		Deutsche Forschungsgemeinschaft [WA2557/2-1, SFB/TRR 57]; Else Kroner-Fresenius Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner-Fresenius Stiftung	This work was supported by grants from the Deutsche Forschungsgemeinschaft (WA2557/2-1 and SFB/TRR 57) and the Else Kroner-Fresenius Stiftung to H.E.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuebor MN, 2004, EUR J PHARMACOL, V497, P343, DOI 10.1016/j.ejphar.2004.07.005; Ajuebor MN, 2004, EUR J IMMUNOL, V34, P2907, DOI 10.1002/eji.200425071; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Berkman N, 1995, J IMMUNOL; Berres ML, 2010, J CLIN INVEST, V120, P4129, DOI 10.1172/JCI41732; Bonecchi R, 1999, J IMMUNOL, V162, P474; Colobran R, 2010, CLIN EXP IMMUNOL, V162, P41, DOI 10.1111/j.1365-2249.2010.04224.x; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Goulding C, 2005, GUT, V54, P1157, DOI 10.1136/gut.2004.055699; Holt AP, 2008, CLIN LIVER DIS, V12, P861, DOI 10.1016/j.cld.2008.07.002; Holt AP, 2009, GASTROENTEROLOGY, V136, P705, DOI 10.1053/j.gastro.2008.10.020; Ishikawa S, 2011, J HEPATOL, V54, P1195, DOI 10.1016/j.jhep.2010.08.022; Karlmark Karlin Raja, 2008, Expert Rev Gastroenterol Hepatol, V2, P233, DOI 10.1586/17474124.2.2.233; MARRA F, 1993, J CLIN INVEST, V92, P1674, DOI 10.1172/JCI116753; Marra F, 2009, SEMIN IMMUNOPATHOL, V31, P345, DOI 10.1007/s00281-009-0169-0; Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X; Nellen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036614; Park O, 2009, HEPATOLOGY, V49, P1683, DOI 10.1002/hep.22813; ROT A, 1992, J EXP MED, V176, P1489, DOI 10.1084/jem.176.6.1489; Roth SJ, 1995, EUR J IMMUNOL, V25, P3482, DOI 10.1002/eji.1830251241; Sahin H, 2012, BIOCH BIOPHYS ACTA; Sahin H, 2012, HEPATOLOGY, V55, P1610, DOI 10.1002/hep.25545; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Stock MK, 2013, INT J CLIN EXP PATHO, V6, P678; Takahashi H, 2002, J LEUKOCYTE BIOL, V72, P1190; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Vicente CP, 1998, MOL CELL BIOCHEM, V187, P11, DOI 10.1023/A:1006886308490; Wasmuth HE, 2009, GASTROENTEROLOGY, V137, P309, DOI 10.1053/j.gastro.2009.03.053; Yang XB, 2011, AM J RESP CELL MOL, V45, P127, DOI 10.1165/rcmb.2010-0265OC	29	42	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66106	10.1371/journal.pone.0066106	http://dx.doi.org/10.1371/journal.pone.0066106			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799074	Green Published, gold, Green Submitted			2022-12-25	WOS:000321397800023
J	Cid, E; Yamamoto, M; Buschbeck, M; Yamamoto, F				Cid, Emili; Yamamoto, Miyako; Buschbeck, Marcus; Yamamoto, Fumiichiro			Murine Cell Glycolipids Customization by Modular Expression of Glycosyltransferases	PLOS ONE			English	Article							SSEA-3	Functional analysis of glycolipids has been hampered by their complex nature and combinatorial expression in cells and tissues. We report an efficient and easy method to generate cells with specific glycolipids. In our proof of principle experiments we have demonstrated the customized expression of two relevant glycosphingolipids on murine fibroblasts, stage-specific embryonic antigen 3 (SSEA-3), a marker for stem cells, and Forssman glycolipid, a xenoantigen. Sets of genes encoding glycosyltansferases were transduced by viral infection followed by multi-color cell sorting based on coupled expression of fluorescent proteins.	[Cid, Emili; Yamamoto, Miyako; Yamamoto, Fumiichiro] Inst Med Predict & Personalitzada Canc IMPPC, Canc Genet & Epigenet Program, ABO Histoblood Grp & Canc Lab, Badalona, Catalunya, Spain; [Buschbeck, Marcus] Inst Med Predict & Personalitzada Canc IMPPC, Canc Genet & Epigenet Program, Chromatin & Cell Fate Lab, Badalona, Catalunya, Spain		Cid, E (corresponding author), Inst Med Predict & Personalitzada Canc IMPPC, Canc Genet & Epigenet Program, ABO Histoblood Grp & Canc Lab, Badalona, Catalunya, Spain.	ecid@imppc.org	Yamamoto, Fumiichiro/F-1478-2016; Buschbeck, Marcus/J-8204-2017; Cid, Emili/F-7207-2016; Yamamoto, Miyako/F-1722-2016	Yamamoto, Fumiichiro/0000-0001-9690-7034; Buschbeck, Marcus/0000-0002-3218-4567; Cid, Emili/0000-0002-5025-352X; Yamamoto, Miyako/0000-0001-9516-1402	Spanish Fondo de Investigaciones Sanitarias (Ministerio de Salud, Instituto Carlos III) [PI11/00454]; Institut de Medicina Predictiva I Personalitzada del Cancer (IMPPC); national Ministerio de Economiay Competitividad (MINECO) [SAF2012-39749, RYC2010-07337]	Spanish Fondo de Investigaciones Sanitarias (Ministerio de Salud, Instituto Carlos III); Institut de Medicina Predictiva I Personalitzada del Cancer (IMPPC); national Ministerio de Economiay Competitividad (MINECO)	The work was supported by the Spanish Fondo de Investigaciones Sanitarias (Ministerio de Salud, Instituto Carlos III) grant PI11/00454 [http://www.isciii.es] and the fund from Institut de Medicina Predictiva I Personalitzada del Cancer (IMPPC) to FY [http://www.imppc.org]. MB is a Ramony Cajal Fellow and supported by national Ministerio de Economiay Competitividad (MINECO) grants SAF2012-39749 and RYC2010-07337 [http://www.mineco.gob.es]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buschbeck M, 2005, EMBO REP, V6, P63, DOI 10.1038/sj.embor.7400316; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; KIT S, 1963, EXP CELL RES, V31, P297, DOI 10.1016/0014-4827(63)90007-7; Morozova KS, 2010, BIOPHYS J, V99, pL13, DOI 10.1016/j.bpj.2010.04.025; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Subach OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028674; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; Yamamoto F, 2012, TRANSFUS MED REV, V26, P103, DOI 10.1016/j.tmrv.2011.08.002; Yanagisawa M, 2011, ASN NEURO, V3, DOI 10.1042/AN20110006; Yu R. K., 2007, COMPREHENSIVE GLYCOS, P73; Yu RK, 2012, NEUROCHEM RES, V37, P1230, DOI 10.1007/s11064-012-0744-y; Zhang XB, 2004, ANN CLIN LAB SCI, V34, P3; Zhou DP, 2000, J BIOL CHEM, V275, P22631, DOI 10.1074/jbc.C000263200	15	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e64728	10.1371/journal.pone.0064728	http://dx.doi.org/10.1371/journal.pone.0064728			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23798992	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300001
J	Li, J; Yang, LJ; Qin, WJ; Zhang, G; Yuan, JL; Wang, FL				Li, Jun; Yang, Lijun; Qin, Weijun; Zhang, Geng; Yuan, Jianlin; Wang, Fuli			Adaptive Induction of Growth Differentiation Factor 15 Attenuates Endothelial Cell Apoptosis in Response to High Glucose Stimulus	PLOS ONE			English	Article							MACROPHAGE INHIBITORY CYTOKINE-1; BETA SUPERFAMILY MEMBER; JUN NH2-TERMINAL KINASE; NF-KAPPA-B; CANCER CELLS; GENE-EXPRESSION; REACTIVE OXYGEN; P53; PROLIFERATION; DYSFUNCTION	Growth differentiation factor 15 (GDF15), a direct target gene of p53, is a multifunctional member of the TGF-beta/BMP superfamily. GDF15 can be induced and is implicated as a key secretory cytokine in response to multiple cellular stimuli. Accumulating evidence indicates that GDF15 is associated with the development and prognosis of diabetes mellitus, while whether GDF15 can be induced by high glucose is unknown. In the present study, we revealed that high glucose could induce GDF15 expression and secretion in cultured human umbilical vein endothelial cells in a ROS-and p53-dependent manner. Inhibition of high glucose-induced GDF15 expression by siRNA demonstrated that adaptively induced GDF15 played a protective role against high glucose-induced human umbilical vein endothelial cell apoptosis via maintaining the active state of PI3K/Akt/eNOS pathway and attenuating NF-kappa B/JNK pathway activation. The protective effects of GDF15 were probably achieved by inhibiting ROS overproduction in high glucose-treated human umbilical vein endothelial cells in a negative feedback manner. Our results suggest that high glucose can promote GDF15 expression and secretion in human umbilical vein endothelial cells, which in turn attenuates high glucose-induced endothelial cell apoptosis.	[Li, Jun] Fourth Mil Med Univ, Dept Burns & Cutaneous Surg, Xijing Hosp, Xian 710032, Peoples R China; [Yang, Lijun; Qin, Weijun; Zhang, Geng; Yuan, Jianlin; Wang, Fuli] Fourth Mil Med Univ, Dept Urol, Xijing Hosp, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Wang, FL (corresponding author), Fourth Mil Med Univ, Dept Urol, Xijing Hosp, Xian 710032, Peoples R China.	wangfuli98@gmail.com		Li, Jun/0000-0001-8702-8054	National Natural Science Foundation of China [81072116, 30872583]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by two grants from the National Natural Science Foundation of China: #81072116 (http://159.226.244.22/portal/Proj_List. asp); #30872583 (http://159.226.244.22/portal/Proj_List.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanas'ev I, 2010, OXID MED CELL LONGEV, V3, P361, DOI 10.4161/oxim.3.6.14415; Ago T, 2006, CIRC RES, V98, P294, DOI 10.1161/01.RES.0000207919.83894.9d; Albertoni M, 2002, ONCOGENE, V21, P4212, DOI 10.1038/sj.onc.1205610; Appierto V, 2009, CARCINOGENESIS, V30, P824, DOI 10.1093/carcin/bgp067; Baek SJ, 2006, PROG LIPID RES, V45, P1, DOI 10.1016/j.plipres.2005.10.001; Baek SJ, 2001, MOL PHARMACOL, V59, P901, DOI 10.1124/mol.59.4.901; Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Brown DA, 2002, LANCET, V359, P2159, DOI 10.1016/S0140-6736(02)09093-1; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Chan D, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-34; Chao CL, 2009, BRIT J NUTR, V101, P1165, DOI 10.1017/S0007114508073637; Dostalova I, 2009, EUR J ENDOCRINOL, V161, P397, DOI 10.1530/EJE-09-0417; Du XL, 1999, FREE RADICAL BIO MED, V27, P752, DOI 10.1016/S0891-5849(99)00079-9; Funk SD, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/569654; Hadi HAR, 2007, VASC HEALTH RISK MAN, V3, P853; Heger J, 2010, J CELL PHYSIOL, V224, P120, DOI 10.1002/jcp.22102; Ho FM, 2000, CIRCULATION, V101, P2618, DOI 10.1161/01.CIR.101.22.2618; Ho FM, 2006, CELL SIGNAL, V18, P391, DOI 10.1016/j.cellsig.2005.05.009; Hromas R, 1997, BBA-GENE STRUCT EXPR, V1354, P40, DOI 10.1016/S0167-4781(97)00122-X; Husaini Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043833; Ido Y, 2002, DIABETES, V51, P159, DOI 10.2337/diabetes.51.1.159; Kelly JA, 2009, CANCER LETT, V277, P38, DOI 10.1016/j.canlet.2008.11.013; Kempf T, 2006, CIRC RES, V98, P351, DOI 10.1161/01.RES.0000202805.73038.48; Kim JS, 2005, MOL CANCER THER, V4, P487; Kim KK, 2008, CARCINOGENESIS, V29, P704, DOI 10.1093/carcin/bgn031; Lawton LN, 1997, GENE, V203, P17, DOI 10.1016/S0378-1119(97)00485-X; Lee SH, 2005, BIOCHEM BIOPH RES CO, V328, P63, DOI 10.1016/j.bbrc.2004.12.138; Li HS, 2005, J CLIN ENDOCR METAB, V90, P3045, DOI 10.1210/jc.2004-0808; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Liu T, 2003, CANCER RES, V63, P5034; Macia L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034868; Matsui-Hirai H, 2011, J PHARMACOL EXP THER, V337, P591, DOI 10.1124/jpet.110.177584; Mraz M, 2011, J CLIN ENDOCR METAB, V96, pE606, DOI 10.1210/jc.2010-1858; Nickel N, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-62; Orimo M, 2009, ARTERIOSCL THROM VAS, V29, P889, DOI 10.1161/ATVBAHA.109.185694; Pang RP, 2007, CANCER LETT, V251, P268, DOI 10.1016/j.canlet.2006.11.032; Paralkar VM, 1998, J BIOL CHEM, V273, P13760, DOI 10.1074/jbc.273.22.13760; Piconi L, 2006, DIABETES-METAB RES, V22, P198, DOI 10.1002/dmrr.613; Senapati S, 2010, ONCOGENE, V29, P1293, DOI 10.1038/onc.2009.420; Sheu ML, 2005, ARTERIOSCL THROM VAS, V25, P539, DOI 10.1161/01.ATV.0000155462.24263.e4; Subramaniam S, 2003, J BIOL CHEM, V278, P8904, DOI 10.1074/jbc.M210037200; Tan MJ, 2000, P NATL ACAD SCI USA, V97, P109, DOI 10.1073/pnas.97.1.109; van den Oever IAM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/792393; Vanhara P, 2009, DIFFERENTIATION, V78, P213, DOI 10.1016/j.diff.2009.07.008; Wadham C, 2007, DIABETES, V56, P2715, DOI 10.2337/db06-1294; Wollert KC, 2007, BASIC RES CARDIOL, V102, P412, DOI 10.1007/s00395-007-0662-3; Xu J, 2006, CIRC RES, V98, P342, DOI 10.1161/01.RES.0000202804.84885.d0; Yan M, 2004, P NATL ACAD SCI USA, V101, P17468, DOI 10.1073/pnas.0406142101; Yokoi T, 2006, DIABETES, V55, P1660, DOI 10.2337/db05-1607; YokoyamaKobayashi M, 1997, J BIOCHEM-TOKYO, V122, P622; Zanetti M, 2008, J MOL MED-JMM, V86, P185, DOI 10.1007/s00109-007-0257-3; Zhang L, 2009, ORAL ONCOL, V45, P627, DOI 10.1016/j.oraloncology.2008.07.017	53	66	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65549	10.1371/journal.pone.0065549	http://dx.doi.org/10.1371/journal.pone.0065549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799024	gold, Green Published, Green Submitted			2022-12-25	WOS:000320363300023
J	Sivro, A; McKinnon, LR; Ji, HZ; Kimani, J; Jaoko, W; Plummer, FA; Su, RC; Ball, TB				Sivro, Aida; McKinnon, Lyle R.; Ji, Hezhao; Kimani, Joshua; Jaoko, Walter; Plummer, Francis A.; Su, Ruey-Chyi; Ball, T. Blake			Interferon Regulatory Factor 1 Polymorphisms Previously Associated with Reduced HIV Susceptibility Have No Effect on HIV Disease Progression	PLOS ONE			English	Article							RESISTANCE; INFECTION; IDENTIFICATION; NAIROBI	Introduction: Interferon regulatory factor 1 (IRF1) is induced by HIV early in the infection process and serves two functions: transactivation of the HIV-1 genome and thus replication, and eliciting antiviral innate immune responses. We previously described three IRF1 polymorphisms that correlate with reduced IRF1 expression and reduced HIV susceptibility. Objective: To determine whether IRF1 polymorphisms previously associated with reduced HIV susceptibility play a role in HIV pathogenesis and disease progression in HIV-infected ART-naive individuals. Methods: IRF1 genotyping for polymorphisms (619, MS and 6516) was performed by PCR in 847 HIV positive participants from a sex worker cohort in Nairobi, Kenya. Rates of CD4+ T cell decline and viral loads (VL) were analyzed using linear mixed models. Results: Three polymorphisms in the IRF1, located at 619, microsatellite region and 6516 of the gene, previously associated with decreased susceptibility to HIV infection show no effect on disease progression, either measured by HIV-1 RNA levels or the slopes of CD4 decline before treatment initiation. Conclusion: Whereas these three polymorphisms in the IRF1 gene protect against HIV-1 acquisition, they appear to exert no discernable effects once infection is established.	[Sivro, Aida; Kimani, Joshua; Plummer, Francis A.; Su, Ruey-Chyi; Ball, T. Blake] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Ball, T. Blake] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [McKinnon, Lyle R.; Kimani, Joshua; Jaoko, Walter; Ball, T. Blake] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [McKinnon, Lyle R.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Ji, Hezhao; Plummer, Francis A.; Ball, T. Blake] Publ Hlth Agcy Canada, Natl Microbiol Labs, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Nairobi; University of Toronto; Public Health Agency of Canada	Ball, TB (corresponding author), Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada.	tball@cc.umanitoba.ca	Jaoko, Walter/AAN-5048-2020	Sivro, Aida/0000-0001-9215-5285; Ji, Hezhao/0000-0002-5451-6294; McKinnon, Lyle/0000-0002-7157-0700; Jaoko, Walter/0000-0002-7134-6581	Canadian Institute of Health Research (CIHR) [103231]; CIHR; International Infectious Diseases and Global Health Training Program (IIDGHTP)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); International Infectious Diseases and Global Health Training Program (IIDGHTP)	This work was supported by the Canadian Institute of Health Research (CIHR - 103231). A. S. and L. R. M. are supported by CIHR Research Fellowships and the International Infectious Diseases and Global Health Training Program (IID&GHTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A Haase, 2005, NAT REV IMMUNOL; Ball TB, 2007, AIDS, V21, P1091, DOI 10.1097/QAD.0b013e3280ef6ae1; Burgener A, 2011, J PROTEOME; Burgener A, 2008, J PROTEOME RES, V7, P4446, DOI 10.1021/pr800406r; Fowke K, 1996, LANCET; Harman A, 2011, HIV INFECT DENDRITIC; Harman AN, 2011, BLOOD, V118, P298, DOI 10.1182/blood-2010-07-297721; Horton RE, 2010, J INFECT DIS, V202, pS377, DOI 10.1086/655971; Ji HZ, 2010, SCAND J INFECT DIS, V42, P389, DOI 10.3109/00365540903496536; Ji HZ, 2004, J HUM GENET, V49, P528, DOI 10.1007/s10038-004-0185-9; Kaul R, 2001, J CLIN INVEST, V107, P341, DOI 10.1172/JCI10714; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Lipsitz SR, 2000, J ROY STAT SOC C-APP, V49, P287, DOI 10.1111/1467-9876.00192; MacDonald KS, 2000, J INFECT DIS, V181, P1581, DOI 10.1086/315472; Marsili G, 2004, ANN NY ACAD SCI, V1030, P636, DOI 10.1196/annals.1329.074; Marsili G, 2012, CYTOKINE GROWTH F R, V23, P255, DOI 10.1016/j.cytogfr.2012.06.001; McKinnon LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049797; McNeil AJ, 1997, STAT MED, V16, P2555, DOI 10.1002/(SICI)1097-0258(19971130)16:22&lt;2555::AID-SIM690&gt;3.0.CO;2-Y; Plummer FA, 1999, IMMUNOL LETT, V66, P27, DOI 10.1016/S0165-2478(98)00182-5; Rodriguez B, 2006, JAMA-J AM MED ASSOC, V296, P1498, DOI 10.1001/jama.296.12.1498; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sgarbanti M, 2002, J EXP MED, V195, P1359, DOI 10.1084/jem.20010753; Sobieszczyk ME, 2011, CURR OPIN HIV AIDS, V6, P427, DOI 10.1097/COH.0b013e3283497155; Su RC, 2011, BLOOD, V117, P2649, DOI 10.1182/blood-2010-10-312462; World Health Organization, 2010, ANTIRETROVIRAL THERA; Yang HB, 2012, J INFECT DIS, V206, P552, DOI 10.1093/infdis/jis379	26	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66253	10.1371/journal.pone.0066253	http://dx.doi.org/10.1371/journal.pone.0066253			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799084	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300069
J	Cen, JR; Shi, MS; Yang, YF; Fu, YX; Zhou, HL; Wang, MQ; Su, ZY; Wei, Q				Cen, Juren; Shi, Mingshu; Yang, Yanfang; Fu, Yanxia; Zhou, Hailing; Wang, Mengqi; Su, Zhenyi; Wei, Qun			Isogarcinol Is a New Immunosuppressant	PLOS ONE			English	Article							CYCLOSPORINE-A; BENZOPHENONE DERIVATIVES; GARCINIA-MANGOSTANA; LYMPHOCYTE-ACTIVATION; ORGAN-TRANSPLANTATION; MEDICINAL PROPERTIES; CARDIAC GROWTH; CALCINEURIN; FK506; INHIBITION	Calcineurin (CN), a unique protein phosphatase, plays an important role in immune regulation. In this study we used CN as a target enzyme to investigate the immunosuppressive properties of a series of natural compounds from Garcinia mangostana L., and discovered an active compound, isogarcinol. Enzymatic assays showed that isogarcinol inhibited CN in a dose-dependent manner. At concentrations resulting in relatively low cytotoxicity isogarcinol significantly inhibited proliferation of murine spleen T-lymphocytes induced by concanavalin A (ConA) and the mixed lymphocyte reaction (MLR). In addition, it performed much better in acute toxicity tests and via oral administration in mice than cyclosporin A (CsA), with few adverse reactions and low toxicity in experimental animals. Oral administration of isogarcinol in mice resulted in a dose-dependent decrease in delayed type hypersensitivity (DTH) and prolonged graft survival in allogeneic skin transplantation. These findings suggest that isogarcinol could serve as a new oral immunomodulatory drug for preventing transplant rejection, and for long-term medication in autoimmune diseases.	[Cen, Juren; Shi, Mingshu; Fu, Yanxia; Zhou, Hailing; Wang, Mengqi; Su, Zhenyi; Wei, Qun] Beijing Normal Univ, Dept Biochem & Mol Biol, Gene Engn & Biotechnol Beijing Key Lab, Beijing 100875, Peoples R China; [Yang, Yanfang] Hubei Univ Chinese Med, Prov & Minist Established Key Lab Resource & Comp, Wuhan, Peoples R China	Beijing Normal University; Hubei University of Chinese Medicine	Wei, Q (corresponding author), Beijing Normal Univ, Dept Biochem & Mol Biol, Gene Engn & Biotechnol Beijing Key Lab, Beijing 100875, Peoples R China.	weiq@bnu.edu.cn	Su, Zhenyi/AHC-5959-2022		National Natural Science Foundation of China; National Important Novel Medicine Research Project; International Cooperation Project; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Important Novel Medicine Research Project; International Cooperation Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The work was supported by grants from the National Natural Science Foundation of China, the National Important Novel Medicine Research Project, the International Cooperation Project and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baksh S, 2000, SEMIN IMMUNOL, V12, P405, DOI 10.1006/smim.2000.0221; BENNETT WM, 1986, ANNU REV MED, V37, P215; BIERER BE, 1993, CURR OPIN IMMUNOL, V5, P763, DOI 10.1016/0952-7915(93)90135-F; Cardenas ME, 1998, TRENDS BIOTECHNOL, V16, P427, DOI 10.1016/S0167-7799(98)01239-6; CLIPSTONE NA, 1993, ANN NY ACAD SCI, V696, P20; Cuesta-Rubio O, 2005, STUD NAT PROD CHEM, V32, P671; Cui JH, 2010, PHARMACOL BIOCHEM BE, V95, P166, DOI 10.1016/j.pbb.2009.12.021; Feng YH, 2002, ACTA PHARMACOL SIN, V23, P893; Gonsette RE, 2004, J NEUROL SCI, V223, P87, DOI 10.1016/j.jns.2004.04.025; Ho S, 1996, CLIN IMMUNOL IMMUNOP, V80, pS40, DOI 10.1006/clin.1996.0140; Hong JC, 2000, SEMIN NEPHROL, V20, P108; Iinuma M, 1996, BIOL PHARM BULL, V19, P311, DOI 10.1248/bpb.19.311; Issa F, 2010, EXPERT REV CLIN IMMU, V6, P155, DOI 10.1586/ECI.09.64; Ito C, 2003, J NAT PROD, V66, P206, DOI 10.1021/np020372g; Jorgensen KA, 2003, SCAND J IMMUNOL, V57, P93, DOI 10.1046/j.1365-3083.2003.01221.x; Kobayashi K, 2001, MICROSC RES TECHNIQ, V53, P241, DOI 10.1002/jemt.1090; Lechler RI, 2005, NAT MED, V11, P605, DOI 10.1038/nm1251; Lei H, 2011, FOOD CHEM, V127, P1169, DOI 10.1016/j.foodchem.2011.01.119; Lei H, 2009, BBA-PROTEINS PROTEOM, V1794, P1269, DOI 10.1016/j.bbapap.2009.04.014; Li JY, 2010, PHARM BIOL, V48, P1177, DOI 10.3109/13880200903573169; Li X, 2012, INT IMMUNOPHARMACOLO; Liang QR, 2003, EMBO J, V22, P5079, DOI 10.1093/emboj/cdg474; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Mantelingu K, 2007, CHEM BIOL, V14, P645, DOI 10.1016/j.chembiol.2007.04.011; Marti G, 2010, MOLECULES, V15, P7106, DOI 10.3390/molecules15107106; Matsumoto K, 2003, BIOL PHARM BULL, V26, P569, DOI 10.1248/bpb.26.569; Moussay E, 2010, RES DETERMINATION GE; Pedraza-Chaverri J, 2008, FOOD CHEM TOXICOL, V46, P3227, DOI 10.1016/j.fct.2008.07.024; Peng LQ, 2011, IUBMB LIFE, V63, P14, DOI 10.1002/iub.408; Rathee P, 2012, PHARM INNOVATION J, V1, P90; Roy J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2100re9; Rukachaisirikul V, 2005, CHEM PHARM BULL, V53, P342, DOI 10.1248/cpb.53.342; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Salem ML, 2005, INT IMMUNOPHARMACOL, V5, P1749, DOI 10.1016/j.intimp.2005.06.008; Shen J, 2006, STUDIES CHEM CONSTIT; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; STALLARD N, 1995, HUM EXP TOXICOL, V14, P315, DOI 10.1177/096032719501400401; Thomson A, 1984, INFLAMM RES, V15, P306; Vega RB, 2003, J BIOL CHEM, V278, P36981, DOI 10.1074/jbc.R300023200; Wang HL, 2007, IUBMB LIFE, V59, P388, DOI 10.1080/15216540701370721; Wang H, 2008, IUBMB LIFE, V60, P549, DOI 10.1002/iub.94; Wang H, 2010, J BIOCHEM, V147, P185, DOI 10.1093/jb/mvp163; Yu LM, 2007, FOOD CHEM, V104, P176, DOI 10.1016/j.foodchem.2006.11.018; Zhou R, 2005, INT IMMUNOPHARMACOL, V5, P1895, DOI 10.1016/j.intimp.2005.06.009	44	96	102	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66503	10.1371/journal.pone.0066503	http://dx.doi.org/10.1371/journal.pone.0066503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785505	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800024
J	Dall, M; Calloe, K; Haupt-Jorgensen, M; Larsen, J; Schmitt, N; Josefsen, K; Buschard, K				Dall, Morten; Calloe, Kirstine; Haupt-Jorgensen, Martin; Larsen, Jesper; Schmitt, Nicole; Josefsen, Knud; Buschard, Karsten			Gliadin Fragments and a Specific Gliadin 33-mer Peptide Close K-ATP Channels and Induce Insulin Secretion in INS-1E Cells and Rat Islets of Langerhans	PLOS ONE			English	Article							GLUTEN-FREE DIET; INTESTINAL PERMEABILITY; FUNCTIONAL-STATE; BETA-CELLS; DIAZOXIDE; EXPOSURE; MOUSE; ONSET; MICE	In non-obese diabetic (NOD) mice, diabetes incidence is reduced by a gluten-free diet. Gluten peptides, such as the compound gliadin, can cross the intestinal barrier and may directly affect pancreatic beta cells. We investigated the effects of enzymatically-digested gliadin in NOD mice, INS-1E cells and rat islets. Six injections of gliadin digest in 6-week-old NOD mice did not affect diabetes development, but increased weight gain (20% increase by day 100). In INS-1E cells, incubation with gliadin digest induced a dose-dependent increase in insulin secretion, up to 2.5-fold after 24 hours. A similar effect was observed in isolated rat islets (1.6-fold increase). In INS-1E cells, diazoxide reduced the stimulatory effect of gliadin digest. Additionally, gliadin digest was shown to decrease current through K-ATP-channels. A specific gliadin 33-mer had a similar effect, both on current and insulin secretion. Finally, INS-1E incubation with gliadin digest potentiated palmitate-induced insulin secretion by 13% compared to controls. Our data suggest that gliadin fragments may contribute to the beta-cell hyperactivity observed prior to the development of type 1 diabetes.	[Dall, Morten; Haupt-Jorgensen, Martin; Larsen, Jesper; Josefsen, Knud; Buschard, Karsten] Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark; [Calloe, Kirstine; Schmitt, Nicole] Univ Copenhagen, Dept Biomed Sci, Fac Hlth & Med Sci, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Danmarks Grundforskningsfond; University of Copenhagen	Dall, M (corresponding author), Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark.	mortendall1988@gmail.com	Haupt-Jorgensen, Martin/K-7424-2019; Calloe, Kirstine/H-8643-2016; Schmitt, Nicole/B-8725-2012	Haupt-Jorgensen, Martin/0000-0003-4088-5862; Calloe, Kirstine/0000-0002-1777-7938; Schmitt, Nicole/0000-0001-9482-9749; Buschard, Karsten/0000-0002-0126-7423; Dall, Morten/0000-0002-8577-3162	Freddy og Kirsten Johansens Fond; Novo Nordisk Foundation; Novo Nordisk Scholarship	Freddy og Kirsten Johansens Fond; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Scholarship(Novo Nordisk)	JL was financed by Freddy og Kirsten Johansens Fond. KC was supported by the Novo Nordisk Foundation. MD received a Novo Nordisk Scholarship 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAEN K, 1990, DIABETES, V39, P697, DOI 10.2337/diabetes.39.6.697; Arancibia SA, 2007, BIOL RES, V40, P97, DOI 10.4067/S0716-97602007000200001; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bjork E, 1996, DIABETES, V45, P1427, DOI 10.2337/diabetes.45.10.1427; Bollyky PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005063; BUSCHARD K, 1991, AUTOIMMUNITY, V10, P65, DOI 10.3109/08916939108997149; Buschard K, 2011, APMIS, V119, P1, DOI 10.1111/j.1600-0463.2011.02765.x; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Carlsson PO, 1998, ENDOCRINOLOGY, V139, P3534, DOI 10.1210/en.139.8.3534; Carratu R, 1999, J PEDIATR GASTR NUTR, V28, P264, DOI 10.1097/00005176-199903000-00010; Chirdo FG, 1998, SCAND J GASTROENTERO, V33, P1186, DOI 10.1080/00365529850172557; Coppieters K, 2012, J CLIN INVEST, V122, P119, DOI 10.1172/JCI59285; Cosnes J, 2008, CLIN GASTROENTEROL H, V6, P753, DOI 10.1016/j.cgh.2007.12.022; Czekanska EM, 2011, METHODS MOL BIOL, V740, P27, DOI 10.1007/978-1-61779-108-6_5; Drago S, 2006, SCAND J GASTROENTERO, V41, P408, DOI 10.1080/00365520500235334; Funda DP, 2008, DIABETES-METAB RES, V24, P59, DOI 10.1002/dmrr.748; Funda DP, 1999, DIABETES-METAB RES, V15, P323; Garcia-Manzanares Alvaro, 2011, World J Gastrointest Pathophysiol, V2, P49, DOI 10.4291/wjgp.v2.i3.49; Gros L, 2002, BRIT J PHARMACOL, V137, P98, DOI 10.1038/sj.bjp.0704836; Guldstrand M, 2002, DIABETES METAB, V28, P448; HOLLANDER PH, 1982, DIABETES, V31, P149, DOI 10.2337/diabetes.31.2.149; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; JALONEN T, 1991, PEDIATR RES, V30, P290, DOI 10.1203/00006450-199109000-00019; Josefsen K, 2010, FEBS LETT, V584, P81, DOI 10.1016/j.febslet.2009.10.086; Junker Y, 2009, GASTROENTEROLOGY, V136, pA468; Liu Zhenping, 2008, Rev Diabet Stud, V5, P232, DOI 10.1900/RDS.2008.5.232; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; MAJNO G, 1987, AM J PATHOL, V128, P210; Matysiak-Budnik T, 2003, GASTROENTEROLOGY, V125, P696, DOI 10.1016/S0016-5085(03)01049-7; Menard S, 2012, AM J PATHOL, V180, P608, DOI 10.1016/j.ajpath.2011.10.019; Neu J, 2005, J PEDIATR GASTR NUTR, V40, P589, DOI 10.1097/01.MPG.0000159636.19346.C1; Newsholme P, 2007, BIOCHEM SOC T, V35, P1180, DOI 10.1042/BST0351180; Pastore MR, 2003, J CLIN ENDOCR METAB, V88, P162, DOI 10.1210/jc.2002-021177; Schmid S, 2004, CLIN IMMUNOL, V111, P108, DOI 10.1016/j.clim.2003.09.012; Schumann M, 2008, GUT, V57, P747, DOI 10.1136/gut.2007.136366; Scott FW, 2002, DIABETES, V51, P73, DOI 10.2337/diabetes.51.1.73; Secondulfo M, 1999, Minerva Gastroenterol Dietol, V45, P187; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Sildorf SM, 2012, BMJ CASE REP; Takano M, 1996, PFLUG ARCH EUR J PHY, V431, P625; Yin H, 2002, DIABETES, V51, P1964, DOI 10.2337/diabetes.51.6.1964	41	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66474	10.1371/journal.pone.0066474	http://dx.doi.org/10.1371/journal.pone.0066474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785500	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800021
J	Ito, K; Date, T; Ikegami, M; Hongo, K; Fujisaki, M; Katoh, D; Yoshino, T; Anzawa, R; Nagoshi, T; Yamashita, S; Inada, K; Matsuo, S; Yamane, T; Yoshimura, M				Ito, Keiichi; Date, Taro; Ikegami, Masahiro; Hongo, Kenichi; Fujisaki, Masami; Katoh, Daisuke; Yoshino, Takuya; Anzawa, Ryuko; Nagoshi, Tomohisa; Yamashita, Seigo; Inada, Keiichi; Matsuo, Seiichiro; Yamane, Teiichi; Yoshimura, Michihiro			An Immunohistochemical Analysis of Tissue Thrombin Expression in the Human Atria	PLOS ONE			English	Article							SMOOTH-MUSCLE; FIBRILLATION; ACTIVATION; BINDING; CELLS	Objective: Thrombin, the final coagulation product of the coagulation cascade, has been demonstrated to have many physiological effects, including pro-fibrotic actions via protease-activated receptor (PAR)-1. Recent investigations have demonstrated that activation of the cardiac local coagulation system was associated with atrial fibrillation. However, the distribution of thrombin in the heart, especially difference between the atria and the ventricle, remains to be clarified. We herein investigated the expression of thrombin and other related proteins, as well as tissue fibrosis, in the human left atria and left ventricle. Methods: We examined the expression of thrombin and other related molecules in the autopsied hearts of patients with and without atrial fibrillation. An immunohistochemical analysis was performed in the left atria and the left ventricle. Results: The thrombin was immunohistologically detected in both the left atria and the left ventricles. Other than in the myocardium, the expression of thrombin was observed in the endocardium and the subendocardium of the left atrium. Thrombin was more highly expressed in the left atrium compared to the left ventricle, which was concomitant with more tissue fibrosis and inflammation, as detected by CD68 expression, in the left atrium. We also confirmed the expression of prothrombin in the left atrium. The expression of PAR-1 was observed in the endocardium, subendocardium and myocardium in the left atrium. In patients with atrial fibrillation, strong thrombin expression was observed in the left atrium. Conclusions: The strong expression levels of thrombin, prothrombin and PAR-1 were demonstrated in the atrial tissues of human autopsied hearts.	[Ito, Keiichi; Date, Taro; Hongo, Kenichi; Fujisaki, Masami; Katoh, Daisuke; Yoshino, Takuya; Anzawa, Ryuko; Nagoshi, Tomohisa; Yamashita, Seigo; Inada, Keiichi; Matsuo, Seiichiro; Yamane, Teiichi; Yoshimura, Michihiro] Jikei Univ, Div Cardiol, Dept Internal Med, Sch Med,Minato Ku, Tokyo, Japan; [Ikegami, Masahiro] Jikei Univ, Dept Pathol, Sch Med, Minato Ku, Tokyo, Japan	Jikei University; Jikei University	Ito, K (corresponding author), Jikei Univ, Div Cardiol, Dept Internal Med, Sch Med,Minato Ku, Tokyo, Japan.	keke-ito@jikei.ac.jp						Aaron NS, 2012, FASEB J, V26, P4540; Akar JG, 2008, J AM COLL CARDIOL, V51, P1790, DOI 10.1016/j.jacc.2007.11.083; Andersen H, 1999, P NATL ACAD SCI USA, V96, P11189, DOI 10.1073/pnas.96.20.11189; AU CL, 1993, HUM REPROD, V8, P17, DOI 10.1093/oxfordjournals.humrep.a137866; Azzawi M, 1997, J ANAT, V191, P417, DOI 10.1046/j.1469-7580.1997.19130417.x; Bogatkevich GS, 2009, ARTHRITIS RHEUM-US, V60, P3455, DOI 10.1002/art.24935; CARNEY DH, 1992, J CLIN INVEST, V89, P1469, DOI 10.1172/JCI115737; Choudhury A, 2003, PATHOPHYSIOL HAEMO T, V33, P282, DOI 10.1159/000083815; Cooper DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021484; HOLLENBERG MD, 1992, MOL PHARMACOL, V42, P186; Horvat R, 1993, EUR J CELL BIOL, V61, P293; LOLLAR P, 1980, J CLIN INVEST, V66, P1222, DOI 10.1172/JCI109973; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; McBane RD, 1997, ARTERIOSCL THROM VAS, V17, P2430, DOI 10.1161/01.ATV.17.11.2430; Pawlinski R, 2007, CIRCULATION, V116, P2298, DOI 10.1161/CIRCULATIONAHA.107.692764; Ruf W, 2003, J THROMB HAEMOST, V1, P1495, DOI 10.1046/j.1538-7836.2003.00300.x; Sabri A, 2003, J BIOL CHEM, V278, P11714, DOI 10.1074/jbc.M213091200; Shiroshita-Takeshita A, 2004, CIRCULATION, V110, P2313, DOI 10.1161/01.CIR.0000145163.56529.D1; Xu J, 2004, CIRCULATION, V109, P363, DOI 10.1161/01.CIR.0000109495.02213.52; Yamashita T, 2010, CIRC J, V74, P262, DOI 10.1253/circj.CJ-09-0644; YAN GX, 1995, AM J PHYSIOL-HEART C, V268, pH1740, DOI 10.1152/ajpheart.1995.268.4.H1740; Yin XL, 2010, AM J PATHOL, V176, P1600, DOI 10.2353/ajpath.2010.090406; ZETTER BR, 1977, P NATL ACAD SCI USA, V74, P596, DOI 10.1073/pnas.74.2.596	23	28	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65817	10.1371/journal.pone.0065817	http://dx.doi.org/10.1371/journal.pone.0065817			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785453	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800069
J	Knudsen, ML; Johansson, DX; Kostic, L; Nordstron, EKL; Tegerstedt, K; Pasetto, A; Applequist, SE; Ljungberg, K; Sirard, JC; Liljestrom, P				Knudsen, Maria L.; Johansson, Daniel X.; Kostic, Linda; Nordstron, Eva K. L.; Tegerstedt, Karin; Pasetto, Anna; Applequist, Steven E.; Ljungberg, Karl; Sirard, Jean-Claude; Liljestrom, Peter			The Adjuvant Activity of Alphavirus Replicons Is Enhanced by Incorporating the Microbial Molecule Flagellin into the Replicon	PLOS ONE			English	Article							SEMLIKI-FOREST-VIRUS; YELLOW-FEVER VACCINE; TOLL-LIKE RECEPTOR-5; BACTERIAL FLAGELLIN; DENDRITIC CELLS; IMMUNE-RESPONSE; FUSION PROTEINS; INNATE IMMUNITY; MESSENGER-RNA; TLR5	Ligands of pattern recognition receptors (PRRs) including Toll-like receptors (TLRs) stimulate innate and adaptive immune responses and are considered as potent adjuvants. Combinations of ligands might act in synergy to induce stronger and broader immune responses compared to stand-alone ligands. Alphaviruses stimulate endosomal TLRs 3, 7 and 8 as well as the cytoplasmic PRR MDA-5, resulting in induction of a strong type I interferon (IFN) response. Bacterial flagellin stimulates TLR5 and when delivered intracellularly the cytosolic PRR NLRC4, leading to secretion of proinflammatory cytokines. Both alphaviruses and flagellin have independently been shown to act as adjuvants for antigen-specific antibody responses. Here, we hypothesized that alphavirus and flagellin would act in synergy when combined. We therefore cloned the Salmonella Typhimurium flagellin (FliC) gene into an alphavirus replicon and assessed its adjuvant activity on the antibody response against co-administered antigen. In mice immunized with recombinant alphavirus, antibody responses were greatly enhanced compared to soluble FliC or control alphavirus. Both IgG1 and IgG2a/c responses were increased, indicating an enhancement of both Th1 and Th2 type responses. The adjuvant activity of FliC-expressing alphavirus was diminished but not abolished in the absence of TLR5 or type I IFN signaling, suggesting the contribution of several signaling pathways and some synergistic and redundant activity of its components. Thus, we have created a recombinant adjuvant that stimulates multiple signaling pathways of innate immunity resulting in a strong and broad antibody response.	[Knudsen, Maria L.; Johansson, Daniel X.; Nordstron, Eva K. L.; Tegerstedt, Karin; Pasetto, Anna; Ljungberg, Karl; Liljestrom, Peter] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Kostic, Linda] Swedish Inst Communicable Dis Control, Unit Immunizat, Solna, Sweden; [Applequist, Steven E.] Karolinska Univ Hosp Huddinge, Karolinska Inst, Ctr Infect Med, Dept Med, Stockholm, Sweden; [Sirard, Jean-Claude] Ctr Infect & Immun Lille, Inst Pasteur Lille, Lille, France; [Sirard, Jean-Claude] Inst Natl Sante & Rech Med, Lille, France; [Sirard, Jean-Claude] Ctr Natl Rech Sci, Lille, France; [Sirard, Jean-Claude] Univ Lille Nord France, Lille, France	Karolinska Institutet; Swedish Institute for Infectious Disease Control; Karolinska Institutet; Karolinska University Hospital; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille	Knudsen, ML (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	maria.knudsen@ki.se	Sirard, Jean-Claude/B-5932-2011; Pasetto, Anna/AAD-6141-2019; Pasetto, Anna/K-6430-2012	Sirard, Jean-Claude/0000-0001-9854-4652; Pasetto, Anna/0000-0002-5254-2173; Liljestrom, Peter/0000-0002-2132-0981; Ljungberg, Karl/0000-0001-7192-6204	Swedish Research Council; Swedish International Development Cooperation Agency; Karolinska Institutet Faculty Funding for Doctoral Students	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency; Karolinska Institutet Faculty Funding for Doctoral Students	This work was supported by the Swedish Research Council (www.vr.se) and the Swedish International Development Cooperation Agency (www.sida.se). MLK is a recipient of Karolinska Institutet Faculty Funding for Doctoral Students (www.ki.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2010, J VIROL, V84, P12093, DOI 10.1128/JVI.00406-10; Applequist SE, 2005, J IMMUNOL, V175, P3882, DOI 10.4049/jimmunol.175.6.3882; Arimilli S, 2008, J VIROL, V82, P10975, DOI 10.1128/JVI.01288-08; Bagchi A, 2007, J IMMUNOL, V178, P1164, DOI 10.4049/jimmunol.178.2.1164; Barry G, 2010, J VIROL, V84, P7369, DOI 10.1128/JVI.02310-09; Barry G, 2009, J GEN VIROL, V90, P1382, DOI 10.1099/vir.0.007336-0; Bates JT, 2009, J IMMUNOL, V182, P7539, DOI 10.4049/jimmunol.0804225; Ben-Yedidia T, 1998, IMMUNOL LETT, V64, P9, DOI 10.1016/S0165-2478(98)00073-X; Bohnenkamp HR, 2007, CELL IMMUNOL, V247, P72, DOI 10.1016/j.cellimm.2007.07.008; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Cuadros C, 2004, INFECT IMMUN, V72, P2810, DOI 10.1128/IAI.72.5.2810-2816.2004; Cunningham AF, 2004, EUR J IMMUNOL, V34, P2986, DOI 10.1002/eji.200425403; Didierlaurent A, 2004, J IMMUNOL, V172, P6922, DOI 10.4049/jimmunol.172.11.6922; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Fink SL, 2007, CELL MICROBIOL, V9, P2562, DOI 10.1111/j.1462-5822.2007.01036.x; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Glasgow GM, 1997, J GEN VIROL, V78, P1559, DOI 10.1099/0022-1317-78-7-1559; Ha H, 2008, J IMMUNOL, V180, P1382, DOI 10.4049/jimmunol.180.3.1382; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hidmark AS, 2005, J VIROL, V79, P10376, DOI 10.1128/JVI.79.16.10376-10385.2005; Hidmark AS, 2006, J VIROL, V80, P7100, DOI 10.1128/JVI.02579-05; Honko AN, 2006, INFECT IMMUN, V74, P1113, DOI 10.1128/IAI.74.2.1113-1120.2006; Huber JP, 2011, IMMUNOLOGY, V132, P466, DOI 10.1111/j.1365-2567.2011.03412.x; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Huleatt JW, 2007, VACCINE, V25, P763, DOI 10.1016/j.vaccine.2006.08.013; Karlsson GB, 2003, METH MOLEC MED, V87, P69; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Liu F, 2010, BIOCHEM BIOPH RES CO, V392, P582, DOI 10.1016/j.bbrc.2010.01.077; Makela SM, 2011, MOL IMMUNOL, V48, P505, DOI 10.1016/j.molimm.2010.10.005; McDonald WF, 2007, J INFECT DIS, V195, P1607, DOI 10.1086/517613; McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Naslund TI, 2007, J IMMUNOL, V178, P6761, DOI 10.4049/jimmunol.178.11.6761; Nempont C, 2008, J IMMUNOL, V181, P2036, DOI 10.4049/jimmunol.181.3.2036; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Rumbo M, 2004, GASTROENTEROLOGY, V127, P213, DOI 10.1053/j.gastro.2004.04.018; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Sanders CJ, 2009, EUR J IMMUNOL, V39, P359, DOI 10.1002/eji.200838804; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007; SJOBERG EM, 1994, BIO-TECHNOL, V12, P1127, DOI 10.1038/nbt1194-1127; Smerdou C, 1999, J VIROL, V73, P1092, DOI 10.1128/JVI.73.2.1092-1098.1999; Smith K, 2003, POETRY REV, V93, P5; Sundback M, 2005, VIROLOGY, V341, P190, DOI 10.1016/j.virol.2005.07.017; Talbot HK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014442; Taylor DN, 2011, VACCINE, V29, P4897, DOI 10.1016/j.vaccine.2011.05.001; Thompson JM, 2006, P NATL ACAD SCI USA, V103, P3722, DOI 10.1073/pnas.0600287103; Thompson JM, 2008, VACCINE, V26, P4998, DOI 10.1016/j.vaccine.2008.07.011; Tosch C, 2009, CANCER GENE THER, V16, P310, DOI 10.1038/cgt.2008.85; Treanor JJ, 2010, VACCINE, V28, P8268, DOI 10.1016/j.vaccine.2010.10.009; Turley CB, 2011, VACCINE, V29, P5145, DOI 10.1016/j.vaccine.2011.05.041; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Vassilieva EV, 2011, MBIO, V2, DOI 10.1128/mBio.00328-10; Ventoso I, 2006, GENE DEV, V20, P87, DOI 10.1101/gad.357006; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Vijay-Kumar M, 2010, EUR J IMMUNOL, V40, P3528, DOI 10.1002/eji.201040421; Wang BZ, 2008, J VIROL, V82, P11813, DOI 10.1128/JVI.01076-08; ZHOU XZ, 1995, P NATL ACAD SCI USA, V92, P3009, DOI 10.1073/pnas.92.7.3009	64	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65964	10.1371/journal.pone.0065964	http://dx.doi.org/10.1371/journal.pone.0065964			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785460	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800062
J	McGroty, SE; Pattaniyil, DT; Patin, D; Blanot, D; Ravichandran, AC; Suzuki, H; Dobson, RCJ; Savka, MA; Hudson, AO				McGroty, Sean E.; Pattaniyil, Dhivya T.; Patin, Delphine; Blanot, Didier; Ravichandran, Arvind C.; Suzuki, Hironori; Dobson, Renwick C. J.; Savka, Michael A.; Hudson, Andre O.			Biochemical Characterization of UDP-N-acetylmuramoyl-L-alanyl-D-glutamate: meso-2,6-diaminopimelate ligase (MurE) from Verrucomicrobium spinosum DSM 4136	PLOS ONE			English	Article							LYSINE BIOSYNTHESIS PATHWAY; L,L-DIAMINOPIMELATE AMINOTRANSFERASE; 2-AMINOPIMELIC ACID; CYTOPLASMIC STEPS; PEPTIDOGLYCAN; DIAMINOPIMELATE; PURIFICATION; PEPTIDES	Verrucomicrobium spinosum is a Gram-negative bacterium that is related to bacteria from the genus Chlamydia. The bacterium is pathogenic towards Drosophila melanogaster and Caenorhabditis elegans, using a type III secretion system to facilitate pathogenicity. V. spinosum employs the recently discovered L, L-diaminopimelate aminotransferase biosynthetic pathway to generate the bacterial cell wall and protein precursors diaminopimelate and lysine. A survey of the V. spinosum genome provides evidence that the bacterium should be able to synthesize peptidoglycan de novo, since all of the necessary genes are present. The enzyme UDP-N-acetylmuramoyl-L-alanyl-D-glutamate: meso-2,6-diaminopimelate ligase (MurE) (E.C. 6.3.2.15) catalyzes a reaction in the cytoplasmic step of peptidoglycan biosynthesis by adding the third amino acid residue to the peptide stem. The murE ortholog from V. spinosum (murE(Vs)) was cloned and was shown to possess UDP-MurNAc-L-Ala-D-Glu: meso-2,6-diaminopimelate ligase activity in vivo using functional complementation. In vitro analysis using the purified recombinant enzyme demonstrated that MurE(Vs) has a pH optimum of 9.6 and a magnesium optimum of 30 mM. meso-Diaminopimelate was the preferred substrate with a Km of 17 mM, when compared to other substrates that are structurally related. Sequence alignment and structural analysis using homology modeling suggest that key residues that make up the active site of the enzyme are conserved in MurE(Vs). Our kinetic analysis and structural model of MurE(Vs) is consistent with other MurE enzymes from Gram-negative bacteria that have been characterized. To verify that V. spinosum incorporates diaminopimelate into its cell wall, we purified peptidoglycan from a V. spinosum culture; analysis revealed the presence of diaminopimelate, consistent with that of a bona fide peptidoglycan from Gram-negative bacteria.	[McGroty, Sean E.; Savka, Michael A.; Hudson, Andre O.] Rochester Inst Technol, Thomas H Gosnell Sch Life Sci, Rochester, NY 14623 USA; [Pattaniyil, Dhivya T.] Rochester Inst Technol, Sch Chem & Mat Sci, Rochester, NY 14623 USA; [Patin, Delphine; Blanot, Didier] Univ Paris 11, Inst Biochim & Biophys Mole culaire & Cellulair, Lab Enveloppes Bacteriennes & Antibiot, Orsay, France; [Patin, Delphine; Blanot, Didier] Ctr Natl Rech Sci, Orsay, France; [Ravichandran, Arvind C.; Suzuki, Hironori; Dobson, Renwick C. J.] Univ Canterbury, Sch Biol Sci, Biomol Interact Ctr, Christchurch 1, New Zealand; [Dobson, Renwick C. J.] Univ Melbourne, Dept Biochem & Mol Biol, Mol & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia	Rochester Institute of Technology; Rochester Institute of Technology; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); University of Canterbury; University of Melbourne	Hudson, AO (corresponding author), Rochester Inst Technol, Thomas H Gosnell Sch Life Sci, Rochester, NY 14623 USA.	aohsbi@rit.edu	Dobson, Renwick/AAZ-7020-2021	Dobson, Renwick/0000-0002-5506-4939; Hudson, Andre/0000-0001-5690-4322; Suzuki, Hironori/0000-0001-9754-4992	National Science Foundation (NSF) [MCB-1120541]; Rochester Institute of Technology (RIT) College of Science; RIT College of Science Faculty Development; NSF [MCB-1120541]; Biochemistry program in the School of Chemical and Material Sciences at RIT; New Zealand Royal Society Marsden Fund [UOC1013]; C.R. Roper Bequest; U.S. Army Research Laboratory; U.S. Army Research Office [W911NF-11-1-0481]; Centre National de la Recherche Scientifique [UMR 8619]; Royal Society of New Zealand; Japan Society for the Promotion of Science	National Science Foundation (NSF)(National Science Foundation (NSF)); Rochester Institute of Technology (RIT) College of Science; RIT College of Science Faculty Development; NSF(National Science Foundation (NSF)); Biochemistry program in the School of Chemical and Material Sciences at RIT; New Zealand Royal Society Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); C.R. Roper Bequest; U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); U.S. Army Research Office; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Royal Society of New Zealand(Royal Society of New Zealand); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by a National Science Foundation (NSF) (MCB-1120541) and a Rochester Institute of Technology (RIT) College of Science 2012 Dean's Research Initiation Grant to AOH. MAS acknowledges a RIT College of Science Faculty Development (FEAD-2012) grant. SEM and DTP were supported by the NSF MCB-1120541 awarded to AOH as undergraduate students in the Bioinformatics program in the Thomas H. Gosnell School of Life Sciences and the Biochemistry program in the School of Chemical and Material Sciences at RIT. RCJD acknowledges: 1) the C.R. Roper Bequest for Fellowship support; 2) the New Zealand Royal Society Marsden Fund for funding support, in part (contract UOC1013); and 3) the U.S. Army Research Laboratory and U.S. Army Research Office under contract/grant number W911NF-11-1-0481 for supported, in part. DP and DB were supported by grants from the Centre National de la Recherche Scientifique (UMR 8619). HS acknowledges the Royal Society of New Zealand and the Japan Society for the Promotion of Science for salary support by the FY 2012 Researcher Exchange Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Babic A, 2007, PROCEEDINGS OF THE 5TH JOINT MEETING ON MEDICINAL CHEMISTRY, P1; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; BERGES DA, 1986, J MED CHEM, V29, P89, DOI 10.1021/jm00151a015; Boniface A, 2006, J BIOL CHEM, V281, P15680, DOI 10.1074/jbc.M506311200; Cox RJ, 1996, NAT PROD REP, V13, P29, DOI 10.1039/np9961300029; Domman DB, 2011, ARCH MICROBIOL, V193, P307, DOI 10.1007/s00203-010-0666-5; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Gordon E, 2001, J BIOL CHEM, V276, P10999, DOI 10.1074/jbc.M009835200; Hudson AO, 2008, J BACTERIOL, V190, P3256, DOI 10.1128/JB.01381-07; Hudson AO, 2006, PLANT PHYSIOL, V140, P292, DOI 10.1104/pp.105.072629; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Hutton CA, 2007, MOL BIOSYST, V3, P458, DOI 10.1039/b705624a; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kuru E, 2012, ANGEW CHEM INT EDIT, V51, P12519, DOI 10.1002/anie.201206749; LEROUX P, 1991, INT J PEPT PROT RES, V37, P103; Liu YC, 2010, J BACTERIOL, V192, P3304, DOI 10.1128/JB.00172-10; Mccoy AJ, 2006, P NATL ACAD SCI USA, V103, P17909, DOI 10.1073/pnas.0608643103; Mengin-Lecreulx D, 1999, J BACTERIOL, V181, P5909, DOI 10.1128/JB.181.19.5909-5914.1999; MENGINLECREULX D, 1982, J BACTERIOL, V151, P1109, DOI 10.1128/JB.151.3.1109-1117.1982; MICHAUD C, 1990, EUR J BIOCHEM, V194, P853, DOI 10.1111/j.1432-1033.1990.tb19479.x; Nachar VR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00183; Paradis-Bleau C, 2009, BIOCHEM J, V421, P263, DOI 10.1042/BJ20081395; Patin D, 2012, ARCH MICROBIOL, V194, P505, DOI 10.1007/s00203-011-0784-8; Patin D, 2010, BIOCHIMIE, V92, P1793, DOI 10.1016/j.biochi.2010.07.009; Patin D, 2009, J BACTERIOL, V191, P7430, DOI 10.1128/JB.01029-09; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; PRESS WH, 1986, NUMERICAL RECIPES AR; Sait M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00211; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; VANHEIJENOORT J, 1968, B SOC CHIM FR, P2828; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Wagner M, 2006, CURR OPIN BIOTECH, V17, P241, DOI 10.1016/j.copbio.2006.05.005	35	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66458	10.1371/journal.pone.0066458	http://dx.doi.org/10.1371/journal.pone.0066458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785498	gold, Green Published			2022-12-25	WOS:000321038800023
J	Mott, PJ; Lazarus, AH				Mott, Patrick J.; Lazarus, Alan H.			CD44 Antibodies and Immune Thrombocytopenia in the Amelioration of Murine Inflammatory Arthritis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; MONOCLONAL-ANTIBODIES; T-CELL; HYALURONAN; PLATELETS; RECEPTOR; MECHANISM; ADHESION; DISTINCT; PLAYERS	Antibodies to CD44 have been used to successfully ameliorate murine models of autoimmune disease. The most often studied disease model has been murine inflammatory arthritis, where a clear mechanism for the efficacy of CD44 antibodies has not been established. We have recently shown in a murine passive-model of the autoimmune disease immune thrombocytopenia (ITP) that some CD44 antibodies themselves can induce thrombocytopenia in mice, and the CD44 antibody causing the most severe thrombocytopenia (IM7), also is known to be highly effective in ameliorating murine models of arthritis. Recent work in the K/BxN serum-induced model of arthritis demonstrated that antibody-induced thrombocytopenia reduced arthritis, causing us to question whether CD44 antibodies might primarily ameliorate arthritis through their thrombocytopenic effect. We evaluated IM7, IRAWB14.4, 5035-41.1D, KM201, KM114, and KM81, and found that while all could induce thrombocytopenia, the degree of protection against serum-induced arthritis was not closely related to the length or severity of the thrombocytopenia. CD44 antibody treatment was also able to reverse established inflammation, while thrombocytopenia induced by an anti-platelet antibody targeting the GPIIbIIIa platelet antigen, could not mediate this effect. While CD44 antibody-induced thrombocytopenia may contribute to some of its therapeutic effect against the initiation of arthritis, for established disease there are likely other mechanisms contributing to its efficacy. Humans are not known to express CD44 on platelets, and are therefore unlikely to develop thrombocytopenia after CD44 antibody treatment. An understanding of the relationship between arthritis, thrombocytopenia, and CD44 antibody treatment remains critical for continued development of CD44 antibody therapeutics.	[Lazarus, Alan H.] Canadian Blood Serv, Toronto, ON, Canada; [Mott, Patrick J.; Lazarus, Alan H.] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Lazarus, Alan H.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Mott, Patrick J.; Lazarus, Alan H.] Univ Toronto, Toronto, ON, Canada	Canadian Blood Services; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto	Lazarus, AH (corresponding author), Canadian Blood Serv, Toronto, ON, Canada.	lazarusa@smh.ca		Lazarus, Alan/0000-0002-5051-6916	Canadian Blood Services-Canadian Institutes of Health Research (CIHR); CIHR; University of Toronto; Queen Elizabeth II/Canadian Arthritis Network Graduate Scholarship	Canadian Blood Services-Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); University of Toronto(University of Toronto); Queen Elizabeth II/Canadian Arthritis Network Graduate Scholarship	This work was supported by grants to AHL from the Canadian Blood Services-Canadian Institutes of Health Research (CIHR) Request For Proposals program and the CIHR (www.blood.ca). PJM was supported by a University of Toronto Fellowship and a Queen Elizabeth II/Canadian Arthritis Network Graduate Scholarship. The views expressed herein do not necessarily represent the view of the Federal Government of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmeier W, 2000, BLOOD, V95, P886, DOI 10.1182/blood.V95.3.886.003k45_886_893; Boilard E, 2012, NAT REV RHEUMATOL, V8, P534, DOI 10.1038/nrrheum.2012.118; Boilard E, 2011, J IMMUNOL, V186, P4361, DOI 10.4049/jimmunol.1002857; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Bonder CS, 2006, BLOOD, V107, P4798, DOI 10.1182/blood-2005-09-3581; Brocke S, 1999, P NATL ACAD SCI USA, V96, P6896, DOI 10.1073/pnas.96.12.6896; Cloutier N, 2012, BLOOD, V120, P1334, DOI 10.1182/blood-2012-02-413047; Colmegna I, 2012, CLIN PHARMACOL THER, V91, P607, DOI 10.1038/clpt.2011.325; Crow AR, 2011, BLOOD, V117, P971, DOI 10.1182/blood-2010-05-280115; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; FEHR K, 1981, ARTHRITIS RHEUM-US, V24, P510, DOI 10.1002/art.1780240310; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; GINSBERG MH, 1978, ARTHRITIS RHEUM, V21, P994, DOI 10.1002/art.1780210825; GLANT TT, 1987, ARTHRITIS RHEUM-US, V30, P201, DOI 10.1002/art.1780300211; Hutas G, 2008, BLOOD, V112, P4999, DOI 10.1182/blood-2008-04-150383; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; KAPLAN RA, 1980, ARTHRITIS RHEUM, V23, P911, DOI 10.1002/art.1780230806; Katoh S, 2003, J CLIN INVEST, V111, P1563, DOI 10.1172/JCI200316583; Khan AI, 2004, J IMMUNOL, V173, P7594, DOI 10.4049/jimmunol.173.12.7594; Kinne RW, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2333; KOSHIISHI I, 1994, BLOOD, V84, P390; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; LESLEY J, 1993, EUR J IMMUNOL, V23, P1902, DOI 10.1002/eji.1830230826; LESLEY J, 1992, EUR J IMMUNOL, V22, P2719, DOI 10.1002/eji.1830221036; McDonald B, 2008, J EXP MED, V205, P915, DOI 10.1084/jem.20071765; Mikecz K, 1999, ARTHRITIS RHEUM, V42, P659, DOI 10.1002/1529-0131(199904)42:4<659::AID-ANR8>3.0.CO;2-Z; Monach Paul A, 2008, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1522s81; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Nedvetzki S, 1999, J AUTOIMMUN, V13, P39, DOI 10.1006/jaut.1999.0294; Nieswandt B, 2000, BLOOD, V96, P2520; Nigrovic PA, 2007, IMMUNOL REV, V217, P19, DOI 10.1111/j.1600-065X.2007.00506.x; Noss EH, 2008, IMMUNOL REV, V223, P252, DOI 10.1111/j.1600-065X.2008.00648.x; PANAYI GS, 1992, ARTHRITIS RHEUM-US, V35, P729, DOI 10.1002/art.1780350702; Schellekens GA, 2000, ARTHRITIS RHEUM-US, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; SHERMAN L, 1994, CURR OPIN CELL BIOL, V6, P726, DOI 10.1016/0955-0674(94)90100-7; Song S, 2005, BLOOD, V105, P1546, DOI 10.1182/blood-2004-05-1886; Wagner UG, 1998, J IMMUNOL, V161, P6390; Weiss L, 2000, P NATL ACAD SCI USA, V97, P285, DOI 10.1073/pnas.97.1.285; Witz Craig A, 2003, Hum Fertil (Camb), V6, P34, DOI 10.1080/1464770312331368973; Zeidler A, 1995, AUTOIMMUNITY, V21, P245, DOI 10.3109/08916939509001943; ZHENG Z, 1995, J CELL BIOL, V130, P485, DOI 10.1083/jcb.130.2.485; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	43	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65805	10.1371/journal.pone.0065805	http://dx.doi.org/10.1371/journal.pone.0065805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785450	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800072
J	Xu, YM; Xu, XF; Lan, RT; Xiong, YW; Ye, CY; Ren, ZH; Liu, L; Zhao, AL; Wu, LF; Xu, JG				Xu, Yanmei; Xu, Xuefang; Lan, Ruiting; Xiong, Yanwen; Ye, Changyun; Ren, Zhihong; Liu, Li; Zhao, Ailan; Wu, Long-Fei; Xu, Jianguo			An O Island 172 Encoded RNA Helicase Regulates the Motility of Escherichia coli O157:H7	PLOS ONE			English	Article							SHIGA TOXIN; IN-VITRO; GENOME SEQUENCE; GENE-EXPRESSION; VIRULENCE; IDENTIFICATION; FLAGELLA; COMPLEX; PROTEIN; COLONIZATION	Enterohaemorrhagic Escherichia coli (EHEC) O157:H7 is a major cause of zoonotic food- and water-borne intestinal infections worldwide with clinical consequences ranging from mild diarrhoea to hemolytic uraemic syndrome. The genome of EHEC O157:H7 contains many regions of unique DNA that are referred to as O islands including the Shiga toxin prophages and pathogenicity islands encoding key virulence factors. However many of these O islands are of unknown function. In this study, genetic analysis was conducted on OI-172 which is a 44,434 bp genomic island with 27 open reading frames. Comparative genome analysis showed that O1-72 is a composite island with progressive gain of genes since O157:H7 evolved from its ancestral O55:H7. A partial OI-172 island was also found in 2 unrelated E. coli strains and 2 Salmonella strains. OI-172 encodes several putative helicases, one of which (Z5898) is a putative DEAH box RNA helicase. To investigate the function of Z5898, a deletion mutant (EDL933 Delta Z5898) was constructed in the O157:H7 strain EDL933. Comparative proteomic analysis of the mutant with the wild-type EDL933 found that flagellin was down-regulated in the Z5898 mutant. Motility assay showed that EDL933 Delta Z5898 migrated slower than the wild-type EDL933 and electron microscopy found no surface flagella. Quantitative reverse transcription PCR revealed that the fliC expression of EDL933 Delta Z5898 was significantly lower while the expression of its upstream regulator gene, fliA, was not affected. Using a fliA and a fliC promoter - green fluorescent protein fusion contruct, Z5898 was found to affect only the fliC promoter activity. Therefore, Z5898 regulates the flagella based motility by exerting its effect on fliC. We conclude that OI-172 is a motility associated O island and hereby name it the MAO island.	[Xu, Yanmei; Xu, Xuefang; Xiong, Yanwen; Ye, Changyun; Ren, Zhihong; Zhao, Ailan; Xu, Jianguo] State Key Lab Infect Dis Prevent & Control Chin C, Beijing, Peoples R China; [Xu, Yanmei; Xu, Xuefang; Xiong, Yanwen; Ye, Changyun; Ren, Zhihong; Zhao, Ailan; Xu, Jianguo] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent & Co, Beijing, Peoples R China; [Xu, Yanmei; Xu, Xuefang; Xiong, Yanwen; Ye, Changyun; Ren, Zhihong; Zhao, Ailan; Xu, Jianguo] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Lan, Ruiting] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Liu, Li] Chinese Acad Sci, Inst Microbiol, Network Informat Ctr, Beijing, Peoples R China; [Wu, Long-Fei] Univ Aix Marseille 2, Inst Microbiol Mediterrane, CNRS, Lab Chim Bacterienne,UPR9043, Marseille, France	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; University of New South Wales Sydney; Chinese Academy of Sciences; Institute of Microbiology, CAS; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Xu, JG (corresponding author), State Key Lab Infect Dis Prevent & Control Chin C, Beijing, Peoples R China.	xujianguo@icdc.cn		Lan, Ruiting/0000-0001-9834-5258	National Basic Research Program of China [2011CB504901]; China Mega-Project for Infectious Disease Grant [2011ZX10004-001]; Chinese National Natural Science Foundation Grant [81290340, 81290345, 81271788]; State Key Laboratory for Infectious Disease Prevention and Control Development Grants [2008SKLID106, 2011SKLID203, 2012SKLID401]; Beijing Municipal Commission of Education Grant [YB20098450101]	National Basic Research Program of China(National Basic Research Program of China); China Mega-Project for Infectious Disease Grant; Chinese National Natural Science Foundation Grant(National Natural Science Foundation of China (NSFC)); State Key Laboratory for Infectious Disease Prevention and Control Development Grants; Beijing Municipal Commission of Education Grant	This work was supported by the National Basic Research Program of China (2011CB504901), China Mega-Project for Infectious Disease Grant (2011ZX10004-001), Chinese National Natural Science Foundation Grant (81290340, 81290345, 81271788), State Key Laboratory for Infectious Disease Prevention and Control Development Grants (2008SKLID106, 2011SKLID203 and 2012SKLID401) and Beijing Municipal Commission of Education Grant (YB20098450101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SE, 2012, J BACTERIOL, V194, P5343, DOI 10.1128/JB.01025-12; Bender JK, 2012, APPL ENVIRON MICROB, V78, P5083, DOI 10.1128/AEM.00617-12; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Berin MC, 2002, CELL MICROBIOL, V4, P635, DOI 10.1046/j.1462-5822.2002.00218.x; Best A, 2005, INFECT IMMUN, V73, P1836, DOI 10.1128/IAI.73.3.1836-1846.2005; Byrd AK, 2012, FRONT BIOSCI-LANDMRK, V17, P2070, DOI 10.2741/4038; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Lay N, 2012, MOL MICROBIOL, V86, P524, DOI 10.1111/j.1365-2958.2012.08209.x; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Dziva F, 2004, MICROBIOL-SGM, V150, P3631, DOI 10.1099/mic.0.27448-0; Francez-Charlot A, 2003, MOL MICROBIOL, V49, P823, DOI 10.1046/j.1365-2958.2003.03601.x; Fricke WF, 2008, J BACTERIOL, V190, P6779, DOI 10.1128/JB.00661-08; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Gruenheid S, 2004, MOL MICROBIOL, V51, P1233, DOI 10.1046/j.1365-2958.2003.03911.x; Iost I, 2013, BIOCH BIOPHYS ACTA; Jagessar KL, 2010, RNA, V16, P1386, DOI 10.1261/rna.2015610; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Klapproth JA, 2000, INFECT IMMUN, V68, P2148, DOI 10.1128/IAI.68.4.2148-2155.2000; Ko M, 2000, J BACTERIOL, V182, P4670, DOI 10.1128/JB.182.16.4670-4672.2000; Koo JT, 2004, MOL MICROBIOL, V52, P1813, DOI 10.1111/j.1365-2958.2004.04099.x; Lehnen D, 2002, MOL MICROBIOL, V45, P521, DOI 10.1046/j.1365-2958.2002.03032.x; Lehti TA, 2012, MICROBIOL-SGM, V158, P1444, DOI 10.1099/mic.0.056499-0; Lemke JJ, 2009, MOL MICROBIOL, V74, P1368, DOI 10.1111/j.1365-2958.2009.06939.x; Liu RY, 2007, P NATL ACAD SCI USA, V104, P7116, DOI 10.1073/pnas.0700266104; LIU XY, 1994, J BACTERIOL, V176, P7345, DOI 10.1128/JB.176.23.7345-7351.1994; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Ramirez V, 2011, J MOL EVOL, V72, P413, DOI 10.1007/s00239-011-9441-8; MACNAB RM, 1992, ANNU REV GENET, V26, P131, DOI 10.1146/annurev.ge.26.120192.001023; Mahajan A, 2009, CELL MICROBIOL, V11, P121, DOI 10.1111/j.1462-5822.2008.01244.x; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Miyamoto Y, 2006, CELL MICROBIOL, V8, P869, DOI 10.1111/j.1462-5822.2005.00673.x; Naylor SW, 2005, MICROBIOL-SGM, V151, P2773, DOI 10.1099/mic.0.28060-0; Nicholls L, 2000, MOL MICROBIOL, V35, P275, DOI 10.1046/j.1365-2958.2000.01690.x; OKA A, 1981, J MOL BIOL, V147, P217, DOI 10.1016/0022-2836(81)90438-1; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Pradel N, 2003, INFECT IMMUN, V71, P4908, DOI 10.1128/IAI.71.9.4908-4916.2003; Roe AJ, 2003, INFECT IMMUN, V71, P5900, DOI 10.1128/IAI.71.10.5900-5909.2003; Salman-Dilgimen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022168; SHIN S, 1995, J BACTERIOL, V177, P4696, DOI 10.1128/jb.177.16.4696-4702.1995; SILVERMAN M, 1974, J BACTERIOL, V120, P1196, DOI 10.1128/JB.120.3.1196-1203.1974; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Soutourina O, 1999, J BACTERIOL, V181, P7500, DOI 10.1128/JB.181.24.7500-7508.1999; Sperandio V, 2002, MOL MICROBIOL, V43, P809, DOI 10.1046/j.1365-2958.2002.02803.x; Stevens MP, 2002, INFECT IMMUN, V70, P5158, DOI 10.1128/IAI.70.9.5158-5166.2002; STOJILJKOVIC I, 1994, J MOL BIOL, V236, P531, DOI 10.1006/jmbi.1994.1163; Su MSW, 2008, MICROBIOL-SGM, V154, P1094, DOI 10.1099/mic.0.2007/013946-0; Tree JJ, 2011, MOL MICROBIOL, V80, P1349, DOI 10.1111/j.1365-2958.2011.07650.x; Tsai NP, 2006, BIOCHEM J, V393, P591, DOI 10.1042/BJ20051201; Wang SY, 2006, J MOL BIOL, V355, P798, DOI 10.1016/j.jmb.2005.11.020; Wells TJ, 2008, ENVIRON MICROBIOL, V10, P589, DOI 10.1111/j.1462-2920.2007.01479.x; Yang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046828; Yin XH, 2009, APPL ENVIRON MICROB, V75, P5779, DOI 10.1128/AEM.00507-09; Yin XH, 2009, APPL ENVIRON MICROB, V75, P4975, DOI 10.1128/AEM.00297-09; Zhou ZM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008700	58	37	37	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e64211	10.1371/journal.pone.0064211	http://dx.doi.org/10.1371/journal.pone.0064211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785398	gold, Green Published, Green Submitted			2022-12-25	WOS:000321038800119
J	Li, JBW; Huang, XY; Zhang, RS; Kim, RY; Yang, RY; Kurata, HT				Li, Jenny B. W.; Huang, Xinyang; Zhang, Roger S.; Kim, Robin Y.; Yang, Runying; Kurata, Harley T.			Decomposition of Slide Helix Contributions to ATP-dependent Inhibition of Kir6.2 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE K+ CHANNELS; POTASSIUM-CHANNEL; SULFONYLUREA RECEPTOR; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; SENSORINEURAL DEAFNESS; ANDERSENS-SYNDROME; INSULIN-SECRETION; STRUCTURAL BASIS; BINDING-SITE	Regulation of inwardly rectifying potassium channels by intracellular ligands couples cell membrane excitability to important signaling cascades and metabolic pathways. We investigated the molecular mechanisms that link ligand binding to the channel gate in ATP-sensitive Kir6.2 channels. In these channels, the "slide helix" forms an interface between the cytoplasmic (ligand-binding) domain and the transmembrane pore, and many slide helix mutations cause loss of function. Using a novel approach to rescue electrically silent channels, we decomposed the contribution of each interface residue to ATP-dependent gating. We demonstrate that effective inhibition by ATP relies on an essential aspartate at residue 58. Characterization of the functional importance of this conserved aspartate, relative to other residues in the slide helix, has been impossible because of loss-of-function of Asp-58 mutant channels. The Asp-58 position exhibits an extremely stringent requirement for aspartate because even a highly conservative mutation to glutamate is insufficient to restore normal channel function. These findings reveal unrecognized slide helix elements that are required for functional channel expression and control of Kir6.2 gating by intracellular ATP.	[Li, Jenny B. W.; Huang, Xinyang; Zhang, Roger S.; Kim, Robin Y.; Yang, Runying; Kurata, Harley T.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Kurata, HT (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada.	harley.kurata@ubc.ca		Kurata, Harley/0000-0003-4357-4189	Canadian Institutes of Health Research (CIHR) [MOP-97998]; National Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institutes of Health Research (CIHR) Operating Grant MOP-97998 and by a National Sciences and Engineering Research Council of Canada (NSERC) Discovery grant (to H. T. K.).	AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Antcliff JF, 2005, EMBO J, V24, P229, DOI 10.1038/sj.emboj.7600487; Batulan Z, 2010, J BIOL CHEM, V285, P14005, DOI 10.1074/jbc.M109.097717; Bavro VN, 2012, NAT STRUCT MOL BIOL, V19, P158, DOI 10.1038/nsmb.2208; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Decher N, 2007, CARDIOVASC RES, V75, P748, DOI 10.1016/j.cardiores.2007.05.010; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Enkvetchakul D, 2003, J GEN PHYSIOL, V122, P471, DOI 10.1085/jgp.200308878; Enkvetchakul D, 2001, BIOPHYS J, V80, P719, DOI 10.1016/S0006-3495(01)76051-1; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; John SA, 2005, J PHYSIOL-LONDON, V568, P931, DOI 10.1113/jphysiol.2005.095638; Khurana A, 2011, J BIOL CHEM, V286, P36686, DOI 10.1074/jbc.M111.249110; Koster JC, 2005, DIABETES, V54, P2645, DOI 10.2337/diabetes.54.9.2645; Koster JC, 2008, BIOPHYS J, V95, P4689, DOI 10.1529/biophysj.108.138685; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kurata HT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000315; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu Z, 2004, ANNU REV PHYSIOL, V66, P103, DOI 10.1146/annurev.physiol.66.032102.150822; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Mannikko R, 2010, HUM MOL GENET, V19, P963, DOI 10.1093/hmg/ddp554; Marthinet E, 2005, J CLIN ENDOCR METAB, V90, P5401, DOI 10.1210/jc.2005-0202; McTaggart JS, 2010, J PHYSIOL-LONDON, V588, P3201, DOI 10.1113/jphysiol.2010.191767; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Paynter JJ, 2010, J BIOL CHEM, V285, P40754, DOI 10.1074/jbc.M110.175687; Pegan S, 2006, BIOCHEMISTRY-US, V45, P8599, DOI 10.1021/bi060653d; Pinney SE, 2008, J CLIN INVEST, V118, P2877, DOI 10.1172/JCI35414; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Proks P, 1999, J PHYSIOL-LONDON, V514, P19, DOI 10.1111/j.1469-7793.1999.019af.x; Proks P, 2004, P NATL ACAD SCI USA, V101, P17539, DOI 10.1073/pnas.0404756101; Ribalet B, 2006, J PHYSIOL-LONDON, V571, P303, DOI 10.1113/jphysiol.2005.100719; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; Schulte U, 1999, P NATL ACAD SCI USA, V96, P15298, DOI 10.1073/pnas.96.26.15298; Schulze-Bahr E, 2005, CIRC RES, V96, P703, DOI 10.1161/01.RES.0000164186.86838.09; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; Shimomura K, 2006, DIABETES, V55, P1705, DOI 10.2337/db05-1640; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Tornovsky S, 2004, J CLIN ENDOCR METAB, V89, P6224, DOI 10.1210/jc.2004-1233; Trapp S, 2003, EMBO J, V22, P2903, DOI 10.1093/emboj/cdg282; Trapp S, 1998, J GEN PHYSIOL, V112, P333, DOI 10.1085/jgp.112.3.333; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Winkler M, 2009, J BIOL CHEM, V284, P6752, DOI 10.1074/jbc.M805435200; Yan FF, 2007, DIABETES, V56, P2339, DOI 10.2337/db07-0150; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	53	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23038	23049		10.1074/jbc.M113.485789	http://dx.doi.org/10.1074/jbc.M113.485789			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23798684	Green Published, hybrid			2022-12-25	WOS:000330598200013
J	Asthana, J; Kapoor, S; Mohan, R; Panda, D				Asthana, Jayant; Kapoor, Sonia; Mohan, Renu; Panda, Dulal			Inhibition of HDAC6 Deacetylase Activity Increases Its Binding with Microtubules and Suppresses Microtubule Dynamic Instability in MCF-7 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINETIC STABILIZATION; ALPHA-TUBULIN; IN-VIVO; ACETYLATION; ACETYLTRANSFERASE; STABILITY; MIGRATION; TRANSPORT; MOTILITY	The post-translational modification of tubulin appears to be a highly controlled mechanism that regulates microtubule functioning. Acetylation of the epsilon-amino group of Lys-40 of alpha-tubulin marks stable microtubules, although the causal relationship between tubulin acetylation and microtubule stability has remained poorly understood. HDAC6, the tubulin deacetylase, plays a key role in maintaining typical distribution of acetylated microtubules in cells. Here, by using tubastatin A, an HDAC6-specific inhibitor, and siRNA-mediated depletion of HDAC6, we have explored whether tubulin acetylation has a role in regulating microtubule stability. We found that whereas both pharmacological inhibition of HDAC6 as well as its depletion enhance microtubule acetylation, only pharmacological inhibition of HDAC6 activity leads to an increase in microtubule stability against cold and nocodazole-induced depolymerizing conditions. Tubastatin A treatment suppressed the dynamics of individual microtubules in MCF-7 cells and delayed the reassembly of depolymerized microtubules. Interestingly, both the localization of HDAC6 on microtubules and the amount of HDAC6 associated with polymeric fraction of tubulin were found to increase in the tubastatin A-treated cells compared with the control cells, suggesting that the pharmacological inhibition of HDAC6 enhances the binding of HDAC6 to microtubules. The evidence presented in this study indicated that the increased binding of HDAC6, rather than the acetylation per se, causes microtubule stability. The results are in support of a hypothesis that in addition to its deacetylase function, HDAC6 might function as a MAP that regulates microtubule dynamics under certain conditions.	[Asthana, Jayant; Kapoor, Sonia; Mohan, Renu; Panda, Dulal] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Panda, D (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	panda@iitb.ac.in	Asthana, Jayant/AFQ-7879-2022	Kapoor, Sonia/0000-0003-2226-8748; Asthana, Dr. Jayant/0000-0002-8961-6308	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by a grant from the Department of Biotechnology, Government of India.	AHMAD FJ, 1993, J NEUROSCI, V13, P856; Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Asthana J, 2012, J BIOL CHEM, V287, P40793, DOI 10.1074/jbc.M112.394353; BAAS PW, 1991, J NEUROSCI RES, V30, P134, DOI 10.1002/jnr.490300115; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; CUEVA JG, 2012, CURR BIOL, V22, P1066, DOI [DOI 10.1016/j.cub.2012.05.012, DOI 10.1016/J.CUB.2012.05.012]; Drummond DR, 2011, SEMIN CELL DEV BIOL, V22, P927, DOI 10.1016/j.semcdb.2011.09.021; Garnham CP, 2012, CYTOSKELETON, V69, P442, DOI 10.1002/cm.21027; Giustiniani J, 2009, CELL SIGNAL, V21, P529, DOI 10.1016/j.cellsig.2008.12.004; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; HALLAK ME, 1977, FEBS LETT, V73, P147, DOI 10.1016/0014-5793(77)80968-X; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Hideshima T, 2005, P NATL ACAD SCI USA, V102, P8567, DOI 10.1073/pnas.0503221102; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Kalebic N, 2013, MOL CELL BIOL, V33, P1114, DOI 10.1128/MCB.01044-12; Kapoor S, 2012, BIOCHEM PHARMACOL, V83, P1495, DOI 10.1016/j.bcp.2012.02.012; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; MARUTA H, 1986, J CELL BIOL, V103, P571, DOI 10.1083/jcb.103.2.571; Matov A, 2010, NAT METHODS, V7, P761, DOI 10.1038/nmeth.1493; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Mohan R, 2008, CANCER RES, V68, P6181, DOI 10.1158/0008-5472.CAN-08-0584; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Palazzo A, 2003, NATURE, V421, P230, DOI 10.1038/421230a; Perdiz D, 2011, CELL SIGNAL, V23, P763, DOI 10.1016/j.cellsig.2010.10.014; Rathinasamy K, 2008, BIOCHEM PHARMACOL, V76, P1669, DOI 10.1016/j.bcp.2008.09.001; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Sudo H, 2010, J NEUROSCI, V30, P7215, DOI 10.1523/JNEUROSCI.0048-10.2010; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; WATSON DF, 1990, J NEUROSCI, V10, P3344; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; WEBSTER DR, 1989, J CELL SCI, V92, P57; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813	41	75	76	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22516	22526		10.1074/jbc.M113.489328	http://dx.doi.org/10.1074/jbc.M113.489328			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23798680	Green Published, hybrid			2022-12-25	WOS:000330596300032
J	Chen, P; Wang, C; Ma, XJ; Zhang, YZ; Liu, Q; Qiu, S; Liu, Q; Tian, J; Ni, JZ				Chen, Ping; Wang, Chao; Ma, Xiaojie; Zhang, Yizhe; Liu, Qing; Qiu, Shi; Liu, Qiong; Tian, Jing; Ni, Jiazuan			Direct Interaction of Selenoprotein R with Clusterin and Its Possible Role in Alzheimer's Disease	PLOS ONE			English	Article							METHIONINE SULFOXIDE REDUCTASE; GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; CLUSTERIN/APOLIPOPROTEIN-J; IDENTIFIES VARIANTS; APOPTOSIS; PROTEIN; CLU; METABOLISM; SELENIUM	Selenoprotein R (SelR) plays an important role in maintaining intracellular redox balance by reducing the R-form of methionine sulfoxide to methionine. As SelR is highly expressed in brain and closely related to Alzheimer's disease (AD), its biological functions in human brain become a research focus. In this paper, the selenocysteine-coding TGA of SelR gene was mutated to cysteine-coding TGC and used to screen the human fetal brain cDNA library with a yeast two-hybrid system. Our results demonstrated that SelR interacts with clusterin (Clu), a chaperone protein. This protein interaction was further verified by fluorescence resonance energy transfer (FRET), coimmunoprecipitation (co-IP), and pull-down assays. The interacting domain of Clu was determined by co-IP to be a dynamic, molten globule structure spanning amino acids 315 to 381 with an amphipathic-helix. The interacting domain of SelR was investigated by gene manipulation, ligand replacement, protein over-expression, and enzyme activity measurement to be a tetrahedral complex consisting of a zinc ion binding with four Cys residues. Study on the mutual effect of SelR and Clu showed synergic property between the two proteins. Cell transfection with SelR gene increased the expression of Clu, while cell transfection with Clu promoted the enzyme activity of SelR. Co-overexpression of SelR and Clu in N2aSW cells, an AD model cell line, significantly decreased the level of intracellular reactive oxygen species. Furthermore, FRET and co-IP assays demonstrated that Clu interacted with beta-amyloid peptide, a pathological protein of AD, which suggested a potential effect of SelR and A beta with the aid of Clu. The interaction between SelR and Clu provides a novel avenue for further study on the mechanism of SelR in AD prevention.	[Wang, Chao; Ni, Jiazuan] Chinese Acad Sci, Changchun Inst Appl Chem, Changchun 130022, Peoples R China; [Chen, Ping; Ma, Xiaojie; Zhang, Yizhe; Liu, Qing; Qiu, Shi; Liu, Qiong; Tian, Jing; Ni, Jiazuan] Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Microbial Genet Engn, Shenzhen, Peoples R China; [Wang, Chao] Chinese Acad Sci, Univ Chinese Acad Sci, Beijing, Peoples R China; [Chen, Ping] Shenzhen Univ, Coll Optoelect Engn, Shenzhen, Peoples R China	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Shenzhen University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shenzhen University	Liu, Q (corresponding author), Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Microbial Genet Engn, Shenzhen, Peoples R China.	liuqiong@szu.edu.cn; jzni@szu.edu.cn	Liu, Qiong/AAK-1556-2021		National Natural Science Foundation of China [31070731, 21271131]; Natural Science Foundation of Guangdong Province [10151806001000023]; Grants of Shenzhen Municipal Science and Technology Industry and Information Technology Commission Research [CXB201005240008A]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Grants of Shenzhen Municipal Science and Technology Industry and Information Technology Commission Research	This work was financially supported by the National Natural Science Foundation of China (No. 31070731 and 21271131), the Natural Science Foundation of Guangdong Province (No. 10151806001000023), and the Grants of Shenzhen Municipal Science and Technology Industry and Information Technology Commission Research (No. CXB201005240008A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aachmann FL, 2010, J BIOL CHEM, V285, P33315, DOI 10.1074/jbc.M110.132308; Atkins JF, 2000, NATURE, V407, P463, DOI 10.1038/35035189; Bailey RW, 2001, BIOCHEMISTRY-US, V40, P11828, DOI 10.1021/bi010135x; Bu WY, 2009, J BIOL CHEM, V284, P11622, DOI 10.1074/jbc.M805940200; Cabreiro F, 2006, ANN NY ACAD SCI, V1067, P37, DOI 10.1196/annals.1354.006; Calero M, 2005, SUB CELL BIOCHEM, V38, P273; Cao G, 2010, J BIOL CHEM, V285, P26081, DOI 10.1074/jbc.M110.103655; Chen P, 2013, INT J MOL SCI, V14, P4385, DOI 10.3390/ijms14034385; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Dobrovolska O, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/586539; Gutacker C, 1999, BIOCHEM J, V339, P759, DOI 10.1042/0264-6021:3390759; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hatfield D.L., 2011, SELENIUM ITS MOL BIO; Huang K., 2009, SELENIUM ITS CHEM BI; Isas JM, 2010, INVEST OPHTH VIS SCI, V51, P1304, DOI 10.1167/iovs.09-4207; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; Keskanokwong T, 2011, EUR HEART J, V32, P305, DOI 10.1093/eurheartj/ehq469; Kim HY, 2004, MOL BIOL CELL, V15, P1055, DOI 10.1091/mbc.E03-08-0629; Kim HY, 2005, BIOCHEMISTRY-US, V44, P8059, DOI 10.1021/bi0501131; Kim N, 2012, J CELL PHYSIOL, V227, P1157, DOI 10.1002/jcp.22836; Kryukov GV, 2002, P NATL ACAD SCI USA, V99, P4245, DOI 10.1073/pnas.072603099; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Levine RL, 2000, IUBMB LIFE, V50, P301, DOI 10.1080/15216540051081056; Liu L, 2009, NANO LETT, V9, P4066, DOI 10.1021/nl902256b; Loef M, 2011, J ALZHEIMERS DIS, V26, P81, DOI 10.3233/JAD-2011-110414; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; Marchetti MA, 2005, INVEST OPHTH VIS SCI, V46, P2007; MINETTI G, 1994, ITAL J BIOCHEM, V43, P273; Nuutinen T, 2009, BRAIN RES REV, V61, P89, DOI 10.1016/j.brainresrev.2009.05.007; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sagher D, 2006, J BIOL CHEM, V281, P31184, DOI 10.1074/jbc.M606962200; Sala A, 2009, ADV CANCER RES, V105, P115, DOI 10.1016/S0065-230X(09)05007-6; Shen LM, 2009, CHEM-BIOL INTERACT, V181, P455, DOI 10.1016/j.cbi.2009.07.013; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Tian J, 2010, ANAL BIOCHEM, V406, P83, DOI 10.1016/j.ab.2010.06.018; Trougakos IP, 2002, INT J BIOCHEM CELL B, V34, P1430, DOI 10.1016/S1357-2725(02)00041-9; Trougakos IP, 2004, CANCER RES, V64, P1834, DOI 10.1158/0008-5472.CAN-03-2664; Vandepoele K, 2010, EXP CELL RES, V316, P1225, DOI 10.1016/j.yexcr.2010.01.019; Xu F, 2008, BBA-MOL BASIS DIS, V1782, P615, DOI 10.1016/j.bbadis.2008.08.004; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291; Zhang Y, 2008, J BIOL CHEM, V283, P2427, DOI 10.1074/jbc.M707951200; Zhang YZ, 2011, J SHENZHEN U SCI ENG, V28, P400	43	16	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66384	10.1371/journal.pone.0066384	http://dx.doi.org/10.1371/journal.pone.0066384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805218	gold, Green Submitted, Green Published			2022-12-25	WOS:000320846500046
J	Gulati, S; Smith, DF; Cummings, RD; Couch, RB; Griesemer, SB; George, KS; Webster, RG; Air, GM				Gulati, Shelly; Smith, David F.; Cummings, Richard D.; Couch, Robert B.; Griesemer, Sara B.; George, Kirsten St.; Webster, Robert G.; Air, Gillian M.			Human H3N2 Influenza Viruses Isolated from 1968 To 2012 Show Varying Preference for Receptor Substructures with No Apparent Consequences for Disease or Spread	PLOS ONE			English	Article							AMINO-ACID CHANGE; BINDING SPECIFICITY; SIALIC-ACID; HEMAGGLUTININ; CELLS; OLIGOSACCHARIDES; NEURAMINIDASE; AGGLUTINATION; RECOGNITION; SEQUENCES	It is generally accepted that human influenza viruses bind glycans containing sialic acid linked alpha 2-6 to the next sugar, that avian influenza viruses bind glycans containing the alpha 2-3 linkage, and that mutations that change the binding specificity might change the host tropism. We noted that human H3N2 viruses showed dramatic differences in their binding specificity, and so we embarked on a study of representative human H3N2 influenza viruses, isolated from 1968 to 2012, that had been isolated and minimally passaged only in mammalian cells, never in eggs. The 45 viruses were grown in MDCK cells, purified, fluorescently labeled and screened on the Consortium for Functional Glycomics Glycan Array. Viruses isolated in the same season have similar binding specificity profiles but the profiles show marked year-to-year variation. None of the 610 glycans on the array (166 sialylated glycans) bound to all viruses; the closest was Neu5Ac alpha 2-6(Gal beta 1-4GlcNAc)(3) in either a linear or biantennary form, that bound 42 of the 45 viruses. The earliest human H3N2 viruses preferentially bound short, branched sialylated glycans while recent viruses bind better to long polylactosamine chains terminating in sialic acid. Viruses isolated in 1996, 2006, 2010 and 2012 bind glycans with alpha 2-3 linked sialic acid; for 2006, 2010 and 2012 viruses this binding was inhibited by oseltamivir, indicating binding of alpha 2-3 sialylated glycans by neuraminidase. More significantly, oseltamivir inhibited virus entry of 2010 and 2012 viruses into MDCK cells. All of these viruses were representative of epidemic strains that spread around the world, so all could infect and transmit between humans with high efficiency. We conclude that the year-to-year variation in receptor binding specificity is a consequence of amino acid sequence changes driven by antigenic drift, and that viruses with quite different binding specificity and avidity are equally fit to infect and transmit in the human population.	[Gulati, Shelly; Air, Gillian M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA; [Smith, David F.; Cummings, Richard D.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Couch, Robert B.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Griesemer, Sara B.; George, Kirsten St.] Wadsworth Ctr, New York State Dept Hlth, Albany, NY USA; [Webster, Robert G.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Emory University; Baylor College of Medicine; State University of New York (SUNY) System; Wadsworth Center; St Jude Children's Research Hospital	Air, GM (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA.	gillian-air@ouhsc.edu		Air, Gillian/0000-0001-5724-3108	NIH through a bridge grant from the Consortium for Functional Glycomics [GM62116]; American Lebanese Syrian Associated Charities;  [GM098791];  [AI18203];  [HHSN272200900007C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM098791] Funding Source: NIH RePORTER	NIH through a bridge grant from the Consortium for Functional Glycomics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH through a bridge grant from the Consortium for Functional Glycomics (GM62116, P.I. James Paulson), GM098791 (RDC), AI18203 (GMA), HHSN272200900007C (RGW) and the American Lebanese Syrian Associated Charities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aich U, 2011, FEBS J, V278, P1699, DOI 10.1111/j.1742-4658.2011.08096.x; Amonsen M, 2007, J VIROL, V81, P8341, DOI 10.1128/JVI.00718-07; Arinaminpathy N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015674; Asaoka N, 2006, MICROBES INFECT, V8, P511, DOI 10.1016/j.micinf.2005.08.006; Cholleti SR, 2012, OMICS, V16, P497, DOI 10.1089/omi.2012.0013; Fazekas de St Groth S, 1977, INFL HEM S BAD NEAR; Ghate AA, 1998, EUR J BIOCHEM, V258, P320, DOI 10.1046/j.1432-1327.1998.2580320.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gulati S, DIS MARKERS IN PRESS; Gulati S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-22; Heimburg-Molinaro J, 2012, METHODS MOL BIOL, V808, P251, DOI 10.1007/978-1-61779-373-8_18; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Ito T, 1997, VIROLOGY, V227, P493, DOI 10.1006/viro.1996.8323; KATZ JM, 1990, J VIROL, V64, P1808, DOI 10.1128/JVI.64.4.1808-1811.1990; Kobayashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040422; Kumari K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-42; LAVER WG, 1981, J MOL BIOL, V145, P339, DOI 10.1016/0022-2836(81)90209-6; LAVER WG, 1981, VIROLOGY, V111, P538, DOI 10.1016/0042-6822(81)90355-X; LEE EU, 1989, J BIOL CHEM, V264, P13848; Li D, 2009, J CLIN MICROBIOL, V47, P466, DOI 10.1128/JCM.00892-08; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Lin YP, 2010, J VIROL, V84, P6769, DOI 10.1128/JVI.00458-10; Macken C, 2001, INT CONGR SER, V1219, P103, DOI 10.1016/S0531-5131(01)00330-2; Medeiros R, 2001, VIROLOGY, V289, P74, DOI 10.1006/viro.2001.1121; Meisen I, 2012, GLYCOBIOLOGY, V22, P1055, DOI 10.1093/glycob/cws077; Nobusawa E, 2000, VIROLOGY, V278, P587, DOI 10.1006/viro.2000.0679; Nobusawa E, 2012, MICROBIOL IMMUNOL, V56, P99, DOI 10.1111/j.1348-0421.2012.00412.x; Nycholat CM, 2012, ANGEW CHEM INT EDIT, V51, P4860, DOI 10.1002/anie.201200596; Oh DY, 2008, J CLIN MICROBIOL, V46, P2189, DOI 10.1128/JCM.00398-08; Popova L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041895; PRIETO PA, 1985, ARCH BIOCHEM BIOPHYS, V241, P281, DOI 10.1016/0003-9861(85)90384-4; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; ROCHA EP, 1993, J GEN VIROL, V74, P2513, DOI 10.1099/0022-1317-74-11-2513; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; Sato K, 2004, EPIDEMIOL INFECT, V132, P399, DOI 10.1017/S0950268803001821; SAUTER NK, 1992, BIOCHEMISTRY-US, V31, P9609, DOI 10.1021/bi00155a013; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; Squires RB, 2012, INFLUENZA OTHER RESP, V6, P404, DOI 10.1111/j.1750-2659.2011.00331.x; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Stevens J, 2010, J VIROL, V84, P8287, DOI 10.1128/JVI.00058-10; Tappert MM, 2011, J VIROL, V85, P12146, DOI 10.1128/JVI.05537-11; Walther T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003223; Zhu XY, 2012, J VIROL, V86, P13371, DOI 10.1128/JVI.01426-12	43	76	80	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66325	10.1371/journal.pone.0066325	http://dx.doi.org/10.1371/journal.pone.0066325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805213	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500041
J	He, XL; Ding, CQ; Han, JL				He, Xue-Lian; Ding, Chang-Qing; Han, Jian-Lin			Lack of Structural Variation but Extensive Length Polymorphisms and Heteroplasmic Length Variations in the Mitochondrial DNA Control Region of Highly Inbred Crested Ibis, Nipponia nippon	PLOS ONE			English	Article							MTDNA CONTROL REGION; MICROSATELLITE LOCI; STURGEON ACIPENSER; SEQUENCE VARIATION; RAPID SEGREGATION; GENETIC DIVERSITY; MUTATION-RATES; TANDEM REPEATS; SIZE VARIATION; TRANSMISSION	The animal mitochondrial DNA (mtDNA) length polymorphism and heteroplasmy are accepted to be universal. Here we report the lack of structural variation but the presence of length polymorphism as well as heteroplasmy in mtDNA control region of an endangered avian species - the Crested Ibis (Nipponia nippon). The complete control region was directly sequenced while the distribution pattern and inheritance of the length variations were examined using both direct sequencing and genotyping of the PCR fragments from captive birds with pedigrees, wild birds and a historical specimen. Our results demonstrated that there was no structural variation in the control region, however, different numbers of short tandem repeats with an identical motif of CA(3)CA(2)CA(3) at the 3'-end of the control region determined the length polymorphisms among and heteroplasmy within individual birds. There were one to three predominant fragments in every bird; nevertheless multiple minor fragments coexist in all birds. These extremely high polymorphisms were suggested to have derived from the 'replication slippage' of a perfect microsatellite evolution following the step-wise mutational model. The patterns of heteroplasmy were found to be shifted between generations and among siblings but rather stable between blood and feather samples. This study provides the first evidence of a very extensive mtDNA length polymorphism and heteroplasmy in the highly inbred Crested Ibis which carries an mtDNA genome lack of structural genetic diversity. The analysis of pedigreed samples also sheds light on the transmission of mtDNA length heteroplasmy in birds following the genetic bottleneck theory. Further research focusing on the generation and transmission of particular mtDNA heteroplasmy patterns in single germ line of Crested Ibis is encouraged by this study.	[He, Xue-Lian; Ding, Chang-Qing] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China; [He, Xue-Lian; Han, Jian-Lin] CAAS, Inst Anim Sci, CAAS ILRI Joint Lab Livestock & Forage Genet Reso, Beijing, Peoples R China; [Han, Jian-Lin] ILRI, Nairobi, Kenya	Beijing Forestry University; CGIAR; International Livestock Research Institute (ILRI); Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; CGIAR; International Livestock Research Institute (ILRI)	Ding, CQ (corresponding author), Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China.	cqding@bjfu.edu.cn; h.jianlin@cgiar.org		He, Xuelian/0000-0001-5968-1486	National Natural Science Foundation of China [30870314]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (#30870314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald GW, 1978, P 1978 C COL WAT GRO, P1; ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325; AVISE JC, 1988, AUK, V105, P516, DOI 10.1093/auk/105.3.516; BALL RM, 1992, AUK, V109, P626; BERG T, 1995, CURR GENET, V27, P257, DOI 10.1007/BF00326158; Berger C, 2011, FORENSIC SCI INT-GEN, V5, P142, DOI 10.1016/j.fsigen.2010.10.002; Bergstrom CT, 1998, GENETICS, V149, P2135; BirdLife International, 2012, IUCN 2012 IUCN RED L; BOYCE TM, 1989, GENETICS, V123, P825; Brown JR, 1996, GENETICS, V142, P525; BROWN JR, 1992, GENETICS, V132, P221; BUROKER NE, 1990, GENETICS, V124, P157; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Cao LQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000756; Chakraborty R, 1997, P NATL ACAD SCI USA, V94, P1041, DOI 10.1073/pnas.94.3.1041; Chen W, 2006, LETT BIOTECHNOLOGY, V17, P651; Cho HJ, 2009, GENES GENET SYST, V84, P297, DOI 10.1266/ggs.84.297; Clayton D A, 2000, Hum Reprod, V15 Suppl 2, P11; Coskun PE, 2003, P NATL ACAD SCI USA, V100, P2174, DOI 10.1073/pnas.0630589100; Crochet PA, 2000, MOL BIOL EVOL, V17, P1797, DOI 10.1093/oxfordjournals.molbev.a026280; DENSMORE LD, 1985, GENETICS, V110, P689; Ding C., 2004, RES CRESTED IBIS; Ding Changqing, 2010, Chinese Birds, V1, P156; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Forster L, 2010, INT J LEGAL MED, V124, P133, DOI 10.1007/s00414-009-0385-0; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Genovart M, 2003, IBIS, V145, P448, DOI 10.1046/j.1474-919X.2003.00187.x; Gill F, 2013, IOC WORLD BIRD LIST; HALE LR, 1986, P NATL ACAD SCI USA, V83, P8813, DOI 10.1073/pnas.83.22.8813; Haring E, 2001, MOL BIOL EVOL, V18, P1892, DOI 10.1093/oxfordjournals.molbev.a003730; HARRISON RG, 1985, SCIENCE, V228, P1446, DOI 10.1126/science.228.4706.1446; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; He LP, 2006, CONSERV GENET, V7, P157, DOI 10.1007/s10592-005-6790-0; HOELZEL AR, 1993, J MOL EVOL, V37, P190, DOI 10.1007/BF02407355; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Ji YJ, 2004, MOL ECOL NOTES, V4, P615, DOI 10.1111/j.1471-8286.2004.00754.x; Kan XZ, 2010, GENET MOL RES, V9, P1204, DOI 10.4238/vol9-2gmr820; Khrapko K, 2008, NAT GENET, V40, P134, DOI 10.1038/ng0208-134; Kidd MG, 1998, MOL BIOL EVOL, V15, P61, DOI 10.1093/oxfordjournals.molbev.a025848; KOEHLER CM, 1991, GENETICS, V129, P247; KONDO R, 1990, GENETICS, V126, P657; Kvist L, 2003, MOL BIOL EVOL, V20, P243, DOI 10.1093/molbev/msg025; LAIPIS PJ, 1988, P NATL ACAD SCI USA, V85, P8107, DOI 10.1073/pnas.85.21.8107; Lei CZ, 2004, ANIM BIOTECHNOL, V9, P181; Liu Yin Zeng, 1981, Acta Zoologica Sinica, V27, P273; Ludwig A, 2000, GENETICS, V156, P1933; Lunt DH, 1998, MOL ECOL, V7, P1441, DOI 10.1046/j.1365-294x.1998.00495.x; Lutz-Bonengel S, 2004, INT J LEGAL MED, V118, P274, DOI 10.1007/s00414-004-0457-0; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; Munwes I, 2011, MOL ECOL, V20, P2878, DOI 10.1111/j.1365-294X.2011.05134.x; Nesbo CL, 1998, GENETICS, V148, P1907; OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; RAND DM, 1986, GENETICS, V114, P955; RAND DM, 1989, GENETICS, V121, P551; Ritchie PA, 2000, GENOME, V43, P613, DOI 10.1139/gen-43-4-613; Roques S, 2004, J HERED, V95, P332, DOI 10.1093/jhered/esh047; Sambrook J, 2001, MOL CLONING LAB MANU, V3rd; Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350; Sekiguchi K, 2003, MITOCHONDRION, V2, P401, DOI 10.1016/S1567-7249(03)00028-X; Shinde D, 2003, NUCLEIC ACIDS RES, V31, P974, DOI 10.1093/nar/gkg178; Shoubridge EA, 2008, SCIENCE, V319, P914, DOI 10.1126/science.1154515; Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1; Sibley CG, 1990, PHYLOGENY CLASSIFICA; SOLIGNAC M, 1983, P NATL ACAD SCI-BIOL, V80, P6942, DOI 10.1073/pnas.80.22.6942; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; [万君兴 Wan Junxing], 2010, [甘肃农业大学学报, Journal of Gansu Agricultural University], V45, P16; WENINK PW, 1994, MOL BIOL EVOL, V11, P22; White DJ, 2009, MOL BIOL EVOL, V26, P1435, DOI 10.1093/molbev/msp073; White DJ, 2008, MOL ECOL, V17, P4925, DOI 10.1111/j.1365-294X.2008.03982.x; Wolff JN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020522; Yamashina Y, 1983, NIPPONIA NIPPON; Zhang B, 2004, BIRD CONSERV INT, V14, P183, DOI 10.1017/S0959270904000231; Zhang B, 2005, THESIS ZHEJIANG U ZH; Zhang YD, 2004, THESIS NW SCI TECH U; [张智 ZHANG Zhi], 2008, [科技导报, Science & Technology Review], V26, P48	78	11	12	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66324	10.1371/journal.pone.0066324	http://dx.doi.org/10.1371/journal.pone.0066324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805212	Green Published, gold, Green Submitted			2022-12-25	WOS:000320846500040
J	Pietrocola, G; Geoghegan, JA; Rindi, S; Di Poto, A; Missineo, A; Consalvi, V; Foster, TJ; Speziale, P				Pietrocola, Giampiero; Geoghegan, Joan A.; Rindi, Simonetta; Di Poto, Antonella; Missineo, Antonino; Consalvi, Valerio; Foster, Timothy J.; Speziale, Pietro			Molecular Characterization of the Multiple Interactions of SpsD, a Surface Protein from Staphylococcus pseudintermedius, with Host Extracellular Matrix Proteins	PLOS ONE			English	Article							MSCRAMM CLUMPING FACTOR; TANDEM BETA-ZIPPER; HUMAN-FIBRINOGEN; CANINE CORNEOCYTES; PLATELET RECEPTOR; MEDIATE ADHERENCE; ATOPIC-DERMATITIS; BINDING DOMAIN; GAMMA-CHAIN; FACTOR-B	Staphylococcus pseudintermedius, a commensal and pathogen of dogs and occasionally of humans, expresses surface proteins potentially involved in host colonization and pathogenesis. Here, we describe the cloning and characterization of SpsD, a surface protein of S. pseudintermedius reported as interacting with extracellular matrix proteins and corneocytes. A ligand screen and Western immunoblotting revealed that the N-terminal A domain of SpsD bound fibrinogen, fibronectin, elastin and cytokeratin 10. SpsD also interfered with thrombin-induced fibrinogen coagulation and blocked ADP-induced platelet aggregation. The binding site for SpsD was mapped to residues 395-411 in the fibrinogen gamma-chain, while binding sites in fibronectin were localized to the N- and C-terminal regions. SpsD also bound to glycine-and serine-rich omega loops within the C-terminal tail region of cytokeratin 10. Ligand binding studies using SpsD variants lacking the C-terminal segment or containing an amino-acid substitution in the putative ligand binding site provided insights into interaction mechanism of SpsD with the different ligands. Together these data demonstrate the multi-ligand binding properties of SpsD and illustrate some interesting differences in the variety of ligands bound by SpsD and related proteins from S. aureus.	[Pietrocola, Giampiero; Rindi, Simonetta; Di Poto, Antonella; Missineo, Antonino; Speziale, Pietro] Inst Biochem, Dept Mol Med, Pavia, Italy; [Geoghegan, Joan A.; Foster, Timothy J.] Trinity Coll Dublin, Moyne Inst Prevent Med, Dept Microbiol, Dublin, Ireland; [Consalvi, Valerio] Univ Roma La Sapienza, Dept Biochem Sci Rossi Fanelli, I-00185 Rome, Italy	University of Pavia; Trinity College Dublin; Sapienza University Rome	Speziale, P (corresponding author), Inst Biochem, Dept Mol Med, Pavia, Italy.	pspeziale@unipv.it	consalvi, valerio/F-1918-2011	PIETROCOLA, GIAMPIERO/0000-0002-7069-8155; Geoghegan, Joan/0000-0002-3788-0668	Fondazione CARIPLO [Vaccines 2009-3546]; Science Foundation Ireland [08/IN.1/B1845]	Fondazione CARIPLO(Fondazione Cariplo); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	The support by Fondazione CARIPLO '[Vaccines 2009-3546]' to P. Speziale is acknowledged. TJF acknowledges the support of Science Foundation Ireland [grant number 08/IN.1/B1845]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannoehr J, 2012, VET DERMATOL, V23, DOI 10.1111/j.1365-3164.2011.01021.x; Bannoehr J, 2011, INFECT IMMUN, V79, P3074, DOI 10.1128/IAI.00137-11; Ben Zakour NL, 2011, J BACTERIOL, V193, P2363, DOI 10.1128/JB.00137-11; Burke FM, 2011, FEBS J, V278, P2359, DOI 10.1111/j.1742-4658.2011.08159.x; Burke FM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-160; Campanile F, 2007, MICROB DRUG RESIST, V13, P7, DOI 10.1089/mdr.2006.9991; Ganesh VK, 2011, J BIOL CHEM, V286, P25963, DOI 10.1074/jbc.M110.217414; Ganesh VK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000226; Geoghegan JA, 2010, J BIOL CHEM, V285, P6208, DOI 10.1074/jbc.M109.062208; Geoghegan JA, 2009, VET MICROBIOL, V138, P345, DOI 10.1016/j.vetmic.2009.03.030; Gerstadt K, 1999, CLIN INFECT DIS, V29, P218, DOI 10.1086/520168; Hair PS, 2008, J INFECT DIS, V198, P125, DOI 10.1086/588825; Hair PS, 2010, INFECT IMMUN, V78, P1717, DOI 10.1128/IAI.01065-09; Hartford O, 1997, MOL MICROBIOL, V25, P1065, DOI 10.1046/j.1365-2958.1997.5291896.x; HAWIGER J, 1989, BIOCHEMISTRY-US, V28, P2909, DOI 10.1021/bi00433a024; Jirouskova M, 2001, THROMB HAEMOSTASIS, V86, P1047; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; Keane FM, 2007, MOL MICROBIOL, V63, P711, DOI 10.1111/j.1365-2958.2006.05552.x; Keane FM, 2007, BIOCHEMISTRY-US, V46, P7226, DOI 10.1021/bi700454x; Kempker R, 2009, AM J MED SCI, V338, P425, DOI 10.1097/MAJ.0b013e3181b0baa9; KLOCZEWIAK M, 1983, THROMB RES, V29, P249, DOI 10.1016/0049-3848(83)90147-0; Laarhoven LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027788; Liu CZ, 2005, THROMB HAEMOSTASIS, V94, P286, DOI 10.1160/TH05-03-0205; McDevitt D, 1997, EUR J BIOCHEM, V247, P416, DOI 10.1111/j.1432-1033.1997.00416.x; MCDEVITT D, 1995, MOL MICROBIOL, V16, P895, DOI 10.1111/j.1365-2958.1995.tb02316.x; McEwan NA, 2000, RES VET SCI, V68, P279, DOI 10.1053/rvsc.2000.0378; McEwan NA, 2005, RES VET SCI, V78, P193, DOI 10.1016/j.rvsc.2004.09.002; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; Mulcahy ME, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003092; O'Connell DP, 1998, J BIOL CHEM, V273, P6821, DOI 10.1074/jbc.273.12.6821; Onuma K, 2012, VET DERMATOL, V23, P17, DOI 10.1111/j.1365-3164.2011.00995.x; Perreten V, 2010, J ANTIMICROB CHEMOTH, V65, P1145, DOI 10.1093/jac/dkq078; Ponnuraj K, 2003, CELL, V115, P217, DOI 10.1016/S0092-8674(03)00809-2; Rich RL, 1999, J BIOL CHEM, V274, P24906, DOI 10.1074/jbc.274.35.24906; Roche FM, 2004, J BIOL CHEM, V279, P38433, DOI 10.1074/jbc.M402122200; Roche FM, 2003, MICROBIOL-SGM, V149, P643, DOI 10.1099/mic.0.25996-0; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Speziale P, 2008, NAT PROTOC, V3, P525, DOI 10.1038/nprot.2008.12; Stegmann R, 2010, J ANTIMICROB CHEMOTH, V65, P2047, DOI 10.1093/jac/dkq241; Tse H, 2011, J BACTERIOL, V193, P1783, DOI 10.1128/JB.00023-11; Vazquez V, 2011, J BIOL CHEM, V286, P29797, DOI 10.1074/jbc.M110.214981; Walsh EJ, 2004, J BIOL CHEM, V279, P50691, DOI 10.1074/jbc.M408713200; Walsh EJ, 2008, MICROBIOL-SGM, V154, P550, DOI 10.1099/mic.0.2007/010868-0; Wann ER, 2000, J BIOL CHEM, V275, P13863, DOI 10.1074/jbc.275.18.13863; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039; ZARDI L, 1985, EUR J BIOCHEM, V146, P571, DOI 10.1111/j.1432-1033.1985.tb08690.x	46	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66901	10.1371/journal.pone.0066901	http://dx.doi.org/10.1371/journal.pone.0066901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805283	Green Published, gold, Green Submitted			2022-12-25	WOS:000320846500111
J	Omae, M; Takada, N; Yamamoto, S; Nakajima, H; Sato, TN				Omae, Madoka; Takada, Norio; Yamamoto, Shohei; Nakajima, Hiroyuki; Sato, Thomas N.			Identification of Inter-Organ Vascular Network: Vessels Bridging between Organs	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; ENDOTHELIAL-CELLS; TRANSGENIC ZEBRAFISH; IN-VIVO; PANCREAS DEVELOPMENT; ANGIOCRINE SIGNALS; SELF-RENEWAL; LIVER; VASCULOGENESIS; REGENERATION	Development and homeostasis of organs and whole body is critically dependent on the circulatory system. In particular, the circulatory system, the railways shuttling oxygen and nutrients among various organs, is indispensible for inter-organ humoral communication. Since the modern view of the anatomy and mechanics of the circulatory system was established in 17th century, it has been assumed that humoral factors are carried to and from organs via vascular branches of the central arteries and veins running along the body axis. Over the past few decades, major advances have been made in understanding molecular and cellular mechanisms underlying the vascularization of organs. However, very little is known about how each organ is linked by vasculature (i.e., inter-organ vascular networks). In fact, the exact anatomy of inter-organ vascular networks has remained obscure. Herein, we report the identification of four distinct vessels, V1(LP), V2(LP), V3(LP) and V4(LP), that bridge between two organs, liver and pancreas in developing zebrafish. We found that these inter-organ vessels can be classified into two types: direct and indirect types. The direct type vessels are those that bridge between two organs via single distinct vessel, to which V1(LP) and V2(LP) vessels belong. The indirect type bridges between two organs via separate branches that emanate from a stem vessel, and V3(LP) and V4(LP) vessels belong to this type. Our finding of V1(LP), V2(LP), V3(LP) and V4(LP) vessels provides the proof of the existence of inter-organ vascular networks. These and other yet-to-be-discovered inter-organ vascular networks may facilitate the direct exchange of humoral factors that are necessary for the coordinated growth, differentiation and homeostasis of the connected organs. It is also possible that the inter-organ vessels serve as tracks for their connected organs to follow during their growth to establish their relative positions and size differences.	[Omae, Madoka; Takada, Norio; Yamamoto, Shohei; Sato, Thomas N.] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; [Nakajima, Hiroyuki] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Cell Biol, Osaka, Japan; [Sato, Thomas N.] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA; [Sato, Thomas N.] Centenary Inst, Sydney, NSW, Australia	Nara Institute of Science & Technology; National Cerebral & Cardiovascular Center - Japan; Cornell University; University of Sydney; Centenary Institute	Sato, TN (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan.	island1005@bs.naist.jp	Nakajima, Hiroyuki/Z-1243-2019	Nakajima, Hiroyuki/0000-0003-4139-2779; Yamamoto, Shohei/0000-0001-8898-4603	JSPS KAKENHI S [22229007]; Takeda Science Foundation	JSPS KAKENHI S(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by JSPS KAKENHI S Grant Number 22229007 (TNS) and Takeda Science Foundation (NT, TNS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Flamme I, 1997, J CELL PHYSIOL, V173, P206, DOI 10.1002/(SICI)1097-4652(199711)173:2<206::AID-JCP22>3.0.CO;2-C; Gabella G., 1995, GRAYS ANATOMY, P1451; Harvey William, 1628, EXCERCITATIO ANATOMI; Her GM, 2003, FEBS LETT, V538, P125, DOI 10.1016/S0014-5793(03)00157-1; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Korzh S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-84; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Wan HY, 2006, EXP CELL RES, V312, P1526, DOI 10.1016/j.yexcr.2006.01.016; Yee NS, 2005, DEV BIOL, V284, P84, DOI 10.1016/j.ydbio.2005.04.035	23	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65720	10.1371/journal.pone.0065720	http://dx.doi.org/10.1371/journal.pone.0065720			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799039	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300035
J	Prieto, M; Wedin, M				Prieto, Maria; Wedin, Mats			Dating the Diversification of the Major Lineages of Ascomycota (Fungi)	PLOS ONE			English	Article							DIVERGENCE TIMES; MOLECULAR CLOCK; PHYLOGENETIC-RELATIONSHIPS; CALIBRATION UNCERTAINTY; FOSSIL CALIBRATIONS; EVOLUTION; LIFE; ORIGIN; MODEL; TREE	Establishing the dates for the origin and main diversification events in the phylogeny of Ascomycota is among the most crucial remaining goals in understanding the evolution of Fungi. There have been several analyses of divergence times in the fungal tree of life in the last two decades, but most have yielded contrasting results for the origin of the major lineages. Moreover, very few studies have provided temporal estimates for a large set of clades within Ascomycota. We performed molecular dating to estimate the divergence times of most of the major groups of Ascomycota. To account for paleontological uncertainty, we included alternative fossil constraints as different scenarios to enable a discussion of the effect of selection of fossils. We used data from 6 molecular markers and 121 extant taxa within Ascomycota. Our various 'relaxed clock' scenarios suggest that the origin and diversification of the Pezizomycotina occurred in the Cambrian. The main lineages of lichen-forming Ascomycota originated at least as early as the Carboniferous, with successive radiations in the Jurassic and Cretaceous generating the diversity of the main modern groups. Our study provides new information about the timing of the main diversification events in Ascomycota, including estimates for classes, orders and families of both lichenized and non-lichenized Ascomycota, many of which had not been previously dated.	[Prieto, Maria; Wedin, Mats] Swedish Museum Nat Hist, Dept Bot, S-10405 Stockholm, Sweden; [Prieto, Maria] Univ Rey Juan Carlos, Dept Biol & Geol, Madrid, Spain	Swedish Museum of Natural History; Universidad Rey Juan Carlos	Prieto, M (corresponding author), Swedish Museum Nat Hist, Dept Bot, S-10405 Stockholm, Sweden.	maria.prieto@nrm.se	Prieto, Maria/Q-5033-2017	Prieto, Maria/0000-0002-1692-9821; Wedin, Mats/0000-0002-8295-5198	Swedish Research Council [VR 621-2009-5372]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This project was funded by the Swedish Research Council (grant VR 621-2009-5372 to MW). The authors thank the Swedish Museum of Natural History for providing complementary facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Paz GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039683; de Paz GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028161; Ayala FJ, 1997, P NATL ACAD SCI USA, V94, P7776, DOI 10.1073/pnas.94.15.7776; Baloch E, 2010, TAXON, V59, P1483, DOI 10.1002/tax.595013; Bell CD, 2005, EVOLUTION, V59, P1245, DOI 10.1111/j.0014-3820.2005.tb01775.x; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Berbee Mary L., 2010, Fungal Biology Reviews, V24, P1, DOI 10.1016/j.fbr.2010.03.001; BERBEE ML, 1993, CAN J BOT, V71, P1114, DOI 10.1139/b93-131; Blair J.E, 2009, TIMETREE LIFE, P213; BRITTEN RJ, 1986, SCIENCE, V231, P1393, DOI 10.1126/science.3082006; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; Brown JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012759; Clarke JT, 2011, NEW PHYTOL, V192, P266, DOI 10.1111/j.1469-8137.2011.03794.x; Divakar PK, 2012, AM J BOT, V99, P2014, DOI 10.3732/ajb.1200258; Donoghue PCJ, 2009, BIOESSAYS, V31, P178, DOI 10.1002/bies.200800128; Dorfelt H, 2005, MYCOL RES, V109, P956, DOI 10.1017/S0953756205003497; Douzery EJP, 2004, P NATL ACAD SCI USA, V101, P15386, DOI 10.1073/pnas.0403984101; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Forest F, 2009, ANN BOT-LONDON, V104, P789, DOI 10.1093/aob/mcp192; Gazis R, 2012, MOL PHYLOGENET EVOL, V65, P294, DOI 10.1016/j.ympev.2012.06.019; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Gueidan C, 2008, STUD MYCOL, P111, DOI 10.3114/sim.2008.61.11; Gueidan C, 2011, FUNGAL BIOL-UK, V115, P987, DOI 10.1016/j.funbio.2011.04.002; Hasegawa M, 2003, GENES GENET SYST, V78, P267, DOI 10.1266/ggs.78.267; HASEGAWA M, 1989, JPN J GENET, V64, P243, DOI 10.1266/jjg.64.243; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Hedges SB, 2004, TRENDS GENET, V20, P242, DOI 10.1016/j.tig.2004.03.004; Hedges SB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-2; Ho SYW, 2007, J AVIAN BIOL, V38, P409, DOI 10.1111/j.2007.0908-8857.04168.x; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kenrick P, 2012, PHILOS T R SOC B, V367, P519, DOI 10.1098/rstb.2011.0271; Leavitt SD, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-176; Lee MSY, 2009, MOL PHYLOGENET EVOL, V50, P661, DOI 10.1016/j.ympev.2008.11.024; Lucking R, 2009, MYCOLOGIA, V101, P810, DOI 10.3852/09-016; Lumbsch HT, 2007, MYCOL RES, V111, P1133, DOI 10.1016/j.mycres.2007.06.016; MAGDEFRAU KARL, 1957, BER DUTCH BOT GES, V70, P433; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Near TJ, 2005, AM NAT, V165, P137, DOI 10.1086/427734; Near TJ, 2004, PHILOS T R SOC B, V359, P1477, DOI 10.1098/rstb.2004.1523; Padovan ACB, 2005, J MOL EVOL, V60, P726, DOI 10.1007/s00239-004-0164-y; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Peterson EB, 2000, LICHENOLOGIST, V32, P298, DOI 10.1006/lich.1999.0257; Peterson Kristin R., 2004, Harvard Papers in Botany, V8, P141; Poinar GO, 2000, LICHENOLOGIST, V32, P263, DOI 10.1006/lich.1999.0258; Poinar GO., 1992, LIFE AMBER; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prieto M, 2013, CLADISTICS, V29, P296, DOI 10.1111/j.1096-0031.2012.00429.x; Pryer KM, 2009, TIMETREE LIFE, P153; Rambaut A, 1998, MOL BIOL EVOL, V15, P442, DOI 10.1093/oxfordjournals.molbev.a025940; Rambaut A., 2007, TRACER V1 4; RENNER SS, 2009, TIMETREE LIFE, P157; Rikkinen J, 2003, MYCOLOGIA, V95, P1032, DOI 10.2307/3761911; Rikkinen J, 2000, MYCOL RES, V104, P7, DOI 10.1017/S0953756299001884; Rikkinen J, 2002, KARSTENIA, V42, P29, DOI DOI 10.29203/KA.2002.384; Rikkinen J, 2008, J EXP BOT, V59, P1007, DOI 10.1093/jxb/ern004; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rutschmann F, 2006, DIVERS DISTRIB, V12, P35, DOI 10.1111/j.1366-9516.2006.00210.x; Rutschmann F, 2007, SYST BIOL, V56, P591, DOI 10.1080/10635150701491156; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Schmidt AR, 2010, P NATL ACAD SCI USA, V107, P7329, DOI 10.1073/pnas.1000948107; Schmitt I., 2010, MYCOLOGY, V1, P75, DOI DOI 10.1080/21501201003631540; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Solds DE, 2008, ANN NY ACAD SCI, V1133, P3, DOI 10.1196/annals.1438.005; Spatafora JW, 2006, MYCOLOGIA, V98, P1018, DOI 10.3852/mycologia.98.6.1018; Spatafora JW, 1998, AM J BOT, V85, P1569, DOI 10.2307/2446483; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Taylor Paul D., 2004, P1, DOI 10.1017/CBO9780511607370.002; Taylor TN, 2005, MYCOLOGIA, V97, P269, DOI 10.3852/mycologia.97.1.269; Taylor TN, 1996, REV PALAEOBOT PALYNO, V90, P249, DOI 10.1016/0034-6667(95)00086-0; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Tuovila H, 2013, FUNGAL DIVERS, V58, P199, DOI 10.1007/s13225-012-0210-9; Wang DYC, 1999, P ROY SOC B-BIOL SCI, V266, P163, DOI 10.1098/rspb.1999.0617; Yang EC, 2012, P NATL ACAD SCI USA, V109, P10960, DOI 10.1073/pnas.1120915109; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024; ZUCKERKANDL EMILE, 1965, P97	79	122	124	1	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65576	10.1371/journal.pone.0065576	http://dx.doi.org/10.1371/journal.pone.0065576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799026	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300026
J	Sabri, F; Sebelik, ME; Meacham, R; Boughter, JD; Challis, MJ; Leventis, N				Sabri, Firouzeh; Sebelik, Merry E.; Meacham, Ryan; Boughter, John D., Jr.; Challis, Mitchell J.; Leventis, Nicholas			In Vivo Ultrasonic Detection of Polyurea Crosslinked Silica Aerogel Implants	PLOS ONE			English	Article							ACOUSTIC PROPERTIES; SCAFFOLDS; POROSITY	Background: Polyurea crosslinked silica aerogels are highly porous, lightweight, and mechanically strong materials with great potential for in vivo applications. Recent in vivo and in vitro studies have demonstrated the biocompatibility of this type of aerogel. The highly porous nature of aerogels allows for exceptional thermal, electric, and acoustic insulating capabilities that can be taken advantage of for non-invasive external imaging techniques. Sound-based detection of implants is a low cost, non-invasive, portable, and rapid technique that is routinely used and readily available in major clinics and hospitals. Methodology: In this study the first in vivo ultrasound response of polyurea crosslinked silica aerogel implants was investigated by means of a GE Medical Systems LogiQe diagnostic ultrasound machine with a linear array probe. Aerogel samples were inserted subcutaneously and sub-muscularly in a) fresh animal model and b) cadaveric human model for analysis. For comparison, samples of polydimethylsiloxane (PDMS) were also imaged under similar conditions as the aerogel samples. Conclusion/significance: Polyurea crosslinked silica aerogel (X-Si aerogel) implants were easily identified when inserted in either of the regions in both fresh animal model and cadaveric model. The implant dimensions inferred from the images matched the actual size of the implants and no apparent damage was sustained by the X-Si aerogel implants as a result of the ultrasonic imaging process. The aerogel implants demonstrated hyperechoic behavior and significant posterior shadowing. Results obtained were compared with images acquired from the PDMS implants inserted at the same location.	[Sabri, Firouzeh] Univ Memphis, Dept Phys, Memphis, TN 38152 USA; [Sebelik, Merry E.; Meacham, Ryan; Challis, Mitchell J.] Univ Tennessee, Ctr Hlth Sci, Dept Otolaryngol Head & Neck Surg, Memphis, TN 38163 USA; [Boughter, John D., Jr.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Leventis, Nicholas] Missouri Univ Sci & Technol, Dept Chem, Rolla, MO USA	University of Memphis; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Missouri System; Missouri University of Science & Technology	Sabri, F (corresponding author), Univ Memphis, Dept Phys, Memphis, TN 38152 USA.	fsabri@memphis.edu			FedEx Institute of Technology, University of Memphis	FedEx Institute of Technology, University of Memphis	The first author would like to thank the FedEx Institute of Technology, University of Memphis, for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLARD JF, 1994, REV SCI INSTRUM, V65, P754, DOI 10.1063/1.1145097; BRINKER CJ, 1994, J MEMBRANE SCI, V94, P85, DOI 10.1016/0376-7388(93)E0129-8; Caponi S, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.214204; Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7; Cujat MO, 2008, J PROSTHET DENT, V99, P218, DOI 10.1016/S0022-3913(08)60046-3; FRICKE J, 1992, INT J HEAT MASS TRAN, V35, P2305, DOI 10.1016/0017-9310(92)90073-2; Fricke J., 1986, SPRINGER P PHYS; Fullerton BA, 2008, ARCH PHYS MED REHAB, V89, P377, DOI 10.1016/j.apmr.2007.09.017; Gibbon WW, 2002, J CLIN ULTRASOUND, V30, P288, DOI 10.1002/jcu.10065; GIBIAT V, 1995, J NON-CRYST SOLIDS, V186, P244, DOI 10.1016/0022-3093(95)00049-6; GRONAUER M, 1986, ACUSTICA, V59, P177; Hong SJ, 2009, ACTA BIOMATER, V5, P1725, DOI 10.1016/j.actbio.2008.12.006; Huynh NT, 2011, PROC SPIE, V7897, DOI 10.1117/12.873302; Kanczler JA, 2008, BIOMATERIALS, V29, P1892, DOI 10.1016/j.biomaterials.2007.12.031; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Katti A, 2006, CHEM MATER, V18, P285, DOI 10.1021/cm0513841; Kherlopian AR, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-74; Laugier P, 2011, BONE QUANTITATIVE ULTRASOUND, P1, DOI 10.1007/978-94-007-0017-8; Leventis N, 2011, AEROGELS HDB ADV SOL; Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005; Lyons L, 1999, 76 ANN M SE SECT APS, V54; Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0; McNally EG, 2008, SKELETAL RADIOL, V37, P99, DOI 10.1007/s00256-007-0356-9; Meacham RK, 2012, OTOLARYNG HEAD NECK, V147, P864, DOI 10.1177/0194599812446677; Middleton WD, 2004, AM J ROENTGENOL, V183, P1449, DOI 10.2214/ajr.183.5.1831449; Park J., 2010, BIOMATERIALS INTRO; Power M, 2001, J NON-CRYST SOLIDS, V285, P303, DOI 10.1016/S0022-3093(01)00471-9; Ren L, 2002, BIOMATERIALS, V23, P4765, DOI 10.1016/S0142-9612(02)00226-0; Sabri F, 2011, ADV SPACE RES, V47, P419, DOI 10.1016/j.asr.2010.09.014; Sabri F, 2011, P 3 ANN ORNL BIOM SC; Sabri F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050686; Sabri F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033242; Silverstein Michael S., POROUS POLYM; Smith NB., 2010, INTRO MED IMAGING PH; Suetens Paul, 2009, FUNDAMENTALS MED IMA; Thomas V, 2006, CURR NANOSCI, V2, P155; Wells PNT, 1999, REP PROG PHYS, V62, P671, DOI 10.1088/0034-4885/62/5/201; Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645	38	32	32	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66348	10.1371/journal.pone.0066348	http://dx.doi.org/10.1371/journal.pone.0066348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799093	Green Published, gold, Green Submitted			2022-12-25	WOS:000320363300077
J	Ambjorn, M; Dubreuil, V; Miozzo, F; Nigon, F; Moller, B; Issazadeh-Navikas, S; Berg, J; Lees, M; Sap, J				Ambjorn, Malene; Dubreuil, Veronique; Miozzo, Federico; Nigon, Fabienne; Moller, Bente; Issazadeh-Navikas, Shohreh; Berg, Jacob; Lees, Michael; Sap, Jan			A Loss-of-Function Screen for Phosphatases that Regulate Neurite Outgrowth Identifies PTPN12 as a Negative Regulator of TrkB Tyrosine Phosphorylation	PLOS ONE			English	Article							RETRACTED ARTICLE. SEE; PEST CONTROLS MOTILITY; SCALE RNAI SCREENS; NEUROTROPHIN RECEPTORS; HUMAN NEUROBLASTOMA; SIGNALING PATHWAYS; NEURONAL POLARITY; HIPPOCAMPAL-NEURONS; CELL-MIGRATION; GROWTH-FACTORS	Alterations in function of the neurotrophin BDNF are associated with neurodegeneration, cognitive decline, and psychiatric disorders. BDNF promotes axonal outgrowth and branching, regulates dendritic tree morphology and is important for axonal regeneration after injury, responses that largely result from activation of its tyrosine kinase receptor TrkB. Although intracellular neurotrophin (NT) signaling presumably reflects the combined action of kinases and phosphatases, little is known about the contributions of the latter to TrkB regulation. The issue is complicated by the fact that phosphatases belong to multiple independently evolved families, which are rarely studied together. We undertook a loss-of-function RNA-interference-based screen of virtually all known (254) human phosphatases to understand their function in BDNF/TrkB-mediated neurite outgrowth in differentiated SH-SY5Y cells. This approach identified phosphatases from diverse families, which either positively or negatively modulate BDNF-TrkB-mediated neurite outgrowth, and most of which have little or no previously established function related to NT signaling. "Classical'' protein tyrosine phosphatases (PTPs) accounted for 13% of the candidate regulatory phosphatases. The top classical PTP identified as a negative regulator of BDNF-TrkB-mediated neurite outgrowth was PTPN12 (also called PTP-PEST). Validation and follow-up studies showed that endogenous PTPN12 antagonizes tyrosine phosphorylation of TrkB itself, and the downstream activation of ERK1/2. We also found PTPN12 to negatively regulate phosphorylation of p130cas and FAK, proteins with previously described functions related to cell motility and growth cone behavior. Our data provide the first comprehensive survey of phosphatase function in NT signaling and neurite outgrowth. They reveal the complexity of phosphatase control, with several evolutionarily unrelated phosphatase families cooperating to affect this biological response, and hence the relevance of considering all phosphatase families when mining for potentially druggable targets.	[Ambjorn, Malene; Moller, Bente; Issazadeh-Navikas, Shohreh; Lees, Michael; Sap, Jan] Univ Copenhagen, Fac Hlth Sci, Dept Biomed Sci, Copenhagen, Denmark; [Ambjorn, Malene; Moller, Bente; Issazadeh-Navikas, Shohreh; Lees, Michael; Sap, Jan] Univ Copenhagen, Fac Hlth Sci, BRIC, Copenhagen, Denmark; [Dubreuil, Veronique; Miozzo, Federico; Nigon, Fabienne; Sap, Jan] Univ Paris, Sorbonne Paris Cite, F-75252 Paris, France; [Berg, Jacob] Tech Univ Denmark, Dept Wind Energy, Roskilde, Denmark	University of Copenhagen; University of Copenhagen; UDICE-French Research Universities; Universite Paris Cite; Technical University of Denmark	Sap, J (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Biomed Sci, Copenhagen, Denmark.	jan.sap@univ-paris-diderot.fr	Issazadeh-Navikas, Shohreh/AAI-7900-2021; Miozzo, Federico/AAC-7305-2022; Berg, Jacob/B-5816-2016	Berg, Jacob/0000-0003-2126-6476; Dubreuil, Veronique/0000-0001-8060-3597; Miozzo, Federico/0000-0003-0818-9525	Vera og Carl Johan Michaelsens legat; Arvid Nilssons Fond; Department of Biomedical Sciences, University of Copenhagen	Vera og Carl Johan Michaelsens legat; Arvid Nilssons Fond; Department of Biomedical Sciences, University of Copenhagen	The work was supported by Vera og Carl Johan Michaelsens legat, Arvid Nilssons Fond, and Department of Biomedical Sciences, University of Copenhagen (http://bmi.ku.dk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Arevalo JC, 2006, CELL MOL LIFE SCI, V63, P1523, DOI 10.1007/s00018-006-6010-1; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Assaife-Lopes N, 2010, J NEUROSCI, V30, P8468, DOI 10.1523/JNEUROSCI.5695-09.2010; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Barr AJ, 2010, FUTURE MED CHEM, V2, P1563, DOI [10.4155/fmc.10.241, 10.4155/FMC.10.241]; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; BENEDETTI M, 1993, P NATL ACAD SCI USA, V90, P7859, DOI 10.1073/pnas.90.16.7859; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; BIEDLER JL, 1973, CANCER RES, V33, P2643; Boyd JG, 2001, J NEUROBIOL, V49, P314, DOI 10.1002/neu.10013; Buchser WJ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.52; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Cimmino F, 2009, ONCOGENE, V28, P2015, DOI 10.1038/onc.2009.70; Clark K, 2010, J CELL BIOCHEM, V109, P808, DOI 10.1002/jcb.22460; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Cowansage Kiriana K, 2010, Curr Mol Pharmacol, V3, P12; Cullen BR, 2006, NAT METHODS, V3, P677, DOI 10.1038/NMETH913; Darenfed H, 2007, CELL MOTIL CYTOSKEL, V64, P97, DOI 10.1002/cm.20168; Davidson D, 2001, EMBO J, V20, P3414, DOI 10.1093/emboj/20.13.3414; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Dijkhuizen PA, 2005, J NEUROBIOL, V62, P278, DOI 10.1002/neu.20100; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Encinas M, 1999, J NEUROCHEM, V73, P1409, DOI 10.1046/j.1471-4159.1999.0731409.x; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Espejo R, 2010, AM J PHYSIOL-CELL PH, V299, pC454, DOI 10.1152/ajpcell.00148.2010; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Faisal A, 2002, J BIOL CHEM, V277, P30144, DOI 10.1074/jbc.M203229200; Falschlehner C, 2010, BIOTECHNOL J, V5, P368, DOI 10.1002/biot.200900277; Faux C, 2007, BBA-MOL CELL RES, V1773, P1689, DOI 10.1016/j.bbamcr.2007.06.008; Garton AJ, 1999, J BIOL CHEM, V274, P3811, DOI 10.1074/jbc.274.6.3811; Gerling N, 2004, NEUROCHEM INT, V44, P505, DOI 10.1016/j.neuint.2003.08.013; GOSLIN K, 1990, J CELL BIOL, V110, P1319, DOI 10.1083/jcb.110.4.1319; Grace EA, 2003, J NEUROSCI, V23, P493, DOI 10.1523/JNEUROSCI.23-02-00493.2003; Gratacos M, 2007, BIOL PSYCHIAT, V61, P911, DOI 10.1016/j.biopsych.2006.08.025; Hafizi S, 2005, FASEB J, V19, P971, DOI 10.1096/fj.04-2532fje; Hafizi S, 2002, BIOCHEM BIOPH RES CO, V299, P793, DOI 10.1016/S0006-291X(02)02718-3; Hafizi S, 2010, BIOCHEM BIOPH RES CO, V399, P396, DOI 10.1016/j.bbrc.2010.07.085; He RJ, 2013, FEBS J, V280, P731, DOI 10.1111/j.1742-4658.2012.08718.x; Hocquemiller M, 2010, J NEUROSCI RES, V88, P202, DOI 10.1002/jnr.22190; Huang YZ, 2008, NEURON, V57, P546, DOI 10.1016/j.neuron.2007.11.026; Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574, DOI 10.1038/35023515; Iwakura Y, 2008, J BIOL CHEM, V283, P15799, DOI 10.1074/jbc.M801553200; Jeanneteau F, 2008, P NATL ACAD SCI USA, V105, P4862, DOI 10.1073/pnas.0709102105; Jeanneteau F, 2010, NAT NEUROSCI, V13, P1373, DOI 10.1038/nn.2655; Jung AS, 2011, CELL CYCLE, V10, P1838, DOI 10.4161/cc.10.11.15776; Kashiwaba M, 2003, FEBS LETT, V538, P197, DOI 10.1016/S0014-5793(03)00153-4; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Labelle C, 2000, DEV BRAIN RES, V123, P1, DOI 10.1016/S0165-3806(00)00069-9; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Loh SHY, 2008, CELL DEATH DIFFER, V15, P283, DOI 10.1038/sj.cdd.4402258; Lykissas MG, 2007, CURR NEUROVASC RES, V4, P143, DOI 10.2174/156720207780637216; Lynch G, 2008, EUR J PHARMACOL, V585, P2, DOI 10.1016/j.ejphar.2007.11.082; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Markova B, 2003, BIOCHEMISTRY-US, V42, P2691, DOI 10.1021/bi0265574; Massa SM, 2010, J CLIN INVEST, V120, P1774, DOI 10.1172/JCI41356; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Minichiello L, 1998, NEURON, V21, P335, DOI 10.1016/S0896-6273(00)80543-7; Miyamoto Y, 2006, P NATL ACAD SCI USA, V103, P10444, DOI 10.1073/pnas.0603914103; Montenegro-Venegas C, 2010, MOL BIOL CELL, V21, P3518, DOI 10.1091/mbc.E09-08-0709; Mustelin Tomas, 2007, V365, P9; Nikolic M, 2002, INT J BIOCHEM CELL B, V34, P731, DOI 10.1016/S1357-2725(01)00167-4; Numakawa T, 2010, HISTOL HISTOPATHOL, V25, P237, DOI 10.14670/HH-25.237; O'Neill GM, 2000, TRENDS CELL BIOL, V10, P111, DOI 10.1016/S0962-8924(99)01714-6; Ohira K, 2009, CURR NEUROPHARMACOL, V7, P276, DOI 10.2174/157015909790031210; PAHLMAN S, 1995, EUR J CANCER, V31A, P453, DOI 10.1016/0959-8049(95)00033-F; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Rajagopal R, 2004, J NEUROSCI, V24, P6650, DOI 10.1523/JNEUROSCI.0010-04.2004; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; ROGERS MV, 1994, NEUROSCIENCE, V60, P479, DOI 10.1016/0306-4522(94)90259-3; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Sacco F, 2012, FEBS LETT, V586, P2732, DOI 10.1016/j.febslet.2012.05.008; Sasaguri H, 2009, FEBS LETT, V583, P213, DOI 10.1016/j.febslet.2008.12.012; Sastry SK, 2006, J BIOL CHEM, V281, P11627, DOI 10.1074/jbc.M600897200; Sastry SK, 2002, J CELL SCI, V115, P4305, DOI 10.1242/jcs.00105; Schecterson LC, 2010, DEV NEUROBIOL, V70, P332, DOI 10.1002/dneu.20767; Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0; Sepp KJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000111; Serres F, 2006, BRAIN RES, V1101, P36, DOI 10.1016/j.brainres.2006.05.023; Shintani T, 2008, J BIOCHEM, V144, P259, DOI 10.1093/jb/mvn064; Sigoillot FD, 2011, ACS CHEM BIOL, V6, P47, DOI 10.1021/cb100358f; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Sirois J, 2006, MECH DEVELOP, V123, P869, DOI 10.1016/j.mod.2006.08.011; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Thoenen H, 2002, NAT NEUROSCI, V5, P1046, DOI 10.1038/nn938; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Tschuch C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-60; Tucker BA, 2008, CELL SIGNAL, V20, P241, DOI 10.1016/j.cellsig.2007.10.014; Urena JM, 2005, J COMP NEUROL, V490, P119, DOI 10.1002/cne.20656; Veillette A, 2009, IMMUNOL REV, V228, P312, DOI 10.1111/j.1600-065X.2008.00747.x; Vickers JC, 2009, BRAIN RES BULL, V80, P217, DOI 10.1016/j.brainresbull.2009.08.004; Waterhouse EG, 2009, MOL CELL NEUROSCI, V42, P81, DOI 10.1016/j.mcn.2009.06.009; Xie HR, 2010, CHINESE MED J-PEKING, V123, P1086, DOI 10.3760/cma.j.issn.0366-6999.2010.08.021; Yamada S, 2007, BIOCHEM BIOPH RES CO, V363, P926, DOI 10.1016/j.bbrc.2007.09.069; Yang P, 2007, EUR J NEUROSCI, V25, P1332, DOI 10.1111/j.1460-9568.2007.05384.x; Yang T, 2006, J NEUROBIOL, V66, P1420, DOI 10.1002/neu.20291; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhang JY, 2000, EUR J NEUROSCI, V12, P4171, DOI 10.1046/j.1460-9568.2000.01312.x; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	105	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65371	10.1371/journal.pone.0065371	http://dx.doi.org/10.1371/journal.pone.0065371			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785422	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800098
J	Mancini, G; Ferrari, PF; Palagi, E				Mancini, Giada; Ferrari, Pier Francesco; Palagi, Elisabetta			In Play We Trust. Rapid Facial Mimicry Predicts the Duration of Playful Interactions in Geladas	PLOS ONE			English	Article							IMITATION; EMPATHY; EXPRESSIONS; LAUGHTER; SIGNALS	The primate play-face is homologous to the human facial display accompanying laughter. Through facial mimicry, the play-face evokes in the perceiver a similar positive emotional state. This sensorimotor and emotional sharing can be adaptive, as it allows individuals to fine-tune their own motor sequences accordingly thus increasing cooperation in play. It has been recently demonstrated that, not only humans and apes, but also geladas are able to mimic others' facial expressions. Here, we describe two forms of facial mimicry in Theropithecus gelada: rapid (RFM, within 1.0 s) and delayed (DFM, within 5.0 s). Play interactions characterized by the presence of RFM were longer than those with DFM thus suggesting that RFM is a good indicator of the quality of communicative exchanges and behavioral coordination. These findings agree with the proposal of a mirror mechanism operating during perception and imitation of facial expressions. In an evolutionary perspective, our findings suggest that RFM not only was already present in the common ancestor of cercopitecoids and hominoids, but also that there is a relationship between RFM and length and quality of playful interactions.	[Mancini, Giada; Ferrari, Pier Francesco] Univ Parma, Dipartimento Biol Evolut & Funz, I-43100 Parma, Italy; [Mancini, Giada; Palagi, Elisabetta] Univ Pisa, Museo Storia Nat, Pisa, Italy; [Palagi, Elisabetta] CNR, Ist Sci & Tecnol Cogniz, Rome, Italy	University of Parma; University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Palagi, E (corresponding author), Univ Pisa, Museo Storia Nat, Pisa, Italy.	betta.palagi@museo.unipi.it	Ferrari, Pier Francesco/G-5547-2017		MIUR (Italy); Direct For Biological Sciences [1300426] Funding Source: National Science Foundation	MIUR (Italy)(Ministry of Education, Universities and Research (MIUR)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	MIUR (Italy) partly covered GM's expenses to stay in Germany to collect data. The authors had no other funding sources for this research, only their salaries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beall PM, 2008, J EXP CHILD PSYCHOL, V101, P206, DOI 10.1016/j.jecp.2008.04.004; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Davila-Ross M, 2011, EMOTION, V11, P1013, DOI 10.1037/a0022594; de Waal FBM, 2009, NATURE, V460, P175, DOI 10.1038/460175a; Decety J, 2008, DEV PSYCHOPATHOL, V20, P1053, DOI 10.1017/S0954579408000503; Demuru E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049613; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Dimberg U, 1998, SCAND J PSYCHOL, V39, P39, DOI 10.1111/1467-9450.00054; Dimberg U, 2002, COGNITION EMOTION, V16, P449, DOI 10.1080/02699930143000356; Ferrari PF, 2009, PHILOS T R SOC B, V364, P2311, DOI 10.1098/rstb.2009.0062; Gervais M, 2005, Q REV BIOL, V80, P395, DOI 10.1086/498281; Hatfield E., 1994, REV PERSONALITY SOCI; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Jones SS, 2009, PHILOS T R SOC B, V364, P2325, DOI 10.1098/rstb.2009.0045; Mancini G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01527; Mancini G, 2009, BEHAV PROCESS, V82, P286, DOI 10.1016/j.beproc.2009.07.007; Niedenthal PM, 2010, BEHAV BRAIN SCI, V33, P417, DOI 10.1017/S0140525X10000865; Norscia I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028472; Palagi E, 2008, ANIM BEHAV, V75, P887, DOI 10.1016/j.anbehav.2007.07.016; Palagi E, 2009, P NATL ACAD SCI USA, V106, P19262, DOI 10.1073/pnas.0910891106; Palagi E, 2011, J COMP PSYCHOL, V125, P11, DOI 10.1037/a0020869; Pellis S. M., 2009, PLAYFUL BRAIN VENTUR; Pellis SM, 1996, AGGRESS VIOLENT BEH, V1, P249, DOI 10.1016/1359-1789(95)00016-X; Pellis SM, 1997, AGGRESSIVE BEHAV, V23, P41, DOI 10.1002/(SICI)1098-2337(1997)23:1<41::AID-AB5>3.0.CO;2-W; Pfeifer JH, 2008, NEUROIMAGE, V39, P2076, DOI 10.1016/j.neuroimage.2007.10.032; Preuschoft S, 1995, FOLIA PRIMATOL, V65, P121, DOI 10.1159/000156878; PROVINE RR, 1993, ETHOLOGY, V95, P291; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Ross MD, 2008, BIOL LETTERS, V4, P27, DOI 10.1098/rsbl.2007.0535; Sato W, 2007, COGNITION, V104, P1, DOI 10.1016/j.cognition.2006.05.001; Schmidt KL, 2001, YEARB PHYS ANTHROPOL, V44, P3, DOI 10.1002/ajpa.20001; Waller BM, 2005, ETHOLOGY, V111, P129, DOI 10.1111/j.1439-0310.2004.01045.x; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Wild B, 2003, PSYCHIAT RES-NEUROIM, V123, P17, DOI 10.1016/S0925-4927(03)00006-4	34	51	51	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66481	10.1371/journal.pone.0066481	http://dx.doi.org/10.1371/journal.pone.0066481			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	172XB	23785501	Green Published, gold			2022-12-25	WOS:000321038800020
J	Telke, AA; Zhuang, N; Ghatge, SS; Lee, SH; Shah, AA; Khan, H; Um, Y; Shin, HD; Chung, YR; Lee, KH; Kim, SW				Telke, Amar A.; Zhuang, Ningning; Ghatge, Sunil S.; Lee, Sook-Hee; Shah, Asad Ali; Khan, Haji; Um, Youngsoon; Shin, Hyun-Dong; Chung, Young Ryun; Lee, Kon Ho; Kim, Seon-Won			Engineering of Family-5 Glycoside Hydrolase (Cel5A) from an Uncultured Bacterium for Efficient Hydrolysis of Cellulosic Substrates	PLOS ONE			English	Article							ENDOGLUCANASE CEL5A; CRYSTAL-STRUCTURE; CELLULASE; BINDING; CRYSTALLOGRAPHY; MECHANISM; SYSTEM; SUITE	Cel5A, an endoglucanase, was derived from the metagenomic library of vermicompost. The deduced amino acid sequence of Cel5A shows high sequence homology with family-5 glycoside hydrolases, which contain a single catalytic domain but no distinct cellulose-binding domain. Random mutagenesis and cellulose-binding module (CBM) fusion approaches were successfully applied to obtain properties required for cellulose hydrolysis. After two rounds of error-prone PCR and screening of 3,000 mutants, amino acid substitutions were identified at various positions in thermotolerant mutants. The most heat-tolerant mutant, Cel5A_2R2, showed a 7-fold increase in thermostability. To enhance the affinity and hydrolytic activity of Cel5A on cellulose substrates, the family-6 CBM from Saccharophagus degradans was fused to the C-terminus of the Cel5A_2R2 mutant using overlap PCR. The Cel5A_2R2-CBM6 fusion protein showed 7-fold higher activity than the native Cel5A on Avicel and filter paper. Cellobiose was a major product obtained from the hydrolysis of cellulosic substrates by the fusion enzyme, which was identified by using thin layer chromatography analysis.	[Telke, Amar A.; Zhuang, Ningning; Ghatge, Sunil S.; Lee, Sook-Hee; Shah, Asad Ali; Khan, Haji; Chung, Young Ryun; Lee, Kon Ho; Kim, Seon-Won] Gyeongsang Natl Univ, Div Appl Life Sci BK21, PMBBRC, Jinju, South Korea; [Um, Youngsoon] KIST, Ctr Environm Technol Res, Seoul, South Korea; [Shin, Hyun-Dong] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Lee, Kon Ho] Gyeongsang Natl Univ, Sch Med, Dept Microbiol, Jinju, South Korea	Gyeongsang National University; Korea Institute of Science & Technology (KIST); University System of Georgia; Georgia Institute of Technology; Gyeongsang National University	Lee, KH (corresponding author), Gyeongsang Natl Univ, Div Appl Life Sci BK21, PMBBRC, Jinju, South Korea.	lkh@gnu.ac.kr; swkim@gnu.ac.kr	Ghatge, Sunil/AAH-3946-2020; Telke, Amar Anandrao/ABF-3247-2020	Telke, Amar Anandrao/0000-0001-9967-5611	International Collaborative R&D Program of Knowledge Economy Technology Innovation Program, MKE; National Research Foundation [NRF-2010-C1AAA001-0029084]; Ministry of Enviromental Science and Technology (MEST); Korea Institute of Science and Technology (KIST) through Future Key Technology Program, Korea; BK21 Program, MEST, Korea	International Collaborative R&D Program of Knowledge Economy Technology Innovation Program, MKE; National Research Foundation; Ministry of Enviromental Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Institute of Science and Technology (KIST) through Future Key Technology Program, Korea; BK21 Program, MEST, Korea(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaMinistry of Education, Science & Technology (MEST), Republic of Korea)	International Collaborative R&D Program of Knowledge Economy Technology Innovation Program, MKE, and a grant (NRF-2010-C1AAA001-0029084) from the National Research Foundation, Ministry of Enviromental Science and Technology (MEST), and the financial support from the Korea Institute of Science and Technology (KIST) through Future Key Technology Program, Korea. Dr. Amar A. Telke and SS Ghatge are supported by fellowship from the BK21 Program, MEST, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbar M, 2010, CHEMCATCHEM, V2, P997, DOI 10.1002/cctc.201000112; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bras JLA, 2011, P NATL ACAD SCI USA, V108, P5237, DOI 10.1073/pnas.1015006108; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Carrard G, 2000, P NATL ACAD SCI USA, V97, P10342, DOI 10.1073/pnas.160216697; CHAN MK, 1995, SCIENCE, V267, P1463, DOI 10.1126/science.7878465; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eckert K, 2002, APPL MICROBIOL BIOT, V60, P428, DOI 10.1007/s00253-002-1131-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kang MS, 2007, J MICROBIOL, V45, P291; KLYOSOV AA, 1990, BIOCHEMISTRY-US, V29, P10577, DOI 10.1021/bi00499a001; Li YC, 2007, APPL ENVIRON MICROB, V73, P3165, DOI 10.1128/AEM.02960-06; Liang CN, 2011, J BIOTECHNOL, V154, P46, DOI 10.1016/j.jbiotec.2011.03.025; Liu WJ, 2010, APPL ENVIRON MICROB, V76, P4914, DOI 10.1128/AEM.00958-10; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; Pereira JH, 2010, J STRUCT BIOL, V172, P372, DOI 10.1016/j.jsb.2010.06.018; RUSSELL RJM, 1994, STRUCTURE, V2, P1157, DOI 10.1016/S0969-2126(94)00118-9; Sambrook J, 2001, MOL CLONING LAB MANU; Santos CR, 2012, BIOCHEM J, V441, P95, DOI 10.1042/BJ20110869; Taylor LE, 2006, J BACTERIOL, V188, P3849, DOI 10.1128/JB.01348-05; Telke AA, 2012, BIORESOURCE TECHNOL, V112, P10, DOI 10.1016/j.biortech.2012.02.066; Vazana Y, 2010, APPL ENVIRON MICROB, V76, P3236, DOI 10.1128/AEM.00009-10; Wang XJ, 2012, APPL MICROBIOL BIOT, V95, P1469, DOI 10.1007/s00253-011-3799-9; Wang YG, 2012, J BIOL CHEM, V287, P29568, DOI 10.1074/jbc.M111.320358; Watson BJ, 2009, J BACTERIOL, V191, P5697, DOI 10.1128/JB.00481-09; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WOOD TM, 1971, BIOCHEM J, V121, P353, DOI 10.1042/bj1210353; Yasir M, 2013, J MICROBIOL, V51, P329, DOI 10.1007/s12275-013-2697-5; Zhang YHP, 2008, J IND MICROBIOL BIOT, V35, P367, DOI 10.1007/s10295-007-0293-6; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003; Zhang Y, 2010, APPL ENVIRON MICROB, V76, P6870, DOI 10.1128/AEM.00896-10; Zhang YHP, 2006, BIOMACROMOLECULES, V7, P644, DOI 10.1021/bm050799c; Zhao JQ, 2012, APPL MICROBIOL BIOT, V95, P947, DOI 10.1007/s00253-011-3807-0	36	17	17	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65727	10.1371/journal.pone.0065727	http://dx.doi.org/10.1371/journal.pone.0065727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785445	gold, Green Published, Green Submitted			2022-12-25	WOS:000321038800077
J	Xiang, B; Wu, JY; Wang, Q; Li, ML; Jiang, LJ; Deng, W; Chen, ZF; He, ZL; Huang, CH; Han, YY; Li, YF; Lin, Y; Liu, X; Wang, YC; Ma, XH; Gong, QY; Li, T; Hu, X				Xiang, Bo; Wu, Jun-yao; Wang, Qiang; Li, Ming-Li; Jiang, Li-Jun; Deng, Wei; Chen, Zhuang-Fei; He, Zong-Ling; Huang, Cao-Hua; Han, Yuan-yuan; Li, Yin-fei; Lin, Yin; Liu, Xiang; Wang, Ying-cheng; Ma, Xiao-Hong; Gong, Qi-yong; Li, Tao; Hu, Xun			Cortical Surface Area Correlates with STON2 Gene Ser307Pro Polymorphism in First-Episode Treatment-Naive Patients with Schizophrenia	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SYNAPTIC VESICLE ENDOCYTOSIS; MAGNETIC-RESONANCE; COMMON VARIANTS; NONPSYCHOTIC SIBLINGS; SYNAPTOTAGMIN; BRAIN; ADAPTER; LOCI; INTERNALIZATION	Background: Evidence shows that STON2 gene is associated with synaptic function and schizophrenia. This study aims to explore the relationship between two functional polymorphisms (Ser307Pro and Ala851Ser) of STON2 gene and the cortical surface area in first-episode treatment-naive patients with schizophrenia and healthy controls. Methodology/Principal Findings: Magnetic resonance imaging of the whole cortical surface area, which was computed by an automated surface-based technique (FreeSurfer), was obtained from 74 first-episode treatment-naive patients with schizophrenia and 55 healthy controls. Multiple regression analysis was performed to investigate the effect of genotype subgroups on the cortical surface area. A significant genotype-by-diagnosis effect on the cortical surface area was observed. Pro-allele carriers of Ser307Pro polymorphism had larger right inferior temporal surface area than Ser/Ser carriers in the patients with schizophrenia; however, no significant difference was found in the same area in the healthy controls. The Ala851Ser polymorphism of STON2 gene was not significantly associated with the cortical surface area in patients with schizophrenia and healthy controls. Conclusions/Significance: The present study demonstrated that the functional variant of the STON2 gene could alter cortical surface area on the right inferior temporal and contribute to the pathogenesis of schizophrenia.	[Xiang, Bo; Wu, Jun-yao; Wang, Qiang; Li, Ming-Li; Jiang, Li-Jun; Deng, Wei; Chen, Zhuang-Fei; He, Zong-Ling; Huang, Cao-Hua; Han, Yuan-yuan; Li, Yin-fei; Lin, Yin; Ma, Xiao-Hong; Li, Tao; Hu, Xun] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China; [Xiang, Bo; Wu, Jun-yao; Wang, Qiang; Li, Ming-Li; Jiang, Li-Jun; Deng, Wei; Chen, Zhuang-Fei; He, Zong-Ling; Huang, Cao-Hua; Han, Yuan-yuan; Li, Yin-fei; Lin, Yin; Liu, Xiang; Wang, Ying-cheng; Ma, Xiao-Hong; Li, Tao] Sichuan Univ, West China Hosp, Mental Hlth Ctr, Chengdu, Sichuan, Peoples R China; [Xiang, Bo; Wu, Jun-yao; Wang, Qiang; Li, Ming-Li; Jiang, Li-Jun; Deng, Wei; Chen, Zhuang-Fei; He, Zong-Ling; Huang, Cao-Hua; Han, Yuan-yuan; Li, Yin-fei; Lin, Yin; Liu, Xiang; Wang, Ying-cheng; Ma, Xiao-Hong; Li, Tao] Sichuan Univ, West China Hosp, Psychiat Lab, Chengdu, Sichuan, Peoples R China; [Gong, Qi-yong] Sichuan Univ, West China Hosp, Dept Radiol, Huaxi MR Res Ctr, Chengdu, Sichuan, Peoples R China; [Hu, Xun] Sichuan Univ, West China Hosp, Huaxi Biobank, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University	Li, T (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China.	litaohx@scu.edu.cn; hxxhu99@163.com	Gong, Qiyong/W-3052-2019; Deng, Wei/AAU-9945-2020; Deng, Wei/GWC-9207-2022	Gong, Qiyong/0000-0002-5912-4871; Ma, Xiaohong/0000-0003-2627-9946; Li, Tao/0000-0003-3831-901X	National Nature Science Foundation of China [81130024, 30530300, 30125014, 30971056, 81271479, 81171275, 81071089]; National Basic Research Program of China (973 Program) [2007CB512301]; Ph.D. Programs Foundation of Ministry of Education of China [20110181110014]; National Key Technology R & D Program of the Ministry of Science and Technology of China during the 12th Five-Year Plan [2012BAI01B06]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); National Key Technology R & D Program of the Ministry of Science and Technology of China during the 12th Five-Year Plan	This work was partly funded by National Nature Science Foundation of China (81130024, 30530300 and 30125014, TL; 30971056 and 81271479, QW; 81171275, WD, 81071089, YCW), the National Basic Research Program of China (973 Program 2007CB512301, TL), the Ph.D. Programs Foundation of Ministry of Education of China (20110181110014, TL), National Key Technology R & D Program of the Ministry of Science and Technology of China during the 12th Five-Year Plan (2012BAI01B06, TL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews J, 1996, GENETICS, V143, P1699; Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; Bailer U, 2000, NEUROPSYCHOBIOLOGY, V42, P175, DOI 10.1159/000026690; Bakken TE, 2011, ARCH GEN PSYCHIAT, V68, P781, DOI 10.1001/archgenpsychiatry.2011.81; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Centonze D, 2004, J NEUROSCI, V24, P8214, DOI 10.1523/JNEUROSCI.1274-04.2004; Chen CH, 1996, AM J MED GENET, V67, P556, DOI 10.1002/(SICI)1096-8628(19961122)67:6<556::AID-AJMG8>3.3.CO;2-P; Chen CH, 2012, SCIENCE, V335, P1634, DOI 10.1126/science.1215330; Chiu YF, 2002, MOL PSYCHIATR, V7, P658, DOI 10.1038/sj.mp.4001045; CHOWDHURY D, 1995, NEUROSCI LETT, V190, P9, DOI 10.1016/0304-3940(95)11487-H; CIULLA TA, 1988, ANAL BIOCHEM, V174, P485, DOI 10.1016/0003-2697(88)90047-4; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Diril MK, 2006, DEV CELL, V10, P233, DOI 10.1016/j.devcel.2005.12.011; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; Fergestad T, 2001, J NEUROSCI, V21, P1218; Fergestad T, 1999, J NEUROSCI, V19, P5847, DOI 10.1523/JNEUROSCI.19-14-05847.1999; First MB., 1997, USERS GUIDE STRUCTUR; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; GOTTESMAN II, 1987, SCHIZOPHRENIA BULL, V13, P23, DOI 10.1093/schbul/13.1.23; Herath P, 2001, HUM BRAIN MAPP, V12, P110, DOI 10.1002/1097-0193(200102)12:2<110::AID-HBM1008>3.0.CO;2-0; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hodgkinson CA, 2004, AM J HUM GENET, V75, P862, DOI 10.1086/425586; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Ji YY, 2009, P NATL ACAD SCI USA, V106, P19593, DOI 10.1073/pnas.0904289106; JOHNSTONE EC, 1989, J NEUROL NEUROSUR PS, V52, P736, DOI 10.1136/jnnp.52.6.736; Joyner AH, 2009, P NATL ACAD SCI USA, V106, P15483, DOI 10.1073/pnas.0901866106; Lien YJ, 2010, GENES BRAIN BEHAV, V9, P695, DOI 10.1111/j.1601-183X.2010.00599.x; Luan ZL, 2011, NEUROREPORT, V22, P288, DOI 10.1097/WNR.0b013e328345ac22; Maritzen T, 2010, TRAFFIC, V11, P8, DOI 10.1111/j.1600-0854.2009.00971.x; Martina JA, 2001, J CELL BIOL, V153, P1111, DOI 10.1083/jcb.153.5.1111; Mattai AA, 2011, J AM ACAD CHILD PSY, V50, P697, DOI 10.1016/j.jaac.2011.03.016; McGuffin P, 1999, NEW ENGL J MED, V341, P370; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P96, DOI 10.1093/schbul/sbn155; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiu AQ, 2009, NEUROIMAGE, V47, P1221, DOI 10.1016/j.neuroimage.2009.05.054; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rapoport J, 2012, MOL PSYCHIAT; Rimol LM, 2010, P NATL ACAD SCI USA, V107, P384, DOI 10.1073/pnas.0908454107; ROSSI A, 1990, BIOL PSYCHIAT, V27, P61, DOI 10.1016/0006-3223(90)90020-3; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Smith SM, 2008, TRENDS NEUROSCI, V31, P559, DOI 10.1016/j.tins.2008.08.005; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tek C, 2002, ARCH GEN PSYCHIAT, V59, P146, DOI 10.1001/archpsyc.59.2.146; Tseng KY, 2004, J NEUROSCI, V24, P5131, DOI 10.1523/JNEUROSCI.1021-04.2004; Walther K, 2004, P NATL ACAD SCI USA, V101, P964, DOI 10.1073/pnas.0307862100; Walther K, 2001, EMBO REP, V2, P634, DOI 10.1093/embo-reports/kve134; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; Xiang Bo, 2012, Zhonghua Yixue Yichuanxue Zazhi, V29, P255, DOI 10.3760/cma.j.issn.1003-9406.2012.03.002; Xiao MF, 2009, J NEUROSCI, V29, P14752, DOI 10.1523/JNEUROSCI.4860-09.2009	57	5	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e64090	10.1371/journal.pone.0064090	http://dx.doi.org/10.1371/journal.pone.0064090			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785397	Green Submitted, gold, Green Published			2022-12-25	WOS:000321038800120
J	Spangenberg, T; Burrows, JN; Kowalczyk, P; McDonald, S; Wells, TNC; Willis, P				Spangenberg, Thomas; Burrows, Jeremy N.; Kowalczyk, Paul; McDonald, Simon; Wells, Timothy N. C.; Willis, Paul			The Open Access Malaria Box: A Drug Discovery Catalyst for Neglected Diseases	PLOS ONE			English	Article								Historically, one of the key problems in neglected disease drug discovery has been identifying new and interesting chemotypes. Phenotypic screening of the malaria parasite, Plasmodium falciparum has yielded almost 30,000 submicromolar hits in recent years. To make this collection more accessible, a collection of 400 chemotypes has been assembled, termed the Malaria Box. Half of these compounds were selected based on their drug-like properties and the others as molecular probes. These can now be requested as a pharmacological test set by malaria biologists, but importantly by groups working on related parasites, as part of a program to make both data and compounds readily available. In this paper, the analysis and selection methodology and characteristics of the compounds are described.	[Spangenberg, Thomas; Burrows, Jeremy N.; McDonald, Simon; Wells, Timothy N. C.; Willis, Paul] MMV, Geneva, Switzerland; [Kowalczyk, Paul] SCYNEXIS Inc, Res Triangle Pk, NC USA		Spangenberg, T (corresponding author), MMV, Geneva, Switzerland.	spangenbergt@mmv.org; willisp@mmv.org		Wells, Timothy/0000-0001-9796-847X				Aguero F, 2008, GENOMIC SCALE PRIORI; [Anonymous], 2012, WORLD MAL REP 2012; Anthony MP, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-316; Anzali S, 2001, J MED CHEM, V44, P2432, DOI 10.1021/jm0010670; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Bemis GW, 1996, DRUGS, V2623, P2887; Bender A, 2011, REVIEW, V2, DOI [10.1039/c0md00165a, DOI 10.1039/C0MD00165A]; Burrows JN, 2011, CURR TOP MED CHEM, V11, P1226; Burrows JN, 2012, MED CHEM ERADICATION, P112; Crowther GJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000804; Delves M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001169; Derbyshire ER, 2011, PARASITE, P7, DOI [10.1371/journal. ppat.1002178, DOI 10.1371/J0URNAL.PPAT.1002178]; Duffy S, 2012, AM J TROP MED HYG, V86, P84, DOI 10.4269/ajtmh.2012.11-0302; Flower DR, 1999, J MOL GRAPH MODEL, V16, p[239, 264]; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Garcia-Bustos JF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002156; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Griffen E, 2011, J MED CHEM, V54, P7739, DOI 10.1021/jm200452d; Guiguemde WA, 2012, CHEM BIOL, V19, P116, DOI 10.1016/j.chembiol.2012.01.004; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; Hack MD, 2011, J CHEM INF MODEL, V51, P3275, DOI 10.1021/ci200446y; Hann M, 1999, J CHEM INF COMP SCI, V39, P897, DOI 10.1021/ci990423o; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Maude RJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-31; Meister S, 2011, IMAGING PLASMODIUM L; Mok S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-391; Nicola G, 2012, J MED CHEM; Nwaka S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001412; Oprea TI, 2000, J COMPUT AID MOL DES, V14, P251, DOI 10.1023/A:1008130001697; Schneider N, 2008, J CHEM INF MODEL, V48, P613, DOI 10.1021/ci700351y; Walters WP, 2003, NAT REV DRUG DISCOV, V2, P259, DOI 10.1038/nrd1063; Wells TN, 2010, DISCOV MED, V9, P389; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005; Welsch ME, 2010, CURR OPIN CHEM BIOL, V14, P347, DOI 10.1016/j.cbpa.2010.02.018	34	249	249	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e62906	10.1371/journal.pone.0062906	http://dx.doi.org/10.1371/journal.pone.0062906			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23798988	Green Published, gold, Green Submitted			2022-12-25	WOS:000321397800001
J	Schubert, M; Spahn, M; Kneitz, S; Scholz, CJ; Joniau, S; Stroebel, P; Riedmiller, H; Kneitz, B				Schubert, Maria; Spahn, Martin; Kneitz, Susanne; Scholz, Claus Juergen; Joniau, Steven; Stroebel, Philipp; Riedmiller, Hubertus; Kneitz, Burkhard			Distinct microRNA Expression Profile in Prostate Cancer Patients with Early Clinical Failure and the Impact of let-7 as Prognostic Marker in High-Risk Prostate Cancer	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; GROUP PROTEIN I(Y); RADICAL PROSTATECTOMY; MYC EXPRESSION; LUNG-CANCER; CELLS; HMGA1; OVEREXPRESSION; IDENTIFICATION; METASTASIS	Background: The identification of additional prognostic markers to improve risk stratification and to avoid overtreatment is one of the most urgent clinical needs in prostate cancer (PCa). MicroRNAs, being important regulators of gene expression, are promising biomarkers in various cancer entities, though the impact as prognostic predictors in PCa is poorly understood. The aim of this study was to identify specific miRNAs as potential prognostic markers in high-risk PCa and to validate their clinical impact. Methodology and Principal Findings: We performed miRNA-microarray analysis in a high-risk PCa study group selected by their clinical outcome (clinical progression free survival (CPFS) vs. clinical failure (CF)). We identified seven candidate miRNAs (let-7a/b/c, miR-515-3p/5p, -181b, -146b, and -361) that showed differential expression between both groups. Further qRT-PCR analysis revealed down-regulation of members of the let-7 family in the majority of a large, well-characterized high-risk PCa cohort (n = 98). Expression of let-7a/b/and -c was correlated to clinical outcome parameters of this group. While let-7a showed no association or correlation with clinical relevant data, let-7b and let-7c were associated with CF in PCa patients and functioned partially as independent prognostic marker. Validation of the data using an independent high-risk study cohort revealed that let-7b, but not let-7c, has impact as an independent prognostic marker for BCR and CF. Furthermore, we identified HMGA1, a non-histone protein, as a new target of let-7b and found correlation of let-7b down-regulation with HMGA1 over-expression in primary PCa samples. Conclusion: Our findings define a distinct miRNA expression profile in PCa cases with early CF and identified let-7b as prognostic biomarker in high-risk PCa. This study highlights the importance of let-7b as tumor suppressor miRNA in high-risk PCa and presents a basis to improve individual therapy for high-risk PCa patients.	[Schubert, Maria; Riedmiller, Hubertus; Kneitz, Burkhard] Univ Hosp, Dept Urol & Pediat Urol, Comprehens Canc Ctr CCC Mainfranken, Wurzburg, Germany; [Spahn, Martin] Univ Hosp Bern, Dept Urol, CH-3010 Bern, Switzerland; [Kneitz, Susanne] Univ Wurzburg, Dept Physiol Chem, D-97070 Wurzburg, Germany; [Scholz, Claus Juergen] Univ Wurzburg, D-97070 Wurzburg, Germany; [Joniau, Steven] Katholieke Univ Leuven Hosp, Dept Urol, Louvain, Belgium; [Stroebel, Philipp] Univ Hosp, Dept Pathol, Gottingen, Germany	University of Wurzburg; University of Bern; University Hospital of Bern; University of Wurzburg; University of Wurzburg; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; University of Gottingen	Schubert, M (corresponding author), Univ Hosp, Dept Urol & Pediat Urol, Comprehens Canc Ctr CCC Mainfranken, Wurzburg, Germany.	Schubert_M@klinik.uni-wuerzburg.de; Kneitz_B@klinik.uni-wuerzburg.de	Scholz, Claus Jürgen/H-3202-2019; Spahn, Martin/A-9128-2015; Joniau, Steven/K-7655-2013	Scholz, Claus Jürgen/0000-0002-6406-7859; Spahn, Martin/0000-0002-5770-9489; Joniau, Steven/0000-0003-3195-9890	German Research Foundation (DFG); University of Wuerzburg [Z-3/14]; Ferdinand Eisenberger grant of the Deutsche Gesellschaft fur Urologie (German Society of Urology) [ScM1/FE-11]; IZKF (Interdisciplinary Center for Clinical Research)	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg; Ferdinand Eisenberger grant of the Deutsche Gesellschaft fur Urologie (German Society of Urology); IZKF (Interdisciplinary Center for Clinical Research)	This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding program Open Access Publishing, a Ferdinand Eisenberger grant of the Deutsche Gesellschaft fur Urologie (German Society of Urology), grant ID ScM1/FE-11; and IZKF (Interdisciplinary Center for Clinical Research), University of Wurzburg, grant ID Z-3/14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Catto JWF, 2011, EUR UROL, V59, P671, DOI 10.1016/j.eururo.2011.01.044; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Fedele M, 1996, CANCER RES, V56, P1896; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Garg Minal, 2012, World J Stem Cells, V4, P62; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Hulf T, 2012, ONCOGENE; Ji JF, 2010, J HEPATOL, V53, P974, DOI 10.1016/j.jhep.2010.07.001; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kong DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033729; Larne O, 2012, INT J CANC; Liau SS, 2007, BRIT J CANCER, V96, P993, DOI 10.1038/sj.bjc.6603654; Liu C, 2012, CANCER RES, V72, P3393, DOI 10.1158/0008-5472.CAN-11-3864; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Man YG, 2011, CANCER GENOM PROTEOM, V8, P235; Martens-Uzunova ES, 2012, ONCOGENE, V31, P978, DOI 10.1038/onc.2011.304; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Mu GY, 2010, HUM PATHOL, V41, P493, DOI 10.1016/j.humpath.2009.08.022; Nadiminty N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032832; Nadiminty N, 2012, J BIOL CHEM, V287, P1527, DOI 10.1074/jbc.M111.278705; Nair VS, 2012, JNCI-J NATL CANCER I, V104, P528, DOI 10.1093/jnci/djs027; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Petrovich Z, 2002, BJU INT, V89, P604, DOI 10.1046/j.1464-410X.2002.02698.x; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Qian PX, 2011, CANCER RES, V71, P6463, DOI 10.1158/0008-5472.CAN-11-1322; Rahman MM, 2009, BRIT J CANCER, V100, P501, DOI 10.1038/sj.bjc.6604883; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Saini S, 2011, CLIN CANCER RES, V17, P5287, DOI 10.1158/1078-0432.CCR-10-2619; Sarhadi V, 2006, J PATHOL, V209, P206, DOI 10.1002/path.1960; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Sokol L, 2011, BRIT J HAEMATOL, V153, P24, DOI 10.1111/j.1365-2141.2011.08581.x; Spahn M, 2010, INT J CANCER, V127, P394, DOI 10.1002/ijc.24715; Spahn M, 2010, EUR UROL, V58, P1, DOI 10.1016/j.eururo.2010.03.001; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Takeuchi I, 2012, PROSTATE, V72, P1124, DOI 10.1002/pros.22460; Tamimi Y, 1996, BRIT J CANCER, V74, P573, DOI 10.1038/bjc.1996.403; TAMIMI Y, 1993, CANCER RES, V53, P5512; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wach S, 2012, INT J CANCER, V130, P611, DOI 10.1002/ijc.26064; Wei JJ, 2011, CLIN CANCER RES, V17, P1297, DOI 10.1158/1078-0432.CCR-10-0993; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162; Yang XJ, 2010, CANCER RES, V70, P9463, DOI 10.1158/0008-5472.CAN-10-2388	48	67	74	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65064	10.1371/journal.pone.0065064	http://dx.doi.org/10.1371/journal.pone.0065064			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23798998	Green Submitted, Green Published, gold			2022-12-25	WOS:000320363300007
J	Tandon, A; Sharma, A; Rodier, JT; Klibanov, AM; Rieger, FG; Mohan, RR				Tandon, Ashish; Sharma, Ajay; Rodier, Jason T.; Klibanov, Alexander M.; Rieger, Frank G.; Mohan, Rajiv R.			BMP7 Gene Transfer via Gold Nanoparticles into Stroma Inhibits Corneal Fibrosis In Vivo	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; CHRONIC KIDNEY-DISEASE; MITOMYCIN-C; PHOTOREFRACTIVE KERATECTOMY; MYOFIBROBLAST DIFFERENTIATION; PTERYGIUM SURGERY; HAZE; EXPRESSION; CELLS; PROLIFERATION	This study examined the effects of BMP7 gene transfer on corneal wound healing and fibrosis inhibition in vivo using a rabbit model. Corneal haze in rabbits was produced with the excimer laser performing -9 diopters photorefractive keratectomy. BMP7 gene was introduced into rabbit keratocytes by polyethylimine-conjugated gold nanoparticles (PEI2-GNPs) transfection solution single 5-minute topical application on the eye. Corneal haze and ocular health in live animals was gauged with stereo-and slit-lamp biomicroscopy. The levels of fibrosis [alpha-smooth muscle actin (alpha SMA), F-actin and fibronectin], immune reaction (CD11b and F4/80), keratocyte apoptosis (TUNEL), calcification (alizarin red, vonKossa and osteocalcin), and delivered-BMP7 gene expression in corneal tissues were quantified with immunofluorescence, western blotting and/or real-time PCR. Human corneal fibroblasts (HCF) and in vitro experiments were used to characterize the molecular mechanism mediating BMP7's anti-fibrosis effects. PEI2-GNPs showed substantial BMP7 gene delivery into rabbit keratocytes in vivo (2x10(4) gene copies/mu g DNA). Localized BMP7 gene therapy showed a significant corneal haze decrease (1.68 +/- 0.31 compared to 3.2 +/- 0.43 in control corneas; p<0.05) in Fantes grading scale. Immunostaining and immunoblot analyses detected significantly reduced levels of alpha SMA (46 +/- 5% p<0.001) and fibronectin proteins (48 +/- 5% p<0.01). TUNEL, CD11b, and F4/80 assays revealed that BMP7 gene therapy is nonimmunogenic and nontoxic for the cornea. Furthermore, alizarin red, vonKossa and osteocalcin analyses revealed that localized PEI2-GNP-mediated BMP7 gene transfer in rabbit cornea does not cause calcification or osteoblast recruitment. Immunofluorescence of BMP7-transefected HCFs showed significantly increased pSmad-1/5/8 nuclear localization (>88%; p<0.0001), and immunoblotting of BMP7-transefected HCFs grown in the presence of TGF beta demonstrated significantly enhanced pSmad-1/5/8 (95%; p<0.001) and Smad6 (53%, p<0.001), and decreased alpha SMA (78%; p<0.001) protein levels. These results suggest that localized BMP7 gene delivery in rabbit cornea modulates wound healing and inhibits fibrosis in vivo by counter balancing TGF beta 1-mediated profibrotic Smad signaling.	[Tandon, Ashish; Sharma, Ajay; Rodier, Jason T.; Rieger, Frank G.; Mohan, Rajiv R.] Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA; [Tandon, Ashish; Sharma, Ajay; Rodier, Jason T.; Mohan, Rajiv R.] Univ Missouri, Sch Med, Mason Eye Inst, Columbia, MO USA; [Klibanov, Alexander M.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Klibanov, Alexander M.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Mohan, Rajiv R.] Univ Missouri, Coll Vet Med, Columbia, MO USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; University of Missouri System; University of Missouri Columbia; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Missouri System; University of Missouri Columbia	Mohan, RR (corresponding author), Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA.	mohanr@health.missouri.edu			Veteran Health Affairs Merit [1I01BX000357-01]; National Eye Institute, National Institutes of Health [RO1EY17294]; National Institutes of Health [RO1EB000244]; Research to Prevent Blindness Unrestricted (Mason Eye Institute) grants; NATIONAL EYE INSTITUTE [R01EY017294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000244] Funding Source: NIH RePORTER	Veteran Health Affairs Merit; National Eye Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Unrestricted (Mason Eye Institute) grants; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The work was supported by 1I01BX000357-01Veteran Health Affairs Merit (RRM), RO1EY17294 National Eye Institute, National Institutes of Health (RRM), RO1EB000244 National Institutes of Health (AMK), and Research to Prevent Blindness Unrestricted (Mason Eye Institute) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedei A, 2006, EUR J OPHTHALMOL, V16, P229, DOI 10.1177/112067210601600206; Buijs JT, 2010, CURR PHARM DESIGN, V16, P1291; Camellin M, 2004, J REFRACT SURG, V20, pS693; Campolongo MJ, 2010, ADV DRUG DELIVER REV, V62, P606, DOI 10.1016/j.addr.2010.03.004; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cho YK, 2012, INVEST OPHTH VIS SCI, V53, P2328, DOI 10.1167/iovs.11-8393; Davies MR, 2003, J AM SOC NEPHROL, V14, P1559, DOI 10.1097/01.ASN.0000068404.57780.DD; Dougherty PJ, 1996, CORNEA, V15, P537; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Gould SE, 2002, KIDNEY INT, V61, P51, DOI 10.1046/j.1523-1755.2002.00103.x; Hung FC, 2002, VISION RES, V42, P427, DOI 10.1016/S0042-6989(01)00242-5; Irache JM, 2011, VET PARASITOL, V180, P47, DOI 10.1016/j.vetpar.2011.05.028; Jang JW, 2009, INVEST OPHTHALMOL VI, V50; Jani PD, 2007, INVEST OPHTH VIS SCI, V48, P2030, DOI 10.1167/iovs.06-0853; Jester JV, 2012, MOL VIS, V18, P1828; Jester JV, 1999, PROG RETIN EYE RES, V18, P311, DOI 10.1016/S1350-9462(98)00021-4; Kim M, 2011, BMB REP, V44, P619, DOI 10.5483/BMBRep.2011.44.10.619; Kinoshita K, 2007, GUT, V56, P706, DOI 10.1136/gut.2006.092460; Mitu G, 2008, FRONT BIOSCI-LANDMRK, V13, P4726, DOI 10.2741/3035; Mohan RR, 2011, CURR MOL MED, V11, P110; Mohan RR, 2012, PROG RETIN EYE RES, V31, P43, DOI 10.1016/j.preteyeres.2011.09.001; Mohan RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018771; Mohan RR, 2010, EXP EYE RES, V91, P238, DOI 10.1016/j.exer.2010.05.013; Mohan RR, 1998, INVEST OPHTH VIS SCI, V39, P2626; Mohan RR, 2003, EXP EYE RES, V76, P71, DOI 10.1016/S0014-4835(02)00251-8; Mohan RR, 2007, IOVS, V48; Murray LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004039; Netto MV, 2006, J REFRACT SURG, V22, P562; Nien CJ, 2011, J CATARACT REFR SURG, V37, P937, DOI 10.1016/j.jcrs.2010.11.035; Piscione TD, 2001, AM J PHYSIOL-RENAL, V280, pF19, DOI 10.1152/ajprenal.2001.280.1.F19; RUBINFELD RS, 1992, OPHTHALMOLOGY, V99, P1647; Safianik B, 2002, BRIT J OPHTHALMOL, V86, P357, DOI 10.1136/bjo.86.3.357; Saika S, 2005, LAB INVEST, V85, P474, DOI 10.1038/labinvest.3700247; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Sharma A, 2011, NANOMED-NANOTECHNOL, V7, P505, DOI 10.1016/j.nano.2011.01.006; Sharma A, 2009, INVEST OPHTH VIS SCI, V50, P2695, DOI 10.1167/iovs.08-2919; Srinivasan M, 2012, ARCH OPHTHALMOL-CHIC, V130, P143, DOI 10.1001/archophthalmol.2011.315; Tandon A, 2010, CURR MOL MED, V10, P565; Tandon A, 2012, J REFRACT SURG, V28, P285, DOI 10.3928/1081597X-20120210-01; Teli MK, 2010, CURR PHARM DESIGN, V16, P1882; Thomas M, 2003, P NATL ACAD SCI USA, V100, P9138, DOI 10.1073/pnas.1233634100; Thornton I, 2008, J REFRACT SURG, V24, P68, DOI 10.3928/1081597X-20080101-13; Vega E, 2012, INT J NANOMED, V7, P1357, DOI 10.2147/IJN.S28481; Vesaluoma M, 1997, CURR EYE RES, V16, P19, DOI 10.1076/ceyr.16.1.19.5119; WALL NA, 1993, J CELL BIOL, V120, P493, DOI 10.1083/jcb.120.2.493; Wei Y, 2006, CYTOTHERAPY, V8, P570, DOI 10.1080/14653240600987690; Wesselinova D, 2011, CURR CANCER DRUG TAR, V11, P164, DOI 10.2174/156800911794328484; Wordinger RJ, 2007, EXP BIOL MED, V232, P979, DOI 10.3181/0510-MR-345; Wu KY, 1999, J OCUL PHARMACOL TH, V15, P401, DOI 10.1089/jop.1999.15.401; Yeh LCC, 2002, J CELL BIOCHEM, V87, P292, DOI 10.1002/jcb.10315; You LT, 2002, INVEST OPHTH VIS SCI, V43, P72; You LT, 1999, INVEST OPHTH VIS SCI, V40, P296; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg M, 2008, PEDIATR NEPHROL, V23, P1395, DOI 10.1007/s00467-008-0818-x; Zouvelou V, 2009, INT J DEV BIOL, V53, P597, DOI 10.1387/ijdb.082648vz	55	73	75	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66434	10.1371/journal.pone.0066434	http://dx.doi.org/10.1371/journal.pone.0066434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799103	Green Submitted, Green Published, gold			2022-12-25	WOS:000320363300082
J	Bertram, R; Helle, L; Kaakinen, JK; Svedstrom, E				Bertram, Raymond; Helle, Laura; Kaakinen, Johanna K.; Svedstrom, Erkki			The Effect of Expertise on Eye Movement Behaviour in Medical Image Perception	PLOS ONE			English	Article							VISUAL-SEARCH; EXPERIENCE; RADIOLOGISTS; PERFORMANCE; ATTENTION; EDUCATION; PATTERNS	The present eye-movement study assessed the effect of expertise on eye-movement behaviour during image perception in the medical domain. To this end, radiologists, computed-tomography radiographers and psychology students were exposed to nine volumes of multi-slice, stack-view, axial computed-tomography images from the upper to the lower part of the abdomen with or without abnormality. The images were presented in succession at low, medium or high speed, while the participants had to detect enlarged lymph nodes or other visually more salient abnormalities. The radiologists outperformed both other groups in the detection of enlarged lymph nodes and their eye-movement behaviour also differed from the other groups. Their general strategy was to use saccades of shorter amplitude than the two other participant groups. In the presence of enlarged lymph nodes, they increased the number of fixations on the relevant areas and reverted to even shorter saccades. In volumes containing enlarged lymph nodes, radiologists' fixation durations were longer in comparison to their fixation durations in volumes without enlarged lymph nodes. More salient abnormalities were detected equally well by radiologists and radiographers, with both groups outperforming psychology students. However, to accomplish this, radiologists actually needed fewer fixations on the relevant areas than the radiographers. On the basis of these results, we argue that expert behaviour is manifested in distinct eye-movement patterns of proactivity, reactivity and suppression, depending on the nature of the task and the presence of abnormalities at any given moment.	[Bertram, Raymond; Helle, Laura] Univ Turku, Ctr Learning Res, Turku, Finland; [Bertram, Raymond; Helle, Laura] Univ Turku, Dept Teacher Educ, Turku, Finland; [Kaakinen, Johanna K.] Univ Turku, Dept Psychol, Turku, Finland; [Svedstrom, Erkki] Univ Turku, Dept Diagnost Radiol, Turku, Finland	University of Turku; University of Turku; University of Turku; University of Turku	Bertram, R (corresponding author), Univ Turku, Ctr Learning Res, Turku, Finland.	rayber@utu.fi	Bertram, Raymond/ABH-2715-2021	Bertram, Raymond/0000-0002-2709-3644; Helle, Laura/0000-0002-0808-9965	Academy of Finland; LearnMedImage [128766]; MedEd [138219]	Academy of Finland(Academy of Finland); LearnMedImage; MedEd	This study was funded by the Academy of Finland (www.aka.fi), project 128766 (LearnMedImage) and project 138219 (MedEd). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Balslev T, 2012, EUR J PAEDIATR NEURO, V16, P161, DOI 10.1016/j.ejpn.2011.07.004; BOSHUIZEN HPA, 1992, COGNITIVE SCI, V16, P153, DOI 10.1207/s15516709cog1602_1; CARMODY DP, 1980, PERCEPTION, V9, P339, DOI 10.1068/p090339; Crundall DE, 1998, ERGONOMICS, V41, P448, DOI 10.1080/001401398186937; Donovan T, 2013, APPL COGNITIVE PSYCH, V27, P43, DOI 10.1002/acp.2869; Drew T, 2013, RADIOGRAPHICS, V33, P263, DOI 10.1148/rg.331125023; ERICSSON KA, 1995, PSYCHOL REV, V102, P211, DOI 10.1037/0033-295X.102.2.211; Gegenfurtner A, 2011, EDUC PSYCHOL REV, V23, P523, DOI 10.1007/s10648-011-9174-7; Ghirardelli ML, 1999, HAEMATOLOGICA, V84, P242; Godwin HJ, 2010, VIS COGN, V18, P1439, DOI 10.1080/13506285.2010.500605; Haikio T, 2011, APPL PSYCHOLINGUIST, V32, P533, DOI 10.1017/S0142716411000208; Haikio T, 2009, J EXP CHILD PSYCHOL, V102, P167, DOI 10.1016/j.jecp.2008.04.002; Helle L, 2012, INSTR SCI, V40, P737, DOI 10.1007/s11251-012-9216-7; Helle L, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S8; Jarodzka H, 2010, LEARN INSTR, V20, P146, DOI 10.1016/j.learninstruc.2009.02.019; Kocak E, 2005, J LAPAROENDOSC ADV S, V15, P575, DOI 10.1089/lap.2005.15.575; Krupinski EA, 1996, ACAD RADIOL, V3, P137, DOI 10.1016/S1076-6332(05)80381-2; Krupinski EA, 2005, ACAD RADIOL, V12, P965, DOI 10.1016/j.acra.2005.03.071; Krupinski EA, 2006, HUM PATHOL, V37, P1543, DOI 10.1016/j.humpath.2006.08.024; Kundel HL, 2007, RADIOLOGY, V242, P396, DOI 10.1148/radiol.2422051997; KUNDEL HL, 1975, RADIOLOGY, V116, P527, DOI 10.1148/116.3.527; Law B., 2004, P EYE TRACKING RES A, P41, DOI [10.1145/968363.968370, DOI 10.1145/968363.968370]; Litchfield D, 2010, J EXP PSYCHOL-APPL, V16, P251, DOI 10.1037/a0020082; Mann DTY, 2007, J SPORT EXERCISE PSY, V29, P457, DOI 10.1123/jsep.29.4.457; Manning D, 2006, RADIOGRAPHY, V12, P134, DOI 10.1016/j.radi.2005.02.003; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; MIURA T, 1990, EYE MIND INFORMATION, P119; MUGGLESTONE MD, 1995, P SOC PHOTO-OPT INS, V2436, P106, DOI 10.1117/12.206840; Nodine CF, 1987, EYE MOVEMENTS PHYSL, P573, DOI DOI 10.1016/B978-0-444-70113-8.50081-3; Pinheiro J, 2001, MIXED EFFECTS MODELS; Posner Michael I., 1988, NATURE EXPERTISE, pxxix; R Development Core Team, 2007, R LANG ENV STAT COMP; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Reingold E. M., 2011, OXFORD HDB EYE MOVEM, P767, DOI 10.1093/oxfordhb/9780199539789.013.0029; Reingold EM, 2001, PSYCHOL SCI, V12, P48, DOI 10.1111/1467-9280.00309; SWENSSON RG, 1980, PERCEPT PSYCHOPHYS, V27, P11, DOI 10.3758/BF03199899; Underwood G, 2003, ERGONOMICS, V46, P629, DOI 10.1080/0014013031000090116; Wilson M, 2010, SURG ENDOSC, V24, P2458, DOI 10.1007/s00464-010-0986-1; Wolfe JM, 2011, TRENDS COGN SCI, V15, P77, DOI 10.1016/j.tics.2010.12.001	42	60	61	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66169	10.1371/journal.pone.0066169	http://dx.doi.org/10.1371/journal.pone.0066169			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	172XB	23785481	Green Submitted, gold, Green Published			2022-12-25	WOS:000321038800041
J	DelGiudice, GD; Fieberg, JR; Sampson, BA				DelGiudice, Glenn D.; Fieberg, John R.; Sampson, Barry A.			A Long-Term Assessment of the Variability in Winter Use of Dense Conifer Cover by Female White-Tailed Deer	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; CHEMICAL IMMOBILIZATION; HOME RANGES; HABITAT USE; SURVIVAL; PREDATION; TEMPERATURE; VEGETATION; MOVEMENTS; MODELS	Backgound: Long-term studies allow capture of a wide breadth of environmental variability and a broader context within which to maximize our understanding of relationships to specific aspects of wildlife behavior. The goal of our study was to improve our understanding of the biological value of dense conifer cover to deer on winter range relative to snow depth and ambient temperature. Methodology/Principal Findings: We examined variation among deer in their use of dense conifer cover during a 12-year study period as potentially influenced by winter severity and cover availability. Female deer were fitted with a mixture of very high frequency (VHF, n = 267) and Global Positioning System (GPS, n = 24) collars for monitoring use of specific cover types at the population and individual levels, respectively. We developed habitat composites for four study sites. We fit multinomial response models to VHF (daytime) data to describe population-level use patterns as a function of snow depth, ambient temperature, and cover availability. To develop alternative hypotheses regarding expected spatio-temporal patterns in the use of dense conifer cover, we considered two sets of competing sub-hypotheses. The first set addressed whether or not dense conifer cover was limiting on the four study sites. The second set considered four alternative sub-hypotheses regarding the potential influence of snow depth and ambient temperature on space use patterns. Deer use of dense conifer cover increased the most with increasing snow depth and most abruptly on the two sites where it was most available, suggestive of an energy conservation strategy. Deer use of dense cover decreased the most with decreasing temperatures on the sites where it was most available. At all four sites deer made greater daytime use (55 to >80% probability of use) of open vegetation types at the lowest daily minimum temperatures indicating the importance of thermal benefits afforded from increased exposure to solar radiation. Date-time plots of GPS data (24 hr) allowed us to explore individual diurnal and seasonal patterns of habitat use relative to changes in snow depth. There was significant among-animal variability in their propensity to be found in three density classes of conifer cover and other open types, but little difference between diurnal and nocturnal patterns of habitat use. Conclusions/Significance: Consistent with our findings reported elsewhere that snow depth has a greater impact on deer survival than ambient temperature, herein our population-level results highlight the importance of dense conifer cover as snow shelter rather than thermal cover. Collectively, our findings suggest that maximizing availability of dense conifer cover in an energetically beneficial arrangement with quality feeding sites should be a prominent component of habitat management for deer.	[DelGiudice, Glenn D.] Minnesota Dept Nat Resources, Forest Wildlife Populat & Res Grp, Forest Lake, MN USA; [DelGiudice, Glenn D.; Fieberg, John R.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [Fieberg, John R.] Minnesota Dept Nat Resources, Biometr Unit, Forest Lake, MN USA; [Sampson, Barry A.] Minnesota Dept Nat Resources, Forest Wildlife Populat & Res Grp, Grand Rapids, MN USA	University of Minnesota System; University of Minnesota Twin Cities	DelGiudice, GD (corresponding author), Minnesota Dept Nat Resources, Forest Wildlife Populat & Res Grp, Forest Lake, MN USA.	glenn.delgiudice@state.mn.us	Fieberg, John/Y-3988-2019	Fieberg, John/0000-0002-3180-7021	Minnesota Department of Natural Resources; Minnesota Deer Hunters Association	Minnesota Department of Natural Resources; Minnesota Deer Hunters Association	Ninety-nine percent of the funding was from within the Minnesota Department of Natural Resources. The Minnesota Deer Hunters Association provided supplemental funding over the duration of the study, but it was limited to no more than 1 percent of the total. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AN CAR US COMM, 1998, J MAMMAL, V79, P1416; Ballard WB, 1999, J WILDLIFE MANAGE, V63, P574, DOI 10.2307/3802645; Beyer D. B., 2010, 3520 MICH DEP NAT RE; Bunnell FL, 1986, IWIFR28 BRIT COL MIN; Carstensen M, 2009, J WILDLIFE MANAGE, V73, P175, DOI 10.2193/2006-107; Clark RG, 2008, J R STAT SOC C-APPL, V57, P535, DOI 10.1111/j.1467-9876.2008.00629.x; CLOVER MELVIN R., 1956, CALIFORNIA FISH AND GAME, V42, P199; Cook JG, 1998, WILDL MONOGR, V141; DELGIUDICE G D, 1989, Transactions of the North American Wildlife and Natural Resources Conference, P134; DelGiudice G. D., 2010, SUMMARIES WILDLIFE R, P55; DelGiudice GD, 2005, WILDLIFE SOC B, V33, P677, DOI 10.2193/0091-7648(2005)33[677:UMOSCC]2.0.CO;2; DelGiudice GD, 1998, J MAMMAL, V79, P227, DOI 10.2307/1382858; DelGiudice GD, 2002, J WILDLIFE MANAGE, V66, P698, DOI 10.2307/3803136; DelGiudice GD, 2001, WILDLIFE SOC B, V29, P1147; DelGiudice GD, 1996, T N AM WILDL NAT RES, P416; DelGiudice GD, 2012, J WILDL MAN IN PRESS; DelGiudice GD, 2001, WILDL MONOGR, V147; Delgiudice GD, 2006, J WILDLIFE MANAGE, V70, P1556, DOI 10.2193/0022-541X(2006)70[1556:ALASAO]2.0.CO;2; Doenier PB, 1997, WILDLIFE SOC B, V25, P235; Doepker RV, 1991, WORKSH P NO WHIT CED, P13; DROLET C A, 1976, Canadian Field-Naturalist, V90, P123; Erb J., 2004, DISTRIBUTION ABUNDAN; Felix AB, 2007, J WILDLIFE MANAGE, V71, P804, DOI 10.2193/2006-366; Fieberg J, 2009, J APPL ECOL, V46, P1018, DOI 10.1111/j.1365-2664.2009.01692.x; Fieberg J, 2008, J MAMMAL, V89, P1529, DOI 10.1644/07-MAMM-A-277.1; Fieberg JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012114; Fuller Mark R., 2005, P377; Garshelis DL, 2012, STATUS MINNESOTA BLA; HAMERSTROM F. N., 1939, JOUR MAMMAL, V20, P206, DOI 10.2307/1374379; HETT J, 1978, ENVIRON MANAGE, V2, P561, DOI 10.1007/BF01866714; HOLTER JB, 1975, CAN J ZOOL, V53, P679, DOI 10.1139/z75-082; Hurst JE, 2008, J WILDLIFE MANAGE, V72, P367, DOI 10.2193/2006-421; Kelsall J, 1971, CANADIAN WILDLIFE SE, V15; Kneib T, 2011, ENVIRON ECOL STAT, V18, P1, DOI 10.1007/s10651-009-0115-2; Kochanny CO, 2009, J WILDLIFE MANAGE, V73, P779, DOI 10.2193/2008-394; Kochanny CO, 2009, THESIS U MINNESOTA S; Kreeger T. J., 2012, HDB WILDLIFE CHEM IM, V4th; KUNKEL KE, 1994, CAN J ZOOL, V72, P1557, DOI 10.1139/z94-207; Lenarz MS, 2010, J WILDLIFE MANAGE, V74, P1013, DOI 10.2193/2009-493; MAUTZ W W, 1978, Wildlife Society Bulletin, V6, P88; MCCONNELL BR, 1970, J RANGE MANAGE, V23, P208, DOI 10.2307/3896390; Mech L.D., 1971, ECOLOGICAL STUDIES T, P51; Moen A.N., 1971, P S SNOW IC REL WILD, P147; Moen A. N., 1973, WILDLIFE ECOLOGY ANA; MOEN AN, 1976, ECOLOGY, V57, P192, DOI 10.2307/1936411; MOEN AN, 1968, J WILDLIFE MANAGE, V32, P338, DOI 10.2307/3798979; MOEN AN, 1968, ECOLOGY, V49, P676, DOI 10.2307/1935531; Morrison SF, 2003, FOREST ECOL MANAG, V172, P173, DOI 10.1016/S0378-1127(01)00809-X; National Oceanic and Atmospheric Administration, 1990, CLIM DAT MINN, V95-111; NELSON ME, 1986, J WILDLIFE MANAGE, V50, P691, DOI 10.2307/3800983; NELSON ME, 1986, J WILDLIFE MANAGE, V50, P471, DOI 10.2307/3801108; OZOGA JJ, 1972, J WILDLIFE MANAGE, V36, P892, DOI 10.2307/3799445; OZOGA JJ, 1968, J WILDLIFE MANAGE, V32, P574, DOI 10.2307/3798938; PARKER KL, 1984, CAN J ZOOL, V62, P1409, DOI 10.1139/z84-202; Potvin F, 2004, CAN J ZOOL, V82, P671, DOI [10.1139/z04-028, 10.1139/Z04-028]; R Core Team, 2021, R LANG ENV STAT COMP; ROBINSON WILLIAM L., 1960, JOUR WILDLIFE MANAGEMENT, V24, P364, DOI 10.2307/3796513; RONGSTAD OJ, 1969, J WILDLIFE MANAGE, V33, P366, DOI 10.2307/3799837; SEVERINGHAUS CW, 1981, NEW YORK FISH GAME J, V28, P61; Severinghaus CW, 1947, T N AM WILDL C, V12, P212; Taylor W, 1956, DEER N AM; TIERSON WC, 1985, J WILDLIFE MANAGE, V49, P760, DOI 10.2307/3801708; TINKLE DW, 1979, BIOSCIENCE, V29, P717, DOI 10.1093/bioscience/29.12.717; US Army, 1956, SNOW HYDR; Verme L. J., 1971, P SNOW IC REL WILDL, P16; VERME LOUIS J., 1965, J FOREST, V63, P523; Webb WN, 1948, T N AM WILDL C, V13, P442; Weber SJ, 1984, WILDLIFE SOC B, V14, P331; WETZEL JF, 1975, J WILDLIFE MANAGE, V39, P59, DOI 10.2307/3800466; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	70	10	10	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65368	10.1371/journal.pone.0065368	http://dx.doi.org/10.1371/journal.pone.0065368			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785421	Green Submitted, Green Published, gold			2022-12-25	WOS:000321038800099
J	Kwon, JH; Lee, N; Park, JY; Yu, YS; Kim, JP; Shin, JH; Kim, DS; Joh, JW; Kim, DS; Choi, KY; Kang, KJ; Kim, G; Moon, YH; Wang, HJ				Kwon, Jung-Hee; Lee, Namgyu; Park, Jin Young; Yu, Yun Suk; Kim, Jin Pyo; Shin, Ji Hye; Kim, Dong-Sik; Joh, Jae Won; Kim, Dae Shick; Choi, Kwan Yong; Kang, Koo-Jeong; Kim, Gundo; Moon, Young Ho; Wang, Hee Jung			Actionable Gene Expression-Based Patient Stratification for Molecular Targeted Therapy in Hepatocellular Carcinoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; SORAFENIB; BIOMARKERS; RESISTANCE; MUTATIONS; PROGNOSIS; RAPAMYCIN; SURVIVAL; CANCER; MODEL	Background: The effectiveness of molecular targeted agents is modest in hepatocellular carcinoma (HCC). Efficacy of molecular targeted therapies has been better in cancer patients with high expression of actionable molecules defined as cognate target molecules. However, patient stratification based on the actionable molecules dictating the effectiveness of targeted drugs has remained understudied in HCC. Experimental Design & Results: Paired tumor and non-tumoral tissues derived from a total of 130 HCC patients were studied. Real-time RT-PCR was used to analyze the mRNA expression of actionable molecules in the tissues. mRNA levels of EGFR, VEGFR2, PDGFR beta, FGFR1, and mTOR were up-regulated in tumors compared to non-tumors in 35.4, 42.3, 61.5, 24.6, and 50.0% of patients, respectively. Up-regulation of EGFR was observed at early stage and tended to gradually decrease toward late stages (BCLC stage A: 41.9%; B: 30.8%; C: 17.6%). Frequency of VEGFR2 expression in tumors at stage C was lower than that in the other stages (BCLC stage A: 45.9%; B: 41.0%; C: 29.4%). PDGFR beta and mTOR were observed to be up-regulated in more than 50% of tumors in all the stages whereas FGFR1 was up-regulated in only about 20% of HCC irrespective of stages. A cluster analysis of actionable gene expression revealed that HCC can be categorized into different subtypes that predict the effectiveness of molecular targeted agents and combination therapies in clinical trials. Analysis of in vitro sensitivity to sorafenib demonstrated that HCC cells with up-regulation of PDGFR beta and c-Raf mRNA are more susceptible to sorafenib treatment in a dose and time-dependent manner than cells with low expression of the genes. Conclusions: mRNA expression analysis of actionable molecules could provide the rationale for new companion diagnostics-based therapeutic strategies in the treatment of HCC.	[Kwon, Jung-Hee; Park, Jin Young; Yu, Yun Suk; Kim, Jin Pyo; Moon, Young Ho] Cbs Biosci Inc, Taejon, South Korea; [Lee, Namgyu; Shin, Ji Hye; Choi, Kwan Yong] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea; [Kim, Dong-Sik] Korea Univ, Div HBP Surg & Liver Transplantat, Dept Surg, Seoul, South Korea; [Joh, Jae Won] Sungkyunkwan Univ, Dept Surg, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Kim, Dae Shick] Sungkyunkwan Univ, Dept Pathol, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Kang, Koo-Jeong] Keimyung Univ, Sch Med, Dept Surg, Taegu, South Korea; [Kim, Gundo] Pukyong Natl Univ, Dept Microbiol, Pusan, South Korea; [Wang, Hee Jung] Ajou Univ, Dept Surg, Sch Med, Suwon 441749, South Korea	Pohang University of Science & Technology (POSTECH); Korea University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Keimyung University; Pukyong National University; Ajou University	Moon, YH (corresponding author), Cbs Biosci Inc, Taejon, South Korea.	yhmoon62@cbsbio.com; wanghj@ajou.ac.kr	Kang, Koo Jeong/Z-4448-2019	Joh, Jae-Won/0000-0003-1732-6210; Kim, Dong-Sik/0000-0002-0608-1580; Lee, Namgyu/0000-0002-2980-2758	CbsBioscience intramural research funds [CBS-11-13]; National R & D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea; Next-Generation BioGreen 21 Program [PJ009503]; Rural Development Administration	CbsBioscience intramural research funds; National R & D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea)	This work was supported by the CbsBioscience intramural research funds CBS-11-13, and a grant from the National R & D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea. NL, JHS, and KYC were supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ009503), Rural Development Administration. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Blivet-Van Eggelpoel MJ, 2012, J HEPATOL, V57, P108, DOI 10.1016/j.jhep.2012.02.019; Buckley AF, 2008, AM J CLIN PATHOL, V129, P245, DOI 10.1309/WF10QAAED3PP93BH; Chen L, 2011, INT J BIOL MARKER, V26, P108, DOI 10.5301/JBM.2011.8322; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Ezzoukhry Z, 2012, INT J CANCER, V131, P2961, DOI 10.1002/ijc.27604; Forner A, 2010, SEMIN LIVER DIS, V30, P61, DOI 10.1055/s-0030-1247133; Gedaly R, 2010, ANTICANCER RES, V30, P4951; Huynh H, 2010, BIOCHEM PHARMACOL, V80, P550, DOI 10.1016/j.bcp.2010.03.034; Huynh H, 2009, J CELL MOL MED, V13, P2673, DOI 10.1111/j.1582-4934.2009.00692.x; Jia JB, 2009, J CANCER RES CLIN, V135, P847, DOI 10.1007/s00432-008-0521-0; Kim SM, 2012, HEPATOLOGY, V55, P1443, DOI 10.1002/hep.24813; Kwon JH, 2010, CLIN CANCER RES, V16, P5511, DOI 10.1158/1078-0432.CCR-10-0825; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2012, CLIN CANCER RES, V18, P2290, DOI 10.1158/1078-0432.CCR-11-2175; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Morelli MP, 2009, MOL CANCER THER, V8, P2546, DOI 10.1158/1535-7163.MCT-09-0380; Nault JC, 2011, SEMIN LIVER DIS, V31, P173, DOI 10.1055/s-0031-1276646; Newell P, 2009, J HEPATOL, V51, P725, DOI 10.1016/j.jhep.2009.03.028; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Patel SH, 2011, ANN SURG ONCOL, V18, P3384, DOI 10.1245/s10434-011-1775-3; Poste G, 2012, CLIN CANCER RES, V18, P1515, DOI 10.1158/1078-0432.CCR-11-2206; Sieghart W, 2012, J HEPATOL, V57, P592, DOI 10.1016/j.jhep.2012.04.034; Smith NR, 2010, CLIN CANCER RES, V16, P3548, DOI 10.1158/1078-0432.CCR-09-2797; Su MC, 2005, CANCER LETT, V224, P117, DOI 10.1016/j.canlet.2004.10.010; Tannapfel A, 2003, GUT, V52, P706, DOI 10.1136/gut.52.5.706; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vidwans SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018257; Villanueva A, 2012, CLIN CANCER RES, V18, P1824, DOI 10.1158/1078-0432.CCR-12-0151; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1410, DOI 10.1053/j.gastro.2011.03.006; Villanueva A, 2010, ANNU REV MED, V61, P317, DOI 10.1146/annurev.med.080608.100623; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; Wang Z, 2008, CLIN CANCER RES, V14, P5124, DOI 10.1158/1078-0432.CCR-07-4774; West L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031906; Williams PM, 2012, CLIN CANCER RES, V18, P1531, DOI 10.1158/1078-0432.CCR-11-2203; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Zhou LD, 2010, MED ONCOL, V27, P255, DOI 10.1007/s12032-009-9201-4; Zhu AX, 2012, SEMIN ONCOL, V39, P493, DOI 10.1053/j.seminoncol.2012.05.014; Ziegler A, 2012, HUM GENET, V131, P1627, DOI 10.1007/s00439-012-1188-9	40	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e64260	10.1371/journal.pone.0064260	http://dx.doi.org/10.1371/journal.pone.0064260			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785399	Green Published, gold, Green Submitted			2022-12-25	WOS:000321038800118
J	Kanzaki, H; Shinohara, F; Kajiya, M; Kodama, T				Kanzaki, Hiroyuki; Shinohara, Fumiaki; Kajiya, Mikihito; Kodama, Tetsuya			The Keap1/Nrf2 Protein Axis Plays a Role in Osteoclast Differentiation by Regulating Intracellular Reactive Oxygen Species Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ANTIOXIDANT RESPONSE ELEMENT; TRANSCRIPTION FACTOR NRF2; RECEPTOR ACTIVATOR; OXIDATIVE STRESS; BONE-MARROW; TRAF FAMILY; RANKL; LIGAND; IDENTIFICATION	Reactive oxygen species (ROS) act as intracellular signaling molecules in the regulation of receptor activator of nuclear factor-kappa B ligand (RANKL)-dependent osteoclast differentiation, but they also have cytotoxic effects that include peroxidation of lipids and oxidative damage to proteins and DNA. Cellular protective mechanisms against oxidative stress include transcriptional control of cytoprotective enzymes by the transcription factor, nuclear factor E2-related factor 2 (Nrf2). This study investigated the relationship between Nrf2 and osteoclastogenesis. Stimulation of osteoclast precursors (mouse primary peritoneal macrophages and RAW 264.7 cells) with RANKL resulted in the up-regulation of kelch-like ECH-associated protein 1 (Keap1), a negative regulator of Nrf2. It also decreased the Nrf2/Keap1 ratio, and it down-regulated cytoprotective enzymes (heme oxygenase-1, gamma-glutamylcysteine synthetase, and glucose-6-phosphate dehydrogenase). Nrf2 overexpression up-regulated the expression of cytoprotective enzymes, decreased ROS levels, decreased the number of tartrate-resistant acid phosphatase-positive multinucleated cells, reduced marker genes for osteoclast differentiation, and attenuated bone destruction in both in vitro and in vivo models. Overexpression of Keap or RNAi knockdown of Nrf2 exerted the opposite actions. In addition, in vivo local Nrf2 overexpression attenuated lipopolysaccharide-mediated RANKL-dependent cranial bone destruction in vivo. This is the first study to show that the Keap1/Nrf2 axis regulates RANKL-dependent osteoclastogenesis through modulation of intracellular ROS signaling via expression of cytoprotective enzymes. This raises the exciting possibility that the Keap1-Nrf2 axis may be a therapeutic target for the treatment of bone destructive disease.	[Kanzaki, Hiroyuki] Tohoku Univ Hosp, Sendai, Miyagi 9808575, Japan; [Kanzaki, Hiroyuki] Tohoku Univ Hosp, Dept Orthodont, Sendai, Miyagi 9808575, Japan; [Shinohara, Fumiaki] Tohoku Univ Hosp, Dept Oral & Maxillofacial Surg, Sendai, Miyagi 9808575, Japan; [Shinohara, Fumiaki] Tohoku Univ, Grad Sch Dent, Sendai, Miyagi 9808575, Japan; [Kajiya, Mikihito] Hiroshima Univ, Div Appl Life Sci, Dept Periodontal Med, Grad Sch Biomed & Hlth Sci, Hiroshima 7348551, Japan; [Kodama, Tetsuya] Tohoku Univ, Dept Biomed Engn, Grad Sch Biomed Engn, Mol Delivery Syst Lab, Sendai, Miyagi 9808575, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Hiroshima University; Tohoku University	Kanzaki, H (corresponding author), Tohoku Univ Hosp, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	kanzaki@dent.tohoku.ac.jp	Kajiya, Mikihito/A-4288-2018; Kanzaki, Hiroyuki/C-7942-2018; Kanzaki, Hiroyuki/M-2764-2019; Kodama, Tetsuya/T-2246-2019	Kajiya, Mikihito/0000-0001-6652-0007; Kanzaki, Hiroyuki/0000-0003-3473-1218; Kanzaki, Hiroyuki/0000-0003-3473-1218; Kodama, Tetsuya/0000-0003-4727-9558	Ministry of Education, Culture, Sports, Science and Technology [23689081]; Nestle Nutrition Council, Japan	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nestle Nutrition Council, Japan	This work was supported by Grant-in-aid for Scientific Research 23689081 from the Ministry of Education, Culture, Sports, Science and Technology and the Nestle Nutrition Council, Japan.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fan WL, 2010, AUTOPHAGY, V6, P614, DOI 10.4161/auto.6.5.12189; FAVREAU LV, 1991, J BIOL CHEM, V266, P4556; Fuller K, 1998, J EXP MED, V188, P997, DOI 10.1084/jem.188.5.997; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Ha H, 2004, EXP CELL RES, V301, P119, DOI 10.1016/j.yexcr.2004.07.035; Hama M, 2012, ARTHRITIS RHEUM-US, V64, P1518, DOI 10.1002/art.33497; Haro ERA, 2011, J PERIODONTAL RES, V46, P361, DOI 10.1111/j.1600-0765.2011.01352.x; HATA K, 1992, BONE, V13, P139, DOI 10.1016/8756-3282(92)90003-F; Hayashi S, 1999, CIRC RES, V85, P663, DOI 10.1161/01.RES.85.8.663; Hayashi SI, 1998, BIOCHEM CELL BIOL, V76, P911; HELFRICH MH, 1987, CELL TISSUE RES, V249, P125, DOI 10.1007/BF00215426; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; INAOKA T, 1995, BIOCHEM BIOPH RES CO, V206, P89, DOI 10.1006/bbrc.1995.1013; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kaneda Y, 2002, MOL THER, V6, P219, DOI 10.1006/mthe.2002.0647; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim HH, 1999, FEBS LETT, V443, P297, DOI 10.1016/S0014-5793(98)01731-1; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Kukita T, 2004, J EXP MED, V200, P941, DOI 10.1084/jem.20040518; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Lee OH, 2007, J BIOL CHEM, V282, P36412, DOI 10.1074/jbc.M706517200; Lee SE, 2002, BONE, V30, P71, DOI 10.1016/S8756-3282(01)00657-3; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; Sasaki H, 2009, J MED INVESTIG, V56, P33, DOI 10.2152/jmi.56.33; Sasaki H, 2009, FREE RADICAL BIO MED, V47, P189, DOI 10.1016/j.freeradbiomed.2009.04.025; Sriarj W, 2009, J BONE MINER METAB, V27, P315, DOI 10.1007/s00774-009-0063-9; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Teitelbaum SL, 1997, J LEUKOCYTE BIOL, V61, P381, DOI 10.1002/jlb.61.4.381; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Wang YQ, 2008, J BONE MINER RES, V23, P260, DOI 10.1359/JBMR.071013; Wei XC, 2005, J BONE MINER RES, V20, P1136, DOI 10.1359/JBMR.050206; Wells PG, 2009, TOXICOL SCI, V108, P4, DOI 10.1093/toxsci/kfn263; Wild AC, 1998, BIOCHEM J, V332, P373, DOI 10.1042/bj3320373; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Wu HP, 2009, J BONE MINER RES, V24, P871, DOI [10.1359/JBMR.081239, 10.1359/jbmr.081239]; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yip KHM, 2005, J BONE MINER RES, V20, P1462, DOI 10.1359/JBMR.050324	46	111	115	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23009	23020		10.1074/jbc.M113.478545	http://dx.doi.org/10.1074/jbc.M113.478545			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23801334	Green Published, hybrid			2022-12-25	WOS:000330598200011
J	Vaidyanathan, VG; Liang, FT; Beard, WA; Shock, DD; Wilson, SH; Cho, BP				Vaidyanathan, Vaidyanathan G.; Liang, Fengting; Beard, William A.; Shock, David D.; Wilson, Samuel H.; Cho, Bongsup P.			Insights into the Conformation of Aminofluorene-Deoxyguanine Adduct in a DNA Polymerase Active Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; TRANSLESION SYNTHESIS; AROMATIC-AMINES; STRUCTURAL INSIGHTS; MUTAGENIC RELEVANCE; KLENOW FRAGMENT; I KLENOW; BETA; FIDELITY; REPLICATION	The active site conformation of the mutagenic fluoroamino-fluorene-deoxyguanine adduct (dG-FAF, N-(2'-deoxyguanosin-8-yl)-7-fluoro-2-aminofluorene) has been investigated in the presence of Klenow fragment of Escherichia coli DNA polymerase I (Kfexo(-)) and DNA polymerase beta (pol beta) using F-19 NMR, insertion assay, and surface plasmon resonance. In a single nucleotide gap, the dG-FAF adduct adopts both a major-groove-oriented and base-displaced stacked conformation, and this heterogeneity is retained upon binding pol beta. The addition of a non-hydrolysable 2'-deoxycytosine-5'-[(alpha,beta)-methyleno] triphosphate (dCMPcPP) nucleotide analog to the binary complex results in an increase of the major groove conformation of the adduct at the expense of the stacked conformation. Similar results were obtained with the addition of an incorrect dAMPcPP analog but with formation of the minor groove binding conformer. In contrast, dG-FAF adduct at the replication fork for the Kfexo(-) complex adopts a mix of the major and minor groove conformers with minimal effect upon the addition of non-hydrolysable nucleotides. For pol beta, the insertion of dCTP was preferred opposite the dG-FAF adduct in a single nucleotide gap assay consistent with 19F NMR data. Surface plasmon resonance binding kinetics revealed that pol beta binds tightly with DNA in the presence of correct dCTP, but the adduct weakens binding with no nucleotide specificity. These results provide molecular insights into the DNA binding characteristics of FAF in the active site of DNA polymerases and the role of DNA structure and sequence on its coding potential.	[Vaidyanathan, Vaidyanathan G.; Liang, Fengting; Cho, Bongsup P.] Univ Rhode Isl, Coll Pharm, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA; [Beard, William A.; Shock, David D.; Wilson, Samuel H.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	University of Rhode Island; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cho, BP (corresponding author), Univ Rhode Isl, Coll Pharm, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA.	bcho@uri.edu	Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293	National Institutes of Health (NIH) [CA098296, P20 RR016457]; NIEHS, NIH [Z01-ES050158, Z01-ES050161]; NIH [1U19CA105010]; NATIONAL CANCER INSTITUTE [R01CA098296, U19CA177547, U19CA105010, R56CA098296] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050158, Z01ES050158, Z01ES050161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103430] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants CA098296 (NCI) and P20 RR016457 (Center for Research Resources) (to B. P. C.) and Research Projects Z01-ES050158 and Z01-ES050161 in the Intramural Research Program of NIEHS, NIH, and in association with NIH Grant 1U19CA105010 (to S. H. W.).	ASTATKE M, 1995, J BIOL CHEM, V270, P1945, DOI 10.1074/jbc.270.4.1945; Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Batra VK, 2006, P NATL ACAD SCI USA, V103, P17231, DOI 10.1073/pnas.0605069103; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Beard WA, 2003, STRUCTURE, V11, P489, DOI 10.1016/S0969-2126(03)00051-0; Beard WA, 2002, J BIOL CHEM, V277, P8235, DOI 10.1074/jbc.M107286200; Beard WA, 2000, MUTAT RES-DNA REPAIR, V460, P231, DOI 10.1016/S0921-8777(00)00029-X; Beland F. A., 1990, HDB EXPT PHARM, P281; Bergoglio V, 2002, CANCER RES, V62, P3511; Canitrot Y, 2004, NUCLEIC ACIDS RES, V32, P5104, DOI 10.1093/nar/gkh848; Canitrot Y, 1998, P NATL ACAD SCI USA, V95, P12586, DOI 10.1073/pnas.95.21.12586; Cavanaugh NA, 2011, J BIOL CHEM, V286, P31650, DOI 10.1074/jbc.M111.253401; Cavanaugh NA, 2010, J BIOL CHEM, V285, P24457, DOI 10.1074/jbc.M110.132407; Chary P, 2012, CHEM RES TOXICOL, V25, P2744, DOI 10.1021/tx300368f; Cho B., 2010, CHEM BIOL DNA DAMAGE, P217; Cho BSP, 2004, J ENVIRON SCI HEAL C, V22, P57, DOI 10.1081/LESC-200038217; Efrati E, 1999, J BIOL CHEM, V274, P15920, DOI 10.1074/jbc.274.22.15920; Efrati E, 1997, J BIOL CHEM, V272, P2559; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Harding MM, 2010, CRYSTALLOGR REV, V16, P247, DOI 10.1080/0889311X.2010.485616; Hoffmann JS, 1996, J BIOL CHEM, V271, P15386, DOI 10.1074/jbc.271.26.15831; Hsu GW, 2004, J BIOL CHEM, V279, P50280, DOI 10.1074/jbc.M409224200; Hubscher U, 2011, CURR OPIN CHEM BIOL, V15, P627, DOI 10.1016/j.cbpa.2011.08.009; Jain N, 2009, NUCLEIC ACIDS RES, V37, P1628, DOI 10.1093/nar/gkn1063; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Klarer AC, 2011, CRIT REV EUKAR GENE, V21, P323, DOI 10.1615/CritRevEukarGeneExpr.v21.i4.30; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; KUNKEL TA, 1979, J BIOL CHEM, V254, P5718; Liang FT, 2008, J MED CHEM, V51, P6460, DOI 10.1021/jm800692a; Liang FT, 2007, J AM CHEM SOC, V129, P12108, DOI 10.1021/ja075271p; Liang FT, 2011, CHEM RES TOXICOL, V24, P597, DOI 10.1021/tx2000587; Lukin M, 2006, CHEM REV, V106, P607, DOI 10.1021/cr0404646; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Meneni SR, 2007, BIOCHEMISTRY-US, V46, P11263, DOI 10.1021/bi700858s; Meneni S, 2007, J MOL BIOL, V366, P1387, DOI 10.1016/j.jmb.2006.12.023; Moon AF, 2007, DNA REPAIR, V6, P1709, DOI 10.1016/j.dnarep.2007.05.009; Neumann HG, 2007, CRIT REV TOXICOL, V37, P211, DOI 10.1080/10408440601028603; Osheroff WP, 2000, J BIOL CHEM, V275, P28033; Patel DJ, 1998, CHEM RES TOXICOL, V11, P391, DOI 10.1021/tx9702143; Patnaik S, 2010, CHEM RES TOXICOL, V23, P1650, DOI 10.1021/tx100341u; Piersen CE, 1996, J BIOL CHEM, V271, P17811, DOI 10.1074/jbc.271.30.17811; PRASAD R, 1994, J BIOL CHEM, V269, P18096; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; Scharer OD, 2011, DNA REPAIR, V10, P667, DOI 10.1016/j.dnarep.2011.04.017; See KY, 2000, MUTAT RES-REV MUTAT, V463, P215, DOI 10.1016/S1383-5742(00)00047-8; Servant L, 2002, J BIOL CHEM, V277, P50046, DOI 10.1074/jbc.M207101200; SINGHAL RK, 1993, J BIOL CHEM, V268, P15906; SIROVER MA, 1977, J BIOL CHEM, V252, P3605; Skipper PL, 2010, CARCINOGENESIS, V31, P50, DOI 10.1093/carcin/bgp267; Stone MP, 2011, CHEM BIODIVERS, V8, P1571, DOI 10.1002/cbdv.201100033; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Turesky RJ, 2011, CHEM RES TOXICOL, V24, P1169, DOI 10.1021/tx200135s; Upton TG, 2009, ORG LETT, V11, P1883, DOI 10.1021/ol701755k; Vaidyanathan VG, 2012, CHEM RES TOXICOL, V25, P1568, DOI 10.1021/tx300289d; Vaidyanathan VG, 2012, BIOCHEMISTRY-US, V51, P1983, DOI 10.1021/bi2017443; Vaisman A, 2000, J BIOL CHEM, V275, P13017, DOI 10.1074/jbc.275.17.13017; Vijg J, 2013, ANNU REV PHYSIOL, V75, P645, DOI 10.1146/annurev-physiol-030212-183715; Wang WN, 2012, J BIOL CHEM, V287, P28215, DOI 10.1074/jbc.M112.366609; Zhou L, 1997, J AM CHEM SOC, V119, P5384, DOI 10.1021/ja9632771	61	5	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23573	23585		10.1074/jbc.M113.476150	http://dx.doi.org/10.1074/jbc.M113.476150			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23798703	Green Published, hybrid			2022-12-25	WOS:000330598200061
J	Huang, C; Wang, J; Chen, Z; Wang, YZ; Zhang, W				Huang, Chao; Wang, Jia; Chen, Zhuo; Wang, Yuzhe; Zhang, Wei			2-phenylethynesulfonamide Prevents Induction of Pro-inflammatory Factors and Attenuates LPS-induced Liver Injury by Targeting NHE1-Hsp70 Complex in Mice	PLOS ONE			English	Article							NF-KAPPA-B; HEAT-SHOCK-PROTEIN; NA+/H+ EXCHANGE; HSP70; LIPOPOLYSACCHARIDE; HEAT-SHOCK-PROTEIN-70; ACTIVATION; APOPTOSIS; APAF-1; RAT	The endotoxin-mediated production of pro-inflammatory cytokines plays an important role in the pathogenesis of liver disorders. Heat shock protein (Hsp70) overexpression has established functions in lipopolysaccharide (LPS)-mediated inflammatory response. However, little is known about the role of Hsp70 activity in LPS signaling. We hypothesized that inhibition of Hsp70 substrate binding activity can ameliorate LPS-induced liver injury by decreasing induction of pro-inflammatory factors. In this study, C57/BL6 mice were injected intraperitoneally with LPS and 2-phenylethynesulfonamide (PES), an inhibitor of Hsp70 substrate binding activity. We found that i. PES prevented LPS-induced increase in serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activity, infiltration of inflammatory cells, and liver cell apoptosis; ii. PES reduced inducible nitric oxide synthase (iNOS) protein expression as well as serum nitric oxide (NO), tumor necrosis factor-alpha (TNF-alpha), and interleukin-6 (IL-6) content in LPS-stimulated mice; iii. PES reduced the mRNA level of iNOS, TNF-alpha, and IL-6 in LPS-stimulated liver. iiii. PES attenuated the degradation of inhibitor of kappa beta-alpha (I kappa B-alpha) as well as the phosphorylation and nuclear translocation of nuclear factor-kappa B (NF-kappa B) in LPS-stimulated liver. Similar changes in the protein expression of inflammatory markers, IkB-alpha degradation, and NF-kappa B phosphorylation and nuclear translocation were observed in RAW 264.7 cells. Further mechanistic studies revealed that PES remarkably reduced the elevation of [Ca2+] i and intracellular pH value (pHi) in LPS-stimulated RAW 264.7 cells. Furthermore, PES significantly reduced the increase in Na+/H+ exchanger 1 (NHE1) association to Hsp70 in LPS-stimulated macrophages and liver, suggesting that NHE1-Hsp70 interaction is required for the involvement of NHE1 in the inflammation response. In conclusion, inhibition of Hsp70 substrate binding activity in vivo reduces the induction of pro-inflammatory factors and prevents LPS-induced liver injury likely by disrupting NHE1-Hsp70 interaction which consequently reduces the activation of I kappa B-alpha-NF-kappa B pathway in liver.	[Huang, Chao; Wang, Jia; Wang, Yuzhe; Zhang, Wei] Nantong Univ, Sch Med, Dept Pharmacol, Nantong, Jiangsu, Peoples R China; [Chen, Zhuo] Nantog First Peoples Hosp, Invas Technol Dept, Nantong, Jiangsu, Peoples R China	Nantong University	Zhang, W (corresponding author), Nantong Univ, Sch Med, Dept Pharmacol, Nantong, Jiangsu, Peoples R China.	asicampa@yahoo.com.cn			National Natural Science Foundation of China [81102428]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China to Dr. Chao Huang (No. 81102428) and also supported by a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agou F, 2002, J BIOL CHEM, V277, P17464, DOI 10.1074/jbc.M201964200; Ambade A, 2012, HEPATOLOGY, V55, P1585, DOI 10.1002/hep.24802; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Boeri D, 2003, EUR J CLIN INVEST, V33, P500, DOI 10.1046/j.1365-2362.2003.01157.x; Colletti LM, 2001, SHOCK, V16, P312, DOI 10.1097/00024382-200116040-00014; El Kasmi KC, 2012, HEPATOLOGY, V55, P1518, DOI 10.1002/hep.25500; Figueiredo C, 2009, BLOOD, V113, P3008, DOI 10.1182/blood-2008-06-162727; Frantz S, 1999, J CLIN INVEST, V104, P271, DOI 10.1172/JCI6709; GANCHI PA, 1992, MOL BIOL CELL, V3, P1339, DOI 10.1091/mbc.3.12.1339; HEMING TA, 1995, J LEUKOCYTE BIOL, V57, P609, DOI 10.1002/jlb.57.4.609; Hsu HY, 2007, MOL PHARMACOL, V71, P344, DOI 10.1124/mol.106.024240; Huang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049954; Huang C, 2010, GLIA, V58, P1415, DOI 10.1002/glia.21017; Jinwal Umesh K, 2010, Mol Cell Pharmacol, V2, P43; Josephs MD, 2000, AM J PHYSIOL-REG I, V278, pR1196, DOI 10.1152/ajpregu.2000.278.5.R1196; Kabbage M, 2008, CELL MOL LIFE SCI, V65, P1390, DOI 10.1007/s00018-008-7535-2; Kaiser M, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.28; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kim HE, 2008, MOL CELL, V30, P239, DOI 10.1016/j.molcel.2008.03.014; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Liu Y, 2010, J NEUROSCI, V30, P15210, DOI 10.1523/JNEUROSCI.3950-10.2010; Luo SX, 2011, AM J PHYSIOL-CELL PH, V301, pC227, DOI 10.1152/ajpcell.00493.2010; Macfarlane SR, 2005, BRIT J PHARMACOL, V145, P535, DOI 10.1038/sj.bjp.0706204; Mamelak D, 2001, J BIOL CHEM, V276, P449, DOI 10.1074/jbc.M006732200; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Nolan JP, 2010, HEPATOLOGY, V52, P1829, DOI 10.1002/hep.23917; Ran RQ, 2004, GENE DEV, V18, P1466, DOI 10.1101/gad.1188204; ROTSTEIN OD, 1987, FEBS LETT, V215, P223, DOI 10.1016/0014-5793(87)80150-3; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Shi YZ, 2006, SHOCK, V26, P277, DOI 10.1097/01.shk.0000223134.17877.ad; SILVA NLCL, 1995, BIOCHEMISTRY-US, V34, P10412, DOI 10.1021/bi00033a013; Tando Y, 1999, AM J PHYSIOL-GASTR L, V277, pG678, DOI 10.1152/ajpgi.1999.277.3.G678; Townsend PA, 2005, INT J BIOCHEM CELL B, V37, P251, DOI 10.1016/j.biocel.2004.03.016; Triantafilou M, 2004, BIOCHEM SOC T, V32, P636, DOI 10.1042/BST0320636; Tung D, 2013, PHARMACOLOGY, V91, P29, DOI 10.1159/000343762; Weiland TJ, 2005, PEPTIDES, V26, P447, DOI 10.1016/j.peptides.2004.10.006; Xue J, 2007, AM J PHYSIOL-REG I, V292, pR2406, DOI 10.1152/ajpregu.00859.2006; Yeh CH, 2010, LEUKEMIA RES, V34, P605, DOI 10.1016/j.leukres.2009.09.014; Zheng Z, 2008, J CEREBR BLOOD F MET, V28, P53, DOI 10.1038/sj.jcbfm.9600502	40	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67582	10.1371/journal.pone.0067582	http://dx.doi.org/10.1371/journal.pone.0067582			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805318	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500146
J	Lin, XJ; Shang, XY; Manorek, G; Howell, SB				Lin, Xinjian; Shang, Xiying; Manorek, Gerald; Howell, Stephen B.			Regulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4	PLOS ONE			English	Article							SEROUS OVARIAN CARCINOGENESIS; DIFFERENTIAL GENE-EXPRESSION; JUNCTION PROTEINS CLAUDIN-3; E-CADHERIN EXPRESSION; CELL-CELL ADHESION; TIGHT JUNCTION; BREAST-CANCER; TUMOR PROGRESSION; FALLOPIAN-TUBE; METASTASIS	The mechanisms that control intracellular adhesion are central to the process of invasion and metastasis. Claudin-3 (CLDN3) and claudin-4 (CLDN4) are major structural molecules of the tight junctions that link epithelial cells. Our prior work has demonstrated that knockdown of the expression of either CLDN3 or CLDN4 produces marked changes in the phenotype of ovarian carcinoma cells including increases in growth rate in vivo, migration, invasion, metastasis, and drug resistance, similar to those produced by the epithelial-to-mesenchymal transition (EMT). We postulated that these changes may result from the ability of CLDN3 or CLDN4 to suppress EMT. In this study we found that knockdown of either CLDN3 or CLDN4 increased cell size and resulted in flattened morphology. While knockdown of CLDN3 or CLDN4 did not alter the expression of vimentin, it significantly down-regulated the level of E-cadherin and up-regulated N-cadherin expression. Conversely, over-expression of CLDN3 or CLDN4 in a cell line that does not express endogenous CLDN3 or CLDN4 decreased N-cadherin expression. Re-expression of E-cadherin in the CLDN3 or CLDN4 knockdown cells reduced migration, invasion and tumor growth in vivo. Loss of either CLDN3 or CLDN4 resulted in activation of the PI3K pathway as evidenced by increased Akt phosphorylation, elevated cellular PIP3 content and PI3K activity as well as up-regulation of the mRNA and protein levels of the transcription factor Twist. Taken together, these findings suggest that CLDN3 and CLDN4 function to sustain an epithelial phenotype and that their loss promotes EMT.	[Lin, Xinjian] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Lin, XJ (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	xlin@ucsd.edu; showell@ucsd.edu			NIH [P30 CA23100, P30 NS047101]; Clayton Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clayton Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Clayton Medical Research Foundation. The authors thank Dr. Kersi Pestonjamasp for sharing expertise on confocal microscopy. NIH grants P30 CA23100 and P30 NS047101 provided support for imaging resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Agarwal R, 2005, CANCER RES, V65, P7378, DOI 10.1158/0008-5472.CAN-05-1036; Bignotti E, 2006, GYNECOL ONCOL, V103, P405, DOI 10.1016/j.ygyno.2006.03.056; Braga VMM, 2002, CURR OPIN CELL BIOL, V14, P546, DOI 10.1016/S0955-0674(02)00373-3; BUICK RN, 1985, CANCER RES, V45, P3668; Cheng TC, 2006, CANCER CHEMOTH PHARM, V58, P384, DOI 10.1007/s00280-005-0171-8; Choi YL, 2007, HISTOL HISTOPATHOL, V22, P1185, DOI 10.14670/HH-22.1185; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; Davidson B, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00033; DISAIA PJ, 1972, AM J OBSTET GYNECOL, V114, P979, DOI 10.1016/0002-9378(72)90109-3; Ersoz S, 2011, PATHOL RES PRACT, V207, P285, DOI 10.1016/j.prp.2011.01.011; Finch A, 2006, GYNECOL ONCOL, V100, P58, DOI 10.1016/j.ygyno.2005.06.065; Franco HL, 2011, NUCLEIC ACIDS RES, V39, P1177, DOI 10.1093/nar/gkq890; Grille SJ, 2003, CANCER RES, V63, P2172; Heinzelmann-Schwarz VA, 2004, CLIN CANCER RES, V10, P4427, DOI 10.1158/1078-0432.CCR-04-0073; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Hewitt KJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-186; Hibbs K, 2004, AM J PATHOL, V165, P397, DOI 10.1016/S0002-9440(10)63306-8; Hough CD, 2000, CANCER RES, V60, P6281; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Itoh M, 2003, J MAMMARY GLAND BIOL, V8, P449, DOI 10.1023/B:JOMG.0000017431.45314.07; Iwanicki MP, 2011, CANC DISCOVERY; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Karreth F, 2004, CANCER BIOL THER, V3, P1058, DOI 10.4161/cbt.3.11.1302; Karst AM, 2011, P NATL ACAD SCI USA, V108, P7547, DOI 10.1073/pnas.1017300108; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Kohler K, 2005, BIOL CELL, V97, P659; Lal-Nag M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-235; Langbein L, 2003, EUR J CELL BIOL, V82, P385, DOI 10.1078/0171-9335-00330; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Levanon K, 2010, ONCOGENE, V29, P1103, DOI 10.1038/onc.2009.402; Lu KH, 2004, CLIN CANCER RES, V10, P3291, DOI 10.1158/1078-0432.CCR-03-0409; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin TA, 2004, EUR J CANCER, V40, P2717, DOI 10.1016/j.ejca.2004.08.008; Martin TA, 2001, HISTOL HISTOPATHOL, V16, P1183, DOI 10.14670/HH-16.1183; Matsuoka T, 2011, J SURG ONCOL, V103, P674, DOI 10.1002/jso.21854; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; Miranda KC, 2001, J BIOL CHEM, V276, P22565, DOI 10.1074/jbc.M101907200; Mullin J M, 2004, Sci STKE, V2004, ppe2, DOI 10.1126/stke.2162004pe2; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Ouban A, 2010, HISTOL HISTOPATHOL, V25, P83, DOI 10.14670/HH-25.83; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rangel LBA, 2003, CLIN CANCER RES, V9, P2567; Rodriguez FJ, 2012, BBA-REV CANCER, V1826, P23, DOI 10.1016/j.bbcan.2012.03.002; Santin AD, 2004, INT J CANCER, V112, P14, DOI 10.1002/ijc.20408; Sawada Norimasa, 2003, Medical Electron Microscopy, V36, P147, DOI 10.1007/s00795-003-0219-y; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; SELBY PJ, 1980, BRIT J CANCER, V41, P52, DOI 10.1038/bjc.1980.7; Senga K, 2012, MOL BIOL CELL, V23, P2845, DOI 10.1091/mbc.E12-02-0097; Shang X, 2012, MOL PHARM; Shang XY, 2012, NEOPLASIA, V14, P974, DOI 10.1593/neo.12942; Szasz AM, 2011, CANCER SCI, V102, P2248, DOI 10.1111/j.1349-7006.2011.02085.x; Tassi RA, 2008, INT J GYNECOL CANCER, V18, P1262, DOI 10.1111/j.1525-1438.2008.01194.x; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tsutsumi K, 2012, ANN SURG ONCOL, V19, pS491, DOI 10.1245/s10434-011-1970-2; VEATCH AL, 1994, INT J CANCER, V58, P393, DOI 10.1002/ijc.2910580315; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang Y, 2012, ONCOGENE, V31, P2512, DOI 10.1038/onc.2011.435; Wittekind C, 2005, ONCOLOGY-BASEL, V69, P14, DOI 10.1159/000086626; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yoshida J, 2009, MED MOL MORPHOL, V42, P82, DOI 10.1007/s00795-008-0436-5; Yu YC, 2006, CLIN EXP METASTAS, V23, P65, DOI 10.1007/s10585-006-9020-3; Yuan XQ, 2009, MOL CANCER THER, V8, P1906, DOI 10.1158/1535-7163.MCT-09-0106; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	75	70	72	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67496	10.1371/journal.pone.0067496	http://dx.doi.org/10.1371/journal.pone.0067496			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805314	gold, Green Published, Green Submitted			2022-12-25	WOS:000320846500142
J	Chung, FH; Lee, HHC; Lee, HC				Chung, Feng-Hsiang; Lee, Henry Hsin-Chung; Lee, Hoong-Chien			ToP: A Trend-of-Disease-Progression Procedure Works Well for Identifying Cancer Genes from Multi-State Cohort Gene Expression Data for Human Colorectal Cancer	PLOS ONE			English	Article							TGF-BETA; HUMAN BREAST; NETWORK; COMPLEX; CELLS; COLON; DISCOVERY; INFORMATION; MICROARRAYS; METASTASIS	Significantly expressed genes extracted from microarray gene expression data have proved very useful for identifying genetic biomarkers of diseases, including cancer. However, deriving a disease related inference from a list of differentially expressed genes has proven less than straightforward. In a systems disease such as cancer, how genes interact with each other should matter just as much as the level of gene expression. Here, in a novel approach, we used the network and disease progression properties of individual genes in state-specific gene-gene interaction networks (GGINs) to select cancer genes for human colorectal cancer (CRC) and obtain a much higher hit rate of known cancer genes when compared with methods not based on network theory. We constructed GGINs by integrating gene expression microarray data from multiple states - healthy control (Nor), adenoma (Ade), inflammatory bowel disease (IBD) and CRC - with protein-protein interaction database and Gene Ontology. We tracked changes in the network degrees and clustering coefficients of individual genes in the GGINs as the disease state changed from one to another. From these we inferred the state sequences Nor-Ade-CRC and Nor-IBD-CRC both exhibited a trend of (disease) progression (ToP) toward CRC, and devised a ToP procedure for selecting cancer genes for CRC. Of the 141 candidates selected using ToP, similar to 50% had literature support as cancer genes, compared to hit rates of 20% to 30% for standard methods using only gene expression data. Among the 16 candidate cancer genes that encoded transcription factors, 13 were known to be tumorigenic and three were novel: CDK1, SNRPF, and ILF2. We identified 13 of the 141 predicted cancer genes as candidate markers for early detection of CRC, 11 and 2 at the Ade and IBD states, respectively.	[Chung, Feng-Hsiang; Lee, Henry Hsin-Chung; Lee, Hoong-Chien] Natl Cent Univ, Inst Syst Biol & Bioinformat, Zhongli, Taiwan; Chung Yuan Christian Univ, Dept Phys, Zhongli, Taiwan; [Chung, Feng-Hsiang] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Zhongli, Taiwan; [Lee, Henry Hsin-Chung; Lee, Hoong-Chien] Cathay Gen Hosp, Cathay Med Res Inst, Taipei, Taiwan	National Central University; Chung Yuan Christian University; National Central University; Cathay General Hospital	Chung, FH (corresponding author), Natl Cent Univ, Inst Syst Biol & Bioinformat, Zhongli, Taiwan.	fabian415@gmail.com; hclee12345@gmail.com	Lee, Henry/GVS-2114-2022		National Science Council (ROC) [NSC 100-2911-I-008-001, NSC 99-2911-I-008-100]; Cathy General Hospital-National Central University Grant [99CGH-NCU-A3]	National Science Council (ROC)(Ministry of Science and Technology, Taiwan); Cathy General Hospital-National Central University Grant	This work was supported by the National Science Council (ROC) grants NSC 100-2911-I-008-001 (for the Center for Dynamical Biomarkers and Translational Medicine, National Central University) and NSC 99-2911-I-008-100, and the Cathy General Hospital-National Central University Grant 99CGH-NCU-A3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Anderson GR, 2001, CURR SCI, V81, P101; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bewick V, 2004, CRIT CARE, V8, P130, DOI 10.1186/cc2836; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Butte A J, 2000, Pac Symp Biocomput, P418; Cardoso J, 2007, BBA-REV CANCER, V1775, P103, DOI 10.1016/j.bbcan.2006.08.004; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; Dudaronek JM, 2007, J IMMUNOL, V179, P7262, DOI 10.4049/jimmunol.179.11.7262; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Galamb O, 2008, DIS MARKERS, V25, P1, DOI 10.1155/2008/586721; Garcia O, 2007, BIOINFORMATICS, V23, P394, DOI 10.1093/bioinformatics/btl605; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gu CC, 2002, GENET EPIDEMIOL, V23, P37, DOI 10.1002/gepi.220; Gyorffy B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005645; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Higgins ME, 2007, NUCLEIC ACIDS RES, V35, pD721, DOI 10.1093/nar/gkl811; Hwang T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-128; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; JACOBSON MD, 1993, NATURE, V361, P365, DOI 10.1038/361365a0; Kendall M.G., 1973, ADV THEORY STAT, V2; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Liang S, 1998, Pac Symp Biocomput, P18; Lin CC, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-138; Lin J, 2007, GENOME RES, V17, P1304, DOI 10.1101/gr.6431107; Linderman GC, 2012, NUCLEIC ACIDS RES, V40, pW152, DOI 10.1093/nar/gks526; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mitelman F, 2000, MUTAT RES-REV MUTAT, V462, P247, DOI 10.1016/S1383-5742(00)00006-5; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nacu S, 2007, BIOINFORMATICS, V23, P850, DOI 10.1093/bioinformatics/btm019; Nannini M, 2009, CANCER TREAT REV, V35, P201, DOI 10.1016/j.ctrv.2008.10.006; Newton MA, 2001, J COMPUT BIOL, V8, P37, DOI 10.1089/106652701300099074; Park T, 2003, BIOINFORMATICS, V19, P694, DOI 10.1093/bioinformatics/btg068; Perez-Diez A, 2007, ADV EXP MED BIOL, V593, P74; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rabbani SA, 1998, INT J ONCOL, V12, P911; RAMBALDI A, 1990, BLOOD, V76, P2565; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Shibayama Masaki, 2011, Cancers (Basel), V3, P2858, DOI 10.3390/cancers3032858; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Skotheim RI, 2007, INT J BIOCHEM CELL B, V39, P1432, DOI 10.1016/j.biocel.2007.02.016; Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thorsen K, 2008, MOL CELL PROTEOMICS, V7, P1214, DOI 10.1074/mcp.M700590-MCP200; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Vucic EA, 2008, PHARMACOGENOMICS, V9, P215, DOI 10.2217/14622416.9.2.215; Watanabe T, 2009, DIS COLON RECTUM, V52, P1941, DOI 10.1007/DCR.0b013e3181b53684; WILLIAMS GT, 1991, CELL, V65, P1097, DOI 10.1016/0092-8674(91)90002-G; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xie YY, 2012, BBA-MOL BASIS DIS, V1822, P875, DOI 10.1016/j.bbadis.2012.02.019; Xiong J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020124; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Zhang SH, 2007, PROTEOMICS, V7, P2856, DOI 10.1002/pmic.200700095; Zhong S, 1999, NAT GENET, V23, P287, DOI 10.1038/15463	68	11	11	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65683	10.1371/journal.pone.0065683	http://dx.doi.org/10.1371/journal.pone.0065683			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799036	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300033
J	Dobrijevic, D; Di Liberto, G; Tanaka, K; de Wouters, T; Dervyn, R; Boudebbouze, S; Binesse, J; Blottiere, HM; Jamet, A; Maguin, E; van de Guchte, M				Dobrijevic, Dragana; Di Liberto, Gaetana; Tanaka, Kosei; de Wouters, Tomas; Dervyn, Rozenn; Boudebbouze, Samira; Binesse, Johan; Blottiere, Herve M.; Jamet, Alexandre; Maguin, Emmanuelle; van de Guchte, Maarten			High-Throughput System for the Presentation of Secreted and Surface-Exposed Proteins from Gram-Positive Bacteria in Functional Metagenomics Studies	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; NF-KAPPA-B; BACILLUS-SUBTILIS; HETEROLOGOUS PROTEIN; ESCHERICHIA-COLI; TRANSFORMATION; OPTIMIZATION; EXPRESSION; MATURATION; MICROBIOTA	Complex microbial ecosystems are increasingly studied through the use of metagenomics approaches. Overwhelming amounts of DNA sequence data are generated to describe the ecosystems, and allow to search for correlations between gene occurrence and clinical (e. g. in studies of the gut microbiota), physico-chemical (e. g. in studies of soil or water environments), or other parameters. Observed correlations can then be used to formulate hypotheses concerning microbial gene functions in relation to the ecosystem studied. In this context, functional metagenomics studies aim to validate these hypotheses and to explore the mechanisms involved. One possible approach is to PCR amplify or chemically synthesize genes of interest and to express them in a suitable host in order to study their function. For bacterial genes, Escherichia coli is often used as the expression host but, depending on the origin and nature of the genes of interest and the test system used to evaluate their putative function, other expression systems may be preferable. In this study, we developed a system to evaluate the role of secreted and surface-exposed proteins from Gram-positive bacteria in the human gut microbiota in immune modulation. We chose to use a Gram-positive host bacterium, Bacillus subtilis, and modified it to provide an expression background that behaves neutral in a cell-based immune modulation assay, in vitro. We also adapted an E. coli - B. subtilis shuttle expression vector for use with the Gateway high-throughput cloning system. Finally, we demonstrate the functionality of this host-vector system through the cloning and expression of a flagellin-coding sequence, and show that the expression-clone elicits an inflammatory response in a human intestinal epithelial cell line. The expression host can easily be adapted to assure neutrality in other assay systems, allowing the use of the presented presentation system in functional metagenomics of the gut and other ecosystems.	[Dobrijevic, Dragana; Di Liberto, Gaetana; Tanaka, Kosei; de Wouters, Tomas; Dervyn, Rozenn; Boudebbouze, Samira; Binesse, Johan; Blottiere, Herve M.; Jamet, Alexandre; Maguin, Emmanuelle; van de Guchte, Maarten] INRA, Micalis UMR1319, Jouy En Josas, France; [Dobrijevic, Dragana; Di Liberto, Gaetana; Tanaka, Kosei; de Wouters, Tomas; Dervyn, Rozenn; Boudebbouze, Samira; Binesse, Johan; Blottiere, Herve M.; Jamet, Alexandre; Maguin, Emmanuelle; van de Guchte, Maarten] AgroParisTech, UMR Micalis, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	van de Guchte, M (corresponding author), INRA, Micalis UMR1319, Jouy En Josas, France.	maarten.vandeguchte@jouy.inra.fr	BLOTTIERE, Hervé M/C-6120-2011	BLOTTIERE, Hervé M/0000-0002-8390-0607; Dobrijevic, Dragana/0000-0001-7591-8105	European Community [215553-2, HEALTH-F4-2007-201052]	European Community(European Commission)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreements no215553-2 ("Crosstalk") and HEALTH-F4-2007-201052 ("MetaHIT"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bambou JC, 2004, J BIOL CHEM, V279, P42984, DOI 10.1074/jbc.M405410200; Barinov A, 2009, PROTEOMICS, V9, P61, DOI 10.1002/pmic.200800195; Bermudez-Humaran LG, 2004, J MED MICROBIOL, V53, P427, DOI 10.1099/jmm.0.05472-0; Bermudez-Humaran LG, 2002, APPL ENVIRON MICROB, V68, P917, DOI 10.1128/AEM.68.2.917-922.2002; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690; CANOSI U, 1978, MOL GEN GENET, V166, P259, DOI 10.1007/BF00267617; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Douillard FP, 2011, PLASMID, V66, P129, DOI 10.1016/j.plasmid.2011.07.001; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fabret C, 2002, MOL MICROBIOL, V46, P25, DOI 10.1046/j.1365-2958.2002.03140.x; Fasehee H, 2011, PROTEOMICS, V11, P3905, DOI 10.1002/pmic.201100174; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; GRUNDY FJ, 1994, J BACTERIOL, V176, P2108, DOI 10.1128/jb.176.7.2108-2110.1994; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Nguyen HD, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-22; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; JENKINSON HF, 1983, J GEN MICROBIOL, V129, P1945; Kaci G, 2011, APPL ENVIRON MICROB, V77, P4681, DOI 10.1128/AEM.03021-10; Kodama T, 2007, J BIOSCI BIOENG, V104, P135, DOI 10.1263/jbb.104.135; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lakhdari O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013092; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McGarr SE, 2005, J CLIN GASTROENTEROL, V39, P98; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ravn P, 2003, MICROBIOL-SGM, V149, P2193, DOI 10.1099/mic.0.26299-0; Rocha CS, 2012, INFLAMM BOWEL DIS, V18, P657, DOI 10.1002/ibd.21834; Rondon MR, 1999, P NATL ACAD SCI USA, V96, P6451, DOI 10.1073/pnas.96.11.6451; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; RYCHLIK W, 1990, NUCLEIC ACIDS RES, V18, P6409, DOI 10.1093/nar/18.21.6409; Scott JR, 2006, ANNU REV MICROBIOL, V60, P397, DOI 10.1146/annurev.micro.60.080805.142256; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; STRAGIER P, 1988, CELL, V52, P697, DOI 10.1016/0092-8674(88)90407-2; Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Zweers JC, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-10	45	11	11	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65956	10.1371/journal.pone.0065956	http://dx.doi.org/10.1371/journal.pone.0065956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799065	gold, Green Published, Green Submitted			2022-12-25	WOS:000320363300055
J	Galeazzi, JM; Mender, BMW; Paredes, M; Tromans, JM; Evans, BD; Minini, L; Stringer, SM				Galeazzi, Juan M.; Mender, Bedeho M. W.; Paredes, Mariana; Tromans, James M.; Evans, Benjamin D.; Minini, Loredana; Stringer, Simon M.			A Self-Organizing Model of the Visual Development of Hand-Centred Representations	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; INVARIANT OBJECT RECOGNITION; LATERAL INTRAPARIETAL AREA; SACCADE-RELATED ACTIVITY; NEURONAL REPRESENTATION; PREMOTOR CORTEX; POSITION; SYSTEM; INFORMATION; FEEDBACK	We show how hand-centred visual representations could develop in the primate posterior parietal and premotor cortices during visually guided learning in a self-organizing neural network model. The model incorporates trace learning in the feed-forward synaptic connections between successive neuronal layers. Trace learning encourages neurons to learn to respond to input images that tend to occur close together in time. We assume that sequences of eye movements are performed around individual scenes containing a fixed hand-object configuration. Trace learning will then encourage individual cells to learn to respond to particular hand-object configurations across different retinal locations. The plausibility of this hypothesis is demonstrated in computer simulations.	[Galeazzi, Juan M.; Mender, Bedeho M. W.; Paredes, Mariana; Tromans, James M.; Evans, Benjamin D.; Minini, Loredana; Stringer, Simon M.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, Oxon, England	University of Oxford	Galeazzi, JM (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, Oxon, England.	juan.galeazzigonzalez@psy.ox.ac.uk		Minini, Loredana/0000-0001-7713-403X; Evans, Benjamin/0000-0002-1734-6070; Galeazzi, Juan M/0000-0003-4221-6988	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [214673, 309944]; Instituto Jalisciense de la Juventud (IJJ) [2011B-1286]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Instituto Jalisciense de la Juventud (IJJ)	This research was supported in part by the Consejo Nacional de Ciencia y Tecnologia (CONACYT, Scholar: 214673 grant no. 309944, http://www.conacyt.gob.mx) and by the Instituto Jalisciense de la Juventud (IJJ, Grant 2011B-1286, http://www.ijj.gob.mx) via a studentship awarded to J. M. Galeazzi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN RA, 1987, EXP BRAIN RES, V67, P316; [Anonymous], 1998, NEURAL NETWORKS BRAI; BARASH S, 1991, J NEUROPHYSIOL, V66, P1109, DOI 10.1152/jn.1991.66.3.1109; BARASH S, 1991, J NEUROPHYSIOL, V66, P1095, DOI 10.1152/jn.1991.66.3.1095; Batista AP, 2007, J NEUROPHYSIOL, V98, P966, DOI 10.1152/jn.00421.2006; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Batista AP, 2001, J NEUROPHYSIOL, V85, P539, DOI 10.1152/jn.2001.85.2.539; Blohm G, 2009, NEURON, V64, P598, DOI 10.1016/j.neuron.2009.11.022; Blohm G, 2009, CEREB CORTEX, V19, P1372, DOI 10.1093/cercor/bhn177; Bosco A, 2010, J NEUROSCI, V30, P14773, DOI 10.1523/JNEUROSCI.2313-10.2010; Bremner LR, 2012, NEURON, V75, P342, DOI 10.1016/j.neuron.2012.03.041; Brozzoli C, 2012, J NEUROSCI, V32, P14573, DOI 10.1523/JNEUROSCI.2660-12.2012; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Buneo CA, 2006, NEUROPSYCHOLOGIA, V44, P2594, DOI 10.1016/j.neuropsychologia.2005.10.011; Buneo CA, 2012, J NEUROPHYSIOL, V108, P187, DOI 10.1152/jn.00137.2011; Caminiti R, 1996, CEREB CORTEX, V6, P319, DOI 10.1093/cercor/6.3.319; Chang SWC, 2010, P NATL ACAD SCI USA, V107, P7951, DOI 10.1073/pnas.0913209107; Chang SWC, 2009, NEURON, V64, P744, DOI 10.1016/j.neuron.2009.11.005; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Desmurget M, 1997, EXP BRAIN RES, V115, P180, DOI 10.1007/PL00005680; Filimon F, 2009, J NEUROSCI, V29, P2961, DOI 10.1523/JNEUROSCI.3211-08.2009; FLANDERS M, 1992, BEHAV BRAIN SCI, V15, P309, DOI 10.1017/S0140525X00068813; Foldiak P, 1991, NEURAL COMPUT, V3, P194, DOI 10.1162/neco.1991.3.2.194; Galletti C, 1996, EUR J NEUROSCI, V8, P30, DOI 10.1111/j.1460-9568.1996.tb01165.x; Galletti C, 2001, EUR J NEUROSCI, V13, P1572, DOI 10.1046/j.0953-816x.2001.01538.x; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Graziano MSA, 2002, ATTENTION PERFORM, V19, P136; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; Hertz J., 1991, INTRO THEORY NEURAL, V1; Holmes NP, 2005, EXP BRAIN RES, V166, P489, DOI 10.1007/s00221-005-2389-4; Makin TR, 2012, EXP BRAIN RES, V219, P421, DOI 10.1007/s00221-012-3089-5; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Pesaran B, 2006, NEURON, V51, P125, DOI 10.1016/j.neuron.2006.05.025; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; Prevosto V, 2011, EUR J NEUROSCI, V33, P444, DOI 10.1111/j.1460-9568.2010.07541.x; Rolls ET, 1990, NETWORK-COMP NEURAL, V1, P407, DOI 10.1088/0954-898X/1/4/002; Rolls ET, 2007, NEURAL COMPUT, V19, P139, DOI 10.1162/neco.2007.19.1.139; ROLLS ET, 1992, PHILOS T R SOC B, V335, P11, DOI 10.1098/rstb.1992.0002; Rolls ET, 2000, NEURAL COMPUT, V12, P2547, DOI 10.1162/089976600300014845; Rolls ET, 2001, NETWORK-COMP NEURAL, V12, P111, DOI 10.1088/0954-898X/12/2/302; Rolls ET, 1997, J COMPUT NEUROSCI, V4, P309, DOI 10.1023/A:1008899916425; ROLLS ET, 1997, EXPT BRAIN RES, V114, P177; ROSSETTI Y, 1995, J NEUROPHYSIOL, V74, P457, DOI 10.1152/jn.1995.74.1.457; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; SAKATA H, 1973, BRAIN RES, V64, P85, DOI 10.1016/0006-8993(73)90172-8; Sarlegna FR, 2009, ADV EXP MED BIOL, V629, P317, DOI 10.1007/978-0-387-77064-2_16; Saunders JA, 2005, EXP BRAIN RES, V162, P458, DOI 10.1007/s00221-004-2064-1; Saunders JA, 2003, EXP BRAIN RES, V152, P341, DOI 10.1007/s00221-003-1525-2; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; Sober SJ, 2005, NAT NEUROSCI, V8, P490, DOI 10.1038/nn1427; Sober SJ, 2003, J NEUROSCI, V23, P6982, DOI 10.1523/JNEUROSCI.23-18-06982.2003; Stringer SM, 2000, NEURAL NETWORKS, V13, P305, DOI 10.1016/S0893-6080(00)00017-4; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	58	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66272	10.1371/journal.pone.0066272	http://dx.doi.org/10.1371/journal.pone.0066272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799086	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000320363300070
J	Kawahara, H; Naito, H; Takara, K; Wakabayashi, T; Kidoya, H; Takakura, N				Kawahara, Hiroki; Naito, Hisamichi; Takara, Kazuhiro; Wakabayashi, Taku; Kidoya, Hiroyasu; Takakura, Nobuyuki			Tumor Endothelial Cell-Specific Drug Delivery System Using Apelin-Conjugated Liposomes	PLOS ONE			English	Article							BLOOD-VESSELS; GROWTH-FACTOR; THERAPY; TIE2	Background: A drug delivery system specifically targeting endothelial cells (ECs) in tumors is required to prevent normal blood vessels from being damaged by angiogenesis inhibitors. The purpose of this study was to investigate whether apelin, a ligand for APJ expressed in ECs when angiogenesis is taking place, can be used for targeting drug delivery to ECs in tumors. Methods and Results: Uptake of apelin via APJ stably expressed in NIH-3T3 cells was investigated using TAMRA (fluorescent probe)-conjugated apelin. Both long and short forms of apelin (apelin 36 and apelin 13) were taken up, the latter more effectively. To improve efficacy of apelin-liposome conjugates, we introduced cysteine, with its sulfhydryl group, to the C terminus of apelin 13, resulting in the generation of apelin 14. In turn, apelin 14 was conjugated to rhodamine-encapsulating liposomes and administered to tumor-bearing mice. In the tumor microenvironment, we confirmed that liposomes were incorporated into the cytoplasm of ECs. In contrast, apelin non-conjugated liposomes were rarely found in the cytoplasm of ECs. Moreover, non-specific uptake of apelin-conjugated liposomes was rarely detected in other normal organs. Conclusions: ECs in normal organs express little APJ; however, upon hypoxic stimulation, such as in tumors, ECs start to express APJ. The present study suggests that apelin could represent a suitable tool to effectively deliver drugs specifically to ECs within tumors.	[Kawahara, Hiroki; Naito, Hisamichi; Takara, Kazuhiro; Wakabayashi, Taku; Kidoya, Hiroyasu; Takakura, Nobuyuki] Osaka Univ, Microbial Dis Res Inst, Dept Signal Transduct, Suita, Osaka 565, Japan; [Takakura, Nobuyuki] Japan Sci & Technol Agcy JST, CREST, Tokyo, Japan	Osaka University; Japan Science & Technology Agency (JST)	Takakura, N (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Signal Transduct, Suita, Osaka 565, Japan.	ntakaku@biken.osaka-u.ac.jp		Naito, Hisamichi/0000-0002-0750-1743	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Education, Science, Sports, and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH547, DOI 10.1152/ajpheart.00616.2005; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Devic E, 1999, MECH DEVELOP, V84, P199, DOI 10.1016/S0925-4773(99)00081-7; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Flamme I, 1997, J CELL PHYSIOL, V173, P206, DOI 10.1002/(SICI)1097-4652(199711)173:2<206::AID-JCP22>3.0.CO;2-C; FOLKMAN J, 1971, J EXP MED, V133, P275, DOI 10.1084/jem.133.2.275; Fukami A, 2002, BIOCHEM BIOPH RES CO, V291, P1065, DOI 10.1006/bbrc.2002.6572; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019; Gerber HP, 2005, CANCER RES, V65, P671; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kidoya H, 2012, ONCOGENE, V31, P3254, DOI 10.1038/onc.2011.489; Kidoya H, 2008, EMBO J, V27, P522, DOI 10.1038/sj.emboj.7601982; Kidoya H, 2010, BLOOD, V115, P3166, DOI 10.1182/blood-2009-07-232306; Lee DK, 2010, BIOCHEM BIOPH RES CO, V395, P185, DOI 10.1016/j.bbrc.2010.03.151; Murphy EJ, 2008, LIPIDS, V43, P105, DOI 10.1007/s11745-008-3156-7; O'Brien MER, 2004, ANN ONCOL, V15, P440, DOI 10.1093/annonc/mdh097; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Presta LG, 1997, CANCER RES, V57, P4593; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Shibuya M, 2006, EXP CELL RES, V10, P49; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8	25	8	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65499	10.1371/journal.pone.0065499	http://dx.doi.org/10.1371/journal.pone.0065499			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799018	Green Submitted, gold, Green Published			2022-12-25	WOS:000320363300019
J	Liu, HY; Zhao, K; Liu, JX				Liu, Hongyun; Zhao, Ke; Liu, Jianxin			Effects of Glucose Availability on Expression of the Key Genes Involved in Synthesis of Milk Fat, Lactose and Glucose Metabolism in Bovine Mammary Epithelial Cells	PLOS ONE			English	Article							GRADED DUODENAL INFUSIONS; FED DAIRY-COWS; GRASS-SILAGE; LACTATION; GLAND; TRANSPORT; SURVIVAL; YIELD; MODEL; ACID	As the main precursor for lactose synthesis, large amounts of glucose are required by lactating dairy cows. Milk yield greatly depends on mammary lactose synthesis due to its osmoregulatory property for mammary uptake of water. Thus, glucose availability to the mammary gland could be a potential regulator of milk production. In the present study, the effect of glucose availability on expression of the key genes involved in synthesis of milk fat, lactose and glucose metabolism in vitro was investigated. Bovine mammary epithelial cells (BMEC) were treated for 12 h with various concentrations of glucose (2.5, 5, 10 or 20 mmol/L). The higher concentrations of glucose (10-20 mmol/L) did not affect the mRNA expression of acetylCoA carboxylase, diacyl glycerol acyl transferase, glycerol-3 phosphate acyl transferase and a-lactalbumin, whereas fatty acid synthase, sterol regulatory element binding protein-1 and beta-1, 4-galactosyl transferase mRNA expression increased at 10 mmol/L and then decreased at 20 mmol/L. The content of lactose synthase increased with increasing concentration of glucose, with addition of highest value at 20 mmol/L of glucose. Moreover, the increased glucose concentration stimulated the activities of pyruvate kinase and glucose-6-phosphate dehydrogenase, and elevated the energy status of the BMEC. Therefore, it was deduced that after increasing glucose availability, the extra absorbed glucose was partitioned to entering the synthesis of milk fat and lactose by the regulation of the mRNA expression of key genes, promoting glucose metabolism by glycolysis and pentose phosphate pathway as well as energy status. These results indicated that the sufficient availability of glucose in BMEC may promote glucose metabolism, and affect the synthesis of milk composition.	[Liu, Hongyun; Zhao, Ke; Liu, Jianxin] Zhejiang Univ, Minist Educ, Key Lab Mol Anim Nutr, Inst Dairy Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Liu, JX (corresponding author), Zhejiang Univ, Minist Educ, Key Lab Mol Anim Nutr, Inst Dairy Sci, Hangzhou 310003, Zhejiang, Peoples R China.	hyliu@zju.edu.cn			China Ministry of Science and Technology [2011CB100801]; earmarked fund for China Agriculture Research System [CARS-37]; National Natural Science Foundation of China [30901034]	China Ministry of Science and Technology(Ministry of Science and Technology, China); earmarked fund for China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Basic Research Program of the China Ministry of Science and Technology (No. 2011CB100801), the earmarked fund for China Agriculture Research System (CARS-37) and the National Natural Science Foundation of China (No. 30901034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM S, 1954, J BIOL CHEM, V211, P31; Al-Trad B, 2009, J DAIRY SCI, V92, P5645, DOI 10.3168/jds.2009-2264; ANNISON EF, 1964, J PHYSIOL-LONDON, V175, P372, DOI 10.1113/jphysiol.1964.sp007522; Bauman DE, 2008, J NUTR, V138, P403, DOI 10.1093/jn/138.2.403; Bell AW, 1997, J MAMMARY GLAND BIOL, V2, P265, DOI 10.1023/A:1026336505343; Bernard L, 2008, ADV EXP MED BIOL, V606, P67, DOI 10.1007/978-0-387-74087-4_2; Bionaz M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-366; Edwards PA, 2000, BBA-MOL CELL BIOL L, V1529, P103, DOI 10.1016/S1388-1981(00)00140-2; Farrell HM, 2004, J DAIRY SCI, V87, P1641, DOI 10.3168/jds.S0022-0302(04)73319-6; Girard J, 1997, ANNU REV NUTR, V17, P325, DOI 10.1146/annurev.nutr.17.1.325; Hammerman PS, 2004, TRENDS BIOCHEM SCI, V29, P586, DOI 10.1016/j.tibs.2004.09.008; Han L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027074; Harvatine KJ, 2009, ANIMAL, V3, P40, DOI 10.1017/S1751731108003133; Humphrey BD, 2008, J NUTR, V138, P1153, DOI 10.1093/jn/138.6.1153; Hurtaud C, 2000, J DAIRY SCI, V83, P2952, DOI 10.3168/jds.S0022-0302(00)75195-2; Hurtaud C, 1998, J DAIRY SCI, V81, P3239, DOI 10.3168/jds.S0022-0302(98)75888-6; JUDSON GJ, 1973, BRIT J NUTR, V29, P175, DOI 10.1079/BJN19730093; Kahn CM, 2010, MERCK VET MANUAL, DOI DOI 10.1071/RD9910501; KIMMICH GA, 1975, ANAL BIOCHEM, V69, P187, DOI 10.1016/0003-2697(75)90580-1; KLEIBER M, 1955, BIOCHIM BIOPHYS ACTA, V17, P252, DOI 10.1016/0006-3002(55)90357-7; Lemosquet S, 2004, J DAIRY SCI, V87, P1767, DOI 10.3168/jds.S0022-0302(04)73332-9; Lemosquet S, 1997, J DAIRY SCI, V80, P2854, DOI 10.3168/jds.S0022-0302(97)76250-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mellenberger R W, 1974, Biochem J, V142, P659; Mobius K, 2010, P NATL ACAD SCI USA, V107, P10436, DOI 10.1073/pnas.1000956107; Oldick BS, 1997, J DAIRY SCI, V80, P1315, DOI 10.3168/jds.S0022-0302(97)76060-0; Ramakrishnan B, 2001, J MOL BIOL, V310, P205, DOI 10.1006/jmbi.2001.4757; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; RENNER ED, 1972, J BIOL CHEM, V247, P5765; Rigout S, 2002, J DAIRY SCI, V85, P595, DOI 10.3168/jds.S0022-0302(02)74113-1; Rulquin H, 2004, J DAIRY SCI, V87, P340, DOI 10.3168/jds.S0022-0302(04)73173-2; Towle HC, 1997, ANNU REV NUTR, V17, P405, DOI 10.1146/annurev.nutr.17.1.405; Vaulont S, 2000, J BIOL CHEM, V275, P31555, DOI 10.1074/jbc.R000016200; Xiao CT, 2005, J DAIRY SCI, V88, P2794, DOI 10.3168/jds.S0022-0302(05)72959-3; Zhao K, 2012, ANIMAL, V6, P488, DOI 10.1017/S1751731111001893; Zhao K, 2010, CELL BIOL INT, V34, P717, DOI 10.1042/CBI20100023	36	38	43	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66092	10.1371/journal.pone.0066092	http://dx.doi.org/10.1371/journal.pone.0066092			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799073	Green Submitted, Green Published, gold			2022-12-25	WOS:000320363300062
J	Novotny, LA; Amer, AO; Brockson, ME; Goodman, SD; Bakaletz, LO				Novotny, Laura A.; Amer, Amal O.; Brockson, M. Elizabeth; Goodman, Steven D.; Bakaletz, Lauren O.			Structural Stability of Burkholderia cenocepacia Biofilms Is Reliant on eDNA Structure and Presence of a Bacterial Nucleic Acid Binding Protein	PLOS ONE			English	Article							SECRETION SYSTEM ACTIVITY; CYSTIC-FIBROSIS PATIENTS; ANTIBIOTIC SUSCEPTIBILITY; LUNG TRANSPLANTATION; RESPONSE REGULATOR; CEPACIA-COMPLEX; DNA; INFLAMMATION; IHF	Cystic fibrosis (CF) is the most common lethal inherited genetic disorder affection Caucasians. Even with medical advances, CF is life-shortening with patients typically surviving only to age 38. Infection of the CF lung by Burkholderia cenocepacia presents exceptional challenges to medical management of these patients as clinically this microbe is resistant to virtually all antibiotics, is highly transmissible and infection of CF patients with this microbe renders them ineligible for lung transplant, often the last lifesaving option. Here we have targeted two abundant components of the B. cenocepacia biofilm for immune intervention: extracellular DNA and DNABII proteins, the latter of which are bacterial nucleic acid binding proteins. Treatment of B. cenocepacia biofilms with antiserum directed at one of these DNABII proteins (integration host factor or IHF) resulted in significant disruption of the biofilm. Moreover, when anti-IHF mediated destabilization of a B. cenocepacia biofilm was combined with exposure to traditional antibiotics, B. cenocepacia resident within the biofilm and thereby typically highly resistant to the action of antibiotics, were now rendered susceptible to killing. Pre-incubation of B. cenocepacia with anti-IHF serum prior to exposure to murine CF macrophages, which are normally unable to effectively degrade ingested B. cenocepacia, resulted in a statistically significant increase in killing of phagocytized B. cenocepacia. Collectively, these findings support further development of strategies that target DNABII proteins as a novel approach for treatment of CF patients, particularly those whose lungs are infected with B. cenocepacia.	[Novotny, Laura A.; Brockson, M. Elizabeth; Goodman, Steven D.; Bakaletz, Lauren O.] Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH USA; [Novotny, Laura A.; Brockson, M. Elizabeth; Goodman, Steven D.; Bakaletz, Lauren O.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Amer, Amal O.] Ctr Microbial Interface Biol, Dept Microbial Infect & Immun, Columbus, OH USA; [Amer, Amal O.] Ohio State Univ, Coll Med, Dept Internal Med, Columbus, OH 43210 USA; [Amer, Amal O.] Ohio State Univ, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Goodman, SD (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH USA.	Steven.Goodman@NationwideChildrens.org; Lauren.Bakaletz@NationwideChildrens.org	Amer, Amal/E-2643-2011; Bakaletz, Lauren/GMW-8490-2022; Goodman, Steven/C-5732-2013		NIDCD/NIH [R01DC011818];  [R01HL094586]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011818] Funding Source: NIH RePORTER	NIDCD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a grant from NIDCD/NIH to LOB and SDG (R01DC011818). Studies in Dr. Amal Amer's laboratory were supported by grant R01HL094586. www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2000, AM J RESP CRIT CARE, V161, P1206, DOI 10.1164/ajrccm.161.4.9907147; Abdulrahman BA, 2011, AUTOPHAGY, V7, P1359, DOI 10.4161/auto.7.11.17660; Aubert D, 2010, J BIOL CHEM, V285, P35988, DOI 10.1074/jbc.M110.120402; Aubert DF, 2008, INFECT IMMUN, V76, P1979, DOI 10.1128/IAI.01338-07; Boleij A, 2009, INFECT IMMUN, V77, P5519, DOI 10.1128/IAI.00384-09; Browning DF, 2010, CURR OPIN MICROBIOL, V13, P773, DOI 10.1016/j.mib.2010.09.013; BUTLER SL, 1995, J CLIN MICROBIOL, V33, P1001, DOI 10.1128/JCM.33.4.1001-1004.1995; Campana Silvia, 2004, J Cyst Fibros, V3, P159, DOI 10.1016/j.jcf.2004.03.010; CASTELLANI C, 1995, ARCH DIS CHILD, V73, P276, DOI 10.1136/adc.73.3.276; Dawson KG, 1999, PEDIATR INFECT DIS J, V18, P816, DOI 10.1097/00006454-199902000-00015; De Soyza A, 2010, J HEART LUNG TRANSPL, V29, P1395, DOI 10.1016/j.healun.2010.06.007; Dubarry N, 2010, APPL ENVIRON MICROB, V76, P1095, DOI 10.1128/AEM.02123-09; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Gao Q, 2000, THESIS U SO CALIFORN; Gavrilin MA, 2012, J IMMUNOL, V188, P3469, DOI 10.4049/jimmunol.1102272; George AM, 2009, FEMS MICROBIOL LETT, V300, P153, DOI 10.1111/j.1574-6968.2009.01704.x; Golini G, 2006, EUR J CLIN MICROBIOL, V25, P175, DOI 10.1007/s10096-006-0099-x; Goodman SD, 2011, MUCOSAL IMMUNOL, V4, P625, DOI 10.1038/mi.2011.27; Graindorge A, 2010, DIAGN MICR INFEC DIS, V66, P29, DOI 10.1016/j.diagmicrobio.2009.06.008; Gustave JE, 2013, J CYST FIBROS, V12, P384, DOI 10.1016/j.jcf.2012.10.011; Hamad MA, 2010, APPL ENVIRON MICROB, V76, P3170, DOI 10.1128/AEM.03024-09; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Hopkins PM, 2009, AM J RESP CRIT CARE, V179, P257, DOI 10.1164/ajrccm.179.3.257; Hung DCI, 2011, J BACTERIOL, V193, P3642, DOI 10.1128/JB.00155-11; Jimenez Luis, 2007, PDA J Pharm Sci Technol, V61, P383; Jones EA, 2012, J INNATE IMMUN; Jurcisek JA, 2007, J BACTERIOL, V189, P3868, DOI 10.1128/JB.01935-06; Jurcisek JA, 2011, JOVE-J VIS EXP, DOI 10.3791/2481; Justice SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048349; Kotrange S, 2011, J LEUKOCYTE BIOL, V89, P481, DOI 10.1189/jlb.0910513; Lechtzin N, 2006, RESPIRATION, V73, P27, DOI 10.1159/000087686; LIPUMA JJ, 1995, NEW ENGL J MED, V332, P820; Lucero CA, 2011, AM J INFECT CONTROL, V39, P775, DOI 10.1016/j.ajic.2010.12.005; Luciani A, 2012, AUTOPHAGY, V8, P1657, DOI 10.4161/auto.21483; Luciani A, 2011, AUTOPHAGY, V7, P104, DOI 10.4161/auto.7.1.13987; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Lunsford RD, 1996, CURR MICROBIOL, V32, P95, DOI 10.1007/s002849900017; Nash EF, 2010, TRANSPL INFECT DIS, V12, P551, DOI 10.1111/j.1399-3062.2010.00525.x; Peeters E, 2008, J HOSP INFECT, V70, P361, DOI 10.1016/j.jhin.2008.08.015; Post J Christopher, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P347, DOI 10.1097/MOO.0b013e3282b97327; Post J Christopher, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P185, DOI 10.1097/01.moo.0000124936.46948.6a; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; SIMPSON IN, 1994, J ANTIMICROB CHEMOTH, V34, P353, DOI 10.1093/jac/34.3.353; Slinger R, 2006, DIAGN MICR INFEC DIS, V56, P247, DOI 10.1016/j.diagmicrobio.2006.04.012; Swinger KK, 2004, CURR OPIN STRUC BIOL, V14, P28, DOI 10.1016/j.sbi.2003.12.003; Vandamme P, 1997, INT J SYST BACTERIOL, V47, P1188, DOI 10.1099/00207713-47-4-1188; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; WINTERS BD, 1993, INFECT IMMUN, V61, P3259, DOI 10.1128/IAI.61.8.3259-3264.1993; Zhang LP, 1999, INFECT IMMUN, V67, P6473	49	61	72	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e67629	10.1371/journal.pone.0067629	http://dx.doi.org/10.1371/journal.pone.0067629			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799151	gold, Green Published, Green Submitted			2022-12-25	WOS:000320363300114
J	Ahi, EP; Guobrandsson, J; Kapralova, KH; Franzdottir, SR; Snorrason, SS; Maier, VH; Jonsson, ZO				Ahi, Ehsan Pashay; Guobrandsson, Johannes; Kapralova, Kalina H.; Franzdottir, Sigriour R.; Snorrason, Sigurour S.; Maier, Valerie H.; Jonsson, Zophonias O.			Validation of Reference Genes for Expression Studies during Craniofacial Development in Arctic Charr	PLOS ONE			English	Article							POTENTIAL REFERENCE GENES; POLYMERASE-CHAIN-REACTION; TIME QUANTITATIVE PCR; SALVELINUS-ALPINUS; RELATIVE QUANTIFICATION; ATLANTIC SALMON; LIFE-HISTORY; RNA-SEQ; RT-PCR; SOX9	Arctic charr (Salvelinus alpinus) is a highly polymorphic species and in Lake Thingvallavatn, Iceland, four phenotypic morphs have evolved. These differences in morphology, especially in craniofacial structures are already apparent during embryonic development, indicating that genes important in the formation of the craniofacial features are expressed differentially between the morphs. In order to generate tools to examine these expression differences in Arctic charr, the aim of the present study was to identify reference genes for quantitative real-time PCR (qPCR). The specific aim was to select reference genes which are able to detect very small expression differences among different morphs. We selected twelve candidate reference genes from the literature, identified corresponding charr sequences using data derived from transcriptome sequencing (RNA-seq) and examined their expression using qPCR. Many of the candidate reference genes were found to be stably expressed, yet their quality-rank as reference genes varied considerably depending on the type of analysis used. In addition to commonly used software for reference gene validation, we used classical statistics to evaluate expression profiles avoiding a bias for reference genes with similar expression patterns (co-regulation). Based on these analyses we chose three reference genes, ACTB, UB2L3 and IF5A1 for further evaluation. Their consistency was assessed in an expression study of three known craniofacially expressed genes, sparc (or osteonectin), matrix metalloprotease 2 (mmp2) and sox9 (sex-determining region Y box 9 protein) using qPCR in embryo heads derived from four charr groups at three developmental time points. The three reference genes were found to be very suitable for studying expression differences between the morphotypes, enabling robust detection of small relative expression changes during charr development. Further, the results showed that sparc and mmp2 are differentially expressed in embryos of different Arctic charr morphotypes.	[Ahi, Ehsan Pashay; Guobrandsson, Johannes; Kapralova, Kalina H.; Snorrason, Sigurour S.; Maier, Valerie H.; Jonsson, Zophonias O.] Univ Iceland, Inst Life & Environm Sci, Reykjavik, Iceland; [Franzdottir, Sigriour R.] Univ Iceland, Biomed Ctr, Reykjavik, Iceland	University of Iceland; University of Iceland	Maier, VH (corresponding author), Univ Iceland, Inst Life & Environm Sci, Reykjavik, Iceland.	valerie@hi.is	Franzdottir, Sigridur/M-2534-2015; Jónsson, Zophonías Oddur/AAO-1354-2020; Jónsson, Zophonías/E-1960-2015	Jónsson, Zophonías Oddur/0000-0001-5798-9647; Maier, Valerie Helene/0000-0003-2193-477X; Pashay Ahi, Ehsan/0000-0002-6528-1187; Kapralova, Kalina/0000-0002-5571-0160; Gudbrandsson, Johannes/0000-0002-2231-0910	Icelandic Centre for Research (RANNIS) [100204011]; University of Iceland	Icelandic Centre for Research (RANNIS); University of Iceland	This project was supported by The Icelandic Centre for Research (RANNIS #100204011) and the University of Iceland Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson RC, 2006, HEREDITY, V97, P211, DOI 10.1038/sj.hdy.6800864; Allendorf F.W., 1984, P1; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Andreassen R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-502; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chiang EFL, 2001, DEV BIOL, V231, P149, DOI 10.1006/dbio.2000.0129; Chlenski A, 2010, SEMIN CELL DEV BIOL, V21, P55, DOI 10.1016/j.semcdb.2009.11.018; Danos N, 2010, J APPL ICHTHYOL, V26, P156, DOI 10.1111/j.1439-0426.2010.01396.x; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Eiriksson G. M., 1999, Journal of Fish Biology, V55, P175, DOI 10.1111/j.1095-8649.1999.tb01054.x; Fujita T, 2002, J ORAL PATHOL MED, V31, P345, DOI 10.1034/j.1600-0714.2002.00188.x; Gilles C, 1998, CANCER RES, V58, P5529; Gorodilov YN, 1996, ENVIRON BIOL FISH, V47, P109, DOI 10.1007/BF00005034; Healy C, 1999, DEV DYNAM, V215, P69, DOI 10.1002/(SICI)1097-0177(199905)215:1<69::AID-DVDY8>3.3.CO;2-E; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Henricson A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-412; Hillegass JM, 2008, TOXICOL SCI, V102, P413, DOI 10.1093/toxsci/kfn010; Hulsey CD, 2005, ZEBRAFISH, V2, P243, DOI 10.1089/zeb.2005.2.243; Javidan Y, 2004, METHOD CELL BIOL, V76, P415; JONSSON B, 1988, CAN J FISH AQUAT SCI, V45, P1537, DOI 10.1139/f88-182; Jorgensen SM, 2006, MAR BIOTECHNOL, V8, P398, DOI 10.1007/s10126-005-5164-4; Kapralova KH, 2011, HEREDITY, V106, P472, DOI 10.1038/hdy.2010.161; Kluver N, 2005, DEV GENES EVOL, V215, P297, DOI 10.1007/s00427-005-0477-x; Koop BF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-545; Koopman P, 2004, GENE, V328, P177, DOI 10.1016/j.gene.2003.12.008; LANE TF, 1994, FASEB J, V8, P163, DOI 10.1096/fasebj.8.2.8119487; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macqueen DJ, 2006, FEBS LETT, V580, P4996, DOI 10.1016/j.febslet.2006.08.016; Macqueen DJ, 2011, MOL ECOL, V20, P3167, DOI 10.1111/j.1365-294X.2011.05172.x; Macqueen DJ, 2010, BIOCHEM BIOPH RES CO, V400, P599, DOI 10.1016/j.bbrc.2010.08.110; Macqueen DJ, 2010, PHYSIOL GENOMICS, V42, P134, DOI 10.1152/physiolgenomics.00045.2010; MALMQUIST HJ, 1992, J ANIM ECOL, V61, P21, DOI 10.2307/5505; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McClung HM, 2007, NEUROSCI LETT, V419, P172, DOI 10.1016/j.neulet.2007.04.037; Mosig RA, 2007, HUM MOL GENET, V16, P1113, DOI 10.1093/hmg/ddm060; Overgard AC, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-36; Parsons KJ, 2010, EVOL DEV, V12, P246, DOI 10.1111/j.1525-142X.2010.00410.x; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; R Development Core Team, 2021, R PROJECT STAT COMPU; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Renn J, 2006, GENE, V372, P208, DOI 10.1016/j.gene.2006.01.011; Rexroad CE, 2003, CYTOGENET GENOME RES, V102, P347, DOI 10.1159/000075773; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rotllant J, 2008, MATRIX BIOL, V27, P561, DOI 10.1016/j.matbio.2008.03.001; Saele O, 2009, COMP BIOCHEM PHYS B, V152, P94, DOI 10.1016/j.cbpb.2008.10.002; SANDLUND OT, 1992, OIKOS, V64, P305, DOI 10.2307/3545056; Seet LF, 2012, J CELL MOL MED, V16, P1245, DOI 10.1111/j.1582-4934.2011.01400.x; Sibthorpe D, 2006, COMP BIOCHEM PHYS B, V145, P371, DOI 10.1016/j.cbpb.2006.08.013; SKULASON S, 1995, TRENDS ECOL EVOL, V10, P366, DOI 10.1016/S0169-5347(00)89135-1; SKULASON S, 1989, BIOL J LINN SOC, V38, P281, DOI 10.1111/j.1095-8312.1989.tb01579.x; SKULASON S, 1989, J FISH BIOL, V35, P225; Socha MJ, 2007, AM J PATHOL, V171, P1104, DOI 10.2353/ajpath.2007.061273; Szabo-Rogers HL, 2010, DEV BIOL, V341, P84, DOI 10.1016/j.ydbio.2009.11.021; Takamatsu N, 1997, GENE, V202, P167, DOI 10.1016/S0378-1119(97)00483-6; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vesterlund L, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-30; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Ward AJW, 2006, FISH FISH, V7, P231, DOI 10.1111/j.1467-2979.2006.00224.x; Whiteley AR, 2007, BIOL J LINN SOC, V92, P253, DOI 10.1111/j.1095-8312.2007.00845.x; Yamanaka M, 2001, J UROLOGY, V166, P2495, DOI 10.1016/S0022-5347(05)65623-6; Yan YL, 2002, DEVELOPMENT, V129, P5065; Ye X, 2010, BIOTECHNOL LETT, V32, P1031, DOI 10.1007/s10529-010-0258-0; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F; Zheng WJ, 2011, FISH SHELLFISH IMMUN, V30, P638, DOI 10.1016/j.fsi.2010.12.014; Zhong QW, 2008, MAR BIOTECHNOL, V10, P310, DOI 10.1007/s10126-007-9064-7	74	23	24	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66389	10.1371/journal.pone.0066389	http://dx.doi.org/10.1371/journal.pone.0066389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785496	Green Published, gold, Green Submitted			2022-12-25	WOS:000321038800026
J	Blanco, G; Hornero-Mendez, D; Lambertucci, SA; Bautista, LM; Wiemeyer, G; Sanchez-Zapata, JA; Garrido-Fernandez, J; Hiraldo, F; Donazar, JA				Blanco, Guillermo; Hornero-Mendez, Damaso; Lambertucci, Sergio A.; Bautista, Luis M.; Wiemeyer, Guillermo; Sanchez-Zapata, Jose A.; Garrido-Fernandez, Juan; Hiraldo, Fernando; Donazar, Jose A.			Need and Seek for Dietary Micronutrients: Endogenous Regulation, External Signalling and Food Sources of Carotenoids in New World Vultures	PLOS ONE			English	Article							PLASMA CAROTENOIDS; INTERSPECIFIC VARIATION; PIGMENTS; COLORATION; BIOAVAILABILITY; METABOLISM; PLUMAGE; ASSOCIATIONS; ABSORPTION; PARASITES	Among birds, vultures show low concentrations of plasma carotenoids due to the combination of their large size, general dull colouration and a diet based on carrion. We recorded the concentration of each carotenoid type present in plasma of the Andean condor (Vultur gryphus) according to age and sex, that determine colour signalling and dominance hierarchies in the carcasses. We compared the carotenoid profile in wild condors with that of captive condors fed with a controlled diet of flesh to test the hypothesis that wild individuals could acquire extra carotenoids from vegetal matter contained in carcass viscera and fresh vegetation. Wild American black vultures (Coragyps atratus) were also sampled to evaluate the potential influence of colouration in the integument on absorption and accumulation patterns of plasma carotenoids. A remarkably higher concentration of lutein than beta-carotene was found in wild condors, while the contrary pattern was recorded in American black vultures and captive condors. We found a consistent decrease in all plasma carotenoids with age, and a lower concentration of most xanthophylls in male compared to female wild condors. Positive correlations of all carotenoids indicated general common absorption and accumulation strategies or a single dietary source containing all pigments found in plasma. The comparatively low total concentration of carotenoids, and especially of lutein rather than beta-carotene, found in captive condors fed with a diet restricted to flesh supports the hypothesis that Andean condors can efficiently acquire carotenoids from vegetal matter in the wild. Andean condors seem to be physiologically more competent in the uptake or accumulation of xanthophylls than American black vultures, which agrees with the use of colour-signalling strategies in sexual and competitive contexts in the Andean condor. This study suggests that vultures may use dietary vegetal supplements that provide pigments and micronutrients that are scarce or missing in carrion.	[Blanco, Guillermo; Bautista, Luis M.] Natl Museum Nat Hist CSIC, Dept Evolutionary Ecol, Madrid, Spain; [Hornero-Mendez, Damaso; Garrido-Fernandez, Juan] Inst Grasa CSIC, Dept Biotecnol, Seville, Spain; [Lambertucci, Sergio A.] CONICET Univ Nacl Comahue, Laboratorio Ecotono INIBIOMA, San Carlos De Bariloche, Rio Negro, Argentina; [Wiemeyer, Guillermo] Jardin Zool Ciudad Buenos Aires, Buenos Aires, DF, Argentina; [Garrido-Fernandez, Juan] Univ Miguel Hernandez, Dept Appl Biol, Alicante, Spain; [Hiraldo, Fernando; Donazar, Jose A.] Estac Biol Donana CSIC, Dept Conservat Biol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de la Grasa (IG); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; Universidad Miguel Hernandez de Elche; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Blanco, G (corresponding author), Natl Museum Nat Hist CSIC, Dept Evolutionary Ecol, Jose Gutierrez Abascal 2, Madrid, Spain.	gblanco@mncn.csic.es	Garrido-Fernández, Juan/K-8222-2017; Hornero-Mendez, Damaso/H-2507-2012; Sanchez-Zapata, Jose Antonio/H-1413-2015; Hiraldo, Fernando/AAA-8314-2019; Blanco, Guillermo/L-3170-2014; Bautista-Sopelana, Luis M./B-1735-2008	Garrido-Fernández, Juan/0000-0002-6796-5646; Hornero-Mendez, Damaso/0000-0002-1781-5703; Sanchez-Zapata, Jose Antonio/0000-0001-8230-4953; Blanco, Guillermo/0000-0001-5742-4929; Bautista-Sopelana, Luis M./0000-0002-1503-652X; Donazar, Jose Antonio/0000-0002-9433-9755; LAMBERTUCCI, SERGIO/0000-0002-2624-2185	Fundacion Banco Bilbao Vizcaya Argentaria project [BIOCON-08-126]; Spanish Ministerio de Economia y Competitividad [CGL2009-12753-C02-01]; CYTED	Fundacion Banco Bilbao Vizcaya Argentaria project; Spanish Ministerio de Economia y Competitividad(Spanish Government); CYTED	This work was funded by Fundacion Banco Bilbao Vizcaya Argentaria project BIOCON-08-126 and project CGL2009-12753-C02-01 from the Spanish Ministerio de Economia y Competitividad. DHM and JGF are members of the IBERCAROT Network financed by CYTED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamford AJ, 2010, ETHOLOGY, V116, P1163, DOI 10.1111/j.1439-0310.2010.01834.x; Blanco G, 2005, P ROY SOC B-BIOL SCI, V272, P1893, DOI 10.1098/rspb.2005.3157; Blas J, 2006, P NATL ACAD SCI USA, V103, P18633, DOI 10.1073/pnas.0609189103; Blas J, 2013, J RAPTOR RE IN PRESS; Bortolotti GR, 1996, P ROY SOC B-BIOL SCI, V263, P1171, DOI 10.1098/rspb.1996.0171; Bortolotti GR, 2000, P ROY SOC B-BIOL SCI, V267, P1433, DOI 10.1098/rspb.2000.1160; BRITTON G, 2004, CAROTENOID HDB; Britton G., 1995, SPECTROSCOPY-US, V1B, P13; Britton G., 1991, METHODS PLANT BIOCH, P473; BRUSH AH, 1990, FASEB J, V4, P2969, DOI 10.1096/fasebj.4.12.2394316; Buckley Neil J., 1999, Birds of North America, V411, P1; Senar JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010716; Carrete M, 2010, ANIM CONSERV, V13, P390, DOI 10.1111/j.1469-1795.2010.00352.x; Casagrande S, 2006, J AVIAN BIOL, V37, P190, DOI 10.1111/j.0908-8857.2006.03515.x; CHEW BP, 1993, J DAIRY SCI, V76, P2804, DOI 10.3168/jds.S0022-0302(93)77619-5; Cohen AA, 2008, AM NAT, V172, P178, DOI 10.1086/589456; Cohen AA, 2009, OECOLOGIA, V161, P673, DOI 10.1007/s00442-009-1423-9; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Davies BH, 1971, CHEM BIOCH PLANT PIG, V2; Davies BH, 1988, HDB CHROMATOGRAPHY, V1; DEL HOYO J., 1996, HDB BIRDS WORLD, V3; Donazar J.A., 1993, BUITRES IBERICOS BIO; Donazar JA, 1999, BEHAV ECOL SOCIOBIOL, V45, P55, DOI 10.1007/s002650050539; Donazar JA, 2002, CONDOR, V104, P832, DOI 10.1650/0010-5422(2002)104[0832:SSOACR]2.0.CO;2; EUGSTER CH, 1995, CAROTENOIDS, V1, P71; Goodwin TW, 1984, ANIMALS, V2; Grether GF, 1999, P ROY SOC B-BIOL SCI, V266, P1317, DOI 10.1098/rspb.1999.0781; Gross J, 1991, PIGMENTS VEGETABLES, DOI DOI 10.1007/978-1-4615-2033-7_3; Hill GE, 1995, AUK, V112, P1054, DOI 10.2307/4089041; Hill GE, 2012, AM NAT, V180, pE127, DOI 10.1086/667861; Hill GE, 2011, ECOL LETT, V14, P625, DOI 10.1111/j.1461-0248.2011.01622.x; Hof KHV, 2000, J NUTR, V130, P503; HUDON J, 1994, AUK, V111, P218, DOI 10.2307/4088529; Isaksson C, 2009, ARDEA, V97, P125, DOI 10.5253/078.097.0116; Juola FA, 2008, COMP BIOCHEM PHYS B, V149, P370, DOI 10.1016/j.cbpb.2007.10.010; Khoo HE, 2011, MOLECULES, V16, P1710, DOI 10.3390/molecules16021710; Lambertucci SA, 2009, ANIM CONSERV, V12, P338, DOI 10.1111/j.1469-1795.2009.00258.x; Lambertucci SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046347; LOZANO GA, 1994, OIKOS, V70, P309, DOI 10.2307/3545643; McGraw KJ, 2006, FUNCT ECOL, V20, P678, DOI 10.1111/j.1365-2435.2006.01121.x; McGraw K.J., 2006, BIRD COLORATION, V1, P177; McGraw KJ, 2005, COMP BIOCHEM PHYS B, V142, P245, DOI 10.1016/j.cbpb.2005.07.012; McGraw KJ, 2004, BIOL J LINN SOC, V83, P273, DOI 10.1111/j.1095-8312.2004.00388.x; MINGUEZMOSQUERA MI, 1993, J AGR FOOD CHEM, V41, P1616, DOI 10.1021/jf00034a018; Nagao A, 2011, BIOFACTORS, V37, P83, DOI 10.1002/biof.151; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Negro JJ, 2006, COMP BIOCHEM PHYS A, V143, P78, DOI 10.1016/j.cbpa.2005.10.028; Negro JJ, 1998, FUNCT ECOL, V12, P307, DOI 10.1046/j.1365-2435.1998.00176.x; Negro JJ, 2000, PHYSIOL BIOCHEM ZOOL, V73, P97, DOI 10.1086/316724; Negro JJ, 2002, NATURE, V416, P807, DOI 10.1038/416807a; Noziere P, 2006, ANIM FEED SCI TECH, V131, P418, DOI 10.1016/j.anifeedsci.2006.06.018; Olson VA, 2006, OIKOS, V112, P620, DOI 10.1111/j.0030-1299.2006.14208.x; Olson VA, 1998, TRENDS ECOL EVOL, V13, P510, DOI 10.1016/S0169-5347(98)01484-0; Palafox-Carlos H, 2011, J FOOD SCI, V76, pR6, DOI 10.1111/j.1750-3841.2010.01957.x; Parada J, 2007, J FOOD SCI, V72, pR21, DOI 10.1111/j.1750-3841.2007.00274.x; Parker RS, 1996, FASEB J, V10, P542, DOI 10.1096/fasebj.10.5.8621054; Schiedt K., 1995, ISOLATION ANAL, V1A, P81; Sternalski A, 2012, PHYSIOL BIOCHEM ZOOL, V85, P364, DOI 10.1086/665981; Sternalski A, 2010, J COMP PHYSIOL B, V180, P33, DOI 10.1007/s00360-009-0384-y; Stradi R, 1996, COMP BIOCHEM PHYS B, V113, P427, DOI 10.1016/0305-0491(95)02064-0; Svensson PA, 2011, BEHAVIOUR, V148, P131, DOI 10.1163/000579510X548673; Tella JL, 2004, J EVOLUTION BIOL, V17, P156, DOI 10.1046/j.1420-9101.2003.00634.x; Tella JL, 1998, PHYSIOL ZOOL, V71, P708, DOI 10.1086/515991; van den Berg H, 1999, NUTR REV, V57, P1, DOI 10.1111/j.1753-4887.1999.tb01769.x; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; Yang A, 2002, MEAT SCI, V60, P35, DOI 10.1016/S0309-1740(01)00102-4	66	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65562	10.1371/journal.pone.0065562	http://dx.doi.org/10.1371/journal.pone.0065562			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785435	Green Published, gold			2022-12-25	WOS:000321038800086
J	Matulova, M; Havlickova, H; Sisak, F; Rychlik, I				Matulova, Marta; Havlickova, Hana; Sisak, Frantisek; Rychlik, Ivan			Vaccination of Chickens with SPI1-lon and SPI1-lon-fliC Mutant of Salmonella enterica Serovar Enteritidis	PLOS ONE			English	Article							III SECRETION SYSTEM; ESCHERICHIA-COLI K-12; ISLAND SPI 1; PATHOGENICITY ISLANDS; BACTERIAL FLAGELLIN; PROTECTIVE EFFICACY; IMMUNE-RESPONSE; TYPHIMURIUM; IMMUNIZATION; VIRULENCE	The prevalence of Salmonella enterica serovar Enteritidis is gradually decreasing in poultry flocks in the EU, which may result in the demand for a vaccine that allows for the differentiation of vaccinated flocks from those infected by wild-type S. Enteritidis. In this study, we therefore constructed a (Salmonella Pathogenicity Island 1) SPI1-lon mutant with or without fliC encoding for S. Enteritidis flagellin. The combination of SPI1-lon mutations resulted in attenuated but immunogenic mutant suitable for oral vaccination of poultry. In addition, the vaccination of chickens with the SPI1-lon-fliC mutant enabled the serological differentiation of vaccinated and infected chickens. The absence of fliC therefore did not affect the immunogenicity of the vaccine strain and allowed for serological differentiation of the vaccinated chickens. The SPI1-lon-fliC mutant is therefore a suitable marker vaccine strain for oral vaccination of poultry.	[Matulova, Marta; Havlickova, Hana; Sisak, Frantisek; Rychlik, Ivan] Vet Res Inst, CS-62132 Brno, Czech Republic	Czech Veterinary Research Institute	Rychlik, I (corresponding author), Vet Res Inst, CS-62132 Brno, Czech Republic.	rychlik@vri.cz	, Ivan/GPS-9674-2022	, Ivan/0000-0001-7995-6483	Czech Ministry of Agriculture [MZE0002716202, QJ1310019]; AdmireVet project from the Czech Ministry of Education [CZ.1.05/2.1.00/01.0006-ED0006/01/01]	Czech Ministry of Agriculture(Ministry of Agriculture, Czech Republic); AdmireVet project from the Czech Ministry of Education	This work has been supported by the projects MZE0002716202 and QJ1310019 of the Czech Ministry of Agriculture and AdmireVet project CZ.1.05/2.1.00/01.0006-ED0006/01/01 from the Czech Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen C, 2007, INFECT IMMUN, V75, P2461, DOI 10.1128/IAI.01357-06; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Beal RK, 2004, VET IMMUNOL IMMUNOP, V100, P151, DOI 10.1016/j.vetimm.2004.04.005; Berndt A, 2007, INFECT IMMUN, V75, P5993, DOI 10.1128/IAI.00695-07; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dieye Y, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-3; Garcia-Calderon CB, 2007, J BACTERIOL, V189, P6635, DOI 10.1128/JB.00640-07; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; GOTTESMAN S, 1985, J BACTERIOL, V162, P1111, DOI 10.1128/JB.162.3.1111-1119.1985; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Iqbal M, 2005, INFECT IMMUN, V73, P2344, DOI 10.1128/IAI.73.4.2344-2350.2005; Jones MA, 2001, INFECT IMMUN, V69, P5471, DOI 10.1128/IAI.69.9.5471-5476.2001; Karasova D, 2009, VACCINE, V27, P5265, DOI 10.1016/j.vaccine.2009.06.060; Karasova D, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-75; Kodama C, 2004, INFECT IMMUN, V72, P2449, DOI 10.1128/IAI.72.4.2449-2451.2004; Kremer CJ, 2011, POULTRY SCI, V90, P752, DOI 10.3382/ps.2010-01076; Lahuerta A, 2011, EURO SURVEILL, V16, p[pii, 19832]; Leyman B, 2012, RES VET SCI, V93, P1168, DOI 10.1016/j.rvsc.2012.05.008; Matsuda K, 2010, VET RES, V41, DOI 10.1051/vetres/2010031; Matulova M, 2012, VACCINE, V30, P2090, DOI 10.1016/j.vaccine.2012.01.050; Matulova M, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-37; Matulova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048101; McNeilly TN, 2008, INFECT IMMUN, V76, P2594, DOI 10.1128/IAI.01452-07; Methner U, 2011, VACCINE, V29, P3248, DOI 10.1016/j.vaccine.2011.02.030; Monack DM, 1996, P NATL ACAD SCI USA, V93, P9833, DOI 10.1073/pnas.93.18.9833; Murray RA, 2000, INFECT IMMUN, V68, P5050, DOI 10.1128/IAI.68.9.5050-5055.2000; Nandre RM, 2011, VET IMMUNOL IMMUNOP, V144, P299, DOI 10.1016/j.vetimm.2011.08.015; Pavlova B, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-16; Pullinger GD, 2007, INFECT IMMUN, V75, P5191, DOI 10.1128/IAI.00784-07; Rychlik I, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-268; Selke M, 2007, INFECT IMMUN, V75, P2476, DOI 10.1128/IAI.01908-06; Slattery A, 2013, J BACTERIOL, V195, P647, DOI 10.1128/JB.01397-12; Takaya A, 2002, J BACTERIOL, V184, P224, DOI 10.1128/JB.184.1.224-232.2002; Wang QF, 2007, J BACTERIOL, V189, P8447, DOI 10.1128/JB.01198-07	34	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e66172	10.1371/journal.pone.0066172	http://dx.doi.org/10.1371/journal.pone.0066172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	23785484	Green Submitted, Green Published, gold			2022-12-25	WOS:000321038800038
J	Baird, BN; Schliekelman, MJ; Ahn, YH; Chen, Y; Roybal, JD; Gill, BJ; Mishra, DK; Erez, B; O'Reilly, M; Yang, Y; Patel, M; Liu, X; Thilaganathan, N; Larina, IV; Dickinson, ME; West, JL; Gibbons, DL; Liu, DD; Kim, MP; Hicks, JM; Wistuba, II; Hanash, SM; Kurie, JM				Baird, Brandi N.; Schliekelman, Mark J.; Ahn, Young-Ho; Chen, Yulong; Roybal, Jonathon D.; Gill, Bartley J.; Mishra, Dhruva K.; Erez, Baruch; O'Reilly, Michael; Yang, Yanan; Patel, Mayuri; Liu, Xin; Thilaganathan, Nishan; Larina, Irina V.; Dickinson, Mary E.; West, Jennifer L.; Gibbons, Don L.; Liu, Diane D.; Kim, Min P.; Hicks, John M.; Wistuba, Ignacio I.; Hanash, Samir M.; Kurie, Jonathan M.			Fibulin-2 Is a Driver of Malignant Progression in Lung Adenocarcinoma	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; TENASCIN-C; METASTASIS; EXPRESSION; CELLS; HOMEOSTASIS; MIR-200; FAMILY; ROLES; GENE	The extracellular matrix of epithelial tumors undergoes structural remodeling during periods of uncontrolled growth, creating regional heterogeneity and torsional stress. How matrix integrity is maintained in the face of dynamic biophysical forces is largely undefined. Here we investigated the role of fibulin-2, a matrix glycoprotein that functions biomechanically as an inter-molecular clasp and thereby facilitates supra-molecular assembly. Fibulin-2 was abundant in the extracellular matrix of human lung adenocarcinomas and was highly expressed in tumor cell lines derived from mice that develop metastatic lung adenocarcinoma from co-expression of mutant K-ras and p53. Loss-offunction experiments in tumor cells revealed that fibulin-2 was required for tumor cells to grow and metastasize in syngeneic mice, a surprising finding given that other intra-tumoral cell types are known to secrete fibulin-2. However, tumor cells grew and metastasized equally well in Fbln2-null and -wild-type littermates, implying that malignant progression was dependent specifically upon tumor cellderived fibulin-2, which could not be offset by other cellular sources of fibulin-2. Fibulin-2 deficiency impaired the ability of tumor cells to migrate and invade in Boyden chambers, to create a stiff extracellular matrix in mice, to cross-link secreted collagen, and to adhere to collagen. We conclude that fibulin-2 is a driver of malignant progression in lung adenocarcinoma and plays an unexpected role in collagen cross-linking and tumor cell adherence to collagen.	[Baird, Brandi N.; Ahn, Young-Ho; Chen, Yulong; Roybal, Jonathon D.; Yang, Yanan; Patel, Mayuri; Liu, Xin; Thilaganathan, Nishan; Gibbons, Don L.; Wistuba, Ignacio I.; Kurie, Jonathan M.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Schliekelman, Mark J.; Hanash, Samir M.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Gill, Bartley J.; West, Jennifer L.] Rice Univ, Dept Bioengn, Houston, TX USA; [Mishra, Dhruva K.; Kim, Min P.] Methodist Hosp Res Inst, Dept Surg, Houston, TX USA; [Erez, Baruch; O'Reilly, Michael] Univ Texas Houston, MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Larina, Irina V.; Dickinson, Mary E.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Liu, Diane D.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Hicks, John M.] Texas Childrens Hosp, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Fred Hutchinson Cancer Center; Rice University; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Baylor College of Medicine	Kurie, JM (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jkurie@mdanderson.org	West, Jennifer L/A-4582-2008	West, Jennifer L/0000-0001-8550-2875; Mishra, Dhruva/0000-0001-8651-005X	Elza and Ina Shackelford-Freeman Lung Cancer Research Professorship [U01 CA141550, T32 GM008362, K08 CA151651];  [R01 CA157450]; NATIONAL CANCER INSTITUTE [U01CA141550, K08CA151651, R01CA157450, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008362] Funding Source: NIH RePORTER	Elza and Ina Shackelford-Freeman Lung Cancer Research Professorship; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by R01 CA157450 (J.M.K., http://grants.nih.gov), The Elza and Ina Shackelford-Freeman Lung Cancer Research Professorship (J.M.K.), U01 CA141550 (S.H., http://grants.nih.gov), T32 GM008362 (B.J.G., http://grants.nih.gov), and K08 CA151651 (D.L.G., http://grants.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcendor DJ, 2011, AM J PATHOL, V179, P1443, DOI 10.1016/j.ajpath.2011.05.024; Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; Dunwell TL, 2009, EPIGENETICS-US, V4, P185, DOI 10.4161/epi.4.3.8752; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Grassel S, 1999, EUR J BIOCHEM, V263, P471, DOI 10.1046/j.1432-1327.1999.00523.x; Law EWL, 2012, ONCOGENE, V31, P728, DOI 10.1038/onc.2011.272; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; O'Connell JT, 2011, P NATL ACAD SCI USA, V108, P16002, DOI 10.1073/pnas.1109493108; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; SAINTIGNY P, 2013, PUBMED; Sasaki T, 1996, J CELL SCI, V109, P2895; Sasaki T, 1997, EMBO J, V16, P3035, DOI 10.1093/emboj/16.11.3035; Schliekelman MJ, 2011, CANCER RES, V71, P7670, DOI 10.1158/0008-5472.CAN-11-0964; Senapati S, 2012, ONCOGENE, V31, P3346, DOI 10.1038/onc.2011.505; Sicot FX, 2008, MOL CELL BIOL, V28, P1061, DOI 10.1128/MCB.01876-07; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; Tsuda T, 2001, DEV DYNAM, V222, P89, DOI 10.1002/dvdy.1172; Tsuda T, 2012, J MOL CELL CARDIOL, V52, P273, DOI 10.1016/j.yjmcc.2011.11.001; White DJ, 2004, INT J BIOCHEM CELL B, V36, P1405, DOI 10.1016/j.biocel.2003.08.016; Yi CH, 2007, AM J PATHOL, V170, P1535, DOI 10.2353/ajpath.2007.060478	27	29	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e67054	10.1371/journal.pone.0067054	http://dx.doi.org/10.1371/journal.pone.0067054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23785517	Green Submitted, gold, Green Published			2022-12-25	WOS:000320440500072
J	de Vries, NKS; van der Veere, CN; Reijneveld, SA; Bos, AF				de Vries, Nathalie K. S.; van der Veere, Christine N.; Reijneveld, Sijmen A.; Bos, Arend F.			Early Neurological Outcome of Young Infants Exposed to Selective Serotonin Reuptake Inhibitors during Pregnancy: Results from the Observational SMOK Study	PLOS ONE			English	Article							ANTIDEPRESSANT DRUG-USE; MEDICATION EXPOSURE; GENERAL MOVEMENTS; PRETERM INFANTS; DEPRESSION; NEWBORN; POPULATION; PREVALENCE; DISORDERS; PATTERNS	Background: Use of selective serotonin reuptake inhibitors (SSRI) during pregnancy is common while the effect on the infant's neurological outcome is unknown. Our objective was to determine the effects of prenatal SSRI-exposure on the infants' neurological functioning, adjusted for maternal mental health. Methods: A prospective observational study from May 2007 to April 2010. The study groups comprised 63 SSRI-exposed infants (SSRI group) and 44 non-exposed infants (non-SSRI group). Maternal depression and anxiety were measured using questionnaires. The main outcome measures during the first week after birth and at three to four months were the quality of the infants' general movements (GMs) according to Prechtl and a detailed motor optimality score. We calculated odds ratios (ORs) and 95% confidence intervals (CIs) for abnormal GM quality in the SSRI and non-SSRI groups, and adjusted for maternal depression, anxiety, and other confounders. The study was registered under 53506435 in the ISRCTN. Findings: All infants were born around term. During the first week, abnormal GMs occurred more frequently in the SSRI group than in the non-SSRI group (59% versus 33%) and the median MOS was lower (13 versus 18). The OR for abnormal GMs in the SSRI versus the non-SSRI group was 3.0 (95% CI, 1.3 to 6.9) and increased after adjustment for confounders. At three to four months, more SSRI-exposed infants had monotonous movements (48% versus 20%) with lower median MOSs (26 versus 28). The OR for monotonous movements was 3? 5 (95% CI, 1.5 to 8.6) and increased after adjusting for confounders. Interpretation: Prenatal exposure to SSRI had an adverse effect on early neurological functioning as reflected by GM quality, irrespective of maternal depression and anxiety, and other confounders. Physicians should take this into account in consultation with parents.	[de Vries, Nathalie K. S.] Med Ctr Leeuwarden, Dept Paediat, Leeuwarden, Netherlands; [van der Veere, Christine N.] Wilhelmina Gasthuis, Dept Paediat, Assen, Netherlands; [Reijneveld, Sijmen A.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Groningen, Netherlands; [Bos, Arend F.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Div Neonatol, Groningen, Netherlands	Medical Center Leeuwarden; University of Groningen; University of Groningen	de Vries, NKS (corresponding author), Med Ctr Leeuwarden, Dept Paediat, Leeuwarden, Netherlands.	nathalie.de.vries@znb.nl		Reijneveld, Sijmen/0000-0002-1206-7523	science foundation for the medical staff of Medical Centre Leeuwarden	science foundation for the medical staff of Medical Centre Leeuwarden	The science foundation for the medical staff of Medical Centre Leeuwarden funded the study. Their grant was used toward paying the research assistant's salary and reimbursement of expenses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2003, AM J OBSTET GYNECOL, V189, P148, DOI 10.1067/mob.2003.336; Bruggink JLM, 2008, J PEDIATR-US, V153, P32, DOI 10.1016/j.jpeds.2007.12.047; Bruggink JLM, 2009, EARLY HUM DEV, V85, P25, DOI 10.1016/j.earlhumdev.2008.05.010; Cooper WO, 2007, AM J OBSTET GYNECOL, V196, P544, DOI 10.1016/j.ajog.2007.01.033; Costei AM, 2002, ARCH PEDIAT ADOL MED, V156, P1129, DOI 10.1001/archpedi.156.11.1129; de Vries NKS, 2010, EARLY HUM DEV, V86, P225, DOI 10.1016/j.earlhumdev.2010.03.004; Debonnel G, 2007, INT J NEUROPSYCHOPH, V10, P51, DOI 10.1017/S1461145705006413; Einspieler C, 2005, MENT RETARD DEV D R, V11, P61, DOI 10.1002/mrdd.20051; Field T, 2006, INFANT BEHAV DEV, V29, P445, DOI 10.1016/j.infbeh.2006.03.003; Field T, 2010, INFANT BEHAV DEV, V33, P409, DOI 10.1016/j.infbeh.2010.04.005; Gentile S, 2011, J AFFECT DISORDERS, V128, P1, DOI 10.1016/j.jad.2010.02.125; Gentile S, 2009, EVID-BASED MENT HEAL, V12, P27, DOI 10.1136/ebmh.12.1.27; Gentile S, 2010, CNS SPECTRUMS, V15, P167, DOI 10.1017/S1092852900027449; Lasa L, 2000, J AFFECT DISORDERS, V57, P261, DOI 10.1016/S0165-0327(99)00088-9; Lattimore Keri A, 2005, J Perinatol, V25, P595; Martini J, 2010, EARLY HUM DEV, V86, P305, DOI 10.1016/j.earlhumdev.2010.04.004; Meades R, 2011, J AFFECT DISORDERS, V133, P1, DOI 10.1016/j.jad.2010.10.009; Montgomery SA, 2008, CNS SPECTRUMS, V13, P27, DOI 10.1017/S1092852900028297; Moses-Kolko EL, 2005, JAMA-J AM MED ASSOC, V293, P2372, DOI 10.1001/jama.293.19.2372; Mulder EJH, 2011, NEUROPSYCHOPHARMACOL, V36, P1961, DOI 10.1038/npp.2011.67; Oberlander TF, 2005, PEDIATRICS, V115, P411, DOI 10.1542/peds.2004-0420; Oberlander TF, 2004, J CLIN PSYCHIAT, V65, P230; PRECHTL HFR, 1974, BRAIN RES, V76, P185, DOI 10.1016/0006-8993(74)90454-5; PRECHTL HFR, 1980, EARLY HUM DEV, V4, P201; Rampono J, 2009, PHARMACOPSYCHIATRY, V42, P95, DOI 10.1055/s-0028-1103296; Salisbury AL, 2011, DEPRESS ANXIETY, V28, P1008, DOI 10.1002/da.20883; Stewart DE, 2011, NEW ENGL J MED, V365, P1605, DOI 10.1056/NEJMcp1102730; Talge NM, 2007, J CHILD PSYCHOL PSYC, V48, P245, DOI 10.1111/j.1469-7610.2006.01714.x; Veere vd, 2007, NED TIJDSCHR GENEES, V151, P2873; Ververs TF, 2009, BJOG-INT J OBSTET GY, V116, P1568, DOI 10.1111/j.1471-0528.2009.02292.x; Ververs T, 2006, EUR J CLIN PHARMACOL, V62, P863, DOI 10.1007/s00228-006-0177-0; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Zeskind PS, 2004, PEDIATRICS, V113, P368, DOI 10.1542/peds.113.2.368	33	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2013	8	5							e64654	10.1371/journal.pone.0064654	http://dx.doi.org/10.1371/journal.pone.0064654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155FM	23785389	Green Published, Green Submitted, gold			2022-12-25	WOS:000319733000074
J	Serra, D; Paixao, J; Nunes, C; Dinis, TCP; Almeida, LM				Serra, Diana; Paixao, Joana; Nunes, Carla; Dinis, Teresa C. P.; Almeida, Leonor M.			Cyanidin-3-Glucoside Suppresses Cytokine-Induced Inflammatory Response in Human Intestinal Cells: Comparison with 5-Aminosalicylic Acid	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; BOWEL-DISEASE; DIETARY ANTHOCYANINS; SIGNAL-TRANSDUCTION; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; IMMUNE-SYSTEM; EXPRESSION	The potential use of polyphenols in the prevention and treatment of chronic inflammatory diseases has been extensively investigated although the mechanisms involved in cellular signaling need to be further elucidated. Cyanidin-3-glucoside is a typical anthocyanin of many pigmented fruits and vegetables widespread in the human diet. In the present study, the protection afforded by cyanidin-3-glucoside against cytokine-triggered inflammatory response was evaluated in the human intestinal HT-29 cell line, in comparison with 5-aminosalicylic acid, a well-established anti-inflammatory drug, used in inflammatory bowel disease. For this purpose, some key inflammatory mediators and inflammatory enzymes were examined. Our data showed that cyanidin-3-glucoside reduced cytokine-induced inflammation in intestinal cells, in terms of NO, PGE(2) and IL-8 production and of iNOS and COX-2 expressions, at a much lower concentration than 5-aminosalicylic acid, suggesting a higher anti-inflammatory efficiency. Interestingly, cyanidin-3-glucoside and 5-aminosalicylic acid neither prevented IkB-alpha degradation nor the activation of NF-kB, but significantly reduced cytokine-induced levels of activated STAT1 accumulated in the cell nucleus. In addition, we established that phosphorylated p38 MAPK was not involved in the protective effect of cyanidin-3-glucoside or 5-aminosalicylic acid. Taking into account the high concentrations of dietary anthocyanins potentially reached in the gastrointestinal tract, cyanidin-3-glucoside may be envisaged as a promising nutraceutical giving complementary benefits in the context of inflammatory bowel disease.	[Serra, Diana; Paixao, Joana; Nunes, Carla; Dinis, Teresa C. P.; Almeida, Leonor M.] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Serra, Diana; Paixao, Joana; Nunes, Carla; Dinis, Teresa C. P.; Almeida, Leonor M.] Univ Coimbra, Fac Pharm, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra	Dinis, TCP (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal.	tcpdinis@ci.uc.pt	Nunes, Carla/AAM-3056-2021; Serra, Francois Jose/A-8789-2011; Nunes, Carla/L-3456-2017; Serra, Diana/M-4062-2017	Nunes, Carla/0000-0002-7452-1592; Serra, Francois Jose/0000-0003-3895-4742; Nunes, Carla/0000-0002-7452-1592; Serra, Diana/0000-0002-5965-0281; Almeida, Leonor Martins/0000-0002-7769-4712; Becher, Veronica/0000-0002-5425-8563; Felix Paixao, Joana Isabel/0000-0002-2050-405X; Dinis, Teresa/0000-0001-6350-5741; Dopazo, Hernan/0000-0001-6125-2357	FCT (Fundacao para a Ciencia e a Tecnologia) [PTDC/SAU-OSM/102907/2008, PEst-C/SAU/LA0001/2013-2014]; FEDER/COMPETE (Fundo Europeu de Desenvolvimento Regional, Portugal through Programa Operacional Factores de Competitividade); FCT [SFRH/BD/7541/2010]	FCT (Fundacao para a Ciencia e a Tecnologia)(Portuguese Foundation for Science and Technology); FEDER/COMPETE (Fundo Europeu de Desenvolvimento Regional, Portugal through Programa Operacional Factores de Competitividade); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the grants PTDC/SAU-OSM/102907/2008 and PEst-C/SAU/LA0001/2013-2014, funded by FCT (Fundacao para a Ciencia e a Tecnologia) and FEDER/COMPETE (Fundo Europeu de Desenvolvimento Regional, Portugal through Programa Operacional Factores de Competitividade). Diana Serra is a recipient of the grant SFRH/BD/7541/2010 from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Aura AM, 2005, EUR J NUTR, V44, P133, DOI 10.1007/s00394-004-0502-2; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; CROTTY B, 1992, BRIT J CLIN PHARMACO, V34, P189, DOI 10.1111/j.1365-2125.1992.tb04124.x; DINIS TCP, 1994, ARCH BIOCHEM BIOPHYS, V315, P161, DOI 10.1006/abbi.1994.1485; Egan LJ, 1999, J BIOL CHEM, V274, P26448, DOI 10.1074/jbc.274.37.26448; Feng YJ, 2011, J DIGEST DIS, V12, P327, DOI 10.1111/j.1751-2980.2011.00525.x; Haspel RL, 1999, P NATL ACAD SCI USA, V96, P10188, DOI 10.1073/pnas.96.18.10188; He JA, 2010, ANNU REV FOOD SCI T, V1, P163, DOI 10.1146/annurev.food.080708.100754; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Jijon HB, 2002, AM J PHYSIOL-CELL PH, V283, pC31, DOI 10.1152/ajpcell.00113.2001; Kay CD, 2009, MOL NUTR FOOD RES, V53, pS92, DOI 10.1002/mnfr.200800461; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Klampfer L, 2006, CURR CANCER DRUG TAR, V6, P107, DOI 10.2174/156800906776056491; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; Kolios G, 2006, EUR J CLIN INVEST, V36, P720, DOI 10.1111/j.1365-2362.2006.01710.x; Kolios G, 2004, IMMUNOLOGY, V113, P427, DOI 10.1111/j.1365-2567.2004.01984.x; KOLIOS G, 1995, BRIT J PHARMACOL, V116, P2866, DOI 10.1111/j.1476-5381.1995.tb15938.x; Kramer OH, 2010, MOL CELL ENDOCRINOL, V315, P40, DOI 10.1016/j.mce.2009.10.007; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050363; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Mauray A, 2010, GENES NUTR, V5, P343, DOI 10.1007/s12263-010-0171-0; McCune LM, 2011, CRIT REV FOOD SCI, V51, P1, DOI 10.1080/10408390903001719; McGhie TK, 2007, MOL NUTR FOOD RES, V51, P702, DOI 10.1002/mnfr.200700092; Miguel M. G., 2011, Journal of Applied Pharmaceutical Science, V1, P7; Min SW, 2010, INT IMMUNOPHARMACOL, V10, P959, DOI 10.1016/j.intimp.2010.05.009; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Paixao J, 2012, CHEM-BIOL INTERACT, V199, P192, DOI 10.1016/j.cbi.2012.08.013; Paixao J, 2011, APOPTOSIS, V16, P976, DOI 10.1007/s10495-011-0632-y; Paul S, 2009, CANCER PREV RES, V2, P650, DOI 10.1158/1940-6207.CAPR-08-0224; Piberger H, 2011, MOL NUTR FOOD RES, V55, P1724, DOI 10.1002/mnfr.201100380; Prior RL, 2006, FREE RADICAL RES, V40, P1014, DOI 10.1080/10715760600758522; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; Romier B, 2009, NUTR REV, V67, P363, DOI 10.1111/j.1753-4887.2009.00210.x; Salerno L, 2002, CURR PHARM DESIGN, V8, P177, DOI 10.2174/1381612023396375; Santos CI, 2011, BBA-REV CANCER, V1816, P38, DOI 10.1016/j.bbcan.2011.03.003; Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096; Schreiber S, 2002, GUT, V51, P379, DOI 10.1136/gut.51.3.379; Sheibanie AF, 2007, J IMMUNOL, V178, P8138, DOI 10.4049/jimmunol.178.12.8138; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Singer II, 1998, GASTROENTEROLOGY, V115, P297, DOI 10.1016/S0016-5085(98)70196-9; Stein RB, 2000, DRUG SAFETY, V23, P429, DOI 10.2165/00002018-200023050-00006; Surh YJ, 2001, J KOREAN MED SCI, V16, pS38, DOI 10.3346/jkms.2001.16.S.S38; Tedeschi E, 2004, MOL PHARMACOL, V65, P111, DOI 10.1124/mol.65.1.111; Wang LS, 2008, CANCER LETT, V269, P281, DOI 10.1016/j.canlet.2008.05.020; Wright K, 1997, J BIOL CHEM, V272, P12626, DOI 10.1074/jbc.272.19.12626; Yoshimura A, 2006, CANCER SCI, V97, P439, DOI 10.1111/j.1349-7006.2006.00197.x; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	50	82	86	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2013	8	9							e73001	10.1371/journal.pone.0073001	http://dx.doi.org/10.1371/journal.pone.0073001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224BO	23798991	Green Published, Green Submitted, gold			2022-12-25	WOS:000324856500030
J	Xiao, Y; Xia, W; Yang, YD; Mason, AS; Lei, XT; Ma, ZL				Xiao, Yong; Xia, Wei; Yang, Yaodong; Mason, Annaliese S.; Lei, Xintao; Ma, Zilong			Characterization and Evolution of Conserved MicroRNA through Duplication Events in Date Palm (Phoenix dactylifera)	PLOS ONE			English	Article							GENOME SEQUENCE; BLACK COTTONWOOD; PLANT MICRORNAS; ORIGINS; BIOGENESIS; DIVERGENCE; BIRTH	MicroRNAs (miRNAs) are important regulators of gene expression at the post-transcriptional level in a wide range of species. Highly conserved miRNAs regulate ancestral transcription factors common to all plants, and control important basic processes such as cell division and meristem function. We selected 21 conserved miRNA families to analyze the distribution and maintenance of miRNAs. Recently, the first genome sequence in Palmaceae was released: date palm (Phoenix dactylifera). We conducted a systematic miRNA analysis in date palm, computationally identifying and characterizing the distribution and duplication of conserved miRNAs in this species compared to other published plant genomes. A total of 81 miRNAs belonging to 18 miRNA families were identified in date palm. The majority of miRNAs in date palm and seven other well-studied plant species were located in intergenic regions and located 4 to 5 kb away from the nearest protein-coding genes. Sequence comparison showed that 67% of date palm miRNA members were present in duplicated segments, and that 135 pairs of miRNA-containing segments were duplicated in Arabidopsis, tomato, orange, rice, apple, poplar and soybean with a high similarity of non coding sequences between duplicated segments, indicating genomic duplication was a major force for expansion of conserved miRNAs. Duplicated miRNA pairs in date palm showed divergence in pre-miRNA sequence and in number of promoters, implying that these duplicated pairs may have undergone divergent evolution. Comparisons between date palm and the seven other plant species for the gain/loss of miR167 loci in an ancient segment shared between monocots and dicots suggested that these conserved miRNAs were highly influenced by and diverged as a result of genomic duplication events.	[Xiao, Yong; Xia, Wei; Yang, Yaodong; Lei, Xintao] Chinese Acad Trop Agr Sci, Hainan Key Lab Trop Oil Crops Biol, Coconuts Res Inst, Wenchang, Hainan, Peoples R China; [Mason, Annaliese S.] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia; [Mason, Annaliese S.] Univ Queensland, Ctr Integrat Legume Res, Brisbane, Qld, Australia; [Ma, Zilong] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Haikou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; University of Queensland; University of Queensland; Chinese Academy of Tropical Agricultural Sciences	Yang, YD (corresponding author), Chinese Acad Trop Agr Sci, Hainan Key Lab Trop Oil Crops Biol, Coconuts Res Inst, Wenchang, Hainan, Peoples R China.	ydyang@tocri.com	Xiao, Yang/N-5021-2017; Mason, Annaliese S/B-8809-2011; HUI, Xiaoyan Hannah/M-5175-2019; Yang, Yaodong/L-8445-2019	Xiao, Yang/0000-0003-3927-1839; Mason, Annaliese S/0000-0003-2701-7964; HUI, Xiaoyan Hannah/0000-0002-7525-5812; Yang, Yaodong/0000-0002-6599-5665; Zhou, Zhiguang/0000-0002-0374-1838	National Natural Science Foundation of China [31101179]; Project for High-Level Returned Scholar of Ministry of Human Resources and Social Security of P.R. China; National Nonprofit Institute [CATAS- ITBB120506]; Australian Research Council Early Career Researcher Award [DE120100668]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project for High-Level Returned Scholar of Ministry of Human Resources and Social Security of P.R. China; National Nonprofit Institute; Australian Research Council Early Career Researcher Award(Australian Research Council)	This work was supported by grants from the National Natural Science Foundation of China (No. 31101179), the Project for High-Level Returned Scholar of Ministry of Human Resources and Social Security of P.R. China (2011), the National Nonprofit Institute Research Grant of CATAS- ITBB120506, and Australian Research Council Early Career Researcher Award (DE120100668). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Bourgis F, 2011, P NATL ACAD SCI USA, V108, P12527, DOI 10.1073/pnas.1106502108; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Csuros M, 2010, BIOINFORMATICS, V26, P1910, DOI 10.1093/bioinformatics/btq315; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Djerbi S, 2005, PLANTA, V221, P739, DOI 10.1007/s00425-005-1498-4; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; Garcia D, 2008, SEMIN CELL DEV BIOL, V19, P586, DOI 10.1016/j.semcdb.2008.07.013; Guddeti S, 2005, CELL RES, V15, P631, DOI 10.1038/sj.cr.7290333; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kozik A, 2002, BIOINFORMATICS, V18, P335, DOI 10.1093/bioinformatics/18.2.335; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Li AL, 2007, CELL RES, V17, P212, DOI 10.1038/sj.cr.7310113; Maher C, 2006, GENOME RES, V16, P510, DOI 10.1101/gr.4680506; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Meunier J, 2013, GENOME RES, V23, P34, DOI 10.1101/gr.140269.112; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Nozawa M, 2012, GENOME BIOL EVOL, V4, P230, DOI 10.1093/gbe/evs002; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Sun J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034092; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37; Turner M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-169; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Varaud E, 2011, PLANT CELL, V23, P973, DOI 10.1105/tpc.110.081653; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Zeng CY, 2010, NUCLEIC ACIDS RES, V38, P981, DOI 10.1093/nar/gkp1035; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028073	40	68	74	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71435	10.1371/journal.pone.0071435	http://dx.doi.org/10.1371/journal.pone.0071435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23799122	Green Submitted, gold, Green Published			2022-12-25	WOS:000323124000057
J	Xiao, Y; Xu, AM; Hui, XY; Zhou, PC; Li, X; Zhong, H; Tang, WL; Huang, G; Zhou, ZG				Xiao, Yang; Xu, Aimin; Hui, Xiaoyan; Zhou, Pengcheng; Li, Xing; Zhong, Hui; Tang, Weili; Huang, Gan; Zhou, Zhiguang			Circulating Lipocalin-2 and Retinol-Binding Protein 4 Are Associated with Intima-Media Thickness and Subclinical Atherosclerosis in Patients with Type 2 Diabetes	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; INSULIN-RESISTANCE; RETINOL-BINDING-PROTEIN-4; INFLAMMATION; OBESITY; EXPRESSION; FAMILY	Background: The lipocalin family proteins, including lipocalin-2 and retinol-binding protein 4 (RBP4), are adipokines closely associated with obesity-related metabolic disorders. In this study, we evaluated the association of serum lipocalin-2 and RBP4 with intima-media thickness (IMT) and subclinical atherosclerosis in type 2 diabetic patients. Methods and Results: Serum levels of lipocalin-2 and RBP4 were measured in 284 type 2 diabetic patients. Subclinical atherosclerosis was assessed by IMT at carotid, femoral and iliac arteries with ultrasound. Patients with subclinical atherosclerosis showed significantly higher circulating concentrations of lipocalin-2 and RBP4 when compared to those without [112.9 (86.4 to 202.1) mu g/L versus 77.2(55.0-150.4) mu g/L, 37.1(32.3-40.8) mg/L versus 23.2(20.1-29.2) mg/L, respectively; P = 0.002, P<0.001, respectively]. Moreover, positive correlations were observed between carotid IMT and lipocalin-2 (r = 0.170, P = 0.018) or RBP4 (r = 0.132, P = 0.040), femoral IMT and lipocalin-2 (r = 0.160, P = 0.027), as well as between iliac IMT and RBP4 (r = 0.241, P<0.001). Multiple logistic regression analysis further demonstrated that these two adipokines were independent risk factors for subclinical atherosclerosis in type 2 diabetes. Conclusion: Circulating levels of lipocalin-2 and RBP4 are positively correlated with carotid IMT and subclinical atherosclerosis in type 2 diabetes, which suggests a potential role of these two lipid-binding chaperones in the pathogenesis of vascular complications of diabetes.	[Xiao, Yang; Li, Xing; Zhong, Hui; Tang, Weili; Huang, Gan; Zhou, Zhiguang] Cent S Univ, Ctr Diabet, Xiangya Hosp 2, Hunan Key Lab Med Epigen, Changsha, Hunan, Peoples R China; [Xiao, Yang; Li, Xing; Zhong, Hui; Tang, Weili; Huang, Gan; Zhou, Zhiguang] Cent S Univ, Inst Metab & Endocrinol, Key Lab Diabet Immunol, Hunan Key Lab Med Epigen,Minist Educ, Changsha, Hunan, Peoples R China; [Xu, Aimin; Hui, Xiaoyan; Zhou, Pengcheng] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Xu, Aimin] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Xiao, Yang; Xu, Aimin] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China	Central South University; Central South University; University of Hong Kong; University of Hong Kong; University of Hong Kong	Zhou, ZG (corresponding author), Cent S Univ, Ctr Diabet, Xiangya Hosp 2, Hunan Key Lab Med Epigen, Changsha, Hunan, Peoples R China.	zhouzg@hotmail.com	Xiao, Yang/N-5021-2017; Mason, Annaliese S/B-8809-2011; HUI, Xiaoyan Hannah/M-5175-2019; Yang, Yaodong/L-8445-2019	Xiao, Yang/0000-0003-3927-1839; Mason, Annaliese S/0000-0003-2701-7964; HUI, Xiaoyan Hannah/0000-0002-7525-5812; Yang, Yaodong/0000-0002-6599-5665; Zhou, Zhiguang/0000-0002-0374-1838	National key technology RD program [2012BAI02B04]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1195]; Hunan Provincial Natural Science Foundation of China [11JJ7005]; National Natural Science Foundation of China [81170725, 81200600]; Hong Kong Collaborative Research Fund [HKU/CRF/10]; Research Fund for the Doctoral Program of Higher Education of China [20110162120014]; Fundamental Research Funds for the Central University [2011QNZT176]	National key technology RD program(National Key Technology R&D Program); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong Collaborative Research Fund; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central University	This work is supported by the National key technology R&D program (2012BAI02B04), Program for Changjiang Scholars and Innovative Research Team in University (IRT1195), Hunan Provincial Natural Science Foundation of China (11JJ7005), the National Natural Science Foundation of China (Grant No. 81170725, to Z.Z.), Hong Kong Collaborative Research Fund (HKU/CRF/10, to A.X.), the National Natural Science Foundation of China (Grant No. 81200600), the Research Fund for the Doctoral Program of Higher Education of China (20110162120014), and the Fundamental Research Funds for the Central University (2011QNZT176, to Y.X.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner F, 2007, AM J TRANSPLANT, V7, P779, DOI 10.1111/j.1600-6143.2006.01723.x; American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS42; Balagopal P, 2007, J CLIN ENDOCR METAB, V92, P1971, DOI 10.1210/jc.2006-2712; Balbarini A, 2000, ANGIOLOGY, V51, P269; Barazzoni R, 2011, CLIN ENDOCRINOL OXF; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bobbert T, 2010, ATHEROSCLEROSIS, V213, P549, DOI 10.1016/j.atherosclerosis.2010.07.063; Bratt T, 1999, BBA-GEN SUBJECTS, V1472, P262, DOI 10.1016/S0304-4165(99)00131-2; Bu DX, 2006, AM J PATHOL, V169, P2245, DOI 10.2353/ajpath.2006.050706; Cabre A, 2007, J INTERN MED, V262, P496, DOI 10.1111/j.1365-2796.2007.01849.x; Choi KM, 2008, EUR J ENDOCRINOL, V158, P203, DOI 10.1530/EJE-07-0633; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Esteve E, 2009, DIABETES CARE, V32, pS362, DOI 10.2337/dc09-S340; Flower DR, 1996, BIOCHEM J, V318, P1; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Goetz DH, 2000, BIOCHEMISTRY-US, V39, P1935, DOI 10.1021/bi992215v; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Hemdahl AL, 2006, ARTERIOSCL THROM VAS, V26, P136, DOI 10.1161/01.ATV.0000193567.88685.f4; Jaffer FA, 2006, J AM COLL CARDIOL, V47, P1328, DOI 10.1016/j.jacc.2006.01.029; Kardys I, 2006, ARTERIOSCL THROM VAS, V26, P631, DOI 10.1161/01.ATV.0000201289.83256.cf; Kotliar Carol, 2008, J Cardiometab Syndr, V3, P60, DOI 10.1111/j.1559-4572.2008.07957.x; Law IKM, 2010, DIABETES, V59, P872, DOI 10.2337/db09-1541; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Liu JT, 2011, BR J PHARM; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Milner KL, 2009, HEPATOLOGY, V49, P1926, DOI 10.1002/hep.22896; Park SE, 2009, ATHEROSCLEROSIS, V204, P23, DOI 10.1016/j.atherosclerosis.2008.08.012; Rabe K, 2008, MOL MED, V14, P741, DOI 10.2119/2008-00058.Rabe; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Solini A, 2009, AM J HYPERTENS, V22, P1001, DOI 10.1038/ajh.2009.116; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yao-Borengasser A, 2007, J CLIN ENDOCR METAB, V92, P2590, DOI 10.1210/jc.2006-0816	36	68	74	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66607	10.1371/journal.pone.0066607	http://dx.doi.org/10.1371/journal.pone.0066607			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799122	Green Published, Green Submitted, gold			2022-12-25	WOS:000321397800042
J	Rayhan, RU; Stevens, BW; Timbol, CR; Adewuyi, O; Walitt, B; VanMeter, JW; Baraniuk, JN				Rayhan, Rakib U.; Stevens, Benson W.; Timbol, Christian R.; Adewuyi, Oluwatoyin; Walitt, Brian; VanMeter, John W.; Baraniuk, James N.			Increased Brain White Matter Axial Diffusivity Associated with Fatigue, Pain and Hyperalgesia in Gulf War Illness	PLOS ONE			English	Article							ATTENTION; VETERANS; MOTION; VALIDATION; MECHANISMS; DISTORTION; MIGRAINE; STIMULI; NETWORK; DORSAL	Background: Gulf War exposures in 1990 and 1991 have caused 25% to 30% of deployed personnel to develop a syndrome of chronic fatigue, pain, hyperalgesia, cognitive and affective dysfunction. Methods: Gulf War veterans (n=31) and sedentary veteran and civilian controls (n=20) completed fMRI scans for diffusion tensor imaging. A combination of dolorimetry, subjective reports of pain and fatigue were correlated to white matter diffusivity properties to identify tracts associated with symptom constructs. Results: Gulf War Illness subjects had significantly correlated fatigue, pain, hyperalgesia, and increased axial diffusivity in the right inferior fronto-occipital fasciculus. ROC generated thresholds and subsequent binary regression analysis predicted CMI classification based upon axial diffusivity in the right inferior fronto-occipital fasciculus. These correlates were absent for controls in dichotomous regression analysis. Conclusion: The right inferior fronto-occipital fasciculus may be a potential biomarker for Gulf War Illness. This tract links cortical regions involved in fatigue, pain, emotional and reward processing, and the right ventral attention network in cognition. The axonal neuropathological mechanism(s) explaining increased axial diffusivity may account for the most prominent symptoms of Gulf War Illness.	[Rayhan, Rakib U.; Timbol, Christian R.; Adewuyi, Oluwatoyin; Baraniuk, James N.] Georgetown Univ, Med Ctr, Dept Med, Div Rheumatol Immunol & Allergy, Washington, DC 20007 USA; [Stevens, Benson W.; VanMeter, John W.] Georgetown Univ, Med Ctr, Dept Neurol, Ctr Funct & Mol Imaging, Washington, DC 20007 USA; [Walitt, Brian] Washington Hosp Ctr, Div Rheumatol, Washington, DC 20010 USA	Georgetown University; Georgetown University; MedStar Washington Hospital Center	Rayhan, RU (corresponding author), Georgetown Univ, Med Ctr, Dept Med, Div Rheumatol Immunol & Allergy, Washington, DC 20007 USA.	rur@georgetown.edu	VanMeter, John W/D-2589-2018	VanMeter, John W/0000-0002-7012-5197; Baraniuk, James Nicholas/0000-0002-1866-4177	Department of Defense Congressionally Directed Medical Research Program (CDMRP) award [W81-XWH-09-1-0526]; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), through the Clinical and Translational Science Awards Program (CTSA) [UL1TR000101, UL1RR031975]	Department of Defense Congressionally Directed Medical Research Program (CDMRP) award; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), through the Clinical and Translational Science Awards Program (CTSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Sources of funding were provided by the Department of Defense Congressionally Directed Medical Research Program (CDMRP) award W81-XWH-09-1-0526. Research support for the Clinical Research Unit at Georgetown University Medical Center was funded in whole or in part with federal funds (Grant #UL1TR000101, previously UL1RR031975) from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), through the Clinical and Translational Science Awards Program (CTSA), a trademark of DHHS, part of the Roadmap Initiative, "Re-Engineering the Clinical Research Enterprise." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson J.L.R, 2007, TR07JA2 FMRIB; Baliki MN, 2012, NAT NEUROSCI, V15, P1117, DOI 10.1038/nn.3153; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Baraniuk JN, 2013, AM J TRANSL RES, V5, P53; Baraniuk JN, 1998, ANN ALLERG ASTHMA IM, V81, P359, DOI 10.1016/S1081-1206(10)63129-8; Barnden LR, 2011, NMR BIOMED, V24, P1302, DOI 10.1002/nbm.1692; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brodersen KH, 2012, NEUROIMAGE, V63, P1162, DOI 10.1016/j.neuroimage.2012.08.035; Brown R., 1828, PHILOS MAG, V4, P161, DOI [10.1080/14786442808674769, DOI 10.1080/14786442808674769]; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Burdach K., 1822, BAUE LEBEN GEHIRNS Z, VSecond; Camara E, 2010, J NEUROSCI, V30, P11398, DOI 10.1523/JNEUROSCI.0111-10.2010; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Chang LC, 2012, MAGN RESON MED, V68, P1654, DOI 10.1002/mrm.24173; Chen JYW, 2011, BRAIN RES, V1392, P121, DOI 10.1016/j.brainres.2011.03.069; Cook DB, 2007, NEUROIMAGE, V36, P108, DOI 10.1016/j.neuroimage.2007.02.033; Cook DB, 2004, J RHEUMATOL, V31, P364; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crombez G, 2005, PAIN, V116, P4, DOI 10.1016/j.pain.2005.03.035; EBELING U, 1992, ACTA NEUROCHIR, V115, P143, DOI 10.1007/BF01406373; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Eisen SA, 2005, ANN INTERN MED, V142, P881, DOI 10.7326/0003-4819-142-11-200506070-00005; Farmer MA, 2012, NEUROSCI LETT, V520, P197, DOI 10.1016/j.neulet.2012.05.001; Farmer MA, 2011, J UROLOGY, V186, P117, DOI 10.1016/j.juro.2011.03.027; Forkel J, 2012, CORTEX; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; Granziera C, 2006, PLOS MED, V3, P1915, DOI 10.1371/journal.pmed.0030402; Gu L, 2012, J TRAUMA AC IN PRESS; Harrison DM, 2013, J NEUROL, V260, P397, DOI 10.1007/s00415-012-6638-8; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; Kang HK, 2009, J OCCUP ENVIRON MED, V51, P401, DOI 10.1097/JOM.0b013e3181a2feeb; Kumar R, 2011, J NEUROL SCI, V307, P106, DOI 10.1016/j.jns.2011.04.028; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lima D, 2008, SCI PAIN, V5, P477; Loeser JD, 2008, PAIN, V137, P473, DOI 10.1016/j.pain.2008.04.025; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Mori S.W., 2005, MRI ATLAS HUMAN WHIT; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Nagae LM, 2012, AM J NEURORADIOL, V33, P1720, DOI 10.3174/ajnr.A3037; Naranch K, 2002, OTOLARYNG HEAD NECK, V127, P387, DOI 10.1067/mhn.2002.129038; Pardini M, 2010, NEUROLOGY, V74, P749, DOI 10.1212/WNL.0b013e3181d25b6b; Petrides M., 2002, PRINCIPLES FRONTAL L; Pierpaoli C, 2010, STOCKH SWED ISMRM 18; Ravindran MK, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-30; Research Advisory Committee on Gulf War Veterans' Illness (RAC-GWVI), 2008, GULF WAR ILLN HLTH G; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Senapati AK, 2005, BRAIN RES, V1036, P173, DOI 10.1016/j.brainres.2004.12.043; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Steele L, 2012, ENVIRON HEALTH PERSP, V120, P112, DOI 10.1289/ehp.1003399; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tajima S, 2010, NEUROL RES INT, V2010, DOI 10.1155/2010/671421; Tang YY, 2012, P NATL ACAD SCI USA, V109, P10570, DOI 10.1073/pnas.1207817109; Tillman GD, 2012, NEUROTOXICOLOGY; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wallin MT, 2009, COGN BEHAV NEUROL, V22, P155, DOI 10.1097/WNN.0b013e3181b278e8; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wasserfallen JB, 1997, J ALLERGY CLIN IMMUN, V100, P16, DOI 10.1016/S0091-6749(97)70189-1; Weissman DH, 2012, NEUROIMAGE, V61, P798, DOI 10.1016/j.neuroimage.2012.03.032; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Wu M, 2008, LECT NOTES COMPUT SC, V5242, P321, DOI 10.1007/978-3-540-85990-1_39	75	119	119	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e58493	10.1371/journal.pone.0058493	http://dx.doi.org/10.1371/journal.pone.0058493			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23798990	Green Published, Green Submitted, gold			2022-12-25	WOS:000317562600025
J	Serra, FCO; Becher, V; Dopazo, H				Serra, Francois; Becher, Veronica; Dopazo, Hernan			Neutral Theory Predicts the Relative Abundance and Diversity of Genetic Elements in a Broad Array of Eukaryotic Genomes	PLOS ONE			English	Article								It is universally true in ecological communities, terrestrial or aquatic, temperate or tropical, that some species are very abundant, others are moderately common, and the majority are rare. Likewise, eukaryotic genomes also contain classes or "species'' of genetic elements that vary greatly in abundance: DNA transposons, retrotransposons, satellite sequences, simple repeats and their less abundant functional sequences such as RNA or genes. Are the patterns of relative species abundance and diversity similar among ecological communities and genomes? Previous dynamical models of genomic diversity have focused on the selective forces shaping the abundance and diversity of transposable elements (TEs). However, ideally, models of genome dynamics should consider not only TEs, but also the diversity of all genetic classes or ``species'' populating eukaryotic genomes. Here, in an analysis of the diversity and abundance of genetic elements in >500 eukaryotic chromosomes, we show that the patterns are consistent with a neutral hypothesis of genome assembly in virtually all chromosomes tested. The distributions of relative abundance of genetic elements are quite precisely predicted by the dynamics of an ecological model for which the principle of functional equivalence is the main assumption. We hypothesize that at large temporal scales an overarching neutral or nearly neutral process governs the evolution of abundance and diversity of genetic elements in eukaryotic genomes.	[Serra, Francois] Ctr Invest Principe Felipe, Evolutionary Genom Lab, Bioinformat & Genom Dept, Valencia, Spain; [Becher, Veronica] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Comp, Buenos Aires, Argentina; [Dopazo, Hernan] Banco Nacl Datos Genet, Inst Genom Humana, Buenos Aires, Argentina; [Dopazo, Hernan] Univ Buenos Aires, Dept Ecol Genet Evoluc, Fac Ciencias Exactas & Nat, Buenos Aires, Argentina; [Serra, Francois] Ctr Nacl Anal Genom CNAG, Struct Genom Team, Barcelona, Spain		Dopazo, H (corresponding author), Banco Nacl Datos Genet, Inst Genom Humana, Buenos Aires, Argentina.; Dopazo, H (corresponding author), Univ Buenos Aires, Dept Ecol Genet Evoluc, Fac Ciencias Exactas & Nat, Buenos Aires, Argentina.	hdopazo@bndg.gob.ar	Nunes, Carla/AAM-3056-2021; Serra, Francois Jose/A-8789-2011; Nunes, Carla/L-3456-2017; Serra, Diana/M-4062-2017	Nunes, Carla/0000-0002-7452-1592; Serra, Francois Jose/0000-0003-3895-4742; Nunes, Carla/0000-0002-7452-1592; Serra, Diana/0000-0002-5965-0281; Almeida, Leonor Martins/0000-0002-7769-4712; Becher, Veronica/0000-0002-5425-8563; Felix Paixao, Joana Isabel/0000-0002-2050-405X; Dinis, Teresa/0000-0001-6350-5741; Dopazo, Hernan/0000-0001-6125-2357	El Ministerio de Ciencia, Tecnologia e Innovacion Productiva-Ministerio de Ciencia e Innovacio' n (MINCy-TMICINN) [AR2009-0009]; MINCyT [BFU2009-13409-C02-01];  [BSC-2009]	El Ministerio de Ciencia, Tecnologia e Innovacion Productiva-Ministerio de Ciencia e Innovacio' n (MINCy-TMICINN); MINCyT; 	This work was supported by El Ministerio de Ciencia, Tecnologia e Innovacion Productiva-Ministerio de Ciencia e Innovacio ' n (MINCy-TMICINN)(AR2009-0009) to BV and HD, by MINCyT (BFU2009-13409-C02-01) to HD, and by BSC-2009 to HD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Bartolome C, 2002, MOL BIOL EVOL, V19, P926, DOI 10.1093/oxfordjournals.molbev.a004150; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blythe RA, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/07/P07018; Brookfield JFY, 2005, NAT REV GENET, V6, P128, DOI 10.1038/nrg1524; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Cavalier-Smith T, 2005, ANN BOT-LONDON, V95, P147, DOI 10.1093/aob/mci010; Etienne RS, 2007, ECOL LETT, V10, P608, DOI 10.1111/j.1461-0248.2007.01052.x; Etienne RS, 2006, SCIENCE, V311, p610B, DOI 10.1126/science.1121914; Etienne RS, 2005, ECOL LETT, V8, P253, DOI 10.1111/j.1461-0248.2004.00717.x; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Fousse L, 2007, ACM T MATH SOFTWARE, V33, DOI 10.1145/1236463.1236468; Granlund T., 2008, GNU MULTIPLE PRECISI; Hankin RKS, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i12; Hubbell Stephen P., 2001, V32, pi; Jabot F, 2008, OIKOS, V117, P1308, DOI 10.1111/j.0030-1299.2008.16724.x; Jabot F, 2011, AM NAT, V178, pE37, DOI 10.1086/660829; Jones E., 2001, SCIPY OPEN SOURCE SC; Kapitonov Vladimir V, 2008, Nat Rev Genet, V9, P411, DOI 10.1038/nrg2165-c1; Kimura MA, 1985, NEUTRAL THEORY MOL E; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Le Rouzic A, 2007, P NATL ACAD SCI USA, V104, P19375, DOI 10.1073/pnas.0705238104; Leonardo TE, 2002, GENET RES, V80, P155, DOI 10.1017/S0016672302009710; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Magurran A.E, 2004, MEASURING BIOL DIVER; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Ohta T, 2011, GENOME BIOL EVOL, V3, P1034, DOI 10.1093/gbe/evr012; Rizzon C, 2002, GENOME RES, V12, P400, DOI 10.1101/gr.210802; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rosindell J, 2011, TRENDS ECOL EVOL, V26, P340, DOI 10.1016/j.tree.2011.03.024; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Venner S, 2009, TRENDS GENET, V25, P317, DOI 10.1016/j.tig.2009.05.003; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; Wilks SS, 1938, ANN MATH STAT, V9, P60, DOI 10.1214/aoms/1177732360; Wright S, 1931, GENETICS, V16, P0097	39	82	86	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6					1	9	e63915	10.1371/journal.pone.0063915	http://dx.doi.org/10.1371/journal.pone.0063915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VL6AY	23798991	Green Published, gold, Green Submitted			2022-12-25	WOS:000891778000001
J	Haupt, VJ; Daminelli, S; Schroeder, M				Haupt, V. Joachim; Daminelli, Simone; Schroeder, Michael			Drug Promiscuity in PDB: Protein Binding Site Similarity Is Key	PLOS ONE			English	Article							MOLECULAR COMPLEXITY; DATABASE; PHARMACOLOGY; ALGORITHM; MECHANISM; BIOLOGY; UPDATE; ALIGN	Drug repositioning applies established drugs to new disease indications with increasing success. A pre-requisite for drug repurposing is drug promiscuity (polypharmacology) - a drug's ability to bind to several targets. There is a long standing debate on the reasons for drug promiscuity. Based on large compound screens, hydrophobicity and molecular weight have been suggested as key reasons. However, the results are sometimes contradictory and leave space for further analysis. Protein structures offer a structural dimension to explain promiscuity: Can a drug bind multiple targets because the drug is flexible or because the targets are structurally similar or even share similar binding sites? We present a systematic study of drug promiscuity based on structural data of PDB target proteins with a set of 164 promiscuous drugs. We show that there is no correlation between the degree of promiscuity and ligand properties such as hydrophobicity or molecular weight but a weak correlation to conformational flexibility. However, we do find a correlation between promiscuity and structural similarity as well as binding site similarity of protein targets. In particular, 71% of the drugs have at least two targets with similar binding sites. In order to overcome issues in detection of remotely similar binding sites, we employed a score for binding site similarity: LigandRMSD measures the similarity of the aligned ligands and uncovers remote local similarities in proteins. It can be applied to arbitrary structural binding site alignments. Three representative examples, namely the anticancer drug methotrexate, the natural product quercetin and the anti-diabetic drug acarbose are discussed in detail. Our findings suggest that global structural and binding site similarity play a more important role to explain the observed drug promiscuity in the PDB than physicochemical drug properties like hydrophobicity or molecular weight. Additionally, we find ligand flexibility to have a minor influence.	[Haupt, V. Joachim; Daminelli, Simone; Schroeder, Michael] Tech Univ Dresden, Biotechnol Ctr BIOTEC, Dresden, Germany	Technische Universitat Dresden	Schroeder, M (corresponding author), Tech Univ Dresden, Biotechnol Ctr BIOTEC, Dresden, Germany.	michael.schroeder@biotec.tu-dresden.de	Schroeder, Michael/A-3040-2010	Weller, Aron/0000-0002-0663-4384; Schroeder, Mariana/0000-0002-9517-4243	EU project "Ponte"; German Federal Ministry of Economics and Technology project "GeneCloud"	EU project "Ponte"; German Federal Ministry of Economics and Technology project "GeneCloud"	Funding by the EU project "Ponte" (http://www.ponte-project.eu) and the German Federal Ministry of Economics and Technology project "GeneCloud" (http://transinsight.com/genecloud) is kindly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzaoui K, 2007, CHEMMEDCHEM, V2, P874, DOI 10.1002/cmdc.200700036; Bakheet TM, 2009, BIOINFORMATICS, V25, P451, DOI 10.1093/bioinformatics/btp002; BELLO AR, 1994, P NATL ACAD SCI USA, V91, P11442, DOI 10.1073/pnas.91.24.11442; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boly R, 2011, INT J ONCOL, V38, P833, DOI 10.3892/ijo.2010.890; Bottegoni G, 2006, BIOINFORMATICS, V22, pE58, DOI 10.1093/bioinformatics/btl212; Brandt W, 2010, CURR TOP MED CHEM, V10, P1361, DOI 10.2174/156802610792232060; Daminelli S, 2012, INTEGR BIOL-UK, V4, P778, DOI 10.1039/c2ib00154c; Davis AP, 2011, NUCLEIC ACIDS RES, V39, pD1067, DOI 10.1093/nar/gkq813; Dudley JT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002648; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gleeson MP, 2011, NAT REV DRUG DISCOV, V10, P197, DOI 10.1038/nrd3367; Gold ND, 2006, J MOL BIOL, V355, P1112, DOI 10.1016/j.jmb.2005.11.044; Gunther S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-293; Guha R, 2006, J CHEM INF MODEL, V46, P991, DOI 10.1021/ci050400b; Hann MM, 2001, J CHEM INF COMP SCI, V41, P856, DOI 10.1021/ci000403i; Haupt VJ, 2011, BRIEF BIOINFORM, V12, P312, DOI 10.1093/bib/bbr011; Heinrich JC, 2011, J CANCER RES CLIN, V137, P1349, DOI 10.1007/s00432-011-1005-1; Hopkins AL, 2006, CURR OPIN STRUC BIOL, V16, P127, DOI 10.1016/j.sbi.2006.01.013; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Kalinina OV, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002043; Kellenberger E, 2006, J CHEM INF MODEL, V46, P717, DOI 10.1021/ci050372x; Kellenberger E, 2008, CURR COMPUT-AID DRUG, V4, P209, DOI 10.2174/157340908785747401; Kinnings SL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000976; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Konc J, 2012, J CHEM INF MODEL, V52, P604, DOI 10.1021/ci2005687; Kroeze W. K., 2012, POLYPHARMACOLOGY DRU, P133, DOI [10.1002/9781118098141.ch7, DOI 10.1002/9781118098141.CH7]; Leach AR, 2011, CURR OPIN CHEM BIOL, V15, P489, DOI 10.1016/j.cbpa.2011.05.008; Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445; Li QL, 2010, DRUG DISCOV TODAY, V15, P1052, DOI 10.1016/j.drudis.2010.10.003; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Liu TY, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002326; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; McGeary RP, 2008, MINI-REV MED CHEM, V8, P1384, DOI 10.2174/138955708786369573; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; Mencher Simon K, 2005, BMC Clin Pharmacol, V5, P3, DOI 10.1186/1472-6904-5-3; Mestres J, 2009, MOL BIOSYST, V5, P1051, DOI 10.1039/b905821b; Morphy R, 2007, DRUG DISCOV TODAY, V12, P156, DOI 10.1016/j.drudis.2006.12.006; Najmanovich R, 2008, BIOINFORMATICS, V24, pI105, DOI 10.1093/bioinformatics/btn263; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; O'Boyle NM, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-5; O'Connor KA, 2005, NAT REV DRUG DISCOV, V4, P1005, DOI 10.1038/nrd1900; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Painter J, 2004, J APPL CRYSTALLOGR, V37, P174, DOI 10.1107/S0021889803025639; Peters JU, 2009, CHEMMEDCHEM, V4, P680, DOI 10.1002/cmdc.200800411; Pujol A, 2010, TRENDS PHARMACOL SCI, V31, P115, DOI 10.1016/j.tips.2009.11.006; Rahman SA, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-12; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sanseau P, 2012, NAT BIOTECHNOL, V30, P317, DOI 10.1038/nbt.2151; Schalon C, 2008, PROTEINS, V71, P1755, DOI 10.1002/prot.21858; van Dijk ADJ, 2005, FEBS J, V272, P293, DOI 10.1111/j.1742-4658.2004.04473.x; Xie L, 2007, PLOS COMPUT BIOL, V3, P2324, DOI 10.1371/journal.pcbi.0030217; Xie L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S9; Xie L, 2008, P NATL ACAD SCI USA, V105, P5441, DOI 10.1073/pnas.0704422105; Xie L, 2012, ANNU REV PHARMACOL, V52, P361, DOI 10.1146/annurev-pharmtox-010611-134630; Xie L, 2009, BIOINFORMATICS, V25, pI305, DOI 10.1093/bioinformatics/btp220; Xie L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002037; Xie L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000387; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhou X, 2008, BIOPHYS J, V95, P3366, DOI 10.1529/biophysj.107.117747; Zhu F, 2010, NUCLEIC ACIDS RES, V38, pD787, DOI 10.1093/nar/gkp1014; [No title captured]	64	109	109	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e65894	10.1371/journal.pone.0065894	http://dx.doi.org/10.1371/journal.pone.0065894			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805191	Green Published, Green Submitted, gold			2022-12-25	WOS:000320846500019
J	Wang, MH; Li, JX; Lim, GE; Johnson, JD				Wang, Minghu; Li, Jiaxu; Lim, Gareth E.; Johnson, James D.			Is Dynamic Autocrine Insulin Signaling Possible? A Mathematical Model Predicts Picomolar Concentrations of Extracellular Monomeric Insulin within Human Pancreatic Islets	PLOS ONE			English	Article							BETA-CELL MASS; INJECTED SOLUBLE INSULIN; SUBCUTANEOUS INJECTION; PHARMACOKINETIC MODEL; ENDOGENOUS INSULIN; GLUCOSE; RECEPTOR; SECRETION; APOPTOSIS; ANALOGS	Insulin signaling is essential for beta-cell survival and proliferation in vivo. Insulin also has potent mitogenic and anti-apoptotic actions on cultured beta-cells, with maximum effect in the high picomolar range and diminishing effect at high nanomolar doses. In order to understand whether these effects of insulin are constitutive or can be subjected to physiological modulation, it is essential to estimate the extracellular concentration of monomeric insulin within an intact islet. Unfortunately, the in vivo concentration of insulin monomers within the islet cannot be measured directly with current technology. Here, we present the first mathematical model designed to estimate the levels of monomeric insulin within the islet extracellular space. Insulin is released as insoluble crystals that exhibit a delayed dissociation into hexamers, dimers, and eventually monomers, which only then can act as signaling ligands. The rates at which different forms of insulin dissolve in vivo have been estimated from studies of peripheral insulin injection sites. We used this and other information to formulate a mathematical model to estimate the local insulin concentration within a single islet as a function of glucose. Model parameters were estimated from existing literature. Components of the model were validated using experimental data, if available. Model analysis predicted that the majority of monomeric insulin in the islet is that which has been returned from the periphery, and the concentration of intra-islet monomeric insulin varies from similar to 50-300 pM when glucose is in the physiological range. Thus, our results suggest that the local concentration of monomeric insulin within the islet is in the picomolar 'sweet spot' range of insulin doses that activate the insulin receptor and have the most potent effects on beta-cells in vitro. Together with experimental data, these estimations support the concept that autocrine/ paracrine insulin signalling within the islet is dynamic, rather than constitutive and saturated.	[Wang, Minghu; Li, Jiaxu] Univ Louisville, Dept Math, Louisville, KY 40292 USA; [Lim, Gareth E.; Johnson, James D.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Lim, Gareth E.; Johnson, James D.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada	University of Louisville; University of British Columbia; University of British Columbia	Li, JX (corresponding author), Univ Louisville, Dept Math, Louisville, KY 40292 USA.	jiaxu.li@louisville.edu; jimjohn@mail.ubc.ca	Tan, Jiafu/A-9980-2016; Yuan, Daojun/R-6048-2016; Tan, Jiafu/J-2422-2013; Yuan, Daojun/D-5555-2011; Wang, Maojun/M-2587-2019; Li, Jiaxu/AAE-7065-2021; Lim, Gareth/G-9143-2017	Yuan, Daojun/0000-0001-6007-5571; Tan, Jiafu/0000-0002-6498-7495; Wang, Maojun/0000-0002-4791-3742; Lim, Gareth/0000-0003-3850-3757; Cheng, Xiaoqian/0000-0002-2544-4260	DOE (Department of Energy's) [DE-EM000197]; National Institutes of Health/National Institute of Dental and Craniofacial Research grant [R01-DE019243]; National Institutes of Health/National Institute of Environmental Health Sciences [P30-ES014443]; Canadian Institutes for Health Research; Juvenile Diabetes Research Foundation; Michael Smith Foundation for Health Research; Canadian Diabetes Association; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES014443] Funding Source: NIH RePORTER	DOE (Department of Energy's); National Institutes of Health/National Institute of Dental and Craniofacial Research grant; National Institutes of Health/National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Diabetes Association; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Minghu Wang and Jiaxu Li were supported in part by DOE (Department of Energy's) grant DE-EM000197. Jiaxu Li is also supported by National Institutes of Health/National Institute of Dental and Craniofacial Research grant R01-DE019243, and National Institutes of Health/National Institute of Environmental Health Sciences grant P30-ES014443. James D. Johnson and Gareth E. Lim were supported by the Canadian Institutes for Health Research, the Juvenile Diabetes Research Foundation, the Michael Smith Foundation for Health Research, and the Canadian Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandro EU, 2008, J BIOL CHEM, V283, P2407, DOI 10.1074/jbc.M703612200; Alejandro EU, 2010, ENDOCRINOLOGY, V151, P502, DOI 10.1210/en.2009-0678; Beith JL, 2008, ENDOCRINOLOGY, V149, P2251, DOI 10.1210/en.2007-1557; Bouche C, 2010, P NATL ACAD SCI USA, V107, P4770, DOI 10.1073/pnas.1000002107; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; CARROLL RJ, 1988, P NATL ACAD SCI USA, V85, P8943, DOI 10.1073/pnas.85.23.8943; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; Engelborghs K, 2001, J MATH BIOL, V42, P361, DOI 10.1007/s002850000072; Evert M, 2004, CANCER RES, V64, P8093, DOI 10.1158/0008-5472.CAN-04-2040; Fisher WE, 1996, J SURG RES, V63, P310, DOI 10.1006/jsre.1996.0266; Gullo L, 1999, ANN ONCOL, V10, P79, DOI 10.1023/A:1008349122106; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; HORUK R, 1979, NATURE, V279, P439, DOI 10.1038/279439a0; HORUK R, 1980, NATURE, V286, P822, DOI 10.1038/286822a0; IshShalom D, 1997, DIABETOLOGIA, V40, pS25, DOI 10.1007/s001250051393; Johnson JD, 2008, CELL CYCLE, V7, P1343, DOI 10.4161/cc.7.10.5865; Johnson JD, 2006, DIABETES, V55, P2737, DOI 10.2337/db05-1455; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799; Jones CNO, 1997, J CLIN ENDOCR METAB, V82, P1834, DOI 10.1210/jc.82.6.1834; Kulkarni RN, 2005, REV ENDOCR METAB DIS, V6, P199, DOI 10.1007/s11154-005-3051-y; Kulkarni RN, 2002, NAT GENET, V31, P111, DOI 10.1038/ng872; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; Li JX, 2006, J THEOR BIOL, V242, P722, DOI 10.1016/j.jtbi.2006.04.002; Li JX, 2012, MATH BIOSCI, V235, P128, DOI 10.1016/j.mbs.2011.11.005; Li JX, 2009, DISCRETE CONT DYN-B, V12, P401, DOI 10.3934/dcdsb.2009.12.401; Li J, 2009, MATH BIOSCI ENG, V6, P41, DOI 10.3934/mbe.2009.6.41; Li XQ, 2006, DIABETES, V55, P2965, DOI 10.2337/db06-0733; Lim GE, 2013, DIABETOLOGIA; Luciani DS, 2005, MOL CELL ENDOCRINOL, V241, P88, DOI 10.1016/j.mce.2005.06.006; MATTHEWS DR, 1985, CLIN ENDOCRINOL, V23, P71, DOI 10.1111/j.1365-2265.1985.tb00185.x; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Michael DJ, 2006, DIABETES, V55, P600, DOI 10.2337/diabetes.55.03.06.db05-1054; MILES KA, 1995, BRIT J RADIOL, V68, P471, DOI 10.1259/0007-1285-68-809-471; MISLER S, 1992, DIABETES, V41, P1221, DOI 10.2337/diabetes.41.10.1221; MOSEKILDE E, 1989, J PHARMACOKINET BIOP, V17, P67, DOI 10.1007/BF01059088; Nyman LR, 2008, J CLIN INVEST; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Palumbo P, 2007, DISCRETE CONT DYN-B, V7, P399; Panunzi S, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-35; Pisania A, 2010, LAB INVEST, V90, P1661, DOI 10.1038/labinvest.2010.124; POLONSKY KS, 1988, J CLIN INVEST, V81, P435, DOI 10.1172/JCI113338; Saisho Y, 2007, CLIN ANAT, V20, P933, DOI 10.1002/ca.20543; Smith H.L., 1995, MATH SURVEYS MONOGR; Soeborg T, 2009, EUR J PHARM SCI, V36, P78, DOI 10.1016/j.ejps.2008.10.018; Song SH, 2000, J CLIN ENDOCR METAB, V85, P4491, DOI 10.1210/jc.85.12.4491; STURIS J, 1991, AM J PHYSIOL, V260, pE801, DOI 10.1152/ajpendo.1991.260.5.E801; Tarin C, 2005, IEEE T BIO-MED ENG, V52, P1994, DOI 10.1109/TBME.2005.857681; TRAJANOSKI Z, 1993, BIOMED TECH, V38, P224, DOI 10.1515/bmte.1993.38.9.224; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; Ueki K, 2003, DIABETES, V52, pA42; Whittaker L, 2008, BIOCHEMISTRY-US, V47, P12900, DOI 10.1021/bi801693h	58	388	397	6	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e64860	10.1371/journal.pone.0064860	http://dx.doi.org/10.1371/journal.pone.0064860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23798995	Green Published, Green Submitted, gold			2022-12-25	WOS:000320363300004
J	Yu, HC; Hou, DR; Liu, CY; Lin, CS; Shiau, CW; Cheng, AL; Chen, KF				Yu, Hui-Chuan; Hou, Duen-Ren; Liu, Chun-Yu; Lin, Chen-Si; Shiau, Chung-Wai; Cheng, Ann-Lii; Chen, Kuen-Feng			Cancerous Inhibitor of Protein Phosphatase 2A Mediates Bortezomib-Induced Autophagy in Hepatocellular Carcinoma Independent of Proteasome	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TUMOR-SUPPRESSOR; CIP2A EXPRESSION; CELL-SURVIVAL; PP2A; UBIQUITIN; AKT; APOPTOSIS; PHOSPHORYLATION	Previously, we reported that cancerous inhibitor of protein phosphatase 2A (CIP2A) mediates the apoptotic effect of bortezomib in hepatocellular carcinoma (HCC). Here, we report a proteasome-independent mechanism by which bortezomib induces autophagy in HCC. Our data indicate that bortezomib activated autophagy in a dose-and time-dependent manner in HCC cell lines including Huh-7, Sk-Hep1, and Hep3B. Bortezomib downregulated CIP2A, phospho-Akt (P-Akt) and phospho-4EBP1 (P-4EBP1) in a dose-and time-dependent manner in all tested HCC cells. Ectopic expression of CIP2A abolished the effect of bortezomib on autophagy. Co-treatment of bortezomib and calyculin A, a PP2A inhibitor, reduced the effect of bortezomib on P-Akt, P-4EBP1, and autophagy. Increased phosphorylation of either Akt or 4EBP1 by ectopic overexpression protected cells from bortezomib-induced autophagy. Furthermore, we examined the effect of Delta Btz, a bortezomib derivative that closely resembles bortezomib structurally but has no proteasome activity, in HCC. Interestingly, Delta Btz demonstrated similar effects to bortezomib on autophagy, CIP2A, P-Akt and P-4EBP1, suggesting that the effect of bortezomib on autophagy is independent of proteasome inhibition. Moreover, our in vivo data showed that both bortezomib and Delta Btz inhibited tumor growth, downregulated CIP2A, P-Akt and induced autophagy in Huh-7 tumors. In conclusion, bortezomib induces autophagy in HCC through a CIP2A-PP2A-Akt-4EBP1 pathway.	[Yu, Hui-Chuan; Chen, Kuen-Feng] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Yu, Hui-Chuan; Cheng, Ann-Lii; Chen, Kuen-Feng] Natl Taiwan Univ Hosp, Natl Ctr Excellence Clin Trial & Res, Taipei, Taiwan; [Lin, Chen-Si; Chen, Kuen-Feng] Natl Taiwan Univ, Sch Vet Med, Taipei 10764, Taiwan; [Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Hou, Duen-Ren] Natl Cent Univ, Dept Chem, Tao Yuan, Taiwan; [Liu, Chun-Yu] Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei, Taiwan; [Shiau, Chung-Wai] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Central University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chen, KF (corresponding author), Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan.	kfchen1970@ntu.edu.tw	Lin, Chen-Si/AAD-3733-2019	Lin, Chen-Si/0000-0003-2254-8344; Chen, Kuen-Feng/0000-0002-4686-7019; HOU, Duen-Ren/0000-0003-1072-2915; Yu, Hongbo/0000-0002-3384-7772; Liu, Jinting/0000-0003-2136-8560; Cheng, Ann-Lii/0000-0002-9152-6512; Suiyi, Zhu/0000-0002-9784-2698	National Taiwan University Hospital [NTUH 101P01]; National Science Council, Taiwan [NSC99-2314-B-002-017-MY2, NSC100-2325-B- 002-036]	National Taiwan University Hospital(National Taiwan University); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study is supported by grants, NTUH 101P01 (KFC) from National Taiwan University Hospital; NSC99-2314-B-002-017-MY2 (KFC), and NSC100-2325-B- 002-036 (KFC) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2002, ONCOLOGIST, V7, P9, DOI 10.1634/theoncologist.7-1-9; Adams J, 1998, BIOORG MED CHEM LETT, V8, P333, DOI 10.1016/S0960-894X(98)00029-8; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Balakumaran BS, 2009, CANCER RES, V69, P7803, DOI 10.1158/0008-5472.CAN-09-0910; Bielinski VA, 2007, EXP CELL RES, V313, P3117, DOI 10.1016/j.yexcr.2007.05.008; Chen KF, 2010, ONCOGENE, V29, P6257, DOI 10.1038/onc.2010.357; Chen KF, 2008, CANCER RES, V68, P6698, DOI 10.1158/0008-5472.CAN-08-0257; Chen KF, 2009, J BIOL CHEM, V284, P11121, DOI 10.1074/jbc.M806268200; Come C, 2009, CLIN CANCER RES, V15, P5092, DOI 10.1158/1078-0432.CCR-08-3283; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Dong QZ, 2011, ANN SURG ONCOL, V18, P857, DOI 10.1245/s10434-010-1313-8; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Eskelinen EL, 2005, CELL DEATH DIFFER, V12, P1468, DOI 10.1038/sj.cdd.4401721; Fels DR, 2008, CANCER RES, V68, P9323, DOI 10.1158/0008-5472.CAN-08-2873; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Katz J, 2010, CANCER BIOL THER, V10, P694, DOI 10.4161/cbt.10.7.12895; Khanna A, 2009, JNCI-J NATL CANCER I, V101, P793, DOI 10.1093/jnci/djp103; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Korolchuk VI, 2009, AUTOPHAGY, V5, P862, DOI 10.4161/auto.8840; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Li CY, 2012, CANCER LETT, V314, P102, DOI 10.1016/j.canlet.2011.09.020; Li YK, 2010, NEOPLASIA, V12, P848, DOI 10.1593/neo.10704; Ling YH, 2002, MOL CANCER THER, V1, P841; Maiuri MC, 2009, CELL DEATH DIFFER, V16, P87, DOI 10.1038/cdd.2008.131; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Morselli E, 2009, BBA-MOL CELL RES, V1793, P1524, DOI 10.1016/j.bbamcr.2009.01.006; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Perrotti D, 2008, CANCER METAST REV, V27, P159, DOI 10.1007/s10555-008-9119-x; Qu W, 2010, MED ONCOL; Richardson Paul G, 2003, Cancer Control, V10, P361; Rosenfeldt MT, 2011, CARCINOGENESIS, V32, P955, DOI 10.1093/carcin/bgr031; Roy S, 2010, SEMIN IMMUNOPATHOL, V32, P383, DOI 10.1007/s00281-010-0213-0; Schmitz KJ, 2008, J HEPATOL, V48, P83, DOI 10.1016/j.jhep.2007.08.018; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; Vaarala MH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-136; Van Hoof C, 2003, BBA-MOL CELL RES, V1640, P97, DOI 10.1016/S0167-4889(03)00029-6; Verslype C, 2009, ANN ONCOL, V20, P1, DOI 10.1093/annonc/mdp281; Voorhees PM, 2006, ANNU REV PHARMACOL, V46, P189, DOI 10.1146/annurev.pharmtox.46.120604.141300; Wang J, 2011, INT J LAB HEMATOL, V33, P290, DOI 10.1111/j.1751-553X.2010.01288.x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhu Keyi, 2009, Proceedings of the American Association for Cancer Research Annual Meeting, V50, P451, DOI 10.1038/onc.2009.343	50	88	89	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55705	10.1371/journal.pone.0055705	http://dx.doi.org/10.1371/journal.pone.0055705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23799106	Green Submitted, gold, Green Published			2022-12-25	WOS:000314597900052
J	Wang, MJ; Yuan, DJ; Gao, WH; Li, Y; Tan, JF; Zhang, XL				Wang, Maojun; Yuan, Daojun; Gao, Wenhui; Li, Yang; Tan, Jiafu; Zhang, Xianlong			A Comparative Genome Analysis of PME and PMEI Families Reveals the Evolution of Pectin Metabolism in Plant Cell Walls	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; METHYLESTERASE; GENE; SEQUENCE; DUPLICATION; POLYPLOIDY; INHIBITORS; KNOWLEDGE; DISPLAY	Pectins are fundamental polysaccharides in the plant primary cell wall. Pectins are synthesized and secreted to cell walls as highly methyl-esterified polymers and then demethyl-esterified by pectin methylesterases (PMEs), which are spatially regulated by pectin methylesterase inhibitors (PMEIs). Although PME and PMEI genes are pivotal in plant cell wall formation, few studies have focused on the evolutionary patterns of the PME and PMEI gene families. In this study, the gene origin, evolution, and expression diversity of these two families were systematically analyzed using 11 representative species, including algae, bryophytes, lycophytes and flowering land plants. The results show that 1) for the two subfamilies (PME and proPME) of PME, the origin of the PME subfamily is consistent with the appearance of pectins in early charophyte cell walls, 2) Whole genome duplication (WGD) and tandem duplication contribute to the expansion of proPME and PMEI families in land plants, 3) Evidence of selection pressure shows that the proPME and PMEI families have rapidly evolved, particularly the PMEI family in vascular plants, and 4) Comparative expression profile analysis of the two families indicates that the eudicot Arabidopsis and monocot rice have different expression patterns. In addition, the gene structure and sequence analyses show that the origin of the PMEI domain may be derived from the neofunctionalization of the pro domain after WGD. This study will advance the evolutionary understanding of the PME and PMEI families and plant cell wall development.	[Wang, Maojun; Yuan, Daojun; Gao, Wenhui; Li, Yang; Tan, Jiafu; Zhang, Xianlong] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	Yuan, DJ (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.	robert@mail.hzau.edu.cn; xlzhang@mail.hzau.edu.cn	Tan, Jiafu/A-9980-2016; Yuan, Daojun/R-6048-2016; Tan, Jiafu/J-2422-2013; Yuan, Daojun/D-5555-2011; Wang, Maojun/M-2587-2019; Li, Jiaxu/AAE-7065-2021; Lim, Gareth/G-9143-2017	Yuan, Daojun/0000-0001-6007-5571; Tan, Jiafu/0000-0002-6498-7495; Wang, Maojun/0000-0002-4791-3742; Lim, Gareth/0000-0003-3850-3757; Cheng, Xiaoqian/0000-0002-2544-4260	National Natural Science Foundation of China [31230056]; National Basic Research Program [2010CB126001]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES014443] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was financially supported by the National Natural Science Foundation of China (NO. 31230056) and National Basic Research Program (2010CB126001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrouk M, 2010, TRENDS PLANT SCI, V15, P479, DOI 10.1016/j.tplants.2010.06.001; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bosch M, 2005, PLANT PHYSIOL, V138, P1334, DOI 10.1104/pp.105.059865; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cao Jun, 2012, PLoS One, V7, pe46944, DOI 10.1371/journal.pone.0046944; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; de Freitas ST, 2012, PLANT J, V71, P824, DOI 10.1111/j.1365-313X.2012.05034.x; Di Matteo A, 2005, PLANT CELL, V17, P849, DOI 10.1105/tpc.104.028886; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fangel JU, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00152; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finet C, 2013, MOL BIOL EVOL, V30, P45, DOI 10.1093/molbev/mss220; Fry SC, 2004, NEW PHYTOL, V161, P641, DOI 10.1111/j.1469-8137.2004.00980.x; Giovane A, 2004, BBA-PROTEINS PROTEOM, V1696, P245, DOI 10.1016/j.bbapap.2003.08.011; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Harholt J, 2010, PLANT PHYSIOL, V153, P384, DOI 10.1104/pp.110.156588; Hongo S, 2012, PLANT CELL, V24, P2624, DOI 10.1105/tpc.112.099325; Jetz W, 2012, TRENDS ECOL EVOL, V27, P151, DOI 10.1016/j.tree.2011.09.007; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Jolie RP, 2010, CARBOHYD RES, V345, P2583, DOI 10.1016/j.carres.2010.10.002; Juge N, 2006, TRENDS PLANT SCI, V11, P359, DOI 10.1016/j.tplants.2006.05.006; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Keegstra K, 2010, PLANT PHYSIOL, V154, P483, DOI 10.1104/pp.110.161240; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Li C, 2012, MOL BIOL EVOL, V29, P3227, DOI 10.1093/molbev/mss131; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li Y, 2002, PLANT PHYSIOL, V128, P854, DOI 10.1104/pp.010658; Lionetti V, 2007, PLANT PHYSIOL, V143, P1871, DOI 10.1104/pp.106.090803; Markovic O, 2004, CARBOHYD RES, V339, P2281, DOI 10.1016/j.carres.2004.06.023; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Peaucelle A, 2011, CURR BIOL, V21, P1720, DOI 10.1016/j.cub.2011.08.057; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; Prochnik SE, 2010, SCIENCE, V329, P223, DOI 10.1126/science.1188800; Ruzicka DR, 2007, PLANT J, V52, P460, DOI 10.1111/j.1365-313X.2007.03257.x; Sarkar P, 2009, J EXP BOT, V60, P3615, DOI 10.1093/jxb/erp245; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Sorensen I, 2011, PLANT J, V68, P201, DOI 10.1111/j.1365-313X.2011.04686.x; Sterling JD, 2001, PLANT PHYSIOL, V127, P360, DOI 10.1104/pp.127.1.360; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang HB, 2010, P NATL ACAD SCI USA, V107, P472, DOI 10.1073/pnas.0908007107; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Timme RE, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-96; Wang CM, 2012, PLANT PHYSIOL, V158, P1523, DOI 10.1104/pp.111.192203; Wang LQ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-282; Wang YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028150; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wolf S, 2009, MOL PLANT, V2, P851, DOI 10.1093/mp/ssp066; Wolf S, 2009, PLANT J, V58, P361, DOI 10.1111/j.1365-313X.2009.03784.x; Yadav S, 2009, PROCESS BIOCHEM, V44, P1, DOI 10.1016/j.procbio.2008.09.012; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhu ZL, 2009, PLANT PHYSIOL, V151, P1943, DOI 10.1104/pp.109.142984; Zimmer A, 2007, MOL GENET GENOMICS, V278, P393, DOI 10.1007/s00438-007-0257-6; Zuccolo A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r48	66	388	397	6	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72082	10.1371/journal.pone.0072082	http://dx.doi.org/10.1371/journal.pone.0072082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23798995	Green Published, gold, Green Submitted			2022-12-25	WOS:000323097300177
J	Lin, CW; Chen, PN; Chen, MK; Yang, WE; Tang, CH; Yang, SF; Hsieh, YS				Lin, Chiao-Wen; Chen, Pei-Ni; Chen, Mu-Kuan; Yang, Wei-En; Tang, Chih-Hsin; Yang, Shun-Fa; Hsieh, Yih-Shou			Kaempferol Reduces Matrix Metalloproteinase-2 Expression by Down-Regulating ERK1/2 and the Activator Protein-1 Signaling Pathways in Oral Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; PROGNOSTIC-SIGNIFICANCE; COLORECTAL-CANCER; TISSUE INHIBITOR; INVASION; FLAVONOIDS; CARCINOMA; MIGRATION; INACTIVATION; INFLAMMATION	Background: Kaempferol has been proposed as a potential drug for cancer chemoprevention and treatment because it is a natural polyphenol contained in plant-based foods. Recent studies have demonstrated that kaempferol protects against cardiovascular disease and cancer. Based on this finding, we investigated the mechanisms by which kaempferol produces the anti-metastatic effect in human tongue squamous cell carcinoma SCC4 cells. Methodology/Principal Findings: In this study, we provided molecular evidence associated with the anti-metastatic effect of kaempferol by demonstrating a substantial suppression of SCC4 cell migration and invasion. This effect was associated with reduced expressions of MMP-2 and TIMP-2 mRNA and protein levels. Analysis of the transcriptional regulation indicated that kaempferol inhibited MMP-2 transcription by suppressing c-Jun activity. Kaempferol also produced an inhibitory effect on the phosphorylation of ERK1/2. Conclusions: These findings provide new insights into the molecular mechanisms involved in the anti-metastatic effect of kaempferol, and are valuable in the prevention of oral cancer metastasis.	[Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan; [Chen, Pei-Ni; Hsieh, Yih-Shou] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Chen, Pei-Ni; Hsieh, Yih-Shou] Chung Shan Med Univ Hosp, Dept Clin Lab, Taichung, Taiwan; [Chen, Mu-Kuan] Changhua Christian Hosp, Dept Otorhinolaryngol Head & Neck Surg, Changhua, Taiwan; [Yang, Wei-En; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Tang, Chih-Hsin] Asia Univ, Coll Hlth Sci, Dept Biotechnol, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Changhua Christian Hospital; Chung Shan Medical University; China Medical University Taiwan; Asia University Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital	Yang, SF (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	ysf@csmu.edu.tw; csmcysh@csmu.edu.tw	Zou, Quan/A-7801-2015; Tang, Chih Hsin/O-5212-2015; Yang, Shun-Fa/AAN-1519-2020	Tang, Chih Hsin/0000-0002-7113-8352; Yang, Shun-Fa/0000-0002-0365-7927; Tsai, Kelvin/0000-0002-1612-2868	National Science Council, Taiwan [NSC-100-2632-B-040-001-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was financially supported by grants from National Science Council, Taiwan (NSC-100-2632-B-040-001-MY3). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker EA, 2006, BRIT J ORAL MAX SURG, V44, P482, DOI 10.1016/j.bjoms.2005.10.005; Bestwick CS, 2005, BBA-MOL BASIS DIS, V1740, P340, DOI 10.1016/j.bbadis.2004.10.005; Bosetti C, 2005, CANCER EPIDEM BIOMAR, V14, P805, DOI 10.1158/1055-9965.EPI-04-0838; Bosetti C, 2006, NUTR CANCER, V56, P123, DOI 10.1207/s15327914nc5602_1; Bourboulia D, 2013, ONCOTARGET, V4, P166; Calderon-Montano JM, 2011, MINI-REV MED CHEM, V11, P298, DOI 10.2174/138955711795305335; Chen HJ, 2013, ONCOL REP, V30, P925, DOI 10.3892/or.2013.2490; Chen PN, 2006, J DENT RES, V85, P220, DOI 10.1177/154405910608500303; Chen PN, 2005, CHEM-BIOL INTERACT, V156, P141, DOI 10.1016/j.cbi.2005.08.005; Chen YJ, 2008, CANCER SCI, V99, P1507, DOI 10.1111/j.1349-7006.2008.00863.x; Chien MH, 2012, FOOD CHEM TOXICOL, V50, P558, DOI 10.1016/j.fct.2011.12.016; Cortes JR, 2007, J IMMUNOL, V179, P3881, DOI 10.4049/jimmunol.179.6.3881; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Vicente JC, 2005, ORAL ONCOL, V41, P568, DOI 10.1016/j.oraloncology.2004.12.008; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Douglas DA, 1997, J PROTEIN CHEM, V16, P237, DOI 10.1023/A:1026348808069; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Fuhrman B, 2001, CURR OPIN LIPIDOL, V12, P41, DOI 10.1097/00041433-200102000-00008; Gohji K, 1996, CANCER RES, V56, P3196; Hong IK, 2005, EXP MOL MED, V37, P230, DOI 10.1038/emm.2005.31; Hong S, 2005, J BIOL CHEM, V280, P25202, DOI 10.1074/jbc.M413985200; Hsieh YS, 2007, CARCINOGENESIS, V28, P977, DOI 10.1093/carcin/bgl221; Huang WW, 2013, INT J ONCOL, V42, P2069, DOI 10.3892/ijo.2013.1909; Huang YB, 2013, INT J UROL; Iype E M, 2001, J Postgrad Med, V47, P171; Jeong JC, 2009, NEUROCHEM RES, V34, P991, DOI 10.1007/s11064-008-9868-5; Kang JW, 2010, PHYTOTHER RES, V24, pS77, DOI 10.1002/ptr.2913; Kawabata K, 2005, BIOSCI BIOTECH BIOCH, V69, P307, DOI 10.1271/bbb.69.307; Labbe D, 2009, J NUTR, V139, P646, DOI 10.3945/jn.108.102616; Leifler KS, 2013, J IMMUNOL, V190, P4420, DOI 10.4049/jimmunol.1202610; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Luo HT, 2009, NUTR CANCER, V61, P554, DOI 10.1080/01635580802666281; Ma CY, 2011, J AGR FOOD CHEM, V59, P9032, DOI 10.1021/jf202027n; Marfe G, 2009, J CELL BIOCHEM, V106, P643, DOI 10.1002/jcb.22044; Massano J, 2006, ORAL SURG ORAL MED O, V102, P67, DOI 10.1016/j.tripleo.2005.07.038; Mink PJ, 2007, AM J CLIN NUTR, V85, P895, DOI 10.1093/ajcn/85.3.895; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; Peng CY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/732578; Rossi M, 2006, CANCER EPIDEM BIOMAR, V15, P1555, DOI 10.1158/1055-9965.EPI-06-0017; Shan B, 2013, ASIAN PAC J TROP MED, V6, P826, DOI 10.1016/S1995-7645(13)60146-7; Sun CY, 2006, ACTA PHARMACOL SIN, V27, P1447, DOI 10.1111/j.1745-7254.2006.00343.x; Valente P, 1998, INT J CANCER, V75, P246, DOI 10.1002/(SICI)1097-0215(19980119)75:2<246::AID-IJC13>3.0.CO;2-B; Wang XX, 2013, TUMOUR BIOL; Weng CJ, 2008, CARCINOGENESIS, V29, P147, DOI 10.1093/carcin/bgm261; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Xiao HB, 2009, EUR J PHARMACOL, V616, P213, DOI 10.1016/j.ejphar.2009.06.022; Yang JS, 2013, FOOD CHEM TOXICOL, V59, P801, DOI 10.1016/j.fct.2013.06.028; Yang SF, 2010, FOOD CHEM TOXICOL, V48, P1052, DOI 10.1016/j.fct.2010.01.019; Yu YL, 2010, J AGR FOOD CHEM, V58, P1630, DOI 10.1021/jf903043r; Zhao MJ, 2013, INT J MED SCI, V10, P995, DOI 10.7150/ijms.5963	50	410	418	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80883	10.1371/journal.pone.0080883	http://dx.doi.org/10.1371/journal.pone.0080883			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278338	Green Published, Green Submitted, gold			2022-12-25	WOS:000327313100123
J	Lin, C; Zou, Y; Qin, J; Liu, XR; Jiang, Y; Ke, CH; Zou, Q				Lin, Chen; Zou, Ying; Qin, Ji; Liu, Xiangrong; Jiang, Yi; Ke, Caihuan; Zou, Quan			Hierarchical Classification of Protein Folds Using a Novel Ensemble Classifier	PLOS ONE			English	Article							REPRESENTATIVE SET; SCOP; RECOGNITION; SELECTION; DATABASE; IMPACT	The analysis of biological information from protein sequences is important for the study of cellular functions and interactions, and protein fold recognition plays a key role in the prediction of protein structures. Unfortunately, the prediction of protein fold patterns is challenging due to the existence of compound protein structures. Here, we processed the latest release of the Structural Classification of Proteins (SCOP, version 1.75) database and exploited novel techniques to impressively increase the accuracy of protein fold classification. The techniques proposed in this paper include ensemble classifying and a hierarchical framework, in the first layer of which similar or redundant sequences were deleted in two manners; a set of base classifiers, fused by various selection strategies, divides the input into seven classes; in the second layer of which, an analogous ensemble method is adopted to predict all protein folds. To our knowledge, it is the first time all protein folds can be intelligently detected hierarchically. Compared with prior studies, our experimental results demonstrated the efficiency and effectiveness of our proposed method, which achieved a success rate of 74.21%, which is much higher than results obtained with previous methods (ranging from 45.6% to 70.5%). When applied to the second layer of classification, the prediction accuracy was in the range between 23.13% and 46.05%. This value, which may not be remarkably high, is scientifically admirable and encouraging as compared to the relatively low counts of proteins from most fold recognition programs. The web server Hierarchical Protein Fold Prediction (HPFP) is available at http://datamining.xmu.edu.cn/software/hpfp.	[Lin, Chen; Zou, Ying; Liu, Xiangrong; Jiang, Yi; Zou, Quan] Xiamen Univ, Sch Informat Sci & Technol, Xiamen, Peoples R China; [Qin, Ji; Ke, Caihuan] Xiamen Univ, Coll Oceanog & Environm Sci, Xiamen, Peoples R China; [Lin, Chen; Liu, Xiangrong] Xiamen Univ, Shenzhen Res Inst, Shenzhen, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Lin, C (corresponding author), Xiamen Univ, Sch Informat Sci & Technol, Xiamen, Peoples R China.	chenlin@xmu.edu.cn; zouquan@xmu.edu.cn	Zou, Quan/A-7801-2015; Tang, Chih Hsin/O-5212-2015; Yang, Shun-Fa/AAN-1519-2020	Tang, Chih Hsin/0000-0002-7113-8352; Yang, Shun-Fa/0000-0002-0365-7927; Tsai, Kelvin/0000-0002-1612-2868	Natural Science Foundation of China [61001013, 61102136]; Natural Science Foundation of Fujian Province of China [2011J05158, 2010J01350]; National Basic Research Program of China [2010CB1264000]; Base Research Project of Shenzhen Bureau of Science, Technology and Information [JC201006030858A, JCYJ20120618155655087]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); National Basic Research Program of China(National Basic Research Program of China); Base Research Project of Shenzhen Bureau of Science, Technology and Information	The work was supported by the Natural Science Foundation of China (No. 61001013, No. 61102136), Natural Science Foundation of Fujian Province of China (No. 2011J05158, No. 2010J01350), The National Basic Research Program of China (No. 2010CB1264000) and the Base Research Project of Shenzhen Bureau of Science, Technology and Information(JC201006030858A, JCYJ20120618155655087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; BOBERG J, 1992, PROTEINS, V14, P265, DOI 10.1002/prot.340140212; Boisvert S, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-110; Bologna G, 2003, ARTIF INTELL MED, V28, P141, DOI 10.1016/S0933-3657(03)00055-1; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Cai YD, 2003, ANAL BIOCHEM, V268, P407; Cai YD, 2010, MOL CELLS, V30, P99, DOI 10.1007/s10059-010-0093-0; Chen K, 2007, BIOINFORMATICS, V23, P2843, DOI 10.1093/bioinformatics/btm475; Chen W, 2012, GENET MOL RES, V11, P174, DOI 10.4238/2012.January.27.4; Cheng XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038979; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1991, PROTEINS, V9, P280, DOI 10.1002/prot.340090406; Ding CHQ, 2001, BIOINFORMATICS, V17, P349, DOI 10.1093/bioinformatics/17.4.349; Dubchak I, 1999, PROTEINS, V35, P401, DOI 10.1002/(SICI)1097-0134(19990601)35:4<401::AID-PROT3>3.0.CO;2-K; Feng JH, 2012, VLDB J, V21, P437, DOI 10.1007/s00778-011-0252-8; FINKELSTEIN AV, 1987, PROG BIOPHYS MOL BIO, V50, P171, DOI 10.1016/0079-6107(87)90013-7; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; HOBOHM U, 1994, PROTEIN SCI, V3, P522; HOBOHM U, 1992, PROTEIN SCI, V1, P409; Holm L, 1999, NUCLEIC ACIDS RES, V27, P244, DOI 10.1093/nar/27.1.244; Honda M, 2005, J AUTOIMMUN, V25, P133, DOI 10.1016/j.jaut.2005.03.009; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nanni L, 2006, NEUROCOMPUTING, V69, P2434, DOI 10.1016/j.neucom.2006.01.026; Shen HB, 2006, BIOINFORMATICS, V22, P1717, DOI 10.1093/bioinformatics/btl170; Shen HB, 2009, J THEOR BIOL, V256, P441, DOI 10.1016/j.jtbi.2008.10.007; Vendruscolo M, 2005, P NATL ACAD SCI USA, V102, P5641, DOI 10.1073/pnas.0500274102; Zhang W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002325; Zhou ZH, 2002, ARTIF INTELL, V137, P239, DOI 10.1016/S0004-3702(02)00190-X; Zou Q, 2013, J COMPUT THEOR NANOS, V10, P1038, DOI 10.1166/jctn.2013.2804	31	410	418	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56499	10.1371/journal.pone.0056499	http://dx.doi.org/10.1371/journal.pone.0056499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	24278338	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200085
J	Li, YY; Xie, J; Wu, SY; Xia, J; Zhang, PF; Liu, C; Zhang, P; Huang, X				Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi			Protein Kinase Regulated by dsRNA Downregulates the Interferon Production in Dengue Virus- and dsRNA-Stimulated Human Lung Epithelial Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; PKR-DEPENDENT ACTIVATION; CELLULAR ACTIVATOR; RIG-I; BINDING PROTEIN; ADAPTER IPS-1; INDUCTION; INFECTION; TRANSLATION	Background: Dengue virus (DENV) is found in the tropical and subtropical regions and affects millions of people annually. Currently, no specific vaccine or antiviral treatment against dengue virus is available. Innate immunity has been shown to be important for host resistance to DENV infection. Although protein kinase regulated by double-stranded RNA (PKR) has been found to promote the innate signaling in response to infection by several viruses, its role in the innate response to DENV infection is still unclear. Our study aimed to investigate the role of PKR in DENV-induced innate immune responses. Methodology/Principal Findings: By RNAi, silencing of PKR significantly enhanced the expression of interferon (IFN)-beta in DENV infected human lung epithelial A549 cells. Western blot and immunofluorescence microscopy data showed that PKR knockdown upregulated the activation of innate signaling cascades including p38 and JNK mitogen-activated protein kinases (MAPKs), interferon regulatory factor-3 and NF-kappa B, following DENV2 infection. Likewise, a negative regulatory effect of PKR on the IFN production was also observed in poly(IC) challenged cells. Moreover, the PKR knockdown-mediated IFN induction was attenuated by RIG-I or IPS-1 silencing. Finally, overexpression of a catalytically inactive PKR mutant (K296R), but not of a mutant lacking dsRNA binding activity (K64E) or the double mutant (K64EK296R), reversed the IFN induction mediated by PKR knockdown, suggesting that the dsRNA binding activity is required for PKR to downregulate IFN production. Conclusions/Significance: PKR acts as a negative regulator of IFN induction triggered by DENVs and poly(IC), and this regulation relies on its dsRNA binding activity. These findings reveal a novel regulatory role for PKR in innate immunity, suggesting that PKR might be a promising target for anti-DENV treatments.	[Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, P (corresponding author), Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China.	zhangp36@mail.sysu.edu.cn; huangxi6@mail.sysu.edu.cn	Liu, Hongliang/P-3444-2014; Scott, Colin/A-4682-2009; Oakeshott, John/B-5365-2009; Teese, Mark George/B-4307-2008; Chen, Huaping/O-3096-2014	Liu, Hongliang/0000-0001-7639-0904; Scott, Colin/0000-0001-6110-6982; Oakeshott, John/0000-0001-8324-7874; Tollefsbol, Trygve/0000-0002-0284-1511; Li, Yong/0000-0002-3595-6673; Li, Yongwen/0000-0001-6102-2949; Teese, Mark George/0000-0002-8003-4918; HUANG, XI/0000-0002-4829-8390; Song, Yajun/0000-0002-6628-2747; Chen, Huaping/0000-0002-9835-5138; Yang, Xianwei/0000-0003-4388-9674	National Natural Science Foundation of China [30972763, 81261160323, 81171576, 30901345, U0832006]; Guangdong innovative research team program [2009010058]; Guangdong Province Universities and Colleges Pearl River School Funded Scheme [2009]; Guangdong Natural Science Foundation [10251008901000013]; National Basic Research Program of China [2010CB530004]; Doctoral Fund of Ministry of Education of China [20100171110047]; Fundamental Research Funds for the Central Universities of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong innovative research team program; Guangdong Province Universities and Colleges Pearl River School Funded Scheme; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); National Basic Research Program of China(National Basic Research Program of China); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (30972763, 81261160323, 81171576, 30901345, U0832006), Guangdong innovative research team program (NO. 2009010058), Guangdong Province Universities and Colleges Pearl River School Funded Scheme (NO. 2009), Guangdong Natural Science Foundation (10251008901000013), National Basic Research Program of China (2010CB530004), Doctoral Fund of Ministry of Education of China (20100171110047), Fundamental Research Funds for the Central Universities of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Arnaud N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002289; Arnaud N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010575; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; Barry G, 2009, J GEN VIROL, V90, P1382, DOI 10.1099/vir.0.007336-0; Bonnet MC, 2006, CELL SIGNAL, V18, P1865, DOI 10.1016/j.cellsig.2006.02.010; Bonnet MC, 2000, MOL CELL BIOL, V20, P4532, DOI 10.1128/MCB.20.13.4532-4542.2000; Boonyaratanakornkit J, 2011, J VIROL, V85, P1495, DOI 10.1128/JVI.01297-10; Brown MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034055; Cheung BKW, 2005, J IMMUNOL, V175, P7218, DOI 10.4049/jimmunol.175.11.7218; COLTHURST DR, 1987, EUR J BIOCHEM, V166, P357, DOI 10.1111/j.1432-1033.1987.tb13523.x; Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000; Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gil J, 2000, APOPTOSIS, V5, P107, DOI 10.1023/A:1009664109241; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999; Katze Michael G., 1995, Trends in Microbiology, V3, P75, DOI 10.1016/S0966-842X(00)88880-0; Kok KH, 2011, CELL HOST MICROBE, V9, P299, DOI 10.1016/j.chom.2011.03.007; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Langland JO, 1999, BIOCHEMISTRY-US, V38, P6361, DOI 10.1021/bi982410u; Lee YR, 2007, VIRUS RES, V126, P216, DOI 10.1016/j.virusres.2007.03.003; McAllister CS, 2012, J BIOL CHEM, V287, P36384, DOI 10.1074/jbc.M112.390039; McAllister CS, 2010, J VIROL, V84, P380, DOI 10.1128/JVI.02630-08; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Nakayama Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000966; Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; Pereira RMS, 2010, FASEB J, V24, P617, DOI 10.1096/fj.09-140053; Pfaller CK, 2011, CURR OPIN IMMUNOL, V23, P573, DOI 10.1016/j.coi.2011.08.009; Pindel A, 2011, J INTERF CYTOK RES, V31, P59, DOI 10.1089/jir.2010.0099; Porterfield J S, 1980, Med Trop (Mars), V40, P493; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; RUSSELL PK, 1967, J IMMUNOL, V99, P291; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Sadler AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000311; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007; Sen A, 2011, J VIROL, V85, P3717, DOI 10.1128/JVI.02634-10; Silva AM, 2004, J BIOL CHEM, V279, P37670, DOI 10.1074/jbc.M406554200; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; Thomas Stephen J, 2003, Adv Virus Res, V61, P235, DOI 10.1016/S0065-3527(03)61006-7; Tissari J, 2005, J IMMUNOL, V174, P4289, DOI 10.4049/jimmunol.174.7.4289; Umareddy I, 2008, J GEN VIROL, V89, P3052, DOI 10.1099/vir.0.2008/001594-0; Weber F, 2006, J INTERF CYTOK RES, V26, P1, DOI 10.1089/jir.2006.26.1; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07; Zhang P, 2009, J VIROL, V83, P5718, DOI 10.1128/JVI.00224-09; Zhang P, 2008, J BIOL CHEM, V283, P34580, DOI 10.1074/jbc.M807029200	63	321	342	10	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55108	10.1371/journal.pone.0055108	http://dx.doi.org/10.1371/journal.pone.0055108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23342141	Green Published, Green Submitted, gold			2022-12-25	WOS:000315210400065
